PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chang, XF; Izumchenko, E; Solis, LM; Kim, MS; Chatterjee, A; Ling, SZ; Monitto, CL; Harari, PM; Hidalgo, M; Goodman, SN; Wistuba, II; Bedi, A; Sidransky, D				Chang, Xiaofei; Izumchenko, Eugene; Solis, Luisa M.; Kim, Myoung Sook; Chatterjee, Aditi; Ling, Shizhang; Monitto, Constance L.; Harari, Paul M.; Hidalgo, Manuel; Goodman, Steve N.; Wistuba, Ignacio I.; Bedi, Atul; Sidransky, David			The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PHASE-II TRIAL; PANCREATIC-CANCER; ACQUIRED-RESISTANCE; ACTIVATING MUTATIONS; NEGATIVE REGULATOR; GEFITINIB; ERLOTINIB; THERAPY	The sensitivity of only a few tumors to anti-epidermal growth factor receptor EGFR tyrosine kinase inhibitors (TKIs) can be explained by the presence of EGFR tyrosine kinase (TK) domain mutations. In addition, such mutations were rarely found in tumor types other than lung, such as pancreatic and head and neck cancer. In this study we sought to elucidate mechanisms of resistance to EGFR-targeted therapies in tumors that do not harbor TK sensitizing mutations in order to identify markers capable of guiding the decision to incorporate these drugs into chemotherapeutic regimens. Here we show that EGFR activity was markedly decreased during the evolution of resistance to the EGFR tyrosine kinase inhibitor (TKI) erlotinib, with a concomitant increase of mitogen-inducible gene 6 (Mig6), a negative regulator of EGFR through the upregulation of the PI3K-AKT pathway. EGFR activity, which was more accurately predicted by the ratio of Mig6/EGFR, highly correlated with erlotinib sensitivity in panels of cancer cell lines of different tissue origins. Blinded testing and analysis in a prospectively followed cohort of lung cancer patients treated with gefitinib alone demonstrated higher response rates and a marked increased in progression free survival for patients with a low Mig6/EGFR ratio (approximately 100 days, P = 0.01).	[Chang, Xiaofei; Izumchenko, Eugene; Kim, Myoung Sook; Chatterjee, Aditi; Bedi, Atul; Sidransky, David] Johns Hopkins Univ, Div Head & Neck Canc Res, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Solis, Luisa M.; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Solis, Luisa M.; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Ling, Shizhang] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Monitto, Constance L.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Harari, Paul M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI USA; [Hidalgo, Manuel] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Hidalgo, Manuel] Ctr Intregral Oncol Clara Campal, Madrid, Spain; [Goodman, Steve N.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Sidransky, D (corresponding author), Johns Hopkins Univ, Div Head & Neck Canc Res, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA.	dsidrans@jhmi.edu	Ling, Shizhang/J-6114-2014; HIDALGO, MANUEL/I-4995-2015	Ling, Shizhang/0000-0002-6856-3577; HIDALGO, MANUEL/0000-0002-3765-3318; Goodman, Steven/0000-0002-3872-5723	NIH [P50 DE019032, U01 CA084986, R37DE012588]; FAMRI [072017_YCSA]; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032, R37DE012588] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAMRI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work as supported by NIH grants SPORE (P50 DE019032) and EDRN U01 CA084986, R37DE012588 (www.nih.gov), and FAMRI-funded 072017_YCSA (http://www.famri.org/intro/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; Benavente S, 2009, CLIN CANCER RES, V15, P1585, DOI 10.1158/1078-0432.CCR-08-2068; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020806; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Harsha HC, 2008, J PROTEOME RES, V7, P4651, DOI 10.1021/pr800139r; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; Jimeno A, 2007, MOL CANCER THER, V6, P1079, DOI 10.1158/1535-7163.MCT-06-0448; Lemos-Gonzalez Y, 2007, TUMOR BIOL, V28, P273, DOI 10.1159/000110425; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massarelli E, 2007, CLIN CANCER RES, V13, P2890, DOI 10.1158/1078-0432.CCR-06-3043; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Parra HS, 2004, BRIT J CANCER, V91, P208, DOI 10.1038/sj.bjc.6601923; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Travis WD, 2004, SEM RESP CRIT CARE M, V25, P475, DOI 10.1055/s-2004-836141; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tzeng CWD, 2007, SURGERY, V141, P464, DOI 10.1016/j.surg.2006.09.009; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Yamasaki F, 2007, CANCER RES, V67, P5779, DOI 10.1158/0008-5472.CAN-06-3020; Ying HQ, 2010, P NATL ACAD SCI USA, V107, P6912, DOI 10.1073/pnas.0914930107; Zhang S, 2011, NAT MED; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	34	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68966	10.1371/journal.pone.0068966	http://dx.doi.org/10.1371/journal.pone.0068966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935914	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700014
J	Holt, RJ; Lefevre, AS; Flatters, IJ; Culmer, P; Wilkie, RM; Henson, BW; Bingham, GP; Mon-Williams, M				Holt, Raymond J.; Lefevre, Alexis S.; Flatters, Ian J.; Culmer, Pete; Wilkie, Richard M.; Henson, Brian W.; Bingham, Geoff P.; Mon-Williams, Mark			Grasping the Changes Seen in Older Adults When Reaching for Objects of Varied Texture	PLOS ONE			English	Article							GRIP STRENGTH; HAND FUNCTION; AGE; PREHENSION; COORDINATION	Old age is associated with reduced mobility of the hand. To investigate age related decline when reaching-to-lift an object we used sophisticated kinematic apparatus to record reaches carried out by healthy older and younger participants. Three objects of different widths were placed at three different distances, with objects having either a high or low friction surface (i.e. rough or slippery). Older participants showed quantitative differences to their younger counterparts - movements were slower and peak speed did not scale with object distance. There were also qualitative differences with older adults showing a greater propensity to stop the hand and adjust finger position before lifting objects. The older participants particularly struggled to lift wide slippery objects, apparently due to an inability to manipulate their grasp to provide the level of precision necessary to functionally enclose the object. These data shed light on the nature of age related changes in reaching-to-grasp movements and establish a powerful technique for exploring how different product designs will impact on prehensile behavior.	[Holt, Raymond J.; Lefevre, Alexis S.; Flatters, Ian J.; Culmer, Pete; Henson, Brian W.] Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England; [Flatters, Ian J.; Wilkie, Richard M.; Mon-Williams, Mark] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Bingham, Geoff P.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Leeds; University of Leeds; Indiana University System; Indiana University Bloomington	Holt, RJ (corresponding author), Univ Leeds, Sch Mech Engn, Leeds, W Yorkshire, England.	R.J.Holt@leeds.ac.uk	Wilkie, Richard M./G-5977-2012	Wilkie, Richard M./0000-0003-4299-7171; Culmer, Pete/0000-0003-2867-0420; Holt, Raymond/0000-0002-1614-5795; Mon-Williams, Mark/0000-0001-7595-8545; Flatters, Ian John/0000-0002-3789-0487	Engineering and Physical Sciences Research Council; White Rose Consortium PhD Studentship Network Grant	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); White Rose Consortium PhD Studentship Network Grant	This study was funded by an Engineering and Physical Sciences Research Council Collaboration Fund obtained by BH, RW, PC, and MMW. ASL is funded through a White Rose Consortium PhD Studentship Network Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Bril B, 2010, J EXP PSYCHOL HUMAN, V36, P825, DOI 10.1037/a0018171; Christou EA, 2011, AGE, V33, P393, DOI 10.1007/s11357-010-9190-4; Flatters IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032770; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Gilles MA, 2003, J MOTOR BEHAV, V35, P79, DOI 10.1080/00222890309602123; HACKEL ME, 1992, PHYS THER, V72, P373, DOI 10.1093/ptj/72.5.373; IBERALL T, 1986, EXPT BRAIN RES SERIE, V15, P158; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; MAHONEY F I, 1965, Md State Med J, V14, P61; Marmon AR, 2011, MED SCI SPORT EXER, V43, P560, DOI 10.1249/MSS.0b013e3181f3f3ab; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Metcalf CD, 2008, HAND THER, V13, P79; Mon-Williams M, 2001, CURR BIOL, V11, P1058, DOI 10.1016/S0960-9822(01)00293-7; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Munro H, 2007, EXP BRAIN RES, V183, P249, DOI 10.1007/s00221-007-1040-y; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Nouri F, 1987, CLIN REHABIL, V1, P233; Raw RK, 2012, J EXP PSYCHOL HUMAN, V38, P735, DOI 10.1037/a0026568; Rosenbaum DA, 1999, EXP BRAIN RES, V128, P92, DOI 10.1007/s002210050823; Shechtman O, 2004, AM J PHYS MED REHAB, V83, P819, DOI 10.1097/01.PHM.0000143398.00788.4E; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; TURVEY MT, 1981, COGNITION, V9, P237, DOI 10.1016/0010-0277(81)90002-0; van Bergen E, 2007, EXP BRAIN RES, V178, P180, DOI 10.1007/s00221-006-0722-1; van Swieten LM, 2010, J EXP PSYCHOL HUMAN, V36, P493, DOI 10.1037/a0017177	27	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69040	10.1371/journal.pone.0069040	http://dx.doi.org/10.1371/journal.pone.0069040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23935918	gold, Green Published			2022-12-27	WOS:000322633700016
J	Acevedo, P; Romero, B; Vicente, J; Caracappa, S; Galluzzo, P; Marineo, S; Vicari, D; Torina, A; Casal, C; de la Fuente, J; Gortazar, C				Acevedo, Pelayo; Romero, Beatriz; Vicente, Joaquin; Caracappa, Santo; Galluzzo, Paola; Marineo, Sandra; Vicari, Domenico; Torina, Alessandra; Casal, Carmen; de la Fuente, Jose; Gortazar, Christian			Tuberculosis Epidemiology in Islands: Insularity, Hosts and Trade	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; MOLECULAR CHARACTERIZATION; SPOLIGOTYPE DIVERSITY; BEIJING GENOTYPE; CLONAL COMPLEX; RISK-FACTORS; SUS-SCROFA; WILD BOAR; BIOGEOGRAPHY; CATTLE	Because of their relative simplicity and the barriers to gene flow, islands are ideal systems to study the distribution of biodiversity. However, the knowledge that can be extracted from this peculiar ecosystem regarding epidemiology of economically relevant diseases has not been widely addressed. We used information available in the scientific literature for 10 old world islands or archipelagos and original data on Sicily to gain new insights into the epidemiology of the Mycobacterium tuberculosis complex (MTC). We explored three nonexclusive working hypotheses on the processes modulating bovine tuberculosis (bTB) herd prevalence in cattle and MTC strain diversity: insularity, hosts and trade. Results suggest that bTB herd prevalence was positively correlated with island size, the presence of wild hosts, and the number of imported cattle, but neither with isolation nor with cattle density. MTC strain diversity was positively related with cattle bTB prevalence, presence of wild hosts and the number of imported cattle, but not with island size, isolation, and cattle density. The three most common spoligotype patterns coincided between Sicily and mainland Italy. However in Sicily, these common patterns showed a clearer dominance than on the Italian mainland, and seven of 19 patterns (37%) found in Sicily had not been reported from continental Italy. Strain patterns were not spatially clustered in Sicily. We were able to infer several aspects of MTC epidemiology and control in islands and thus in fragmented host and pathogen populations. Our results point out the relevance of the intensity of the cattle commercial networks in the epidemiology of MTC, and suggest that eradication will prove more difficult with increasing size of the island and its environmental complexity, mainly in terms of the diversity of suitable domestic and wild MTC hosts.	[Acevedo, Pelayo] Ctr Recerca Sanitat Anim, Bellaterra, Cerdanyola Del, Spain; [Acevedo, Pelayo; Vicente, Joaquin; de la Fuente, Jose; Gortazar, Christian] Univ Castilla La Mancha, SaBio IREC, CSIC, Junta Comunidades Castilla La Mancha, E-13071 Ciudad Real, Spain; [Acevedo, Pelayo] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, InBio Lab Associado, Vairao, Portugal; [Romero, Beatriz; Casal, Carmen] Univ Complutense Madrid, Ctr Vigilancia Sanitaria Vet, Sch Vet, Madrid, Spain; [Caracappa, Santo; Galluzzo, Paola; Marineo, Sandra; Vicari, Domenico; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia, Palermo, Italy; [de la Fuente, Jose] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade do Porto; Complutense University of Madrid; IZS Sicilia; Oklahoma State University System; Oklahoma State University - Stillwater	Acevedo, P (corresponding author), Ctr Recerca Sanitat Anim, Campus Univ Autonoma Barcelona IRTA, Bellaterra, Cerdanyola Del, Spain.	pacevedo@irec.csic.es	Galluzzo, Paola/D-9494-2016; Acevedo, Pelayo/L-6737-2013; Marineo, Sandra/P-8649-2015; Casal Comendador, Carmen/E-8998-2016; Caracappa, Santo/P-8657-2015; Gortazar, Christian/E-7918-2012; Torina, Alessandra/I-3029-2016; Romero, Beatriz/J-5942-2015; Vicari, Domenico/H-3440-2016; Vicente, Joaquin/K-7822-2013	Galluzzo, Paola/0000-0003-1766-5327; Acevedo, Pelayo/0000-0002-3509-7696; Marineo, Sandra/0000-0002-0771-8416; Casal Comendador, Carmen/0000-0003-2433-2870; Caracappa, Santo/0000-0002-7218-1408; Gortazar, Christian/0000-0003-0012-4006; Torina, Alessandra/0000-0003-1555-8309; Romero, Beatriz/0000-0001-5263-1806; Vicari, Domenico/0000-0002-8902-6383; Vicente, Joaquin/0000-0001-8416-3672	EU [278976 ANTIGONE, FAU2008-00004-C03]; Beatriu de Pinos fellowship; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya; COFUND Programme-Marie Curie Actions under 7th Framework Programme of the European Community; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/90320/2012]; European Social Fund	EU(European Commission); Beatriu de Pinos fellowship; "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya(Generalitat de Catalunya); COFUND Programme-Marie Curie Actions under 7th Framework Programme of the European Community; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF))	This is a contribution to the EU FP7 grant number 278976 ANTIGONE and the research project FAU2008-00004-C03. PA was supported by a Beatriu de Pinos fellowship funded by "Comissionat per a Universitats i Recerca del Departament d'Innovacio, Universitats i Empresa'' of the Generalitat de Catalunya, and the COFUND Programme-Marie Curie Actions under 7th Framework Programme of the European Community. PA is currently funded from the SFRH/BPD/90320/2012 post-doctoral grant by Portuguese Fundacao para a Ciencia e a Tecnologia and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2012, NATURWISSENSCHAFTEN, V99, P515, DOI 10.1007/s00114-012-0926-0; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANSES, 2010, INTERNAL REPORT; Apanius V, 2000, ECOLOGY, V81, P1959, DOI 10.1890/0012-9658(2000)081[1959:IATEIP]2.0.CO;2; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Baldi A, 2003, GLOBAL ECOL BIOGEOGR, V12, P1, DOI 10.1046/j.1466-822X.2003.00323.x; Benjamin S, 2007, SICILY 3000 YEARS HU; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Bowman DD, 2006, VET PARASITOL, V139, P293, DOI 10.1016/j.vetpar.2006.04.020; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caracappa S., 1999, Parassitologia (Rome), V41, P17; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; de Bellocq JG, 2002, ECOGRAPHY, V25, P173, DOI 10.1034/j.1600-0587.2002.250205.x; de Bellocq JG, 2003, PARASITOL RES, V90, P64, DOI 10.1007/s00436-002-0806-1; Di Marco V, 2012, J CLIN MICROBIOL, V50, P1209, DOI 10.1128/JCM.06544-11; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Durr PA, 2000, REV SCI TECH OIE, V19, P675, DOI 10.20506/rst.19.3.1241; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fromont E, 2001, PARASITOLOGY, V123, P143, DOI 10.1017/S0031182001008277; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Gomez-Tejedor C, 2004, VETER ITAL SER, V40, P57; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; Gortazar C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-27; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Hartley M, 2010, EUR J WILDLIFE RES, V56, P401, DOI 10.1007/s10344-009-0334-8; Humblet MF, 2010, J CLIN MICROBIOL, V48, P2802, DOI 10.1128/JCM.00293-10; Ishtiaq F, 2010, J BIOGEOGR, V37, P120, DOI 10.1111/j.1365-2699.2009.02189.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Krebs J., 1997, PB3423 HMSO; KURIS AM, 1980, AM NAT, V116, P570, DOI 10.1086/283647; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Margalef R., 1957, GEN SYST, V3, P36, DOI DOI 10.12691/AJSS-2-5-1; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Matos F, 2010, VET MED-CZECH, V55, P133, DOI 10.17221/137/2009-VETMED; McCullagh P, 1989, MONOGRAPHS STAT APPL, V37, P1, DOI DOI 10.1007/978-1-4899-3242-6; Mertzanidou D, 2008, IUCN RED LIST THREAT, V2008, DOI [10.2305/IUCN.UK.2008.RLTS.T42188A10656554.en, DOI 10.2305/IUCN.UK.2008.RLTS.T42188A10656554.EN]; Meyer RM, 1998, P 102 ANN M US AN HL; Millet J, 2007, J CLIN MICROBIOL, V45, P3606, DOI 10.1128/JCM.00348-07; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; OREILLY LM, 1995, TUBERCLE LUNG DIS, V76, P1, DOI 10.1016/0962-8479(95)90591-X; Poulin R, 2004, BASIC APPL ECOL, V5, P423, DOI 10.1016/j.baae.2004.08.003; Reperant LA, 2010, VECTOR-BORNE ZOONOT, V10, P105, DOI 10.1089/vbz.2008.0208; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P866, DOI 10.1016/j.meegid.2011.09.004; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Scheiner SM, 2009, ECOHEALTH, V6, P483, DOI 10.1007/s10393-010-0298-x; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Smith G. C., 2009, MANAGEMENT DIS WILD; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2012, INFECT GENET EVOL, V12, P857, DOI 10.1016/j.meegid.2011.09.007; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Smith NH, 2011, INFECT GENET EVOL, V11, P1340, DOI 10.1016/j.meegid.2011.04.027; Vellend M, 2003, AM NAT, V162, P358, DOI 10.1086/377189; WALTHER BA, 1995, PARASITOL TODAY, V11, P306, DOI 10.1016/0169-4758(95)80047-6; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Wilson CJ, 2003, MAMMAL REV, V33, P302, DOI 10.1046/j.1365-2907.2003.00016.x; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	71	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71074	10.1371/journal.pone.0071074	http://dx.doi.org/10.1371/journal.pone.0071074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923053	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700225
J	Ding, JG; Chen, BW; Xia, XJ; Mao, WH; Shi, K; Zhou, YH; Yu, JQ				Ding, Jiangang; Chen, Biwei; Xia, Xiaojian; Mao, Weihua; Shi, Kai; Zhou, Yanhong; Yu, Jingquan			Cytokinin-Induced Parthenocarpic Fruit Development in Tomato Is Partly Dependent on Enhanced Gibberellin and Auxin Biosynthesis	PLOS ONE			English	Article							LAGENARIA-LEUCANTHA; CROSS-TALK; HORMONAL-REGULATION; SET; GROWTH; POLLINATION; ARABIDOPSIS; GA; N-(2-CHLORO-4-PYRIDYL)-N'-PHENYLUREA; PERSPECTIVE	Fruit set of plants largely depends on the biosynthesis and crosstalk of phytohormones. To date the role of cytokinins (CKs) in the fruit development is less understood. Here, we showed that parthenocarpic fruit could be induced by 1-(2-chloro-4-pyridyl)-3-phenylurea (CPPU, an active CK) in tomato (Solanum lycopersicum cv. Micro-Tom). The fresh weight of CPPU-induced parthenocarpic fruits was comparable with that induced by GA(3). Importantly, CPPU-induced parthenocarpy was found to be compromised by simultaneous application of paclobutrazol (a GA biosynthesis inhibitor), and this effect could be restored by exogenous GA(3). Like pollination, CPPU-induced fruit showed enhanced accumulation of GA(1+3) and indole-3-acetic (IAA), which were accompanied by elevated expression of GA biosynthesis genes like SlGPS, SlGA20ox1, SlGA20ox2 and SlGA3ox1, and IAA biosynthesis gene ToFZY. Elevated GAs level in CPPU-induced fruits was also associated with down-regulation of GA inactivation genes, namely SlGA2ox1,2,3,4,5 in comparison with untreated control. These results suggested that CKs may induce parthenocarpy in tomato partially through modulation of GA and IAA metabolisms.	[Ding, Jiangang; Chen, Biwei; Xia, Xiaojian; Mao, Weihua; Shi, Kai; Zhou, Yanhong; Yu, Jingquan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Jingquan] Minist Agr, Key Lab Hort Plants Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Ding, Jiangang] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs; Southwest University of Science & Technology - China	Zhou, YH (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	yanhongzhou@zju.edu.cn	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165	National Basic Research Program of China [2009CB119000]; Program for New Century Excellent Talents in University; Fok Ying-Tong Education Foundation [132024]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by the National Basic Research Program of China (2009CB119000), the Program for New Century Excellent Talents in University, and the Fok Ying-Tong Education Foundation (132024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOHNER J, 1988, PLANT GROWTH REGUL, V7, P141; Bourdon M, 2010, PROG BOT, V71, P101, DOI 10.1007/978-3-642-02167-1_4; Serrani JC, 2007, PLANT PHYSIOL, V145, P246, DOI 10.1104/pp.107.098335; Serrani JC, 2010, PLANT PHYSIOL, V153, P851, DOI 10.1104/pp.110.155424; Chandler JW, 2011, J PLANT GROWTH REGUL, V30, P242, DOI 10.1007/s00344-010-9180-x; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; Fos M, 2000, PLANT PHYSIOL, V122, P471, DOI 10.1104/pp.122.2.471; Fos M, 2001, PHYSIOL PLANTARUM, V111, P545, DOI 10.1034/j.1399-3054.2001.1110416.x; Fu FQ, 2008, J EXP BOT, V59, P2299, DOI 10.1093/jxb/ern093; Fujisawa Hiroyuki, 2011, JOURNAL OF AGRICULTURAL SCIENCE TOKYO NOGYO DAIGAKU, V56, P118; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Greenboim-Wainberg Y, 2005, PLANT CELL, V17, P92, DOI 10.1105/tpc.104.028472; Hirano K, 2008, TRENDS PLANT SCI, V13, P192, DOI 10.1016/j.tplants.2008.02.005; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Koiwai Masaru, 2012, Horticultural Research (Japan), V11, P87, DOI 10.2503/hrj.11.87; Lewis DH, 1996, PHYSIOL PLANTARUM, V98, P187, DOI [10.1111/j.1399-3054.1996.tb00691.x, 10.1034/j.1399-3054.1996.980123.x]; Li Y, 2003, J EXP BOT, V54, P1245, DOI 10.1093/jxb/erg124; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAPELLI S, 1981, PLANT SCI LETT, V22, P227, DOI 10.1016/0304-4211(81)90235-2; Mariotti L, 2011, J PLANT GROWTH REGUL, V30, P405, DOI 10.1007/s00344-011-9204-1; Martinelli F, 2009, J EXP BOT, V60, P3873, DOI 10.1093/jxb/erp227; Nitsch L, 2012, J PLANT PHYSIOL, V169, P878, DOI 10.1016/j.jplph.2012.02.004; Ohara H, 1997, J JPN SOC HORTIC SCI, V65, P692; Olimpieri I, 2007, PLANTA, V226, P877, DOI 10.1007/s00425-007-0533-z; Rebers M, 1999, PLANT J, V17, P241, DOI 10.1046/j.1365-313X.1999.00366.x; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; Serrani JC, 2007, J PLANT GROWTH REGUL, V26, P211, DOI 10.1007/s00344-007-9014-7; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Trueman SJ, 2010, AFR J AGR RES, V5, P3402; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Yu JQ, 1999, ENVIRON EXP BOT, V42, P121, DOI 10.1016/S0098-8472(99)00025-8; Yu JQ, 2001, J HORTIC SCI BIOTECH, V76, P231; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946	40	47	57	8	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70080	10.1371/journal.pone.0070080	http://dx.doi.org/10.1371/journal.pone.0070080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922914	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700131
J	Patel, BA; Horner, AM; Thompson, NE; Barrett, L; Henzi, SP				Patel, Biren A.; Horner, Angela M.; Thompson, Nathan E.; Barrett, Louise; Henzi, S. Peter			Ontogenetic Scaling of Fore- and Hind Limb Posture in Wild Chacma Baboons (Papio hamadryas ursinus)	PLOS ONE			English	Article							MUSCULOSKELETAL DESIGN; ERYTHROCEBUS-PATAS; SYMMETRICAL GAITS; BONE GEOMETRY; CEBUS-APELLA; PRIMATE; MONKEYS; TERRESTRIAL; SPEED; LOCOMOTION	Large-scale interspecific studies of mammals ranging between 0.04-280 kg have shown that larger animals walk with more extended limb joints. Within a taxon or clade, however, the relationship between body size and joint posture is less straightforward. Factors that may affect the lack of congruence between broad and narrow phylogenetic analyses of limb kinematics include limited sampling of (1) ranges of body size, and/or (2) numbers of individuals. Unfortunately, both issues are inherent in laboratory-based or zoo locomotion research. In this study, we examined the relationship between body mass and elbow and knee joint angles (our proxies of fore- and hind limb posture, respectively) in a cross-sectional ontogenetic sample of wild chacma baboons (Papio hamadryas ursinus) habituated in the De Hoop Nature Reserve, South Africa. Videos were obtained from 33 individuals of known age (12 to >= 108 months) and body mass (2-29.5 kg) during walking trials. Results show that older, heavier baboons walk with significantly more extended knee joints but not elbow joints. This pattern is consistent when examining only males, but not within the female sample. Heavier, older baboons also display significantly less variation in their hind limb posture compared to lighter, young animals. Thus, within this ontogenetic sample of a single primate species spanning an order of magnitude in body mass, hind limb posture exhibited a postural scaling phenomenon while the forelimbs did not. These findings may further help explain 1) why younger mammals (including baboons) tend to have relatively stronger bones than adults, and 2) why humeri appear relatively weaker than femora (in at least baboons). Finally, this study demonstrates how field-acquired kinematics can help answer fundamental biomechanical questions usually addressed only in animal gait laboratories.	[Patel, Biren A.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Horner, Angela M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Thompson, Nathan E.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Barrett, Louise; Henzi, S. Peter] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Barrett, Louise; Henzi, S. Peter] Univ S Africa, Appl Behav Ecol & Ecosyst Res Unit, Florida, South Africa	University of Southern California; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Lethbridge; University of South Africa	Patel, BA (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	birenpat@usc.edu	Patel, Biren/B-8373-2016	Thompson, Nathan/0000-0002-9273-3636; Henzi, Peter/0000-0001-6175-1674	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was funded by a National Research Foundation of South Africa grant to S. P. Henzi (http://www.nrf.ac.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Altmann J, 2001, BABOON MOTHERS INFAN; ALTMANN SA, 1987, J ZOOL, V211, P215, DOI 10.1111/j.1469-7998.1987.tb01530.x; [Anonymous], 1999, WALKERS MAMMALS WORL; Barrett L, 2004, J HUM EVOL, V46, P215, DOI 10.1016/j.jhevol.2003.11.005; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; BIEWENER AA, 1991, J BIOMECH, V24, P19, DOI 10.1016/0021-9290(91)90374-V; Brassey CA, 2013, ANAT REC, V296, P395, DOI 10.1002/ar.22658; Busse C., 1980, Botswana Notes and Records, V12, P15; Carlson KJ, 2005, AM J PHYS ANTHROPOL, V127, P312, DOI 10.1002/ajpa.20124; CARRIER DR, 1983, J ZOOL, V201, P27; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; DEMES B, 1994, J HUM EVOL, V26, P353, DOI 10.1006/jhev.1994.1023; Franz TM, 2005, J HUM EVOL, V48, P199, DOI 10.1016/j.jhevol.2004.11.004; Galilei G, 1638, DIALOGUES 2 NEW SPEC; Gray J., 1968, ANIMAL LOCOMOTION; HAUSFATER G, 1977, FOLIA PRIMATOL, V27, P41, DOI 10.1159/000155775; Heinrich RE, 1999, J ZOOL, V247, P215, DOI 10.1017/S0952836999002095; Henzi SP, 2005, J ZOOL, V265, P215, DOI 10.1017/S0952836904006399; Henzi SP, 1998, ANIM BEHAV, V55, P1421, DOI 10.1006/anbe.1997.0716; HENZI SP, 1992, INT J PRIMATOL, V13, P601, DOI 10.1007/BF02551256; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; Isbell LA, 1998, AM J PHYS ANTHROPOL, V105, P199, DOI 10.1002/(SICI)1096-8644(199802)105:2<199::AID-AJPA7>3.0.CO;2-Q; Kimura T., 1979, P297; Lammers AR, 2002, J ZOOL, V258, P485, DOI 10.1017/S0952836902001644; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Larson SG, 2001, J ZOOL, V255, P353, DOI 10.1017/S0952836901001455; Larson SG, 2000, AM J PHYS ANTHROPOL, V112, P87, DOI 10.1002/(SICI)1096-8644(200005)112:1<87::AID-AJPA9>3.0.CO;2-B; Nekaris KAI, 2007, AM J PRIMATOL, V69, P112, DOI 10.1002/ajp.20331; Osborn HF, 1900, AM NAT, V34, P89, DOI 10.1086/277565; Patel BA, 2010, INT J PRIMATOL, V31, P191, DOI 10.1007/s10764-010-9394-6; Patel BA, 2010, ANAT REC, V293, P710, DOI 10.1002/ar.21128; Patel BA, 2010, AM J PHYS ANTHROPOL, V141, P222, DOI 10.1002/ajpa.21138; Patel BA, 2009, AM J PHYS ANTHROPOL, V140, P92, DOI 10.1002/ajpa.21039; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Polk JD, 2002, J EXP BIOL, V205, P3399; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; POLK JD, 2001, THESIS SUNY STONY BR; Polk JD, 2009, AM J PHYS ANTHROPOL, V140, P359, DOI 10.1002/ajpa.21083; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Raichlen DA, 2005, J HUM EVOL, V49, P415, DOI 10.1016/j.jhevol.2005.05.004; Raichlen DA, 2004, THESIS U TEXAS AUSTI; Ron T, 1996, BEHAVIOUR, V133, P475, DOI 10.1163/156853996X00549; ROSE M C, 1977, Primates, V18, P59, DOI 10.1007/BF02382953; RUBIN CT, 1982, J EXP BIOL, V101, P187; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Ruff C, 2003, J HUM EVOL, V45, P317, DOI 10.1016/j.jhevol.2003.08.006; Schmitt D, 2004, J HUM EVOL, V46, P239, DOI 10.1016/j.jhevol.2003.11.008; Schmitt D, 2011, DEV PRIMATOL-PROG PR, P7, DOI 10.1007/978-1-4419-1420-0_2; Shapiro LJ, 2011, DEV PRIMATOL-PROG PR, P335, DOI 10.1007/978-1-4419-1420-0_17; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Stevens NJ, 2006, AM J PHYS ANTHROPOL, V129, P399, DOI 10.1002/ajpa.20359; VILENSKY JA, 1990, AM J PHYS ANTHROPOL, V81, P441, DOI 10.1002/ajpa.1330810313; Wallace IJ, 2008, J HUM EVOL, V54, P783, DOI 10.1016/j.jhevol.2007.10.008; Wang Q, 2012, DEV PRIMATOL-PROG PR, P177, DOI 10.1007/978-1-4614-1046-1_8; Wells JP, 2001, AM J PHYS ANTHROPOL, V115, P80, DOI 10.1002/ajpa.1059; Young JW, 2012, J HUM EVOL, V62, P473, DOI 10.1016/j.jhevol.2012.01.003; Young JW, 2010, BIOL LETTERS, V6, P197, DOI 10.1098/rsbl.2009.0773; Young JW, 2009, J EXP BIOL, V212, P1576, DOI 10.1242/jeb.025460; Zeininger A, 2009, AM J PHYS ANTHROPOL, P279	62	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71020	10.1371/journal.pone.0071020	http://dx.doi.org/10.1371/journal.pone.0071020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923046	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700220
J	Pentheroudakis, G; Kotoula, V; Eleftheraki, AG; Tsolaki, E; Wirtz, RM; Kalogeras, KT; Batistatou, A; Bobos, M; Dimopoulos, MA; Timotheadou, E; Gogas, H; Christodoulou, C; Papadopoulou, K; Efstratiou, I; Scopa, CD; Papaspyrou, I; Vlachodimitropoulos, D; Linardou, H; Samantas, E; Pectasides, D; Pavlidis, N; Fountzilas, G				Pentheroudakis, George; Kotoula, Vassiliki; Eleftheraki, Anastasia G.; Tsolaki, Eleftheria; Wirtz, Ralph M.; Kalogeras, Konstantine T.; Batistatou, Anna; Bobos, Mattheos; Dimopoulos, Meletios A.; Timotheadou, Eleni; Gogas, Helen; Christodoulou, Christos; Papadopoulou, Kyriaki; Efstratiou, Ioannis; Scopa, Chrisoula D.; Papaspyrou, Irene; Vlachodimitropoulos, Dimitrios; Linardou, Helena; Samantas, Epaminontas; Pectasides, Dimitrios; Pavlidis, Nicholas; Fountzilas, George			Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)	PLOS ONE			English	Article							PATHOLOGISTS GUIDELINE RECOMMENDATIONS; IN-SITU HYBRIDIZATION; ESTROGEN-RECEPTOR; AMERICAN-SOCIETY	Background: Discrepant data have been published on the incidence and prognostic significance of ESR1 gene amplification in early breast cancer. Patients and Methods: Formalin-fixed paraffin-embedded tumor blocks were collected from women with early breast cancer participating in two HeCOG adjuvant trials. Messenger RNA was studied by quantitative PCR, ER protein expression was centrally assessed using immunohistochemistry (IHC) and ESR1 gene copy number by dual fluorescent in situ hybridization probes. Results: In a total of 1010 women with resected node-positive early breast adenocarcinoma, the tumoral ESR1/CEP6 gene ratio was suggestive of deletion in 159 (15.7%), gene gain in 551 (54.6%) and amplification in 42 cases (4.2%), with only 30 tumors (3%) harboring five or more ESR1 copies. Gene copy number ratio showed a significant, though weak correlation to mRNA and protein expression (Spearman's Rho <0.23, p = 0.01). ESR1 clusters were observed in 9.5% (57 gain, 38 amplification) of cases. In contrast to mRNA and protein expression, which were favorable prognosticators, gene copy number changes did not obtain prognostic significance. When ESR1/CEP6 gene ratio was combined with function (as defined by ER protein and mRNA expression) in a molecular classifier, the Gene Functional profile, it was functional status that impacted on prognosis. In univariate analysis, patients with functional tumors (positive ER protein expression and gene ratio normal or gain/amplification) fared better than those with non-functional tumors with ESR1 gain (HR for relapse or death 0.49-0.64, p = 0.003). Significant interactions were observed between gene gain/amplification and paclitaxel therapy (trend for DFS benefit from paclitaxel only in patients with ESR1 gain/amplification, p = 0.066) and Gene Functional profile with HER2 amplification (Gene Functional profile prognostic only in HER2-normal cases, p = 0.029). Conclusions: ESR1 gene deletion and amplification do not constitute per se prognostic markers, instead they can be classified to distinct prognostic groups according to their protein-mediated functional status.	[Pentheroudakis, George; Pavlidis, Nicholas] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Kotoula, Vassiliki; Papadopoulou, Kyriaki] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Eleftheraki, Anastasia G.] Data Off, Hellen Cooperat Oncol Grp, Sect Biostat, Athens, Greece; [Tsolaki, Eleftheria; Bobos, Mattheos] Aristotle Univ Thessaloniki, Sch Med, Hellen Fdn Canc Res, Mol Oncol Lab, GR-54006 Thessaloniki, Greece; [Wirtz, Ralph M.] Stratifyer Mol Pathol GmbH, Cologne, Germany; [Kalogeras, Konstantine T.; Timotheadou, Eleni; Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Kalogeras, Konstantine T.] Data Off, Hellen Cooperat Oncol Grp, Translat Res Sect, Athens, Greece; [Batistatou, Anna] Ioannina Univ Hosp, Dept Pathol, Ioannina, Greece; [Dimopoulos, Meletios A.] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece; [Gogas, Helen] Univ Athens, Sch Med, Laiko Gen Hosp, Dept Med 1, GR-11527 Athens, Greece; [Christodoulou, Christos] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Efstratiou, Ioannis] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Scopa, Chrisoula D.] Univ Patras, Sch Med, Univ Hosp, Dept Pathol, GR-26110 Patras, Greece; [Papaspyrou, Irene] Alexandra Hosp, Dept Pathol, Athens, Greece; [Vlachodimitropoulos, Dimitrios] Univ Athens, Sch Med, Evgenid Hosp, Pathol Lab, GR-10679 Athens, Greece; [Linardou, Helena] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Samantas, Epaminontas] Agii Anargiri Canc Hosp, Dept Med Oncol 3, Athens, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece	University Hospital Ioannina; Aristotle University of Thessaloniki; Hellenic Cooperative Oncology Group; Aristotle University of Thessaloniki; Stratifyer Molecular Pathology GmbH; Aristotle University of Thessaloniki; Papageorgiou Hospital; Hellenic Cooperative Oncology Group; University Hospital Ioannina; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; University of Patras; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Hippokration General Hospital	Pentheroudakis, G (corresponding author), Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece.	gpenther@otenet.gr	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Fountzilas, George/ABF-2139-2020; Bobos, Mattheos/L-5702-2019; TIMOTHEADOU, ELENI/AAM-6301-2020	Bobos, Mattheos/0000-0001-5662-9201; Linardou, Helena/0000-0002-2906-6607; Papadopoulou, Kyriaki/0000-0003-0389-4209; Vlachodimitropoulos, Dimitris/0000-0002-8720-9960; Dimopoulos, Meletios/0000-0001-8990-3254; ELEFTHERAKI, ANASTASIA/0000-0003-1826-4699; Fountzilas, George/0000-0001-8045-2186	Hellenic Foundation for Cancer Research	Hellenic Foundation for Cancer Research	Funded by Hellenic Foundation for Cancer Research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Brown LA, 2008, NAT GENET, V40, P806, DOI 10.1038/ng0708-806; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Fountzilas G, 2011, ANTICANCER RES, V31, P3007; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Horlings HM, 2008, NAT GENET, V40, P807, DOI 10.1038/ng0708-807; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Moelans CB, 2011, CELL ONCOL, V34, P475, DOI 10.1007/s13402-011-0043-7; Moelans CB, 2010, CELL ONCOL; Nielsen KV, 2011, BREAST CANCER RES TR, V127, P345, DOI 10.1007/s10549-010-0984-y; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Pentheroudakis G, 2009, BREAST CANCER RES TR, V116, P131, DOI 10.1007/s10549-008-0144-9; Reis-Filho JS, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809b; Tomita S, 2009, CANCER SCI, V100, P1012, DOI 10.1111/j.1349-7006.2009.01145.x; Trudeau M, 2005, LANCET ONCOL, V6, P886, DOI 10.1016/S1470-2045(05)70424-1; Umemura S, 2004, APPL IMMUNOHISTO M M, V12, P8; Vincent-Salomon A, 2008, NAT GENET, V40, P809, DOI 10.1038/ng0708-809a; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zhang YM, 2000, VIRCHOWS ARCH, V436, P271, DOI 10.1007/s004280050040	23	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70634	10.1371/journal.pone.0070634	http://dx.doi.org/10.1371/journal.pone.0070634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923010	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700198
J	Tang, LL; Wang, LY; Liao, Q; Wang, QW; Xu, LT; Bu, SZ; Huang, Y; Zhang, C; Ye, HD; Xu, XT; Liu, Q; Ye, M; Mai, YF; Duan, SW				Tang, Linlin; Wang, Lingyan; Liao, Qi; Wang, Qinwen; Xu, Leiting; Bu, Shizhong; Huang, Yi; Zhang, Cheng; Ye, Huadan; Xu, Xuting; Liu, Qiong; Ye, Meng; Mai, Yifeng; Duan, Shiwei			Genetic Associations with Diabetes: Meta-Analyses of 10 Candidate Polymorphisms	PLOS ONE			English	Article							INSULIN-RESISTANCE; APOLIPOPROTEIN A5; APOA5 GENE; JAPANESE POPULATION; CHINESE POPULATION; METABOLIC SYNDROME; CHROMOSOME 1Q21; CELIAC-DISEASE; CELL FUNCTION; PIMA-INDIANS	Aims: The goal of our study is to investigate the combined contribution of 10 genetic variants to diabetes susceptibility. Methods: Bibliographic databases were searched from 1970 to Dec 2012 for studies that reported on genetic association study of diabetes. After a comprehensive filtering procedure, 10 candidate gene variants with informative genotype information were collected for the current meta-anlayses. Using the REVMAN software, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the combined contribution of the selected genetic variants to diabetes. Results: A total of 37 articles among 37,033 cases and 54,716 controls were involved in the present meta-analyses of 10 genetic variants. Three variants were found to be significantly associated with type 1 diabetes (T1D): NLRP1 rs12150220 (OR = 0.71, 95% CI = 0.55-0.92, P = 0.01), IL2RA rs11594656 (OR = 0.86, 95% CI = 0.82-0.91, P<0.00001), and CLEC16A rs725613 (OR = 0.71, 95% CI = 0.55-0.92, P = 0.01). APOA5 -1131T/C polymorphism was shown to be significantly associated with of type 2 diabetes (T2D, OR = 1.27, 95% CI = 1.03-1.57, P = 0.03). No association with diabetes was showed in the meta-analyses of other six genetic variants, including SLC2A10 rs2335491, ATF6 rs2070150, KLF11 rs35927125, CASQ1 rs2275703, GNB3 C825T, and IL12B 1188A/C. Conclusion: Our results demonstrated that IL2RA rs11594656 and CLEC16A rs725613 are protective factors of T1D, while NLRP1 rs12150220 and APOA5 -1131T/C are risky factors of T1D and T2D, respectively.	[Tang, Linlin; Liao, Qi; Wang, Qinwen; Xu, Leiting; Bu, Shizhong; Huang, Yi; Zhang, Cheng; Ye, Huadan; Xu, Xuting; Liu, Qiong; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Tang, Linlin; Ye, Meng; Mai, Yifeng] Ningbo Univ, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Lingyan] Ningbo 2 Hosp, Bank Blood Prod, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Ye, M (corresponding author), Ningbo Univ, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China.	dryemeng@yahoo.com.cn; nbmyf@msn.com; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022	Huang, Yi/0000-0003-3598-9747; Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919]; Ningbo social development research projects [2012C50032]; K.C. Wong Magna Fund in Ningbo University; Natural Science Foundation of Ningbo [2007A610077]; Program for Innovative Research Team in Zhejiang Province [2010R50046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ningbo social development research projects; K.C. Wong Magna Fund in Ningbo University; Natural Science Foundation of Ningbo; Program for Innovative Research Team in Zhejiang Province	The research was supported by the grants from National Natural Science Foundation of China (No. 31100919), Ningbo social development research projects(2012C50032), K.C. Wong Magna Fund in Ningbo University, Natural Science Foundation of Ningbo (2007A610077), and Program for Innovative Research Team in Zhejiang Province (2010R50046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinova AE, 2010, J ENDOCRINOL INVEST, V33, P451, DOI [10.3275/6766, 10.1007/BF03346623]; Aminkeng F, 2010, HUM IMMUNOL, V71, P1233, DOI 10.1016/j.humimm.2010.09.006; Andersen G, 2006, DIABETOLOGIA, V49, P75, DOI 10.1007/s00125-005-0049-7; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Banos R, 1999, Cyberpsychol Behav, V2, P143, DOI 10.1089/cpb.1999.2.143; Beck-Nielsen H, 1999, DRUGS, V58, P7, DOI 10.2165/00003495-199958001-00003; Bento JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-42; Bhaskar S, 2011, GENET TEST MOL BIOMA, V15, P507, DOI 10.1089/gtmb.2010.0207; Chandak GR, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-76; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Charriere S, 2008, CLIN CHIM ACTA, V394, P99, DOI 10.1016/j.cca.2008.04.013; Chistiakov DA, 2008, IMMUNOL LETT, V118, P1, DOI 10.1016/j.imlet.2008.03.002; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Chu WS, 2007, DIABETES, V56, P856, DOI 10.2337/db06-1305; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; Das SK, 2004, DIABETES, V53, P3300, DOI 10.2337/diabetes.53.12.3300; Dendrou CA, 2008, J CLIN IMMUNOL, V28, P685, DOI 10.1007/s10875-008-9237-9; Dorfmeister B, 2007, BBA-MOL BASIS DIS, V1772, P355, DOI 10.1016/j.bbadis.2006.11.008; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Esteve E, 2004, DIABETOLOGIA, V47, P355, DOI 10.1007/s00125-003-1308-0; Fichna M, 2012, TISSUE ANTIGENS, V79, P198, DOI 10.1111/j.1399-0039.2011.01828.x; Florez JC, 2006, DIABETES, V55, P3620, DOI 10.2337/db06-0867; Fu M, 2004, DIABETES, V53, P3292, DOI 10.2337/diabetes.53.12.3292; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; Garg G, 2012, J IMMUNOL, V188, P4644, DOI 10.4049/jimmunol.1100272; Grarup N, 2007, CURR OPIN CLIN NUTR, V10, P420, DOI 10.1097/MCO.0b013e3281e2c9ab; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hayakawa T, 2007, METABOLISM, V56, P44, DOI 10.1016/j.metabol.2006.08.020; Hiramatsu M, 2012, INT J MOL MED, V30, P185, DOI 10.3892/ijmm.2012.976; Hu C, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-3; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Jakel H, 2006, ANN MED, V38, P2, DOI 10.1080/07853890500407488; Jenkins A B, 2000, Twin Res, V3, P148, DOI 10.1375/twin.3.3.148; Jiang H, 2011, CLIN NUTR, V30, P730, DOI 10.1016/j.clnu.2011.05.006; Jiang YD, 2005, DIABETIC MED, V22, P1690, DOI 10.1111/j.1464-5491.2005.01715.x; Kawasaki E, 2009, J CLIN ENDOCR METAB, V94, P947, DOI 10.1210/jc.2008-1596; Kiani JG, 2005, NEUROENDOCRINOL LETT, V26, P87; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Li XF, 2008, J HUAZHONG U SCI-MED, V28, P653, DOI 10.1007/s11596-008-0608-5; Lin WH, 2006, DIABETOLOGIA, V49, P1214, DOI 10.1007/s00125-006-0218-3; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Luopajarvi K, 2012, PEDIATR DIABETES, V13, P400, DOI 10.1111/j.1399-5448.2012.00852.x; Ma L, 2008, J CLIN ENDOCR METAB, V93, P3644, DOI 10.1210/jc.2008-0546; Magitta NF, 2009, GENES IMMUN, V10, P120, DOI 10.1038/gene.2008.85; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martinez A, 2010, ANN RHEUM DIS, V69, P309, DOI 10.1136/ard.2008.098376; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McCormack RM, 2002, GENES IMMUN, V3, P433, DOI 10.1038/sj.gene.6363893; Meex SJR, 2007, J CLIN ENDOCR METAB, V92, P2720, DOI 10.1210/jc.2006-2280; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Mohlke KL, 2005, MOL GENET METAB, V85, P323, DOI 10.1016/j.ymgme.2005.04.011; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nistico L, 2002, DIABETES, V51, P1649, DOI 10.2337/diabetes.51.5.1649; Nowak M, 2008, J MOL BIOL, V380, P789, DOI 10.1016/j.jmb.2008.04.057; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Pruneta-Deloche V, 2005, ATHEROSCLEROSIS, V181, P403, DOI 10.1016/j.atherosclerosis.2005.01.034; Qiao Yan, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P965; RITVO RA, 1987, SOC WORK HEALTH CARE, V13, P39; Santiago JL, 2005, HUM IMMUNOL, V66, P897, DOI 10.1016/j.humimm.2005.06.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Soter MO, 2012, MOL BIOL REP, V39, P7541, DOI 10.1007/s11033-012-1588-x; Sparso T, 2007, MOL GENET METAB, V92, P278, DOI 10.1016/j.ymgme.2007.06.011; Talmud PJ, 2006, DIABETOLOGIA, V49, P2337, DOI 10.1007/s00125-006-0387-0; Tanahashi T, 2008, DIABETIC MED, V25, P19, DOI 10.1111/j.1464-5491.2007.02315.x; Thameem F, 2006, DIABETES, V55, P839, DOI 10.2337/diabetes.55.03.06.db05-1002; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Wang X, 2009, DIABETOLOGIA, V52, P2578, DOI 10.1007/s00125-009-1524-3; World Health Organization, 2011, BURD MORT MORB RISK; Wu XP, 2009, CLIN ENDOCRINOL, V71, P46, DOI 10.1111/j.1365-2265.2008.03437.x; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Zhai Guang-Hua, 2007, Yichuan, V29, P541, DOI 10.1360/yc-007-0541; Zhang H, 2012, J HEPATOL; Zoledziewska M, 2009, GENES IMMUN, V10, P15, DOI 10.1038/gene.2008.84; Zurawek M, 2011, DIABETES RES CLIN PR, V92, pE49, DOI 10.1016/j.diabres.2011.02.004	86	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70301	10.1371/journal.pone.0070301	http://dx.doi.org/10.1371/journal.pone.0070301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922971	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700166
J	Yuan, ZS; Liu, H; Zhang, XS; Li, FY; Zhao, JH; Zhang, FR; Xue, FZ				Yuan, Zhongshang; Liu, Hong; Zhang, Xiaoshuai; Li, Fangyu; Zhao, Jinghua; Zhang, Furen; Xue, Fuzhong			From Interaction to Co-Association -A Fisher r-To-z Transformation-Based Simple Statistic for Real World Genome-Wide Association Study	PLOS ONE			English	Article							GAIN-OF-FUNCTION; MISSING HERITABILITY; VARIANTS; RISK	Currently, the genetic variants identified by genome wide association study (GWAS) generally only account for a small proportion of the total heritability for complex disease. One crucial reason is the underutilization of gene-gene joint effects commonly encountered in GWAS, which includes their main effects and co-association. However, gene-gene co-association is often customarily put into the framework of gene-gene interaction vaguely. From the causal graph perspective, we elucidate in detail the concept and rationality of gene-gene co-association as well as its relationship with traditional gene-gene interaction, and propose two Fisher r-to-z transformation-based simple statistics to detect it. Three series of simulations further highlight that gene-gene co-association refers to the extent to which the joint effects of two genes differs from the main effects, not only due to the traditional interaction under the nearly independent condition but the correlation between two genes. The proposed statistics are more powerful than logistic regression under various situations, cannot be affected by linkage disequilibrium and can have acceptable false positive rate as long as strictly following the reasonable GWAS data analysis roadmap. Furthermore, an application to gene pathway analysis associated with leprosy confirms in practice that our proposed gene-gene co-association concepts as well as the correspondingly proposed statistics are strongly in line with reality.	[Yuan, Zhongshang; Zhang, Xiaoshuai; Li, Fangyu; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Liu, Hong; Zhang, Furen] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Zhao, Jinghua] MRC Epidemiol Unit, Cambridge, England; [Zhao, Jinghua] Inst Metab Sci, Cambridge, England	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; University of Cambridge	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020; Yuan, Zhongshang/GVT-8351-2022; Zhang, Xiaoshuai/AAG-7019-2019	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [31200994, 31071155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (31200994, 31071155). (http://www.nsfc.gov.cn/nsfc/cen/00/download.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher RA, 1914, BIOMETRIKA, V10, P507; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Kam-Thong Tony, 2011, Eur J Hum Genet, V19, P465, DOI 10.1038/ejhg.2010.196; Kang GL, 2008, J THEOR BIOL, V250, P362, DOI 10.1016/j.jtbi.2007.10.001; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Peng QQ, 2010, EUR J HUM GENET, V18, P582, DOI 10.1038/ejhg.2009.223; Rajapakse I, 2012, GENET EPIDEMIOL, V36, P622, DOI 10.1002/gepi.21656; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wellek S, 2009, HUM HERED, V67, P128, DOI 10.1159/000179560; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Yuan ZS, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-83; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062129; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	27	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70774	10.1371/journal.pone.0070774	http://dx.doi.org/10.1371/journal.pone.0070774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923021	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700206
J	Zhang, B; Jarrell, JA; Price, JV; Tabakman, SM; Li, YG; Gong, M; Hong, GS; Feng, J; Utz, PJ; Dai, HJ				Zhang, Bo; Jarrell, Justin A.; Price, Jordan V.; Tabakman, Scott M.; Li, Yanguang; Gong, Ming; Hong, Guosong; Feng, Ju; Utz, Paul J.; Dai, Hongjie			An Integrated Peptide-Antigen Microarray on Plasmonic Gold Films for Sensitive Human Antibody Profiling	PLOS ONE			English	Article							SMALL-MOLECULE MICROARRAY; PROTEIN MICROARRAYS; SPOT SYNTHESIS; ARRAYS; FLUORESCENCE; BINDING; EPITOPE; SPECIFICITY; RESOLUTION; DIAGNOSIS	High-throughput screening for interactions of peptides with a variety of antibody targets could greatly facilitate proteomic analysis for epitope mapping, enzyme profiling, drug discovery and biomarker identification. Peptide microarrays are suited for such undertaking because of their high-throughput capability. However, existing peptide microarrays lack the sensitivity needed for detecting low abundance proteins or low affinity peptide-protein interactions. This work presents a new peptide microarray platform constructed on nanostructured plasmonic gold substrates capable of metal enhanced NIR fluorescence enhancement (NIR-FE) by hundreds of folds for screening peptide-antibody interactions with ultrahigh sensitivity. Further, an integrated histone peptide and whole antigen array is developed on the same plasmonic gold chip for profiling human antibodies in the sera of systemic lupus erythematosus (SLE) patients, revealing that collectively a panel of biomarkers against unmodified and post-translationally modified histone peptides and several whole antigens allow more accurate differentiation of SLE patients from healthy individuals than profiling biomarkers against peptides or whole antigens alone.	[Zhang, Bo; Tabakman, Scott M.; Li, Yanguang; Gong, Ming; Hong, Guosong; Feng, Ju; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Jarrell, Justin A.; Price, Jordan V.; Utz, Paul J.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Utz, Paul J.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Zhang, Bo/J-9536-2018; Li, Yanguang/A-2319-2014; Hong, Guosong/A-7551-2013; Dai, Hongjie/ABC-4574-2021	Zhang, Bo/0000-0003-0743-4816; Li, Yanguang/0000-0003-0506-0451; Hong, Guosong/0000-0002-8858-4471; Gong, Ming/0000-0002-1584-1211; Zhang, Bo/0000-0001-8745-2752	NIH-NCI [5R01CA135109-02]; Stanford SPARK program; Stanford BioX-SIGF fellowship; Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI) [HHSN288201000034C]; NIH [5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019, 4 U19 AI090019]; Canadian Institutes of Health Research [2 OR-92141]; Alliance for Lupus Research [21858]; European Union [261382]; NATIONAL CANCER INSTITUTE [R01CA135109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, U19AI082719, U19AI056363, U19AI090019] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stanford SPARK program; Stanford BioX-SIGF fellowship; Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alliance for Lupus Research; European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by NIH-NCI 5R01CA135109-02 and the Stanford SPARK program. B.Z. is the recipient of Stanford BioX-SIGF fellowship. P.J.U. is the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award and is supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics contract HHSN288201000034C, Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; grants from the NIH (5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019 and 4 U19 AI090019); Canadian Institutes of Health Research (2 OR-92141); Alliance for Lupus Research (grant number 21858); a gift from the Ben May Trust and a gift from the Floren Family Trust. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 261382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; Blasco H, 2007, J IMMUNOL METHODS, V325, P127, DOI 10.1016/j.jim.2007.06.011; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Carlsson A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005033; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Dieker JW, 2007, ARTHRITIS RHEUM-US, V56, P1921, DOI 10.1002/art.22646; Duburcq X, 2004, BIOCONJUGATE CHEM, V15, P307, DOI 10.1021/bc034226d; Dulkeith E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.203002; Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; Foong YM, 2012, CURR OPIN CHEM BIOL, V16, P234, DOI 10.1016/j.cbpa.2011.12.007; Fort E, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/1/013001; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; GEOKAS MC, 1982, ANN INTERN MED, V97, P389, DOI 10.7326/0003-4819-97-3-389; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Gill JM, 2003, AM FAM PHYSICIAN, V68, P2179; GNANN JW, 1987, J INFECT DIS, V156, P261, DOI 10.1093/infdis/156.2.261; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; Hong GS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1698; Hong GS, 2011, ANGEW CHEM INT EDIT, V50, P4644, DOI 10.1002/anie.201100934; Hong GS, 2010, J AM CHEM SOC, V132, P15920, DOI 10.1021/ja1087997; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Kannangai R, 2001, J CLIN VIROL, V22, P41, DOI 10.1016/S1386-6532(01)00170-6; Kattah MG, 2006, NAT METHODS, V3, P745, DOI 10.1038/nmeth910; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; KITAMURA K, 1994, FEBS LETT, V351, P35, DOI 10.1016/0014-5793(94)00810-8; Kochinyan S, 2007, BIOTECHNIQUES, V42, P63, DOI 10.2144/000112311; Lesaicherre ML, 2002, BIOORG MED CHEM LETT, V12, P2079, DOI 10.1016/S0960-894X(02)00379-7; Liu CC, 2009, BEST PRACT RES CL RH, V23, P507, DOI 10.1016/j.berh.2009.01.008; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Lu ZQJ, 2007, J ROY STAT SOC A STA, V170, P1178; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; MacBeath G, 2000, SCIENCE, V289, P1760; Mertens H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115123; Min DH, 2004, CURR OPIN CHEM BIOL, V8, P554, DOI 10.1016/j.cbpa.2004.08.007; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Panicker RC, 2004, COMB CHEM HIGH T SCR, V7, P547; Papp K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044824; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Petricoin EF, 2003, J NUTR, V133, p2476S, DOI 10.1093/jn/133.7.2476S; Price JV, 2012, NAT MED, V18, P1434, DOI 10.1038/nm.2913; Reimer U, 2002, CURR OPIN BIOTECH, V13, P315, DOI 10.1016/S0958-1669(02)00339-7; Salisbury CM, 2002, J AM CHEM SOC, V124, P14868, DOI 10.1021/ja027477q; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Schneider G, 2006, NANO LETT, V6, P530, DOI 10.1021/nl052441s; SETTE A, 1994, MOL IMMUNOL, V31, P813, DOI 10.1016/0161-5890(94)90019-1; Sun L, 2004, BIOTECHNIQUES, V37, P430, DOI 10.2144/04373RR01; Tabakman SM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1477; Tabakman SM, 2011, SMALL, V7, P499, DOI 10.1002/smll.201001836; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; Waddell E, 2000, ANAL CHEM, V72, P5907, DOI 10.1021/ac0009705; Wegner GJ, 2002, ANAL CHEM, V74, P5161, DOI 10.1021/ac025922u; Weiser AA, 2005, ANAL BIOCHEM, V342, P300, DOI 10.1016/j.ab.2005.04.033; Zhang B, 2013, NANO RES, V6, P113, DOI 10.1007/s12274-012-0286-2	58	31	33	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71043	10.1371/journal.pone.0071043	http://dx.doi.org/10.1371/journal.pone.0071043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923050	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700222
J	Kanitkar, M; Jaiswal, A; Deshpande, R; Bellare, J; Kale, VP				Kanitkar, Meghana; Jaiswal, Amit; Deshpande, Rucha; Bellare, Jayesh; Kale, Vaijayanti P.			Enhanced Growth of Endothelial Precursor Cells on PCG-Matrix Facilitates Accelerated, Fibrosis-Free, Wound Healing: A Diabetic Mouse Model	PLOS ONE			English	Article							PROGENITOR CELLS; EXTRACELLULAR-MATRIX; IN-VITRO; ELECTROSPUN; SCAFFOLDS; POLYCAPROLACTONE; HYDROXYAPATITE; ANGIOGENESIS; NANOFIBER; ADHESION	Diabetes mellitus (DM)-induced endothelial progenitor cell (EPC) dysfunction causes impaired wound healing, which can be rescued by delivery of large numbers of 'normal' EPCs onto such wounds. The principal challenges herein are (a) the high number of EPCs required and (b) their sustained delivery onto the wounds. Most of the currently available scaffolds either serve as passive devices for cellular delivery or allow adherence and proliferation, but not both. This clearly indicates that matrices possessing both attributes are 'the need of the day' for efficient healing of diabetic wounds. Therefore, we developed a system that not only allows selective enrichment and expansion of EPCs, but also efficiently delivers them onto the wounds. Murine bone marrow-derived mononuclear cells (MNCs) were seeded onto a PolyCaprolactone-Gelatin (PCG) nano-fiber matrix that offers a combined advantage of strength, biocompatibility wettability; and cultured them in EGM2 to allow EPC growth. The efficacy of the PCG matrix in supporting the EPC growth and delivery was assessed by various in vitro parameters. Its efficacy in diabetic wound healing was assessed by a topical application of the PCG-EPCs onto diabetic wounds. The PCG matrix promoted a high-level attachment of EPCs and enhanced their growth, colony formation, and proliferation without compromising their viability as compared to Poly L-lactic acid (PLLA) and Vitronectin (VN), the matrix and non-matrix controls respectively. The PCG-matrix also allowed a sustained chemotactic migration of EPCs in vitro. The matrix-effected sustained delivery of EPCs onto the diabetic wounds resulted in an enhanced fibrosis-free wound healing as compared to the controls. Our data, thus, highlight the novel therapeutic potential of PCG-EPCs as a combined 'growth and delivery system' to achieve an accelerated fibrosis-free healing of dermal lesions, including diabetic wounds.	[Kanitkar, Meghana; Deshpande, Rucha; Kale, Vaijayanti P.] Natl Ctr Cell Sci, Pune, Maharashtra, India; [Jaiswal, Amit; Bellare, Jayesh] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kale, VP (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Univ Pune Campus, Pune, Maharashtra, India.	vpkale@nccs.res.in	Bellare, Jayesh/AAO-8713-2020; Kale, Vaijayanti/R-9342-2019; Jaiswal, Amit Kumar/S-9640-2019	Bellare, Jayesh/0000-0002-6792-8327; Kale, Vaijayanti/0000-0001-7498-7563; Jaiswal, Amit Kumar/0000-0002-6566-3580				Albiero M, 2011, DIABETOLOGIA, V54, P945, DOI 10.1007/s00125-010-2007-2; Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389; Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Balaji S, 2012, WOUND REPAIR REGEN, V20, P15, DOI 10.1111/j.1524-475X.2011.00750.x; Bauer SM, 2005, J VASC SURG, V41, P699, DOI 10.1016/j.jvs.2005.01.015; Bertolotti A, 2009, IN VIVO, V23, P929; Builles N, 2010, BIOMATERIALS, V31, P8313, DOI 10.1016/j.biomaterials.2010.07.066; Caiado F, 2011, BIOMATERIALS, V32, P7096, DOI 10.1016/j.biomaterials.2011.06.022; Camci-Unal G, 2013, J TISSUE ENG REGEN M, V7, P337, DOI 10.1002/term.517; Chen KY, 2013, J TISSUE ENG REGEN M, V7, P708, DOI 10.1002/term.1461; Contreras JL, 2003, SURGERY, V134, P390, DOI 10.1067/msy.2003.250; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Drela E, 2012, ADV CLIN EXP MED, V21, P249; Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410; Hartman O, 2010, LANGMUIR, V26, P7380; Jaiswal AK, 2012, J BIOACT COMPAT POL, V27, P356, DOI 10.1177/0883911512447211; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kahn MB, 2011, DIABETES, V60, P1295, DOI 10.2337/db10-1080; Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047; Kluger PJ, 2010, J MATER SCI-MATER M, V21, P2665, DOI 10.1007/s10856-010-4128-z; Li FYL, 2012, CIRCULATION, V126, P1267, DOI 10.1161/CIRCULATIONAHA.112.108159; Lu LX, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015002; Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020; Menegazzo L, 2012, BIOFACTORS, V38, P194, DOI 10.1002/biof.1016; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Murasawa S, 2005, PHYSIOLOGY, V20, P36, DOI 10.1152/physiol.00033.2004; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004; Schneider RK, 2010, BIOMATERIALS, V31, P7948, DOI 10.1016/j.biomaterials.2010.07.003; Sego Sherril, 2007, Nephrol Nurs J, V34, P631; Seo JP, 2012, RES VET SCI; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shim IK, 2010, J BIOMED MATER RES B, V95B, P150, DOI 10.1002/jbm.b.31695; Skotak M, 2010, J BIOMED MATER RES A, V95A, P828, DOI 10.1002/jbm.a.32850; Tan QA, 2010, SCAND J CLIN LAB INV, V70, P313, DOI 10.3109/00365511003774593; Tong HW, 2012, J BIOMAT SCI-POLYM E, V23, P779, DOI 10.1163/092050611X560708; Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017; Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8	50	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69960	10.1371/journal.pone.0069960	http://dx.doi.org/10.1371/journal.pone.0069960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922871	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900122
J	Cervantes, M; Vila, A; Nicolas, FE; Moxon, S; de Haro, JP; Dalmay, T; Torres-Martinez, S; Ruiz-Vazquez, RM				Cervantes, Maria; Vila, Ana; Nicolas, Francisco E.; Moxon, Simon; de Haro, Juan P.; Dalmay, Tamas; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.			A Single Argonaute Gene Participates in Exogenous and Endogenous RNAi and Controls Cellular Functions in the Basal Fungus Mucor circinelloides	PLOS ONE			English	Article							MECHANISMS; BIOGENESIS; AUTOLYSIS; ALIGNMENT; SIRNA	The mechanism of RNAi is well described in metazoans where it plays a role in diverse cellular functions. However, although different classes of endogenous small RNAs (esRNAs) have been identified in fungi, their biological roles are poorly described due, in part, to the lack of phenotype of mutants affected in the biogenesis of these esRNAs. Argonaute proteins are one of the key components of the RNAi pathways, in which different members of this protein family participate in the biogenesis of a wide repertoire of esRNAs molecules. Here we identified three argonaute genes of the fungus Mucor circinelloides and investigated their participation in exogenous and endogenous RNAi. We found that only one of the ago genes, ago-1, is involved in RNAi during vegetative growth and is required for both transgene-induced RNA silencing and the accumulation of distinct classes of esRNAs derived from exons (ex-siRNAs). Classes I and II ex-siRNAs bind to Ago-1 to control mRNA accumulation of the target protein coding genes. Class III ex-siRNAs do not specifically bind to Ago-1, but requires this protein for their production, revealing the complexity of the biogenesis pathways of ex-siRNAs. We also show that ago-1 is involved in the response to environmental signals, since vegetative development and autolysis induced by nutritional stress are affected in ago-1(-) M. circinelloides mutants. Our results demonstrate that a single Ago protein participates in the production of different classes of esRNAs that are generated through different pathways. They also highlight the role of ex-siRNAs in the regulation of endogenous genes in fungi and expand the range of biological functions modulated by RNAi.	[Cervantes, Maria; Vila, Ana; Nicolas, Francisco E.; de Haro, Juan P.; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia, Spain; [Nicolas, Francisco E.] Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Moxon, Simon; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Murcia; University of East Anglia	Ruiz-Vazquez, RM (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia, Spain.	rmruiz@um.es	Nicolás, Francisco E./D-5717-2014; Torres-Martinez, Santiago/K-7660-2014; Ruiz-Vázquez, Rosa María/K-6778-2014; Dalmay, Tamas/E-1377-2011	Nicolás, Francisco E./0000-0003-3762-5971; Torres-Martinez, Santiago/0000-0002-7083-4516; Ruiz-Vázquez, Rosa María/0000-0002-6675-8506; Moxon, Simon/0000-0003-4644-1816; Dalmay, Tamas/0000-0003-1492-5429	Spanish Ministerio de Ciencia e Innovacion [BFU2006-02408, BFU2009-07220]; FEDER; Spanish Ministerio de Economia y Competitividad [BFU2012-32246]; U-IMPACT Program (Marie Curie Action, 7th Framework Programme of the EU) within the Regional Campus of International Excellence "Campus Mare Nostrum" (Murcia, Spain); BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); U-IMPACT Program (Marie Curie Action, 7th Framework Programme of the EU) within the Regional Campus of International Excellence "Campus Mare Nostrum" (Murcia, Spain); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BFU2006-02408 and BFU2009-07220, co-financed by FEDER); and the Spanish Ministerio de Economia y Competitividad (BFU2012-32246). F.E.N. was funded by the U-IMPACT Program (Marie Curie Action, 7th Framework Programme of the EU) within the Regional Campus of International Excellence "Campus Mare Nostrum" (Murcia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchon N, 2006, HEREDITY, V96, P195, DOI 10.1038/sj.hdy.6800789; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chayakulkeeree M, 2006, EUR J CLIN MICROBIOL, V25, P215, DOI 10.1007/s10096-006-0107-1; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Corrochano LM, 2010, FUNGAL GENET BIOL, V47, P893, DOI 10.1016/j.fgb.2010.04.007; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Nicolas FE, 2008, FEMS MICROBIOL LETT, V280, P81, DOI 10.1111/j.1574-6968.2007.01044.x; Nicolas FE, 2007, FUNGAL GENET BIOL, V44, P504, DOI 10.1016/j.fgb.2006.09.003; Nicolas FE, 2009, J BIOTECHNOL, V142, P123, DOI 10.1016/j.jbiotec.2009.04.003; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Nunes Cristiano C., 2011, Fungal Biology Reviews, V25, P172, DOI 10.1016/j.fbr.2011.10.001; Ocampo J, 2012, EUKARYOT CELL, V11, P989, DOI 10.1128/EC.00017-12; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Quiles-Rosillo MD, 2003, FUNGAL GENET BIOL, V38, P122, DOI 10.1016/S1087-1845(02)00519-4; Sambrook J., 2001, MOL CLONING LAB MANU; Silva F, 2008, MOL MICROBIOL, V70, P1026, DOI 10.1111/j.1365-2958.2008.06470.x; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; Xue ZH, 2012, MOL CELL, V46, P299, DOI 10.1016/j.molcel.2012.03.019; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716	39	37	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69283	10.1371/journal.pone.0069283	http://dx.doi.org/10.1371/journal.pone.0069283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935973	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000325211000098
J	Day, MV; Bobocel, DR				Day, Martin V.; Bobocel, D. Ramona			The Weight of a Guilty Conscience: Subjective Body Weight as an Embodiment of Guilt	PLOS ONE			English	Article							MORAL EMOTIONS; SHAME; SELF; PRONENESS; ATTRIBUTION; PERCEPTION; METAPHOR	Guilt is an important social and moral emotion. In addition to feeling unpleasant, guilt is metaphorically described as a "weight on one's conscience." Evidence from the field of embodied cognition suggests that abstract metaphors may be grounded in bodily experiences, but no prior research has examined the embodiment of guilt. Across four studies we examine whether i) unethical acts increase subjective experiences of weight, ii) feelings of guilt explain this effect, and iii) whether there are consequences of the weight of guilt. Studies 1-3 demonstrated that unethical acts led to more subjective body weight compared to control conditions. Studies 2 and 3 indicated that heightened feelings of guilt mediated the effect, whereas other negative emotions did not. Study 4 demonstrated a perceptual consequence. Specifically, an induction of guilt affected the perceived effort necessary to complete tasks that were physical in nature, compared to minimally physical tasks.	[Day, Martin V.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Bobocel, D. Ramona] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	Princeton University; University of Waterloo	Day, MV (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	mvday@princeton.edu		Day, Martin/0000-0001-5274-1626; Bobocel, Ramona/0000-0001-8721-8114	Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by a Social Sciences and Humanities Research Council of Canada grant to D. Ramona Bobocel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerstrom J, 2012, SOC COGNITION, V30, P181, DOI 10.1521/soco.2012.30.2.181; Amodio DM, 2007, PSYCHOL SCI, V18, P524, DOI 10.1111/j.1467-9280.2007.01933.x; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Caouette J, 2012, EUR J SOC PSYCHOL, V42, P363, DOI 10.1002/ejsp.1857; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Cohen TR, 2012, CURR DIR PSYCHOL SCI, V21, P355, DOI 10.1177/0963721412454874; Cohen TR, 2011, J PERS SOC PSYCHOL, V100, P947, DOI 10.1037/a0022641; Grant AM, 2010, J APPL PSYCHOL, V95, P108, DOI 10.1037/a0017974; Hoyle R.H., 2002, RES METHODS SOCIAL R; KUGLER K, 1992, J PERS SOC PSYCHOL, V62, P318, DOI 10.1037/0022-3514.62.2.318; Lakoff George, 2003, METAPHOR WE LIVE BY; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lee SWS, 2010, PSYCHOL SCI, V21, P1423, DOI 10.1177/0956797610382788; Lewis H., 1971, SHAME GUILT NEUROSIS; Lickel B, 2005, GROUP PROCESS INTERG, V8, P145, DOI 10.1177/1368430205051064; MCGRAW KM, 1987, J PERS SOC PSYCHOL, V53, P247, DOI 10.1037/0022-3514.53.2.247; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; NIEDENTHAL PM, 1994, J PERS SOC PSYCHOL, V67, P585, DOI 10.1037/0022-3514.67.4.585; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Slepian ML, 2012, J EXP PSYCHOL GEN, V141, P619, DOI 10.1037/a0027598; Slepian ML, 2011, PSYCHOL SCI, V22, P26, DOI 10.1177/0956797610390388; Smith ER, 2004, ADV EXP SOC PSYCHOL, V36, P53, DOI 10.1016/S0065-2601(04)36002-8; Smith RW, 2002, SYR S PEACE, P138; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Tangney J.P., 2003, SHAME GUILT; TANGNEY JP, 1990, J PERS SOC PSYCHOL, V59, P102, DOI 10.1037/0022-3514.59.1.102; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wohl M.J.A., 2006, EUR REV SOC PSYCHOL, V17, P1, DOI [DOI 10.1080/10463280600574815, https://doi.org/10.1080/10463280600574815]; Wolf ST, 2010, SELF IDENTITY, V9, P337, DOI 10.1080/15298860903106843; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	38	19	21	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69546	10.1371/journal.pone.0069546	http://dx.doi.org/10.1371/journal.pone.0069546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936041	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700032
J	Besnier, F; Glover, KA				Besnier, Francois; Glover, Kevin A.			ParallelStructure: A R Package to Distribute Parallel Runs of the Population Genetics Program STRUCTURE on Multi-Core Computers	PLOS ONE			English	Article							MARKERS	This software package provides an R-based framework to make use of multi-core computers when running analyses in the population genetics program STRUCTURE. It is especially addressed to those users of STRUCTURE dealing with numerous and repeated data analyses, and who could take advantage of an efficient script to automatically distribute STRUCTURE jobs among multiple processors. It also consists of additional functions to divide analyses among combinations of populations within a single data set without the need to manually produce multiple projects, as it is currently the case in STRUCTURE. The package consists of two main functions: MPI_structure() and parallel_structure() as well as an example data file. We compared the performance in computing time for this example data on two computer architectures and showed that the use of the present functions can result in several-fold improvements in terms of computation time. ParallelStructure is freely available at https://r-forge.r-project.org/projects/parallstructure/.	[Besnier, Francois; Glover, Kevin A.] Inst Marine Res, Dept Populat Genet, N-5024 Bergen, Norway; [Glover, Kevin A.] Univ Bergen, Fac Math & Nat Sci, Dept Informat, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Besnier, F (corresponding author), Inst Marine Res, Dept Populat Genet, POB 1870, N-5024 Bergen, Norway.	francois.besnier@imr.no			Norwegian research council	Norwegian research council(Research Council of NorwayEuropean Commission)	This work was funded by the Norwegian research council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom N, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2001, GENETICS, V159, P699; Team RDC, 2013, R LANG ENV STAT COMP; Yu H., 2002, R NEWS, V2, P10, DOI DOI 10.1016/S0167-8191(02)00175-8	14	111	112	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70651	10.1371/journal.pone.0070651	http://dx.doi.org/10.1371/journal.pone.0070651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923012	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700199
J	Cazzonelli, CI; Vanstraelen, M; Simon, S; Yin, KD; Carron-Arthur, A; Nisar, N; Tarle, G; Cuttriss, AJ; Searle, IR; Benkova, E; Mathesius, U; Masle, J; Friml, J; Pogson, BJ				Cazzonelli, Christopher I.; Vanstraelen, Marleen; Simon, Sibu; Yin, Kuide; Carron-Arthur, Ashley; Nisar, Nazia; Tarle, Gauri; Cuttriss, Abby J.; Searle, Iain R.; Benkova, Eva; Mathesius, Ulrike; Masle, Josette; Friml, Jiri; Pogson, Barry J.			Role of the Arabidopsis PIN6 Auxin Transporter in Auxin Homeostasis and Auxin-Mediated Development	PLOS ONE			English	Article							ROOT HAIR-CELLS; INDOLE-3-BUTYRIC ACID; RESPONSE ELEMENTS; PLANT DEVELOPMENT; TOBACCO CELLS; IN-VIVO; EFFLUX; THALIANA; PROTEINS; GROWTH	Plant-specific PIN-formed (PIN) efflux transporters for the plant hormone auxin are required for tissue-specific directional auxin transport and cellular auxin homeostasis. The Arabidopsis PIN protein family has been shown to play important roles in developmental processes such as embryogenesis, organogenesis, vascular tissue differentiation, root meristem patterning and tropic growth. Here we analyzed roles of the less characterised Arabidopsis PIN6 auxin transporter. PIN6 is auxin-inducible and is expressed during multiple auxin-regulated developmental processes. Loss of pin6 function interfered with primary root growth and lateral root development. Misexpression of PIN6 affected auxin transport and interfered with auxin homeostasis in other growth processes such as shoot apical dominance, lateral root primordia development, adventitious root formation, root hair outgrowth and root waving. These changes in auxin-regulated growth correlated with a reduction in total auxin transport as well as with an altered activity of DR5-GUS auxin response reporter. Overall, the data indicate that PIN6 regulates auxin homeostasis during plant development.	[Cazzonelli, Christopher I.; Yin, Kuide; Carron-Arthur, Ashley; Nisar, Nazia; Cuttriss, Abby J.; Pogson, Barry J.] Australian Natl Univ, Australian Res Council Ctr Excellence Plant Energ, Coll Med Biol & Environm, Res Sch Biol, Canberra, ACT, Australia; [Tarle, Gauri; Searle, Iain R.; Mathesius, Ulrike; Masle, Josette] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Yin, Kuide] Heilongjiang August First Land Reclamat Univ, Sch Life Sci & Biotechnol, Daqing, Peoples R China; [Vanstraelen, Marleen; Simon, Sibu; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Syst Biol, VIB, B-9000 Ghent, Belgium; [Vanstraelen, Marleen; Simon, Sibu; Benkova, Eva; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium; [Simon, Sibu; Benkova, Eva; Friml, Jiri] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Searle, Iain R.] Univ Adelaide, Sch Mol & Biomed Sci, Sch Agr Food & Wine, Adelaide, SA, Australia	Australian National University; Australian National University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Institute of Science & Technology - Austria; University of Adelaide	Cazzonelli, CI (corresponding author), Australian Natl Univ, Australian Res Council Ctr Excellence Plant Energ, Coll Med Biol & Environm, Res Sch Biol, Canberra, ACT, Australia.	christopher.cazzonelli@anu.edu.au	Vanstraelen, Marleen/AAI-4202-2021; Friml, Jiri/D-9511-2012; Cazzonelli, Christopher I/A-5347-2010; Searle, Iain/AAE-8869-2019; Pogson, Barry J/C-9953-2009; Mathesius, Ulrike/C-9767-2009	Friml, Jiri/0000-0002-8302-7596; Cazzonelli, Christopher I/0000-0003-3096-3193; Pogson, Barry J/0000-0003-1869-2423; Mathesius, Ulrike/0000-0002-3557-0105; Searle, Iain/0000-0003-4306-9756	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology [CE0561495]; ARC [FT100100669]; ARC QEII Fellowship [DP988846]; chinese government; Research Foundation-Flanders; European Research Council [ERC-2007-Stg-207362-HCPO, ERC-2011-StG-20101109-PSDP]	Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology(Australian Research Council); ARC(Australian Research Council); ARC QEII Fellowship(Australian Research Council); chinese government; Research Foundation-Flanders(FWO); European Research Council(European Research Council (ERC)European Commission)	CIC and BJP were supported by the Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology (CE0561495). UM was supported by an ARC Future Fellowship (FT100100669). IS was supported by an ARC QEII Fellowship (DP988846). KY was supported by the chinese government on a visiting fellowship. This work was supported by a postdoctoral fellowship of the Research Foundation-Flanders (MV), and the European Research Council with a Starting Independent Research Grant (ERC-2007-Stg-207362-HCPO) (to EB and ERC-2011-StG-20101109-PSDP to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel B, 2001, J PLANT GROWTH REGUL, V20, P198, DOI 10.1007/s003440010025; Bartel B, 1997, ANNU REV PLANT PHYS, V48, P49; Bender RL, 2013, PLANT J; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bosco C.D., 2012, PLANT J; Buer CS, 2003, PLANT PHYSIOL, V132, P1085, DOI 10.1104/pp.102.019182; Cazzonelli CI, 2010, MOL PLANT, V3, P174, DOI 10.1093/mp/ssp092; Cazzonelli CI, 2008, TRANSGENIC RES, V17, P437, DOI 10.1007/s11248-007-9117-8; Cazzonelli CI, 2006, PLANTA, V224, P582, DOI 10.1007/s00425-006-0250-z; Cazzonelli CI, 2005, TRANSGENIC RES, V14, P941, DOI 10.1007/s11248-005-2539-2; Chen ZY, 2009, PLANT CELL, V21, P1972, DOI 10.1105/tpc.108.062653; Cho M, 2007, PLANT CELL, V19, P3930, DOI 10.1105/tpc.107.054288; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cuttriss AJ, 2007, FUNCT PLANT BIOL, V34, P663, DOI 10.1071/FP07034; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Dun EA, 2006, PLANT PHYSIOL, V142, P812, DOI 10.1104/pp.106.086868; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Ganguly A, 2010, PLANT PHYSIOL, V153, P1046, DOI 10.1104/pp.110.156505; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Grunewald W, 2010, EMBO J, V29, P2700, DOI 10.1038/emboj.2010.181; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Malamy JE, 1997, DEVELOPMENT, V124, P33; MITCHELL EK, 1975, PHYSIOL PLANTARUM, V33, P290, DOI 10.1111/j.1399-3054.1975.tb03171.x; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Negi S, 2008, PLANT J, V55, P175, DOI 10.1111/j.1365-313X.2008.03495.x; Noh B, 2003, NATURE, V423, P999, DOI 10.1038/nature01716; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; OKADA K, 1994, PLANT MOL BIOL, V26, P1357, DOI 10.1007/BF00016480; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Ruts T, 2012, PLANT J, V72, P154, DOI 10.1111/j.1365-313X.2012.05073.x; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tian Q, 1999, DEVELOPMENT, V126, P711; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Velten J., 2008, TRANSGENIC PLANT J, V2, P1; Viaene T, 2012, TRENDS PLANT SCI; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	74	45	53	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70069	10.1371/journal.pone.0070069	http://dx.doi.org/10.1371/journal.pone.0070069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922907	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700128
J	Kostromina, E; Wang, XR; Han, WP				Kostromina, Elena; Wang, Xiaorui; Han, Weiping			Altered Islet Morphology but Normal Islet Secretory Function In Vitro in a Mouse Model with Microvascular Alterations in the Pancreas	PLOS ONE			English	Article							IMPAIRED INSULIN-SECRETION; ENDOTHELIAL GROWTH-FACTOR; GLUCOSE-INTOLERANCE; FACTOR-A; VEGF-A; EXPRESSION; VASCULARIZATION; SYNAPTOTAGMIN-7; LANGERHANS; SIGNALS	Background: Our previous studies have shown that signal transducer and activator of transcription 3 (STAT3) signaling is important for the development of pancreatic microvasculature via its regulation of vascular endothelial growth factor-A (VEGF-A). Pancreas-specific STAT3-KO mice exhibit glucose intolerance and impaired insulin secretion in vivo, along with microvascular alterations in the pancreas. However, the specific role of STAT3 signaling in the regulation of pancreatic islet development and function is not entirely understood. Methodology/Principal Findings: To investigate the role of STAT3 signaling in the formation and maintenance of pancreatic islets, we studied pancreas-specific STAT3-KO mice. Histological analysis showed that STAT3 deficiency affected pancreatic islet morphology. We found an increased proportion of small-sized islets and a reduced fraction of medium-sized islets, indicating abnormal islet development in STAT3-KO mice. Interestingly, the islet area relative to the whole pancreas area in transgenic and control mice was not significantly different. Immunohistochemical analysis on pancreatic cryosections revealed abnormalities in islet architecture in STAT3-KO mice: the pattern of peripheral distribution of glucagon-positive a-cells was altered. At the same time, islets belonging to different size categories isolated from STAT3-KO mice exhibited normal glucose-stimulated insulin secretion in perifusion experiments in vitro when compared to control mice. Conclusions: Our data demonstrate that STAT3 signaling in the pancreas is required for normal islet formation and/or maintenance. Altered islet size distribution in the KO mice does not result in an impaired islet secretory function in vitro. Therefore, our current study supports that the glucose intolerance and in vivo insulin secretion defect in pancreas-specific STAT3-KO mice is due to altered microvasculature in the pancreas, and not intrinsic beta-cell function.	[Kostromina, Elena; Wang, Xiaorui; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Singapore, Singapore; [Han, Weiping] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Wang, Xiaorui; Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Han, Weiping] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Han, WP (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Singapore, Singapore.	weiping_han@sbic.a-star.edu.sg	Kostromina, E/GPS-9245-2022; Kostromina, Elena/K-3220-2016	Kostromina, Elena/0000-0002-9728-7938	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore (to WH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Ahlgren U, 2011, TYPE 1 DIABETES PATH, P269; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bonner-Weir S, 2005, JOSLINS DIABETES MEL, P41; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Brunicardi FC, 1996, DIABETES, V45, P385, DOI 10.2337/diab.45.4.385; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cleaver O, 2004, CURR TOP DEV BIOL, V62, P1; COLELLA RM, 1985, LIFE SCI, V37, P1059, DOI 10.1016/0024-3205(85)90597-1; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAWSON CM, 1982, J MEMBRANE BIOL, V64, P33, DOI 10.1007/BF01870766; Ellenbroek JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056922; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Han WP, 2010, EMBO MOL MED, V2, P196, DOI 10.1002/emmm.201000074; Huang HH, 2011, EXP DIABETES RES, DOI 10.1155/2011/481427; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Marks V, 1992, NUTR REGULATION INSU, P41; Meda P, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/621249; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Schwartz MW, 2010, DIABETES, V59, P2991, DOI 10.2337/db10-1149; Takeda K, 2001, ARCH IMMUNOL THER EX, V49, P279; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624	40	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71277	10.1371/journal.pone.0071277	http://dx.doi.org/10.1371/journal.pone.0071277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923060	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700231
J	Tada, S; Yasui, T; Nakatsuji, Y; Okuno, T; Koda, T; Mochizuki, H; Sakoda, S; Kikutani, H				Tada, Satoru; Yasui, Teruhito; Nakatsuji, Yuji; Okuno, Tatsusada; Koda, Toru; Mochizuki, Hideki; Sakoda, Saburo; Kikutani, Hitoshi			BAFF Controls Neural Cell Survival through BAFF Receptor	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; DISEASE PROGRESSION; DOPAMINERGIC-NEURONS; PROLONGS SURVIVAL; ANIMAL-MODEL; ALS MODEL; DELIVERY; NEURODEGENERATION; DEGENERATION	Various neuroprotective factors have been shown to help prevention of neuronal cell death, which is responsible for the progression of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). However, most of these therapeutic potentials have been tested by administration of recombinant proteins, transgenic expression or virus vector-mediated gene transfer. Therefore, it remains to be clarified whether any endogenous factors has advantage for neuroprotection in a pathological nervous system. Here we show the role of BAFF-R signaling pathway in the control of neural cell survival. Both B cell-activating factor (BAFF) and its receptor (BAFF-R) are expressed in mouse neurons and BAFF-R deficiency reduces the survival of primary cultured neurons. Although many studies have so far addressed the functional role of BAFF-R on the differentiation of B cells, impaired BAFF-R signaling resulted in accelerated disease progression in an animal model of inherited ALS. We further demonstrate that BAFF-R deficient bone marrow cells or genetic depletion of B cells does not affect the disease progression, indicating that BAFF-mediated signals on neurons, not on B cells, support neural cell survival. These findings suggest opportunities to improve therapeutic outcome for patients with neurodegenerative diseases by synthesized BAFF treatment.	[Tada, Satoru; Nakatsuji, Yuji; Okuno, Tatsusada; Koda, Toru; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Tada, Satoru; Yasui, Teruhito; Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr IFReC, Dept Mol Immunol, Suita, Osaka 565, Japan; [Sakoda, Saburo] Natl Toneyama Hosp, Dept Neurol, Toyonaka, Osaka, Japan	Osaka University; Osaka University	Yasui, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr IFReC, Dept Mol Immunol, Suita, Osaka 565, Japan.	yasui@ragtime.biken.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp		Tada, Satoru/0000-0002-0323-5644	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24790883]; MEXT [20229007]; GSR on Innovative Areas from MEXT [24111531]; Japanese Ministry of Health, Labour and Welfare [22590931]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); GSR on Innovative Areas from MEXT; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was financially supported in part by Grant-in-Aid for Young Scientists (B) to ST (No. 24790883) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant-in-Aid for Scientific Research (GSR, S) to HK (No. 20229007) from MEXT, GSR on Innovative Areas to HM (No. 24111531) from MEXT, and Health and Labour Sciences Research Grants for Intractable Diseases to YN (No. 22590931) from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Blesch A, 2006, BRAIN PATHOL, V16, P295, DOI 10.1111/j.1750-3639.2006.00036.x; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Castellani Rudy J, 2007, Expert Rev Neurother, V7, P473, DOI 10.1586/14737175.7.5.473; Chen J, 2010, J NEUROENDOCRINOL, V22, P1072, DOI 10.1111/j.1365-2826.2010.02054.x; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Dewil M, 2007, NEUROPATH APPL NEURO, V33, P499, DOI 10.1111/j.1365-2990.2007.00850.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Kanzawa T, 2000, J NEUROSCI RES, V62, P383, DOI 10.1002/1097-4547(20001101)62:3<383::AID-JNR8>3.0.CO;2-6; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Nagahara AH, 2009, EXP NEUROL, V215, P153, DOI 10.1016/j.expneurol.2008.10.004; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naor S, 2009, J NEUROL, V256, P1228, DOI 10.1007/s00415-009-5097-3; Nawa M, 2012, CELL DEATH DIFFER, V19, P1398, DOI 10.1038/cdd.2012.19; Okuno T, 2005, J NEUROSCI RES, V81, P874, DOI 10.1002/jnr.20599; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Sun W, 2002, J NEUROSCI, V22, P6537; Tada S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-19; Tolosa L, 2009, NEUROSCIENCE, V158, P1348, DOI 10.1016/j.neuroscience.2008.10.060; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	30	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70924	10.1371/journal.pone.0070924	http://dx.doi.org/10.1371/journal.pone.0070924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923031	Green Published, gold			2022-12-27	WOS:000323369700213
J	Joice, R; Lipsitch, M				Joice, Regina; Lipsitch, Marc			Targeting Imperfect Vaccines against Drug-Resistance Determinants: A Strategy for Countering the Rise of Drug Resistance	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC-RESISTANCE; NASAL COLONIZATION; UNITED-STATES; EFFLUX PUMPS; FITNESS COST; PENICILLIN	The growing prevalence of antimicrobial resistance in major pathogens is outpacing discovery of new antimicrobial classes. Vaccines mitigate the effect of antimicrobial resistance by reducing the need for treatment, but vaccines for many drug-resistant pathogens remain undiscovered or have limited efficacy, in part because some vaccines selectively favor pathogen strains that escape vaccine-induced immunity. A strain with even a modest advantage in vaccinated hosts can have high fitness in a population with high vaccine coverage, which can offset a strong selection pressure such as antimicrobial use that occurs in a small fraction of hosts. We propose a strategy to target vaccines against drug-resistant pathogens, by using resistance-conferring proteins as antigens in multicomponent vaccines. Resistance determinants may be weakly immunogenic, offering only modest specific protection against resistant strains. Therefore, we assess here how varying the specific efficacy of the vaccine against resistant strains would affect the proportion of drug-resistant vs. -sensitive strains population-wide for three pathogens - Streptococcus pneumoniae, Staphylococcus aureus, and influenza virus - in which drug resistance is a problem. Notably, if such vaccines confer even slightly higher protection (additional efficacy between 1% and 8%) against resistant variants than sensitive ones, they may be an effective tool in controlling the rise of resistant strains, given current levels of use for many antimicrobial agents. We show that the population-wide impact of such vaccines depends on the additional effect on resistant strains and on the overall effect (against all strains). Resistance-conferring accessory gene products or resistant alleles of essential genes could be valuable as components of vaccines even if their specific protective effect is weak.	[Joice, Regina; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu		Joice Cordy, Regina/0000-0002-5369-0215; Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health Models of Infectious Disease Agent Study program [1 U54 GM088558]; National Institute of Allergy and Infectious Diseases [T32 AI007535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638, T32AI007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	United States National Institutes of Health Models of Infectious Disease Agent Study program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards 1 U54 GM088558 from the United States National Institutes of Health Models of Infectious Disease Agent Study program (ML) and T32 AI007535 from the National Institute of Allergy and Infectious Diseases (RJ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY R, 1974, J INFECT DIS, V129, P720, DOI 10.1093/infdis/129.6.720; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; [Anonymous], P NATL ACAD SCI US, V109, P3623; Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; BEUTNER KR, 1979, J INFECT DIS, V140, P844, DOI 10.1093/infdis/140.6.844; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; CDC, 2009, NAT HOSP DISCH SURV; Centers for Disease Control and Prevention, 2010, GON IS SURV PROJ GIS; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chao DL, 2012, J R SOC INTERFACE, V9, P648, DOI 10.1098/rsif.2011.0427; Charpentier E, 2000, MICROBES INFECT, V2, P1855, DOI 10.1016/S1286-4579(00)01345-9; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; Creech CB, 2005, PEDIATR INFECT DIS J, V24, P617, DOI 10.1097/01.inf.0000168746.62226.a4; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Finkelstein JA, 2001, PEDIATRICS, V108, pU113; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Greby Stacie M., 2012, Morbidity and Mortality Weekly Report, V61, P647; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Hicks LA, 2011, CLIN INFECT DIS, V53, P631, DOI 10.1093/cid/cir443; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Horn DL, 1998, CLIN INFECT DIS, V26, P1341, DOI 10.1086/516375; Huang SS, 2011, CRIT CARE, V15, DOI 10.1186/cc10445; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lee GM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-110; Levin BR, 1997, CLIN INFECT DIS, V24, pS9, DOI 10.1093/clinids/24.Supplement_1.S9; Li Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002989; Link-Gelles R, J INFECT DI IN PRESS; Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lipsitch M, 2001, TRENDS MICROBIOL, V9, P438, DOI 10.1016/S0966-842X(01)02130-8; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lo WT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015791; Mattner F, 2010, INFECTION, V38, P363, DOI 10.1007/s15010-010-0038-8; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Musher DM, 2006, NEW ENGL J MED, V354, P1522, DOI 10.1056/NEJMe068038; Nielsen KL, 2012, J ANTIMICROB CHEMOTH, V67, P1325, DOI 10.1093/jac/dks051; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Patel SN, 2011, ANTIMICROB AGENTS CH, V55, P3703, DOI 10.1128/AAC.00237-11; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Rossolini GM, 2010, CURR OPIN MICROBIOL, V13, P582, DOI 10.1016/j.mib.2010.08.006; Sabol KE, 2006, ANN PHARMACOTHER, V40, P1125, DOI 10.1345/aph.1G404; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Tekle YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050688; Temime L, 2004, ANTIMICROB AGENTS CH, V48, P2206, DOI 10.1128/AAC.48.6.2206-2213.2004; Trzcinski K, 2006, J INFECT DIS, V193, P1296, DOI 10.1086/501367; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Zarantonelli ML, 2006, J ANTIMICROB CHEMOTH, V57, P924, DOI 10.1093/jac/dkl066; Zhu YH, 2011, IMMUNOL LETT, V140, P68, DOI 10.1016/j.imlet.2011.06.009	62	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68940	10.1371/journal.pone.0068940	http://dx.doi.org/10.1371/journal.pone.0068940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935910	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300016
J	Avci-Adali, M; Steinle, H; Michel, T; Schlensak, C; Wendel, HP				Avci-Adali, Meltem; Steinle, Heidrun; Michel, Tatjana; Schlensak, Christian; Wendel, Hans P.			Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTOR-2; IN-VIVO; CYTOSOLIC DNA; RNA; INFLAMMASOME; PATHWAY; SENSOR; OLIGODEOXYNUCLEOTIDES; COAGULATION	Target specific short single-stranded DNA (ssDNA) molecules, called aptamers, are auspicious ligands for numerous in vivo applications. However, aptamers are synthetic molecules, which might be recognized by the immune cells in vivo and induce an activation of the innate immune system. Thus, immune activation potential of synthetic ssDNA oligonucleotides (ODNs) was determined using a well established closed-loop circulation model. Fresh human blood was incubated at 37 degrees C for 2 or 4 hours with ssDNA ODNs (SB_ODN) or CpG ODN as positive control. Transcriptional changes were determined by microarray analyses. Blood samples containing SB_ODN demonstrated after 4 hours a significant regulation of 295 transcripts. Amongst others, CCL8, CXCL10, CCL7 and CXCL11 were highest regulated genes. Gene Ontology terms and KEGG pathway analyses exhibited that the differentially expressed genes belong to the transcripts that are regulated during an immune and inflammatory response, and were overrepresented in TLR signaling pathway. This study shows for the first time the potential of aptamers to activate immune system after systemic application into the human blood. Thus, we highly recommend performing of these preclinical tests with potential aptamer-based therapeutics.	[Avci-Adali, Meltem; Steinle, Heidrun; Michel, Tatjana; Schlensak, Christian; Wendel, Hans P.] Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Wendel, HP (corresponding author), Univ Tubingen Hosp, Dept Thorac Cardiac & Vasc Surg, Tubingen, Germany.	hans-peter.wendel@med.uni-tuebingen.de		Avci-Adali, Meltem/0000-0003-4008-4272	European Social Funds in Baden-Wuerttemberg, Germany; MWK-BW, Germany; German Federal Ministry of Education and Research (BMBF)	European Social Funds in Baden-Wuerttemberg, Germany; MWK-BW, Germany; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was funded by the European Social Funds in Baden-Wuerttemberg, Germany, the MWK-BW, Germany and the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; CHANDLER AB, 1958, LAB INVEST, V7, P110; Charlton J, 1997, CHEM BIOL, V4, P809, DOI 10.1016/S1074-5521(97)90114-9; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; El Kebir D, 2008, ARCH IMMUNOL THER EX, V56, P41, DOI 10.1007/s00005-008-0008-3; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Hong H, 2011, CURR MED CHEM, V18, P4195, DOI 10.2174/092986711797189691; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jilma-Stohlawetz P, 2011, THROMB HAEMOSTASIS, V106, P539, DOI 10.1160/TH11-02-0069; Karbach J, 2012, CANCER RES, V72, P4304, DOI 10.1158/0008-5472.CAN-12-0257; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Paul A, 2010, CLIN APPL THROMB-HEM, V16, P161, DOI 10.1177/1076029608329580; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Schafer R, 2007, ROFO-FORTSCHR RONTG, V179, P1009, DOI 10.1055/s-2007-963409; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Shimosato T, 2006, CELL MICROBIOL, V8, P485, DOI 10.1111/j.1462-5822.2005.00640.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; Wu CCN, 2008, CELL IMMUNOL, V251, P78, DOI 10.1016/j.cellimm.2008.04.001; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yasuda K, 2006, EUR J IMMUNOL, V36, P431, DOI 10.1002/eji.200535210	41	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68810	10.1371/journal.pone.0068810	http://dx.doi.org/10.1371/journal.pone.0068810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935890	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000038
J	Dossa, GGO; Paudel, E; Fujinuma, J; Yu, HY; Chutipong, W; Zhang, Y; Paz, S; Harrison, RD				Dossa, Gbadamassi G. O.; Paudel, Ekananda; Fujinuma, Junichi; Yu, Haiying; Chutipong, Wanlop; Zhang, Yuan; Paz, Sherryl; Harrison, Rhett D.			Factors Determining Forest Diversity and Biomass on a Tropical Volcano, Mt. Rinjani, Lombok, Indonesia	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; ELEVATIONAL GRADIENT; ABOVEGROUND BIOMASS; VASCULAR EPIPHYTES; COMMUNITY BIOMASS; CURRENT KNOWLEDGE; MOUNT KINABALU; PATTERNS; DENSITY; PRODUCTIVITY	Tropical volcanoes are an important but understudied ecosystem, and the relationships between plant species diversity and compositional change and elevation may differ from mountains created by uplift, because of their younger and more homogeneous soils. We sampled vegetation over an altitudinal gradient on Mt. Rinjani, Lombok, Indonesia. We modeled alpha- (plot) and beta- (among plot) diversity (Fisher's alpha), compositional change, and biomass against elevation and selected covariates. We also examined community phylogenetic structure across the elevational gradient. We recorded 902 trees and shrubs among 92 species, and 67 species of ground-cover plants. For understorey, subcanopy and canopy plants, an increase in elevation was associated with a decline in alpha-diversity, whereas data for ground-cover plants suggested a hump-shaped pattern. Elevation was consistently the most important factor in determining alpha-diversity for all components. The alpha-diversity of ground-cover vegetation was also negatively correlated with leaf area index, which suggests low light conditions in the understorey may limit diversity at lower elevations. Beta-diversity increased with elevation for ground-cover plants and declined at higher elevations for other components of the vegetation. However, statistical power was low and we could not resolve the relative importance to beta-diversity of different factors. Multivariate GLMs of variation in community composition among plots explained 67.05%, 27.63%, 18.24%, and 19.80% of the variation (deviance) for ground-cover, understorey, subcanopy and canopy plants, respectively, and demonstrated that elevation was a consistently important factor in determining community composition. Above-ground biomass showed no significant pattern with elevation and was also not significantly associated with alpha-diversity. At lower elevations communities had a random phylogenetic structure, but from 1600 m communities were phylogenetically clustered. This suggests a greater role of environmental filtering at higher elevations, and thus provides a possible explanation for the observed decline in diversity with elevation.	[Dossa, Gbadamassi G. O.; Zhang, Yuan] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Dossa, Gbadamassi G. O.; Paudel, Ekananda; Zhang, Yuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dossa, Gbadamassi G. O.] Northeast Agr Univ, Sch Resources & Environm, Harbin, Peoples R China; [Dossa, Gbadamassi G. O.; Paudel, Ekananda; Yu, Haiying; Chutipong, Wanlop; Zhang, Yuan; Paz, Sherryl] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Program Field Studies Trop Asia, Mengla, Yunnan, Peoples R China; [Paudel, Ekananda; Yu, Haiying; Harrison, Rhett D.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Fujinuma, Junichi] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Yu, Haiying; Harrison, Rhett D.] East Asia Off, World Agroforestry Ctr, Kunming, Yunnan, Peoples R China; [Chutipong, Wanlop] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Conservat Ecol Program, Bangkok, Thailand; [Paz, Sherryl] Caraga State Univ, Butuan City, Philippines	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Hokkaido University; King Mongkuts University of Technology Thonburi	Harrison, RD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	r.harrison@cgiar.org		Dossa, Gbadamassi G.O./0000-0001-9767-7306; Fujinuma, Junichi/0000-0001-9004-4709; Harrison, Rhett/0000-0001-9055-3546	CAPaBLE grant from the Asia-Pacific Network for Global Change Research [CBA2010-03NSY-Indrawan]; ICRAF, East Asia Office; Hokkaido University	CAPaBLE grant from the Asia-Pacific Network for Global Change Research; ICRAF, East Asia Office(CGIAR); Hokkaido University	The field course "Developing the capacity for teaching biodiversity and conservation in the Asia-Pacific region" during which this research was conducted was supported through a CAPaBLE grant from the Asia-Pacific Network for Global Change Research (#CBA2010-03NSY-Indrawan). ICRAF, East Asia Office gave additional financial support for EN and HY and Hokkaido University gave additional support for JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; Astawa B, 2004, 10 BIENN C INT ASS S, P1; Austrheim G, 2002, PLANT ECOL, V161, P193, DOI 10.1023/A:1020315718720; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Balvanera P, 2002, J VEG SCI, V13, P145, DOI 10.1111/j.1654-1103.2002.tb02034.x; Barton K., 2013, MUMIN MULTIMODEL INF; Begon M., 2009, ECOLOGY INDIVIDUALS; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bhattarai KR, 2004, FOLIA GEOBOT, V39, P57, DOI 10.1007/BF02803264; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Carpenter C, 2005, J BIOGEOGR, V32, P999, DOI 10.1111/j.1365-2699.2005.01249.x; Chadwick OA, 2003, CHEM GEOL, V202, P195, DOI 10.1016/j.chemgeo.2002.09.001; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chazdon R. L., 1984, PHYSL ECOLOGY PLANTS, P553; Culmsee H, 2010, J BIOGEOGR, V37, P960, DOI 10.1111/j.1365-2699.2009.02269.x; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; del Moral R, 2010, ARCT ANTARCT ALP RES, V42, P335, DOI 10.1657/1938-4246-42.3.335; Del Moral Roger, 1999, V16, P137; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Flenley JR, 2011, J BIOGEOGR, V38, P809, DOI 10.1111/j.1365-2699.2011.02480.x; Frazer GW, 1999, VERSION 2 0 IMAGING; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Grace JB, 2001, OIKOS, V92, P193, DOI 10.1034/j.1600-0706.2001.920201.x; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Harrison RD, 2001, J BIOGEOGR, V28, P1311, DOI 10.1046/j.1365-2699.2001.00641.x; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Huston M. A., 1994, BIOL DIVERSITY; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kuper W, 2004, J BIOGEOGR, V31, P1477, DOI 10.1111/j.1365-2699.2004.01093.x; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Marler TE, 2011, PAC SCI, V65, P157, DOI 10.2984/65.2.157; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; Ohlemuller R, 2000, ECOL LETT, V3, P262, DOI 10.1046/j.1461-0248.2000.00151.x; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PALMER M.W., 1997, P OKLA ACAD SCI, V77, P17; PALMER MW, 1991, J VEG SCI, V2, P361, DOI 10.2307/3235928; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Propastin P, 2011, INT J GEOGR INF SCI, V25, P455, DOI 10.1080/13658816.2010.518570; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Richter M., 2009, LANDSC ONLINE, V12, P1, DOI [10.3097/LO.200912, DOI 10.3097/LO.200912]; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Thornton Ian W., 1997, KRAKATAU DESTRUCTION; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; WHITTAKER RJ, 1989, J BIOGEOGR, V16, P413, DOI 10.2307/2845105; Wyatt JL, 2004, OECOLOGIA, V140, P26, DOI 10.1007/s00442-004-1554-y; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067	72	27	27	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67720	10.1371/journal.pone.0067720	http://dx.doi.org/10.1371/journal.pone.0067720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935842	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000016
J	Lucchetti, J; Marino, M; Papa, S; Tortarolo, M; Guiso, G; Pozzi, S; Bonetto, V; Caccia, S; Beghi, E; Bendotti, C; Gobbi, M				Lucchetti, Jacopo; Marino, Marianna; Papa, Simonetta; Tortarolo, Massimo; Guiso, Giovanna; Pozzi, Silvia; Bonetto, Valentina; Caccia, Silvio; Beghi, Ettore; Bendotti, Caterina; Gobbi, Marco			A Mouse Model of Familial ALS Has Increased CNS Levels of Endogenous Ubiquinol(9/10) and Does Not Benefit from Exogenous Administration of Ubiquinol(10)	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; COENZYME Q(10); MITOCHONDRIAL; PLASMA; DISEASE; PEROXYNITRITE; PATHOGENESIS; OXIDATION; STRESS; SINGLE	Oxidative stress and mitochondrial impairment are the main pathogenic mechanisms of Amyotrophic Lateral Sclerosis (ALS), a severe neurodegenerative disease still lacking of effective therapy. Recently, the coenzyme-Q (CoQ) complex, a key component of mitochondrial function and redox-state modulator, has raised interest for ALS treatment. However, while the oxidized form ubiquinone(10) was ineffective in ALS patients and modestly effective in mouse models of ALS, no evidence was reported on the effect of the reduced form ubiquinol(10), which has better bioavailability and antioxidant properties. In this study we compared the effects of ubiquinone(10) and a new stabilized formulation of ubiquinol(10) on the disease course of SOD1(G93A) transgenic mice, an experimental model of fALS. Chronic treatments (800 mg/kg/day orally) started from the onset of disease until death, to mimic the clinical trials that only include patients with definite ALS symptoms. Although the plasma levels of CoQ(10) were significantly increased by both treatments (from <0.20 to 3.0-3.4 mu g/mL), no effect was found on the disease progression and survival of SOD1(G93A) mice. The levels of CoQ(10) in the brain and spinal cord of ubiquinone(10)- or ubiquinol(10)-treated mice were only slightly higher (<= 10%) than the endogenous levels in vehicle-treated mice, indicating poor CNS availability after oral dosing and possibly explaining the lack of pharmacological effects. To further examine this issue, we measured the oxidized and reduced forms of CoQ(9/10) in the plasma, brain and spinal cord of symptomatic SOD1(G93A) mice, in comparison with age-matched SOD1(WT). Levels of ubiquinol(9/10), but not ubiquinone(9/10), were significantly higher in the CNS, but not in plasma, of SOD1(G93A) mice, suggesting that CoQ redox system might participate in the mechanisms trying to counteract the pathology progression. Therefore, the very low increases of CoQ(10) induced by oral treatments in CNS might be not sufficient to provide significant neuroprotection in SOD1(G93A) mice.	[Lucchetti, Jacopo; Guiso, Giovanna; Caccia, Silvio; Gobbi, Marco] IRCCS Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, Milan, Italy; [Marino, Marianna; Papa, Simonetta; Tortarolo, Massimo; Beghi, Ettore; Bendotti, Caterina] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Pozzi, Silvia; Bonetto, Valentina] IRCCS Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bendotti, C (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy.	caterina.bendotti@marionegri.it; marco.gobbi@marionegri.it	Gobbi, Marco/J-2638-2016; Beghi, Ettore/AAA-7426-2020; Lucchetti, Jacopo/K-7835-2016; Papa, Simonetta/AAJ-9394-2020; Tortarolo, Massimo/AAA-8048-2020; Bonetto, Valentina/ABB-6383-2020; Bonetto, Valentina/I-4694-2018; Silvia, Pozzi/AAF-9396-2019; Bendotti, Caterina/AAB-2273-2020	Gobbi, Marco/0000-0003-1014-6225; Beghi, Ettore/0000-0003-2542-0469; Lucchetti, Jacopo/0000-0002-9503-8786; Papa, Simonetta/0000-0002-6062-649X; Tortarolo, Massimo/0000-0003-3078-2341; Bonetto, Valentina/0000-0003-0456-2054; Bonetto, Valentina/0000-0003-0456-2054; Silvia, Pozzi/0000-0002-1500-8158; Bendotti, Caterina/0000-0003-1055-1271	Sintofarm S.p.A., Guastalla (RE), Italy; Fondazione Telethon Funding Source: Custom	Sintofarm S.p.A., Guastalla (RE), Italy; Fondazione Telethon(Fondazione Telethon)	The work was partly funded by Sintofarm S.p.A., Guastalla (RE), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Bendotti C, 2004, TRENDS MOL MED, V10, P393, DOI 10.1016/j.molmed.2004.06.009; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; EDLUND C, 1992, BIOCHEM CELL BIOL, V70, P422, DOI 10.1139/o92-065; EDLUND C, 1994, NEUROCHEM INT, V25, P35, DOI 10.1016/0197-0186(94)90050-7; Hosoe K, 2007, REGUL TOXICOL PHARM, V47, P19, DOI 10.1016/j.yrtph.2006.07.001; HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U; Kaufmann P, 2009, ANN NEUROL, V66, P235, DOI 10.1002/ana.21743; Kontush A, 1999, BIOFACTORS, V9, P225, DOI 10.1002/biof.5520090217; Lagendijk J, 1996, J LIPID RES, V37, P67; Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199; Littarru GP, 2007, MITOCHONDRION, V7, pS168, DOI 10.1016/j.mito.2007.03.002; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Mosca F, 2002, ANAL BIOCHEM, V305, P49, DOI 10.1006/abio.2002.5653; Murata T, 2008, J NEUROL SCI, V267, P66, DOI 10.1016/j.jns.2007.09.038; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Podda M, 1996, J LIPID RES, V37, P893; Poderoso JJ, 2009, ARCH BIOCHEM BIOPHYS, V484, P214, DOI 10.1016/j.abb.2008.12.020; Pravst I, 2010, CRIT REV FOOD SCI, V50, P269, DOI 10.1080/10408390902773037; Schopfer F, 2000, BIOCHEM J, V349, P35, DOI 10.1042/0264-6021:3490035; Sohmiya M, 2005, J NEUROL SCI, V228, P49, DOI 10.1016/j.jns.2004.09.030; TAKADA M, 1982, BIOCHIM BIOPHYS ACTA, V679, P308, DOI 10.1016/0005-2728(82)90301-2; TAKADA M, 1984, METHOD ENZYMOL, V105, P147; Tang PH, 2004, CLIN CHIM ACTA, V341, P173, DOI 10.1016/j.cccn.2003.12.002; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007	28	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69540	10.1371/journal.pone.0069540	http://dx.doi.org/10.1371/journal.pone.0069540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936040	gold, Green Submitted, Green Published			2022-12-27	WOS:000325211000133
J	Rulisa, S; Kateera, F; Bizimana, JP; Agaba, S; Dukuzumuremyi, J; Baas, L; Harelimana, JD; Mens, PF; Boer, KR; de Vries, PJ				Rulisa, Stephen; Kateera, Fredrick; Bizimana, Jean Pierre; Agaba, Steven; Dukuzumuremyi, Javier; Baas, Lisette; Harelimana, Jean de Dieu; Mens, Petra F.; Boer, Kimberly R.; de Vries, Peter J.			Malaria Prevalence, Spatial Clustering and Risk Factors in a Low Endemic Area of Eastern Rwanda: A Cross Sectional Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; RURAL AREA; ANTIMALARIAL; CHILDREN; TANZANIA; AFRICA; TRANSMISSION; HEALTH	Background: Rwanda reported significant reductions in malaria burden following scale up of control intervention from 2005 to 2010. This study sought to; measure malaria prevalence, describe spatial malaria clustering and investigate for malaria risk factors among health-centre-presumed malaria cases and their household members in Eastern Rwanda. Methods: A two-stage health centre and household-based survey was conducted in Ruhuha sector, Eastern Rwanda from April to October 2011. At the health centre, data, including malaria diagnosis and individual level malaria risk factors, was collected. At households of these Index cases, a follow-up survey, including malaria screening for all household members and collecting household level malaria risk factor data, was conducted. Results: Malaria prevalence among health centre attendees was 22.8%. At the household level, 90 households (out of 520) had at least one malaria-infected member and the overall malaria prevalence for the 2634 household members screened was 5.1%. Among health centre attendees, the age group 5-15 years was significantly associated with an increased malaria risk and a reported ownership of >= 4 bednets was significantly associated with a reduced malaria risk. At the household level, age groups 5-15 and >15 years and being associated with a malaria positive index case were associated with an increased malaria risk, while an observed ownership of >= 4 bednets was associated with a malaria risk-protective effect. Significant spatial malaria clustering among household cases with clusters located close to water-based agro-ecosystems was observed. Conclusions: Malaria prevalence was significantly higher among health centre attendees and their household members in an area with significant household spatial malaria clustering. Circle surveillance involving passive case finding at health centres and proactive case detection in households can be a powerful tool for identifying household level malaria burden, risk factors and clustering.	[Rulisa, Stephen] Natl Univ Rwanda, Univ Teaching Hosp Kigali, Kigali, Rwanda; [Kateera, Fredrick; Mens, Petra F.; de Vries, Peter J.] Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Rulisa, Stephen; Agaba, Steven; Dukuzumuremyi, Javier; Baas, Lisette; Harelimana, Jean de Dieu; Mens, Petra F.; Boer, Kimberly R.; de Vries, Peter J.] INTERACT Project, Amsterdam Inst Global Hlth & Dev, Kigali, Rwanda; [Mens, Petra F.; Boer, Kimberly R.] KIT Biomed Res, Royal Trop Inst, KIT, Amsterdam, Netherlands; [Bizimana, Jean Pierre] Natl Univ Rwanda, Fac Sci, Dept Geog, Butare, Rwanda; [Kateera, Fredrick] Rwanda Biomed Ctr, Med Res Ctr, Kigali, Rwanda; [de Vries, Peter J.] Tergooiziekenhuizen, Dept Internal Med, Hilversum, Netherlands	University of Rwanda; University of Amsterdam; Academic Medical Center Amsterdam; University of Rwanda; Rwanda Biomedical Center	Kateera, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Infect Dis Trop Med & AIDS, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	fkkateera@yahoo.com	Rulisa, Stephen/E-3914-2018	Rulisa, Stephen/0000-0002-5357-7626	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) through the Infectious diseases Network for Treatment and Research in Africa (INTERACT) - programme (Rwanda/Uganda) [NWOA_6LRD4R_Eng]	Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) through the Infectious diseases Network for Treatment and Research in Africa (INTERACT) - programme (Rwanda/Uganda)	This study was funded by Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases (NACCAP) through the Infectious diseases Network for Treatment and Research in Africa (INTERACT) - programme (Rwanda/Uganda) URL: http://www.nwo.nl/nwohome.nsf/pages/NWOA_6LRD4R_Eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Coleman M, 2010, T ROY SOC TROP MED H, V104, P143, DOI 10.1016/j.trstmh.2009.07.010; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Fontecha GA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-119; Goovaerts Pierre, 2006, Int J Health Geogr, V5, P52, DOI 10.1186/1476-072X-5-52; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-156; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Konradsen F, 2003, AM J TROP MED HYG, V68, P177, DOI 10.4269/ajtmh.2003.68.177; Loha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047354; Martens W J, 1995, Med War, V11, P202, DOI 10.1080/07488009508409240; Ministry of Health, 2009, HLTH SECT STRAT PLAN, P82; Ministry of Health-Rwanda, 2009, INT DEM HLTH SURV 20; Mmbando BP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-145; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; President's Malaria Initiative (PMI), 2010, MAL OP PLAN RWAN RWA; President's Malaria Initiative (PMI), 2011, MAL OP PLAN RWAND FY; Roll Back Malaria Partnership, 2005, GLOB STRAT PLAN 2005; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, WORLD MAL REP 2011; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; World Health Organization, 2007, MAL EL FIELD MAN LOW	36	54	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69443	10.1371/journal.pone.0069443	http://dx.doi.org/10.1371/journal.pone.0069443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936018	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000122
J	Zou, XH; Li, Y; Wang, Y; Zhou, YM; Liu, Y; Xin, JQ				Zou, Xiaohui; Li, Yuan; Wang, Yang; Zhou, Yumei; Liu, Yang; Xin, Jiuqing			Molecular Cloning and Characterization of a Surface-Localized Adhesion Protein in Mycoplasma bovis Hubei-1 Strain	PLOS ONE			English	Article							LIPOPROTEINS	Mycoplasma bovis (M. bovis) is an important pathogen that causes various bovine diseases, such as mastitis in cows and pneumonia in calves. The surface proteins are generally thought to play a central role in the pathogenesis of this organism. We screened the entire genome of M. bovis Hubei-1 and discovered a gene named vpmaX that encodes the 25 kDa variable surface lipoprotein A (VpmaX). Sequence analysis revealed that VpmaX contains several repetitive units and a typical bacterial lipoprotein signal sequence. The vpmaX gene was cloned and expressed in E. coli to obtain recombinant VpmaX (rVpmaX). Western blot analysis using a rabbit antibody against rVpmaX demonstrated that VpmaX is a membrane protein. Immunostaining visualized via confocal laser scanning microscopy showed that rVpmaX was able to adhere to embryonic bovine lung cells (EBL), and this was also confirmed by a sandwich ELISA. In summary, a surface-localized adhesion protein was identified in M. bovis Hubei-1.	[Zou, Xiaohui; Li, Yuan; Wang, Yang; Zhou, Yumei; Xin, Jiuqing] CAAS, Harbin Vet Res Inst, Natl Contagious Bovine Pleuropneumonia Reference, Div Bacterial Dis,State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Liu, Yang] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Xin, JQ (corresponding author), CAAS, Harbin Vet Res Inst, Natl Contagious Bovine Pleuropneumonia Reference, Div Bacterial Dis,State Key Lab Vet Biotechnol, Harbin, Peoples R China.	xinjiuqing2001@126.com	Zhou, Yu/HHN-3071-2022		National Natural Science Foundations of China [31072131]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundations of China, No 31072131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird DW, 2008, INFECT IMMUN, V76, P5768, DOI 10.1128/IAI.00160-08; Bolland JR, 2012, FEMS MICROBIOL LETT, V331, P25, DOI 10.1111/j.1574-6968.2012.02551.x; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Chang HY, 2011, J BACTERIOL, V193, P1726, DOI 10.1128/JB.01228-10; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; HALE HH, 1962, CORNELL VET, V52, P582; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Hermeyer K, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-9; Hopfe M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-55; LeGrand DL, 1996, FEMS MICROBIOL LETT, V144, P267; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Markham PF, 1998, INFECT IMMUN, V66, P2845, DOI 10.1128/IAI.66.6.2845-2853.1998; Maunsell FP, 2009, VET CLIN N AM-FOOD A, V25, P139, DOI 10.1016/j.cvfa.2008.10.011; Mudahi-Orenstein S, 2003, INFECT IMMUN, V71, P3812, DOI 10.1128/IAI.71.7.3812-3820.2003; Qi J, 2012, PLOS ONE, V7, DOI [10.1371/journal. pone.0038239, DOI 10.1371/J0URNAL.P0NE.0038239, 10.1371/journal.pone.0038239]; ROSENGARTEN R, 1994, INFECT IMMUN, V62, P5066, DOI 10.1128/IAI.62.11.5066-5074.1994; Sachse K, 1996, ZBL BAKT-INT J MED M, V284, P80, DOI 10.1016/S0934-8840(96)80157-5; Sachse K, 2000, INFECT IMMUN, V68, P680, DOI 10.1128/IAI.68.2.680-687.2000; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Seto S, 2001, J BACTERIOL, V183, P1621, DOI 10.1128/JB.183.5.1621-1630.2001; Song YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038002, 10.1371/journal.pone.0052230]; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Xin J, 2008, CHINESE J PREVENTIVE, V9	28	20	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69644	10.1371/journal.pone.0069644	http://dx.doi.org/10.1371/journal.pone.0069644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936063	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000140
J	Cocolin, L; Alessandria, V; Botta, C; Gorra, R; De Filippis, F; Ercolini, D; Rantsiou, K				Cocolin, Luca; Alessandria, Valentina; Botta, Cristian; Gorra, Roberta; De Filippis, Francesca; Ercolini, Danilo; Rantsiou, Kalliopi			NaOH-Debittering Induces Changes in Bacterial Ecology during Table Olives Fermentation	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; NATURALLY BLACK OLIVES; MICROBIAL-POPULATIONS; LACTOBACILLUS-PLANTARUM; DIVERSITY; SEARCH; YEASTS; IDENTIFICATION; BIODIVERSITY; MICROFLORA	Limited information is available on the impact of the NaOH treatment on table olive fermentations, and for this reason a polyphasic approach has been adopted here to investigate its effect on the fermentation dynamics and bacterial biodiversity. The microbial counts of the main groups involved in the transformation have not shown any differences, apart from a more prompt start of the fermentation when the olives were subjected to the NaOH treatment. The data produced by culture-independent analyses highlighted that the fermentation of table olives not treated with NaOH is the result of the coexistence of two different ecosystems: the surface of the olives and the brines. A sodium hydroxide treatment not only eliminates this difference, but also affects the bacterial ecology of the olives to a great extent. As proved by high-throughput sequencing, the fermentation of the olives not treated with NaOH was characterized by the presence of halophilic bacteria, which were substituted by Lactobacillus at the later stages of the fermentation, while enterobacteria were dominant when the olives were treated with sodium hydroxide. Higher biodiversity was found for Lactobacillus plantarum isolated during untreated fermentation. Different biotypes were found on the olive surface and in the brines. When the debittering process was carried out, a decrease in the number of L. plantarum biotypes were observed and those originating from the surface of the olive did not differentiate from the ones present in the brines.	[Cocolin, Luca; Alessandria, Valentina; Botta, Cristian; Gorra, Roberta; Rantsiou, Kalliopi] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy; [De Filippis, Francesca; Ercolini, Danilo] Univ Naples Federico II, Dipartimento Agr, Portici, Italy	University of Turin; University of Naples Federico II	Cocolin, L (corresponding author), Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy.	lucasimone.cocolin@unito.it	Ercolini, Danilo/B-2431-2009; Cocolin, Luca/H-5091-2012; Botta, Cristian/F-5885-2013; De Filippis, Francesca/K-3816-2016	Ercolini, Danilo/0000-0003-3061-9560; Cocolin, Luca/0000-0003-4799-7074; Botta, Cristian/0000-0003-1102-3294; De Filippis, Francesca/0000-0002-3474-2884; GORRA, ROBERTA/0000-0002-7007-7113	EU [243471- PROBIOLIVES]	EU(European Commission)	The research conducted to obtain these results received funding from the EU (FP7/2007 2013), under grant agreement no. 243471- PROBIOLIVES (www.probiolives.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2011, INT J FOOD MICROBIOL, V144, P487, DOI 10.1016/j.ijfoodmicro.2010.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Aponte M, 2010, FOOD MICROBIOL, V27, P162, DOI 10.1016/j.fm.2009.09.010; Arroyo-Lopez FN, 2006, FOOD MICROBIOL, V23, P791, DOI 10.1016/j.fm.2006.02.008; Arroyo-Lopez FN, 2012, INT J FOOD MICROBIOL, V160, P42, DOI 10.1016/j.ijfoodmicro.2012.08.003; Arroyo-Lopez FN, 2012, FOOD MICROBIOL, V32, P295, DOI 10.1016/j.fm.2012.07.003; Arroyo-Lopez FN, 2008, INT J FOOD MICROBIOL, V128, P189, DOI 10.1016/j.ijfoodmicro.2008.08.018; Arroyo-Lopez F. N., 2010, CURRENT RES TECHNOLO, P1452; Bautista-Gallego J, 2011, INT J FOOD MICROBIOL, V147, P89, DOI 10.1016/j.ijfoodmicro.2011.03.013; Bevilacqua A, 2009, INT J FOOD SCI TECH, V44, P2198, DOI 10.1111/j.1365-2621.2009.02060.x; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Botta C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00245; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chanikha M, 2008, INT J FOOD MICROBIOL, V122, P211, DOI [10.1010/j.ijfoodmicro.2007.11.052, 10.1016/j.ijfoodmicro.2007.11.052]; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cocolin L, 2004, APPL ENVIRON MICROB, V70, P1883, DOI 10.1128/AEM.70.4.1883-1894.2004; Dal Bello B, 2010, LWT-FOOD SCI TECHNOL, V43, P1151, DOI 10.1016/j.lwt.2010.03.008; De Bellis P, 2010, INT J FOOD MICROBIOL, V140, P6, DOI 10.1016/j.ijfoodmicro.2010.02.024; Doulgeraki AI, 2013, LWT-FOOD SCI TECHNOL, V50, P353, DOI 10.1016/j.lwt.2012.07.003; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ercolini D, 2006, INT J FOOD MICROBIOL, V112, P291, DOI 10.1016/j.ijfoodmicro.2006.09.003; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Ercolini D, 2012, APPL ENVIRON MICROB, V78, P8142, DOI 10.1128/AEM.02218-12; Ercolini D, 2011, APPL ENVIRON MICROB, V77, P7372, DOI 10.1128/AEM.05521-11; Garrido-Fernandez A., 1997, TABLE OLIVES PRODUCT; Hernandez A, 2007, FOOD MICROBIOL, V24, P346, DOI 10.1016/j.fm.2006.07.022; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Hurtado A, 2012, FOOD MICROBIOL, V31, P1, DOI 10.1016/j.fm.2012.01.006; Hurtado A, 2011, FOOD MICROBIOL, V28, P1514, DOI 10.1016/j.fm.2011.07.010; Hurtado A, 2010, FOOD MICROBIOL, V27, P731, DOI 10.1016/j.fm.2010.03.006; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Masoud W, 2011, INT DAIRY J, V21, P142, DOI 10.1016/j.idairyj.2010.10.007; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nychas GJE, 2002, LETT APPL MICROBIOL, V34, P173, DOI 10.1046/j.1472-765x.2002.01077.x; O'Sullivan LA, 2008, J MICROBIOL METH, V75, P579, DOI 10.1016/j.mimet.2008.08.006; Panagou EZ, 2008, FOOD MICROBIOL, V25, P348, DOI 10.1016/j.fm.2007.10.005; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Randazzo CL, 2012, FOOD MICROBIOL, V32, P87, DOI 10.1016/j.fm.2012.04.013; Rantsiou K, 2008, INT J FOOD MICROBIOL, V126, P36, DOI 10.1016/j.ijfoodmicro.2008.04.031; Roth E, 2011, INT J FOOD MICROBIOL, V147, P26, DOI 10.1016/j.ijfoodmicro.2011.02.032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Gomez AH, 2006, GRASAS ACEITES, V57, P86; Shannon CE, 1949, AT&T TECH J, V27, P359; Silva T, 2011, LWT-FOOD SCI TECHNOL, V44, P1349, DOI 10.1016/j.lwt.2011.01.029; Tassou CC, 2002, FOOD MICROBIOL, V19, P605, DOI 10.1006/fmic.2002.0480; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; UNAPROL, 2012, MON AZ OL FRANT; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x	54	61	62	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69074	10.1371/journal.pone.0069074	http://dx.doi.org/10.1371/journal.pone.0069074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935928	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700018
J	Murima, P; de Sessions, PF; Lim, V; Naim, ANM; Bifani, P; Boshoff, HIM; Sambandamurthy, VK; Dick, T; Hibberd, ML; Schreiber, M; Rao, SPS				Murima, Paul; de Sessions, Paola Florez; Lim, Vivian; Naim, Ahmad Nazri Mohamed; Bifani, Pablo; Boshoff, Helena I. M.; Sambandamurthy, Vasan K.; Dick, Thomas; Hibberd, Martin L.; Schreiber, Mark; Rao, Srinivasa P. S.			Exploring the Mode of Action of Bioactive Compounds by Microfluidic Transcriptional Profiling in Mycobacteria	PLOS ONE			English	Article							DRUG DISCOVERY; TUBERCULOSIS; SCREEN; ARRAY; MICROARRAYS; MECHANISMS; PREDICTION; INHIBITORS; BIOLOGY; AGENTS	Most candidate anti-bacterials are identified on the basis of their whole cell anti-bacterial activity. A critical bottleneck in the early discovery of novel anti-bacterials is tracking the structure activity relationship (SAR) of the novel compounds synthesized during the hit to lead and lead optimization stage. It is often very difficult for medicinal chemists to visualize if the novel compounds synthesized for understanding SAR of a particular scaffold have similar molecular mechanism of action (MoA) as that of the initial hit. The elucidation of the molecular MoA of bioactive inhibitors is critical. Here, a new strategy and routine assay for MoA de-convolution, using a microfluidic platform for transcriptional profiling of bacterial response to inhibitors with whole cell activity has been presented. First a reference transcriptome compendium of Mycobacterial response to various clinical and investigational drugs was built. Using feature reduction, it was demonstrated that subsets of biomarker genes representative of the whole genome are sufficient for MoA classification and deconvolution in a medium-throughput microfluidic format ultimately leading to a cost effective and rapid tool for routine antibacterial drug-discovery programs.	[Murima, Paul; Lim, Vivian; Bifani, Pablo; Sambandamurthy, Vasan K.; Dick, Thomas; Schreiber, Mark; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, Singapore, Singapore; [de Sessions, Paola Florez; Naim, Ahmad Nazri Mohamed; Hibberd, Martin L.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Boshoff, Helena I. M.] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Dick, Thomas] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Schreiber, Mark] Novartis Inst Biomed Res, Cambridge, MA USA	Novartis; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National University of Singapore; Novartis	Schreiber, M (corresponding author), Novartis Inst Trop Dis, Singapore, Singapore.	mark.schrieber@novartis.com; srinivasa.rao@novartis.com	Dick, Thomas/AAB-4109-2019; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Bifani, Pablo/0000-0001-9651-6439; Hibberd, Martin/0000-0001-8587-1849	Novartis Institute for Tropical Diseases (NITD); Genome Institute of Singapore (GIS); Intramural Research Program of NIAID, National Institutes of Health	Novartis Institute for Tropical Diseases (NITD); Genome Institute of Singapore (GIS)(Agency for Science Technology & Research (A*STAR)); Intramural Research Program of NIAID, National Institutes of Health	This work was funded, in part, by Novartis Institute for Tropical Diseases (NITD), Genome Institute of Singapore (GIS) and the Intramural Research Program of NIAID, National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Barczak AK, 2012, P NATL ACAD SCI USA, V109, P6217, DOI 10.1073/pnas.1119540109; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Chan Pan F., 2002, Current Drug Targets - Infectious Disorders, V2, P291, DOI 10.2174/1568005023342227; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dick T, 2011, FUTURE MICROBIOL, V6, P603, DOI [10.2217/FMB.11.26, 10.2217/fmb.11.26]; Frantz S, 2005, NAT REV DRUG DISCOV, V4, P362, DOI 10.1038/nrd1746; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Keller TH, 2011, CURR OPIN CHEM BIOL, V15, P529, DOI 10.1016/j.cbpa.2011.06.007; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kurabachew M, 2008, J ANTIMICROB CHEMOTH, V62, P713, DOI 10.1093/jac/dkn269; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Mangan JA, 1997, NUCLEIC ACIDS RES, V25, P675, DOI 10.1093/nar/25.3.675; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Payne D J, 2001, Curr Opin Investig Drugs, V2, P1028; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; R Development Core Team, 2008, R LANG ENV STAT COMP; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Sanz LM, 2011, ANTIMICROB AGENTS CH, V55, P5740, DOI 10.1128/AAC.05188-11; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Stekel D, 2003, ANAL RELATIONSHIPS G, P139; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410	33	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69191	10.1371/journal.pone.0069191	http://dx.doi.org/10.1371/journal.pone.0069191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935951	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000322633700019
J	Ma, J; Zhang, YC; Chen, XY; Jin, Y; Chen, DX; Wu, Y; Cui, J; Wang, HT; Liu, J; Li, N; Gao, F				Ma, Jie; Zhang, Yingchun; Chen, Xinyue; Jin, Yi; Chen, Dexi; Wu, Yun; Cui, Jing; Wang, Haitao; Liu, Jia; Li, Ning; Gao, Feng			Association of Preexisting Drug-Resistance Mutations and Treatment Failure in Hepatitis B Patients	PLOS ONE			English	Article							LAMIVUDINE THERAPY; VIRUS POLYMERASE; YMDD-MOTIF; HBV; REPLICATION; POPULATIONS; HIV; RECOMMENDATIONS; NUCLEOSIDE; EVOLUTION	The role of preexisting minority drug-resistance mutations in treatment failure has not been fully understood in chronic hepatitis B patients. To understand mechanisms of drug resistance, we analyzed drug-resistance mutations in 46 treatment-failure patients and in 29 treatment-naive patients and determined linkage patterns of the drug-resistance mutations in individual viral genomes using a highly sensitive parallel allele-specific sequencing (PASS) method. Lamivudine resistance (LAMr) mutations were predominant in treatment-failure patients, irrespective of the inclusion of LAM in the regimen. The primary LAMr mutations M204V and M204I were detected in 100% and 30% of the treatment-failure patients, respectively. Two secondary LAMr mutations (L180M and V173L) were also found in most treatment-failure patients (87% and 78%, respectively). The linkages containing these three mutations dominated the resistant viruses. Importantly, minority LAMr mutations present in < 2% of the viral population were detected in 83% of the treatment-naive patients. Moreover, the low-frequency same linked LAMr mutations (< 0.15%) were detected in 24% of the treatment-naive patients. Our results demonstrate that the selection of preexisting minority linked LAMr mutations may be an important mechanism for the rapid development of LAM resistance, caution the continuous use of LAM to treat drug-experienced and -naive hepatitis B patients, and underline the importance of the detection of minority single and linked drug-resistance mutations before initiating antiviral therapy.	[Ma, Jie; Chen, Dexi; Li, Ning] Beijing Inst Liver Dis, Beijing, Peoples R China; [Ma, Jie; Zhang, Yingchun; Wu, Yun; Cui, Jing; Wang, Haitao] Beijing Baihuirui Biotechnol Inc, Beijing, Peoples R China; [Chen, Xinyue; Jin, Yi; Li, Ning] Capital Med Univ, Beijing Youan Hosp, Dept Med, Beijing, Peoples R China; [Li, Ning] Capital Med Univ, Beijing Youan Hosp, Dept Surg, Beijing, Peoples R China; [Liu, Jia] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Gao, Feng] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Capital Medical University; Capital Medical University; Peking University; Duke University	Li, N (corresponding author), Beijing Inst Liver Dis, Beijing, Peoples R China.	liningya@ccmu.edu.cn; fgao@duke.edu	chen, xinyue/HHR-9308-2022		China Primary Health Care Foundation	China Primary Health Care Foundation	The work was funded by China Primary Health Care Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Bhattacharya D, 2010, CLIN INFECT DIS, V51, P1201, DOI 10.1086/656624; Bosch FX, 2005, CLIN LIVER DIS, V9, pv; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Cai FP, 2007, NAT METHODS, V4, P123, DOI 10.1038/nmeth995; Chinese Society of Hepatology and Society of Infectious Diseases, 2011, CHINESE J INTERNAL M, V50, P168; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Cuestas ML, 2010, ANTIVIR RES, V87, P74, DOI 10.1016/j.antiviral.2010.04.005; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fu L, 1998, BIOCHEM PHARMACOL, V55, P1567, DOI 10.1016/S0006-2952(98)00050-1; Inoue J, 2011, J VIRAL HEPATITIS, V18, P206, DOI 10.1111/j.1365-2893.2010.01301.x; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lam Yuk-Fai, 2011, Curr Hepat Rep, V10, P235, DOI 10.1007/s11901-011-0109-z; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Liu Y, 2011, J VIRAL HEPATITIS, V18, pe29, DOI 10.1111/j.1365-2893.2010.01360.x; Locarnini S, 2008, HEPATOL INT, V2, P147, DOI 10.1007/s12072-008-9048-3; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Margeridon-Thermet S, 2010, VIRUSES-BASEL, V2, P2696, DOI 10.3390/v2122696; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Menzo S, 2009, J INFECT DIS, V200, P1798, DOI 10.1086/647991; Metzner Karin J, 2006, J HIV Ther, V11, P74; Nakanishi H, 2005, INTERVIROLOGY, V48, P381, DOI 10.1159/000086065; Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052; Ono SK, 2001, J CLIN INVEST, V107, P449, DOI 10.1172/JCI11100; Pallier C, 2006, J VIROL, V80, P643, DOI 10.1128/JVI.80.2.643-653.2006; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pawlotsky JM, 2008, GASTROENTEROLOGY, V134, P405, DOI 10.1053/j.gastro.2007.11.036; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Tipples GA, 1996, HEPATOLOGY, V24, P714, DOI 10.1053/jhep.1996.v24.pm0008781348; Wang DN, 2011, J VIROL, V85, P6403, DOI 10.1128/JVI.02389-10; Warner N, 2007, ANTIMICROB AGENTS CH, V51, P2285, DOI 10.1128/AAC.01499-06; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e; Yeh CT, 2000, HEPATOLOGY, V31, P1318, DOI 10.1053/jhep.2000.7296; Yim HJ, 2006, HEPATOLOGY, V44, P703, DOI 10.1002/hep.21290; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e67606	10.1371/journal.pone.0067606	http://dx.doi.org/10.1371/journal.pone.0067606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935839	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200004
J	Rodrigues, PMG; Grigaravicius, P; Remus, M; Cavalheiro, GR; Gomes, AL; Martins, MR; Frappart, L; Reuss, D; McKinnon, PJ; von Deimling, A; Martins, RAP; Frappart, PO				Rodrigues, Paulo M. G.; Grigaravicius, Paulius; Remus, Martina; Cavalheiro, Gabriel R.; Gomes, Anielle L.; Martins, Mauricio R.; Frappart, Lucien; Reuss, David; McKinnon, Peter J.; von Deimling, Andreas; Martins, Rodrigo A. P.; Frappart, Pierre-Olivier			Nbn and Atm Cooperate in a Tissue and Developmental Stage-Specific Manner to Prevent Double Strand Breaks and Apoptosis in Developing Brain and Eye	PLOS ONE			English	Article							TARGETED DISRUPTION; SYNDROME GENE; MURINE MODEL; DNA-DAMAGE; NBS1; REPAIR; CELLS; ATAXIA; PHOSPHORYLATION; REQUIREMENT	Nibrin (NBN or NBS1) and ATM are key factors for DNA Double Strand Break (DSB) signaling and repair. Mutations in NBN or ATM result in Nijmegen Breakage Syndrome and Ataxia telangiectasia. These syndromes share common features such as radiosensitivity, neurological developmental defects and cancer predisposition. However, the functional synergy of Nbn and Atm in different tissues and developmental stages is not yet understood. Here, we show in vivo consequences of conditional inactivation of both genes in neural stem/progenitor cells using Nestin-Cre mice. Genetic inactivation of Atm in the central nervous system of Nbn-deficient mice led to reduced life span and increased DSBs, resulting in increased apoptosis during neural development. Surprisingly, the increase of DSBs and apoptosis was found only in few tissues including cerebellum, ganglionic eminences and lens. In sharp contrast, we showed that apoptosis associated with Nbn deletion was prevented by simultaneous inactivation of Atm in developing retina. Therefore, we propose that Nbn and Atm collaborate to prevent DSB accumulation and apoptosis during development in a tissue-and developmental stage-specific manner.	[Grigaravicius, Paulius; Remus, Martina; Reuss, David; von Deimling, Andreas; Frappart, Pierre-Olivier] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Rodrigues, Paulo M. G.; Cavalheiro, Gabriel R.; Gomes, Anielle L.; Martins, Rodrigo A. P.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, Brazil; [Martins, Mauricio R.] Univ Fed Rio de Janeiro, CCS, IBCCF, Programa Pos Grad Biofis, Rio De Janeiro, Brazil; [Reuss, David; von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Frappart, Lucien] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Ruprecht Karls University Heidelberg; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); St Jude Children's Research Hospital	Martins, RAP (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, Brazil.	rodrigo.martins@icb.ufrj.br; p.frappart@dkfz.de	von Deimling, Andreas/F-7774-2013; Martins, Rodrigo/W-7604-2019; Martins, Rodrigo A. P./A-4701-2010	von Deimling, Andreas/0000-0002-5863-540X; Martins, Rodrigo/0000-0002-8420-6991; Martins, Rodrigo A. P./0000-0002-8420-6991; Grigaravicius, Paulius/0000-0001-5107-1042; Rodrigues Cavalheiro, Gabriel/0000-0002-8534-5555; Rocha-Martins, Mauricio/0000-0001-6881-6733; FRAPPART, PIERRE-OLIVIER/0000-0002-8142-3878	Deutsche Forschungsgemeinschaft (DFG) [FR 2704/1-1, FR 2704/2-1]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); PIBIC program (CNPq/UFRJ); NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PIBIC program (CNPq/UFRJ); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG): FR 2704/1-1 and FR 2704/2-1 to POF and by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to RAPM. PMGR and GRC received undergrad students' fellowships through the PIBIC program (CNPq/UFRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman CA, 2009, MOL CELL BIOL, V29, P483, DOI 10.1128/MCB.01525-08; Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021; Baleriola J, 2010, CELL DEATH DIFFER, V17, P1697, DOI 10.1038/cdd.2010.46; Baranes K, 2009, EXP NEUROL, V218, P24, DOI 10.1016/j.expneurol.2009.03.026; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bekiesinska-Figatowska M, 2000, NEURORADIOLOGY, V42, P43, DOI 10.1007/s002340050011; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Brazel CY, 2003, PROG NEUROBIOL, V69, P49, DOI 10.1016/S0301-0082(03)00002-9; Chechlacz M, 2001, J NEUROCHEM, V78, P141, DOI 10.1046/j.1471-4159.2001.00380.x; Chiruvella KK, 2012, J MOL BIOL, V417, P197, DOI 10.1016/j.jmb.2012.01.029; Crawford T O, 1998, Semin Pediatr Neurol, V5, P287, DOI 10.1016/S1071-9091(98)80007-7; Crawford TO, 2000, NEUROLOGY, V54, P1505, DOI 10.1212/WNL.54.7.1505; Dar I, 2011, J BIOL CHEM, V286, P15361, DOI 10.1074/jbc.M110.204172; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Demuth I, 2004, HUM MOL GENET, V13, P2385, DOI 10.1093/hmg/ddh278; DerKaloustian VM, 1996, AM J MED GENET, V65, P21, DOI 10.1002/(SICI)1096-8628(19961002)65:1<21::AID-AJMG3>3.0.CO;2-0; Di Virgilio M, 2005, J CELL BIOL, V171, P765, DOI 10.1083/jcb.200506029; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Frappart PO, 2008, DNA REPAIR, V7, P1051, DOI 10.1016/j.dnarep.2008.03.007; Frappart PO, 2007, EMBO J, V26, P2732, DOI 10.1038/sj.emboj.7601703; Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228; Galron R, 2011, J MOL NEUROSCI; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Gralek Miroslawa, 2011, Klin Oczna, V113, P153; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Khan AO, 2008, J AAPOS, V12, P186, DOI 10.1016/j.jaapos.2007.09.016; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lavin MF, 2007, BRIT MED BULL, V81-82, P129, DOI 10.1093/bmb/ldm012; Lee Y, 2012, EMBO J; Leemput J, 2009, MOL VIS, V15, P393; Li R, 2012, CELL RES, V22, P859, DOI 10.1038/cr.2012.3; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Njaine B, 2010, EUR J NEUROSCI, V32, P311, DOI 10.1111/j.1460-9568.2010.07286.x; Ramirez-Lugo JS, 2011, CELL CYCLE, V10, P469, DOI 10.4161/cc.10.3.14711; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Seemanova E, 2006, J MED GENET, V43, P218, DOI 10.1136/jmg.2005.035287; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Taylor EM, 2010, NUCLEIC ACIDS RES, V38, P441, DOI 10.1093/nar/gkp905; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vemuri MC, 2001, CELL DEATH DIFFER, V8, P245, DOI 10.1038/sj.cdd.4400806; Wilda M, 2000, HUM MOL GENET, V9, P1739, DOI 10.1093/hmg/9.12.1739; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Wonders C, 2005, NEUROSCIENTIST, V11, P199, DOI 10.1177/1073858404270968; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Zhou ZW, 2012, DNA REPAIR, V11, P210, DOI 10.1016/j.dnarep.2011.10.021; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	66	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69209	10.1371/journal.pone.0069209	http://dx.doi.org/10.1371/journal.pone.0069209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935957	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200028
J	Wilkinson, RR; Sharkey, KJ				Wilkinson, Robert R.; Sharkey, Kieran J.			An Exact Relationship Between Invasion Probability and Endemic Prevalence for Markovian SIS Dynamics on Networks	PLOS ONE			English	Article							H5N1 AVIAN INFLUENZA; SPREAD; METASTABILITY; DISTRIBUTIONS; PERSISTENCE; BEHAVIOR; DISEASES; MODELS	Understanding models which represent the invasion of network-based systems by infectious agents can give important insights into many real-world situations, including the prevention and control of infectious diseases and computer viruses. Here we consider Markovian susceptible-infectious-susceptible (SIS) dynamics on finite strongly connected networks, applicable to several sexually transmitted diseases and computer viruses. In this context, a theoretical definition of endemic prevalence is easily obtained via the quasi-stationary distribution (QSD). By representing the model as a percolation process and utilising the property of duality, we also provide a theoretical definition of invasion probability. We then show that, for undirected networks, the probability of invasion from any given individual is equal to the (probabilistic) endemic prevalence, following successful invasion, at the individual (we also provide a relationship for the directed case). The total (fractional) endemic prevalence in the population is thus equal to the average invasion probability (across all individuals). Consequently, for such systems, the regions or individuals already supporting a high level of infection are likely to be the source of a successful invasion by another infectious agent. This could be used to inform targeted interventions when there is a threat from an emerging infectious disease.	[Wilkinson, Robert R.; Sharkey, Kieran J.] Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Sharkey, KJ (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England.	kjs@liv.ac.uk		Sharkey, Kieran/0000-0002-7210-9246	EPSRC [EP/J00474X/1]; EPSRC (DTA studentship); EPSRC [EP/J00474X/1]; EPSRC (DTA studentship); Engineering and Physical Sciences Research Council [1092460, EP/J00474X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC (DTA studentship)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC (DTA studentship)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	KJS acknowledges support from EPSRC (EP/J00474X/1). RRW acknowledges support from EPSRC (DTA studentship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Bailey NTJ, 1975, MATH THEORY INFECT D; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Chatterjee S, 2009, ANN PROBAB, V37, P2332, DOI 10.1214/09-AOP471; Darroch J.N., 1965, J APPL PROBAB, V2, P88, DOI [10.2307/3211876, DOI 10.2307/3211876]; DARROCH JN, 1967, J APPL PROBAB, V4, P192, DOI 10.2307/3212311; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; FINE PEM, 1982, INT J EPIDEMIOL, V11, P15, DOI 10.1093/ije/11.1.15; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grimmett G, 2010, PROBABILITY GRAPHS, P127; HARRIS TE, 1974, ANN PROBAB, V2, P969, DOI 10.1214/aop/1176996493; HARRIS TE, 1976, ANN PROBAB, V4, P175, DOI 10.1214/aop/1176996129; HARRIS TE, 1978, ANN PROBAB, V6, P355, DOI 10.1214/aop/1176995523; Hethcote H.W., 1984, SPRINGER LECT NOTES; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; House T, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0436; Jonkers ART, 2010, J R SOC INTERFACE, V7, P695, DOI 10.1098/rsif.2009.0304; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kenah E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036113; Kephart J. O., 1993, Proceedings 1993 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.93CH3290-4), P2, DOI 10.1109/RISP.1993.287647; Kephart J. O., 1991, Proceedings. 1991 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.91CH2986-8), P343, DOI 10.1109/RISP.1991.130801; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Nasell I, 1996, ADV APPL PROBAB, V28, P895, DOI 10.2307/1428186; Nasell I, 1995, EPIDEMIC MODELS THEI, P71; Neal P, 2008, J APPL PROBAB, V45, P513, DOI 10.1239/jap/1214950364; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; SCHONMANN RH, 1985, J STAT PHYS, V41, P445, DOI 10.1007/BF01009017; Sharkey KJ, 2008, P ROY SOC B-BIOL SCI, V275, P19, DOI 10.1098/rspb.2007.1100; Simonis A, 1996, J STAT PHYS, V83, P1225, DOI 10.1007/BF02179561; WEISS G H, 1971, Mathematical Biosciences, V11, P261, DOI 10.1016/0025-5564(71)90087-3	40	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69028	10.1371/journal.pone.0069028	http://dx.doi.org/10.1371/journal.pone.0069028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935916	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200018
J	Hu, DL; Liu, B; Dijkshoorn, L; Wang, L; Reeves, PR				Hu, Dalong; Liu, Bin; Dijkshoorn, Lenie; Wang, Lei; Reeves, Peter R.			Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme	PLOS ONE			English	Article							O-ANTIGEN; GENE-CLUSTER; CAPSULAR POLYSACCHARIDES; IDENTIFICATION; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; ORGANIZATION; EMULSAN; COMPLEX; RAG-1	We have sequenced the gene clusters for type strains of the Acinetobacter baumannii serotyping scheme developed in the 1990s, and used the sequences to better understand diversity in surface polysaccharides of the genus. We obtained genome sequences for 27 available serovar type strains, and identified 25 polysaccharide gene cluster sequences. There are structures for 12 of these polysaccharides, and in general the genes present are appropriate to the structure where known. This greatly facilitates interpretation. We also find 53 different glycosyltransferase genes, and for 7 strains can provisionally allocate specific genes to all linkages. We identified primers that will distinguish the 25 sequence forms by PCR or microarray, or alternatively the genes can be used to determine serotype by "molecular serology". We applied the latter to 190 Acinetobacter genome-derived gene-clusters, and found 76 that have one of the 25 gene-cluster forms. We also found novel gene clusters and added 52 new gene-cluster sequence forms with different wzy genes and different gene contents. Altogether, the strains that have one of the original 25 sequence forms include 98 A. baumannii (24 from our strains) and 5 A. nosocomialis (3 from our strains), whereas 32 genomes from 12 species other than A. baumannii or A. nosocomialis, all have new sequence forms. One of the 25 serovar type sequences is found to be in European clone I (EC I), 2 are in EC II but none in EC III. The public genome strains add an additional 52 new sequence forms, and also bring the number found in EC I to 5, in EC II to 9 and in EC III to 2.	[Hu, Dalong; Liu, Bin; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Liu, Bin; Wang, Lei] Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin, Peoples R China; [Dijkshoorn, Lenie] Leiden Univ, Dept Infect Dis, Med Ctr, Leiden, Netherlands; [Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Reeves, Peter R.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	Nankai University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Sydney	Reeves, PR (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	peter.reeves@sydney.edu.au	Wang, Lei/C-5176-2009; Hu, Dalong/GOP-2877-2022; Reeves, Peter R/A-6064-2008	Wang, Lei/0000-0003-4427-0881; Hu, Dalong/0000-0003-2047-2868; Reeves, Peter R/0000-0003-4479-7974	National Key Program for Infectious Diseases of China [2013ZX10004216-001-001]; National 863 program of China [2011AA100901-2]; National Natural Science Foundation of China (NSFC) Program [31030002]; NSFC general program [31270003]	National Key Program for Infectious Diseases of China; National 863 program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC) Program(National Natural Science Foundation of China (NSFC)); NSFC general program(National Natural Science Foundation of China (NSFC))	The project was supported by the National Key Program for Infectious Diseases of China (2013ZX10004216-001-001); the National 863 program of China (2011AA100901-2); National Natural Science Foundation of China (NSFC) Program (31030002); NSFC general program (31270003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Csiszovszki Z, 2011, MBIO, P2; Cunneen MM, 2011, GLYCOBIOLOGY, V21, P1140, DOI 10.1093/glycob/cwr010; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Dams-Kozlowska H, 2008, APPL MICROBIOL BIOT, V81, P201, DOI 10.1007/s00253-008-1664-2; Dams-Kozlowska H, 2008, APPL MICROBIOL BIOT, V78, P677, DOI 10.1007/s00253-008-1346-0; Dams-Kozlowska H, 2007, APPL ENVIRON MICROB, V73, P4020, DOI 10.1128/AEM.00401-07; Dams-Kozlowska H, 2008, J MICROBIOL BIOTECHN, V18, P1890, DOI 10.4014/jmb.0800.049; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; FRAENKEL DG, 1996, ESCHERICHIA COLI SAL, P189; Fregolino E, 2011, CARBOHYD RES, V346, P973, DOI 10.1016/j.carres.2011.03.024; Fregolino E, 2010, EUR J ORG CHEM, V2010, P1345, DOI 10.1002/ejoc.200901396; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Hanuszkiewicz A, 2008, CHEM-EUR J, V14, P10251, DOI 10.1002/chem.200800958; Hanuszkiewicz A, 2008, EUR J ORG CHEM, V2008, P6183, DOI 10.1002/ejoc.200800887; Hao YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P195, DOI 10.1007/978-3-7091-0733-1_7; Haseley SR, 1998, EUR J BIOCHEM, V251, P189, DOI 10.1046/j.1432-1327.1998.2510189.x; Hong YQ, 2012, MOL MICROBIOL, V84, P620, DOI 10.1111/j.1365-2958.2012.08048.x; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; KAPLAN N, 1985, EUR J BIOCHEM, V152, P453, DOI 10.1111/j.1432-1033.1985.tb09218.x; KENNEDY EP, 1996, ESCHERICHIA COLI SAL, P1064; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Konradsen HB, 2005, VACCINE, V23, P1368, DOI 10.1016/j.vaccine.2004.09.011; Larkin A, 2009, BIOCHEMISTRY-US, V48, P5446, DOI 10.1021/bi900186u; Li YY, 2009, J MED MICROBIOL, V58, P69, DOI 10.1099/jmm.0.000794-0; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Liu B, 2010, GLYCOBIOLOGY, V20, P679, DOI 10.1093/glycob/cwq015; LIU D, 1991, J BACTERIOL, V173, P4814, DOI 10.1128/jb.173.15.4814-4819.1991; Mercaldi MP, 2008, BIOMACROMOLECULES, V9, P1988, DOI 10.1021/bm800239p; Munoz R, 2011, SYST APPL MICROBIOL, V34, P169, DOI 10.1016/j.syapm.2011.03.001; Nakar D, 2001, MICROBIOL-SGM, V147, P1937, DOI 10.1099/00221287-147-7-1937; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Pantophlet R, 2002, CLIN DIAGN LAB IMMUN, V9, P60, DOI 10.1128/CDLI.9.1.60-65.2002; Reeves PR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P319; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; REISFELD A, 1972, APPL MICROBIOL, V24, P363, DOI 10.1128/AEM.24.3.363-368.1972; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; TRAUB WH, 1991, ZBL BAKT-INT J MED M, V275, P487; TRAUB WH, 1989, J CLIN MICROBIOL, V27, P2713, DOI 10.1128/JCM.27.12.2713-2716.1989; Traub WH, 2000, CHEMOTHERAPY, V46, P282, DOI 10.1159/000007300; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vinogradov EV, 2002, EUR J BIOCHEM, V269, P422, DOI 10.1046/j.0014-2956.2001.02647.x; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Watson DC, 2011, GLYCOBIOLOGY, V21, P99, DOI 10.1093/glycob/cwq135; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; ZUCKERBERG A, 1979, APPL ENVIRON MICROB, V37, P414, DOI 10.1128/AEM.37.3.414-420.1979	62	95	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70329	10.1371/journal.pone.0070329	http://dx.doi.org/10.1371/journal.pone.0070329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922982	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700176
J	Kerner, GSMA; Schuuring, E; Sietsma, J; Hiltermann, TJN; Pieterman, RM; de Leede, GPJ; van Putten, JWG; Liesker, J; Renkema, TEJ; van Hengel, P; Platteel, I; Timens, W; Groen, HJM				Kerner, Gerald S. M. A.; Schuuring, Ed; Sietsma, Johanna; Hiltermann, Thijo J. N.; Pieterman, Remge M.; de Leede, Gerard P. J.; van Putten, John W. G.; Liesker, Jeroen; Renkema, Tineke E. J.; van Hengel, Peter; Platteel, Inge; Timens, Wim; Groen, Harry J. M.		CTMM Air Force Consortium	Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical Outcome	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; OPEN-LABEL; PHASE-III; 1ST-LINE TREATMENT; GEFITINIB; CHEMOTHERAPY; ADENOCARCINOMA; MULTICENTER; ERLOTINIB	Introduction: In randomly assigned studies with EGFR TKI only a minor proportion of patients with NSCLC have genetically profiled biopsies. Guidelines provide evidence to perform EGFR and KRAS mutation analysis in non-squamous NSCLC. We explored tumor biopsy quality offered for mutation testing, different mutations distribution, and outcome with EGFR TKI. Patient and Methods: Clinical data from 8 regional hospitals were studied for patient and tumor characteristics, treatment and overall survival. Biopsies sent to the central laboratory were evaluated for DNA quality and subsequently analyzed for mutations in exons 18-21 of EGFR and exon 2 of KRAS by bidirectional sequence analysis. Results: Tumors from 442 subsequent patients were analyzed. For 74 patients (17%) tumors were unsuitable for mutation analysis. Thirty-eight patients (10.9%) had EGFR mutations with 79% known activating mutations. One hundred eight patients (30%) had functional KRAS mutations. The mutation spectrum was comparable to the Cosmic database. Following treatment in the first or second line with EGFR TKI median overall survival for patients with EGFR (n = 14), KRAS (n = 14) mutations and wild type EGFR/KRAS (n = 31) was not reached, 20 and 9 months, respectively. Conclusion: One out of every 6 tumor samples was inadequate for mutation analysis. Patients with EGFR activating mutations treated with EGFR-TKI have the longest survival.	[Kerner, Gerald S. M. A.; Hiltermann, Thijo J. N.; Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Schuuring, Ed; Sietsma, Johanna; Platteel, Inge; Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Sietsma, Johanna] Martini Hosp, Dept Pathol, Groningen, Netherlands; [Pieterman, Remge M.] Ommelander Hosp, Dept Pulm Dis, Delfzijl, Netherlands; [de Leede, Gerard P. J.] Bethesda Hosp, Dept Pulm Dis, Hoogeveen, Netherlands; [van Putten, John W. G.] Martini Hosp, Dept Pulm Dis, Groningen, Netherlands; [Liesker, Jeroen] Scheper Hosp, Dept Pulm Dis, Emmen, Netherlands; [Renkema, Tineke E. J.] Refaja Hosp, Dept Pulm Dis, Stadskanaal, Netherlands; [van Hengel, Peter] Wilhelmina Gasthuis, Dept Pulm Dis, Assen, Netherlands	University of Groningen; University of Groningen; Martini Hospital; University of Groningen; Martini Hospital	Kerner, GSMA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands.	g.s.m.a.kerner@umcg.nl	, HiltermannTJN/ABA-9144-2021; Groen, Harry/AAP-2242-2021; Timens, Wim/K-5570-2013	Timens, Wim/0000-0002-4146-6363; Groen, Harry J.M./0000-0002-2978-5265; Kerner, Gerald/0000-0003-3386-6831	CTMM Air Force consortium; CTMM	CTMM Air Force consortium; CTMM	This work was partly funded by the CTMM Air Force consortium (http://www.ctmm.nl). CTMM pays for GSMAK's salary and had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No other external funding sources for this study.	Blons H, 2006, AM J SURG PATHOL, V30, P1309, DOI 10.1097/01.pas.0000213285.65907.31; Brugger W, 2011, J CLIN ONCOL; Brugger W, 2011, J CLIN ONCOL, V29, P4113, DOI 10.1200/JCO.2010.31.8162; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Garassino MC, 2011, J CLIN ONCOL, V29, P3835, DOI 10.1200/JCO.2011.36.7847; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Graziano SL, 1999, J CLIN ONCOL, V17, P668, DOI 10.1200/JCO.1999.17.2.668; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hetzel J, 2012, EUR RESPIR J, V39, P685, DOI 10.1183/09031936.00033011; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Janne PA, 2006, CLIN CANCER RES, V12, P751, DOI 10.1158/1078-0432.CCR-05-2047; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Laack E, 2011, J THORAC ONCOL, V6, P199, DOI 10.1097/JTO.0b013e3181fb7cf1; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Xu JM, 2009, J CANCER RES CLIN, V135, P771, DOI 10.1007/s00432-008-0512-1; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Yatabe Y, 2005, AM J SURG PATHOL, V29, P633, DOI 10.1097/01.pas.0000157935.28066.35; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	48	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70346	10.1371/journal.pone.0070346	http://dx.doi.org/10.1371/journal.pone.0070346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922984	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700178
J	Tang, C; Lan, DL; Zhang, HR; Ma, J; Yue, H				Tang, Cheng; Lan, Daoliang; Zhang, Huanrong; Ma, Jing; Yue, Hua			Transcriptome Analysis of Duck Liver and Identification of Differentially Expressed Transcripts in Response to Duck Hepatitis A Virus Genotype C Infection	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; METHYLATION PATTERN; MOLECULAR ANALYSIS; REACTIVE PROTEIN; B-VIRUS; CYP26A1; ADAM; NORMALIZATION; REVEALS; PATHWAY	Background: Duck is an economically important poultry and animal model for human viral hepatitis B. However, the molecular mechanisms underlying host-virus interaction remain unclear because of limited information on the duck genome. This study aims to characterize the duck normal liver transcriptome and to identify the differentially expressed transcripts at 24 h after duck hepatitis A virus genotype C (DHAV-C) infection using Illumina-Solexa sequencing. Results: After removal of low-quality sequences and assembly, a total of 52,757 unigenes was obtained from the normal liver group. Further blast analysis showed that 18,918 unigenes successfully matched the known genes in the database. GO analysis revealed that 25,116 unigenes took part in 61 categories of biological processes, cellular components, and molecular functions. Among the 25 clusters of orthologous group categories (COG), the cluster for "General function prediction only" represented the largest group, followed by "Transcription" and "Replication, recombination, and repair." KEGG analysis showed that 17,628 unigenes were involved in 301 pathways. Through comparison of normal and infected transcriptome data, we identified 20 significantly differentially expressed unigenes, which were further confirmed by real-time polymerase chain reaction. Of the 20 unigenes, nine matched the known genes in the database, including three upregulated genes (virus replicase polyprotein, LRRC3B, and PCK1) and six down-regulated genes (CRP, AICL-like 2, L1CAM, CYB26A1, CHAC1, and ADAM32). The remaining 11 novel unigenes that did not match any known genes in the database may provide a basis for the discovery of new transcripts associated with infection. Conclusion: This study provided a gene expression pattern for normal duck liver and for the previously unrecognized changes in gene transcription that are altered during DHAV-C infection. Our data revealed useful information for future studies on the duck genome and provided new insights into the molecular mechanism of host-DHAV-C interaction.	[Tang, Cheng; Zhang, Huanrong; Ma, Jing; Yue, Hua] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China; [Lan, Daoliang] Southwest Univ Nationalities, Coll Tibetan Plateau Res, Chengdu, Peoples R China	Southwest Minzu University; Southwest Minzu University	Yue, H (corresponding author), Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China.	yhua900@yahoo.com.cn			National Hightech R&D Program (863 Program) [2012AA101304]; Veterinary Medicine Discipline Program of Southwest University for Nationalities [2011XWD-S0906]	National Hightech R&D Program (863 Program)(National High Technology Research and Development Program of China); Veterinary Medicine Discipline Program of Southwest University for Nationalities	This work was supported by funding from the National Hightech R&D Program (863 Program-2012AA101304) and by Veterinary Medicine Discipline Program of Southwest University for Nationalities (2011XWD-S0906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATONO Y, 1989, Gastroenterologia Japonica, V24, P655; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Brocker Chad N., 2009, Human Genomics, V4, P43; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Che WL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/730923; Cho SY, 2011, DIAGN MICR INFEC DIS, V69, P400, DOI 10.1016/j.diagmicrobio.2010.10.015; Cova Lucyna, 2004, Methods Mol Med, V96, P261; Dou Li-ping, 2007, Chinese Medical Sciences Journal, V22, P187; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fu Y, 2008, VET MICROBIOL, V131, P247, DOI 10.1016/j.vetmic.2008.03.011; Gambino R, 1997, CLIN CHEM, V43, P2017; Gillet G, 1996, TRENDS MICROBIOL, V4, P312, DOI 10.1016/0966-842X(96)10047-0; Goebel G, 2012, BRIT J CANCER, V106, P189, DOI 10.1038/bjc.2011.510; Hamann J, 1997, IMMUNOGENETICS, V45, P295, DOI 10.1007/s002510050208; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Huang QX, 2012, J CLIN MICROBIOL, V50, P3318, DOI 10.1128/JCM.01080-12; Huang YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-556; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Kim M, 2008, CANCER RES, V68, P7147, DOI 10.1158/0008-5472.CAN-08-0667; Kondratov AG, 2012, MOL MED REP, V5, P509, DOI 10.3892/mmr.2011.681; Lecube A, 2006, DIABETES CARE, V29, P1140, DOI 10.2337/dc05-1995; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Luciani F, 2012, TRENDS BIOTECHNOL, V30, P443, DOI 10.1016/j.tibtech.2012.05.005; Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nascimento MM, 2005, BRAZ J MED BIOL RES, V38, P783, DOI 10.1590/S0100-879X2005000500017; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Qadri I, 2012, J BIOL CHEM, V287, P37340, DOI 10.1074/jbc.M112.384743; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schultz U, 2004, ADV VIRUS RES, V63, P1, DOI 10.1016/S0065-3527(04)63001-6; Shima M, 1996, TOHOKU J EXP MED, V178, P287, DOI 10.1620/tjem.178.287; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; SUMMERS J, 1981, HEPATOLOGY, V1, P179, DOI 10.1002/hep.1840010215; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Thomas M, 2008, BIOCHEM SOC T, V36, P459, DOI 10.1042/BST0360459; Thomson BJ, 2001, INT J EXP PATHOL, V82, P65, DOI 10.1111/j.1365-2613.2001.iep195.x; TING CN, 1993, GENOMICS, V16, P698, DOI 10.1006/geno.1993.1250; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Wang LY, 2008, VIRUS GENES, V37, P52, DOI 10.1007/s11262-008-0233-1; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu Zhou-Min, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P22; Xu ZM, 2008, BMB REP, V41, P230, DOI 10.5483/BMBRep.2008.41.3.230; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996; Zhang HR, 2012, AVIAN PATHOL, V41, P613, DOI 10.1080/03079457.2012.745641	60	3	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71051	10.1371/journal.pone.0071051	http://dx.doi.org/10.1371/journal.pone.0071051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923051	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700223
J	Vereyken, EJF; Kraaij, MD; Baan, CC; Rezaee, F; Weimar, W; Wood, KJ; Leenen, PJM; Rowshani, AT				Vereyken, Elly J. F.; Kraaij, Marina D.; Baan, Carla C.; Rezaee, Farhad; Weimar, Willem; Wood, Kathryn J.; Leenen, Pieter J. M.; Rowshani, Ajda T.			A Shift towards Pro-Inflammatory CD16+Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; MIXED LYMPHOCYTE CULTURE; DENDRITIC CELLS; CD14(++)CD16(+) MONOCYTES; CD14(+)CD16(+) MONOCYTES; IFN-GAMMA; CLASS-II; MACROPHAGES; RECEPTOR; DISEASE	Background: The presence of monocyte-macrophage lineage cells in rejecting kidney transplants is associated with worse graft outcome. At present, it is still unclear how the monocyte-macrophage related responses develop after transplantation. Here, we studied the dynamics, phenotypic and functional characteristics of circulating monocytes during the first 6 months after transplantation and aimed to establish the differences between kidney transplant recipients and healthy individuals. Methods: Phenotype, activation status and cytokine production capacity of classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical (CD14+CD16++), monocytes were determined by flow cytometry in a cohort of 33 healthy individuals, 30 renal transplant recipients at transplantation, 19 recipients at 3 months and 16 recipients at 6 months after transplantation using a cross-sectional approach. Results: The percentage of both CD16+ monocyte subsets was significantly increased in transplant recipients compared to healthy individuals, indicative of triggered innate immunity (p <= 0.039). Enhanced production capacity of tumor necrosis factor-alpha, interferon-gamma and interleukin-1 beta was observed by monocytes at transplantation compared to healthy individuals. Remarkably, three months post-transplant, in presence of potent immunosuppressive drugs and despite improved kidney function, interferon-gamma, tumor necrosis factor-alpha and interleukin-10 production capacity still remained significantly increased. Conclusion: Our data demonstrate a skewed balance towards pro- inflammatory CD16+ monocytes that is present at the time of transplantation and retained for at least 6 months after transplantation. This shift could be one of the important drivers of early post-transplant cellular immunity.	[Vereyken, Elly J. F.; Kraaij, Marina D.; Baan, Carla C.; Weimar, Willem; Rowshani, Ajda T.] Erasmus Univ, Med Ctr, Dept Nephrol & Transplantat, Rotterdam, Netherlands; [Rezaee, Farhad] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Wood, Kathryn J.] Univ Oxford, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford, England; [Leenen, Pieter J. M.] Erasmus Univ, Dept Immunol, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Oxford; Erasmus University Rotterdam; Erasmus MC	Rowshani, AT (corresponding author), Erasmus Univ, Med Ctr, Dept Nephrol & Transplantat, Rotterdam, Netherlands.	t.rowshani@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013	Leenen, Pieter JM/0000-0001-9860-2920; Baan, Carla/0000-0003-2274-2788	Erasmus Medical University [102178]	Erasmus Medical University	This work is supported by Erasmus Medical University fellowship award to A.T. Rowshani, MD, PhD (Project number: 102178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AN, 1997, EUR HEART J, V18, P1024; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Buob D, 2011, TRANSPLANTATION, V92, P170, DOI 10.1097/TP.0b013e31821eab65; Cao Q, 2011, NEPHRON EXP NEPHROL, V117, pE47, DOI 10.1159/000320595; Cartwright NH, 2000, TRANSPL IMMUNOL, V8, P109, DOI 10.1016/S0966-3274(00)00015-0; Chadban SJ, 2010, SEMIN NEPHROL, V30, P278, DOI 10.1016/j.semnephrol.2010.03.009; Dayyani F, 2003, J LEUKOCYTE BIOL, V74, P33, DOI 10.1189/jlb.1202612; De Serres SA, 2011, TRANSPLANTATION, V91, P552, DOI 10.1097/TP.0b013e318205b3c1; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Girlanda R, 2008, AM J TRANSPLANT, V8, P600, DOI 10.1111/j.1600-6143.2007.02109.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Hutchinson JA, 2011, J IMMUNOL, V187, P2072, DOI 10.4049/jimmunol.1100762; Janols H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-205; Jose MD, 2003, TRANSPLANTATION, V76, P1015, DOI 10.1097/01.TP.0000083507.67995.13; Kawanaka N, 2002, NEPHRON, V90, P64, DOI 10.1159/000046316; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; KUTUKCULER N, 1995, TRANSPLANT INT, V8, P45, DOI 10.1007/BF00366710; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagayama H, 2000, J IMMUNOL, V165, P59, DOI 10.4049/jimmunol.165.1.59; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nockher WA, 1998, INFECT IMMUN, V66, P2782, DOI 10.1128/IAI.66.6.2782-2790.1998; Ozdemir BS, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P1, DOI 10.1007/978-3-642-14255-0_1; Pietila TE, 2005, J LEUKOCYTE BIOL, V78, P909, DOI 10.1189/jlb.1204721; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Qi F, 2008, TRANSPLANTATION, V86, P1267, DOI 10.1097/TP.0b013e318188d433; Ring GH, 1999, TRANSPLANTATION, V67, P1362, DOI 10.1097/00007890-199905270-00012; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rowshani AT, 2012, TRANSPLANTATION, V94, P309, DOI 10.1097/TP.0b013e318250c10f; Sadeghi M, 2003, CLIN TRANSPLANT, V17, P151, DOI 10.1034/j.1399-0012.2003.00037.x; Saionji K, 2001, ACTA HAEMATOL-BASEL, V105, P21, DOI 10.1159/000046528; Sarhan D, 2013, EUR J IMMUNOL, V43, P249, DOI 10.1002/eji.201242735; Scherberich JE, 2004, KIDNEY BLOOD PRESS R, V27, P177, DOI 10.1159/000079807; Sester U, 2001, NEPHROL DIAL TRANSPL, V16, P1402, DOI 10.1093/ndt/16.7.1402; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Suresh V, 2005, TRANSPL INT, V18, P1067, DOI 10.1111/j.1432-2277.2005.00172.x; Testro AG, 2011, J GASTROEN HEPATOL, V26, P155, DOI 10.1111/j.1440-1746.2010.06324.x; Tinckam KJ, 2005, KIDNEY INT, V68, P1866, DOI 10.1111/j.1523-1755.2005.00606.x; Uehara S, 2007, AM J TRANSPLANT, V7, P57, DOI 10.1111/j.1600-6143.2006.01599.x; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wilson HM, 2005, AM J PATHOL, V167, P27, DOI 10.1016/S0002-9440(10)62950-1; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Xie L, 2012, LIVER TRANSPLANT, V18, P444, DOI 10.1002/lt.22480; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	49	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70152	10.1371/journal.pone.0070152	http://dx.doi.org/10.1371/journal.pone.0070152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922945	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700148
J	Hsu, TW; Kuo, KL; Hung, SC; Huang, PH; Chen, JW; Tarng, DC				Hsu, Ta-Wei; Kuo, Ko-Lin; Hung, Szu-Chun; Huang, Po-Hsun; Chen, Jaw-Wen; Tarng, Der-Cherng			Progression of Kidney Disease in Non-Diabetic Patients with Coronary Artery Disease: Predictive Role of Circulating Matrix Metalloproteinase-2,-3, and-9	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MATRIX-METALLOPROTEINASE-9; ACTIVATION; LEVEL; MMP-9; DYSFUNCTION; INHIBITION; PROGNOSIS	Background: Circulating matrix metalloproteinase (MMP)-2, -3 and -9 are well recognized in predicting cardiovascular outcome in coronary artery disease (CAD), but their risks for chronic kidney disease (CKD) are lacking. Therefore, the present study aimed to investigate whether circulating MMP levels could independently predict future kidney disease progression in non-diabetic CAD patients. Methods: The prospective study enrolled 251 non-diabetic subjects referred for coronary angiography, containing normal coronary artery (n = 30) and CAD with insignificant (n = 95) and significant (n = 126) stenosis. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI formula. eGFR decline rate was calculated and the primary endpoint was a decline in eGFR over 25% from baseline. Results: The eGFR decline rate (ml/min/1.73 m(2) per year) in patients with CAD (1.22 [-1.27, 1.05]) was greater than that in those with normal coronary artery (0.21 [-2.63, 0.47], P<0.01). The circulating MMP-2, -3 and -9 were independently associated with faster eGFR decline among CAD patients. The mean follow-up period was 8.5 +/- 2.4 years, and 39 patients reached the primary endpoint. In multivariate Cox regression model, the adjusted hazard ratios of MMP-2 >= 861 ng/mL, MMP-3 >= 227 ng/mL and MMP-9 >= 49 ng/mL for predicting CKD progression were 2.47 (95% CI, 1.21 to 5.07), 2.15 (1.12 to 4.18), and 4.71 (2.14 to 10.4), respectively. While added to a model of conventional risk factors and baseline eGFR, MMP-2, -3 and -9 further significantly improved the model predictability for CKD progression (c statistic, 0.817). In the sensitivity analyses, the results were similar no matter if we changed the endpoints of a decline of >20% in eGFR from baseline or final eGFR, 60 mL/min/1.73 m(2). Conclusion: Circulating MMP-2, -3 and -9 are independently associated with kidney disease progression in non-diabetic CAD patients and add incremental predictive power to conventional risk factors.	[Hsu, Ta-Wei] Natl Yang Ming Univ Hosp, Div Nephrol, Yilan, Taiwan; [Kuo, Ko-Lin; Hung, Szu-Chun] Buddhist Tzu Chi Hosp, Div Nephrol, Taipei Branch, Taipei, Taiwan; [Huang, Po-Hsun; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Po-Hsun; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	dctarng@vghtpe.gov.tw		Kuo, Ko-Lin/0000-0002-7477-0388	National Science Council [NSC 96-2628-B-010-001-MY3, NSC99-2314-B-010-004-MY3]; Taipei Veterans General Hospital [V100C-143, V100E4-003, VN100-002]; National Yang-Ming University Hospital [RD2009-011]; Bureau of Health Promotion, Department of Health [DOH98-HP-1110]; Ministry of Education's aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University Hospital; Bureau of Health Promotion, Department of Health; Ministry of Education's aim for the Top University Plan(Ministry of Education, Taiwan)	This research was supported by grants from the National Science Council (NSC 96-2628-B-010-001-MY3 and NSC99-2314-B-010-004-MY3), Taipei Veterans General Hospital (V100C-143, V100E4-003, and VN100-002), National Yang-Ming University Hospital (RD2009-011), Bureau of Health Promotion, Department of Health (DOH98-HP-1110), and Ministry of Education's aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chang HR, 2006, CLIN CHIM ACTA, V366, P243, DOI 10.1016/j.cca.2005.10.007; Cheng SF, 2003, AM J PATHOL, V162, P1937, DOI 10.1016/S0002-9440(10)64327-1; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Death AK, 2002, J AM COLL CARDIOL, V39, P1943, DOI 10.1016/S0735-1097(02)01907-1; Dhillon OS, 2010, CLIN SCI, V118, P249, DOI 10.1042/CS20090226; Ebihara I, 1998, AM J KIDNEY DIS, V32, P544, DOI 10.1016/S0272-6386(98)70015-0; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; Fang Z, 2009, J HUAZHONG U SCI-MED, V29, P710, DOI 10.1007/s11596-009-0607-1; FRIDMAN R, 1995, CANCER RES, V55, P2548; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Kiyosue A, 2010, CIRC J, V74, P786, DOI 10.1253/circj.CJ-09-0715; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Lods N, 2003, J AM SOC NEPHROL, V14, P2861, DOI 10.1097/01.ASN.0000092789.67966.5C; Nagano M, 2009, AM J NEPHROL, V29, P109, DOI 10.1159/000151439; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; O'Hare AM, 2005, ARCH INTERN MED, V165, P1481, DOI 10.1001/archinte.165.13.1481; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Shlipak MG, 2009, ATHEROSCLEROSIS, V204, P298, DOI 10.1016/j.atherosclerosis.2008.08.016; Son JW, 2003, INT J CARDIOL, V88, P77, DOI 10.1016/S0167-5273(02)00368-6; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Uzu T, 2010, J AM SOC NEPHROL, V21, P520, DOI 10.1681/ASN.2009050558; van Domburg RT, 2008, J AM SOC NEPHROL, V19, P158, DOI 10.1681/ASN.2006101112; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wu TC, 2005, EUR J CLIN INVEST, V35, P537, DOI 10.1111/j.1365-2362.2005.01548.x; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Ye ZX, 2008, CLIN BIOCHEM, V41, P292, DOI 10.1016/j.clinbiochem.2007.11.004; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	38	26	26	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70132	10.1371/journal.pone.0070132	http://dx.doi.org/10.1371/journal.pone.0070132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922934	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900151
J	Shen, DW; Xie, F; Edwards, WB				Shen, Duanwen; Xie, Fei; Edwards, W. Barry			Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)	PLOS ONE			English	Article							PHASE-I TRIAL; MONOCLONAL-ANTIBODY; AMERICAN SOCIETY; INHIBITORS; CANCER; J591; TARGET; INTERNALIZATION; AGENT	The aim of this study was to identify potential ligands of PSMA suitable for further development as novel PSMA-targeted peptides using phage display technology. The human PSMA protein was immobilized as a target followed by incubation with a 15-mer phage display random peptide library. After one round of prescreening and two rounds of screening, high-stringency screening at the third round of panning was performed to identify the highest affinity binders. Phages which had a specific binding activity to PSMA in human prostate cancer cells were isolated and the DNA corresponding to the 15-mers were sequenced to provide three consensus sequences: GDHSPFT, SHFSVGS and EVPRLSLLAVFL as well as other sequences that did not display consensus. Two of the peptide sequences deduced from DNA sequencing of binding phages, SHSFSVGSGDHSPFT and GRFLTGGTGRLLRIS were labeled with 5-carboxyfluorescein and shown to bind and co-internalize with PSMA on human prostate cancer cells by fluorescence microscopy. The high stringency requirements yielded peptides with affinities K-D similar to 1 mu M or greater which are suitable starting points for affinity maturation. While these values were less than anticipated, the high stringency did yield peptide sequences that apparently bound to different surfaces on PSMA. These peptide sequences could be the basis for further development of peptides for prostate cancer tumor imaging and therapy.	[Shen, Duanwen] Washington Univ, St Louis, MO USA; [Xie, Fei; Edwards, W. Barry] Univ Pittsburgh, Pittsburgh, PA 15213 USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Edwards, WB (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15213 USA.	edwardsw@upmc.edu	Edwards, Wilson/AAD-8002-2021	Edwards, Wilson/0000-0002-6070-8778	Department of Defense Prostate Cancer Research Program New Investigator Award [W81XWH-08-1-0387]; Department of Energy Integrated Research Training Program of Excellence in Radiochemistry [DESC0002032]	Department of Defense Prostate Cancer Research Program New Investigator Award(United States Department of Defense); Department of Energy Integrated Research Training Program of Excellence in Radiochemistry	This work was funded by the Department of Defense Prostate Cancer Research Program New Investigator Award (W81XWH-08-1-0387, WBE) and a Department of Energy Integrated Research Training Program of Excellence in Radiochemistry (DESC0002032, FX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, CANCER RES, V66, P9171, DOI 10.1158/0008-5472.CAN-06-1520; Agnew HD, 2009, ANGEW CHEM INT EDIT, V48, P4944, DOI 10.1002/anie.200900488; Arter JA, 2012, ANAL CHEM, V84, P2776, DOI 10.1021/ac203143y; Bander NH, 2005, J CLIN ONCOL, V23, P4591, DOI 10.1200/JCO.2005.05.160; Banerjee SR, 2008, J MED CHEM, V51, P4504, DOI 10.1021/jm800111u; Banerjee SR, 2011, ONCOTARGET, V2, P1244; Banerjee SR, 2011, ANGEW CHEM INT EDIT, V50, P9167, DOI 10.1002/anie.201102872; Banerjee SR, 2010, J MED CHEM, V53, P5333, DOI 10.1021/jm100623e; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Basch E, 2012, J CLIN ONCOL, V30, P3020, DOI 10.1200/JCO.2012.43.3441; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chen Y, 2011, CLIN CANCER RES, V17, P7645, DOI 10.1158/1078-0432.CCR-11-1357; Chen Y, 2009, BIOCHEM BIOPH RES CO, V390, P624, DOI 10.1016/j.bbrc.2009.10.017; Chen Y, 2008, J MED CHEM, V51, P7933, DOI 10.1021/jm801055h; Davis MI, 2005, P NATL ACAD SCI USA, V102, P5981, DOI 10.1073/pnas.0502101102; Diehnelt CW, 2010, PLOS ONE, V5; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Haubner R, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P247, DOI 10.1007/978-3-642-12945-2_19; Hessels D, 2004, EXPERT REV MOL DIAGN, V4, P513, DOI 10.1586/14737159.4.4.513; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Humblet Valerie, 2005, Mol Imaging, V4, P448; Kim S, 2012, ANGEW CHEM INT EDIT, V51, P1890, DOI 10.1002/anie.201107894; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li SZ, 2009, MOL CANCER THER, V8, P1239, DOI 10.1158/1535-7163.MCT-08-1098; Lim HS, 2009, BIOORG MED CHEM LETT, V19, P3866, DOI 10.1016/j.bmcl.2009.03.153; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Lupold SE, 2004, MOL CANCER THER, V3, P597; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Milowsky MI, 2004, J CLIN ONCOL, V22, P2522, DOI 10.1200/JCO.2004.09.154; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Morris MJ, 2007, CLIN CANCER RES, V13, P2707, DOI 10.1158/1078-0432.CCR-06-2935; Morris MJ, 2005, CLIN CANCER RES, V11, P7454, DOI 10.1158/1078-0432.CCR-05-0826; Nam RK, 2012, J ONCOL PRACT, V8, P315, DOI 10.1200/JOP.2012.000715; Newton JR, 2006, NEOPLASIA, V8, P772, DOI 10.1593/neo.06331; Noren KA, 2001, METHODS, V23, P169, DOI 10.1006/meth.2000.1118; Pawlyk A. C., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Quinn AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp899; Roobol MJ, 2004, UROLOGY, V63, P309, DOI 10.1016/j.urology.2003.09.083; Shen DW, 2007, FEBS LETT, V581, P1793, DOI 10.1016/j.febslet.2007.03.067; Sodee DB, 2004, J CLIN ONCOL, V22, P379, DOI 10.1200/JCO.2004.99.163; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902; Xiao Z, 2001, CANCER RES, V61, P6029; Yi F, 2009, J BIOMOL SCREEN, V14, P273, DOI 10.1177/1087057108330114; Yu JN, 1996, METHOD ENZYMOL, V267, P3; Zhu ZY, 1999, CELL RES, V9, P271, DOI 10.1038/sj.cr.7290026	47	23	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68339	10.1371/journal.pone.0068339	http://dx.doi.org/10.1371/journal.pone.0068339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935860	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000322433300006
J	Caceres, C; Taboada, FG; Hofer, J; Anadon, R				Caceres, Carlos; Gonzalez Taboada, Fernando; Hoefer, Juan; Anadon, Ricardo			Phytoplankton Growth and Microzooplankton Grazing in the Subtropical Northeast Atlantic	PLOS ONE			English	Article							COMMUNITY STRUCTURE; METABOLIC BALANCE; PRODUCTION-RATES; CHLOROPHYLL-A; NE ATLANTIC; ARABIAN SEA; PLANKTON; BIOMASS; GYRE; PROCHLOROCOCCUS	Dilution experiments were performed to estimate phytoplankton growth and microzooplankton grazing rates during two Lagrangian surveys in inner and eastern locations of the Eastern North Atlantic Subtropical Gyre province (NAST-E). Our design included two phytoplankton size fractions (0.2-5 mu m and >5 mu m) and five depths, allowing us to characterize differences in growth and grazing rates between size fractions and depths, as well as to estimate vertically integrated measurements. Phytoplankton growth rates were high (0.11-1.60 d(-1)), especially in the case of the large fraction. Grazing rates were also high (0.15-1.29 d(-1)), suggesting high turnover rates within the phytoplankton community. The integrated balances between phytoplankton growth and grazing losses were close to zero, although deviations were detected at several depths. Also, O-2 supersaturation was observed up to 110 m depth during both Lagrangian surveys. These results add up to increased evidence indicating an autotrophic metabolic balance in oceanic subtropical gyres.	[Caceres, Carlos; Gonzalez Taboada, Fernando; Hoefer, Juan; Anadon, Ricardo] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Asturias, Spain	University of Oviedo	Caceres, C (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Asturias, Spain.	Carlos.l.caceres@gmail.com	Taboada, Fernando González/L-2783-2015; Caceres, Carlos/AAT-1704-2020	Taboada, Fernando González/0000-0001-7634-887X; Caceres, Carlos/0000-0002-3995-8705; Hofer, Juan/0000-0002-5887-4929	CARPOS (MEC) [REN2003-09532-C03-03]; DOS MARES [CTM2010-21810-C03-03]; MEC [AP2008-03658]; FICYT ''Severo Ochoa'' fellowship (Gobierno del Principado de Asturias) [PCTI2006-09]; CARPOS (MEC); RADIAL (IEO-Universidad de Oviedo) project	CARPOS (MEC)(Spanish Government); DOS MARES; MEC(European Commission); FICYT ''Severo Ochoa'' fellowship (Gobierno del Principado de Asturias); CARPOS (MEC)(Spanish Government); RADIAL (IEO-Universidad de Oviedo) project	This research has been supported by CARPOS (MEC, REN2003-09532-C03-03) and DOS MARES (CTM2010-21810-C03-03) projects. CC was supported by a FPU fellowship by MEC (AP2008-03658) and FGT by a FICYT ''Severo Ochoa'' fellowship (PCTI2006-09, Gobierno del Principado de Asturias). JH was supported by research contracts from CARPOS (MEC) and RADIAL (IEO-Universidad de Oviedo) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN T, 1991, MAR ECOL PROG SER, V69, P67, DOI 10.3354/meps069067; Aranguren-Gassis M, 2012, DEEP-SEA RES PT I, V68, P116, DOI 10.1016/j.dsr.2012.06.004; Aranguren-Gassis M, 2011, DEEP-SEA RES PT I, V58, P768, DOI 10.1016/j.dsr.2011.05.003; ARENOVSKI AL, 1995, J PLANKTON RES, V17, P801, DOI 10.1093/plankt/17.4.801; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bonachela JA, 2011, P NATL ACAD SCI USA, V108, P20633, DOI 10.1073/pnas.1118012108; Bricaud A, 1999, MAR ECOL PROG SER, V188, P21, DOI 10.3354/meps188021; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Calvo-Diaz A, 2011, APPL ENVIRON MICROB, V77, P5739, DOI 10.1128/AEM.00066-11; Cermeno P, 2005, LIMNOL OCEANOGR, V50, P1438, DOI 10.4319/lo.2005.50.5.1438; Duarte MC, 2001, LIMNOL OCEANOGR, V46, P425, DOI 10.4319/lo.2001.46.2.0425; Edwards ES, 1999, DEEP-SEA RES PT II, V46, P843, DOI 10.1016/S0967-0645(98)00130-1; Emerson S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003095; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GIESKES WWC, 1979, NETH J SEA RES, V13, P58, DOI 10.1016/0077-7579(79)90033-4; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Taboada FG, 2010, DEEP-SEA RES PT I, V57, P65, DOI 10.1016/j.dsr.2009.09.005; Hartmann M, 2012, P NATL ACAD SCI USA, V109, P5756, DOI 10.1073/pnas.1118179109; Huete-Ortega M, 2012, P ROY SOC B-BIOL SCI, V279, P1815, DOI 10.1098/rspb.2011.2257; Huskin I, 2001, J PLANKTON RES, V23, P671, DOI 10.1093/plankt/23.7.671; Isla JA, 2004, J PLANKTON RES, V26, P1301, DOI 10.1093/plankt/fbh121; Jacquet S, 2001, APPL ENVIRON MICROB, V67, P782, DOI 10.1128/AEM.67.2.782-790.2001; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Karl DM, 1998, LIMNOL OCEANOGR, V43, P1270, DOI 10.4319/lo.1998.43.6.1270; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Landry MR, 1998, DEEP-SEA RES PT II, V45, P2353, DOI 10.1016/S0967-0645(98)00074-5; LAWS EA, 1984, LIMNOL OCEANOGR, V29, P1161, DOI 10.4319/lo.1984.29.6.1161; LAWS EA, 1987, LIMNOL OCEANOGR, V32, P905, DOI 10.4319/lo.1987.32.4.0905; LEHMAN JT, 1982, SCIENCE, V216, P729, DOI 10.1126/science.216.4547.729; Lessard EJ, 1998, AQUAT MICROB ECOL, V16, P173, DOI 10.3354/ame016173; Letelier RM, 1998, AQUAT MICROB ECOL, V15, P265, DOI 10.3354/ame015265; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mann KH, 2006, VERTICAL STRUCTURE O, P68; Maranon E, 2005, LIMNOL OCEANOGR, V50, P299, DOI 10.4319/lo.2005.50.1.0299; Maranon E, 2000, DEEP-SEA RES PT I, V47, P825, DOI 10.1016/S0967-0637(99)00087-4; Maranon E, 2007, AQUAT MICROB ECOL, V48, P261, DOI 10.3354/ame048261; Marra J., 2002, PHYTOPLANKTON PRODUC, P78, DOI DOI 10.1002/9780470995204.CH4; MCCARTHY JJ, 1979, SCIENCE, V203, P670, DOI 10.1126/science.203.4381.670; Moran XAG, 2007, J MAR RES, V65, P545, DOI 10.1357/002224007782689102; Moreno-Ostos E, 2011, SCI MAR, V75, P379, DOI 10.3989/scimar.2011.75n2379; Nicholson D, 2008, LIMNOL OCEANOGR, V53, P2226, DOI 10.4319/lo.2008.53.5_part_2.2226; Perez V, 2006, DEEP-SEA RES PT I, V53, P1616, DOI 10.1016/j.dsr.2006.07.008; PETERSON BJ, 1980, ANNU REV ECOL SYST, V11, P359, DOI 10.1146/annurev.es.11.110180.002043; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; POMEROY LR, 1994, APPL ENVIRON MICROB, V60, P328, DOI 10.1128/AEM.60.1.328-332.1994; Quay PD, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003665; Quevedo M, 2001, MAR ECOL PROG SER, V221, P29, DOI 10.3354/meps221029; R Core Team, 2021, R LANGUAGE ENV STAT; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; Robinson C., 2008, MICROB ECOL OCEAN, p299, DOI DOI 10.1002/9780470281840.CH9; Seymour JR, 2009, AM NAT, V173, pE15, DOI 10.1086/593004; SHELDON RW, 1984, LIMNOL OCEANOGR, V29, P1342, DOI 10.4319/lo.1984.29.6.1342; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Stelfox-Widdicombe CE, 2000, MAR ECOL PROG SER, V208, P1, DOI 10.3354/meps208001; STERNER RW, 1986, SCIENCE, V231, P605, DOI 10.1126/science.231.4738.605; Strom S, 2002, HYDROBIOLOGIA, V480, P41, DOI 10.1023/A:1021224832646; Teira E, 2005, DEEP-SEA RES PT I, V52, P569, DOI 10.1016/j.dsr.2004.11.007; Teira E, 2003, MAR ECOL PROG SER, V249, P53, DOI 10.3354/meps249053; Thorpe SA, 2007, INTRODUCTION TO OCEAN TURBULENCE, P116; Treguer P., 1975, MANUEL ANAL SELS NUT; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; VILLAREAL TA, 1993, NATURE, V363, P709, DOI 10.1038/363709a0; Villareal TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033109; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zubkov MV, 1998, DEEP-SEA RES PT I, V45, P1339, DOI 10.1016/S0967-0637(98)00015-6; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	80	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69159	10.1371/journal.pone.0069159	http://dx.doi.org/10.1371/journal.pone.0069159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935946	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000085
J	de Sena, DP; Fabricio, DD; Lopes, MHI; da Silva, VD				de Sena, David P.; Fabricio, Daniela D.; Lopes, Maria Helena I.; da Silva, Vinicius D.			Computer-Assisted Teaching of Skin Flap Surgery: Validation of a Mobile Platform Software for Medical Students	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; BENCH MODEL FIDELITY; OPERATING-ROOM PERFORMANCE; SURGICAL SKILLS; TECHNICAL SKILL; VIRTUAL-REALITY; SIMULATION; EDUCATION; ACQUISITION; FEEDBACK	The purpose of this study was to develop and validate a multimedia software application for mobile platforms to assist in the teaching and learning process of design and construction of a skin flap. Traditional training in surgery is based on learning by doing. Initially, the use of cadavers and animal models appeared to be a valid alternative for training. However, many conflicts with these training models prompted progression to synthetic and virtual reality models. Fifty volunteer fifth- and sixth-year medical students completed a pretest and were randomly allocated into two groups of 25 students each. The control group was exposed for 5 minutes to a standard text-based print article, while the test group used multimedia software describing how to fashion a rhomboid flap. Each group then performed a cutaneous flap on a training bench model while being evaluated by three blinded BSPS (Brazilian Society of Plastic Surgery) board-certified surgeons using the OSATS (Objective Structured Assessment of Technical Skill) protocol and answered a post-test. The text-based group was then tested again using the software. The computer-assisted learning (CAL) group had superior performance as confirmed by checklist scores (p<0.002), overall global assessment (p = 0.017) and post-test results (p<0.001). All participants ranked the multimedia method as the best study tool. CAL learners exhibited better subjective and objective performance when fashioning rhomboid flaps as compared to those taught with standard print material. These findings indicate that students preferred to learn using the multimedia method.	[de Sena, David P.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Hlth Sci, Porto Alegre, RS, Brazil; [Fabricio, Daniela D.] Pontificia Univ Catolica Rio Grande do Sul, Dept Otorhinolaryngol, Hosp Sao Lucas, Porto Alegre, RS, Brazil; [Lopes, Maria Helena I.] Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Dept Internal Med, Porto Alegre, RS, Brazil; [da Silva, Vinicius D.] Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Dept Pathol & Radiat, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	da Silva, VD (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Dept Pathol & Radiat, Porto Alegre, RS, Brazil.	vinids@pucrs.br	da Silva, Vinicius Duval/AAE-9220-2021; da Silva, Vinicius D/C-5289-2013	da Silva, Vinicius Duval/0000-0003-3515-0263; da Silva, Vinicius D/0000-0003-3515-0263	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [475934/2011-3]; CNPq PQ fellowship [305531/2012-3]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq PQ fellowship	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant number 475934/2011-3 conceded to VDS. VDS is also recipient of CNPq PQ fellowship, grant number 305531/2012-3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, MACROMEDIA FLASH MX; Bashankaev B, 2011, SURG ENDOSC, V25, P28, DOI 10.1007/s00464-010-1123-x; BORGES AF, 1981, PLAST RECONSTR SURG, V67, P458, DOI 10.1097/00006534-198104000-00007; Folse JR, 1996, SURGERY, V120, P575, DOI 10.1016/S0039-6060(96)80001-8; Glicksman JT, 2009, LARYNGOSCOPE, V119, P466, DOI 10.1002/lary.20083; Grober ED, 2004, ANN SURG, V240, P374, DOI 10.1097/01.sla.0000133346.07434.30; Hammoud MM, 2008, AM J OBSTET GYNECOL, V199, P338, DOI 10.1016/j.ajog.2008.05.002; Ilie VG, 2008, MICROSURG, V28, P571, DOI 10.1002/micr.20541; Jensen AR, 2009, AM J SURG, V197, P82, DOI 10.1016/j.amjsurg.2008.06.039; Lehmann KS, 2005, ANN SURG, V241, P442, DOI 10.1097/01.sla.0000154552.89886.91; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Matsumoto ED, 2002, J UROLOGY, V167, P1243, DOI 10.1016/S0022-5347(05)65274-3; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Nousiainen M, 2008, SURGERY, V143, P539, DOI 10.1016/j.surg.2007.10.022; Palter VN, 2011, ANN SURG, V253, P886, DOI 10.1097/SLA.0b013e31821263ec; Park SS, 2007, LOCAL FLAPS FACIAL R, P213; Porte MC, 2007, AM J SURG, V193, P105, DOI 10.1016/j.amjsurg.2006.03.016; Reznick R, 1997, AM J SURG, V173, P226, DOI 10.1016/S0002-9610(97)89597-9; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Rogers DA, 2000, J SURG RES, V92, P53, DOI 10.1006/jsre.2000.5844; Rogers DA, 2000, AM J SURG, V179, P341, DOI 10.1016/S0002-9610(00)00341-X; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Seymour NE, 2008, WORLD J SURG, V32, P182, DOI 10.1007/s00268-007-9307-9; Sidhu RS, 2007, J VASC SURG, V45, P343, DOI 10.1016/j.jvs.2006.09.040; Spencer F C, 1979, Bull Am Coll Surg, V64, P15; Stefanidis D, 2012, ANN SURG, V255, P30, DOI 10.1097/SLA.0b013e318220ef31; Sturm LP, 2008, ANN SURG, V248, P166, DOI 10.1097/SLA.0b013e318176bf24; Sutherland LM, 2006, ANN SURG, V243, P291, DOI 10.1097/01.sla.0000200839.93965.26; Tan SSY, 2011, SCOT MED J, V56, P104, DOI 10.1258/smj.2011.011098; Wanzel KR, 2002, PLAST RECONSTR SURG, V109, P258, DOI 10.1097/00006534-200201000-00041	30	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e65833	10.1371/journal.pone.0065833	http://dx.doi.org/10.1371/journal.pone.0065833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935818	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000003
J	John, T; Starmans, MHW; Chen, YT; Russell, PA; Barnett, SA; White, SC; Mitchell, PL; Walkiewicz, M; Azad, A; Lambin, P; Tsao, MS; Deb, S; Altorki, N; Wright, G; Knight, S; Boutros, PC; Cebon, JS				John, Thomas; Starmans, Maud H. W.; Chen, Yao-Tseng; Russell, Prudence A.; Barnett, Stephen A.; White, Shane C.; Mitchell, Paul L.; Walkiewicz, Marzena; Azad, Arun; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon; Boutros, Paul C.; Cebon, Jonathan S.			The Role of Cancer-Testis Antigens as Predictive and Prognostic Markers in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; ADJUVANT CHEMOTHERAPY; EXPRESSION; GENE; CISPLATIN; MELANOMA; PACLITAXEL; DOCETAXEL; SURGERY; BENEFIT	Background: Cancer-Testis Antigens (CTAs) are immunogenic proteins that are poor prognostic markers in non-small cell lung cancer (NSCLC). We investigated expression of CTAs in NSCLC and their association with response to chemotherapy, genetic mutations and survival. Methods: We studied 199 patients with pathological N2 NSCLC treated with neoadjuvant chemotherapy (NAC; n = 94), postoperative observation (n = 49), adjuvant chemotherapy (n = 47) or unknown (n = 9). Immunohistochemistry for NY-ESO-1, MAGE-A and MAGE-C1 was performed. Clinicopathological features, response to neoadjuvant treatment and overall survival were correlated. DNA mutations were characterized using the Sequenom Oncocarta panel v1.0. Affymetrix data from the JBR. 10 adjuvant chemotherapy study were obtained from a public repository, normalised and mapped for CTAs. Results: NY-ESO-1 was expressed in 50/199 (25%) samples. Expression of NY-ESO-1 in the NAC cohort was associated with significantly increased response rates (P = 0.03), but not overall survival. In the post-operative cohort, multivariate analyses identified NY-ESO-1 as an independent poor prognostic marker for those not treated with chemotherapy (HR 2.61, 95% CI 1.28-5.33; P = 0.008), whereas treatment with chemotherapy and expression of NY-ESO-1 was an independent predictor of improved survival (HR 0.267, 95% CI 0.07-0.980; P = 0.046). Similar findings for MAGE-A were seen, but did not meet statistical significance. Independent gene expression data from the JBR. 10 dataset support these findings but were underpowered to demonstrate significant differences. There was no association between oncogenic mutations and CTA expression. Conclusions: NY-ESO-1 was predictive of increased response to neoadjuvant chemotherapy and benefit from adjuvant chemotherapy. Further studies investigating the relationship between these findings and immune mechanisms are warranted.	[John, Thomas; Walkiewicz, Marzena; Azad, Arun; Deb, Siddhartha; Cebon, Jonathan S.] Austin Hlth, Ludwig Inst Canc Res, Melbourne, Vic, Australia; [John, Thomas; Barnett, Stephen A.; White, Shane C.; Mitchell, Paul L.; Azad, Arun; Knight, Simon; Cebon, Jonathan S.] Austin Hlth, Dept Med Oncol, Melbourne, Vic, Australia; [John, Thomas; Barnett, Stephen A.; White, Shane C.; Mitchell, Paul L.; Azad, Arun; Knight, Simon; Cebon, Jonathan S.] Austin Hlth, Dept Thorac Surg, Melbourne, Vic, Australia; [Starmans, Maud H. W.; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Starmans, Maud H. W.; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol Maastro, Maastricht, Netherlands; [Chen, Yao-Tseng; Altorki, Nasser] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA; [Russell, Prudence A.; Wright, Gavin] St Vincents Hosp, Melbourne, Vic, Australia; [Tsao, Ming-Sound] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Maastricht University; Cornell University; NewYork-Presbyterian Hospital; St Vincent's Hospital Melbourne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	John, T (corresponding author), Austin Hlth, Ludwig Inst Canc Res, Melbourne, Vic, Australia.	tom.john@ludwig.edu.au	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Tsao, Ming Sound/0000-0002-9160-5405; John, Thomas/0000-0003-3399-5342; Wright, Gavin/0000-0002-7000-9305; Boutros, Paul/0000-0003-0553-7520; Cebon, Jonathan/0000-0002-3898-950X; Lambin, Philippe/0000-0001-7961-0191	Victorian Cancer Agency, Clinical Research Fellowship [CRF09-04]; Pfizer Cancer Research grant; Center for Translational Molecular Medicine (AIRFORCE) [030-103]; National Health & Medical Research Council (NHMRC) of Australia [487905, 542510, 1007381]; Ontario Institute for Cancer Research through the Government of Ontario; Victorian State Government	Victorian Cancer Agency, Clinical Research Fellowship; Pfizer Cancer Research grant; Center for Translational Molecular Medicine (AIRFORCE); National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ontario Institute for Cancer Research through the Government of Ontario; Victorian State Government	This work was supported by the Victorian Cancer Agency, Clinical Research Fellowship (CRF09-04), a Pfizer Cancer Research grant, the Center for Translational Molecular Medicine (www.ctmm.nl) (AIRFORCE Project Ref. 030-103), National Health & Medical Research Council (NHMRC) of Australia Practitioner Fellowship (487905) and Project grants (542510 & 1007381) as well as the Ontario Institute for Cancer Research through funding provided by the Government of Ontario to PB. Supported in part by the Operational Infrastructure Support Program Funding of the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Curigliano G, 2011, ANN ONCOL, V22, P98, DOI 10.1093/annonc/mdq325; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Felip E, 2010, J CLIN ONCOL, V28, P3138, DOI 10.1200/JCO.2009.27.6204; Gedye C, 2009, CANCER IMMUNOL IMMUN, V58, P1635, DOI 10.1007/s00262-009-0672-0; Goss GD, 2010, ASCO M, V28; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; John T, 2008, CLIN CANCER RES, V14, P3291, DOI 10.1158/1078-0432.CCR-07-1322; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Nicholaou T, 2006, IMMUNOL CELL BIOL, V84, P303, DOI 10.1111/j.1440-1711.2006.01446.x; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2000, CANCER LETT, V150, P155, DOI 10.1016/S0304-3835(99)00385-7; Shanafelt TD, 2004, J CLIN ONCOL, V22, P1966, DOI 10.1200/JCO.2004.08.176; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shigematsu Y, 2010, LUNG CANCER, V68, P105, DOI 10.1016/j.lungcan.2009.05.010; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Song WA, 2010, J THORAC ONCOL, V5, P510, DOI 10.1097/JTO.0b013e3181cd3345; Strauss GM, 2012, J CLIN ONCOL, V30, P128, DOI 10.1200/JCO.2011.39.7570; Suzuki T, 2007, ONCOL REP, V18, P329; Tajima K, 2003, LUNG CANCER-J IASLC, V42, P23, DOI 10.1016/S0169-5002(03)00244-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Whitehurst AW, 2010, CANCER RES, V70, P7652, DOI 10.1158/0008-5472.CAN-10-0840; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yoshida N, 2006, INT J ONCOL, V28, P1089; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	37	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67876	10.1371/journal.pone.0067876	http://dx.doi.org/10.1371/journal.pone.0067876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935846	Green Published, gold			2022-12-27	WOS:000325211000020
J	Neville, BA; Sheridan, PO; Harris, HMB; Coughlan, S; Flint, HJ; Duncan, SH; Jeffery, IB; Claesson, MJ; Ross, RP; Scott, KP; O'Toole, PW				Neville, B. Anne; Sheridan, Paul O.; Harris, Hugh M. B.; Coughlan, Simone; Flint, Harry J.; Duncan, Sylvia H.; Jeffery, Ian B.; Claesson, Marcus J.; Ross, R. Paul; Scott, Karen P.; O'Toole, Paul W.			Pro-Inflammatory Flagellin Proteins of Prevalent Motile Commensal Bacteria Are Variably Abundant in the Intestinal Microbiome of Elderly Humans	PLOS ONE			English	Article							BUTYRATE-PRODUCING BACTERIA; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; TRANSLATION INITIATION; SP NOV.; SEQUENCE; ALIGNMENT; PATHWAY; CSRA; HOMEOSTASIS	Some Eubacterium and Roseburia species are among the most prevalent motile bacteria present in the intestinal microbiota of healthy adults. These flagellate species contribute "cell motility" category genes to the intestinal microbiome and flagellin proteins to the intestinal proteome. We reviewed and revised the annotation of motility genes in the genomes of six Eubacterium and Roseburia species that occur in the human intestinal microbiota and examined their respective locus organization by comparative genomics. Motility gene order was generally conserved across these loci. Five of these species harbored multiple genes for predicted flagellins. Flagellin proteins were isolated from R. inulinivorans strain A2-194 and from E. rectale strains A1-86 and M104/1. The amino-termini sequences of the R. inulinivorans and E. rectale A1-86 proteins were almost identical. These protein preparations stimulated secretion of interleukin-8 (IL-8) from human intestinal epithelial cell lines, suggesting that these flagellins were pro-inflammatory. Flagellins from the other four species were predicted to be pro-inflammatory on the basis of alignment to the consensus sequence of pro-inflammatory flagellins from the beta- and gamma-proteobacteria. Many fliC genes were deduced to be under the control of sigma(28). The relative abundance of the target Eubacterium and Roseburia species varied across shotgun metagenomes from 27 elderly individuals. Genes involved in the flagellum biogenesis pathways of these species were variably abundant in these metagenomes, suggesting that the current depth of coverage used for metagenomic sequencing (3.13-4.79 Gb total sequence in our study) insufficiently captures the functional diversity of genomes present at low (<= 1%) relative abundance. E. rectale and R. inulinivorans thus appear to synthesize complex flagella composed of flagellin proteins that stimulate IL-8 production. A greater depth of sequencing, improved evenness of sequencing and improved metagenome assembly from short reads will be required to facilitate in silico analyses of complete complex biochemical pathways for low-abundance target species from shotgun metagenomes.	[Neville, B. Anne; Harris, Hugh M. B.; Coughlan, Simone; Jeffery, Ian B.; Claesson, Marcus J.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Sheridan, Paul O.; Flint, Harry J.; Duncan, Sylvia H.; Scott, Karen P.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Ross, R. Paul] Teagasc Moorepk Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University of Aberdeen; Teagasc	O'Toole, PW (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	pwotoole@ucc.ie	Scott, Karen/ABD-5484-2021; Claesson, Marcus/K-7639-2015; Ross, Paul/A-7584-2015; O'Toole, Paul W/G-1593-2012; Claesson, Marcus/AAE-4145-2019	Scott, Karen/0000-0002-4608-0013; Claesson, Marcus/0000-0002-5712-0623; Ross, Paul/0000-0003-4876-8839; O'Toole, Paul W/0000-0001-5377-0824; Claesson, Marcus/0000-0002-5712-0623; Sheridan, Paul/0000-0001-8243-5718; Coughlan, Simone/0000-0002-0181-2399; Jeffery, Ian/0000-0001-9183-7292	Science Foundation Ireland [07/IN.1/B1780]; Irish Research Council for Science Engineering and Technology; Government of Ireland National Development Plan by way of a Department of Agriculture Food and Marine, and Health Research Board FHRI; Science Foundation Ireland award; Scottish Government Rural and Environment Science and Analytical Service Division (RESAS); RESAS; APC, UCC	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Government of Ireland National Development Plan by way of a Department of Agriculture Food and Marine, and Health Research Board FHRI; Science Foundation Ireland award(Science Foundation Ireland); Scottish Government Rural and Environment Science and Analytical Service Division (RESAS); RESAS; APC, UCC	This work was supported by a Principal Investigator Award (07/IN.1/B1780) from Science Foundation Ireland to PWOT. BAN was the recipient of an Embark studentship from the Irish Research Council for Science Engineering and Technology. HMBH and IBJ were supported by the Government of Ireland National Development Plan by way of a Department of Agriculture Food and Marine, and Health Research Board FHRI award to the ELDERMET project, as well as by a Science Foundation Ireland award to the Alimentary Pharmabiotic Centre (APC). The RINH, UoA receives funding from the Scottish Government Rural and Environment Science and Analytical Service Division (RESAS). POS's studentship is jointly funded by RESAS and the APC, UCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2006, APPL ENVIRON MICROB, V72, P6371, DOI 10.1128/AEM.00701-06; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003; Brown J, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P99; BRYANT MP, 1972, AM J CLIN NUTR, V25, P1324; Carvalho FA, 2012, MUCOSAL IMMUNOL, V5, P288, DOI 10.1038/mi.2012.8; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dalebroux ZD, 2012, NAT REV MICROBIOL, V10, P203, DOI 10.1038/nrmicro2720; De Filippo C, 2012, BRIEF BIOINFORM, V13, P696, DOI 10.1093/bib/bbs070; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Euzeby J, 2010, LACHNOSPIRACEAE; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forde BM, 2013, GENOMICS COMMENSAL L; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Kalmokoff ML, 2000, ANAEROBE, V6, P93, DOI 10.1006/anae.1999.0308; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lakhdari O, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/282356; LANDER E S, 1988, Genomics, V2, P231; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004; MARTIN JH, 1985, J GEN MICROBIOL, V131, P2075; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Smith K, 2003, POETRY REV, V93, P5; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Snyder LAS, 2009, TRENDS MICROBIOL, V17, P1, DOI 10.1016/j.tim.2008.10.002; STANTON TB, 1984, J GEN MICROBIOL, V130, P173; Stanton TB, 2009, BERGEYS MANUAL SYSTE, P954; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Tamames J, 2001, GENOME BIOL, V2; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; WADE WG, 2009, BERGEYS MANUAL SYSTE, V3, P865; Wade WG, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P823, DOI 10.1007/0-387-30744-3_28; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Warnecke F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-231; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Yonekura K, 2005, STRUCTURE, V13, P407, DOI 10.1016/j.str.2005.02.003; Zaslaver A, 2006, PHYS BIOL, V3, P183, DOI 10.1088/1478-3975/3/3/003	80	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68919	10.1371/journal.pone.0068919	http://dx.doi.org/10.1371/journal.pone.0068919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935906	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000062
J	Rohr, AK; Hammerstad, M; Andersson, KK				Rohr, Asmund Kjendseth; Hammerstad, Marta; Andersson, K. Kristoffer			Tuning of Thioredoxin Redox Properties by Intramolecular Hydrogen Bonds	PLOS ONE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ACTIVE-SITE; NRDH-REDOXIN; RIBONUCLEOTIDE REDUCTASE; SULFHYDRYL-GROUPS; DISULFIDE BOND; PK(A) VALUES; PROTEIN; CYSTEINE; THIOL	Thioredoxin-like proteins contain a characteristic C-x-x-C active site motif and are involved in a large number of biological processes ranging from electron transfer, cellular redox level maintenance, and regulation of cellular processes. The mechanism for deprotonation of the buried C-terminal active site cysteine in thioredoxin, necessary for dissociation of the mixed-disulfide intermediate that occurs under thiol/disulfide mediated electron transfer, is not well understood for all thioredoxin superfamily members. Here we have characterized a 8.7 kD thioredoxin (BC3987) from Bacillus cereus that unlike the typical thioredoxin appears to use the conserved Thr8 side chain near the unusual C-P-P-C active site to increase enzymatic activity by forming a hydrogen bond to the buried cysteine. Our hypothesis is based on biochemical assays and thiolate pK(a) titrations where the wild type and T8A mutant are compared, phylogenetic analysis of related thioredoxins, and QM/MM calculations with the BC3987 crystal structure as a precursor for modeling of reduced active sites. We suggest that our model applies to other thioredoxin subclasses with similar active site arrangements.	[Rohr, Asmund Kjendseth; Hammerstad, Marta; Andersson, K. Kristoffer] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo	Rohr, AK (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	a.k.rohr@ibv.uio.no	Kjendseth, Åsmund Røhr/O-2543-2016	Kjendseth, Åsmund Røhr/0000-0002-4956-4865	Steering Board for Molecular Life Sciences at the University of Oslo (EMBIO); Norwegian Research Council [177661V30, 138370V30, 214239/F20, 218412/F50]; Norwegian Cancer Society [539012]	Steering Board for Molecular Life Sciences at the University of Oslo (EMBIO); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This research was supported by the Steering Board for Molecular Life Sciences at the University of Oslo (EMBIO), the Norwegian Research Council (grants 177661V30, 138370V30, 214239/F20, 218412/F50, synchrotron related research in the Oslo region, SYGOR), and 539012 Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K.K., 2008, RIBONUCLEOTIDE REDUC; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arner ES, 2001, CURR PROTOC TOXICOL, V7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENESCH RE, 1955, J BIOL CHEM, V216, P663; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bettegowda C, 2006, NAT BIOTECHNOL, V24, P1573, DOI 10.1038/nbt1256; Bindoli A, 2008, ANTIOXID REDOX SIGN, V10, P1549, DOI 10.1089/ars.2008.2063; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665; Carvalho ATP, 2006, J PHYS CHEM B, V110, P5758, DOI 10.1021/jp053275f; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Frisch MJ, 2004, GAUSSIAN 03 D0 2; Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427; Ho BK, 2005, PROTEIN SCI, V14, P1011, DOI 10.1110/ps.041156905; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; Jobb G, 2004, TREEFINDER POWERFUL; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; LeMaster DM, 1996, BIOCHEMISTRY-US, V35, P14876, DOI 10.1021/bi961607o; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; LI HM, 1993, BIOCHEMISTRY-US, V32, P5800, DOI 10.1021/bi00073a012; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P865, DOI 10.1002/bit.260180608; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; MATHIEU I, 1992, BIOCHEM J, V285, P255, DOI 10.1042/bj2850255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehler EL, 2002, PROTEINS, V48, P283, DOI 10.1002/prot.10153; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; POLGAR L, 1974, FEBS LETT, V38, P187, DOI 10.1016/0014-5793(74)80110-9; Porter MA, 2006, PROTEINS, V63, P621, DOI 10.1002/prot.20879; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h; RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070; Reynolds CM, 2002, BIOCHEMISTRY-US, V41, P1990, DOI 10.1021/bi011802p; Rickard GA, 2008, J PHYS CHEM B, V112, P5774, DOI 10.1021/jp710917t; Roos G, 2006, J PHYS CHEM B, V110, P557, DOI 10.1021/jp0549780; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Starks CM, 2007, PROTEIN SCI, V16, P92, DOI 10.1110/ps.062519707; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; TANFORD C, 1957, J AM CHEM SOC, V79, P5333, DOI 10.1021/ja01577a001; Tomter AB, 2013, COORDIN CHEM REV, V257, P3, DOI 10.1016/j.ccr.2012.05.021; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d	71	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69411	10.1371/journal.pone.0069411	http://dx.doi.org/10.1371/journal.pone.0069411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936007	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000115
J	Zhong, XM; Li, JP; Dou, HC; Deng, SJ; Wang, GF; Jiang, Y; Wang, YJ; Zhou, ZB; Wang, L; Yan, F				Zhong, Xiaomei; Li, Jianping; Dou, Huacheng; Deng, Shijun; Wang, Guofei; Jiang, Yu; Wang, Yongjie; Zhou, Zebing; Wang, Li; Yan, Fei			Fuzzy Nonlinear Proximal Support Vector Machine for Land Extraction Based on Remote Sensing Image	PLOS ONE			English	Article							NEURAL-NETWORKS; CLASSIFICATION; PREDICTION; ACCURACY; ALGORITHMS	Currently, remote sensing technologies were widely employed in the dynamic monitoring of the land. This paper presented an algorithm named fuzzy nonlinear proximal support vector machine (FNPSVM) by basing on ETM+ remote sensing image. This algorithm is applied to extract various types of lands of the city Da'an in northern China. Two multi-category strategies, namely "one-against-one" and "one-against-rest" for this algorithm were described in detail and then compared. A fuzzy membership function was presented to reduce the effects of noises or outliers on the data samples. The approaches of feature extraction, feature selection, and several key parameter settings were also given. Numerous experiments were carried out to evaluate its performances including various accuracies (overall accuracies and kappa coefficient), stability, training speed, and classification speed. The FNPSVM classifier was compared to the other three classifiers including the maximum likelihood classifier (MLC), back propagation neural network (BPN), and the proximal support vector machine (PSVM) under different training conditions. The impacts of the selection of training samples, testing samples and features on the four classifiers were also evaluated in these experiments.	[Zhong, Xiaomei] Tianjin Chengjian Univ, Tianjin, Peoples R China; [Li, Jianping; Dou, Huacheng; Deng, Shijun; Wang, Guofei; Jiang, Yu; Wang, Yongjie; Zhou, Zebing; Wang, Li] Tianjin Inst Geotech Invest & Surveying, Tianjin, Peoples R China; [Li, Jianping; Dou, Huacheng; Deng, Shijun; Wang, Guofei; Jiang, Yu; Wang, Yongjie; Zhou, Zebing; Wang, Li] Tianjin StarGIS Informat Engn Co Ltd, Tianjin, Peoples R China; [Yan, Fei] Beijing Forestry Univ, Beijing, Peoples R China	Tianjin Chengjian University; Beijing Forestry University	Li, JP (corresponding author), Tianjin Inst Geotech Invest & Surveying, Tianjin, Peoples R China.	ljpzl@126.com	zhou, zhou/HCH-1084-2022					Bai YP, 2005, CHAOS SOLITON FRACT, V26, P559, DOI 10.1016/j.chaos.2005.01.064; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Campbell JB, 1996, INTRO REMOTE SENSING; [陈建军 Chen Jianju], 2003, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V17, P101; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Dash M., 1997, Intelligent Data Analysis, V1; Dwivedi RS, 1998, INT J REMOTE SENS, V19, P605, DOI 10.1080/014311698215883; Eitrich T, 2006, J COMPUT APPL MATH, V196, P425, DOI 10.1016/j.cam.2005.09.009; Foody GM, 1996, INT J REMOTE SENS, V17, P1317, DOI 10.1080/01431169608948706; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Fung G., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P77, DOI 10.1145/502512.502527; Girolami M, 2002, IEEE T NEURAL NETWOR, V13, P780, DOI 10.1109/TNN.2002.1000150; Golub GH., 2013, MATRIX COMPUTATIONS; Guo Hu-sheng, 2009, Computer Engineering and Applications, V45, P51, DOI 10.3778/j.issn.1002-8331.2009.02.014; Hecht-Nielsen R., 1992, IEEE T NEURAL NETWOR, p65e93, DOI [10.1016/B978-0-12-741252-8.50010-8, DOI 10.1016/B978-0-12-741252-8.50010-8, 10.1109/IJCNN.1989.118638, DOI 10.1109/IJCNN.1989.118638]; HIXSON M, 1980, PHOTOGRAMM ENG REM S, V46, P1547; Hsu C-W, 2004, TECHNICAL REPORT; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Huang Z, 2004, DECIS SUPPORT SYST, V37, P543, DOI 10.1016/S0167-9236(03)00086-1; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Jayadeva, 2004, NEUROCOMPUTING, V61, P401, DOI 10.1016/j.neucom.2004.02.004; Jayadeva, 2005, NEUROCOMPUTING, V67, P426, DOI 10.1016/j.neucom.2004.09.002; Kim DW, 2005, PATTERN RECOGN LETT, V26, P879, DOI 10.1016/j.patrec.2004.10.001; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Li Q., 2009, J JILIN U ENG TECHNO, V39, P131; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Lin J, 2010, J REMOTE SENSING, V14, P173; Liu Han, 2010, Journal of Shanghai Jiaotong University, V44, P962; Liu Y, 2006, PATTERN RECOGN, V39, P1333, DOI 10.1016/j.patcog.2005.10.006; Luo Y, 2001, REMOTE SENSING INFOR, V4, P12; Mahesh P, 2005, P COMP VIS PATT REC; Mangasarian OL, 2000, ADV NEUR IN, P135; [梅建新 Mei Jianxin], 2004, [武汉大学学报. 信息科学版, Geomatics and Information Science of Wuhan University], V29, P912; Min JH, 2005, EXPERT SYST APPL, V28, P603, DOI 10.1016/j.eswa.2004.12.008; Pal M, 2005, INT J REMOTE SENS, V26, P1007, DOI 10.1080/01431160512331314083; ROSENFIELD GH, 1986, PHOTOGRAMM ENG REM S, V52, P223; Shih FY, 2005, IMAGE VISION COMPUT, V23, P877, DOI 10.1016/j.imavis.2005.05.015; Smits PC, 1999, INT J REMOTE SENS, V20, P1461, DOI 10.1080/014311699212560; Stehman SV, 1999, INT J REMOTE SENS, V20, P2347, DOI 10.1080/014311699212065; Stehman SV, 1998, REMOTE SENS ENVIRON, V64, P331, DOI 10.1016/S0034-4257(98)00010-8; Tay FEH, 2001, OMEGA-INT J MANAGE S, V29, P309, DOI 10.1016/S0305-0483(01)00026-3; Theodoridis S., 2003, PATTERN RECOGNITION; Tsujinishi D, 2003, NEURAL NETWORKS, V16, P785, DOI 10.1016/S0893-6080(03)00110-2; Vapnik V., 2013, NATURE STAT LAERNING; [汪闽 Wang Min], 2005, [遥感学报, Journal of Remote Sensing], V9, P271; Xuegong Zhang, 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P3, DOI 10.1109/NNSP.1999.788117; Yi JQ, 2007, APPL MATH COMPUT, V185, P976, DOI 10.1016/j.amc.2006.07.020; Zenren Y, 1999, APPL ARTIFICIAL NEUR; Zhan Y, 2004, IMAGE PROCESSING ANA; Zhu Jianghong, 2011, Geomatics and Information Science of Wuhan University, V36, P301	51	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69434	10.1371/journal.pone.0069434	http://dx.doi.org/10.1371/journal.pone.0069434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936016	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000120
J	Nijhuis, EHJ; van Walsum, AMV; Norris, DG				Nijhuis, Emil H. J.; van Walsum, Anne-Marie van Cappellen; Norris, David G.			Topographic Hub Maps of the Human Structural Neocortical Network	PLOS ONE			English	Article							HUMAN BRAIN; GENDER-DIFFERENCES; FUNCTIONAL ARCHITECTURE; STROKE INCIDENCE; DEFAULT NETWORK; SEX-DIFFERENCES; CONNECTIVITY; ATTENTION; AREAS; ORGANIZATION	Hubs within the neocortical structural network determined by graph theoretical analysis play a crucial role in brain function. We mapped neocortical hubs topographically, using a sample population of 63 young adults. Subjects were imaged with high resolution structural and diffusion weighted magnetic resonance imaging techniques. Multiple network configurations were then constructed per subject, using random parcellations to define the nodes and using fibre tractography to determine the connectivity between the nodes. The networks were analysed with graph theoretical measures. Our results give reference maps of hub distribution measured with betweenness centrality and node degree. The loci of the hubs correspond with key areas from known overlapping cognitive networks. Several hubs were asymmetrically organized across hemispheres. Furthermore, females have hubs with higher betweenness centrality and males have hubs with higher node degree. Female networks have higher small-world indices.	[Nijhuis, Emil H. J.; Norris, David G.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Nijhuis, Emil H. J.; van Walsum, Anne-Marie van Cappellen; Norris, David G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Walsum, Anne-Marie van Cappellen] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6525 ED Nijmegen, Netherlands; [Norris, David G.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Duisburg, Germany	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen; University of Duisburg Essen	Nijhuis, EHJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	emil.nijhuis@gmail.com	van Cappellen van Walsum, Anne-Marie/H-3240-2015; Nijhuis, Emil/K-7077-2013; Norris, David G/A-1937-2010	Norris, David G/0000-0002-3699-6917				Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ayala CN, 2002, STROKE, V33, P1197, DOI 10.1161/01.STR.0000015028.52771.D1; Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bosma Ingeborg, 2009, Nonlinear Biomed Phys, V3, P9, DOI 10.1186/1753-4631-3-9; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cook P.A., 2006, 14 SCI M INT SOC MAG; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Henriksson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036859; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kim M, 2006, NEUROIMAGE, V32, P1243, DOI 10.1016/j.neuroimage.2006.06.006; Kochunov P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00120; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LOCKE S, 1965, ARCH NEUROL-CHICAGO, V13, P471, DOI 10.1001/archneur.1965.00470050019002; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; NIEUWENHUYS R, 2007, HUMAN CENTRAL NERVOU, pCH15; Pareto V., 1896, MANUAL POLITICAL EC; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Persky Rebecca W, 2010, Curr Cardiol Rep, V12, P6, DOI 10.1007/s11886-009-0080-2; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; ROLAND PE, 1980, J NEUROPHYSIOL, V43, P118, DOI 10.1152/jn.1980.43.1.118; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; SEBER GAF, 2008, CLUSTER ANAL MULTIVA, P347, DOI DOI 10.1002/9780470316641.CH7.ACCESSED; Silva GS, 2010, CEREBROVASC DIS, V30, P470, DOI 10.1159/000317088; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; TOMASI D, 2011, NEUROIMAGE; TUCH DS, 1999, P 7 ANN M ISMRM PHIL, P321; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; VISSER E, 2010, P 18 ANN M ISMRM, V18, P3459; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wyller TB, 1997, CLIN REHABIL, V11, P171, DOI 10.1177/026921559701100211; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zwiers MP, 2010, NEUROIMAGE, V53, P565, DOI 10.1016/j.neuroimage.2010.06.014	87	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65511	10.1371/journal.pone.0065511	http://dx.doi.org/10.1371/journal.pone.0065511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23935801	gold, Green Published			2022-12-27	WOS:000320440500042
J	Sasaki, S; Kobayashi, M; Futagi, Y; Ogura, J; Yamaguchi, H; Takahashi, N; Iseki, K				Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Takahashi, Natsuko; Iseki, Ken			Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)	PLOS ONE			English	Article							LACTIC-ACID EFFLUX; CANCER-CELLS; LUNG-CANCER; EXPRESSION; MCT4; INHIBITION; SUBSTRATE; SITE; MEMBRANE; CONFIRMS	Background: Monocarboxylate transporters (MCTs) transport monocarboxylates such as lactate, pyruvate and ketone bodies. These transporters are very attractive therapeutic targets in cancer. Elucidations of the functions and structures of MCTs is necessary for the development of effective medicine which targeting these proteins. However, in comparison with MCT1, there is little information on location of the function moiety of MCT4 and which constituent amino acids govern the transport function of MCT4. The aim of the present work was to determine the molecular mechanism of L-lactate transport via hMCT4. Experimental approach: Transport of L-lactate via hMCT4 was determined by using hMCT4 cRNA-injected Xenopus laevis oocytes. hMCT4 mediated L-lactate uptake in oocytes was measured in the absence and presence of chemical modification agents and 4,4'-diisothiocyanostilbene-2,2'-disulphonate (DIDS). In addition, L-lactate uptake was measured by hMCT4 arginine mutants. Immunohistochemistry studies revealed the localization of hMCT4. Results: In hMCT4-expressing oocytes, treatment with phenylglyoxal (PGO), a compound specific for arginine residues, completely abolished the transport activity of hMCT4, although this abolishment was prevented by the presence of L-lactate. On the other hand, chemical modifications except for PGO treatment had no effect on the transport activity of hMCT4. The transporter has six conserved arginine residues, two in the transmembrane-spanning domains (TMDs) and four in the intracellular loops. In hMCT4-R278 mutants, the uptake of L-lactate is void of any transport activity without the alteration of hMCT4 localization. Conclusions: Our results suggest that Arg-278 in TMD8 is a critical residue involved in substrate, L-lactate recognition by hMCT4.	[Sasaki, Shotaro; Kobayashi, Masaki; Futagi, Yuya; Ogura, Jiro; Yamaguchi, Hiroaki; Iseki, Ken] Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut, Sapporo, Hokkaido 060, Japan; [Takahashi, Natsuko] Hokkaido Pharmaceut Univ, Sch Pharm, Otaru, Hokkaido, Japan; [Iseki, Ken] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Iseki, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Div Pharmasci, Lab Clin Pharmaceut & Therapeut, Kita 12, Sapporo, Hokkaido 060, Japan.	ken-i@pharm.hokudai.ac.jp	Yamaguchi, Hiroaki/G-9969-2012; kobayashi, masaki/B-1638-2015; Ogura, Jiro/F-7260-2012	Yamaguchi, Hiroaki/0000-0003-3021-6120; Ogura, Jiro/0000-0001-5139-137X; Futagi, Yuya/0000-0003-2829-2845	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24790138, 25460184] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yoseph O, 1998, J NEURO-ONCOL, V36, P149, DOI 10.1023/A:1005819604858; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Calero CI, 2008, J NEUROCHEM, V105, P2367, DOI 10.1111/j.1471-4159.2008.05319.x; Carpenter L, 1996, BBA-BIOMEMBRANES, V1279, P157, DOI 10.1016/0005-2736(95)00254-5; Chen HC, 2010, INTEGR SER INFORM SY, V21, P147, DOI 10.1007/978-1-4419-1278-7_10; Colen CB, 2011, NEOPLASIA, V13, P620, DOI 10.1593/neo.11134; Cuff MA, 2002, J PHYSIOL-LONDON, V539, P361, DOI 10.1113/jphysiol.2001.014241; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; GEORGE AL, 1979, BIOCHEM BIOPH RES CO, V87, P59, DOI 10.1016/0006-291X(79)91646-2; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Hatta H, 2001, AM J PHYSIOL-ENDOC M, V281, pE749, DOI 10.1152/ajpendo.2001.281.4.E749; Izumi H, 2011, CANCER SCI, V102, P1007, DOI 10.1111/j.1349-7006.2011.01908.x; Kido Y, 2000, PHARMACEUT RES, V17, P55, DOI 10.1023/A:1007518525161; Kobayashi M, 2006, INT J PHARMACEUT, V317, P19, DOI 10.1016/j.ijpharm.2006.02.043; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; KRAMER W, 1990, BIOCHIM BIOPHYS ACTA, V1028, P174, DOI 10.1016/0005-2736(90)90152-E; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Meredith D, 2002, CELL PHYSIOL BIOCHEM, V12, P227, DOI 10.1159/000066282; Nakayama Y, 2012, EXP THER MED, V3, P25, DOI 10.3892/etm.2011.361; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Pinheiro C, 2008, INT J GYNECOL PATHOL, V27, P568, DOI 10.1097/PGP.0b013e31817b5b40; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Price NT, 1998, BIOCHEM J, V329, P321; Settle P, 2004, PLACENTA, V25, P496, DOI 10.1016/j.placenta.2003.11.009; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stroffekova K, 1998, AM J PHYSIOL, V275, P1113; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Witkiewicz AK, 2012, CELL CYCLE, V11, P1108, DOI 10.4161/cc.11.6.19530; WOOD PG, 1992, J MEMBRANE BIOL, V127, P139; YAMAGUCHI M, 1985, ARCH BIOCHEM BIOPHYS, V243, P20, DOI 10.1016/0003-9861(85)90769-6	43	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e67690	10.1371/journal.pone.0067690	http://dx.doi.org/10.1371/journal.pone.0067690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935841	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700005
J	Nojima, A; Yamashita, M; Yoshida, Y; Shimizu, I; Ichimiya, H; Kamimura, N; Kobayashi, Y; Ohta, S; Ishii, N; Minamino, T				Nojima, Aika; Yamashita, Masakatsu; Yoshida, Yohko; Shimizu, Ippei; Ichimiya, Harumi; Kamimura, Naomi; Kobayashi, Yoshio; Ohta, Shigeo; Ishii, Naoaki; Minamino, Tohru			Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice	PLOS ONE			English	Article							C-ELEGANS DAF-16; INSULIN-RECEPTOR; GENE-EXPRESSION; FAMILY-MEMBER; TOR PATHWAY; LONGEVITY; KINASE; LONG; METABOLISM; RESISTANCE	There is increasing evidence that nutrient-sensing machinery is critically involved in the regulation of aging. The insulin/insulin-like growth factor-1 signaling pathway is the best-characterized pathway with an influence on longevity in a variety of organisms, ranging from yeast to rodents. Reduced expression of the receptor for this pathway has been reported to prolong the lifespan; however, the underlying mechanisms are largely unknown. Here we show that haploinsufficiency of Akt1 leads to an increase of the lifespan in mice. Akt1(+/-) mice had a lower body weight than their littermates with less fat mass and normal glucose metabolism. Ribosomal biogenesis and the mitochondrial DNA content were significantly reduced in these mice, along with a decrease of oxidative stress. Consistent with the results obtained in mice, inhibition of Akt-1 promoted longevity in nematodes (Caenorhabditis elegans), whereas activation of Akt-1 shortened the lifespan. Inhibition of Akt-1 led to a decrease of ribosomal gene expression and the mitochondrial DNA content in both human cells and nematodes. Moreover, deletion of ribosomal gene expression resulted in a decrease of the mitochondrial DNA content and normalized the lifespan shortened by Akt-1 activation in nematodes. These results suggest that an increase of mitochondrial amount and energy expenditure associated with enhanced protein synthesis accelerates both aging and the onset of age-associated diseases.	[Nojima, Aika; Yoshida, Yohko; Shimizu, Ippei; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan; [Yamashita, Masakatsu] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan; [Ichimiya, Harumi; Kamimura, Naomi; Ohta, Shigeo] Nippon Med Sch, Grad Sch Med, Inst Dev & Aging Sci, Dept Biochem & Cell Biol,Nakahara Ku, Kawasaki, Kanagawa, Japan; [Ishii, Naoaki] Tokai Univ, Sch Med, Dept Mol Life Sci Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan; [Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Chiba University; Kazusa DNA Research Institute; Nippon Medical School; Tokai University; Niigata University; Japan Science & Technology Agency (JST)	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Culture, Sports, Science and Technology of Japan [24390195]; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant #24390195), grants from the Uehara Memorial Foundation (http: //www.ueharazaidan.or.jp/), the SENSHIN Medical Research Foundation (www.mt-pharma.co.jp/zaidan/index.html), and the Takeda Science Foundation (www.takeda-sci.or.jp/) (to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knight EM, 2012, DIS MODEL MECH; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Minamino T, 2002, CURR OPIN LIPIDOL, V13, P537, DOI 10.1097/00041433-200210000-00010; Minamino T, 2008, NAT CLIN PRACT CARD, V5, P637, DOI 10.1038/ncpcardio1324; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Moniaux N, 2011, HEPATOLOGY, V53, P618, DOI 10.1002/hep.24087; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Newberg A, 2003, NUCL MED COMMUN, V24, P785, DOI 10.1097/01.mnm.0000080249.50447.99; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Zhou B, 2012, P NATL ACAD SCI USA, V109, pE1201, DOI 10.1073/pnas.1119304109; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	60	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69178	10.1371/journal.pone.0069178	http://dx.doi.org/10.1371/journal.pone.0069178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935948	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200026
J	Panosa, C; Tebar, F; Ferrer-Batalle, M; Fonge, H; Seno, M; Reilly, RM; Massaguer, A; De Llorens, R				Panosa, Clara; Tebar, Francesc; Ferrer-Batalle, Montserrat; Fonge, Humphrey; Seno, Masaharu; Reilly, Raymond M.; Massaguer, Anna; De Llorens, Rafael			Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity	PLOS ONE			English	Article							HUMAN BREAST-CANCER; POTATO CARBOXYPEPTIDASE INHIBITOR; FACTOR RECEPTOR; SIGNALING NETWORK; FACTOR-ALPHA; EXPRESSION; PROTEIN; ACTIVATION; MECHANISM; CELLS	The members of the epidermal growth factor (EGF)/ErbB family are prime targets for cancer therapy. However, the therapeutic efficiency of the existing anti-ErbB agents is limited. Thus, identifying new molecules that inactivate the ErbB receptors through novel strategies is an important goal on cancer research. In this study we have developed a shorter form of human EGF (EGFt) with a truncated C-terminal as a novel EGFR inhibitor. EGFt was designed based on the superimposition of the three-dimensional structures of EGF and the Potato Carboxypeptidase Inhibitor (PCI), an EGFR blocker previously described by our group. The peptide was produced in E. coli with a high yield of the correctly folded peptide. EGFt showed specificity and high affinity for EGFR but induced poor EGFR homodimerization and phosphorylation. Interestingly, EGFt promoted EGFR internalization and translocation to the cell nucleus although it did not stimulate the cell growth. In addition, EGFt competed with EGFR native ligands, inhibiting the proliferation of cancer cells. These data indicate that EGFt may be a potential EGFR blocker for cancer therapy. In addition, the lack of EGFR-mediated growth-stimulatory activity makes EGFt an excellent delivery agent to target toxins to tumours over-expressing EGFR.	[Panosa, Clara; Ferrer-Batalle, Montserrat; Massaguer, Anna; De Llorens, Rafael] Univ Girona, Dept Biol, Biochem & Mol Biol Unit, Girona, Catalunya, Spain; [Tebar, Francesc] Univ Barcelona, Dept Cell Biol Immunol & Neurosci, Barcelona, Catalunya, Spain; [Fonge, Humphrey; Reilly, Raymond M.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Seno, Masaharu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama, Japan; [Reilly, Raymond M.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	Universitat de Girona; University of Barcelona; University of Toronto; Okayama University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Massaguer, A (corresponding author), Univ Girona, Dept Biol, Biochem & Mol Biol Unit, Campus Montilivi, Girona, Catalunya, Spain.	anna.massaguer@udg.edu	SENO, Masaharu/B-2092-2011; Massaguer, Anna/L-5993-2014; Tebar, Francesc/H-1498-2015	SENO, Masaharu/0000-0001-8547-6259; Massaguer, Anna/0000-0003-1312-593X; Tebar, Francesc/0000-0002-9522-9726; , Montserrat/0000-0001-6024-6828	University of Girona [AP2007-01953, IdIBGi-PUG2007A/10]; Generalitat de Catalunya (Spain) [SGR00065]; Spanish Ministry of Health [RETICCC -RD06/0020/0041]; Ministerio de Economia y Competitividad of Spain [BFU2009-13526/BMC, BFU2012-38259]	University of Girona; Generalitat de Catalunya (Spain)(Generalitat de Catalunya); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This study has been supported by a predoctoral grant from the University of Girona awarded to C. Panosa (grant AP2007-01953), by grants from Generalitat de Catalunya (Spain) (SGR00065), Spanish Ministry of Health (RETICCC -RD06/0020/0041) and the University of Girona (IdIBGi-PUG2007A/10) awarded to R. de Llorens. This study was also supported by grants BFU2009-13526/BMC and BFU2012-38259 from Ministerio de Economia y Competitividad of Spain to F. Tebar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZANO MA, 1989, CANCER RES, V49, P2898; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Benavente S, 2009, CLIN CANCER RES, V15, P1585, DOI 10.1158/1078-0432.CCR-08-2068; BISHOP WP, 1995, GASTROENTEROLOGY, V109, P1882, DOI 10.1016/0016-5085(95)90755-6; Blanco-Aparicio C, 1998, J BIOL CHEM, V273, P12370, DOI 10.1074/jbc.273.20.12370; Brand TM, 2011, DISCOV MED, V12, P419; CANALS F, 1992, BIOCHEMISTRY-US, V31, P4493, DOI 10.1021/bi00133a016; Carrion-Salip D, 2012, INT J ONCOL, V41, P1128, DOI 10.3892/ijo.2012.1509; CHANG JY, 1995, J BIOL CHEM, V270, P9207, DOI 10.1074/jbc.270.16.9207; Chang JY, 2005, ANAL BIOCHEM, V342, P78, DOI 10.1016/j.ab.2005.03.038; Chen P, 2003, J NUCL MED, V44, P1469; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Ferrer-Soler L, 2007, INT J MOL MED, V20, P3; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Huang HW, 2010, BIOCHEM BIOPH RES CO, V402, P705, DOI 10.1016/j.bbrc.2010.10.089; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Marshall J, 2006, CANCER-AM CANCER SOC, V107, P1207, DOI 10.1002/cncr.22133; Mas JM, 1998, J MOL BIOL, V284, P541, DOI 10.1006/jmbi.1998.2194; MATSUNAMI RK, 1991, J CELL BIOCHEM, V46, P242, DOI 10.1002/jcb.240460307; Motulsky HJ, 1995, PRISM; Nakamura T, 2005, J BIOTECHNOL, V116, P211, DOI 10.1016/j.jbiotec.2004.10.021; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; RAY P, 1988, BIOCHEMISTRY-US, V27, P7289, DOI 10.1021/bi00419a017; Reddy CC, 1998, MED BIOL ENG COMPUT, V36, P499, DOI 10.1007/BF02523222; Reilly RM, 1998, J NUCL MED, V39, P1036; Reilly RM, 2000, J NUCL MED, V41, P903; Reilly RM, 2000, J NUCL MED, V41, P429; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sitja-Arnau M, 2005, CANCER LETT, V226, P169, DOI 10.1016/j.canlet.2005.01.025; Soler LF, 2003, J CHROMATOGR B, V788, P113, DOI 10.1016/S1570-0232(02)01035-8; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yotsumoto F, 2009, ANTICANCER RES, V29, P4879	45	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69325	10.1371/journal.pone.0069325	http://dx.doi.org/10.1371/journal.pone.0069325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935985	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200034
J	April, J; Hanner, RH; Mayden, RL; Bernatchez, L				April, Julien; Hanner, Robert H.; Mayden, Richard L.; Bernatchez, Louis			Metabolic Rate and Climatic Fluctuations Shape Continental Wide Pattern of Genetic Divergence and Biodiversity in Fishes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; FRESH-WATER; ECOLOGICAL SPECIATION; COREGONUS-CLUPEAFORMIS; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; HYBRID INVIABILITY; GENERATION TIME; BODY-SIZE; DIVERSITY	Taxonomically exhaustive and continent wide patterns of genetic divergence within and between species have rarely been described and the underlying evolutionary causes shaping biodiversity distribution remain contentious. Here, we show that geographic patterns of intraspecific and interspecific genetic divergence among nearly all of the North American freshwater fish species (>750 species) support a dual role involving both the late Pliocene-Pleistocene climatic fluctuations and metabolic rate in determining latitudinal gradients of genetic divergence and very likely influencing speciation rates. Results indicate that the recurrent glacial cycles caused global reduction in intraspecific diversity, interspecific genetic divergence, and species richness at higher latitudes. At the opposite, longer geographic isolation, higher metabolic rate increasing substitution rate and possibly the rapid accumulation of genetic incompatibilities, led to an increasing biodiversity towards lower latitudes. This indicates that both intrinsic and extrinsic factors similarly affect micro and macro evolutionary processes shaping global patterns of biodiversity distribution. These results also indicate that factors favouring allopatric speciation are the main drivers underlying the diversification of North American freshwater fishes.	[April, Julien; Bernatchez, Louis] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [April, Julien] Minist Dev Durable Environm Faune & Parcs, Quebec City, PQ, Canada; [Hanner, Robert H.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Laval University; University of Guelph; Saint Louis University	April, J (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada.	julien.april.1@ulaval.ca		Bernatchez, Louis/0000-0002-8085-9709	Natural Sciences and Engineering Research Council of Canada; Canadian research chair in genomics and conservation of aquatic resources	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian research chair in genomics and conservation of aquatic resources	This research was supported through funding to the Canadian Barcode of Life Network from the Natural Sciences and Engineering Research Council of Canada and other sponsors (listed at http://www.BOLNET.ca), as well as the Canadian research chair in genomics and conservation of aquatic resources. This study represents a contribution to the research program of Quebec-Ocean. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 1973, FRESHWATER FISHES CA; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; BERNATCHEZ L, 1990, EVOLUTION, V44, P1263, DOI 10.1111/j.1558-5646.1990.tb05230.x; Bernatchez L, 1997, MOL ECOL, V6, P73, DOI 10.1046/j.1365-294X.1997.00156.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Carlander KD, 1997, HDB FRESHWATER FISHE; Coyne JA, 2011, P NATL ACAD SCI USA, V108, P12975, DOI 10.1073/pnas.1110061108; Da Silva MNF, 1998, MOL ECOL, V7, P475, DOI 10.1046/j.1365-294x.1998.00276.x; DOBZHANSKY T., 1951, Genetics and the origin of species.; Dowle EJ, 2013, HEREDITY, V110, P501, DOI 10.1038/hdy.2013.4; Edmands S, 2002, TRENDS ECOL EVOL, V17, P520, DOI 10.1016/S0169-5347(02)02585-5; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Froese R., 2012, FISHBASE; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gavrilets S, 2003, EVOLUTION, V57, P2197; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; GOULD S J, 1977, Paleobiology, V3, P115; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hawkins BA, 2001, ENDEAVOUR, V25, P133, DOI 10.1016/S0160-9327(00)01369-7; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hocutt C. H., 1986, ZOOGEOGRAPHY N AM FR; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL E; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Lee DS, 1980, ATLAS N AM FRESHWATE; Lu GQ, 1999, EVOLUTION, V53, P1491, DOI 10.1111/j.1558-5646.1999.tb05413.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Mayden RL, 1992, SYSTEMATICS HIST ECO; Mayr E., 1963, ANIMAL SPECIES EVOLU; McPhail J. D, 1970, Bull. Fish. Res. Bd Can., V173, P1; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Mendelson TC, 2003, EVOLUTION, V57, P317; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Muller HJ, 1942, BIOL S, V6, P71; Nelson J. S., 2004, Common and scientific names of fishes from the United States, Canada and Mexico; Page LM, 1991, FIELD GUIDE FRESHWAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reznick DN, 2009, NATURE, V457, P837, DOI 10.1038/nature07894; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schonhuth S, 2010, MOL PHYLOGENET EVOL, V55, P77, DOI 10.1016/j.ympev.2009.10.030; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Stebbins G. L., 1974, Flowering plants. Evolution above the species level.; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Taylor EB, 1999, REV FISH BIOL FISHER, V9, P299, DOI 10.1023/A:1008955229420; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Tobias JA, 2008, SCIENCE, V319, DOI 10.1126/science.1150568; Travisano Michael, 1995, Evolution, V49, P189, DOI 10.1111/j.1558-5646.1995.tb05970.x; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wallace A. R., 1878, P356; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590	78	22	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70296	10.1371/journal.pone.0070296	http://dx.doi.org/10.1371/journal.pone.0070296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922969	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700164
J	Liao, YT; Yang, SY; Liu, HC; Chen, WJ; Chen, CC; Hung, YN; Kuo, CJ				Liao, Ya-Tang; Yang, Shu-Yu; Liu, Hsing-Cheng; Chen, Wei J.; Chen, Chiao-Chicy; Hung, Yen-Ni; Kuo, Chian-Jue			Cardiac Complications Associated with Short-Term Mortality in Schizophrenia Patients Hospitalized for Pneumonia: A Nationwide Case-Control Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ANTIPSYCHOTIC-DRUG USE; RISK; HYPERGLYCEMIA; ADMISSIONS; OUTCOMES; VOLUME	Background: Pneumonia is one of most prevalent infectious diseases worldwide and is associated with considerable mortality. In comparison to general population, schizophrenia patients hospitalized for pneumonia have poorer outcomes. We explored the risk factors of short-term mortality in this population because the information is lacking in the literature. Methods: In a nationwide schizophrenia cohort, derived from the National Health Insurance Research Database in Taiwan, that was hospitalized for pneumonia between 2000 and 2008 (n = 1,741), we identified 141 subjects who died during their hospitalizations or shortly after their discharges. Based on risk-set sampling in a 1:4 ratio, 468 matched controls were selected from the study cohort (i.e., schizophrenia cohort with pneumonia). Physical illnesses were categorized as preexisting and incident illnesses that developed after pneumonia respectively. Exposures to medications were categorized by type, duration, and defined daily dose. We used stepwise conditional logistic regression to explore the risk factors for short-term mortality. Results: Pre-existing arrhythmia was associated with short-term mortality (adjusted risk ratio [RR] = 4.99, p<0.01). Several variables during hospitalization were associated with increased mortality risk, including incident arrhythmia (RR = 7.44, p<0.01), incident heart failure (RR = 5.49, p = 0.0183) and the use of hypoglycemic drugs (RR = 2.32, p<0.01). Furthermore, individual antipsychotic drugs (such as clozapine) known to induce pneumonia were not significantly associated with the risk. Conclusions: Incident cardiac complications following pneumonia are associated with increased short-term mortality. These findings have broad implications for clinical intervention and future studies are needed to clarify the mechanisms of the risk factors.	[Liao, Ya-Tang; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yang, Shu-Yu; Liu, Hsing-Cheng; Kuo, Chian-Jue] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Yang, Shu-Yu] Kaohsiung Med Univ, Coll Pharm, Grad Inst Clin Pharm, Kaohsiung, Taiwan; [Liu, Hsing-Cheng; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Liu, Hsing-Cheng; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Chen, Chiao-Chicy] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Chiao-Chicy] Mackay Med Coll, Dept Psychiat, Taipei, Taiwan; [Hung, Yen-Ni] Natl Yang Ming Univ, Dept Nursing, Sch Nursing, Taipei 112, Taiwan; [Hung, Yen-Ni] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan	National Taiwan University; Taipei City Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Mackay Memorial Hospital; Mackay Medical College; National Yang Ming Chiao Tung University; Taipei Medical University	Kuo, CJ (corresponding author), Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan.	tcpckuo@seed.net.tw		Chen, Wei Jen/0000-0001-5899-5870	National Science Council of Taiwan [NSC 99-2314-B-532-003-MY3, NSC 99-2314-B-532-002-MY2, NSC102-2628-B-532-001-MY3]; Taipei City Hospital, Taipei, Taiwan [99001-62-004, 10001-62-005, 10001-62-017, 10101-62-008]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital, Taipei, Taiwan	This research was supported by grants from the National Science Council (NSC 99-2314-B-532-003-MY3, NSC 99-2314-B-532-002-MY2, NSC102-2628-B-532-001-MY3) of Taiwan, and Taipei City Hospital (99001-62-004, 10001-62-005, 10001-62-017, 10101-62-008), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YH, 2011, SCHIZOPHRENIA BULL, V37, P1088, DOI 10.1093/schbul/sbq019; Chen YH, 2010, PSYCHIAT RES, V178, P160, DOI 10.1016/j.psychres.2008.07.023; Chou FHC, 2013, J PSYCHIATR RES, V47, P460, DOI 10.1016/j.jpsychires.2012.12.007; Colice GL, 2004, CHEST, V125, P2140, DOI 10.1378/chest.125.6.2140; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Gau SSF, 2008, J CLIN PSYCHOPHARM, V28, P271, DOI 10.1097/JCP.0b013e3181723713; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Lepper PM, 2012, BMJ-BRIT MED J, V28, p[344, e3397]; Lin HC, 2008, AM J RESP CRIT CARE, V177, P989, DOI 10.1164/rccm.200706-813OC; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Mandal P, 2011, QJM-INT J MED, V104, P489, DOI 10.1093/qjmed/hcq247; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; MCMAHON MM, 1995, INFECT DIS CLIN N AM, V9, P1; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Song JH, 2011, INT J ANTIMICROB AG, V38, P108, DOI 10.1016/j.ijantimicag.2011.02.017; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; WHO-Collaborating-Centre-for-Drug-Statistic-Methodology, 2009, ATC IND DDDS; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Yang SY, 2013, J CLIN PSYCHIAT, V74, pE79, DOI 10.4088/JCP.12m07938; Yende S, 2010, THORAX, V65, P870, DOI 10.1136/thx.2010.136317	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70142	10.1371/journal.pone.0070142	http://dx.doi.org/10.1371/journal.pone.0070142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23922940	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700145
J	Mohanty, S; Kim, J; Ganesan, LP; Phillips, GS; Robinson, JM; Anderson, CL				Mohanty, Sudhasri; Kim, Jonghan; Ganesan, Latha P.; Phillips, Gary S.; Robinson, John M.; Anderson, Clark L.			Abundant Intracellular IgG in Enterocytes and Endoderm Lacking FcRn	PLOS ONE			English	Article							NEONATAL-RAT; ANTIBODY TRANSPORT; IMMUNOGLOBULIN-G; SMALL-INTESTINE; YOLK-SAC; ELECTRON TOMOGRAPHY; RECEPTOR; BINDING; CELLS; MHC	FcRn, a non-classical MHCI molecule, transports IgG from mother to young and regulates the rate of IgG degradation throughout life. Brambell proposed a mechanism that unified these two functions, saying that IgG was pinocytosed nonspecifically by the cell into an FcRn-expressing endosome, where, at low pH, it bound to FcRn and was exocytosed. This theory was immediately challenged by claims that FcRn specificity for ligand could be conferred at the cell surface in neonatal jejunum. Assessing Brambell's hypothesis we found abundant nonspecifically endocytosed IgG present in the cytoplasm of FcRn(-/-) enterocytes. Further, IgG was present in the intercellular clefts and the cores of FcRn(+/+) but not FcRn(-/-) jejunum. FcRn specificity for ligand could be determined within the cell.	[Mohanty, Sudhasri; Kim, Jonghan; Ganesan, Latha P.; Anderson, Clark L.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Phillips, Gary S.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Robinson, John M.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Northeastern University	Anderson, CL (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	anderson.48@osu.edu			NIH [HD38764]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by NIH R01 grant HD38764. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AHOUSE JJ, 1993, J IMMUNOL, V151, P6076; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Anderson CL, 2006, TRENDS IMMUNOL, V27, P343, DOI 10.1016/j.it.2006.05.004; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; BERRYMAN M, 1995, J CELL SCI, V108, P2347; BRAMBELL FW, 1966, LANCET, V2, P1087, DOI 10.1016/S0140-6736(66)92190-8; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Claypool SM, 2004, MOL BIOL CELL, V15, P1746, DOI 10.1091/mbc.E03-11-0832; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; He WZ, 2007, J STRUCT BIOL, V160, P103, DOI 10.1016/j.jsb.2007.07.004; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Junghans RP, 1997, IMMUNOL RES, V16, P29, DOI 10.1007/BF02786322; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kuo TT, 2009, J BIOL CHEM, V284, P8292, DOI 10.1074/jbc.M805877200; Ladinsky MS, 2012, MOL BIOL CELL, V23, P2537, DOI 10.1091/mbc.E12-02-0093; Leach JL, 1996, J IMMUNOL, V157, P3317; McCarthy KM, 2000, J CELL SCI, V113, P1277; McCarthy KM, 2001, J CELL SCI, V114, P1591; Mohanty S, 2010, J REPROD IMMUNOL, V84, P133, DOI 10.1016/j.jri.2009.10.008; Newton EE, 2005, J CELL SCI, V118, P2461, DOI 10.1242/jcs.02367; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Praetor A, 1999, J CELL SCI, V112, P2291; Praetor A, 2002, J CELL SCI, V115, P2389; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; RODEWALD R, 1970, J CELL BIOL, V45, P635, DOI 10.1083/jcb.45.3.635; RODEWALD R, 1973, J CELL BIOL, V58, P189, DOI 10.1083/jcb.58.1.189; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Tzaban S, 2009, J CELL BIOL, V185, P673, DOI 10.1083/jcb.200809122; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Waldmann TA, 1973, CIBA F SYMP, V9, P5; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70863	10.1371/journal.pone.0070863	http://dx.doi.org/10.1371/journal.pone.0070863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923029	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700212
J	Podewils, LJ; Gler, MTS; Quelapio, MI; Chen, MP				Podewils, Laura Jean; Gler, Maria Tarcela S.; Imelda Quelapio, Maria; Chen, Michael P.			Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; PULMONARY TUBERCULOSIS; ADHERENCE; DEFAULT	Background: The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-factorial and complex. Identifying patterns of treatment interruption that predict poor outcomes can be used to target program activities aiming to improve treatment adherence. Objective: To characterize patterns of treatment interruption among MDR TB patients and determine the association between patterns and treatment outcomes. Methods: Retrospective analysis of MDR TB patients. A treatment interruption was defined as any time that a patient missed a prescribed dose of treatment for at least 1 day but for a period of less than 2 consecutive months. Patients were characterized by the number, length and variability of interruptions, variability of time between interruptions, and percent of missed doses. Final treatment outcome was dichotomized as a successful (cured or completed) or poor outcome (defaulted, failed, or died). Risk ratios were calculated to determine the association between characteristics of treatment interruption and treatment outcomes. All analyses were conducted in 6 month treatment intervals. Results: Only 7.0% of 583 patients completed treatment without interruption. Of the remaining 542 patients, the median time to the first interruption was 2K months (70 days). In multivariate analysis, patients who had longer interruptions with sporadic variability during the 6-12 month or the 12-18 month treatment period had a significantly increased risk for poor outcomes compared to patients who had short, regular interruptions (RRadj 4.37, 95% CI 1.2-15.8; = 0.03 and RRadj 3.38, 95% CI 1.6-7.1; p = 0.001, respectively). In addition, missing 10% or more of the prescribed doses during any 6 month period in the initial 18 months of therapy significantly increased the risk for poor outcomes (RRadj range 1.55-2.35; p-value range 0.01-0.005). Conclusion: Patients that miss more consecutive days of treatment with sporadic interruption patterns or a greater proportion of treatment are at an increased risk for poor treatment outcomes.	[Podewils, Laura Jean; Chen, Michael P.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Gler, Maria Tarcela S.; Imelda Quelapio, Maria] Trop Dis Fdn, Manila, Philippines	Centers for Disease Control & Prevention - USA	Podewils, LJ (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	lpp8@cdc.gov			Global Fund	Global Fund	The project was supported by the Global Fund grant to the Tropical Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; [Anonymous], 2008, GUID PROGR MAN DRUG; Driver CR, 2005, J PUBLIC HEALTH MAN, V11, P361; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Gler MT, 2012, INT J TUBERC LUNG D, V16, P955, DOI 10.5588/ijtld.11.0502; Gust DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018435; Jakubowiak W, 2009, INT J INFECT DIS, V13, P362, DOI 10.1016/j.ijid.2008.07.015; Kizito KW, 2011, T ROY SOC TROP MED H, V105, P52, DOI 10.1016/j.trstmh.2010.08.015; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Mesfin MM, 2009, HEALTH POLICY PLANN, V24, P457, DOI 10.1093/heapol/czp030; Munro SA, PLOS MED, V4, pe238; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Philippines National Tuberculosis Program, 2006, YEARL ACC REP DRUG R; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; World Health Organisation, 2011, WHOHTMTB201116; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169	16	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70064	10.1371/journal.pone.0070064	http://dx.doi.org/10.1371/journal.pone.0070064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922904	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700126
J	Shawi, M; Chu, TW; Martinez-Marignac, V; Yu, Y; Gryaznov, SM; Johnston, JB; Lees-Miller, SP; Assouline, SE; Autexier, C; Aloyz, R				Shawi, May; Chu, Tsz Wai; Martinez-Marignac, Veronica; Yu, Y.; Gryaznov, Sergei M.; Johnston, James B.; Lees-Miller, Susan P.; Assouline, Sarit E.; Autexier, Chantal; Aloyz, Raquel			Telomerase Contributes to Fludarabine Resistance in Primary Human Leukemic Lymphocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; IGVH MUTATION STATUS; CHLORAMBUCIL CYTOTOXICITY; RNA COMPONENT; INHIBITION; SUBGROUPS; LENGTH; CELLS; EXPRESSION; SURVIVAL	We report that Imetelstat, a telomerase inhibitor that binds to the RNA component of telomerase (hTR), can sensitize primary CLL lymphocytes to fludarabine in vitro. This effect was observed in lymphocytes from clinically resistant cases and with cytogenetic abnormalities associated with bad prognosis. Imetelstat mediated-sensitization to fludarabine was not associated with telomerase activity, but with the basal expression of Ku80. Since both Imetelstat and Ku80 bind hTR, we assessed 1) if Ku80 and Imetelstat alter each other's binding to hTR in vitro and 2) the effect of an oligonucleotide complementary to the Ku binding site in hTR (Ku oligo) on the survival of primary CLL lymphocytes exposed to fludarabine. We show that Imetelstat interferes with the binding of Ku70/80 (Ku) to hTR and that the Ku oligo can sensitize CLL lymphocytes to FLU. Our results suggest that Ku binding to hTR may contribute to fludarabine resistance in CLL lmphocytes. This is the first report highlighting the potentially broad effectiveness of Imetelstat in CLL, and the potential biological and clinical implications of a functional interaction between Ku and hTR in primary human cancer cells.	[Shawi, May; Chu, Tsz Wai; Autexier, Chantal; Aloyz, Raquel] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Shawi, May; Autexier, Chantal] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Assouline, Sarit E.; Aloyz, Raquel] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Shawi, May; Chu, Tsz Wai; Autexier, Chantal] McGill Univ, Jewish Gen Hosp, Bloomfield Ctr Res Ageing, Montreal, PQ H3T 1E2, Canada; [Martinez-Marignac, Veronica; Assouline, Sarit E.; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Martinez-Marignac, Veronica; Assouline, Sarit E.; Aloyz, Raquel] McGill Univ, Jewish Gen Hosp, Canc Segal Ctr, Montreal, PQ H3T 1E2, Canada; [Gryaznov, Sergei M.] Geron Corp, Menlo Pk, CA USA; [Johnston, James B.] Canc Care Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Yu, Y.; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Southern Alberta Canc Res Inst, Calgary, AB, Canada	McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; Geron Corporation; University of Calgary	Aloyz, R (corresponding author), McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada.	raquel.aloyz@mcgill.ca	Aloyz, Raquel S/N-6606-2013	Aloyz, Raquel S/0000-0002-6812-497X; Shawi, May/0000-0001-6005-3938; Lees-Miller, Susan/0000-0001-5809-2516	Leukemia & Lymphoma Society of America [6291-11, 700428]; Canadian Institutes of Health Research [MOP-81215]; Cole Foundation Fellowship; Canadian Institutes of Health Research Canada Graduate Scholarship; McGill University Faculty of Medicine Internal Studentship; McGill Integrated Cancer Research Training Program; Cancer Care Manitoba Foundation	Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cole Foundation Fellowship; Canadian Institutes of Health Research Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); McGill University Faculty of Medicine Internal Studentship; McGill Integrated Cancer Research Training Program; Cancer Care Manitoba Foundation	This work was supported by a grant from the Leukemia & Lymphoma Society of America to RA (6291-11) in addition to a Canadian Cancer Society (#700428) and Canadian Institutes of Health Research (MOP-81215) to CA. MS was supported by a Cole Foundation Fellowship and a Canadian Institutes of Health Research Canada Graduate Scholarship and TWC was supported by a McGill University Faculty of Medicine Internal Studentship and the McGill Integrated Cancer Research Training Program. CA is a Chercheur National of the Fonds de la Recherche en Sante du Quebec. The authors thank the Manitoba CLL tissue bank (funded by Cancer Care Manitoba Foundation) for the IgVH mutation analysis and Dr. Jacques van Meel for BIBR1532. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, CANCER LETT, V178, P187, DOI 10.1016/S0304-3835(01)00838-2; Amrein L, 2011, LEUKEMIA, V25, P1512, DOI 10.1038/leu.2011.110; Amrein L, 2008, BRIT J HAEMATOL, V143, P698, DOI [10.1111/j.1365-2141.2008.07418.x, 10.1111/j.1365-2141.2008.07418.x ]; Amrein L, 2007, J PHARMACOL EXP THER, V321, P848, DOI 10.1124/jpet.106.118356; Asai A, 2003, CANCER RES, V63, P3931; Austen B, 2005, BLOOD, V106, P3175, DOI 10.1182/blood-2004-11-4516; Autexier C, 1999, NUCLEIC ACIDS RES, V27, P2227, DOI 10.1093/nar/27.10.2227; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bachand F, 2001, NUCLEIC ACIDS RES, V29, P3385, DOI 10.1093/nar/29.16.3385; Bechter OE, 1998, CANCER RES, V58, P4918; Bollmann FM, 2008, BIOESSAYS, V30, P728, DOI 10.1002/bies.20793; Brennan SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012487; CaligarisCappio F, 1996, BLOOD, V87, P2615, DOI 10.1182/blood.V87.7.2615.bloodjournal8772615; Choi EK, 2002, J PATHOL, V198, P121, DOI 10.1002/path.1164; Christodoulopoulos G, 1998, CANCER RES, V58, P1789; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Damle RN, 2004, BLOOD, V103, P375, DOI 10.1182/blood-2003-04-1345; de Campos-Nebel M, 2008, MUTAT RES-FUND MOL M, V646, P8, DOI 10.1016/j.mrfmmm.2008.08.013; Deaglio S, 2003, BLOOD, V102, P2146, DOI 10.1182/blood-2003-03-0989; Elter T, 2006, EXPERT OPIN PHARMACO, V7, P1641, DOI 10.1517/14656566.7.12.1641; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Gu JF, 2008, GENE DEV, V22, P411, DOI 10.1101/gad.1646608; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hebb J, 2010, CANC CHEMOTHER PHARM; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Jackson SR, 2007, CANCER RES, V67, P1121, DOI 10.1158/0008-5472.CAN-06-2306; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Moll U, 1999, ONCOGENE, V18, P3114, DOI 10.1038/sj.onc.1202640; Morabito F, 1998, BRIT J HAEMATOL, V102, P528, DOI 10.1046/j.1365-2141.1998.00813.x; Moreno C, 2008, BLOOD REV, V22, P211, DOI 10.1016/j.blre.2008.03.003; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Obermann EC, 2007, J CLIN PATHOL, V60, P794, DOI 10.1136/jcp.2006.040956; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; Pettitt AR, 1999, BRIT J HAEMATOL, V105, P986, DOI 10.1046/j.1365-2141.1999.01448.x; Pettitt AR, 2001, BLOOD, V98, P814, DOI 10.1182/blood.V98.3.814; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Rampazzo E, 2012, HAEMATOL-HEMATOL J, V97, P56, DOI 10.3324/haematol.2011.049874; Ratain MJ, 2010, EJC SUPPL, V8, P123, DOI 10.1016/S1359-6349(10)72095-4; Ricca I, 2007, LEUKEMIA, V21, P697, DOI 10.1038/sj.leu.2404544; Sampath Deepa, 2007, Curr Oncol Rep, V9, P361, DOI 10.1007/s11912-007-0048-6; Sellmann L, 2011, INT J HEMATOL, V93, P74, DOI 10.1007/s12185-010-0750-2; Terrin L, 2007, LEUKEMIA, V21, P965, DOI 10.1038/sj.leu.2404607; Ting NSY, 2009, NUCLEIC ACIDS RES, V37, P6105, DOI 10.1093/nar/gkp636; Ting NSY, 2005, NUCLEIC ACIDS RES, V33, P2090, DOI 10.1093/nar/gki342; Trentin L, 1999, BRIT J HAEMATOL, V106, P662, DOI 10.1046/j.1365-2141.1999.01620.x; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Willmore E, 2008, CLIN CANCER RES, V14, P3984, DOI 10.1158/1078-0432.CCR-07-5158; Wu XP, 2012, BBA-MOL CELL RES, V1823, P2130, DOI 10.1016/j.bbamcr.2012.08.003; Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020	52	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70428	10.1371/journal.pone.0070428	http://dx.doi.org/10.1371/journal.pone.0070428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922990	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700182
J	Sultan, AA; Tata, LJ; Grainge, MJ; West, J				Sultan, Alyshah Abdul; Tata, Laila J.; Grainge, Matthew J.; West, Joe			The Incidence of First Venous Thromboembolism in and around Pregnancy Using Linked Primary and Secondary Care Data: A Population Based Cohort Study from England and Comparative Meta-Analysis	PLOS ONE			English	Article							HOSPITAL EPISODE STATISTICS; RISK-FACTORS; POSTPARTUM PERIOD; PUERPERIUM; VALIDATION; DIAGNOSES; DISEASE; CANCER; WOMEN	Background: Recent linkage between primary and secondary care data has provided valuable information for studying heath outcomes that may initially present in different health care settings. The aim of this study was therefore, twofold: to use linked primary and secondary care data to determine an optimum definition for estimating the incidence of first VTE in and around pregnancy; and secondly to conduct a systematic literature review of studies on perinatal VTE incidence with the purpose of comparing our estimates. Methods: We used primary care data from the Clinical Practice Research Datalink (CPRD), which incorporates linkages to secondary care contained within Hospital Episode Statistics (HES) between 1997 and 2010 to estimate the incidence rate of VTE in the antepartum and postpartum period. We systematically searched the literature on the incidence of VTE during antepartum and postpartum periods and performed a meta-analysis to provide comparison. Findings: Using combined CPRD and HES data and a restrictive VTE definition, the absolute rate during the antepartum period and first six weeks postpartum (early postpartum) were 99 (95% CI 85-116) and 468 (95% CI 391-561) per 100,000 person-years respectively. These were comparable to the pooled estimates from our meta-analysis (using studies after 2005) during the antepartum period (118/100,000 person-years) and early postpartum (424/100,000 person-years). When we used only secondary care data to identify VTE events, incidence was lower during the early postpartum period (308/100,000 person-years), whereas relying only on primary care data lead to lower incidence during the time around delivery, but higher rates during the postpartum period (558/100,000 person-years). Conclusion: Using combined CPRD and HES data gives estimates of the risk of VTE in and around pregnancy that are comparable to the existing literature. It also provides more accurate estimation of the date of VTE diagnosis which will allow risk stratification during specific pregnancy and postpartum periods.	[Sultan, Alyshah Abdul; Tata, Laila J.; Grainge, Matthew J.; West, Joe] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham	Sultan, AA (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	alyshah.sultan@hotmail.com	West, Joe/M-3867-2019; West, Joe/I-6637-2012; Tata, Laila/J-5227-2012	West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Tata, Laila/0000-0002-6404-8658; Grainge, Matthew/0000-0001-7181-4042				Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Chan LY, 2001, OBSTET GYNECOL, V98, P471, DOI 10.1016/S0029-7844(01)01476-4; Cochrane Pregnancy and Childbirth Group, SEARCH METH ID TRIAL; Crooks C, 2012, BMC HEALTH SERV RES, P12; Crooks C, 2013, THESIS U NOTTINGHAM; Dattani N, 2012, HLTH STAT Q, P53; Drife J, 2003, BRIT MED BULL, V67, P177, DOI 10.1093/bmb/ldg010; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Eaton SC, 2008, PHARMACOEPIDEM DR S, V17, pS214; Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3; Haggaz AARD, 2003, INT J GYNECOL OBSTET, V83, P309, DOI 10.1016/S0020-7292(03)00302-3; Health & Social Care Information Centre, 2011, NHS MAT STAT ENGL 20; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Horsted F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001275; Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James K V, 1996, Cardiovasc Surg, V4, P777, DOI 10.1016/S0967-2109(96)00042-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7; Lindqvist PG, 2008, VASC HEALTH RISK MAN, V4, P1081, DOI 10.2147/VHRM.S2831; Liu SL, 2009, J OBSTET GYNAECOL CA, V31, P611, DOI 10.1016/S1701-2163(16)34240-2; Lyall H, 2008, BRIT J HAEMATOL, V142, P309, DOI 10.1111/j.1365-2141.2008.07174.x; McColl MD, 1997, THROMB HAEMOSTASIS, V78, P1183; O'Connor DJ, 2011, ANN VASC SURG, V25, P9, DOI 10.1016/j.avsg.2010.04.003; Res HS, 2001, EPIDEMIOLOGY, V12, P456, DOI 10.1097/00001648-200107000-00016; Royal College of Obstetricians and Gynaecologist, 2010, ROYAL COLL OBST GY B; Sharma S, 2008, AUST NZ J OBSTET GYN, V48, P44, DOI 10.1111/j.1479-828X.2007.00799.x; Simpson EL, 2001, BRIT J OBSTET GYNAEC, V108, P56, DOI 10.1111/j.1471-0528.2001.00004.x; Soomro RM, 2002, ANGIOLOGY, V53, P429, DOI 10.1177/000331970205300409; Sultan AA, 2012, BRIT J HAEMATOL, V156, P366, DOI 10.1111/j.1365-2141.2011.08956.x; Thomas T, 2007, ALIMENT PHARM THER, V25, P657, DOI 10.1111/j.1365-2036.2007.03241.x; Virkus RA, 2011, THROMB HAEMOSTASIS, V106, P304, DOI 10.1160/TH10-12-0823; Wright FL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-161	37	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70310	10.1371/journal.pone.0070310	http://dx.doi.org/10.1371/journal.pone.0070310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922975	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700170
J	Cucchiara, B; Wolf, RL; Nagae, L; Zhang, Q; Kasner, S; Datta, R; Aguirre, GK; Detre, JA				Cucchiara, Brett; Wolf, Ronald L.; Nagae, Lidia; Zhang, Quan; Kasner, Scott; Datta, Ritobrato; Aguirre, Geoffrey K.; Detre, John A.			Migraine with Aura Is Associated with an Incomplete Circle of Willis: Results of a Prospective Observational Study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CORTICAL SPREADING DEPRESSION; VERTEBRAL ARTERY HYPOPLASIA; RISK-FACTOR; GENDER-DIFFERENCES; MR-ANGIOGRAPHY; STROKE; BRAIN; HEADACHE	Objective: To compare the prevalence of an incomplete circle of Willis in patients with migraine with aura, migraine without aura, and control subjects, and correlate circle of Willis variations with alterations in cerebral perfusion. Methods: Migraine with aura, migraine without aura, and control subjects were prospectively enrolled in a 1:1:1 ratio. Magnetic resonance angiography was performed to examine circle of Willis anatomy and arterial spin labeled perfusion magnetic resonance imaging to measure cerebral blood flow. A standardized template rating system was used to categorize circle of Willis variants. The primary pre-specified outcome measure was the frequency of an incomplete circle of Willis. The association between circle of Willis variations and cerebral blood flow was also analyzed. Results: 170 subjects were enrolled (56 migraine with aura, 61 migraine without aura, 53 controls). An incomplete circle of Willis was significantly more common in the migraine with aura compared to control group (73% vs. 51%, p = 0.02), with a similar trend for the migraine without aura group (67% vs. 51%, p = 0.08). Using a quantitative score of the burden of circle of Willis variants, migraine with aura subjects had a higher burden of variants than controls (p = 0.02). Compared to those with a complete circle, subjects with an incomplete circle had greater asymmetry in hemispheric cerebral blood flow (p = 0.05). Specific posterior cerebral artery variants were associated with greater asymmetries of blood flow in the posterior cerebral artery territory. Conclusions: An incomplete circle of Willis is more common in migraine with aura subjects than controls, and is associated with alterations in cerebral blood flow.	[Cucchiara, Brett; Kasner, Scott; Datta, Ritobrato; Aguirre, Geoffrey K.; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Wolf, Ronald L.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Nagae, Lidia] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA; [Zhang, Quan] Tianjin Med Univ, Dept Radiol, Tianjin, Peoples R China	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Tianjin Medical University	Cucchiara, B (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	cucchiar@mail.med.upenn.edu		Aguirre, Geoffrey/0000-0002-4028-3100	National Institute of Neurological Disorders and Stroke [NS061572, NS058386, NS045839, EB015893]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS058386, P30NS045839, R01NS061572] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Study sponsorship/funding was provided by National Institute of Neurological Disorders and Stroke (NS061572, NS058386, NS045839, EB015893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, EUR J RADIOL, V53, P450, DOI 10.1016/j.ejrad.2004.05.010; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Bugnicourt JM, 2009, HEADACHE, V49, P879, DOI 10.1111/j.1526-4610.2009.01389.x; BURING JE, 1995, ARCH NEUROL-CHICAGO, V52, P129, DOI 10.1001/archneur.1995.00540260031012; Cavestro C, 2011, CAN J NEUROL SCI, V38, P494, DOI 10.1017/S0317167100011926; Cucchiara B, 2008, MED HYPOTHESES, V70, P860, DOI 10.1016/j.mehy.2007.05.057; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DEBENEDITTIS G, 1995, HEADACHE, V35, P264; DIETRICH WD, 1994, J CEREBR BLOOD F MET, V14, P20, DOI 10.1038/jcbfm.1994.4; Esposito G, 1996, J NUCL MED, V37, P559; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; FAZEKAS F, 1992, HEADACHE, V32, P287, DOI 10.1111/j.1526-4610.1992.hed3206287.x; GALLAI V, 1994, ACTA NEUROL SCAND, V89, P47; GUR RE, 1990, SCHIZOPHRENIA BULL, V16, P247, DOI 10.1093/schbul/16.2.247; Hendrikse J, 2005, RADIOLOGY, V235, P184, DOI 10.1148/radiol.2351031799; Hoksbergen AWJ, 2003, CEREBROVASC DIS, V16, P191, DOI 10.1159/000071115; Ikeda K, 2009, HEADACHE; Krabbe-Hartkamp MJ, 1998, RADIOLOGY, V207, P103, DOI 10.1148/radiology.207.1.9530305; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; LAURITZEN M, 1983, ANN NEUROL, V14, P569, DOI 10.1002/ana.410140512; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lovrencic-Huzjan A, 1998, CEPHALALGIA, V18, P684, DOI 10.1046/j.1468-2982.1998.1810684.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Merikangas KR, 1997, ARCH NEUROL-CHICAGO, V54, P362, DOI 10.1001/archneur.1997.00550160012009; MIRALLES M, 1995, EUR J VASC ENDOVASC, V10, P424, DOI 10.1016/S1078-5884(05)80164-9; OLESEN J, 1993, BRAIN, V116, P187, DOI 10.1093/brain/116.1.187; PEARCE JMS, 1965, NEUROLOGY, V15, P333, DOI 10.1212/WNL.15.4.333; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perren F, 2007, NEUROLOGY, V68, P65, DOI 10.1212/01.wnl.0000250258.76706.98; SCHOMER DF, 1994, NEW ENGL J MED, V330, P1565, DOI 10.1056/NEJM199406023302204; Schoonman GG, 2010, HEADACHE, V50, P151, DOI 10.1111/j.1526-4610.2009.01559.x; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; STANG PE, 1992, NEUROLOGY, V42, P1657, DOI 10.1212/WNL.42.9.1657; STEWART WF, 1991, AM J EPIDEMIOL, V134, P1111, DOI 10.1093/oxfordjournals.aje.a116014; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; van der Grond J, 2004, NEUROLOGY, V63, P1452; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Willinek WA, 2003, RADIOLOGY, V229, P913, DOI 10.1148/radiol.2293020782	42	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71007	10.1371/journal.pone.0071007	http://dx.doi.org/10.1371/journal.pone.0071007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923042	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900184
J	Eliseyev, A; Aksenova, T				Eliseyev, Andrey; Aksenova, Tetiana			Recursive N-Way Partial Least Squares for Brain-Computer Interface	PLOS ONE			English	Article							TENSOR DISCRIMINANT-ANALYSIS; ALGORITHMS; SWITCH; PLS	In the article tensor-input/tensor-output blockwise Recursive N-way Partial Least Squares (RNPLS) regression is considered. It combines the multi-way tensors decomposition with a consecutive calculation scheme and allows blockwise treatment of tensor data arrays with huge dimensions, as well as the adaptive modeling of time-dependent processes with tensor variables. In the article the numerical study of the algorithm is undertaken. The RNPLS algorithm demonstrates fast and stable convergence of regression coefficients. Applied to Brain Computer Interface system calibration, the algorithm provides an efficient adjustment of the decoding model. Combining the online adaptation with easy interpretation of results, the method can be effectively applied in a variety of multi-modal neural activity flow modeling tasks.	[Eliseyev, Andrey; Aksenova, Tetiana] CEA, CLINATEC, Grenoble, France	CEA	Eliseyev, A (corresponding author), CEA, CLINATEC, Grenoble, France.	eliseyev.andrey@gmail.com	Eliseyev, Andrey/I-1434-2019	Aksenova, Tetiana/0000-0003-4007-2343; Eliseyev, Andrey/0000-0002-0312-889X	grant CE ICoBI from the Nanosciences Foundation; RTRA; Edmond J. Safra Philanthropic Foundation	grant CE ICoBI from the Nanosciences Foundation; RTRA; Edmond J. Safra Philanthropic Foundation	This work was partially supported by grant CE ICoBI from the Nanosciences Foundation, RTRA and a non-restricted research grant from the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova TI, 1988, J OPTIMALITY SOVIET, V21, P36; Anh Huy Phan, 2010, 2010 Proceedings of International Conference on Advanced Technologies for Communications (ATC 2010), P138, DOI 10.1109/ATC.2010.5672697; Bro R, 1996, J CHEMOMETR, V10, P47, DOI 10.1002/(SICI)1099-128X(199601)10:1<47::AID-CEM400>3.0.CO;2-C; Bro R., 1998, THESIS U AMSTERDAM N; Chao Z.C., 2010, FRONT NEUROENG, V3, P1; Cook RD, 1982, RESIDUALS INFLUENCE; Dayal BS, 1997, J PROCESS CONTR, V7, P169, DOI 10.1016/S0959-1524(97)80001-7; Eliseyev A, 2011, LECT NOTES COMPUT SC, V6792, P17, DOI 10.1007/978-3-642-21738-8_3; Eliseyev A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046012; Foerster M, 2012, BIOMED CIRC SYST C, P232, DOI 10.1109/BioCAS.2012.6418454; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Golub G. H., 1989, MATRIX COMPUTATIONS; HARSHMAN R. A., 1970, UCLA WORKING PAPERS, V16, P84; Helland IS, 2001, CHEMOMETR INTELL LAB, V58, P97, DOI 10.1016/S0169-7439(01)00154-X; HELLAND K, 1992, CHEMOMETR INTELL LAB, V14, P129, DOI 10.1016/0169-7439(92)80098-O; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lee HW, 2007, IND ENG CHEM RES, V46, P955, DOI 10.1021/ie061094+; Li J, 2010, PATTERN RECOGN LETT, V31, P619, DOI 10.1016/j.patrec.2009.11.012; Li J, 2009, IEEE T NEUR SYS REH, V17, P107, DOI 10.1109/TNSRE.2008.2008394; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; Martinez-Montes E, 2004, NEUROIMAGE, V22, P1023, DOI 10.1016/j.neuroimage.2004.03.038; Mason SG, 2000, IEEE T BIO-MED ENG, V47, P1297, DOI 10.1109/10.871402; Morup M, 2008, NEURAL COMPUT, V20, P2112, DOI 10.1162/neco.2008.11-06-407; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Nazarpour K., 2006, P 14 EUR SIGN PROC C; Pruzansky, 1989, MULTIWAY DATA ANAL, P463; Qin SJ, 1998, COMPUT CHEM ENG, V22, P503, DOI 10.1016/S0098-1354(97)00262-7; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Vijaysai P, 2003, IND ENG CHEM RES, V42, P540, DOI 10.1021/ie020042r; Wang X, 2003, CONTROL ENG PRACT, V11, P613, DOI 10.1016/S0967-0661(02)00096-5; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhao Q., 2011, ADV NEURAL INFORM PR, V24, P1269; Zhao Q, 2012, IEEE T PATT IN PRESS; Zhao QB, 2009, LECT NOTES COMPUT SC, V5863, P221, DOI 10.1007/978-3-642-10677-4_25	39	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69962	10.1371/journal.pone.0069962	http://dx.doi.org/10.1371/journal.pone.0069962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922873	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900124
J	Gagern, A; van den Bergh, J; Sumaila, UR				Gagern, Antonius; van den Bergh, Jeroen; Rashid Sumaila, Ussif			Trade-Based Estimation of Bluefin Tuna Catches in the Eastern Atlantic and Mediterranean, 2005-2011	PLOS ONE			English	Article								The Eastern Atlantic and Mediterranean stock of Bluefin tuna Thunnus thynnus (BFTE) has long been considered overfished and at risk of collapse. Although ICCAT quotas for this stock have decreased considerably over the past years, uncertainty exists about the degree of catch beyond this quota. The extent of such catch is an important piece of information in stock assessment models as well as being an indicator of the effectiveness of fisheries management. We present a model using Bluefin tuna trade data to infer actual catches. Basing our calculations on 25 countries involved in BFTE trade, we estimate that between 2005 and 2011, allowable quotas were exceeded by 44 percent. This gap between catch and quotas has slightly increased over past years, leading to estimated excess catches of 57 percent for the period between 2008 and 2011. To improve assessments, preparation and design of BFTE management, we suggest that the estimated total removals reported in this paper be included in stock assessment models for BFTE. An implication of our findings is that ICCAT member states should take stronger measures to monitor and enforce compliance with quotas.	[Gagern, Antonius; van den Bergh, Jeroen] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain; [van den Bergh, Jeroen] ICREA, Barcelona, Spain; [van den Bergh, Jeroen] Vrije Univ Amsterdam, Fac Econ & Business Adm, Amsterdam, Netherlands; [van den Bergh, Jeroen] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Rashid Sumaila, Ussif] Univ British Columbia, Fisheries Ctr, Fisheries Econ Res Unit, Vancouver, BC V5Z 1M9, Canada	Autonomous University of Barcelona; ICREA; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of British Columbia	Gagern, A (corresponding author), Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain.	antonius.gagern@gmail.com	van den Bergh, Jeroen C.J.M./C-7103-2008; Sumaila, U. Rashid/ABE-6475-2020	van den Bergh, Jeroen C.J.M./0000-0003-3415-3083; 	Pew Charitable Trusts; ICREA Funding Source: Custom	Pew Charitable Trusts; ICREA(ICREA)	Funding was provided by the Pew Charitable Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Sabata E, 2012, MAXISEIZURE BLUEFIN; EC, 2006, STAT TRAD GOODS US G; Eurostat, 2012, EUR YOUR KEY EUR STA; Galaz T, 2011, 11 YEARS 1995 2005 E; ICCAT, 2006, CONV FACT FISH PROD; ICCAT, 2011, ICCAT REP 2010 2011; ICIJ, 2010, BLACK MARK BLUEF; KATAVIC I, 2002, COLLECTIVE VOLUME SC, V54, P472; Katavic I, 2003, P S DOM BLUEF TUN TH, V60, P95; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Pew, 2011, MIND GAP AN MED BLUE; SCRS, 2012, 58152012 SCRS ICCAT; SCRS, 2012, REP STAND COMM RES S; Sumaila UR, 2012, MAR POLICY, V36, P502, DOI 10.1016/j.marpol.2011.08.010; Taylor NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027693; Ticina V, 2007, AQUACULTURE, V269, P538, DOI 10.1016/j.aquaculture.2007.05.029; Tudela S, 2011, COLLECT VOL SCI PAP, V68, P140; WWF, 2012, WWF UNC MASS UNR TRA	18	7	7	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69959	10.1371/journal.pone.0069959	http://dx.doi.org/10.1371/journal.pone.0069959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922870	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900121
J	Niegsch, M; Fabritius, ML; Anhoj, J				Niegsch, Mark; Fabritius, Maria Louise; Anhoj, Jacob			Imperfect Implementation of an Early Warning Scoring System in a Danish Teaching Hospital: A Cross-Sectional Study	PLOS ONE			English	Article							MEDICAL EMERGENCY TEAM; CARDIAC ARRESTS; ADVERSE EVENTS; MORTALITY; ANTECEDENTS; NURSES; CARE; DETERIORATION; ADMISSION; RESPONSES	Background: In 2007, the initiation of a patient safety campaign led to the introduction of Ward Observational Charts (WOC) and Medical Early Warning Score (MEWS) at Naestved Regional Hospital. This included systematic measuring of vital signs of all patients in order to prevent patient deterioration and assure timely and correct initiation of treatment. The aim of this study was to assess to what degree WOC guidelines being followed by ward staff. Design and Setting: A 7-day prospective, observational, randomised, cross-sectional, point prevalence study of WOC guideline compliance in hospitalised patients on twelve wards at Naestved Hospital. Results: The study included 132 patients. Of these, 58% had been observed and managed correctly according to WOC guidelines. 77% had all MEWS elements recorded by staff. One patient had no MEWS elements recorded. Only 38% of patients with abnormal MEWS were correctly escalated by nursing staff. Staff was aware of the abnormal MEWS observed by investigator in 60% of the patients. Each element of WOC was on average recorded by staff in 90% of the patients. Conclusion: At the time of our study, the long-term implementation of WOC guidelines has not been completed satisfactorily. The lacking component in the implementation of MEWS and WOC is the documentation of action taken upon finding an abnormal value. Unsuccessful implementation could result in incorrect results from evaluation of an early warning system. We suggest a redesign of the training programme to educate staff in recognising and caring for critically ill patients at Naestved Hospital.	[Niegsch, Mark] Bispebjerg Hosp, Anaesthesiol Dept Z, DK-2400 Copenhagen, Denmark; [Fabritius, Maria Louise] Copenhagen Univ Hosp, Ctr Head & Orthopaed, Anaesthesiol Dept 4231, Copenhagen, Denmark; [Anhoj, Jacob] P610 Hvidovre Hosp, Danish Soc Patient Safety, Hvidovre, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Niegsch, M (corresponding author), Bispebjerg Hosp, Anaesthesiol Dept Z, DK-2400 Copenhagen, Denmark.	mark@niegsch.dk	Zixuan, Huang/ABI-3557-2020	Anhoj, Jacob/0000-0002-7701-1774; Fabritius, Maria Louise/0000-0002-6497-2963	Danish Society for Patient Safety	Danish Society for Patient Safety	The study was funded by a grant from The Danish Society for Patient Safety. None of the authors have financial or other competing interests in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Carey R.G., 2003, IMPROVING HEALTHCARE; Considine J, 2005, J ADV NURS, V49, P624, DOI 10.1111/j.1365-2648.2004.03337.x; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Fuhrmann L, 2008, RESUSCITATION, V77, P325, DOI 10.1016/j.resuscitation.2008.01.009; Fuhrmann Lone, 2009, Ugeskr Laeger, V171, P502; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2002, INTENS CARE MED, V28, P1629, DOI 10.1007/s00134-002-1496-y; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Jacques T, 2006, RESUSCITATION, V69, P175, DOI 10.1016/j.resuscitation.2005.08.015; Jones D, 2005, CRIT CARE, V9, pR808, DOI 10.1186/cc3906; Jones S, 2011, CRIT CARE RESUSC, V13, P83; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; Laurens N, 2011, RESUSCITATION, V82, P707, DOI 10.1016/j.resuscitation.2010.11.031; Laurens NH, 2010, INT J NURS PRACT, V16, P533, DOI 10.1111/j.1440-172X.2010.01879.x; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; Mitchell IA, 2010, RESUSCITATION, V81, P658, DOI 10.1016/j.resuscitation.2010.03.001; Mohammed Ma, 2009, Br J Nurs, V18, P18; Nurmi J, 2005, ACTA ANAESTH SCAND, V49, P702, DOI 10.1111/j.1399-6576.2005.00679.x; Oakey Robert J, 2006, Nurs Stand, V20, P48; Odell M, 2009, J ADV NURS, V65, P1992, DOI 10.1111/j.1365-2648.2009.05109.x; Prytherch DR, 2006, RESUSCITATION, V70, P173, DOI 10.1016/j.resuscitation.2005.12.002; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Smith AF, 1998, RESUSCITATION, V37, P133, DOI 10.1016/S0300-9572(98)00056-2; Smith GB, 2002, RESUSCITATION, V52, P281, DOI 10.1016/S0300-9572(01)00477-4; Urbaniak G. C., 2012, RES RANDOMIZER VERSI	28	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70068	10.1371/journal.pone.0070068	http://dx.doi.org/10.1371/journal.pone.0070068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922906	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900139
J	Tsai, J; Abe, K; Boulet, SL; Beckman, MG; Hooper, WC; Grant, AM				Tsai, James; Abe, Karon; Boulet, Sheree L.; Beckman, Michele G.; Hooper, W. Craig; Grant, Althea M.			Predictive Accuracy of 29-Comorbidity Index for In-Hospital Deaths in US Adult Hospitalizations with a Diagnosis of Venous Thromboembolism	PLOS ONE			English	Article							COMORBIDITY MEASURES; ADMINISTRATIVE DATA; RISK-FACTORS; PULMONARY-EMBOLISM; PROGNOSTIC IMPORTANCE; MORTALITY; DISEASE; PROPHYLAXIS; VALIDATION; OUTCOMES	Background: Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant source of mortality and morbidity worldwide. By analyzing data of the 2010 Nationwide Inpatient Sample from the Agency for Healthcare Research and Quality (AHRQ), we evaluated the predictive accuracy of the AHRQ's 29-comorbidity index with in-hospital death among US adult hospitalizations with a diagnosis of VTE. Methods: We assessed the case-fatality and prevalence of comorbidities among a sample of 153,518 adult hospitalizations with a diagnosis of VTE that comprised 87,605 DVTs and 65,913 PEs (with and without DVT). We estimated adjusted odds ratios and 95% confidence intervals with multivariable logistic regression models by using comorbidities as predictors and status of in-hospital death as an outcome variable. We assessed the c-statistics for the predictive accuracy of the logistic regression models. Results: In 2010, approximately 41,944 in-hospital deaths (20,212 with DVT and 21,732 with PE) occurred among 770,137 hospitalizations with a diagnosis of VTE. When compared separately to hospitalizations with VTE, DVT, or PE that had no corresponding comorbidities, congestive heart failure, chronic pulmonary disease, coagulopathy, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer, other neurological disorders, peripheral vascular disorders, pulmonary circulation disorders, renal failure, solid tumor without metastasis, and weight loss were positively and independently associated with 10% - 125% increased likelihoods of in-hospital death. The c-statistic values ranged from 0.776 to 0.802. Conclusion: The results of this study indicated that comorbidity was associated independently with risk of death among hospitalizations with VTE and among hospitalizations with DVT or PE. The AHRQ 29-comorbidity index provides acceptable to excellent predictive accuracy for in-hospital deaths among adult hospitalizations with VTE and among those with DVT or PE.	[Tsai, James; Beckman, Michele G.; Hooper, W. Craig; Grant, Althea M.] Natl Ctr Birth Defects & Dev Disabil, Ctr Dis Control & Prevent, Div Blood Disorders, Atlanta, GA USA; [Abe, Karon] Natl Ctr Chron Dis Prevent & Hlth Promot, Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Tsai, J (corresponding author), Natl Ctr Birth Defects & Dev Disabil, Ctr Dis Control & Prevent, Div Blood Disorders, Atlanta, GA USA.	jxt9@cdc.gov		Tsai, James/0000-0002-3114-124X; Boulet, Sheree/0000-0002-7638-7374				Agency for Healthcare Research and Quality (AHRQ), 2012, INTR HCUP NAT INP SA; AHRQ, 2012, COM SOFTW VERS 3 7; AHRQ, 2012, HCUP FREQ ASK QUEST; AHRQ, 2012, PROC CLASS 2012; AHRQ, 2012, MAJ OP ROOM PROC IND; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Byles JE, 2005, J CLIN EPIDEMIOL, V58, P997, DOI 10.1016/j.jclinepi.2005.02.025; CDC, 2012, MMWR-MORBID MORTAL W, V61, P402; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chu YT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-140; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DHHS, 2008, SURG GEN CALL ACT PR; Dominick KL, 2005, ARTHRIT RHEUM-ARTHR, V53, P666, DOI 10.1002/art.21440; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gross CP, 2007, J GEN INTERN MED, V22, P321, DOI 10.1007/s11606-006-0019-x; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Hosmer D. W., 2010, APPL LOGISTIC REGRES; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; Johnston JA, 2002, MED CARE, V40, P929, DOI 10.1097/00005650-200210000-00010; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kelly J, 2002, AGE AGEING, V31, P235, DOI 10.1093/ageing/31.4.235; Krivak TC, 2007, OBSTET GYNECOL, V109, P761, DOI 10.1097/01.AOG.0000255819.10187.70; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lin J, 2003, J VASC SURG, V37, P976, DOI 10.1067/mva.2003.191; Nijkeuter M, 2007, CHEST, V131, P517, DOI 10.1378/chest.05-2799; Ocak G, 2013, J THROMB HAEMOST, V11, P116, DOI 10.1111/jth.12043; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Rius C, 2008, J CLIN EPIDEMIOL, V61, P796, DOI 10.1016/j.jclinepi.2007.09.006; Sachdev M, 2004, J AM COLL CARDIOL, V43, P576, DOI 10.1016/j.jacc.2003.10.031; Smith SB, 2012, J EMERG MED, V42, P1, DOI 10.1016/j.jemermed.2011.06.004; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Tsai J, 2012, PLOS ONE, V7; Tsai J, 2012, ARCH INTERN MED, V172, P960, DOI 10.1001/archinternmed.2012.198; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; White RH, 2010, THROMB RES, V126, P61, DOI 10.1016/j.thromres.2010.03.009	41	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70061	10.1371/journal.pone.0070061	http://dx.doi.org/10.1371/journal.pone.0070061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922902	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900137
J	Verbruggen, F; Adams, RC; van 't Wout, F; Stevens, T; McLaren, IPL; Chambers, CD				Verbruggen, Frederick; Adams, Rachel C.; van 't Wout, Felice; Stevens, Tobias; McLaren, Ian P. L.; Chambers, Christopher D.			Are the Effects of Response Inhibition on Gambling Long-Lasting?	PLOS ONE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; SELF-CONTROL; RISK-TAKING; DRUG-USE; IMPULSIVITY; INTERVENTIONS; DRINKING; MODEL	A recent study has shown that short-term training in response inhibition can make people more cautious for up to two hours when making decisions. However, the longevity of such training effects is unclear. In this study we tested whether training in the stop-signal paradigm reduces risky gambling when the training and gambling task are separated by 24 hours. Two independent experiments revealed that the aftereffects of stop-signal training are negligible after 24 hours. This was supported by Bayes factors that provided strong support for the null hypothesis. These findings indicate the need to better optimise the parameters of inhibition training to achieve clinical efficacy, potentially by strengthening automatic associations between specific stimuli and stopping.	[Verbruggen, Frederick; van 't Wout, Felice; Stevens, Tobias; McLaren, Ian P. L.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Adams, Rachel C.; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	University of Exeter; Cardiff University	Verbruggen, F (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	F.L.J.Verbruggen@exeter.ac.uk	Chambers, Chris/E-7827-2010; Verbruggen, Frederick/R-6357-2017	Verbruggen, Frederick/0000-0002-7958-0719; Chambers, Chris/0000-0001-6058-4114; Adams, Rachel/0000-0002-8053-0671	Economic and Social Research Council [ES/J00815X/1]; Wales Institute of Cognitive Neuroscience; European Research Council (ERC) under the European Union/ERC [312445]; ESRC [ES/J00815X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wales Institute of Cognitive Neuroscience; European Research Council (ERC) under the European Union/ERC(European Research Council (ERC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding came from an Economic and Social Research Council Grant (ES/J00815X/1) to FV, CDC, IPLM, a Wales Institute of Cognitive Neuroscience Grant to CDC, and a starting grant to FV from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 312445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Berkman ET, 2012, CHILD DEV PERSPECTIV; Billieux J, 2012, PSYCHIAT RES, V198, P291, DOI 10.1016/j.psychres.2012.01.001; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brevers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050647; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Clark L, 2012, PSYCHOPHYSIOLOGY, V49, P1436, DOI 10.1111/j.1469-8986.2012.01454.x; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI [10.1093/acprof:oso/9780195391381.003.0008, DOI 10.1093/ACPROF:OSO/9780195391381.003.0008]; Colzato LS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00199; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Friese M, 2011, SELF IDENTITY, V10, P336, DOI 10.1080/15298868.2010.536417; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Grant JE, 2010, PSYCHOPHARMACOLOGY, V212, P603, DOI 10.1007/s00213-010-1994-5; Guerrieri R, 2012, APPETITE, V59, P96, DOI 10.1016/j.appet.2012.04.006; Houben K, 2011, DRUG ALCOHOL DEPEN, V116, P132, DOI 10.1016/j.drugalcdep.2010.12.011; Houben K, 2011, J BEHAV THER EXP PSY, V42, P384, DOI 10.1016/j.jbtep.2011.02.008; Houben K, 2011, APPETITE, V56, P345, DOI 10.1016/j.appet.2010.12.017; Jasinska AJ, 2012, APPETITE, V59, P738, DOI 10.1016/j.appet.2012.08.001; Jones A, 2013, EXP CLIN PSYCHOPHARM, V21, P8, DOI 10.1037/a0030683; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Leeman RF, 2012, PSYCHOPHARMACOLOGY, V219, P469, DOI 10.1007/s00213-011-2550-7; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lipszyc J, 2010, J INT NEUROPSYCH SOC, V16, P1064, DOI 10.1017/S1355617710000895; Lo CC, 2009, J NEUROSCI, V29, P9059, DOI 10.1523/JNEUROSCI.6164-08.2009; Muraven M, 2010, J EXP SOC PSYCHOL, V46, P465, DOI 10.1016/j.jesp.2009.12.011; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Nederkoorn C, 2012, APPETITE, V59, P96; Nederkoorn C, 2007, BEHAV RES THER, V45, P1071, DOI 10.1016/j.brat.2006.05.009; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Noel X, 2013, CURR OPIN N IN PRESS; Noel X, 2007, NEUROPSYCHOLOGY, V21, P778, DOI 10.1037/0894-4105.21.6.778; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Shuster J, 2009, CONSCIOUS COGN, V18, P471, DOI 10.1016/j.concog.2009.01.004; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2012, PSYCHOL SCI, V23, P805, DOI 10.1177/0956797611434538; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verbruggen F, 2009, J EXP PSYCHOL HUMAN, V35, P835, DOI 10.1037/a0012726; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547	53	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70155	10.1371/journal.pone.0070155	http://dx.doi.org/10.1371/journal.pone.0070155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922948	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000322838900159
J	Feher, VA; Randall, A; Baldi, P; Bush, RM; de la Maza, LM; Amaro, RE				Feher, Victoria A.; Randall, Arlo; Baldi, Pierre; Bush, Robin M.; de la Maza, Luis M.; Amaro, Rommie E.			A 3-Dimensional Trimeric beta-Barrel Model for Chlamydia MOMP Contains Conserved and Novel Elements of Gram-Negative Bacterial Porins	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CRYSTAL-STRUCTURE; OLIGOMERIZATION STATE; FUNCTIONAL-CHARACTERIZATION; TRANSMEMBRANE DOMAINS; SECONDARY STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; NEURAL-NETWORK; WEB SERVER	Chlamydia trachomatis is the most prevalent cause of bacterial sexually transmitted diseases and the leading cause of preventable blindness worldwide. Global control of Chlamydia will best be achieved with a vaccine, a primary target for which is the major outer membrane protein, MOMP, which comprises similar to 60% of the outer membrane protein mass of this bacterium. In the absence of experimental structural information on MOMP, three previously published topology models presumed a16-stranded barrel architecture. Here, we use the latest beta-barrel prediction algorithms, previous 2D topology modeling results, and comparative modeling methodology to build a 3D model based on the 16-stranded, trimeric assumption. We find that while a 3D MOMP model captures many structural hallmarks of a trimeric 16-stranded beta-barrel porin, and is consistent with most of the experimental evidence for MOMP, MOMP residues 320-334 cannot be modeled as beta-strands that span the entire membrane, as is consistently observed in published 16-stranded beta-barrel crystal structures. Given the ambiguous results for beta-strand delineation found in this study, recent publications of membrane beta-barrel structures breaking with the canonical rule for an even number of beta-strands, findings of beta-barrels with strand-exchanged oligomeric conformations, and alternate folds dependent upon the lifecycle of the bacterium, we suggest that although the MOMP porin structure incorporates canonical 16-stranded conformations, it may have novel oligomeric or dynamic structural changes accounting for the discrepancies observed.	[Feher, Victoria A.; Amaro, Rommie E.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Randall, Arlo; Baldi, Pierre] Univ Calif Irvine, Sch Informat & Comp Sci, Irvine, CA USA; [Randall, Arlo; Baldi, Pierre] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Bush, Robin M.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [de la Maza, Luis M.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Amaro, RE (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA.	ramaro@ucsd.edu			National Institutes of Health through the NIH Director's New Innovator Award Program [DP2-OD007237]; National Institutes of Health through the NSF TeraGrid Supercomputer resources grant [LRAC CHE060073N]; National Institute of General Medical Sciences MIDAS grant [U01-GM076499]; NIH/NLM Pathway to Independence Award [K99LM010821]; NIH [5T15LM007743, LM010235-01A1]; NSF [MRI EIA-0321390, 0513376]; Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI-67888]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM076499] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010235, K99LM010821] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NSF TeraGrid Supercomputer resources grant; National Institute of General Medical Sciences MIDAS grant; NIH/NLM Pathway to Independence Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by the National Institutes of Health through the NIH Director's New Innovator Award Program DP2-OD007237 and through the NSF TeraGrid Supercomputer resources grant LRAC CHE060073N to REA; National Institute of General Medical Sciences MIDAS grant U01-GM076499 to RMB;NIH/NLM Pathway to Independence Award (K99LM010821) to AR; NIH (5T15LM007743 and LM010235-01A1) and NSF (MRI EIA-0321390 and 0513376) to PB, and Public Health Service grant AI-67888 from the National Institute of Allergy and Infectious Diseases to LdlM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEHR W, 1988, P NATL ACAD SCI USA, V85, P4000, DOI 10.1073/pnas.85.11.4000; Bagos PG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-7; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BARBOUR AG, 1982, J BACTERIOL, V151, P420, DOI 10.1128/JB.151.1.420-428.1982; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Crowder S, 2001, J MOL BIOL, V310, P793, DOI 10.1006/jmbi.2001.4740; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; Diederichs K, 1998, PROTEIN SCI, V7, P2413, DOI 10.1002/pro.5560071119; Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; FOX A, 1990, INFECT IMMUN, V58, P835, DOI 10.1128/IAI.58.3.835-837.1990; Garrow AG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-56; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Ghuysen JM, 1999, ANTIMICROB AGENTS CH, V43, P2339, DOI 10.1128/AAC.43.10.2339; Gromiha MM, 2005, BIOINFORMATICS, V21, P961, DOI 10.1093/bioinformatics/bti126; Gromiha MM, 2004, J COMPUT CHEM, V25, P762, DOI 10.1002/jcc.10386; HATCH TP, 1981, J BACTERIOL, V146, P426, DOI 10.1128/JB.146.1.426-429.1981; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; Huang ZW, 2010, J ELECTRON MICROSC, V59, P237, DOI 10.1093/jmicro/dfp057; Jackups R, 2005, J MOL BIOL, V354, P979, DOI 10.1016/j.jmb.2005.09.094; Jones HM, 2000, GENE, V258, P173, DOI 10.1016/S0378-1119(00)00367-X; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451; KREUSCH A, 1994, J MOL BIOL, V243, P891, DOI 10.1006/jmbi.1994.1690; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Meyer JEW, 1997, J MOL BIOL, V266, P761, DOI 10.1006/jmbi.1996.0823; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Naveed H, 2012, BIOPHYS J, V102, p469A, DOI 10.1016/j.bpj.2011.11.2573; Naveed H, 2012, J MOL BIOL, V419, P89, DOI 10.1016/j.jmb.2012.02.043; Naveed H, 2009, P NATL ACAD SCI USA, V106, P12735, DOI 10.1073/pnas.0902169106; NEWHALL WJ, 1983, J BACTERIOL, V154, P998, DOI 10.1128/JB.154.2.998-1001.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nunes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013171; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Rodriguez-Maranon MJ, 2002, PROTEIN SCI, V11, P1854, DOI 10.1110/ps.3650102; Sanchez KM, 2011, BIOPHYS J, V100, P2121, DOI 10.1016/j.bpj.2011.03.018; Schachter J., 1978, HUMAN CHLAMYDIAL INF; Schmid B, 1998, PROTEIN SCI, V7, P1603, DOI 10.1002/pro.5560070714; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Schulz GE, 1996, CURR OPIN STRUC BIOL, V6, P485, DOI 10.1016/S0959-440X(96)80113-8; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Stamm WE, 2008, SEXUALLY TRANSMITTED, P575; Sugawara E, 2012, FEBS J; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Taylor H. R., 2008, TRACHOMA BLINDING SC; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Waldispuhl J, 2006, NUCLEIC ACIDS RES, V34, pW189, DOI 10.1093/nar/gkl205; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; WHO, 2013, IN VACC RES; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yen TY, 2005, BIOCHEMISTRY-US, V44, P6250, DOI 10.1021/bi047775v; YUAN Y, 1989, INFECT IMMUN, V57, P1040, DOI 10.1128/IAI.57.4.1040-1049.1989; Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1; Zeth K, 2008, J BIOENERG BIOMEMBR, V40, P127, DOI 10.1007/s10863-008-9144-z; Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371; Zhai YF, 2002, PROTEIN SCI, V11, P2196, DOI 10.1110/ps.0209002	76	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68934	10.1371/journal.pone.0068934	http://dx.doi.org/10.1371/journal.pone.0068934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935908	Green Published, gold			2022-12-27	WOS:000322433300015
J	Liou, SF; Hsu, JH; Lin, IL; Ho, ML; Hsu, PC; Chen, LW; Chen, IJ; Yeh, JL				Liou, Shu-Fen; Hsu, Jong-Hau; Lin, I-Ling; Ho, Mei-Ling; Hsu, Pei-Chuan; Chen, Li-Wen; Chen, Ing-Jun; Yeh, Jwu-Lai			KMUP-1 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss: Roles of MAPKs, Akt, NF-kappa B and Calcium/Calcineurin/NFATc1 Pathways	PLOS ONE			English	Article							RECEPTOR ACTIVATOR; SMOOTH-MUSCLE; K+ CHANNELS; CYCLIC-GMP; PHOSPHODIESTERASE-4 INHIBITOR; CARDIAC-HYPERTROPHY; SIGNAL-TRANSDUCTION; DOWN-REGULATION; DIFFERENTIATION; CELLS	Background: KMUP-1 is a xanthine derivative with inhibitory activities on the phosphodiesterase (PDE) 3,4 and 5 isoenzymes to suppress the degradation of cyclic AMP and cyclic GMP. However, the effects of KMUP-1 on osteoclast differentiation are still unclear. In this study, we investigated whether KMUP-1 inhibits osteoclastogenesis induced by RANKL in RAW 264.7 cells and bone loss induced by ovariectomy in mice, and the underlying mechanisms. Principal Findings: In vitro, KMUP-1 inhibited RANKL-induced TRAP activity, the formation of multinucleated osteoclasts and resorption-pit formation. It also inhibited key mediators of osteoclastogenesis including IL-1 beta, IL-6, TNF-alpha and HMGB1. In addition, KMUP-1 inhibited RANKL-induced activation of signaling molecules (Akt, MAPKs, calcium and NF-kappa B), mRNA expression of osteoclastogensis-associated genes (TRAP, MMP-9, Fra-1, and cathepsin K) and transcription factors (c-Fos and NFATc1). Furthermore, most inhibitory effects of KMUP-1 on RANKL-mediated signal activations were reversed by a protein kinase A inhibitor (H89) and a protein kinase G inhibitor (KT5823). In vivo, KMUP-1 prevented loss of bone mineral content, preserved serum alkaline phosphate and reduced serum osteocalcin in ovariectomized mice. Conclusions: KMUP-1 inhibits RANKL-induced osteoclastogenesis in vitro and protects against ovariectomy-induced bone loss in vivo. These effects are mediated, at least in part, by cAMP and cGMP pathways. Therefore, KMUP-1 may have a role in pharmacologic therapy of osteoporosis.	[Liou, Shu-Fen] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Hsu, Jong-Hau] Kaohsiung Med Univ Hosp, Dept Paediat, Kaohsiung, Taiwan; [Hsu, Jong-Hau] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Paediat, Kaohsiung, Taiwan; [Lin, I-Ling] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Sch Med, Coll Med, Dept & Grad Inst Pharmacol, Kaohsiung, Taiwan; [Hsu, Pei-Chuan; Chen, Li-Wen; Chen, Ing-Jun; Yeh, Jwu-Lai] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Physiol, Kaohsiung, Taiwan	Chia Nan University of Pharmacy & Science; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yeh, JL (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Physiol, Kaohsiung, Taiwan.	jwulai@kmu.edu.tw		Ho, Mei-Ling/0000-0001-8064-8488	National Science Council, Taiwan [NSC 99-2320-B-037-015-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grant NSC 99-2320-B-037-015-MY3 (J-LY) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Bahlous Afef, 2006, Tunis Med, V84, P751; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Holliday LS, 1997, AM J PHYSIOL-RENAL, V272, pF283, DOI 10.1152/ajprenal.1997.272.3.F283; Hong MH, 2000, J BONE MINER RES, V15, P911, DOI 10.1359/jbmr.2000.15.5.911; Hsu YY, 2010, TOXICOLOGY, V268, P46, DOI 10.1016/j.tox.2009.11.021; Kim HH, 2003, EXP CELL RES, V289, P368, DOI 10.1016/S0014-4827(03)00288-X; Kim YY, 2010, MOL CELLS, V29, P277, DOI 10.1007/s10059-010-0027-x; Kinoshita T, 2000, BONE, V27, P811, DOI 10.1016/S8756-3282(00)00395-1; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kwak HB, 2010, BONE, V46, P724, DOI 10.1016/j.bone.2009.10.042; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lin RJ, 2002, BRIT J PHARMACOL, V135, P1159, DOI 10.1038/sj.bjp.0704554; Liu CM, 2007, PROSTATE, V67, P1397, DOI 10.1002/pros.20634; Liu CM, 2009, PROSTATE, V69, P610, DOI 10.1002/pros.20919; Mediero A, 2013, BRIT J PHARMACOL, V3, DOI [10.1111/bph.12227, DOI 10.1111/BPH.12227.[]; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; Szulc P, 2001, CALCIFIED TISSUE INT, V69, P229, DOI 10.1007/s00223-001-1059-1; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tintut Y, 2002, J BIOL CHEM, V277, P14221, DOI 10.1074/jbc.M111551200; Tsutsumimoto T, 2002, BONE, V31, P396, DOI 10.1016/S8756-3282(02)00839-6; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Waki Y, 1999, JPN J PHARMACOL, V79, P477, DOI 10.1254/jjp.79.477; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wu BN, 2006, MOL PHARMACOL, V70, P977, DOI 10.1124/mol.106.024919; Wu BN, 2004, BRIT J PHARMACOL, V142, P1105, DOI 10.1038/sj.bjp.0705791; Wu BN, 2001, BRIT J PHARMACOL, V134, P265, DOI 10.1038/sj.bjp.0704231; Wu X, 2012, J BONE MINER RES, V27, P1298, DOI 10.1002/jbmr.1576; Yamagami H, 2003, BIOCHEM PHARMACOL, V66, P801, DOI 10.1016/S0006-2952(03)00409-X; Yeh JL, 2013, ATHEROSCLEROSIS, V226, P364, DOI 10.1016/j.atherosclerosis.2012.12.005; Yeh JL, 2010, BRIT J PHARMACOL, V159, P1151, DOI 10.1111/j.1476-5381.2009.00587.x; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234	41	21	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69468	10.1371/journal.pone.0069468	http://dx.doi.org/10.1371/journal.pone.0069468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936022	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300041
J	Chiang, JK; Kuo, TBJ; Fu, CH; Koo, M				Chiang, Jui-Kun; Kuo, Terry B. J.; Fu, Chin-Hua; Koo, Malcolm			Predicting 7-Day Survival Using Heart Rate Variability in Hospice Patients with Non-Lung Cancers	PLOS ONE			English	Article							PROGNOSTIC TOOLS; ASSOCIATION; TAIWAN; LENGTH; TIME	Background: A simple and accurate survival prediction tool can facilitate decision making processes for hospice patients with advanced cancers. The objectives of this study were to explore the association of cardiac autonomic functions and survival in patients with advanced cancer and to evaluate the prognostic value of heart rate variability (HRV) in 7-day survival prediction. Methods: A prospective study was conducted on 138 patients with advanced cancer recruited from the hospice ward of a regional hospital in southern Taiwan. Information on functional status and symptom burden of the patients was recorded. Frequency-domain HRV was obtained for the evaluation of cardiac autonomic functions at admission. The end point of the study was defined as the survival status at day 7 after admission to the hospice ward. Multivariate logistic regression analyses were performed to evaluate the independent associations between HRV indices and survival of 7 days or less. Results: The median survival time of the patients was 20 days (95% CI, 17-28 days). Results from the multivariate logistic regression analysis indicated that the natural logarithm-transformed high-frequency power (lnHFP) of a value less than 2 (OR = 3.8, p = 0.008) and ECOG performance status of 3 or 4 (OR = 3.4, p = 0.023) were significantly associated with a higher risk of survival of 7 days or less. Receiver operating characteristic (ROC) curve analysis revealed that the area under the curve was 0.71 (95% CI, 0.61-0.81). Conclusions: In hospice patients with non-lung cancers, an lnHPF value below 2 at hospice admission was significantly associated with survival of 7 days or less. HRV might be used as a non-invasive and objective tool to facilitate medical decision making by improving the accuracy in survival prediction.	[Chiang, Jui-Kun] Buddhist Dalin Tzu Chi Gen Hosp, Dept Family Med, Chiayi, Taiwan; [Kuo, Terry B. J.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Fu, Chin-Hua] Buddhist Dalin Tzu Chi Gen Hosp, Dept Neurol, Chiayi, Taiwan; [Fu, Chin-Hua] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Koo, Malcolm] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Koo, M (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan.	m.koo@utoronto.ca	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167	Buddhist Dalin Tzu Chi General Hospital [DTCRD96-18, DTCRD99(2)-I-04]	Buddhist Dalin Tzu Chi General Hospital	This study was supported by grants from the Buddhist Dalin Tzu Chi General Hospital (Project No. DTCRD96-18, DTCRD99(2)-I-04) and no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Camm AJ, 1996, CIRCULATION, V93, P1043; Chiang JK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-137; Chiang JK, 2010, J PAIN SYMPTOM MANAG, V39, P673, DOI 10.1016/j.jpainsymman.2009.09.014; Chow E, 2005, INT J RADIAT ONCOL, V61, P870, DOI 10.1016/j.ijrobp.2004.07.697; Chow E, 2001, CLIN ONCOL-UK, V13, P209, DOI 10.1007/s001740170078; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Chuang RB, 2004, J PAIN SYMPTOM MANAG, V28, P115, DOI 10.1016/j.jpainsymman.2003.11.008; Fadul N, 2010, J PAIN SYMPTOM MANAG, V39, P283, DOI 10.1016/j.jpainsymman.2009.06.014; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Lau F, 2007, J PALLIAT CARE, V23, P93, DOI 10.1177/082585970702300205; Miller Susan C, 2003, J Palliat Med, V6, P725, DOI 10.1089/109662103322515239; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Rosenthal Mark A., 1993, Palliative Medicine, V7, P199, DOI 10.1177/026921639300700306; Singh JP, 1998, HYPERTENSION, V32, P293, DOI 10.1161/01.HYP.32.2.293; Stone P, 2008, PALLIATIVE MED, V22, P711, DOI 10.1177/0269216308095200; Tang ST, 2007, J PAIN SYMPTOM MANAG, V33, P446, DOI 10.1016/j.jpainsymman.2006.09.027; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	24	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69482	10.1371/journal.pone.0069482	http://dx.doi.org/10.1371/journal.pone.0069482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936027	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000127
J	Lackner, P; Vahmjanin, A; Hu, Q; Krafft, PR; Rolland, W; Zhang, JH				Lackner, Peter; Vahmjanin, Alexander; Hu, Qin; Krafft, Paul R.; Rolland, William; Zhang, John H.			Chronic Hydrocephalus after Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							INTRACRANIAL-PRESSURE; RATS; MODEL	Chronic communicating hydrocephalus is a significant health problem affecting up to 20% of survivors of spontaneous subarachnoid hemorrhage (SAH). The development of new treatment strategies is hampered by the lack of well characterized disease models. This study investigated the incidence of chronic hydrocephalus by evaluating the temporal profile of intracranial pressure (ICP) elevation after SAH, induced by endovascular perforation in rats. Twenty-five adult male Sprague-Dawley rats (260-320g) were subjected to either endovascular perforation or sham surgery. Five animals died after SAH induction. At 7, 14 and 21 days after surgery ICP was measured by stereotaxic puncture of the cisterna magna in SAH (n=10) and SHAM (n=10) animals. On day 21 T-maze test was performed and the number of alterations and latency to decision was recorded. On day 23, samples were processed for histological analyses. The relative ventricle area was evaluated in coronal Nissl stained sections. On day 7 after surgery all animals showed normal ICP. The absolute ICP values were significantly higher in SAH compared to SHAM animals on day 21 (8.26 +/- 4.53 mmHg versus 4.38 +/- 0.95 mmHg) but not on day 14. Observing an ICP of 10mmHg as cut-off, 3 animals showed elevated ICP on day 14 and another animal on day 21. The overall incidence of ICP elevation was 40% in SAH animals. On day 21, results of T-maze testing were significantly correlated with ICP values, i.e. animals with elevated ICP showed a lower number of alterations and a delayed decision. Histology yielded a significantly higher (3.59 fold increased) relative ventricle area in SAH animals with ICP elevation compared to SAH animals without ICP elevation. In conclusion, the current study shows that experimental SAH leads to chronic hydrocephalus, which is associated with ICP elevation, behavioral alterations and ventricular dilation in about 40% of SAH animals.	[Lackner, Peter; Vahmjanin, Alexander; Hu, Qin; Krafft, Paul R.; Rolland, William; Zhang, John H.] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA; [Lackner, Peter] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria	Loma Linda University; Medical University of Innsbruck	Lackner, P (corresponding author), Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA.	peter.lackner@i-med.ac.at	Hu, Qin/N-8930-2017	Hu, Qin/0000-0002-2270-8822; Zhang, John H./0000-0002-4319-4285	National Institutes of Health [NS053407]; Austrian Society of Neurology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Society of Neurology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a grant (NS053407) from the National Institutes of Health to JHZ. PL was supported by the Austrian Society of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Chu SH, 2011, MOL MED REP, V4, P785, DOI 10.3892/mmr.2011.500; Dorai Z, 2003, NEUROSURGERY, V52, P763, DOI 10.1227/01.NEU.0000053222.74852.2D; Fathali N, 2010, INTENS CARE MED, V36, P1602, DOI 10.1007/s00134-010-1913-6; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Germanwala AV, 2010, NEUROSURG CLIN N AM, V21, P263, DOI 10.1016/j.nec.2009.10.013; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; JAMES AE, 1975, J NEUROL SCI, V24, P151, DOI 10.1016/0022-510X(75)90231-2; Kusaka G, 2004, J NEUROSCI METH, V135, P121, DOI 10.1016/j.jneumeth.2003.12.013; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; MADDUX GW, 1974, J NUTR, V104, P478, DOI 10.1093/jn/104.4.478; Okubo S, 2013, STROKE, V44, P547, DOI 10.1161/STROKEAHA.112.662312; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004	18	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69571	10.1371/journal.pone.0069571	http://dx.doi.org/10.1371/journal.pone.0069571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936048	Green Published, gold			2022-12-27	WOS:000325211000135
J	Salari, K; Karczewski, KJ; Hudgins, L; Ormond, KE				Salari, Keyan; Karczewski, Konrad J.; Hudgins, Louanne; Ormond, Kelly E.			Evidence That Personal Genome Testing Enhances Student Learning in a Course on Genomics and Personalized Medicine	PLOS ONE			English	Article							PHARMACOGENETICS; CURRICULUM; EDUCATION	An emerging debate in academic medical centers is not about the need for providing trainees with fundamental education on genomics, but rather the most effective educational models that should be deployed. At Stanford School of Medicine, a novel hands-on genomics course was developed in 2010 that provided students the option to undergo personal genome testing as part of the course curriculum. We hypothesized that use of personal genome testing in the classroom would enhance the learning experience of students. No data currently exist on how such methods impact student learning; thus, we surveyed students before and after the course to determine its impact. We analyzed responses using paired statistics from the 31 medical and graduate students who completed both pre-course and post-course surveys. Participants were stratified by those who did (N = 23) or did not (N = 8) undergo personal genome testing. In reflecting on the experience, 83% of students who underwent testing stated that they were pleased with their decision compared to 12.5% of students who decided against testing (P = 0.00058). Seventy percent of those who underwent personal genome testing self-reported a better understanding of human genetics on the basis of having undergone testing. Further, students who underwent personal genome testing demonstrated an average 31% increase in pre- to post-course scores on knowledge questions (P = 3.5 x 10(-6)); this was significantly higher (P = 0.003) than students who did not undergo testing, who showed a nonsignificant improvement. Undergoing personal genome testing and using personal genotype data in the classroom enhanced students' self-reported and assessed knowledge of genomics, and did not appear to cause significant anxiety. At least for self-selected students, the incorporation of personal genome testing can be an effective educational tool to teach important concepts of clinical genomic testing.	[Salari, Keyan; Karczewski, Konrad J.; Ormond, Kelly E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hudgins, Louanne] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Ormond, Kelly E.] Stanford Univ, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Salari, K (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	ksalari@partners.org	Ormond, Kelly E/I-5676-2019; Karczewski, Jakub/L-7326-2018	Ormond, Kelly E/0000-0002-1033-0818; Karczewski, Jakub/0000-0001-9322-7842; Karczewski, Konrad/0000-0003-2878-4671				Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Genzen JR, 2007, CLIN LAB MED, V27, P343, DOI 10.1016/j.cll.2007.03.007; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Haga SB, 2011, J GEN INTERN MED, V26, P834, DOI 10.1007/s11606-011-1651-7; Johnson DS, 2010, HUM REPROD, V25, P1066, DOI 10.1093/humrep/dep452; Johnson JA, 2012, CLIN PHARMACOL THER, V92, P437, DOI 10.1038/clpt.2012.125; Knoell DL, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730343; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; Ormond KE, 2011, GENET MED, V13, P400, DOI 10.1097/GIM.0b013e31820562f6; Pulley JM, 2012, CLIN PHARMACOL THER, V92, P87, DOI 10.1038/clpt.2011.371; Salari K, 2011, ACAD MED, V86, P925, DOI 10.1097/ACM.0b013e3182223acf; Salari K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000138; Sanderson SC, 2008, GENET TEST, V12, P59, DOI 10.1089/gte.2007.0047; Sharp Richard R, 2011, Genet Med, V13, P750, DOI 10.1097/GIM.0b013e318228821f; Srinivasan BS, 2010, REPROD BIOMED ONLINE, V21, P537, DOI 10.1016/j.rbmo.2010.05.012; Vernez SL, 2013, GENOME MED, V5, DOI 10.1186/gm428; Walt DR, 2011, GENET MED, V13, P63, DOI 10.1097/GIM.0b013e3181f872ac; Wiener CM, 2010, ACAD MED, V85, P498, DOI 10.1097/ACM.0b013e3181ccbebf; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	20	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68853	10.1371/journal.pone.0068853	http://dx.doi.org/10.1371/journal.pone.0068853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935898	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000045
J	Sui, T; Ge, YB; Liu, WJ; Zhao, ZBK; Zhang, N; Cao, XJ				Sui, Tao; Ge, Yingbin; Liu, Wujun; Zhao, Zongbao K.; Zhang, Ning; Cao, Xiaojian			An Acetylcholinesterase Antibody-Based Quartz Crystal Microbalance for the Rapid Identification of Spinal Ventral and Dorsal Roots	PLOS ONE			English	Article							PERIPHERAL-NERVE; HISTOCHEMICAL IDENTIFICATION; IMMOBILIZATION METHODS; SENSORY FASCICLES; MOTOR; DISSIPATION; NEURONS; IMMUNOHISTOCHEMISTRY; NANOPARTICLES; IMMUNOSENSOR	Differences in the levels of acetylcholinesterase (AChE) in ventral and dorsal spinal roots can be used to differentiate the spinal nerves. Although many methods are available to assay AChE, a rapid and sensitive method has not been previously developed. Here, we describe an antibody-based quartz crystal microbalance (QCM) assay and its application for the quantification of AChE in the solutions of ventral and dorsal spinal roots. The frequency variation of the QCM device corresponds to the level of AChE over a wide dynamic range (0.5-10 mu g/ml), which is comparable to the response range of the ELISA method. The frequency shift caused by the ventral roots is 3-fold greater than that caused by the dorsal roots. The antibody-based QCM sensor was stable across many successive replicate samples, and the method required less than 10 min, including the AChE extraction and analysis steps. This method is a rapid and convenient means for the quantification of AChE in biological samples and may be applicable for distinguishing the ventral and dorsal roots during surgical operations.	[Sui, Tao; Zhang, Ning; Cao, Xiaojian] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing, Jiangsu, Peoples R China; [Ge, Yingbin] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Liu, Wujun; Zhao, Zongbao K.] Chinese Acad Sci, Dalian Inst Chem Phys, Div Biotechnol, Dalian, Peoples R China	Nanjing Medical University; Nanjing Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Zhao, ZBK (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Div Biotechnol, Dalian, Peoples R China.	zhaozb@dicp.ac.cn; jssryzhangning@163.com; xiaojiancao@gmail.com	Zhao, Zongbao K/F-5518-2011; Liu, Wujun/E-3164-2017	Zhao, Zongbao K/0000-0003-0654-1193; Liu, Wujun/0000-0002-6594-4315	National Natural Science Foundation of China [81171694, 30973058]; Jiangsu Province Nature Science Foundation [BE2010743]; Jiangsu graduate student innovation project [CXZZ11_0721]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-015]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Nature Science Foundation; Jiangsu graduate student innovation project; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (Grant #81171694, #30973058), Jiangsu Province Nature Science Foundation (BE2010743), Jiangsu graduate student innovation project (CXZZ11_0721), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (No. IRT-015) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva N, 2012, SENSOR ACTUAT B-CHEM, V164, P15, DOI 10.1016/j.snb.2012.01.051; Babacan S, 2000, BIOSENS BIOELECTRON, V15, P615, DOI 10.1016/S0956-5663(00)00115-9; Bayramoglu G, 2012, BIOPROC BIOSYST ENG, V35, P423, DOI 10.1007/s00449-011-0581-4; Chung NN, 2012, J BIOMED MATER RES A, V100A, P1600, DOI 10.1002/jbm.a.34100; DEUTINGER M, 1993, J NEUROSURG, V78, P709, DOI 10.3171/jns.1993.78.5.0709; Du D, 2011, BIOSENS BIOELECTRON; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GRUBER H, 1973, BRAIN RES, V51, P207, DOI 10.1016/0006-8993(73)90373-9; Hattori Yasunori, 2004, Tech Hand Up Extrem Surg, V8, P189, DOI 10.1097/01.bth.0000134712.83301.0a; HE YS, 1988, PLAST RECONSTR SURG, V82, P125; Janshoff A, 1996, EUR BIOPHYS J BIOPHY, V25, P105, DOI 10.1007/s002490050022; Kanaya Fuminori, 2002, Tech Hand Up Extrem Surg, V6, P140, DOI 10.1097/00130911-200209000-00007; KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kim DM, 2010, BIOSENS BIOELECTRON, V25, P1781, DOI 10.1016/j.bios.2009.12.024; Kim N, 2007, BIOSENS BIOELECTRON, V22, P1593, DOI 10.1016/j.bios.2006.07.009; KOELLE GB, 1955, J PHARMACOL EXP THER, V114, P167; MCNEILL ME, 1978, ANAT RECORD, V190, P155, DOI 10.1002/ar.1091900113; MURATSUGU M, 1993, ANAL CHEM, V65, P2933, DOI 10.1021/ac00068a036; OKAHATA Y, 1990, ANAL CHEM, V62, P1431, DOI 10.1021/ac00213a017; Prall YG, 1998, LIFE SCI, V63, P177, DOI 10.1016/S0024-3205(98)00258-6; Salmain M, 2011, BIOSENS BIOELECTRON, V29, P140, DOI 10.1016/j.bios.2011.08.007; SATOH K, 1983, BRAIN RES BULL, V11, P693, DOI 10.1016/0361-9230(83)90013-8; Shepherd AJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3485; Tang W, 2012, CHEM COMMUN, V48, P6678, DOI 10.1039/c2cc32747c; THOMPSON M, 1986, ANAL CHEM, V58, P1206, DOI 10.1021/ac00297a051; Wang H, 2011, J TRAUMA, V71, P1246, DOI 10.1097/TA.0b013e31822503a7; WARD MD, 1990, SCIENCE, V249, P1000, DOI 10.1126/science.249.4972.1000; WILLIAMS HB, 1986, HAND CLIN, V2, P689; Xie SF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3086611; Yan MQ, 2012, J HAZARD MATER, V215, P115, DOI 10.1016/j.jhazmat.2012.02.039; Zhao W, 2008, ANAL CHEM, V80, P3769, DOI 10.1021/ac702395c; Zhou XC, 2001, BIOSENS BIOELECTRON, V16, P85, DOI 10.1016/S0956-5663(00)00136-6	33	6	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69049	10.1371/journal.pone.0069049	http://dx.doi.org/10.1371/journal.pone.0069049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935920	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000071
J	O'Connor, JJM; Fraccaro, PJ; Pisanski, K; Tigue, CC; Feinberg, DR				O'Connor, Jillian J. M.; Fraccaro, Paul J.; Pisanski, Katarzyna; Tigue, Cara C.; Feinberg, David R.			Men's Preferences for Women's Femininity in Dynamic Cross-Modal Stimuli	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; VOICE PITCH; FUNDAMENTAL-FREQUENCY; LISTENERS ASSESSMENTS; FORMANT FREQUENCIES; FACIAL MASCULINITY; ESTROGEN-LEVELS; ATTRACTIVENESS; FACE; CUES	Men generally prefer feminine women's faces and voices over masculine women's faces and voices, and these cross-modal preferences are positively correlated. Men's preferences for female facial and vocal femininity have typically been investigated independently by presenting soundless still images separately from audio-only vocal recordings. For the first time ever, we presented men with short video clips in which dynamic faces and voices were simultaneously manipulated in femininity/masculinity. Men preferred feminine men's faces over masculine men's faces, and preferred masculine men's voices over feminine men's voices. We found that men preferred feminine women's faces and voices over masculine women's faces and voices. Men's attractiveness ratings of both feminine and masculine faces were increased by the addition of vocal femininity. Also, men's attractiveness ratings of feminine and masculine voices were increased by the addition of facial femininity present in the video. Men's preferences for vocal and facial femininity were significantly and positively correlated when stimuli were female, but not when they were male. Our findings complement other evidence for cross-modal femininity preferences among male raters, and show that preferences observed in studies using still images and/or independently presented vocal stimuli are also observed when dynamic faces and voices are displayed simultaneously in video format.	[O'Connor, Jillian J. M.; Fraccaro, Paul J.; Pisanski, Katarzyna; Tigue, Cara C.; Feinberg, David R.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Feinberg, DR (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	feinberg@mcmaster.ca	Pisanski, Katarzyna/F-7291-2019; Feinberg, David/C-1249-2009; O'Connor, Jillian/F-5686-2011	Pisanski, Katarzyna/0000-0003-0992-2477; Feinberg, David/0000-0003-4179-1446; Fraccaro, Paul/0000-0002-7986-1051; O'Connor, Jillian/0000-0002-4539-1020	Social Science and Humanities Research Council of Canada [410-09-2924]; Ontario's Ministry of Economic Development and Innovation Early Researcher Award [ER11-08-084]; Canada Foundation for Innovation Leaders Opportunity Fund [17515]	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Ontario's Ministry of Economic Development and Innovation Early Researcher Award; Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	Funding for the project was provided by: Social Science and Humanities Research Council of Canada (http://sshrc-crsh.gc.ca; Grant #410-09-2924) Ontario's Ministry of Economic Development and Innovation Early Researcher Award (http://www.mri.gov.on.ca/; Grant Number: ER11-08-084), and Canada Foundation for Innovation Leaders Opportunity Fund (http://www.innovation.ca/; Grant #17515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awan SN, 2006, CLIN LINGUIST PHONET, V20, P171, DOI 10.1080/02699200400026918; Boersma P, 2021, PRAAT DOING PHONETIC; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P1841, DOI 10.1121/1.401664; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; DeBruine LM, 2010, J EXP PSYCHOL HUMAN, V36, P751, DOI 10.1037/a0016457; Dunson DB, 2002, HUM REPROD, V17, P1399, DOI 10.1093/humrep/17.5.1399; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; Feinberg DR, 2008, EVOL HUM BEHAV, V29, P233, DOI 10.1016/j.evolhumbehav.2007.12.008; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fitzgerald C, 1998, YALE J BIOL MED, V71, P367; Fraccaro P.J., 2011, J EVOLUTIONARY PSYCH, V9, P57, DOI [10.1556/JEP.9.2011.33.1, DOI 10.1556/JEP.9.2011.33.1]; Fraccaro PJ, 2010, EVOL PSYCHOL-US, V8, P447, DOI 10.1177/147470491000800311; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Gray AW, 2012, EVOL PSYCHOL-US, V10, P66, DOI 10.1177/147470491201000108; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Jones BC, 2013, BIOL PSYCHOL, V92, P233, DOI 10.1016/j.biopsycho.2012.11.014; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Lander K, 2008, ANIM BEHAV, V75, P817, DOI 10.1016/j.anbehav.2007.07.001; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2008, BEHAV ECOL, V19, P902, DOI 10.1093/beheco/arn049; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Morrison ER, 2010, ETHOLOGY, V116, P1234, DOI 10.1111/j.1439-0310.2010.01839.x; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Nishio M, 2008, FOLIA PHONIATR LOGO, V60, P120, DOI 10.1159/000118510; O'Connor JJM, 2012, ETHOLOGY, V118, P321, DOI 10.1111/j.1439-0310.2011.02013.x; O'Connor JJM, 2012, PERS INDIV DIFFER, V52, P369, DOI 10.1016/j.paid.2011.10.036; O'Connor JJM, 2011, EVOL PSYCHOL-US, V9, P64, DOI 10.1177/147470491100900109; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pisanski K, 2012, EVOL HUM BEHAV, V33, P509, DOI 10.1016/j.evolhumbehav.2012.01.004; Pisanski K, 2011, J ACOUST SOC AM, V129, P2201, DOI 10.1121/1.3552866; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Re DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032719; Roder S, 2013, EVOL PSYCHOL-US, V11, P227; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Smith FG, 2009, BEHAV ECOL, V20, P441, DOI 10.1093/beheco/arn141; Smith MJL, 2012, HORM BEHAV, V61, P12, DOI 10.1016/j.yhbeh.2011.09.005; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tiddeman B, 2002, VISUAL COMPUT, V18, P218, DOI 10.1007/s003710100142; Titze IR, 1994, PRINCIPLES VOICE PRO; TRAUNMULLER H, 1990, J ACOUST SOC AM, V88, P97, DOI 10.1121/1.399849; Venners SA, 2006, HUM REPROD, V21, P2272, DOI 10.1093/humrep/del187; Welling L., 2007, J EVOLUTIONARY PSYCH, V5, P131, DOI [DOI 10.1556/JEP.2007.1012, 10.1556/JEP.2007.1012]; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; ZUCKERMAN M, 1993, J NONVERBAL BEHAV, V17, P119, DOI 10.1007/BF01001960	57	10	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69531	10.1371/journal.pone.0069531	http://dx.doi.org/10.1371/journal.pone.0069531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936037	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700031
J	Hobiger, K; Utesch, T; Mroginski, MA; Seebohm, G; Friedrich, T				Hobiger, Kirstin; Utesch, Tillmann; Mroginski, Maria Andrea; Seebohm, Guiscard; Friedrich, Thomas			The Linker Pivot in Ci-VSP: The Key to Unlock Catalysis	PLOS ONE			English	Article							PHOSPHOINOSITIDE PHOSPHATASE-ACTIVITY; PTEN TUMOR-SUPPRESSOR; MOLECULAR-DYNAMICS; ELECTROSTATICS; PROTEINS; CANCER	In the voltage-sensitive phosphatase Ci-VSP, conformational changes in the transmembrane voltage sensor domain (VSD) are transduced to the intracellular catalytic domain (CD) leading to its dephosphorylation activity against membrane-embedded phosphoinositides. The linker between both domains is proposed to be crucial for the VSD-CD coupling. With a combined approach of electrophysiological measurements on Xenopus oocytes and molecular dynamics simulations of a Ci-VSP model embedded in a lipid bilayer, we analyzed how conformational changes in the linker mediate the interaction between the CD and the activated VSD. In this way, we identified specific residues in the linker that interact with well-defined amino acids in one of the three loops forming the active site of the protein, named TI loop. With our results, we shed light into the early steps of the coupling process between the VSD and the CD, which are based on fine-tuned electrostatic and hydrophobic interactions between the linker, the membrane and the CD.	[Hobiger, Kirstin; Utesch, Tillmann; Mroginski, Maria Andrea; Friedrich, Thomas] Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Berlin, Germany; [Seebohm, Guiscard] Univ Hosp Munster, Inst Genet Heart Dis, Dept Cardiovasc Med, Munster, Germany	Technical University of Berlin; University of Munster	Hobiger, K (corresponding author), Tech Univ Berlin, Max Volmer Lab Biophys Chem, Inst Chem, Berlin, Germany.	kirstin.hobiger@tu-berlin.de	Friedrich, Thomas/AAA-3418-2022		Cluster of Excellence Unifying Concepts in Catalysis; Berlin International Graduate School of Natural Science and Engineering	Cluster of Excellence Unifying Concepts in Catalysis(German Research Foundation (DFG)); Berlin International Graduate School of Natural Science and Engineering	This work was funded by grants from the Cluster of Excellence Unifying Concepts in Catalysis, and the Berlin International Graduate School of Natural Science and Engineering, both launched by the German federal and state governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hobiger K, 2012, BIOPHYS J, V102, P1313, DOI 10.1016/j.bpj.2012.02.027; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koenderink JB, 2005, BBA-BIOMEMBRANES, V1669, P61, DOI 10.1016/j.bbamem.2005.01.003; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Kurokawa T, 2012, P NATL ACAD SCI US; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu LJ, 2012, NAT STRUCT MOL BIOL, V19, P633, DOI 10.1038/nsmb.2289; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matsuda M, 2011, J BIOL CHEM; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shi Yihui, 2006, V39, P265; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215	26	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70272	10.1371/journal.pone.0070272	http://dx.doi.org/10.1371/journal.pone.0070272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922964	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700160
J	Kong, CC; Zhao, Y; Cui, XL; Zhang, XM; Cui, HY; Xue, M; Wang, YF				Kong, Congcong; Zhao, Yan; Cui, Xianlan; Zhang, Xiaomin; Cui, Hongyu; Xue, Mei; Wang, Yunfeng			Complete Genome Sequence of the First Chinese Virulent Infectious Laryngotracheitis Virus	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; LIVE ATTENUATED VACCINES; MOLECULAR-BIOLOGY; HEPARAN-SULFATE; GENE-EXPRESSION; GLYCOPROTEIN-B; UNITED-STATES; DNA; ENTRY; PCR	Infectious laryngotracheitis (ILT) is an acute respiratory disease caused by infectious laryngotracheitis virus (ILTV). The complete genome sequences of five attenuated ILTV vaccine strains and six virulent ILTV strains as well as two Australian ILTV field strains have been published in Australia and the USA so far. To provide the complete genome sequence information of ILTVs from different geographic regions, the whole genome of ILTV LJS09 isolated in China was sequenced. The genome of ILTV LJS09 was 153,201 bp in length, and contained 79 ORFs. Most of the ORFs had high sequence identity with homologous ORFs of reference strains. There was a large fragment deletion within the noncoding region of unique long region (U-L) of ILTV LJS09 compared with SA2 and A20 strains. Though the origin binding protein of ILTV LJS09 existed, there was no AT-rich region in strain LJS09. Alignments of the amino acid sequences revealed seven mutations at amino acids 71 (Arg -> Lys), 116 (Ala -> Val), 207 (Thr -> Ile) and 644 (Thr -> Ile) on glycoprotein B, 155 (Phe -> Ser) and 376 (Arg -> His) on glycoprotein D and 8 (Gln -> Pro) on glycoprotein L of ILTV LJS09 compared to those of virulent strain (USDA) as ILTV LJS09 did not grow on chicken embryo fibroblasts, suggesting the role of the key seven amino acids in determination of the cell tropism of ILTV LJS09. This is the first complete genome sequence of the virulent strain of ILTV in Asia using the conventional PCR method, which will help to facilitate the future molecular biological research of ILTVs.	[Kong, Congcong; Zhao, Yan; Cui, Hongyu; Xue, Mei; Wang, Yunfeng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Kong, Congcong; Zhao, Yan; Cui, Hongyu; Xue, Mei; Wang, Yunfeng] Natl Engn Res Ctr Vet Biol, Harbin, Peoples R China; [Cui, Xianlan] Hlth Anim Lab, Dept Primary Ind Pk Water & Environm, Prospect, Tas, Australia; [Zhang, Xiaomin] Yunnan Agr Univ, Inst Anim Sci & Technol, Kunming, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Yunnan Agricultural University	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard [0302012009]	Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard	This research was supported by the Basic Scientific Research Operation Cost of State-leveled Public Welfare Scientific Research Courtyard (0302012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Antal Z, 2004, CURR GENET, V46, P240, DOI 10.1007/s00294-004-0524-6; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; BENPORAT T, 1977, VIROLOGY, V79, P292, DOI 10.1016/0042-6822(77)90356-7; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Chang PC, 1997, J VIROL METHODS, V66, P179, DOI 10.1016/S0166-0934(97)00050-5; Chen J, 2013, J VIROL, V87, P3620, DOI 10.1128/JVI.03245-12; Fuchs W, 1996, J GEN VIROL, V77, P2221, DOI 10.1099/0022-1317-77-9-2221; Fuchs W, 2007, VET RES, V38, P261, DOI 10.1051/vetres:200657; Garcia M, 2001, AVIAN DIS, V45, P558, DOI 10.2307/1592895; GODOWSKI PJ, 1986, P NATL ACAD SCI USA, V83, P256, DOI 10.1073/pnas.83.2.256; GOLDENBERGER D, 1995, PCR METH APPL, V4, P368; Graham DA, 2000, AVIAN PATHOL, V29, P57, DOI 10.1080/03079450094298; GRIFFIN AM, 1991, J GEN VIROL, V72, P393, DOI 10.1099/0022-1317-72-2-393; GUY JS, 1991, AVIAN DIS, V35, P348, DOI 10.2307/1591188; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Huang W, 2011, CELL BIOCHEM BIOPHYS, V61, P115, DOI 10.1007/s12013-011-9167-7; HUGHES CS, 1991, ARCH VIROL, V121, P213, DOI 10.1007/BF01316755; IGARASHI K, 1993, J VIROL, V67, P2123, DOI 10.1128/JVI.67.4.2123-2132.1993; JOHNSON MA, 1991, ARCH VIROL, V119, P181, DOI 10.1007/BF01310669; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; LEIB DA, 1987, ARCH VIROL, V93, P287, DOI 10.1007/BF01310982; LOCKSHON D, 1986, J VIROL, V58, P513, DOI 10.1128/JVI.58.2.513-521.1986; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Oldoni I, 2008, AVIAN DIS, V52, P59, DOI 10.1637/8054-070607-Reg; POLVINOBODNAR M, 1987, J VIROL, V61, P3528, DOI 10.1128/JVI.61.11.3528-3535.1987; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Uchida H, 2013, J VIROL, V87, P1430, DOI 10.1128/JVI.02804-12; Uchida H, 2010, J VIROL, V84, P12200, DOI 10.1128/JVI.01633-10; Wagner LM, 2012, J VIROL, V86, P6862, DOI 10.1128/JVI.00651-12; Wang J, 2011, VIRUS RES, V160, P316, DOI 10.1016/j.virusres.2011.07.004; WATSON RJ, 1980, NATURE, V285, P329, DOI 10.1038/285329a0; Westra DF, 1997, J VIROL, V71, P2285, DOI 10.1128/JVI.71.3.2285-2291.1997; Whalley JM, 2007, ARCH VIROL, V152, P717, DOI 10.1007/s00705-006-0885-x; Whitbeck JC, 1997, J VIROL, V71, P6083, DOI 10.1128/JVI.71.8.6083-6093.1997; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; Ziemann K, 1998, J VIROL, V72, P847, DOI 10.1128/JVI.72.1.847-852.1998	43	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70154	10.1371/journal.pone.0070154	http://dx.doi.org/10.1371/journal.pone.0070154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922947	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700149
J	Nebuloni, M; Zawada, L; Ferri, A; Tosoni, A; Zerbi, P; Resnati, M; Poli, G; Genovese, L; Alfano, M				Nebuloni, Manuela; Zawada, Lidia; Ferri, Angelita; Tosoni, Antonella; Zerbi, Pietro; Resnati, Massimo; Poli, Guido; Genovese, Luca; Alfano, Massimo			HIV-1 Infected Lymphoid Organs Upregulate Expression and Release of the Cleaved Form of uPAR That Modulates Chemotaxis and Virus Expression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMINOGEN-ACTIVATOR RECEPTOR; FOLLICULAR DENDRITIC CELLS; UROKINASE RECEPTOR; ANTIRETROVIRAL THERAPY; HIV-1 INFECTION; HUMAN MACROPHAGES; TYPE-1 INFECTION; MONOCYTIC CELLS; PLASMA-LEVELS	Cell-associated receptor for urokinase plasminogen activator (uPAR) is released as both full-length soluble uPAR (suPAR) and cleaved (c-suPAR) form that maintain ability to bind to integrins and other receptors, thus triggering and modulating cell signaling responses. Concerning HIV-1 infection, plasma levels of suPAR have been correlated with the severity of disease, levels of immune activation and ineffective immune recovery also in individuals receiving combination anti-retroviral therapy (cART). However, it is unknown whether and which suPAR forms might contribute to HIV-1 induced pathogenesis and to the related state of immune activation. In this regard, lymphoid organs represent an import site of chronic immune activation and virus persistence even in individuals receiving cART. Lymphoid organs of HIV-1(+) individuals showed an enhanced number of follicular dendritic cells, macrophages and endothelial cells expressing the cell-associated uPAR in comparison to those of uninfected individuals. In order to investigate the potential role of suPAR forms in HIV-1 infection of secondary lymphoid organs, tonsil histocultures were established from HIV-1 seronegative individuals and infected ex vivo with CCR5- and CXCR4-dependent HIV-1 strains. The levels of suPAR and c-suPAR were significantly increased in HIV-infected tonsil histocultures supernatants in comparison to autologous uninfected histocultures. Supernatants from infected and uninfected cultures before and after immunodepletion of suPAR forms were incubated with the chronically infected promonocytic U1 cell line characterized by a state of proviral latency in unstimulated conditions. In the contest of HIV-conditioned supernatants we established that c-suPAR, but not suPAR, inhibited chemotaxis and induced virus expression in U1 cells. In conclusion, lymphoid organs are an important site of production and release of both suPAR and c-suPAR, this latter form being endowed with the capacity of inhibiting chemotaxis and inducing HIV-1 expression.	[Nebuloni, Manuela; Zawada, Lidia; Ferri, Angelita; Tosoni, Antonella; Zerbi, Pietro] Univ Milan, Pathol Unit, Luigi Sacco Dept Biomed & Clin Sci, Milan, Italy; [Resnati, Massimo] Ist Sci San Raffaele, Div Genet & Cell Biol, Mol Genet Unit, I-20132 Milan, Italy; [Poli, Guido] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy; [Poli, Guido; Genovese, Luca; Alfano, Massimo] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunopathogenesis Unit, I-20132 Milan, Italy	University of Milan; Luigi Sacco Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Alfano, M (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, AIDS Immunopathogenesis Unit, I-20132 Milan, Italy.	massimo.alfano@hsr.it	Poli, Guido/AAL-4161-2020; Massimo, Resnati/AAN-5854-2020; Alfano, Massimo/AAC-1950-2019; NEBULONI, MANUELA/L-3969-2017; Zerbi, Pietro/L-1518-2017	Poli, Guido/0000-0001-7241-4526; Massimo, Resnati/0000-0002-4804-4569; Alfano, Massimo/0000-0002-6904-9158; NEBULONI, MANUELA/0000-0002-2773-734X; Zerbi, Pietro/0000-0001-7611-2605	Italian Minister of Health [40H11]	Italian Minister of Health	The study was supported by the Italian Minister of Health (grant #40H11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif L, 2006, J GEN VIROL, V87, P2539, DOI 10.1099/vir.0.81915-0; Alfano M, 2005, AIDS, V19, P1007, DOI 10.1097/01.aids.0000174446.40379.3b; Alfano M, 2001, J IMMUNOL, V166, P1863, DOI 10.4049/jimmunol.166.3.1863; Alfano M, 2002, P NATL ACAD SCI USA, V99, P8862, DOI 10.1073/pnas.142078099; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; ALFANO M, 2007, HIV MACROPHAGE, P89; Alfano M, 2009, BLOOD, V113, P1699, DOI 10.1182/blood-2008-02-138412; Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005; Andersen O, 2008, J MED VIROL, V80, P209, DOI 10.1002/jmv.21114; Ansari AW, 2011, EUR J IMMUNOL, V41, P3412, DOI 10.1002/eji.201141676; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cinque P, 2004, ANN NEUROL, V55, P687, DOI 10.1002/ana.20076; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Cross AK, 1999, GLIA, V28, P183, DOI 10.1002/(SICI)1098-1136(199912)28:3<183::AID-GLIA2>3.0.CO;2-3; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Elia C, 2007, J LEUKOCYTE BIOL, V82, P1212, DOI 10.1189/jlb.0407251; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Graziano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023674; GRAZIOSI C, 1993, AIDS, V7, pS53, DOI 10.1097/00002030-199311002-00012; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Gross E, 2003, J LEUKOCYTE BIOL, V74, P781, DOI 10.1189/jlb.0403187; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaufman L, 2010, ADV CHRONIC KIDNEY D, V17, P36, DOI 10.1053/j.ackd.2009.08.012; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Li BQ, 2001, BLOOD, V97, P2941, DOI 10.1182/blood.V97.10.2941; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Lomholt AF, 2010, ACTA ONCOL, V49, P805, DOI 10.3109/0284186X.2010.491086; MASUCCI MT, 1991, J BIOL CHEM, V266, P8655; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Nalla AK, 2011, CELL SIGNAL, V23, P1299, DOI 10.1016/j.cellsig.2011.03.011; Nebuloni M, 2009, J NEUROVIROL, V15, P99, DOI 10.1080/13550280802400692; Nedellec R, 2009, J VIROL, V83, P8353, DOI 10.1128/JVI.00780-09; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; NYKJAER A, 1994, J IMMUNOL, V152, P505; Ostrowski SR, 2006, SCAND J IMMUNOL, V63, P478, DOI 10.1111/j.1365-3083.2006.001768.x; Ostrowski SR, 2010, SOLUBLE FACTORS MEDIATING INNATE IMMUNE RESPONSES TO HIV INFECTION, P81; Ostrowski SR, 2005, JAIDS-J ACQ IMM DEF, V39, P23, DOI 10.1097/01.qai.0000157950.02076.a6; Ostrowski SR, 2004, JAIDS-J ACQ IMM DEF, V35, P337, DOI 10.1097/00126334-200404010-00002; Palmisano I, 2012, P NATL ACAD SCI USA, V109, pE2284, DOI 10.1073/pnas.1202174109; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; Perrin L, 1998, J INFECT DIS, V177, P1497, DOI 10.1086/515303; Porter BO, 2010, CLIN IMMUNOL, V136, P42, DOI 10.1016/j.clim.2010.02.010; Ragin AB, 2010, PROTEOM CLIN APPL, V4, P295, DOI 10.1002/prca.200900083; Resnati M, 2006, J IMMUNOL METHODS, V308, P192, DOI 10.1016/j.jim.2005.10.013; Rusnati M, 1997, AIDS, V11, P727, DOI 10.1097/00002030-199706000-00005; Schacker T, 2011, GLOBAL ANTIVIRAL S2, P28; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Shimizu N, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-52; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Sidenius N, 2004, J NEUROIMMUNOL, V157, P133, DOI 10.1016/j.jneuroim.2004.08.038; Sidenius N, 2000, BLOOD, V96, P4091; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Small-Howard AL, 2010, J IMMUNOASS IMMUNOCH, V31, P131, DOI 10.1080/15321811003617438; Speth C, 1998, IMMUNOBIOLOGY, V199, P152, DOI 10.1016/S0171-2985(98)80071-5; TENNERRACZ K, 1994, RES VIROLOGY, V145, P177, DOI 10.1016/S0923-2516(07)80020-3; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Wada M, 2001, BIOCHEM BIOPH RES CO, V284, P346, DOI 10.1006/bbrc.2001.4965; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	77	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70606	10.1371/journal.pone.0070606	http://dx.doi.org/10.1371/journal.pone.0070606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923008	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700197
J	Ling, J; Zheng, HM; Katzianer, DS; Wang, H; Zhong, ZT; Zhu, J				Ling, Jun; Zheng, Huiming; Katzianer, David S.; Wang, Hui; Zhong, Zengtao; Zhu, Jun			Applying Reversible Mutations of Nodulation and Nitrogen-Fixation Genes to Study Social Cheating in Rhizobium etli-Legume Interaction	PLOS ONE			English	Article							SANCTIONS; REPLACEMENT; COOPERATION; EVOLUTION; SELECTION; PLASMIDS	Mutualisms are common in nature, though these symbioses can be quite permeable to cheaters in situations where one individual parasitizes the other by discontinuing cooperation yet still exploits the benefits of the partnership. In the Rhizobium-legume system, there are two separate contexts, namely nodulation and nitrogen fixation processes, by which resident Rhizobium individuals can benefit by cheating. Here, we constructed reversible and irreversible mutations in key nodulation and nitrogen-fixation pathways of Rhizobium etli and compared their interaction with plant hosts Phaseolus vulgaris to that of wild type. We show that R. etli reversible mutants deficient in nodulation factor production are capable of intra-specific cheating, wherein mutants exploit other Rhizobium individuals capable of producing these factors. Similarly, we show that R. etli mutants are also capable of cheating inter-specifically, colonizing the host legume yet contributing nothing to the partnership in terms of nitrogen fixation. Our findings indicate that cheating is possible in both of these frameworks, seemingly without damaging the stability of the mutualism itself. These results may potentially help explain observations suggesting that legume plants are commonly infected by multiple bacterial lineages during the nodulation process.	[Ling, Jun; Zheng, Huiming; Wang, Hui; Zhong, Zengtao; Zhu, Jun] Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Katzianer, David S.; Zhu, Jun] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	Nanjing Agricultural University; University of Pennsylvania; Pennsylvania Medicine	Zhong, ZT (corresponding author), Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.	mol_microb@njau.edu.cn; junzhu@mail.med.upenn.edu	Zhong, Zengtao/E-2533-2016		973 project [CB126502]; Ph.D. programs foundation of Minister of Education (MOE) [20120097110016]; NSFC [31170077]	973 project(National Basic Research Program of China); Ph.D. programs foundation of Minister of Education (MOE); NSFC(National Natural Science Foundation of China (NSFC))	This study is supported by a 973 project (CB126502, to J.Z.), the Ph.D. programs foundation of Minister of Education (MOE) (20120097110016, to J.Z.), and an NSFC award (31170077, to Z.Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Dao DN, 2000, MICROBIOL-SGM, V146, P1505, DOI 10.1099/00221287-146-7-1505; Denison RF, 2000, AM NAT, V156, P567, DOI 10.1086/316994; Dumas Z, 2012, J EVOLUTION BIOL, V25, P473, DOI 10.1111/j.1420-9101.2011.02437.x; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Gonzalez V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r36; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; HUNT S, 1993, ANNU REV PLANT PHYS, V44, P483, DOI 10.1146/annurev.pp.44.060193.002411; Jitacksorn S, 2008, APPL ENVIRON MICROB, V74, P3749, DOI 10.1128/AEM.02939-07; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MOAWAD M, 1987, BIOL FERT SOILS, V5, P112, DOI 10.1007/BF00257644; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; POUPOT R, 1995, J BIOL CHEM, V270, P6050, DOI 10.1074/jbc.270.11.6050; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; ROLFE BG, 1980, AUST J BIOL SCI, V33, P491; Sambrook J., 2001, MOL CLONING LAB MANU; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; SILVESTER WB, 1982, CAN J FOREST RES, V12, P646, DOI 10.1139/x82-098; SMITH JM, 1989, NATURE, V341, P284, DOI 10.1038/341284a0; Valderrama B, 1996, J BACTERIOL, V178, P3119, DOI 10.1128/jb.178.11.3119-3126.1996; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878	29	5	5	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70138	10.1371/journal.pone.0070138	http://dx.doi.org/10.1371/journal.pone.0070138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922937	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900153
J	Abiko, M; Furuta, K; Yamauchi, Y; Fujita, C; Taoka, M; Isobe, T; Okamoto, T				Abiko, Mafumi; Furuta, Kensyo; Yamauchi, Yoshio; Fujita, Chiharu; Taoka, Masato; Isobe, Toshiaki; Okamoto, Takashi			Identification of Proteins Enriched in Rice Egg or Sperm Cells by Single-Cell Proteomics	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; DNA-REPLICATION; MAJOR PROTEINS; PLANT; DATABASE; PLAYS	In angiosperms, female gamete differentiation, fertilization, and subsequent zygotic development occur in embryo sacs deeply embedded in the ovaries. Despite their importance in plant reproduction and development, how the egg cell is specialized, fuses with the sperm cell, and converts into an active zygote for early embryogenesis remains unclear. This lack of knowledge is partly attributable to the difficulty of direct analyses of gametes in angiosperms. In the present study, proteins from egg and sperm cells obtained from rice flowers were separated by one-dimensional polyacrylamide gel electrophoresis and globally identified by highly sensitive liquid chromatography coupled with tandem mass spectroscopy. Proteome analyses were also conducted for seedlings, callus, and pollen grains to compare their protein expression profiles to those of gametes. The proteomics data have been deposited to the ProteomeXchange with identifier PXD000265. A total of 2,138 and 2,179 expressed proteins were detected in egg and sperm cells, respectively, and 102 and 77 proteins were identified as preferentially expressed in egg and sperm cells, respectively. Moreover, several rice or Arabidopsis lines with mutations in genes encoding the putative gamete-enriched proteins showed clear phenotypic defects in seed set or seed development. These results suggested that the proteomic data presented in this study are foundational information toward understanding the mechanisms of reproduction and early development in angiosperms.	[Abiko, Mafumi; Furuta, Kensyo; Okamoto, Takashi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Yamauchi, Yoshio; Fujita, Chiharu; Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Tokyo 158, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University	Okamoto, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan.	okamoto-takashi@tmu.ac.jp	Isobe, Toshiaki/Q-9279-2017	Taoka, Masato/0000-0001-5554-4951	Ministry of Education, Culture, Sports, Science and Technology of Japan [21112007]; Japan Society for the Promotion of Science [20570206]; Grants-in-Aid for Scientific Research [21112007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 21112007 to T.O.) and from the Japan Society for the Promotion of Science (No. 20570206 to T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechenmacher L, 2009, PLANT PHYSIOL, V149, P670, DOI 10.1104/pp.108.131649; CALVERT ME, 2003, REPROD BIOL ENDOCRIN, V14, P1; Dai SJ, 2012, MOL CELL PROTEOMICS, V11, P1622, DOI 10.1074/mcp.R112.021550; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Gou XP, 1999, ACTA BOT SIN, V41, P669; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Guignard M.L., 1899, REV G N BOT, V11, P129; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Kranz Erhard, 2008, V427, P51, DOI 10.1007/978-1-59745-273-1_4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mihara M, 2010, NUCLEIC ACIDS RES, V38, pD835, DOI 10.1093/nar/gkp831; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; Nestler J, 2011, J PROTEOME RES, V10, P2525, DOI 10.1021/pr200003k; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Ohnishi T, 2011, PLANT PHYSIOL, V155, P881, DOI 10.1104/pp.110.167502; Okamoto T, 2005, ACTA BIOL CRACOV BOT, V47, P17; Okamoto T, 2004, PLANT CELL PHYSIOL, V45, P1406, DOI 10.1093/pcp/pch161; Okamoto T, 2011, METHODS MOL BIOL, V710, P17, DOI 10.1007/978-1-61737-988-8_2; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Shimada M, 1999, MOL BIOL CELL, V10, P3991, DOI 10.1091/mbc.10.12.3991; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; Taoka M, 2000, ELECTROPHORESIS, V21, P1872, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1872::AID-ELPS1872>3.0.CO;2-#; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Uchiumi T, 2006, SEX PLANT REPROD, V19, P37, DOI 10.1007/s00497-006-0020-x; Uchiumi T, 2007, J PLANT RES, V120, P575, DOI 10.1007/s10265-007-0095-y; Van Cutsem E, 2011, PROTEOMICS, V11, P440, DOI 10.1002/pmic.201000356; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang YY, 2006, SEX PLANT REPROD, V19, P103, DOI 10.1007/s00497-006-0029-1; Xia Shi-Tou, 2007, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V33, P179; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; ZHANG GC, 1992, PLANT PHYSIOL, V99, P54, DOI 10.1104/pp.99.1.54; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263; Zhu MM, 2012, J PROTEOME RES, V11, P3728, DOI 10.1021/pr300213k; Zhu MM, 2009, MOL CELL PROTEOMICS, V8, P752, DOI 10.1074/mcp.M800343-MCP200	41	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69578	10.1371/journal.pone.0069578	http://dx.doi.org/10.1371/journal.pone.0069578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936051	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300051
J	Ge, XH; Han, FF; Huang, YX; Zhang, Y; Yang, TY; Bai, C; Guo, XJ				Ge, Xiahui; Han, Fengfeng; Huang, Yanxi; Zhang, Yue; Yang, Tianyun; Bai, Chong; Guo, Xuejun			Is Obstructive Sleep Apnea Associated with Cardiovascular and All-Cause Mortality?	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; RISK-FACTOR; HYPOPNEA; EVENTS; STROKE	Background: Studies have reported inconsistent findings regarding the association between obstructive sleep apnea (OSA) and future risks of cardiovascular and all-cause mortality. We conducted a meta-analysis to investigate whether OSA is an independent predictor for future cardiovascular and all-cause mortality using prospective observational studies. Methods: Electronic literature databases (Medline and Embase) were searched for prospective observational studies published prior to December 2012. Only observational studies that assessed baseline OSA and future risk of cardiovascular and all-cause mortality were selected. Pooled hazard risk (HR) and corresponding 95% confidence intervals (CI) were calculated for categorical risk estimates. Subgroup analyses were based on the severity of OSA. Results: Six studies with 11932 patients were identified and analyzed, with 239 reporting cardiovascular mortality, and 1397 all-cause mortality. Pooled HR of all-cause mortality was 1.19 (95% CI, 1.00 to 1.41) for moderate OSA and 1.90 (95% CI, 1.29 to 2.81) for severe OSA. Pooled HR of cardiovascular mortality was 1.40 (95% CI, 0.77 to 2.53) for moderate OSA and 2.65 (95% CI, 1.82 to 3.85) for severe OSA. There were no differences in cardiovascular mortality in continuous positive airway pressure (CPAP) treatment compared with healthy subjects (HR 0.82; 95% CI, 0.50 to 1.33). Conclusions: Severe OSA is a strong independent predictor for future cardiovascular and all-cause mortality. CPAP treatment was associated with decrease cardiovascular mortality.	[Ge, Xiahui; Han, Fengfeng; Huang, Yanxi; Zhang, Yue; Yang, Tianyun; Guo, Xuejun] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Resp Med, Shanghai 200030, Peoples R China; [Bai, Chong] Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Bai, C (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Resp Med, Shanghai 200030, Peoples R China.	guoxj1122@hotmail.com; bai7878@126.com						BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hudgel DW, 2012, J CLIN SLEEP MED, V8, P9, DOI 10.5664/jcsm.1648; Johansson P, 2011, SLEEP MED, V12, P748, DOI 10.1016/j.sleep.2011.03.012; Khayat R, 2009, HEART FAIL REV, V14, P143, DOI 10.1007/s10741-008-9112-z; Kokkarinen J, 2011, AM J RESP CRIT CARE, V183, P950, DOI 10.1164/ajrccm.183.7.950; Korostovtseva LS, 2011, MED SCI MONITOR, V17, pCR146, DOI 10.12659/MSM.881448; Launois SH, 2007, SLEEP MED REV, V11, P87, DOI 10.1016/j.smrv.2006.08.005; Lavie P, 2005, EUR RESPIR J, V25, P514, DOI 10.1183/09031936.05.00051504; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; Martinez-Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909, DOI 10.1164/rccm.201203-0448OC; McDaid C, 2009, HEALTH TECHNOL ASSES, V13, P1; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Quan SF, 2002, SLEEP, V25, P843; Rich J, 2012, OTOLARYNG HEAD NECK, V147, P583, DOI 10.1177/0194599812450256; Sahlin C, 2008, ARCH INTERN MED, V168, P297, DOI 10.1001/archinternmed.2007.70; Shah NA, 2010, SLEEP BREATH, V14, P131, DOI 10.1007/s11325-009-0298-7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; Won CH, 2012, SLEEP BREATH; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yeboah J, 2011, ATHEROSCLEROSIS, V219, P963, DOI 10.1016/j.atherosclerosis.2011.08.021; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2008, SLEEP, V31, P1071	36	58	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69432	10.1371/journal.pone.0069432	http://dx.doi.org/10.1371/journal.pone.0069432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936014	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300039
J	Teoh, WL; Khoo, MBC; Teh, SY				Teoh, Wei Lin; Khoo, Michael B. C.; Teh, Sin Yin			Optimal Designs of the Median Run Length Based Double Sampling (X)over-bar Chart for Minimizing the Average Sample Size	PLOS ONE			English	Article							S-CONTROL CHARTS; EWMA CONTROL CHARTS; GENETIC ALGORITHMS; STATISTICAL DESIGN; CONSTRUCTION	Designs of the double sampling (DS) (X) over bar chart are traditionally based on the average run length (ARL) criterion. However, the shape of the run length distribution changes with the process mean shifts, ranging from highly skewed when the process is in-control to almost symmetric when the mean shift is large. Therefore, we show that the ARL is a complicated performance measure and that the median run length (MRL) is a more meaningful measure to depend on. This is because the MRL provides an intuitive and a fair representation of the central tendency, especially for the rightly skewed run length distribution. Since the DS (X) over bar chart can effectively reduce the sample size without reducing the statistical efficiency, this paper proposes two optimal designs of the MRL-based DS (X) over bar chart, for minimizing (i) the in-control average sample size (ASS) and (ii) both the in-control and out-of-control ASSs. Comparisons with the optimal MRL-based EWMA (X) over bar and Shewhart (X) over bar charts demonstrate the superiority of the proposed optimal MRL-based DS (X) over bar chart, as the latter requires a smaller sample size on the average while maintaining the same detection speed as the two former charts. An example involving the added potassium sorbate in a yoghurt manufacturing process is used to illustrate the effectiveness of the proposed MRL-based DS (X) over bar chart in reducing the sample size needed.	[Teoh, Wei Lin] Jalan Univ, Univ Tunku Abdul Rahman, Fac Sci, Dept Phys & Math Sci, Kampar, Perak, Malaysia; [Khoo, Michael B. C.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Teh, Sin Yin] Univ Sains Malaysia, Sch Management, George Town, Malaysia	Universiti Tunku Abdul Rahman (UTAR); Universiti Sains Malaysia; Universiti Sains Malaysia	Khoo, MBC (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	mkbc@usm.my	Teh, Sin Yin/K-9196-2019; Khoo, Michael B.C./D-9033-2012; Teh, Sin Yin/E-3768-2010; Teoh, Wei Lin/T-2701-2019	Teh, Sin Yin/0000-0001-9439-4407; Khoo, Michael B.C./0000-0002-3245-1127; Teh, Sin Yin/0000-0001-9439-4407; Teoh, Wei Lin/0000-0003-4715-1490	KPI allocation of the School of Mathematical Sciences, Universiti Sains Malaysia (USM)	KPI allocation of the School of Mathematical Sciences, Universiti Sains Malaysia (USM)	This research is supported by the KPI allocation of the School of Mathematical Sciences, Universiti Sains Malaysia (USM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparisi F, 2009, COMPUT OPER RES, V36, P3204, DOI 10.1016/j.cor.2009.02.024; Costa AFB, 2011, INT J PROD ECON, V130, P224, DOI 10.1016/j.ijpe.2010.12.021; Carot V, 2002, INT J PROD RES, V40, P2175, DOI 10.1080/00207540210128260; Croasdale R, 1974, INT J PROD RES, V12, P585; Das N, 2009, INT J ADV MANUF TECH, V41, P799, DOI 10.1007/s00170-008-1524-3; DAUDIN JJ, 1992, J QUAL TECHNOL, V24, P78, DOI 10.1080/00224065.1992.12015231; Rodrigues AAD, 2011, J APPL STAT, V38, P87, DOI 10.1080/02664760903266007; GAN FF, 1993, J STAT COMPUT SIM, V45, P169, DOI 10.1080/00949659308811479; Golosnoy V., 2007, SEQUENTIAL ANAL, V26, P195, DOI [10.1080/07474940701247099, DOI 10.1080/07474940701247099]; Gupta B.C., 2007, STAT QUALITY CONTROL; He D, 2006, EUR J OPER RES, V168, P122, DOI 10.1016/j.ejor.2004.04.033; He D, 2003, INT J PROD RES, V41, P2663, DOI 10.1080/0020754031000093187; He D, 2002, INT J PROD RES, V40, P1387, DOI 10.1080/00207540110118415; He D, 2002, QUAL RELIAB ENG INT, V18, P343, DOI 10.1002/qre.466; Hsu LF, 2004, INT J PROD RES, V42, P1043, DOI 10.1080/00207540310001632439; Hsu LF, 2007, QUAL RELIAB ENG INT, V23, P269, DOI 10.1002/qre.776; Khoo MBC, 2012, IIE TRANS, V44, P765, DOI [10.1080/0740817X.2011.609526, 10.1080/0740817X.2012.609526]; Khoo MBC, 2011, IIE TRANS, V43, P23, DOI 10.1080/0740817X.2010.491503; Lee PH, 2012, COMMUN STAT-THEOR M, V41, P153, DOI 10.1080/03610926.2010.521283; Lee PH, 2010, INT J PRODUCT DEV, V12, P324; Low CK, 2012, COMMUN STAT-SIMUL C, V41, P1463, DOI 10.1080/03610918.2011.606950; Maravelakis PE, 2005, COMMUN STAT-SIMUL C, V34, P1069, DOI 10.1080/03610910500308719; Montgomery DC, 2009, INT J PRODUCTION RES; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PALM AC, 1990, J QUAL TECHNOL, V22, P289, DOI 10.1080/00224065.1990.11979261; Thaga K, 2003, THESIS U MANITOBA WI; Torng CC, 2010, J APPL STAT, V37, P955, DOI 10.1080/02664760902984634; Torng CC, 2009, EXPERT SYST APPL, V36, P12621, DOI 10.1016/j.eswa.2009.05.017; Torng CC, 2009, INT J PROD ECON, V120, P495, DOI 10.1016/j.ijpe.2009.03.013; ZADEH LA, 1963, IEEE T AUTOMAT CONTR, VAC 8, P59, DOI 10.1109/TAC.1963.1105511	30	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68580	10.1371/journal.pone.0068580	http://dx.doi.org/10.1371/journal.pone.0068580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935873	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300008
J	Kumar, M; Allison, DF; Baranova, NN; Wamsley, JJ; Katz, AJ; Bekiranov, S; Jones, DR; Mayo, MW				Kumar, Manish; Allison, David F.; Baranova, Natalya N.; Wamsley, J. Jacob; Katz, Adam J.; Bekiranov, Stefan; Jones, David R.; Mayo, Marty W.			NF-kappa B Regulates Mesenchymal Transition for the Induction of Non-Small Cell Lung Cancer Initiating Cells	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; TGF-BETA; EPITHELIAL-CELLS; SIDE-POPULATION; KINASE ALPHA; IN-VITRO; EXPRESSION; TRANSCRIPTION; METASTASIS	The epithelial-to-mesenchymal transition (EMT) is a de-differentiation process that has been implicated in metastasis and the generation of cancer initiating cells (CICs) in solid tumors. To examine EMT in non-small cell lung cancer (NSCLC), we utilized a three dimensional (3D) cell culture system in which cells were co-stimulated with tumor necrosis factor alpha (TNF) and transforming growth factor beta (TGFb). NSCLC spheroid cultures display elevated expression of EMT master-switch transcription factors, TWIST1, SNAI1/Snail1, SNAI2/Slug and ZEB2/Sip1, and are highly invasive. Mesenchymal NSCLC cultures show CIC characteristics, displaying elevated expression of transcription factors KLF4, SOX2, POU5F1/Oct4, MYCN, and KIT. As a result, these putative CIC display a cancer "stem-like'' phenotype by forming lung metastases under limiting cell dilution. The pleiotropic transcription factor, NF-kappa B, has been implicated in EMT and metastasis. Thus, we set out to develop a NSCLC model to further characterize the role of NF-kappa B activation in the development of CICs. Here, we demonstrate that induction of EMT in 3D cultures results in constitutive NF-kappa B activity. Furthermore, inhibition of NF-kappa B resulted in the loss of TWIST1, SNAI2, and ZEB2 induction, and a failure of cells to invade and metastasize. Our work indicates that NF-kappa B is required for NSCLC metastasis, in part, by transcriptionally upregulating master-switch transcription factors required for EMT.	[Kumar, Manish; Allison, David F.; Baranova, Natalya N.; Wamsley, J. Jacob; Bekiranov, Stefan; Jones, David R.; Mayo, Marty W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Jones, David R.] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Katz, Adam J.] Univ Florida, Coll Med, Dept Surg, Div Plast & Reconstruct Surg, Gainesville, FL USA	University of Virginia; University of Virginia; State University System of Florida; University of Florida	Mayo, MW (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	mwm3y@virginia.edu		Jones, David/0000-0002-3318-0146	National Institutes of Health [R01CA132580, R01CA104397, R01CA136705]; NATIONAL CANCER INSTITUTE [R01CA132580, R01CA104397, T32CA009156, T32CA009109, R01CA136705, P30CA044579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by National Institutes of Health grants R01CA132580, R01CA104397 (to M.W.M.), and R01CA136705 (to D.R.J.). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akunuru S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.93; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Baird AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014593; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Dieter SM, 2011, CELL STEM CELL, V9, P357, DOI 10.1016/j.stem.2011.08.010; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kirschmann DA, 2002, CANCER RES, V62, P4478; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mayo MW, 2001, METHOD ENZYMOL, V333, P73; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nitz MD, 2008, METHOD ENZYMOL, V439, P219, DOI 10.1016/S0076-6879(07)00417-X; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thulke Stefanie, 2003, Haematologica, V88, pELT18; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu Q, 2000, GENE DEV, V14, P163; Zu XY, 2012, CELL TISSUE RES, V347, P73, DOI 10.1007/s00441-011-1225-3	60	78	83	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68597	10.1371/journal.pone.0068597	http://dx.doi.org/10.1371/journal.pone.0068597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935876	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200012
J	Chen, XP; Zhang, TH; Shi, JJ; Xu, P; Gu, ZX; Sandham, A; Yang, L; Ye, QS				Chen, Xuepeng; Zhang, Tianhou; Shi, Jiejun; Xu, Ping; Gu, Zexu; Sandham, Andrew; Yang, Lei; Ye, Qingsong			Notch1 Signaling Regulates the Proliferation and Self-Renewal of Human Dental Follicle Cells by Modulating the G1/S Phase Transition and Telomerase Activity	PLOS ONE			English	Article							DIFFERENTIATION IN-VITRO; CYCLE; PROGRESSION; INTEGRATION; EXPRESSION	Multipotent human dental follicle cells (HDFCs) have been intensively studied in periodontal regeneration research, yet the role of Notch1 in HDFCs has not been fully understood. The aim of the current study is to explore the role of Notch1 signaling in HDFCs self-renewal and proliferation. HDFCs were obtained from the extracted wisdom teeth from adolescent patients. Regulation of Notch1 signaling in the HDFCs was achieved by overexpressing the exogenous intracellular domain of Notch1 (ICN1) or silencing Notch1 by shRNA. The regulatory effects of Notch1 on HDFC proliferation, cell cycle distribution and the expression of cell cycle regulators were investigated through various molecular technologies, including plasmid construction, retrovirus preparation and infection, qRT-PCR, western blot, RBP-Jk luciferase reporter and cell proliferation assay. Our data clearly show that constitutively activation of Notch1 stimulates the HDFCs proliferation while inhibition of the Notch1 suppresses their proliferation in vitro. In addition, the HDFCs proliferation is associated with the increased expression of cell cycle regulators, e. g. cyclin D1, cyclin D2, cyclin D3, cyclin E1, CDK2, CDK4, CDK6, and SKP2 and the decreased expression of p27(kip1). Moreover, our data show that the G1/S phase transition (indicating proliferation) and telomerase activity (indicating self-renewal) can be enhanced by overexpression of ICN1 but halted by inhibition of Notch1. Together, the current study provides evidence for the first time that Notch1 signaling regulates the proliferation and self-renewal capacity of HDFCs through modulation of the G1/S phase transition and the telomerase activity.	[Chen, Xuepeng; Shi, Jiejun] Zhejiang Univ, Hosp Stomatol, Dept Orthodont, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Tianhou] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Stomatol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Ping] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Gu, Zexu; Yang, Lei] Fourth Mil Med Univ, Dept Orthodont, Qindu Stomatol Coll, Xian 710032, Shaanxi, Peoples R China; [Sandham, Andrew; Ye, Qingsong] James Cook Univ, Sch Med & Dent, Dept Orthodont, Cairns, Qld, Australia	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Zoology, CAS; Air Force Military Medical University; James Cook University	Chen, XP (corresponding author), Zhejiang Univ, Hosp Stomatol, Dept Orthodont, Hangzhou 310003, Zhejiang, Peoples R China.	cxp1979@163.com; qingsongye@hotmail.com	Ye, Adam/AAR-9145-2020	Ye, Adam/0000-0002-2868-9247	Zhejiang Provincial Natural Science Foundation of China [LQ12H14001]; Scientific Research Fund of Zhejiang Provincial Education Department [Y200909021]; Scientific Research Fund of Zhejiang Provincial Health Department [2012KYA126]; Traditional Chinese Medicine Science Research Fund of Zhejiang Province [2012ZB101]; JCU FAIG research grant; JCU Rising Star grant	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Scientific Research Fund of Zhejiang Provincial Education Department; Scientific Research Fund of Zhejiang Provincial Health Department; Traditional Chinese Medicine Science Research Fund of Zhejiang Province; JCU FAIG research grant; JCU Rising Star grant	This work was supported through funding from Zhejiang Provincial Natural Science Foundation of China (No. LQ12H14001) (http://www.zjnsf.gov.cn/), the Scientific Research Fund of Zhejiang Provincial Education Department (No. Y200909021) (http://www.zjedu.gov.cn/gb/index1.html), the Scientific Research Fund of Zhejiang Provincial Health Department (No. 2012KYA126) (http://www.zjwst.gov.cn/), the Traditional Chinese Medicine Science Research Fund of Zhejiang Province (No. 2012ZB101) (http://www.zjwst.gov.cn/), JCU FAIG research (2011) (http://www.jcu.edu.au/) and JCU Rising Star (2012) grants (http://www.jcu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Chen XP, 2007, ACTA PHARMACOL SIN, V28, P985, DOI 10.1111/j.1745-7254.2007.00586.x; [陈学鹏 Chen Xuepeng], 2012, [中国细胞生物学学报, Chinese Journal of Cell Biology], V34, P447; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Das D, 2010, DEV BIOL, V348, P153, DOI 10.1016/j.ydbio.2010.09.018; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Duan L, 2006, BIOL CELL, V98, P479, DOI 10.1042/BC20060020; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Jeon BG, 2011, CELL TRANSPLANT, V20, P1693, DOI 10.3727/096368911X565001; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Luan XG, 2006, STEM CELLS DEV, V15, P595, DOI 10.1089/scd.2006.15.595; Morsczeck C, 2005, CELL BIOL INT, V29, P567, DOI 10.1016/j.cellbi.2005.03.020; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Noseda M, 2006, CELL CYCLE, V5, P2704, DOI 10.4161/cc.5.23.3515; Qin LL, 2013, CELL SIGNAL, V25, P561, DOI 10.1016/j.cellsig.2012.11.003; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Schwanbeck R, 2011, EUR J CELL BIOL, V90, P572, DOI 10.1016/j.ejcb.2010.10.004; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vollner F, 2009, DIFFERENTIATION, V77, P433, DOI 10.1016/j.diff.2009.03.002; Wang SW, 2009, NUCLEIC ACIDS RES, V37, P2618, DOI 10.1093/nar/gkp125; Wright WE, 1996, DEV GENET, V18, P173; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yokoi T, 2007, CELL TISSUE RES, V327, P301, DOI 10.1007/s00441-006-0257-6; Zhou Jie, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P631, DOI 10.3760/cma.j.issn.1002-0098.2012.10.013	28	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69967	10.1371/journal.pone.0069967	http://dx.doi.org/10.1371/journal.pone.0069967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922876	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000323369700111
J	Krzyzowska, M; Baska, P; Orlowski, P; Zdanowski, R; Winnicka, A; Eriksson, K; Stankiewicz, W				Krzyzowska, Malgorzata; Baska, Piotr; Orlowski, Piotr; Zdanowski, Robert; Winnicka, Anna; Eriksson, Kristina; Stankiewicz, Wanda			HSV-2 Regulates Monocyte Inflammatory Response via the Fas/FasL Pathway	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; CELL-DEATH; VAGINAL MUCOSAE; IMMUNE MICE; B-CELLS; INFECTION; APOPTOSIS; EXPRESSION; PROTECTION; FAS	Monocytic cells represent important cellular elements of the innate and adaptive immune responses in viral infections. We assessed the role of Fas/FasL in promoting monocyte apoptosis during HSV-2 infection by using an in vitro model based on the murine RAW 264.7 monocytic cell line and an in vivo murine model of HSV-2 infection applied to C57BL6, MRL-Fas(lpr)/J (Fas-/-) and C3-Fasl(gld)/J (FasL-/-) mice. HSV-2 infection of the monocytic cell line led to early induction of apoptosis, with no protective expression of anti-apoptotic Bcl-2. HSV-2 infected monocytes up-regulated Fas and FasL expression early during in vitro infection but were susceptible to Fas induced apoptosis. The vaginal monocytes in the HSV-2 murine model of infection up-regulated FasL expression and were susceptible to Fas induced apoptosis. HSV-2 infection of Fas and FasL-deficient mice led to decreased apoptosis of monocytes and impaired recruitment of NK, CD4+ and CD8+ T cells within the infection sites. The vaginal lavages of HSV-2 infected Fas and FasL- deficient showed decreased production of CXCL9, CXCL10 and TNF-alpha in comparison to HSV-2 infected wild-type mice strain. The decreased recruitment of immune competent cells was accompanied by delayed virus clearance from the infected tissue. Triggering of the Fas receptor on HSV-2 infected monocytes in vitro up-regulated the expression of CXCL9 chemokines and the cytokine TNF-alpha. Our study provides novel insights on the role of Fas/FasL pathway not only in apoptosis of monocytes but also in regulating local immune response by monocytes during HSV-2 infection.	[Krzyzowska, Malgorzata; Baska, Piotr] Warsaw Univ Life Sci, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland; [Krzyzowska, Malgorzata; Orlowski, Piotr; Zdanowski, Robert; Stankiewicz, Wanda] Mil Inst Hyg & Epidemiol, Warsaw, Poland; [Winnicka, Anna] Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Eriksson, Kristina] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Warsaw University of Life Sciences; Military Institute of Hygiene & Epidemiology (MIHE); Warsaw University of Life Sciences; University of Gothenburg	Krzyzowska, M (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland.	krzyzowskam@yahoo.com		Krzyzowska, Malgorzata/0000-0002-8409-3974; Baska, Piotr/0000-0001-8150-4187; Winnicka, Anna/0000-0001-9918-3430; Zdanowski, Robert/0000-0003-0455-1072	National Science Centre [N N401 178839]; ERG FP7-PEOPLE-RG fellowship [276907]	National Science Centre(National Science Centre, Poland); ERG FP7-PEOPLE-RG fellowship	This work was supported by National Science Centre grant no. N N401 178839 and ERG FP7-PEOPLE-2010-RG fellowship no. 276907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Chensue SW, 2001, CLIN MICROBIOL REV, V14, P821, DOI 10.1128/CMR.14.4.821-835.2001; Cumberbatch M, 1997, ADV EXP MED BIOL, V417, P125; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Fleck M, 1999, VIRAL IMMUNOL, V12, P263, DOI 10.1089/vim.1999.12.263; Han JY, 2007, VIROLOGY, V359, P253, DOI 10.1016/j.virol.2006.09.038; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Koyama AH, 1998, ARCH VIROL, V143, P2435, DOI 10.1007/s007050050473; Krzyzowska M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.14; KULESZMARTIN M, 1985, CARCINOGENESIS, V6, P1245, DOI 10.1093/carcin/6.9.1245; Mastino A, 1997, CELL DEATH DIFFER, V4, P629, DOI 10.1038/sj.cdd.4400289; Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999; Milligan GN, 2001, J REPROD IMMUNOL, V49, P49, DOI 10.1016/S0165-0378(00)00080-2; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mocellin S, 2010, CURR MED CHEM, V17, P2713, DOI 10.2174/092986710791859342; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Ozaki N, 1997, NEUROSCI LETT, V228, P99, DOI 10.1016/S0304-3940(97)00364-9; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Parr MB, 1998, J VIROL, V72, P2677, DOI 10.1128/JVI.72.4.2677-2685.1998; Perkins D, 2003, J VIROL, V77, P1292, DOI 10.1128/JVI.77.2.1292-1305.2003; Ramaswamy M, 2009, RESULTS PROBL CELL D, V49, P17, DOI 10.1007/400_2008_24; Sciortino MT, 2006, VIROLOGY, V356, P136, DOI 10.1016/j.virol.2006.08.001; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Thapa M, 2008, Open Immunol J, V1, P33, DOI 10.2174/1874226200801010033; Thapa M, 2008, J IMMUNOL, V180, P1098, DOI 10.4049/jimmunol.180.2.1098; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Yedowitz JC, 2005, VIROLOGY, V342, P297, DOI 10.1016/j.virol.2005.07.036; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70308	10.1371/journal.pone.0070308	http://dx.doi.org/10.1371/journal.pone.0070308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922974	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700169
J	Sernbo, S; Borrebaeck, CAK; Uhlen, M; Jirstrom, K; Ek, S				Sernbo, Sandra; Borrebaeck, Carl A. K.; Uhlen, Mathias; Jirstrom, Karin; Ek, Sara			Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro	PLOS ONE			English	Article							CYTOPLASMIC LOCALIZATION; ADJUVANT TAMOXIFEN; PROGNOSTIC VALUE; DOWN-REGULATION; SAM68; RNA; GENE; PROLIFERATION; LINE; ACTIVATION	T-STAR (testis-signal transduction and activation of RNA) is an RNA binding protein, containing an SH3-binding domain and thus potentially playing a role in integration of cell signaling and RNA metabolism. The specific function of T-STAR is unknown and its implication in cancer is poorly characterized. Expression of T-STAR has been reported in human testis, muscle and brain tissues, and is associated with a growth-inhibitory role in immortalized fibroblasts. The aim of this paper was to investigate the functional role of T-STAR through (i) survival analysis of patients with primary invasive breast cancer and (ii) experimental evaluation of the effect of T-STAR on breast cancer cell growth. T-STAR protein expression was analysed by immunohistochemistry (IHC) in tissue microarrays with tumors from 289 patients with primary invasive breast cancer, and correlations to clinicopathological characteristics, recurrence-free and overall survival (RFS and OS) and established tumor markers such as HER2 and ER status were evaluated. In addition, the function of T-STAR was investigated using siRNA-mediated knock-down and overexpression of the gene in six breast cancer cell lines. Of the tumors analysed, 86% showed nuclear T-STAR expression, which was significantly associated with an improved RFS and strongly associated with positive HER2 status and negative hormone receptor status. Furthermore, experimental data showed that overexpression of T-STAR decreased cellular growth while knock-down increased it, as shown both by thymidine incorporation and metabolic activity. In summary, we demonstrate that T-STAR protein expression correlates with an improved RFS in primary breast cancer. This is supported by functional data, indicating that T-STAR regulation is of importance both for breast cancer biology and clinical outcome but future studies are needed to determine a potential role in patient stratification.	[Sernbo, Sandra; Borrebaeck, Carl A. K.; Ek, Sara] Lund Univ, CREATE Hlth, Dept Immunotechnol, Lund, Sweden; [Uhlen, Mathias] Royal Inst Technol, AlbaNova Univ Ctr, Dept Biotechnol, Stockholm, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Div Pathol, Dept Clin Sci, Lund, Sweden	Lund University; Royal Institute of Technology; Lund University; Skane University Hospital	Ek, S (corresponding author), Lund Univ, CREATE Hlth, Dept Immunotechnol, Lund, Sweden.	sara.ek@immun.lth.se	Uhlen, Mathias/B-3262-2016; ek, sara/E-8018-2015; Uhlen, Mathias/AAV-8746-2021; Ek, Sara/AAI-2353-2021	Uhlen, Mathias/0000-0002-4858-8056; ek, sara/0000-0002-1388-4912; Ek, Sara/0000-0002-1388-4912	Lund Institute of Technology (LTH); Cancerfonden [12/0565]; CREATE Health, a strategic Center for Translational Cancer Research	Lund Institute of Technology (LTH); Cancerfonden(Swedish Cancer Society); CREATE Health, a strategic Center for Translational Cancer Research	The study was supported by the Lund Institute of Technology (LTH), Cancerfonden (12/0565) and CREATE Health, a strategic Center for Translational Cancer Research (www.createhealth.lth.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anko ML, 2012, TRENDS BIOCHEM SCI, V37, P255, DOI 10.1016/j.tibs.2012.02.005; Artzt K, 2010, ADV EXP MED BIOL, V693, P1; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Borgquist S, 2008, J CLIN PATHOL, V61, P197, DOI 10.1136/jcp.2006.040378; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Conrotto P, 2011, MOL ONCOL; Dubsky Peter C, 2002, Clin Breast Cancer, V3, P65, DOI 10.3816/CBC.2002.n.013; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; Ehrmann I, 2010, ADV EXP MED BIOL, V693, P67; Ek S, 2006, MOL CELL PROTEOMICS, V5, P1072, DOI 10.1074/mcp.M600077-MCP200; Feng Y, 2010, ADV EXP MED BIOL, V693, P25; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Huot ME, 2012, MOL CELL, V46, P187, DOI 10.1016/j.molcel.2012.02.007; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Jirstrom K, 2005, J CLIN PATHOL, V58, P1135, DOI 10.1136/jcp.2005.027185; Johannsson OT, 2003, LAB INVEST, V83, P387, DOI 10.1097/01.LAB.0000060030.10652.8C; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Jonsson L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-114; Kool J, 2001, CELL GROWTH DIFFER, V12, P535; Lee JS, 1999, GENE, V240, P133, DOI 10.1016/S0378-1119(99)00421-7; Li Z, 2012, ANN ONCOL, V23, P638, DOI 10.1093/annonc/mdr290; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ramakrishnan P, 2011, MOL CELL, V43, P167, DOI 10.1016/j.molcel.2011.05.007; Ross JS, 2011, BIOMARK MED, V5, P277, DOI [10.2217/BMM.11.29, 10.2217/bmm.11.29]; Ruiz Christian, 2012, Swiss Med Wkly, V142, pw13587, DOI 10.4414/smw.2012.13587; Ryder SP, 2010, ADV EXP MED BIOL, V693, P37; Sernbo S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-405; Sette C, 2010, ADV EXP MED BIOL, V693, P54; Song LB, 2010, J PATHOL, V222, P227, DOI 10.1002/path.2751; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Venables JP, 1999, HUM MOL GENET, V8, P959, DOI 10.1093/hmg/8.6.959; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Vogel CL, 2001, ONCOLOGY-BASEL, V61, P37, DOI 10.1159/000055400; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zhang L, 2006, WORLD J GASTROENTERO, V12, P4056, DOI 10.3748/wjg.v12.i25.4056; Zhang ZL, 2009, CANCER EPIDEM BIOMAR, V18, P2685, DOI 10.1158/1055-9965.EPI-09-0097	44	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70596	10.1371/journal.pone.0070596	http://dx.doi.org/10.1371/journal.pone.0070596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923007	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700196
J	Lee, KM; Chiu, KB; Sansing, HA; Inglis, FM; Baker, KC; MacLean, AG				Lee, Kim M.; Chiu, Kevin B.; Sansing, Hope A.; Inglis, Fiona M.; Baker, Kate C.; MacLean, Andrew G.			Astrocyte Atrophy and Immune Dysfunction in Self-Harming Macaques	PLOS ONE			English	Article							SUICIDE ATTEMPTS; STEREOTYPIC BEHAVIOR; INJURIOUS-BEHAVIOR; PREFRONTAL CORTEX; RISK-FACTORS; DEPRESSION; PREVALENCE; FLUOXETINE; STRESS; PLASTICITY	Background: Self-injurious behavior (SIB) is a complex condition that exhibits a spectrum of abnormal neuropsychological and locomotor behaviors. Mechanisms for neuropathogenesis could include irregular immune activation, host soluble factors, and astrocyte dysfunction. Methods: We examined the role of astrocytes as modulators of immune function in macaques with SIB. We measured changes in astrocyte morphology and function. Paraffin sections of frontal cortices from rhesus macaques identified with SIB were stained for glial fibrillary acidic protein (GFAP) and Toll-like receptor 2 (TLR2). Morphologic features of astrocytes were determined using computer-assisted camera lucida. Results: There was atrophy of white matter astrocyte cell bodies, decreased arbor length in both white and gray matter astrocytes, and decreased bifurcations and tips on astrocytes in animals with SIB. This was combined with a five-fold increase in the proportion of astrocytes immunopositive for TLR2. Conclusions: These results provide direct evidence that SIB induces immune activation of astrocytes concomitant with quantifiably different morphology.	[Lee, Kim M.; Chiu, Kevin B.; Sansing, Hope A.; Baker, Kate C.; MacLean, Andrew G.] Tulane Natl Primate Res Ctr, Covington, LA USA; [Lee, Kim M.; MacLean, Andrew G.] Tulane Univ, Sch Med, Tulane Program Biomed Sci, New Orleans, LA 70112 USA; [Chiu, Kevin B.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Baker, Kate C.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; [Inglis, Fiona M.; Baker, Kate C.; MacLean, Andrew G.] Tulane Univ, Tulane Program Neurosci, New Orleans, LA 70118 USA; [Inglis, Fiona M.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [MacLean, Andrew G.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	MacLean, AG (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA USA.	amaclean@tulane.edu	MacLean, Andrew/R-9906-2019	Lee, Kim/0000-0002-5675-1896; MacLean, Andrew/0000-0002-0356-0674	PHS [OD11104, RR00164, MH077544, P20RR15637]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077544] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by PHS grants OD11104, RR00164, MH077544 (AGM), P20RR15637 (FMI), Non PHS support included Tulane Committee on Research Summer Fellowship (AGM), and Tulane Neuroscience Program funding (AGM, KBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, Vxii; Bentson KL, 2010, AM J PRIMATOL, V72, P725, DOI 10.1002/ajp.20831; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Clark KH, 2012, NEUROTOX RES; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Drew BL, 2001, ARCH PSYCHIAT NURS, V15, P99, DOI 10.1053/apnu.2001.23748; DULIT RA, 1994, AM J PSYCHIAT, V151, P1305; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Eyre H, 2012, PSYCHONEUROENDOCRINO, V37, P1397, DOI 10.1016/j.psyneuen.2012.03.019; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fontenot MB, 2009, J AM ASSOC LAB ANIM, V48, P176; Fontenot MB, 2005, COMPARATIVE MED, V55, P67; Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787; Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Kempf DJ, 2012, COMPARATIVE MED, V62, P209; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Klonsky ED, 2003, AM J PSYCHIAT, V160, P1501, DOI 10.1176/appi.ajp.160.8.1501; Lechuga-Sancho AM, 2006, ENDOCRINOLOGY, V147, P5314, DOI 10.1210/en.2006-0766; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Leonard Brian E., 2010, Current Immunology Reviews, V6, P205; Major CA, 2009, LIFE SCI, V85, P753, DOI 10.1016/j.lfs.2009.10.003; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; McKernan DP, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.37; Norton PJ, 2008, J BEHAV THER EXP PSY, V39, P515, DOI 10.1016/j.jbtep.2007.10.010; Novak MA, 2003, AM J PRIMATOL, V59, P3, DOI 10.1002/ajp.10063; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Oh DH, 2012, EUR NEUROPSYCHOPHARM, V22, P330, DOI 10.1016/j.euroneuro.2011.09.001; Prithviraj R, 2008, DEV NEUROBIOL, V68, P247, DOI 10.1002/dneu.20590; Renner NA, 2012, J CELL PHYSL; Renner NA, 2011, NON-FLAVIVIRUS ENCEPHALITIS, P87; Renner NA, 2011, J NEUROVIROL, V17, P146, DOI 10.1007/s13365-010-0017-y; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Safavi-Abbasi S, 2001, GLIA, V36, P102, DOI 10.1002/glia.1099; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun JD, 2012, NEUROPSYCHOPHARMACOL, V37, P1305, DOI 10.1038/npp.2011.319; Suyemoto KL, 1998, CLIN PSYCHOL REV, V18, P531, DOI 10.1016/S0272-7358(97)00105-0; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zlotnick C, 1997, J AM ACAD CHILD PSY, V36, P793, DOI 10.1097/00004583-199706000-00016	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69980	10.1371/journal.pone.0069980	http://dx.doi.org/10.1371/journal.pone.0069980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922882	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900130
J	Qi, XL; Zhang, LZ; Chen, YM; Gao, L; Wu, G; Qin, LT; Wang, YQ; Ren, XG; Gao, YL; Gao, HL; Wang, XM				Qi, Xiaole; Zhang, Lizhou; Chen, Yuming; Gao, Li; Wu, Guan; Qin, Liting; Wang, Yongqiang; Ren, Xiangang; Gao, Yulong; Gao, Honglei; Wang, Xiaomei			Mutations of Residues 249 and 256 in VP2 Are Involved in the Replication and Virulence of Infectious Bursal Disease Virus	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SWISS-MODEL; PATHOGENIC PHENOTYPE; ANTIGENIC DIVERSITY; ESCHERICHIA-COLI; CATALYTIC DYAD; AMINO-ACIDS; PROTEIN; IDENTIFICATION; ATTENUATION	Infectious bursal disease virus (IBDV) is a pathogen of worldwide significance to the poultry industry. Although the P-DE and P-FG domains of the capsid protein VP2 contribute significantly to virulence and fitness, the detailed molecular basis for the pathogenicity of IBDV is still not fully understood. Because residues 253 and 284 of VP2 are not the sole determinants of virulence, we hypothesized that other residues involved in virulence and fitness might exist in the P-DE and P-FG domains of VP2. To test this, five amino acid changes selected by sequence comparison of the P-DE and P-FG domains of VP2 were introduced individually using a reverse genetics system into the virulent strain (rGx-F9VP2). Then reverse mutations of the selected residues 249 and 256 were introduced individually into the attenuated strain (rGt). Seven modified viruses were generated and evaluated in vitro (CEF cells) and in vivo (SPF chicken). For residue 249, Q249R could elevate in vitro and reduce in vivo the replication of rGx-F9VP2 while R249Q could reduce in vitro and elevate in vivo the replication of rGt; meanwhile Q249R reduced the virulence of rGx-F9VP2 while R249Q increased the virulence of rGt, which indicated that residue 249 significantly contributed to the replication and virulence of IBDV. For residue 256, I256V could elevate in vitro and reduce in vivo the replication of rGx-F9VP2 while V256I could reduce in vitro but didn't change in vivo the replication of rGt; although V256I didn't increase the virulence of rGt, I256V obviously reduced the virulence of virulent IBDV. The present results demonstrate for the first time, to different extent, residues 249 and 256 of VP2 are involved in the replication efficiency and virulence of IBDV; this is not only beneficial to further understanding of pathogenic mechanism but also to the design of newly tailored vaccines against IBDV.	[Qi, Xiaole; Zhang, Lizhou; Chen, Yuming; Gao, Li; Wu, Guan; Qin, Liting; Wang, Yongqiang; Ren, Xiangang; Gao, Yulong; Gao, Honglei; Wang, Xiaomei] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, XM (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	xmw@hvri.ac.cn	Zhang, Lizhou/AAI-1145-2021	Zhang, Lizhou/0000-0002-2637-9712	National Natural Science Foundation of China [30901083]; National Basic Research Program (973) of China [2005CB523202]; China-France Cai-Yuanpei Program [2011008007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) of China(National Basic Research Program of China); China-France Cai-Yuanpei Program	This study was supported by grants from the National Natural Science Foundation of China (number 30901083), the National Basic Research Program (973) of China (number 2005CB523202), and the China-France Cai-Yuanpei Program (2011008007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AZAD AA, 1987, VIROLOGY, V161, P145, DOI 10.1016/0042-6822(87)90180-2; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Boot HJ, 2000, J VIROL, V74, P6701, DOI 10.1128/JVI.74.15.6701-6711.2000; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Gao L, 2011, VACCINE, V29, P5550, DOI 10.1016/j.vaccine.2011.04.106; Garriga D, 2006, J VIROL, V80, P6895, DOI 10.1128/JVI.00368-06; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jackwood DJ, 2008, VIROLOGY, V377, P110, DOI 10.1016/j.virol.2008.04.018; Jackwood DJ, 2012, AVIAN DIS, V56, P574, DOI 10.1637/10053-010912-ResNote.1; JACKWOOD DH, 1987, AVIAN DIS, V31, P766, DOI 10.2307/1591028; JAGADISH MN, 1988, J VIROL, V62, P1084, DOI 10.1128/JVI.62.3.1084-1087.1988; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Le Nouen C, 2006, J GEN VIROL, V87, P209, DOI 10.1099/vir.0.81184-0; Le Nouen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028064; Lee CC, 2006, J STRUCT BIOL, V155, P74, DOI 10.1016/j.jsb.2006.02.014; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Letzel T, 2007, J VIROL, V81, P12827, DOI 10.1128/JVI.01501-07; Lim BL, 1999, J VIROL, V73, P2854, DOI 10.1128/JVI.73.4.2854-2862.1999; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; LUCIO B, 1980, AVIAN DIS, V24, P189, DOI 10.2307/1589778; Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Muller H, 2003, VET MICROBIOL, V97, P153, DOI 10.1016/j.vetmic.2003.08.005; Mundt E, 1999, J GEN VIROL, V80, P2067, DOI 10.1099/0022-1317-80-8-2067; MUNDT E, 1995, J GEN VIROL, V76, P437, DOI 10.1099/0022-1317-76-2-437; Qi X, 2007, J VIROL METHODS, V142, P81, DOI 10.1016/j.jviromet.2007.01.021; Qi XL, 2009, ANTIVIR RES, V84, P225, DOI 10.1016/j.antiviral.2009.09.006; Raue R, 2004, AVIAN PATHOL, V33, P181, DOI 10.1080/03079450310001652112; Rautenschlein S, 2003, AVIAN DIS, V47, P66, DOI 10.1637/0005-2086(2003)047[0066:CIOMIA]2.0.CO;2; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Schroder A, 2000, J GEN VIROL, V81, P533, DOI 10.1099/0022-1317-81-2-533; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; van Loon AAWM, 2002, J GEN VIROL, V83, P121, DOI 10.1099/0022-1317-83-1-121; von Einem UI, 2004, J GEN VIROL, V85, P2221, DOI 10.1099/vir.0.19772-0; Wang XiaoMei, 2003, Agricultural Sciences in China, V2, P566; Wang XM, 2004, AVIAN DIS, V48, P77, DOI 10.1637/7061; Wang YQ, 2009, J VIROL METHODS, V157, P205, DOI 10.1016/j.jviromet.2009.01.001; Yamaguchi T, 1996, VIROLOGY, V223, P219, DOI 10.1006/viro.1996.0470	44	31	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70982	10.1371/journal.pone.0070982	http://dx.doi.org/10.1371/journal.pone.0070982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923037	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900182
J	Croisier, H; Tan, XH; Perez-Zoghbi, JF; Sanderson, MJ; Sneyd, J; Brook, BS				Croisier, Huguette; Tan, Xiahui; Perez-Zoghbi, Jose F.; Sanderson, Michael J.; Sneyd, James; Brook, Bindi S.			Activation of Store-Operated Calcium Entry in Airway Smooth Muscle Cells: Insight from a Mathematical Model	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; CA2+ ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; KINETIC-MODEL; OSCILLATIONS; STIM1; CONTRACTION; OLIGOMERIZATION; ORAI	Intracellular Ca2+ dynamics of airway smooth muscle cells (ASMC) mediate ASMC contraction and proliferation, and thus play a key role in airway hyper-responsiveness (AHR) and remodelling in asthma. We evaluate the importance of store-operated Ca2+ entry (SOCE) in these Ca2+ dynamics by constructing a mathematical model of ASMC Ca2+ signaling based on experimental data from lung slices. The model confirms that SOCE is elicited upon sufficient Ca2+ depletion of the sarcoplasmic reticulum (SR), while receptor-operated Ca2+ entry (ROCE) is inhibited in such conditions. It also shows that SOCE can sustain agonist-induced Ca2+ oscillations in the absence of other Ca2+ influx. SOCE up-regulation may thus contribute to AHR by increasing the Ca2+ oscillation frequency that in turn regulates ASMC contraction. The model also provides an explanation for the failure of the SERCA pump blocker CPA to clamp the cytosolic vertical bar Ca2+vertical bar of ASMC in lung slices, by showing that CPA is unable to maintain the SR empty of Ca2+. This prediction is confirmed by experimental data from mouse lung slices, and strongly suggests that CPA only partially inhibits SERCA in ASMC.	[Croisier, Huguette; Brook, Bindi S.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Tan, Xiahui; Sanderson, Michael J.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Perez-Zoghbi, Jose F.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Sneyd, James] Univ Auckland, Dept Math, Auckland, New Zealand	University of Nottingham; University of Massachusetts System; University of Massachusetts Worcester; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Auckland	Croisier, H (corresponding author), Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England.	Huguette.Croisier@nottingham.ac.uk	Brook, Bindi/O-6704-2016; Sneyd, James/C-8995-2009	Brook, Bindi/0000-0001-9883-4131; Sneyd, James/0000-0001-7305-2862; Perez-Zoghbi, Jose Francisco/0000-0002-7554-6468	Medical Research Council [G0901174]; National Institutes of Health [HL103405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103405] Funding Source: NIH RePORTER; MRC [G0901174] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BSB acknowledges funding from the Medical Research Council (http://www.mrc.ac.uk), New Investigator Grant: G0901174. MJS is supported by a grant from National Institutes of Health (http://www.nih.gov): HL103405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Bai Y, 2006, AM J PHYSIOL-LUNG C, V291, pL208, DOI 10.1152/ajplung.00494.2005; Bai Y, 2009, AM J PHYSIOL-LUNG C, V297, pL347, DOI 10.1152/ajplung.90559.2008; Bai Y, 2009, AM J PHYSIOL-LUNG C, V296, pL947, DOI 10.1152/ajplung.90288.2008; Berridge MJ, 2009, CELL SIGNALLING BIOL, V3, P21; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Brook BS, 2010, RESP PHYSIOL NEUROBI, V170, P44, DOI 10.1016/j.resp.2009.11.006; Brook BS, 2013, MATH MED BI IN PRESS; Brumen M, 2005, J BIOL PHYS, V31, P515, DOI 10.1007/s10867-005-2409-4; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Doedel E, 1991, INT J BIFURCAT CHAOS, V1, P745, DOI 10.1142/S0218127491000555; Doedel E, 1991, INT J BIFURCAT CHAOS, V1, P493, DOI 10.1142/S0218127491000397; Gao YD, 2010, PULM PHARMACOL THER, V23, P182, DOI 10.1016/j.pupt.2009.12.005; GERTHOFFER WT, 1991, AM J PHYSIOL, V261, pL15, DOI 10.1152/ajplung.1991.261.2.L15; Gin E, 2009, CHAOS, V19, DOI 10.1063/1.3184540; Haberichter T, 2002, BIOELECTROCHEMISTRY, V57, P129, DOI 10.1016/S1567-5394(02)00063-4; Herrera AM, 2002, AM J PHYSIOL-CELL PH, V282, pC310, DOI 10.1152/ajpcell.00390.2001; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Keener J, 2008, MATH PHYSL; Kowalewski JM, 2006, MATH BIOSCI, V204, P232, DOI 10.1016/j.mbs.2006.03.001; Lauzon AM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00191; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu WJ, 2010, MATH BIOSCI, V228, P110, DOI 10.1016/j.mbs.2010.08.013; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mahn K, 2009, P NATL ACAD SCI USA, V106, P10775, DOI 10.1073/pnas.0902295106; Mak DOD, 2003, J GEN PHYSIOL, V122, P583, DOI 10.1085/jgp.200308809; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Moynihan B, 2008, AM J PHYSIOL-LUNG C, V295, pL171, DOI 10.1152/ajplung.00457.2007; ODONNELL ME, 1994, PHYSIOL REV, V74, P683, DOI 10.1152/physrev.1994.74.3.683; Ong HL, 2007, J BIOL CHEM, V282, P12176, DOI 10.1074/jbc.M609435200; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ressmeyer AR, 2010, AM J RESP CELL MOL, V43, P179, DOI 10.1165/rcmb.2009-0222OC; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Roux E, 2006, PROG BIOPHYS MOL BIO, V90, P64, DOI 10.1016/j.pbiomolbio.2005.05.004; Roux E, 2004, BIOPHYS J, V86, P2583, DOI 10.1016/S0006-3495(04)74313-1; Sathish V, 2009, AM J PHYSIOL-LUNG C, V297, pL26, DOI 10.1152/ajplung.00026.2009; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Shuttleworth TJ, 2012, FRONT BIOSCI-LANDMRK, V17, P847, DOI 10.2741/3960; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Siekmann I, 2012, BIOPHYS J, V103, P658, DOI 10.1016/j.bpj.2012.07.016; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Tang YH, 1996, BIOPHYS J, V70, P246, DOI 10.1016/S0006-3495(96)79567-X; Trebak M, 2011, J PHYSIOL-LONDON, V589, P5337, DOI 10.1113/jphysiol.2011.220517; Wang I, 2008, BIOPHYS J, V94, P2053, DOI 10.1529/biophysj.107.113977; Wang IY, 2010, BIOPHYS J, V98, P1170, DOI 10.1016/j.bpj.2009.12.4273; White TA, 2006, AM J RESP CELL MOL, V35, P243, DOI 10.1165/rcmb.2006-0003OC; Wiesner TF, 1996, AM J PHYSIOL-CELL PH, V270, pC1556, DOI 10.1152/ajpcell.1996.270.5.C1556; Zou JJ, 2011, J APPL PHYSIOL, V110, P1256, DOI 10.1152/japplphysiol.01124.2010	61	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69598	10.1371/journal.pone.0069598	http://dx.doi.org/10.1371/journal.pone.0069598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936056	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300053
J	Mitchell, HD; Eisfeld, AJ; Sims, AC; McDermott, JE; Matzke, MM; Webb-Robertson, BJM; Tilton, SC; Tchitchek, N; Josset, L; Li, CJ; Ellis, AL; Chang, JH; Heegel, RA; Luna, ML; Schepmoes, AA; Shukla, AK; Metz, TO; Neumann, G; Benecke, AG; Smith, RD; Baric, RS; Kawaoka, Y; Katze, MG; Waters, KM				Mitchell, Hugh D.; Eisfeld, Amie J.; Sims, Amy C.; McDermott, Jason E.; Matzke, Melissa M.; Webb-Robertson, Bobbi-Jo M.; Tilton, Susan C.; Tchitchek, Nicolas; Josset, Laurence; Li, Chengjun; Ellis, Amy L.; Chang, Jean H.; Heegel, Robert A.; Luna, Maria L.; Schepmoes, Athena A.; Shukla, Anil K.; Metz, Thomas O.; Neumann, Gabriele; Benecke, Arndt G.; Smith, Richard D.; Baric, Ralph S.; Kawaoka, Yoshihiro; Katze, Michael G.; Waters, Katrina M.			A Network Integration Approach to Predict Conserved Regulators Related to Pathogenicity of Influenza and SARS-CoV Respiratory Viruses	PLOS ONE			English	Article							PANCREATIC-ISLET PROTEOME; IMMUNE-RESPONSES; SOFTWARE PACKAGE; GENE-EXPRESSION; HOST RESPONSE; CORONAVIRUS; INFECTION; CELLS; THROUGHPUT; MODEL	Respiratory infections stemming from influenza viruses and the Severe Acute Respiratory Syndrome corona virus (SARS-CoV) represent a serious public health threat as emerging pandemics. Despite efforts to identify the critical interactions of these viruses with host machinery, the key regulatory events that lead to disease pathology remain poorly targeted with therapeutics. Here we implement an integrated network interrogation approach, in which proteome and transcriptome datasets from infection of both viruses in human lung epithelial cells are utilized to predict regulatory genes involved in the host response. We take advantage of a novel "crowd-based'' approach to identify and combine ranking metrics that isolate genes/proteins likely related to the pathogenicity of SARS-CoV and influenza virus. Subsequently, a multivariate regression model is used to compare predicted lung epithelial regulatory influences with data derived from other respiratory virus infection models. We predicted a small set of regulatory factors with conserved behavior for consideration as important components of viral pathogenesis that might also serve as therapeutic targets for intervention. Our results demonstrate the utility of integrating diverse 'omic datasets to predict and prioritize regulatory features conserved across multiple pathogen infection models.	[Mitchell, Hugh D.; McDermott, Jason E.; Matzke, Melissa M.; Webb-Robertson, Bobbi-Jo M.; Tilton, Susan C.; Waters, Katrina M.] Pacific NW Natl Lab, Computat Sci & Math Div, Richland, WA 99352 USA; [Eisfeld, Amie J.; Li, Chengjun; Ellis, Amy L.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA; [Sims, Amy C.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Tchitchek, Nicolas; Josset, Laurence; Chang, Jean H.; Benecke, Arndt G.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Benecke, Arndt G.] Univ Paris 06, CNRS, UMR7224, Paris, France; [Heegel, Robert A.; Luna, Maria L.; Schepmoes, Athena A.; Shukla, Anil K.; Metz, Thomas O.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Saitama, Japan; [Waters, Katrina M.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Tokyo; University of Tokyo; University of Washington; University of Washington Seattle	Mitchell, HD (corresponding author), Pacific NW Natl Lab, Computat Sci & Math Div, Richland, WA 99352 USA.	hugh.mitchell@pnnl.gov	Smith, Richard D/J-3664-2012; Josset, Laurence/A-7960-2015; Sims, Amy C/HGD-6501-2022; Li, Chengjun/GWM-7661-2022; Benecke, Arndt G./T-1079-2019	Smith, Richard D/0000-0002-2381-2349; Josset, Laurence/0000-0002-7158-1186; Sims, Amy C/0000-0003-0178-4225; Eisfeld, Amie/0000-0003-2231-3107; Mitchell, Hugh/0000-0003-0143-8461; Waters, Katrina/0000-0003-4696-5396; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; Tchitchek, Nicolas/0000-0003-3307-0446; Metz, Tom/0000-0001-6049-3968; McDermott, Jason/0000-0003-2961-2572	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200800060C]; NIH [P41 GM103493]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract No. HHSN272200800060C, and with NIH Grant P41 GM103493. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chitra P, 2011, CLIN CHIM ACTA, V412, P1151, DOI 10.1016/j.cca.2011.01.037; Chow Vincent T. K., 2009, P295, DOI 10.1142/9789812833808_0013; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016022; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Donaldson EF, 2008, J VIROL, V82, P11948, DOI 10.1128/JVI.01804-08; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Hallock P, 2012, OMICS, V16, P37, DOI 10.1089/omi.2011.0054; Han B, 2012, LAB INVEST, V92, P1285, DOI 10.1038/labinvest.2012.92; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Herrero LJ, 2011, P NATL ACAD SCI USA, V108, P12048, DOI 10.1073/pnas.1101089108; Hong M, 2008, VIRAL IMMUNOL, V21, P153, DOI 10.1089/vim.2007.0108; Hurley D, 2012, NUCLEIC ACIDS RES, V40, P2377, DOI 10.1093/nar/gkr902; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Imielinski M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014910; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kanzawa N, 2006, FEBS LETT, V580, P6807, DOI 10.1016/j.febslet.2006.11.046; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Katoh N, 2000, J VET MED SCI, V62, P37, DOI 10.1292/jvms.62.37; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; McDermott JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-28; McDermott JE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-190; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; McDermott JE, 2011, BIOCOMPUT-PAC SYM, P314; McDermott JE, 2009, J COMPUT BIOL, V16, P169, DOI 10.1089/cmb.2008.04TT; Metz TO, 2006, J PROTEOME RES, V5, P3345, DOI 10.1021/pr060322n; Mizutani T, 2006, BIOCHEM BIOPH RES CO, V347, P261, DOI 10.1016/j.bbrc.2006.06.086; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Sims AC, 2013, J VIROL, V87, P3885, DOI 10.1128/JVI.02520-12; Smits SL, 2011, J VIROL, V85, P4234, DOI 10.1128/JVI.02395-10; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; Tekir SD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00046; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Versteeg GA, 2007, J VIROL, V81, P10981, DOI 10.1128/JVI.01033-07; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Waters KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034515; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Webb-Robertson BJM, 2010, J PROTEOME RES, V9, P5748, DOI 10.1021/pr1005247; Yoon H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-100; Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang L, 2009, INFECT GENET EVOL, V9, P1148, DOI 10.1016/j.meegid.2009.07.006; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zornetzer GA, 2010, J VIROL, V84, P11297, DOI 10.1128/JVI.01130-10	69	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69374	10.1371/journal.pone.0069374	http://dx.doi.org/10.1371/journal.pone.0069374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935999	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300037
J	Perez-Valero, I; Gonzalez-Baeza, A; Estebanez, M; Montes-Ramirez, ML; Bayon, C; Pulido, F; Bernardino, JI; Zamora, FX; Monge, S; Gaya, F; Lagarde, M; Rubio, R; Hernando, A; Arnalich, F; Arribas, JR				Perez-Valero, Ignacio; Gonzalez-Baeza, Alicia; Estebanez, Miriam; Montes-Ramirez, Maria L.; Bayon, Carmen; Pulido, Federico; Bernardino, Jose I.; Zamora, Francisco X.; Monge, Susana; Gaya, Francisco; Lagarde, Maria; Rubio, Rafael; Hernando, Asuncion; Arnalich, Francisco; Arribas, Jose R.			Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy	PLOS ONE			English	Article							FLUID HIV RNA; CEREBROSPINAL-FLUID; NUCLEOSIDE ANALOGS; MONET TRIAL; DARUNAVIR/RITONAVIR; CNS; DISORDERS; RITONAVIR; INFECTION	Background: In patients who remain virologically suppressed in plasma with triple-drug ART a switch to protease inhibitor monotherapy maintains high rates of suppression; however it is unknown if protease inhibitor monotherapy is associated to a higher rate of neurocognitive impairment. Methods: In this observational, cross-sectional study we included patients with plasma virological suppression (>= 1 year) without concomitant major neurocognitive confounders, currently receiving for >= 1 year boosted lopinavir or darunavir as monotherapy or as triple ART. Neurocognitive impairment was defined as per the 2007 consensus of the American Association of Neurology. The association between neurocognitive impairment and protease inhibitor monotherapy, adjusted by significant confounders, was analysed. Results: Of the 191 included patients - triple therapy: 96, 1-2 years of monotherapy: 40 and > 2 years of monotherapy: 55 proportions (95% CI) with neurocognitive impairment were: overall, 27.2% (20.9-33.6); triple therapy, 31.6% (22.1-41.0); short-term monotherapy, 25.0% (11.3-38.7); long-term monotherapy: 21.4% (10.5-32.3); p = 0.38. In all groups, neurocognitive impairment was mildly symptomatic or asymptomatic by self-report. There were not significant differences in Global Deficit Score by group. In the regression model confounding variables for neurocognitive impairment were years on ART, ethnicity, years of education, transmission category and the HOMA index. Adjusted by these variables the Odds Ratio ( 95% CI) for neurocognitive impairment of patients receiving short-term monotherapy was 0.85 (0.29-2.50) and for long-term monotherapy 0.40 (0.14-1.15). Conclusions: Compared to triple drug antiretroviral therapy, monotherapy with lopinavir/ritonavir or darunavir/ritonavir in patients with adequate plasma suppression was not associated with a higher rate of asymptomatic neurocognitive impairment than triple drug ART.	[Perez-Valero, Ignacio; Gonzalez-Baeza, Alicia; Estebanez, Miriam; Montes-Ramirez, Maria L.; Bernardino, Jose I.; Zamora, Francisco X.; Gaya, Francisco; Arnalich, Francisco; Arribas, Jose R.] Hosp Univ La Paz IdiPAZ, HIV Unit, Internal Med Serv, Madrid, Spain; [Bayon, Carmen] Hosp Univ La Paz IdiPAZ, Psychiat Serv, Madrid, Spain; [Pulido, Federico; Lagarde, Maria; Rubio, Rafael] Hosp Univ 12 Octubre I 12, HIV Unit, Internal Med Serv, Madrid, Spain; [Monge, Susana] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain; [Hernando, Asuncion] Univ Europea Madrid, Dept Especialidades Med, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); European University of Madrid	Perez-Valero, I (corresponding author), Hosp Univ La Paz IdiPAZ, HIV Unit, Internal Med Serv, Madrid, Spain.	iperez.hulp@salud.madrid.org	Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/AAF-5924-2021; Arnalich, Francisco/J-8184-2017; Valero, Ignacio Perez/AAL-5466-2021; Gayá Moreno, Francisco/ABE-9251-2021; Monge, Susana/H-9210-2017; GRANDE, ANTONIO HERNANDO/U-1411-2019; Valero, Ignacio Pérez/AAD-6566-2020; Pulido, Federico/B-8417-2009; Bernardino, José Ignacio/AAD-1637-2019; Valero, Ignacio Pérez/G-5909-2016; Bernardino, Jose Ignacio/H-7898-2017; Hernando, Asuncion/M-7916-2014; Arribas, Jose/A-1595-2015	Arnalich, Francisco/0000-0003-2943-0373; Gayá Moreno, Francisco/0000-0002-9779-4876; GRANDE, ANTONIO HERNANDO/0000-0002-7307-8859; Valero, Ignacio Pérez/0000-0002-3488-7135; Pulido, Federico/0000-0002-7414-8812; Bernardino, José Ignacio/0000-0003-3501-8529; Valero, Ignacio Pérez/0000-0002-3488-7135; Bernardino, Jose Ignacio/0000-0003-3501-8529; GONZALEZ-BAEZA, ALICIA/0000-0002-2265-8976; de Lagarde, Maria/0000-0002-7712-6977; Bayon, Carmen/0000-0002-2018-6135; Rubio Garcia, Rafael/0000-0001-8132-4303; Hernando, Asuncion/0000-0002-1901-1119; Monge, Susana/0000-0003-1412-3012; Gonzalez-Baeza, Alicia/0000-0003-4351-5947; Arribas, Jose/0000-0002-7410-9450; Estebanez, Miriam/0000-0003-4509-9123	Fondo de Investigaciones Sanitarias, Insituto de Salud Carlos III [PI10/00483]; Rio Hortega fellowships; Fondo de Investigaciones Sanitarias; Instituto de Investigacion Hospital 12 de Octubre (i+12); "Red de Investigacion en SIDA'' (AIDS Research Network) (RIS) [RD07/0006/2007]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512] Funding Source: NIH RePORTER	Fondo de Investigaciones Sanitarias, Insituto de Salud Carlos III; Rio Hortega fellowships; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Investigacion Hospital 12 de Octubre (i+12); "Red de Investigacion en SIDA'' (AIDS Research Network) (RIS); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant PI10/00483, Fondo de Investigaciones Sanitarias, Insituto de Salud Carlos III. Dr I. Perez-Valero, Dr. M. Estebanez, Dr. F. X. Zamora and S. Monge are supported by Rio Hortega fellowships financed by Fondo de Investigaciones Sanitarias. Dr. M. Lagarde is supported by a fellowship financed by Instituto de Investigacion Hospital 12 de Octubre (i+12). Dr. J.R. Arribas is an investigator from the Programa de Intensificacion de la Actividad Investigadora en el SNS (I3SNS). IdiPAZ AIDS and infectious diseases investigator group is partially supported by "Red de Investigacion en SIDA'' (AIDS Research Network) (RIS) RD07/0006/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Capparelli EV, 2005, AIDS, V19, P949, DOI 10.1097/01.aids.0000171409.38490.48; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Clifford DB, 2010, NEUROLOGY, V74, P1248, DOI 10.1212/WNL.0b013e3181dd4e31; Du Pasquier RA, 2013, AIDS, V27, P203, DOI 10.1097/QAD.0b013e32835a9a4a; Ellis RJ, 2000, NEUROLOGY, V54, P927, DOI 10.1212/WNL.54.4.927; Estebanez M, 2012, CURR HIV-AIDS REP, V9, P179, DOI 10.1007/s11904-012-0112-1; Gisslen M, 2012, SCAND J INFECT DIS, V44, P997, DOI 10.3109/00365548.2012.690526; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Letendre S., 2010, 17 C RETR OPP INF SA; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Marraa CM, 2009, AIDS, V23, P1359, DOI 10.1097/QAD.0b013e32832c4152; Panel members of the European AIDS Clinical Society, 2012, EUR AIDS CLIN SOC GU; Paton NI, 2011, AIDS, V25, P393, DOI 10.1097/QAD.0b013e328342fb7b; Peluso MJ, 2012, AIDS, V26, P1765, DOI 10.1097/QAD.0b013e328355e6b2; Perez-Valero I, 2011, J ANTIMICROB CHEMOTH, V66, P1954, DOI 10.1093/jac/dkr229; Robertson KR, 2010, NEUROLOGY, V74, P1260, DOI 10.1212/WNL.0b013e3181d9ed09; Robertson K, 2012, J NEUROVIROL, V18, P388, DOI 10.1007/s13365-012-0120-3; Santos J, 2012, 19 C RETR OPP INF SE; Santos JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037442; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Winston A, 2012, INT J STD AIDS, V23, P225, DOI 10.1258/ijsa.2011.011330; Winston A, 2011, 13 EUR AIDS C BELGR; Yilmaz A, 2009, AIDS RES HUM RETROV, V25, P457, DOI 10.1089/aid.2008.0216; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69493	10.1371/journal.pone.0069493	http://dx.doi.org/10.1371/journal.pone.0069493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936029	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300043
J	Babcock, JJ; Du, F; Xu, KP; Wheelan, SJ; Li, M				Babcock, Joseph J.; Du, Fang; Xu, Kaiping; Wheelan, Sarah J.; Li, Min			Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors	PLOS ONE			English	Article							POTASSIUM CHANNELS; QT INTERVAL; K+ CHANNEL; UP-REGULATION; MODEL; IDENTIFICATION; COMPOUND; ELECTROPHYSIOLOGY; LEUKEMIA; BLOCKADE	Growing evidence suggests that drugs interact with diverse molecular targets mediating both therapeutic and toxic effects. Prediction of these complex interactions from chemical structures alone remains challenging, as compounds with different structures may possess similar toxicity profiles. In contrast, predictions based on systems-level measurements of drug effect may reveal pharmacologic similarities not evident from structure or known therapeutic indications. Here we utilized drug-induced transcriptional responses in the Connectivity Map (CMap) to discover such similarities among diverse antagonists of the human ether-a-go-go related (hERG) potassium channel, a common target of promiscuous inhibition by small molecules. Analysis of transcriptional profiles generated in three independent cell lines revealed clusters enriched for hERG inhibitors annotated using a database of experimental measurements (hERGcentral) and clinical indications. As a validation, we experimentally identified novel hERG inhibitors among the unannotated drugs in these enriched clusters, suggesting transcriptional responses may serve as predictive surrogates of cardiotoxicity complementing existing functional assays.	[Babcock, Joseph J.; Du, Fang; Li, Min] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Babcock, Joseph J.; Du, Fang; Li, Min] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD USA; [Xu, Kaiping; Li, Min] Johns Hopkins Univ, Sch Med, JHICC, Baltimore, MD USA; [Wheelan, Sarah J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wheelan, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA.	swheelan@jhmi.edu; minli@jhmi.edu	Du, Fang/I-4134-2014		National Institutes of Health [GM078579, MH084691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by grants to M. L. from the National Institutes of Health (GM078579, MH084691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2010, TOPGO TOPGO ENRICHME; Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744; Bengtsson H., 2008, AROMA AFFYMETRIX GEN; Berger SI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000723; Bridal TR, 2010, ASSAY DRUG DEV TECHN, V8, P755, DOI 10.1089/adt.2010.0267; Broccatelli F, 2012, MOL PHARMACEUT, V9, P2290, DOI 10.1021/mp300156r; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Davies MR, 2012, AM J PHYSIOL-HEART C, V302, pH1466, DOI 10.1152/ajpheart.00808.2011; Doddareddy MR, 2010, CHEMMEDCHEM, V5, P716, DOI 10.1002/cmdc.201000024; Du F, 2011, ASSAY DRUG DEV TECHN, V9, P580, DOI 10.1089/adt.2011.0425; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Nueda MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S9; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kang JS, 2001, J PHARMACOL EXP THER, V299, P290; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kikuchi K, 2005, BRIT J PHARMACOL, V144, P840, DOI 10.1038/sj.bjp.0706095; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S2; Li HR, 2012, P NATL ACAD SCI USA, V109, P4609, DOI 10.1073/pnas.1200305109; Li QY, 2008, MOL PHARMACEUT, V5, P117, DOI 10.1021/mp700124e; MA C, 2010, P 1 ACM INT C BIOINF, P520; Mirams GR, 2011, CARDIOVASC RES, V91, P53, DOI 10.1093/cvr/cvr044; Mohammad S, 1997, AM J PHYSIOL-HEART C, V273, pH2534, DOI 10.1152/ajpheart.1997.273.5.H2534; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nigsch F, 2011, EXPERT OPIN DRUG MET, V7, P1497, DOI 10.1517/17425255.2011.632632; Obers S, 2010, N-S ARCH PHARMACOL, V381, P385, DOI 10.1007/s00210-010-0496-7; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Potet F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380162; R Development Core Team, 2012, R LANG ENV STAT COMP; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Roy J, 2008, ONCOL REP, V19, P1511; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Shah RR, 2002, BRIT J CLIN PHARMACO, V54, P188, DOI 10.1046/j.1365-2125.2002.01627.x; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Sorota S, 2005, ASSAY DRUG DEV TECHN, V3, P47, DOI 10.1089/adt.2005.3.47; Suessbrich H, 1996, FEBS LETT, V385, P77, DOI 10.1016/0014-5793(96)00355-9; Takashima K, 2006, LIFE SCI, V78, P2787, DOI 10.1016/j.lfs.2005.11.010; Tan YX, 2006, BIOINFORMATICS, V22, P77, DOI 10.1093/bioinformatics/bti737; Toyoshiba H, 2009, TOXICOL LETT, V186, P52, DOI 10.1016/j.toxlet.2008.08.009; Tropsha A, 2007, CURR PHARM DESIGN, V13, P3494, DOI 10.2174/138161207782794257; Valentin Jean-Pierre, 2009, Journal of Pharmacological and Toxicological Methods, V60, P152, DOI 10.1016/j.vascn.2009.05.011; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Yuill KH, 2004, BIOCHEM BIOPH RES CO, V318, P556, DOI 10.1016/j.bbrc.2004.04.063; Zhang HK, 2012, P NATL ACAD SCI USA, V109, P11866, DOI 10.1073/pnas.1205266109; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zou BY, 2010, ASSAY DRUG DEV TECHN, V8, P743, DOI 10.1089/adt.2010.0339	66	18	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69513	10.1371/journal.pone.0069513	http://dx.doi.org/10.1371/journal.pone.0069513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936032	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000129
J	Chen, Y; Lin, G; Guo, ZQ; Zhou, ZF; He, ZY; Ye, YB				Chen, Yu; Lin, Gen; Guo, Zeng-qing; Zhou, Zhi-feng; He, Zhi-yong; Ye, Yun-bin			Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy	PLOS ONE			English	Article							MHC CLASS-I; CUTTING EDGE; NK CELLS; NKG2D; STRESS; RECEPTOR; LIGANDS; IMMUNORECEPTOR; IMMUNOTHERAPY; RECOGNITION	Objective: To investigate the clinical significance of the expression of MHC class I chain-related gene A (MICA) in patients with advanced non-small cell lung cancer and explore the relationship between MICA expression and the efficacy of cytokine-induced killer cell (CIK) therapy for treating advanced non-small cell lung cancer. Methods: We obtained data on 222 patients with advanced non-small cell lung cancer, including data on MICA expression, age, gender, ECOG score, pathological type, stage, treatment history (including 38 patients who were given autologous CIK cell infusion), and overall survival (OS). MICA expression in lung cancer tissue was evaluated by immunohistochemical staining. Analyses of MICA expression, and CIK therapy association with survival outcomes were performed using Cox proportional models, Kaplan-Meier methods, and the log-rank test. Result: s MICA was expressed in both membrane and cytoplasm. MICA expression correlated with the stage of lung cancer, ECOG score, gender and age. Multivariate COX regression analysis showed that the expression of MICA was an independent prognostic factor of advanced non-small cell lung cancer (p = 0.002). In subgroup analysis, we divided the 222 patients into CIK and control groups. In the CIK group, the medium OS (mOS) of patients with a high expression of MICA was longer than in those with low expression of MICA (27 months vs. 13 months). In the control group, the mOS in patients with a high expression of MICA was shorter than in patients with low MICA expression (9 months vs. 18 months). COX regression analysis showed that the MICA expression affects the effect of CIK therapy (p<0.0001). Conclusion: 1) The high expression of MICA is one of the indicators of a poor prognosis for advanced non-small cell lung cancer patients. 2) The high expression of MICA might be one of the predictive factors for successful CIK therapy.	[Chen, Yu; Lin, Gen; Guo, Zeng-qing; He, Zhi-yong] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Med Oncol, Fuzhou, Fujian Province, Peoples R China; [Zhou, Zhi-feng; Ye, Yun-bin] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Lab Immunooncol, Fuzhou, Fujian Province, Peoples R China; [Chen, Yu; Lin, Gen; Guo, Zeng-qing; Zhou, Zhi-feng; He, Zhi-yong; Ye, Yun-bin] Fujian Key Lab Translat Canc Med, Fuzhou, Fujian Province, Peoples R China; [Guo, Zeng-qing] Fujian Prov Key Lab Tumor Biotherapy, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University	He, ZY (corresponding author), Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Med Oncol, Fuzhou, Fujian Province, Peoples R China.	heyong1015@163.com; zjyunbin@189.cn			Foundation for Young Scholars of Fujian Provincial Department of Health, China [2011-1-24]	Foundation for Young Scholars of Fujian Provincial Department of Health, China	The project was supported by the Foundation for Young Scholars of Fujian Provincial Department of Health, China. (Grant No. 2011-1-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Busche A, 2006, HUM GENE THER, V17, P135, DOI 10.1089/hum.2006.17.135; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Friese MA, 2003, CANCER RES, V63, P8996; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Helms MW, 2010, CANCER IMMUNOL IMMUN, V59, P1325, DOI 10.1007/s00262-010-0860-y; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Huang BC, 2011, J IMMUNOTHER, V34, P289, DOI 10.1097/CJI.0b013e31820e1b0d; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakimi K, 2009, LUNG CANCER, V65, P1, DOI 10.1016/j.lungcan.2008.10.018; Lanier LL, 2001, NAT MED, V7, P1178, DOI 10.1038/nm1101-1178; Madjd Zahra, 2007, Cancer Immun, V7, P17; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Pardoll DM, 2001, SCIENCE, V294, P534, DOI 10.1126/science.1066284; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Shi M, 2004, WORLD J GASTROENTERO, V10, P1146; Stroncek D, 2010, CYTOTHERAPY, V12, P425, DOI 10.3109/14653240903511952; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Xiao P, 2008, HISTOPATHOLOGY, V52, P640, DOI 10.1111/j.1365-2559.2008.02989.x; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	33	26	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69044	10.1371/journal.pone.0069044	http://dx.doi.org/10.1371/journal.pone.0069044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935919	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000070
J	Pang, Y; Li, Q; Ou, XC; Sohn, H; Zhang, ZY; Li, JC; Xia, H; Kam, KM; O'Brien, RJ; Chi, JY; Huan, ST; Chin, DP; Zhao, YL				Pang, Yu; Li, Qiang; Ou, Xichao; Sohn, Hojoon; Zhang, Zhiying; Li, Junchen; Xia, Hui; Kam, Kai Man; O'Brien, Richard J.; Chi, Junying; Huan, Shitong; Chin, Daniel P.; Zhao, Yan-lin			Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RAPID DIAGNOSIS; MECHANISMS; COUNTRIES; CULTURE; MTB/RIF; SAMPLES; SYSTEM	Background: Genechip (CapitalBio, Beijing, China) is a system for diagnosing resistance to rifampin and isoniazid, which shows high efficiency in detecting drug-resistant tuberculosis. Here, we firstly evaluated the costs of Genechip for detecting the drug susceptibility of Mycobacterium tuberculosis, compared to conventional drug susceptibility test (DST) in laboratories in China. Methodology/Principal Findings: Data on the costs of the two tests were collected at four hospitals. Costs were calculated using the essential factor cost calculation method. The costs of diagnosing a single case of multidrug-resistant tuberculosis (MDR-TB) using Genechip and DST were US$22.38 and $53.03, respectively. Taking into account the effect on costs from failure of a certain number of tests to accurately diagnose MDR-TB, the costs of Genechip and DST increased by 17.65% and 5.22%, respectively. The cost of both tests decreased with the increasing prevalence of MDR-TB disease, and the cost of Genechip at a sensitivity of more than 50% was lower than that of DST. When price of Genechip was varied to 50%, 80%, 150%, and 200% of the original price, the cost of Genechip at sensitivities of more than 30%, 40%, 60%, and 70%, respectively, was also lower than that of DST. Conclusions/Significance: This study showed that Genechip was a more cost-effective method of diagnosing MDR-TB compared to conventional DST.	[Pang, Yu; Li, Qiang; Ou, Xichao; Xia, Hui; Chi, Junying; Zhao, Yan-lin] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Zhang, Zhiying; Li, Junchen] PATH, Beijing, Peoples R China; [Kam, Kai Man] Chinese Univ Hong Kong, Fac Med, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [O'Brien, Richard J.] FIND, Geneva, Switzerland; [Huan, Shitong; Chin, Daniel P.] China Off, Bill & Melinda Gates Fdn, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese University of Hong Kong; Foundation For Innovative New Diagnostics	Chin, DP (corresponding author), China Off, Bill & Melinda Gates Fdn, Beijing, Peoples R China.	daniel.chin@gatesfoundation.org; zhaoyanlin@chinatb.org	Sohn, Hojoon/AAL-2856-2020; KAM, Kai Man/K-4546-2012	Sohn, Hojoon/0000-0001-5837-3844; KAM, Kai Man/0000-0003-0579-0307	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was supported by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Villaorduna C, 2008, CLIN INFECT DIS, V47, P487, DOI 10.1086/590010; Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Engstrom A, 2012, J CLIN MICROBIOL, V50, P2026, DOI 10.1128/JCM.06664-11; Goyal M, 1997, EUR RESPIR J, V10, P1120, DOI 10.1183/09031936.97.10051120; Guo Y, 2009, INT J TUBERC LUNG D, V13, P914; Harris G, 2000, J CLIN PATHOL, V53, P615, DOI 10.1136/jcp.53.8.615; Kim SJ, 2007, INT J TUBERC LUNG D, V11, P138; Matteelli A, 2007, EXPERT REV ANTI-INFE, V5, P857, DOI 10.1586/14787210.5.5.857; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Palacios JJ, 1999, EUR J CLIN MICROBIOL, V18, P265, DOI 10.1007/s100960050275; Pang Y, 2013, J CLIN MICROBIOL, V51, P1707, DOI 10.1128/JCM.03436-12; Scherer LC, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-216; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2011, WHO GLOBAL TUBERCULO; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	22	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69267	10.1371/journal.pone.0069267	http://dx.doi.org/10.1371/journal.pone.0069267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935970	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000096
J	Poliquin, PO; Chen, JK; Cloutier, M; Trudeau, LE; Jolicoeur, M				Poliquin, Pierre O.; Chen, Jingkui; Cloutier, Mathieu; Trudeau, Louis-Eric; Jolicoeur, Mario			Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PATHWAYS; GENE; PATHOGENESIS; METABOLITES; DYSFUNCTION; MUTATIONS	Parkinson's disease (PD) is a multifactorial disease known to result from a variety of factors. Although age is the principal risk factor, other etiological mechanisms have been identified, including gene mutations and exposure to toxins. Deregulation of energy metabolism, mostly through the loss of complex I efficiency, is involved in disease progression in both the genetic and sporadic forms of the disease. In this study, we investigated energy deregulation in the cerebral tissue of animal models (genetic and toxin induced) of PD using an approach that combines metabolomics and mathematical modelling. In a first step, quantitative measurements of energy-related metabolites in mouse brain slices revealed most affected pathways. A genetic model of PD, the Park2 knockout, was compared to the effect of CCCP, a complex I blocker. Model simulated and experimental results revealed a significant and sustained decrease in ATP after CCCP exposure, but not in the genetic mice model. In support to data analysis, a mathematical model of the relevant metabolic pathways was developed and calibrated onto experimental data. In this work, we show that a short-term stress response in nucleotide scavenging is most probably induced by the toxin exposure. In turn, the robustness of energy-related pathways in the model explains how genetic perturbations, at least in young animals, are not sufficient to induce significant changes at the metabolite level.	[Poliquin, Pierre O.; Chen, Jingkui; Cloutier, Mathieu; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada; [Cloutier, Mathieu] Ecole Polytech, Gerad, Montreal, PQ H3C 3A7, Canada; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; Universite de Montreal	Jolicoeur, M (corresponding author), Ecole Polytech, Dept Chem Engn, POB 6079, Montreal, PQ H3C 3A7, Canada.	mario.jolicoeur@polymtl.ca	Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377	NSERC; Canadian Foundation for Innovation; Canada Research Chair program; Canadian Institutes of Health Research; Brain Canada Foundation (Krembil Foundation)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation (Krembil Foundation)	This work was supported by an NSERC Discovery grant (M.J.), the Canadian Foundation for Innovation (M.J.), the Canada Research Chair program (M.J.), the Canadian Institutes of Health Research (L.-E.T.), and the Brain Canada Foundation (Krembil Foundation) (L.-E.T.). The funders had a specific role in study design (M.J.), data collection (M.J. and L.-E.T.) and analysis (M.J.), decision to publish (M.J.), and preparation of the manuscript (M.J. and L.-E.T).	BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bergareche A, 2004, J NEUROL, V251, P340, DOI 10.1007/s00415-004-0333-3; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cloutier M, 2012, IET SYST BIOL, V6, P65, DOI 10.1049/iet-syb.2011.0075; Cloutier M, 2012, IET SYST BIOL, V6, P86, DOI 10.1049/iet-syb.2011.0076; Cloutier M, 2009, J COMPUTATIONAL NEUR, V24; Cloutier M, 2010, J R SOC INTERFACE, V7, P651, DOI 10.1098/rsif.2009.0371; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Faijes M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-27; Fermaglich J, 1996, JAMA-J AM MED ASSOC, V275, P407; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Haefner J. W., 1996, MODELING BIOL SYSTEM; Hammami I, 2012, BIOCHEM BIOPH RES CO, V425, P724, DOI 10.1016/j.bbrc.2012.07.139; Heinrich R., 1996, REGULATION CELLULAR; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Langston JW, 1995, CASE FORZEN ADDICTS; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Matsumine H, 1997, AM J HUM GENET, V60, P588; Miller GW, 2007, TOXICOL SCI, V100, P1, DOI 10.1093/toxsci/kfm223; NLoM NLoM, 2011, GEN HOM REF PP GEN H; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Qi Z, 2009, SYNAPSE, V63, P1133, DOI 10.1002/syn.20686; RINNE JO, 1989, ANN NEUROL, V26, P47, DOI 10.1002/ana.410260107; Ritter JB, 2008, ANAL BIOCHEM, V373, P349, DOI 10.1016/j.ab.2007.10.037; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sneppen K, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036005; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; Viartis, 2009, PARK DIS; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; von Bohlen und Halbach O, 2004, PROG NEUROBIOL, V73, P151, DOI 10.1016/j.pneurobio.2004.05.002; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wellstead P, 2010, WILEY INTERDISCIP RE, V3, P1	40	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69146	10.1371/journal.pone.0069146	http://dx.doi.org/10.1371/journal.pone.0069146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935941	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000325211000082
J	Yi, XL; Du, LP; Hou, SP; Li, FZ; Chen, YY; Kijlstra, A; Yang, PZ				Yi, Xianglong; Du, Liping; Hou, Shengping; Li, Fuzhen; Chen, Yuanyuan; Kijlstra, Aize; Yang, Peizeng			FGFR1OP tagSNP but Not CCR6 Polymorphisms Are Associated with Vogt-Koyanagi-Harada Syndrome in Chinese Han	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASE; UVEITIS; RECEPTOR	Background: Polymorphisms of the CC chemokine receptor 6 (CCR6) and FGFR10P tagSNP (locus close to CCR6) at 6q27 have recently been reported to be associated with the susceptibility to several immune-related diseases. This study was designed to determine the association of CCR6 and FGFR10P (tag) SNPs with Vogt-Koyanagi-Harada (VKH) syndrome, an autoimmune disease directed against melanocytes, in two independent Chinese Han populations. Methodology/Principal Findings: A total of 601 VKH patients and 725 healthy controls from two Chinese Han populations were genotyped by the polymerase chain reaction-restriction fragment length polymorphism method. Hardy-Weinberg equilibrium was tested using the chi(2) test. Genotype frequencies were estimated by direct counting. Allele and genotype frequencies were compared between patients and controls using the chi(2) test. The frequency of the A allele of rs2301436 was significantly higher both in Cohort 1 and Cohort 2 as compared with two separate controls (P = 0.044; P = 0.049, respectively). The significance was lost after Bonferroni correction in both cohorts (Pc = 0.516; Pc = 0.392, respectively). The frequency of the A allele was significantly higher in the combined patient group as compared with all controls before and after Bonferroni correction (P = 0.005, Pc = 0.025). The genotype and allele frequencies of rs3093024, rs6902119, rs3093023 and rs968334 were not different between patients with VKH and healthy controls based on analysis either for both cohorts or for the patients and controls in total. Analysis according to extra ocular clinical findings including headache, alopecia and poliosis, vitiligo and tinnitus did not show any association of the five polymorphisms with these parameters. Conclusion: These results suggest that the rs2301436 tagSNP of FGFR10P is positively associated with susceptibility to VKH syndrome in the tested Chinese Han populations. No association was found for the tested CCR6 SNPs.	[Yi, Xianglong; Du, Liping; Hou, Shengping; Li, Fuzhen; Chen, Yuanyuan; Yang, Peizeng] Chongqing Med Univ, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Affiliated Hosp 1, Chongqing, Peoples R China; [Yi, Xianglong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Urumqi, Xinjiang, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Xinjiang Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Chongqing Key Lab Ophthalmol, Chongqing Eye Inst, Affiliated Hosp 1, Chongqing, Peoples R China.	peizengycmu@126.com	Chen, Yuanyuan/GXG-2130-2022; Du, Liping/M-9495-2019		National Basic Research Program of China (973 Program) [2011CB510200]; Natural Science Foundation [81130019]; Natural Science Foundation (Chongqing Key Laboratory of Ophthalmology (CSTC)) [2008CA5003]; Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program; Ministry of Health; Basic Research program of Chongqing and District science fund project of natural science fund [81260150]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation (Chongqing Key Laboratory of Ophthalmology (CSTC)); Health Bureau of Chongqing; Fund for PAR-EU Scholars Program; Ministry of Health; Basic Research program of Chongqing and District science fund project of natural science fund	This work was supported by National Basic Research Program of China (973 Program) (2011CB510200), Key Project of Natural Science Foundation(81130019, Chongqing Key Laboratory of Ophthalmology (CSTC,2008CA5003), Key Project of Health Bureau of Chongqing (2012-1-003), Fund for PAR-EU Scholars Program, Clinic Key Project of Ministry of Health, Basic Research program of Chongqing and District science fund project of natural science fund (81260150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bykhovskaya I, 2005, AM J OPHTHALMOL, V140, P674, DOI 10.1016/j.ajo.2005.04.052; Du LP, 2009, OCUL IMMUNOL INFLAMM, V17, P249, DOI 10.1080/09273940902999356; Iqniebi A, 2009, MOL VIS, V15, P1876; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Levinson RD, 2008, HUM IMMUNOL, V69, P349, DOI 10.1016/j.humimm.2008.04.005; Norose K, 1996, BRIT J OPHTHALMOL, V80, P1002, DOI 10.1136/bjo.80.11.1002; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Read Russell W, 2002, Ophthalmol Clin North Am, V15, P333, DOI 10.1016/S0896-1549(02)00025-1; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Touitou V, 2005, AM J OPHTHALMOL, V140, P949, DOI 10.1016/j.ajo.2005.06.020; Yamaki K, 2000, J IMMUNOL, V165, P7323, DOI 10.4049/jimmunol.165.12.7323; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606; Zamecki KJ, 2010, AM J OPHTHALMOL, V149, P189, DOI 10.1016/j.ajo.2009.09.018	18	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69358	10.1371/journal.pone.0069358	http://dx.doi.org/10.1371/journal.pone.0069358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935994	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000108
J	Croft, QPP; Formenti, F; Talbot, NP; Lunn, D; Robbins, PA; Dorrington, KL				Croft, Quentin P. P.; Formenti, Federico; Talbot, Nick P.; Lunn, Daniel; Robbins, Peter A.; Dorrington, Keith L.			Variations in Alveolar Partial Pressure for Carbon Dioxide and Oxygen Have Additive Not Synergistic Acute Effects on Human Pulmonary Vasoconstriction	PLOS ONE			English	Article							GAS-MIXING SYSTEM; VASCULAR-RESPONSE; BLOOD-FLOW; HUMAN-LUNG; DOPPLER-ECHOCARDIOGRAPHY; STIMULUS INTERACTION; RESPIRATORY CONTROL; CAROTID-BODY; HYPERCAPNIA; HYPOXIA	The human pulmonary vasculature constricts in response to hypercapnia and hypoxia, with important consequences for homeostasis and adaptation. One function of these responses is to direct blood flow away from poorly-ventilated regions of the lung. In humans it is not known whether the stimuli of hypercapnia and hypoxia constrict the pulmonary blood vessels independently of each other or whether they act synergistically, such that the combination of hypercapnia and hypoxia is more effective than the sum of the responses to each stimulus on its own. We independently controlled the alveolar partial pressures of carbon dioxide (PA(CO2)) and oxygen (PA(O2)) to examine their possible interaction on human pulmonary vasoconstriction. Nine volunteers each experienced sixteen possible combinations of four levels of PA(CO2) (+6, +1, -4 and -9 mmHg, relative to baseline) with four levels of PA(O2) (175, 100, 75 and 50 mmHg). During each of these sixteen protocols Doppler echocardiography was used to evaluate cardiac output and systolic tricuspid pressure gradient, an index of pulmonary vasoconstriction. The degree of constriction varied linearly with both PA(CO2) and the calculated haemoglobin oxygen desaturation (1-S-O2). Mixed effects modelling delivered coefficients defining the interdependence of cardiac output, systolic tricuspid pressure gradient, ventilation, PA(CO2) and S-O2. No interaction was observed in the effects on pulmonary vasoconstriction of carbon dioxide and oxygen (p>0.64). Direct effects of the alveolar gases on systolic tricuspid pressure gradient greatly exceeded indirect effects arising from concurrent changes in cardiac output.	[Croft, Quentin P. P.; Formenti, Federico; Talbot, Nick P.; Robbins, Peter A.; Dorrington, Keith L.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Lunn, Daniel] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; University of Oxford	Dorrington, KL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	keith.dorrington@dpag.ox.ac.uk	Formenti, Federico/F-3501-2012; Robbins, Peter/C-7846-2016	Formenti, Federico/0000-0003-4289-0761; Talbot, Nick/0000-0002-9186-8950; Robbins, Peter/0000-0002-4975-0609	Dunhill Medical Trust; The Dunhill Medical Trust [R178/1110] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); The Dunhill Medical Trust(Dunhill Medical Trust)	This work was funded by the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanos GM, 2005, PFLUG ARCH EUR J PHY, V450, P372, DOI 10.1007/s00424-005-1422-6; Balanos GM, 2003, J APPL PHYSIOL, V94, P1543, DOI 10.1152/japplphysiol.00890.2002; BARER GR, 1970, J PHYSIOL-LONDON, V211, P139, DOI 10.1113/jphysiol.1970.sp009271; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; BENUMOF JL, 1975, J APPL PHYSIOL, V38, P846, DOI 10.1152/jappl.1975.38.5.846; BINDSLEV L, 1985, ACTA ANAESTH SCAND, V29, P547, DOI 10.1111/j.1399-6576.1985.tb02251.x; Brimioulle S, 1996, J APPL PHYSIOL, V81, P1535, DOI 10.1152/jappl.1996.81.4.1535; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CARLSSON AJ, 1985, ACTA ANAESTH SCAND, V29, P346, DOI 10.1111/j.1399-6576.1985.tb02212.x; Dehnert C, 2007, RESP PHYSIOL NEUROBI, V158, P266, DOI 10.1016/j.resp.2007.05.002; Dorrington KL, 2010, J APPL PHYSIOL, V108, P1084, DOI 10.1152/japplphysiol.90963.2008; Dorrington KL, 2004, PFLUG ARCH EUR J PHY, V449, P1, DOI 10.1007/s00424-004-1296-z; Euler Us V, 1946, ACTA PHYSL SCAND, V12, P301, DOI [10.1111/j.1748-1716.1946.tb00389.x, DOI 10.1111/J.1748-1716.1946.TB00389.X]; GRANT BJB, 1976, J APPL PHYSIOL, V40, P216, DOI 10.1152/jappl.1976.40.2.216; GROVES BM, 1987, J APPL PHYSIOL, V63, P521, DOI 10.1152/jappl.1987.63.2.521; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; Howell K, 2004, EXP PHYSIOL, V89, P66, DOI 10.1113/expphysiol.2003.026765; HOWSON MG, 1987, J PHYSIOL-LONDON, V394, pP7; Ketabchi F, 2009, AM J PHYSIOL-LUNG C, V297, pL977, DOI 10.1152/ajplung.00074.2009; Kiss L, 2000, AM J RESP CRIT CARE, V161, P1917, DOI 10.1164/ajrccm.161.6.9906058; Kovacs G, 2012, EUR RESPIR J, V39, P319, DOI 10.1183/09031936.00008611; LAHIRI S, 1975, RESP PHYSIOL, V24, P249, DOI 10.1016/0034-5687(75)90017-1; Liu C, 2007, J PHYSIOL-LONDON, V579, P215, DOI 10.1113/jphysiol.2006.118190; LLOYD B B, 1958, Q J Exp Physiol Cogn Med Sci, V43, P214; MARSHALL BE, 1994, INTENS CARE MED, V20, P379, DOI 10.1007/BF01720916; MARSHALL C, 1983, J APPL PHYSIOL, V55, P711, DOI 10.1152/jappl.1983.55.3.711; Milledge J.S., 2007, HIGH ALTITUDE MED PH, Vfourth; MORRELL NW, 1995, RESP PHYSIOL, V100, P271, DOI 10.1016/0034-5687(95)00002-U; MOTLEY HL, 1947, AM J PHYSIOL, V150, P315, DOI 10.1152/ajplegacy.1947.150.2.315; Naeije R, 2001, CRIT CARE, V5, P67, DOI 10.1186/cc989; NOBLE WH, 1981, CAN ANAESTH SOC J, V28, P422, DOI 10.1007/BF03010350; PEACOCK AJ, 1990, RESP MED, V84, P335, DOI 10.1016/S0954-6111(08)80063-7; Peers C, 2004, EXP PHYSIOL, V89, P60, DOI 10.1113/expphysiol.2003.002657; ROBBINS PA, 1982, J APPL PHYSIOL, V52, P1353, DOI 10.1152/jappl.1982.52.5.1353; ROBBINS PA, 1982, J APPL PHYSIOL, V52, P1358, DOI 10.1152/jappl.1982.52.5.1358; Roy A, 2000, RESP PHYSIOL, V122, P15, DOI 10.1016/S0034-5687(00)00116-X; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; SHEEHAN DW, 1993, RESP PHYSIOL, V94, P91, DOI 10.1016/0034-5687(93)90059-J; SHIRAI M, 1986, J APPL PHYSIOL, V61, P440, DOI 10.1152/jappl.1986.61.2.440; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Smith TG, 2008, J PHYSIOL-LONDON, V586, P5999, DOI 10.1113/jphysiol.2008.160960; Stevenson J G, 1989, J Am Soc Echocardiogr, V2, P157; Sylvester JT, 2005, PHYSIOL REV, V92, P367; Talbot NP, 2005, J APPL PHYSIOL, V98, P1125, DOI 10.1152/japplphysiol.00903.2004; VILES PH, 1968, AM J PHYSIOL, V215, P1170, DOI 10.1152/ajplegacy.1968.215.5.1170; VILES PH, 1968, CIRC RES, V22, P325, DOI 10.1161/01.RES.22.3.325; VISWANATHAN R, 1976, RESPIRATION, V33, P165, DOI 10.1159/000193731; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003; West JB, 1990, VENTILATION BLOOD FL, V5th	49	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e67886	10.1371/journal.pone.0067886	http://dx.doi.org/10.1371/journal.pone.0067886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935847	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700006
J	Hovi, T; Paananen, A; Blomqvist, S; Savolainen-Kopra, C; Al-Hello, H; Smura, T; Shimizu, H; Nadova, K; Sobotova, Z; Gavrilin, E; Roivainen, M				Hovi, Tapani; Paananen, Anja; Blomqvist, Soile; Savolainen-Kopra, Carita; Al-Hello, Haider; Smura, Teemu; Shimizu, Hiroyuki; Nadova, Katarina; Sobotova, Zdenka; Gavrilin, Eugene; Roivainen, Merja			Characteristics of an Environmentally Monitored Prolonged Type 2 Vaccine Derived Poliovirus Shedding Episode that Stopped without Intervention	PLOS ONE			English	Article							UNITED-STATES; SEWAGE; POLIOMYELITIS; VIRUS; OUTBREAK; IDENTIFICATION; EVOLUTION; SEARCH; STRAIN; WATERS	Vaccine derived poliovirus (VDPV) type 2 strains strongly divergent from the corresponding vaccine strain, Sabin 2, were repeatedly isolated from sewage in Slovakia over a period of 22 months in 2003-2005. Cell cultures of stool specimens from known immune deficient patients and from an identified putative source population of 500 people failed to identify the potential excretor(s) of the virus. The occurrence of VDPV in sewage stopped without any intervention. No paralytic cases were reported in Slovakia during the episode. According to a GenBank search and similarity plotting-analysis, the closest known relative of the first isolate PV2/03/SVK/E783 through all main sections of the genome was the type 2 poliovirus Sabin strain, with nucleotide identities in 5UTR, P1, P2, P3, and 3'UTR parts of the genome of 88.6, 85.9, 87.3, 88.5, and 94.0 percent, respectively. Phenotypic properties of selected Slovakian aVDPV strains resembled those of VDPV strains isolated from immune deficient individuals with prolonged PV infection (iVDPV), including antigenic changes and moderate neurovirulence in the transgenic mouse model. One hundred and two unique VP1 coding sequences were determined from VDPV strains isolated from 34 sewage specimens. Nucleotide differences from Sabin 2 in the VP1 coding region ranged from 12.5 to 15.6 percent, and reached a maximum of 9.6 percent between the VDPV strains under study. Most of the nucleotide substitutions were synonymous but as many as 93 amino acid positions out of 301 in VP1 showed substitutions. We conclude that (1) individuals with prolonged poliovirus infection are not as rare as suggested by the studies on immune deficient patients known to the health care systems and (2) genetic divergence of VDPV strains may remain extensive during years long replication in humans.	[Hovi, Tapani; Paananen, Anja; Blomqvist, Soile; Savolainen-Kopra, Carita; Al-Hello, Haider; Smura, Teemu; Roivainen, Merja] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Virol Unit, Helsinki, Finland; [Shimizu, Hiroyuki] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Nadova, Katarina] Municipal Skal, Ctr Hlth, Skalica, Slovakia; [Sobotova, Zdenka] Author Publ Hlth Slovak Republ, Natl Reference Ctr Poliomyelitis, Bratislava, Slovakia; [Gavrilin, Eugene] WHO, Reg Off Europe, Div Communicable Dis Hlth Secur & Environm, DK-2100 Copenhagen, Denmark	Finland National Institute for Health & Welfare; National Institute of Infectious Diseases (NIID); World Health Organization	Hovi, T (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Virol Unit, Helsinki, Finland.	tapani.hovi@thl.fi	Hovi, Tapani/AAJ-4828-2020; Smura, Teemu/K-6421-2012; Hovi, Tapani/AAG-9156-2020; Shimizu, Hiroyuki/AAU-9621-2020; Smura, Teemu P/C-4063-2016	Smura, Teemu/0000-0002-9187-3151; Shimizu, Hiroyuki/0000-0002-2987-2377; Al-Hello, Haider/0000-0001-8206-1226	WHO; Ministry of Health, Labour, and Welfare of Japan	WHO(World Health Organization); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The host institutes harbour memebers of the World Health Organization (WHO) Polio Laboratory Network and have received partial financial support from WHO. The host institute of HS received partial support as a Grant-in-Aid for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cernakova B, 2005, EUR J CLIN MICROBIOL, V24, P438, DOI 10.1007/s10096-005-1331-9; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; Hovi T, 2001, EPIDEMIOL INFECT, V127, P101, DOI 10.1017/S0950268801005787; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KINNUNEN L, 1991, J GEN VIROL, V72, P2483, DOI 10.1099/0022-1317-72-10-2483; Lentz KN, 1997, STRUCTURE, V5, P961, DOI 10.1016/S0969-2126(97)00249-9; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Martin J, 2006, BIOLOGICALS, V34, P117, DOI 10.1016/j.biologicals.2006.02.005; Martin J, 2000, J VIROL, V74, P3001, DOI 10.1128/JVI.74.7.3001-3010.2000; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; Odoom JK, 2008, J VIROL, V82, P9179, DOI 10.1128/JVI.00468-08; POYRY T, 1988, APPL ENVIRON MICROB, V54, P371; Roivainen M, 2010, EURO SURVEILL, V15; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Shulman LM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000069; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thibaut HJ, 2012, BIOCHEM PHARMACOL, V83, P185, DOI 10.1016/j.bcp.2011.08.016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; Vinje J, 2004, J INFECT DIS, V189, P1168, DOI 10.1086/382545; World Health Organization, 2003, GUID ENV SURV POL CI	32	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e66849	10.1371/journal.pone.0066849	http://dx.doi.org/10.1371/journal.pone.0066849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935826	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700003
J	Fox, M; McCarthy, O; Over, M				Fox, Matthew; McCarthy, Owen; Over, Mead			A Novel Approach to Accounting for Loss to Follow-Up when Estimating the Relationship between CD4 Count at ART Initiation and Mortality	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAMS; SUB-SAHARAN AFRICA; RAPID SCALE-UP; THERAPY; OUTCOMES; ADULTS; KHAYELITSHA; PREVENTION; EXPERIENCE; SETTINGS	Background: While CD4 strongly predicts mortality on antiretroviral therapy (ART), estimates from programmatic data suffer from incomplete patient outcomes. Methods: We conducted a pooled analysis of one-year mortality data on ART accounting for lost patients. We identified articles reporting one-year mortality by ART initiation CD4 count. We estimated the average mortality among those lost as the value that maximizes the fit of a regression of the natural log of mortality on the natural log of the imputed mean CD4 count in each band. Results: We found 20 studies representing 64,426 subjects and 51 CD4 observations. Without correcting for losses, one-year mortality was >4.8% for all CD4 counts <200 cells/mm(3). When searching over different values for mortality among those lost, the best fitting model occurs at 60% mortality. In this model, those with a CD4 <= 200 had a one-year mortality above 8.7, while those with a CD4>500 had a one-year mortality <6.8%. Comparing those starting ART at 500 vs. 50, one-year mortality risk was reduced by 54% (6.8 vs. 12.5%). Regardless of CD4 count, mortality was substantially higher than when assuming no mortality among those lost, ranging from a 23-94% increase. Conclusions: Our best fitting regression estimates that every 10% increase in CD4 count at initiation is associated with a 2.8% decline in one-year mortality, including those lost. Our study supports the health benefits of higher thresholds for CD4 count initiation and suggests that reports of programmatic ART outcomes can and should adjust results for mortality among those lost.	[Fox, Matthew] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Fox, Matthew] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Hlth Econ & Epidemiol Res Off, ZA-2001 Johannesburg, South Africa; [McCarthy, Owen; Over, Mead] Ctr Global Dev, Washington, DC USA	Boston University; Boston University; University of Witwatersrand	Fox, M (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	mfox@bu.edu	Fox, Matthew/K-2004-2019	Fox, Matthew/0000-0001-9887-0634	National Institute of Allergy and Infectious Diseases [K01AI083097]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases (Matthew Fox). The opinions expressed herein are those of the authors and do not necessarily reflect the views of the National Institutes of Health or NIAID. Mead Over and Owen McCarthy were financed by the Bill & Melinda Gates Foundation, through its support for the book, Achieving an AIDS Transition: Preventing Infections to Sustain Treatment, Washington: Center for Global Development, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Egger M, 2007, 14 C RETR OPP INF LO; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HLTH; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Nattrass N, 2006, DEV POLICY REV, V24, P321, DOI 10.1111/j.1467-7679.2006.00327.x; Over M, 2009, REV EC DEV, V23, P37; Over M, 2008, WHITE HOUSE WORLD GL; Over M, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000279713.39675.1c; Over M, 2006, SEX TRANSM DIS, V33, pS145, DOI 10.1097/01.olq.0000238457.93426.0d; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin D, 1972, J ROYAL STAT SOC C, V21, P6; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2007, FIN RES REQ ACH UN A; WHO, 2010, ANT THER HIV INF AD; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	37	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69300	10.1371/journal.pone.0069300	http://dx.doi.org/10.1371/journal.pone.0069300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935977	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200032
J	Rogers, AC; Huetter, L; Hoekstra, N; Collins, D; Collaco, A; Baird, AW; Winter, DC; Ameen, N; Geibel, JP; Kopic, S				Rogers, Ailin C.; Huetter, Lisa; Hoekstra, Nadia; Collins, Danielle; Collaco, Anne; Baird, Alan W.; Winter, Desmond C.; Ameen, Nadia; Geibel, John P.; Kopic, Sascha			Activation of AMPK Inhibits Cholera Toxin Stimulated Chloride Secretion in Human and Murine Intestine	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-KINASE; FLUID SECRETION; CFTR INHIBITOR; COLONIC CRYPTS; ION-TRANSPORT; EXCHANGE; CHANNEL; SODIUM; SENSOR	Increased intestinal chloride secretion through chloride channels, such as the cystic fibrosis transmembrane conductance regulator (CFTR), is one of the major molecular mechanisms underlying enterotoxigenic diarrhea. It has been demonstrated in the past that the intracellular energy sensing kinase, the AMP-activated protein kinase (AMPK), can inhibit CFTR opening. We hypothesized that pharmacological activation of AMPK can abrogate the increased chloride flux through CFTR occurring during cholera toxin (CTX) mediated diarrhea. Chloride efflux was measured in isolated rat colonic crypts using real-time fluorescence imaging. AICAR and metformin were used to activate AMPK in the presence of the secretagogues CTX or forskolin (FSK). In order to substantiate our findings on the whole tissue level, short-circuit current (SCC) was monitored in human and murine colonic mucosa using Ussing chambers. Furthermore, fluid accumulation was measured in excised intestinal loops. CTX and forskolin (FSK) significantly increased chloride efflux in isolated colonic crypts. The increase in chloride efflux could be offset by using the AMPK activators AICAR and metformin. In human and mouse mucosal sheets, CTX and FSK increased SCC. AICAR and metformin inhibited the secretagogue induced rise in SCC, thereby confirming the findings made in isolated crypts. Moreover, AICAR decreased CTX stimulated fluid accumulation in excised intestinal segments. The present study suggests that pharmacological activation of AMPK effectively reduces CTX mediated increases in intestinal chloride secretion, which is a key factor for intestinal water accumulation. AMPK activators may therefore represent a supplemental treatment strategy for acute diarrheal illness.	[Rogers, Ailin C.; Collins, Danielle; Baird, Alan W.; Winter, Desmond C.] Univ Coll Dublin, Dublin 2, Ireland; [Rogers, Ailin C.; Collins, Danielle; Baird, Alan W.; Winter, Desmond C.] St Vincents Univ Hosp, Dublin 4, Ireland; [Huetter, Lisa] Paracelsus Med Univ, Inst Physiol & Pathophysiol, Salzburg, Austria; [Huetter, Lisa; Geibel, John P.; Kopic, Sascha] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Hoekstra, Nadia; Collaco, Anne; Ameen, Nadia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Ameen, Nadia; Geibel, John P.; Kopic, Sascha] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	University College Dublin; University College Dublin; Saint Vincent's University Hospital; Paracelsus Private Medical University; Yale University; Yale University; Yale University	Kopic, S (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA.	sascha.kopic@gmail.com	collins, danielle/AAF-1291-2021	Rogers, Ailin/0000-0001-6215-5487; Baird, Alan/0000-0002-3926-9838	Charles W. Ohse grant for surgical research (Yale University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007017, R01DK077065] Funding Source: NIH RePORTER	Charles W. Ohse grant for surgical research (Yale University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Charles W. Ohse grant for surgical research (Yale University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Collins D, 2011, ANN SURG, V254, P957, DOI 10.1097/SLA.0b013e31821d477f; Cuthbert AW, 1999, BRIT J PHARMACOL, V126, P358, DOI 10.1038/sj.bjp.0702290; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; King JD, 2009, AM J PHYSIOL-CELL PH, V297, pC94, DOI 10.1152/ajpcell.00677.2008; King JD, 2012, J BIOL CHEM; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kongsuphol P, 2009, PFLUG ARCH EUR J PHY, V457, P1071, DOI 10.1007/s00424-008-0577-3; Kopic S, 2010, TOXINS, V2, P2132, DOI 10.3390/toxins2082132; Kopic S, 2010, CELL PHYSIOL BIOCHEM, V25, P195, DOI 10.1159/000276553; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; Rotte A, 2010, BIOCHEM BIOPH RES CO, V398, P677, DOI 10.1016/j.bbrc.2010.06.135; Sidani S, 2009, PFLUG ARCH EUR J PHY, V459, P39, DOI 10.1007/s00424-009-0698-3; SINGH SK, 1995, J CLIN INVEST, V96, P2373, DOI 10.1172/JCI118294; Siwiak M, 2012, J MOL MODEL, V18, P83, DOI 10.1007/s00894-011-1029-0; Subramanya SB, 2007, AM J PHYSIOL-GASTR L, V293, pG857, DOI 10.1152/ajpgi.00462.2006; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Walker J, 2003, AM J PHYSIOL-GASTR L, V285, pG850, DOI 10.1152/ajpgi.00077.2003; Winter DC, 1999, J MEMBRANE BIOL, V170, P17	28	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69050	10.1371/journal.pone.0069050	http://dx.doi.org/10.1371/journal.pone.0069050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935921	Green Submitted, gold, Green Published			2022-12-27	WOS:000323114200019
J	Bergerot, A; Rigby, M; Bouvier, G; Marcaggi, P				Bergerot, Astrid; Rigby, Mark; Bouvier, Guy; Marcaggi, Paikan			Persistent Posttetanic Depression at Cerebellar Parallel Fiber to Purkinje Cell Synapses	PLOS ONE			English	Article							LONG-TERM DEPRESSION; PROTEIN-KINASE-C; SYNAPTIC-TRANSMISSION; GRANULE CELL; NITRIC-OXIDE; TRANSMITTER RELEASE; PHORBOL ESTERS; POTENTIATION; PLASTICITY; DIACYLGLYCEROL	Plasticity at the cerebellar parallel fiber to Purkinje cell synapse may underlie information processing and motor learning. In vivo, parallel fibers appear to fire in short high frequency bursts likely to activate sparsely distributed synapses over the Purkinje cell dendritic tree. Here, we report that short parallel fiber tetanic stimulation evokes a similar to 7-15% depression which develops over 2 min and lasts for at least 20 min. In contrast to the concomitantly evoked short-term endocannabinoid-mediated depression, this persistent posttetanic depression (PTD) does not exhibit a dependency on the spatial pattern of synapse activation and is not caused by any detectable change in presynaptic calcium signaling. This persistent PTD is however associated with increased paired-pulse facilitation and coefficient of variation of synaptic responses, suggesting that its expression is presynaptic. The chelation of postsynaptic calcium prevents its induction, suggesting that post-to presynaptic (retrograde) signaling is required. We rule out endocannabinoid signaling since the inhibition of type 1 cannabinoid receptors, monoacylglycerol lipase or vanilloid receptor 1, or incubation with anandamide had no detectable effect. The persistent PTD is maximal in pre-adolescent mice, abolished by adrenergic and dopaminergic receptors block, but unaffected by adrenergic and dopaminergic agonists. Our data unveils a novel form of plasticity at parallel fiber synapses: a persistent PTD induced by physiologically relevant input patterns, age-dependent, and strongly modulated by the monoaminergic system. We further provide evidence supporting that the plasticity mechanism involves retrograde signaling and presynaptic diacylglycerol.	[Bergerot, Astrid; Rigby, Mark; Marcaggi, Paikan] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Bouvier, Guy; Marcaggi, Paikan] Ecole Normale Super, Inst Biol, F-75231 Paris, France; [Bouvier, Guy; Marcaggi, Paikan] INSERM, U1024, Paris, France; [Bouvier, Guy; Marcaggi, Paikan] CNRS, UMR8197, Paris, France	University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Marcaggi, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	marcaggi@biologie.ens.fr	Marcaggi, Païkan/GYU-1658-2022; Marcaggi, Païkan/P-5855-2016	Marcaggi, Païkan/0000-0003-3575-8340; Bouvier, Guy/0000-0002-6160-7186	United Kingdom Medical Research Council [G0600064]; Wellcome Trust; Region Ile de France; Medical Research Council [G0600064] Funding Source: researchfish; MRC [G0600064] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Region Ile de France(Region Ile-de-France); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Career Development Award G0600064 from the United Kingdom Medical Research Council to PM, a Wellcome Trust studentship to MR, and a studentship from the Region Ile de France to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol K, 2012, J PHYSIOL-LONDON, V590, P2977, DOI 10.1113/jphysiol.2012.232074; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Atterbury A, 2009, J PHYSIOL-LONDON, V587, P4497, DOI 10.1113/jphysiol.2009.176420; Barili P, 2000, BRAIN RES, V854, P130, DOI 10.1016/S0006-8993(99)02306-9; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Crepel F, 2007, J NEUROPHYSIOL, V97, P824, DOI 10.1152/jn.00735.2006; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; Doering CJ, 2004, J BIOL CHEM, V279, P29709, DOI 10.1074/jbc.M308693200; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Fioravante D, 2012, J NEUROSCI, V32, P13004, DOI 10.1523/JNEUROSCI.0683-12.2012; Foster KA, 2005, J NEUROSCI, V25, P11655, DOI 10.1523/JNEUROSCI.4029-05.2005; FREEDMAN R, 1976, BRIT J PHARMACOL, V57, P603, DOI 10.1111/j.1476-5381.1976.tb10391.x; Furutani K, 2006, P NATL ACAD SCI USA, V103, P8528, DOI 10.1073/pnas.0600497103; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Goto JI, 2006, NEUROSCI RES, V55, P28, DOI 10.1016/j.neures.2006.01.001; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; KIMOTO Y, 1981, NEUROSCIENCE, V6, P47, DOI 10.1016/0306-4522(81)90242-6; Kreitzer FR, 2009, PHARMACOL THERAPEUT, V122, P83, DOI 10.1016/j.pharmthera.2009.01.005; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Neale SA, 2001, EUR J NEUROSCI, V14, P1313, DOI 10.1046/j.0953-816x.2001.01769.x; Qiu DL, 2009, PFLUG ARCH EUR J PHY, V457, P865, DOI 10.1007/s00424-008-0555-9; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Shin JH, 2005, J NEUROPHYSIOL, V94, P4281, DOI 10.1152/jn.00661.2005; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	66	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70277	10.1371/journal.pone.0070277	http://dx.doi.org/10.1371/journal.pone.0070277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922966	Green Published, gold			2022-12-27	WOS:000323369700162
J	Fourmann, JB; Tillault, AS; Blaud, M; Leclerc, F; Branlant, C; Charpentier, B				Fourmann, Jean-Baptiste; Tillault, Anne-Sophie; Blaud, Magali; Leclerc, Fabrice; Branlant, Christiane; Charpentier, Bruno			Comparative Study of Two Box H/ACA Ribonucleoprotein Pseudouridine-Synthases: Relation between Conformational Dynamics of the Guide RNA, Enzyme Assembly and Activity	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; CRYSTAL-STRUCTURE; SUBSTRATE RNA; CONSERVED PSEUDOURIDINE; PROTEIN L7AE; SOLUBLE-RNA; SITE; BINDING; COMPLEX; RECONSTITUTION	Multiple RNA-guided pseudouridine synthases, H/ACA ribonucleoprotein particles (RNPs) which contain a guide RNA and four proteins, catalyze site-specific post-transcriptional isomerization of uridines into pseudouridines in substrate RNAs. In archaeal particles, the guide small RNA (sRNA) is anchored by the pseudouridine synthase aCBF5 and the ribosomal protein L7Ae. Protein aNOP10 interacts with both aCBF5 and L7Ae. The fourth protein, aGAR1, interacts with aCBF5 and enhances catalytic efficiency. Here, we compared the features of two H/ACA sRNAs, Pab21 and Pab91, from Pyrococcus abyssi. We found that aCBF5 binds much more weakly to Pab91 than to Pab21. Surprisingly, the Pab91 sRNP exhibits a higher catalytic efficiency than the Pab21 sRNP. We thus investigated the molecular basis of the differential efficiencies observed for the assembly and catalytic activity of the two enzymes. For this, we compared profiles of the extent of lead-induced cleavages in these sRNAs during a stepwise reconstitution of the sRNPs, and analyzed the impact of the absence of the aNOP10-L7Ae interaction. Such probing experiments indicated that the sRNAs undergo a series of conformational changes upon RNP assembly. These changes were also evaluated directly by circular dichroism (CD) spectroscopy, a tool highly adapted to analyzing RNA conformational dynamics. In addition, our results reveal that the conformation of helix P1 formed at the base of the H/ACA sRNAs is optimized in Pab21 for efficient aCBF5 binding and RNP assembly. Moreover, P1 swapping improved the assembly of the Pab91 sRNP. Nonetheless, efficient aCBF5 binding probably also relies on the pseudouridylation pocket which is not optimized for high activity in the case of Pab21.	[Fourmann, Jean-Baptiste; Tillault, Anne-Sophie; Blaud, Magali; Leclerc, Fabrice; Branlant, Christiane; Charpentier, Bruno] Univ Lorraine, Lab Ingn Mol & Physiopathol Articulaire IMoPA, Unite Mixte Rech Ctr Natl Rech Sci, Biopole, Vandoeuvre Les Nancy, France	Universite de Lorraine	Charpentier, B (corresponding author), Univ Lorraine, Lab Ingn Mol & Physiopathol Articulaire IMoPA, Unite Mixte Rech Ctr Natl Rech Sci, Biopole, Vandoeuvre Les Nancy, France.	bruno.charpentier@univ-lorraine.fr	Leclerc, Fabrice/A-5891-2011	Leclerc, Fabrice/0000-0002-5641-1525; Branlant, Christiane/0000-0003-4728-5499; CHARPENTIER, Bruno/0000-0003-2955-2987; Blaud, Magali/0000-0001-8425-9754; Tillault, Anne-Sophie/0000-0001-8000-1828	Agence Nationale de la Recherche [ANR-08-BLAN-0036-01]; French Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique; Pole de Recherche Scientifique et Technologique "Bioingenierie" of the Lorraine region	Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministere de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Pole de Recherche Scientifique et Technologique "Bioingenierie" of the Lorraine region(Region Grand-Est)	This work was supported by the Agence Nationale de la Recherche [ANR-08-BLAN-0036-01], the French Ministere de l'Enseignement Superieur et de la Recherche [doctoral fellowships to J.-B.F. and A.-S.T.], the Centre National de la Recherche Scientifique, and the Pole de Recherche Scientifique et Technologique "Bioingenierie" of the Lorraine region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Badis G, 2003, RNA, V9, P771, DOI 10.1261/rna.5240503; Baker DL, 2008, BIOCHEMISTRY-US, V47, P1500, DOI 10.1021/bi701606m; Baker DL, 2005, GENE DEV, V19, P1238, DOI 10.1101/gad.1309605; Bortolin ML, 1999, EMBO J, V18, P457, DOI 10.1093/emboj/18.2.457; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; Charpentier B, 2007, METHOD ENZYMOL, V425, P389, DOI 10.1016/S0076-6879(07)25016-5; Charron C, 2004, J MOL BIOL, V342, P757, DOI 10.1016/j.jmb.2004.07.046; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Duan JQ, 2009, MOL CELL, V34, P427, DOI 10.1016/j.molcel.2009.05.005; Ejby M, 2007, P NATL ACAD SCI USA, V104, P19410, DOI 10.1073/pnas.0706558104; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Hamma T, 2004, STRUCTURE, V12, P893, DOI 10.1016/S0969-2126(04)00096-6; Hamma T, 2005, NAT STRUCT MOL BIOL, V12, P1101, DOI 10.1038/nsmb1036; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Kaya Y, 2003, RNA, V9, P711, DOI 10.1261/rna.5230603; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koo BK, 2011, J MOL BIOL, V411, P927, DOI 10.1016/j.jmb.2011.06.022; Koonin EV, 1996, METHOD ENZYMOL, V266, P295; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Li S, 2011, GENE DEV, V25, P2409, DOI 10.1101/gad.175299.111; Liang B, 2008, RNA, V14, P2086, DOI 10.1261/rna.1109808; Liang B, 2007, NAT STRUCT MOL BIOL, V14, P1189, DOI 10.1038/nsmb1336; Liang B, 2009, NAT STRUCT MOL BIOL, V16, P740, DOI 10.1038/nsmb.1624; Lindell M, 2002, RNA, V8, P534, DOI 10.1017/S1355838201020416; Loomis C AM, 2012, STRATUSLAB CLOUD DIS; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MAJOR F, 1991, SCIENCE, V253, P1255, DOI 10.1126/science.1716375; Manival X, 2006, NUCLEIC ACIDS RES, V34, P826, DOI 10.1093/nar/gkj482; Marmier-Gourrier N, 2003, RNA, V9, P821, DOI 10.1261/rna.2130503; Miller BT, 2008, J CHEM INF MODEL, V48, P1920, DOI 10.1021/ci800133b; Muller S, 2008, NUCLEIC ACIDS RES, V36, P2459, DOI 10.1093/nar/gkn077; Muller S, 2007, NUCLEIC ACIDS RES, V35, P5610, DOI 10.1093/nar/gkm606; Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Omer AD, 2003, MOL MICROBIOL, V48, P617, DOI 10.1046/j.1365-2958.2003.03483.x; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Reddy SY, 2003, BIOPHYS J, V84, P1421, DOI 10.1016/S0006-3495(03)74957-1; Reichow SL, 2008, BIOCHEMISTRY-US, V47, P6148, DOI 10.1021/bi800418p; Roovers M, 2006, NUCLEIC ACIDS RES, V34, P4293, DOI 10.1093/nar/gkl530; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Watanabe Y, 2000, NUCLEIC ACIDS RES, V28, P2342, DOI 10.1093/nar/28.12.2342; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yang CX, 2005, J BIOL CHEM, V280, P6655, DOI 10.1074/jbc.M413288200; Yang XX, 2012, NUCLEIC ACIDS RES, V40, P10925, DOI 10.1093/nar/gks882; Youssef OA, 2007, NUCLEIC ACIDS RES, V35, P6196, DOI 10.1093/nar/gkm673; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zhou J, 2010, BIOCHEMISTRY-US, V49, P6276, DOI 10.1021/bi1006699	58	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70313	10.1371/journal.pone.0070313	http://dx.doi.org/10.1371/journal.pone.0070313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922977	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700172
J	Priglinger, CS; Szober, CM; Priglinger, SG; Merl, J; Euler, KN; Kernt, M; Gondi, G; Behler, J; Geerlof, A; Kampik, A; Ueffing, M; Hauck, SM				Priglinger, Claudia S.; Szober, Christoph M.; Priglinger, Siegfried G.; Merl, Juliane; Euler, Kerstin N.; Kernt, Marcus; Gondi, Gabor; Behler, Jennifer; Geerlof, Arie; Kampik, Anselm; Ueffing, Marius; Hauck, Stefanie M.			Galectin-3 Induces Clustering of CD147 and Integrin-beta 1 Transmembrane Glycoprotein Receptors on the RPE Cell Surface	PLOS ONE			English	Article							COLLAGENASE-STIMULATORY FACTOR; RETINAL-PIGMENT EPITHELIUM; MATRIX METALLOPROTEINASE INDUCER; FIBROBLAST-GROWTH-FACTOR; IMMUNOGLOBULIN SUPERFAMILY; PROLIFERATIVE VITREORETINOPATHY; TUMOR PROGRESSION; NEURAL RETINA; UP-REGULATION; LABEL-FREE	Proliferative vitreoretinopathy (PVR) is a blinding disease frequently occurring after retinal detachment surgery. Adhesion, migration and matrix remodeling of dedifferentiated retinal pigment epithelial (RPE) cells characterize the onset of the disease. Treatment options are still restrained and identification of factors responsible for the abnormal behavior of the RPE cells will facilitate the development of novel therapeutics. Galectin-3, a carbohydrate-binding protein, was previously found to inhibit attachment and spreading of retinal pigment epithelial cells, and thus bares the potential to counteract PVR-associated cellular events. However, the identities of the corresponding cell surface glycoprotein receptor proteins on RPE cells are not known. Here we characterize RPE-specific Gal-3 containing glycoprotein complexes using a proteomic approach. Integrin-beta 1, integrin-alpha 3 and CD147/EMMPRIN, a transmembrane glycoprotein implicated in regulating matrix metalloproteinase induction, were identified as potential Gal-3 interactors on RPE cell surfaces. In reciprocal immunoprecipitation experiments we confirmed that Gal-3 associated with CD147 and integrin-beta 1, but not with integrin-alpha 3. Additionally, association of Gal-3 with CD147 and integrin-beta 1 was observed in co-localization analyses, while integrin-alpha 3 only partially co-localized with Gal-3. Blocking of CD147 and integrin-beta 1 on RPE cell surfaces inhibited binding of Gal-3, whereas blocking of integrin-alpha 3 failed to do so, suggesting that integrin-alpha 3 is rather an indirect interactor. Importantly, Gal-3 binding promoted pronounced clustering and co-localization of CD147 and integrin-beta 1, with only partial association of integrin-alpha 3. Finally, we show that RPE derived CD147 and integrin-beta 1, but not integrin-alpha 3, carry predominantly beta-1,6-N-actyl-D-glucosamine-branched glycans, which are high-affinity ligands for Gal-3. We conclude from these data that extracellular Gal-3 triggers clustering of CD147 and integrin-beta 1 via interaction with beta 1,6-branched N-glycans on RPE cells and hypothesize that Gal-3 acts as a positive regulator for CD147/integrin-beta 1 clustering and therefore modifies RPE cell behavior contributing to the pathogenesis of PVR. Further investigations at this pathway may aid in the development of specific therapies for PVR.	[Priglinger, Claudia S.; Szober, Christoph M.; Euler, Kerstin N.; Kernt, Marcus; Kampik, Anselm] Univ Munich, Dept Ophthalmol, Munich, Germany; [Priglinger, Claudia S.; Priglinger, Siegfried G.] Allgemeines Krankenhaus Stadt Linz, Dept Ophthalmol, Linz, Austria; [Merl, Juliane; Behler, Jennifer; Ueffing, Marius; Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Unit Prot Sci, Neuherberg, Germany; [Gondi, Gabor] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Unit Gene Vectors, Neuherberg, Germany; [Geerlof, Arie] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Prot Express & Purificat Facil, Inst Biol Struct, Neuherberg, Germany; [Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany	University of Munich; Kepler University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Priglinger, CS (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	claudia.alge-priglinger@med.uni-muenchen.de	Merl-Pham, Juliane/N-7258-2014; Hauck, Stefanie/B-3300-2013	Merl-Pham, Juliane/0000-0002-3422-4083; Hauck, Stefanie/0000-0002-1630-6827	Deutsche Forschungsgemeinschaft (DFG) [PR 1248-2/1]; scientific association of ophthalmology in Germany (Deutsche ophthalmologische Gesellschaft, DOG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); scientific association of ophthalmology in Germany (Deutsche ophthalmologische Gesellschaft, DOG)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Research Grant PR 1248-2/1 (C. P.) and the Research Grant of the scientific association of ophthalmology in Germany (Deutsche ophthalmologische Gesellschaft, DOG) 2007 (C. P.). The funders had no role in study design, data collection and Analysis, decission to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Alge CS, 2003, INVEST OPHTH VIS SCI, V44, P3629, DOI 10.1167/iovs.02-1225; Alge-Priglinger CS, 2011, BIOCHIMIE, V93, P477, DOI 10.1016/j.biochi.2010.10.021; Alge-Priglinger CS, 2009, MOL VIS, V15, P2162; ALTRUDA F, 1989, GENE, V85, P445, DOI 10.1016/0378-1119(89)90438-1; ANDERSON DH, 1990, INVEST OPHTH VIS SCI, V31, P81; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; BISWAS C, 1995, CANCER RES, V55, P434; Bougatef F, 2009, BLOOD, V114, P5547, DOI 10.1182/blood-2009-04-217380; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; CAMPOCHIARO PA, 1993, EXP EYE RES, V57, P539, DOI 10.1006/exer.1993.1158; Casar B, 2012, ONCOGENE; Cassidy L, 1998, BRIT J OPHTHALMOL, V82, P181, DOI 10.1136/bjo.82.2.181; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Chiampanichayakul S, 2006, IMMUNOBIOLOGY, V211, P167, DOI 10.1016/j.imbio.2005.08.007; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Diskin S, 2009, GLYCOBIOLOGY, V19, P29, DOI 10.1093/glycob/cwn100; ELLIS SM, 1989, CANCER RES, V49, P3385; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FADOOL JM, 1993, DEV DYNAM, V196, P252, DOI 10.1002/aja.1001960406; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; GRIERSON I, 1994, EYE, V8, P255, DOI 10.1038/eye.1994.54; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Gu JG, 2012, GLYCOCONJUGATE J, V29, P599, DOI 10.1007/s10719-012-9386-1; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; Hittelet A, 2003, INT J CANCER, V103, P370, DOI 10.1002/ijc.10843; Iacobini C, 2003, J AM SOC NEPHROL, V14, pS264, DOI 10.1097/01.ASN.0000077402.95720.B4; Inohara H, 2008, BIOCHEM BIOPH RES CO, V376, P605, DOI 10.1016/j.bbrc.2008.09.041; KASINRERK W, 1992, J IMMUNOL, V149, P847; KATAOKA H, 1993, CANCER RES, V53, P3154; Kato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046576; Kim HRC, 1999, CANCER RES, V59, P4148; Kim JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/821940; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kon CH, 1999, INVEST OPHTH VIS SCI, V40, P705; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; LAING JG, 1988, BIOCHEMISTRY-US, V27, P5329, DOI 10.1021/bi00414a057; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Miki T, 2010, MOL CANCER RES, V8, P665, DOI 10.1158/1541-7786.MCR-09-0351; Mitamura Y, 2000, AM J OPHTHALMOL, V129, P678, DOI 10.1016/S0002-9394(00)00360-3; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; MIYAUCHI T, 1990, J BIOCHEM-TOKYO, V107, P316, DOI 10.1093/oxfordjournals.jbchem.a123045; Miyoshi E, 2012, BMB REP, V45, P554, DOI 10.5483/BMBRep.2012.45.10.190; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; MURAOKA K, 1993, INT J CANCER, V55, P19, DOI 10.1002/ijc.2910550105; NEHME CL, 1993, J CELL BIOL, V120, P687, DOI 10.1083/jcb.120.3.687; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3475; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Saussez S, 2008, LARYNGOSCOPE, V118, P1583, DOI 10.1097/MLG.0b013e31817b0718; SCHLOSSHAUER B, 1995, EUR J CELL BIOL, V68, P159; SEULBERGER H, 1990, EMBO J, V9, P2151, DOI 10.1002/j.1460-2075.1990.tb07384.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szober CM, 2012, INT J MOL SCI, V13, P14053, DOI 10.3390/ijms131114053; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Tomita T, 2002, ARTHRITIS RHEUM, V46, P373, DOI 10.1002/art.10050; VandenBrule FA, 1996, HUM PATHOL, V27, P1185, DOI 10.1016/S0046-8177(96)90313-5; WELLER M, 1991, EXP EYE RES, V53, P275, DOI 10.1016/0014-4835(91)90084-R; Yoshida S, 2000, EUR J BIOCHEM, V267, P4372, DOI 10.1046/j.1432-1327.2000.01482.x; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x	76	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70011	10.1371/journal.pone.0070011	http://dx.doi.org/10.1371/journal.pone.0070011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922889	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700117
J	Terasaki, H; Kase, S; Shirasawa, M; Otsuka, H; Hisatomi, T; Sonoda, S; Ishida, S; Ishibashi, T; Sakamoto, T				Terasaki, Hiroto; Kase, Satoru; Shirasawa, Makoto; Otsuka, Hiroki; Hisatomi, Toshio; Sonoda, Shozo; Ishida, Susumu; Ishibashi, Tatsuro; Sakamoto, Taiji			TNF-alpha Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-kappa B Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; CHOROIDAL NEOVASCULAR MEMBRANES; ACTIVATED PROTEIN-KINASES; MACULAR DEGENERATION; OXIDATIVE-STRESS; EXPRESSION; INHIBITION; CHORIOCAPILLARIS; MACROPHAGES	Asymmetrical secretion of vascular endothelial growth factor (VEGF) by retinal pigment epithelial (RPE) cells in situ is critical for maintaining the homeostasis of the retina and choroid. VEGF is also involved in the development and progression of age-related macular degeneration (AMD). We studied the effect of tumor necrosis factor-alpha (TNF-alpha) on the secretion of VEGF in polarized and non-polarized RPE cells (P-RPE cells and N-RPE cells, respectively) in culture and in situ in rats. A subretinal injection of TNF-alpha caused a decrease in VEGF expression and choroidal atrophy. Porcine RPE cells were seeded on Transwell (TM) filters, and their maturation and polarization were confirmed by the asymmetrical VEGF secretion and trans electrical resistance. Exposure to TNF-alpha decreased the VEGF secretion in P-RPE cells but increased it in N-RPE cells in culture. TNF-alpha inactivated JNK in P-RPE cells but activated it in N-RPE cells, and TNF-alpha activated NF-kappa B in P-RPE cells but not in N-RPE cells. Inhibition of NF-kappa B activated JNK in both types of RPE cells indicating crosstalk between JNK and NF-kappa B. TNF-alpha induced the inhibitory effects of NF-kappa B on JNK in P-RPE cells because NF-kappa B is continuously inactivated. In N-RPE cells, however, it was not evident because NF-kappa B was already activated. The basic activation pattern of JNK and NF-kappa B and their crosstalk led to opposing responses of RPE cells to TNF-alpha. These results suggest that VEGF secretion under inflammatory conditions depends on cellular polarization, and the TNF-alpha-induced VEGF down-regulation may result in choroidal atrophy in polarized physiological RPE cells. TNF-alpha-induced VEGF up-regulation may cause neovascularization by non-polarized or non-physiological RPE cells.	[Terasaki, Hiroto; Shirasawa, Makoto; Otsuka, Hiroki; Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan; [Kase, Satoru; Ishida, Susumu] Hokkaido Univ, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Hisatomi, Toshio; Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Fukuoka 812, Japan	Kagoshima University; Hokkaido University; Kyushu University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp		Hisatomi, Toshio/0000-0003-2552-9595	Research Committee on 18 Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare; Ministry of Education, Science, and Culture of the Japanese Government [20390450]	Research Committee on 18 Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare; Ministry of Education, Science, and Culture of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by a grant from the Research Committee on 18 Chorioretinal Degeneration and Optic Atrophy, Ministry of Health, Labor, and Welfare (to TS), and by a Grant-in-Aid for Scientific Research (No 20390450) from the Ministry of Education, Science, and Culture of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Bian ZM, 2007, INVEST OPHTH VIS SCI, V48, P2738, DOI 10.1167/iovs.06-1023; Bian ZM, 2007, EXP EYE RES, V84, P812, DOI 10.1016/j.exer.2006.12.016; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; BOK D, 1993, J CELL SCI, P189; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Honorati MC, 2004, OSTEOARTHR CARTILAGE, V12, P683, DOI 10.1016/j.joca.2004.05.009; Josko J, 2004, MED SCI MONITOR, V10, pRA89; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; MARMOR MF, 1980, INVEST OPHTH VIS SCI, V19, P893; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Martelli A, 2009, REPRODUCTION, V137, P45, DOI 10.1530/REP-08-0117; MILLER SS, 1982, P NATL ACAD SCI-BIOL, V79, P2111, DOI 10.1073/pnas.79.6.2111; Nagineni CN, 2012, J CELL PHYSIOL, V227, P116, DOI 10.1002/jcp.22708; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Otsuka H, 2010, AM J PATHOL, V177, P2268, DOI 10.2353/ajpath.2010.100134; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Rizzolo LJ, 1997, HISTOL HISTOPATHOL, V12, P1057; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Woo JM, 2012, MOL VIS, V18, P901; Yin YM, 2009, BIOMED PHARMACOTHER, V63, P429, DOI 10.1016/j.biopha.2009.04.045; Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101; Yoshino Y, 2006, INT J ONCOL, V29, P981; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	42	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69994	10.1371/journal.pone.0069994	http://dx.doi.org/10.1371/journal.pone.0069994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922887	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700115
J	Maki-Marttunen, T; Acimovic, J; Ruohonen, K; Linne, ML				Maki-Marttunen, Tuomo; Acimovic, Jugoslava; Ruohonen, Keijo; Linne, Marja-Leena			Structure-Dynamics Relationships in Bursting Neuronal Networks Revealed Using a Prediction Framework	PLOS ONE			English	Article							LOW MAGNESIUM; CORTICAL-NEURONS; COMPLEX NETWORKS; SYNCHRONY; OSCILLATIONS; ORGANIZATION; GENERATION; EMERGENCE; PATTERNS; EPILEPSY	The question of how the structure of a neuronal network affects its functionality has gained a lot of attention in neuroscience. However, the vast majority of the studies on structure-dynamics relationships consider few types of network structures and assess limited numbers of structural measures. In this in silico study, we employ a wide diversity of network topologies and search among many possibilities the aspects of structure that have the greatest effect on the network excitability. The network activity is simulated using two point-neuron models, where the neurons are activated by noisy fluctuation of the membrane potential and their connections are described by chemical synapse models, and statistics on the number and quality of the emergent network bursts are collected for each network type. We apply a prediction framework to the obtained data in order to find out the most relevant aspects of network structure. In this framework, predictors that use different sets of graph-theoretic measures are trained to estimate the activity properties, such as burst count or burst length, of the networks. The performances of these predictors are compared with each other. We show that the best performance in prediction of activity properties for networks with sharp in-degree distribution is obtained when the prediction is based on clustering coefficient. By contrast, for networks with broad in-degree distribution, the maximum eigenvalue of the connectivity graph gives the most accurate prediction. The results shown for small (N = 100) networks hold with few exceptions when different neuron models, different choices of neuron population and different average degrees are applied. We confirm our conclusions using larger (N = 900) networks as well. Our findings reveal the relevance of different aspects of network structure from the viewpoint of network excitability, and our integrative method could serve as a general framework for structure-dynamics studies in biosciences.	[Maki-Marttunen, Tuomo; Acimovic, Jugoslava; Linne, Marja-Leena] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Maki-Marttunen, Tuomo; Ruohonen, Keijo] Tampere Univ Technol, Dept Math, FIN-33101 Tampere, Finland	Tampere University; Tampere University	Maki-Marttunen, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tuomo.maki-marttunen@tut.fi		Acimovic, Jugoslava/0000-0001-5216-681X; Linne, Marja-Leena/0000-0003-2577-7329; Maki-Marttunen, Tuomo/0000-0002-7082-2507	TISE graduate school, Academy of Finland [132877]; Foundation of Tampere University of Technology; KAUTE foundation	TISE graduate school, Academy of Finland; Foundation of Tampere University of Technology; KAUTE foundation	This work was supported by TISE graduate school, Academy of Finland project 132877, Foundation of Tampere University of Technology, and KAUTE foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2011, EURASIP J BIOINFORM, DOI 10.1155/2011/616382; Aertsen A, 2011, FRONTIERS COMPUTATIO; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Baltz T, 2011, J NEUROPHYSIOL, V106, P1500, DOI 10.1152/jn.00889.2010; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beggs JM, 2003, J NEUROSCI, V23, P11167; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B, 2003, SIAM PROC S, P132; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Cardanobile S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037911; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; de No RL, 1933, ARCH NEURO PSYCHIATR, V30, P245, DOI 10.1001/archneurpsyc.1933.02240140009001; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Gaiteri C, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00010; Garcia GC, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00050; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI DOI 10.4249/SCH0LARPEDIA.1430; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; Golomb D, 2006, J NEUROPHYSIOL, V95, P1049, DOI 10.1152/jn.00932.2005; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Gomez-Gardenes J, 2007, INT J BIFURCAT CHAOS, V17, P2501, DOI 10.1142/S0218127407018579; Gritsun TA, 2010, BIOL CYBERN, V102, P293, DOI 10.1007/s00422-010-0366-x; Guo DQ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051921; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Jia LC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.088101; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kaiser Marcus, 2010, Front Neuroinform, V4, P8, DOI 10.3389/fninf.2010.00008; Keefer EW, 2001, J NEUROPHYSIOL, V86, P3030, DOI 10.1152/jn.2001.86.6.3030; Kim BJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045101; Kitano K, 2002, NEUROCOMPUTING, V44, P473, DOI 10.1016/S0925-2312(02)00404-6; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Legrand JC, 2004, EUR J NEUROSCI, V19, P521, DOI 10.1111/j.0953-816X.2003.03143.x; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MacCluer CR, 2000, SIAM REV, V42, P487, DOI 10.1137/S0036144599359449; Maheswaranathan N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00015; Maki-Marttunen Tuomo, 2011, Front Comput Neurosci, V5, P26, DOI 10.3389/fncom.2011.00026; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morelli LG, 2004, EUR PHYS J B, V38, P495, DOI 10.1140/epjb/e2004-00144-7; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Perez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019900; Restrepo JG, 2006, PHYSICA D, V224, P114, DOI 10.1016/j.physd.2006.08.026; Restrepo JG, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056119; ROBINSON HPC, 1993, J NEUROPHYSIOL, V70, P1606, DOI 10.1152/jn.1993.70.4.1606; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Shanahan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041924; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tsodyks M, 2000, J NEUROSCI, V20; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vlachos I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002311; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1996, J NEUROSCI, V16, P6402; Watanabe S, 1996, NEUROSCI LETT, V210, P41, DOI 10.1016/0304-3940(96)12653-7; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhao Liqiong, 2011, Front Comput Neurosci, V5, P28, DOI 10.3389/fncom.2011.00028	77	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69373	10.1371/journal.pone.0069373	http://dx.doi.org/10.1371/journal.pone.0069373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935998	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300036
J	Liang, GZ; Liu, YL; Shi, BZ; Zhao, J; Zheng, J				Liang, Guizhao; Liu, Yonglan; Shi, Bozhi; Zhao, Jun; Zheng, Jie			An Index for Characterization of Natural and Non-Natural Amino Acids for Peptidomimetics	PLOS ONE			English	Article							INORGANIC-BINDING PEPTIDES; ATOMIC INTERACTION FIELD; BIOLOGICAL-ACTIVITY; ACTIVITY MODEL; PHAGE DISPLAY; DESCRIPTORS; PREDICTION; DESIGN; QSAR; RECEPTOR	Bioactive peptides and peptidomimetics play a pivotal role in the regulation of many biological processes such as cellular apoptosis, host defense, and biomineralization. In this work, we develop a novel structural matrix, Index of Natural and Non-natural Amino Acids (NNAAIndex), to systematically characterize a total of 155 physiochemical properties of 22 natural and 593 non-natural amino acids, followed by clustering the structural matrix into 6 representative property patterns including geometric characteristics, H-bond, connectivity, accessible surface area, integy moments index, and volume and shape. As a proof-of-principle, the NNAAIndex, combined with partial least squares regression or linear discriminant analysis, is used to develop different QSAR models for the design of new peptidomimetics using three different peptide datasets, i. e., 48 bittertasting dipeptides, 58 angiotensin-converting enzyme inhibitors, and 20 inorganic-binding peptides. A comparative analysis with other QSAR techniques demonstrates that the NNAAIndex method offers a stable and predictive modeling technique for in silico large-scale design of natural and non-natural peptides with desirable bioactivities for a wide range of applications.	[Liang, Guizhao; Liu, Yonglan; Shi, Bozhi] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Liang, Guizhao; Zhao, Jun; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	Chongqing University; University System of Ohio; University of Akron	Liang, GZ (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China.	gzliang@cqu.edu.cn; zhengj@uakron.edu	Liu, Yonglan/AAT-2329-2021; Zhao, Jun/G-6883-2011; Zheng, Jie/B-5057-2013	Liu, Yonglan/0000-0001-5280-5992; Zheng, Jie/0000-0003-1547-3612	Natural Science Foundation Project of Chongqing CSTC [cstc2012gg-gjhz10003]; National Natural Science Foundation of China [10901169]; Fundamental Research Funds for Central Universities [CDJZR11 23 00 09, CQDXWL-2012-129]; National Science Foundation (CAREER) of USA [CBET-0952624, CBET-1158447]; Directorate For Engineering [0952624, 1158447] Funding Source: National Science Foundation	Natural Science Foundation Project of Chongqing CSTC(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation (CAREER) of USA(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the Natural Science Foundation Project of Chongqing CSTC (number cstc2012gg-gjhz10003), National Natural Science Foundation of China (number 10901169), Fundamental Research Funds for Central Universities (number CDJZR11 23 00 09 and number CQDXWL-2012-129), and the National Science Foundation (CAREER Award CBET-0952624 and CBET-1158447) of USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Miki, 2002, Current Topics in Medicinal Chemistry, V2, P1381, DOI 10.2174/1568026023392887; Andersson PM, 1998, CHEMOMETR INTELL LAB, V42, P41, DOI 10.1016/S0169-7439(98)00062-8; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apostolopoulos V, 2002, CURR MED CHEM, V9, P411, DOI 10.2174/0929867023370969; ASAO M, 1987, J MED CHEM, V30, P1873, DOI 10.1021/jm00393a031; Bak A, 2007, J CHEM INF MODEL, V47, P1469, DOI 10.1021/ci700025m; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; COCCHI M, 1993, QUANT STRUCT-ACT REL, V12, P1, DOI 10.1002/qsar.19930120102; COLLANTES ER, 1995, J MED CHEM, V38, P2705, DOI 10.1021/jm00014a022; de Armas RR, 2004, BIOORGAN MED CHEM, V12, P4815, DOI 10.1016/j.bmc.2004.07.017; Donatan S, 2009, MAT SCI ENG C-BIO S, V29, P14, DOI 10.1016/j.msec.2008.05.003; Doytchinova IA, 2006, J MED CHEM, V49, P2193, DOI 10.1021/jm050876m; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gainer JV, 1998, NEW ENGL J MED, V339, P1285, DOI 10.1056/NEJM199810293391804; Gfeller D., 2012, NUCLEIC ACIDS RES, V41, pD327; Gramatica P, 2004, J CHEM INF COMP SCI, V44, P1794, DOI 10.1021/ci049923u; HANSCH C, 1962, NATURE, V194, P178, DOI 10.1038/194178b0; Hasegawa K, 1997, J CHEM INF COMP SCI, V37, P306, DOI 10.1021/ci960047x; Helland IS, 2001, CHEMOMETR INTELL LAB, V58, P97, DOI 10.1016/S0169-7439(01)00154-X; HELLBERG S, 1987, J MED CHEM, V30, P1126, DOI 10.1021/jm00390a003; HELLBERG S, 1991, INT J PEPT PROT RES, V37, P414; Hicks RP, 2007, J MED CHEM, V50, P3026, DOI 10.1021/jm061489v; Hou TJ, 2006, J PROTEOME RES, V5, P32, DOI 10.1021/pr0502267; Ianni JC, 2006, ANGEW CHEM INT EDIT, V45, P5502, DOI 10.1002/anie.200600329; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Ko E, 2011, J AM CHEM SOC; Kuenzli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009946; Li YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037396; Liang G, 2009, AMINO ACIDS, V37, P583, DOI 10.1007/s00726-008-0177-8; Liang GZ, 2007, BIOPOLYMERS, V88, P401, DOI 10.1002/bip.20669; Liang GZ, 2008, CHEM BIOL DRUG DES, V71, P345, DOI 10.1111/j.1747-0285.2008.00641.x; Liang GZ, 2009, EUR J MED CHEM, V44, P1144, DOI 10.1016/j.ejmech.2008.06.011; Liang GZ, 2006, ACTA PHYS-CHIM SIN, V22, P388, DOI 10.3866/PKU.WHXB20060327; Liang GZ, 2006, ACTA CHIM SINICA, V64, P393; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mei H, 2005, BIOPOLYMERS, V80, P775, DOI 10.1002/bip.20296; Molina E, 2004, J CHEM INF COMP SCI, V44, P515, DOI 10.1021/ci0342019; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; Nettles JH, 2006, J MED CHEM, V49, P6802, DOI 10.1021/jm060902w; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; OLSON GL, 1993, J MED CHEM, V36, P3039, DOI 10.1021/jm00073a001; Palmblad M, 2010, J COMB CHEM, V12, P65, DOI 10.1021/cc9001235; Puzyn T, 2011, NAT NANOTECHNOL, V6, P175, DOI [10.1038/nnano.2011.10, 10.1038/NNANO.2011.10]; Puzyn T, 2009, SMALL, V5, P2494, DOI 10.1002/smll.200900179; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; Sun HY, 2008, ACCOUNTS CHEM RES, V41, P1264, DOI 10.1021/ar8000553; Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Tian FF, 2007, J PEPT SCI, V13, P549, DOI 10.1002/psc.892; Tian FF, 2007, J MOL STRUCT, V830, P106, DOI 10.1016/j.molstruc.2006.07.004; Vedani A, 2005, J MED CHEM, V48, P3700, DOI 10.1021/jm050185q; Vedani A, 2002, J MED CHEM, V45, P2139, DOI 10.1021/jm011005p; Venkatraman V, 2010, J CHEM INF MODEL, V50, P2079, DOI 10.1021/ci100263p; Vreuls C, 2010, J INORG BIOCHEM, V104, P1013, DOI 10.1016/j.jinorgbio.2010.05.008; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yang L, 2010, AMINO ACIDS, V38, P805, DOI 10.1007/s00726-009-0287-y; Zaliani A, 1999, J CHEM INF COMP SCI, V39, P525, DOI 10.1021/ci980211b; Zelzer M, 2010, CHEM SOC REV, V39, P3351, DOI 10.1039/c0cs00035c; Zhou P, 2008, CURR COMPUT-AID DRUG, V4, P311, DOI 10.2174/157340908786785994	69	11	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67844	10.1371/journal.pone.0067844	http://dx.doi.org/10.1371/journal.pone.0067844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935845	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000019
J	Lin, HL; Zou, H; Wang, QZ; Liu, CX; Lang, LL; Hou, XX; Li, ZJ				Lin, Hualiang; Zou, Hong; Wang, Qinzhou; Liu, Chunxiao; Lang, Lingling; Hou, Xuexin; Li, Zhenjun			Short-Term Effect of El Nino-Southern Oscillation on Pediatric Hand, Foot and Mouth Disease in Shenzhen, China	PLOS ONE			English	Article							ENTEROVIRUS 71; TIME-SERIES; MORTALITY; TEMPERATURE; EPIDEMIOLOGY; HERPANGINA; OUTBREAK; MODELS; FEVER	Hand, foot and mouth disease (HFMD) was an emerging viral infectious disease in recent years in Shenzhen. The underlying risk factors have not yet been systematically examined. This study analyzed the short-term effect of El Nino-Southern Oscillation on pediatric HFMD in Shenzhen, China. Daily count of HFMD among children aged below 15 years old, Southern Oscillation Index (SOI), and weather variables were collected to construct the time series. A distributed lag non-linear model was applied to investigate the effect of daily SOI on pediatric HFMD occurrence during 2008-2010. We observed an acute effect of SOI variation on HFMD occurrence. The extremely high SOI (SOI = 45, with 0 as reference) was associated with increased HFMD, with the relative risk (RR) being 1.66 (95% Confidence Interval [CI]: 1.34-2.04). Further analyses of the association between HFMD and daily mean temperature and relative humidity supported the correlation between pediatric HFMD and SOI. Meteorological factors might be important predictors of pediatric HFMD occurrence in Shenzhen.	[Lin, Hualiang; Lang, Lingling] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Lin, Hualiang; Lang, Lingling] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zou, Hong] Baoan Chron Dis Prevent & Cure Hosp, Shenzhen, Peoples R China; [Wang, Qinzhou] Chinese Univ Hong Kong, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Liu, Chunxiao] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen, Peoples R China; [Hou, Xuexin; Li, Zhenjun] China CDC, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, ZJ (corresponding author), China CDC, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	lizhenjun@icdc.cn	Lin, Hualiang/E-6622-2010	Lin, Hualiang/0000-0002-2462-5158				Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Earnest A, 2011, EPIDEMIOLOGY INFECT, V1, P1, DOI DOI 10.1017/S095026881100183X; Fletcher L, 2004, IMPORTANCE BIOAEROSO; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Jiang M, 2012, NEW ENGL J MED, V367, P91, DOI 10.1056/NEJMc1110981; Latif M, 2009, P NATL ACAD SCI USA, V106, P20578, DOI 10.1073/pnas.0710860105; Lin H, 2012, ATMOS ENVIRON, DOI [10.1016/j.atmo-senv.2012.08.043, DOI 10.1016/J.ATM0-SENV.2012.08.043]; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Lu A, 2012, ADV SPACE RES, V50, P1362, DOI 10.1016/j.asr.2012.06.033; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Morris RS, 2002, REV SCI TECH OIE, V21, P557, DOI 10.20506/rst.21.3.1363; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Power SB, 2011, CLIM DYNAM, V37, P1745, DOI 10.1007/s00382-010-0951-7; SELLERS R F, 1970, Journal of Hygiene, V68, P565; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao P, 2010, J CLIMATE, V23, P1544, DOI 10.1175/2009JCLI2660.1	34	36	39	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e65585	10.1371/journal.pone.0065585	http://dx.doi.org/10.1371/journal.pone.0065585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935817	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000002
J	Qu, Y; Wang, YP; Ma, JL; Zhang, Y; Meng, NN; Li, H; Wang, Y; Wei, WB				Qu, Yi; Wang, Yupeng; Ma, Jinlan; Zhang, Yue; Meng, Nana; Li, Hao; Wang, Yan; Wei, Wenbin			Overexpression of High Mobility Group A1 Protein in Human Uveal Melanomas: Implication for Prognosis	PLOS ONE			English	Article							TUMOR PROGRESSION; INCREASED EXPRESSION; MALIGNANT-MELANOMA; CHOROIDAL MELANOMA; TRANSGENIC MICE; HMGA1; SURVIVAL; GENE; INVASIVENESS; REAPPRAISAL	There is increasing evidence that the high mobility group A1 (HMGA1) protein, which functions as a transcriptional master regulator, plays critical roles in tumor progression. We evaluated HMGA1 expression in 89 primary uveal melanomas (UM) by immunohistochemistry to determine the clinicopathological and prognostic value of HMGA1 in UM after adjusting for other prognostic variables. Nuclear expression of HMGA1 was detected in 44% UMs. High expression levels of HMGA1 were more frequent in UMs with high levels of epithelioid cell pattern, mitoses count, and Ki67 labeling index (P = 0.025, P<0.0001, P = 0.0018; respectively), and HMGA1 expression levels were directly correlated with Ki67 labeling indexes and mitoses counts (R = 0.31, P<0.0001; R = 0.27, P<0.0068; respectively). High expression of HMGA1 was also independently associated with an increased risk of distant metastases as determined using the Cox proportional hazards regression model (multivariate hazard ratio: 3.44; 95% confidence interval: 1.56-7.60; log rank P = 0.0022). Moreover, high HMGA1 expression was associated with shorter UM-specific survival (multivariate hazard ratio: 2.41; 95% confidence interval: 1.10-5.53; log rank P = 0.041). These findings suggest that high levels of HMGA1 are associated with adverse clinical outcomes in UM patients and that further evaluation of HMGA1 as a potential therapeutic target in UM is warranted.	[Qu, Yi; Ma, Jinlan; Zhang, Yue; Meng, Nana; Li, Hao] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China; [Wang, Yupeng] Shandong Univ, Sch Med, Jinan 250100, Peoples R China; [Wang, Yan] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Peoples R China; [Wei, Wenbin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	Shandong University; Shandong University; Shandong University; Capital Medical University	Qu, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	drquyi@gmail.com; trweiwenbin@yahoo.com.cn	wei, wei/HHR-8613-2022		Shandong Science and Technology Developing Project, China [2012GSF12121]; Shandong University, China [2012ZD025]; Shandong Provincial Natural Science Foundation [Y2008C78]	Shandong Science and Technology Developing Project, China; Shandong University, China; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported in part by Shandong Science and Technology Developing Project, China (2012GSF12121), a Free Exploration Grant of Shandong University, China (2012ZD025), and Shandong Provincial Natural Science Foundation (Y2008C78). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Chiappetta G, 1996, ONCOGENE, V13, P2439; Chuma Makoto, 2004, Keio Journal of Medicine, V53, P90, DOI 10.2302/kjm.53.90; Collaborative Ocular Melanoma Study Group, 2001, Arch Ophthalmol, V119, P670; Coupland SE, 2008, OPHTHALMOLOGY, V115, P1778, DOI 10.1016/j.ophtha.2008.04.025; Damato B, 2009, EYE, V23, P2152, DOI [10.1038/eye.2009.235, 10.1038/eye.2009.235-cme]; Damato B, 2007, OPHTHALMOLOGY, V114, P1925, DOI 10.1016/j.ophtha.2007.06.012; Diener-West M, 2004, J CLIN ONCOL, V22, P2438, DOI 10.1200/jco.2004.08.194; DIENERWEST M, 1992, ARCH OPHTHALMOL-CHIC, V110, P245, DOI 10.1001/archopht.1992.01080140101036; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Eskelin S, 2001, OPHTHALMOLOGY, V108, P830, DOI 10.1016/S0161-6420(00)00608-4; Eskelin S, 2000, OPHTHALMOLOGY, V107, P1443, DOI 10.1016/S0161-6420(00)00182-2; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Flohr AM, 2003, HISTOL HISTOPATHOL, V18, P999, DOI 10.14670/HH-18.999; FOLBERG R, 1993, OPHTHALMOLOGY, V100, P1389; FOLBERG R, 1992, HUM PATHOL, V23, P1298, DOI 10.1016/0046-8177(92)90299-I; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gragoudas E, 2002, ARCH OPHTHALMOL-CHIC, V120, P1665; Griewank KG, 2013, PATHOLOGY, V45, P18, DOI 10.1097/PAT.0b013e32835c6505; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hristov AC, MOD PATHOL, V23, P98; Johansson CC, 2010, INT J CANCER, V126, P2682, DOI 10.1002/ijc.24984; Kim IK, 2010, ARCH OPHTHALMOL-CHIC, V128, P871, DOI 10.1001/archophthalmol.2010.121; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; MCLEAN IW, 1978, AM J OPHTHALMOL, V86, P557, DOI 10.1016/0002-9394(78)90307-0; MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0; MOOY CM, 1990, OPHTHALMOLOGY, V97, P1275; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Palmieri D, 2012, ONCOGENE, V31, P3857, DOI 10.1038/onc.2011.557; Prescher G, 1996, LANCET, V347, P1222; Pyrhonen S, 1998, EUR J CANCER, V34, pS27; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Shields CL, 2011, OPHTHALMOLOGY, V118, P396, DOI 10.1016/j.ophtha.2010.05.023; Singh AD, 2003, OPHTHALMOLOGY, V110, P962, DOI 10.1016/S0161-6420(03)00077-0; Takaha N, 2012, J UROLOGY, V187, P2215, DOI 10.1016/j.juro.2012.01.069; Triozzi PL, 2008, CANCER TREAT REV, V34, P247, DOI 10.1016/j.ctrv.2007.12.002; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Wang EL, 2010, HISTOPATHOLOGY, V56, P501, DOI 10.1111/j.1365-2559.2010.03495.x; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wood LJ, 2000, CANCER RES, V60, P4256; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68724	10.1371/journal.pone.0068724	http://dx.doi.org/10.1371/journal.pone.0068724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935884	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000035
J	van Mulukom, V; Schacter, DL; Corballis, MC; Addis, DR				van Mulukom, Valerie; Schacter, Daniel L.; Corballis, Michael C.; Addis, Donna Rose			Re-Imagining the Future: Repetition Decreases Hippocampal Involvement in Future Simulation	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; EPISODIC MEMORY; HUMAN AMYGDALA; RELATIONAL INFORMATION; PREFRONTAL CORTEX; EVENT; ACTIVATION; NOVELTY; NETWORK; RECOLLECTION	Imagining or simulating future events has been shown to activate the anterior right hippocampus (RHC) more than remembering past events does. One fundamental difference between simulation and memory is that imagining future scenarios requires a more extensive constructive process than remembering past experiences does. Indeed, studies in which this constructive element is reduced or eliminated by "pre-imagining" events in a prior session do not report differential RHC activity during simulation. In this fMRI study, we examined the effects of repeatedly simulating an event on neural activity. During scanning, participants imagined 60 future events; each event was simulated three times. Activation in the RHC showed a significant linear decrease across repetitions, as did other neural regions typically associated with simulation. Importantly, such decreases in activation could not be explained by non-specific linear time-dependent effects, with no reductions in activity evident for the control task across similar time intervals. Moreover, the anterior RHC exhibited significant functional connectivity with the whole-brain network during the first, but not second and third simulations of future events. There was also evidence of a linear increase in activity across repetitions in right ventral precuneus, right posterior cingulate and left anterior prefrontal cortex, which may reflect source recognition and retrieval of internally generated contextual details. Overall, our findings demonstrate that repeatedly imagining future events has a decremental effect on activation of the hippocampus and many other regions engaged by the initial construction of the simulation, possibly reflecting the decreasing novelty of simulations across repetitions, and therefore is an important consideration in the design of future studies examining simulation.	[van Mulukom, Valerie; Corballis, Michael C.; Addis, Donna Rose] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [van Mulukom, Valerie; Corballis, Michael C.; Addis, Donna Rose] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Schacter, Daniel L.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Auckland; University of Auckland; Harvard University	Addis, DR (corresponding author), Univ Auckland, Sch Psychol, Auckland 1, New Zealand.	d.addis@auckland.ac.nz	Addis, Donna Rose/AAF-2307-2022; Addis, Donna Rose/AEZ-1941-2022	Schacter, Daniel/0000-0002-2460-6061; Corballis, Michael/0000-0002-3126-6114; van Mulukom, Valerie/0000-0002-0549-7365; Addis, Donna Rose/0000-0002-6231-1491	Royal Society of NZ Marsden Grant [UOA0810]; National Institute of Mental Health [MH060941]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER	Royal Society of NZ Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a Royal Society of NZ Marsden Grant UOA0810 to DRA and a National Institute of Mental Health grant MH060941 to DLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00173; Addis DR, 2011, HIPPOCAMPUS, V21, P1045, DOI 10.1002/hipo.20870; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034; Blackford JU, 2010, NEUROIMAGE, V50, P1188, DOI 10.1016/j.neuroimage.2009.12.083; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; CARROLL JS, 1978, J EXP SOC PSYCHOL, V14, P88, DOI 10.1016/0022-1031(78)90062-8; Clark JM, 2004, BEHAV RES METH INS C, V36, P371, DOI 10.3758/BF03195584; Conway MA, 2003, NEUROPSYCHOLOGIA, V41, P334, DOI 10.1016/S0028-3932(02)00165-3; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; De Brigard F, 2013, NEUROPSYCHO IN PRESS, DOI [10.1016/j.neuropsychologia.2013.01.015, DOI 10.1016/J.NEUR0PSY-CH0L0GIA.2013.01.015]; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hassabis D, 2007, J NEUROSCI, V27, P14365, DOI 10.1523/JNEUROSCI.4549-07.2007; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kohler S, 2005, HIPPOCAMPUS, V15, P763, DOI 10.1002/hipo.20098; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Martin VC, 2011, P NATL ACAD SCI USA, V108, P13858, DOI 10.1073/pnas.1105816108; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; Mumford JA, 2008, USING CONTRASTS TEST; Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Preston AR, 2004, HIPPOCAMPUS, V14, P148, DOI 10.1002/hipo.20009; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; SHERMAN SJ, 1985, PERS SOC PSYCHOL B, V11, P118, DOI 10.1177/0146167285111011; Simons JS, 2005, NEUROPSYCHOLOGIA, V43, P1774, DOI 10.1016/j.neuropsychologia.2005.02.004; Summerfield JJ, 2010, NEUROPSYCHOLOGIA, V48, P1501, DOI 10.1016/j.neuropsychologia.2010.01.022; Svoboda E, 2009, J NEUROSCI, V29, P3073, DOI 10.1523/JNEUROSCI.3452-08.2009; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2014, SOC COGN AFFECT NEUR, V9, P712, DOI 10.1093/scan/nst035; Szpunar KK, 2013, J EXP PSYCHOL GEN, V142, P323, DOI 10.1037/a0028877; Talairach I., 1988, COPLANAR STEREOTACTI; Vul E., 2009, FDN ISSUES HUMAN BRA, P71; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Weiler JA, 2010, BEHAV BRAIN RES, V212, P196, DOI 10.1016/j.bbr.2010.04.013; Weiler JA, 2010, HIPPOCAMPUS, V20, P685, DOI 10.1002/hipo.20695; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026	54	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69596	10.1371/journal.pone.0069596	http://dx.doi.org/10.1371/journal.pone.0069596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936055	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000139
J	Kong, J; Spaeth, R; Cook, A; Kirsch, I; Claggett, B; Vangel, M; Gollub, RL; Smoller, JW; Kaptchuk, TJ				Kong, Jian; Spaeth, Rosa; Cook, Amanda; Kirsch, Irving; Claggett, Brian; Vangel, Mark; Gollub, Randy L.; Smoller, Jordan W.; Kaptchuk, Ted J.			Are All Placebo Effects Equal? Placebo Pills, Sham Acupuncture, Cue Conditioning and Their Association	PLOS ONE			English	Article							DISPOSITIONAL OPTIMISM; ANALGESIA; EXPECTANCY; NEEDLE; DISSOCIATION; MECHANISMS; TRIALS; BLIND; FMRI	Placebo treatments and healing rituals have been used to treat pain throughout history. The present within-subject crossover study examines the variability in individual responses to placebo treatment with verbal suggestion and visual cue conditioning by investigating whether responses to different types of placebo treatment, as well as conditioning responses, correlate with one another. Secondarily, this study also examines whether responses to sham acupuncture correlate with responses to genuine acupuncture. Healthy subjects were recruited to participate in two sequential experiments. Experiment one is a five-session crossover study. In each session, subjects received one of four treatments: placebo pills (described as Tylenol), sham acupuncture, genuine acupuncture, or no treatment rest control condition. Before and after each treatment, paired with a verbal suggestion of positive effect, each subject's pain threshold, pain tolerance, and pain ratings to calibrated heat pain were measured. At least 14 days after completing experiment one, all subjects were invited to participate in experiment two, during which their analgesic responses to conditioned visual cues were tested. Forty-eight healthy subjects completed experiment one, and 45 completed experiment two. The results showed significantly different effects of genuine acupuncture, placebo pill and rest control on pain threshold. There was no significant association between placebo pills, sham acupuncture and cue conditioning effects, indicating that individuals may respond to unique healing rituals in different ways. This outcome suggests that placebo response may be a complex behavioral phenomenon that has properties that comprise a state, rather than a trait characteristic. This could explain the difficulty of detecting a signature for "placebo responders." However, a significant association was found between the genuine and sham acupuncture treatments, implying that the non-specific effects of acupuncture may contribute to the analgesic effect observed in genuine acupuncture analgesia.	[Kong, Jian; Spaeth, Rosa; Cook, Amanda; Gollub, Randy L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Kong, Jian; Spaeth, Rosa; Cook, Amanda; Gollub, Randy L.; Smoller, Jordan W.] Harvard Univ, Sch Med, Charlestown, MA USA; [Kirsch, Irving; Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies, Boston, MA 02215 USA; [Kirsch, Irving] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Claggett, Brian] Harvard Univ, Sch Med, Div Cardiovasc Med, Boston, MA USA; [Claggett, Brian] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vangel, Mark] MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Plymouth; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kong, J (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA.	kongj@nmr.mgh.harvard.edu	Kirsch, Irving/P-9316-2019	Gollub, Randy L./0000-0002-9434-4044	NCCAM [KO1AT003883, R21AT004497, R01AT006364, R01AT005280, K24AT004095, P01 AT006663]; NIDA [R03AT218317]; NIMH [K24MH094614]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005280] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K01AT003883, R21AT004497] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095, R01AT006364, P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614] Funding Source: NIH RePORTER	NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by KO1AT003883 (NCCAM), R21AT004497 (NCCAM), R03AT218317 (NIDA), and R01AT006364 (NCCAM) to Jian Kong; R01AT005280 (NCCAM) to Randy Gollub; K24AT004095 (NCCAM) to Ted Kaptchuk; K24MH094614 (NIMH) to Jordan W. Smoller, and P01 AT006663 (NCCAM) to Bruce Rosen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Brody H, 2011, JAMA-J AM MED ASSOC, V306, P2612, DOI 10.1001/jama.2011.1850; Charron J, 2006, CLIN J PAIN, V22, P204, DOI 10.1097/01.ajp.0000161526.25374.e5; Cheng XN, 1987, CHINESE ACUPUNCTURE, P513; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; CONOVER WJ, 1982, BIOMETRICS, V38, P715, DOI 10.2307/2530051; de Craen AJM, 2000, J NEUROL, V247, P183, DOI 10.1007/s004150050560; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; Geers AL, 2010, J PAIN, V11, P1165, DOI 10.1016/j.jpain.2010.02.014; GELFAND S, 1964, CAN J PSYCHOLOGY, V18, P36, DOI 10.1037/h0083283; GOLDMAN AR, 1965, J NERV MENT DIS, V140, P272, DOI 10.1097/00005053-196504000-00003; GRACELY RH, 1978, PAIN, V5, P5, DOI 10.1016/0304-3959(78)90020-9; Gracely RH, 1994, TXB PAIN, P315; GRENFELL RF, 1961, JAMA-J AM MED ASSOC, V176, P124, DOI 10.1001/jama.1961.03040150040010; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; HUBER PJ, 1973, ANN STAT, V1, P799, DOI 10.1214/aos/1176342503; Kaptchuk TJ, 2008, CONTEMP CLIN TRIALS, V29, P587, DOI 10.1016/j.cct.2008.02.002; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kleinhenz J, 1999, PAIN, V83, P235, DOI 10.1016/S0304-3959(99)00107-4; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2005, J PAIN, V6, P55, DOI 10.1016/j.jpain.2004.10.005; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Kong J, 2013, PAIN, V154, P459, DOI 10.1016/j.pain.2012.12.004; Kong J, 2009, NEUROIMAGE, V47, P1066, DOI 10.1016/j.neuroimage.2009.05.087; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; ROBERTS AH, 1993, CLIN PSYCHOL REV, V13, P375, DOI 10.1016/0272-7358(93)90010-J; Shapiro Elaine, 1997, POWERFUL PLACEBO ANC; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Stux G, 1997, BASICS ACUPUNCTURE, P110; TRAUT EF, 1956, ARCH INTERN MED, V98, P181, DOI 10.1001/archinte.1956.00250260055007; TRAUT EF, 1957, ANN RHEUM DIS, V16, P18, DOI 10.1136/ard.16.1.18; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wasan AD, 2010, J PAIN, V11, P555, DOI 10.1016/j.jpain.2009.09.013; Whalley B, 2008, J PSYCHOSOM RES, V64, P537, DOI 10.1016/j.jpsychores.2007.11.007; White P, 2003, PAIN, V106, P401, DOI 10.1016/j.pain.2003.08.013	50	66	68	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e67485	10.1371/journal.pone.0067485	http://dx.doi.org/10.1371/journal.pone.0067485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935833	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700004
J	Manco, M; Spreghini, MR; Luciano, R; Pensini, C; Sforza, RW; Rustico, C; Cappa, M; Morino, GS				Manco, Melania; Spreghini, Maria Rita; Luciano, Rosa; Pensini, Cecilia; Sforza, Rita Wietrzycowska; Rustico, Carmela; Cappa, Marco; Morino, Giuseppe Stefano			Insulin Sensitivity from Preschool to School Age in Patients with Severe Obesity	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; BETA-CELL FUNCTION; METABOLIC SYNDROME; BODY-COMPOSITION; RESISTANCE; CHILDREN; CHILDHOOD; PUBERTY; STAGE; INDEXES	Background: Insulin sensitivity decreases at puberty transition, but little information has been provided on its earlier time-course. Aim of the present study was to describe the time-course of insulin sensitivity in severely obese children at the transition from preschool to school age. Research design and methods: Retrospective study of a cohort of 47 severely obese [Body Mass Index (BMI) >= 99 degrees percentile] preschoolers evaluated twice, once between 2 and 6 years of age, and once before age 8. Glucose tolerance, Whole Body Insulin Sensitivity Index (WBISI), Insulinogenic Index (IGI); beta-cell demand index (BCDI) and Insulin Secretion-Sensitivity Index 2 (ISSI-2) were longitudinally estimated during the oral glucose tolerance test. Results: After a median follow-up of 2.23 (1-4.52) y, obese patients showed significant decrease in WBISI (p<0.0001), and increase in fasting (p = 0.005) and 2 h glucose (2HG, p = 0.001). One child in preschool age and 4 school age children presented with 2HG between 7.8-11.1 mmol/l. Best predictors of WBISI, 2HG and BCDI in the school age were changes in BMI z-score (R-2 = 0.309; p = 0.002; beta = -0.556), ISSI-2 (R-2 = 0.465; p<0.0001; beta = -0.682), and BMI z-score (R-2 = 0.246; p = 0.008; 0.496), respectively. Conclusions: In morbidly obese children, insulin sensitivity seems to decline even before pubertal transition, but changes in total adiposity can only partially explain this variation.	[Manco, Melania; Pensini, Cecilia] Bambino Gesu Children Hosp, Res Unit Multifactorial Dis, Sci Directorate, Rome, Italy; [Spreghini, Maria Rita; Sforza, Rita Wietrzycowska; Rustico, Carmela; Morino, Giuseppe Stefano] Bambino Gesu Children Hosp, Unit Clin Nutr, Rome, Italy; [Cappa, Marco] Bambino Gesu Children Hosp, Unit Endocrinol & Diabetol, Rome, Italy; [Luciano, Rosa] Bambino Gesu Children Hosp, Dept Lab Med, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Manco, M (corresponding author), Bambino Gesu Children Hosp, Res Unit Multifactorial Dis, Sci Directorate, Rome, Italy.	melania.manco@opbg.net	Manco, Melania/M-1058-2013	Manco, Melania/0000-0002-6581-975X; CAPPA, MARCO/0000-0001-5647-7519	Italian 5x1000 contribution; Italian Ministry of Health [RF-OPG-20081142374, RC 201102T002598, RC 201102R002566]	Italian 5x1000 contribution; Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by the Italian 5x1000 contribution 2008, and by grants from the Italian Ministry of Health to MM (RF-OPG-20081142374), RL (RC 201102T002598), CP (RC 201102R002566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Arslanian S, 1996, J CLIN ENDOCR METAB, V81, P1058, DOI 10.1210/jc.81.3.1058; Cali AMG, 2009, DIABETES CARE, V32, P456, DOI 10.2337/dc08-1274; Caprio S, 1996, DIABETOLOGIA, V39, P1489, DOI 10.1007/s001250050603; COOK JS, 1993, J CLIN ENDOCR METAB, V77, P725, DOI 10.1210/jc.77.3.725; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Guercio G, 2003, J CLIN ENDOCR METAB, V88, P1389, DOI 10.1210/jc.2002-020979; Jasik CB, 2008, ANN NY ACAD SCI, V1135, P265, DOI 10.1196/annals.1429.009; Jeffery AN, 2007, DIABETES CARE, V30, P2962, DOI 10.2337/dc07-0178; Jeffery AN, 2012, DIABETES CARE, V35, P536, DOI 10.2337/dc11-1281; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Manco M, 2012, ACTA DIABETOL, V49, P435, DOI 10.1007/s00592-012-0384-3; Manco M, 2011, J AM COLL NUTR, V30, P295, DOI 10.1080/07315724.2011.10719972; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Nguyen QM, 2008, DIABETES CARE, V31, P2044, DOI 10.2337/dc08-0898; Nolfe G, 2012, EUR J ENDOCRINOL, V166, P107, DOI 10.1530/EJE-11-0827; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; TRAVERS SH, 1995, J CLIN ENDOCR METAB, V80, P172, DOI 10.1210/jc.80.1.172; Weiss R, 2005, DIABETES, V54, P1735, DOI 10.2337/diabetes.54.6.1735; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503; Yeckel CW, 2005, J CLIN ENDOCR METAB, V90, P747, DOI 10.1210/jc.2004-1258	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68628	10.1371/journal.pone.0068628	http://dx.doi.org/10.1371/journal.pone.0068628			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935878	Green Submitted, Green Published, gold			2022-12-27	WOS:000322633700011
J	van Sonderen, E; Sanderman, R; Coyne, JC				van Sonderen, Eric; Sanderman, Robbert; Coyne, James C.			Ineffectiveness of Reverse Wording of Questionnaire Items: Let's Learn from Cows in the Rain	PLOS ONE			English	Article							RESPONSE FORMATS; BIPOLARITY; VALIDATION	Objective: We examined the effectiveness of reverse worded items as a means of reducing or preventing response bias. We first distinguished between several types of response bias that are often confused in literature. We next developed arguments why reversing items is probably never a good way to address response bias. We proposed testing whether reverse wording affects response bias with item-level data from the Multidimensional Fatigue Inventory (MFI-20), an instrument that contains reversed worded items. Methods: With data from 700 respondents, we compared scores on items that were similar with respect either to content or to direction of wording. Psychometric properties of sets of these items worded in the same direction were compared with sets consisting of both straightforward and reversed worded items. Results: We did not find evidence that ten reverse-worded items prevented response bias. Instead, the data suggest scores were contaminated by respondent inattention and confusion. Conclusions: Using twenty items, balanced for scoring direction, to assess fatigue did not prevent respondents from inattentive or acquiescent answering. Rather, fewer mistakes are made with a 10-item instrument with items posed in the same direction. Such a format is preferable for both epidemiological and clinical studies.	[van Sonderen, Eric; Sanderman, Robbert; Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Sect Hlth Psychol, Dept Hlth Sci, Groningen, Netherlands; [Coyne, James C.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	University of Groningen; University of Pennsylvania; Pennsylvania Medicine	van Sonderen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Hlth Psychol, Dept Hlth Sci, Groningen, Netherlands.	f.l.p.van.sonderen@umcg.nl						Baumgartner H, 2001, J MARKETING RES, V38, P143, DOI 10.1509/jmkr.38.2.143.18840; Bradley KD, 2008, J COLL TEACH LEARN, V5, P39, DOI DOI 10.19030/tlc.v5i8.1240; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Drolet AL., 2001, J SERV RES-US, V3, P196, DOI [10.1177/109467050133001, DOI 10.1177/109467050133001]; Fresco DM, 2002, BEHAV RES THER, V40, P313, DOI 10.1016/S0005-7967(00)00113-3; Hazlett-Stevens H, 2004, ASSESSMENT, V11, P361, DOI 10.1177/1073191104269872; Hinz A, 2007, GMS PSYCHOSOC MED, V4, pDoc07; Krosnick JA, 1999, ANNU REV PSYCHOL, V50, P537, DOI 10.1146/annurev.psych.50.1.537; Merritt SM, 2012, J BUS PSYCHOL, V27, P421, DOI 10.1007/s10869-011-9252-3; Meyer J.P., 1991, HUM RESOUR MANAGE R, V1, P61, DOI [10.1016/1053-4822(91)90011-Z, DOI 10.1016/1053-4822(91)90011-Z]; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; Romberg-Camps MJL, 2010, INFLAMM BOWEL DIS, V16, P2137, DOI 10.1002/ibd.21285; RORER LG, 1965, PSYCHOL BULL, V63, P129, DOI 10.1037/h0021888; Roszkowski MJ, 2010, ASSESS EVAL HIGH EDU, V35, P117, DOI 10.1080/02602930802618344; Russell JA, 1999, PSYCHOL BULL, V125, P611, DOI 10.1037/0033-2909.125.5.611; Russell JA, 1999, PSYCHOL BULL, V125, P3, DOI 10.1037/0033-2909.125.1.3; SCHMITT N, 1985, APPL PSYCH MEAS, V9, P367, DOI 10.1177/014662168500900405; SCHRIESHEIM CA, 1981, EDUC PSYCHOL MEAS, V41, P1101, DOI 10.1177/001316448104100420; Segura SL, 2003, J PERS SOC PSYCHOL, V85, P956, DOI 10.1037/0022-3514.85.5.956; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42; Spector PE, 1997, J MANAGE, V23, P659, DOI 10.1177/014920639702300503; Swain SD, 2008, J MARKETING RES, V45, P116, DOI 10.1509/jmkr.45.1.116; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Watson D, 1999, PSYCHOL BULL, V125, P601, DOI 10.1037/0033-2909.125.5.601; Weijters B., 2006, RESPONSE STYLES CONS; Weijters B, 2013, PSYCHOL METHODS, V18, P320, DOI 10.1037/a0032121; Woods CM, 2006, J PSYCHOPATHOL BEHAV, V28, P189, DOI 10.1007/s10862-005-9004-7	29	269	272	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68967	10.1371/journal.pone.0068967	http://dx.doi.org/10.1371/journal.pone.0068967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23935915	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700015
J	Sasai, N; Saitoh, N; Saitoh, H; Nakao, M				Sasai, Nobuhiro; Saitoh, Noriko; Saitoh, Hisato; Nakao, Mitsuyoshi			The Transcriptional Cofactor MCAF1/ATF7IP Is Involved in Histone Gene Expression and Cellular Senescence	PLOS ONE			English	Article							HETEROCHROMATIN FORMATION; PREMATURE SENESCENCE; METHYLTRANSFERASE SETDB1; ONCOGENIC RAS; REPRESSION; PML; FIBROBLASTS; PROTEIN; CELLS	Cellular senescence is post-mitotic or oncogene-induced events combined with nuclear remodeling. MCAF1 (also known as hAM or ATF7IP), a transcriptional cofactor that is overexpressed in various cancers, functions in gene activation or repression, depending on interacting partners. In this study, we found that MCAF1 localizes to PML nuclear bodies in human fibroblasts and non-cancerous cells. Interestingly, depletion of MCAF1 in fibroblasts induced premature senescence that was characterized by cell cycle arrest, SA-beta-gal activity, and senescence-associated heterochromatic foci (SAHF) formation. Under this condition, core histones and the linker histone H1 significantly decreased at both mRNA and protein levels, resulting in reduced nucleosome formation. Consistently, in activated Ras-induced senescent fibroblasts, the accumulation of MCAF1 in PML bodies was enhanced via the binding of this protein to SUMO molecules, suggesting that sequestration of MCAF1 to PML bodies promotes cellular senescence. Collectively, these results reveal that MCAF1 is an essential regulator of cellular senescence.	[Sasai, Nobuhiro; Saitoh, Noriko; Nakao, Mitsuyoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Saitoh, Hisato] Kumamoto Univ, Dept Biol Sci, Grad Sch Sci & Technol, Kumamoto, Japan; [Nakao, Mitsuyoshi] Japan Sci & Technol Agcy, Tokyo, Japan	Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST)	Nakao, M (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan.	mnakao@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (CREST); Grants-in-Aid for Scientific Research [24659152] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Science and Technology Agency (CREST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Cho S, 2011, J BIOL CHEM, V286, P41115, DOI 10.1074/jbc.M111.248534; De Graeve F, 2000, ONCOGENE, V19, P1807, DOI 10.1038/sj.onc.1203492; Ferbeyre G, 2000, GENE DEV, V14, P2015; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fujita N, 2003, MOL CELL BIOL, V23, P2834, DOI 10.1128/MCB.23.8.2834-2843.2003; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rai TS, 2012, BBA-GENE REGUL MECH, V1819, P322, DOI 10.1016/j.bbagrm.2011.07.014; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Yates KE, 2008, AGING CELL, V7, P609, DOI 10.1111/j.1474-9726.2008.00411.x; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	34	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68478	10.1371/journal.pone.0068478	http://dx.doi.org/10.1371/journal.pone.0068478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935871	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200011
J	Coleman, SJ; Zeng, Z; Hestand, MS; Liu, JZ; Macleod, JN				Coleman, Stephen J.; Zeng, Zheng; Hestand, Matthew S.; Liu, Jinze; Macleod, James N.			Analysis of Unannotated Equine Transcripts Identified by mRNA Sequencing	PLOS ONE			English	Article							KRAB; EXPRESSION; GENES; ANNOTATION; PROTEINS; SEARCH; BLAST	Sequencing of equine mRNA (RNA-seq) identified 428 putative transcripts which do not map to any previously annotated or predicted horse genes. Most of these encode the equine homologs of known protein-coding genes described in other species, yet the potential exists to identify novel and perhaps equine-specific gene structures. A set of 36 transcripts were prioritized for further study by filtering for levels of expression (depth of RNA-seq read coverage), distance from annotated features in the equine genome, the number of putative exons, and patterns of gene expression between tissues. From these, four were selected for further investigation based on predicted open reading frames of greater than or equal to 50 amino acids and lack of detectable homology to known genes across species. Sanger sequencing of RT-PCR amplicons from additional equine samples confirmed expression and structural annotation of each transcript. Functional predictions were made by conserved domain searches. A single transcript, expressed in the cerebellum, contains a putative kruppel associated box (KRAB) domain, suggesting a potential function associated with zinc finger proteins and transcriptional regulation. Overall levels of conserved synteny and sequence conservation across a 1MB region surrounding each transcript were approximately 73% compared to the human, canine, and bovine genomes; however, the four loci display some areas of low conservation and sequence inversion in regions that immediately flank these previously unannotated equine transcripts. Taken together, the evidence suggests that these four transcripts are likely to be equine-specific.	[Coleman, Stephen J.; Hestand, Matthew S.; Macleod, James N.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY USA; [Zeng, Zheng; Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	Macleod, JN (corresponding author), Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY USA.	jnmacleod@uky.edu		Coleman, Stephen/0000-0001-7686-4866	University of Kentucky Gluck Equine Research Foundation; Morris Animal Foundation; National Science Foundation [EF-0850237]; Kentucky Biomedical Research Infrastructure Network; National Institutes of Health [KY-INBRE P20 RR16481]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006272] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1054631] Funding Source: National Science Foundation	University of Kentucky Gluck Equine Research Foundation; Morris Animal Foundation; National Science Foundation(National Science Foundation (NSF)); Kentucky Biomedical Research Infrastructure Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by the University of Kentucky Gluck Equine Research Foundation, the Morris Animal Foundation, the National Science Foundation (EF-0850237), and the Kentucky Biomedical Research Infrastructure Network supported in part by National Institutes of Health grant KY-INBRE P20 RR16481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; BELLEFROID EJ, 1993, EMBO J, V12, P1363, DOI 10.1002/j.1460-2075.1993.tb05781.x; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Kadota K, 2003, PHYSIOL GENOMICS, V12, P251, DOI 10.1152/physiolgenomics.00153.2002; Kasprzyk A., 2011, DATABASE-OXFORD, V2011, DOI DOI 10.1093/DATABASE/BAR049; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Lorenz P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-206; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Radwan A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-186; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	24	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70125	10.1371/journal.pone.0070125	http://dx.doi.org/10.1371/journal.pone.0070125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922931	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700143
J	Tench, CR; Tanasescu, R; Auer, DP; Constantinescu, CS				Tench, Christopher R.; Tanasescu, Radu; Auer, Dorothee P.; Constantinescu, Cris S.			Coordinate Based Meta-Analysis of Functional Neuroimaging Data; False Discovery Control and Diagnostics	PLOS ONE			English	Article							ALE METAANALYSIS; BRAINMAP; WORKING; MEMORY	Coordinate based meta-analysis (CBMA) is widely used to find regions of consistent activation across fMRI studies that have been selected for their functional relevance to a given hypothesis. Only reported coordinates (foci), and a model of their spatial uncertainty, are used in the analysis. Results are clusters of foci where multiple studies have reported in the same spatial region, indicating functional relevance. There are several published methods that perform the analysis in a voxel-wise manner, resulting in around 10(5) statistical tests, and considerable emphasis placed on controlling the risk of type 1 statistical error. Here we address this issue by dramatically reducing the number of tests, and by introducing a new false discovery rate control: the false cluster discovery rate (FCDR). FCDR is particularly interpretable and relevant to the results of CBMA, controlling the type 1 error by limiting the proportion of clusters that are expected under the null hypothesis. We also introduce a data diagnostic scheme to help ensure quality of the analysis, and demonstrate its use in the example studies. We show that we control the false clusters better than the widely used ALE method by performing numerical experiments, and that our clustering scheme results in more complete reporting of structures relevant to the functional task.	[Tench, Christopher R.; Tanasescu, Radu; Constantinescu, Cris S.] Univ Nottingham, Queens Med Ctr, Div Clin Neurol, Nottingham NG7 2RD, England; [Tanasescu, Radu] Univ Med & Pharm Carol Davila Bucharest, Colentina Hosp, Dept Neurol Neurosurg & Psychiat, Bucharest, Romania; [Auer, Dorothee P.] Univ Nottingham, Queens Med Ctr, Nottingham NG7 2RD, England; [Auer, Dorothee P.] Univ Nottingham, Queens Med Ctr, ARUK Natl Pain Ctr, Nottingham NG7 2RD, England	University of Nottingham; Carol Davila University of Medicine & Pharmacy; University of Nottingham; University of Nottingham	Tench, CR (corresponding author), Univ Nottingham, Queens Med Ctr, Div Clin Neurol, Nottingham NG7 2RD, England.	Christopher.Tench@nottingham.ac.uk	Tanasescu, Radu/B-2453-2008	Tanasescu, Radu/0000-0003-2282-1793; Auer, Dorothee P./0000-0002-4745-3635; Constantinescu, Cris/0000-0003-2066-7585	University of Nottingham	University of Nottingham	Funding came from the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Costafreda Sergi G, 2009, Front Neuroinform, V3, P33, DOI 10.3389/neuro.11.033.2009; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Radua J, 2012, EUR PSYCHIAT, V27, P605, DOI 10.1016/j.eurpsy.2011.04.001; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Salimi-Khorshidi G, 2009, NEUROIMAGE, V45, P810, DOI 10.1016/j.neuroimage.2008.12.039; Talairach J., 1988, COPLANAR STEREOTAXIC; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wager TD, 2007, SOC COGN AFFECT NEUR, V2, P150, DOI 10.1093/scan/nsm015	24	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70143	10.1371/journal.pone.0070143	http://dx.doi.org/10.1371/journal.pone.0070143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922941	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700146
J	Costa, EC; Gaspar, VM; Marques, JG; Coutinho, P; Correia, IJ				Costa, Elisabete C.; Gaspar, Vitor M.; Marques, Joao G.; Coutinho, Paula; Correia, Ilidio J.			Evaluation of Nanoparticle Uptake in Co-culture Cancer Models	PLOS ONE			English	Article							DRUG-DELIVERY; BREAST-CANCER; CELL-CULTURE; MICROENVIRONMENTAL INFLUENCES; EXTRACELLULAR-MATRIX; TUMOR-CELLS; FIBROBLASTS; THERAPEUTICS; NANOTECHNOLOGY; MECHANISMS	Co-culture models are currently bridging the gap between classical cultures and in vivo animal models. Exploring this novel approach unlocks the possibility to mimic the tumor microenvironment in vitro, through the establishment of cancer-stroma synergistic interactions. Notably, these organotypic models offer a perfect platform for the development and preclinical evaluation of candidate nanocarriers loaded with anti-tumoral drugs in a high throughput screening mode, with lower costs and absence of ethical issues. However, this evaluation was until now limited to co-culture systems established with precise cell ratios, not addressing the natural cell heterogeneity commonly found in different tumors. Therefore, herein the multifunctional nanocarriers efficiency was characterized in various fibroblast-MCF-7 co-culture systems containing different cell ratios, in order to unravel key design parameters that influence nanocarrier performance and the therapeutic outcome. The successful establishment of the co-culture models was confirmed by the tissue-like distribution of the different cells in culture. Nanoparticles incubation in the various co-culture systems reveals that these nanocarriers possess targeting specificity for cancer cells, indicating their suitability for being used in this illness therapy. Additionally, by using different co-culture ratios, different nanoparticle uptake profiles were obtained. These findings are of crucial importance for the future design and optimization of new drug delivery systems, since their real targeting capacity must be addressed in heterogenous cell populations, such as those found in tumors.	[Costa, Elisabete C.; Gaspar, Vitor M.; Marques, Joao G.; Coutinho, Paula; Correia, Ilidio J.] Univ Beira Interior, CICS, Covilha, Portugal; [Coutinho, Paula] Unidade Invest Desenvolvimento Interior UDI, Guarda, Portugal	Universidade da Beira Interior	Correia, IJ (corresponding author), Univ Beira Interior, CICS, Covilha, Portugal.	icorreia@ubi.pt	Gaspar, Vítor/AAB-3045-2022; Coutinho, Paula/H-5423-2013; Correia, Ilidio/S-8295-2016; Correia, I. J./AAE-2400-2020; Gaspar, Vítor/B-1602-2017	Coutinho, Paula/0000-0001-6832-3082; Correia, Ilidio/0000-0003-1613-9675; Correia, I. J./0000-0003-1613-9675; Gaspar, Vítor/0000-0002-0372-2493; Costa, Elisabete/0000-0002-0490-0095	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/80402/2011, PTDC/EME-TME/103375/2008, PTDC/EBB-BIO/114320/2009, PEst-OE/EGE/UI4056/2011]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (FCT), SFRH/BD/80402/2011, PTDC/EME-TME/103375/2008, PTDC/EBB-BIO/114320/2009 and PEst-OE/EGE/UI4056/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; BASKIN LS, 1993, J UROLOGY, V150, P1260, DOI 10.1016/S0022-5347(17)35757-9; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2007, BIOCHEM SOC T, V35, P18, DOI 10.1042/BST0350018; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Burguera EF, 2010, EUR CELLS MATER, V19, P166, DOI 10.22203/eCM.v019a17; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Duell BL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852419; ENGEL LW, 1978, CANCER RES, V38, P4327; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gaspar VM, 2011, J CONTROL RELEASE, V156, P212, DOI 10.1016/j.jconrel.2011.08.007; Gaspar VM, 2013, NANOTECHNOL IN PRESS, V24, DOI [10.1088/0957-4484/1024/1027/275101, DOI 10.1088/0957-4484/1024/1027/275101]; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; HogenEsch H, 2012, J CONTROL RELEASE, V164, P183, DOI 10.1016/j.jconrel.2012.02.031; Iamazaki ET, 2004, COLLOID POLYM SCI, V283, P33, DOI 10.1007/s00396-004-1083-6; KNAZEK RA, 1977, J NATL CANCER I, V58, P419, DOI 10.1093/jnci/58.2.419; Ko YH, 2011, CANCER BIOL THER, V12, P1085, DOI 10.4161/cbt.12.12.18671; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Le Droumaguet B, 2012, ACS NANO, V6, P5866, DOI 10.1021/nn3004372; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu LX, 2010, J NANOPART RES, V12, P1637, DOI 10.1007/s11051-009-9722-y; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luo K, 2012, BIOMATERIALS, V33, P4917, DOI 10.1016/j.biomaterials.2012.03.030; Malvezzi M, 2012, ANN ONCOL, V23, P1044, DOI 10.1093/annonc/mds024; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2521, DOI 10.4161/cc.10.15.16584; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P2423, DOI 10.4161/cc.9.12.12048; Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004; Mitra S, 2012, CANCER SCI, V103, P400, DOI 10.1111/j.1349-7006.2011.02183.x; Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Nagpal K, 2010, CHEM PHARM BULL, V58, P1423, DOI 10.1248/cpb.58.1423; Nakase I, 2012, J CONTROL RELEASE, V159, P181, DOI 10.1016/j.jconrel.2012.01.016; Ostman A, 2012, NAT MED, V18, P1332, DOI 10.1038/nm.2938; Parveen S, 2012, NANOMED-NANOTECHNOL, V8, P147, DOI 10.1016/j.nano.2011.05.016; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Purpura KA, 2012, BIOMATERIALS, V33, P1271, DOI 10.1016/j.biomaterials.2011.10.051; Santos JL, 2010, MOL PHARMACEUT, V7, P763, DOI 10.1021/mp9002877; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; STAMMATI AP, 1981, TOXICOLOGY, V20, P91, DOI 10.1016/0300-483X(81)90046-9; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Strell C, 2012, UPSALA J MED SCI, V117, P187, DOI 10.3109/03009734.2012.654859; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Tumarkin E, 2011, INTEGR BIOL-UK, V3, P653, DOI 10.1039/c1ib00002k; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Wu H, 2013, BIOMATERIALS, V34, P1213, DOI 10.1016/j.biomaterials.2012.08.072; Yih TC, 2006, J CELL BIOCHEM, V97, P1184, DOI 10.1002/jcb.20796	58	38	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70072	10.1371/journal.pone.0070072	http://dx.doi.org/10.1371/journal.pone.0070072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922909	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900141
J	Curcio, A; Torella, D; Iaconetti, C; Pasceri, E; Sabatino, J; Sorrentino, S; Giampa, S; Micieli, M; Polimeni, A; Henning, BJ; Leone, A; Catalucci, D; Ellison, GM; Condorelli, G; Indolfi, C				Curcio, Antonio; Torella, Daniele; Iaconetti, Claudio; Pasceri, Eugenia; Sabatino, Jolanda; Sorrentino, Sabato; Giampa, Salvatore; Micieli, Mariella; Polimeni, Alberto; Henning, Beverley J.; Leone, Angelo; Catalucci, Daniele; Ellison, Georgina M.; Condorelli, Gianluigi; Indolfi, Ciro			MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; DE-POINTES ARRHYTHMIAS; PROLIFERATION IN-VITRO; CARDIAC-HYPERTROPHY; ENHANCED SUSCEPTIBILITY; MYOCARDIAL-INFARCTION; CELL PROLIFERATION; VIVO; ACTIVATION; EXPRESSION	Downregulation of the muscle-specific microRNA-1 (miR-1) mediates the induction of pathologic cardiac hypertrophy. Dysfunction of the gap junction protein connexin 43 (Cx43), an established miR-1 target, during cardiac hypertrophy leads to ventricular tachyarrhythmias (VT). However, it is still unknown whether miR-1 and Cx43 are interconnected in the pro-arrhythmic context of hypertrophy. Thus, in this study we investigated whether a reduction in the extent of cardiac hypertrophy could limit the pathological electrical remodeling of Cx43 and the onset of VT by modulating miR-1 levels. Wistar male rats underwent mechanical constriction of the ascending aorta to induce pathologic left ventricular hypertrophy (LVH) and afterwards were randomly assigned to receive 10mg/kg valsartan, VAL (LVH +VAL) delivered in the drinking water or placebo (LVH) for 12 weeks. Sham surgery was performed for control groups. Programmed ventricular stimulation reproducibly induced VT in LVH compared to LVH+VAL group. When compared to sham controls, rats from LVH group showed a significant decrease of miR-1 and an increase of Cx43 expression and its ERK1/2-dependent phosphorylation, which displaces Cx43 from the gap junction. Interestingly, VAL administration to rats with aortic banding significantly reduced cardiac hypertrophy and prevented miR-1 down-regulation and Cx43 up-regulation and phosphorylation. Gain-and loss-of-function experiments in neonatal cardiomyocytes (NCMs) in vitro confirmed that Cx43 is a direct target of miR-1. Accordingly, in vitro angiotensin II stimulation reduced miR-1 levels and increased Cx43 expression and phosphorylation compared to un-stimulated NCMs. Finally, in vivo miR-1 cardiac overexpression by an adenoviral vector intra-myocardial injection reduced Cx43 expression and phosphorylation in mice with isoproterenol-induced LVH. In conclusion, miR-1 regulates Cx43 expression and activity in hypertrophic cardiomyocytes in vitro and in vivo. Treatment of pressure overload-induced myocyte hypertrophy reduces the risk of life-threatening VT by normalizing miR-1 expression levels with the consequent stabilization of Cx43 expression and activity within the gap junction.	[Curcio, Antonio; Torella, Daniele; Iaconetti, Claudio; Pasceri, Eugenia; Sabatino, Jolanda; Sorrentino, Sabato; Giampa, Salvatore; Micieli, Mariella; Polimeni, Alberto; Leone, Angelo; Ellison, Georgina M.; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Lab Mol & Cellular Cardiol, Div Cardiol, Catanzaro, Italy; [Indolfi, Ciro] Magna Graecia Univ Catanzaro, URT Natl Res Council, Catanzaro, Italy; [Torella, Daniele; Henning, Beverley J.; Ellison, Georgina M.] Liverpool John Moores Univ, Biostem Unit, RISES, Liverpool L3 5UX, Merseyside, England; [Catalucci, Daniele] Humanitas Clin & Res Ctr, Milan, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Liverpool John Moores University	Indolfi, C (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Lab Mol & Cellular Cardiol, Div Cardiol, Catanzaro, Italy.	indolfi@unicz.it	Polimeni, Alberto/M-9243-2019; Sorrentino, Sabato/D-3297-2019; Catalucci, Daniele/B-6745-2015; Curcio, Antonio/K-4822-2018; Polimeni, Alberto AP/K-4731-2018; Sabatino, Jolanda/AAO-5173-2020; Sabatino, Jolanda/M-2506-2017; Ellison-Hughes, Georgina M./B-4597-2016; Catalucci, Daniele/AAA-6056-2022; Condorelli, Gianluigi/Q-6736-2017	Polimeni, Alberto/0000-0002-9166-3031; Sorrentino, Sabato/0000-0002-8316-7134; Catalucci, Daniele/0000-0001-7041-6114; Polimeni, Alberto AP/0000-0002-9166-3031; Sabatino, Jolanda/0000-0002-1661-5419; Ellison-Hughes, Georgina M./0000-0002-2733-3361; Catalucci, Daniele/0000-0001-7041-6114; TORELLA, Daniele/0000-0002-4915-5084; Cottle, Beverley/0000-0001-5751-1328; INDOLFI, Ciro/0000-0003-1241-6487; Curcio, Antonio/0000-0003-3213-4436; Condorelli, Gianluigi/0000-0003-0481-6843	Ministry of the Education, University and Research of Italy [PRIN2003065977_002, RBAU018WWP_001]	Ministry of the Education, University and Research of Italy	This study was supported, in part, by Grants for Scientific Research from the Ministry of the Education, University and Research of Italy (PRIN2003065977_002, RBAU018WWP_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Biagetti MO, 2006, HEART RHYTHM, V3, P832, DOI 10.1016/j.hrthm.2006.03.010; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chin BB, 2007, RADIOLOGY, V245, P440, DOI 10.1148/radiol.2452061973; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Curcio A, 2004, AM J PHYSIOL-HEART C, V286, pH902, DOI 10.1152/ajpheart.00130.2003; Curcio A, 2006, AM J PHYSIOL-HEART C, V291, pH1754, DOI 10.1152/ajpheart.01199.2005; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Emdad L, 2001, J MOL CELL CARDIOL, V33, P219, DOI 10.1006/jmcc.2000.1293; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Horita S, 2002, HYPERTENSION, V40, P707, DOI 10.1161/01.HYP.0000036449.70110.DE; House Stacey L, 2010, Mol Cell Pharmacol, V2, P143; Huang CX, 2004, CIRC J, V68, P1205, DOI 10.1253/circj.68.1205; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Iaconetti C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0296-y; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Indolfi C, 2002, CIRCULATION, V106, P2118, DOI 10.1161/01.CIR.0000034047.70205.97; Indolfi C, 2011, BASIC RES CARDIOL, V106, P667, DOI 10.1007/s00395-011-0172-1; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; Kozhevnikov DO, 2002, CIRCULATION, V105, P1128, DOI 10.1161/hc0902.104711; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x; MCLENACHAN JM, 1987, NEW ENGL J MED, V317, P787, DOI 10.1056/NEJM198709243171302; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Mongiardo Annalisa, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P275; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Pourdjabbar A, 2005, AM J PHYSIOL-HEART C, V288, pH1997, DOI 10.1152/ajpheart.00671.2004; Ripplinger CM, 2007, CIRC RES, V101, P1049, DOI 10.1161/CIRCRESAHA.107.161240; Saffitz JE, 1999, CARDIOVASC RES, V42, P309, DOI 10.1016/S0008-6363(99)00023-1; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sovari AA, 2011, J AM COLL CARDIOL, V58, P2332, DOI 10.1016/j.jacc.2011.07.048; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Torella D, 2011, CIRC RES, V109, P880, DOI 10.1161/CIRCRESAHA.111.240150; Torella D, 2009, AM J PHYSIOL-HEART C, V297, pH2015, DOI 10.1152/ajpheart.00738.2009; Tsai CT, 2007, CIRC RES, V100, P1476, DOI 10.1161/01.RES.0000268497.93085.e1; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	56	56	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70158	10.1371/journal.pone.0070158	http://dx.doi.org/10.1371/journal.pone.0070158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922949	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900160
J	Li, CY; Zuo, CW; Deng, GM; Kuang, RB; Yang, QS; Hu, CH; Sheng, O; Zhang, S; Ma, LJ; Wei, YR; Yang, J; Liu, SW; Biswas, MK; Viljoen, A; Yi, GJ				Li, Chunyu; Zuo, Cunwu; Deng, Guiming; Kuang, Ruibin; Yang, Qiaosong; Hu, Chunhua; Sheng, Ou; Zhang, Sheng; Ma, Lijun; Wei, Yuerong; Yang, Jing; Liu, Siwen; Biswas, Manosh Kumar; Viljoen, Altus; Yi, Ganjun			Contamination of Bananas with Beauvericin and Fusaric Acid Produced by Fusarium oxysporum f. sp cubense	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; WILT; RESISTANCE; SUBGLUTINANS; RESPIRATION; AGENT	Background: Fusarium wilt, caused by the fungal pathogen Fusarium oxysporum f. sp. cubense (Foc), is one of the most destructive diseases of banana. Toxins produced by Foc have been proposed to play an important role during the pathogenic process. The objectives of this study were to investigate the contamination of banana with toxins produced by Foc, and to elucidate their role in pathogenesis. Methodology/Principal Findings: Twenty isolates of Foc representing races 1 and 4 were isolated from diseased bananas in five Chinese provinces. Two toxins were consistently associated with Foc, fusaric acid (FA) and beauvericin (BEA). Cytotoxicity of the two toxins on banana protoplast was determined using the Alamar Blue assay. The virulence of 20 Foc isolates was further tested by inoculating tissue culture banana plantlets, and the contents of toxins determined in banana roots, pseudostems and leaves. Virulence of Foc isolates correlated well with toxin deposition in the host plant. To determine the natural occurrence of the two toxins in banana plants with Fusarium wilt symptoms, samples were collected before harvest from the pseudostems, fruit and leaves from 10 Pisang Awak 'Guangfen #1' and 10 Cavendish 'Brazilian' plants. Fusaric acid and BEA were detected in all the tissues, including the fruits. Conclusions/Signficance: The current study provides the first investigation of toxins produced by Foc in banana. The toxins produced by Foc, and their levels of contamination of banana fruits, however, were too low to be of concern to human and animal health. Rather, these toxins appear to contribute to the pathogenicity of the fungus during infection of banana plants.	[Li, Chunyu; Kuang, Ruibin; Yang, Qiaosong; Hu, Chunhua; Sheng, Ou; Wei, Yuerong; Biswas, Manosh Kumar; Yi, Ganjun] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China; [Li, Chunyu; Kuang, Ruibin; Yang, Qiaosong; Hu, Chunhua; Sheng, Ou; Wei, Yuerong; Biswas, Manosh Kumar; Yi, Ganjun] Minist Agr, Key Lab South Subtrop Fruit Biol & Genet Resource, Guangzhou, Guangdong, Peoples R China; [Zuo, Cunwu; Deng, Guiming; Yang, Jing; Biswas, Manosh Kumar] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Ma, Lijun] Univ Massachusetts, Coll Nat Sci, Broad Inst, Cambridge, MA USA; [Viljoen, Altus] Univ Stellenbosch, Dept Plant Pathol, Matieland, South Africa; [Zhang, Sheng] Cornell Univ, Prote & Mass Spectrometry Core Facil, Ithaca, NY USA; Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Wuhan, Hubei, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Massachusetts System; Stellenbosch University; Cornell University; Huazhong Agricultural University	Viljoen, A (corresponding author), Univ Stellenbosch, Dept Plant Pathol, Private Bag X1, Matieland, South Africa.	altus@sun.ac.za; yiganjun@vip.163.com	Ma, Li-Jun/AAG-2359-2020; Li, Chunyu/AAB-7399-2020; Yang, Qiaosong/AAX-4986-2020; Sheng, Ou/AFP-0617-2022	Viljoen, Altus/0000-0001-7146-0491	National Natural Science Fund [U1131004, 30971991]; National Banana Industry and Technology System Project [nycytx-33]; Guangdong Natural Science Fund [10151064001000007, 10451064001006121]; Commonwealth Industry (Agriculture) Specific Fund [200903049-10]; International Collaborative Project [2010DFA32470, 2013DFB30400]; 948 Project of the Department of Agriculture [2011-G16]; 863 project [2011AA10020602]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Banana Industry and Technology System Project; Guangdong Natural Science Fund; Commonwealth Industry (Agriculture) Specific Fund; International Collaborative Project; 948 Project of the Department of Agriculture; 863 project(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Fund (U1131004 and 30971991), National Banana Industry and Technology System Project (nycytx-33), the Guangdong Natural Science Fund (10151064001000007 and 10451064001006121), the Commonwealth Industry (Agriculture) Specific Fund (200903049-10), and the International Collaborative Project (2010DFA32470 and 2013DFB30400) and the 948 Project of the Department of Agriculture (2011-G16) and 863 project (2011AA10020602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, NATURE WILT DIS PLAN; BACON CW, 1995, MYCOPATHOLOGIA, V129, P29, DOI 10.1007/BF01139334; BECKMAN CH, 1961, PHYTOPATHOLOGY, V51, P507; BUDDENHAGEN IW, 1990, FUSARIUM WILT OF BANANA, P107; CHAKRABARTI DK, 1989, J PHYTOPATHOL, V125, P238, DOI 10.1111/j.1439-0434.1989.tb01065.x; Cote FX, 1996, PHYSIOL PLANTARUM, V97, P285, DOI 10.1034/j.1399-3054.1996.970211.x; DALTON A, 1984, PLANT PHYSIOL, V74, P39, DOI 10.1104/pp.74.1.39; DAVIS D, 1969, J PHYTOPATHOL, V59, P1391; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Drysdale R. B., 1984, The applied mycology of Fusarium. Symposium of the British Mycological Society held at Queen Mary College, London, September 1982., P95; Englberger Lois, 2003, Food and Nutrition Bulletin, V24, P303; Fakhouri W, 2003, PHYSIOL MOL PLANT P, V63, P263, DOI 10.1016/j.pmpp.2004.03.004; Foulkes D, 1977, TROP ANIM PROD, V3, P114; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Gapillout I, 1995, EUR J PLANT PATHOL, V102, P127; GAUMANN E, 1957, PHYTOPATHOLOGY, V47, P342; Hamill R. L, 1969, TETRAHEDRON LETT, V49, P4255; HIDAKA H, 1969, J ANTIBIOT, V22, P228, DOI 10.7164/antibiotics.22.228; Hwang SC, 2004, PLANT DIS, V88, P580, DOI 10.1094/PDIS.2004.88.6.580; Kuzniak E, 2001, J PHYTOPATHOL, V149, P575, DOI 10.1046/j.1439-0434.2001.00682.x; Lemmens-Gruber R, 2000, MYCOPATHOLOGIA, V149, P5, DOI 10.1023/A:1007293812007; Li CY, 2011, EUR J PLANT PATHOL, V131, P327, DOI 10.1007/s10658-011-9811-5; Logrieco A, 1998, APPL ENVIRON MICROB, V64, P3084; Logrieco A, 2001, ADV MICROBI IN PRESS; MARRE MT, 1993, PHYSIOL MOL PLANT P, V42, P141, DOI 10.1006/pmpp.1993.1012; Matsumoto K., 1999, Fruits (Paris), V54, P97; Moretti A, 2002, EUR J PLANT PATHOL, V108, P661, DOI 10.1023/A:1020674929084; MORETTI A, 1995, MYCOL RES, V99, P282, DOI 10.1016/S0953-7562(09)80899-X; MORPURGO R, 1994, EUPHYTICA, V75, P121, DOI 10.1007/BF00024539; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Pavlovkin J, 2006, PLANT SOIL ENVIRON, V52, P492, DOI 10.17221/3539-PSE; Ploetz R., 2004, Infomusa, V13, P11; Ploetz R. C., 2000, P143; Ploetz R. C., 1990, FUSARIUM WILT BANANA; Porter J. K., 1993, P 6 C EUR PIN SOC E, V19, P23; Ren YP, 2007, J CHROMATOGR A, V1143, P48, DOI 10.1016/j.chroma.2006.12.064; Samadi L, 2006, PLANTA, V225, P223, DOI 10.1007/s00425-006-0345-6; Song HH, 2009, FOOD ADDIT CONTAM A, V26, P518, DOI 10.1080/02652030802562904; Stover R.H., 1962, FUSARIAL WILT PANAMA; STOVER RH, 1986, FRUITS, V41, P175; SUN EJ, 1984, TROP AGR, V61, P7; TOMODA H, 1992, J ANTIBIOT, V45, P1626, DOI 10.7164/antibiotics.45.1626; Venter SL, 1998, POTATO RES, V41, P289, DOI 10.1007/BF02358198; WAITE B. H., 1953, PLANT DIS REPORTER, V37, P79; Xiao W, 2007, PLANT CELL TISS ORG, V90, P191, DOI 10.1007/s11240-007-9241-4; Xu WY, 2004, CHINESE J TROPICAL C, V4, P25	46	47	74	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70226	10.1371/journal.pone.0070226	http://dx.doi.org/10.1371/journal.pone.0070226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922960	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900162
J	Puri, RV; Reddy, PV; Tyagi, AK				Puri, Rupangi Verma; Reddy, P. Vineel; Tyagi, Anil K.			Secreted Acid Phosphatase (SapM) of Mycobacterium tuberculosis Is Indispensable for Arresting Phagosomal Maturation and Growth of the Pathogen in Guinea Pig Tissues	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; BIOGENESIS; MODEL; MACROPHAGES; VIRULENCE; PHAGOLYSOSOMES; PHAGOCYTOSIS; ACTIVATION; INFECTION; EFFECTORS	Tuberculosis (TB) is responsible for nearly 1.4 million deaths globally every year and continues to remain a serious threat to human health. The problem is further complicated by the growing incidence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), emphasizing the need for the development of new drugs against this disease. Phagosomal maturation arrest is an important strategy employed by Mycobacterium tuberculosis to evade the host immune system. Secretory acid phosphatase (SapM) of M. tuberculosis is known to dephosphorylate phosphotidylinositol 3-phosphate (PI3P) present on phagosomes. However, there have been divergent reports on the involvement of SapM in phagosomal maturation arrest in mycobacteria. This study was aimed at reascertaining the involvement of SapM in phagosomal maturation arrest in M. tuberculosis. Further, for the first time, we have also studied whether SapM is essential for the pathogenesis of M. tuberculosis. By deleting the sapM gene of M. tuberculosis, we demonstrate that MtbDsapM is defective in the arrest of phagosomal maturation as well as for growth in human THP-1 macrophages. We further show that MtbDsapM is severely attenuated for growth in the lungs and spleen of guinea pigs and has a significantly reduced ability to cause pathological damage in the host when compared with the parental strain. Also, the guinea pigs infected with MtbDsapM exhibited a significantly enhanced survival when compared with M. tuberculosis infected animals. The importance of SapM in phagosomal maturation arrest as well as in the pathogenesis of M. tuberculosis establishes it as an attractive target for the development of new therapeutic molecules against tuberculosis.	[Puri, Rupangi Verma; Reddy, P. Vineel; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India	University of Delhi	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in			Department of Biotechnology, Ministry of Science and Technology, India	Department of Biotechnology, Ministry of Science and Technology, India	This work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, India. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bachrach G, 2000, MICROBIOL-UK, V146, P297, DOI 10.1099/00221287-146-2-297; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; DASGUPTA SK, 1993, J BACTERIOL, V175, P5186, DOI 10.1128/JB.175.16.5186-5192.1993; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Deretic V, 1999, MOL MICROBIOL, V31, P1603, DOI 10.1046/j.1365-2958.1999.01279.x; Deretic V, 1997, ELECTROPHORESIS, V18, P2542, DOI 10.1002/elps.1150181409; Desjardins M, 1997, J CELL SCI, V110, P2303; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Esteban MA, 1998, CELL TISSUE RES, V293, P133, DOI 10.1007/s004410051105; Festjens N, 2011, EMBO MOL MED, V3, P222, DOI 10.1002/emmm.201000125; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; GELFAND JA, 1976, J IMMUNOL, V116, P595; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li W, 2011, J CELL BIOCHEM, V112, P2688, DOI 10.1002/jcb.23218; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Mukherjee K, 2002, J CELL SCI, V115, P3693, DOI 10.1242/jcs.00034; North RJ, 1999, INFECT IMMUN, V67, P5483, DOI 10.1128/IAI.67.10.5483-5485.1999; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Saikolappan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036198; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Seto Shintaro, 2011, Nihon Rinsho, V69, P1373; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; WHO, 2011, TUB MDR TB XDR TB 20; WHO, 2012, TUB GLOB FACTS 2011	46	50	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70514	10.1371/journal.pone.0070514	http://dx.doi.org/10.1371/journal.pone.0070514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923000	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900171
J	Esposito, R; Cilli, F; Pieramico, V; Ferretti, A; Macchia, A; Tommasi, M; Saggino, A; Ciavardelli, D; Manna, A; Navarra, R; Cieri, F; Stuppia, L; Tartaro, A; Sensi, SL				Esposito, Roberto; Cilli, Franco; Pieramico, Valentina; Ferretti, Antonio; Macchia, Antonella; Tommasi, Marco; Saggino, Aristide; Ciavardelli, Domenico; Manna, Antonietta; Navarra, Riccardo; Cieri, Filippo; Stuppia, Liborio; Tartaro, Armando; Sensi, Stefano L.			Acute Effects of Modafinil on Brain Resting State Networks in Young Healthy Subjects	PLOS ONE			English	Article							WORKING-MEMORY; DIFFUSION TENSOR; FUNCTIONAL CONNECTIVITY; DOPAMINE TRANSPORTER; PROGRESSIVE MATRICES; INHIBITORY CONTROL; PREFRONTAL CORTEX; PARIETAL CORTEX; DEFAULT MODE; LONG-TERM	Background: There is growing debate on the use of drugs that promote cognitive enhancement. Amphetamine-like drugs have been employed as cognitive enhancers, but they show important side effects and induce addiction. In this study, we investigated the use of modafinil which appears to have less side effects compared to other amphetamine-like drugs. We analyzed effects on cognitive performances and brain resting state network activity of 26 healthy young subjects. Methodology: A single dose (100 mg) of modafinil was administered in a double-blind and placebo-controlled study. Both groups were tested for neuropsychological performances with the Raven's Advanced Progressive Matrices II set (APM) before and three hours after administration of drug or placebo. Resting state functional magnetic resonance (rs-FMRI) was also used, before and after three hours, to investigate changes in the activity of resting state brain networks. Diffusion Tensor Imaging (DTI) was employed to evaluate differences in structural connectivity between the two groups. Protocol ID: Modrest_2011; NCT01684306; http://clinicaltrials.gov/ct2/show/NCT01684306. Principal Findings: Results indicate that a single dose of modafinil improves cognitive performance as assessed by APM. Rs-fMRI showed that the drug produces a statistically significant increased activation of Frontal Parietal Control (FPC; p<0.04) and Dorsal Attention (DAN; p<0.04) networks. No modifications in structural connectivity were observed. Conclusions and Significance: Overall, our findings support the notion that modafinil has cognitive enhancing properties and provide functional connectivity data to support these effects.	[Esposito, Roberto; Ferretti, Antonio; Manna, Antonietta; Navarra, Riccardo; Cieri, Filippo; Tartaro, Armando; Sensi, Stefano L.] Univ G dAnnunzio, Dept Neurosci & Imaging, Pescara, Italy; [Esposito, Roberto; Cilli, Franco; Pieramico, Valentina; Ciavardelli, Domenico; Sensi, Stefano L.] Univ G dAnnunzio, Mol Neurol Unit, Ctr Excellence Aging, Pescara, Italy; [Macchia, Antonella; Tommasi, Marco; Saggino, Aristide; Stuppia, Liborio] Univ G dAnnunzio, Dept Psychol Sci, Pescara, Italy; [Ciavardelli, Domenico] Kore Univ Enna, Sch Engn Architecture & Motor Sci, Enna, Italy; [Sensi, Stefano L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Sensi, Stefano L.] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Sensi, Stefano L.] Univ Calif Irvine, Inst Mind Impairments & Neurol Disorders, Irvine, CA USA	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universita Kore di ENNA; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sensi, SL (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Pescara, Italy.	ssensi@uci.edu	Sensi, Stefano L./J-3164-2016; Tommasi, Marco/G-4917-2013; tartaro, armando at/K-2184-2016; Sensi, Stefano L./O-1335-2019; Cieri, Filippo/ABD-8928-2021	Sensi, Stefano L./0000-0002-0710-2574; Tommasi, Marco/0000-0002-4876-0530; tartaro, armando at/0000-0003-0095-2792; Sensi, Stefano L./0000-0002-0710-2574; Cieri, Filippo/0000-0002-2103-1418; Stuppia, Liborio/0000-0002-6232-0996; Esposito, Roberto/0000-0003-4708-6860; FERRETTI, Antonio/0000-0002-8459-0129; Navarra, Riccardo/0000-0003-2520-1530	Italian Department of Education	Italian Department of Education	SLS is supported by funds from the Italian Department of Education [Fondo per gli Investimenti della Ricerca di Base (FIRB) 2003; Programmi di Ricerca di Rilevante Interesse nazionale (PRIN) 2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Baranski JV, 2004, HUM PSYCHOPHARM CLIN, V19, P323, DOI 10.1002/hup.596; Barbey AK, 2013, BRAIN STRUCT FUNCT; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Brady KT, 2011, PHARMACOL BIOCHEM BE, V99, P285, DOI 10.1016/j.pbb.2011.04.017; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dawson N, 2012, SCHIZOPHRENIA BULL, V38, P457, DOI 10.1093/schbul/sbq090; Dean AC, 2011, J STUD ALCOHOL DRUGS, V72, P943, DOI 10.15288/jsad.2011.72.943; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; Finke K, 2010, PSYCHOPHARMACOLOGY, V210, P317, DOI 10.1007/s00213-010-1823-x; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Ghahremani DG, 2011, NEUROPSYCHOPHARMACOL, V36, P950, DOI 10.1038/npp.2010.233; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hayden BY, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00018; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; Huang ZJ, 2008, NEURON, V59, P355, DOI 10.1016/j.neuron.2008.07.029; Ishizuka T, 2010, NEUROSCI LETT, V483, P193, DOI 10.1016/j.neulet.2010.08.005; James LM, 2011, PSYCHOPHARMACOLOGY, V215, P643, DOI 10.1007/s00213-010-2158-3; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kahbazi M, 2009, PSYCHIAT RES, V168, P234, DOI 10.1016/j.psychres.2008.06.024; Kalechstein AD, 2013, NEUROPHARMACOLOGY, V64, P472, DOI 10.1016/j.neuropharm.2012.06.064; Kollins SH, 2001, PHARMACOL BIOCHEM BE, V68, P611, DOI 10.1016/S0091-3057(01)00464-6; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2011, PSYCHOPHARMACOLOGY, V215, P23, DOI 10.1007/s00213-010-2111-5; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Moldofsky H, 2000, SLEEP MED, V1, P109, DOI 10.1016/S1389-9457(99)00014-3; Morgan RE, 2007, PHARMACOL BIOCHEM BE, V86, P531, DOI 10.1016/j.pbb.2007.01.015; Muller U, 2004, PSYCHOPHARMACOLOGY, V177, P161, DOI 10.1007/s00213-004-1926-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Phillips JM, 2013, CEREB CORTEX; Pierard C, 2006, PHARMACOL BIOCHEM BE, V83, P1, DOI 10.1016/j.pbb.2005.11.018; Raggi A, 2011, NEUROSCI BIOBEHAV R, V35, P1144, DOI 10.1016/j.neubiorev.2010.12.001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Randall DC, 2004, PHARMACOL BIOCHEM BE, V77, P547, DOI 10.1016/j.pbb.2003.12.016; Rasetti R, 2010, NEUROPSYCHOPHARMACOL, V35, P2101, DOI 10.1038/npp.2010.83; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Schmaal L, 2013, BIOL PSYCHIAT; Schmaal L, 2013, BIOL PSYCHIAT, V73, P211, DOI 10.1016/j.biopsych.2012.06.032; Schweizer K, 2007, PERS INDIV DIFFER, V43, P1998, DOI 10.1016/j.paid.2007.06.008; Sesack S R, 1998, Adv Pharmacol, V42, P171; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1420; Volkow ND, 2009, JAMA-J AM MED ASSOC, V301, P1148, DOI 10.1001/jama.2009.351; Wesensten NJ, 2005, J SLEEP RES, V14, P255, DOI 10.1111/j.1365-2869.2005.00468.x; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yuan ZN, 2012, BEHAV BRAIN RES, V229, P384, DOI 10.1016/j.bbr.2012.01.037; Zack M, 2009, J PSYCHOPHARMACOL, V23, P660, DOI 10.1177/0269881108091072	69	35	35	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69224	10.1371/journal.pone.0069224	http://dx.doi.org/10.1371/journal.pone.0069224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935959	Green Published, gold			2022-12-27	WOS:000322433300027
J	Niu, DH; Wang, L; Sun, FY; Liu, ZJ; Li, JL				Niu, Donghong; Wang, Lie; Sun, Fanyue; Liu, Zhanjiang; Li, Jiale			Development of Molecular Resources for an Intertidal Clam, Sinonovacula constricta, Using 454 Transcriptome Sequencing	PLOS ONE			English	Article							AMYLASE GENE POLYMORPHISM; GROWTH-RELATED TRAITS; EST-SSR MARKERS; QTL; ASSOCIATION; COAST; IDENTIFICATION; EXPRESSION; GENERATION; LARVAE	Background: The razor clam Sinonovacula constricta is a benthic intertidal bivalve species with important commercial value. Despite its economic importance, knowledge of its transcriptome is scarce. Next generation sequencing technologies offer rapid and efficient tools for generating large numbers of sequences, which can be used to characterize the transcriptome, to develop effective molecular markers and to identify genes associated with growth, a key breeding trait. Results: Total RNA was isolated from the mantle, gill, liver, siphon, gonad and muscular foot tissues. High-throughput deep sequencing of S. constricta using 454 pyrosequencing technology yielded 859,313 high-quality reads with an average read length of 489 bp. Clustering and assembly of these reads produced 16,323 contigs and 131,346 singletons with average lengths of 1,376 bp and 458 bp, respectively. Based on transcriptome sequencing, 14,615 sequences had significant matches with known genes encoding 147,669 predicted proteins. Subsequently, previously unknown growth-related genes were identified. A total of 13,563 microsatellites (SSRs) and 13,634 high-confidence single nucleotide polymorphism loci (SNPs) were discovered, of which almost half were validated. Conclusion: De novo sequencing of the razor clam S. constricta transcriptome on the 454 GS FLX platform generated a large number of ESTs. Candidate growth factors and a large number of SSRs and SNPs were identified. These results will impact genetic studies of S. constricta.	[Niu, Donghong; Wang, Lie; Li, Jiale] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources Certific, Shanghai, Peoples R China; [Niu, Donghong; Wang, Lie; Li, Jiale] Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Sun, Fanyue; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA	Shanghai Ocean University; Auburn University System; Auburn University	Li, JL (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources Certific, Shanghai, Peoples R China.	jlli@shou.edu.cn	Liu, Zhanjiang/R-9633-2019; li, jia/GVT-7587-2022		"863'' Hi-tech research and development program of China [2012AA10A400-3]; National Natural Science Foundation of China [31101897]; Shanghai University Knowledge Service Platform [ZF1206]	"863'' Hi-tech research and development program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai University Knowledge Service Platform	This study was supported by the "863'' Hi-tech research and development program of China (2012AA10A400-3), the National Natural Science Foundation of China (31101897), and the Shanghai University Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2012, INT J MOL SCI, V13, P10583, DOI 10.3390/ijms130810583; Chen Jun, 2010, Zoological Research, V31, P345, DOI 10.3724/SP.J.1141.2010.04345; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cong RH, 2013, BIOCHEM SYST ECOL, V46, P36, DOI 10.1016/j.bse.2012.09.008; Coppe A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044185; Feng BB, 2010, MAR BIOTECHNOL, V12, P282, DOI 10.1007/s10126-009-9216-z; Guo L, 2011, ANIM GENET, V42, P339, DOI 10.1111/j.1365-2052.2011.02172.x; Guo X, 2012, MAR BIOTECHNOL, V14, P218, DOI 10.1007/s10126-011-9405-4; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Hemmer-Hansen J, 2011, MOL ECOL RESOUR, V11, P71, DOI 10.1111/j.1755-0998.2010.02940.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Houston RD, 2009, ANIM GENET, V40, P753, DOI 10.1111/j.1365-2052.2009.01883.x; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Huvet A, 2008, ANIM GENET, V39, P662, DOI 10.1111/j.1365-2052.2008.01776.x; Jung H., 2012, REV AQUACULT, V4, P1; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Keskin E, 2013, MITOCHONDRIAL DNA; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1147, DOI 10.1016/j.fsi.2011.02.017; Li H, 2011, COMP BIOCH PHYSL B, V161, P315; Li HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046926; Li XH, 2012, MOL BIOL REP, V39, P4359, DOI 10.1007/s11033-011-1223-2; Liu LS, 2012, MOL BIOL REP, V39, P9211, DOI 10.1007/s11033-012-1794-6; Lu X, 2013, MAR BIOTECHNOL, V15, P16, DOI 10.1007/s10126-012-9453-4; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Meyer E, 2010, J EXP BIOL, V213, P749, DOI 10.1242/jeb.037242; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Niu DH, 2008, PERIODICAL OCEAN U C, V38, P733; Niu DH, 2012, ZOOL STUD, V51, P406; Niu Dong-Hong, 2010, Chinese Journal of Zoology, V45, P11; Peakall R, 2005, MOL ECOLOGY NOTES, V6, P288; Petersen JL, 2012, AQUACULTURE, V350, P200, DOI 10.1016/j.aquaculture.2012.03.039; Prudence M, 2006, ANIM GENET, V37, P348, DOI 10.1111/j.1365-2052.2006.01481.x; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sanchez-Ramos I, 2012, SCI WORLD J, DOI 10.1100/2012/369802; van der Merwe M, 2011, MAR BIOTECHNOL, V13, P1125, DOI 10.1007/s10126-011-9376-5; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang HX, 2011, GENES GENET SYST, V86, P197, DOI 10.1266/ggs.86.197; Wang XL, 2010, COMP BIOCHEM PHYS B, V155, P327, DOI 10.1016/j.cbpb.2009.12.001; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Ye L, 2006, CHINA FISHERIES, V372, P65; Yue X, 2012, FISH SHELLFISH IMMUN, V33, P559, DOI 10.1016/j.fsi.2012.06.007; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]	48	52	55	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e67456	10.1371/journal.pone.0067456	http://dx.doi.org/10.1371/journal.pone.0067456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935831	Green Submitted, gold, Green Published			2022-12-27	WOS:000322433300001
J	Brink, MC; Piebes, DGE; de Groote, ML; Luijsterburg, MS; Casas-Delucchi, CS; van Driel, R; Rots, MG; Cardoso, MC; Verschure, PJ				Brink, Maartje C.; Piebes, Diewertje G. E.; de Groote, Marloes L.; Luijsterburg, Martijn S.; Casas-Delucchi, Corella S.; van Driel, Roel; Rots, Marianne G.; Cardoso, M. Cristina; Verschure, Pernette J.			A Role for MeCP2 in Switching Gene Activity via Chromatin Unfolding and HP1 gamma Displacement	PLOS ONE			English	Article							BINDING PROTEIN MECP2; RETT-SYNDROME MUTATIONS; METHYLATED DNA; LIVING CELLS; TRANSCRIPTIONAL REPRESSION; NEURONAL MATURATION; HISTONE DEACETYLASE; CHROMOSOMAL PROTEIN; REMODELING COMPLEX; DOMAINS	Methyl-CpG-binding protein 2 (MeCP2) is generally considered to act as a transcriptional repressor, whereas recent studies suggest that MeCP2 is also involved in transcription activation. To gain insight into this dual function of MeCP2, we assessed the impact of MeCP2 on higher-order chromatin structure in living cells using mammalian cell systems harbouring a lactose operator and reporter gene-containing chromosomal domain to assess the effect of lactose repressor-tagged MeCP2 (and separate MeCP2 domains) binding in living cells. Our data reveal that targeted binding of MeCP2 elicits extensive chromatin unfolding. MeCP2-induced chromatin unfolding is triggered independently of the methyl-cytosine-binding domain. Interestingly, MeCP2 binding triggers the loss of HP1 gamma at the chromosomal domain and an increased HP1 gamma mobility, which is not observed for HP1 alpha and HP1 beta. Surprisingly, MeCP2-induced chromatin unfolding is not associated with transcriptional activation. Our study suggests a novel role for MeCP2 in reorganizing chromatin to facilitate a switch in gene activity.	[Brink, Maartje C.; Piebes, Diewertje G. E.; Luijsterburg, Martijn S.; van Driel, Roel; Verschure, Pernette J.] Univ Amsterdam, Netherlands Inst Syst Biol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [de Groote, Marloes L.; Rots, Marianne G.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Casas-Delucchi, Corella S.; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	University of Amsterdam; University of Groningen; Technical University of Darmstadt	Verschure, PJ (corresponding author), Univ Amsterdam, Netherlands Inst Syst Biol, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	P.J.Verschure@uva.nl	Brink, Maartje/C-9927-2015; Casas-Delucchi, Corella S/F-9549-2012; Luijsterburg, Martijn/A-7663-2015	Casas-Delucchi, Corella S/0000-0003-2531-1123	Netherlands Organization for Scientific Research [VIDI-016041311, NWO-Meervoud-83607001, VIDI-91786373]; Deutsche Forschungsgemeinschaft	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Support was provided by the Netherlands Organization for Scientific Research VIDI-016041311, NWO-Meervoud-83607001 to PJV, VIDI-91786373 to MGR and Deutsche Forschungsgemeinschaft to MCC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Belmont AS, 1999, METHOD CELL BIOL, V58, P203; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; de Leeuw W, 2006, IEEE T VIS COMPUT GR, V12, P1251, DOI 10.1109/TVCG.2006.195; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; de Leon-Guerrero SD, 2011, EUR J NEUROSCI, V33, P1563, DOI 10.1111/j.1460-9568.2011.07658.x; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Elvazova ER, 2009, J MOL BIOL, V386, P929, DOI 10.1016/j.jmb.2008.12.022; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hamer KM, 2002, HYBRIDOMA HYBRIDOM, V21, P245, DOI 10.1089/153685902760213859; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Hines KA, 2009, GENETICS, V182, P967, DOI 10.1534/genetics.109.105338; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hu KP, 2006, NAT GENET, V38, P962, DOI 10.1038/ng0906-962; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jost KL, PLOS ONE, V6; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; LaSalle JM, 2007, EPIGENETICS-US, V2, P5, DOI 10.4161/epi.2.1.3697; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Matsumura S, 2010, J VIROL, V84, P2318, DOI 10.1128/JVI.01097-09; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, CIBA F SYMP, V214, P6; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rohlf FJ., 2011, BIOMETRY PRINCIPLES; Rottach A, 2008, HYBRIDOMA, V27, P91, DOI 10.1089/hyb.2007.0555; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; van Steensel B, 2011, EMBO J, V30, P1885, DOI 10.1038/emboj.2011.135; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; Verschure PJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1303, DOI 10.1177/002215540205001003; Vicent GP, 2008, J STEROID BIOCHEM, V109, P344, DOI 10.1016/j.jsbmb.2008.03.015; Volpi EV, 2000, J CELL SCI, V113, P1565; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	69	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69347	10.1371/journal.pone.0069347	http://dx.doi.org/10.1371/journal.pone.0069347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935992	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000106
J	Marshall, CS; Curtis, AJ; Spelman, T; O'Brien, DP; Greig, J; Shanks, L; du Cros, P; Casas, EC; da Fonseca, MS; Athan, E; Elliott, JH				Marshall, Catherine S.; Curtis, Andrea J.; Spelman, Tim; O'Brien, Daniel P.; Greig, Jane; Shanks, Leslie; du Cros, Philipp; Casas, Esther C.; da Fonseca, Marcio Silveira; Athan, Eugene; Elliott, Julian H.			Impact of Hiv-Associated Conditions on Mortality in People Commencing Anti-Retroviral Therapy in Resource Limited Settings	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; SUB-SAHARAN AFRICA; CRYPTOCOCCAL MENINGITIS; IMMUNE RECONSTITUTION; 1ST YEAR; TUBERCULOSIS; OUTCOMES; PREDICTORS; PROGRAM; BURDEN	Objectives: To identify associations between specific WHO stage 3 and 4 conditions diagnosed after ART initiation and all cause mortality for patients in resource-limited settings (RLS). Design, Setting: Analysis of routine program data collected prospectively from 25 programs in eight countries between 2002 and 2010. Subjects, Participants: 36,664 study participants with median ART follow-up of 1.26 years (IQR 0.55-2.27). Outcome Measures: Using a proportional hazards model we identified factors associated with mortality, including the occurrence of specific WHO clinical stage 3 and 4 conditions during the 6-months following ART initiation. Results: There were 2922 deaths during follow-up (8.0%). The crude mortality rate was 5.41 deaths per 100 person-years (95% CI: 5.21-5.61). The diagnosis of any WHO stage 3 or 4 condition during the first 6 months of ART was associated with increased mortality (HR: 2.21; 95% CI: 1.97-2.47). After adjustment for age, sex, region and pre-ART CD4 count, a diagnosis of extrapulmonary cryptococcosis (aHR: 3.54; 95% CI: 2.74-4.56), HIV wasting syndrome (aHR: 2.92; 95% CI: 2.21 -3.85), non-tuberculous mycobacterial infection (aHR: 2.43; 95% CI: 1.80-3.28) and Pneumocystis pneumonia (aHR: 2.17; 95% CI 1.80-3.28) were associated with the greatest increased mortality. Cerebral toxoplasmosis, pulmonary and extra-pulmonary tuberculosis, Kaposi's sarcoma and oral and oesophageal candidiasis were associated with increased mortality, though at lower rates. Conclusions: A diagnosis of certain WHO stage 3 and 4 conditions is associated with an increased risk of mortality in those initiating ART in RLS. This information will assist initiatives to reduce excess mortality, including prioritization of resources for diagnostics, therapeutic interventions and research.	[Marshall, Catherine S.; Elliott, Julian H.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Curtis, Andrea J.; Spelman, Tim; Elliott, Julian H.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Spelman, Tim; Elliott, Julian H.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [O'Brien, Daniel P.; Shanks, Leslie; Casas, Esther C.; da Fonseca, Marcio Silveira] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [O'Brien, Daniel P.; Athan, Eugene] Geelong Hosp, Dept Infect Dis, Geelong, Vic, Australia; [O'Brien, Daniel P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia; [Greig, Jane; du Cros, Philipp] Medecins Sans Frontieres, Manson Unit, London, England; [Athan, Eugene] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; Doctors Without Borders; Geelong Hospital; Royal Melbourne Hospital; University of Melbourne; Doctors Without Borders; Deakin University	Marshall, CS (corresponding author), Royal Darwin Hosp, Div Med, Darwin, NT, Australia.	catherine.marshall@nt.gov.au	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; du Cros, Philipp/0000-0002-3599-029X; Curtis, Andrea/0000-0003-2407-770X; Greig, Jane/0000-0003-2732-0023; Athan, Eugene/0000-0001-9838-6471	M�decins Sans Fronti�res [OCA_pilot_00_Greig, OCA_ERB_009_20_OBrien] Funding Source: researchfish	M�decins Sans Fronti�res		Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2011, AUT REAL TIM NUCL AC; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Curtis AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052019; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Jarvis JN, 2010, CLIN INFECT DIS, V51, P1463, DOI 10.1086/657405; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Lynen L, 2006, CLIN HIV AIDS CARE G; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; WHO, 2010, ANT THER HIV INF AD; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440; World Health Organisation, 2006, ANT THER AD AD RES L; World Health Organization, 2004, SCAL ANT THER RES LT; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	36	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68445	10.1371/journal.pone.0068445	http://dx.doi.org/10.1371/journal.pone.0068445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935870	Green Published, gold			2022-12-27	WOS:000325211000030
J	Scheibe, FJB; Waiswa, P; Kadobera, D; Muller, O; Ekstrom, AM; Sarker, M; Neuhann, HWF				Scheibe, Florian J. B.; Waiswa, Peter; Kadobera, Daniel; Mueller, Olaf; Ekstroem, Anna M.; Sarker, Malabika; Neuhann, H. W. Florian			Effective Coverage for Antiretroviral Therapy in a Ugandan District with a Decentralized Model of Care	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RESOURCE-LIMITED SETTINGS; HIV-1 DRUG-RESISTANCE; FOLLOW-UP; TREATMENT PROGRAMS; VIROLOGICAL FAILURE; PATIENT RETENTION; HIGH PREVALENCE; PATIENTS LOST; 1ST YEAR	Introduction: While increasing access to antiretroviral therapy (ART) is reported from many African countries, data on effective coverage particular from settings without external support or research remains scarce. We examined and report effective coverage data from a public ART program in rural Uganda. Methods: We conducted a retrospective cohort study at all ART-providing governmental health facilities in Iganga District, Eastern Uganda. Based on all HIV patients registered between April 2004 and September 2009 (n = 4775), we assessed indicators of program performance and determined rates of retention and Cox proportional hazards for attrition. Effective ART coverage was calculated using projections (SPECTRUM software) adapted to the district demographic structure and number of people receiving ART. Results: By September 2009, district public sector effective ART coverage was 10.3% for adults and 1.9% for children. After a median follow-up of 26.9 months, overall ART retention was 54.7%. The probability of retention was 0.72 (95% confidence interval (CI) 0.69-0.75) at 12 and 0.58 (CI 0.54-0.62) at 36 months after ART initiation. Individual health facilities differed considerably regarding performance indicators and retention. Overall, 198 (16.9%) individual files of 1171 registered ART patients were lost. Young adult age (15-24 years) had a higher risk of attrition (HR 2.1, CI 1.4-3.2) as well as WHO stage I (HR 4.8, CI 1.9-11.8) and WHO stage IV (HR 2.5, CI 1.3-4.7). An interval >= 6 weeks between HIV testing and ART initiation was associated with a reduced risk (HR 0.6, CI 0.47-0.78). Conclusion: Compared to reported national data effective ART coverage in Iganga District was low. Intensified efforts to improve access, retention in care, and quality of documentation are urgently needed. Children and young adults require special attention in the program.	[Scheibe, Florian J. B.; Mueller, Olaf; Sarker, Malabika; Neuhann, H. W. Florian] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Scheibe, Florian J. B.] Ortenau Klinikum, Dept Cardiol Pulmonol, Offenburg, Germany; [Waiswa, Peter; Ekstroem, Anna M.] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Waiswa, Peter] Karolinska Inst, IHCAR, Div Global Hlth, Stockholm, Sweden; [Waiswa, Peter; Kadobera, Daniel] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh	Ruprecht Karls University Heidelberg; Makerere University; Karolinska Institutet; Bangladesh Rural Advancement Committee BRAC; BRAC University	Neuhann, HWF (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.	florian.neuhann@uni-heidelberg.de		Sarker, Malabika/0000-0001-7293-8805	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is a part of the project "Effects of Antiretrovirals for HIV on African health systems, Maternal and Child Health" (ARVMAC, www.arvmac.eu), supported financially by the European Commission 6th Framework Program. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2013, JAIDS-J ACQ IMM DEF, V62, pE7, DOI 10.1097/QAI.0b013e3182706401; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Assefa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038555; Bajunirwe Francis, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P139, DOI 10.1177/1545109709332470; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chang LVW, 2009, JAIDS-J ACQ IMM DEF, V50, P276, DOI 10.1097/QAI.0b013e3181988375; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; District Health Office Iganga, 2009, ANN REPORT; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; El-Khatib Z, 2011, J AIDS CLIN RES, V2; Estopinal CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049564; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kirunda KA, 2008, SATURDAY MONITOR, P11; Koole O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040971; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lubega M, 2010, HEALTH POLICY, V95, P153, DOI 10.1016/j.healthpol.2009.11.021; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Martin JA, 2008, AEROSPACE AM, V46, P6; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Miiro G, 2009, TROP MED INT HEALTH, V14, P556, DOI 10.1111/j.1365-3156.2009.02259.x; Ministry of Health Republic of Uganda, 2007, 2004 2005 SER BEH SU; Ministry of Health RoU, 2012, 2011 UG AIDS IND SUR; Ministry of Health - Government of Malawi, 2011, Q HIV PROGR REP; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Olle-Goig JE, 2009, HLTH POLICY DEV, P60; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Rwabwogo Odrek, 2007, UG DISTR INF HDB; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Searle C, 2010, STUD HEALTH TECHNOL, V160, P476, DOI 10.3233/978-1-60750-588-4-476; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Tenthani L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-140; The Director General Health Services, 2008, NAT ANT TREATM CAR G; The STD/AIDS Control Programme Ministry of Health Republic of Uganda The HIVDR Technical Working Group for Uganda, 2009, TRACK HIV DRUG RES F; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Uganda AIDS Commission, 2010, UG COUNTR PROGR REP; Uganda Bureau of Statistics, 2009, 2009 STAT ABSTR; Uganda Bureau of Statistics, 2011, 2011 STAT ABSTR; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; UNAIDS, 2011, UNAIDS 2011 2015 STR; UNAIDS, 2011, UG HIV EST 2009; UNAIDS, 2011, WORLD AIDS DAY REP 2; Unge C, 2009, JAIDS-J ACQ IMM DEF, V50, P397, DOI 10.1097/QAI.0b013e318194618e; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Windisch R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-25; World Health Organization, 2010, MON EQ ACC AIDS TREA, P69; World Health Organization, 2010, HIV DRUG RES EARL WA; World Health Organization, 2011, M REP 13 15 SEPT 201; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Yu JKL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002065	72	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69433	10.1371/journal.pone.0069433	http://dx.doi.org/10.1371/journal.pone.0069433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936015	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000119
J	Li, RT; Wu, W; Liu, Q; Wu, PY; Xie, L; Zhu, ZS; Yang, M; Qian, XP; Ding, Y; Yu, LX; Jiang, XQ; Guan, WX; Liu, BR				Li, Rutian; Wu, Wei; Liu, Qin; Wu, Puyuan; Xie, Li; Zhu, Zhenshu; Yang, Mi; Qian, Xiaoping; Ding, Yin; Yu, Lixia; Jiang, Xiqun; Guan, Wenxian; Liu, Baorui			Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; POOR-PROGNOSIS; CANCER-THERAPY; CONJUGATE; MMP-9; METASTASIS; EXPRESSION; INHIBITORS; CARCINOMA; EFFICACY	Aims: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery. Materials and Methods: mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared from mPEG-PCL, NPs prepared from mPEG-PCL copolymer were used as positive control. Docetaxel-loading NPs using mPEG-pep-PCL and mPEG-PCL were prepared by nano-precipitation method, mentioned as Gel-NPs and Con-NPs, respectively. The morphologic changes of the NPs after treatment with gelatinases were observed macroscopically by spectrophotometer and microscopically by transmission electron microscopy (TEM) and atomic force microscopy (AFM). The cellular uptake amount and cytotoxicity of Gel-NPs and Con-NPs, respectively, in cell lines with different levels of gelatinase expression were studied. Moreover, the cytotoxicity study on the primary cancer cells isolated from pericardial fluids from a patient with late-stage lung cancer was conducted. Results: The Gel-NPs aggregated in response to gelatinases, which was confirmed macroscopically and microscopically. The cellular uptake amount of Gel-NPs was correlated with the level of gelatinases. The in vitro antitumor effect of Gel-NPs was also correlated with the level of gelatinases and was superior to Taxotere (commercially available docetaxel) as well as the Con-NPs. The cytotoxicity study on the primary lung cancer cells also confirmed the effectiveness of Gel-NPs. Conclusion: The results in this study preliminarily demonstrated the effectiveness of gelatinase-responsive targeting strategy and the prospect of this intelligent nano-drug delivery system though further studies are needed.	[Li, Rutian; Liu, Qin; Wu, Puyuan; Xie, Li; Yang, Mi; Qian, Xiaoping; Yu, Lixia; Liu, Baorui] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, Nanjing 210008, Jiangsu, Peoples R China; [Li, Rutian; Liu, Qin; Wu, Puyuan; Xie, Li; Yang, Mi; Qian, Xiaoping; Yu, Lixia; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Wei; Jiang, Xiqun] Nanjing Univ, Lab Mesoscop Chem, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Wei; Jiang, Xiqun] Nanjing Univ, Dept Polymer Sci & Engn, Coll Chem & Chem Engn, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Zhenshu] China Pharmaceut Univ, Dept Pharmaceut Anal, Nanjing, Jiangsu, Peoples R China; [Ding, Yin] Nanjing Univ, Sch Chem & Chem Engn, Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China; [Guan, Wenxian] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; China Pharmaceutical University; Nanjing University; Nanjing University	Guan, WX (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China.	Guanwenxian@163.com; Baoruiliu@nju.edu.cn	Wu, Wei/ABC-1888-2021; Yang, Mi/GQA-8758-2022; Jiang, Xiqun/I-8128-2014	Wu, Wei/0000-0003-1845-2809; Jiang, Xiqun/0000-0003-0483-0282	National Natural Science Foundation of China [81101751, 81172281 81101816, 21105047]; Nanjing Medical Science and technique Development Foundation (Youth Foundation Level 3); Nanjing Medical Science and technique Development Foundation (Outstanding Youth Foundation) [JQX12003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Science and technique Development Foundation (Youth Foundation Level 3); Nanjing Medical Science and technique Development Foundation (Outstanding Youth Foundation)	This work was supported by National Natural Science Foundation of China (no. 81101751, 81172281 81101816 and 21105047), Nanjing Medical Science and technique Development Foundation (Youth Foundation Level 3) and Nanjing Medical Science and technique Development Foundation (Outstanding Youth Foundation, JQX12003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buergy D, 2009, INT J CANCER, V125, P894, DOI 10.1002/ijc.24462; Chau Y, 2006, INT J CANCER, V118, P1519, DOI 10.1002/ijc.21495; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foda HD, 2001, DRUG DISCOV TODAY, V6, P478, DOI 10.1016/S1359-6446(01)01752-4; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Ghadiali JE, 2008, ADV MATER, V20, P4359, DOI 10.1002/adma.200703158; Gullotti E, 2009, MOL PHARMACEUT, V6, P1041, DOI 10.1021/mp900090z; Hatakeyama H, 2007, GENE THER, V14, P68, DOI 10.1038/sj.gt.3302843; Huo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048752; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Kang GD, 2006, EUR J PHARM BIOPHARM, V63, P340, DOI 10.1016/j.ejpb.2006.01.001; Karakoti AS, 2011, ANGEW CHEM INT EDIT, V50, P1980, DOI 10.1002/anie.201002969; Kremer R, 2010, BRIT J CANCER, V102, P1180, DOI 10.1038/sj.bjc.6605607; Kuittinen O, 1999, ANTICANCER RES, V19, P4395; Lamparter S, 2005, AM J CARDIOL, V95, P1065, DOI 10.1016/j.amjcard.2004.12.059; Lee GY, 2007, EUR J PHARM BIOPHARM, V67, P646, DOI 10.1016/j.ejpb.2007.03.023; Li R, 2011, PLOS ONE, V6; Li RT, 2009, INT J PHARMACEUT, V379, P158, DOI 10.1016/j.ijpharm.2009.06.007; Li XL, 2008, EUR J PHARM BIOPHARM, V70, P726, DOI 10.1016/j.ejpb.2008.06.016; Liu Q, 2012, INT J NANOMED, V7, P281, DOI 10.2147/IJN.S26697; Liu Z, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-270; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Makhof A, 2009, EUR J PHARM BIOPHARM, V72, P1, DOI 10.1016/j.ejpb.2008.12.013; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mishra DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045308; Mohamad A, 2006, EUR J PHARM BIOPHARM, V64, P173, DOI 10.1016/j.ejpb.2006.04.006; Nomura Y, 2007, SCAND J GASTROENTERO, V42, P1070, DOI 10.1080/00365520701435881; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Pinhassi RI, 2010, BIOMACROMOLECULES, V11, P294, DOI 10.1021/bm900853z; Rosen H, 2005, NAT REV DRUG DISCOV, V4, P381, DOI 10.1038/nrd1721; Scherer RL, 2008, MOL IMAGING, V7, P118, DOI 10.2310/7290.2008.00010; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Sharma S, 2011, MOL VIS, V17, P2898; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026803; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; WEINGARTEN H, 1986, BIOCHEM BIOPH RES CO, V139, P1184, DOI 10.1016/S0006-291X(86)80302-3; Wu W, 2009, MED ONCOL, V26, P117, DOI 10.1007/s12032-008-9087-6; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Zhang Y, 2006, NANO LETT, V6, P1988, DOI 10.1021/nl0611586	44	22	22	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69643	10.1371/journal.pone.0069643	http://dx.doi.org/10.1371/journal.pone.0069643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936062	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200041
J	Bernabo, G; Levy, G; Ziliani, M; Caeiro, LD; Sanchez, DO; Tekiel, V				Bernabo, Guillermo; Levy, Gabriela; Ziliani, Maria; Caeiro, Lucas D.; Sanchez, Daniel O.; Tekiel, Valeria			TcTASV-C, a Protein Family in Trypanosoma cruzi that Is Predominantly Trypomastigote-Stage Specific and Secreted to the Medium	PLOS ONE			English	Article							SURFACE PROTEIN; GENE-EXPRESSION; TRANS-SIALIDASE; ALANINE-RICH; EPIGENETIC REGULATION; GENOMIC ORGANIZATION; MULTIGENE FAMILIES; CHAGAS-DISEASE; MASP FAMILY; SEQUENCE	Among the several multigene families codified by the genome of T. cruzi, the TcTASV family was the latest discovered. The TcTASV (Trypomastigote, Alanine, Serine, Valine) family is composed of similar to 40 members, with conserved carboxi- and amino-termini but with a variable central core. According to the length and sequence of the central region the family is split into 3 subfamilies. The TcTASV family is conserved in the genomes of - at least - lineages TcI and TcVI and has no orthologues in other trypanosomatids. In the present work we focus on the study of the TcTASV-C subfamily, composed by 16 genes in the CL Brener strain. We determined that TcTASV-C is preferentially expressed in trypomastigotes, but it is not a major component of the parasite. Both immunoflourescence and flow cytometry experiments indicated that TcTASV-C has a clonal expression, i.e. it is not expressed by all the parasites of a certain population at the same time. We also determined that TcTASV-C is phosphorylated and glycosylated. TASV-C is attached to the parasite surface by a GPI anchor and is shed spontaneously into the medium. About 30% of sera from infected hosts reacted with TcTASV-C, confirming its exposition to the immune system. Its superficial localization and secretory nature suggest a possible role in host-parasite interactions.	[Bernabo, Guillermo; Levy, Gabriela; Ziliani, Maria; Caeiro, Lucas D.; Sanchez, Daniel O.; Tekiel, Valeria] Univ Nacl San Martin UNSAM, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Tekiel, V (corresponding author), Univ Nacl San Martin UNSAM, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH, CONICET, Buenos Aires, DF, Argentina.	valet@iib.unsam.edu.ar		Levy, Gabriela Vanesa/0000-0002-7638-3509; Tekiel, Valeria/0000-0003-2981-2312; sanchez, daniel/0000-0002-5427-7764	ANPCyT, Argentina [PICT 2006- 488]; Consejo Nacional de Investigaciones Cientificas y Tecnicas - CONICET, Argentina [PIP 2011- 329]; Fundacion Bunge y Born "Subsidios para Investigacion en Enfermedad de Chagas", Argentina [FBB45/12]	ANPCyT, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas - CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Bunge y Born "Subsidios para Investigacion en Enfermedad de Chagas", Argentina	This work was supported by grants of ANPCyT, Argentina (PICT 2006- 488 to VT; http://www.agencia.gov.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas - CONICET, Argentina (PIP 2011- 329 to VT; http://www.conicet.gov.ar/), and Fundacion Bunge y Born "Subsidios para Investigacion en Enfermedad de Chagas", Argentina (FBB45/12 to VT; http://www.fundacionbyb.org/index.asp). VT and DOS are members of the Research Career, and MZ and GB fellows of CONICET; GL is a fellow of Fundacion Bunge y Born. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Aguero F, 2004, MOL BIOCHEM PARASIT, V136, P221, DOI 10.1016/j.molbiopara.2004.04.002; Aguero F, 2006, NUCLEIC ACIDS RES, V34, pD428, DOI 10.1093/nar/gkj108; ALMEIDA IC, 1994, BRAZ J MED BIOL RES, V27, P443; Alsford S, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.7; Anez N, 2004, TROP MED INT HEALTH, V9, P1319, DOI 10.1111/j.1365-3156.2004.01333.x; Araujo PR, 2011, MEM I OSWALDO CRUZ, V106, P257, DOI 10.1590/S0074-02762011000300002; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baida RCP, 2006, INFECT IMMUN, V74, P1537, DOI 10.1128/IAI.74.3.1537-1546.2006; Barderi P, 1998, BIOCHEM J, V330, P951, DOI 10.1042/bj3300951; Bartholomeu DC, 2009, NUCLEIC ACIDS RES, V37, P3407, DOI 10.1093/nar/gkp172; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; Buscaglia CA, 1999, BLOOD, V93, P2025, DOI 10.1182/blood.V93.6.2025.406k19_2025_2032; Butikofer P, 1999, J CELL SCI, V112, P1785; Canepa GE, 2012, BIOCHEM J, V444, P211, DOI 10.1042/BJ20120074; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Cerqueira GC, 2008, MOL BIOCHEM PARASIT, V157, P65, DOI 10.1016/j.molbiopara.2007.10.002; Cordero EM, 2009, J PROTEOME RES, V8, P3642, DOI 10.1021/pr800887u; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; Cuevas IC, 2003, INFECT IMMUN, V71, P5739, DOI 10.1128/IAI.71.10.5739-5749.2003; Cunha-Neto E, 2011, ADV PARASIT, V76, P129, DOI 10.1016/B978-0-12-385895-5.00006-2; da Silva CV, 2009, MICROBES INFECT, V11, P563, DOI 10.1016/j.micinf.2009.03.007; Di Noia JM, 2002, J EXP MED, V195, P401, DOI 10.1084/jem.20011433; DiNoia JM, 1996, J BIOL CHEM, V271, P32078, DOI 10.1074/jbc.271.50.32078; dos Santos SL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001779; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Ekanayake DK, 2011, MOL CELL BIOL, V31, P1690, DOI 10.1128/MCB.01277-10; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Figueiredo LM, 2009, NAT REV MICROBIOL, V7, P504, DOI 10.1038/nrmicro2149; Fragoso CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007074; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Garcia Eliseo, 2010, Proceedings 4th European Conference on Antennas and Propagation (EuCAP 2010); HARLOW E, 1998, USING ANTIBODIES LAB; Kim D, 2005, GENE, V346, P153, DOI 10.1016/j.gene.2004.10.014; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; De Pablos LM, 2012, INFECT IMMUN, V80, P2258, DOI 10.1128/IAI.06225-11; Nakayasu ES, 2012, J PROTEOME RES, V11, P237, DOI 10.1021/pr200806s; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; Ramirez JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000899; Sambrook J., 2001, MOL CLONING LAB MANU; SCHENKMAN S, 1991, EXP PARASITOL, V72, P76, DOI 10.1016/0014-4894(91)90123-E; SCHENKMAN S, 1993, PARASITOL TODAY, V9, P218, DOI 10.1016/0169-4758(93)90017-A; Songthamwat D, 2007, PARASITOL INT, V56, P273, DOI 10.1016/j.parint.2007.05.004; Stanne TM, 2010, EUKARYOT CELL, V9, P136, DOI 10.1128/EC.00281-09; Staquicini DI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000613; TDR Disease Reference Group WHO, 2012, WHO TECHN REP SER; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Tekiel V, 2009, VACCINE, V27, P1323, DOI 10.1016/j.vaccine.2008.12.056; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Verdun RE, 1998, INFECT IMMUN, V66, P5393, DOI 10.1128/IAI.66.11.5393-5398.1998; Vitelli-Avelar DM, 2008, SCAND J IMMUNOL, V68, P516, DOI 10.1111/j.1365-3083.2008.02167.x; Vitelli-Avelar DM, 2007, J IMMUNOL METHODS, V318, P102, DOI 10.1016/j.jim.2006.10.009; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	64	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71192	10.1371/journal.pone.0071192	http://dx.doi.org/10.1371/journal.pone.0071192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923058	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700229
J	Lim, PS; Jeng, YC; Wu, MY; Pai, MA; Wu, TK; Liu, CS; Chen, CH; Kuo, YC; Chien, SW; Chen, HP				Lim, Paik Seong; Jeng, Yachung; Wu, Ming Ying; Pai, Mei-Ann; Wu, Tsai-Kun; Liu, Chia-San; Chen, Chan Hsu; Kuo, Yuan-Chuan; Chien, Shiaw-Wen; Chen, Hung Ping			Serum Oxidized Albumin and Cardiovascular Mortality in Normoalbuminemic Hemodialysis Patients: A Cohort Study	PLOS ONE			English	Article							OXIDATIVE STRESS; REDOX STATE; MERCAPT CONVERSION; DIALYSIS PATIENTS; OXIDANT STRESS; NITRIC-OXIDE; ANTIOXIDANT; PLASMA; INFLAMMATION; ASSOCIATION	Background: Substantial evidence suggests that increased oxidative stress in hemodialysis (HD) patients may contribute to cardiovascular complications. Oxidative modifications of human serum albumin (HSA), the largest thiol pool in plasma, alter its biological properties and may affect its antioxidant potential in HD patients. Methods: We conducted a long-term follow-up study in a cohort of normoalbuminemic HD patients to examine the impact of redox state of serum albumin on patients' survival by measuring the human nonmercaptoalbumin (HNA) fraction of HSA. Results: After adjusting for potential demographic, anthropometric, and clinical confounders, a positive association of HNA level with the risk of death from cardiovascular disease (CVD) and all-cause mortality was observed in normoalbuminemic HD patients. Using stratified analysis, we found a stronger association between HNA level and the risk of death from CVD and all-cause mortality in patients with pre-existing CVD. Conclusions: Serum HNA level is a positive predictor of mortality in normoalbuminemic HD patients, especially among those with pre-existing CVD. Increased oxidative stress resulting from biological changes in serum albumin levels could contribute to accelerated atherosclerosis and the development of cardiovascular disease in HD patients.	[Lim, Paik Seong; Wu, Ming Ying; Pai, Mei-Ann; Wu, Tsai-Kun; Liu, Chia-San; Chen, Chan Hsu; Kuo, Yuan-Chuan; Chien, Shiaw-Wen; Chen, Hung Ping] Tungs Taichung Metroharbour Hosp, Div Renal Med, Taichung, Taiwan; [Lim, Paik Seong] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Jeng, Yachung] Tungs Taichung Metroharbour Hosp, Dept Med Res, Div Epidemiol & Biostat, Taichung, Taiwan	Providence University - Taiwan	Jeng, YC (corresponding author), Tungs Taichung Metroharbour Hosp, Dept Med Res, Div Epidemiol & Biostat, Taichung, Taiwan.	yachungjeng@gmail.com						Amaral S, 2008, CLIN J AM SOC NEPHRO, V3, P759, DOI 10.2215/CJN.02720707; Beddhu S, 2002, AM J KIDNEY DIS, V40, P721, DOI 10.1053/ajkd.2002.35679; Bourdon E, 1999, FASEB J, V13, P233, DOI 10.1096/fasebj.13.2.233; Cha MK, 1996, BIOCHEM BIOPH RES CO, V222, P619, DOI 10.1006/bbrc.1996.0793; Cooper BA, 2004, AM J KIDNEY DIS, V43, P61, DOI 10.1053/j.ajkd.2003.08.045; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; Daschner M, 1996, KIDNEY INT, V50, P1268, DOI 10.1038/ki.1996.437; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; DEAN RT, 1991, FREE RADICAL BIO MED, V11, P161, DOI 10.1016/0891-5849(91)90167-2; DEMASTER EG, 1995, BIOCHEMISTRY-US, V34, P11494, DOI 10.1021/bi00036a023; Descamps-Latscha B, 2001, KIDNEY INT, V59, pS108; Djousse L, 2002, CIRCULATION, V106, P2919, DOI 10.1161/01.CIR.0000042673.07632.76; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; ERA S, 1995, BBA-PROTEIN STRUCT M, V1247, P12, DOI 10.1016/0167-4838(94)00166-E; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hayashi T., 2000, PATHOPHYSIOLOGY, V6, P237, DOI [10.1016/S0928-4680(99)00022-X, DOI 10.1016/S0928-4680(99)00022-X]; Himmelfarb J, 2001, KIDNEY INT, V60, P358, DOI 10.1046/j.1523-1755.2001.00807.x; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; ISEKI K, 1993, KIDNEY INT, V44, P115, DOI 10.1038/ki.1993.220; Ishii T, 2011, NEPHRON CLIN PRACT, V117, pC230, DOI 10.1159/000320201; JANATOVA J, 1968, J BIOL CHEM, V243, P3612; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kalantar-Zadeh K, 2006, AM J KIDNEY DIS, V48, P59, DOI 10.1053/j.ajkd.2006.03.047; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Lim PS, 2007, NEPHROLOGY, V12, P18, DOI 10.1111/j.1440-1797.2006.00745.x; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; Mera K, 2005, HYPERTENS RES, V28, P973, DOI 10.1291/hypres.28.973; Michelis R, 2010, BIOCHEM BIOPH RES CO, V401, P137, DOI 10.1016/j.bbrc.2010.09.027; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Ogasawara Y, 2007, J CHROMATOGR B, V845, P157, DOI 10.1016/j.jchromb.2006.08.006; Peters T, 1996, ALL ALBUMIN BIOCH GE, P51; RADI R, 1991, J BIOL CHEM, V266, P4244; Roberts MA, 2006, NEPHROL DIAL TRANSPL, V21, P1611, DOI 10.1093/ndt/gfl053; Soejima A, 2004, BLOOD PURIFICAT, V22, P525, DOI 10.1159/000082524; SOGAMI M, 1985, INT J PEPT PROT RES, V25, P398; SOGAMI M, 1985, J CHROMATOGR, V332, P19, DOI 10.1016/S0021-9673(01)83283-0; Terawaki H, 2004, KIDNEY INT, V66, P1988, DOI 10.1111/j.1523-1755.2004.00969.x; Terawaki H, 2010, THER APHER DIAL, V14, P465, DOI 10.1111/j.1744-9987.2010.00841.x; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; Tomida M, 2003, JPN J PHYSIOL, V53, P351, DOI 10.2170/jjphysiol.53.351	44	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70822	10.1371/journal.pone.0070822	http://dx.doi.org/10.1371/journal.pone.0070822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923025	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700208
J	Pratchett, MS; McCowan, D; Maynard, JA; Heron, SF				Pratchett, Morgan S.; McCowan, Dominique; Maynard, Jeffrey A.; Heron, Scott F.			Changes in Bleaching Susceptibility among Corals Subject to Ocean Warming and Recurrent Bleaching in Moorea, French Polynesia	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF CORALS; COMMUNITIES; RESILIENCE; MORTALITY; FUTURE; SHIFTS; IMPACTS; DISTURBANCE; RESPONSES	Background: Climate-induced coral bleaching poses a major threat to coral reef ecosystems, mostly because of the sensitivities of key habitat-forming corals to increasing temperature. However, susceptibility to bleaching varies greatly among coral genera and there are likely to be major changes in the relative abundance of different corals, even if the wholesale loss of corals does not occur for several decades. Here we document variation in bleaching susceptibility among key genera of reef-building corals in Moorea, French Polynesia, and compare bleaching incidence during mass-bleaching events documented in 1991, 1994, 2002 and 2007. Methodology/Principal Findings: This study compared the proportion of colonies that bleached for four major genera of reef-building corals (Acropora, Montipora, Pocillopora and Porites), during each of four well-documented bleaching events from 1991 to 2007. Acropora and Montipora consistently bleached in far greater proportions (up to 98%) than Pocillopora and Porites. However, there was an apparent and sustained decline in the proportion of colonies that bleached during successive bleaching events, especially for Acropora and Montipora. In 2007, only 77% of Acropora colonies bleached compared with 98% in 1991. Temporal variation in the proportion of coral colonies bleached may be attributable to differences in environmental conditions among years. Alternately, the sustained declines in bleaching incidence among highly susceptible corals may be indicative of acclimation or adaptation. Conclusions/Significance: Coral genera that are highly susceptible to coral bleaching, and especially Acropora and Montipora, exhibit temporal declines in their susceptibility to thermal anomalies at Moorea, French Polynesia. One possible explanation for these findings is that gradual removal of highly susceptible genotypes (through selective mortality of individuals, populations, and/or species) is producing a coral assemblage that is more resistant to sustained and ongoing ocean warming.	[Pratchett, Morgan S.; McCowan, Dominique] James Cook Univ North Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Maynard, Jeffrey A.] CRIOBE, Lab Excellence CORAIL USR CNRS EPHE 3278, Papetoai, Moorea, France; [Maynard, Jeffrey A.] CREST Res Pk UNCW, Ctr Marine Sci, Wilmington, NC USA; [Heron, Scott F.] Natl Ocean & Atmospher Adm Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Marine Geophys Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia	James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University	Pratchett, MS (corresponding author), James Cook Univ North Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.	morgan.pratchett@jcu.edu.au	Pratchett, Morgan S/A-9256-2010; Heron, Scott F/E-7928-2011; Pratchett, Morgan/AAW-5179-2020	Pratchett, Morgan S/0000-0002-1862-8459; Pratchett, Morgan/0000-0002-1862-8459; Maynard, Dr Jeffrey/0000-0002-6444-6373; Heron, Scott/0000-0001-5262-6978	Australian Research Council Centre of Excellence for Coral Reef Studies; Australian Research Council (Australian Research Fellowship); Centre National de la Recherche Scientifique; Centre de Recherches Insulaires et Observatoire de l'Environnement	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council (Australian Research Fellowship)(Australian Research Council); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Centre de Recherches Insulaires et Observatoire de l'Environnement	This research was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies. The work was supported by grants to MP from the Australian Research Council (Australian Research Fellowship) and from and from Centre National de la Recherche Scientifique and Centre de Recherches Insulaires et Observatoire de l'Environnement to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bena C, 2004, B MAR SCI, V75, P115; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dunne RP, 2001, CORAL REEFS, V20, P201; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; KARLSON RH, 1993, CORAL REEFS, V12, P117, DOI 10.1007/BF00334469; Karlson RH, 2004, NATURE, V429, P867, DOI 10.1038/nature02685; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penin L, 2007, CR BIOL, V330, P171, DOI 10.1016/j.crvi.2006.12.003; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pichon M, 1985, P 5 INT COR REEF S, V1, P73; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Salvat B, 1992, P 8 INT COR REEF S G, V1, P73; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Stone L, 1999, ECOL LETT, V2, P325, DOI 10.1046/j.1461-0248.1999.00092.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Trapon ML, 2011, MAR BIOL, P1; van Woesik R, 2012, CORAL REEFS, V31, P633, DOI 10.1007/s00338-012-0911-2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilkinson C., 2004, STATUS CORAL REEFS W	51	107	108	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70443	10.1371/journal.pone.0070443	http://dx.doi.org/10.1371/journal.pone.0070443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922992	gold, Green Accepted, Green Published			2022-12-27	WOS:000323369700183
J	Richard, G; Trivedi, N; Belta, C; Amar, S				Richard, Guilhem; Trivedi, Niraj; Belta, Calin; Amar, Salomon			Partial Restoration of Macrophage Alteration from Diet-Induced Obesity in Response to Porphyromonas gingivalis Infection	PLOS ONE			English	Article							SIGNALING MECHANISMS; INTEGRATIVE ANALYSIS; IMMUNE-RESPONSES; HOST-DEFENSE; EXPRESSION; GENE; MICE; INFLAMMATION; ACTIVATION; MOUSE	Obesity is a chronic inflammatory disease that weakens macrophage innate immune response to infections. Since M1 polarization is crucial during acute infectious diseases, we hypothesized that diet-induced obesity inhibits M1 polarization of macrophages in the response to bacterial infections. Bone marrow macrophages (BMMW) from lean and obese mice were exposed to live Porphyromonas gingivalis (P. gingivalis) for three incubation times (1 h, 4 h and 24 h). Flow cytometry analysis revealed that the M1 polarization was inhibited after P. gingivalis exposure in BMMW from obese mice when compared with BMMW from lean counterparts. Using a computational approach in conjunction with microarray data, we identified switching genes that may differentially control the behavior of response pathways in macrophages from lean and obese mice. The two most prominent switching genes were thrombospondin 1 and arginase 1. Protein expression levels of both genes were higher in obese BMMW than in lean BMMW after exposure to P. gingivalis. Inhibition of either thrombospondin 1 or arginase 1 by specific inhibitors recovered the M1 polarization of BMMW from obese mice after P. gingivalis exposure. These data indicate that thrombospondin 1 and arginase 1 are important bacterial response genes, whose regulation is altered in macrophages from obese mice.	[Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA; [Richard, Guilhem; Trivedi, Niraj; Belta, Calin; Amar, Salomon] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA	Boston University; Boston University	Amar, S (corresponding author), Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA.	samar@bu.edu		Amar, Salomon/0000-0002-0017-5930; Richard, Guilhem/0000-0002-6544-4257	National Institute of Dental and Craniofacial Research [DE15989]; National Science Foundation [EF-1137906, EF-1137900]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015989] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Institute of Dental and Craniofacial Research, DE15989, and the National Science Foundation under grant numbers EF-1137906 and EF-1137900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cosgrove EJ, 2008, BIOINFORMATICS, V24, P2482, DOI 10.1093/bioinformatics/btn476; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553; Haas MJ, 2010, DIABETES-METAB RES, V26, P90, DOI 10.1002/dmrr.1057; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Lobo JC, 2010, BIOL TRACE ELEM RES, V135, P16, DOI 10.1007/s12011-009-8504-9; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Takigawa I, 2008, BIOINFORMATICS, V24, P250, DOI 10.1093/bioinformatics/btm575; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777; Zhou QD, 2011, P NATL ACAD SCI USA, V108, P2867, DOI 10.1073/pnas.1019270108; Zhou QD, 2009, P NATL ACAD SCI USA, V106, P10740, DOI 10.1073/pnas.0904412106	36	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70320	10.1371/journal.pone.0070320	http://dx.doi.org/10.1371/journal.pone.0070320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922979	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700173
J	Sharma, NK; Gupta, A; Prabhakar, S; Singh, R; Sharma, SK; Chen, W; Anand, A				Sharma, Neel Kamal; Gupta, Amod; Prabhakar, Sudesh; Singh, Ramandeep; Sharma, Suresh Kumar; Chen, Wei; Anand, Akshay			Association between CFH Y402H Polymorphism and Age Related Macular Degeneration in North Indian Cohort	PLOS ONE			English	Article							COMPLEMENT-FACTOR-H; CIGARETTE-SMOKING; RISK; VARIANT; GENE; POPULATION; PREVALENCE; SUSCEPTIBILITY; SUGGESTS; PROTEIN	The purpose of the study was to determine serum complement factor H (CFH) levels in patients of age related macular degeneration (AMD) and examine its association with CFH Y402H polymorphism. 115 AMD patients and 61 normal controls were recruited in this study. The single nucleotide polymorphism was assayed by real time PCR and serum CFH levels were measured by ELISA and standardized to total serum protein. Chi-square test was applied to polymorphism analysis while Mann Whitney U-statistic for CFH-levels. Mendelian randomization approach was used for determining causal relationship. The genotype frequency differed between the AMD patients (TT-18.3%, TC-41.3% and CC-40.4%) and controls (TT-76.3%, TC-13.6%, and CC-10.1%) (p = 0001). The frequency of alleles was also significantly different when AMD (T-39% and C-61%) was compared to controls (T-83% and C-17%) (p = 0.0001). Level of serum CFH was significantly lower in AMD patients as compared to normal controls (p = 0.001). Our data showed that the CFH Y402H polymorphism is a risk factor for AMD in the North Indian population. Mendelian randomization approach revealed that CFH Y402H polymorphism affects AMD risk through the modification of CFH serum levels.	[Sharma, Neel Kamal; Prabhakar, Sudesh; Anand, Akshay] Post Grad Inst Med Educ & Res, Dept Neurol, Chandigarh, India; [Gupta, Amod; Singh, Ramandeep] Post Grad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh 160014, India; [Chen, Wei] UPMC, Childrens Hosp Pittsburgh, Div Pulm Med Allergy & Immunol, Pittsburgh, PA USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anand, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.	akshay1anand@rediffmail.com	Gupta, Amod/V-7633-2017; Chen, Wei/AAX-5994-2020; anand, Akshay/AAI-1586-2019	Gupta, Amod/0000-0001-8427-5738; Chen, Wei/0000-0001-7196-8703; 	Indian Council of Medical research, India [45/11/2010-HUM/BMS]	Indian Council of Medical research, India(Indian Council of Medical Research (ICMR))	The authors acknowledge Indian Council of Medical research, India for providing funds (45/11/2010-HUM/BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Fisher SA, 2007, BRIT J OPHTHALMOL, V91, P576, DOI 10.1136/bjo.2006.105577; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fuse N, 2006, AM J OPHTHALMOL, V142, P1074, DOI 10.1016/j.ajo.2006.07.030; Goverdhan SV, 2008, EYE, V22, P849, DOI 10.1038/sj.eye.6702830; Greenfield JR, 2004, EUR J CLIN INVEST, V34, P590, DOI 10.1111/j.1365-2362.2004.01389.x; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hodge WG, 2006, OPHTHALMOLOGY, V113, P1165, DOI 10.1016/j.ophtha.2006.02.043; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kaur I, 2006, INVEST OPHTH VIS SCI, V47, P3729, DOI 10.1167/iovs.05-1430; Kornsteiner M, 2008, ANN NUTR METAB, V52, P37, DOI 10.1159/000118629; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; Nirmalan PK, 2004, ARCH OPHTHALMOL-CHIC, V122, P581, DOI 10.1001/archopht.122.4.581; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Scott WK, 2007, OPHTHALMOLOGY, V114, P1151, DOI 10.1016/j.ophtha.2006.08.054; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Sharma NK, 2013, GENE, V523, P106, DOI 10.1016/j.gene.2013.03.052; Sharma NK, 2012, CURR NEUROVASC RES, V9, P256; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Shuler RK, 2007, ARCH OPHTHALMOL-CHIC, V125, P63, DOI 10.1001/archopht.125.1.63; Silva AS, 2012, MOL VIS, V18, P2288; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Uka J, 2006, RETINA-J RET VIT DIS, V26, P985, DOI 10.1097/01.iae.0000244068.18520.3e; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; Wener MH, 2000, J RHEUMATOL, V27, P2351; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	43	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70193	10.1371/journal.pone.0070193	http://dx.doi.org/10.1371/journal.pone.0070193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922956	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700156
J	Boudreau, P; Dumont, GA; Boivin, DB				Boudreau, Philippe; Dumont, Guy A.; Boivin, Diane B.			Circadian Adaptation to Night Shift Work Influences Sleep, Performance, Mood and the Autonomic Modulation of the Heart	PLOS ONE			English	Article							INTERMITTENT BRIGHT LIGHT; RATE-VARIABILITY; PSYCHOMOTOR VIGILANCE; SUBSEQUENT RECOVERY; PHASE POSITION; MELATONIN; RISK; IMPACT; RESTRICTION; ALERTNESS	Our aim was to investigate how circadian adaptation to night shift work affects psychomotor performance, sleep, subjective alertness and mood, melatonin levels, and heart rate variability (HRV). Fifteen healthy police officers on patrol working rotating shifts participated to a bright light intervention study with 2 participants studied under two conditions. The participants entered the laboratory for 48 h before and after a series of 7 consecutive night shifts in the field. The nighttime and daytime sleep periods were scheduled during the first and second laboratory visit, respectively. The subjects were considered "adapted" to night shifts if their peak salivary melatonin occurred during their daytime sleep period during the second visit. The sleep duration and quality were comparable between laboratory visits in the adapted group, whereas they were reduced during visit 2 in the non-adapted group. Reaction speed was higher at the end of the waking period during the second laboratory visit in the adapted compared to the non-adapted group. Sleep onset latency (SOL) and subjective mood levels were significantly reduced and the LF:HF ratio during daytime sleep was significantly increased in the non-adapted group compared to the adapted group. Circadian adaptation to night shift work led to better performance, alertness and mood levels, longer daytime sleep, and lower sympathetic dominance during daytime sleep. These results suggest that the degree of circadian adaptation to night shift work is associated to different health indices. Longitudinal studies are required to investigate long-term clinical implications of circadian misalignment to atypical work schedules.	[Boudreau, Philippe; Boivin, Diane B.] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada; [Boudreau, Philippe; Boivin, Diane B.] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Dumont, Guy A.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; University of British Columbia	Boivin, DB (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada.	diane.boivin@douglas.mcgill.ca		Dumont, Guy/0000-0003-2048-4391; Boudreau, Philippe/0000-0002-9367-2919	Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	This work was supported by the Institut de Recherche Robert-Sauve en Sante et en Securite du Travail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; ALTERMAN T, 2012, AM J IND MED; Anders D, 2010, CHRONOBIOL INT, V27, P1609, DOI 10.3109/07420528.2010.504317; [Anonymous], 5 EUR WORK COND SURV; Axelsson J, 2008, CHRONOBIOL INT, V25, P297, DOI 10.1080/07420520802107031; Baehr EK, 1999, AM J PHYSIOL-REG I, V277, pR1598, DOI 10.1152/ajpregu.1999.277.6.R1598; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Binici Z, 2011, STROKE, V42, P3196, DOI 10.1161/STROKEAHA.110.607697; Bjorvatn B, 2006, SLEEP, V29, P821, DOI 10.1093/sleep/29.6.821; Boivin DB, 2005, IND HEALTH, V43, P34, DOI 10.2486/indhealth.43.34; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Boivin DB, 2012, CHRONOBIOL INT, V29, P629, DOI 10.3109/07420528.2012.675252; Boivin DB, 2012, CHRONOBIOL INT, V29, P619, DOI 10.3109/07420528.2012.675257; Bonde JP, 2012, SCAND J WORK ENV HEA, V38, P380, DOI 10.5271/sjweh.3282; BOUDREAU P, 2012, C P IEEE ENG MED BIO; Boudreau P, 2012, CHRONOBIOL INT, V29, P757, DOI 10.3109/07420528.2012.674592; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brandenberger G, 2003, J SLEEP RES, V12, P173, DOI 10.1046/j.1365-2869.2003.00353.x; Buckheit J. B, 1995, TECHNICAL REPORT; Camm AJ, 1996, EUR HEART J, V17, P354; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chapdelaine S, 2012, J SLEEP RES, V21, P380, DOI 10.1111/j.1365-2869.2012.00998.x; Chua ECP, 2012, SLEEP, V35, P325, DOI 10.5665/sleep.1688; Chung MH, 2012, IND HEALTH, V50, P24, DOI 10.2486/indhealth.MS1305; Chung MH, 2009, SCAND J WORK ENV HEA, V35, P180, DOI 10.5271/sjweh.1324; Coleman RM, 1982, SLEEPING WAKING DISO, P265; Crowley SJ, 2004, SLEEP, V27, P1077, DOI 10.1093/sleep/27.6.1077; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Dettoni JL, 2012, J APPL PHYSIOL, V113, P232, DOI 10.1152/japplphysiol.01604.2011; Di Milia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045856; Dinges DF, 1997, SLEEP, V20, P267; Dorrian J, 2003, SLEEP, V26, P871, DOI 10.1093/sleep/26.7.871; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Driesen K, 2010, CHRONOBIOL INT, V27, P1062, DOI 10.3109/07420528.2010.489877; Dula DJ, 2001, ANN EMERG MED, V38, P152, DOI 10.1067/mem.2001.116024; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; FERGUSON SA, 2010, APPL ERGON; Folkard S, 2008, CHRONOBIOL INT, V25, P215, DOI 10.1080/07420520802106835; Freitas J, 1997, J ELECTROCARDIOL, V30, P39, DOI 10.1016/S0022-0736(97)80033-7; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Frost P, 2009, SCAND J WORK ENV HEA, V35, P163, DOI 10.5271/sjweh.1319; Furlan R, 2000, CIRCULATION, V102, P1912, DOI 10.1161/01.CIR.102.16.1912; Gamble KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018395; Garde AH, 2009, INT ARCH OCC ENV HEA, V82, P1219, DOI 10.1007/s00420-009-0419-4; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Ha M, 2001, J Hum Ergol (Tokyo), V30, P229; Haavisto ML, 2010, J SLEEP RES, V19, P444, DOI 10.1111/j.1365-2869.2010.00823.x; Hansen JH, 2010, INT ARCH OCC ENV HEA, V83, P607, DOI 10.1007/s00420-010-0547-x; Holmes A L, 2001, J Hum Ergol (Tokyo), V30, P223; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Horowitz TS, 2001, AM J PHYSIOL-ENDOC M, V281, pE384, DOI 10.1152/ajpendo.2001.281.2.E384; Horwitz IB, 2004, OCCUP MED-OXFORD, V54, P556, DOI 10.1093/occmed/kqh093; Iber C, 2007, AASM MANUAL SCORING; Ishibashi Keita, 2007, Journal of Physiological Anthropology, V26, P39, DOI 10.2114/jpa2.26.39; Ishii N, 2005, AUTON NEUROSCI-BASIC, V122, P94, DOI 10.1016/j.autneu.2005.08.010; Ito H, 2001, INT J CARDIOL, V79, P231, DOI 10.1016/S0167-5273(01)00439-9; James FO, 2004, CHRONOBIOL INT, V21, P961, DOI 10.1081/CBI-200035944; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Koskinen T, 2009, AUTON NEUROSCI-BASIC, V145, P81, DOI 10.1016/j.autneu.2008.10.011; Lamond N, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.11.e13; Lamond N, 2004, ERGONOMICS, V47, P154, DOI 10.1080/00140130310001617930; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Lombardi DA, 2012, CHRONOBIOL INT, V29, P556, DOI 10.3109/07420528.2012.675253; Macchi MM, 2002, ACCIDENT ANAL PREV, V34, P825, DOI 10.1016/S0001-4575(01)00089-6; Magrini A, 2006, Int J Immunopathol Pharmacol, V19, P31; Malmberg B, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-239; Mitani S, 2006, INT ARCH OCC ENV HEA, V79, P27, DOI 10.1007/s00420-005-0026-y; Murata K, 2005, INT ARCH OCC ENV HEA, V78, P287, DOI 10.1007/s00420-004-0592-4; Niu SF, 2011, J NURS RES, V19, P68, DOI 10.1097/JNR.0b013e31820c1879; Paech GM, 2010, APPL ERGON, V41, P600, DOI 10.1016/j.apergo.2009.12.017; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Revell VL, 2006, J CLIN ENDOCR METAB, V91, P54, DOI 10.1210/jc.2005-1009; Rimmer DW, 2000, AM J PHYSIOL-REG I, V279, pR1574, DOI 10.1152/ajpregu.2000.279.5.R1574; Ruggiero JS, 2012, BIOL RES NURS, V14, P225, DOI 10.1177/1099800411408413; Santhi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001233; Sasseville A, 2009, CHRONOBIOL INT, V26, P913, DOI 10.1080/07420520903044398; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; SHANAHAN TL, 1991, J CLIN ENDOCR METAB, V73, P227, DOI 10.1210/jcem-73-2-227; Shechter A, 2010, SLEEP, V33, P647, DOI 10.1093/sleep/33.5.647; Sloan RP, 2008, AUTON NEUROSCI-BASIC, V139, P78, DOI 10.1016/j.autneu.2008.01.006; Smith MR, 2012, NAT SCI SLEEP, V4, P111, DOI 10.2147/NSS.S10372; Smith MR, 2009, SLEEP, V32, P1481, DOI 10.1093/sleep/32.11.1481; Smith MR, 2009, J BIOL RHYTHM, V24, P161, DOI 10.1177/0748730409332068; Smith MR, 2008, SLEEP, V31, P1639, DOI 10.1093/sleep/31.12.1639; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Takahashi M, 2005, IND HEALTH, V43, P171, DOI 10.2486/indhealth.43.171; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Van Dongen HPA, 2006, CHRONOBIOL INT, V23, P1139, DOI 10.1080/07420520601100971; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Viola AU, 2008, AM J PHYSIOL-HEART C, V295, pH2156, DOI 10.1152/ajpheart.00662.2008; Viola AU, 2002, J BIOL RHYTHM, V17, P539, DOI 10.1177/0748730402238236; Violanti JM, 2012, AM J IND MED, V55, P217, DOI 10.1002/ajim.22007; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wehrens SM, 2012, SCAND J WORK ENV HEA, V38, P171, DOI 10.5271/sjweh.3197; Wong IS, 2011, SCAND J WORK ENV HEA, V37, P54, DOI 10.5271/sjweh.3124; Wyszecki G., 2000, COLOR SCI CONCEPTS M; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004; Zhou X, 2012, J SLEEP RES, V21, P40, DOI 10.1111/j.1365-2869.2011.00924.x	109	65	67	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70813	10.1371/journal.pone.0070813	http://dx.doi.org/10.1371/journal.pone.0070813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23923024	gold, Green Published			2022-12-27	WOS:000322838900177
J	Craig, J; Mikhailenko, I; Noyes, N; Migliorini, M; Strickland, DK				Craig, Julie; Mikhailenko, Irina; Noyes, Nathaniel; Migliorini, Mary; Strickland, Dudley K.			The LDL Receptor-Related Protein 1 (LRP1) Regulates the PDGF Signaling Pathway by Binding the Protein Phosphatase SHP-2 and Modulating SHP-2-Mediated PDGF Signaling Events	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; TYROSINE-PHOSPHATASE; CYTOPLASMIC DOMAIN; VASCULAR WALL; INTIMAL HYPERPLASIA; CORECEPTOR FUNCTION; PORCINE ARTERIES; BETA-RECEPTOR; IN-VIVO	Background: The PDGF signaling pathway plays a major role in several biological systems, including vascular remodeling that occurs following percutaneous transluminal coronary angioplasty. Recent studies have shown that the LDL receptor-related protein 1 (LRP1) is a physiological regulator of the PDGF signaling pathway. The underlying mechanistic details of how this regulation occurs have yet to be resolved. Activation of the PDGF receptor beta (PDGFR beta) leads to tyrosine phosphorylation of the LRP1 cytoplasmic domain within endosomes and generates an LRP1 molecule with increased affinity for adaptor proteins such as SHP-2 that are involved in signaling pathways. SHP-2 is a protein tyrosine phosphatase that positively regulates the PDGFRb pathway, and is required for PDGF-mediated chemotaxis. We investigated the possibility that LRP1 may regulate the PDGFRb signaling pathway by binding SHP-2 and competing with the PDGFRb for this molecule. Methodology/Principal Findings: To quantify the interaction between SHP-2 and phosphorylated forms of the LRP1 intracellular domain, we utilized an ELISA with purified recombinant proteins. These studies revealed high affinity binding of SHP-2 to phosphorylated forms of both LRP1 intracellular domain and the PDGFRb kinase domain. By employing the well characterized dynamin inhibitor, dynasore, we established that PDGF-induced SHP-2 phosphorylation primarily occurs within endosomal compartments, the same compartments in which LRP1 is tyrosine phosphorylated by activated PDGFRb. Immunofluorescence studies revealed colocalization of LRP1 and phospho-SHP-2 following PDGF stimulation of fibroblasts. To define the contribution of LRP1 to SHP-2-mediated PDGF chemotaxis, we employed fibroblasts expressing LRP1 and deficient in LRP1 and a specific SHP-2 inhibitor, NSC-87877. Our results reveal that LRP1 modulates SHP-2-mediated PDGF-mediated chemotaxis. Conclusions/Significance: Our data demonstrate that phosphorylated forms of LRP1 and PDGFRb compete for SHP-2 binding, and that expression of LRP1 attenuates SHP-2-mediated PDGF signaling events.	[Craig, Julie; Mikhailenko, Irina; Noyes, Nathaniel; Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu		Noyes, Nathaniel/0000-0002-6962-8360	NIH [PO1 HL54710, HL50784, HL114379];  [T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698, R01HL050784, R01HL114379, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants PO1 HL54710, HL50784, HL114379 (DKS). NN was supported by T32 HL007698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1997, CIRCULATION, V96, P1906, DOI 10.1161/01.CIR.96.6.1906; Adachi M, 1997, VIRCHOWS ARCH, V430, P321, DOI 10.1007/BF01092755; Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Betsholtz C, 2004, CURR OPIN NEPHROL HY, V13, P45, DOI 10.1097/00041552-200401000-00007; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chang YZ, 2004, AM J PHYSIOL-HEART C, V287, pH2201, DOI 10.1152/ajpheart.00520.2004; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; George D, 2003, ADV EXP MED BIOL, V532, P141; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Lu XL, 1998, ONCOGENE, V17, P441, DOI 10.1038/sj.onc.1201988; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Micke P, 2009, BIOCHEM BIOPH RES CO, V382, P678, DOI 10.1016/j.bbrc.2009.03.078; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; NABEL EG, 1993, J CLIN INVEST, V91, P1822, DOI 10.1172/JCI116394; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Panek RL, 1997, ARTERIOSCL THROM VAS, V17, P1283, DOI 10.1161/01.ATV.17.7.1283; POMPILI VJ, 1995, ARTERIOSCL THROM VAS, V15, P2254, DOI 10.1161/01.ATV.15.12.2254; Qi JH, 1999, J BIOL CHEM, V274, P14455, DOI 10.1074/jbc.274.20.14455; Ranganathan S, 2004, J BIOL CHEM; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Sharma S, 2011, PHARMACOL THERAPEUT, V129, P260, DOI 10.1016/j.pharmthera.2010.11.003; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Won KJ, 2011, J PHARMACOL SCI, V115, P164, DOI 10.1254/jphs.10250FP; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	45	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70432	10.1371/journal.pone.0070432	http://dx.doi.org/10.1371/journal.pone.0070432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922991	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900169
J	Hassan, SS; Cho, JE; Akram, M; Fielding, KL; Dockrell, HM; Cliff, JM				Hassan, Syeda S.; Cho, Jang-Eun; Akram, Muhammad; Fielding, Katherine L.; Dockrell, Hazel M.; Cliff, Jacqueline M.			Modulation of NKG2D Expression in Human CD8(+) T Cells Corresponding with Tuberculosis Drug Cure	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MYCOBACTERIUM-TUBERCULOSIS; GENE-EXPRESSION; IMMUNE-RESPONSE; DOWN-REGULATION; CUTTING EDGE; TGF-BETA; LIGAND; RECEPTOR; COSTIMULATION	Background: Biomarkers predicting tuberculosis treatment response and cure would facilitate drug development. This study investigated expression patterns of the co-stimulation molecule NKG2D in human tuberculosis and treatment to determine its potential usefulness as a host biomarker of tuberculosis drug efficacy. Methods: Tuberculosis patients (n = 26) were recruited in Lahore, Pakistan, at diagnosis and followed up during treatment. Household contacts (n = 24) were also recruited. NKG2D expression was measured by qRT-PCR in RNA samples both ex vivo and following overnight mycobacterial stimulation in vitro. Protein expression of NKG2D and granzyme B was measured by flow cytometry. Results: NKG2D expression in newly diagnosed tuberculosis patients was similar to household contacts in ex vivo RNA, but was higher following in vitro stimulation. The NKG2D expression was dramatically reduced by intensive phase chemotherapy, in both ex vivo blood RNA and CD8(+) T cell protein expression, but then reverted to higher levels after the continuation phase in successfully treated patients. Conclusion: The changes in NKG2D expression through successful treatment reflect modulation of the peripheral cytotoxic T cell response. This likely reflects firstly in vivo stimulation by live Mycobacterium tuberculosis, followed by the response to dead bacilli, antigen-release and finally immunopathology resolution. Such changes in host peripheral gene expression, alongside clinical and microbiological indices, could be developed into a biosignature of tuberculosis drug-induced cure to be used in future clinical trials.	[Hassan, Syeda S.; Cho, Jang-Eun; Dockrell, Hazel M.; Cliff, Jacqueline M.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Fielding, Katherine L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Akram, Muhammad] Gulab Devi Chest Hosp, Lahore, Punjab, Pakistan	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Hassan, SS (corresponding author), Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge, England.	jackie.Cliff@lshtm.ac.uk		Cliff, Jackie/0000-0002-5653-1818; Dockrell, Hazel/0000-0003-1869-9107	University of London Central Research Fund [AR/CRF/B]; EDCTP [IP.2009.32040.011]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	University of London Central Research Fund; EDCTP; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University of London Central Research Fund (Grant # AR/CRF/B) http://www.london.ac.uk/awards_pg.html. JMC salary support was provided by the EDCTP (Grant: IP.2009.32040.011) http://www.edctp.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Burgess SJ, 2008, IMMUNOL RES, V40, P18, DOI 10.1007/s12026-007-0060-9; Burton MJ, 2004, INFECT IMMUN, V72, P7352, DOI 10.1128/IAI.72.12.7352-7356.2004; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Cerboni C, 2009, BLOOD, V113, P2955, DOI 10.1182/blood-2008-06-165944; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Cliff JM, 2004, J IMMUNOL, V173, P485, DOI 10.4049/jimmunol.173.1.485; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Friese MA, 2004, CANCER RES, V64, P7596, DOI 10.1158/0008-5472.CAN-04-1627; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hessmann M, 2010, IMMUNOBIOLOGY; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Karimi M, 2005, J IMMUNOL, V175, P7819, DOI 10.4049/jimmunol.175.12.7819; Kloss M, 2008, J IMMUNOL, V181, P6711, DOI 10.4049/jimmunol.181.10.6711; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Parasa VRR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037448; Park YP, 2011, BLOOD, V118, P3019, DOI 10.1182/blood-2011-04-346825; Rajasekaran K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012635; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rausch A, 2006, EUR J IMMUNOL, V36, P1156, DOI 10.1002/eji.200535290; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Rozen S, 2000, Methods Mol Biol, V132, P365; Serbina NV, 1999, INFECT IMMUN, V67, P3980, DOI 10.1128/IAI.67.8.3980-3988.1999; Smith SM, 2000, J IMMUNOL, V165, P7088, DOI 10.4049/jimmunol.165.12.7088; Stegelmann F, 2005, J IMMUNOL, V175, P7474, DOI 10.4049/jimmunol.175.11.7474; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Upshaw JL, 2006, SEMIN IMMUNOL, V18, P167, DOI 10.1016/j.smim.2006.03.001; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Vankayalapati R, 2005, J IMMUNOL, V175, P4611, DOI 10.4049/jimmunol.175.7.4611; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WHO, 2010, GLOB TUB CONTR REP; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	50	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70063	10.1371/journal.pone.0070063	http://dx.doi.org/10.1371/journal.pone.0070063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922903	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900138
J	Hayashi, N; George, J; Takeuchi, M; Fukumura, A; Toshikuni, N; Arisawa, T; Tsutsumi, M				Hayashi, Nobuhiko; George, Joseph; Takeuchi, Masayoshi; Fukumura, Atsushi; Toshikuni, Nobuyuki; Arisawa, Tomiyasu; Tsutsumi, Mikihiro			Acetaldehyde-Derived Advanced Glycation End-Products Promote Alcoholic Liver Disease	PLOS ONE			English	Article							INTRALOBULAR DISTRIBUTION; OXIDATIVE STRESS; RAT; DEHYDROGENASE; GLYCOSYLATION; PATHOGENESIS; MECHANISMS; FIBROSIS; ADDUCTS; GROWTH	Background: Chronic ingestion of ethanol increases acetaldehyde and leads to the production of acetaldehyde-derived advanced glycation end-products (AA-AGE). We evaluated the toxicity of AA-AGE on hepatocytes and studied the role of AA-AGE in the pathogenesis of alcoholic liver disease (ALD). Methods: Rat hepatocyte cultures were treated with N-ethyllysine (NEL) or AA-AGE and the cell viability was evaluated using MTT assay. Male Wistar rats were fed with liquid diet containing 5% ethanol for 8 weeks following normal diet for another 12 weeks. A group of animals was sacrificed at 4th, 6th, and 8th week and the remaining animals at 12th, 14th, 16th, 18th, and 20th week. The liver sections were stained for AA-AGE and 4-hydroxy-2-nonenal (4-HNE). Liver biopsy obtained from ALD patients was also stained for AA-AGE and 4-HNE. Results: Hepatocyte viability was significantly reduced in cultures treated with AA-AGE compared to NEL treated or control cultures. Severe fatty degeneration was observed during chronic administration of ethanol increasing from 4-8 weeks. The staining of AA-AGE and 4-HNE was correlated with the degree of ALD in both rat and human. In rats, hepatic fatty degeneration was completely disappeared and the staining for both AA-AGE and 4-HNE returned to normal at 12th week of abstinence. Staining for AA-AGE and 4-HNE was completely absent in normal human liver. Conclusions: The data demonstrated that AA-AGE is toxic to hepatocytes, but not NEL. Chronic ethanol ingestion produces AA-AGE and reactive oxygen species that contribute to the pathogenesis of ALD. Abstinence of alcohol results in complete disappearance of both AA-AGE and 4-HNE along with fatty degeneration suggesting that AA-AGE plays a significant role in the pathogenesis of ALD.	[Hayashi, Nobuhiko; George, Joseph; Fukumura, Atsushi; Tsutsumi, Mikihiro] Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan; [Takeuchi, Masayoshi] Kanazawa Med Univ, Dept Adv Med, Uchinada, Ishikawa 92002, Japan; [Toshikuni, Nobuyuki; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa 92002, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University	George, J (corresponding author), Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan.	georgej@kanazawa-med.ac.jp; tsutsumi@kanazawa-med.ac.jp	George, Joseph/P-8447-2018	George, Joseph/0000-0001-5354-7884	Japan Society for the Promotion of Science [22300264 (MT2)]; Kanazawa Medical University, Japan [SR2012-04]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanazawa Medical University, Japan	This work was supported in part by grants from the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (B)], #22300264 (MT2) and by Grant No. SR2012-04 (MT) for research from Kanazawa Medical University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p15S, DOI 10.1111/j.1530-0277.2001.tb02369.x; Freeman TL, 2005, ALCOHOL CLIN EXP RES, V29, P1310, DOI 10.1097/01.ALC.0000171484.52201.52; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x; Jeong KS, 2000, ARCH BIOCHEM BIOPHYS, V384, P81, DOI 10.1006/abbi.2000.2119; Kimura Y, 2010, J GASTROENTEROL, V45, P750, DOI 10.1007/s00535-010-0203-y; Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018; LIEBER CS, 1970, AM J CLIN NUTR, V23, P474; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NORDMANN R, 1994, ALCOHOL ALCOHOLISM, V29, P513; Papeleu Peggy, 2006, Methods Mol Biol, V320, P229; POPPER H, 1980, AM J PATHOL, V98, P695; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; SCHILLER CD, 1992, TOXICOL IN VITRO, V6, P575, DOI 10.1016/0887-2333(92)90070-8; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Takeuchi M, 1999, MOL MED, V5, P393, DOI 10.1007/BF03402128; Takeuchi M, 2003, J NEUROPATH EXP NEUR, V62, P486, DOI 10.1093/jnen/62.5.486; Takeuchi M, 2001, MOL MED, V7, P783, DOI 10.1007/BF03401969; Takeuchi M, 2000, MOL MED, V6, P114, DOI 10.1007/BF03401779; Takeuchi Masayoshi, 2001, Current Molecular Medicine (Hilversum), V1, P305, DOI 10.2174/1566524013363735; Takeuchi M, 2010, CURR DRUG TARGETS, V11, P1468, DOI 10.2174/1389450111009011468; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Vlassara H, 1997, DIABETES, V46, pS19, DOI 10.2337/diab.46.2.S19; VLASSARA H, 1994, LAB INVEST, V70, P138; Watabiki T, 1999, ALCOHOL CLIN EXP RES, V23, p52S, DOI 10.1111/j.1530-0277.1999.tb04534.x; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; YAMAUCHI M, 1988, HEPATOLOGY, V8, P243, DOI 10.1002/hep.1840080209; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005	35	27	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70034	10.1371/journal.pone.0070034	http://dx.doi.org/10.1371/journal.pone.0070034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922897	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900135
J	Ku, HL; Lin, CS; Chao, HT; Tu, PC; Li, CT; Cheng, CM; Su, TP; Lee, YC; Hsieh, JC				Ku, Hsiao-Lun; Lin, Chia-Shu; Chao, Hsiang-Tai; Tu, Pei-Chi; Li, Cheng-Ta; Cheng, Chou-Ming; Su, Tung-Ping; Lee, Ying-Chiao; Hsieh, Jen-Chuen			Brain Signature Characterizing the Body-Brain-Mind Axis of Transsexuals	PLOS ONE			English	Article							TO-FEMALE TRANSSEXUALS; SEX HORMONAL TREATMENT.; DEFAULT MODE; CEREBRAL ACTIVATION; PREFRONTAL CORTEX; WHITE-MATTER; FMRI; MICROSTRUCTURE; DIFFERENCE	Individuals with gender identity disorder (GID), who are commonly referred to as transsexuals (TXs), are afflicted by negative psychosocial stressors. Central to the psychological complex of TXs is the conviction of belonging to the opposite sex. Neuroanatomical and functional brain imaging studies have demonstrated that the GID is associated with brain alterations. In this study, we found that TXs identify, when viewing male-female couples in erotic or non-erotic ("neutral") interactions, with the couple member of the desired gender in both situations. By means of functional magnetic resonance imaging, we found that the TXs, as opposed to controls (CONs), displayed an increased functional connectivity between the ventral tegmental area, which is associated with dimorphic genital representation, and anterior cingulate cortex subregions, which play a key role in social exclusion, conflict monitoring and punishment adjustment. The neural connectivity pattern suggests a brain signature of the psychosocial distress for the gender-sex incongruity of TXs.	[Ku, Hsiao-Lun; Tu, Pei-Chi; Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Ku, Hsiao-Lun; Lin, Chia-Shu; Cheng, Chou-Ming; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Integrated Brain Res Unit, Dept Med Res & Educ, Taipei, Taiwan; [Ku, Hsiao-Lun] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Lin, Chia-Shu] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Chao, Hsiang-Tai] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Hsiang-Tai] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping; Lee, Ying-Chiao] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Psychiat, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Hsieh, Jen-Chuen] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	yclee@vghtpe.gov.tw; jchsieh@ym.edu.tw	Ku, Hsiao-Lun/G-6053-2016; Lin, Chia-shu/AAA-5143-2019; Li, Cheng-Ta/AAI-5759-2021; Lin, Chia-Shu/HGD-7267-2022	Ku, Hsiao-Lun/0000-0002-5640-5256; Li, Cheng-Ta/0000-0002-0670-1153; Lin, Chia-Shu/0000-0002-6575-0887	National Science Council [99-2314-B-075-018]; Taipei Veterans General Hospital [V100E3-002, V101C-201, V101E3-002]; Brain Research Center of National Yang-Ming University [98A-C-B501_23]; The Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center of National Yang-Ming University; The Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University	Supported by The National Science Council (99-2314-B-075-018), Taipei Veterans General Hospital (V100E3-002, V101C-201, V101E3-002), Brain Research Center of National Yang-Ming University (98A-C-B501_23), and The Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Australian Passport Office Department of Foreign Affairs and Trade Australian Government, 2011, SEX GEND DIV PASSP A; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Bond M, 1986, EMPIRICAL STUDIES EG, P127; Castillo M, 2012, CNN NEWS        0511; Eisenberger NI, 2009, NEUROIMAGE, V47, P881, DOI 10.1016/j.neuroimage.2009.04.040; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garcia-Falgueras A, 2008, BRAIN, V131, P3132, DOI 10.1093/brain/awn276; Georgiadis JR, 2006, EUR J NEUROSCI, V24, P3305, DOI 10.1111/j.1460-9568.2006.05206.x; Gizewski ER, 2009, J SEX MED, V6, P440, DOI 10.1111/j.1743-6109.2008.00981.x; Gooren LJ, 2011, NEW ENGL J MED, V364, P1251, DOI 10.1056/NEJMcp1008161; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Holstege G, 2003, J NEUROSCI, V23, P9185; Hoshiai M, 2010, PSYCHIAT CLIN NEUROS, V64, P514, DOI 10.1111/j.1440-1819.2010.02118.x; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Lee YC, 2000, DEV DEFENSE STYLE QU; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lombardi EL, 2001, J HOMOSEXUAL, V42, P89, DOI 10.1300/J082v42n01_05; Luders E, 2009, NEUROIMAGE, V46, P904, DOI 10.1016/j.neuroimage.2009.03.048; Matsumoto Y, 2009, PSYCHIAT CLIN NEUROS, V63, P715, DOI 10.1111/j.1440-1819.2009.02017.x; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Ruz M, 2011, NEUROIMAGE, V54, P1685, DOI 10.1016/j.neuroimage.2010.08.039; Slavich GM, 2010, P NATL ACAD SCI USA, V107, P14817, DOI 10.1073/pnas.1009164107; Sommer IEC, 2008, EUR NEUROPSYCHOPHARM, V18, P215, DOI 10.1016/j.euroneuro.2007.10.002; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Terada S, 2011, PSYCHIAT RES, V190, P159, DOI 10.1016/j.psychres.2011.04.024; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0	34	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70808	10.1371/journal.pone.0070808	http://dx.doi.org/10.1371/journal.pone.0070808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923023	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900176
J	Wodarz, D; Komarova, NL				Wodarz, Dominik; Komarova, Natalia L.			Dependence of the Firearm-Related Homicide Rate on Gun Availability: A Mathematical Analysis	PLOS ONE			English	Article							CRIME; RISK; OWNERSHIP; BENEFITS; PURCHASE; SUICIDE; GROWTH; ACCESS; MODEL; LAWS	In the USA, the relationship between the legal availability of guns and the firearm-related homicide rate has been debated. It has been argued that unrestricted gun availability promotes the occurrence of firearm-induced homicides. It has also been pointed out that gun possession can protect potential victims when attacked. This paper provides a first mathematical analysis of this tradeoff, with the goal to steer the debate towards arguing about assumptions, statistics, and scientific methods. The model is based on a set of clearly defined assumptions, which are supported by available statistical data, and is formulated axiomatically such that results do not depend on arbitrary mathematical expressions. According to this framework, two alternative scenarios can minimize the gun-related homicide rate: a ban of private firearms possession, or a policy allowing the general population to carry guns. Importantly, the model identifies the crucial parameters that determine which policy minimizes the death rate, and thus serves as a guide for the design of future epidemiological studies. The parameters that need to be measured include the fraction of offenders that illegally possess a gun, the degree of protection provided by gun ownership, and the fraction of the population who take up their right to own a gun and carry it when attacked. Limited data available in the literature were used to demonstrate how the model can be parameterized, and this preliminary analysis suggests that a ban of private firearm possession, or possibly a partial reduction in gun availability, might lower the rate of firearm-induced homicides. This, however, should not be seen as a policy recommendation, due to the limited data available to inform and parameterize the model. However, the model clearly defines what needs to be measured, and provides a basis for a scientific discussion about assumptions and data.	[Wodarz, Dominik; Komarova, Natalia L.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Wodarz, Dominik; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	dwodarz@uci.edu	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674	University of California Irvine	University of California Irvine(University of California System)	This work was not funded by external grants. However, the authors received salary and internal funds from the University of California Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; Amengual P, 2006, COMPUT SCI ENG, V8, P88, DOI 10.1109/MCSE.2006.99; AVIITZHAK B, 1973, J CRIM JUST, V1, P185, DOI 10.1016/0047-2352(73)90061-5; Bennett T., 2004, HOWARD J CRIMINAL JU, V43, P237, DOI [DOI 10.1111/J.1468, 10.1111/j.1468-2311.2004.00325.x]; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Branas CC, 2009, AM J PUBLIC HEALTH, V99, P2034, DOI 10.2105/AJPH.2008.143099; Brantingham P, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P9, DOI 10.1007/978-3-211-09442-6_2; Brantingham PL, 2005, IEEE SYS MAN CYBERN, P3667; *CHIC POL DEP, 2010, 2010 CHICAGO MURDER; COOK PJ, 1981, ANN AM ACAD POLIT SS, V455, P63, DOI 10.1177/000271628145500107; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Flitney AP, 2004, J OPT B-QUANTUM S O, V6, pS860, DOI 10.1088/1464-4266/6/8/036; FOX JA, 1981, MODELS QUANTITATIVE; *GALL, 2013, GALL POLL GUN OWN US; HELMBOLD RL, 1995, NAV RES LOG, V42, P435, DOI 10.1002/1520-6750(199504)42:3<435::AID-NAV3220420308>3.0.CO;2-2; HELMBOLD RL, 1993, EUR J OPER RES, V65, P278, DOI 10.1016/0377-2217(93)90341-J; Hemenway D, 2000, Violence Vict, V15, P257; Hemenway D, 2000, J TRAUMA, V49, P985, DOI 10.1097/00005373-200012000-00001; Hemenway D, 2006, PRIVATE GUNS PUBLIC; Hemenway D, 2011, AM J LIFESTYLE MED, V5, P502, DOI 10.1177/1559827610396294; Jacobs J., 2002, CAN GUN CONTROL WORK; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Kennedy BP, 1998, SOC SCI MED, V47, P7, DOI 10.1016/S0277-9536(98)00097-5; Kleck G, 1995, J CRIM LAW CRIM, V86, P150, DOI 10.2307/1144004; Kleck G, 1998, JAMA-J AM MED ASSOC, V280, P473, DOI 10.1001/jama.280.5.473; Klieve H, 2009, SOC PSYCH PSYCH EPID, V44, P285, DOI 10.1007/s00127-008-0435-9; Lott, 2010, MORE GUNS LESS CRIME; Ludwig J., 2003, EVALUATING GUN POLIC; Malleson N, 2010, COMPUT ENVIRON URBAN, V34, P236, DOI 10.1016/j.compenvurbsys.2009.10.005; MAXFIELD MG, 1989, CRIMINOLOGY, V27, P671, DOI 10.1111/j.1745-9125.1989.tb01050.x; McCall PL, 2008, SOC SCI RES, V37, P721, DOI 10.1016/j.ssresearch.2007.09.007; Mercy J.A., 2003, EVALUATING GUN POLIC, P157; Miller M, 2007, J TRAUMA, V62, P1029, DOI 10.1097/01.ta.0000198214.24056.40; *PHIL POL DEP, 2011, 2011 PHIL MURD SHOOT; Phillips L., 1981, EC CRIME CONTROL; PINCOMBE AH, 2010, ANZIAM J, V51, pC482; Reaves Brian A., 2006, VIOLENT FELONS LARGE; Shah S, 2010, AM J PUBLIC HEALTH, V100, P967, DOI 10.2105/AJPH.2009.188383; Short MB, 2010, SIAM J APPL DYN SYST, V9, P462, DOI 10.1137/090759069; Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307; WINTEMUTE G, 2010, AM J PUBLIC HEALTH, V100, P67968; Wintemute GJ, 2001, JAMA-J AM MED ASSOC, V285, P1019, DOI 10.1001/jama.285.8.1019; Wright MA, 1999, AM J PUBLIC HEALTH, V89, P88, DOI 10.2105/AJPH.89.1.88; Zawitz M. W., 2000, HOMICIDE TRENDS US 1	45	4	4	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71606	10.1371/journal.pone.0071606	http://dx.doi.org/10.1371/journal.pone.0071606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23923062	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900191
J	Belhaj, A; Dewachter, L; Kerbaul, F; Brimioulle, S; Dewachter, C; Naeije, R; Rondelet, B				Belhaj, Asmae; Dewachter, Laurence; Kerbaul, Francois; Brimioulle, Serge; Dewachter, Celine; Naeije, Robert; Rondelet, Benoit			Heme Oxygenase-1 and Inflammation in Experimental Right Ventricular Failure on Prolonged Overcirculation-Induced Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; CARBON-MONOXIDE; EXPRESSION; PREVENTION; INTERLEUKIN-19; APOPTOSIS; CELLS; HEART; IL-33	Heme oxygenase (HO)-1 is a stress response enzyme which presents with cardiovascular protective and anti-inflammatory properties. Six-month chronic overcirculation-induced pulmonary arterial hypertension (PAH) in piglets has been previously reported as a model of right ventricular (RV) failure related to the RV activation of apoptotic and inflammatory processes. We hypothesized that altered HO-1 signalling could be involved in both pulmonary vascular and RV changes. Fifteen growing piglets were assigned to a sham operation (n = 8) or to an anastomosis of the left innominate artery to the pulmonary arterial trunk (n = 7). Six months later, hemodynamics was evaluated after closure of the shunt. After euthanasia of the animals, pulmonary and myocardial tissue was sampled for pathobiological evaluation. Prolonged shunting was associated with a tendency to decreased pulmonary gene and protein expressions of HO-1, while pulmonary gene expressions of interleukin (IL)-33, IL-19, intercellular adhesion molecule (ICAM)-1 and -2 were increased. Pulmonary expressions of constitutive HO-2 and pro-inflammatory tumor necrosis factor (TNF)-alpha remained unchanged. Pulmonary vascular resistance (evaluated by pressure/flow plots) was inversely correlated to pulmonary HO-1 protein and IL-19 gene expressions, and correlated to pulmonary ICAM-1 gene expression. Pulmonary arteriolar medial thickness and PVR were inversely correlated to pulmonary IL-19 expression. RV expression of HO-1 was decreased, while RV gene expressions TNF-alpha and ICAM-2 were increased. There was a correlation between RV ratio of end-systolic to pulmonary arterial elastances and RV HO-1 expression. These results suggest that downregulation of HO-1 is associated to PAH and RV failure.	[Belhaj, Asmae; Dewachter, Laurence; Kerbaul, Francois; Brimioulle, Serge; Dewachter, Celine; Naeije, Robert; Rondelet, Benoit] Univ Libre Bruxelles, Fac Med, Physiol Lab, Brussels, Belgium; [Belhaj, Asmae; Rondelet, Benoit] Catholic Univ Louvain, Hop Mt Godinne, Serv Chirurg Cardiovasc & Thorac, Yvoir, Belgium; [Belhaj, Asmae; Rondelet, Benoit] Univ Libre Bruxelles, Hop Erasme, Serv Chirurg Thorac, Brussels, Belgium; [Kerbaul, Francois] Univ Marseille, Hop La Timone, Dept Anesthesie & Reanimat, Marseille, France; [Brimioulle, Serge] Univ Libre Bruxelles, Hop Erasme, Serv Soins Intensifs, Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Universite Libre de Bruxelles; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Libre de Bruxelles	Rondelet, B (corresponding author), Univ Libre Bruxelles, Fac Med, Physiol Lab, Brussels, Belgium.	benoit.rondelet@ulb.ac.be			Fonds de la Recherche Scientifique Medicale FNRS [3.4637.09]; Belgian Foundation for Cardiac Surgery; Erasmus Foundation (Belgium); Pfizer	Fonds de la Recherche Scientifique Medicale FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation for Cardiac Surgery; Erasmus Foundation (Belgium); Pfizer(Pfizer)	This work was supported by grants from the "Fonds de la Recherche Scientifique Medicale FNRS)'' (grant number 3.4637.09) and the Belgian Foundation for Cardiac Surgery. C.D. was supported by the Erasmus Foundation (Belgium) and is a FNRS doctoral fellow ("Aspirant FNRS''; Belgium). L.D. was supported by a Pfizer research grant and is a FNRS postdoctoral fellow ("Charge de Recherches''; Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Brimioulle S, 1999, CARDIOVASC RES, V42, P183, DOI 10.1016/S0008-6363(98)00301-0; Brimioulle S, 2003, AM J PHYSIOL-HEART C, V284, pH1625, DOI 10.1152/ajpheart.01023.2002; Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Christou H, 2000, CIRC RES, V86, P1224, DOI 10.1161/01.RES.86.12.1224; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Demyanets S, 2010, ARTERIOSCLER THROMB, V31, P2080; Dewachter C, 2012, AM J RESP CRIT CARE, V185, pA3462; Dewachter C, 2010, CRIT CARE MED, V38, P1405, DOI 10.1097/CCM.0b013e3181de8bd3; Dewachter L, 2006, AM J RESP CRIT CARE, V174, P1025, DOI 10.1164/rccm.200602-304OC; Dorfmuller P, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-119; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Gabunia K, 2012, J BIOL CHEM, V287, P2477, DOI 10.1074/jbc.M111.312470; Haddad F, 2008, CIRCULATION, V117, P1436, DOI 10.1161/CIRCULATIONAHA.107.653576; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; KATAYOSE D, 1993, BIOCHEM BIOPH RES CO, V191, P587, DOI 10.1006/bbrc.1993.1258; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Li XQ, 2011, ACTA PHARMACOL SIN, V32, P217, DOI 10.1038/aps.2010.187; Liang OD, 2011, STEM CELLS, V29, P99, DOI 10.1002/stem.548; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Naeije R, 2011, TEXTBOOK OF PULMONARY VASCULAR DISEASE, P61, DOI 10.1007/978-0-387-87429-6_4; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Peyton KJ, 2002, BLOOD, V99, P4443, DOI 10.1182/blood.V99.12.4443; Rondelet B, 2005, AM J PHYSIOL-HEART C, V289, pH2319, DOI 10.1152/ajpheart.00518.2005; Rondelet B, 2004, CIRCULATION, V110, P2220, DOI 10.1161/01.CIR.0000143836.40431.F5; Rondelet B, 2003, CIRCULATION, V107, P1329, DOI 10.1161/01.CIR.0000053443.27512.33; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Sungprem K, 2009, PEDIATR CARDIOL, V30, P472, DOI 10.1007/s00246-008-9374-1; Takeuchi M, 2003, J INT MED RES, V31, P413, DOI 10.1177/147323000303100509; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tian Y, 2008, AM J PATHOL, V173, P901, DOI 10.2353/ajpath.2008.080163; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Villamor E, 2000, PEDIATR RES, V48, P546, DOI 10.1203/00006450-200010000-00021; Vitali SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005978; Wauthy P, 2003, J THORAC CARDIOV SUR, V126, P1434, DOI 10.1016/S0022-5223(03)01183-8; Winer BJ, 1991, STAT PRINCIPLES EXPT, P220; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhou HL, 2006, LAB INVEST, V86, P62, DOI 10.1038/labinvest.3700361	50	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69470	10.1371/journal.pone.0069470	http://dx.doi.org/10.1371/journal.pone.0069470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936023	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300042
J	Kang, MY; Dai, C; Ji, WY; Jiang, Y; Yuan, ZY; Chen, HYH				Kang, Muyi; Dai, Cheng; Ji, Wenyao; Jiang, Yuan; Yuan, Zhiyou; Chen, Han Y. H.			Biomass and Its Allocation in Relation to Temperature, Precipitation, and Soil Nutrients in Inner Mongolia Grasslands, China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; FINE-ROOT BIOMASS; GLOBAL ANALYSIS; CLIMATE; ECOSYSTEM; PATTERNS; NITROGEN; LIMITATION; TURNOVER; MODELS	Aim: Understanding and predicting ecosystem functioning such as biomass accumulation requires an accurate assessment of large-scale patterns of biomass distribution and partitioning in relation to climatic and soil environments. Methods: We sampled above- and belowground biomass from 26 sites spanning 1500 km in Inner Mongolian grasslands, compared the difference in aboveground, belowground biomass and below-aboveground biomass ratio (AGB, BGB, and B/A, respectively) among meadow steppe, typical steppe, and desert steppe types. The relationships between AGB, BGB, B/A and climatic and soil environments were then examined. Results: We found that AGB and BGB differed significantly among three types of grasslands while B/A did not differ. Structural equation model analyses indicated that mean annual precipitation was the strongest positive driver for AGB and BGB. AGB was also positively associated with soil organic carbon, whereas B/A was positively associated with total soil nitrogen. Conclusions: These results indicated that precipitation positively influence plant production in Inner Mongolian grasslands. Contrary to the prediction from the optimal partitioning hypothesis, biomass allocation to belowground increased with soil total nitrogen, suggesting that more productive sites may increase belowground allocation as an adaptive strategy to potentially high fire frequencies.	[Kang, Muyi; Dai, Cheng; Ji, Wenyao; Jiang, Yuan; Chen, Han Y. H.] Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yuan, Zhiyou; Chen, Han Y. H.] Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada; [Chen, Han Y. H.] Anhui Agr Univ, Coll Forestry & Gardening, Hefei, Peoples R China	Beijing Normal University; Lakehead University; Anhui Agricultural University	Kang, MY (corresponding author), Beijing Normal Univ, Coll Resources Sci & Technol, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	kangmy@bnu.edu.cn; jiangy@bnu.edu.cn	Yuan, ZY/G-5362-2010; Yuan, ZY/F-2980-2012; 袁, 志友/T-2987-2019; jiang, anyi/GPT-0379-2022; Chen, Han YH/A-1359-2008	Yuan, ZY/0000-0003-0925-3226; 袁, 志友/0000-0003-0925-3226; Chen, Han YH/0000-0001-9477-5541	State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University; National Science Foundation of China [41271059]; Natural Science and Engineering Council of Canada [DG 283336-09];  [2008-KF-03]	State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); 	This research was supported by the Project (2008-KF-03) funded by the State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University, the National Science Foundation of China (number 41271059), and Natural Science and Engineering Council of Canada (DG 283336-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CHINESE SOIL TAXOMOM; Bhattachan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033996; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Brassard BW, 2013, J ECOL, V101, P210, DOI 10.1111/1365-2745.12023; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Chinese Academy of Sciences, 2001, VEG ATL CHIN; Clough Y, 2012, ECOLOGY, V93, P1809, DOI 10.1890/11-1899.1; Coupland RT, 1979, GRASSLAND ECOSYSTEMS, P41; Darby FA, 2008, ESTUAR COAST, V31, P223, DOI 10.1007/s12237-007-9014-7; Epstein HE, 2002, ECOLOGY, V83, P320, DOI 10.1890/0012-9658(2002)083[0320:RPODAP]2.0.CO;2; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Gedroc JJ, 1996, FUNCT ECOL, V10, P44, DOI 10.2307/2390260; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; Han Bin, 2006, Zhiwu Shengtai Xuebao, V30, P553; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heggenstaller AH, 2009, AGRON J, V101, P1363, DOI 10.2134/agronj2008.0225x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lee EH, 2007, FOREST ECOL MANAG, V242, P195, DOI 10.1016/j.foreco.2007.01.033; Lee M, 2010, PHIL T R SOC LOND B, V365; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Matthews B, 2012, ECOLOGY, V93, P2435, DOI 10.1890/11-2289.1; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Munkhtsetseg E, 2007, J ARID ENVIRON, V70, P94, DOI 10.1016/j.jaridenv.2006.11.013; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Schenk HJ, 2005, GEODERMA, V126, P129, DOI 10.1016/j.geoderma.2004.11.018; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; SHANTZ HL, 1954, ECOLOGY, V35, P143, DOI 10.2307/1931110; St Clair SB, 2009, GLOBAL CHANGE BIOL, V15, P3018, DOI 10.1111/j.1365-2486.2009.01862.x; Stomp M, 2011, ECOLOGY, V92, P2096, DOI 10.1890/10-1023.1; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Vinton MA, 1997, OECOLOGIA, V110, P393, DOI 10.1007/s004420050174; Vogt KA, 1998, PLANT SOIL, V200, P71, DOI 10.1023/A:1004313515294; WILSON JB, 1988, J APPL ECOL, V25, P279, DOI 10.2307/2403626; Xia J, 2008, NEW PHYTOL, V179; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yuan ZY, 2012, P ROY SOC B-BIOL SCI, V279, P3796, DOI 10.1098/rspb.2012.0955; Yuan ZY, 2010, CRIT REV PLANT SCI, V29, P204, DOI 10.1080/07352689.2010.483579	44	27	43	8	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69561	10.1371/journal.pone.0069561	http://dx.doi.org/10.1371/journal.pone.0069561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936045	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300047
J	Simoncini, D; Zhang, KYJ				Simoncini, David; Zhang, Kam Y. J.			Efficient Sampling in Fragment-Based Protein Structure Prediction Using an Estimation of Distribution Algorithm	PLOS ONE			English	Article							SUITE	Fragment assembly is a powerful method of protein structure prediction that builds protein models from a pool of candidate fragments taken from known structures. Stochastic sampling is subsequently used to refine the models. The structures are first represented as coarse-grained models and then as all-atom models for computational efficiency. Many models have to be generated independently due to the stochastic nature of the sampling methods used to search for the global minimum in a complex energy landscape. In this paper we present EdaFold(AA), a fragment-based approach which shares information between the generated models and steers the search towards native-like regions. A distribution over fragments is estimated from a pool of low energy all-atom models. This iteratively-refined distribution is used to guide the selection of fragments during the building of models for subsequent rounds of structure prediction. The use of an estimation of distribution algorithm enabled EdaFold(AA) to reach lower energy levels and to generate a higher percentage of near-native models. EdaFold(AA) uses an all-atom energy function and produces models with atomic resolution. We observed an improvement in energy-driven blind selection of models on a benchmark of 20 in comparison with the Rosetta AbInitioRelax protocol.	[Simoncini, David; Zhang, Kam Y. J.] RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan	RIKEN	Zhang, KYJ (corresponding author), RIKEN, Inst Labs, Zhang Initiat Res Unit, Wako, Saitama, Japan.	kamzhang@riken.jp	Simoncini, David/AAA-5204-2021; Zhang, Kam Y. J./B-3552-2012	Simoncini, David/0000-0002-3772-5473; Zhang, Kam Y. J./0000-0002-9282-8045	RIKEN Initiative Research Unit program	RIKEN Initiative Research Unit program	Funded by RIKEN Initiative Research Unit program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AN, 2012, P NATL ACAD SCI USA, V109, P17442, DOI 10.1073/pnas.1209000109; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Berenger F, 2011, BIOINFORMATICS, V27, P939, DOI 10.1093/bioinformatics/btr072; BLOW DM, 1961, ACTA CRYSTALLOGR, V14, P1195, DOI 10.1107/S0365110X61003454; BOWIE JU, 1994, P NATL ACAD SCI USA, V91, P4436, DOI 10.1073/pnas.91.10.4436; Chikenji G, 2003, J CHEM PHYS, V119, P6895, DOI 10.1063/1.1597474; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee J, 2004, PROTEINS, V56, P704, DOI 10.1002/prot.20150; Li SC, 2008, PROTEIN SCI, V17, P1925, DOI 10.1110/ps.036442.108; Lourenco HR, 2002, HDB METAHEURISTICS, P321, DOI DOI 10.1007/0-306-48056-5_11; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Simoncini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038799; Simons KT, 1999, PROTEINS, P171; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68954	10.1371/journal.pone.0068954	http://dx.doi.org/10.1371/journal.pone.0068954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935913	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300018
J	Blanco, A; de la Hoya, M; Osorio, A; Diez, O; Miramar, MD; Infante, M; Martinez-Bouzas, C; Torres, A; Lasa, A; Llort, G; Brunet, J; Grana, B; Segura, PP; Garcia, MJ; Gutierrez-Enriquez, S; Carracedo, A; Tejada, MI; Velasco, EA; Calvo, MT; Balmana, J; Benitez, J; Caldes, T; Vega, A				Blanco, Ana; de la Hoya, Miguel; Osorio, Ana; Diez, Orland; Dolores Miramar, Maria; Infante, Mar; Martinez-Bouzas, Cristina; Torres, Asuncion; Lasa, Adriana; Llort, Gemma; Brunet, Joan; Grana, Begona; Perez Segura, Pedro; Jose Garcia, Maria; Gutierrez-Enriquez, Sara; Carracedo, Angel; Tejada, Maria-Isabel; Velasco, Eladio A.; Calvo, Maria-Teresa; Balmana, Judith; Benitez, Javier; Caldes, Trinidad; Vega, Ana			Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases	PLOS ONE			English	Article							ONSET BREAST-CANCER; FANCONI-ANEMIA; BRCA2-INTERACTING PROTEIN; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; HIGH-RISK; BRCA2; VARIANTS; PARTNER; WOMEN	Background: The PALB2 gene, also known as FANCN, forms a bond and co-localizes with BRCA2 in DNA repair. Germline mutations in PALB2 have been identified in approximately 1% of familial breast cancer and 3-4% of familial pancreatic cancer. The goal of this study was to determine the prevalence of PALB2 mutations in a population of BRCA1/BRCA2 negative breast cancer patients selected from either a personal or family history of pancreatic cancer. Methods: 132 non-BRCA1/BRCA2 breast/ovarian cancer families with at least one pancreatic cancer case were included in the study. PALB2 mutational analysis was performed by direct sequencing of all coding exons and intron/exon boundaries, as well as multiplex ligation-dependent probe amplification. Results: Two PALB2 truncating mutations, the c.1653T>A (p.Tyr551Stop) previously reported, and c.3362del (p.Gly1121ValfsX3) which is a novel frameshift mutation, were identified. Moreover, several PALB2 variants were detected; some of them were predicted as pathological by bioinformatic analysis. Considering truncating mutations, the prevalence rate of our population of BRCA1/2-negative breast cancer patients with pancreatic cancer is 1.5%. Conclusions: The prevalence rate of PALB2 mutations in non-BRCA1/BRCA2 breast/ovarian cancer families, selected from either a personal or family pancreatic cancer history, is similar to that previously described for unselected breast/ovarian cancer families. Future research directed towards identifying other gene(s) involved in the development of breast/pancreatic cancer families is required.	[Blanco, Ana; Carracedo, Angel; Vega, Ana] Univ Santiago de Compostela, Fdn Publ Galega Med Xen, Serv Galego Saude,Inst Invest Sanitarias Santiago, Grp Med Xen,Spanish Network Rare Dis CIBERER, Santiago De Compostela, A Coruna, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Hosp Clin San Carlos, Lab Oncol Mol, Madrid, Spain; [Osorio, Ana; Jose Garcia, Maria] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Human Genet Grp, Madrid, Spain; [Osorio, Ana; Jose Garcia, Maria; Benitez, Javier] Spanish Network Rare Dis CIBERER, Madrid, Spain; [Diez, Orland; Gutierrez-Enriquez, Sara] Univ Autonoma Barcelona, Oncogenet Lab, Univ Hosp Vall dHebron, VHIO,VHIR, E-08193 Barcelona, Spain; [Dolores Miramar, Maria; Calvo, Maria-Teresa] Hosp Univ Miguel Servet, Serv Bioquim Clin, Secc Genet, Zaragoza, Spain; [Infante, Mar; Velasco, Eladio A.] Univ Valladolid UVA, Inst Biol & Genet Mol, Valladolid, Spain; [Infante, Mar; Velasco, Eladio A.] CSIC, Valladolid, Spain; [Martinez-Bouzas, Cristina; Tejada, Maria-Isabel] Hosp Univ Cruces, Serv Genet, Lab Genet Mol, Bilbao, Spain; [Torres, Asuncion] Hosp Univ St Joan, IISPV, Unitat Consell Genet, Reus, Spain; [Lasa, Adriana] Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain; [Llort, Gemma] Inst Oncol Valles, Unidad Consejo Genet, Sabadell, Terrassa, Spain; [Brunet, Joan] Girona Biomed Res Inst, Catalan Inst Oncol, Hereditary Canc Program, Girona, Spain; [Grana, Begona] Hosp Arquitecto Marcide, Area Sanitaria Ferrol, Unidade Alto Risco Cancro Consello Xenet, La Coruna, Spain; [Perez Segura, Pedro] Hosp Clin San Carlos, Dept Med Oncol, Madrid, Spain; [Balmana, Judith] Univ Hosp Vall dHebron, Dept Med Oncol, Barcelona, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Hospital Clinico San Carlos; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Vall d'Hebron Institut d'Oncologia (VHIO); Miguel Servet University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Cruces; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital of Santa Creu i Sant Pau; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Complejo Hospitalario Universitario de Ferrol; Hospital Clinico San Carlos; Hospital Universitari Vall d'Hebron; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Vega, A (corresponding author), Univ Santiago de Compostela, Fdn Publ Galega Med Xen, Serv Galego Saude,Inst Invest Sanitarias Santiago, Grp Med Xen,Spanish Network Rare Dis CIBERER, Santiago De Compostela, A Coruna, Spain.	ana.vega@usc.es	Osorio, Ana/I-4324-2014; Graña, Begoña/M-2542-2014; Infante, Mar/V-4913-2017; Infante, Mar/AAW-2034-2020; Pérez, Ana/T-4583-2019; Carracedo, Angel/D-4257-2012; Velasco-Sampedro, Eladio Andrés/D-1432-2016; García, María J/G-1361-2016; Vega, Ana/R-4758-2019; Martinez-Delgado, Beatriz/B-6833-2013; de la Hoya, MIguel/Z-2911-2019; balmaña, judith/AAH-1908-2019; TEJADA, Maria-Isabel/O-5051-2019; Gutierrez, Sara/GXE-9832-2022; Lasa, Adriana/H-4745-2017; Brunet, Joan/C-5292-2018	Osorio, Ana/0000-0001-8124-3984; Infante, Mar/0000-0002-7197-5249; Infante, Mar/0000-0002-7197-5249; Carracedo, Angel/0000-0003-1085-8986; Velasco-Sampedro, Eladio Andrés/0000-0002-9682-5589; García, María J/0000-0002-2236-9912; Martinez-Delgado, Beatriz/0000-0001-6834-350X; TEJADA, Maria-Isabel/0000-0002-7334-1864; Lasa, Adriana/0000-0001-9957-9646; Blanco Perez, Ana/0000-0002-2535-8311; Balmana, Judith/0000-0002-0762-6415; diez, orland/0000-0001-7339-0570; Gutierrez-Enriquez, Sara/0000-0002-1711-6101; Brunet, Joan/0000-0003-1945-3512; de la Hoya, Miguel/0000-0002-8113-1410	Xunta de Galicia [10PXIB 9101297PR]; FMM Foundation; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) [09/00859]; Fundacion Mutua Madrilena (FMM) Research Grant [FMM-08]; Miguel Servet contract of the Instituto de Salud Carlos III; Consejeria de Sanidad from the Junta de Castilla y Leon [BIO39/VA27/10]; Consejeria de Educacion from the Junta de Castilla y Leon [CSI004A10-2]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); FMM Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fundacion Mutua Madrilena (FMM) Research Grant; Miguel Servet contract of the Instituto de Salud Carlos III; Consejeria de Sanidad from the Junta de Castilla y Leon; Consejeria de Educacion from the Junta de Castilla y Leon	This research was supported by grants from the Xunta de Galicia (10PXIB 9101297PR) and FMM Foundation given to AV. MH was supported from the Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) Research Grant 09/00859, and Fundacion Mutua Madrilena (FMM) Research Grant FMM-08. SGE is supported by a Miguel Servet contract of the Instituto de Salud Carlos III. EAV was supported in part by grants BIO39/VA27/10 (Consejeria de Sanidad) and CSI004A10-2 (Consejeria de Educacion) from the Junta de Castilla y Leon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2001, AM J PATHOL, V159, P1619, DOI 10.1016/S0002-9440(10)63008-8; Adank MA, 2011, BREAST CANCER RES TR, V127, P357, DOI 10.1007/s10549-010-1001-1; Balia C, 2010, FAM CANCER, V9, P531, DOI 10.1007/s10689-010-9382-1; Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Chan PA, 2007, HUM MUTAT, V28, P683, DOI 10.1002/humu.20492; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Ghiorzo P, 2012, FAM CANCER, V11, P41, DOI 10.1007/s10689-011-9483-5; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; Harinck F, 2012, EUR J HUM GENET, V20, P577, DOI 10.1038/ejhg.2011.226; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x; Southey MC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2796; Stadler ZK, 2011, J MED GENET, V48, P523, DOI 10.1136/jmg.2010.087379; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Williams S, 2012, ANAL IN SILICO TOOLS; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamamoto H, 2001, CANCER RES, V61, P3139; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	40	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67538	10.1371/journal.pone.0067538	http://dx.doi.org/10.1371/journal.pone.0067538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935836	Green Published, gold			2022-12-27	WOS:000325211000013
J	Hao, GF; Tan, Y; Yang, SG; Wang, ZF; Zhan, CG; Xi, Z; Yang, GF				Hao, Ge-Fei; Tan, Ying; Yang, Sheng-Gang; Wang, Zhi-Fang; Zhan, Chang-Guo; Xi, Zhen; Yang, Guang-Fu			Computational and Experimental Insights into the Mechanism of Substrate Recognition and Feedback Inhibition of Protoporphyrinogen Oxidase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; HUMAN BUTYRYLCHOLINESTERASE; IX OXIDASE; DRUG-RESISTANCE; ATOMIC CHARGES; CODON DELETION; FREE-ENERGIES; MEAN FORCE; HERBICIDES	Protoporphyrinogen IX oxidase (PPO; EC 1.3.3.4) is an essential enzyme catalyzing the last common step in the pathway leading to heme and chlorophyll biosynthesis. Great interest in PPO inhibitors arises from both its significance to agriculture and medicine. However, the discovery of PPO inhibitors with ultrahigh potency and selectivity is hampered due to lack of structural and mechanistic understanding about the substrate recognition, which remains a longstanding question central in porphyrin biology. To understand the mechanism, a novel binding model of protogen (protoporphyrinogen IX, the substrate) was developed through extensive computational simulations. Subsequently, amino acid residues that are critical for protogen binding identified by computational simulations were substituted by mutagenesis. Kinetic analyses of these mutants indicated that these residues were critical for protogen binding. In addition, the calculated free energies of protogen binding with these mutants correlated well with the experimental data, indicating the reasonability of the binding model. On the basis of this novel model, the fundamental mechanism of substrate recognition was investigated by performing potential of mean force (PMF) calculations, which provided an atomic level description of conformational changes and pathway intermediates. The free energy profile revealed a feedback inhibition mechanism of proto (protoporphyrin IX, the product), which was also in agreement with experimental evidence. The novel mechanistic insights obtained from this study present a new starting point for future rational design of more efficient PPO inhibitors based on the product-bound PPO structure.	[Hao, Ge-Fei; Tan, Ying; Yang, Sheng-Gang; Wang, Zhi-Fang; Yang, Guang-Fu] Cent China Normal Univ, Coll Chem, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China; [Tan, Ying; Wang, Zhi-Fang; Xi, Zhen] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China; [Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA	Central China Normal University; Nankai University; University of Kentucky	Zhan, CG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA.	zhan@uky.edu; zhenxi@nankai.edu.cn; gfyang@mail.ccnu.edu.cn	TAN, YING/AAT-4671-2020	TAN, YING/0000-0003-2957-0165	National Basic Research Program of China [2010CB126103]; NSFC [20902034, 20925206]; National Key Technologies RD Program [2011BAE06B05]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work was supported in part by the National Basic Research Program of China (No. 2010CB126103), the NSFC (No. 20902034, and 20925206), and the National Key Technologies R&D Program (2011BAE06B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V., 2005, US Pat., Patent No. [20050049228 A1, 20050049228]; Arnould S, 1998, P NATL ACAD SCI USA, V95, P10553, DOI 10.1073/pnas.95.18.10553; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Case D, 2006, AMBER 9; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dayan FE, 2011, AM SCI, V99, P236, DOI 10.1511/2011.90.236; Dayan FE, 2010, BBA-PROTEINS PROTEOM, V1804, P1548, DOI 10.1016/j.bbapap.2010.04.004; Denton H, 2010, BIOCHEM J, V425, P603, DOI 10.1042/BJ20090896; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FRIEDEN E, 1963, NATURE, V198, P834, DOI 10.1038/198834a0; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gao DQ, 2006, ANGEW CHEM INT EDIT, V45, P653, DOI 10.1002/anie.200503025; HALLING BP, 1994, ACS SYM SER, V559, P280; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; Hao GF, 2011, J COMPUT AID MOL DES, V25, P213, DOI 10.1007/s10822-011-9412-6; Hao GF, 2010, J PHYS CHEM B, V114, P9663, DOI 10.1021/jp102546s; Hao GF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010742; Hao GF, 2009, J PHYS CHEM B, V113, P4865, DOI 10.1021/jp807442n; Heinemann IU, 2007, BIOCHEM J, V402, P575, DOI 10.1042/BJ20061321; Huang XQ, 2011, J PHYS CHEM B, V115, P11254, DOI 10.1021/jp2047807; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jeong E, 2003, BIOORG CHEM, V31, P389, DOI 10.1016/S0045-2068(03)00093-2; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Maneli MH, 2003, BBA-PROTEINS PROTEOM, V1650, P10, DOI 10.1016/S1570-9639(03)00186-9; MATRINGE M, 1989, BIOCHEM J, V260, P231, DOI 10.1042/bj2600231; Meazza G, 2004, PEST MANAG SCI, V60, P1178, DOI 10.1002/ps.923; Moghissi K, 2009, PHOTODIAGN PHOTODYN, V6, P159, DOI 10.1016/j.pdpdt.2009.07.026; Morishita T, 2000, J CHEM PHYS, V113, P2976, DOI 10.1063/1.1287333; Pan YM, 2005, P NATL ACAD SCI USA, V102, P16656, DOI 10.1073/pnas.0507332102; Pan YM, 2008, J AM CHEM SOC, V130, P5140, DOI 10.1021/ja077972s; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; POULSON R, 1976, J BIOL CHEM, V251, P3730; POULSON R, 1975, J BIOL CHEM, V250, P1269; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Siebel G. L., 1990, COMPREHENSIVE MED CH, VIV, P125; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Zeldenrust F, 2009, NEURAL NETWORKS, V22, P1139, DOI 10.1016/j.neunet.2009.07.015; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u	48	19	19	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69198	10.1371/journal.pone.0069198	http://dx.doi.org/10.1371/journal.pone.0069198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935953	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000088
J	Li, T; Zhuang, QY; Weng, XS; Zhou, L; Bian, YY				Li, Tao; Zhuang, Qianyu; Weng, Xisheng; Zhou, Lei; Bian, Yanyan			Cemented versus Uncemented Hemiarthroplasty for Femoral Neck Fractures in Elderly Patients: A Meta-Analysis	PLOS ONE			English	Article							PROSPECTIVE RANDOMIZED-TRIAL; BIPOLAR HEMIARTHROPLASTY; HIP-FRACTURES; BONE-CEMENT; PROSTHESES; ARTHROPLASTY; MANAGEMENT; MORTALITY; THOMPSON	Objective: Controversy still exists regarding using cemented or uncemented hemiarthroplasty for femoral neck fractures in elderly patients. The aim of this study is to compare the effectiveness and safety of the two surgical techniques in femoral neck fracture patients over 70 years old. Methods: We searched PUBMED, EMBASE, Cochrane Library, CNKI and VIP Database from inception to December 2012 for relevant randomized controlled trials (RCTs). Outcomes of interest include postoperative hip function, residue pain, complication rates, mortality, reoperation rate, operation time and intraoperative blood loss. Odds ratios (OR) and weighted mean differences (WMD) from each trial were pooled using random-effects model or fixed-effects model given on the heterogeneity of the included studies. Results: 7 RCTs involving 1,125 patients (1,125 hips) were eligible for meta-analysis. Our results demonstrate that cemented hemiarthroplasty is associated with better postoperative hip function (OR = 0.48, 95% CI, 0.31-0.76; P = 0.002), lower residual pain (OR = 0.43, 95% CI, 0.29-0.64; P<0.0001), less implant-related complications (OR = 0.15, 95%CI, 0.09-0.26; P<0.00001) and longer operation time (WMD = 7.43 min, 95% CI, 5.37-9.49 min; P<0.00001). No significant difference was observed between the two groups in mortality, cardiovascular and cerebrovascular complications, local complications, general complications, reoperation rate and intraoperative blood loss. Conclusions: Compared with uncemented hemiarthroplasty, the existing evidence indicates that cemented hemiarthroplasty can achieve better hip function, lower residual pain and less implant-related complications with no increased risk of mortality, cardiovascular and cerebrovascular complications, general complications, local complications and reoperation rate in treating elderly patients with femoral neck fractures.	[Li, Tao; Zhuang, Qianyu; Weng, Xisheng; Zhou, Lei; Bian, Yanyan] Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Weng, XS (corresponding author), Chinese Acad Med Sci, Dept Orthopaed Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	xshweng@medmail.com.cn		Weng, Xisheng/0000-0002-6021-1462				Azegami S, 2011, HIP INT, V21, P509, DOI 10.5301/HIP.2011.8640; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; CHRISTIE J, 1994, J BONE JOINT SURG BR, V76B, P409, DOI 10.1302/0301-620X.76B3.8175843; Clark DI, 2001, J BONE JOINT SURG BR, V83B, P414, DOI 10.1302/0301-620X.83B3.11477; Crossman PT, 2002, INJURY, V33, P383, DOI 10.1016/S0020-1383(02)00002-5; DeAngelis JP, 2012, J ORTHOP TRAUMA, V26, P135, DOI 10.1097/BOT.0b013e318238b7a5; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; EMERY RJH, 1991, J BONE JOINT SURG BR, V73, P322, DOI 10.1302/0301-620X.73B2.2005165; Faraj AA, 1999, INJURY, V30, P671, DOI 10.1016/S0020-1383(99)00169-2; Figved W, 2009, CLIN ORTHOP RELAT R, V467, P2426, DOI 10.1007/s11999-008-0672-y; HOLT EM, 1994, INJURY, V25, P91, DOI 10.1016/0020-1383(94)90109-0; Hossain M, 2012, INJURY, V43, P2161, DOI 10.1016/j.injury.2012.08.043; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jameson SS, 2012, INJURY IN PRESS; Kesmezacar H, 2010, J TRAUMA, V68, P153, DOI 10.1097/TA.0b013e31819adc50; Khan RJK, 2002, INJURY, V33, P13, DOI 10.1016/S0020-1383(01)00101-2; Khan RJK, 2002, INT ORTHOP, V26, P229, DOI 10.1007/s00264-002-0356-2; LIVESLEY PJ, 1993, INJURY, V24, P236, DOI 10.1016/0020-1383(93)90176-7; LO WH, 1994, CLIN ORTHOP RELAT R, P75; Luo XP, 2012, ARCH ORTHOP TRAUM SU, V132, P455, DOI 10.1007/s00402-011-1436-9; Parker MI, 2010, J BONE JOINT SURG BR, V92B, P116, DOI 10.1302/0301-620X.92B1.22753; Parker MJ, 2010, ARTHROPLASTIES BONE; Parker MJ, 2006, ARTHROPLASTIES BONE; Parvizi J, 1999, CLIN ORTHOP RELAT R, P39; SADR B, 1977, INJURY, V8, P234, DOI 10.1016/0020-1383(77)90137-1; Santini S, 2005, J ORTHOP TRAUMATOL, V6, P80, DOI 10.1007/s10195-005-0086-5; Singh U, 2011, JMS, V1, P19; SONNEHOLM S, 1982, ACTA ORTHOP SCAND, V53, P953, DOI 10.3109/17453678208992854; Taylor F, 2012, J BONE JOINT SURG AM, V94A, P577, DOI 10.2106/JBJS.K.00006	29	48	54	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68903	10.1371/journal.pone.0068903	http://dx.doi.org/10.1371/journal.pone.0068903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935902	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000060
J	Tewarie, P; Schoonheim, MM; Stam, CJ; van der Meer, ML; van Dijk, BW; Barkhof, F; Polman, CH; Hillebrand, A				Tewarie, Prejaas; Schoonheim, Menno M.; Stam, Cornelis J.; van der Meer, Marieke L.; van Dijk, Bob W.; Barkhof, Frederik; Polman, Chris H.; Hillebrand, Arjan			Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; BRAIN-TUMOR PATIENTS; LOW-GRADE GLIOMA; FUNCTIONAL CONNECTIVITY; GREY-MATTER; OSCILLATIONS; SYNCHRONIZATION; IMPAIRMENT; PATTERNS; FMRI	The relation between pathological findings and clinical and cognitive decline in Multiple Sclerosis remains unclear. Here, we tested the hypothesis that altered functional connectivity could provide a missing link between structural findings, such as thalamic atrophy and white matter lesion load, and clinical and cognitive dysfunction. Resting-state magnetoencephalography recordings from 21 MS patients and 17 gender-and age matched controls were projected onto atlas-based regions-of-interest using beamforming. Average functional connectivity was computed for each ROI and literature-based resting-state networks using the phase-lag index. Structural measures of whole brain and thalamic atrophy and lesion load were estimated from MRI scans. Global analyses showed lower functional connectivity in the alpha2 band and higher functional connectivity in the beta band in patients with Multiple Sclerosis. Additionally, alpha2 band functional connectivity was lower for the patients in two resting-state networks, namely the default mode network and the visual network. Higher beta band functional connectivity was found in the default mode network and in the temporo-parietal network. Lower alpha2 band functional connectivity in the visual network was related to lower thalamic volumes. Beta band functional connectivity correlated positively with disability scores, most prominently in the default mode network, and correlated negatively with cognitive performance in this network. These findings illustrate the relationship between thalamic atrophy, altered functional connectivity and clinical and cognitive dysfunction in MS, which could serve as a bridge to understand how neurodegeneration is associated with altered functional connectivity and subsequently clinical and cognitive decline.	[Tewarie, Prejaas; van der Meer, Marieke L.; Polman, Chris H.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Tewarie, Prejaas; Stam, Cornelis J.; van Dijk, Bob W.; Hillebrand, Arjan] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Tewarie, Prejaas; Stam, Cornelis J.; van Dijk, Bob W.; Hillebrand, Arjan] Vrije Univ Amsterdam Med Ctr, Magnetoencephalog Ctr, Amsterdam, Netherlands; [Schoonheim, Menno M.; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Schoonheim, Menno M.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [van Dijk, Bob W.] Vrije Univ Amsterdam Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Tewarie, P (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands.	p.tewarie@vumc.nl	Schoonheim, Menno M/X-5398-2018; Barkhof, Frederik/AAJ-6226-2020; Schoonheim, Menno/AAI-6853-2021	Schoonheim, Menno M/0000-0002-2504-6959; Barkhof, Frederik/0000-0003-3543-3706; Schoonheim, Menno/0000-0002-2504-6959; Stam, Cornelis/0000-0001-9163-7274; Hillebrand, Arjan/0000-0002-8508-3532	Dutch MS Research Foundation [02-358b, 05-358c, 08-650, 09-358d, 10-718]	Dutch MS Research Foundation	This study was sponsored by the Dutch MS Research Foundation, grant numbers 02-358b, 05-358c, 08-650, 09-358d and 10-718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Bo L, 2009, ACTA NEUROL SCAND, V120, P51, DOI 10.1111/j.1600-0404.2009.01216.x; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bosma I, 2008, J NEURO-ONCOL, V88, P77, DOI 10.1007/s11060-008-9535-3; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Cover KS, 2006, NEUROIMAGE, V29, P783, DOI 10.1016/j.neuroimage.2005.08.048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Dell'Acqua ML, 2010, HUM BRAIN MAPP, V31, P1588, DOI 10.1002/hbm.20961; Douw L, 2008, EXP NEUROL, V212, P285, DOI 10.1016/j.expneurol.2008.03.013; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Douw L, 2009, NEUROIMAGE, V46, P584, DOI 10.1016/j.neuroimage.2009.02.034; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gallo A, 2012, NEUROLOGY, V79, P1458, DOI 10.1212/WNL.0b013e31826d5eea; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Hardmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042087; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Helekar SA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00219; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hipp JF, 2012, NAT NEUROSCI; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hui HB, 2010, NEUROIMAGE, V49, P3161, DOI 10.1016/j.neuroimage.2009.10.078; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leavitt VM, 2012, MULT SCLER J, V18, P409, DOI 10.1177/1352458511423651; Leocani L, 2000, J NEUROL NEUROSUR PS, V69, P192, DOI 10.1136/jnnp.69.2.192; Liley DTJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051906; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meer vdM, 2012, CLIN DISABILIT UNPUB; Muthukumaraswamy SD, 2011, CLIN NEUROPHYSIOL, V122, P2324, DOI 10.1016/j.clinph.2011.04.003; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Parisi L., 2012, BRAIN IMAGING BEHAV; Peraza LR, 2012, J NEUROSCI METH, V207, P189, DOI 10.1016/j.jneumeth.2012.04.007; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46; Schoonheim MM, 2010, NEUROLOGY, V74, P1246, DOI 10.1212/WNL.0b013e3181db9957; Schoonheim MM, 2011, HUM BRAIN MAPP; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Singh KD, 2012, NEUROIMAGE, V62, P1121, DOI 10.1016/j.neuroimage.2012.01.028; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tao GZ, 2009, J NEUROL SCI, V282, P39, DOI 10.1016/j.jns.2008.12.035; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Tecchio F, 2008, BRAIN, V131, P1783, DOI 10.1093/brain/awn087; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Dellen E, 2013, NEUROIMAGE-CLIN, V2, P1, DOI 10.1016/j.nicl.2012.10.007; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vrba J, 1999, RECENT ADV BIOMAGNET	84	54	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69318	10.1371/journal.pone.0069318	http://dx.doi.org/10.1371/journal.pone.0069318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935983	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700025
J	Kumar, S; Jordan, MC; Datla, R; Cloutier, S				Kumar, Santosh; Jordan, Mark C.; Datla, Raju; Cloutier, Sylvie			The LuWD40-1 Gene Encoding WD Repeat Protein Regulates Growth and Pollen Viability in Flax (Linum Usitatissimum L.)	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; REVERSE TRANSCRIPTION; EXPRESSION ANALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MESSENGER-RNA; HISTONE H4; TRANSFORMATION; ARABIDOPSIS; IDENTIFICATION	As a crop, flax holds significant commercial value for its omega-3 rich oilseeds and stem fibres. Canada is the largest producer of linseed but there exists scope for significant yield improvements. Implementation of mechanisms such as male sterility can permit the development of hybrids to assist in achieving this goal. Temperature sensitive male sterility has been reported in flax but the leakiness of this system in field conditions limits the production of quality hybrid seeds. Here, we characterized a 2,588 bp transcript differentially expressed in male sterile lines of flax. The twelve intron gene predicted to encode a 368 amino acid protein has five WD40 repeats which, in silico, form a propeller structure with putative nucleic acid and histone binding capabilities. The LuWD40-1 protein localized to the nucleus and its expression increased during the transition and continued through the vegetative stages (seed, etiolated seedling, stem) while the transcript levels declined during reproductive development (ovary, anthers) and embryonic morphogenesis of male fertile plants. Knockout lines for LuWD40-1 in flax failed to develop shoots while overexpression lines showed delayed growth phenotype and were male sterile. The non-viable flowers failed to open and the pollen grains from these flowers were empty. Three independent transgenic lines overexpressing the LuWD40-1 gene had,80% non-viable pollen, reduced branching, delayed flowering and maturity compared to male fertile genotypes. The present study provides new insights into a male sterility mechanism present in flax.	[Kumar, Santosh; Cloutier, Sylvie] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Kumar, Santosh; Jordan, Mark C.; Cloutier, Sylvie] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Datla, Raju] CNR, Saskatoon, SK, Canada	University of Manitoba; Agriculture & Agri Food Canada	Cloutier, S (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	Sylvie.J.Cloutier@agr.gc.ca	Datla, Raju/AGR-7376-2022; Datla, Raju/H-3820-2011	Datla, Raju/0000-0003-0790-5569	Agriculture and Agri-Food Canada A-base grant [1785]	Agriculture and Agri-Food Canada A-base grant(Agriculture & Agri Food Canada)	The project was funded through Agriculture and Agri-Food Canada A-base grant No. 1785. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Bateson W, 1921, J GENET, V11, P269, DOI 10.1007/BF02983063; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Cloutier S, 2012, THEOR APPL GENET, V125, P685, DOI 10.1007/s00122-012-1860-4; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Colditz F, 2004, PLANT MOL BIOL, V55, P109, DOI 10.1007/s11103-004-0499-1; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Firmage DH, 2001, ACTA HORT ISHS, V561, P587; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Gao XQ, 2012, PLANTA, V235, P713, DOI 10.1007/s00425-011-1532-7; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hafidh S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-24; Hammond J. L., 2010, P ACM TERAGRID, P1; Han MJ, 2006, PLANT CELL PHYSIOL, V47, P1457, DOI 10.1093/pcp/pcl013; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Himmelbach A, 2007, PLANT PHYSIOL, V145, P1192, DOI 10.1104/pp.107.111575; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Hui Z, 2010, P 63 FLAX I US, P112; Janda L, 1996, J BACTERIOL, V178, P1487, DOI 10.1128/jb.178.5.1487-1489.1996; Jhala AJ, 2011, HEREDITY, V106, P557, DOI 10.1038/hdy.2010.81; Kumar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-684; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Li HJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-169; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Paoli M, 2001, NAT STRUCT BIOL, V8, P744, DOI 10.1038/nsb0901-744; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Ragupathy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-217; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Sitterlin D, 2004, GENE, V326, P107, DOI 10.1016/j.gene.2003.10.024; Sivamani E, 2009, PLANT CELL REP, V28, P213, DOI 10.1007/s00299-008-0636-4; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Sorensen MB, 2001, CURR BIOL, V11, P277, DOI 10.1016/S0960-9822(01)00072-0; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Twell D, 1994, MOL CELLULAR ASPECTS; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Venglat P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-74; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wijayanto T, 1999, IN VITRO CELL DEV-PL, V35, P456; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Xiang DQ, 2011, PLANT CELL, V23, P4348, DOI 10.1105/tpc.111.091777; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953	79	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69124	10.1371/journal.pone.0069124	http://dx.doi.org/10.1371/journal.pone.0069124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935935	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200024
J	Morgan, S; Lopes, F; Gourley, C; Anderson, RA; Spears, N				Morgan, Stephanie; Lopes, Federica; Gourley, Charlie; Anderson, Richard A.; Spears, Norah			Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin	PLOS ONE			English	Article							PRIMORDIAL FOLLICLE; GERM-CELL; IN-VITRO; ADJUVANT CHEMOTHERAPY; MOUSE OOCYTES; APOPTOSIS; DNA; FAILURE; RESERVE; IMPACT	Purpose: Chemotherapy treatment in premenopausal women has been linked to ovarian follicle loss and premature ovarian failure; the exact mechanism by which this occurs is uncertain. Here, two commonly used chemotherapeutic agents (cisplatin and doxorubicin) were added to a mouse ovary culture system, to compare the sequence of events that leads to germ cell loss. The ability of imatinib mesylate to protect the ovary against cisplatin or doxorubicin-induced ovarian damage was also examined. Experimental design: Newborn mouse ovaries were cultured for a total of six days, exposed to a chemotherapeutic agent on the second day: this allowed for the examination of the earliest stages of follicle development. Cleaved PARP and TUNEL were used to assess apoptosis following drug treatment. Imatinib was added to cultures with cisplatin and doxorubicin to determine any protective effect. Results: Histological analysis of ovaries treated with cisplatin showed oocyte-specific damage; in comparison doxorubicin preferentially caused damage to the granulosa cells. Cleaved PARP expression significantly increased for cisplatin (16 fold, p<0.001) and doxorubicin (3 fold, p<0.01). TUNEL staining gave little evidence of primordial follicle damage with either drug. Imatinib had a significant protective effect against cisplatin-induced follicle damage (p<0.01) but not against doxorubicin treatment. Conclusion: Cisplatin and doxorubicin both induced ovarian damage, but in a markedly different pattern, with imatinib protecting the ovary against damage by cisplatin but not doxorubicin. Any treatment designed to block the effects of chemotherapeutic agents on the ovary may need to be specific to the drug(s) the patient is exposed to.	[Morgan, Stephanie; Lopes, Federica; Spears, Norah] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Gourley, Charlie] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Spears, N (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	nspears@staffmail.ed.ac.uk		Lopes, Federica/0000-0001-5266-9521	MRC (Medical Research Council) [G1002118]; BBSRC (Biotechnology and Biological Sciences Research Council) studentship; MRC [G1100357, G1002033, G1002118] Funding Source: UKRI; Medical Research Council [G1002033, G1002118, G1100357] Funding Source: researchfish; Chief Scientist Office [SCD/11] Funding Source: researchfish	MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC (Biotechnology and Biological Sciences Research Council) studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by MRC (Medical Research Council) grant G1002118, SM was supported by a BBSRC (Biotechnology and Biological Sciences Research Council) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Bar-Joseph H, 2010, REPROD TOXICOL, V30, P566, DOI 10.1016/j.reprotox.2010.07.003; Barpe DR, 2010, EUR J PHARM SCI, V41, P458, DOI 10.1016/j.ejps.2010.07.015; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Bines J, 1996, J CLIN ONCOL, V14, P1718, DOI 10.1200/JCO.1996.14.5.1718; BRUNING PF, 1990, BRIT J CANCER, V61, P308, DOI 10.1038/bjc.1990.58; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Chiarelli AM, 1999, AM J EPIDEMIOL, V150, P245; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Driancourt MA, 2000, REV REPROD, V5, P143, DOI 10.1530/revreprod/5.3.143; Dunlap Beth, 2006, J Support Oncol, V4, P398; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Gonfloni S, 2010, ONCOGENE, V29, P6193, DOI 10.1038/onc.2010.410; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; GREENE RF, 1983, CANCER RES, V43, P3417; Jeanes H, 2007, EXPERT OPIN PHARMACO, V8, P279, DOI 10.1517/14656566.8.3.279; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Kerr JB, 2012, NAT MED, V18, P1170, DOI 10.1038/nm.2889; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Letourneau JM, 2012, CANCER-AM CANCER SOC, V118, P1933, DOI 10.1002/cncr.26403; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Maiani E, 2012, NAT MED, V18, P1172, DOI 10.1038/nm.2852; MARCELLO MF, 1990, CANCER, V66, P2099, DOI 10.1002/1097-0142(19901115)66:10<2099::AID-CNCR2820661010>3.0.CO;2-3; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meirow D, 2007, HUM REPROD, V22, P1626, DOI 10.1093/humrep/dem027; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Meirow D, 1999, HUM REPROD, V14, P1903, DOI 10.1093/humrep/14.7.1903; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Merkwitz C, 2011, PROG HISTOCHEM CYTO, V46, P131, DOI 10.1016/j.proghi.2011.09.001; Morgan S, 2012, HUM REPROD UPDATE, V18, P525, DOI 10.1093/humupd/dms022; Murray A, 2000, SEMIN REPROD MED, V18, P109, DOI 10.1055/s-2000-12550; Muruvi W, 2005, THERIOGENOLOGY, V64, P1357, DOI 10.1016/j.theriogenology.2005.02.010; Nilsson EE, 2006, REPRODUCTION, V131, P1007, DOI 10.1530/rep.1.00978; Oktem O, 2007, CANCER-AM CANCER SOC, V110, P2222, DOI 10.1002/cncr.23071; Pace A, 2010, NEUROLOGY, V74, P762, DOI 10.1212/WNL.0b013e3181d5279e; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; PFEIFLE CE, 1985, J CLIN ONCOL, V3, P237, DOI 10.1200/JCO.1985.3.2.237; Pytel D, 2009, ANTI-CANCER AGENT ME, V9, P66, DOI 10.2174/187152009787047752; Raz A, 2002, J ASSIST REPROD GEN, V19, P500, DOI 10.1023/A:1020318704960; SANDERS JE, 1988, J CLIN ONCOL, V6, P813, DOI 10.1200/JCO.1988.6.5.813; Schultheis B, 2012, LEUKEMIA RES, V36, P271, DOI 10.1016/j.leukres.2011.09.025; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Soleimani R, 2011, AGING-US, V3, P782, DOI 10.18632/aging.100363; Spears N, 2003, DEVELOPMENT, V130, P5481, DOI 10.1242/dev.00707; Springer LN, 1996, TOXICOL APPL PHARM, V139, P394, DOI 10.1006/taap.1996.0180; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Urien S, 2004, BRIT J CLIN PHARMACO, V57, P756, DOI 10.1111/j.1365-2125.2004.02082.x; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Yucebilgin MS, 2004, AUST NZ J OBSTET GYN, V44, P6, DOI 10.1111/j.1479-828X.2004.00143.x	53	101	104	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70117	10.1371/journal.pone.0070117	http://dx.doi.org/10.1371/journal.pone.0070117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922929	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700141
J	Braitstein, P; Ayaya, S; Nyandiko, WM; Kamanda, A; Koech, J; Gisore, P; Atwoli, L; Vreeman, RC; Duefield, C; Ayuku, DO				Braitstein, Paula; Ayaya, Samuel; Nyandiko, Winstone M.; Kamanda, Allan; Koech, Julius; Gisore, Peter; Atwoli, Lukoye; Vreeman, Rachel C.; Duefield, Corey; Ayuku, David O.			Nutritional Status of Orphaned and Separated Children and Adolescents Living in Community and Institutional Environments in Uasin Gishu County, Kenya	PLOS ONE			English	Article							HIGH HIV PREVALENCE; SUB-SAHARAN AFRICA; STREET CHILDREN; FOOD SECURITY; HEALTH; CARE; PATTERNS; AIDS; CHILDHOOD; DIAGNOSIS	Objective: To describe the nutritional status of orphaned and separated children and adolescents (OSCA) living in households in the community (HH), on the street, and those in institutional environments in western Kenya. Methods: The study enrolled OSCA from 300 randomly selected households (HH), 19 Charitable Children's Institutions (CCIs), and 100 street-involved children. Measures of malnutrition were standardized with Z-scores using World Health Organization criteria; Z-scores <=-2 standard deviations (sd) were moderate-severe malnutrition. Data were analyzed using multivariable logistic regression adjusting for child age, sex, HIV status, whether the child had been hospitalized in the previous year, time living with current guardian, and intra-household clustering for adequacy of diet and moderate-severe malnutrition. Results: Included are data from 2862 participants (1337 in CCI's, 1425 in HH's, and 100 street youth). The population was 46% female with median age at enrolment of 11.1 years. Only 4.4% of households and institutions reported household food security; 93% of children in HH reported an adequate diet vs. 95% in CCI's and 99% among street youth. After adjustment, OSCA in HH were less likely to have an adequate diet compared to those in CCI's (AOR 0.4, 95% CI 0.2-1.0). After adjustment, there were no differences between the categories of children on weight-for-age, weight-for-height, or BMI-for-age. Children living in HH (AOR 2.6, 95% CI: 2.0-3.4) and street youth (AOR: 5.9, 95% CI: 3.6-9.5) were more likely than children in CCI's to be low height-for-age. Conclusion: OSCA in HH are less likely to have an adequate diet compared to children in CCI's. They and street children are more likely to be moderately-severely low height-for-age compared to children in CCI's, suggesting chronic malnutrition among them.	[Braitstein, Paula] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Ayaya, Samuel; Nyandiko, Winstone M.; Gisore, Peter] Moi Univ, Coll Hlth Sci, Sch Med, Dept Child Hlth & Pediat, Eldoret, Kenya; [Kamanda, Allan] Moi Teaching & Referral Hosp, Eldoret, Kenya; [Koech, Julius] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Atwoli, Lukoye] Moi Univ, Coll Hlth Sci, Sch Med, Dept Mental Hlth, Eldoret, Kenya; [Vreeman, Rachel C.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Duefield, Corey] Brown Univ, Ctr Stat Sci, Sch Publ Hlth, Providence, RI 02912 USA; [Ayuku, David O.] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya	Indiana University System; Indiana University-Purdue University Indianapolis; Moi University; University of Toronto; Moi University; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; Brown University; Moi University	Braitstein, P (corresponding author), Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.	pbraitstein@yahoo.com	Ayuku, David/AAB-8485-2019	Atwoli, Lukoye/0000-0001-7710-9723	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD060478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Broadhead I, 2012, RWANDA CHILD POLICY; Bryant John H, 2009, Health Hum Rights, V11, P65; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Coates J., 2006, HOUSEHOLD FOOD INSEC; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Government of Kenya, 2005, CHILDR REG S53, V89; Government of Kenya, 2010, DEM HLTH SURV 2008 2; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Heymann J, 2007, AIDS CARE, V19, P337, DOI 10.1080/09540120600763225; Hosegood V, 2007, POP STUD-J DEMOG, V61, P327, DOI 10.1080/00324720701524292; Isaranurug S, 2009, MATERN CHILD HLTH J, V13, P138, DOI 10.1007/s10995-008-0335-3; Kamanda A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-91; Kapavarapu PK, 2012, TROP MED INT HEALTH, V17, P962, DOI 10.1111/j.1365-3156.2012.03022.x; Kimani-Murage EW, 2011, J URBAN HEALTH, V88, P282, DOI 10.1007/s11524-010-9491-z; Lindblade KA, 2003, TROP MED INT HEALTH, V8, P67, DOI 10.1046/j.1365-3156.2003.00987.x; Mansourian M, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-149; Miller CM, 2006, AM J PUBLIC HEALTH, V96, P1429, DOI 10.2105/AJPH.2005.072280; Miller CM, 2007, SOC SCI MED, V64, P2476, DOI 10.1016/j.socscimed.2007.03.002; Monasch R, 2004, AIDS, V18, pS55, DOI 10.1097/00002030-200406002-00007; Musa DI, 2012, TROP MED INT HEALTH, V17, P1369, DOI 10.1111/j.1365-3156.2012.03083.x; Mushtaq MU, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-31; Mushtaq MU, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-790; Nair P H, 1981, Indian Pediatr, V18, P299; Nhate V, 2005, ORPHANS DISCRIMINATI, P1; Nyambedha EO, 2003, SOC SCI MED, V57, P301, DOI 10.1016/S0277-9536(02)00359-3; Nyambedha EO, 2001, HEALTH POLICY, V58, P83, DOI 10.1016/S0168-8510(01)00145-2; Rivers J, 2010, FOOD NUTR BULL, V31, pS264, DOI 10.1177/15648265100313S305; Sarker M, 2005, TROP MED INT HEALTH, V10, P210, DOI 10.1111/j.1365-3156.2004.01377.x; Schenk K, 2005, ETHICAL GUIDELINES G; Seth R, 2005, SUBST USE MISUSE, V40, P1659, DOI 10.1080/10826080500222792; Sherman SS, 2005, J URBAN HEALTH, V82, pIV113, DOI 10.1093/jurban/jti113; STEGEN G, 1969, PEDIATRICS, V43, P260; Thielman N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038109; Uasin Gishu County, 2012, WELC COUNT CHAMP; UN-Habitat, 2008, STAT AFR CIT FRAM AD; UNICEF, 2012, STAT WORLDS CHILDR U; UNICEF, 2012, KEN GLANC; UNICEF, 1986, CHILDR ESP DIFF CIRC; UNICEF, 2004, FRAM PROT CAR SUPP O; UNICEF, 2006, AFR ORPH VULN GEN CH; UNICEF Malawi, 2005, REP PIL SURV ORPH OT; UNICEF Zimbabwe Ministry of Public Service and Social Welfare Zimbabwe, 2005, SURV ORPH OTH VULN C; Veale A, 2003, CHILD ABUSE NEGLECT, V27, P253, DOI 10.1016/S0145-2134(03)00005-X; Wamani H., 2007, BMC Pediatrics, V7; Watts H, 2007, TROP MED INT HEALTH, V12, P584, DOI 10.1111/j.1365-3156.2007.01832.x; Whetten K, 2008, AIDS CARE, V20, P1233, DOI 10.1080/09540120801918636; Whetten K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008169; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2007, WHO CAR DEF HIV SURV	49	35	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70054	10.1371/journal.pone.0070054	http://dx.doi.org/10.1371/journal.pone.0070054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922900	Green Submitted, gold, Green Published			2022-12-27	WOS:000322838900136
J	Cao, LS; Wang, J; Chen, YL; Deng, HT; Wang, ZX; Wu, JW				Cao, Lu-Sha; Wang, Jue; Chen, Yuling; Deng, Haiteng; Wang, Zhi-Xin; Wu, Jia-Wei			Structural Basis for the Regulation of Maternal Embryonic Leucine Zipper Kinase	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; UBIQUITIN-ASSOCIATED DOMAINS; MELK; PHOSPHORYLATION; FAMILY; MARK/PAR-1; CELLS; AMPK; PROLIFERATION; CONFORMATION	MELK (maternal embryonic leucine zipper kinase), which is a member of the AMPK (AMP-activated protein kinase)-related kinase family, plays important roles in diverse cellular processes and has become a promising drug target for certain cancers. However, the regulatory mechanism of MELK remains elusive. Here, we report the crystal structure of a fragment of human MELK that contains the kinase domain and ubiquitin-associated (UBA) domain. The UBA domain tightly binds to the back of the kinase domain, which may contribute to the proper conformation and activity of the kinase domain. Interestingly, the activation segment in the kinase domain displays a unique conformation that contains an intramolecular disulfide bond. The structural and biochemical analyses unravel the molecular mechanisms for the autophosphorylation/ activation of MELK and the dependence of its catalytic activity on reducing agents. Thus, our results may provide the basis for designing specific MELK inhibitors for cancer treatment.	[Wu, Jia-Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wu, JW (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022	Deng, Haiteng/0000-0001-9496-1280; Cao, Lusha/0000-0002-6157-6893	China National Key Basic Research Program [2011CB910803]; Natural Science Foundation of China [31130062, 31070643]; Tsinghua University [20121080028]	China National Key Basic Research Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work is supported in part by grants 2011CB910803 (China National Key Basic Research Program, http://www.973.gov.cn) to J.W.W. and Z.X.W., 31130062 and 31070643 (Natural Science Foundation of China, http://www.nsfc.gov.cn) and 20121080028 (Tsinghua University, http://www.tsinghua.edu.cn) to J.W.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Madura K, 2002, CELL CYCLE, V1, P233, DOI 10.4161/cc.1.4.130; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirey G, 2005, CELL CYCLE, V4, P806, DOI 10.4161/cc.4.6.1716; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; PARIS J, 1990, DEV BIOL, V140, P221, DOI 10.1016/0012-1606(90)90070-Y; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Saito R, 2005, MOL CELL BIOL, V25, P6682, DOI 10.1128/MCB.25.15.6682-6693.2005; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2012, J BIOL CHEM, V287, P20811, DOI 10.1074/jbc.M111.331827; Seong HA, 2012, J BIOL CHEM, V287, P20797, DOI 10.1074/jbc.M112.347757; Seong HA, 2010, J BIOL CHEM, V285, P30959, DOI 10.1074/jbc.M110.138370; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200	48	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70031	10.1371/journal.pone.0070031	http://dx.doi.org/10.1371/journal.pone.0070031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922895	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900133
J	Mishra, A; Vij, M; Kumar, D; Taneja, V; Mondal, AK; Bothra, A; Rao, V; Ganguli, M; Taneja, B				Mishra, Arpit; Vij, Manika; Kumar, Dhirendra; Taneja, Vibha; Mondal, Anupam Kumar; Bothra, Ankur; Rao, Vivek; Ganguli, Munia; Taneja, Bhupesh			Integration Host Factor of Mycobacterium tuberculosis, mIHF, Compacts DNA by a Bending Mechanism	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEIN; VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; H-NS; BINDING PROTEIN; BACTERIAL CHROMATIN; HIGH-AFFINITY; SEQUENCE; PHASE; FIS	The bacterial chromosomal DNA is folded into a compact structure called as 'nucleoid' so that the bacterial genome can be accommodated inside the cell. The shape and size of the nucleoid are determined by several factors including DNA supercoiling, macromolecular crowding and nucleoid associated proteins (NAPs). NAPs bind to different sites of the genome in sequence specific or non-sequence specific manner and play an important role in DNA compaction as well as regulation. Until recently, few NAPs have been discovered in mycobacteria owing to poor sequence similarities with other histone-like proteins of eubacteria. Several putative NAPs have now been identified in Mycobacteria on the basis of enriched basic residues or histone-like "PAKK'' motifs. Here, we investigate mycobacterial Integration Host Factor (mIHF) for its architectural roles as a NAP using atomic force microscopy and DNA compaction experiments. We demonstrate that mIHF binds DNA in a non-sequence specific manner and compacts it by a DNA bending mechanism. AFM experiments also indicate a dual architectural role for mIHF in DNA compaction as well as relaxation. These results suggest a convergent evolution in the mechanism of E. coli and mycobacterial IHF in DNA compaction.	[Mishra, Arpit; Vij, Manika; Kumar, Dhirendra; Taneja, Vibha; Mondal, Anupam Kumar; Bothra, Ankur; Rao, Vivek; Ganguli, Munia; Taneja, Bhupesh] CSIR Inst Genom & Integrat Biol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Taneja, B (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	btaneja@igib.res.in	Mishra, Arpit/AAA-1134-2019; Kumar, Dhirendra/AAE-7237-2021; Bothra, Ankur/AAD-9423-2020	Mishra, Arpit/0000-0002-8700-4498; Bothra, Ankur/0000-0002-9038-740X; Mondal, Anupam/0000-0002-3572-6392; Kumar, Dhirendra/0000-0002-4349-3605	Council of Scientific and Industrial Research, India (CSIR); Department of Science and Technology-Inspire (DST-Inspire); Department of Biotechnology - BioInformatics National Certification (DBT-BINC) India; Innovative Young Biotechnology Award, DBT, India; DST, India [GAP-0060]	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology-Inspire (DST-Inspire); Department of Biotechnology - BioInformatics National Certification (DBT-BINC) India; Innovative Young Biotechnology Award, DBT, India; DST, India(Department of Science & Technology (India))	AM, AB and MV thank Council of Scientific and Industrial Research, India (CSIR); DK acknowledges Department of Science and Technology-Inspire (DST-Inspire); and AKM acknowledges Department of Biotechnology - BioInformatics National Certification (DBT-BINC) India for research fellowships. VT acknowledges fellowship from Innovative Young Biotechnology Award, DBT, India. This work was supported by GAP-0060 project grant of DST, India to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Basu D, 2009, NUCLEIC ACIDS RES, V37, P4944, DOI 10.1093/nar/gkp502; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Chen JM, 2008, NUCLEIC ACIDS RES, V36, P2123, DOI 10.1093/nar/gkm1162; CUKIERKA.R, 1972, P NATL ACAD SCI USA, V69, P3643, DOI 10.1073/pnas.69.12.3643; Dame RT, 2002, FEBS LETT, V529, P151, DOI 10.1016/S0014-5793(02)03363-X; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Dona V, 2008, J BACTERIOL, V190, P5963, DOI 10.1128/JB.00622-08; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kamashev D, 1999, EMBO J, V18, P5434, DOI 10.1093/emboj/18.19.5434; Kamashev D, 2000, EMBO J, V19, P6527, DOI 10.1093/emboj/19.23.6527; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kumar A, 2011, J BIOL CHEM, V286, P19652, DOI 10.1074/jbc.M110.200428; Kumar S, 2010, PLOS ONE, V5, DOI [10.1371/journal.-pone.0012551, DOI 10.1371/J0URNAL.-P0NE.0012551]; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049885; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Mann RA, 2012, J CONTROL RELEASE, V157, P260, DOI 10.1016/j.jconrel.2011.09.081; Mukherjee A, 2009, FEMS MICROBIOL LETT, V291, P232, DOI 10.1111/j.1574-6968.2008.01458.x; NASH HA, 1981, J BIOL CHEM, V256, P9246; Pedulla ML, 1998, J BACTERIOL, V180, P5473, DOI 10.1128/JB.180.20.5473-5477.1998; Pedulla ML, 1996, P NATL ACAD SCI USA, V93, P15411, DOI 10.1073/pnas.93.26.15411; Pena CEA, 1997, J MOL BIOL, V266, P76, DOI 10.1006/jmbi.1996.0774; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Sharadamma N, 2010, NUCLEIC ACIDS RES, V38, P3555, DOI 10.1093/nar/gkq064; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Stonehouse E, 2008, J BACTERIOL, V190, P4736, DOI 10.1128/JB.00089-08; SU CJ, 1990, J BACTERIOL, V172, P4705, DOI 10.1128/jb.172.8.4705-4707.1990; Swiercz JP, 2013, NUCLEIC ACIDS RES, V41, P4171, DOI 10.1093/nar/gkt095; Tessmer I, 2005, J MOL BIOL, V350, P254, DOI 10.1016/j.jmb.2005.04.043; Travers A, 2005, CURR OPIN GENET DEV, V15, P507, DOI 10.1016/j.gde.2005.08.006; Uplekar S, 2013, NUCLEIC ACIDS RES, V41, P961, DOI 10.1093/nar/gks1260; van Noort J, 1999, NUCLEIC ACIDS RES, V27, P3875, DOI 10.1093/nar/27.19.3875; van Noort J, 2004, P NATL ACAD SCI USA, V101, P6969, DOI 10.1073/pnas.0308230101; VARSHAVSKY AJ, 1977, NUCLEIC ACIDS RES, V4, P2725, DOI 10.1093/nar/4.8.2725; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; Weisberg RA, 1996, MOL MICROBIOL, V19, P642, DOI 10.1046/j.1365-2958.1996.t01-2-442924.x; Werlang ICR, 2009, MICROBIOL-SGM, V155, P2652, DOI 10.1099/mic.0.030148-0; Wolfe LM, 2010, J PROTEOME RES, V9, P5816, DOI 10.1021/pr1005873; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5; Yang YH, 2012, ANTON LEEUW INT J G, V101, P479, DOI 10.1007/s10482-011-9657-z	56	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69985	10.1371/journal.pone.0069985	http://dx.doi.org/10.1371/journal.pone.0069985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922883	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900131
J	Ke, CC; Liu, RS; Suetsugu, A; Kimura, H; Ho, JH; Lee, OK; Hoffman, RM				Ke, Chien-Chih; Liu, Ren-Shyan; Suetsugu, Atsushi; Kimura, Hiroaki; Ho, Jennifer H.; Lee, Oscar K.; Hoffman, Robert M.			In Vivo Fluorescence Imaging Reveals the Promotion of Mammary Tumorigenesis by Mesenchymal Stromal Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; CANCER STEM-CELLS; BONE-MARROW; BREAST-CANCER; TUMOR STROMA; DIFFERENTIATION; MOUSE; MIGRATION; PROTEINS; GROWTH	Mesenchymal stromal cells (MSCs) are multipotent adult stem cells which are recruited to the tumor microenvironment (TME) and influence tumor progression through multiple mechanisms. In this study, we examined the effects of MSCs on the tunmorigenic capacity of 4T1 murine mammary cancer cells. It was found that MSC-conditioned medium increased the proliferation, migration, and efficiency of mammosphere formation of 4T1 cells in vitro. When co-injected with MSCs into the mouse mammary fat pad, 4T1 cells showed enhanced tumor growth and generated increased spontaneous lung metastasis. Using in vivo fluorescence color-coded imaging, the interaction between GFP-expressing MSCs and RFP-expressing 4T1 cells was monitored. As few as five 4T1 cells could give rise to tumor formation when co-injected with MSCs into the mouse mammary fat pad, but no tumor was formed when five or ten 4T1 cells were implanted alone. The elevation of tumorigenic potential was further supported by gene expression analysis, which showed that when 4T1 cells were in contact with MSCs, several oncogenes, cancer markers, and tumor promoters were upregulated. Moreover, in vivo longitudinal fluorescence imaging of tumorigenesis revealed that MSCs created a vascularized environment which enhances the ability of 4T1 cells to colonize and proliferate. In conclusion, this study demonstrates that the promotion of mammary cancer progression by MSCs was achieved through the generation of a cancer-enhancing microenvironment to increase tumorigenic potential. These findings also suggest the potential risk of enhancing tumor progression in clinical cell therapy using MSCs. Attention has to be paid to patients with high risk of breast cancer when considering cell therapy with MSCs.	[Ke, Chien-Chih; Suetsugu, Atsushi; Kimura, Hiroaki; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Ke, Chien-Chih; Liu, Ren-Shyan] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lee, Oscar K.] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Liu, Ren-Shyan] Natl Yang Ming Univ, Sch Med, Dept Nucl Med, Taipei 112, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Natl PET Cyclotron Ctr, Taipei, Taiwan; [Liu, Ren-Shyan] Natl Comprehens Mouse Phenotyping & Drug Testing, Taiwan Mouse Clin, Taipei, Taiwan; [Ho, Jennifer H.] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Ho, Jennifer H.] Taipei Med Univ, Wan Fang Med Ctr, Ctr Stem Cell Res, Taipei, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei 112, Taiwan	Anti Cancer Inc; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; University of California System; University of California San Diego; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Yang Ming Chiao Tung University	Lee, OK (corresponding author), Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan.	kslee@vghtpe.gov.tw; all@anticancer.com	Ke, Chien-Chih/ABF-7414-2020; 柯, 建志/HHS-4905-2022	Ke, Chien-Chih/0000-0002-9360-5476; 	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program [NSC100-2911-I-009-101]; Taipei Veterans General Hospital [VGH100E1-010, VGH100C-056, VN100-05, VGH100D-003-2, V99ER2-013]; National Science Council, Taiwan [NSC100-2120-M-010-001, NSC100-2314-B-010-030-MY3, NSC100-2321-B-010-019, NSC99-3111-B-010-002, NSC98-2314-B-010-001-MY3, NSC 99-2911-I-010-501, NSC 99-3114-B-002-005, NSC98-2911-I-010-009]; Department of Health [DOH100-TD-C-111 -007]; Ministry of Education; Aim for the Top University Plan; US National Cancer Institute (NCI) [CA132971]; Taipei medical University, Wan-Fang Hospital [102swf02]	UST-UCSD International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council I-RiCE Program; Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan); US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taipei medical University, Wan-Fang Hospital	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC100-2911-I-009-101. The authors also acknowledge financial support from the Taipei Veterans General Hospital (VGH100E1-010, VGH100C-056, VN100-05, VGH100D-003-2 and V99ER2-013), the National Science Council, Taiwan (NSC100-2120-M-010-001, NSC100-2314-B-010-030-MY3, NSC100-2321-B-010-019, NSC99-3111-B-010-002, NSC98-2314-B-010-001-MY3, NSC 99-2911-I-010-501, NSC 99-3114-B-002-005 and NSC98-2911-I-010-009) and the Department of Health (DOH100-TD-C-111 -007). This study was also supported by a grant from the Ministry of Education, Aim for the Top University Plan, a US National Cancer Institute (NCI) grant CA132971 and a Taipei medical University, Wan-Fang Hospital grant 102swf02.	Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Dai LJ, 2011, CANCER LETT, V305, P8, DOI 10.1016/j.canlet.2011.02.012; Feng B, 2009, CANCER BIOTHER RADIO, V24, P717, DOI 10.1089/cbr.2009.0652; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Jin LH, 2008, MOL CANCER THER, V7, P48, DOI 10.1158/1535-7163.MCT-07-0042; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li L, 2011, J CELL PHYSIOL, V226, P1860, DOI 10.1002/jcp.22511; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Suetsugu A, 2011, J CELL BIOCHEM, V112, P949, DOI 10.1002/jcb.23011; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228	32	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69658	10.1371/journal.pone.0069658	http://dx.doi.org/10.1371/journal.pone.0069658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936067	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300057
J	Najafian, B; Mauer, M				Najafian, Behzad; Mauer, Michael			Predilection of Segmental Glomerulosclerosis Lesions for the Glomerulotubular Junction Area in Type 1 Diabetic Patients: A Novel Mapping Method	PLOS ONE			English	Article							GLOMERULAR VOLUME; ABNORMALITIES; NEPHROPATHY; RAT	The location of segmental glomerular lesions in relation to the vascular or tubular pole may have diagnostic or prognostic significance. We have developed a model-based method to estimate the distance from a glomerular lesion to a given landmark (vascular or tubular pole) or the glomerular center and applied this to biopsies from 5 microalbuminuric, 5 normoalbuminuric and 7 proteinuric type 1 diabetic patients and 5 normal controls. The distance from each glomerular adhesion to the glomerulotubular junction was measured and divided by the glomerular radius, allowing comparability among different glomeruli, assuming a spherical shape for Bowman's capsule, an assumption which was validated. The frequency of adhesions in 6 glomerular zones with equal height (zone I adjacent to the glomerulotubular junction and zones II-VI progressively farther away) was determined: 59% of adhesions were in zone I, 15% in zone II, 16% in zone III, 7% in zone IV and 3% in zone VI (adjacent to the hilus). In glomeruli with only one adhesion, 82% of these were in zone I. This new method accurately localizes segmental lesions within glomeruli and revealed a marked predilection in type 1 diabetic patients for segmental sclerosis to develop at the glomerulotubular junction.	[Najafian, Behzad] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mauer, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@uw.edu	Mauer, Michael/ABD-5415-2020	Najafian, Behzad/0000-0002-0904-6721	National Institutes of Health [DK13083, DK054638, DK51975]; GCRC [M01-RR00400]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054638, R01DK051975, P01DK013083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health (DK13083, DK054638 and DK51975) and GCRC grant M01-RR00400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; HOWIE AJ, 1993, NEPHROL DIAL TRANSPL, V8, P590; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; MORITA M, 1990, J PATHOL, V162, P245, DOI 10.1002/path.1711620311; MORITA M, 1990, CLIN NEPHROL, V33, P211; Najafian B, 2003, J AM SOC NEPHROL, V14, P908, DOI 10.1097/01.ASN.0000057854.32413.81; Najafian B, 2002, J AM SOC NEPHROL, V13, P2697, DOI 10.1097/01.ASN.0000033381.53882.25; Najafian B, 2006, J AM SOC NEPHROL, V17, pS53, DOI 10.1681/ASN.2005121342; NEWBOLD KM, 1990, J PATHOL, V162, P149, DOI 10.1002/path.1711620208; Perico N, 1996, KIDNEY INT, V49, P1283, DOI 10.1038/ki.1996.183; REMUZZI A, 1995, KIDNEY INT, V48, P155, DOI 10.1038/ki.1995.279; REMUZZI A, 1990, KIDNEY INT, V38, P851, DOI 10.1038/ki.1990.281; SANDISON A, 1992, DIABETES, V41, P952, DOI 10.2337/diabetes.41.8.952; Stokes MB, 2004, KIDNEY INT, V65, P1690, DOI 10.1111/j.1523-1755.2004.00563.x; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69253	10.1371/journal.pone.0069253	http://dx.doi.org/10.1371/journal.pone.0069253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935967	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300029
J	Al-Chaqmaqchi, HAM; Moshfegh, A; Dadfar, E; Paulsson, J; Hassan, M; Jacobson, SH; Lundahl, J				Al-Chaqmaqchi, Heevy Abdulkareem Musa; Moshfegh, Ali; Dadfar, Elham; Paulsson, Josefin; Hassan, Moustapha; Jacobson, Stefan H.; Lundahl, Joachim			Activation of Wnt/beta-Catenin Pathway in Monocytes Derived from Chronic Kidney Disease Patients	PLOS ONE			English	Article							LEUKOCYTE TRANSENDOTHELIAL MIGRATION; WNT SIGNALING PATHWAY; GENE-EXPRESSION; DENDRITIC CELLS; BETA-CATENIN; IMMUNE DYSFUNCTION; ENDOTHELIAL-CELLS; INFLAMMATION; MACROPHAGES; ADHESION	Patients with chronic kidney disease (CKD) have significantly increased morbidity and mortality resulting from infections and cardiovascular diseases. Since monocytes play an essential role in host immunity, this study was directed to explore the gene expression profile in order to identify differences in activated pathways in monocytes relevant to the pathophysiology of atherosclerosis and increased susceptibility to infections. Monocytes from CKD patients (stages 4 and 5, estimated GFR <20 ml/min/1.73 m(2)) and healthy donors were collected from peripheral blood. Microarray gene expression profile was performed and data were interpreted by GeneSpring software and by PANTHER tool. Western blot was done to validate the pathway members. The results demonstrated that 600 and 272 genes were differentially up- and down regulated respectively in the patient group. Pathways involved in the inflammatory response were highly expressed and the Wnt/beta-catenin signaling pathway was the most significant pathway expressed in the patient group. Since this pathway has been attributed to a variety of inflammatory manifestations, the current findings may contribute to dysfunctional monocytes in CKD patients. Strategies to interfere with this pathway may improve host immunity and prevent cardiovascular complications in CKD patients.	[Al-Chaqmaqchi, Heevy Abdulkareem Musa] Karolinska Inst, Dept Lab Med, Div Expt Canc Med, Clin Res Ctr, Stockholm, Sweden; [Moshfegh, Ali] Karolinska Hosp, CCK, Dept Pathol & Oncol, S-10401 Stockholm, Sweden; [Moshfegh, Ali] Karolinska Inst, Stockholm, Sweden; [Dadfar, Elham; Paulsson, Josefin; Lundahl, Joachim] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Hassan, Moustapha] Karolinska Univ Hosp Huddinge, Clin Res Ctr KFC, Novum, Stockholm, Sweden; [Jacobson, Stefan H.] Karolinska Inst, Danderyd Univ Hosp, Div Nephrol, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Al-Chaqmaqchi, HAM (corresponding author), Karolinska Inst, Dept Lab Med, Div Expt Canc Med, Clin Res Ctr, Stockholm, Sweden.	Heevy.Al-Chaqmaqchi@ki.se	Hassan, Moustapha/H-9260-2015	Hassan, Moustapha/0000-0003-1927-5859	Karolinska Institutet, Stockholm, Sweden; Stockholm County Council, Stockholm, Sweden; Amgen Europe	Karolinska Institutet, Stockholm, Sweden; Stockholm County Council, Stockholm, Sweden(Stockholm County Council); Amgen Europe(Amgen)	Funding was provided by Karolinska Institutet, Stockholm, Sweden, Stockholm County Council, Stockholm, Sweden and Amgen Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta D, 2002, EXP NEPHROL, V10, P139; Amann K, 2003, CLIN NEPHROL, V60, pS13; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carrero JJ, 2008, BLOOD PURIFICAT, V26, P291, DOI 10.1159/000126926; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Faure V, 2006, INT IMMUNOL, V18, P1453, DOI 10.1093/intimm/dxl077; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; HaagWeber M, 1996, SEMIN NEPHROL, V16, P192; Hauser AB, 2008, PERITON DIALYSIS INT, V28, pS183; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Lee DK, 2006, BIOCHEM BIOPH RES CO, V347, P109, DOI 10.1016/j.bbrc.2006.06.082; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Polzer K, 2008, JOINT BONE SPINE, V75, P105, DOI 10.1016/j.jbspin.2007.10.005; Ramirez R, 2011, CONTRIB NEPHROL, V171, P57, DOI 10.1159/000327134; Rees AJ, 2010, SEMIN NEPHROL, V30, P216, DOI 10.1016/j.semnephrol.2010.03.002; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Yilmaz MI, 2007, CLIN NEPHROL, V68, P1; [No title captured]	43	22	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68937	10.1371/journal.pone.0068937	http://dx.doi.org/10.1371/journal.pone.0068937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935909	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000065
J	Bohl, C; Bowder, D; Thompson, J; Abrahamyan, L; Gonzalez-Ramirez, S; Mao, YD; Sodroski, J; Wood, C; Xiang, SH				Bohl, Christopher; Bowder, Dane; Thompson, Jesse; Abrahamyan, Levon; Gonzalez-Ramirez, Sandra; Mao, Youdong; Sodroski, Joseph; Wood, Charles; Xiang, Shi-hua			A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 GP120; V1/V2 DOMAIN; AIDS; NEUTRALIZATION; PATHOGENESIS; ARCHITECTURE; ANTIBODIES; CHIMPANZEE; INFECTION	The V1 and V2 variable regions of the primate immunodeficiency viruses contribute to the trimer association domain of the gp120 exterior envelope glycoprotein. A pair of V2 cysteine residues at 183 and 191 ("twin cysteines") is present in several simian immunodeficiency viruses, human immunodeficiency virus type 2 (HIV-2) and some SIVcpz lineages, but not in HIV-1. To examine the role of this potentially disulfide-bonded twin-cysteine motif, the cysteine residues in the SIVmac239 envelope glycoproteins were individually and pairwise substituted by alanine residues. All of the twin-cysteine mutants exhibited decreases in gp120 association with the Env trimer, membrane-fusing activity, and ability to support virus entry. Thus, the twin-cysteine motif plays a role in Env trimer stabilization in SIV and may do so in HIV-2 and some SIVcpz as well. This implies that HIV-1 lost the twin-cysteines, and may have relatively unstable Env trimers compared to SIV and HIV-2.	[Bohl, Christopher; Bowder, Dane; Thompson, Jesse; Abrahamyan, Levon; Gonzalez-Ramirez, Sandra; Wood, Charles; Xiang, Shi-hua] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Thompson, Jesse; Xiang, Shi-hua] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Bohl, Christopher; Bowder, Dane; Abrahamyan, Levon; Gonzalez-Ramirez, Sandra; Wood, Charles; Xiang, Shi-hua] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Mao, Youdong; Sodroski, Joseph] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Mao, Youdong; Sodroski, Joseph] Harvard Univ, Sch Med, Div Aids, Dept Microbiol & Immunol, Boston, MA USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sodroski, Joseph] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Xiang, SH (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA.	sxiang2@unl.edu	Wood, Charles/AAH-4536-2021; Abrahamyan, Levon/E-1982-2013; Mao, Youdong/AFJ-2673-2022	Abrahamyan, Levon/0000-0002-0849-0134; Mao, Youdong/0000-0001-9302-2257; Bohl, Christopher/0000-0003-4312-5172; Wood, Charles/0000-0002-4256-1530	Bill and Melinda Gates Foundation; National Institutes of Health (NIH) [AI24755, AI67854]; National Institutes of Health (NIH) (Center for AIDS Research) [AI060354]; International AIDS Vaccine Initiative; Public Health Service grants NIGMS COBRE [P30 GM103509, D43 TW001492, T32 AI060547]; FOGARTY INTERNATIONAL CENTER [D43TW001429] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, R01AI024755, P30AI060354, T32AI060547, U01AI067854, R37AI024755] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) (Center for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Public Health Service grants NIGMS COBRE; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Bill and Melinda Gates Foundation, and the National Institutes of Health (NIH) (AI24755, AI67854 and Center for AIDS Research Award AI060354), the International AIDS Vaccine Initiative and the late William F. McCarty-Cooper, and the Public Health Service grants NIGMS COBRE grant P30 GM103509, D43 TW001492 and T32 AI060547; DB is an NIH Ruth L. Kirschstein Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen B, 2005, J ASIAN NAT PROD RES, V7, P197, DOI 10.1080/10286020310001653336; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; Finzi A, 2012, J VIROL, V86, P8974, DOI 10.1128/JVI.01076-12; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GREGORY T, 1991, ADV EXP MED BIOL, V303, P1; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Hirsch VM, 2004, AIDS REV, V6, P40; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 2012, COLD SPRING HARB PER, V1; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mao Y, 2012, NAT STRUCT MOL BIOL; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pandrea Ivona, 2010, Curr HIV/AIDS Rep, V7, P28, DOI 10.1007/s11904-009-0034-8; Pandrea I, 2009, CURR HIV RES, V7, P57, DOI 10.2174/157016209787048456; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	45	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69406	10.1371/journal.pone.0069406	http://dx.doi.org/10.1371/journal.pone.0069406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936006	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000114
J	Huang, CY; Zhao, JJ; Lv, L; Chen, YB; Li, YF; Jiang, SS; Wang, W; Pan, K; Zheng, Y; Zhao, BW; Wang, DD; Chen, YM; Yang, L; Zhou, ZW; Xia, JC				Huang, Chun-yu; Zhao, Jing-jing; Lv, Lin; Chen, Yi-bing; Li, Yuan-fang; Jiang, Shan-shan; Wang, Wei; Pan, Ke; Zheng, Yan; Zhao, Bai-wei; Wang, Dan-dan; Chen, Yong-ming; Yang, Lei; Zhou, Zhi-wei; Xia, Jian-chuan			Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; HUMAN ZN-ALPHA-2-GLYCOPROTEIN CDNA; PLASMA ZN-ALPHA-2-GLYCOPROTEIN; CHROMOSOMAL ASSIGNMENT; TUMOR-SUPPRESSOR; ZINC-ALPHA(2)-GLYCOPROTEIN; CLONING; ADENOCARCINOMA; SEQUENCE; MARKER	Background: 2-Zinc-glycoprotein 1 (AZGP1) is a multidisciplinary protein that participates in many important functions in the human body, including fertilization, immunoregulation and lipid mobilization. Recently, it has been shown that AZGP1 is also involved in carcinogenesis and tumor differentiation. In this study, we investigated the expression levels and prognostic value of AZGP1 in primary gastric cancers. Methods and Results: We examined the expression of AZGP1 in 35 paired cancerous and matched adjacent noncancerous gastric mucosa tissues by real-time quantitative RT-PCR (qRT-PCR) and western blotting. Furthermore, we analyzed AZGP1 expression in 248 patients who underwent resection procedures between 2005 and 2007 using immunohistochemistry. The relationships between the AZGP1 expression levels, the clinicopathological factors, and patient survival were investigated. AZGP1 expression was significantly reduced at both the mRNA (P = 0.023) and protein levels (P = 0.019) in tumor tissue samples, compared with expression in matched adjacent non-tumor tissue samples. The immunohistochemical staining data showed that AZGP1 expression was significantly decreased in 52.8% (131/248) of gastric adenocarcinoma cases. Clinicopathological analysis showed that the reduced expression of AZGP1 was significantly correlated with tumor location (P = 0.011), histological grade (P = 0.005) and T stage (P = 0.008). Kaplan-Meier survival curves revealed that the reduced expression of AZGP1 was associated with a poor prognosis in gastric adenocarcinoma patients (P = 0.009). Multivariate Cox analysis identified AZGP1 expression was an independent prognostic factor for overall survival of gastric adenocarcinoma patients (HR = 1.681, 95% CI = 1.134-2.494, P = 0.011). Conclusions: Our study suggests that AZGP1 might serve as a candidate tumor suppressor and a potential prognostic biomarker in gastric carcinogenesis.	[Huang, Chun-yu] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Zhao, Jing-jing; Lv, Lin; Chen, Yi-bing; Li, Yuan-fang; Jiang, Shan-shan; Wang, Wei; Pan, Ke; Zheng, Yan; Zhao, Bai-wei; Wang, Dan-dan; Chen, Yong-ming; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Zhao, Jing-jing; Lv, Lin; Chen, Yi-bing; Li, Yuan-fang; Jiang, Shan-shan; Wang, Wei; Pan, Ke; Zheng, Yan; Zhao, Bai-wei; Wang, Dan-dan; Chen, Yong-ming; Zhou, Zhi-wei; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu; Li, Yuan-fang; Wang, Wei; Zheng, Yan; Zhao, Bai-wei; Chen, Yong-ming; Yang, Lei; Zhou, Zhi-wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhou, ZW (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.	zhouzhw@sysucc.org.cn; xiajch@mail.sysu.edu.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543	Ministry of Education of China [20100171110084]	Ministry of Education of China(Ministry of Education, China)	This work was supported by Doctoral Fund of Ministry of Education of China (20100171110084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI T, 1988, P NATL ACAD SCI USA, V85, P679, DOI 10.1073/pnas.85.3.679; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Brysk MM, 1999, CANCER LETT, V137, P117, DOI 10.1016/S0304-3835(98)00347-4; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Descazeaud A, 2006, PROSTATE, V66, P1037, DOI 10.1002/pros.20405; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FREIJE JP, 1991, FEBS LETT, V290, P247, DOI 10.1016/0014-5793(91)81271-9; FRENETTE G, 1987, PROSTATE, V11, P257, DOI 10.1002/pros.2990110306; GAGNON S, 1990, AM J PATHOL, V136, P1147; Hale LP, 2001, CLIN CANCER RES, V7, P846; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; He N, 2001, J CELL BIOCHEM, P162; Hirai K, 1998, CANCER RES, V58, P2359; Irmak S, 2005, PROTEOMICS, V5, P4296, DOI 10.1002/pmic.200402005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kong B, 2010, ONCOGENE, V29, P5146, DOI 10.1038/onc.2010.258; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; OHKUBO I, 1990, BIOCHIM BIOPHYS ACTA, V1034, P152, DOI 10.1016/0304-4165(90)90069-9; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Sanchez LM, 1997, P NATL ACAD SCI USA, V94, P4626, DOI 10.1073/pnas.94.9.4626; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; UEYAMA H, 1993, BIOCHEMISTRY-US, V32, P12968, DOI 10.1021/bi00211a004; UEYAMA H, 1991, BIOCHEM BIOPH RES CO, V177, P696, DOI 10.1016/0006-291X(91)91844-3; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang XF, 2004, WORLD J GASTROENTERO, V10, P3405; Zorin N A, 2006, Ontogenez, V37, P12; Zorin N. A., 2006, Biomeditsinskaya Khimiya, V52, P229	32	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69155	10.1371/journal.pone.0069155	http://dx.doi.org/10.1371/journal.pone.0069155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935945	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000084
J	Joseph, AM; Adhihetty, PJ; Wawrzyniak, NR; Wohlgemuth, SE; Picca, A; Kujoth, GC; Prolla, TA; Leeuwenburgh, C				Joseph, Anna-Maria; Adhihetty, Peter J.; Wawrzyniak, Nicholas R.; Wohlgemuth, Stephanie E.; Picca, Anna; Kujoth, Gregory C.; Prolla, Tomas A.; Leeuwenburgh, Christiaan			Dysregulation of Mitochondrial Quality Control Processes Contribute to Sarcopenia in a Mouse Model of Premature Aging	PLOS ONE			English	Article							NRF-2 TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; PROTEIN IMPORT; DIRECT PHOSPHORYLATION; OXIDATIVE CAPACITY; POINT MUTATIONS; DNA MUTATIONS; AUTOPHAGY; EXPRESSION; BIOGENESIS	Mitochondrial DNA (mtDNA) mutations lead to decrements in mitochondrial function and accelerated rates of these mutations has been linked to skeletal muscle loss (sarcopenia). The purpose of this study was to investigate the effect of mtDNA mutations on mitochondrial quality control processes in skeletal muscle from animals (young; 3-6 months and older; 8-15 months) expressing a proofreading-deficient version of mtDNA polymerase gamma (PolG). This progeroid aging model exhibits elevated mtDNA mutation rates, mitochondrial dysfunction, and a premature aging phenotype that includes sarcopenia. We found increased expression of the mitochondrial biogenesis regulator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) and its target proteins, nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (Tfam) in PolG animals compared to wild-type (WT) (P<0.05). Muscle from older PolG animals displayed higher mitochondrial fission protein 1 (Fis1) concurrent with greater induction of autophagy, as indicated by changes in Atg5 and p62 protein content (P<0.05). Additionally, levels of the Tom22 import protein were higher in PolG animals when compared to WT (P<0.05). In contrast, muscle from normally-aged animals exhibited a distinctly different expression profile compared to PolG animals. Older WT animals appeared to have higher fusion (greater Mfn1/Mfn2, and lower Fis1) and lower autophagy (Beclin-1 and p62) compared to young WT suggesting that autophagy is impaired in aging muscle. In conclusion, muscle from mtDNA mutator mice display higher mitochondrial fission and autophagy levels that likely contribute to the sarcopenic phenotype observed in premature aging and this differs from the response observed in normally-aged muscle.	[Joseph, Anna-Maria; Wohlgemuth, Stephanie E.; Leeuwenburgh, Christiaan] Univ Florida, Div Biol Aging, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA; [Adhihetty, Peter J.; Wawrzyniak, Nicholas R.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA; [Picca, Anna] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Joseph, AM (corresponding author), Univ Florida, Div Biol Aging, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA.	amjoseph@ufl.edu	Picca, Anna/K-2305-2018	Picca, Anna/0000-0001-7032-3487; Leeuwenburgh, Christiaan/0000-0003-0826-4257	University of Florida, Claude D. Pepper Older Americans Independence Center (OAIC); National Institutes of Health/National Institute on Aging [1P30AG028740];  [NIH AG17994]; NATIONAL INSTITUTE ON AGING [P30AG028740, R01AG017994] Funding Source: NIH RePORTER	University of Florida, Claude D. Pepper Older Americans Independence Center (OAIC); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to CL (NIH AG17994), as well as by the University of Florida, Claude D. Pepper Older Americans Independence Center (OAIC). The OAIC is funded by the National Institutes of Health/National Institute on Aging (1P30AG028740). Additional support was provided by start-up funds to PJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blesa JR, 2008, BIOCHEM CELL BIOL, V86, P46, DOI [10.1139/O07-151, 10.1139/o07-151]; Blesa JR, 2007, GENE, V391, P198, DOI 10.1016/j.gene.2006.12.024; Blesa JR, 2004, MITOCHONDRION, V3, P251, DOI 10.1016/j.mito.2004.02.001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Craig EE, 1998, AM J PHYSIOL-CELL PH, V275, pC1508, DOI 10.1152/ajpcell.1998.275.6.C1508; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; de Cavanagh EMV, 2003, FASEB J, V17, P1096, DOI 10.1096/fj.02-0063fje; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Gaugler M, 2011, J APPL PHYSIOL, V111, P192, DOI 10.1152/japplphysiol.00175.2011; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; McMullen CA, 2009, EXP GERONTOL, V44, P420, DOI 10.1016/j.exger.2009.03.006; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; O'Leary MF, 2012, AM J PHYSIOL-CELL PH; ORLANDER J, 1978, ACTA PHYSIOL SCAND, V104, P249, DOI 10.1111/j.1748-1716.1978.tb06277.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picca A, 2012, AGE DORDR; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rungi AA, 2002, BBA-MOL BASIS DIS, V1586, P146, DOI 10.1016/S0925-4439(01)00072-2; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Takahashi M, 1998, AM J PHYSIOL-CELL PH, V274, pC1380, DOI 10.1152/ajpcell.1998.274.5.C1380; TANDLER B, 1986, ANN NY ACAD SCI, V488, P65; Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Wanagat J, 2002, J MOL CELL CARDIOL, V34, P17, DOI 10.1006/jmcc.2001.1483; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamada T, 2012, J PHYSIOL-LONDON, V590, P6187, DOI 10.1113/jphysiol.2012.240077; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	69	103	105	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69327	10.1371/journal.pone.0069327	http://dx.doi.org/10.1371/journal.pone.0069327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935986	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000102
J	Kucherlapati, MH; Esfahani, S; Habibollahi, P; Wang, JN; Still, ER; Bronson, RT; Mahmood, U; Kucherlapati, RS				Kucherlapati, Melanie H.; Esfahani, Shadi; Habibollahi, Peiman; Wang, Junning; Still, Eric R.; Bronson, Roderick T.; Mahmood, Umar; Kucherlapati, Raju S.			Genotype Directed Therapy in Murine Mismatch Repair Deficient Tumors	PLOS ONE			English	Article							DUAL PI3K/MTOR INHIBITOR; SERINE METABOLISM; CANCER; NVP-BEZ235; PI3K; IDENTIFICATION; COMBINATION; ACTIVATION; EXPRESSION; CARCINOMA	The PI3K/AKT/mTOR pathway has frequently been found activated in human tumors. We show that in addition to Wnt signaling dysfunction, the PI3K/AKT/mTOR pathway is often upregulated in mouse Msh2(-/-) initiated intestinal tumors. NVP-BEZ235 is a dual PI3K/mTOR inhibitor toxic to many cancer cell lines and currently involved in clinical trials. We have treated two mouse models involving Msh2 that develop small intestinal and/or colonic tumors with NVP-BEZ235, and a subset of animals with NVP-BEZ235 and MEK inhibitor ADZ4266. The disease phenotype has been followed with pathology, F-18 FDG PET imaging, and endoscopy. Intestinal adenocarcinomas are significantly decreased in multiplicity by both drug regimens. The majority of tumors treated with combined therapy regress significantly, while a small number of highly progressed tumors persist. We have examined PTEN, AKT, MEK 1&2, MAPK, S6K, mTOR, PDPK1, and Cyclin D1 and find variable alterations that include downregulation of PTEN, upregulation of AKT and changes in its phosphorylated forms, upregulation of pMEK 1&2, p42p44MAPK, pS6K, and Cyclin D1. Apoptosis has been found intact in some tumors and not in others. Our data indicate that NVP-BEZ235 alone and in combination with ADZ4266 are effective in treating a proportion of colorectal cancers, but that highly progressed resistant tumors grow in the presence of the drugs. Pathways upregulated in some resistant tumors also include PDPK1, suggesting that metabolic inhibitors may also be useful in treating these tumors.	[Kucherlapati, Melanie H.; Wang, Junning; Still, Eric R.; Kucherlapati, Raju S.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Kucherlapati, Melanie H.; Wang, Junning; Still, Eric R.; Kucherlapati, Raju S.] Brigham & Womens Hosp Boston, Dept Med, Div Genet, Boston, MA USA; [Esfahani, Shadi; Habibollahi, Peiman; Mahmood, Umar] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Rodent Histopathol Core, Boston, MA USA; [Bronson, Roderick T.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; [Bronson, Roderick T.] Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tufts University; Tufts University	Kucherlapati, RS (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	mkucherlapati@partners.org	Kucherlapati, Melanie/GXN-1132-2022; Kucherlapati, Raju/ABC-8807-2021	Mahmood, Umar/0000-0001-7414-6123; Abdar Esfahani, Shadi/0000-0002-6077-4580	National Cancer Institute (NCI) [5U01CA084301-13]; NATIONAL CANCER INSTITUTE [U01CA084301] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work in this study was supported by a grant from the National Cancer Institute (NCI) to Raju S. Kucherlapati and Umar Mahmood, entitled: Mouse Models for Human Cancer, 5U01CA084301-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Blaser B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-86; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; DeBerardinis RJ, 2011, CELL METAB, V14, P285, DOI 10.1016/j.cmet.2011.08.004; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Funovics MA, 2006, GASTROINTEST ENDOSC, V64, P589, DOI 10.1016/j.gie.2006.02.048; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051240; Luo J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2932; Lyssiotis CA, 2012, CELL, V151, P1155, DOI 10.1016/j.cell.2012.11.020; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Morelli MP, 2012, CLIN CANCER RES, V18, P1051, DOI 10.1158/1078-0432.CCR-11-1507; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Sato S, 2004, J BIOL CHEM, V279, P33759, DOI 10.1074/jbc.M402055200; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; SNELL K, 1988, BRIT J CANCER, V57, P87, DOI 10.1038/bjc.1988.15; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zito CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031331	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68817	10.1371/journal.pone.0068817	http://dx.doi.org/10.1371/journal.pone.0068817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935891	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000039
J	Schreiner, H; Li, Y; Cline, J; Tsiagbe, VK; Fine, DH				Schreiner, Helen; Li, Yu; Cline, Joshua; Tsiagbe, Vincent K.; Fine, Daniel H.			A Comparison of Aggregatibacter actinomycetemcomitans (Aa) Virulence Traits in a Rat Model for Periodontal Disease	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; CELL-CYCLE ARREST; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; T-CELLS; JUVENILE PERIODONTITIS; NUCLEOTIDE-SEQUENCE; BONE-RESORPTION; IMMUNE-RESPONSE; LEUKOTOXIN GENE; FAMILY	Our aim was to explore the effects of Cytolethal Distending toxin (Cdt) in a well established rat model of periodontal disease where leukotoxin (LtxA) was thought to have no known effect. In vitro studies, were used to assess CdtB activity using Aa Leukotoxin as a negative control. These studies showed that both CdtB and LtxA (unexpectedly) exerted significant effects on CD4(+) T cells. As a result we decided to compare the effects of these two prominent Aa virulence factors on bone loss using our rat model of Aa-induced periodontitis. In this model, Aa strains, mutant in cdtB and ltxA, were compared to their parent non-mutant strains and evaluated for colonization, antibody response to Aa, bone loss and disease. We found that bone loss/disease caused by the ltxA mutant strain, in which cdtB was expressed, was significantly less (p<0.05) than that due to the wild type strain. On the other hand, the disease caused by cdtB mutant strain, in which ltxA was expressed, was not significantly different from the wild type strain. This data indicates that Aa LtxA exerts a greater effect on bone loss than Cdt in this rat model of periodontal disease and supports the utility of this model to dissect specific virulence factors as they relate to immunopathology in studies of Aa-induced disease.	[Schreiner, Helen; Li, Yu; Tsiagbe, Vincent K.; Fine, Daniel H.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; [Cline, Joshua; Tsiagbe, Vincent K.; Fine, Daniel H.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Tsiagbe, Vincent K.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Schreiner, H (corresponding author), Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA.	hschrein@sdm.rutgers.edu			Foundation of UMDNJ; National Institute of Dental and Craniofacial Research [DE017968, DE021172]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021172, R01DE017968] Funding Source: NIH RePORTER	Foundation of UMDNJ; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded in part from a grant from the Foundation of UMDNJ (www.foundationofumdnj.org) to the first author. Dr. Fine's contribution to the study was funded in part by funding from grants DE017968 and DE021172 from the National Institute of Dental and Craniofacial Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for the study.	ANOLIK R, 1981, CLIN PEDIATR, V20, P653, DOI 10.1177/000992288102001007; Balashova NV, 2006, INFECT IMMUN, V74, P2015, DOI 10.1128/IAI.74.4.2015-2021.2006; Belibasakis GN, 2008, APMIS, V116, P499, DOI 10.1111/j.1600-0463.2008.01017.x; Belibasakis GN, 2005, INFECT IMMUN, V73, P342, DOI 10.1128/IAI.73.1.342-351.2005; Bhattacharjee MK, 2007, GENE, V399, P53, DOI 10.1016/j.gene.2007.04.026; Damek-Poprawa M, 2011, J DENT RES, V90, P874, DOI 10.1177/0022034511403743; DiFranco K, 2013, COMP MED IN PRESS, V63; Dileepan T, 2007, INFECT IMMUN, V75, P4851, DOI 10.1128/IAI.00314-07; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Fine DH, 2009, J CLIN PERIODONTOL, V36, P106, DOI 10.1111/j.1600-051X.2008.01353.x; Fives-Taylor P, 1995, Adv Dent Res, V9, P55; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Kachlany SC, 2000, INFECT IMMUN, V68, P6094, DOI 10.1128/IAI.68.11.6094-6100.2000; Kaplan JB, 2002, J CLIN MICROBIOL, V40, P1181, DOI 10.1128/JCm.40.4.1181-1187.2002; KRAIG E, 1990, INFECT IMMUN, V58, P920, DOI 10.1128/IAI.58.4.920-929.1990; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Li Y, 2010, MOL ORAL MICROBIOL, V25, P275, DOI 10.1111/j.2041-1014.2010.00576.x; MARTIN BF, 1967, NEUROLOGY, V17, P833, DOI 10.1212/WNL.17.9.833; MOORE WEC, 1985, INFECT IMMUN, V48, P507, DOI 10.1128/IAI.48.2.507-519.1985; Ohara M, 2011, J PERIODONTAL RES, V46, P389, DOI 10.1111/j.1600-0765.2011.01348.x; Rabin SDP, 2009, INFECT IMMUN, V77, P3161, DOI 10.1128/IAI.01227-08; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; Taichman N S, 1987, Oral Microbiol Immunol, V2, P97, DOI 10.1111/j.1399-302X.1987.tb00270.x; TAICHMAN NS, 1980, INFECT IMMUN, V28, P258, DOI 10.1128/IAI.28.1.258-268.1980; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Thomson VJ, 1999, J BACTERIOL, V181, P7298, DOI 10.1128/JB.181.23.7298-7307.1999; TOWNSEND TR, 1969, JAMA-J AM MED ASSOC, V210, P558; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Welch RA, 1995, INFECT AGENT DIS, V4, P254; Yaun A, 1992, CHEST, V101, P1450; YOSHIE H, 1987, J PERIODONTAL RES, V22, P499, DOI 10.1111/j.1600-0765.1987.tb02061.x; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69382	10.1371/journal.pone.0069382	http://dx.doi.org/10.1371/journal.pone.0069382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936002	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000111
J	O'Callaghan-Gordo, C; Bassat, Q; Diez-Padrisa, N; Morais, L; Machevo, S; Nhampossa, T; Quinto, L; Alonso, PL; Roca, A				O'Callaghan-Gordo, Cristina; Bassat, Quique; Diez-Padrisa, Nuria; Morais, Luis; Machevo, Sonia; Nhampossa, Tacilta; Quinto, Llorenc; Alonso, Pedro L.; Roca, Anna			Lower Respiratory Tract Infections Associated with Rhinovirus during Infancy and Increased Risk of Wheezing during Childhood. A Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SYNCYTIAL-VIRUS BRONCHIOLITIS; HOSPITALIZED CHILDREN; RURAL MOZAMBIQUE; HIGH-PREVALENCE; 1ST YEAR; ASTHMA; EPIDEMIOLOGY; ETIOLOGY; ILLNESSES	Background and Objectives: Although association between respiratory syncytial virus infection and later asthma development has been established, little is known about the role of other respiratory viruses. Rhinovirus was considered a mild pathogen of the upper respiratory tract but current evidence suggests that rhinovirus is highly prevalent among children with lower respiratory tract infections (LRTI). The aim of the study was to evaluate whether LRTI hospitalization associated with rhinovirus during infancy was associated with an increased risk of wheezing - a proxy measure of asthma - during childhood. Methods: During a 12 months period, all infants <1 year admitted to Manhica District Hospital with symptoms of LRTI who survived the LRTI episode, were enrolled in the study cohort. Nasopharyngeal aspirates were collected on admission for viral determination and study infants were classified according to presence or not of rhinovirus. The study cohort was passively followed-up at the Manhica District Hospital for up to 4 years and 9 months to evaluate the association between LRTI associated with rhinovirus in infancy and wheezing during childhood. Findings and Conclusions: A total of 220 infants entered the cohort; 25% of them had rhinovirus detected during the LRTI episode as opposed to 75% who tested negative for rhinovirus. After adjusting for sex and age and HIV infection at recruitment, infants hospitalized with LRTI associated with rhinovirus had higher incidence of subsequent visits with wheezing within the year following hospitalization [Rate ratio=1.68, (95% confidence interval=1.02-2.75); Wald test p-value = 0.039]. No evidence of increased incidence rate of visits with wheezing was observed for the remaining follow-up period. Our data suggest a short term increased risk of wheezing after an initial episode of LRTI with RV.	[O'Callaghan-Gordo, Cristina; Bassat, Quique; Diez-Padrisa, Nuria; Quinto, Llorenc; Alonso, Pedro L.; Roca, Anna] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [O'Callaghan-Gordo, Cristina; Bassat, Quique; Morais, Luis; Machevo, Sonia; Nhampossa, Tacilta; Alonso, Pedro L.; Roca, Anna] Ctr Invest Saude Manhica, Manhica, Maputo, Mozambique; [Roca, Anna] MRC Unit, Banjul, Gambia	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of London; London School of Hygiene & Tropical Medicine	O'Callaghan-Gordo, C (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	cristina.ocallaghan@cresib.cat	Bassat, Quique/P-2341-2016; Alonso, Pedro L/AAZ-3645-2020; Diez-Padrisa, Nuria/AAE-1000-2020	Bassat, Quique/0000-0003-0875-7596; Alonso, Pedro L/0000-0003-3292-3443; Quinto, Llorenc/0000-0001-9992-6951; O'Callaghan-Gordo, Cristina/0000-0002-4229-2991	Health Research Found of the Spanish Ministry of Science and Innovation [FIS: PS09/01843]; Spanish Agency of International Cooperation; Spanish Ministry of Science and Innovation [FIS: CM05/00134, RYC-2008-02777]	Health Research Found of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Spanish Agency of International Cooperation(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study was supported by a grant from the Health Research Found of the Spanish Ministry of Science and Innovation (FIS: PS09/01843). The Centro de Investigacao em Sa de da Manhica receives major core funding from the Spanish Agency of International Cooperation (http://www.micinn.es/portal/site/MICINN/). QB and AR were supported during the time of the study implementation by grants from the Spanish Ministry of Science and Innovation (FIS: CM05/00134 and Ramon y Cajal: RYC-2008-02777, respectively; http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2002, MANHICA DEMOGRAPHIC, P189; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-8; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Dharmage SC, 2009, EUR RESPIR J, V33, P237, DOI 10.1183/09031936.00062907; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gern JE, 2000, J ALLERGY CLIN IMMUN, V105, pS497, DOI 10.1016/S0091-6749(00)90050-2; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P532, DOI 10.1016/j.jaci.2011.06.037; HAZLETT DTG, 1988, AM J TROP MED HYG, V39, P632, DOI 10.4269/ajtmh.1988.39.632; Hyvarinen MK, 2005, PEDIATR PULM, V40, P316, DOI 10.1002/ppul.20273; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lehtinen P, 2007, J ALLERGY CLIN IMMUN, V119, P570, DOI 10.1016/j.jaci.2006.11.003; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Margolis P, 1999, PEDIATR INFECT DIS J, V18, pS23; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; O'Callaghan-Gordo C, 2011, TROP MED INT HEALTH, V16, P1054, DOI 10.1111/j.1365-3156.2011.02811.x; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Onyango CO, 2012, J MED VIROL, V84, P823, DOI 10.1002/jmv.23251; Papadopoulos Nikolaos G, 2004, Paediatr Respir Rev, V5 Suppl A, pS191, DOI 10.1016/S1526-0542(04)90036-X; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Puig C, 2010, ARCH BRONCONEUMOL, V46, P514, DOI 10.1016/j.arbres.2010.07.001; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Smuts HE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-65; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120	38	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69370	10.1371/journal.pone.0069370	http://dx.doi.org/10.1371/journal.pone.0069370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935997	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700026
J	Jalili, A; Mertz, KD; Romanov, J; Wagner, C; Kalthoff, F; Stuetz, A; Pathria, G; Gschaider, M; Stingl, G; Wagner, SN				Jalili, Ahmad; Mertz, Kirsten D.; Romanov, Julia; Wagner, Christine; Kalthoff, Frank; Stuetz, Anton; Pathria, Gaurav; Gschaider, Melanie; Stingl, Georg; Wagner, Stephan N.			NVP-LDE225, a potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; THERAPEUTIC TARGET; BRAF; EXPRESSION; INHIBITION; MUTATIONS; RESISTANCE; REVEALS	Melanoma is one of the most aggressive cancers and its incidence is increasing worldwide. So far there are no curable therapies especially after metastasis. Due to frequent mutations in members of the mitogen-activated protein kinase (MAPK) signaling pathway, this pathway is constitutively active in melanoma. It has been shown that the SONIC HEDGEHOG (SHH)-GLI and MAPK signaling pathway regulate cell growth in many tumors including melanoma and interact with each other in the regulation of cell proliferation and survival. Here we show that the SHH-GLI pathway is active in human melanoma cell lines as they express downstream target of this pathway GLI1. Expression of GLI1 was significantly higher in human primary melanoma tissues harboring BRAF(V600E) mutation than those with wild type BRAF. Pharmacologic inhibition of BRAF(V600E) in human melanoma cell lines resulted in decreased expression of GLI1 thus demonstrating interaction of SHH-GLI and MAPK pathways. Inhibition of SHH-GLI pathway by the novel small molecule inhibitor of smoothened NVP-LDE225 was followed by inhibition of cell growth and induction of apoptosis in human melanoma cell lines, interestingly with both BRAF(V600E) and BRAF(Wild Type) status. NVP-LDE225 was potent in reducing cell proliferation and inducing tumor growth arrest in vitro and in vivo, respectively and these effects were superior to the natural compound cyclopamine. Finally, we conclude that inhibition of SHH-GLI signaling pathway in human melanoma by the specific smoothened inhibitor NVP-LDE225 could have potential therapeutic application in human melanoma even in the absence of BRAF(V600E) mutation and warrants further investigations.	[Jalili, Ahmad; Romanov, Julia; Wagner, Christine; Pathria, Gaurav; Gschaider, Melanie; Stingl, Georg; Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Mertz, Kirsten D.; Kalthoff, Frank; Stuetz, Anton] Novartis Inst Biomed Res, Vienna, Austria; [Wagner, Stephan N.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria	Medical University of Vienna; Novartis; Austrian Academy of Sciences	Jalili, A (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria.	ahmad.jalili@meduniwien.ac.at	Mertz, Kirsten/AAY-1660-2020	Mertz, Kirsten/0000-0002-3074-6925; Wagner, Stephan/0000-0003-4941-7029	FWF-Austrian Science Fund grant [L590.B12]; Research Grant of the Austrian Society for Dermatology and Venerology; Austrian Science Fund (FWF) [L 590] Funding Source: researchfish	FWF-Austrian Science Fund grant; Research Grant of the Austrian Society for Dermatology and Venerology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is supported by the FWF-Austrian Science Fund grant (L590.B12) to Stephan N. Wagner and Research Grant of the Austrian Society for Dermatology and Venerology to Ahmad Jalili. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; BRYDEN MM, 1971, J ANAT, V110, P507; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dabrowska-Iwanicka A, 2002, J CANCER RES CLIN, V128, P433, DOI 10.1007/s00432-002-0356-z; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; GROB PJ, 1985, EUR J CLIN MICROBIOL, V4, P408, DOI 10.1007/BF02148694; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Hsu Mei-Yu, 2002, MELANOMA WISTAR MELA, P259; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jalili A, 2012, J NATL CANCER I, V104, P1673, DOI 10.1093/jnci/djs373; Jalili A, 2011, J INVEST DERMATOL, V131, P1886, DOI 10.1038/jid.2011.136; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Lipinski RJ, 2005, DEV DYNAM, V233, P829, DOI 10.1002/dvdy.20414; Lok KH, 2008, J GASTROEN HEPATOL, V23, P406, DOI 10.1111/j.1440-1746.2007.05079.x; Lopez-Bergami P, 2011, PIGMENT CELL MELANOM; Mahoney S, 2010, J CLIN ONCOL S, V28, p15s; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Miller-Moslin K, 2009, J MED CHEM, V52, P3954, DOI 10.1021/jm900309j; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Raffel C, 1997, CANCER RES, V57, P842; Reifenberger J, 1998, CANCER RES, V58, P1798; Schwartz GK, 2009, J CLIN ONCOL, V27; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; STEWART CF, 1987, CLIN PHARMACY, V6, P548; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; STOLOW MA, 1995, NUCLEIC ACIDS RES, V23, P2555, DOI 10.1093/nar/23.13.2555; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WAGNER EF, 1985, EMBO J, V4, P663, DOI 10.1002/j.1460-2075.1985.tb03680.x; Wagner P L, 1985, Dimens Crit Care Nurs, V4, P81, DOI 10.1097/00003465-198503000-00004; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zhang XD, 2003, ONCOGENE, V22, P2869, DOI 10.1038/sj.onc.1206427	68	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69064	10.1371/journal.pone.0069064	http://dx.doi.org/10.1371/journal.pone.0069064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935925	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200022
J	Bagaria, S; Ponnalagu, D; Bisht, S; Karande, AA				Bagaria, Shradha; Ponnalagu, Devasena; Bisht, Shveta; Karande, Anjali A.			Mechanistic Insights into the Neutralization of Cytotoxic Abrin by the Monoclonal Antibody D6F10	PLOS ONE			English	Article							RICIN A-CHAIN; RIBOSOME-INACTIVATING PROTEINS; B-CELL EPITOPES; IN-VITRO; ABRUS-PRECATORIUS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; DIPHTHERIA-TOXIN; INHIBITION; SUBUNIT	Abrin, an A/B toxin obtained from the Abrus precatorius plant is extremely toxic and a potential bio-warfare agent. Till date there is no antidote or vaccine available against this toxin. The only known neutralizing monoclonal antibody against abrin, namely D6F10, has been shown to rescue the toxicity of abrin in cells as well as in mice. The present study focuses on mapping the epitopic region to understand the mechanism of neutralization of abrin by the antibody D6F10. Truncation and mutational analysis of abrin A chain revealed that the amino acids 74-123 of abrin A chain contain the core epitope and the residues Thr112, Gly114 and Arg118 are crucial for binding of the antibody. In silico analysis of the position of the mapped epitope indicated that it is present close to the active site cleft of abrin A chain. Thus, binding of the antibody near the active site blocks the enzymatic activity of abrin A chain, thereby rescuing inhibition of protein synthesis by the toxin in vitro. At 1: 10 molar concentration of abrin: antibody, the antibody D6F10 rescued cells from abrin-mediated inhibition of protein synthesis but did not prevent cell attachment of abrin. Further, internalization of the antibody bound to abrin was observed in cells by confocal microscopy. This is a novel finding which suggests that the antibody might function intracellularly and possibly explains the rescue of abrin's toxicity by the antibody in whole cells and animals. To our knowledge, this study is the first report on a neutralizing epitope for abrin and provides mechanistic insights into the poorly understood mode of action of anti-A chain antibodies against several toxins including ricin.	[Bagaria, Shradha; Ponnalagu, Devasena; Karande, Anjali A.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Bisht, Shveta] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Karande, AA (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	anjali@biochem.iisc.ernet.in	Ponnalagu, Devasena/AAK-6651-2021	Bisht, Shveta/0000-0002-5566-3472; PONNALAGU, DEVASENA/0000-0003-2731-9778	CSIR	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank the CSIR for providing financial support to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; APTER FM, 1993, INFECT IMMUN, V61, P5271, DOI 10.1128/IAI.61.12.5271-5278.1993; Bagaria A, 2006, J BIOL CHEM, V281, P34465, DOI 10.1074/jbc.M601777200; BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Behring E, 1890, DEUT MED WOCHENSCHR, V16, P1113, DOI [10.1055/s-0029-1207589, DOI 10.1055/S-0029-1207589]; BENSON S, 1975, EUR J BIOCHEM, V59, P573, DOI 10.1111/j.1432-1033.1975.tb02484.x; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; Carra JH, 2007, VACCINE, V25, P4149, DOI 10.1016/j.vaccine.2007.03.011; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; FOXWELL BMJ, 1985, TOXICOLOGY, V34, P79, DOI 10.1016/0300-483X(85)90080-0; Grodzki AC, 2010, METHODS MOL BIOL, V588, P33, DOI 10.1007/978-1-59745-324-0_5; Han YH, 2011, HUM VACCINES, V7, P838, DOI 10.4161/hv.7.8.16258; HEGDE R, 1991, ANAL BIOCHEM, V194, P101, DOI 10.1016/0003-2697(91)90156-N; Hesselberth JR, 2000, J BIOL CHEM, V275, P4937, DOI 10.1074/jbc.275.7.4937; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045595; ISLAM MS, 1990, J CLIN LAB IMMUNOL, V33, P11; Kindt T.J., 2007, KUBY IMMUNOLOGY; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Lord J M, 1991, Semin Cell Biol, V2, P15; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; MATSUDA M, 1992, EUR J EPIDEMIOL, V8, P1, DOI 10.1007/BF02427384; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; McHugh CA, 2004, PROTEIN SCI, V13, P2736, DOI 10.1110/ps.04897904; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028; OLSNES S, 1975, J IMMUNOL, V114, P1743; OLSNES S, 1976, J BIOL CHEM, V251, P3985; OLSNES S, 1974, J IMMUNOL, V113, P842; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PAPPENHEIMER AM, 1972, IMMUNOCHEMISTRY, V9, P891, DOI 10.1016/0019-2791(72)90163-2; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Rao L, 1996, ANAL BIOCHEM, V241, P173, DOI 10.1006/abio.1996.0395; Roday S, 2004, BIOCHEMISTRY-US, V43, P4923, DOI 10.1021/bi0498499; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Song KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062417; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; STIRPE F, 1992, BIO-TECHNOL, V10, P405, DOI 10.1038/nbt0492-405; Surendranath K, 2008, CLIN VACCINE IMMUNOL, V15, P737, DOI 10.1128/CVI.00254-07; Tanaka KSE, 2001, BIOCHEMISTRY-US, V40, P6845, DOI 10.1021/bi010499p; Vance DJ, 2012, TOXICON, V60, P874, DOI 10.1016/j.toxicon.2012.06.014; Yermakova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044317; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZUCKER DR, 1984, MOL IMMUNOL, V21, P785, DOI 10.1016/0161-5890(84)90165-2	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70273	10.1371/journal.pone.0070273	http://dx.doi.org/10.1371/journal.pone.0070273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922965	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000323369700161
J	Charlton, BD; Whisson, DA; Reby, D				Charlton, Benjamin D.; Whisson, Desley A.; Reby, David			Free-Ranging Male Koalas Use Size-Related Variation in Formant Frequencies to Assess Rival Males	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; VOCAL-TRACT LENGTH; DEER DAMA-DAMA; RED DEER; BODY-SIZE; DESCENDED LARYNX; INDICATE LARGER; DOMESTIC DOG; CUES; ROARS	Although the use of formant frequencies in nonhuman animal vocal communication systems has received considerable recent interest, only a few studies have examined the importance of these acoustic cues to body size during intra-sexual competition between males. Here we used playback experiments to present free-ranging male koalas with re-synthesised bellow vocalisations in which the formants were shifted to simulate either a large or a small adult male. We found that male looking responses did not differ according to the size variant condition played back. In contrast, male koalas produced longer bellows and spent more time bellowing when they were presented with playbacks simulating larger rivals. In addition, males were significantly slower to respond to this class of playback stimuli than they were to bellows simulating small males. Our results indicate that male koalas invest more effort into their vocal responses when they are presented with bellows that have lower formants indicative of larger rivals, but also show that males are slower to engage in vocal exchanges with larger males that represent more dangerous rivals. By demonstrating that male koalas use formants to assess rivals during the breeding season we have provided evidence that male-male competition constitutes an important selection pressure for broadcasting and attending to size-related formant information in this species. Further empirical studies should investigate the extent to which the use of formants during intra-sexual competition is widespread throughout mammals.	[Charlton, Benjamin D.; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Whisson, Desley A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia	University of Sussex; Deakin University	Charlton, BD (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	b.d.charlton@sussex.ac.uk	Whisson, Desley A/H-9578-2013; Whisson, Desley/V-9422-2019	Whisson, Desley A/0000-0002-4221-0706; Whisson, Desley/0000-0002-4221-0706; Reby, David/0000-0001-9261-1711; Charlton, Benjamin/0000-0002-0218-7177	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	BDC was financially supported by a Leverhulme Trust Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Bradbury Jack W., 1998, pi; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2010, ANIM BEHAV, V79, P1221, DOI 10.1016/j.anbehav.2010.02.018; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Charrier I, 2011, J COMP PSYCHOL, V125, P385, DOI 10.1037/a0024513; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis WAH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1229, DOI 10.1007/s00265-010-1136-4; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Frey R, 2003, J ANAT, V203, P451, DOI 10.1046/j.1469-7580.2003.00232.x; Frey R, 2007, J ANAT, V211, P717, DOI 10.1111/j.1469-7580.2007.00818.x; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Handasyde, 1999, KOALA NATURAL HIST C; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; Jackson S., 2003, AUSTR MAMMALS BIOL C; Koren L, 2009, BEHAV ECOL SOCIOBIOL, V63, P581, DOI 10.1007/s00265-008-0693-2; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; LITTLEJOHN MJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P363, DOI 10.1007/BF00295550; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; MASATAKA N, 1994, FOLIA PRIMATOL, V63, P115, DOI 10.1159/000156803; McElligott AG, 2006, J ZOOL, V270, P340, DOI 10.1111/j.1469-7998.2006.00144.x; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; MCGREGOR PK, 1997, BIOACOUSTICS, V8, P253; Mitchell P., 1990, P151; MOULINES E, 1990, SPEECH COMMUN, V9, P453, DOI 10.1016/0167-6393(90)90021-Z; Naguib M, 1997, ANIM BEHAV, V54, P1535, DOI 10.1006/anbe.1997.9997; Nelson BS, 2003, J ACOUST SOC AM, V113, P2901, DOI 10.1121/1.1564817; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake TM, 2001, P ROY SOC B-BIOL SCI, V268, P1183, DOI 10.1098/rspb.2001.1648; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Riede T, 1999, J EXP BIOL, V202, P2859; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Slabbekoorn H, 1997, ANIM BEHAV, V54, P955, DOI 10.1006/anbe.1997.0499; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; SMITH M, 1980, AUST WILDLIFE RES, V7, P35; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; van Doorn GS, 2004, AM NAT, V164, P173, DOI 10.1086/422203; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WAGNER WE, 1989, ANIM BEHAV, V38, P1025, DOI 10.1016/S0003-3472(89)80141-1; WELLS KD, 1984, BEHAVIOUR, V91, P128, DOI 10.1163/156853984X00254; Wyman MT, 2012, ANIM BEHAV, V84, P1381, DOI 10.1016/j.anbehav.2012.08.037; ZIELINSKI WJ, 1993, ANIM BEHAV, V45, P873, DOI 10.1006/anbe.1993.1108	61	18	19	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70279	10.1371/journal.pone.0070279	http://dx.doi.org/10.1371/journal.pone.0070279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922967	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323369700163
J	Miwa, S; Takeuchi, A; Shirai, T; Taki, J; Yamamoto, N; Nishida, H; Hayashi, K; Tanzawa, Y; Kimura, H; Igarashi, K; Ooi, A; Tsuchiya, H				Miwa, Shinji; Takeuchi, Akihiko; Shirai, Toshiharu; Taki, Junichi; Yamamoto, Norio; Nishida, Hideji; Hayashi, Katsuhiro; Tanzawa, Yoshikazu; Kimura, Hiroaki; Igarashi, Kentaro; Ooi, Akishi; Tsuchiya, Hiroyuki			Prognostic Value of Radiological Response to Chemotherapy in Patients with Osteosarcoma	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; MALIGNANT BONE; TUMOR RESPONSE; TECHNETIUM-99M-MIBI; SCINTIGRAPHY; PREDICTION; CORRELATE; SURVIVAL	Background: Chemotherapy is essential to improve the prognosis of the patients with osteosarcoma, and the response to chemotherapy is an important prognostic factor. In this study, the impact of various radiological examinations on overall survival (OS) and event-free survival (EFS) was evaluated. Method: Eighty-two patients with high-grade osteosarcoma were included in this study, and we evaluated the following factors for prognostic significance: age (>= 40 years), gender (male), tumor location (truncal site), metastatic disease, histological response to chemotherapy, radiological response to chemotherapy assessed using X-ray, angiography, CT, MRI, Tl-201 scintigraphy, and Tc-99m-MIBI scintigraphy (Tc-99m-MIBI), and combined radiological score (CRS). Results: Univariate analyses revealed that metastatic disease, histological response, Tc-99m-MIBI, and CRS were significantly correlated with OS. Multivariate analyses showed that metastatic disease (OS: HR 35.9, P<0.001; EFS: HR 17.32, P<0.001) was an independent predictor of OS and EFS. Tumor location (HR 36.1, P = 0.003), histological response (HR 31.1, P = 0.036), and Tc-99m-MIBI (HR 18.4, P = 0.038) were significant prognostic factors for OS. Moreover, CRS was a marginally significant predictor of OS and EFS. Conclusion: The chemotherapeutic effects evaluated by Tc-99m-MIBI and CRS could be considered as prognostic factors in osteosarcoma.	[Miwa, Shinji; Takeuchi, Akihiko; Shirai, Toshiharu; Yamamoto, Norio; Nishida, Hideji; Hayashi, Katsuhiro; Tanzawa, Yoshikazu; Kimura, Hiroaki; Igarashi, Kentaro; Tsuchiya, Hiroyuki] Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan; [Taki, Junichi] Kanazawa Univ, Sch Med, Dept Biotracer Med, Kanazawa, Ishikawa 920, Japan; [Ooi, Akishi] Kanazawa Univ, Sch Med, Dept Mol & Cellular Pathol, Kanazawa, Ishikawa 920, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, Kanazawa, Ishikawa 920, Japan.	tsuchi@med.kanazawa-u.ac.jp	Hayashi, K/C-4685-2015; Takeuchi, Akihiko/AAJ-1563-2020; Miwa, Shinji/AAI-9309-2020	Hayashi, K/0000-0001-8665-2154; Takeuchi, Akihiko/0000-0002-4071-5620; Miwa, Shinji/0000-0002-5962-8287; Igarashi, Kentaro/0000-0003-2278-1736				Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; BEANLANDS RSB, 1990, CIRCULATION, V82, P1802, DOI 10.1161/01.CIR.82.5.1802; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; CARVALHO PA, 1992, J NUCL MED, V33, P1516; Cheon GJ, 2009, J NUCL MED, V50, P1435, DOI 10.2967/jnumed.109.063602; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Kawai A, 1998, CANCER, V82, P851, DOI 10.1002/(SICI)1097-0142(19980301)82:5<851::AID-CNCR8>3.0.CO;2-M; Kawai A, 1999, J SURG ONCOL, V70, P109, DOI 10.1002/(SICI)1096-9098(199902)70:2<109::AID-JSO9>3.0.CO;2-X; KOSTAKOGLU L, 1995, EUR J NUCL MED, V22, P1232, DOI 10.1007/BF00801605; Kunisada T, 1999, CANCER, V86, P949, DOI 10.1002/(SICI)1097-0142(19990915)86:6<949::AID-CNCR9>3.0.CO;2-H; Laverdiere C, 2005, CLIN CANCER RES, V11, P2561, DOI 10.1158/1078-0432.CCR-04-1089; LIN J, 1995, EUR J NUCL MED, V22, P553, DOI 10.1007/BF00817281; Magnan H, 2010, CANCER-AM CANCER SOC, V116, P4147, DOI 10.1002/cncr.25375; Min DL, 2013, ASIA-PAC J CLIN ONCO, V9, P71, DOI 10.1111/j.1743-7563.2012.01560.x; Miwa S, 2012, J SURG ONCOL, V106, P273, DOI 10.1002/jso.23074; Miwa S, 2011, INT J CLIN ONCOL, V16, P373, DOI 10.1007/s10147-011-0194-6; Nishida Y, 2009, J SURG ONCOL, V100, P48, DOI 10.1002/jso.21287; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; ROSEN G, 1982, CANCER-AM CANCER SOC, V49, P1221, DOI 10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E; ROSEN G, 1993, CLIN ORTHOP RELAT R, P302; Soderlund V, 1997, EUR J NUCL MED, V24, P511, DOI 10.1007/s002590050083; Taki J, 1997, J NUCL MED, V38, P501; Taki J, 2008, J ORTHOP RES, V26, P411, DOI 10.1002/jor.20522; Taki J, 2010, CLIN NUCL MED, V35, P154, DOI 10.1097/RLU.0b013e3181cc637d; Tsuchiya H, 1999, CLIN ORTHOP RELAT R, P27; Ueda T, 2008, J ORTHOP SCI, V13, P304, DOI 10.1007/s00776-008-1235-5; VANDERWOUDE HJ, 1995, AM J ROENTGENOL, V165, P593, DOI 10.2214/ajr.165.3.7645476	28	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70015	10.1371/journal.pone.0070015	http://dx.doi.org/10.1371/journal.pone.0070015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922892	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700120
J	Salomone, F; Cardarelli, F; Signore, G; Boccardi, C; Beltram, F				Salomone, Fabrizio; Cardarelli, Francesco; Signore, Giovanni; Boccardi, Claudia; Beltram, Fabio			In Vitro Efficient Transfection by CM18-Tat(11) Hybrid Peptide: A New Tool for Gene-Delivery Applications	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; PLASMID DNA; ENDOSOMAL ESCAPE; NUCLEAR IMPORT; VIRAL VECTORS; DESIGN; EXPRESSION; STRATEGIES; THERAPY; PROTEIN	Cell penetrating peptides (CPPs) are actively researched as non-viral molecular carriers for the controlled delivery of nucleic acids into cells, but widespread application is severely hampered by their trapping into endosomes. Here we show that the recently introduced endosomolytic CM18-Tat(11) hybrid peptide (KWKLFKKIGAVLKVLTTG-YGRKKRRQRRR, residues 1-7 of Cecropin-A, 2-12 of Melittin, and 47-57 of HIV-1 Tat protein) can be exploited to obtain a self-assembled peptide-DNA vector which maintains the CM18-Tat(11) ability to enter cells and destabilize vesicular membranes, concomitantly yielding high DNA transfection efficiency with no detectable cytotoxic effects. Different peptide-DNA stoichiometric ratios were tested to optimize vector size, charge, and stability characteristics. The transfection efficiency of selected candidates is quantitatively investigated by the luciferase-reporter assay. Vector intracellular trafficking is monitored in real time and in live cells by confocal microscopy. In particular, fluorescence resonant energy transfer (FRET) between suitably-labeled peptide and DNA modules was exploited to monitor complex disassembly during endocytosis, and this process is correlated to transfection timing and efficiency. We argue that these results can open the way to the rational design and application of CM18-Tat(11)-based systems for gene-delivery purposes.	[Salomone, Fabrizio; Beltram, Fabio] Scuola Normale Super Pisa, NEST, I-56100 Pisa, Italy; [Salomone, Fabrizio; Beltram, Fabio] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Salomone, Fabrizio; Cardarelli, Francesco; Signore, Giovanni; Boccardi, Claudia; Beltram, Fabio] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Cardarelli, F (corresponding author), Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, Pisa, Italy.	francesco.cardarelli@iit.it	Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; signore, giovanni/GOV-6118-2022; Signore, Giovanni/J-8465-2019; Signore, Giovanni/A-3526-2010	Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Signore, Giovanni/0000-0002-0067-2240; Signore, Giovanni/0000-0002-0067-2240; salomone, fabrizio/0000-0002-9083-3932				Banks GA, 2003, GENE THER, V10, P1766, DOI 10.1038/sj.gt.3302076; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2012, MOL PHARMACEUT, V9, P334, DOI 10.1021/mp200374e; Coonrod A, 1997, GENE THER, V4, P1313, DOI 10.1038/sj.gt.3300536; Dean DA, 1999, CURR EYE RES, V19, P66, DOI 10.1076/ceyr.19.1.66.5344; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Escriou V, 1998, CELL BIOL TOXICOL, V14, P95, DOI 10.1023/A:1007425803756; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Gooding M, 2012, CHEM BIOL DRUG DES, V80, P787, DOI 10.1111/cbdd.12052; Hoyer J, 2012, ACCOUNTS CHEM RES, V45, P1048, DOI 10.1021/ar2002304; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; James MB, 2000, MOL THER, V1, P339, DOI 10.1006/mthe.2000.0054; Jo JI, 2008, EUR J PHARM BIOPHARM, V68, P90, DOI 10.1016/j.ejpb.2007.04.021; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Lehto T, 2011, MOL THER, V19, P1457, DOI 10.1038/mt.2011.10; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; Liu BR, 2012, GENE, V505, P37, DOI 10.1016/j.gene.2012.05.053; Liu ZH, 2005, J CONTROL RELEASE, V102, P699, DOI 10.1016/j.jconrel.2004.10.013; Ludtke JJ, 2002, MOL THER, V5, P579, DOI 10.1006/mthe.2002.0581; Lundin P, 2008, BIOCONJUGATE CHEM, V19, P2535, DOI 10.1021/bc800212j; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Meade BR, 2008, ADV DRUG DELIVER REV, V60, P530, DOI 10.1016/j.addr.2007.10.004; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pollard H, 2001, J GENE MED, V3, P153, DOI 10.1002/jgm.160; Pozzi D, 2012, BBA-BIOMEMBRANES, V1818, P2335, DOI 10.1016/j.bbamem.2012.05.017; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tseng WC, 1997, J BIOL CHEM, V272, P25641, DOI 10.1074/jbc.272.41.25641; Viola JR, 2010, EXPERT OPIN DRUG DEL, V7, P721, DOI 10.1517/17425241003716810; Warnock JN, 2011, METHODS MOL BIOL, V737, P1, DOI 10.1007/978-1-61779-095-9_1; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Yi WJ, 2012, BIOCONJUGATE CHEM, V23, P125, DOI 10.1021/bc2005472; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zelphati O, 1999, HUM GENE THER, V10, P15, DOI 10.1089/10430349950019156	41	21	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70108	10.1371/journal.pone.0070108	http://dx.doi.org/10.1371/journal.pone.0070108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922923	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700135
J	Jones, LM; Rayson, SJ; Flemming, AJ; Urwin, PE				Jones, Laura M.; Rayson, Samantha J.; Flemming, Anthony J.; Urwin, Peter E.			Adaptive and Specialised Transcriptional Responses to Xenobiotic Stress in Caenorhabditis elegans Are Regulated by Nuclear Hormone Receptors	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; PREGNANE-X-RECEPTOR; DRUG-METABOLIZING-ENZYMES; OXIDATIVE STRESS; GENE-EXPRESSION; C. ELEGANS; BETA-NAPHTHOFLAVONE; DROSOPHILA; NEMATODES; TUBULIN	Characterisation of the pathways by which xenobiotics are metabolised and excreted in both target and non-target organisms is crucial for the rational design of effective and specific novel bioactive molecules. Consequently, we have investigated the induced responses of the model nematode Caenorhabditis elegans to a variety of xenobiotics which represent a range of putative modes of action. The majority of genes that were specifically induced in preliminary microarray analyses encoded enzymes from Phase I and II metabolism, including cytochrome P450s, short chain dehydrogenases, UDP-glucuronosyl transferases and glutathione transferases. Changes in gene expression were confirmed by quantitative PCR and GFP induction in reporter strains driven by promoters for transcription of twelve induced enzymes was investigated. The particular complement of metabolic genes induced was found to be highly contingent on the xenobiotic applied. The known regulators of responses to applied chemicals ahr-1, hif-1, mdt-15 and nhr-8 were not required for any of these inducible responses and skn-1 regulated GFP expression from only two of the promoters. Reporter strains were used in conjunction with systematic RNAi screens to identify transcription factors which drive expression of these genes under xenobiotic exposure. These transcription factors appeared to regulate specific xenobiotic responses and have no reported phenotypes under standard conditions. Focussing on nhr-176 we demonstrate the role of this transcription factor in mediating the resistance to thiabendazole.	[Jones, Laura M.; Rayson, Samantha J.; Urwin, Peter E.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Flemming, Anthony J.] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	University of Leeds; Syngenta	Urwin, PE (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	p.e.urwin@leeds.ac.uk		Urwin, Peter Edward/0000-0003-0398-2372	Biotechnology and Biological Sciences Research Council of the UK (BBSRC); Syngenta UK through an Industrial Partnership Award [BB/G007071/1]; BBSRC; Syngenta through an industrial CASE award; Biotechnology and Biological Sciences Research Council [BB/G007071/1] Funding Source: researchfish; BBSRC [BB/G007071/1] Funding Source: UKRI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta UK through an Industrial Partnership Award(Syngenta); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta through an industrial CASE award(Syngenta); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by the Biotechnology and Biological Sciences Research Council of the UK (BBSRC) in partnership with Syngenta UK through an Industrial Partnership Award (Grant No. BB/G007071/1). SJR was the recipient of a PhD studentship funded by BBSRC in partnership with Syngenta through an industrial CASE award. One of the authors, Dr Anthony J. Flemming, is an employee of Syngenta UK. AJF, an employee of Syngenta UK, was involved in study design and preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Antebi A, 1998, DEVELOPMENT, V125, P1191; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bakhetia M, 2008, INT J PARASITOL, V38, P1589, DOI 10.1016/j.ijpara.2008.05.003; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Chakrapani BPS, 2008, J BIOSCIENCES, V33, P269, DOI 10.1007/s12038-008-0044-5; CHUKWUDEBE AC, 1994, J AGR FOOD CHEM, V42, P2964, DOI 10.1021/jf00048a060; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Custodia N, 2001, ANN NY ACAD SCI, V948, P32; DRISCOLL M, 1989, J CELL BIOL, V109, P2993, DOI 10.1083/jcb.109.6.2993; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hart AC, 2006, BEHAVIOUR; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009267; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Johnstone IL, 1999, PRACT APPROACH SER, V213, P201; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kohle C, 2009, BIOCHEM PHARMACOL, V77, P689, DOI 10.1016/j.bcp.2008.05.020; KWA MSG, 1995, J MOL BIOL, V246, P500, DOI 10.1006/jmbi.1994.0102; Laing ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031367; Laing ST, 2010, BIOCHEM J, V432, P505, DOI 10.1042/BJ20101346; Lewis JA, 1995, METHOD CELL BIOL, P365; Lindblom TH, 2001, CURR BIOL, V11, P864, DOI 10.1016/S0960-9822(01)00236-6; LUBEGA GW, 1991, EXP PARASITOL, V73, P203, DOI 10.1016/0014-4894(91)90023-P; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Maglich JM, 2001, GENOME BIOL, V2; Magner DB, 2008, TRENDS ENDOCRIN MET, V19, P153, DOI 10.1016/j.tem.2008.02.005; Masuyama H, 2005, MOL ENDOCRINOL, V19, P1170, DOI 10.1210/me.2004-0434; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Menzel R, 2001, ARCH BIOCHEM BIOPHYS, V395, P158, DOI 10.1006/abbi.2001.2568; Menzel R, 2007, J MOL BIOL, V370, P1, DOI 10.1016/j.jmb.2007.04.058; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Pretti C, 2001, COMP BIOCHEM PHYS C, V130, P133, DOI 10.1016/S1532-0456(01)00231-9; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Ruiz-Laguna J, 2005, GENE EXPRESSION, V12, P165, DOI 10.3727/000000005783992061; Ruiz-Laguna J, 2006, ENVIRON SCI TECHNOL, V40, P3646, DOI 10.1021/es060056e; Schleit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028036; Singh MP, 2011, TOXICOL APPL PHARM, V253, P14, DOI 10.1016/j.taap.2011.03.006; Sluder AE, 1999, GENOME RES, V9, P103; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Tomita M, 2006, INT J MOL MED, V17, P37; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Gilst M, 2002, CRIT REV EUKAR GENE, V12, P65; VANFLETEREN JR, 1972, NEMATOLOGICA, V18, P325, DOI 10.1163/187529272X00593; Vinuela A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012145; Vrailas-Mortimer A, 2011, DEV CELL, V21, P783, DOI 10.1016/j.devcel.2011.09.002; Weber KP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-81; Wren JF, 2011, ECOTOXICOLOGY, V20, P397, DOI 10.1007/s10646-010-0591-z; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	70	33	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69956	10.1371/journal.pone.0069956	http://dx.doi.org/10.1371/journal.pone.0069956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922869	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900120
J	Sakai, Y; Koike, M; Hasegawa, H; Yamanouchi, K; Soyama, A; Takatsuki, M; Kuroki, T; Ohashi, K; Okano, T; Eguchi, S				Sakai, Yusuke; Koike, Makiko; Hasegawa, Hideko; Yamanouchi, Kosho; Soyama, Akihiko; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Ohashi, Kazuo; Okano, Teruo; Eguchi, Susumu			Rapid Fabricating Technique for Multi-Layered Human Hepatic Cell Sheets by Forceful Contraction of the Fibroblast Monolayer	PLOS ONE			English	Article							HEPATOCYTES; COCULTURE; LIVER; HEPG2; KERATINOCYTES; MICROARRAY; CULTURE; TISSUES; LINE	Cell sheet engineering is attracting attention from investigators in various fields, from basic research scientists to clinicians focused on regenerative medicine. However, hepatocytes have a limited proliferation potential in vitro, and it generally takes a several days to form a sheet morphology and multi-layered sheets. We herein report our rapid and efficient technique for generating multi-layered human hepatic cell (HepaRG (R) cell) sheets using pre-cultured fibroblast monolayers derived from human skin (TIG-118 cells) as a feeder layer on a temperature-responsive culture dish. Multi-layered TIG-118/HepaRG cell sheets with a thick morphology were harvested on day 4 of culturing HepaRG cells by forceful contraction of the TIG-118 cells, and the resulting sheet could be easily handled. In addition, the human albumin and alpha 1-antitrypsin synthesis activities of TIG-118/HepaRG cells were approximately 1.2 and 1.3 times higher than those of HepaRG cells, respectively. Therefore, this technique is considered to be a promising modality for rapidly fabricating multi-layered human hepatocyte sheets from cells with limited proliferation potential, and the engineered cell sheet could be used for cell transplantation with highly specific functions.	[Sakai, Yusuke; Koike, Makiko; Hasegawa, Hideko; Yamanouchi, Kosho; Soyama, Akihiko; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan; [Ohashi, Kazuo; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Nagasaki University; Tokyo Women's Medical University	Eguchi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 852, Japan.	sueguchi@nagasaki-u.ac.jp	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Okano, Teruo/0000-0002-4470-9842; Soyama, Akihiko/0000-0003-2932-4300; Sakai, Yusuke/0000-0001-7999-9731	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for Scientific Research, Basic Research (C), the Regenerative Medicine Support Project in Nagasaki Prefecture, and Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (K.O., T.O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Cho CH, 2010, BIOTECHNIQUES, V48, P47, DOI 10.2144/000113317; Fukuda J, 2003, CELL TRANSPLANT, V12, P51, DOI 10.3727/000000003783985151; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228; Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045; Ito A, 2007, J BIOSCI BIOENG, V104, P371, DOI 10.1263/jbb.104.371; Josse R, 2008, LONG TERM FUNCTIONAL; Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084; Kim MH, 2011, J BIOSCI BIOENG, V112, P289, DOI 10.1016/j.jbiosc.2011.05.015; Kino-Oka M, 2012, J BIOSCI BIOENG, V113, P128, DOI 10.1016/j.jbiosc.2011.09.001; Kusumi T, 2009, J BIOSCI BIOENG, V107, P552, DOI 10.1016/j.jbiosc.2009.01.005; Mori R, 2008, J BIOSCI BIOENG, V106, P237, DOI 10.1263/jbb.106.237; Nakazawa K, 2011, J BIOPROCESS BIOTECH, VS3, P002; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; Ohki T, 2011, TECH GASTROINTEST EN, V13, P105, DOI 10.1016/j.tgie.2011.01.003; Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sakai Y, 2007, ACTA BIOMATER, V3, P1033, DOI 10.1016/j.actbio.2007.06.004; Sakai Y, 2010, J BIOSCI BIOENG, V109, P395, DOI 10.1016/j.jbiosc.2009.10.001; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Sekine W, 2011, J BIOCHIP TISSUE C S, VS1, P007; Tamura T, 2008, J MATER SCI-MATER M, V19, P2071, DOI 10.1007/s10856-007-3305-1; Tsuda Y, 2006, BIOCHEM BIOPH RES CO, V348, P937, DOI 10.1016/j.bbrc.2006.07.138	32	21	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70970	10.1371/journal.pone.0070970	http://dx.doi.org/10.1371/journal.pone.0070970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923035	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900180
J	Santos, JR; Munoz-Moreno, JA; Molto, J; Prats, A; Curran, A; Domingo, P; Llibre, JM; McClernon, DR; Bravo, I; Canet, J; Watson, V; Back, D; Clotet, B				Santos, Jose R.; Munoz-Moreno, Jose A.; Molto, Jose; Prats, Anna; Curran, Adria; Domingo, Pere; Llibre, Josep M.; McClernon, Daniel R.; Bravo, Isabel; Canet, Jaume; Watson, Victoria; Back, David; Clotet, Bonaventura			Virological Efficacy in Cerebrospinal Fluid and Neurocognitive Status in Patients with Long-Term Monotherapy Based on Lopinavir/Ritonavir: An Exploratory Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; PROTEASE INHIBITORS; RITONAVIR; LOPINAVIR; TOXICITY; STRATEGY; THERAPY; TRIAL	Background: Data on suppression of HIV replication in the CNS and on the subsequent risk of neurocognitive impairment using monotherapy with boosted protease inhibitors are limited. Methods: Ours was an exploratory cross-sectional study in patients on lopinavir/ritonavir-based monotherapy (LPV/r-MT) or standard triple therapy (LPV/r-ART) for at least 96 weeks who maintained a plasma viral load <50 copies/mL. HIV-1 RNA in CSF was determined by HIV-1 SuperLow assay (lower limit of detection, 1 copy/mL). Neurocognitive functioning was assessed using a recommended battery of neuropsychological tests covering 7 areas. Neurocognitive impairment (NCI) was determined and also a global deficit score (GDS) for study comparisons. Results: Seventeen patients on LPV/r-MT and 17 on LPV/r-ART were included. Fourteen (82.4%) patients on LPV/r-MT and 16 (94.1%) on LPV/r-ART had HIV-1 RNA <1 copy/mL in CSF (p = 0.601). NCI was observed in 7 patients on LPV/r-MT and in 10 on LPV/r-ART (41% vs 59%; p = 0.494). Mean (SD) GDS was 0.22 (0.20) in patients on LPV/r-MT and 0.47 (0.34) in those on LPV/r-ART (p = 0.012). Conclusions: Suppression of HIV in CSF is similar in individuals with durable plasma HIV-1 RNA suppression who are receiving LPV/r-MT or LPV/r-ART for at least 96 weeks. Findings for HIV-1 replication in CSF and neurocognitive status indicate that this strategy seems to be safe for CNS functioning.	[Santos, Jose R.; Munoz-Moreno, Jose A.; Molto, Jose; Prats, Anna; Llibre, Josep M.; Bravo, Isabel; Clotet, Bonaventura] Hosp Univ Germans Trias Pujol, Lluita Contra SIDA Fdn, Barcelona, Spain; [Santos, Jose R.; Munoz-Moreno, Jose A.; Molto, Jose; Prats, Anna; Llibre, Josep M.] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Curran, Adria] Hosp Valle De Hebron, Dept Infect Dis, Barcelona, Spain; [Domingo, Pere] Hosp Santa Creu & Sant Pau, Infect Dis Unit, Barcelona, Spain; [McClernon, Daniel R.] BioMONTR, Res Triangle Pk, NC USA; [Canet, Jaume] Hosp Univ Germans Trias Pujol, Dept Anesthesiol, Barcelona, Spain; [Canet, Jaume] Hosp Univ Germans Trias Pujol, Postoperat Care Unit, Barcelona, Spain; [Watson, Victoria; Back, David] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Watson, Victoria] Royal Liverpool Hosp Trust, Bioanalyt Facil, Liverpool, Merseyside, England; [Clotet, Bonaventura] IrsiCaixa Fdn, Barcelona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital of Santa Creu i Sant Pau; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; University of Liverpool; Institut de Recerca de la Sida - IrsiCaixa	Santos, JR (corresponding author), Hosp Univ Germans Trias Pujol, Lluita Contra SIDA Fdn, Barcelona, Spain.	jrsantos@flsida.org	Domingo, Pere/AAP-7571-2021; Domingo, Pere/CAF-3577-2022; Muñoz-Moreno, Jose A./P-1242-2014	Domingo, Pere/0000-0003-1138-5770; Muñoz-Moreno, Jose A./0000-0002-7239-5422; Curran, Adrian/0000-0002-1263-0814; Molto, Jose/0000-0003-4564-1963; Prats, Anna/0000-0002-3586-4525	Lluita contra la SIDA Foundation (Barcelona, Spain); Abbott laboratories (Abbott Park, Illinois, USA); National Institute for Health Research, United Kingdom; National Institute for Health Research [BRF-2011-029] Funding Source: researchfish	Lluita contra la SIDA Foundation (Barcelona, Spain); Abbott laboratories (Abbott Park, Illinois, USA)(Abbott Laboratories); National Institute for Health Research, United Kingdom(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported in part by Lluita contra la SIDA Foundation (Barcelona, Spain) and Abbott laboratories (Abbott Park, Illinois, USA). Victoria Watson is funded by a Doctoral Research Fellowship award from the National Institute for Health Research, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo website, GUID US ANT AG HIV 1, P1; [Anonymous], 2011, EUR AIDS CLIN SOC EA; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Beck A, 1979, COGNITIVE THERAPY DE; Benton AL, 1994, MULTILINGUAL APHASIA; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Bunupuradah T, 2012, 19 C RETR OPP INF 5; Capparelli EV, 2005, AIDS, V19, P949, DOI 10.1097/01.aids.0000171409.38490.48; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Culberson W., 2001, TOWER LONDON DREXEL; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Droste JAH, 2003, JAIDS-J ACQ IMM DEF, V32, P287, DOI 10.1097/00126334-200303010-00007; Escobar I, 2006, ENFERM INFEC MICR CL, V24, P490, DOI 10.1157/13092464; GESIDA website, PAN EXP GES PLAN NAC; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Golden C.J., 1978, STROOP COLOR WORD TE; Golden C.J., 2001, STROOP TEST COLORES; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hickman D, 2004, ANTIMICROB AGENTS CH, V48, P2911, DOI 10.1128/AAC.48.8.2911-2917.2004; Kolta S, 2011, CURR HIV RES, V9, P31, DOI 10.2174/157016211794582687; Letendre S, 2009, 16 C RETR OPP INF 8; Letendre Scott, 2011, Top Antivir Med, V19, P137; Letendre SL, 2007, CLIN INFECT DIS, V45, P1511, DOI 10.1086/523002; Letendre Scott L, 2010, Top HIV Med, V18, P45; Marraa CM, 2009, AIDS, V23, P1359, DOI 10.1097/QAD.0b013e32832c4152; Matthews C, 1964, INSTRUCTION MANUAL A; McClernon AM, 2011, NEW HIV 1 SUPERLOW A; Molto J, 2007, J ANTIMICROB CHEMOTH, V60, P436, DOI 10.1093/jac/dkm198; MUNOZMORENO JA, 2007, RES FOCUS COGNITIVE; Paton NI, 2011, AIDS, V25, P393, DOI 10.1097/QAD.0b013e328342fb7b; Pulido F, 2008, 48 ICAAC 25 28 OCT 2; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; REITAN RM, 1985, TRAIL MAKING TEST HA; REITAN RM, 1985, GROOVED PEGBOARD HAL; Reitan RM, 1974, CLIN NEUROPSYCHOLOGY; SMITH A, 2002, TEST SIMBOLOS DIGITO; Smith A., 1973, SYMBOL DIGIT MODALIT, DOI 10.1037/t27513-000; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Valantin MA, 2010, 17 C RETR OPP INF CR; Wechsler D, 2003, WAIS 3 ESCALA INTELI; Weschler D, 1997, ADM SCORING MANUAL W; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	47	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70201	10.1371/journal.pone.0070201	http://dx.doi.org/10.1371/journal.pone.0070201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922957	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900161
J	Tamminen, K; Lappalainen, S; Huhti, L; Vesikari, T; Blazevic, V				Tamminen, Kirsi; Lappalainen, Suvi; Huhti, Leena; Vesikari, Timo; Blazevic, Vesna			Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CD4(+) T-CELLS; VP6 PROTEIN; INTRANASAL IMMUNIZATION; NEUTRALIZING-ANTIBODY; ORAL IMMUNIZATION; IN-VITRO; B-CELLS; PROTECTION; GASTROENTERITIS	Rotavirus (RV) and norovirus (NoV) are the two major causes of viral gastroenteritis (GE) in children worldwide. We have developed an injectable vaccine design to prevent infection or GE induced with these enteric viruses. The trivalent combination vaccine consists of NoV capsid (VP1) derived virus-like particles (VLPs) of GI-3 and GII-4 representing the two major NoV genogroups and tubular RV recombinant VP6 (rVP6), the most conserved and abundant RV protein. Each component was produced in insect cells by a recombinant baculovirus expression system and combined in vitro. The vaccine components were administered intramuscularly to BALB/c mice either separately or in the trivalent combination. High levels of NoV and RV type specific serum IgGs with high avidity (> 50%) as well as intestinal IgGs were detected in the immunized mice. Cross-reactive IgG antibodies were also elicited against heterologous NoV VLPs not used for immunization (GII-4 NO, GII-12 and GI-1 VLPs) and to different RVs from cell cultures. NoV-specific serum antibodies blocked binding of homologous and heterologous VLPs to the putative receptors, histo-blood group antigens, suggesting broad NoV neutralizing activity of the sera. Mucosal antibodies of mice immunized with the trivalent combination vaccine inhibited RV infection in vitro. In addition, cross-reactive T cell immune responses to NoV and RV-specific antigens were detected. All the responses were sustained for up to six months. No mutual inhibition of the components in the trivalent vaccine combination was observed. In conclusion, the NoV GI and GII VLPs combination induced broader cross-reactive and potentially neutralizing immune responses than either of the VLPs alone. Therefore, trivalent vaccine might induce protective immune responses to the vast majority of circulating NoV and RV genotypes.	[Tamminen, Kirsi; Lappalainen, Suvi; Huhti, Leena; Vesikari, Timo; Blazevic, Vesna] Univ Tampere, Sch Med, Vaccine Res Ctr, FIN-33101 Tampere, Finland	Tampere University	Blazevic, V (corresponding author), Univ Tampere, Sch Med, Vaccine Res Ctr, FIN-33101 Tampere, Finland.	vesna.blazevic@uta.fi	Blazevic, Vesna/AAJ-8283-2021; Blazevic, Vesna/Q-3183-2017	Blazevic, Vesna/0000-0001-8201-6118; Blazevic, Vesna/0000-0001-8201-6118; Heinimaki, Suvi/0000-0001-9374-4583	UMN Pharma Inc., Japan	UMN Pharma Inc., Japan	This study was in part supported by UMN Pharma Inc., Japan (http://www.umnpharma.com/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Atmar RL, 2012, EXPERT REV VACCINES, V11, P1023, DOI [10.1586/erv.12.78, 10.1586/ERV.12.78]; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bertolotti-Ciarlet A, 2003, VACCINE, V21, P3885, DOI 10.1016/S0264-410X(03)00308-6; Blazevic V, 2011, VACCINE, V29, P8126, DOI 10.1016/j.vaccine.2011.08.026; Blutt SE, 2008, J VIROL, V82, P3135, DOI 10.1128/JVI.01727-07; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bucardo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025962; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chen SC, 1998, J VIROL, V72, P5757, DOI 10.1128/JVI.72.7.5757-5761.1998; Cherian T, 2012, VACCINE, V30, pA3, DOI 10.1016/j.vaccine.2011.10.007; Choi AH, 2002, VACCINE, V20, P3310, DOI 10.1016/S0264-410X(02)00315-8; Coffin SE, 1999, J IMMUNOL, V163, P3064; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Dennehy PH, 2011, PEDIATR INFECT DIS J, V30, P63, DOI 10.1097/INF.0b013e3182059102; Donato CM, 2012, J INFECT DIS, V206, P377, DOI 10.1093/infdis/jis361; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Estes MK, 2007, FIELDS VIROLOGY, P1917; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Fromantin C, 2001, J VIROL, V75, P11010, DOI 10.1128/JVI.75.22.11010-11016.2001; Ghosh MK, 2002, VACCINE, V20, P1369, DOI 10.1016/S0264-410X(01)00467-4; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hansman GS, 2006, J GEN VIROL, V87, P909, DOI 10.1099/vir.0.81532-0; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Hemming M, 2013, EUR J PEDIATR, V172, P739, DOI 10.1007/s00431-013-1945-3; Hemming M, 2012, PEDIATR INFECT DIS J, V31, P992, DOI 10.1097/INF.0b013e31825d611e; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Huhti L, 2010, ARCH VIROL, V155, P1855, DOI 10.1007/s00705-010-0768-z; KNOWLTON DR, 1991, J VIROL METHODS, V33, P127, DOI 10.1016/0166-0934(91)90013-P; Koo HL, 2012, J PEDIAT INFECT DIS, V2, P57; Lappalainen S, 2011, VACCINES ENTERIC DIS; Lepault J, 2001, EMBO J, V20, P1498, DOI 10.1093/emboj/20.7.1498; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lindesmith LC, 2010, J VIROL, V84, P1800, DOI 10.1128/JVI.02179-09; LoBue AD, 2010, J VIROL, V84, P8530, DOI 10.1128/JVI.00727-10; Lobue AD, 2009, J VIROL, V83, P3212, DOI 10.1128/JVI.01650-08; McNeal MM, 2002, J VIROL, V76, P560, DOI 10.1128/JVI.76.2.560-568.2002; McNeal MM, 2007, VIRAL IMMUNOL, V20, P571, DOI 10.1089/vim.2007.0055; McNeal MM, 2007, VIROLOGY, V363, P410, DOI 10.1016/j.virol.2007.01.041; Nurminen K, 2011, J MED VIROL, V83, P525, DOI 10.1002/jmv.21990; Parez N, 2004, J VIROL, V78, P12489, DOI 10.1128/JVI.78.22.12489-12496.2004; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Puustinen L, 2011, SCAND J INFECT DIS, V43, P804, DOI 10.3109/00365548.2011.588610; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Rockx B, 2005, J MED VIROL, V77, P439, DOI 10.1002/jmv.20473; Ruggeri FM, 1998, J VIROL, V72, P2708, DOI 10.1128/JVI.72.4.2708-2714.1998; Schwartz-Cornil I, 2002, J VIROL, V76, P8110, DOI 10.1128/JVI.76.16.8110-8117.2002; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Someya Y, 2011, J GEN VIROL, V92, P2320, DOI 10.1099/vir.0.033985-0; Tamminen K, 2012, IMMUNOLOGY, V135, P89, DOI 10.1111/j.1365-2567.2011.03516.x; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Velasquez LS, 2011, VACCINE, V29, P5221, DOI 10.1016/j.vaccine.2011.05.027; Vinje J, 2010, J INFECT DIS, V202, P1623, DOI 10.1086/657088; Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16; Ward RL, 2010, J INFECT DIS, V202, pS101, DOI 10.1086/653556; Ward RL, 1996, J CLIN MICROBIOL, V34, P983, DOI 10.1128/JCM.34.4.983-985.1996; White LJ, 1997, J VIROL, V71, P8066, DOI 10.1128/JVI.71.10.8066-8072.1997; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zhou HL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-3	67	77	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70409	10.1371/journal.pone.0070409	http://dx.doi.org/10.1371/journal.pone.0070409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922988	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900167
J	Blatrix, R; Debaud, S; Salas-Lopez, A; Born, C; Benoit, L; McKey, DB; Atteke, C; Djieto-Lordon, C				Blatrix, Rumsais; Debaud, Sarah; Salas-Lopez, Alex; Born, Celine; Benoit, Laure; McKey, Doyle B.; Atteke, Christiane; Djieto-Lordon, Champlain			Repeated Evolution of Fungal Cultivar Specificity in Independently Evolved Ant-Plant-Fungus Symbioses	PLOS ONE			English	Article							BARTERIA PASSIFLORACEAE; MUTUALISM; DNA; PSEUDOMYRMECINAE; AGRICULTURE; ASSOCIATION; PHYLOGENIES	Some tropical plant species possess hollow structures (domatia) occupied by ants that protect the plant and in some cases also provide it with nutrients. Most plant-ants tend patches of chaetothyrialean fungi within domatia. In a few systems it has been shown that the ants manure the fungal patches and use them as a food source, indicating agricultural practices. However, the identity of these fungi has been investigated only in a few samples. To examine the specificity and constancy of ant-plant-fungus interactions we characterised the content of fungal patches in an extensive sampling of three ant-plant symbioses (Petalomyrmex phylax/Leonardoxa africana subsp. africana, Aphomomyrmex afer/Leonardoxa africana subsp. letouzeyi and Tetraponera aethiops/Barteria fistulosa) by sequencing the Internal Transcribed Spacers of ribosomal DNA. For each system the content of fungal patches was constant over individuals and populations. Each symbiosis was associated with a specific, dominant, primary fungal taxon, and to a lesser extent, with one or two specific secondary taxa, all of the order Chaetothyriales. A single fungal patch sometimes contained both a primary and a secondary taxon. In one system, two founding queens were found with the primary fungal taxon only, one that was shown in a previous study to be consumed preferentially. Because the different ant-plant symbioses studied have evolved independently, the high specificity and constancy we observed in the composition of the fungal patches have evolved repeatedly. Specificity and constancy also characterize other cases of agriculture by insects.	[Blatrix, Rumsais; Debaud, Sarah; Salas-Lopez, Alex; Born, Celine; Benoit, Laure; McKey, Doyle B.] Univ Montpellier 2, CNRS, CIRAD Bios, Ctr Ecol Fonct & Evolut, Montpellier, France; [McKey, Doyle B.] Inst Univ France, Montpellier, France; [Atteke, Christiane] Univ Sci & Tech Masuku, Dept Biol, Franceville, Gabon; [Djieto-Lordon, Champlain] Univ Yaounde I, Zool Lab, Yaounde, Cameroon	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Institut Universitaire de France; University of Yaounde I	Blatrix, R (corresponding author), Univ Montpellier 2, CNRS, CIRAD Bios, Ctr Ecol Fonct & Evolut, Montpellier, France.	rumsais.blatrix@cefe.cnrs.fr		Salas-Lopez, Alex/0000-0003-3899-4314; Blatrix, Rumsais/0000-0003-1662-7791	network "Bibliotheque du Vivant''; CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Centre National de Sequencage); French Agence Nationale de la Recherche [ANR-06-JCJC-0127]	network "Bibliotheque du Vivant''; CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; INRA; CEA (Centre National de Sequencage); French Agence Nationale de la Recherche(French National Research Agency (ANR))	This project was supported by the network "Bibliotheque du Vivant'' (http://bdv.ups-tise.fr/), funded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Centre National de Sequencage). It was also funded by grants to R. Blatrix and D. McKey from three programmes of the French Agence Nationale de la Recherche (www.agence-nationale-recherche.fr): "Young scientists'' (research agreement no. ANR-06-JCJC-0127), "Biodiversity'' (IFORA project) and "Sixth extinction'' (C3A project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Bailey IW, 1920, ECOLOGY, V1, P174, DOI 10.2307/1929134; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; BATRA LR, 1966, SCIENCE, V153, P193, DOI 10.1126/science.153.3732.193; BATRA LR, 1985, P INDIAN AS-PLANT SC, V94, P137; Blatrix R, 2012, P ROY SOC B-BIOL SCI, V279, P3940, DOI 10.1098/rspb.2012.1403; Blatrix R, 2009, PLANT SIGNAL BEHAV, V4, P554, DOI 10.4161/psb.4.6.8733; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Breteler FJ, 1999, ADANSONIA, V21, P306; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilmus S, 2009, APPL ENVIRON MICROB, V75, P4324, DOI 10.1128/AEM.00455-09; Frederickson ME, 2005, NATURE, V437, P495, DOI 10.1038/437495a; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gaume L, 1998, P ROY SOC B-BIOL SCI, V265, P569, DOI 10.1098/rspb.1998.0332; Gebhardt Heiko, 2004, Mycological Progress, V3, P95, DOI 10.1007/s11557-006-0080-1; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gullan Penny J., 1997, World Crop Pests, V7A, P351; HAANSTAD JO, 1985, MICROBIAL ECOL, V11, P267, DOI 10.1007/BF02010605; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; Heath JJ, 2010, ENTOMOL EXP APPL, V137, P36, DOI 10.1111/j.1570-7458.2010.01040.x; JANZEN DH, 1972, ECOLOGY, V53, P885, DOI 10.2307/1934304; Lauth Jeremie, 2011, Communicative & Integrative Biology, V4, P728; Letourneau DK, 1998, ECOLOGY, V79, P593, DOI 10.1890/0012-9658(1998)079[0593:ASBAFP]2.0.CO;2; Mayer VE, 2009, P ROY SOC B-BIOL SCI, V276, P3265, DOI 10.1098/rspb.2009.0768; McKey Doyle, 2005, P386, DOI 10.1017/CBO9780511541971.017; McKey Doyle B., 2000, Adansonia (Paris), V22, P71; Miehe H, 1911, ABHANDL K SACH GE MP, V32, P312; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2012, CURR OPIN MICROBIOL, V15, P269, DOI 10.1016/j.mib.2012.03.001; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Peccoud J, 2013, MOL PHYLOGENET EVOL, V66, P824, DOI 10.1016/j.ympev.2012.11.006; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Ruiz-Gonzalez MX, 2011, BIOL LETTERS, V7, P475, DOI 10.1098/rsbl.2010.0920; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Silva-Pinhati ACO, 2004, BRAZ J MED BIOL RES, V37, P1463, DOI 10.1590/S0100-879X2004001000004; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yumoto T, 1999, ECOL RES, V14, P393, DOI 10.1046/j.1440-1703.1999.00307.x	55	17	17	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68101	10.1371/journal.pone.0068101	http://dx.doi.org/10.1371/journal.pone.0068101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935854	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300004
J	Maiga, A; Merlin, J; Marcon, E; Rouget, C; Larregola, M; Gilquin, B; Fruchart-Gaillard, C; Lajeunesse, E; Marchetti, C; Lorphelin, A; Bellanger, L; Summers, RJ; Hutchinson, DS; Evans, BA; Servent, D; Gilles, N				Maiga, Arhamatoulaye; Merlin, Jon; Marcon, Elodie; Rouget, Celine; Larregola, Maud; Gilquin, Bernard; Fruchart-Gaillard, Carole; Lajeunesse, Evelyne; Marchetti, Charles; Lorphelin, Alain; Bellanger, Laurent; Summers, Roger J.; Hutchinson, Dana S.; Evans, Bronwyn A.; Servent, Denis; Gilles, Nicolas			Orthosteric Binding of rho-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the alpha(1A)-Adrenoceptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GPCRDB INFORMATION-SYSTEM; CONOPEPTIDE RHO-TIA; ALPHA(1B)-ADRENERGIC RECEPTOR; AGONIST BINDING; CRYSTAL-STRUCTURE; DRUG DISCOVERY; ALLOSTERIC INTERACTIONS; FUNCTIONAL SELECTIVITY; MUSCARINIC RECEPTORS	rho-Da1a is a three-finger fold toxin from green mamba venom that is highly selective for the alpha(1A)-adrenoceptor. This toxin has atypical pharmacological properties, including incomplete inhibition of H-3-prazosin or I-125-HEAT binding and insurmountable antagonist action. We aimed to clarify its mode of action at the alpha(1A)-adrenoceptor. The affinity (pKi 9.26) and selectivity of rho-Da1a for the alpha(1A)-adrenoceptor were confirmed by comparing binding to human adrenoceptors expressed in eukaryotic cells. Equilibrium and kinetic binding experiments were used to demonstrate that rho-Da1a, prazosin and HEAT compete at the alpha(1A)-adrenoceptor. rho-Da1a did not affect the dissociation kinetics of H-3-prazosin or I-125-HEAT, and the IC50 of rho-Da1a, determined by competition experiments, increased linearly with the concentration of radioligands used, while the residual binding by rho-Da1a remained stable. The effect of rho-Da1a on agonist-stimulated Ca2+ release was insurmountable in the presence of phenethylamine- or imidazoline-type agonists. Ten mutations in the orthosteric binding pocket of the alpha(1A)-adrenoceptor were evaluated for alterations in rho-Da1a affinity. The D106(3.32)A and the S188(5.42)A/S192(5.46)A receptor mutations reduced toxin affinity moderately (6 and 7.6 times, respectively), while the F86(2.64)A, F288(6.51)A and F312(7.39)A mutations diminished it dramatically by 18- to 93-fold. In addition, residue F86(2.64) was identified as a key interaction point for I-125-HEAT, as the variant F86(2.64)A induced a 23-fold reduction in HEAT affinity. Unlike the M1 muscarinic acetylcholine receptor toxin MT7, rho-Da1a interacts with the human alpha(1A)-adrenoceptor orthosteric pocket and shares receptor interaction points with antagonist (F86(2.64), F288(6.51) and F312(7.39)) and agonist (F288(6.51) and F312(7.39)) ligands. Its selectivity for the alpha(1A)-adrenoceptor may result, at least partly, from its interaction with the residue F86(2.64), which appears to be important also for HEAT binding.	[Maiga, Arhamatoulaye; Marcon, Elodie; Rouget, Celine; Larregola, Maud; Fruchart-Gaillard, Carole; Lajeunesse, Evelyne; Servent, Denis; Gilles, Nicolas] Serv Ingn Mol Prot, Commissariat Energie Atom & Energies Alternat, iBiTec S, Gif Sur Yvette, France; [Merlin, Jon; Summers, Roger J.; Hutchinson, Dana S.; Evans, Bronwyn A.] Monash Univ, Dept Pharmacol, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Merlin, Jon; Summers, Roger J.; Hutchinson, Dana S.; Evans, Bronwyn A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Gilquin, Bernard] Serv Bioenerget Biol Struct & Mecanismes, Commissariat Energie Atom & Energies Alternat, iBiTec S, Gif Sur Yvette, France; [Marchetti, Charles; Lorphelin, Alain; Bellanger, Laurent] Serv Biochim & Toxicol Nucl, Commissariat Energie Atom & Energies Alternat, iBEB, Bagnols Sur Ceze, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Monash University; Monash University; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA	Gilles, N (corresponding author), Serv Ingn Mol Prot, Commissariat Energie Atom & Energies Alternat, iBiTec S, Gif Sur Yvette, France.	Nicolas.gilles@cea.fr	Fruchart Gaillard, Carole/GWV-2801-2022; Summers, Roger J/F-6351-2011; Merlin, Jon/AEQ-9115-2022	Fruchart Gaillard, Carole/0000-0002-3149-4774; Summers, Roger J/0000-0002-8367-4056; Merlin, Jon/0000-0002-0062-795X; Servent, Denis/0000-0002-0774-1691; Larregola, Maud/0000-0002-9196-3552; Hutchinson, Dana/0000-0001-9947-0106				Ahmed M, 2008, BIOL PHARM BULL, V31, P598, DOI 10.1248/bpb.31.598; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Cavalli A, 1996, FEBS LETT, V399, P9, DOI 10.1016/S0014-5793(96)01286-0; Chen SH, 1999, J BIOL CHEM, V274, P16320, DOI 10.1074/jbc.274.23.16320; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 1999, EUR J PHARMACOL, V382, P217, DOI 10.1016/S0014-2999(99)00550-6; Compeer MG, 2012, BRIT J PHARMACOL, V166, P1833, DOI 10.1111/j.1476-5381.2012.01896.x; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Grunewald S, 2004, RECEPTOR CHANNEL, V10, P37, DOI 10.1080/10606820490279466; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hamaguchi N, 1996, BIOCHEMISTRY-US, V35, P14312, DOI 10.1021/bi961024e; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Hwa J, 1996, J BIOL CHEM, V271, P6322, DOI 10.1074/jbc.271.11.6322; HWA J, 1995, J BIOL CHEM, V270, P23189, DOI 10.1074/jbc.270.39.23189; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koivula K, 2010, TOXICON, V56, P440, DOI 10.1016/j.toxicon.2010.05.001; Kukkonen A, 2004, J BIOL CHEM, V279, P50923, DOI 10.1074/jbc.M406424200; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Leppik RA, 2000, MOL PHARMACOL, V57, P436, DOI 10.1124/mol.57.3.436; Lew MJ, 1997, ANN NY ACAD SCI, V812, P179, DOI 10.1111/j.1749-6632.1997.tb48166.x; LEW MJ, 1995, TRENDS PHARMACOL SCI, V16, P328, DOI 10.1016/S0165-6147(00)89066-5; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lima V, 2005, EUR J PHARMACOL, V508, P183, DOI 10.1016/j.ejphar.2004.12.011; Maiga A, 2012, TOXICON, V59, P487, DOI 10.1016/j.toxicon.2011.03.009; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Mohr K, 2003, RECEPTOR CHANNEL, V9, P229, DOI 10.1080/10606820308264; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Olianas MC, 2004, EUR J PHARMACOL, V487, P65, DOI 10.1016/j.ejphar.2004.01.029; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palea S, 2012, BR J PHARM IN PRESS; Perret BG, 2003, PROTEIN EXPRES PURIF, V31, P123, DOI 10.1016/S1046-5928(03)00140-2; Porter JE, 1996, J BIOL CHEM, V271, P28318, DOI 10.1074/jbc.271.45.28318; Quinton L, 2010, BRIT J PHARMACOL, V159, P316, DOI 10.1111/j.1476-5381.2009.00532.x; Ragnarsson L, 2013, J BIOL CHEM, V288, P1814, DOI 10.1074/jbc.M112.430785; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Rouget C, 2010, BRIT J PHARMACOL, V161, P1361, DOI 10.1111/j.1476-5381.2010.00966.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Shen GS, 2000, DRUG DISCOV TODAY, V5, P98, DOI 10.1016/S1359-6446(99)01454-3; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Takahashi K, 2007, BIOL PHARM BULL, V30, P1891, DOI 10.1248/bpb.30.1891; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Waelbroeck M, 1996, EUR J PHARMACOL, V305, P187, DOI 10.1016/0014-2999(96)00136-7; Waugh DJJ, 2001, J BIOL CHEM, V276, P25366, DOI 10.1074/jbc.M103152200; Waugh DJJ, 2000, J BIOL CHEM, V275, P11698, DOI 10.1074/jbc.275.16.11698; Wetzel JM, 1996, RECEPTOR CHANNEL, V4, P165; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	57	8	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68841	10.1371/journal.pone.0068841	http://dx.doi.org/10.1371/journal.pone.0068841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935897	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300011
J	O'Sullivan, L; Cuffe, JSM; Paravicini, TM; Campbell, S; Dickinson, H; Singh, RR; Gezmish, O; Black, MJ; Moritz, KM				O'Sullivan, Lee; Cuffe, James S. M.; Paravicini, Tamara M.; Campbell, Sally; Dickinson, Hayley; Singh, Reetu R.; Gezmish, Oksan; Black, M. Jane; Moritz, Karen M.			Prenatal Exposure to Dexamethasone in the Mouse Alters Cardiac Growth Patterns and Increases Pulse Pressure in Aged Male Offspring	PLOS ONE			English	Article							MATERNAL PROTEIN RESTRICTION; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; NEPHRON NUMBER; GLUCOCORTICOID EXPOSURE; GENE-EXPRESSION; CORTICOSTERONE EXPOSURE; PLACENTAL GROWTH; EARLY GESTATION; RENAL INJURY	Exposure to synthetic glucocorticoids during development can result in later cardiovascular and renal disease in sheep and rats. Although prenatal glucocorticoid exposure is associated with impaired renal development, less is known about effects on the developing heart. This study aimed to examine the effects of a short-term exposure to dexamethasone (60 hours from embryonic day 12.5) on the developing mouse heart, and cardiovascular function in adult male offspring. Dexamethasone (DEX) exposed fetuses were growth restricted compared to saline treated controls (SAL) at E14.5, but there was no difference between groups at E17.5. Heart weights of the DEX fetuses also tended to be smaller at E14.5, but not different at E17.5. Cardiac AT(1a)R, Bax, and IGF-1 mRNA expression was significantly increased by DEX compared to SAL at E17.5. In 12-month-old offspring DEX exposure caused an increase in basal blood pressure of similar to 3 mmHg. In addition, DEX exposed mice had a widened pulse pressure compared to SAL. DEX exposed males at 12 months had an approximate 25% reduction in nephron number compared to SAL, but no difference in cardiomyocyte number. Exposure to DEX in utero appears to adversely impact on nephrogenesis and heart growth but is not associated with a cardiomyocyte deficit in male mice in adulthood, possibly due to compensatory growth of the myocardium following the initial insult. However, the widened pulse pressure may be indicative of altered vascular compliance.	[O'Sullivan, Lee; Cuffe, James S. M.; Paravicini, Tamara M.; Campbell, Sally; Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Dickinson, Hayley] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Gezmish, Oksan; Black, M. Jane] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Monash University; Monash University	Moritz, KM (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	k.moritz@uq.edu.au	O'Sullivan, Lee/N-2740-2016; Moritz, Karen/G-2508-2015; Cuffe, James/H-1003-2016	O'Sullivan, Lee/0000-0002-3225-3040; Moritz, Karen/0000-0002-8085-0034; Cuffe, James/0000-0002-2675-8149; Black, Mary Jane/0000-0002-9253-3773	University of Queensland Research Foundation; International Post-graduate Research Scholarship; Asutralian Post-graduate Award; Australian Research Council Post-doctoral fellowship; National Health and Medical Research Council Fellowship	University of Queensland Research Foundation; International Post-graduate Research Scholarship(Australian Government); Asutralian Post-graduate Award; Australian Research Council Post-doctoral fellowship(Australian Research Council); National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of Queensland Research Foundation. LO'S is supported by an International Post-graduate Research Scholarship, JC by an Asutralian Post-graduate Award, HD by an Australian Research Council Post-doctoral fellowship and KM by a National Health and Medical Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Bechtold AG, 2008, J PHYSIOL-LONDON, V586, P673, DOI 10.1113/jphysiol.2007.141580; Black MJ, 2012, AM J PHYSIOL-REG I, V302, pR1101, DOI 10.1152/ajpregu.00030.2012; Bramlage CP, 2009, HYPERTENSION, V54, P1115, DOI 10.1161/HYPERTENSIONAHA.109.136580; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Cuffe JSM, 2011, PLACENTA, V32, P981, DOI 10.1016/j.placenta.2011.09.009; Cullen-McEwen LA, 2011, AM J PHYSIOL-RENAL, V300, pF1448, DOI 10.1152/ajprenal.00055.2011; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; Dickinson H, 2005, AM J PHYSIOL-RENAL, V289, pF273, DOI 10.1152/ajprenal.00400.2004; Dickinson H, 2007, AM J PHYSIOL-REG I, V292, pR453, DOI 10.1152/ajpregu.00481.2006; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dostal DE, 2000, REGUL PEPTIDES, V91, P1, DOI 10.1016/S0167-0115(99)00123-8; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Goh JM, 2011, AM J PHYSIOL-HEART C, V300, pH645, DOI 10.1152/ajpheart.00689.2010; Habib S, 2011, AM J HYPERTENS, V24, P96, DOI 10.1038/ajh.2010.177; Harrison M, 2009, BRIT J NUTR, V101, P1020, DOI 10.1017/S0007114508057607; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR1768, DOI 10.1152/ajpregu.00442.2006; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Huetteman DA, 2009, METHODS MOL BIOL, V573, P57, DOI 10.1007/978-1-60761-247-6_4; Igosheva N, 2004, J PHYSIOL-LONDON, V557, P273, DOI 10.1113/jphysiol.2003.056911; Igosheva N, 2007, J PHYSIOL-LONDON, V582, P665, DOI 10.1113/jphysiol.2007.130252; Langdown ML, 2001, J ENDOCRINOL, V169, P11, DOI 10.1677/joe.0.1690011; Li SF, 2012, REPROD SCI, V19, P260, DOI 10.1177/1933719111418374; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Lim K, 2010, ANAT REC, V293, P431, DOI 10.1002/ar.21084; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Mazzuca MQ, 2010, J PHYSIOL-LONDON, V588, P1997, DOI 10.1113/jphysiol.2010.187849; Molnar J, 2003, J PHYSIOL-LONDON, V547, P61, DOI 10.1113/jphysiol.2002.032565; Moritz K, 2002, ENDOCRINOLOGY, V143, P1159, DOI 10.1210/en.143.4.1159; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2009, J PHYSIOL-LONDON, V587, P2635, DOI 10.1113/jphysiol.2009.170407; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Moss TJM, 2001, AM J PHYSIOL-REG I, V281, pR960, DOI 10.1152/ajpregu.2001.281.3.R960; O'Connell BA, 2011, BIOL REPROD, V85, P1040, DOI 10.1095/biolreprod.111.093369; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Peers A, 2001, KIDNEY INT, V59, P425, DOI 10.1046/j.1523-1755.2001.059002425.x; Prescott SL, 2009, CURR OPIN ALLERGY CL, V9, P417, DOI 10.1097/ACI.0b013e328330634f; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Schmidt M, 2003, INT J DEV NEUROSCI, V21, P125, DOI 10.1016/S0736-5748(03)00030-3; Schreuder MF, 2006, J HYPERTENS, V24, P1337, DOI 10.1097/01.hjh.0000234114.33025.fd; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Sundgren NC, 2003, AM J PHYSIOL-REG I, V285, pR1481, DOI 10.1152/ajpregu.00232.2003; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Swali A, 2010, J PHYSIOL-LONDON, V588, P3809, DOI 10.1113/jphysiol.2010.194928; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Tonkiss J, 1998, HYPERTENSION, V32, P108, DOI 10.1161/01.HYP.32.1.108; Traister A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037802; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR955, DOI 10.1152/ajpregu.00455.2004; Woods LL, 2006, AM J PHYSIOL-REG I, V291, pR1069, DOI 10.1152/ajpregu.00753.2005; Yosypiv IV, 2011, PEDIATR NEPHROL, V26, P1499, DOI 10.1007/s00467-011-1820-2; Zimanyi MA, 2006, DIABETOLOGIA, V49, P801, DOI 10.1007/s00125-006-0175-x; Zimanyi MA, 2002, PEDIATR NEPHROL, V17, P1000, DOI 10.1007/s00467-002-0998-8; Zohdi V, 2007, AM J PHYSIOL-REG I, V293, pR1267, DOI 10.1152/ajpregu.00119.2007	63	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69149	10.1371/journal.pone.0069149	http://dx.doi.org/10.1371/journal.pone.0069149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935943	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300025
J	Vanhove, J				Vanhove, Jan			The Critical Period Hypothesis in Second Language Acquisition: A Statistical Critique and a Reanalysis	PLOS ONE			English	Article							LANGUAGE-ACQUISITION; AGE-DIFFERENCES; PSYCHOLOGY; POWER; CONSTRAINTS; BONFERRONI; JUDGMENTS; ENGLISH	In second language acquisition research, the critical period hypothesis (CPH) holds that the function between learners' age and their susceptibility to second language input is non-linear. This paper revisits the indistinctness found in the literature with regard to this hypothesis's scope and predictions. Even when its scope is clearly delineated and its predictions are spelt out, however, empirical studies-with few exceptions-use analytical (statistical) tools that are irrelevant with respect to the predictions made. This paper discusses statistical fallacies common in CPH research and illustrates an alternative analytical method (piecewise regression) by means of a reanalysis of two datasets from a 2010 paper purporting to have found cross-linguistic evidence in favour of the CPH. This reanalysis reveals that the specific age patterns predicted by the CPH are not cross-linguistically robust. Applying the principle of parsimony, it is concluded that age patterns in second language acquisition are not governed by a critical period. To conclude, this paper highlights the role of confirmation bias in the scientific enterprise and appeals to second language acquisition researchers to reanalyse their old datasets using the methods discussed in this paper. The data and R commands that were used for the reanalysis are provided as supplementary materials.	Univ Fribourg, Dept Multilingualism, CH-1700 Fribourg, Switzerland	University of Fribourg	Vanhove, J (corresponding author), Univ Fribourg, Dept Multilingualism, CH-1700 Fribourg, Switzerland.	jan.vanhove@unifr.ch	Vanhove, Jan/J-1146-2019	Vanhove, Jan/0000-0002-4607-4836				Abrahamsson N, 2009, LANG LEARN, V59, P249, DOI 10.1111/j.1467-9922.2009.00507.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Bialystok E, 1999, SEC LANG ACQ RES, P161; Bialystok E., 1999, BILING-LANG COGN, V2, P127, DOI DOI 10.1017/S1366728999000231; Bialystok E, 2002, STUDIES 2 LANGUAGE A, V24, P481, DOI DOI 10.1017/S0272263102003054; Birdsong D, 2001, J MEM LANG, V44, P235, DOI 10.1006/jmla.2000.2750; Birdsong D., 1999, 2 LANGUAGE ACQUISITI; Birdsong D, 2006, LANG LEARN, V56, P9, DOI 10.1111/j.1467-9922.2006.00353.x; Birdsong D, 2009, NEW HANDBOOK OF SECOND LANGUAGE ACQUISITION, 2ND EDITION, P401; BLALOCK HM, 1963, SOC FORCES, V42, P233, DOI 10.2307/2575696; Champely S., 2009, PWR BASIC FUNCTIONS; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COOK VJ, 1992, LANG LEARN, V42, P557, DOI 10.1111/j.1467-1770.1992.tb01044.x; DeKeyser R., 2006, AGE L2 ACQUISITION T, P49; DeKeyser R, 2010, APPL PSYCHOLINGUIST, V31, P413, DOI 10.1017/S0142716410000056; DeKeyser Robert M., 2000, STUD SECOND LANG ACQ, V22, P499, DOI 10.1017/S0272263100004022; Field A, 2013, DISCOVERING STAT USI; Firebaugh G, 2007, SOCIOL METHOD RES, V36, P200, DOI 10.1177/0049124107306663; Flege JE, 2006, J PHONETICS, V34, P153, DOI 10.1016/j.wocn.2005.05.001; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Flege JE, 1999, SEC LANG ACQ RES, P101; Fox J, 2002, ROBUST REGRESSION AP; Fugelsang JA, 2004, CAN J EXP PSYCHOL, V58, P86, DOI 10.1037/h0085799; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; GROSJEAN F, 1989, BRAIN LANG, V36, P3, DOI 10.1016/0093-934X(89)90048-5; Hakuta K, 2003, PSYCHOL SCI, V14, P31, DOI 10.1111/1467-9280.01415; Hyltenstam K., 2003, HDB 2 LANGUAGE ACQUI, P539, DOI DOI 10.1002/9780470756492.CH17; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; JOHNSON JS, 1992, LANG LEARN, V42, P217, DOI 10.1111/j.1467-1770.1992.tb00708.x; KOEHLER JJ, 1993, ORGAN BEHAV HUM DEC, V56, P28, DOI 10.1006/obhd.1993.1044; KRASHEN SD, 1979, TESOL QUART, V13, P573, DOI 10.2307/3586451; Kroll J.F., 2005, HDB BILINGUALISM PSY; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Long M. H., 2005, IRAL-INT REV APPL LI, V43, P287, DOI DOI 10.1515/IRAL.2005.43.4.287; Long M. H., 2007, PROBLEMS SLA; Mackey A., 2012, ROUTLEDGE HDB 2 LANG, P442, DOI DOI 10.1006/COGP.2001.0769; Marinova-Todd SH, 2000, TESOL QUART, V34, P9, DOI 10.2307/3588095; McDonald JL, 2000, APPL PSYCHOLINGUIST, V21, P395, DOI 10.1017/S0142716400003064; Munoz C, 2011, LANG TEACHING, V44, P1, DOI 10.1017/S0261444810000327; MYNATT CR, 1977, Q J EXP PSYCHOL, V29, P85, DOI 10.1080/00335557743000053; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NEWPORT EL, 1991, J PIAGET SY, P111; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; OLKIN I, 1995, PSYCHOL BULL, V118, P155, DOI 10.1037/0033-2909.118.1.155; PATKOWSKI MS, 1980, LANG LEARN, V30, P449, DOI 10.1111/j.1467-1770.1980.tb00328.x; Penfield W., 1959, SPEECH BRAIN MECH; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B, 2012, MASS SUPPORT FUNCTIO; Rothman J, 2008, LANG LINGUIST COMPAS, V2, P1063, DOI 10.1111/j.1749-818x.2008.00098.x; Ruben RJ, 1997, ACTA OTO-LARYNGOL, V117, P202, DOI 10.3109/00016489709117769; Schmidt FL, 1996, PSYCHOL METHODS, V1, P115, DOI 10.1037/1082-989X.1.2.115; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Singleton, 2005, IRAL-INT REV APPL LI, V43, P269, DOI DOI 10.1515/IRAL.2005.43.4.269; Singleton D., 2007, INTERLINGUISTICA, V17, P48; SNOW CE, 1978, CHILD DEV, V49, P1114, DOI 10.2307/1128751; SNOW CE, 1977, LANG SPEECH, V20, P357, DOI 10.1177/002383097702000407; Stevens G, 2004, PSYCHOL SCI, V15, P215, DOI 10.1111/j.0956-7976.2004.01503012.x; Stevens G, 1999, LANG SOC, V28, P555; Weisstein EW, 2012, DISCONTINUITY MATHWO; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; WHITE L, 1996, 2 LANGUAGE RES, V0012; Zuur Alain F., 2009, P1	74	39	40	8	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69172	10.1371/journal.pone.0069172	http://dx.doi.org/10.1371/journal.pone.0069172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	191SQ	23935947	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300026
J	Chowdhury, SP; Dietel, K; Randler, M; Schmid, M; Junge, H; Borriss, R; Hartmann, A; Grosch, R				Chowdhury, Soumitra Paul; Dietel, Kristin; Raendler, Manuela; Schmid, Michael; Junge, Helmut; Borriss, Rainer; Hartmann, Anton; Grosch, Rita			Effects of Bacillus amyloliquefaciens FZB42 on Lettuce Growth and Health under Pathogen Pressure and Its Impact on the Rhizosphere Bacterial Community	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; PLANT-GROWTH; FUNCTIONAL-CHARACTERIZATION; MULTIVARIATE ANALYSES; BIOCONTROL AGENT; GENE CLUSTERS; SUBTILIS; SOIL; ANTAGONISTS; RESISTANCE	The soil-borne pathogen Rhizoctonia solani is responsible for crop losses on a wide range of important crops worldwide. The lack of effective control strategies and the increasing demand for organically grown food has stimulated research on biological control. The aim of the present study was to evaluate the rhizosphere competence of the commercially available inoculant Bacillus amyloliquefaciens FZB42 on lettuce growth and health together with its impact on the indigenous rhizosphere bacterial community in field and pot experiments. Results of both experiments demonstrated that FZB42 is able to effectively colonize the rhizosphere (7.45 to 6.61 Log(10) CFU g(-1) root dry mass) within the growth period of lettuce in the field. The disease severity (DS) of bottom rot on lettuce was significantly reduced from severe symptoms with DS category 5 to slight symptom expression with DS category 3 on average through treatment of young plants with FZB42 before and after planting. The 16S rRNA gene based fingerprinting method terminal restriction fragment length polymorphism (T-RFLP) showed that the treatment with FZB42 did not have a major impact on the indigenous rhizosphere bacterial community. However, the bacterial community showed a clear temporal shift. The results also indicated that the pathogen R. solani AG1-IB affects the rhizosphere microbial community after inoculation. Thus, we revealed that the inoculant FZB42 could establish itself successfully in the rhizosphere without showing any durable effect on the rhizosphere bacterial community.	[Chowdhury, Soumitra Paul; Schmid, Michael; Hartmann, Anton] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Microbe Plant Interact, Neuherberg, Germany; [Dietel, Kristin; Raendler, Manuela; Junge, Helmut; Borriss, Rainer] ABiTEP GmbH, Berlin, Germany; [Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops, Grossbeeren, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Grosch, R (corresponding author), Leibniz Inst Vegetable & Ornamental Crops, Grossbeeren, Germany.	grosch@igzev.de	Schmid, Michael/D-7105-2013; Hartmann, Anton/AAN-8922-2020; Chowdhury, Soumitra Paul/AAA-5346-2020; Grosch, Rita/HHM-5490-2022; Hartmann, Anton/D-8070-2013; Borriss, Rainer/C-5026-2012	Chowdhury, Soumitra Paul/0000-0002-8576-8857; Borriss, Rainer/0000-0003-3726-1004; Grosch, Rita/0000-0002-7179-5715	Federal Ministry of Education and Research (BMBF) [0315654A, 0315654C]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work (part of the network "PATHCONTROL'') was funded by grants from Federal Ministry of Education and Research (BMBF) to Prof. Rainer Borriss (Grant 0315654A) and to Prof. Anton Hartmann (Grant 0315654C). No other external funding received. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesemoye AO, 2009, APPL MICROBIOL BIOT, V85, P1, DOI 10.1007/s00253-009-2196-0; Adesina MF, 2009, FEMS MICROBIOL ECOL, V69, P62, DOI 10.1111/j.1574-6941.2009.00685.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Correa OS, 2009, APPL SOIL ECOL, V41, P185, DOI 10.1016/j.apsoil.2008.10.007; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Davis R M, 1997, COMPENDIUM LETTUCE D, P15; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Gotz M, 2006, FEMS MICROBIOL ECOL, V56, P207, DOI 10.1111/j.1574-6941.2006.00093.x; Grosch R, 2005, CAN J MICROBIOL, V51, P345, DOI 10.1139/W05-002; Grosch R, 2004, EUR J PLANT PATHOL, V110, P53, DOI 10.1023/B:EJPP.0000010137.69498.10; Grosch R, 1999, Z PFLANZENK PFLANZEN, V106, P568; Grosch R, 2006, MYCOL RES, V110, P1464, DOI 10.1016/j.mycres.2006.09.014; Grosch R, 2012, PLANT SOIL, V361, P343, DOI 10.1007/s11104-012-1239-y; Guel A, 2008, SPAN J AGRIC RES, V6, P422, DOI 10.5424/sjar/2008063-335; Gutezeit B, 1993, GEMUSE, V29, P106; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hallmann J, 1999, SOIL BIOL BIOCHEM, V31, P551, DOI 10.1016/S0038-0717(98)00146-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kofoet A., 2001, Gemuse (Munchen), V37, P10; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee B, 2012, ANN BOT-LONDON, V110, P281, DOI 10.1093/aob/mcs055; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Martin FN, 2003, ANNU REV PHYTOPATHOL, V41, P325, DOI 10.1146/annurev.phyto.41.052002.095514; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Muller H, 2009, FEMS MICROBIOL ECOL, V67, P468, DOI 10.1111/j.1574-6941.2008.00635.x; Nihorimbere V, 2012, FEMS MICROBIOL ECOL, V79, P176, DOI 10.1111/j.1574-6941.2011.01208.x; Ongena M, 2005, APPL MICROBIOL BIOT, V67, P692, DOI 10.1007/s00253-004-1741-0; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Osborne CA, 2010, APPL ENVIRON MICROB, V76, P1471, DOI 10.1128/AEM.02072-09; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Scherwinski K, 2008, FEMS MICROBIOL ECOL, V64, P106, DOI 10.1111/j.1574-6941.2007.00421.x; Scholz R, 2011, J BACTERIOL, V193, P215, DOI 10.1128/JB.00784-10; Silo-Suh LA, 1998, CURR MICROBIOL, V37, P6; Tiago I, 2004, CURR MICROBIOL, V49, P407, DOI 10.1007/s00284-004-4353-0; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Yao A. V., 2006, Archives of Phytopathology and Plant Protection, V39, P323, DOI 10.1080/03235400600655347; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7	53	190	197	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68818	10.1371/journal.pone.0068818	http://dx.doi.org/10.1371/journal.pone.0068818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935892	Green Published, gold			2022-12-27	WOS:000325211000040
J	Fountzilas, G; Kotoula, V; Pectasides, D; Kouvatseas, G; Timotheadou, E; Bobos, M; Mavropoulou, X; Papadimitriou, C; Vrettou, E; Raptou, G; Koutras, A; Razis, E; Bafaloukos, D; Samantas, E; Pentheroudakis, G; Skarlos, DV				Fountzilas, George; Kotoula, Vassiliki; Pectasides, Dimitrios; Kouvatseas, George; Timotheadou, Eleni; Bobos, Mattheos; Mavropoulou, Xanthipi; Papadimitriou, Christos; Vrettou, Eleni; Raptou, Georgia; Koutras, Angelos; Razis, Evangelia; Bafaloukos, Dimitrios; Samantas, Epaminontas; Pentheroudakis, George; Skarlos, Dimosthenis V.			Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial	PLOS ONE			English	Article							EPOTHILONE-B ANALOG; MICROTUBULE-STABILIZING AGENTS; MESSENGER-RNA EXPRESSION; MISMATCH REPAIR PROTEINS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; CLINICAL-TRIAL; PROGESTERONE-RECEPTOR; PERIPHERAL NEUROPATHY; PLUS CAPECITABINE	To explore the activity and safety of two schedules of ixabepilone, as first line chemotherapy, in patients with metastatic breast cancer previously treated with adjuvant chemotherapy, a randomized non-comparative phase II study was conducted. From November 2008 until December 2010, 64 patients were treated with either ixabepilone 40 mg/m(2) every 3 weeks (Group A, 32 patients) or ixabepilone 20 mg/m(2) on days 1, 8 and 15 every 4 weeks (Group B, 32 patients). Overall response rate (the primary end point) was 47% in Group A and 50% in Group B. The most frequent severe adverse events were neutropenia (32% vs. 23%), metabolic disturbances (29% vs. 27%) and sensory neuropathy (12% vs. 27%). Two patients in Group A and 3 in Group B developed febrile neutropenia. After a median follow-up of 22.7 months, median progression-free survival (PFS) was 9 months in Group A and 12 months in Group B. Median survival was 26 months in Group A, whereas it was not reached in Group B. Multiple genetic and molecular markers were examined in tumor and peripheral blood DNA, but none of them was associated with ORR or drug toxicity. Favorable prognostic markers included: the T-variants of ABCB1 SNPs c.2677G/A/T, c.1236C/T and c.3435C/T, as well as high MAPT mRNA and Tau protein expression, which were all associated with the ER/PgR-positive phenotype; absence of TopoIIa; and, an interaction between low TUBB3 mRNA expression and Group B. Upon multivariate analysis, tumor ER-positivity was a favorable (p = 0.0092) and TopoIIa an unfavorable (p = 0.002) prognostic factor for PFS; PgR-positivity was favorable (p = 0.028) for survival. In conclusion, ixabepilone had a manageable safety profile in both the 3-weekly and weekly schedules. A number of markers identified in the present trial appear to deserve further evaluation for their prognostic and/or predictive value in larger multi-arm studies.	[Fountzilas, George; Timotheadou, Eleni] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece; [Kotoula, Vassiliki; Vrettou, Eleni; Raptou, Georgia] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Kouvatseas, George] Hlth Data Specialists Ltd, Athens, Greece; [Bobos, Mattheos] Aristotle Univ Thessaloniki, Sch Med, Mol Oncol Lab, Hellen Fdn Canc Res, GR-54006 Thessaloniki, Greece; [Mavropoulou, Xanthipi] Aristotle Univ Thessaloniki, Sch Med, AHEPA Hosp, Dept Radiol, GR-54006 Thessaloniki, Greece; [Papadimitriou, Christos] Univ Athens, Alexandra Hosp, Sch Med, Dept Clin Therapeut, Athens, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Univ Hosp, Div Oncol,Dept Med, GR-26110 Patras, Greece; [Razis, Evangelia] Hygeia Hosp, Dept Med Oncol 3, Athens, Greece; [Bafaloukos, Dimitrios] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Samantas, Epaminontas] Agii Anargiri Canc Hosp, Dept Med Oncol 3, Athens, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Skarlos, Dimosthenis V.] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece	Aristotle University of Thessaloniki; Papageorgiou Hospital; Aristotle University of Thessaloniki; Hippokration General Hospital; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Ahepa University Hospital; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; University of Patras; Hygeia Hospital; University Hospital Ioannina	Fountzilas, G (corresponding author), Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Hosp, Dept Med Oncol, GR-54006 Thessaloniki, Greece.	fountzil@auth.gr	Fountzilas, George/ABF-2139-2020; TIMOTHEADOU, ELENI/AAM-6301-2020; Bobos, Mattheos/L-5702-2019	Bobos, Mattheos/0000-0001-5662-9201; Fountzilas, George/0000-0001-8045-2186	Bristol-Myers Squibb Company; HeCOG research grant [HE BR08_IXA]	Bristol-Myers Squibb Company(Bristol-Myers Squibb); HeCOG research grant	This study was supported by an Investigator Sponsored Research Agreement with Bristol-Myers Squibb Company. Dr. Alessandra Aloe, MD, Oncology Medical Lead GMA EMEA, Bristol-Myers Squibb was involved in the design of the study and the revision of the manuscript before its submission to a scientific journal. Translational research was supported by a HeCOG research grant: HE BR08_IXA.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Altmann KH, 2003, MINI-REV MED CHEM, V3, P149, DOI 10.2174/1389557033405269; Altmann KH, 2000, BBA-REV CANCER, V1470, pM79, DOI 10.1016/S0304-419X(00)00009-3; Andreopoulou E, 2008, CLIN BREAST CANCER, V8, pS54, DOI 10.3816/CBC.2008.s.001; Baselga J, 2009, J CLIN ONCOL, V27, P526, DOI 10.1200/JCO.2007.14.2646; Batistatou A, 2004, IN VIVO, V18, P661; Bergmann TK, 2011, EUR J CLIN PHARMACOL, V67, P693, DOI 10.1007/s00228-011-1007-6; BOLLAG DM, 1995, CANCER RES, V55, P2325; Chien AJ, 2008, SEMIN ONCOL, V35, pS1, DOI 10.1053/j.seminoncol.2008.02.010; Cortes J, 2012, BREAST CANCER RES TR, V133, P821, DOI 10.1007/s10549-011-1875-6; Denduluri N, 2007, J CLIN ONCOL, V25, P3421, DOI 10.1200/JCO.2006.10.0784; Dickson N, 2006, J CLIN ONCOL S, V24, P2040; Egerton N, 2010, CANCER CHEMOTH PHARM, V66, P1005, DOI 10.1007/s00280-010-1467-x; Fedier A, 2001, INT J CANCER, V93, P571, DOI 10.1002/ijc.1356; Fountzilas G, 2009, BREAST CANCER RES TR, V115, P87, DOI 10.1007/s10549-008-0047-9; Fritz P, 2005, BREAST CANCER RES, V7, pR374, DOI 10.1186/bcr1012; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gifford G, 2004, CLIN CANCER RES, V10, P4420, DOI 10.1158/1078-0432.CCR-03-0732; Haldar S, 1997, CANCER RES, V57, P229; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Ibrahim Nuhad K, 2010, Cancer Manag Res, V2, P169; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kadra G, 2012, BREAST CANCER RES TR, V132, P1035, DOI 10.1007/s10549-011-1687-8; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Kanakkanthara A, 2012, MOL CANCER THER, V11, P393, DOI 10.1158/1535-7163.MCT-11-0614; Kolman Ada, 2005, Curr Opin Investig Drugs, V6, P616; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Lee FYF, 2001, CLIN CANCER RES, V7, P1429; Lee JJ, 2005, SEMIN ONCOL, V32, pS22, DOI 10.1053/j.seminoncol.2005.09.013; LONG BH, 1991, CANCER RES, V51, P5275; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Murata H, 2005, CANCER LETT, V223, P143, DOI 10.1016/j.canlet.2004.09.039; Murata H, 2002, ONCOGENE, V21, P5696, DOI 10.1038/sj.onc.1205683; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Paradiso A, 2005, ANN ONCOL, V16, P14, DOI 10.1093/annonc/mdi902; Pentheroudakis G, 2009, BREAST CANCER RES TR, V116, P131, DOI 10.1007/s10549-008-0144-9; Perez EA, 2007, J CLIN ONCOL, V25, P3407, DOI 10.1200/JCO.2006.09.3849; Perez EA, 2010, BREAST CANCER RES TR, V121, P261, DOI 10.1007/s10549-010-0824-0; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Pusztai L, 2007, ANN ONCOL, V18, P15, DOI 10.1093/annonc/mdm534; Pusztai L, 2009, J CLIN ONCOL, V27, P4287, DOI 10.1200/JCO.2008.21.6887; Rivera E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2573; Roche H, 2007, J CLIN ONCOL, V25, P3415, DOI 10.1200/JCO.2006.09.7535; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Rugo HS, 2012, J CLIN ONCOL S15S, V30, P1002; Rugo HS, 2009, ASCO M, V27, P1029; Sanchez-Navarro I, 2010, BIOTECHNIQUES, V48, P389, DOI 10.2144/000113388; Seidman AD, 1998, J CLIN ONCOL, V16, P3353, DOI 10.1200/JCO.1998.16.10.3353; Seve P, 2005, CLIN CANCER RES, V11, P5481, DOI 10.1158/1078-0432.CCR-05-0285; Shen KL, 2000, J SURG ONCOL, V74, P100, DOI 10.1002/1096-9098(200006)74:2<100::AID-JSO5>3.0.CO;2-O; Sissung TM, 2006, EUR J CANCER, V42, P2893, DOI 10.1016/j.ejca.2006.06.017; Smith JW, 2010, ASCO BREAST CANC S, V268; Smoter M, 2011, CANCER CHEMOTH PHARM, V68, P553, DOI 10.1007/s00280-011-1696-7; Sparano JA, 2010, J CLIN ONCOL, V28, P3256, DOI 10.1200/JCO.2009.24.4244; Spratlin J, 2007, CRIT REV ONCOL HEMAT, V61, P222, DOI 10.1016/j.critrevonc.2006.09.006; Thomas E, 2007, J CLIN ONCOL, V25, P3399, DOI 10.1200/JCO.2006.08.9102; Thomas ES, 2007, J CLIN ONCOL, V25, P5210, DOI 10.1200/JCO.2007.12.6557; Toppmeyer DL, 2010, AM J CLIN ONCOL-CANC, V33, P516, DOI 10.1097/COC.0b013e3181b9cd52; Vahdat LT, 2012, SUPPORT CARE CANCER, V20, P2661, DOI 10.1007/s00520-012-1384-0; Wartmann M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P123, DOI 10.2174/1568011023354489	61	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69256	10.1371/journal.pone.0069256	http://dx.doi.org/10.1371/journal.pone.0069256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935969	gold, Green Submitted, Green Published			2022-12-27	WOS:000325211000095
J	Grosche, A; Grosche, J; Tackenberg, M; Scheller, D; Gerstner, G; Gumprecht, A; Pannicke, T; Hirrlinger, PG; Wilhelmsson, U; Huttmann, K; Hartig, W; Steinhauser, C; Pekny, M; Reichenbach, A				Grosche, Antje; Grosche, Jens; Tackenberg, Mark; Scheller, Dorit; Gerstner, Gwendolyn; Gumprecht, Annett; Pannicke, Thomas; Hirrlinger, Petra G.; Wilhelmsson, Ulrika; Huettmann, Kerstin; Haertig, Wolfgang; Steinhaeuser, Christian; Pekny, Milos; Reichenbach, Andreas			Versatile and Simple Approach to Determine Astrocyte Territories in Mouse Neocortex and Hippocampus	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CEREBRAL-CORTEX; EXPRESSION; CELLS; BRAIN; COLOCALIZATION; HYPERTROPHY; POPULATIONS; EFFICACY; NEURONS	Background: Besides their neuronal support functions, astrocytes are active partners in neuronal information processing. The typical territorial structure of astrocytes (the volume of neuropil occupied by a single astrocyte) is pivotal for many aspects of glia-neuron interactions. Methods: Individual astrocyte territorial volumes are measured by Golgi impregnation, and astrocyte densities are determined by S100 beta immunolabeling. These data are compared with results from conventionally applied methods such as dye filling and determination of the density of astrocyte networks by biocytin loading. Finally, we implemented our new approach to investigate age-related changes in astrocyte territories in the cortex and hippocampus of 5- and 21-month-old mice. Results: The data obtained by our simplified approach based on Golgi impregnation were compared to previously published dye filling experiments, and yielded remarkably comparable results regarding astrocyte territorial volumes. Moreover, we found that almost all coupled astrocytes (as indicated by biocytin loading) were immunopositive for S100 beta. A first application of this new experimental approach gives insight in age-dependent changes in astrocyte territorial volumes. They increased with age, while cell densities remained stable. In 5-month-old mice, the overlap factor was close to 1, revealing little or no interdigitation of astrocyte territories. However, in 21-month-old mice, the overlap factor was more than 2, suggesting that processes of adjacent astrocytes interdigitate. Conclusion: Here we verified the usability of a simple, versatile method for assessing astrocyte territories and the overlap factor between adjacent territories. Second, we found that there is an age-related increase in territorial volumes of astrocytes that leads to loss of the strict organization in non-overlapping territories. Future studies should elucidate the physiological relevance of this adaptive reaction of astrocytes in the aging brain and the methods presented in this study might be a powerful tool to do so.	[Grosche, Antje; Grosche, Jens; Tackenberg, Mark; Scheller, Dorit; Gerstner, Gwendolyn; Gumprecht, Annett; Pannicke, Thomas; Hirrlinger, Petra G.; Haertig, Wolfgang; Reichenbach, Andreas] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Grosche, Antje] Univ Regensburg, Fac Med, Inst Human Genet, D-93053 Regensburg, Germany; [Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil,Sahlgrenska Acad, Gothenburg, Sweden; [Huettmann, Kerstin; Steinhaeuser, Christian] Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany	Leipzig University; University of Regensburg; University of Gothenburg; University of Bonn	Grosche, A (corresponding author), Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany.	antje.grosche@klinik.uni-regensburg.de	Reichenbach, Andreas/B-2510-2017; Grosche, Antje/N-1978-2014; Pannicke, Thomas/A-5078-2017	Grosche, Antje/0000-0003-0338-7530; Pannicke, Thomas/0000-0001-7435-9540; Wilhelmsson, Ulrika/0000-0003-3227-2687	Deutsche Forschungsgemeinschaft [FOR 748, GRK 1097, RE 849/16-1, SPP 1172, PA 615/2-1, SFB/TR3]; European Community [FP7-202167]; Swedish Medical Research Council [11548]; AFA Research Foundation; ALF Goteborg [11392]; Sten A. Olsson Foundation for Research and Culture, Soderberg Foundations; Hjarnfonden, Hagstromer's Foundation Millenium; Free Mason Foundation; Amlov's Foundation; NanoNet COST Action [BM1002]; EU FP 7 Program EduGlia [237956]; EU FP 7 Program TargetBraIn [279017]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AFA Research Foundation; ALF Goteborg; Sten A. Olsson Foundation for Research and Culture, Soderberg Foundations; Hjarnfonden, Hagstromer's Foundation Millenium; Free Mason Foundation; Amlov's Foundation; NanoNet COST Action(European Cooperation in Science and Technology (COST)); EU FP 7 Program EduGlia; EU FP 7 Program TargetBraIn	The work was supported by Deutsche Forschungsgemeinschaft (FOR 748 to AG and AR, GRK 1097 and RE 849/16-1 to AR, SPP 1172 to AR and CS, PA 615/2-1 to TP. SFB/TR3 to CS), the European Community (FP7-202167 NeuroGlia to CS), the Swedish Medical Research Council (project 11548), AFA Research Foundation, ALF Goteborg (project 11392), Sten A. Olsson Foundation for Research and Culture, Soderberg Foundations, Hjarnfonden, Hagstromer's Foundation Millenium, the Free Mason Foundation, Amlov's Foundation, NanoNet COST Action (BM1002), the EU FP 7 Program EduGlia (237956 to A. R. and M. P.) and the EU FP 7 Program TargetBraIn (279017 to M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta F, 1998, MICROSC RES TECHNIQ, V43, P29, DOI 10.1002/(SICI)1097-0029(19981001)43:1<29::AID-JEMT5>3.0.CO;2-H; BERCIANO MT, 1995, ANAT RECORD, V243, P129, DOI 10.1002/ar.1092430115; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; BRAAK H, 1985, PROG NEUROBIOL, V25, P93, DOI 10.1016/0301-0082(85)90001-2; Brauch RA, 2006, J AFFECT DISORDERS, V91, P87, DOI 10.1016/j.jad.2005.08.015; BUBENAITE J., 1929, ZEITSCHR WISS MIKROSK, V46, P359; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Catalani A, 2002, MECH AGEING DEV, V123, P481, DOI 10.1016/S0047-6374(01)00356-6; David JP, 1997, NEUROSCI LETT, V235, P53, DOI 10.1016/S0304-3940(97)00708-8; Degen J, 2012, FASEB J, V26, P4576, DOI 10.1096/fj.12-207183; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Hartig W, 1997, BRAIN RES PROTOC, V2, P35, DOI 10.1016/S1385-299X(97)00026-3; Heinemann U, 2000, EPILEPSIA, V41, pS185, DOI 10.1111/j.1528-1157.2000.tb01579.x; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kimelberg HK, 2007, NEURON GLIA BIOL, V3, P181, DOI 10.1017/S1740925X08000094; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Liddell JR, 2006, J NEUROSCI RES, V84, P578, DOI 10.1002/jnr.20957; Liddell JR, 2010, GLIA, V58, P1500, DOI 10.1002/glia.21024; LINDSEY JD, 1979, J GERONTOL, V34, P661, DOI 10.1093/geronj/34.5.661; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Matthias K, 2003, J NEUROSCI, V23, P1750; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MATUS A, 1975, NATURE, V258, P746, DOI 10.1038/258746a0; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Nilsson M, 2007, J REHABIL MED, V39, P345, DOI 10.2340/16501977-0084; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Reichenbach A, 2008, ASTROCYTES PATHO PHY, P245; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; Schipke CG, 2008, CEREB CORTEX, V18, P2450, DOI 10.1093/cercor/bhn009; Schroder W, 2000, EPILEPSIA, V41, pS181, DOI 10.1111/j.1528-1157.2000.tb01578.x; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; UNGER JW, 1992, ACTA NEUROPATHOL, V83, P636, DOI 10.1007/BF00299414; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Wallraff A, 2004, GLIA, V48, P36, DOI 10.1002/glia.20040; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wolff J R, 1970, Triangle, V9, P153; Wolff JR, 1976, HDB ELECTROENCEPHA A, V2A, P26; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	66	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69143	10.1371/journal.pone.0069143	http://dx.doi.org/10.1371/journal.pone.0069143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935940	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000081
J	Hao, HJ; Hui, WJ; Liu, P; Lv, QY; Zeng, XT; Jiang, H; Wang, YZ; Zheng, X; Zheng, YL; Li, JC; Zhou, XY; Jiang, YQ				Hao, Huaijie; Hui, Wenjia; Liu, Peng; Lv, Qingyu; Zeng, Xiaotao; Jiang, Hua; Wang, Yanzi; Zheng, Xin; Zheng, Yuling; Li, Jianchun; Zhou, Xuyu; Jiang, Yongqiang			Effect of Licochalcone A on Growth and Properties of Streptococcus suis	PLOS ONE			English	Article							THIOL-ACTIVATED HEMOLYSIN; BIOFILM FORMATION; SUILYSIN; RESISTANCE; MECHANISM; VIRULENCE; AGENT	Streptococcus suis (S. suis) is an important emerging worldwide pig pathogen and zoonotic agent with rapid evolution of virulence and drug resistance. In this study, we wanted to investigate the effect of licochalcone A on growth and properties of Streptococcus suis. The antimicrobial activity of licochalcone A was tested by growth inhibition assay and the minimal inhibitory concentrations (MICs) also were determined. The effect of licochalcone A on S. suis biofilm formation was characterized by crystal violet staining. The effect of licochalcone A on suilysin secretion was evaluated by titration of hemolytic activity. To understand the antimicrobial effect, gene expression profile of S. suis treated by licochalcone A was analyzed by DNA microarray. Our results demonstrated that licochalcone A showed antimicrobial activity on S. suis with MICs of 4 mu g/ml for S. suis serotype 2 strains and 8 mu g/ml for S. suis serotype 7 strains. Biofilm formation was inhibited by 30-40% in the presence of licochalcone A (3 mu g/ml) and suilysin secretion was also significantly inhibited in the presence of licochalcone A (1.5 mu g/ml). The gene expression profile of S. suis in the presence of licochalcone A showed that 132 genes were differentially regulated, and we analyzed the regulated genes in the aspect of the bacterial cell cycle control. Among the deregulated genes, the genes responsible for the mass doubling was increased expression, but the genes responsible for DNA replication and cell division were inhibited the expression. So, we think the regulation of the cell cycle genes might provide a mechanistic understanding of licochalcone A mediated antimicrobial effect against S. suis.	[Hao, Huaijie; Hui, Wenjia; Liu, Peng; Lv, Qingyu; Zeng, Xiaotao; Jiang, Hua; Wang, Yanzi; Zheng, Xin; Zheng, Yuling; Jiang, Yongqiang] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Hao, Huaijie; Zhou, Xuyu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Hui, Wenjia; Li, Jianchun] Shenyang Pharmaceut Univ, Dept Tradit Chinese Med Pharmacol, Shenyang, Peoples R China; [Wang, Yanzi] Jiangsu Prov Xuzhou Pharmaceut Vocat Coll, Dept Pharm, Xuzhou, Peoples R China; [Zheng, Xin] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shenyang Pharmaceutical University; Shenyang Pharmaceutical University	Li, JC (corresponding author), Shenyang Pharmaceut Univ, Dept Tradit Chinese Med Pharmacol, Shenyang, Peoples R China.	lijianchun0317@sina.com.cn; zhouxy@im.ac.cn; jiangyq@nic.bmi.ac.cn	Zhou, Xuyu/L-7422-2019; Hao, Huaijie/D-3861-2017; Liu, Peng/V-9305-2019	Zhou, Xuyu/0000-0002-6626-0898; Hao, Huaijie/0000-0002-1928-4205; 	National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation of China [81171528]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2012CB518804) and the National Natural Science Foundation of China (81171528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Numani D, 2003, CLIN EXP IMMUNOL, V133, P67, DOI 10.1046/j.1365-2249.2003.02189.x; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Bonifait L, 2008, APPL ENVIRON MICROB, V74, P4969, DOI 10.1128/AEM.00558-08; CHEN M, 1994, ANTIMICROB AGENTS CH, V38, P1470, DOI 10.1128/AAC.38.7.1470; Coenye T, 2007, RES MICROBIOL, V158, P386, DOI 10.1016/j.resmic.2007.02.001; Cui YM, 2008, Z NATURFORSCH C, V63, P361; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Funakoshi-Tago M, 2009, MOL PHARMACOL, V76, P745, DOI 10.1124/mol.109.057448; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Grenier D, 2009, VET J, V179, P292, DOI 10.1016/j.tvjl.2007.09.005; Haraguchi H, 1998, PHYTOCHEMISTRY, V48, P125, DOI 10.1016/S0031-9422(97)01105-9; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACOBS AAC, 1995, VET REC, V137, P295, DOI 10.1136/vr.137.12.295; JACOBS AAC, 1994, INFECT IMMUN, V62, P1742, DOI 10.1128/IAI.62.5.1742-1748.1994; King SJ, 2001, INFECT IMMUN, V69, P7572, DOI 10.1128/IAI.69.12.7572-7582.2001; Li W, 2010, MICROBIOL IMMUNOL, V54, P380, DOI 10.1111/j.1348-0421.2010.00228.x; Lun SH, 2005, VET MICROBIOL, V105, P169, DOI 10.1016/j.vetmic.2004.10.017; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Messier C, 2011, MYCOSES, V54, pE801, DOI 10.1111/j.1439-0507.2011.02028.x; Norton PM, 1999, FEMS IMMUNOL MED MIC, V26, P25, DOI 10.1111/j.1574-695X.1999.tb01369.x; Qiu J, 2010, LETT APPL MICROBIOL, V50, P223, DOI 10.1111/j.1472-765X.2009.02783.x; Qiu JZ, 2010, FEMS MICROBIOL LETT, V307, P135, DOI 10.1111/j.1574-6968.2010.01973.x; ROBERTSON ID, 1989, EPIDEMIOL INFECT, V103, P157, DOI 10.1017/S0950268800030454; Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854; Tsukiyama RI, 2002, ANTIMICROB AGENTS CH, V46, P1226, DOI 10.1128/AAC.46.5.1226-1230.2002; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Wei Y, 2011, ANN MICROBIOL, V61, P505, DOI 10.1007/s13213-010-0165-6; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Zeng XT, 2011, VECTOR-BORNE ZOONOT, V11, P215, DOI 10.1089/vbz.2009.0225	31	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67728	10.1371/journal.pone.0067728	http://dx.doi.org/10.1371/journal.pone.0067728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935843	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000017
J	Kolawole, DO; Adeyanju, A; Schaumburg, F; Akinyoola, AL; Lawal, OO; Amusa, YB; Kock, R; Becker, K				Kolawole, Deboye O.; Adeyanju, Adeniran; Schaumburg, Frieder; Akinyoola, Akinyele L.; Lawal, Oladejo O.; Amusa, Yemisi B.; Koeck, Robin; Becker, Karsten			Characterization of Colonizing Staphylococcus aureus Isolated from Surgical Wards' Patients in a Nigerian University Hospital	PLOS ONE			English	Article							METHICILLIN-RESISTANT; METICILLIN-RESISTANT; ENTEROTOXIN GENES; VIRULENCE FACTORS; TOXIN GENES; PREVALENCE; STRAINS; MRSA; IDENTIFICATION; EPIDEMIOLOGY	In contrast to developed countries, only limited data on the prevalence, resistance and clonal structure of Staphylococcus aureus are available for African countries. Since S. aureus carriage is a risk factor for postoperative wound infection, patients who had been hospitalized in surgical wards in a Nigerian University Teaching Hospital were screened for S. aureus carriage. All S. aureus isolates were genotyped (spa, agr) and assigned to multilocus sequence types (MLST). Species affiliation, methicillin-resistance, and the possession of pyrogenic toxin superantigens (PTSAg), exfoliative toxins (ETs) and Panton-Valentine Leukocidin (PVL) were analyzed. Of 192 patients screened, the S. aureus carrier rate was 31.8 % (n = 61). Of these isolates, 7 (11.5%) were methicillin-resistant (MRSA). The isolates comprised 24 spa types. The most frequent spa types were t064, t084, t311, and t1931, while the most prevalent MLST clonal complexes were CC5 and CC15. The most frequent PTSAg genes detected were seg/sei (41.0%) followed by seb (29.5%), sea (19.7%), seh (14.7%) and sec (11.5). The difference between the possession of classical and newly described PTSAg genes was not significant (63.9% versus 59.0% respectively; P = 0.602). PVL encoding genes were found in 39.3% isolates. All MRSA isolates were PVL negative, SCCmec types I and VI in MLST CC 5 and CC 30, respectively. Typing of the accessory gene regulator (agr) showed the following distribution: agr group 1 (n = 20), group II (n = 17), group III (n = 14) and group IV (n = 10). Compared to European data, enterotoxin gene seb and PVL-encoding genes were more prevalent in Nigerian methicillin-susceptible S. aureus isolates, which may therefore act as potential reservoir for PVL and PTSAg genes.	[Kolawole, Deboye O.; Adeyanju, Adeniran] Obafemi Awolowo Univ, Dept Microbiol, Ife, Nigeria; [Lawal, Oladejo O.; Amusa, Yemisi B.] Obafemi Awolowo Univ, Dept Surg, Ife, Nigeria; [Akinyoola, Akinyele L.] Obafemi Awolowo Univ, Dept Orthoped Surg & Traumatol, Ife, Nigeria; [Adeyanju, Adeniran] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria; [Koeck, Robin] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Schaumburg, Frieder; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	Obafemi Awolowo University; Obafemi Awolowo University; Obafemi Awolowo University; Obafemi Awolowo University; University of Munster; University of Munster	Adeyanju, A (corresponding author), Obafemi Awolowo Univ, Dept Microbiol, Ife, Nigeria.	niran.adeyanju@gmail.com	Becker, Karsten/O-2302-2018; Schaumburg, Frieder/E-4464-2016; Köck, Robin/AAC-1552-2019	Becker, Karsten/0000-0002-6391-1341; Amusa, Yemisi/0000-0002-8812-5398	Obafemi Awolowo University/Carnegie Corporation of New York (OAU/CCNY); Deutsche Forschungsgemeinschaft - Initiative on African-German Research Projects in Infectious Diseases [PAK296]	Obafemi Awolowo University/Carnegie Corporation of New York (OAU/CCNY); Deutsche Forschungsgemeinschaft - Initiative on African-German Research Projects in Infectious Diseases(German Research Foundation (DFG))	This study was supported by a grant from the Obafemi Awolowo University/Carnegie Corporation of New York (OAU/CCNY) partnership and by the Deutsche Forschungsgemeinschaft - Initiative on African-German Research Projects in Infectious Diseases, #PAK296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEKEYE JD, 1984, J HYG-CAMBRIDGE, V93, P531, DOI 10.1017/S0022172400065104; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Antri K, 2011, CLIN MICROBIOL INFEC, V17, P526, DOI 10.1111/j.1469-0691.2010.03273.x; Aydin A, 2011, INT J FOOD MICROBIOL, V148, P99, DOI 10.1016/j.ijfoodmicro.2011.05.007; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; Becker K, 2006, J CLIN MICROBIOL, V44, P229, DOI 10.1128/JCM.44.1.229-231.2006; Becker K, 2004, MOL NUTR FOOD RES, V48, P488, DOI 10.1002/mnfr.200400044; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Becker K., 2011, MANUAL CLIN MICROBIO; Blaiotta G, 2006, APPL ENVIRON MICROB, V72, P6117, DOI 10.1128/AEM.00773-06; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P160, DOI 10.1111/j.1469-0691.2010.03219.x; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Davis SL, 2007, J CLIN MICROBIOL, V45, P1705, DOI 10.1128/JCM.02311-06; De Sousa MA, 2000, MICROB DRUG RESIST, V6, P133, DOI 10.1089/107662900419447; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; El-Huneidi W, 2006, DIAGN MICR INFEC DIS, V56, P127, DOI 10.1016/j.diagmicrobio.2006.04.002; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fournier Benedicte, 2008, P131; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Heysell SK, 2011, SAMJ S AFR MED J, V101, P332, DOI 10.7196/SAMJ.4462; Hu DL, 2008, J MED MICROBIOL, V57, P1106, DOI 10.1099/jmm.0.2008/002790-0; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kriegeskorte A, 2012, EMERG INFECT DIS, V18, P1016, DOI 10.3201/eid1806.110910; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mellmann A, 2008, J CLIN MICROBIOL, V46, P2805, DOI 10.1128/JCM.00071-08; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; MIETHKE T, 1993, IMMUNOBIOLOGY, V189, P270, DOI 10.1016/S0171-2985(11)80362-1; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Peck KR, 2009, J KOREAN MED SCI, V24, P585, DOI 10.3346/jkms.2009.24.4.585; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shittu A, 2006, WOUNDS, V18, P77; Shittu A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-286; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; SU YC, 1995, APPL ENVIRON MICROB, V61, P1438, DOI 10.1128/AEM.61.4.1438-1443.1995; Torres-Sangiao E, 2012, J MED MICROBIOL, V61, P305, DOI 10.1099/jmm.0.036889-0; Truong H, 2011, SAMJ S AFR MED J, V101, P413; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009	47	29	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68721	10.1371/journal.pone.0068721	http://dx.doi.org/10.1371/journal.pone.0068721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935883	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000034
J	McNeill, A; Wu, RM; Tzen, KY; Aguiar, PC; Arbelo, JM; Barone, P; Bhatia, K; Barsottini, O; Bonifati, V; Bostantjopoulou, S; Bressan, R; Cossu, G; Cortelli, P; Felicio, A; Ferraz, HB; Herrera, J; Houlden, H; Hoexter, M; Isla, C; Lees, A; Lorenzo-Betancor, O; Mencacci, NE; Pastor, P; Pappata, S; Pellecchia, MT; Silveria-Moriyama, L; Varrone, A; Foltynie, T; Schapira, AHV				McNeill, Alisdair; Wu, Ruey-Meei; Tzen, Kai-Yuan; Aguiar, Patricia C.; Arbelo, Jose M.; Barone, Paolo; Bhatia, Kailash; Barsottini, Orlando; Bonifati, Vincenzo; Bostantjopoulou, Sevasti; Bressan, Rodrigo; Cossu, Giovanni; Cortelli, Pietro; Felicio, Andre; Ferraz, Henrique B.; Herrera, Joanna; Houlden, Henry; Hoexter, Marcelo; Isla, Concepcion; Lees, Andrew; Lorenzo-Betancor, Oswaldo; Mencacci, Niccolo E.; Pastor, Pau; Pappata, Sabina; Pellecchia, Maria Teresa; Silveria-Moriyama, Laura; Varrone, Andrea; Foltynie, Tom; Schapira, Anthony H. V.			Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis	PLOS ONE			English	Article							ALPHA-SYNUCLEIN GENE; GLUCOCEREBROSIDASE MUTATION; NIGROSTRIATAL DYSFUNCTION; PET; CARRIERS; LRRK2; I-123-FP-CIT; DUPLICATION; TRANSPORTER; PROGRESSION	Objectives: To compare the dopaminergic neuronal imaging features of different subtypes of genetic Parkinson's Disease. Methods: A retrospective study of genetic Parkinson's diseases cases in which DaTSCAN (123I-FP-CIT) had been performed. Specific non-displaceable binding was calculated for bilateral caudate and putamen for each case. The right: left asymmetry index and striatal asymmetry index was calculated. Results: Scans were available from 37 cases of monogenetic Parkinson's disease (7 glucocerebrosidase (GBA) mutations, 8 alpha-synuclein, 3 LRRK2, 7 PINK1, 12 Parkin). The asymmetry of radioligand uptake for Parkinson's disease with GBA or LRRK2 mutations was greater than that for Parkinson's disease with alpha synuclein, PINK1 or Parkin mutations. Conclusions: The asymmetry of radioligand uptake in Parkinsons disease associated with GBA or LRRK2 mutations suggests that interactions with additional genetic or environmental factors may be associated with dopaminergic neuronal loss.	[McNeill, Alisdair; Schapira, Anthony H. V.] UCL, Dept Clin Neurosci, Inst Neurol, London, England; [McNeill, Alisdair] Birmingham Womens Hosp, Reg Genet Unit, Dept Clin Genet, Birmingham, W Midlands, England; [Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei, Taiwan; [Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Coll Med, Dept Nucl Med, Taipei, Taiwan; [Aguiar, Patricia C.; Bressan, Rodrigo; Felicio, Andre; Hoexter, Marcelo] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Arbelo, Jose M.] Hosp Univ Insular Gran Canaria, Dept Neurol, Parkinsons & Movement Disorders Unit, Las Palmas Gran Canaria, Spain; [Barone, Paolo; Pellecchia, Maria Teresa] Univ Salerno, Ctr Neurodegenerat Dis, Salerno, Fisciano Provin, Italy; [Bhatia, Kailash; Lees, Andrew; Silveria-Moriyama, Laura; Foltynie, Tom] UCL, Inst Neurol, Sobell Dept Motor Sci, London, England; [Barsottini, Orlando] Univ Fed Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Bostantjopoulou, Sevasti] Aristotle Univ Thessaloniki, G Papanikolaou Hosp, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Cossu, Giovanni] Gen Hosp S Michele AOB G Brotzu, Neurol Serv, Cagliari, Italy; [Cossu, Giovanni] Gen Hosp S Michele AOB G Brotzu, Stroke Unit, Cagliari, Italy; [Cortelli, Pietro] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Ferraz, Henrique B.] Univ Fed Sao Paulo UNIFESP, EPM, Div Movement Disorders, Sao Paulo, Brazil; [Houlden, Henry; Mencacci, Niccolo E.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Herrera, Joanna; Isla, Concepcion; Lorenzo-Betancor, Oswaldo; Pastor, Pau] Univ Navarra, Div Neurosci, Ctr Appl Med Res, Neurogenet Lab, E-31080 Pamplona, Spain; [Pappata, Sabina; Varrone, Andrea] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Varrone, Andrea] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	University of London; University College London; Birmingham Women's Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Hospital Israelita Albert Einstein; University of Salerno; University of London; University College London; Universidade Federal de Sao Paulo (UNIFESP); Erasmus University Rotterdam; Erasmus MC; Aristotle University of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki; University of Bologna; Universidade Federal de Sao Paulo (UNIFESP); University of London; University College London; University of Navarra; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Karolinska Institutet	Schapira, AHV (corresponding author), UCL, Dept Clin Neurosci, Inst Neurol, London, England.	a.schapira@ucl.ac.uk	Barsottini, O/E-9117-2010; Pastor, Pau/C-9834-2009; Bressan, Rodrigo A/E-9178-2010; Barone, Paolo/AAC-4886-2022; Lorenzo-Betancor, Oswaldo/J-2753-2019; de Carvalho Aguiar, Patricia/E-8520-2010; Pellecchia, Maria Teresa/AHH-4069-2022; Schapira, Anthony H V/A-1245-2010; Lees, Andrew J/A-6605-2009; Mencacci, Niccolo/N-8569-2013; Hoexter, Marcelo Q/D-7620-2013; cossu, giovanni/AAC-6331-2022; Cortelli, Pietro/K-6063-2016; Moriyama, Laura Silveira/G-4592-2014; Houlden, Henry J/C-1532-2008; Silveira-Moriyama, Laura/G-4592-2014	Barsottini, O/0000-0002-0107-0831; Pastor, Pau/0000-0002-7493-8777; Bressan, Rodrigo A/0000-0002-0868-4449; Lorenzo-Betancor, Oswaldo/0000-0002-5607-8363; de Carvalho Aguiar, Patricia/0000-0003-2957-9573; Schapira, Anthony H V/0000-0002-3018-3966; Lees, Andrew J/0000-0002-2476-4385; Mencacci, Niccolo/0000-0003-3383-9665; Hoexter, Marcelo Q/0000-0002-9302-4380; Moriyama, Laura Silveira/0000-0003-2184-626X; Houlden, Henry J/0000-0002-2866-7777; Cortelli, Pietro/0000-0002-3633-8818; Bhatia, Kailash/0000-0001-8185-286X; PELLECCHIA, MARIA TERESA/0000-0002-6217-313X; TZEN, KAI-YUAN/0000-0002-5657-8579; Silveira-Moriyama, Laura/0000-0002-8267-0977; Wu, Ruey-Meei/0000-0002-4947-5467	Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; United Kingdom Medical Research Council [G1001983]; Wellcome Trust; Parkinson's Disease UK; Kattan Trust; Medical Research Council [G1001983, MR/J004758/1, G108/638, G0802760, G1001253, MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [K-0901, G-1104] Funding Source: researchfish; MRC [MR/J004758/1, G1001983, G1001253, G108/638, G0802760, MC_G1000735] Funding Source: UKRI	Wellcome Trust/MRC Joint Call in Neurodegeneration award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Parkinson's Disease UK; Kattan Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee. AM was supported by a United Kingdom Medical Research Council Research Training Fellowship and Centenary Award (G1001983). AHVS is supported by the Wellcome Trust, Parkinson's Disease UK and the Kattan Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025622; Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Ahn TB, 2008, NEUROLOGY, V70, P43, DOI 10.1212/01.wnl.0000271080.53272.c7; Barsottini OGP, 2009, ARQ NEURO-PSIQUIAT, V67, P7, DOI 10.1590/S0004-282X2009000100003; Bohnen NI, 2012, NEUROLOGY; Bostantjopoulou S, 2008, HELL J NUCL MED, V11, P157; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Isaias IU, 2006, MOVEMENT DISORD, V21, P1144, DOI 10.1002/mds.20909; Kagi G, 2010, MOVEMENT DISORD, V25, P1279, DOI 10.1002/mds.22897; Kessler KR, 2005, J NEURAL TRANSM, V112, P1345, DOI 10.1007/s00702-005-0281-9; Khan NL, 2002, BRAIN, V125, P2248, DOI 10.1093/brain/awf237; Kitada T, 2012, CURR TREAT OPTION NE, V14, P230, DOI 10.1007/s11940-012-0175-8; Kono S, 2007, J NEUROL SCI, V252, P181, DOI 10.1016/j.jns.2006.10.019; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McNeill A, 2012, J NEUROL NEUROSUR PS, V83, P853, DOI 10.1136/jnnp-2012-302402; Nishioka K, 2009, MOVEMENT DISORD, V24, P1811, DOI 10.1002/mds.22682; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pavese N, 2009, MOVEMENT DISORD, V24, P2260, DOI 10.1002/mds.22817; Plotkin M, 2005, J NEURAL TRANSM, V112, P677, DOI 10.1007/s00702-004-0208-x; Ribeiro MJ, 2009, J NUCL MED, V50, P1244, DOI 10.2967/jnumed.109.063529; Samaranch L, 2010, BRAIN, V133, P1128, DOI 10.1093/brain/awq051; Samii A, 1999, NEUROLOGY, V53, P2097, DOI 10.1212/WNL.53.9.2097; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Sunwoo MK, 2011, J CLIN NEUROL, V7, P99, DOI 10.3988/jcn.2011.7.2.99; Varrone A, 2004, NEUROLOGY, V63, P2097, DOI 10.1212/01.WNL.0000145765.19094.94; Warner TT, 1998, J NEUROL NEUROSUR PS, V65, P378, DOI 10.1136/jnnp.65.3.378; Weng YH, 2007, J NEUROL, V254, P1347, DOI 10.1007/s00415-007-0534-7	35	49	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69190	10.1371/journal.pone.0069190	http://dx.doi.org/10.1371/journal.pone.0069190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935950	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000086
J	Balkenius, A; Dacke, M				Balkenius, Anna; Dacke, Marie			Learning of Multi-Modal Stimuli in Hawkmoths	PLOS ONE			English	Article							MANDUCA-SEXTA; MACROGLOSSUM-STELLATARUM; NOCTURNAL HAWKMOTHS; COLOR PREFERENCES; FEEDING-BEHAVIOR; OLFACTORY CUES; SYNERGY; FLOWERS; MOTH	The hawkmoth, Manduca sexta, uses both colour and odour to find flowers when foraging for nectar. In the present study we investigated how vision and olfaction interact during learning. Manduca sexta were equally attracted to a scented blue coloured feeding target (multimodal stimulus) as to one that does not carry any scent (unimodal stimulus; visual) or to an invisible scented target (unimodal stimulus; odour). This naive attraction to multimodal as well as to unimodal stimuli could be manipulated through training. Moths trained to feed from a blue, scented multimodal feeding target will, when tested in a set-up containing all three feeding targets, select the multimodal target as well as the scented, unimodal target, but ignore the visual target. Interestingly, moths trained to feed from a blue, unimodal visual feeding target will select the visual target as well as the scented, multimodal target, but ignore the unimodal odour target. Our results indicate that a multimodal target is perceived as two separate modalities, colour and odour, rather than as a unique fused target. These findings differ from earlier studies of desert ants that perceive combined visual and odour signals as a unique fused stimulus following learning trials.	[Balkenius, Anna] Swedish Univ Agr Sci, Dept Chem Ecol, Alnarp, Sweden; [Dacke, Marie] Lund Univ, Dept Biol, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Balkenius, A (corresponding author), Swedish Univ Agr Sci, Dept Chem Ecol, Alnarp, Sweden.	anna.balkenius@slu.se			Swedish Research Council FORMAS [2008-506]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was funded by a grant (2008-506) to AB from the Swedish Research Council FORMAS (www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; Balkenius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032133; Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Balkenius A, 2010, J EXP BIOL, V213, P3257, DOI 10.1242/jeb.045161; Balkenius A, 2009, J EXP BIOL, V212, P535, DOI 10.1242/jeb.021220; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Brantjes N. B. M., 1978, The pollination of flowers by insects, P13; Chow DM, 2011, J NEUROSCI, V31, P15035, DOI 10.1523/JNEUROSCI.1736-11.2011; CUTLER DE, 1995, J EXP BIOL, V198, P1909; Gingras G, 2009, J NEUROSCI, V29, P4897, DOI 10.1523/JNEUROSCI.4120-08.2009; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Goyret J, 2009, P ROY SOC B-BIOL SCI, V276, P2739, DOI 10.1098/rspb.2009.0456; Kelber A, 1996, J EXP BIOL, V199, P1127; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; Pfaff Michael, 2003, Entomologische Zeitschrift, V113, P360; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Raguso RA, 2007, J INSECT PHYSIOL, V53, P923, DOI 10.1016/j.jinsphys.2007.03.007; Raguso Robert A., 1999, Plant Species Biology, V14, P95, DOI 10.1046/j.1442-1984.1999.00014.x; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Steck K, 2011, J EXP BIOL, V214, P1307, DOI 10.1242/jeb.053579; Theobald JC, 2010, P ROY SOC B-BIOL SCI, V277, P853, DOI 10.1098/rspb.2009.1677	23	7	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71137	10.1371/journal.pone.0071137	http://dx.doi.org/10.1371/journal.pone.0071137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923057	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700228
J	Wang, QC; Liu, XY; Zhou, JC; Huang, YS; Zhang, SJ; Shen, JG; Loera, S; Yuan, XM; Chen, WJ; Jin, M; Shibata, S; Liu, YB; Chu, PG; Wang, LB; Yen, Y				Wang, Qinchuan; Liu, Xiyong; Zhou, Jichun; Huang, Yasheng; Zhang, Shengjie; Shen, Jianguo; Loera, Sofia; Yuan, Xiaoming; Chen, Wenjun; Jin, Mei; Shibata, Stephen; Liu, Yingbin; Chu, Peiguo; Wang, Linbo; Yen, Yun			Ribonucleotide Reductase Large Subunit M1 Predicts Poor Survival Due to Modulation of Proliferative and Invasive Ability of Gastric Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; M2 SUBUNIT; IN-VITRO; GEMCITABINE; OVEREXPRESSION; CHEMOTHERAPY; PTEN; GENES; CELLS; RRM1	Objectives: We aimed to investigate the prognostic value of RRM1 in GC patients. Methods: A total of assessable 389 GC patients with clinicopathological and survival information were enrolled from City of Hope (COH, n = 67) and Zhejiang University (ZJU, n = 322). RRM1 protein expression was determined by immunohistochemistry on FFPE tissue samples. Kaplan-Meier and Cox analyses were used to measure survival. Ras/Raf activity and invasion assays were used to evaluate the role of RRM1 in GC cell lines. Results: In vitro experiments demonstrated RRM1 activated Ras/Raf/MAPK signal transduction and promoted GC cell proliferation. Meanwhile, RRM1 expression was significantly associated with lymph node involvement, tumor size, Ki67 expression, histological subtype and histological grade in the GC tissue samples (p<0.05). Kaplan-Meier analysis illustrated that high RRM1 expression predicted poor survival in GC patients in the COH and ZJU cohorts (log-rank p<0.01). In multivariate Cox analysis, the hazard ratios of RRM1 for overall survival were 2.55 (95% CI 1.27-5.15) and 1.51 (95% CI 1.07-2.13) in the COH and ZJU sets, respectively. In particular, RRM1 specifically predicted the outcome of advanced GCs with poor differentiation and high proliferative ability. Furthermore, inhibition of RRM1 by siRNA significantly reduced the dNTP pool, Ras/Raf and MMP-9 activities and the levels of p-MEK, p-ERK and NF-kappa B, resulting in growth retardation and reduced invasion in AGS and NCI-N87 cells. Conclusions: RRM1 overexpression predicts poor survival in GC patients with advanced TNM stage. RRM1 could potentially serve as prognostic biomarker and therapeutic target for GCs.	[Wang, Qinchuan; Zhou, Jichun; Zhang, Shengjie; Shen, Jianguo; Yuan, Xiaoming; Chen, Wenjun; Wang, Linbo; Yen, Yun] Zhejiang Univ, Sch Med, Affiliated Sir Runrun Shaw Hosp, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Mei] Zhejiang Univ, Sch Med, Affiliated Sir Runrun Shaw Hosp, Dept Pathol, Hangzhou, Peoples R China; [Wang, Qinchuan; Liu, Xiyong; Huang, Yasheng; Yen, Yun] City Hope Comprehens Canc Ctr, Dept Anat Pathol, Duarte, CA USA; [Shibata, Stephen] City Hope Comprehens Canc Ctr, Dept Med Oncol, Duarte, CA USA; [Liu, Yingbin] Shanghai Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Yen, Yun] Taipei Med Univ, Taipei, Taiwan	Zhejiang University; Zhejiang University; City of Hope; City of Hope; Shanghai Jiao Tong University; Taipei Medical University	Wang, LB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Sir Runrun Shaw Hosp, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	wanglinbo@medmail.com.cn; yyen@coh.org	wang, lin/GSE-3040-2022; Yen, Yun/H-9591-2016; Liu, Yingbin/AAI-1919-2020; Wang, Qinchuan/AAX-7392-2020; Zhou, Jichun/Q-8646-2019; Liu, Xiyong/E-1646-2019; LIU, YING/GZL-7252-2022	Liu, Yingbin/0000-0001-6110-0185; Zhou, Jichun/0000-0002-0727-4034; Liu, Xiyong/0000-0002-0259-3669; 	National Institutes of Health (NIH) [R01, CA127541]; National Nature Science Foundation of China (NSFC) [81101659/H1609]; Nature Science Foundation of Zhejiang province, China (NSFZ) [Y2110073]; NATIONAL CANCER INSTITUTE [R01CA127541] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Zhejiang province, China (NSFZ); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health (NIH) grants (R01, CA127541), National Nature Science Foundation of China (NSFC) 81101659/H1609, Nature Science Foundation of Zhejiang province, China (NSFZ) Y2110073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Cent Eur J Public Health, V11, P177; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Correale P, 2005, CANCER CHEMOTH PHARM, V56, P563, DOI 10.1007/s00280-005-1024-1; Demetter P, 2012, ACTA GASTRO-ENT BELG, V75, P210; Elnaggar M, 2012, CURR PHARM DESIGN, V18, P2811, DOI 10.2174/138161212800626175; Fan HZ, 1996, P NATL ACAD SCI USA, V93, P14036, DOI 10.1073/pnas.93.24.14036; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Fisher SL, 2012, TRANSFORMING PLACES: LESSONS FROM APPALACHIA, P1; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kurata N, 2011, INT J ONCOL, V39, P473, DOI 10.3892/ijo.2011.1058; Lee JJ, 2010, LUNG CANCER, V70, P205, DOI 10.1016/j.lungcan.2010.02.005; Liu XY, 2006, CLIN CANCER RES, V12, P6337, DOI 10.1158/1078-0432.CCR-06-0799; Liu XY, 2011, CANCER RES, V71, P3202, DOI 10.1158/0008-5472.CAN-11-0054; Liu XY, 2005, BIOCHEM PHARMACOL, V70, P1288, DOI 10.1016/j.bcp.2005.08.005; Lori F, 1999, ANTIVIR THER, V4, P101; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Madaan K, 2012, EXPERT REV ANTICANC, V12, P19, DOI [10.1586/ERA.11.175, 10.1586/era.11.175]; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Qiu WH, 2006, BIOCHEM BIOPH RES CO, V340, P428, DOI 10.1016/j.bbrc.2005.12.019; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Souglakos J, 2008, BRIT J CANCER, V98, P1710, DOI 10.1038/sj.bjc.6604344; Tanwar PS, 2013, CARCINOGENESIS; Wagner AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub2; Wang X, 2010, MED ONCOL, V27, P484, DOI 10.1007/s12032-009-9239-3; Wonganan P, 2012, CANCER BIOL THER, V13, P908, DOI 10.4161/cbt.20843; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Zhang GB, 2012, CANCER CHEMOTH PHARM, V69, P1277, DOI 10.1007/s00280-012-1834-x; Zhang KQ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-11; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou BS, 2006, HYBRIDOMA, V25, P264, DOI 10.1089/hyb.2006.25.264; Zhou BS, 1998, CLIN EXP METASTAS, V16, P43	49	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70191	10.1371/journal.pone.0070191	http://dx.doi.org/10.1371/journal.pone.0070191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922955	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700155
J	Wang, YG; Yang, XH; Shi, ZJ				Wang, Yange; Yang, Xiaohui; Shi, Zhongjie			The Formation of the Patterns of Desert Shrub Communities on the Western Ordos Plateau, China: The Roles of Seed Dispersal and Sand Burial	PLOS ONE			English	Article							SPATIAL ASSOCIATION; POPULATION-DYNAMICS; SEMIARID SHRUBLAND; GERMINATION; SURVIVAL; GROWTH; PLANTS; FACILITATION; EMERGENCE; RESTORATION	The western Ordos Plateau is a key area of shrub diversity and a National Nature Reserve of endangered shrub species in north-west China. Desert expansion is becoming the most important threat to these endangered species. However, little is known about the effects of sand burial on the dynamics of the shrub community. This study aims to investigate how the shrubs as a community and as different individual shrubs respond to the disturbances caused by the desert expansion. The approach used by this study is to separate the seed-dispersal strategy from the sand-burial forces that are involved in structuring the shrub communities at different disturbance stages. Four communities for different disturbance stages were surveyed by using 50650 m plots. The individual shrubs were classified into coloniser and successor groups at the seed-dispersal stage and strong and weak sand-burial tolerance groups at the sand-expansion stage. We employed spatial point pattern analysis with null models for each community to examine the seed-dispersal strategy and sand-burial forces affecting community distribution patterns. At the seed-dispersal stage, the interactions between the colonisers and the successors showed significant positive correlation at a scale of 0-1 m and significant negative correlation at a scale of 2 m; significant negative correlations between the groups with strong and weak sand-burial tolerance in the early stage of sand expansion at scales of 3-6 m, and significant positive correlation in the later stage of sand expansion at a scale of 13 m, were found. Seed-dispersal strategy is a reasonable mechanism to explain the shrub community pattern formation in the earlier stages, whereas sand burial is the primary reason for the disappearance of shrubs with weak sand-burial tolerance, this irreversible disturbance causes homogenisation of the community structure and produces aging populations of shrub species. This has an important influence on the succession direction of desert shrub communities.	[Wang, Yange; Yang, Xiaohui; Shi, Zhongjie] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Yang, XH (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.	yangxh@caf.ac.cn; shizj@caf.ac.cn		Yang, Xiaohui/0000-0002-5453-2702	State Forestry Administration Public Welfare Research Foundation [201204203]; National Natural Science Foundation of China [41271033]; State Sci. & Tech. Supporting Project [2006BAD26B05]	State Forestry Administration Public Welfare Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Sci. & Tech. Supporting Project	This research was funded in part by State Forestry Administration Public Welfare Research Foundation (201204203), the National Natural Science Foundation of China (41271033) and State Sci. & Tech. Supporting Project (2006BAD26B05). We thank Prof. Longjun Ci for her comments on this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Armas C, 2009, J VEG SCI, V20, P535, DOI 10.1111/j.1654-1103.2009.01055.x; Benard RB, 2008, PLANT ECOL, V194, P195, DOI 10.1007/s11258-007-9284-y; Breshears DD, 1998, INT J PLANT SCI, V159, P1010, DOI 10.1086/314083; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Cody ML, 2000, J VEG SCI, V11, P351, DOI 10.2307/3236627; DAY TA, 1989, VEGETATIO, V80, P37, DOI 10.1007/BF00049139; DEAN WRJ, 1991, AFR J ECOL, V29, P11, DOI 10.1111/j.1365-2028.1991.tb00815.x; Diggle P., 2003, STAT ANAL SPATIAL PO; DISRAELI DJ, 1984, J ECOL, V72, P145, DOI 10.2307/2260010; Esler KJ., 1999, KAROO ECOLOGICAL PAT, P123, DOI [https://doi.org/10.1017/cbo9780511541988.012, DOI 10.1017/CBO9780511541988.012, 10.1017/cbo9780511541988.012]; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; FRANCO AC, 1988, ECOLOGY, V69, P1731, DOI 10.2307/1941151; Fulbright TE, 1995, ACTA OECOL, V16, P621; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Jia B.Q., 2002, J ARID LAND RESOUR E, V16, P96; Jia RL, 2008, SOIL BIOL BIOCHEM, V40, P2827, DOI 10.1016/j.soilbio.2008.07.029; Kent M, 2001, PROG PHYS GEOG, V25, P455, DOI 10.1177/030913330102500401; [李秋艳 LI QiuYan], 2006, [生态学报, Acta Ecologica Sinica], V26, P1802; Li Rong-ping, 2004, Yingyong Shengtai Xuebao, V15, P1865; Li XR, 2001, J ARID ENVIRON, V47, P271, DOI 10.1006/jare.2000.0707; Liu F, 2007, FRONTIERS BIOL CHINA, V2, P431; Liu YX., 1988, J DESERT RES, V8, P11; Marone L, 1998, PLANT ECOL, V137, P143, DOI 10.1023/A:1009776601012; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; MAUN MA, 1986, AM J BOT, V73, P450, DOI 10.2307/2444088; MILTON SJ, 1993, J ARID ENVIRON, V24, P63, DOI 10.1006/jare.1993.1005; Miriti MN, 2007, ECOLOGY, V88, P1177, DOI 10.1890/06-1006; Montane F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028652; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Peng F, 2012, CHIN J DESERT RES, V32, P593; PRENTICE IC, 1985, VEGETATIO, V63, P133, DOI 10.1007/BF00044064; Schurr FM, 2004, PLANT ECOL, V173, P271, DOI 10.1023/B:VEGE.0000029335.13948.87; Sperry JS, 2002, FUNCT ECOL, V16, P367, DOI 10.1046/j.1365-2435.2002.00628.x; Stoyan D, 2000, SCAND J STAT, V27, P641, DOI 10.1111/1467-9469.00213; Stoyan D., 1994, FRACTALS RANDOM SHAP; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Terrados J, 1997, MAR ECOL PROG SER, V152, P295, DOI 10.3354/meps152295; Toft CA, 2003, ECOL MONOGR, V73, P605, DOI 10.1890/02-4080; VALIENTEBANUET A, 1991, J VEG SCI, V2, P15, DOI 10.2307/3235893; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Wang GH, 2005, BIODIVERS CONSERV, V14, P3187, DOI 10.1007/s10531-004-0386-8; West NE, 1983, TEMPERATE DESERTS SE; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2004, USER MANUAL PROGRAMI; Yang C., 2002, CONSERVATION BIOL TE; Yang MX, 1997, INNER MONGOLIA ENV P, V9, P25; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; YEATON RI, 1990, VEGETATIO, V88, P103, DOI 10.1007/BF00044827; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yu OiuShi, 2005, Acta Phytoecologica Sinica, V29, P591; [曾彦军 Zeng Yanjun], 2004, [生态学报, Acta Ecologica Sinica], V24, P1629; Zhang H, 2001, ACTA PHYTOECOLOGICA, V25, P366; ZHANG JH, 1990, CAN J BOT, V68, P304, DOI 10.1139/b90-041; Zhang X., 1994, ACTA ECOL SIN, V18, P1, DOI DOI 10.1111/1365-2745.12089; Zhang Ying-juan, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P126; Zhao W., 2003, ADV EARTH SCI, V18, P257; [No title captured]	64	11	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69970	10.1371/journal.pone.0069970	http://dx.doi.org/10.1371/journal.pone.0069970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922877	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900126
J	Crittenden, MR; Savage, T; Cottam, B; Bahjat, KS; Redmond, WL; Bambina, S; Kasiewicz, M; Newell, P; Jackson, AM; Gough, MJ				Crittenden, Marka R.; Savage, Talicia; Cottam, Benjamin; Bahjat, Keith S.; Redmond, William L.; Bambina, Shelly; Kasiewicz, Melissa; Newell, Pippa; Jackson, Andrew M.; Gough, Michael J.			The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL IMMUNITY; SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; MAMMARY-CARCINOMA; LOCAL RADIATION; MOUSE MODEL; INTERLEUKIN-1; INFLAMMATION; INHIBITION	Expansion of myeloid-lineage leukocytes in tumor-bearing mice has been proposed as a cause of systemic immunosuppression. We demonstrate that radiation therapy of tumors leads to a decline in myeloid cell numbers in the blood and a decrease in spleen size. The frequency of myeloid cells does not decline to the level seen in tumor-free mice: we demonstrate that metastatic disease can prevent myeloid cell numbers from returning to baseline, and that tumor recurrence from residual disease correlates with re-expansion of myeloid lineage cells. Radiation therapy results in increased proliferation of T cells in the spleen and while T cell responses to foreign antigens are not altered by tumor burden or myeloid cell expansion, responses to tumor-associated antigens are increased after radiation therapy. These data demonstrate that myeloid cell numbers are directly linked to primary tumor burden, that this population contracts following radiation therapy, and that radiation therapy may open a therapeutic window for immunotherapy of residual disease.	[Crittenden, Marka R.; Savage, Talicia; Cottam, Benjamin; Bahjat, Keith S.; Redmond, William L.; Bambina, Shelly; Kasiewicz, Melissa; Gough, Michael J.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA; [Crittenden, Marka R.; Newell, Pippa] Oregon Clin, Portland, OR USA; [Newell, Pippa] Providence Portland Med Ctr, Providence Hepatobiliary & Pancreat Canc Program, Portland, OR USA; [Jackson, Andrew M.] Univ Nottingham, Acad Unit Clin Oncol, Tumour Interact Grp, Nottingham NG7 2RD, England	Providence Portland Medical Center; Providence Portland Medical Center; University of Nottingham	Gough, MJ (corresponding author), Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA.	michael.gough@providence.org	Gough, Michael/AAY-3419-2020; Jackson, Andrew M/I-5929-2013	Gough, Michael/0000-0002-5575-0074; Jackson, Andrew M/0000-0003-4739-4804; Redmond, William/0000-0002-2572-1731	Susan G Komen For the Cure Career Catalyst Award [KG110131]; American Cancer Society Research Scholar Grant [RSG-12-168-01-LIB]; Wayne D. Kuni and Joan E. Kuni Foundation Kuni Scholar Award	Susan G Komen For the Cure Career Catalyst Award(Susan G. Komen Breast Cancer Foundation); American Cancer Society Research Scholar Grant(American Cancer Society); Wayne D. Kuni and Joan E. Kuni Foundation Kuni Scholar Award	This study was supported by research funding from a Susan G Komen For the Cure Career Catalyst Award (KG110131) and an American Cancer Society Research Scholar Grant (RSG-12-168-01-LIB) to MJG, and a Wayne D. Kuni and Joan E. Kuni Foundation Kuni Scholar Award to MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 2009, CANC IMMUNOL IMMUNOT; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Bronte V, 1999, J IMMUNOL, V162, P5728; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chi CH, 2010, CANCER BIOTHER RADIO, V25, P39, DOI 10.1089/cbr.2009.0699; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Crittenden MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039295; De Santo C, 2005, P NATL ACAD SCI USA, V102, P4185, DOI 10.1073/pnas.0409783102; Demaria S, 2005, CLIN CANCER RES, V11, P728; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Donkor MK, 2009, INT IMMUNOPHARMACOL, V9, P937, DOI 10.1016/j.intimp.2009.03.021; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; FIBBE WE, 1986, BLOOD, V68, P1316; FIBBE WE, 1989, EXP HEMATOL, V17, P229; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gough MJ, 2010, J IMMUNOTHER, V33, P798, DOI 10.1097/CJI.0b013e3181ee7095; Hannan R, 2012, CANC IMMUNOLOGY IMMU; HERRMANN F, 1988, J CLIN INVEST, V81, P1415, DOI 10.1172/JCI113471; Kaminski JM, 2005, CANCER TREAT REV, V31, P159, DOI 10.1016/j.ctrv.2005.03.004; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Kusmartsev S, 2003, CANCER RES, V63, P4441; Kwilas Anna R, 2012, Front Oncol, V2, P104, DOI 10.3389/fonc.2012.00104; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; PAMER EG, 1991, NATURE, V353, P852, DOI 10.1038/353852a0; PANG G, 1994, CLIN EXP IMMUNOL, V96, P437, DOI 10.1111/j.1365-2249.1994.tb06048.x; PRIEBE TS, 1992, CANCER CHEMOTH PHARM, V29, P485, DOI 10.1007/BF00684853; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Sarkar D, 2012, PLOS ONE, V7, pe40677; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; SEUNG LP, 1995, P NATL ACAD SCI USA, V92, P6254, DOI 10.1073/pnas.92.14.6254; Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Shi WY, 2006, ANTICANCER RES, V26, P3445; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SUZUKI A, 1992, BRIT J CANCER, V65, P515, DOI 10.1038/bjc.1992.106; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Tamai H, 2008, CLIN IMMUNOL, V127, P66, DOI 10.1016/j.clim.2007.12.001; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Xu YQ, 2012, ONCOLOGIST, V17, P125, DOI 10.1634/theoncologist.2011-0220; Yokouchi H, 2008, CANCER SCI, V99, P361, DOI 10.1111/j.1349-7006.2007.00664.x	54	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69527	10.1371/journal.pone.0069527	http://dx.doi.org/10.1371/journal.pone.0069527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936036	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300045
J	Yu, YY; Shiou, SR; Guo, YE; Lu, L; Westerhoff, M; Sun, J; Petrof, EO; Claud, EC				Yu, Yueyue; Shiou, Sheng-Ru; Guo, Yuee; Lu, Lei; Westerhoff, Maria; Sun, Jun; Petrof, Elaine O.; Claud, Erika C.			Erythropoietin Protects Epithelial Cells from Excessive Autophagy and Apoptosis in Experimental Neonatal Necrotizing Enterocolitis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BCL-X-L; HUMAN-MILK; ISCHEMIA/REPERFUSION INJURY; CROHNS-DISEASE; NITRIC-OXIDE; RAT MODEL; GUT; MODULATION; INFANTS	Neonatal necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease of preterm infants. Increased intestinal epithelium permeability is an early event in NEC pathogenesis. Autophagy and apoptosis are induced by multiple stress pathways which may impact the intestinal barrier, and they have been associated with pathogenesis of diverse gastrointestinal diseases including inflammatory bowel disease. Using both in vitro and in vivo models, this study investigates autophagy and apoptosis under experimental NEC stresses. Furthermore this study evaluates the effect of erythropoietin (Epo), a component of breast milk previously shown to decrease the incidence of NEC and to preserve intestinal barrier function, on intestinal autophagy and apoptosis. It was found that autophagy and apoptosis are both rapidly up regulated in NEC in vivo as indicated by increased expression of the autophagy markers Beclin 1 and LC3II, and by evidence of apoptosis by TUNEL and cleaved caspase-3 staining. In the rat NEC experimental model, autophagy preceded the onset of apoptosis in intestine. In vitro studies suggested that Epo supplementation significantly decreased both autophagy and apoptosis via the Akt/mTOR signaling pathway and the MAPK/ERK pathway respectively. These results suggest that Epo protects intestinal epithelium from excessive autophagy and apoptosis in experimental NEC.	[Yu, Yueyue; Shiou, Sheng-Ru; Guo, Yuee; Lu, Lei; Claud, Erika C.] Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA; [Claud, Erika C.] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA; [Westerhoff, Maria] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sun, Jun] Rush Univ, Dept Med, Chicago, IL 60612 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; Rush University; Queens University - Canada	Claud, EC (corresponding author), Univ Chicago, Dept Pediat, Sect Neonatol, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institute of Child Health and Human Development [R01 HD059123]; National Institutes of Health [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Child Health and Human Development Grant R01 HD059123, National Institute of Child Health and Human Development website: http://www.nichd.nih.gov, and National Institutes of Health Grant DK42086, National Institute of Health website: http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; CAPLAN MS, 1990, J PEDIATR-US, V116, P960, DOI 10.1016/S0022-3476(05)80661-4; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dame C, 2001, BIOL NEONATE, V79, P228; Fiordaliso F, 2005, P NATL ACAD SCI USA, V102, P2046, DOI 10.1073/pnas.0409329102; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Gibson GR, 1998, BRIT J NUTR, V80, pS209, DOI 10.1017/S0007114500006048; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Guneli E, 2007, MOL MED, V13, P509, DOI 10.2119/2007-00032.Guneli; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Huett A, 2010, INFLAMM BOWEL DIS, V16, P152, DOI 10.1002/ibd.20991; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jin S, 2008, AM J PHYSIOL-GASTR L, V294, pG928, DOI 10.1152/ajpgi.00219.2007; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Juul SE, 1999, PEDIATR RES, V46, P263, DOI 10.1203/00006450-199909000-00003; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kling PJ, 1998, PEDIATR RES, V43, P216, DOI 10.1203/00006450-199802000-00010; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kumral A, 2003, BIOL NEONATE, V84, P325, DOI 10.1159/000073642; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liedel JL, 2011, PEDIATR RES, V69, P395, DOI 10.1203/PDR.0b013e3182114ec9; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; McGuire W, 2003, ARCH DIS CHILD-FETAL, V88, P11; McPherson RJ, 2007, GROWTH HORM IGF RES, V17, P424, DOI 10.1016/j.ghir.2007.05.006; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mori S, 2008, SURGERY, V143, P556, DOI 10.1016/j.surg.2007.12.013; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Quelle FW, 1998, GENE DEV, V12, P1099, DOI 10.1101/gad.12.8.1099; Rafiee P, 2005, BASIC RES CARDIOL, V100, P187, DOI 10.1007/s00395-004-0508-1; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Shin CE, 2000, J PEDIATR SURG, V35, P173, DOI 10.1016/S0022-3468(00)90005-8; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Sui XW, 2000, BRIT J HAEMATOL, V110, P63, DOI 10.1046/j.1365-2141.2000.02145.x; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; Westcarr S, 1999, J SUBMICR CYTOL PATH, V31, P15; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	66	66	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69620	10.1371/journal.pone.0069620	http://dx.doi.org/10.1371/journal.pone.0069620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936061	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300056
J	Ashoor, A; Nordman, JC; Veltri, D; Yang, KHS; Al Kury, L; Shuba, Y; Mahgoub, M; Howarth, FC; Sadek, B; Shehu, A; Kabbani, N; Oz, M				Ashoor, Abrar; Nordman, Jacob C.; Veltri, Daniel; Yang, Keun-Hang Susan; Al Kury, Lina; Shuba, Yaroslav; Mahgoub, Mohamed; Howarth, Frank C.; Sadek, Bassem; Shehu, Amarda; Kabbani, Nadine; Oz, Murat			Menthol Binding and Inhibition of alpha 7-Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							NICOTINIC RECEPTORS; SMOKING-BEHAVIOR; CIGARETTE-SMOKE; XENOPUS-OOCYTES; PHARMACOLOGY; CHANNELS; DESENSITIZATION; MONOTERPENOIDS; INVOLVEMENT; MODULATION	Menthol is a common compound in pharmaceutical and commercial products and a popular additive to cigarettes. The molecular targets of menthol remain poorly defined. In this study we show an effect of menthol on the alpha(7) subunit of the nicotinic acetylcholine (nACh) receptor function. Using a two-electrode voltage-clamp technique, menthol was found to reversibly inhibit alpha(7)-nACh receptors heterologously expressed in Xenopus oocytes. Inhibition by menthol was not dependent on the membrane potential and did not involve endogenous Ca2+-dependent Cl- channels, since menthol inhibition remained unchanged by intracellular injection of the Ca2+ chelator BAPTA and perfusion with Ca2+-free bathing solution containing Ba2+. Furthermore, increasing ACh concentrations did not reverse menthol inhibition and the specific binding of [I-125] alpha-bungarotoxin was not attenuated by menthol. Studies of alpha(7)-nACh receptors endogenously expressed in neural cells demonstrate that menthol attenuates alpha(7) mediated Ca2+ transients in the cell body and neurite. In conclusion, our results suggest that menthol inhibits alpha(7)-nACh receptors in a noncompetitive manner.	[Ashoor, Abrar; Al Kury, Lina; Shuba, Yaroslav; Mahgoub, Mohamed; Sadek, Bassem; Oz, Murat] UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Lab Funct Lipid, Al Ain, U Arab Emirates; [Nordman, Jacob C.; Kabbani, Nadine] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Veltri, Daniel] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Yang, Keun-Hang Susan] Chapman Univ, Schmid Coll Sci & Technol, Dept Biol Sci, Orange, CA USA; [Howarth, Frank C.] UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [Shehu, Amarda] George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA	United Arab Emirates University; George Mason University; George Mason University; Chapman University System; Chapman University; United Arab Emirates University; George Mason University	Oz, M (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Lab Funct Lipid, Al Ain, U Arab Emirates.	Murat_Oz@uaeu.ac.ae	Veltri, Daniel/V-7538-2017; Kury, Lina Al/Y-3421-2019; Shuba, Yaroslav/AAT-6758-2021	Veltri, Daniel/0000-0002-6101-6693; Shehu, Amarda/0000-0001-5230-4610; Nordman, Jacob/0000-0003-2513-7831; Mahgoub, Mohamed/0000-0001-8873-660X	CMHS, UAE University; IRP/NIDA of NIH, DHHS; Jeffress Memorial Trust Grant [J-953]; NSF IIS CAREER Award [1144106]; LABCO partner of Sigma-Aldrich; Div Of Information & Intelligent Systems [1144106] Funding Source: National Science Foundation	CMHS, UAE University; IRP/NIDA of NIH, DHHS; Jeffress Memorial Trust Grant; NSF IIS CAREER Award; LABCO partner of Sigma-Aldrich; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported by grants from CMHS, UAE University and support from IRP/NIDA of NIH, DHHS to MO and a Jeffress Memorial Trust Grant (J-953) to NK. DV is supported in part by NSF IIS CAREER Award No. 1144106 to AS. Research in our laboratory is also supported by LABCO partner of Sigma-Aldrich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahijevych K, 2004, NICOTINE TOB RES, V6, pS17, DOI 10.1080/14622200310001649469; Ahijevych K, 2010, NICOTINE TOB RES, V12, pS110, DOI 10.1093/ntr/ntq203; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; Brody AL, 2012, INT J NEUROPSYCHOPH, V1, P1, DOI DOI 10.1017/S1461145712001022; Brunzell DH, 2009, NEBR SYM MOTIV, V55, P17, DOI 10.1007/978-0-387-78748-0_3; Brunzell DH, 2012, NEUROPSYCHOPHARMACOL, V37, P1134, DOI 10.1038/npp.2011.299; Dessirier JM, 2001, PHYSIOL BEHAV, V73, P25, DOI 10.1016/S0031-9384(01)00431-0; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farco JA, 2013, MINI-REV MED CHEM, V13, P124; Fenster CP, 1999, J NEUROSCI, V19, P4804; Foulds J, 2010, NICOTINE TOB RES, V12, pS102, DOI 10.1093/ntr/ntq166; Galeotti N, 2002, NEUROSCI LETT, V322, P145, DOI 10.1016/S0304-3940(01)02527-7; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Giovino GA, 2004, NICOTINE TOB RES, V6, pS67, DOI 10.1080/14622203710001649696; Grabus SD, 2005, EUR J PHARMACOL, V515, P90, DOI 10.1016/j.ejphar.2005.03.044; Hall AC, 2004, EUR J PHARMACOL, V506, P9, DOI 10.1016/j.ejphar.2004.10.026; Hall AC, 2008, EUR J PHARMACOL, V667, P175; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman Allison C, 2011, Tob Induc Dis, V9 Suppl 1, pS5, DOI 10.1186/1617-9625-9-S1-S5; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Klasen K, 2012, PFLUG ARCH EUR J PHY, V463, P779, DOI 10.1007/s00424-012-1098-7; Lee LY, 2007, PULM PHARMACOL THER, V20, P355, DOI 10.1016/j.pupt.2006.10.007; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Marin M, 2012, ADV EXP MED BIOL, V740, P1073, DOI 10.1007/978-94-007-2888-2_49; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Miyazawa M, 1997, J AGR FOOD CHEM, V45, P677, DOI 10.1021/jf960398b; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Nordman JC, 2012, J CELL SCI IN PRESS; Orhan I, 2008, Z NATURFORSCH C, V63, P547; Oz M, 1998, MOL PHARMACOL, V54, P1106, DOI 10.1124/mol.54.6.1106; Oz M, 2004, N-S ARCH PHARMACOL, V369, P252, DOI 10.1007/s00210-003-0838-9; Pan R, 2012, J PHARMACOL EXP THER, V343, P661, DOI 10.1124/jpet.112.196717; Park TJ, 2003, BIOCHEM PHARMACOL, V65, P83, DOI 10.1016/S0006-2952(02)01444-2; Park TJ, 2001, BIOCHEM PHARMACOL, V61, P787, DOI 10.1016/S0006-2952(01)00547-0; Picciotto MR, 2013, COLD SPRING IN PRESS; Ruskin D, 2008, NICOTINE TOB RES, V10, P1753, DOI 10.1080/14622200802443734; Samet JM, 2011, MENTHOL CIGARETTES P; SANDS SB, 1993, BIOPHYS J, V65, P2614, DOI 10.1016/S0006-3495(93)81296-7; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Williams DB, 2002, J NEUROSCI, V22, P7417; Willis DN, 2011, FASEB J, V25, P4434, DOI 10.1096/fj.11-188383; Yosipovitch G, 1996, ARCH DERMATOL RES, V288, P245, DOI 10.1007/s004030050053; Zia S, 1997, RES COMMUN MOL PATH, V97, P243	59	52	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67674	10.1371/journal.pone.0067674	http://dx.doi.org/10.1371/journal.pone.0067674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935840	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000015
J	Carlson-Banning, KM; Chou, A; Liu, Z; Hamill, RJ; Song, YC; Zechiedrich, L				Carlson-Banning, Kimberly M.; Chou, Andrew; Liu, Zhen; Hamill, Richard J.; Song, Yongcheng; Zechiedrich, Lynn			Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae	PLOS ONE			English	Article							CANDIDA-ALBICANS; LIPID-A; GALACTOSE SENSITIVITY; LIPOPOLYSACCHARIDE; OLAMINE; EXPRESSION; VIRULENCE; GENE; BIOSYNTHESIS; METABOLISM	Antibiotic-resistant infections caused by gram-negative bacteria are a major healthcare concern. Repurposing drugs circumvents the time and money limitations associated with developing new antimicrobial agents needed to combat these antibiotic-resistant infections. Here we identified the off-patent antifungal agent, ciclopirox, as a candidate to repurpose for antibiotic use. To test the efficacy of ciclopirox against antibiotic-resistant pathogens, we used a curated collection of Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates that are representative of known antibiotic resistance phenotypes. We found that ciclopirox, at 5-15 mu g/ml concentrations, inhibited bacterial growth regardless of the antibiotic resistance status. At these same concentrations, ciclopirox reduced growth of Pseudomonas aeruginosa clinical isolates, but some of these pathogens required higher ciclopirox concentrations to completely block growth. To determine how ciclopirox inhibits bacterial growth, we performed an overexpression screen in E. coli. This screen revealed that galE, which encodes UDP-glucose 4-epimerase, rescued bacterial growth at otherwise restrictive ciclopirox concentrations. We found that ciclopirox does not inhibit epimerization of UDP-galactose by purified E. coli GalE; however, Delta galU, Delta galE, Delta rfaI, or Delta rfaB mutant strains all have lower ciclopirox minimum inhibitory concentrations than the parent strain. The galU, galE, rfaI, and rfaB genes all encode enzymes that use UDP-galactose or UDP-glucose for galactose metabolism and lipopolysaccharide (LPS) biosynthesis. Indeed, we found that ciclopirox altered LPS composition of an E. coli clinical isolate. Taken together, our data demonstrate that ciclopirox affects galactose metabolism and LPS biosynthesis, two pathways important for bacterial growth and virulence. The lack of any reported fungal resistance to ciclopirox in over twenty years of use in the clinic, its excellent safety profiles, novel target(s), and efficacy, make ciclopirox a promising potential antimicrobial agent to use against multidrug-resistant problematic gram-negative pathogens.	[Carlson-Banning, Kimberly M.; Song, Yongcheng; Zechiedrich, Lynn] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Carlson-Banning, Kimberly M.; Chou, Andrew; Hamill, Richard J.; Zechiedrich, Lynn] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Chou, Andrew; Hamill, Richard J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Liu, Zhen; Song, Yongcheng; Zechiedrich, Lynn] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Hamill, Richard J.] Michael E DeBakey VA Med Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zechiedrich, L (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	elz@bcm.edu	Zechiedrich, Elizabeth Lynn/S-4720-2019	Zechiedrich, Lynn/0000-0003-0533-1637	National Institutes of Health [R21 AI088123]; NIH [R01 AI054830]; Infection and Immunity Training Program [NIH T32 AI55413]; Michael E. DeBakey VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055413, R01AI054830, R21AI088123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infection and Immunity Training Program; Michael E. DeBakey VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health R21 AI088123 to Y.S. and NIH R01 AI054830 to L.Z. A. C. is a fellow in the Infection and Immunity Training Program (NIH T32 AI55413). This project was supported in part by facilities and resources of the Michael E. DeBakey VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAKER MA, 1984, BLOOD, V63, P1194; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; BRAGA PC, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1368; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Bullen Rogers H.J, 1978, ROLE IRON BACTERIAL, P1; Chen X, 1999, BIOTECHNOL LETT, V21, P1131, DOI 10.1023/A:1005678225031; Chopra S, 2010, J ANTIMICROB CHEMOTH, V65, P2598, DOI 10.1093/jac/dkq353; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Cornelis P, 2002, ENVIRON MICROBIOL, V4, P787, DOI 10.1046/j.1462-2920.2002.00369.x; Csiszovszki Z, 2011, MBIO, V2, P1, DOI [10.1128/mBio.00053-11, DOI 10.1128/MBI0.00053-11]; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Deng LS, 2009, J MED CHEM, V52, P6539, DOI 10.1021/jm9012592; DITTMAR W, 1973, ARZNEIMITTEL-FORSCH, V23, P670; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fuse K, 2013, J INFECT CHEMOTHER, V19, P82, DOI 10.1007/s10156-012-0457-9; Garsin DA, 2012, MBIO, V3, P1, DOI [10.1128/mBio.00172-12., DOI 10.1128/MBI0.00172-12]; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gorke B, 2008, GENE DEV, V22, P2914, DOI 10.1101/gad.1717808; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ho TD, 2007, INFECT IMMUN, V75, P1661, DOI 10.1128/IAI.01342-06; Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90; Ji SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017646; JUE SG, 1985, DRUGS, V29, P330, DOI 10.2165/00003495-198529040-00002; Jumpstart Consortium HMP Data Generation Working Group, 2012, PLOS ONE, V7; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kim HU, 2010, MOL BIOSYST, V6, P339, DOI 10.1039/b916446d; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Ko SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027844; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Lee SJ, 2005, BRIT J PHARMACOL, V145, P469, DOI 10.1038/sj.bjp.0706206; Leem SH, 2003, MOL CELLS, V15, P55; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Loui C, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-183; Marolda Cristina L., 2006, V347, P237; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; Morgan-Linnell SK, 2009, ANTIMICROB AGENTS CH, V53, P235, DOI 10.1128/AAC.00665-08; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Niou YK, 2009, BIOCHEM BIOPH RES CO, V390, P313, DOI 10.1016/j.bbrc.2009.09.120; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Ramstedt M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209536; RIVERA M, 1993, FEMS MICROBIOL LETT, V108, P183, DOI 10.1111/j.1574-6968.1993.tb06096.x; Ross KL, 2004, MOL GENET METAB, V83, P103, DOI 10.1016/j.ymgme.2004.07.005; SAKURAI K, 1978, CHEMOTHERAPY, V24, P68, DOI 10.1159/000237762; Sigle HC, 2005, J ANTIMICROB CHEMOTH, V55, P663, DOI 10.1093/jac/dki089; Singh V, 2007, FUNGAL GENET BIOL, V44, P563, DOI 10.1016/j.fgb.2006.11.006; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Sousa SA, 2011, BIOTECHNOLOGY OF BIOPOLYMERS, P257; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; Swick MC, 2011, ANTIMICROB AGENTS CH, V55, P921, DOI 10.1128/AAC.00996-10; Tarawneh RT, 2005, INT J PHARMACEUT, V289, P179, DOI 10.1016/j.ijpharm.2004.11.009; Urbaniak MD, 2006, BIOORG MED CHEM LETT, V16, P5744, DOI 10.1016/j.bmcl.2006.08.091; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wasilenko J, 2006, J BIOL CHEM, V281, P8443, DOI 10.1074/jbc.M600778200; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Weir SJ, 2011, J CLIN PHARM THER, V36, P128, DOI 10.1111/j.1365-2710.2010.01172.x; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	85	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69646	10.1371/journal.pone.0069646	http://dx.doi.org/10.1371/journal.pone.0069646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936064	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000141
J	Ma, ZT; Wang, YL; Zhao, HY; Xu, AT; Wang, YQ; Tang, J; Feng, WH				Ma, Zhitao; Wang, Yalan; Zhao, Haiyan; Xu, Ao-Tian; Wang, Yongqiang; Tang, Jun; Feng, Wen-hai			Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 4 Induces Apoptosis Dependent on Its 3C-Like Serine Protease Activity	PLOS ONE			English	Article							CELL-DEATH; PRRS VIRUS; IN-VIVO; CLEAVAGE; INFECTION; LUNGS; PIGS; PATHOGENESIS; ACTIVATION; EXPRESSION	Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious disease in pigs caused by PRRS virus (PRRSV). Although PRRSV infection-induced cell apoptosis has been established, the related viral protein is still unknown. Here, we reported that PRRSV nonstructural protein 4 (nsp4) was a critical apoptosis inducer. Nsp4 could activate caspase-3, -8, and -9. Using truncated constructs without different domains in nsp4, we demonstrated that the full-length of nsp4 structure was required for its apoptosis-inducing activity. Furthermore, using site-directed mutagenesis to inactivate the 3C-like serine protease activity of nsp4, we showed that nsp4-induced apoptosis was dependent on its serine protease activity. The ability of nsp4 to induce apoptosis was significantly impaired by His39, Asp64, and Ser118 mutations, suggesting that His39, Asp64, and Ser118 were essential for nsp4 to trigger apoptosis. In conclusion, our present work showed that PRRSV nsp4 could induce apoptosis in host cells and might be partially responsible for the apoptosis induced by PRRSV infection. PRRSV 3C-like protease-mediated apoptosis represents the first report in the genus Arterivirus, family Arteriviridae.	[Ma, Zhitao; Wang, Yalan; Zhao, Haiyan; Xu, Ao-Tian; Wang, Yongqiang; Tang, Jun; Feng, Wen-hai] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Ma, Zhitao; Wang, Yalan; Zhao, Haiyan; Feng, Wen-hai] China Agr Univ, Coll Biol Sci, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Xu, Ao-Tian; Tang, Jun] China Agr Univ, Coll Vet Med, Dept Basic Vet Med, Beijing 100094, Peoples R China; [Wang, Yongqiang] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Tang, J (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	jtang@cau.edu.cn; whfeng@cau.edu.cn		Tripp, Ralph/0000-0002-2924-9956	Natural Science Foundation of China [30770101]; State Key Laboratory of Agrobiotechnology, China Agricultural University, China [2010SKLAB06-1]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agrobiotechnology, China Agricultural University, China	This work was supported by the Natural Science Foundation of China (#30770101), Faculty Starting Grant and State Key Laboratory of Agrobiotechnology (Grant 2010SKLAB06-1), China Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET RES, V28, P305; Barco A, 2000, VIROLOGY, V266, P352, DOI 10.1006/viro.1999.0043; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Choi C, 2002, RES VET SCI, V72, P45, DOI 10.1053/rvsc.2001.0519; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fernandez A, 2002, VIRUS RES, V83, P103, DOI 10.1016/S0168-1702(01)00426-9; Gomez-Laguna J, 2012, TRANSBOUND EMERG DIS; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kim TS, 2002, VIRUS RES, V85, P133, DOI 10.1016/S0168-1702(02)00029-1; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Labarque GG, 2001, ADV EXP MED BIOL, V494, P691; Lee C, 2004, VIRUS RES, V104, P33, DOI 10.1016/j.virusres.2004.03.001; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Lin CW, 2006, FEMS IMMUNOL MED MIC, V46, P375, DOI 10.1111/j.1574-695X.2006.00045.x; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Music Nedzad, 2010, Animal Health Research Reviews, V11, P135, DOI 10.1017/S1466252310000034; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989; Snijder EJ, 1996, J BIOL CHEM, V271, P4864, DOI 10.1074/jbc.271.9.4864; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; St-Louis MC, 2007, VIROLOGY, V367, P147, DOI 10.1016/j.virol.2007.05.023; Suarez P, 1996, J VIROL, V70, P2876; Suarez P, 2000, VET RES, V31, P47, DOI 10.1051/vetres:2000056; Sur JH, 1997, J VIROL, V71, P9170, DOI 10.1128/JVI.71.12.9170-9179.1997; Sur JH, 1998, VET PATHOL, V35, P506, DOI 10.1177/030098589803500605; Tian XS, 2009, J MOL BIOL, V392, P977, DOI 10.1016/j.jmb.2009.07.062; Xu AT, 2010, BIOTECHNOL LETT, V32, P1905, DOI 10.1007/s10529-010-0370-1; Zaragoza C, 2006, P NATL ACAD SCI USA, V103, P19051, DOI 10.1073/pnas.0606019103; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	36	52	58	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69387	10.1371/journal.pone.0069387	http://dx.doi.org/10.1371/journal.pone.0069387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936003	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000112
J	Isami, K; Haraguchi, K; So, K; Asakura, K; Shirakawa, H; Mori, Y; Nakagawa, T; Kaneko, S				Isami, Kouichi; Haraguchi, Kayo; So, Kanako; Asakura, Kayoko; Shirakawa, Hisashi; Mori, Yasuo; Nakagawa, Takayuki; Kaneko, Shuji			Involvement of TRPM2 in Peripheral Nerve Injury-Induced Infiltration of Peripheral Immune Cells into the Spinal Cord in Mouse Neuropathic Pain Model	PLOS ONE			English	Article							POTENTIAL MELASTATIN 2; CHANNEL; CA2+; SYSTEM; INFLUX; TRANSECTION; MODULATION; BARRIER; CLONING	Recent evidence suggests that transient receptor potential melastatin 2 (TRPM2) expressed in immune cells plays an important role in immune and inflammatory responses. We recently reported that TRPM2 expressed in macrophages and spinal microglia contributes to the pathogenesis of inflammatory and neuropathic pain aggravating peripheral and central pronociceptive inflammatory responses in mice. To further elucidate the contribution of TRPM2 expressed by peripheral immune cells to neuropathic pain, we examined the development of peripheral nerve injury-induced neuropathic pain and the infiltration of immune cells (particularly macrophages) into the injured nerve and spinal cord by using bone marrow (BM) chimeric mice by crossing wildtype (WT) and TRPM2-knockout (TRPM2-KO) mice. Four types of BM chimeric mice were prepared, in which irradiated WT or TRPM2- KO recipient mice were transplanted with either WT- or TRPM2- KO donor mousederived green fluorescence protein-positive (GFP(+)) BM cells ( TRPM2(BM+/Rec+,) TRPM2(BM-/Rec+), TRPM2(BM+/Rec-), and TRPM2(BM-/Rec-) mice). Mechanical allodynia induced by partial sciatic nerve ligation observed in TRPM2(BM+/Rec+) mice was attenuated in TRPM2(BM-/Rec+), TRPM2(BM+/Rec-), and TRPM2(BM-/Rec-) mice. The numbers of GFP(+) BM-derived cells and Iba1/GFP double-positive macrophages in the injured sciatic nerve did not differ among chimeric mice 14 days after the nerve injury. In the spinal cord, the number of GFP(+BM-) derived cells, particularly GFP/Iba1 double-positive macrophages, was significantly decreased in the three TRPM2-KO chimeric mouse groups compared with TRPM2(BM+/Rec+) mice. However, the numbers of GFP(-)/Iba1(+) resident microglia did not differ among chimeric mice. These results suggest that TRPM2 plays an important role in the infiltration of peripheral immune cells, particularly macrophages, into the spinal cord, rather than the infiltration of peripheral immune cells into the injured nerves and activation of spinal-resident microglia. The spinal infiltration of macrophages mediated by TRPM2 may contribute to the pathogenesis of neuropathic pain.	[Isami, Kouichi; Haraguchi, Kayo; So, Kanako; Asakura, Kayoko; Shirakawa, Hisashi; Nakagawa, Takayuki; Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan	Kyoto University; Kyoto University	Nakagawa, T (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan.	tnakaga@pharm.kyoto-u.ac.jp	Kaneko, Shuji/AAR-1005-2021	Kaneko, Shuji/0000-0001-5152-5809; Shirakawa, Hisashi/0000-0002-4129-0978; Nakagawa, Takayuki/0000-0003-1890-0843	Ministry of Education, Culture, Sport, Science and Technology of Japan [23790641, 21390022, 24111527]; Salt Science Research Foundation [12C4]; Grants-in-Aid for Scientific Research [25670285] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (a Grant-in-Aid for Young Scientist (B) to T.N. [23790641], a Grant-in-Aid for Scientific Research (B) to S.K. [21390022], a Grant-in-Aid for Scientific Research on Innovative Area 'Brain Environment' to T.N. [24111527]), and by a grant from the Salt Science Research Foundation, No. 12C4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; BROK HPM, 1993, J IMMUNOL, V151, P6451; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Cao L, 2009, EUR J IMMUNOL, V39, P3562, DOI 10.1002/eji.200939657; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; Melzer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047617; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Sweitzer SM, 2002, PAIN, V100, P163, DOI 10.1016/S0304-3959(02)00257-9; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; Wehrhahn J, 2010, J IMMUNOL, V184, P2386, DOI 10.4049/jimmunol.0902474; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	38	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e66410	10.1371/journal.pone.0066410	http://dx.doi.org/10.1371/journal.pone.0066410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935822	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200002
J	Vignon, C; Debeissat, C; Georget, MT; Bouscary, D; Gyan, E; Rosset, P; Herault, O				Vignon, Christine; Debeissat, Christelle; Georget, Marie-Therese; Bouscary, Didier; Gyan, Emmanuel; Rosset, Philippe; Herault, Olivier			Flow Cytometric Quantification of All Phases of the Cell Cycle and Apoptosis in a Two-Color Fluorescence Plot	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN MARROW CULTURES; CHROMATIN-STRUCTURE; ANTITUMOR-ACTIVITY; PROLIFERATION; MECHANISM; MITOSIS	An optimal technology for cell cycle analysis would allow the concomitant measurement of apoptosis, G0, G1, S, G2 and M phases in combination with cell surface phenotyping. We have developed an easy method in flow cytometry allowing this discrimination in an only two- color fluorescent plot. It is based on the concomitant use of 7-amino-actinomycin D and the antibodies anti-Ki67 and anti-phospho(Ser10)-histone H3, both conjugated to Alexa Fluor (R) 488 to discriminate G0 and M phases, respectively. The method is particularly valuable in a clinical setting as verified in our laboratory by analyzing human leukemic cells from marrow samples or after exposure to cell cycle modifiers.	[Vignon, Christine; Gyan, Emmanuel; Herault, Olivier] Univ Tours, Tours, France; [Vignon, Christine; Gyan, Emmanuel; Herault, Olivier] CNRS, LNOx team, UMR 7292, Tours, France; [Debeissat, Christelle; Georget, Marie-Therese; Herault, Olivier] CHRU Tours, Serv Hematol Biol, Tours, France; [Bouscary, Didier] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Gyan, Emmanuel] CHRU Tours, Serv Hematol Clin & Therapie Cellulaire, Tours, France; [Rosset, Philippe] CHRU Tours, Serv Chirurg Orthoped & Traumatol, Tours, France	Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; CHU Tours	Herault, O (corresponding author), Univ Tours, Tours, France.	olivier.herault@univ-tours.fr		Debeissat, Christelle/0000-0002-5812-7296; Herault, Olivier/0000-0002-7419-1124; GYAN, Emmanuel/0000-0002-7651-9189; Bouscary, Didier/0000-0003-3654-5064	Ligue Nationale Contre le Cancer; International Rotary Club of Blois	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); International Rotary Club of Blois	This research was supported by the the Ligue Nationale Contre le Cancer and the International Rotary Club of Blois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen Paul R, 2004, Methods Mol Biol, V281, P213; Bernstein BE, 2002, CHEM BIOL, V9, P1167, DOI 10.1016/S1074-5521(02)00265-X; CASHMAN J, 1985, BLOOD, V66, P1002; COWDEN RR, 1981, HISTOCHEMISTRY, V72, P391, DOI 10.1007/BF00501781; EAVES CJ, 1991, BLOOD, V78, P110; GALLO RC, 1971, J NATL CANCER I, V46, P789; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Herault O, 1998, BRIT J HAEMATOL, V103, P343, DOI 10.1046/j.1365-2141.1998.01015.x; Herault O, 2004, CELL DEATH DIFFER, V11, pS207, DOI 10.1038/sj.cdd.4401471; Lacombe F, 1997, LEUKEMIA, V11, P1878, DOI 10.1038/sj.leu.2400847; NOWELL PC, 1960, CANCER RES, V20, P462; Paraguassu-Braga FH, 2003, CELL DEATH DIFFER, V10, P1101, DOI 10.1038/sj.cdd.4401279; RIEDER CL, 1992, J CELL SCI, V102, P387; SCHWARTING R, 1986, J IMMUNOL METHODS, V90, P65, DOI 10.1016/0022-1759(86)90384-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Willems L, 2012, LEUKEMIA, V26, P1195, DOI 10.1038/leu.2011.339; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; ZELENIN AV, 1984, CYTOMETRY, V5, P348, DOI 10.1002/cyto.990050410	18	67	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68425	10.1371/journal.pone.0068425	http://dx.doi.org/10.1371/journal.pone.0068425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935867	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200008
J	Beste, KY; Spangler, CM; Burhenne, H; Koch, KW; Shen, YQ; Tang, WJ; Kaever, V; Seifert, R				Beste, Kerstin Y.; Spangler, Corinna M.; Burhenne, Heike; Koch, Karl-Wilhelm; Shen, Yuequan; Tang, Wei-Jen; Kaever, Volkhard; Seifert, Roland			Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases Cyaa and Edema Factor	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; ACTIVATION; INHIBITORS; BINDING; DOMAIN; TOXIN; SITE; PHOSPHORYLATION; PURIFICATION; CALMODULIN	Guanylyl cyclases (GCs) regulate many physiological processes by catalyzing the synthesis of the second messenger cGMP. The GC family consists of seven particulate GCs (pGCs) and a nitric oxide-activated soluble GC (sGC). Rat sGC alpha(1)beta(1) possesses much broader substrate specificity than previously assumed. Moreover, the exotoxins CyaA from Bordetella pertussis and edema factor (EF) from Bacillus anthracis possess nucleotidyl cyclase (NC) activity. pGC-A is a natriuretic peptide-activated homodimer with two catalytic sites that act cooperatively. Here, we studied the NC activity of rat pGC-A in membranes of stably transfected HEK293 cells using a highly sensitive and specific HPLC-MS/MS technique. GTP and ITP were effective, and ATP and XTP were only poor, pGC-A substrates. In contrast to sGC, pGC-A did not use CTP and UTP as substrates. pGC-E and pGC-F expressed in bovine rod outer segment membranes used only GTP as substrate. In intact HEK293 cells, pGC-A generated only cGMP. In contrast to pGCs, EF and CyaA showed very broad substrate-specificity. In conclusion, NCs exhibit different substrate-specificities, arguing against substrate-leakiness of enzymes and pointing to distinct physiological functions of cyclic purine and pyrimidine nucleotides.	[Beste, Kerstin Y.; Spangler, Corinna M.; Burhenne, Heike; Kaever, Volkhard; Seifert, Roland] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Burhenne, Heike; Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry Metabol, Hannover, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Biochem Grp, D-26111 Oldenburg, Germany; [Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Hannover Medical School; Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Nankai University; University of Chicago	Seifert, R (corresponding author), Hannover Med Sch, Inst Pharmacol, Hannover, Germany.	seifert.roland@mh-hannover.de	Koch, Karl-Wilhelm/C-9551-2015; Kaever, Volkhard/G-3280-2013; Bähre, Heike/AAL-7873-2021; Seifert, Roland/G-3189-2013	Koch, Karl-Wilhelm/0000-0003-1501-0044; Tang, Wei-Jen/0000-0002-8267-8995	Deutsche Forschungsgemeinschaft [Se 529/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, grant Se 529/5-2 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; Beste KY, 2013, BIOL CHEM, V394, P261, DOI 10.1515/hsz-2012-0282; Beste KY, 2012, BIOCHEMISTRY-US, V51, P194, DOI 10.1021/bi201259y; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; CHRISMAN TD, 1975, J BIOL CHEM, V250, P374; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; GARBERS DL, 1975, BIOCHIM BIOPHYS ACTA, V377, P174, DOI 10.1016/0005-2744(75)90298-3; GAZZANO H, 1991, BIOCHIM BIOPHYS ACTA, V1077, P99, DOI 10.1016/0167-4838(91)90531-4; Gottle M, 2012, TOXINS, V4, P505, DOI 10.3390/toxins4070505; Gottle M, 2010, BIOCHEMISTRY-US, V49, P5494, DOI 10.1021/bi100684g; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Guo Q, 2004, J BIOL CHEM, V279, P29427, DOI 10.1074/jbc.M402689200; IVANOVA K, 1990, EUR J PHARM-MOLEC PH, V189, P317, DOI 10.1016/0922-4106(90)90125-H; Joubert S, 2007, BIOCHEM PHARMACOL, V73, P954, DOI 10.1016/j.bcp.2006.12.008; KIMURA H, 1975, J BIOL CHEM, V250, P4810; Koch KW, 2010, MOL CELL BIOCHEM, V334, P105, DOI 10.1007/s11010-009-0330-z; KOCH KW, 1990, J BIOL CHEM, V265, P9659; KOCH KW, 1994, EMBO J, V13, P3312, DOI 10.1002/j.1460-2075.1994.tb06633.x; Kuhn Michaela, 2009, V191, P47, DOI 10.1007/978-3-540-68964-5_4; KUROSE H, 1987, FEBS LETT, V219, P375, DOI 10.1016/0014-5793(87)80256-9; MARALA RB, 1991, FEBS LETT, V281, P73, DOI 10.1016/0014-5793(91)80361-6; NAMBI P, 1981, ENDOCRINOLOGY, V108, P2025, DOI 10.1210/endo-108-5-2025; Nashida T, 2000, MOL CELL BIOCHEM, V208, P27, DOI 10.1023/A:1007010821772; NEWTON RP, 1992, RAPID COMMUN MASS SP, V6, P601, DOI 10.1002/rcm.1290061004; NEWTON RP, 1986, BIOCHEM J, V236, P431, DOI 10.1042/bj2360431; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Reinecke D, 2011, FEBS LETT, V585, P3259, DOI 10.1016/j.febslet.2011.09.004; Robinson JW, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003253; Schroter J, 2010, FEBS J, V277, P2440, DOI 10.1111/j.1742-4658.2010.07658.x; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; Seifert R, 2012, TRENDS MICROBIOL, V20, P343, DOI 10.1016/j.tim.2012.04.002; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; SHIGEMATSU Y, 1993, LIFE SCI, V53, P865, DOI 10.1016/0024-3205(93)90509-2; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Thorpe DS, 1996, BIOCHEM BIOPH RES CO, V218, P670, DOI 10.1006/bbrc.1996.0120; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899	44	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70223	10.1371/journal.pone.0070223	http://dx.doi.org/10.1371/journal.pone.0070223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922959	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700158
J	Chou, CY; Hsu, CC; Chiang, SC; Ho, CC; Chou, CL; Wu, MS; Chang, YL; Tsai, HY; Chen, TJ; Chou, YC				Chou, Chia-Yu; Hsu, Chia-Chen; Chiang, Shu-Chiung; Ho, Chin-Chin; Chou, Chia-Lin; Wu, Min-Shan; Chang, Yuh-Lih; Tsai, Han-Yi; Chen, Tzeng-Ji; Chou, Yueh-Ching			Association between Physician Specialty and Risk of Prescribing Inappropriate Pill Splitting	PLOS ONE			English	Article							ERRORS; MEDICATIONS; TABLETS; SAFETY; CARE	Background: Prescription errors that occur due to the process of pill splitting are a common medication problem; however, available prescription information involving inappropriate pill splitting and its associated factors is lacking. Methods: We retrospectively evaluated a cohort of ambulatory prescriptions involving extended-release or enteric-coated formulations in a Taiwan medical center during a 5-month period in 2010. For this study, those pill splitting prescriptions involving special oral formulations were defined as inappropriate prescriptions. Information obtained included patient demographics, prescriber specialty and prescription details, which were assessed to identify factors associated with inappropriate pill splitting. Results: There were 1,252 inappropriate prescriptions identified in this cohort study, representing a prescription frequency for inappropriate pill splitting of 1.0% among 124,300 prescriptions with special oral formulations. Among 35 drugs with special oral formulations in our study, 20 different drugs (57.1%, 20/35) had ever been prescribed to split. Anti-diabetic agents, cardiovascular agents and central nervous system agents were the most common drug classes involved in inappropriate splitting. The rate of inappropriate pill splitting was higher in older (over 65 years of age) patients (1.1%, 832/75,387). Eighty-seven percent (1089/1252) of inappropriate prescriptions were prescribed by internists. The rate of inappropriate pill splitting was highest from endocrinologists (3.4%, 429/12,477), nephrologists (1.3%, 81/6,028) and cardiologists (1.3%, 297/23,531). Multivariate logistic regression analysis revealed that the strongest factor associated with individual specific drug of inappropriate splitting was particular physician specialties. Conclusion: This study provides important insights into the inappropriate prescription of special oral formulation related to pill splitting, and helps to aggregate information that can assist medical professionals in creating processes for reducing inappropriate pill splitting in the future.	[Chou, Chia-Yu] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Chou, Chia-Yu; Chang, Yuh-Lih; Chou, Yueh-Ching] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan; [Chou, Chia-Yu; Ho, Chin-Chin; Chou, Yueh-Ching] Taipei Med Univ, Coll Pharm, Taipei, Taiwan; [Chou, Chia-Yu] Natl Def Med Ctr, Dept Internal Med, Sch Med, Taipei, Taiwan; [Chou, Chia-Yu; Tsai, Han-Yi] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Hsu, Chia-Chen; Ho, Chin-Chin; Chou, Chia-Lin; Wu, Min-Shan; Chang, Yuh-Lih; Tsai, Han-Yi; Chou, Yueh-Ching] Taipei Vet Gen Hosp, Dept Pharm, Taipei, Taiwan; [Chiang, Shu-Chiung; Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; National Defense Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chou, YC (corresponding author), Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 112, Taiwan.	ycchou@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021; Hsu, Chia-Chen/AAB-3117-2019		Taipei Veterans General Hospital [V102A-053]; National Science Council	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Taipei Veterans General Hospital (V102A-053) and the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khaja KAJ, 2005, INT J CLIN PHARM TH, V43, P294; Bachynsky J, 2002, PHARMACOECONOMICS, V20, P339, DOI 10.2165/00019053-200220050-00005; Cohen JS, 2000, GERIATRICS-US, V55, P54; Cornish P, 2005, CAN MED ASSOC J, V172, P871, DOI 10.1503/cmaj.050176; Lesar TS, 2002, J GEN INTERN MED, V17, P579, DOI 10.1046/j.1525-1497.2002.11056.x; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002; Munar MY, 2007, AM FAM PHYSICIAN, V75, P1487; Noviasky J, 2006, J FAM PRACTICE, V55, P707; Paparella S, 2010, J EMERG NURS, V36, P156, DOI 10.1016/j.jen.2009.11.019; Quinzler R, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-30; Schier JG, 2003, ANN PHARMACOTHER, V37, P1420, DOI 10.1345/aph.1D091; Senst BL, 2001, AM J HEALTH-SYST PH, V58, P1126, DOI 10.1093/ajhp/58.12.1126; Sera LC, 2012, CLIN GERIATR MED, V28, P273, DOI 10.1016/j.cger.2012.01.007; van Santen E, 2002, EUR J PHARM BIOPHARM, V53, P139, DOI 10.1016/S0939-6411(01)00228-4; Verrue C, 2011, J ADV NURS, V67, P26, DOI 10.1111/j.1365-2648.2010.05477.x	16	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70113	10.1371/journal.pone.0070113	http://dx.doi.org/10.1371/journal.pone.0070113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922926	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700138
J	Fremont-Rahl, JJ; Ge, ZM; Umana, C; Whary, MT; Taylor, NS; Muthupalani, S; Carey, MC; Fox, JG; Maurer, KJ				Fremont-Rahl, Jacqueline J.; Ge, Zhongming; Umana, Carlos; Whary, Mark T.; Taylor, Nancy S.; Muthupalani, Sureshkumar; Carey, Martin C.; Fox, James G.; Maurer, Kirk J.			An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis	PLOS ONE			English	Article							GUT MICROBIOME; OBESITY; DISEASE; MUCIN; CHOLELITHIASIS; BACTERIA; HORMONE; FLORA	Background and Aims: Cholesterol gallstone disease is a complex process involving both genetic and environmental variables. No information exists regarding what role if any the indigenous gastrointestinal microbiota may play in cholesterol gallstone pathogenesis and whether variations in the microbiota can alter cholesterol gallstone prevalence rates. Methods: Genetically related substrains (BALB/cJ and BALB/cJBomTac) and (BALB/AnNTac and BALB/cByJ) of mice obtained from different vendors were compared for cholesterol gallstone prevalence after being fed a lithogenic diet for 8 weeks. The indigenous microbiome was altered in these substrains by oral gavage of fecal slurries as adults, by cross-fostering to mice with divergent flora at <1day of age or by rederiving into a germ-free state. Results: Alterations in the indigenous microbiome altered significantly the accumulation of mucin gel and normalized gallbladder weight but did not alter cholesterol gallstone susceptibility in conventionally housed SPF mice. Germ-free rederivation rendered mice more susceptible to cholesterol gallstone formation. This susceptibility appeared to be largely due to alterations in gallbladder size and gallbladder wall inflammation. Colonization of germ-free mice with members of altered Schaedler flora normalized the gallstone phenotype to a level similar to conventionally housed mice. Conclusions: These data demonstrate that alterations in the gastrointestinal microbiome may alter aspects of cholesterol gallstone pathogenesis and that in the appropriate circumstances these changes may impact cholesterol cholelithogenesis.	[Fremont-Rahl, Jacqueline J.; Ge, Zhongming; Umana, Carlos; Whary, Mark T.; Taylor, Nancy S.; Muthupalani, Sureshkumar; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Carey, Martin C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA; [Carey, Martin C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Maurer, Kirk J.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; [Maurer, Kirk J.] Cornell Univ, Ctr Anim Resources & Educ, Ithaca, NY USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Cornell University; Cornell University	Maurer, KJ (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	Kirk.J.Maurer@Dartmouth.edu	Muthupalani, Sureshkumar/C-7244-2015	Ge, Zhongming/0000-0003-0924-7563	National Institutes of Health [K08 DK077728, T32OD010978, P30ES002109, R01AT004326, R37DK036588]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK036588, K08DK077728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978, R01OD011141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health grants K08 DK077728 (KJM), T32OD010978 (JGF), P30ES002109 (JGF), R01AT004326 (JGF), and R37DK036588 (MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2010, BBA-MOL CELL BIOL L, V1801, P240, DOI 10.1016/j.bbalip.2009.09.009; Behar J, 2013, NEUROGASTROENT MOTIL, V25, P283, DOI 10.1111/nmo.12094; Carey MC, 2002, HEPATOLOGY, V36, P781, DOI 10.1053/jhep.2002.36545; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Hayashi T, 2001, DIGESTION, V63, P28, DOI 10.1159/000051907; HILGERS J, 1985, CURR TOP MICROBIOL, V122, P19; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Jones SA, 2012, ADV EXP MED BIOL, V728, P171, DOI 10.1007/978-1-4614-0887-1_11; Jungst C, 2006, BEST PRACT RES CL GA, V20, P1053, DOI 10.1016/j.bpg.2006.03.007; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729; Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Liu B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a386; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maurer KJ, 2007, GASTROENTEROLOGY, V133, P1304, DOI 10.1053/j.gastro.2007.07.005; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Morowitz MJ, 2011, SURG CLIN N AM, V91, P771, DOI 10.1016/j.suc.2011.05.001; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; POTTER M, 1985, CURR TOP MICROBIOL, V122, P1; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; SNYDER JD, 1987, INT ARCH ALLER A IMM, V82, P351, DOI 10.1159/000234225; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; VANBERGEHENEGOUWEN GP, 1978, GASTROENTEROLOGY, V75, P879; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; Wang David Q-H, 2004, Curr Gastroenterol Rep, V6, P140, DOI 10.1007/s11894-004-0042-1; Wang DQH, 1997, J LIPID RES, V38, P1395; Wang HH, 2006, GASTROENTEROLOGY, V131, P210, DOI 10.1053/j.gastro.2006.04.011; Wang HH, 2004, AM J PHYSIOL-GASTR L, V287, pG547, DOI 10.1152/ajpgi.00097.2004; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whary MT, 2011, IMMUNOLOGY, V133, P165, DOI 10.1111/j.1365-2567.2011.03423.x; Wittenburg H, 2010, BEST PRACT RES CL GA, V24, P747, DOI 10.1016/j.bpg.2010.07.004	41	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70657	10.1371/journal.pone.0070657	http://dx.doi.org/10.1371/journal.pone.0070657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923015	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700202
J	Kalivoda, EJ; Brothers, KM; Stella, NA; Schmitt, MJ; Shanks, RMQ				Kalivoda, Eric J.; Brothers, Kimberly M.; Stella, Nicholas A.; Schmitt, Matthew J.; Shanks, Robert M. Q.			Bacterial Cyclic AMP-Phosphodiesterase Activity Coordinates Biofilm Formation	PLOS ONE			English	Article							3',5'-CYCLIC-AMP CAMP PHOSPHODIESTERASE; RECEPTOR PROTEIN; ESCHERICHIA-COLI; SERRATIA-MARCESCENS; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; CATABOLITE REPRESSION; RPOS EXPRESSION; CPDA GENE; VIRULENCE	Biofilm-related infections are a major contributor to human disease, and the capacity for surface attachment and biofilm formation are key attributes for the pathogenesis of microbes. Serratia marcescens type I fimbriae-dependent biofilms are coordinated by the adenylate cyclase, CyaA, and the cyclic 3',5'-adenosine monophosphate (cAMP)-cAMP receptor protein (CRP) complex. This study uses S. marcescens as a model system to test the role of cAMP-phosphodiesterase activity in controlling biofilm formation. Herein we describe the characterization of a putative S. marcescens cAMP-phosphodiesterase gene (SMA3506), designated as cpdS, and demonstrated to be a functional cAMP-phosphodiesterase both in vitro and in vivo. Deletion of cpdS resulted in defective biofilm formation and reduced type I fimbriae production, whereas multicopy expression of cpdS conferred a type I fimbriae-dependent hyper-biofilm. Together, these results support a model in which bacterial cAMP-phosphodiesterase activity modulates biofilm formation.	[Kalivoda, Eric J.; Brothers, Kimberly M.; Stella, Nicholas A.; Schmitt, Matthew J.; Shanks, Robert M. Q.] Univ Pittsburgh, Dept Ophthalmol, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shanks, RMQ (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA.	shanksrm@upmc.edu	Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Brothers, Kimberly/0000-0003-2055-9760	NIH [AI085570, EY08098]; Research to Prevent Blindness Career Development Award; Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH grant AI085570 and a Research to Prevent Blindness Career Development Award to RS and support from NIH grant EY08098, the Eye and Ear Foundation of Pittsburgh, and unrestricted funds from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; ADEGBOLA RA, 1982, INFECT IMMUN, V38, P306, DOI 10.1128/IAI.38.1.306-315.1982; ALPER MD, 1978, J BACTERIOL, V133, P149, DOI 10.1128/JB.133.1.149-157.1978; ALPER MD, 1975, J BACTERIOL, V122, P1081, DOI 10.1128/JB.122.3.1081-1090.1975; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; BOTSFORD JL, 1984, J BACTERIOL, V160, P826, DOI 10.1128/JB.160.2.826-830.1984; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; BOTSFORD JL, 1978, MOL GEN GENET, V165, P47, DOI 10.1007/BF00270375; Burke D., 2000, METHODS YEAST GENETI; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; CURTISS R, 1988, VACCINE, V6, P155, DOI 10.1016/S0264-410X(88)80020-3; Dove SL, 1997, MOL GEN GENET, V254, P13, DOI 10.1007/s004380050385; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gunther NW, 2002, INFECT IMMUN, V70, P3344, DOI 10.1128/IAI.70.7.3344-3354.2002; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hantke K, 2011, J BACTERIOL, V193, P1086, DOI 10.1128/JB.01399-10; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Higashida H, 2002, ANAL BIOCHEM, V308, P106, DOI 10.1016/S0003-2697(02)00237-3; HOSONO K, 1988, METHOD ENZYMOL, V159, P497; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Huynh TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042874; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Inclan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015867; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Labbate M, 2007, J BACTERIOL, V189, P2702, DOI 10.1128/JB.01582-06; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Lee HJ, 2008, J BIOL CHEM, V283, P30438, DOI 10.1074/jbc.M802219200; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Lin CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054430; Macfadyen LP, 1998, J BACTERIOL, V180, P4401, DOI 10.1128/JB.180.17.4401-4405.1998; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; NICHOLS WA, 1990, MOL MICROBIOL, V4, P2119, DOI 10.1111/j.1365-2958.1990.tb00573.x; Nolan LM, 2012, MICROBIOLOGYOPEN, V1, P490, DOI 10.1002/mbo3.49; OKABAYASHI T, 1970, BIOCHIM BIOPHYS ACTA, V220, P116, DOI 10.1016/0005-2744(70)90235-4; Petersen S, 2002, INFECT IMMUN, V70, P3665, DOI 10.1128/IAI.70.7.3665-3672.2002; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rice SA, 2005, J BACTERIOL, V187, P3477, DOI 10.1128/JB.187.10.3477-3485.2005; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shanks RMQ, 2013, RES MICROBIOL, V164, P38, DOI 10.1016/j.resmic.2012.10.006; Shanks RMQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036398; Shanks RMQ, 2012, ARCH MICROBIOL, V194, P575, DOI 10.1007/s00203-012-0793-2; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Ueguchi C, 2001, J BACTERIOL, V183, P520, DOI 10.1128/JB.183.2.520-527.2001; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; WINKLER U, 1975, ARCH MICROBIOL, V104, P189, DOI 10.1007/BF00447323	69	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71267	10.1371/journal.pone.0071267	http://dx.doi.org/10.1371/journal.pone.0071267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923059	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700230
J	Kaneko, H; Kikuchi, K; Nakai, M; Somfai, T; Noguchi, J; Tanihara, F; Ito, J; Kashiwazaki, N				Kaneko, Hiroyuki; Kikuchi, Kazuhiro; Nakai, Michiko; Somfai, Tamas; Noguchi, Junko; Tanihara, Fuminori; Ito, Junya; Kashiwazaki, Naomi			Generation of Live Piglets for the First Time Using Sperm Retrieved from Immature Testicular Tissue Cryopreserved and Grafted into Nude Mice	PLOS ONE			English	Article							PORCINE TESTIS TISSUE; IN-VITRO; VIABLE PIGLETS; HEAD INJECTION; MOUSE EMBRYOS; DONOR AGE; XENOGRAFTS; SPERMATOGENESIS; VITRIFICATION; MATURATION	Cryopreservation of immature testicular tissues is essential for increasing the possibilities of offspring generation by testicular xenografting for agricultural or medical purposes. However, successful production of offspring from the sperm involved has never been reported previously. In the present study, therefore, using intracytoplasmic sperm injection (ICSI), we examined whether xenogeneic sperm obtained from immature pig testicular tissue after cryopreservation would have the capacity to produce live piglets. Testicular fragments from 9- to 11-day-old piglets were vitrified after 10- or 20-min immersion in vitrification solution containing ethylene glycol (EG), polyvinyl pyrrolidone (PVP) and trehalose as cryoprotectants, and then stored in liquid nitrogen for more than 140 days. Thirty nude mice were assigned to each immersion-time group. Testicular fragments were transplanted under the back skin of castrated mice immediately after warming and removal of the cryoprotectants. Blood and testicular grafts were then recovered from the recipient mice on days 60, 120, 180 and 230-350 (day 0 = grafting). Histological assessment of the testicular grafts and analyses of inhibin and testosterone production revealed no significant differences between the two immersion-time groups, indicating equal growth activity of the cryopreserved tissues. A single sperm obtained from a mouse in each group on day 230-350 was injected into an in vitro-matured porcine oocyte, and then the ICSI oocytes were transferred to the oviducts of estrus-synchronized recipient gilts. One out of 4 gilts that had received oocytes fertilized using sperm from the 10-min immersion group delivered 2 live piglets, and one of another 4 gilts from the 20-min group delivered 4 live piglets. Thus, we have successfully generated porcine offspring utilizing sperm from immature testicular tissues after cryopreservation and transplantation into nude mice. The present model using pigs will be applicable to many large animals, since pigs are phylogenetically distant from the murine recipients.	[Kaneko, Hiroyuki; Kikuchi, Kazuhiro; Noguchi, Junko] Natl Inst Agrobiol Sci, Anim Dev & Differentiat Res Unit, Tsukuba, Ibaraki, Japan; [Kikuchi, Kazuhiro; Tanihara, Fuminori] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Nakai, Michiko] Natl Inst Agrobiol Sci, Transgen Pig Res Unit, Tsukuba, Ibaraki, Japan; [Somfai, Tamas] NARO Inst Livestock & Grassland Sci, Anim Breeding & Reprod Div, Tsukuba, Ibaraki, Japan; [Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan	National Institute of Agrobiological Sciences - Japan; Yamaguchi University; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan; Azabu University	Kikuchi, K (corresponding author), Natl Inst Agrobiol Sci, Anim Dev & Differentiat Res Unit, Tsukuba, Ibaraki, Japan.	kiku@affrc.go.jp		Tanihara, Fuminori/0000-0002-2158-5808	Japanese Society for the Promotion of Science (JSPS) [21380175, 22380153]; Grants-in-Aid for Scientific Research [22380153] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science (JSPS) to H. Kaneko (21380175) and K. Kikuchi (22380153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrishami M, 2010, THERIOGENOLOGY, V73, P512, DOI 10.1016/j.theriogenology.2009.09.035; Abrishami M, 2010, THERIOGENOLOGY, V73, P86, DOI 10.1016/j.theriogenology.2009.08.004; Ahn HJ, 2002, MOL REPROD DEV, V61, P466, DOI 10.1002/mrd.10040; Caires KC, 2008, REPROD DOMEST ANIM, V43, P280, DOI 10.1111/j.1439-0531.2008.01175.x; Colenbrander B., 1982, Control of pig reproduction, P3; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; Dziuk P, 1985, J Reprod Fertil Suppl, V33, P57; HAMADA T, 1989, J ENDOCRINOL, V122, P697, DOI 10.1677/joe.0.1220697; Honaramooz A, 2002, NATURE, V418, P778, DOI 10.1038/nature00918; Honaramooz A, 2004, BIOL REPROD, V70, P1500, DOI 10.1095/biolreprod.103.025536; Jahnukainen K, 2007, HUM REPROD, V22, P1060, DOI 10.1093/humrep/del471; Kaneko H, 2002, BIOL REPROD, V67, P1840, DOI 10.1095/biolreprod.102.007591; Kaneko H, 2008, J REPROD DEVELOP, V54, P480, DOI 10.1262/jrd.20081; Kashiwakura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049450; Kawarasaki T, 2009, ANIM REPROD SCI, V112, P8, DOI 10.1016/j.anireprosci.2008.03.022; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Kim Y, 2007, REPROD FERT DEVELOP, V19, P869, DOI 10.1071/RD07056; Nakai M, 2007, ZYGOTE, V15, P15, DOI 10.1017/S0967199406003935; Nakai M, 2003, BIOL REPROD, V68, P1003, DOI 10.1095/biolreprod.102.009506; Nakai M, 2009, THERIOGENOLOGY, V72, P2, DOI 10.1016/j.theriogenology.2008.10.020; Nakai M, 2010, REPRODUCTION, V139, P331, DOI 10.1530/REP-09-0509; Oatley OM, 2004, BIOL REPROD, V71, P494, DOI 10.1095/biolreprod.104.027953; Ohnuma K, 2007, DOMEST ANIM ENDOCRIN, V33, P410, DOI 10.1016/j.domaniend.2006.08.004; Peter FH, 1994, PHYSL REPROD, P1335; Phillips DJ, 2005, DOMEST ANIM ENDOCRIN, V28, P1, DOI 10.1016/j.domaniend.2004.05.006; Poels J, 2012, THERIOGENOLOGY, V77, P1008, DOI 10.1016/j.theriogenology.2011.10.015; Poels J, 2013, HUM REPROD, V28, P578, DOI 10.1093/humrep/des455; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rathi R, 2005, REPRODUCTION, V130, P923, DOI 10.1530/rep.1.00912; Rathi R, 2006, REPRODUCTION, V131, P1091, DOI 10.1530/rep.1.01101; Rathi R, 2008, ENDOCRINOLOGY, V149, P5288, DOI 10.1210/en.2008-0311; Schlatt S, 2002, REPRODUCTION, V124, P339, DOI 10.1530/rep.0.1240339; Schmidt JA, 2006, BIOL REPROD, V75, P167, DOI 10.1095/biolreprod.105.049817; Schmidt JA, 2006, BIOL REPROD, V75, P160, DOI 10.1095/biolreprod.105.049825; Shinohara T, 2002, HUM REPROD, V17, P3039, DOI 10.1093/humrep/17.12.3039; Snedaker AK, 2004, J ANDROL, V25, P926; Somfai T, 2010, THERIOGENOLOGY, V73, P147, DOI 10.1016/j.theriogenology.2009.08.008; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; Sun QY, 2008, BIOL REPROD, V79, P1014, DOI 10.1095/biolreprod.108.070409; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; Van Saen D, 2011, HUM REPROD, V26, P282, DOI 10.1093/humrep/deq321; Wakayama T., 2002, PRINCIPLES CLONING, P301; Zeng W, 2009, REPROD FERT DEVELOP, V21, P489, DOI 10.1071/RD08235; Zeng WX, 2007, MOL REPROD DEV, V74, P674, DOI 10.1002/mrd.20670	45	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70989	10.1371/journal.pone.0070989	http://dx.doi.org/10.1371/journal.pone.0070989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923039	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700217
J	Nakayama, K; Moriwaki, K; Imai, T; Shinzaki, S; Kamada, Y; Murata, K; Miyoshi, E				Nakayama, Kotarosumitomo; Moriwaki, Kenta; Imai, Taku; Shinzaki, Shinichiro; Kamada, Yoshihiro; Murata, Kohei; Miyoshi, Eiji			Mutation of GDP-Mannose-4,6-Dehydratase in Colorectal Cancer Metastasis	PLOS ONE			English	Article							ADHESION DEFICIENCY-II; GDP-FUCOSE TRANSPORTER; CARBOHYDRATE DETERMINANTS; INCOMPLETE-SYNTHESIS; MOLECULAR-CLONING; CELLS	Fucosylation is a crucial oligosaccharide modification in cancer. The known function of fucosylation in cancer is to mediate metastasis through selectin ligand-dependent processes. Previously, we found complete loss of fucosylation in the colon cancer cell line HCT116 due to a mutation in the GDP-fucose synthetic enzyme, GDP-mannose-4,6-dehydratase (GMDS). Loss of fucosylation led to escape of cancer cells from tumor immune surveillance followed by tumor progression and metastasis, suggesting a novel function of fucosylation in tumor progression pathway. In the present study, we investigated the frequency of GMDS mutation in a number of clinical colorectal cancer tissue samples: 81 samples of primary colorectal cancer tissue and 39 samples of metastatic lesion including liver and lymph node. Four types of deletion mutation in GMDS were identified in original cancer tissues as well as metastatic lesions. The frequency of GMDS mutation was slightly higher in metastatic lesions (12.8%, 5/39 samples) than in original cancer tissues (8.6%, 7/81 samples). No mutation of the GMDS gene was observed in normal colon tissues surrounding cancer tissues, suggesting that the mutation is somatic rather than in the germline. Immunohistochemical analysis revealed complete loss of fucosylation in three cases of cancer tissue. All three cases had GMDS mutation. In one of three cases, loss of fucosylation was observed in only metastatic lesion, but not its original colon cancer tissue. These data demonstrate involvement of GMDS mutation in the progression of colorectal cancer.	[Nakayama, Kotarosumitomo; Moriwaki, Kenta; Imai, Taku; Shinzaki, Shinichiro; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan; [Murata, Kohei] Suita Municipal Hosp, Dept Surg, Osaka, Japan	Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp	Kamada, Yoshihiro/AHC-1613-2022; Kamada, Yoshihiro/H-3309-2019; Kamada, Yoshihiro/GQA-8854-2022	Kamada, Yoshihiro/0000-0001-5485-902X; Kamada, Yoshihiro/0000-0001-5485-902X; Moriwaki, Kenta/0000-0002-8724-4715	New Energy and Industrial Technology Development Organization (NEDO) as a part of the Developing Technology Project for Implementing Sugar Chain Functions in Japan; Global COE Program of Osaka University; Ministry of Education, Culture, Sports, Science and Technology of Japan	New Energy and Industrial Technology Development Organization (NEDO) as a part of the Developing Technology Project for Implementing Sugar Chain Functions in Japan; Global COE Program of Osaka University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan and was partially supported by the New Energy and Industrial Technology Development Organization (NEDO) as a part of the Developing Technology Project for Implementing Sugar Chain Functions in Japan. This work was also supported in part by the Global COE Program of Osaka University funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	AOYAGI Y, 1985, LANCET, V2, P1353; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Moriwaki K, 2010, GLYCOCONJUGATE J, V27, P649, DOI 10.1007/s10719-010-9310-5; Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; REGUIGNEARNOULD I, 1995, CYTOGENET CELL GENET, V71, P158, DOI 10.1159/000134098; Sakuma K, 2006, BIOCHEM BIOPH RES CO, V340, P829, DOI 10.1016/j.bbrc.2005.12.072; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; SZYMENDERA JJ, 1986, TUMOR BIOL, V7, P333; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Yakubenia S, 2006, FEBS J, V273, P4390, DOI 10.1111/j.1742-4658.2006.05438.x	18	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70298	10.1371/journal.pone.0070298	http://dx.doi.org/10.1371/journal.pone.0070298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922970	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700165
J	Warimwe, GM; Recker, M; Kiragu, EW; Buckee, CO; Wambua, J; Musyoki, JN; Marsh, K; Bull, PC				Warimwe, George M.; Recker, Mario; Kiragu, Esther W.; Buckee, Caroline O.; Wambua, Juliana; Musyoki, Jennifer N.; Marsh, Kevin; Bull, Peter C.			Plasmodium falciparum var Gene Expression Homogeneity as a Marker of the Host-Parasite Relationship under Different Levels of Naturally Acquired Immunity to Malaria	PLOS ONE			English	Article							ERYTHROCYTE SURFACE-ANTIGENS; INFECTED ERYTHROCYTES; CLINICAL MALARIA; ANTIBODIES; CHILDREN; PROTECTION; MORBIDITY; DIVERSITY; SEQUENCE; KENYA	Acquired immunity to Plasmodium falciparum infection causes a change from frequent, sometimes life-threatening, malaria in young children to asymptomatic, chronic infections in older children and adults. Little is known about how this transition occurs but antibodies to the extremely diverse PfEMP1 parasite antigens are thought to play a role. PfEMP1 is encoded by a family of 60 var genes that undergo clonal antigenic variation, potentially creating an antigenically heterogeneous infecting population of parasites within the host. Previous theoretical work suggests that antibodies to PfEMP1 may play a role in "orchestrating" their expression within infections leading to sequential, homogeneous expression of var genes, and prolonged infection chronicity. Here, using a cloning and sequencing approach we compare the var expression homogeneity (VEH) between isolates from children with asymptomatic and clinical infections. We show that asymptomatic infections have higher VEH than clinical infections and a broader host antibody response. We discuss this in relation to the potential role of host antibodies in promoting chronicity of infection and parasite survival through the low transmission season.	[Warimwe, George M.; Kiragu, Esther W.; Wambua, Juliana; Musyoki, Jennifer N.; Marsh, Kevin; Bull, Peter C.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Pathogen Vector & Human Biol Dept, Kilifi, Kenya; [Warimwe, George M.] Univ Oxford, Jenner Inst, Oxford, England; [Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Buckee, Caroline O.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Marsh, Kevin; Bull, Peter C.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Kenya Medical Research Institute; University of Oxford; Jenner Institute; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford	Bull, PC (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Pathogen Vector & Human Biol Dept, Kilifi, Kenya.	pbull@kemri-wellcome.org		Recker, Mario/0000-0001-9489-1315; Bull, Peter/0000-0002-7674-6752	Wellcome Trust [092741, 084535, 077092, 076030, 084538]; Royal Society	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	PCB and GMW were supported by Wellcome Trust (www.wellcome.ac.uk/)Programme Grants (092741, 084535 and 077092 to PCB and/or KM) and Project Grant (076030 to PCB and KM). GMW was also supported by a Wellcome Trust Strategic Award (084538 to KM). MR is funded by a Royal Society (royalsociety.org/) University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Buckee CO, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002451; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; FORSYTH KP, 1989, AM J TROP MED HYG, V41, P259, DOI 10.4269/ajtmh.1989.41.259; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; IQBAL J, 1993, T ROY SOC TROP MED H, V87, P583, DOI 10.1016/0035-9203(93)90097-A; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Kyes S, 1997, AM J TROP MED HYG, V57, P205, DOI 10.4269/ajtmh.1997.57.205; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; Merrick CJ, 2012, J INFECT DIS, V205, P1593, DOI 10.1093/infdis/jis239; Michael C, 1999, J CELL SCI, V112, P3187; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; VIRIYAKOSOL S, 1995, B WORLD HEALTH ORGAN, V73, P85; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; Warimwe GM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003247; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70467	10.1371/journal.pone.0070467	http://dx.doi.org/10.1371/journal.pone.0070467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922996	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700186
J	Zhang, J; Wang, P; Ouyang, HQ; Yin, JH; Liu, AH; Ma, CZ; Liu, LM				Zhang, Juan; Wang, Peng; Ouyang, Huaqiang; Yin, Jianhua; Liu, Aihua; Ma, Chunzheng; Liu, Luming			Targeting Cancer-Related Inflammation: Chinese Herbal Medicine Inhibits Epithelial-to-Mesenchymal Transition in Pancreatic Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVE MEDICINE; QINGYIHUAJI FORMULA; LIVER METASTASES; MOUSE MODEL; CELLS; CARCINOMA; GEMCITABINE; PROGRESSION; COMPLEMENTARY	Pancreatic cancer is an almost universally fatal disease resulting from early invasion of adjacent structures and metastasis and the lack of an effective treatment modality. Our previous studies have shown that Qingyihuaji Formula (QYHJ), a seven-herb Chinese medicine formula, had significant anti-cancer effects in pancreatic cancer. Here, we examined the effects of QYHJ on pancreatic cancer cell invasion and metastasis and the potential associated mechanism(s). We found that QYHJ inhibited both tumor growth and metastasis in nude mice with human pancreatic cancer cell xenografts. Further study indicated that QYHJ inhibited epithelial-to-mesenchymal transition (EMT), which is characterized by increased E-cadherin expression and decreased vimentin, N-cadherin and Slug expression. Interleukin 6 (IL-6), a pro-inflammatory cytokine produced mainly by macrophages, could promote cancer cell EMT and invasion. In contrast, treatment with QYHJ inhibited cancer-related inflammation in tumors by decreasing infiltration of tumor-associated macrophages and IL-6 production, thus preventing cell invasion and metastasis. These results suggested that the Chinese herbal medicine QYHJ could inhibit pancreatic cancer cell invasion and metastasis in part by reversing tumor-supporting inflammation.	[Zhang, Juan; Wang, Peng; Ouyang, Huaqiang; Yin, Jianhua; Liu, Luming] Fudan Univ, Dept Integrat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Zhang, Juan; Wang, Peng; Ouyang, Huaqiang; Yin, Jianhua; Liu, Luming] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Juan; Liu, Aihua; Ma, Chunzheng] Henan Univ TCM, Dept Clin Med Coll 2, Zhengzhou, Peoples R China	Fudan University; Fudan University; Henan University of Traditional Chinese Medicine	Ma, CZ (corresponding author), Henan Univ TCM, Dept Clin Med Coll 2, Zhengzhou, Peoples R China.	mchzh666@126.com; llm1010@yahoo.com.cn		Ouyang, Huaqiang/0000-0002-7702-2545	National Science Foundation of China [81001061, 81072942, 81173461]; Shanghai Nature Science Fund, Shanghai, China [09ZR1406800]; Doctoral Programs Foundation of Ministry of Education of China [20090071120076]; Shanghai Science and Technology Committee Rising-Star Program [11QA1401300]; Medical Talents Training Program of Health Bureau of Shanghai [XYQ2011008]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Fund, Shanghai, China; Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shanghai Science and Technology Committee Rising-Star Program; Medical Talents Training Program of Health Bureau of Shanghai	This study was supported by National Science Foundation of China (81001061, 81072942, 81173461); Shanghai Nature Science Fund, Shanghai, China (09ZR1406800); Doctoral Programs Foundation of Ministry of Education of China (20090071120076); Shanghai Science and Technology Committee Rising-Star Program (11QA1401300); and Medical Talents Training Program of Health Bureau of Shanghai (XYQ2011008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chang KH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-196; Chen Z, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/635702; Chen Z, 2008, J ALTERN COMPLEM MED, V14, P1049, DOI 10.1089/acm.2008.0039; Dong P, 2011, J ETHNOPHARMACOL, V137, P1373, DOI 10.1016/j.jep.2011.08.005; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Graeser R, 2009, PANCREAS, V38, P330, DOI 10.1097/MPA.0b013e31819436e6; HELLE M, 1991, PROG CLIN BIOL RES, V367, P61; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Kim DK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-155; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; [刘恩莉 Liu Enchi], 2004, [肿瘤, Tumor], V24, P11; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; McCulloch M, 2006, J CLIN ONCOL, V24, P419, DOI 10.1200/JCO.2005.03.6392; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Ouyang HQ, 2011, PANCREAS, V40, P120, DOI 10.1097/MPA.0b013e3181e6e398; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai CH, 2009, CLIN CANCER RES, V15, P5435, DOI 10.1158/1078-0432.CCR-09-0298; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wang P, 2010, INTEGR CANCER THER, V9, P50, DOI 10.1177/1534735409359179; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Xiong W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-219; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yin JH, 2012, INTEGR CANCER THER, V11, P37, DOI 10.1177/1534735411400315; Zhen T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003562	46	27	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70334	10.1371/journal.pone.0070334	http://dx.doi.org/10.1371/journal.pone.0070334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922983	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700177
J	Hanson, JE; La, H; Plise, E; Chen, YH; Ding, X; Hanania, T; Sabath, EV; Alexandrov, V; Brunner, D; Leahy, E; Steiner, P; Liu, LC; Scearce-Levie, K; Zhou, Q				Hanson, Jesse E.; La, Hank; Plise, Emile; Chen, Yung-Hsiang; Ding, Xiao; Hanania, Taleen; Sabath, Emily V.; Alexandrov, Vadim; Brunner, Dani; Leahy, Emer; Steiner, Pascal; Liu, Lichuan; Scearce-Levie, Kimberly; Zhou, Qiang			SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; MOUSE MODEL; ALZHEIMERS-DISEASE; MEMORY FORMATION; ACETYLATION; MICE; HIPPOCAMPUS; FEAR; VORINOSTAT	Suberoylanilide hydroxamic acid (SAHA) is an inhibitor of histone deacetylases (HDACs) used for the treatment of cutaneous T cell lymphoma (CTCL) and under consideration for other indications. In vivo studies suggest reducing HDAC function can enhance synaptic function and memory, raising the possibility that SAHA treatment could have neurological benefits. We first examined the impacts of SAHA on synaptic function in vitro using rat organotypic hippocampal brain slices. Following several days of SAHA treatment, basal excitatory but not inhibitory synaptic function was enhanced. Presynaptic release probability and intrinsic neuronal excitability were unaffected suggesting SAHA treatment selectively enhanced postsynaptic excitatory function. In addition, long-term potentiation (LTP) of excitatory synapses was augmented, while long-term depression (LTD) was impaired in SAHA treated slices. Despite the in vitro synaptic enhancements, in vivo SAHA treatment did not rescue memory deficits in the Tg2576 mouse model of Alzheimer's disease (AD). Along with the lack of behavioral impact, pharmacokinetic analysis indicated poor brain availability of SAHA. Broader assessment of in vivo SAHA treatment using high-content phenotypic characterization of C57Bl6 mice failed to demonstrate significant behavioral effects of up to 150 mg/kg SAHA following either acute or chronic injections. Potentially explaining the low brain exposure and lack of behavioral impacts, SAHA was found to be a substrate of the blood brain barrier (BBB) efflux transporters Pgp and Bcrp1. Thus while our in vitro data show that HDAC inhibition can enhance excitatory synaptic strength and potentiation, our in vivo data suggests limited brain availability may contribute to the lack of behavioral impact of SAHA following peripheral delivery. These results do not predict CNS effects of SAHA during clinical use and also emphasize the importance of analyzing brain drug levels when interpreting preclinical behavioral pharmacology.	[Hanson, Jesse E.; Steiner, Pascal; Scearce-Levie, Kimberly; Zhou, Qiang] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [La, Hank; Plise, Emile; Chen, Yung-Hsiang; Ding, Xiao; Liu, Lichuan] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Hanania, Taleen; Sabath, Emily V.; Alexandrov, Vadim; Brunner, Dani; Leahy, Emer] PsychoGenics Inc, Tarrytown, NY USA; [Brunner, Dani] Columbia Univ, Dept Psychiat, New York, NY USA	Roche Holding; Genentech; Roche Holding; Genentech; Columbia University	Hanson, JE (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	jesseeh@gene.com	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113	Genentech	Genentech(Roche HoldingGenentech)	While conducting this study, all authors were paid employees of either Genentech, a member of the Roche Group, or Psychogenics Inc. The work done for this study at Psychogenics was funded by a research contract with Genentech. There were no other funders for this work. Genentech authors participated in the study design and decision to publish the work done at Psychogenics, but did not participate in the data collection or analysis done by Psychogenics.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Balducci C, 2011, J ALZHEIMERS DIS, V24, P799, DOI 10.3233/JAD-2011-101839; Beconi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044498; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brunner D, 2012, POLYPHARMACOLOGY DRU, P301; Butler KV, 2008, CURR PHARM DESIGN, V14, P505; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Duvic M, 2007, BIOL-TARGETS THER, V1, P377; Fass DM, 2013, NEUROPHARMACOLOGY; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hanson JE, 2013, J NEUROSCI, V33, P5924, DOI 10.1523/JNEUROSCI.3162-12.2013; Hanson JE, 2010, SPRINGER PROTOC HAND, P299, DOI 10.1007/978-1-60761-292-6_18; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lee J, 2009, BRAIN RES, V1288, P125, DOI 10.1016/j.brainres.2009.06.095; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liner Kevin J 2nd, 2010, Curr HIV/AIDS Rep, V7, P85, DOI 10.1007/s11904-010-0042-8; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lund CV, 2006, J NEURO-ONCOL, V78, P19, DOI 10.1007/s11060-005-9068-y; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Martinez-Iglesias O, 2008, CLIN TRANSL ONCOL, V10, P395, DOI 10.1007/s12094-008-0221-x; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Roberds SL, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00103; Sakajiri S, 2005, EXP HEMATOL, V33, P53, DOI 10.1016/j.exphem.2004.09.008; Schenberg EE, 2008, HIPPOCAMPUS, V18, P1089, DOI 10.1002/hipo.20475; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Spiller SE, 2008, J NEURO-ONCOL, V87, P133, DOI 10.1007/s11060-007-9505-1; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tessier P, 2009, BIOORG MED CHEM LETT, V19, P5684, DOI 10.1016/j.bmcl.2009.08.010; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Ververis K, 2011, AM J TRANSL RES, V3, P454; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261	49	86	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69964	10.1371/journal.pone.0069964	http://dx.doi.org/10.1371/journal.pone.0069964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922875	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900125
J	Seidenari, S; Arginelli, F; Dunsby, C; French, PMW; Konig, K; Magnoni, C; Talbot, C; Ponti, G				Seidenari, Stefania; Arginelli, Federica; Dunsby, Christopher; French, Paul M. W.; Koenig, Karsten; Magnoni, Cristina; Talbot, Clifford; Ponti, Giovanni			Multiphoton Laser Tomography and Fluorescence Lifetime Imaging of Melanoma: Morphologic Features and Quantitative Data for Sensitive and Specific Non-Invasive Diagnostics	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; BASAL-CELL CARCINOMA; IN-VIVO; CONFOCAL MICROSCOPY; CUTANEOUS MELANOMA; COMMON NEVI; DERMOSCOPY; RESOLUTION; METAANALYSIS; ACCURACY	Multiphoton laser tomography (MPT) combined with fluorescence lifetime imaging (FLIM) is a non-invasive imaging technique, based on the study of fluorescence decay times of naturally occurring fluorescent molecules, enabling a non-invasive investigation of the skin with subcellular resolution. The aim of this retrospective observational ex vivo study, was to characterize melanoma both from a morphologic and a quantitative point of view, attaining an improvement in the diagnostic accuracy with respect to dermoscopy. In the training phase, thirty parameters, comprising both cytological descriptors and architectural aspects, were identified. The training set included 6 melanomas with a mean Breslow thickness +/- S.D. of 0.89 +/- 0.48 mm. In the test phase, these parameters were blindly evaluated on a test data set consisting of 25 melanomas, 50 nevi and 50 basal cell carcinomas. Melanomas in the test phase comprised 8 in situ lesions and had a mean thickness +/- S. D. of 0.77 +/- 1.2 mm. Moreover, quantitative FLIM data were calculated for special areas of interest. Melanoma was characterized by the presence of atypical short lifetime cells and architectural disorder, in contrast to nevi presenting typical cells and a regular histoarchitecture. Sensitivity and specificity values for melanoma diagnosis were 100% and 98%, respectively, whereas dermoscopy achieved the same sensitivity, but a lower specificity (82%). Mean fluorescence lifetime values of melanocytic cells did not vary between melanomas and nevi, but significantly differed from those referring to basal cell carcinoma enabling a differential diagnosis based on quantitative data. Data from prospective preoperative trials are needed to confirm if MPT/FLIM could increase diagnostic specificity and thus reduce unnecessary surgical excisions.	[Seidenari, Stefania; Arginelli, Federica; Magnoni, Cristina] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy; [Dunsby, Christopher; French, Paul M. W.; Talbot, Clifford] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London, England; [Koenig, Karsten] Univ Saarland, Dept Biophoton & Lasertechnol, D-66123 Saarbrucken, Germany; [Koenig, Karsten] JenLab GmbH, Jena, Germany; [Ponti, Giovanni] Univ Hosp Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy	Universita di Modena e Reggio Emilia; Imperial College London; Saarland University; JenLab GmbH; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Ponti, G (corresponding author), Univ Hosp Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy.	giovanni.ponti@unimore.it	Ponti, Giovanni/A-5565-2012; French, Paul/E-8649-2011; Magnoni, Cristina/F-5367-2017	Ponti, Giovanni/0000-0002-1971-7306; Magnoni, Cristina/0000-0002-6081-4925; French, Paul/0000-0002-0478-6755	European Communities [HEALTH-f7-2008-201577]	European Communities(European Commission)	The study was supported by the European Communities (grant agreement number HEALTH-f7-2008-201577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Arginelli F, 2013, SKIN RES TECHNOL, V19, P194, DOI 10.1111/srt.12035; Bafounta ML, 2001, ARCH DERMATOL, V137, P1343; Becker W, 2007, MICROSC RES TECHNIQ, V70, P403, DOI 10.1002/jemt.20432; Benati E, 2011, SKIN RES TECHNOL, V17, P295, DOI 10.1111/j.1600-0846.2011.00496.x; Dimitrow E, 2009, EXP DERMATOL, V18, P509, DOI 10.1111/j.1600-0625.2008.00815.x; Dimitrow E, 2009, J INVEST DERMATOL, V129, P1752, DOI 10.1038/jid.2008.439; Elson D, 2004, PHOTOCH PHOTOBIO SCI, V3, P795, DOI 10.1039/b316456j; Gulledge CJ, 1996, ANTICANCER RES, V16, P741; Hoffmann K, 2001, J INVEST DERMATOL, V116, P629, DOI 10.1046/j.1523-1747.2001.01288.x; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; LAKOWICZ JR, 1993, SENSOR ACTUAT B-CHEM, V11, P133, DOI 10.1016/0925-4005(93)85248-9; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Leupold D, 2011, PIGM CELL MELANOMA R, V24, P438, DOI 10.1111/j.1755-148X.2011.00853.x; Lin SJ, 2007, EUR J DERMATOL, V17, P361; Manfredini M, 2013, SKIN RES TECHNOL, V19, pE433, DOI 10.1111/j.1600-0846.2012.00661.x; Massi G, 2004, HISTOLOGICAL DIAGNOS, P385; Palero JA, 2011, BIOMED OPT EXPRESS, V2, P1030, DOI 10.1364/BOE.2.001030; Pellacani G, 2008, J EUR ACAD DERMATOL, V22, P213, DOI 10.1111/j.1468-3083.2007.02388.x; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellicani G, 2005, J AM ACAD DERMATOL, V53, P979, DOI 10.1016/j.jaad.2005.08.022; Riemann I, 2004, PROC SPIE, V5463, P21, DOI 10.1117/12.545561; SALOPEK TG, 1991, PIGM CELL RES, V4, P172, DOI 10.1111/j.1600-0749.1991.tb00435.x; Sanchez WY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3466580; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Schneckenburger H, 2004, J FLUORESC, V14, P649, DOI 10.1023/B:JOFL.0000039351.09916.cc; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; Seidenari S, 2010, BRIT J DERMATOL, V163, P302, DOI 10.1111/j.1365-2133.2010.09821.x; Seidenari S, 2012, EXP DERMATOL, V21, P831, DOI 10.1111/j.1600-0625.2012.01554.x; Seidenari S, 2013, SKIN RES TECHNOL, V19, pE297, DOI 10.1111/j.1600-0846.2012.00643.x; Seidenari S, 2012, DERMATOLOGY, V224, P262, DOI 10.1159/000338696; Seidenari S, 2012, MELANOMA RES, V22, P151, DOI 10.1097/CMR.0b013e328350fa28; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Skvara H, 2005, ARCH DERMATOL, V141, P155, DOI 10.1001/archderm.141.2.155; Teuchner K, 1999, PHOTOCHEM PHOTOBIOL, V70, P146, DOI 10.1562/0031-8655(1999)070<0146:FTPEFO>2.3.CO;2; Teuchner K, 2000, J FLUORESC, V10, P275, DOI 10.1023/A:1009453228102; Tromme I, 2012, BRIT J DERMATOL, V167, P778, DOI 10.1111/j.1365-2133.2012.11042.x; Tsai TH, 2009, J DERMATOL SCI, V56, P1, DOI 10.1016/j.jdermsci.2009.06.008; Vestergaard ME, 2008, BRIT J DERMATOL, V159, P669, DOI 10.1111/j.1365-2133.2008.08713.x	41	55	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70682	10.1371/journal.pone.0070682	http://dx.doi.org/10.1371/journal.pone.0070682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923016	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900174
J	Vivas, M; Zas, R; Sampedro, L; Solla, A				Vivas, Maria; Zas, Rafael; Sampedro, Luis; Solla, Alejandro			Environmental Maternal Effects Mediate the Resistance of Maritime Pine to Biotic Stress	PLOS ONE			English	Article							PITCH CANKER DISEASE; ADAPTIVE EPIGENETIC MEMORY; FUSARIUM-CIRCINATUM; TRANSGENERATIONAL PLASTICITY; SEED SIZE; PERFORMANCE; HERBIVORY; PLANTS; SUSCEPTIBILITY; CONSEQUENCES	The resistance to abiotic stress is increasingly recognised as being impacted by maternal effects, given that environmental conditions experienced by parent (mother) trees affect stress tolerance in offspring. We hypothesised that abiotic environmental maternal effects may also mediate the resistance of trees to biotic stress. The influence of maternal environment and maternal genotype and the interaction of these two factors on early resistance of Pinus pinaster half-sibs to the Fusarium circinatum pathogen was studied using 10 mother genotypes clonally replicated in two contrasting environments. Necrosis length of infected seedlings was 16% shorter in seedlings grown from favourable maternal environment seeds than in seedlings grown from unfavourable maternal environment seeds. Damage caused by F. circinatum was mediated by maternal environment and maternal genotype, but not by seed mass. Mechanisms unrelated to seed provisioning, perhaps of epigenetic nature, were probably involved in the transgenerational plasticity of P. pinaster, mediating its resistance to biotic stress. Our findings suggest that the transgenerational resistance of pines due to an abiotic stress may interact with the defensive response of pines to a biotic stress.	[Vivas, Maria; Solla, Alejandro] Univ Extremadura, Plasencia, Caceres, Spain; [Zas, Rafael; Sampedro, Luis] Mision Biol Galicia MBG CSIC, Pontevedra, Galicia, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Solla, A (corresponding author), Univ Extremadura, Plasencia, Caceres, Spain.	asolla@unex.es	Solla, Alejandro/L-3096-2014; Zas, Rafael/I-5729-2014; Sampedro, Luis/B-7187-2011; Vivas, María/X-6806-2019	Solla, Alejandro/0000-0002-2596-1612; Zas, Rafael/0000-0001-6563-2461; Sampedro, Luis/0000-0002-3921-2575; Vivas, María/0000-0003-2712-417X	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) Project [RTA2007-100]; Ministerio de Ciencia e Innovacion Espanol National Research Project FENOPIN [AGL2012-40151-C03-01]; EUFEDER; Centro de Investigacion Forestal de Lourizan; Ministerio de Ciencia e Innovacion Espanol	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) Project; Ministerio de Ciencia e Innovacion Espanol National Research Project FENOPIN; EUFEDER(European Commission); Centro de Investigacion Forestal de Lourizan; Ministerio de Ciencia e Innovacion Espanol(Instituto de Salud Carlos III)	This work was supported by Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) Project RTA2007-100 and Ministerio de Ciencia e Innovacion Espanol National Research Project FENOPIN (AGL2012-40151-C03-01) and co-financed by EUFEDER. LS and MV were supported by a DOC-INIA grant at Centro de Investigacion Forestal de Lourizan and by a FPU-PREDOC grant from Ministerio de Ciencia e Innovacion Espanol, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter BJ, 2006, FOREST ECOL MANAG, V235, P14, DOI 10.1016/j.foreco.2006.07.011; Agrawal AA, 2001, AM NAT, V157, P555, DOI 10.1086/319932; Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.1890/0012-9658(2002)083[3408:HAMEMA]2.0.CO;2; [Anonymous], 2006, BLACKWELL PUB PROF; Berra D, 2010, P 15 C SOC ESP FIT V, P282; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Castro J., 2006, Handbook of seed science and technology, P397; Castro J, 1999, NEW PHYTOL, V144, P153, DOI 10.1046/j.1469-8137.1999.00495.x; Cendan C, 2013, ENVIRON EXP BOT, V94, P66, DOI 10.1016/j.envexpbot.2011.11.022; Donohue K, 2009, PHILOS T R SOC B, V364, P1059, DOI 10.1098/rstb.2008.0291; Elwell AL, 2011, PLANT CELL ENVIRON, V34, P291, DOI 10.1111/j.1365-3040.2010.02243.x; Fry JD, 2004, GENETIC ANAL COMPLEX, P11; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Gordon TR, 2011, FOREST PATHOL, V41, P227, DOI 10.1111/j.1439-0329.2010.00678.x; Gordon TR, 1998, PLANT PATHOL, V47, P706; Gordon TR, 1998, HORTSCIENCE, V33, P868, DOI 10.21273/HORTSCI.33.5.868; Herman JJ, 2012, INTEGR COMP BIOL, V52, P77, DOI 10.1093/icb/ics041; Herman JJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00102; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Iturritxa E, 2011, FUNGAL BIOL-UK, V115, P288, DOI 10.1016/j.funbio.2010.12.014; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Landeras E, 2005, PLANT DIS, V89, P1015, DOI 10.1094/PD-89-1015A; Latzel V, 2010, OIKOS, V119, P1700, DOI 10.1111/j.1600-0706.2010.18737.x; LEISHMAN MR, 2000, EVOLUTIONARY ECOLOGY, P00031; LINDGREN D, 1994, TREE PHYSIOL, V14, P323, DOI 10.1093/treephys/14.3.323; Linkies A, 2010, NEW PHYTOL, V186, P817, DOI 10.1111/j.1469-8137.2010.03249.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Matheson A. C., 2006, Australian Forestry, V69, P101; Metz J, 2010, J ECOL, V98, P697, DOI 10.1111/j.1365-2745.2010.01652.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schmale DG, 2003, PLANT PATHOL, V52, P720, DOI 10.1111/j.1365-3059.2003.00925.x; Skroppa T, 2010, TREE GENET GENOMES, V6, P93, DOI 10.1007/s11295-009-0231-z; Solla A, 2011, EUR J PLANT PATHOL, V130, P477, DOI 10.1007/s10658-011-9767-5; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stoehr MU, 1998, CAN J FOREST RES, V28, P418, DOI 10.1139/cjfr-28-3-418; Violle C, 2009, FUNCT ECOL, V23, P612, DOI 10.1111/j.1365-2435.2009.01539.x; Vivas M, 2012, FOREST SYST, V21, P289, DOI 10.5424/fs/2012212-02172; Vivas M, 2012, FORESTRY, V85, P185, DOI 10.1093/forestry/cpr055; Webber J, 2005, TREE PHYSIOL, V25, P1219, DOI 10.1093/treephys/25.10.1219; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Wingfield MJ, 2008, AUSTRALAS PLANT PATH, V37, P319, DOI 10.1071/AP08036; Yakovlev I, 2012, SEED SCI RES, V22, P63, DOI 10.1017/S0960258511000535; Zas R, 2004, SILVAE GENET, V53, P175, DOI 10.1515/sg-2004-0032; Zas R, 2013, HEREDITY, V111, P248, DOI 10.1038/hdy.2013.44	53	41	43	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70148	10.1371/journal.pone.0070148	http://dx.doi.org/10.1371/journal.pone.0070148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922944	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900157
J	Blons, H; Rouleau, E; Charrier, N; Chatellier, G; Cote, JF; Pages, JC; de Fraipont, F; Boyer, JC; Merlio, JP; Morel, A; Gorisse, MC; de Cremoux, P; Leroy, K; Milano, G; Ouafik, L; Merlin, JL; Le Corre, D; Aucouturier, P; Sabourin, JC; Nowak, F; Frebourg, T; Emile, JF; Durand-Zaleski, I; Laurent-Puig, P				Blons, Helene; Rouleau, Etienne; Charrier, Nathanael; Chatellier, Gilles; Cote, Jean-Francois; Pages, Jean-Christophe; de Fraipont, Florence; Boyer, Jean-Christophe; Merlio, Jean Philippe; Morel, Alain; Gorisse, Marie-Claude; de Cremoux, Patricia; Leroy, Karen; Milano, Gerard; Ouafik, L'Houcine; Merlin, Jean-Louis; Le Corre, Delphine; Aucouturier, Pascaline; Sabourin, Jean-Christophe; Nowak, Frederique; Frebourg, Thierry; Emile, Jean-Francois; Durand-Zaleski, Isabelle; Laurent-Puig, Pierre		MOKAECM Collaborative Group	Performance and Cost Efficiency of KRAS Mutation Testing for Metastatic Colorectal Cancer in Routine Diagnosis: The MOKAECM Study, a Nationwide Experience	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; COLD-PCR; COMMON MUTATIONS; CURVE ANALYSIS; BRAF; EGFR; CETUXIMAB; THERAPY; PROGRAM; TISSUES	Purpose: Rapid advances in the understanding of cancer biology have transformed drug development thus leading to the approval of targeted therapies and to the development of molecular tests to select patients that will respond to treatments. KRAS status has emerged as a negative predictor of clinical benefit from anti-EGFR antibodies in colorectal cancer, and anti-EGFR antibodies use was limited to KRAS wild type tumors. In order to ensure wide access to tumor molecular profiling, the French National Cancer Institute (INCa) has set up a national network of 28 regional molecular genetics centers. Concurrently, a nationwide external quality assessment for KRAS testing (MOKAECM) was granted to analyze reproducibility and costs. Methods: 96 cell-line DNAs and 24 DNA samples from paraffin embedded tumor tissues were sent to 40 French laboratories. A total of 5448 KRAS results were collected and analyzed and a micro-costing study was performed on sites for 5 common methods by an independent team of health economists. Results: This work provided a baseline picture of the accuracy and reliability of KRAS analysis in routine testing conditions at a nationwide level. Inter-laboratory Kappa values were >0.8 for KRAS results despite differences detection methods and the use of in-house technologies. Specificity was excellent with only one false positive in 1128 FFPE data, and sensitivity was higher for targeted techniques as compared to Sanger sequencing based methods that were dependent upon local expertise. Estimated reagent costs per patient ranged from (sic)5.5 to (sic)19.0. Conclusion: The INCa has set-up a network of public laboratories dedicated to molecular oncology tests. Our results showed almost perfect agreements in KRAS testing at a nationwide level despite different testing methods ensuring a cost-effective equal access to personalized colorectal cancer treatment.	[Blons, Helene; Le Corre, Delphine; Laurent-Puig, Pierre] INSERM, UMR S775, Paris, France; [Blons, Helene; Chatellier, Gilles; Laurent-Puig, Pierre] Univ Paris 05, Paris, France; [Blons, Helene; Laurent-Puig, Pierre] Hopital Europe Georges Pompidou, Dept Biol, Assistance Publique Hopitaux Paris, Paris, France; [Rouleau, Etienne] Inst Curie, Paris, France; [Charrier, Nathanael; Durand-Zaleski, Isabelle] Henri Mondor Albert Chenevier Hosp, Dept Publ Hlth, Assistance Publ Hopitaux Paris, Creteil, France; [Charrier, Nathanael] URCEco Ile France, Paris, France; [Chatellier, Gilles] URC Paris, Hop Europe Georges Pompidou, Assistance Publ Hop Paris, Paris, France; [Cote, Jean-Francois; Emile, Jean-Francois] Univ Versailles, EA4340, Versailles, France; [Chatellier, Gilles] Paris Hopital Ambroise Pare, Assistance Publ Hop, Boulogne Billancourt, France; [Pages, Jean-Christophe] Univ Francois Rabelais Tours, Fac Med, INSERM, U966, Tours, France; [de Fraipont, Florence] Grenoble Univ Hosp, Dept Biol, Grenoble, France; [Boyer, Jean-Christophe] Univ Nimes Hosp, Dept Biochem, F-30006 Nimes, France; [Merlio, Jean Philippe] Bordeaux Univ, Hosp Segalene, Dept Tumor Biol, Pessac, France; [Merlio, Jean Philippe] Bordeaux Univ, EA 2406, Bordeaux, France; [Morel, Alain] INSERM, U892, F-75654 Paris 13, France; [Morel, Alain] Univ Angers, Angers, France; [Gorisse, Marie-Claude] Inst Jean Godinot, Reims, France; [de Cremoux, Patricia] Assistance Publ Hop Paris, Mol Oncol Unit, Dept Biochem, Paris, France; [Leroy, Karen] Henri Mondor Hosp, Dept Pathol, Assistance Publ Hop Paris, Creteil, France; [Milano, Gerard] Inst Laccassagne, Nice, France; [Ouafik, L'Houcine] Aix Marseille Univ, INSERM, CRO2 UMR911, AP HM,CHU Nord,Serv Transfert Oncol Biol, Marseille, France; [Merlin, Jean-Louis] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France; [Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Surg & Mol Pathol, Rouen, France; [Sabourin, Jean-Christophe] INSERM, U1079, Rouen, France; [Nowak, Frederique] INCa Inst Natl Canc, Boulogne Billancourt, France; [Frebourg, Thierry] Rouen Univ Hosp, Dept Genet, INSERM, U614, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Montpellier; CHU de Nimes; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UNICANCER; Institut Jean Godinot; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Laurent-Puig, P (corresponding author), INSERM, UMR S775, Paris, France.	pierre.laurent-puig@parisdescartes.fr	Denis, Marc G/K-8049-2015; Morel, Alain/AAU-7496-2021; Frebourg, Thierry/AAK-8390-2020; Laurent-Puig, Pierre/K-3641-2019; Bièche, Ivan/O-7399-2017; laurent-puig, pierre/B-2226-2013; Leroy, Karen/E-9235-2011; de Fraipont, Florence/P-4936-2014	Denis, Marc G/0000-0001-5865-3248; Laurent-Puig, Pierre/0000-0001-8475-5459; Bièche, Ivan/0000-0002-2430-5429; laurent-puig, pierre/0000-0001-8475-5459; Leroy, Karen/0000-0002-4379-0140; Ouafik, L'Houcine/0000-0002-4848-1232; Pages, Jean-Christophe/0000-0002-6852-5546; Frebourg, Thierry/0000-0003-0399-4007; de Fraipont, Florence/0000-0001-9594-6584; Blons, Helene/0000-0002-0572-8426; morel, alain/0000-0003-0125-1883; Milano, Gerard/0000-0003-2478-0040	French National Cancer Institute (INCa) project [STIC2008/IC0803/NI08001]	French National Cancer Institute (INCa) project	The MOKAECM study: Evaluation de la detection des Mutations de l'Oncogene KRAS pour le traitement par les Anticorps anti-EGFR des patients porteurs d'un cancer Colorectal Metastatique was supported by the French National Cancer Institute (INCa) project number STIC2008/IC0803/NI08001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NATURE, V473, P253; Bellon E, 2011, ONCOLOGIST, V16, P467, DOI 10.1634/theoncologist.2010-0429; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dufort S, 2009, ANAL BIOCHEM, V391, P166, DOI 10.1016/j.ab.2009.05.027; Fleiss J.L., 2013, STAT METHODS RATES P; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Heideman DA, 2012, J MOL DIAGN, V8; Huang Q, 2010, MOL CELL PROBE, V24, P376, DOI 10.1016/j.mcp.2010.07.010; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kristensen LS, 2010, HUM MUTAT, V31, P1366, DOI 10.1002/humu.21358; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Lang AH, 2011, J MOL DIAGN, V13, P23, DOI 10.1016/j.jmoldx.2010.11.007; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Mancini I, 2010, J MOL DIAGN, V12, P705, DOI 10.2353/jmoldx.2010.100018; Mancl EE, 2009, AM J HEALTH-SYST PH, V66, P2105, DOI 10.2146/ajhp090036; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Packham D, 2009, DIAGN MOL PATHOL, V18, P62, DOI 10.1097/PDM.0b013e318182af52; Pinto P, 2011, CANCER GENET-NY, V204, P439, DOI 10.1016/j.cancergen.2011.07.003; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Rutter CM, 2000, ACAD RADIOL, V7, P413, DOI 10.1016/S1076-6332(00)80381-5; Solassol J, 2011, INT J MOL SCI, V12, P3191, DOI 10.3390/ijms12053191; Song C, 2011, DIAGN MOL PATHOL, V20, P81, DOI 10.1097/PDM.0b013e3181fde92f; Thunnissen E, 2011, J CLIN PATHOL, V64, P884, DOI 10.1136/jclinpath-2011-200163; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057	32	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68945	10.1371/journal.pone.0068945	http://dx.doi.org/10.1371/journal.pone.0068945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935912	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300017
J	Hall, BG; Cardenas, H; Barlow, M				Hall, Barry G.; Cardenas, Heliodoro; Barlow, Miriam			Using Complete Genome Comparisons to Identify Sequences Whose Presence Accurately Predicts Clinically Important Phenotypes	PLOS ONE			English	Article							ESCHERICHIA-COLI; PAN-GENOME; SHIGELLA; STRAINS; K-12	In clinical settings it is often important to know not just the identity of a microorganism, but also the danger posed by that particular strain. For instance, Escherichia coli can range from being a harmless commensal to being a very dangerous enterohemorrhagic (EHEC) strain. Determining pathogenic phenotypes can be both time consuming and expensive. Here we propose a simple, rapid, and inexpensive method of predicting pathogenic phenotypes on the basis of the presence or absence of short homologous DNA segments in an isolate. Our method compares completely sequenced genomes without the necessity of genome alignments in order to identify the presence or absence of the segments to produce an automatic alignment of the binary string that describes each genome. Analysis of the segment alignment allows identification of those segments whose presence strongly predicts a phenotype. Clinical application of the method requires nothing more that PCR amplification of each of the set of predictive segments. Here we apply the method to identifying EHEC strains of E. coli and to distinguishing E. coli from Shigella. We show in silico that with as few as 8 predictive sequences, if even three of those predictive sequences are amplified the probability of being EHEC or Shigella is >0.99. The method is thus very robust to the occasional amplification failure for spurious reasons. Experimentally, we apply the method to screening a set of 98 isolates to distinguishing E. coli from Shigella, and EHEC from non-EHEC E. coli strains and show that all isolates are correctly identified.	[Hall, Barry G.; Barlow, Miriam] Bellingham Res Inst, Bellingham, WA USA; [Cardenas, Heliodoro; Barlow, Miriam] Univ Calif Merced, Merced, CA USA	University of California System; University of California Merced	Barlow, M (corresponding author), Bellingham Res Inst, Bellingham, WA USA.	miriam.barlow@gmail.com			Institute of General Medical Sciences of the National Institutes of Health [1R15GM090164-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090164] Funding Source: NIH RePORTER	Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant number 1R15GM090164-01A1 from the Institute of General Medical Sciences of the National Institutes of Health to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Hall BG, 2013, GENOME BIOL EVOL, V5, P1176, DOI 10.1093/gbe/evt085; Hall BG, 2010, MICROBIOL-SGM, V156, P1060, DOI 10.1099/mic.0.035188-0; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Iowa State University, 2009, TECHN FACT SHEET ENT; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; OCHMAN H, 1983, J GEN MICROBIOL, V129, P2715; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; POLLARD DR, 1990, J CLIN MICROBIOL, V28, P540, DOI 10.1128/JCM.28.3.540-545.1990; Rolland K, 1998, MICROBIOL-SGM, V144, P2667, DOI 10.1099/00221287-144-9-2667; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Sims GE, 2011, P NATL ACAD SCI USA, V108, P8329, DOI 10.1073/pnas.1105168108; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	21	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68901	10.1371/journal.pone.0068901	http://dx.doi.org/10.1371/journal.pone.0068901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935901	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000058
J	Herrera, B; Garcia-Alvaro, M; Cruz, S; Walsh, P; Fernandez, M; Roncero, C; Fabregat, I; Sanchez, A; Inman, GJ				Herrera, Blanca; Garcia-Alvaro, Maria; Cruz, Silvia; Walsh, Peter; Fernandez, Margarita; Roncero, Cesareo; Fabregat, Isabel; Sanchez, Aranzazu; Inman, Gareth J.			BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-9; GROWTH-FACTOR RECEPTOR; C-MET AUTOCRINE; TGF-BETA; SENSITIVE BIOASSAY; UP-REGULATION; LIVER-CELLS; APOPTOSIS; IDENTIFICATION; INHIBITION	TGF-beta family members play a relevant role in tumorigenic processes, including hepatocellular carcinoma (HCC), but a specific implication of the Bone Morphogenetic Protein (BMP) subfamily is still unknown. Although originally isolated from fetal liver, little is known about BMP9, a BMP family member, and its role in liver physiology and pathology. Our results show that BMP9 promotes growth in HCC cells, but not in immortalized human hepatocytes. In the liver cancer cell line HepG2, BMP9 triggers Smad1,5,8 phosphorylation and inhibitor of DNA binding 1 (Id1) expression up-regulation. Importantly, by using chemical inhibitors, ligand trap and gene silencing approaches we demonstrate that HepG2 cells autocrinely produce BMP9 that supports their proliferation and anchorage independent growth. Additionally, our data reveal that in HepG2 cells BMP9 triggers cell cycle progression, and strikingly, completely abolishes the increase in the percentage of apoptotic cells induced by long-term incubation in low serum. Collectively, our data unveil a dual role for BMP9, both promoting a proliferative response and exerting a remarkable anti-apoptotic function in HepG2 cells, which result in a robust BMP9 effect on liver cancer cell growth. Finally, we show that BMP9 expression is increased in 40% of human HCC tissues compared with normal human liver as revealed by immunohistochemistry analysis, suggesting that BMP9 signaling may be relevant during hepatocarcinogenesis in vivo. Our findings provide new clues for a better understanding of BMPs contribution, and in particular BMP9, in HCC pathogenesis that may result in the development of effective and targeted therapeutic interventions.	[Herrera, Blanca; Garcia-Alvaro, Maria; Cruz, Silvia; Fernandez, Margarita; Roncero, Cesareo; Sanchez, Aranzazu] Univ Complutense Madrid, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria,Hosp Clin San Carlos IDISSC, Madrid, Spain; [Walsh, Peter; Inman, Gareth J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Scotland; [Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Fabregat, Isabel] Univ Barcelona, Barcelona, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; University of Dundee; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Herrera, B (corresponding author), Univ Complutense Madrid, Fac Farm, Dep Bioquim & Biol Mol 2, Inst Invest Sanitaria,Hosp Clin San Carlos IDISSC, Madrid, Spain.	bm.herrera@farm.ucm.es	Sánchez, Aránzazu/H-7810-2015; Herrera, Blanca/K-1803-2014; Cruz-Gil, Silvia/AAA-7663-2019; Roncero, Cesáreo/H-9039-2015; Fernández, Margarita/H-9077-2015; Fabregat, Isabel/H-7038-2015	Sánchez, Aránzazu/0000-0001-9145-6633; Herrera, Blanca/0000-0002-2415-2055; Roncero, Cesáreo/0000-0001-7608-8553; Fernández, Margarita/0000-0001-7207-2028; Inman, Gareth/0000-0002-6264-4253; Fabregat, Isabel/0000-0003-0136-8440	Comunidad de Madrid, Spain [S2010/BMD-2402]; Association for International Cancer Research; Cancer Research UK; Tenovus Scotland; Ninewells Cancer Campaign, UK; FIS-ISCIII's (Health Research Fund -Institute of Health Carlos III, Spain); Competitive Research Funding Programme [PI10/00274]	Comunidad de Madrid, Spain(Comunidad de Madrid); Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Tenovus Scotland; Ninewells Cancer Campaign, UK; FIS-ISCIII's (Health Research Fund -Institute of Health Carlos III, Spain); Competitive Research Funding Programme	M. Garcia-Alvaro is the recipient of a research assistant contract (grant S2010/BMD-2402, Comunidad de Madrid, Spain). This work has been supported by the Association for International Cancer Research, Cancer Research UK, Tenovus Scotland and the Ninewells Cancer Campaign, UK (P. W and G.J.I.); and by a research grant from the FIS-ISCIII's (Health Research Fund -Institute of Health Carlos III, Spain). The work was also supported by Competitive Research Funding Programme (Ref. PI10/00274) to B. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2010, ENDOCR-RELAT CANCER, V17, pR123, DOI 10.1677/ERC-09-0273; Bidart M, 2011, CELL MOL LIFE SCI; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Caja L, 2011, J HEPATOL, V55, P351, DOI 10.1016/j.jhep.2010.10.041; Celeste AJ, 1994, J BONE MINER RES  S1, P136; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Conner EA, 1997, BIOCHEM BIOPH RES CO, V236, P396, DOI 10.1006/bbrc.1997.6938; Cunha S, 2011, BLOOD; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DEJUAN C, 1992, EXP CELL RES, V202, P495, DOI 10.1016/0014-4827(92)90104-G; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Guo XD, 2012, PATHOL ONCOL RES, V18, P635, DOI 10.1007/s12253-011-9488-2; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Herrera B, 2012, CURR PHARM IN PRESS; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Horiguchi N, 2002, ONCOGENE, V21, P1791, DOI 10.1038/sj.onc.1205248; Hsieh SY, 2011, HEPATOLOGY, V53, P504, DOI 10.1002/hep.24083; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Kang S, 2003, EUR J ENDOCRINOL, V148, P147, DOI 10.1530/eje.0.1480147; Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Li Q, 2013, CANC SCI; Ljubimova JY, 1997, J HISTOCHEM CYTOCHEM, V45, P79, DOI 10.1177/002215549704500111; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Maegdefrau U, 2011, LAB INVEST, V91, P1615, DOI 10.1038/labinvest.2011.123; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Ortiz C, 2008, BIOCHEM PHARMACOL, V75, P1935, DOI 10.1016/j.bcp.2008.02.015; Park JES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030075; Plouhinec JL, 2011, CURR OPIN GENET DEV, V21, P696, DOI 10.1016/j.gde.2011.09.001; Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015; Sancho P, 2011, BIOCHEM PHARMACOL, V81, P917, DOI 10.1016/j.bcp.2011.01.007; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Singh A, 2010, CYTOKINE GROWTH F R, V21, P299, DOI 10.1016/j.cytogfr.2010.06.003; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Sun HC, 2004, J CANCER RES CLIN, V130, P307, DOI 10.1007/s00432-003-0530-y; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wang YD, 2008, MOL ENDOCRINOL, V22, P1622, DOI 10.1210/me.2007-0527; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xie Q, 2001, WORLD J GASTROENTERO, V7, P816, DOI 10.3748/wjg.v7.i6.816; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	56	55	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69535	10.1371/journal.pone.0069535	http://dx.doi.org/10.1371/journal.pone.0069535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936038	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000325211000131
J	Rohr, CS; Okon-Singer, H; Craddock, RC; Villringer, A; Margulies, DS				Rohr, Christiane S.; Okon-Singer, Hadas; Craddock, R. Cameron; Villringer, Arno; Margulies, Daniel S.			Affect and the Brain's Functional Organization: A Resting-State Connectivity Approach	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; AFFECT SCHEDULE PANAS; NEGATIVE AFFECT; SOCIAL COGNITION; FACIAL EXPRESSIONS; MAJOR DEPRESSION; INDIVIDUAL-DIFFERENCES; SUBGENUAL CINGULATE; EEG ASYMMETRY	The question of how affective processing is organized in the brain is still a matter of controversial discussions. Based on previous initial evidence, several suggestions have been put forward regarding the involved brain areas: (a) right-lateralized dominance in emotional processing, (b) hemispheric dominance according to positive or negative valence, (c) one network for all emotional processing and (d) region-specific discrete emotion matching. We examined these hypotheses by investigating intrinsic functional connectivity patterns that covary with results of the Positive and Negative Affective Schedule (PANAS) from 65 participants. This approach has the advantage of being able to test connectivity rather than activation, and not requiring a potentially confounding task. Voxelwise functional connectivity from 200 regions-of-interest covering the whole brain was assessed. Positive and negative affect covaried with functional connectivity involving a shared set of regions, including the medial prefrontal cortex, the anterior cingulate, the visual cortex and the cerebellum. In addition, each affective domain had unique connectivity patterns, and the lateralization index showed a right hemispheric dominance for negative affect. Therefore, our results suggest a predominantly right-hemispheric network with affect-specific elements as the underlying organization of emotional processes.	[Rohr, Christiane S.; Okon-Singer, Hadas; Villringer, Arno; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Rohr, Christiane S.; Okon-Singer, Hadas; Villringer, Arno; Margulies, Daniel S.] Humboldt Univ, Berlin Sch Mind & Brain, Mind Brain Inst, D-10099 Berlin, Germany; [Craddock, R. Cameron] Child Mind Inst, New York, NY USA; [Craddock, R. Cameron] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Max Planck Society; Humboldt University of Berlin; Nathan Kline Institute for Psychiatric Research	Margulies, DS (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	margulies@cbs.mpg.de	Craddock, Cameron/P-1980-2014; Margulies, Daniel/L-4719-2016	Craddock, Cameron/0000-0002-4950-1303; Margulies, Daniel/0000-0002-8880-9204; Villringer, Arno/0000-0003-2604-2404	Max Planck Society; Berlin School of Mind and Brain	Max Planck Society(Max Planck Society); Berlin School of Mind and Brain	Funding for the individuals involved in the current study was received from the Max Planck Society and the Berlin School of Mind and Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; BURTON LA, 1989, BRAIN COGNITION, V11, P210, DOI 10.1016/0278-2626(89)90018-3; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 2007, EUR J NEUROSCI, V25, P3422, DOI 10.1111/j.1460-9568.2007.05604.x; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COSTA PT, 1992, PERS INDIV DIFFER, V13, P653, DOI 10.1016/0191-8869(92)90236-I; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; DAVIDSON RJ, 1985, PSYCHOPHYSIOLOGY, V22, P353, DOI 10.1111/j.1469-8986.1985.tb01615.x; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; DAVIDSON RJ, 1987, BRAIN COGNITION, V6, P403, DOI 10.1016/0278-2626(87)90136-9; DAVIDSON RJ, 1993, BEHAV NEUROSCI, V107, P1106, DOI 10.1037/0735-7044.107.6.1106; Egloff B, 1998, PERS INDIV DIFFER, V25, P1101, DOI 10.1016/S0191-8869(98)00105-6; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Erhan H, 1998, BRAIN COGNITION, V37, P286, DOI 10.1006/brcg.1998.0984; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gunturkun O, 2000, CURR BIOL, V10, P1079, DOI 10.1016/S0960-9822(00)00671-0; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hasler G, 2007, J NEUROSCI, V27, P6313, DOI 10.1523/JNEUROSCI.5369-06.2007; Heberlein AS, 2005, NEUROIMAGE, V28, P770, DOI 10.1016/j.neuroimage.2005.06.064; Hussey E, 2009, J NEUROSCI, V29, P301, DOI 10.1523/JNEUROSCI.5205-08.2009; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Kang DH, 2013, PROG NEURO-PSYCHOPH, V40, P340, DOI 10.1016/j.pnpbp.2012.11.001; Kanske P, 2011, HUM BRAIN MAPP, V32, P198, DOI 10.1002/hbm.21012; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEVINE SC, 1986, BRAIN COGNITION, V5, P291, DOI 10.1016/0278-2626(86)90033-3; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; MANDAL MK, 1991, CORTEX, V27, P247, DOI 10.1016/S0010-9452(13)80129-3; Matthews S, 2009, PSYCHIAT RES-NEUROIM, V172, P1, DOI 10.1016/j.pscychresns.2008.08.006; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mennes M, 2011, FRONT PSYCHIAT, P2; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MEYER GJ, 1989, J PERS SOC PSYCHOL, V57, P691, DOI 10.1037/0022-3514.57.4.691; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Paradiso S, 1999, AM J GERIAT PSYCHIAT, V7, P244, DOI 10.1097/00019442-199908000-00009; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Royet JP, 2001, NEUROIMAGE, V13, P506, DOI 10.1006/nimg.2000.0704; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; STARKSTEIN SE, 1989, BRIT J PSYCHIAT, V155, P79, DOI 10.1192/bjp.155.1.79; Straube T, 2009, NEUROIMAGE, V44, P975, DOI 10.1016/j.neuroimage.2008.10.022; Tellegen A, 1999, PSYCHOL SCI, V10, P297, DOI 10.1111/1467-9280.00157; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Tuccitto DE, 2010, EDUC PSYCHOL MEAS, V70, P125, DOI 10.1177/0013164409344522; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; van Reekum CM, 2007, J COGNITIVE NEUROSCI, V19, P237, DOI 10.1162/jocn.2007.19.2.237; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wolf U, 2009, J NEUROPSYCH CLIN N, V21, P245, DOI 10.1176/appi.neuropsych.21.3.245; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	79	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68015	10.1371/journal.pone.0068015	http://dx.doi.org/10.1371/journal.pone.0068015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935850	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000023
J	Torres-Rovira, L; Tarrade, A; Astiz, S; Mourier, E; Perez-Solana, M; de la Cruz, P; Gomez-Fidalgo, E; Sanchez-Sanchez, R; Chavatte-Palmer, P; Gonzalez-Bulnes, A				Torres-Rovira, Laura; Tarrade, Anne; Astiz, Susana; Mourier, Eve; Perez-Solana, Mariluz; de la Cruz, Paloma; Gomez-Fidalgo, Ernesto; Sanchez-Sanchez, Raul; Chavatte-Palmer, Pascale; Gonzalez-Bulnes, Antonio			Sex and Breed-Dependent Organ Development and Metabolic Responses in Foetuses from Lean and Obese/Leptin Resistant Swine	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; RECEPTOR GENE POLYMORPHISMS; LEPTIN RECEPTOR; REPRODUCTIVE PROCESS; INSULIN SENSITIVITY; BODY-COMPOSITION; NEWBORN PIGLETS; OVULATION RATE; BIRTH-WEIGHT; DUTCH FAMINE	The present study aimed to determine the effects of breed and sex on growth patterns and metabolic features of advanced-pregnancy foetuses exposed to the same environmental conditions. Thus, at Day 62 of pregnancy, swine foetuses from an obese breed with leptin resistance (Iberian breed) were compared to lean crossbred foetuses (25% Large White x25% Landrace x50% Pietrain). There were differential developmental patterns in foetuses with leptin resistance, mainly a higher relative weight of the brain resembling "brain-sparing effect". Prioritization of brain growth may be protective for the adequate growth and postnatal survival of the Iberian individuals, an ancient breed reared in extensive semi-feral conditions for centuries. There were also clear sex-related differences in foetal development and metabolism in the Iberian breed. Female Iberian foetuses were similar in size and weight to male littermates but had a significantly higher relative liver to body weight ratio resembling "liver-sparing effect" and a trend for a higher relative intestine to body ratio. Moreover, the availability of triglycerides, cholesterol and IL-6 in female Iberian foetuses was similar to that of lean crossbred foetuses. Overall, these features may favour a better postnatal survival and development of females, the sex more critical for the species survival. These findings set the basis for future translational studies aimed at increasing the knowledge on the interaction between genetic and environmental factors in the early programming of the adult phenotype.	[Torres-Rovira, Laura; Astiz, Susana; Perez-Solana, Mariluz; de la Cruz, Paloma; Gomez-Fidalgo, Ernesto; Sanchez-Sanchez, Raul; Gonzalez-Bulnes, Antonio] INIA, Madrid, Spain; [Tarrade, Anne; Mourier, Eve; Chavatte-Palmer, Pascale] INRA, Biol Dev & Reprod UMR1198, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gonzalez-Bulnes, A (corresponding author), INIA, Madrid, Spain.	bulnes@inia.es	Astiz, Susana/AAN-8769-2021; Gonzalez-Bulnes, Antonio/K-7691-2015; Chavatte-Palmer, Pascale/K-7349-2012; Sánchez, Raúl Sánchez/M-8694-2019	Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Chavatte-Palmer, Pascale/0000-0002-4581-6092; Sánchez, Raúl Sánchez/0000-0002-2987-5906; Couturier-Tarrade, Anne/0000-0003-1559-5476; de la Cruz, Paloma/0000-0002-5143-6029; Torres-Rovira, Laura/0000-0003-1467-7533	GEMINI COST ACTION [FA0702]	GEMINI COST ACTION	The collaborative work between INIA and INRA groups was supported by GEMINI COST ACTION FA0702 (STSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfer J, 2000, MOL HUM REPROD, V6, P595, DOI 10.1093/molehr/6.7.595; Andronowska A, 2008, REPROD BIOL, V8, P43, DOI 10.1016/S1642-431X(12)60003-5; Antipatis C, 2000, BRIT J NUTR, V84, P125; Ashworth CJ, 2001, J REP FER S, P233; Astiz S, 2013, REPROD DOMESTIC ANIM; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bee G, 2004, J ANIM SCI, V82, P826; Bellver J, 2007, FERTIL STERIL, V88, P446, DOI 10.1016/j.fertnstert.2006.11.162; Blomberg LA, 2010, PLACENTA, V31, P549, DOI 10.1016/j.placenta.2010.03.005; Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; British Society of Animal Science, 2003, NUTR REQ STAND PIGS; Cetin I, 2002, PEDIATR RES, V52, P750, DOI 10.1203/00006450-200211000-00023; Charneca R, 2010, SPAN J AGRIC RES, V8, P317, DOI 10.5424/sjar/2010082-1192; COCHRANE WA, 1965, CAN MED ASSOC J, V93, P893; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; DAWKINS MJR, 1966, BRIT MED BULL, V22, P27, DOI 10.1093/oxfordjournals.bmb.a070432; Fernandez-Figares I, 2007, LIVEST SCI, V110, P73, DOI 10.1016/j.livsci.2006.10.002; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Freking BA, 2007, J ANIM SCI, V85, P2093, DOI 10.2527/jas.2006-766; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041759; Gonzalez RR, 2000, J CLIN ENDOCR METAB, V85, P4883, DOI 10.1210/jc.85.12.4883; Gonzalez-Anover P, 2011, REPROD DOMEST ANIM, V46, P1011, DOI 10.1111/j.1439-0531.2011.01776.x; Gonzalez-Anover P, 2011, GEN COMP ENDOCR, V170, P200, DOI 10.1016/j.ygcen.2010.10.006; Gonzalez-Anover P, 2011, THERIOGENOLOGY, V75, P34, DOI 10.1016/j.theriogenology.2010.07.009; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Gonzalez-Bulnes A, 2012, GEN COMP ENDOCR, V176, P94, DOI 10.1016/j.ygcen.2011.12.038; Gonzalez-Bulnes A, 2012, CURR DIABETES REV, V8, P144, DOI 10.2174/157339912799424537; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Haugen G, 2005, CIRC RES, V96, P12, DOI 10.1161/01.RES.0000152391.45273.A2; Huhn RO, 1969, LAB ANIM SCI, V22, P552; Kuhn G, 2002, FLEISCHWIRTSCHAFT, V82, P128; Liu C, 2012, J NUTR BIOCH; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; McNeil CJ, 2005, REPRODUCTION, V129, P757, DOI 10.1530/rep.1.00451; Metges CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031390; Metwally M, 2008, ANN NY ACAD SCI, V1127, P140, DOI 10.1196/annals.1434.000; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Mizuta E, 2008, HYPERTENS RES, V31, P1069, DOI 10.1291/hypres.31.1069; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nieto R, 2002, BRIT J NUTR, V88, P39, DOI 10.1079/BJN2002591; Ollivier L, 2009, ANIMAL, V3, P915, DOI 10.1017/S1751731109004297; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pasquali R, 2006, REPROD BIOMED ONLINE, V12, P542, DOI 10.1016/S1472-6483(10)61179-0; PEELING AN, 1994, METAB BRAIN DIS, V9, P33, DOI 10.1007/BF01996072; Perry B, 2002, BRAIN MIND, V3, P79, DOI DOI 10.1023/A:1016557824657; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Ratky J, 2005, J REPROD DEVELOP, V51, P427, DOI 10.1262/jrd.17016; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Reed MG, 2010, J MICROSC-OXFORD, V239, P54, DOI 10.1111/j.1365-2818.2009.03356.x; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; RUDOLPH AM, 1984, J DEV PHYSIOL, V6, P11; RUWE PJ, 1991, J ANIM SCI, V69, P1935, DOI 10.2527/1991.6951935x; Salihagic-Kadic A, 2006, J MATERN-FETAL NEO M, V19, P387, DOI 10.1080/14767050600637861; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Sattar N, 1999, J CLIN ENDOCR METAB, V84, P128, DOI 10.1210/jc.84.1.128; Scully Tony, 2012, Nature, V485, pS2; SECCOMBE DW, 1977, BIOCHIM BIOPHYS ACTA, V488, P402, DOI 10.1016/0005-2760(77)90199-0; SHELLEY HJ, 1961, BRIT MED BULL, V17, P137, DOI 10.1093/oxfordjournals.bmb.a069888; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Silio L., 2000, ICAR Technical Series, P511; SMITH CA, 1947, AM J DIS CHILD, V73, P243; STEIN Z, 1975, PEDIATR RES, V9, P76, DOI 10.1203/00006450-197509020-00004; STEIN Z, 1975, PEDIATR RES, V9, P70, DOI 10.1203/00006450-197509020-00003; Street ME, 2011, EUR J ENDOCRINOL, V164, P45, DOI 10.1530/EJE-10-0752; Street ME, 2009, CLIN ENDOCRINOL, V71, P394, DOI 10.1111/j.1365-2265.2009.03533.x; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Torres-Rovira L, 2012, ANIM PROD SCI, V52, P58, DOI 10.1071/AN11140; Torres-Rovira L, 2013, ENDOCRINE METABOLIC; Trahair J F, 1997, Equine Vet J Suppl, P40; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; WEBEL SK, 1974, J ANIM SCI, V38, P960, DOI 10.2527/jas1974.385960x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; ZIMMET PZ, 1995, DIABETES CARE, V18, P1050, DOI 10.2337/diacare.18.7.1050	85	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e66728	10.1371/journal.pone.0066728	http://dx.doi.org/10.1371/journal.pone.0066728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935823	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000005
J	Bates, DO; Mavrou, A; Qiu, Y; Carter, JG; Hamdollah-Zadeh, M; Barratt, S; Gammons, MV; Millar, AB; Salmon, AHJ; Oltean, S; Harper, SJ				Bates, David O.; Mavrou, Athina; Qiu, Yan; Carter, James G.; Hamdollah-Zadeh, Maryam; Barratt, Shaney; Gammons, Melissa V.; Millar, Ann B.; Salmon, Andrew H. J.; Oltean, Sebastian; Harper, Steven J.			Detection of VEGF-A(xxx)b Isoforms in Human Tissues	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INHIBITORY SPLICE VARIANT; ANGIOGENIC ISOFORMS; VEGF; VEGF(165)B; EXPRESSION; BALANCE; LUNG; EVOLUTION; CARCINOMA	Vascular Endothelial Growth Factor-A (VEGF-A) can be generated as multiple isoforms by alternative splicing. Two families of isoforms have been described in humans, pro-angiogenic isoforms typified by VEGF-A(165)a, and anti-angiogenic isoforms typified by VEGF-A(165)b. The practical determination of expression levels of alternative isoforms of the same gene may be complicated by experimental protocols that favour one isoform over another, and the use of specific positive and negative controls is essential for the interpretation of findings on expression of the isoforms. Here we address some of the difficulties in experimental design when investigating alternative splicing of VEGF isoforms, and discuss the use of appropriate control paradigms. We demonstrate why use of specific control experiments can prevent assumptions that VEGF-A(165)b is not present, when in fact it is. We reiterate, and confirm previously published experimental design protocols that demonstrate the importance of using positive controls. These include using known target sequences to show that the experimental conditions are suitable for PCR amplification of VEGF-A(165)b mRNA for both q-PCR and RT-PCR and to ensure that mispriming does not occur. We also provide evidence that demonstrates that detection of VEGF-A(165)b protein in mice needs to be tightly controlled to prevent detection of mouse IgG by a secondary antibody. We also show that human VEGF(165)b protein can be immunoprecipitated from cultured human cells and that immunoprecipitating VEGF-A results in protein that is detected by VEGF-A(165)b antibody. These findings support the conclusion that more information on the biology of VEGF-A(165)b isoforms is required, and confirm the importance of the experimental design in such investigations, including the use of specific positive and negative controls.	[Bates, David O.; Mavrou, Athina; Qiu, Yan; Carter, James G.; Hamdollah-Zadeh, Maryam; Barratt, Shaney; Gammons, Melissa V.; Salmon, Andrew H. J.; Oltean, Sebastian; Harper, Steven J.] Univ Bristol, Sch Physiol & Pharmacol, Microvasc Res Labs, Bristol, Avon, England; [Barratt, Shaney; Millar, Ann B.; Salmon, Andrew H. J.] Sch Clin Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Bates, DO (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Microvasc Res Labs, Bristol, Avon, England.	David.Bates@nottingham.ac.uk		gammons, melissa/0000-0001-9661-9331; Oltean, Sebastian/0000-0001-7890-8439; Carter, James/0000-0003-1860-9677; Barratt, Shaney/0000-0003-3067-7349; Bates, David/0000-0003-4850-2360	MRC; Prostate Cancer Research UK; BBSRC; British Heart Foundation; Kidney Research UK; Cancer Research UK; Richard Bright VEGF Research Trust; Biotechnology and Biological Sciences Research Council [BB/J007293/2, BB/J007293/1] Funding Source: researchfish; British Heart Foundation [PG/11/20/28792] Funding Source: researchfish; Kidney Research UK [RP18/2010] Funding Source: researchfish; Medical Research Council [G0600920, G1002073, G0802829] Funding Source: researchfish; BBSRC [BB/J007293/2, BB/J007293/1] Funding Source: UKRI; MRC [G0600920, G0802829, G1002073] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Prostate Cancer Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Cancer Research UK(Cancer Research UK); Richard Bright VEGF Research Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the MRC, Prostate Cancer Research UK, the BBSRC, the British Heart Foundation, Kidney Research UK and Cancer Research UK and the Richard Bright VEGF Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Baba T, 2011, DEV DYN; Ballmer-Hofer K, 2011, BLOOD; Bates DO, 2002, CANCER RES, V62, P4123; Bates DO, 2012, CLIN CANC R IN PRESS; Cui TG, 2004, AM J PHYSIOL-RENAL, V286, pF767, DOI 10.1152/ajprenal.00337.2003; Ehlken C, 2010, AM J OPHTHALMOL, V152; Ergorul C, 2008, MOL VIS, V14, P1517; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; Manetti M, 2011, CIRC RES, V109, pE14, DOI 10.1161/CIRCRESAHA.111.242057; Mcfee RM, 2012, CELL TISSUE RES, V349, P635, DOI 10.1007/s00441-012-1330-y; Michels D, 2008, ACTA OPHTHALMOL SCAN, V86, P59; Miller-Kasprzak E, 2008, BIOMED PHARMACOTHER, V62, P158, DOI 10.1016/j.biopha.2007.07.015; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Peiris-Pages M, 2010, J PATHOL, V222, P138, DOI 10.1002/path.2746; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Rennel E, 2009, BRIT J CANCER, V101, P1250; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Schumacher VA, 2007, J AM SOC NEPHROL, V18, P719, DOI 10.1681/ASN.2006020124; Simpson A, 2012, AM J RESP CRIT CARE, V185, P1197, DOI 10.1164/rccm.201112-2191OC; Sugnet C W, 2004, Pac Symp Biocomput, P66; Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355; Varet J, 2010, AM J PHYSIOL-LUNG C, V298, pL768, DOI 10.1152/ajplung.00353.2009; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMS AC, 1990, CANCER RES, V50, P4724; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Woolard J, 2011, CHEM SCI, V2, P273, DOI 10.1039/c0sc00297f; Xu JX, 2011, GENE, V487, P143, DOI 10.1016/j.gene.2011.06.024; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103	36	60	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68399	10.1371/journal.pone.0068399	http://dx.doi.org/10.1371/journal.pone.0068399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935865	Green Submitted, gold, Green Published			2022-12-27	WOS:000322633700008
J	Bekaert, M; Lowe, NR; Bishop, SC; Bron, JE; Taggart, JB; Houston, RD				Bekaert, Michael; Lowe, Natalie R.; Bishop, Stephen C.; Bron, James E.; Taggart, John B.; Houston, Ross D.			Sequencing and Characterisation of an Extensive Atlantic Salmon (Salmo salar L.) MicroRNA Repertoire	PLOS ONE			English	Article							EXPRESSION; GENES; BIOGENESIS; GENOME; PREDICTION; DISCOVERY; TARGETS	Atlantic salmon (Salmo salar L.), a member of the family Salmonidae, is a totemic species of ecological and cultural significance that is also economically important in terms of both sports fisheries and aquaculture. These factors have promoted the continuous development of genomic resources for this species, furthering both fundamental and applied research. MicroRNAs (miRNA) are small endogenous non-coding RNA molecules that control spatial and temporal expression of targeted genes through post-transcriptional regulation. While miRNA have been characterised in detail for many other species, this is not yet the case for Atlantic salmon. To identify miRNAs from Atlantic salmon, we constructed whole fish miRNA libraries for 18 individual juveniles (fry, four months post hatch) and characterised them by Illumina high-throughput sequencing (total of 354,505,167 paired-ended reads). We report an extensive and partly novel repertoire of miRNA sequences, comprising 888 miRNA genes (547 unique mature miRNA sequences), quantify their expression levels in basal conditions, examine their homology to miRNAs from other species and identify their predicted target genes. We also identify the location and putative copy number of the miRNA genes in the draft Atlantic salmon reference genome sequence. The Atlantic salmon miRNAs experimentally identified in this study provide a robust large-scale resource for functional genome research in salmonids. There is an opportunity to explore the evolution of salmonid miRNAs following the relatively recent whole genome duplication event in salmonid species and to investigate the role of miRNAs in the regulation of gene expression in particular their contribution to variation in economically and ecologically important traits.	[Bekaert, Michael; Bron, James E.; Taggart, John B.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Lowe, Natalie R.; Bishop, Stephen C.; Houston, Ross D.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Lowe, Natalie R.; Bishop, Stephen C.; Houston, Ross D.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland	University of Stirling; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Bekaert, M (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.	michael.bekaert@stir.ac.uk	Bron, James E/B-6231-2018	Bron, James E/0000-0003-3544-0519; Taggart, John/0000-0002-3843-9663; Houston, Ross/0000-0003-1805-0762; Bekaert, Michael/0000-0002-1206-7654	British Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H022007/1, BB/F002750/1, BB/F001959/1]; Roslin Institute's BBSRC Institute Strategic Funding Grant; Scottish Government; BBSRC [BBS/E/D/20211552, BB/H022007/1, BB/F002750/1, BB/F001959/1, BBS/E/D/20310000] Funding Source: UKRI; MRC [MR/K001744/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20310000, BB/H022007/1, BBS/E/D/20211552, BB/F002750/1, BB/F001959/1] Funding Source: researchfish; Medical Research Council [MR/K001744/1] Funding Source: researchfish	British Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Roslin Institute's BBSRC Institute Strategic Funding Grant; Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Biotechnology and Biological Sciences Research Council (BBSRC) grants (BB/H022007/1, BB/F002750/1, BB/F001959/1), by Roslin Institute's BBSRC Institute Strategic Funding Grant, and by the Strategic Partnership for Animal Science Excellence (SPACE) funding programme of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barozai MYK, 2012, GENE, V499, P163, DOI 10.1016/j.gene.2012.03.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Begemann G, 2008, ZEBRAFISH, V5, P111, DOI 10.1089/zeb.2008.0528; Bicker S, 2008, J CELL MOL MED, V12, P1466, DOI 10.1111/j.1582-4934.2008.00400.x; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Meng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034394; Mennigen JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038604; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mtango NR, 2009, MOL REPROD DEV, V76, P255, DOI 10.1002/mrd.20950; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes D, 2012, BIOINFORMATION, V8, P284, DOI 10.6026/97320630008284; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Smit AFA, 2013, REPEATMASKER OPENSOU; Solomon A, 2008, DEV BIOL, V316, P191, DOI 10.1016/j.ydbio.2007.12.046; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	50	26	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70136	10.1371/journal.pone.0070136	http://dx.doi.org/10.1371/journal.pone.0070136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922936	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700144
J	Cohen, JL; Yadav, P; Moucheraud, C; Alphs, S; Larson, PS; Arkedis, J; Massaga, J; Sabot, O				Cohen, Jessica L.; Yadav, Prashant; Moucheraud, Corrina; Alphs, Sarah; Larson, Peter S.; Arkedis, Jean; Massaga, Julius; Sabot, Oliver			Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectional Study in Remote Regions of Tanzania	PLOS ONE			English	Article							AFFORDABLE MEDICINES FACILITY; INSECTICIDE-TREATED NETS; PRIVATE DRUG SHOPS; ARTEMETHER-LUMEFANTRINE; ECONOMIC-IMPACT; CASE-MANAGEMENT; GLOBAL SUBSIDY; MARKET SHARE; AVAILABILITY; KENYA	Background: The Affordable Medicines Facility-malaria (AMFm) is a pilot program that uses price subsidies to increase access to Artemisinin Combination Therapies (ACTs), currently the most effective malaria treatment. Recent evidence suggests that availability and affordability of ACTs in retail sector drug shops (where many people treat malaria) has increased under the AMFm, but it is unclear whether household level ACT use has increased. Methods and Findings: Household surveys were conducted in two remote regions of Tanzania (Mtwara and Rukwa) in three waves: March 2011, December 2011 and March 2012, corresponding to 3, 13 and 16 months into the AMFm implementation respectively. Information about suspected malaria episodes including treatment location and medications taken was collected. Respondents were also asked about antimalarial preferences and perceptions about the availability of these medications. Significant increases in ACT use, preference and perceived availability were found between Rounds 1 and 3 though not for all measures between Rounds 1 and 2. ACT use among suspected malaria episodes was 51.1% in March 2011 and increased by 10.9 percentage points by Round 3 (p=.017). The greatest increase was among retail sector patients, where ACT use increased from 31% in Round 1 to 49% in Round 2 (p=.037) and to 61% (p<.0001) by Round 3. The fraction of suspected malaria episodes treated in the retail sector increased from 30.2% in Round 1 to 46.7% in Round 3 (p=.0009), mostly due to a decrease in patients who sought no treatment at all. No significant changes in public sector treatment seeking were found. Conclusions: The AMFm has led to significant increases in ACT use for suspected malaria, especially in the retail sector. No evidence is found supporting the concerns that the AMFm would crowd out public sector treatment or neglect patients in remote areas and from low SES groups.	[Cohen, Jessica L.; Moucheraud, Corrina] Harvard Univ, Harvard Sch Publ Hlth, Global Hlth & Populat Dept, Boston, MA 02115 USA; [Cohen, Jessica L.] Brookings Inst, Washington, DC 20036 USA; [Yadav, Prashant; Alphs, Sarah; Larson, Peter S.] Univ Michigan, Ross Sch Business, William Davidson Inst, Ann Arbor, MI 48109 USA; [Yadav, Prashant; Alphs, Sarah; Larson, Peter S.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Arkedis, Jean] Results Dev Inst, Washington, DC USA; [Massaga, Julius] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Sabot, Oliver] Slingshot, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Brookings Institution; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institute of Medical Research	Cohen, JL (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Global Hlth & Populat Dept, Boston, MA 02115 USA.	cohenj@hsph.harvard.edu		Yadav, Prashant/0000-0001-7836-6641; Larson, Peter/0000-0002-6621-7902	Clinton Health Access Initiative; Bill and Melinda Gates Foundation; Department for International Development	Clinton Health Access Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development	Study funding provided by the Clinton Health Access Initiative, the Bill and Melinda Gates Foundation and the Department for International Development. The funding source had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adeyi O, 2010, LANCET, V376, P1869, DOI 10.1016/S0140-6736(10)61189-0; [Anonymous], 2012, IND EV PHAS 1 AFF ME; [Anonymous], AMFM REACHING POORES; Asenso-Okyere K, 2011, AGR ECON-BLACKWELL, V42, P293, DOI 10.1111/j.1574-0862.2010.00515.x; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Cohen J, 2012, 17943 NAT BUR EC RES; Cohen JM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S6; Cook AG, 2006, FORECASTING PHARM IN; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fink G, 2013, HLTH POLICY PLANNING, DOI [10.1093/heapol/czt041, DOI 10.1093/HEAP0L/CZT041]; Fink G, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-12; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; GOODMAN CA, 2000, GLOBAL FORUM HLTH RE; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Halliday KE, 2012, TROP MED INT HEALTH, V17, P532, DOI 10.1111/j.1365-3156.2012.02971.x; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kamal-Yanni M, 2010, LANCET, V375, P121, DOI 10.1016/S0140-6736(10)60048-7; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-3; Ministry of Planning Economy and Empowerment (MPEE), 2006, NAT POP POL; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; O'Connell KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-326; Onwujekwe O, 2010, HEALTH POLICY, V94, P144, DOI 10.1016/j.healthpol.2009.09.010; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Patouillard E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-50; Rogers EM, 1962, DIFFUSION INNOVATION; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Sudoi RK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-37; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, 22 BOARD M SOF 13 15, pGF; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yadav P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-299; Yamey G, 2012, B WORLD HEALTH ORGAN, V90, P452, DOI 10.2471/BLT.11.091199; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70713	10.1371/journal.pone.0070713	http://dx.doi.org/10.1371/journal.pone.0070713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23923018	Green Published, gold			2022-12-27	WOS:000323369700203
J	Saito, T; Chiba, T; Yuki, K; Zen, Y; Oshima, M; Koide, S; Motoyama, T; Ogasawara, S; Suzuki, E; Ooka, Y; Tawada, A; Tada, M; Kanai, F; Takiguchi, Y; Iwama, A; Yokosuka, O				Saito, Tomoko; Chiba, Tetsuhiro; Yuki, Kaori; Zen, Yoh; Oshima, Motohiko; Koide, Shuhei; Motoyama, Tenyu; Ogasawara, Sadahisa; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Tada, Motohisa; Kanai, Fumihiko; Takiguchi, Yuichi; Iwama, Atsushi; Yokosuka, Osamu			Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO; REDUCED RISK; MAINTENANCE; MORTALITY; VIABILITY; MECHANISM; PATHWAY; DISEASE; KINASE	Metformin has been widely used as an oral drug for diabetes mellitus for approximately 60 years. Interestingly, recent reports showed that metformin exhibited an anti-tumor action in a wide range of malignancies including hepatocellular carcinoma (HCC). In the present study, we investigated its impact on tumor-initiating HCC cells. Metformin suppressed cell growth and induced apoptosis in a dose-dependent manner. Flow cytometric analysis showed that metformin treatment markedly reduced the number of tumor-initiating epithelial cell adhesion molecule (EpCAM)(+) HCC cells. Non-adherent sphere formation assays of EpCAM(+) cells showed that metformin impaired not only their sphere-forming ability, but also their self-renewal capability. Consistent with this, immunostaining of spheres revealed that metformin significantly decreased the number of component cells positive for hepatic stem cell markers such as EpCAM and a-fetoprotein. In a xenograft transplantation model using non-obese diabetic/severe combined immunodeficient mice, metformin and/or sorafenib treatment suppressed the growth of tumors derived from transplanted HCC cells. Notably, the administration of metformin but not sorafenib decreased the number of EpCAM(+) cells and impaired their self-renewal capability. As reported, metformin activated AMP-activated protein kinase (AMPK) through phosphorylation; however its inhibitory effect on the mammalian target of rapamycin (mTOR) pathway did not necessarily correlate with its anti-tumor activity toward EpCAM(+) tumor-initiating HCC cells. These results indicate that metformin is a promising therapeutic agent for the elimination of tumor-initiating HCC cells and suggest as-yet-unknown functions other than its inhibitory effect on the AMPK/mTOR pathway.	[Saito, Tomoko; Chiba, Tetsuhiro; Yuki, Kaori; Motoyama, Tenyu; Ogasawara, Sadahisa; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Tada, Motohisa; Kanai, Fumihiko; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Saito, Tomoko; Chiba, Tetsuhiro; Yuki, Kaori; Oshima, Motohiko; Koide, Shuhei; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Zen, Yoh] Kings Coll Hosp London, Inst Liver Studies, London, England; [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan	Chiba University; Chiba University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064; Koide, Shuhei/0000-0001-8599-6115	Ministry of Education, Culture, Sports, Science and Technology, Japan; Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research [23591136, 25460977] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Foundation for the Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants for the Global COE program (Global Center for Education and Research in Immune System Regulation and Treatment) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jsps.go.jp/j-globalcoe/); grants from Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST)(http://www.jst.go.jp/kisoken/crest/); and the Foundation for the Promotion of Cancer Research (http://www.fpcr.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Bhat M, 2013, HEPATOLOGY IN PRESS; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Chen TM, 2011, J GASTROEN HEPATOL, V26, P858, DOI 10.1111/j.1440-1746.2011.06664.x; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Shank JJ, 2012, GYNECOL ONCOL, V127, P390, DOI 10.1016/j.ygyno.2012.07.115; Shirouzu Y, 2010, J SURG RES, V159, P705, DOI 10.1016/j.jss.2008.07.035; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhu AX, 2011, CANCER-AM CANCER SOC, V117, P5094, DOI 10.1002/cncr.26165; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	32	49	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70010	10.1371/journal.pone.0070010	http://dx.doi.org/10.1371/journal.pone.0070010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922888	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700116
J	Kuhnt, D; Bauer, MHA; Sommer, J; Merhof, D; Nimsky, C				Kuhnt, Daniela; Bauer, Miriam H. A.; Sommer, Jens; Merhof, Dorit; Nimsky, Christopher			Optic Radiation Fiber Tractography in Glioma Patients Based on High Angular Resolution Diffusion Imaging with Compressed Sensing Compared with Diffusion Tensor Imaging - Initial Experience	PLOS ONE			English	Article							ROBUST UNCERTAINTY PRINCIPLES; GUIDED NEUROSURGERY; DT-MRI; RECONSTRUCTION; TRACKING; RESECTION; EXTENT; NEURONAVIGATION; VISUALIZATION; DISSECTION	Objective: Up to now, fiber tractography in the clinical routine is mostly based on diffusion tensor imaging (DTI). However, there are known drawbacks in the resolution of crossing or kissing fibers and in the vicinity of a tumor or edema. These restrictions can be overcome by tractography based on High Angular Resolution Diffusion Imaging (HARDI) which in turn requires larger numbers of gradients resulting in longer acquisition times. Using compressed sensing (CS) techniques, HARDI signals can be obtained by using less non-collinear diffusion gradients, thus enabling the use of HARDI-based fiber tractography in the clinical routine. Methods: Eight patients with gliomas in the temporal lobe, in proximity to the optic radiation (OR), underwent 3T MRI including a diffusion-weighted dataset with 30 gradient directions. Fiber tractography of the OR using a deterministic streamline algorithm based on DTI was compared to tractography based on reconstructed diffusion signals using HARDI+CS. Results: HARDI+CS based tractography displayed the OR more conclusively compared to the DTI-based results in all eight cases. In particular, the potential of HARDI+CS-based tractography was observed for cases of high grade gliomas with significant peritumoral edema, larger tumor size or closer proximity of tumor and reconstructed fiber tract. Conclusions: Overcoming the problem of long acquisition times, HARDI+CS seems to be a promising basis for fiber tractography of the OR in regions of disturbed diffusion, areas of high interest in glioma surgery.	[Kuhnt, Daniela; Bauer, Miriam H. A.; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany; [Bauer, Miriam H. A.] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Sommer, Jens] Univ Marburg, Dept Psychiat, Marburg, Germany; [Merhof, Dorit] Rhein Westfal TH Aachen, Inst Imaging & Comp Vis, Aachen, Germany; [Bauer, Miriam H. A.] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany	Philipps University Marburg; St Anne's University Hospital Brno (FNUSA-ICRC); Philipps University Marburg; RWTH Aachen University; Philipps University Marburg	Kuhnt, D (corresponding author), Univ Marburg, Dept Neurosurg, Marburg, Germany.	kuhntd@med.uni-marburg.de	Merhof, Dorit/AAV-7892-2021; Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Bopp, Miriam H. A./0000-0003-1574-7572	von Behring Roentgen Foundation, Germany [58-0044]; European Regional Development Fund - Project FNUSA - ICRC [CZ.1.05/1.1.00/02.0123]	von Behring Roentgen Foundation, Germany; European Regional Development Fund - Project FNUSA - ICRC	This work was supported in part by von Behring Roentgen Foundation, Germany (58-0044) and European Regional Development Fund - Project FNUSA - ICRC (No. CZ.1.05/1.1.00/02.0123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Archip N, 2007, NEUROIMAGE, V35, P609, DOI 10.1016/j.neuroimage.2006.11.060; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berger M S, 1996, Clin Neurosurg, V43, P324; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2006, FOUND COMPUT MATH, V6, P227, DOI 10.1007/s10208-004-0162-x; Cao A, 2008, MED PHYS, V35, P1593, DOI 10.1118/1.2870216; Chen XL, 2007, SURG NEUROL, V68, P285, DOI 10.1016/j.surneu.2007.05.005; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Duffau H, 2002, J NEUROL NEUROSUR PS, V73, P733, DOI 10.1136/jnnp.73.6.733; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Gasser T, 2005, NEUROSURGERY, V57, P94, DOI 10.1227/01.NEU.0000163488.91335.C5; Gratiolet P., 1839, ANATOMIE COMP SYSTEM; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Klingler J, 1935, SCHWEIZ ARCH NEUROL, V36, P247; Kuhnt D, 2011, NEUROSURGERY; Kuhnt D, 2013, NEUROSURGERY, V72, pA165, DOI 10.1227/NEU.0b013e318270d9fb; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Landgraf P, 2011, BILDVERARBEITUNG MED; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Merhof D., 2007, RECONSTRUCTION VISUA; Merhof D, 2009, STEREOT FUNCT NEUROS, V87, P50, DOI 10.1159/000195720; Meyer A, 1907, T ASSOC AM PHYSICIAN, V22, P7; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Michailovich O, 2010, LECT NOTES COMPUT SC, V6361, P607; Michailovich O, 2010, IEEE T IMAGE PROCESS, V19, P461, DOI 10.1109/TIP.2009.2035886; Miga MI, 2003, IEEE T MED IMAGING, V22, P973, DOI 10.1109/TMI.2003.815868; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Nimsky C, 2007, NEUROSURGERY, V61, P178, DOI [10.1227/01.neu.0000279214.00139.3b, 10.1227/01.NEU.0000144842.18771.30]; Nimsky C, 2006, NEUROIMAGE, V30, P1219, DOI 10.1016/j.neuroimage.2005.11.001; Parraga RG, 2012, NEUROSURGERY, V71, P160, DOI 10.1227/NEU.0b013e3182556fde; Prckovska V, 2011, IEEE T VIS COMPUT GR, V17, P1407, DOI 10.1109/TVCG.2010.244; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; ROBERTS DW, 1986, J NEUROSURG, V65, P545, DOI 10.3171/jns.1986.65.4.0545; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Sincoff EH, 2004, J NEUROSURG, V101, P739, DOI 10.3171/jns.2004.101.5.0739; Stadlbauer A, 2008, J NUCL MED, V49, P721, DOI 10.2967/jnumed.107.049213; Staempfli P, 2007, J MAGN RESON IMAGING, V26, P886, DOI 10.1002/jmri.21098; Tao XF, 2009, CHINESE MED J-PEKING, V122, P178, DOI 10.3760/cma.j.issn.0366-6999.2009.02.013; The Slicer Community, 2012, 3D SLIC; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Ture U, 2000, NEUROSURGERY, V47, P417, DOI 10.1097/00006123-200008000-00028; Wang F, 2008, J NEUROSURG, V108, P775, DOI 10.3171/JNS/2008/108/4/0775; Wu WT, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822efcae; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92	56	29	32	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70973	10.1371/journal.pone.0070973	http://dx.doi.org/10.1371/journal.pone.0070973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923036	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900181
J	Qin, JZ; Dai, J; Xu, ZH; Chen, DY; Qin, JH; Shi, DQ; Teng, HJ; Jiang, Q				Qin, Jizheng; Dai, Jin; Xu, Zhihong; Chen, Dongyang; Qin, Jianghui; Shi, Dongquan; Teng, Huajian; Jiang, Qing			Genetic Polymorphism of NOS3 with Susceptibility to Deep Vein Thrombosis after Orthopedic Surgery: A Case-Control Study in Chinese Han Population	PLOS ONE			English	Article							OXIDE SYNTHASE GENE; NITRIC-OXIDE; VENOUS THROMBOEMBOLISM; ESSENTIAL-HYPERTENSION; ENDOTHELIAL FUNCTION; L-ARGININE; RISK; ACTIVATION; HUMANS; AGE	Deep vein thrombosis is one of the common complications of orthopedic surgery. Studies indicated that genetic factors played a considerable role in the pathogenesis of deep vein thrombosis. Endothelial nitric oxide synthase which encoded by nitric oxide synthase 3 (NOS3), can generate nitric oxide in endothelial cells. As a predominant regulator for vascular homeostasis, nitric oxide might be involved in the pathogenesis of thrombosis. It had been proved that the NOS3 polymorphism (rs1799983) was associated with the development of cardiovascular diseases. Our objective was to evaluate the association between the NOS3 polymorphism (rs1799983) and deep vein thrombosis after orthopedic surgery in Chinese Han population. The polymorphism was genotyped in 224 subjects with deep vein thrombosis after orthopedic surgery and 580 controls. Allele and genotype frequencies were compared between subjects with deep vein thrombosis and control subjects. The allele and genotype frequencies of the NOS3 polymorphism (rs1799983) were significantly different between subjects with deep vein thrombosis and control subjects. There were also significant differences when the subjects were stratified by gender, surgery type and hypertension status. These findings suggested that the NOS3 polymorphism (rs1799983) was associated with susceptibility to the deep vein thrombosis after orthopedic surgery in Chinese Han population, and NOS3 might play a role in the development of deep vein thrombosis after orthopedic surgery.	[Qin, Jizheng; Dai, Jin; Xu, Zhihong; Chen, Dongyang; Qin, Jianghui; Shi, Dongquan; Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing, Jiangsu, Peoples R China; [Qin, Jizheng; Dai, Jin; Xu, Zhihong; Chen, Dongyang; Qin, Jianghui; Shi, Dongquan; Teng, Huajian; Jiang, Qing] Nanjing Univ, Model Anim Res Ctr, Joint Res Ctr Bone & Joint Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Jiang, Q (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Nanjing, Jiangsu, Peoples R China.	qingj@nju.edu.cn	Shi, Dongquan/ABG-6949-2021; shi, dongquan/ABH-3078-2021; Dai, Jin/GVT-2414-2022; shi, dongquan/AAE-9956-2020	shi, dongquan/0000-0002-4769-7816; Dai, Jin/0000-0003-3063-746X; 	National Natural Sciences of China [30973046, 81271945]; China National Funds for Distinguished Young Scientists [81125013]	National Natural Sciences of China(National Natural Science Foundation of China (NSFC)); China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Sciences of China (No. 30973046, No. 81271945), and China National Funds for Distinguished Young Scientists (No. 81125013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2005, J AM COLL CARDIOL, V46, P1101, DOI 10.1016/j.jacc.2005.05.072; Bates SM, 2012, CHEST S, V141, pe691S; De Stefano V, 2003, HAEMATOLOGICA, V88, P61; DOHI Y, 1990, HYPERTENSION, V16, P170, DOI 10.1161/01.HYP.16.2.170; EGASHIRA K, 1993, CIRCULATION, V88, P77, DOI 10.1161/01.CIR.88.1.77; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Heil SG, 2004, J THROMB HAEMOST, V2, P750, DOI 10.1111/j.1538-7836.2004.00701.x; Hoffmann IS, 2005, J HUM HYPERTENS, V19, P233, DOI 10.1038/sj.jhh.1001801; KUNG CF, 1995, HYPERTENSION, V25, P194, DOI 10.1161/01.HYP.25.2.194; Li YY, 2011, THROMB RES, V127, P324, DOI 10.1016/j.thromres.2010.11.034; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P879; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Ordonez AJG, 2000, THROMB RES, V99, P563, DOI 10.1016/S0049-3848(00)00288-7; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; Scott-Burden Timothy, 1993, Circulation, V87, pV51; Taddei S, 1997, HYPERTENSION, V29, P736, DOI 10.1161/01.HYP.29.3.736; TADDEI S, 1995, CIRCULATION, V91, P1981, DOI 10.1161/01.CIR.91.7.1981; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z	22	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70033	10.1371/journal.pone.0070033	http://dx.doi.org/10.1371/journal.pone.0070033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922896	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900134
J	Rossi, A; Lord, J				Rossi, Alessandra; Lord, Janet			Adiponectin Inhibits Neutrophil Phagocytosis of Escherichia coli by Inhibition of PKB and ERK 1/2 MAPK Signalling and Mac-1 Activation	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; MEDIATED PHAGOCYTOSIS; INSULIN-RESISTANCE; REGULATED KINASE; TYROSINE KINASE; CELL ACTIVATION; MACROPHAGES; RECEPTORS; OBESITY	Full length adiponectin is a potent immune modulatory adipokine, impacting upon the actions of several immune cells. Neutrophil oxidative burst has been shown to decrease in response to adiponectin, and we speculated that it could have other effects on neutrophil function. Here we report that adiponectin reduces the phagocytic ability of human neutrophils, decreasing significantly the ingestion of opsonised E. coli by these cells in whole blood (p<0.05) and as isolated neutrophils (p<0.05). We then determined the mechanisms involved. We observed that the activation of Mac-1, the receptor engaged in complement-mediated phagocytosis, was decreased by adiponectin in response to E. coli stimulation. Moreover, treatment of neutrophils with adiponectin prior to incubation with E. coli significantly inhibited signalling through the PI3K/PKB and ERK 1/2 pathways, with a parallel reduction of F-actin content. Studies with pharmacological inhibitors showed that inhibition of PI3K/PKB, but not ERK 1/2 signalling was able to prevent the activation of Mac-1. In conclusion, we propose that adiponectin negatively affects neutrophil phagocytosis, reducing the uptake of E. coli and inhibiting Mac-1 activation, the latter by blockade of the PI3K/PKB signal pathway.	[Rossi, Alessandra; Lord, Janet] Univ Birmingham, Med Res Council Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham	Lord, J (corresponding author), Univ Birmingham, Med Res Council Ctr Immune Regulat, Sch Immun & Infect, Birmingham, W Midlands, England.	J.M.Lord@bham.ac.uk		Rossi, Alessandra/0000-0002-9904-4702; Lord, Janet/0000-0003-1030-6786	Marie Curie Initial Training Network fellowship [PITN-2009-238665 NINA]	Marie Curie Initial Training Network fellowship	This work and A. R. were funded by a Marie Curie Initial Training Network fellowship (PITN-2009-238665 NINA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2005, CLIN ENDOCRINOL, V62, P114, DOI 10.1111/j.1365-2265.2004.02182.x; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Anderson SI, 2000, J CELL SCI, V113, P2737; [Anonymous], BIOCH PHARM, V69, P1225; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Chedid P, 2012, AM J PATHOL, V180, P682, DOI 10.1016/j.ajpath.2011.10.013; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Dang PMC, 2011, BIOCHEM PHARMACOL, V82, P1145, DOI 10.1016/j.bcp.2011.07.070; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Dillon Skyler P., 2009, Biotechnology Journal, V4, P1210, DOI 10.1002/biot.200800273; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Eggleton P, 1998, TRENDS CELL BIOL, V8, P428, DOI 10.1016/S0962-8924(98)01373-7; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Giraldo E, 2010, MOL CELL BIOCHEM, V333, P115, DOI 10.1007/s11010-009-0211-5; Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; JEPSEN LV, 1982, SCAND J CLIN LAB INV, V42, P235; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Jung MY, 2012, J IMMUNOL, V188, P2592, DOI 10.4049/jimmunol.1102588; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Kim KY, 2006, J IMMUNOL, V176, P5958, DOI 10.4049/jimmunol.176.10.5958; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Luo JX, 2010, J CELL BIOCHEM, V110, P910, DOI 10.1002/jcb.22603; Ma WC, 2012, CELL IMMUNOL, V274, P72, DOI 10.1016/j.cellimm.2012.02.001; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; McLeish KR, 1998, J LEUKOCYTE BIOL, V64, P835, DOI 10.1002/jlb.64.6.835; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Rooyakkers AWJ, 2005, MICROB PATHOGENESIS, V39, P57, DOI 10.1016/j.micpath.2005.05.001; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Taborda CP, 2002, IMMUNITY, V16, P791, DOI 10.1016/S1074-7613(02)00328-X; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tsang JYS, 2011, INT IMMUNOPHARMACOL, V11, P604, DOI 10.1016/j.intimp.2010.11.009; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang JP, 2005, BIOCHEM PHARMACOL, V69, P1225, DOI 10.1016/j.bcp.2005.01.013; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	55	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69108	10.1371/journal.pone.0069108	http://dx.doi.org/10.1371/journal.pone.0069108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935932	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300023
J	Chanda, P; Huang, HL; Arking, DE; Bader, JS				Chanda, Pritam; Huang, Hailiang; Arking, Dan E.; Bader, Joel S.			Fast Association Tests for Genes with FAST	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LOCI; TRAITS	Gene-based tests of association can increase the power of a genome-wide association study by aggregating multiple independent effects across a gene or locus into a single stronger signal. Recent gene-based tests have distinct approaches to selecting which variants to aggregate within a locus, modeling the effects of linkage disequilibrium, representing fractional allele counts from imputation, and managing permutation tests for p-values. Implementing these tests in a single, efficient framework has great practical value. Fast ASsociation Tests (FAST) addresses this need by implementing leading gene-based association tests together with conventional SNP-based univariate tests and providing a consolidated, easily interpreted report. Fast scales readily to genome-wide SNP data with millions of SNPs and tens of thousands of individuals, provides implementations that are orders of magnitude faster than original literature reports, and provides a unified framework for performing several gene based association tests concurrently and efficiently on the same data. Availability: https://bitbucket.org/baderlab/fast/downloads/FAST.tar.gz, with documentation at https://bitbucket.org/baderlab/fast/wiki/Home	[Chanda, Pritam; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Chanda, Pritam; Bader, Joel S.] Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA; [Chanda, Pritam; Bader, Joel S.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD USA; [Huang, Hailiang] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Huang, Hailiang] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University	Bader, JS (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	joel.bader@jhu.edu		Huang, Hailiang/0000-0003-1461-5762	Robert J. Kleberg Jr. and Helen C. Kleberg Foundation; NSF [DMS-1228248]; Simons Foundation [SFARI 137603]	Robert J. Kleberg Jr. and Helen C. Kleberg Foundation; NSF(National Science Foundation (NSF)); Simons Foundation	JSB and PC acknowledge funding from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation. JSB and DEA acknowledge funding from the NSF (DMS-1228248). DEA, JSB, PC and HH acknowledge funding from the Simons Foundation (SFARI 137603 to DEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bacanu SA, 2012, GENET EPIDEMIOL, V36, P333, DOI 10.1002/gepi.21625; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Camargo M, 2012, EUR J MED GENET, V55, P510, DOI 10.1016/j.ejmg.2012.06.005; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Knuth DE, 1997, ART COMPUTER PROGRAM; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Ortega JM, 2000, CLASSICS APPL MATH; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Tang CS, 2012, BIOINFORMATICS, V28, P845, DOI 10.1093/bioinformatics/bts051	22	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68585	10.1371/journal.pone.0068585	http://dx.doi.org/10.1371/journal.pone.0068585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935874	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000031
J	Milsted, AJ; Hale, JR; Frey, JG; Neylon, C				Milsted, Andrew J.; Hale, Jennifer R.; Frey, Jeremy G.; Neylon, Cameron			LabTrove: A Lightweight, Web Based, Laboratory "Blog" as a Route towards a Marked Up Record of Work in a Bioscience Research Laboratory	PLOS ONE			English	Article							CHEMISTRY	Background: The electronic laboratory notebook (ELN) has the potential to replace the paper notebook with a marked-up digital record that can be searched and shared. However, it is a challenge to achieve these benefits without losing the usability and flexibility of traditional paper notebooks. We investigate a blog-based platform that addresses the issues associated with the development of a flexible system for recording scientific research. Methodology/Principal Findings: We chose a blog-based approach with the journal characteristics of traditional notebooks in mind, recognizing the potential for linking together procedures, materials, samples, observations, data, and analysis reports. We implemented the LabTrove blog system as a server process written in PHP, using a MySQL database to persist posts and other research objects. We incorporated a metadata framework that is both extensible and flexible while promoting consistency and structure where appropriate. Our experience thus far is that LabTrove is capable of providing a successful electronic laboratory recording system. Conclusions/Significance: LabTrove implements a one-item one-post system, which enables us to uniquely identify each element of the research record, such as data, samples, and protocols. This unique association between a post and a research element affords advantages for monitoring the use of materials and samples and for inspecting research processes. The combination of the one-item one-post system, consistent metadata, and full-text search provides us with a much more effective record than a paper notebook. The LabTrove approach provides a route towards reconciling the tensions and challenges that lie ahead in working towards the long-term goals for ELNs. LabTrove, an electronic laboratory notebook (ELN) system from the Smart Research Framework, based on a blog-type framework with full access control, facilitates the scientific experimental recording requirements for reproducibility, reuse, repurposing, and redeployment.	[Milsted, Andrew J.; Hale, Jennifer R.; Frey, Jeremy G.] Univ Southampton, Dept Chem, Southampton SO9 5NH, Hants, England; [Neylon, Cameron] Rutherford Appleton Lab, ISIS Neutron Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Southampton; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Frey, JG (corresponding author), Univ Southampton, Dept Chem, Southampton SO9 5NH, Hants, England.	j.g.frey@soton.ac.uk	Frey, Jeremy G./ABC-1436-2021	Frey, Jeremy G./0000-0003-0842-4302; Milsted, Andrew/0000-0003-4693-8785; Neylon, Cameron/0000-0002-0068-716X	Biotechnology and Biological Sciences Research Council [BB/D00652X/1]; UK e-Science programme EPSRC [GR/R67729/01]; BBSRC [BB/D00652X/1] Funding Source: UKRI; EPSRC [EP/G026238/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C008863/1, EP/G026238/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK e-Science programme EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Biotechnology and Biological Sciences Research Council (Grant no. BB/D00652X/1) and the UK e-Science programme EPSRC grant GR/R67729/01 for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams N., 2009, NAT PRECEDINGS, DOI [DOI 10.1038/NPRE.2009.3714.1, 10.1038/npre.2009.3714.1]; Ali AbdelAziem A, 2011, BMC RES NOTES, V4, DOI [10.1186/1756-0500-4-138, DOI 10.1186/1756-0500-4-138.CAMER0N, 10.1186/1756-0500-4-311, DOI 10.1186/1756-0500-4-311]; Bechhofer S, 2013, FUTURE GENER COMP SY, V29, P599, DOI 10.1016/j.future.2011.08.004; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Borkum M., 2010, E-Science 2010. Proceedings 6th IEEE International Conference on E-Science (E-Science 2010), P316, DOI 10.1109/eScience.2010.18; Bradley J, 2003, COMMUNICATION; Bradley JC, 2011, COLLABORATIVE COMPUT, P425; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Committee on Science Engineering and PP (COSEPUP), 1995, BEING SCI RESP COND; Day P., 1999, PHILOS TREE SELECTIO, V1st; De Roure D, 2010, COMPUTER, V43, P90; De Roure D, 2009, FUTURE GENER COMP SY, V25, P561, DOI 10.1016/j.future.2008.06.010; EISENBERG A, 1982, J CHEM EDUC, V59, P1045, DOI 10.1021/ed059p1045; Frey J, 2004, UK E SCI ALL HANDS M; Frey J. G., 2003, P 1 INT WORKSH HYP S; Frey JG, 2013, CONCURR COMP-PRACT E, V25, P481, DOI 10.1002/cpe.2922; Frey JG, 2009, DRUG DISCOV TODAY, V14, P552, DOI 10.1016/j.drudis.2009.03.007; Frey JG, UNPUB; Frey JG, 2008, INT J DIGITAL CURATI, V3, P44, DOI DOI 10.2218/IJDC.V3I1.41; Hirst T, 2010, OUSEFULINFO BLOG; Hughes G, 2004, ORG BIOMOL CHEM, V2, P3284, DOI 10.1039/b410075a; Hulme M., 2009, SHOW YOUR WORKING WH; Jones AR, 2009, OMICS, V13, P239, DOI 10.1089/omi.2008.0080; Kanare H. M., 1985, WRITING LAB NOTEBOOK; Murray-Rust P, 2004, ORG BIOMOL CHEM, V2, P3192, DOI 10.1039/b410732b; Neylon C, 2010, SCI OPEN 2012; Neylon Cameron, 2009, Autom Exp, V1, P3, DOI 10.1186/1759-4499-1-3; Pavlis RR, 2011, ELN PAPERLESS LAB; Revere, 2009, SCIENCEBLOGS     MAY; Rodgers R, 2011, OPEN REPOSITORIES 20; Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054; Schraefel MC, 2004, CHI 2004; Schraefel MC, 2004, P 5 C DES INT SYST P, P49, DOI DOI 10.1145/1013115.1013124; Smith Wendy S, 2011, BMC Res Notes, V4, P138, DOI 10.1186/1756-0500-4-138; Stamcar M, 2005, MARKOS MBLOG; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Taylor KR, 2006, J WEB SEMANT, V4, P84, DOI 10.1016/j.websem.2006.03.003; Taylor KR, 2006, J CHEM INF MODEL, V46, P939, DOI 10.1021/ci050378m; Zuiker A, SCI BLOGGING AGGREGA	41	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67460	10.1371/journal.pone.0067460	http://dx.doi.org/10.1371/journal.pone.0067460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935832	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325211000011
J	Namosha, E; Sartorius, B; Tanser, F				Namosha, Elias; Sartorius, Benn; Tanser, Frank			Spatial Clustering of All-Cause and HIV-Related Mortality in a Rural South African Population (2000-2006)	PLOS ONE			English	Article							GEOGRAPHIC ANALYSIS; COHORT PROFILE; UNITED-STATES; CANCER; IMPACT; RISK; CARE	Background: Sub-Saharan Africa bears a disproportionate burden of HIV infection. Knowledge of the spatial distribution of HIV outcomes is vital so that appropriate public health interventions can be directed at locations most in need. In this regard, spatial clustering analysis of HIV-related mortality events has not been performed in a rural sub-Saharan African setting. Methodology and Results: Kulldorff's spatial scan statistic was used to identify HIV-related and all-cause mortality clusters (p<0.05) in a population-based demographic surveillance survey in rural KwaZulu Natal, South Africa (2000-2006). The analysis was split pre (2000-2003) and post (2004-2006) rollout of antiretroviral therapy, respectively. Between 2000-2006 a total of 86,175 resident individuals >= 15 years of age were under surveillance and 5,875 deaths were recorded (of which 2,938 were HIV-related) over 343,060 person-years of observation (crude all-cause mortality rate 17.1/1000). During both time periods a cluster of high HIV-related (RR = 1.46/1.51, p = 0.001) and high all-cause mortality (RR = 1.35/1.38, p = 0.001) was identified in peri-urban communities near the National Road. A consistent low-risk cluster was detected in the urban township in both time periods (RR = 0.60/0.39, p = 0.003/0.005) and in the first time period (2000-2003) a large cluster of low HIV-related and all-cause mortality in a remote rural area was identified. Conclusions: HIV-related and all-cause mortality exhibit strong spatial clustering tendencies in this population. Highest HIV-related mortality and all-cause mortality occurred in the peri-urban communities along the National Road and was lowest in the urban township and remote rural communities. The geography of HIV-related mortality corresponded closely to the geography of HIV prevalence, with the notable exception of the urban township where high HIV-related mortality would have been expected on the basis of the high HIV prevalence. Our results suggest that HIV treatment and care programmes should be strengthened in easy-to-reach high density, peri-urban populations near National Roads where both HIV-related and all-cause mortality are highest.	[Namosha, Elias; Sartorius, Benn] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Namosha, Elias] Papua New Guinea Inst Med Res, Papua, Guinea; [Tanser, Frank] Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of Witwatersrand; University of Kwazulu Natal	Tanser, F (corresponding author), Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.	tanserf@africacentre.ac.za	Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000; , bennsartorius/0000-0001-6761-2325	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR); National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; Wellcome Trust, UK [082384/Z/07/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust, UK(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Elias Namosha was supported by the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR). Frank Tanser was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grant # 082384/Z/07/Z)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola O, 2004, INT J HEALTH GEOGR, V3, P1; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; BESAG J, 1991, J ROY STAT SOC A STA, V154, P143, DOI 10.2307/2982708; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Fukuda Y, 2005, INT J HEALTH GEOGR, V4, P16, DOI DOI 10.1186/1476-072X; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Green C, 2003, SOC SCI MED, V57, P551, DOI 10.1016/S0277-9536(02)00380-5; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Hosegood Victoria., 2016, AFRICAN HOUSEHOLDS C, P58; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Jemal A, 2002, INT J CANCER, V101, P168, DOI 10.1002/ijc.10594; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 1998, SOFTWARE SPATIAL SPA; Lawson AB, 2001, PROBABILITY STAT, P298; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Michaud JM, 2003, SEX TRANSM DIS, V30, P533, DOI 10.1097/00007435-200307000-00001; Muhwava W, 2008, MONOGRAPH SERIES, V2; Municipality UD, 2011, UMKH DISTR MUN INT D; Rosenberg MS, 1999, EUR J EPIDEMIOL, V15, P15, DOI 10.1023/A:1007559728848; Sankoh OA, 2001, INT J EPIDEMIOL, V30, P485, DOI 10.1093/ije/30.3.485; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Tanser F, 2000, TROP MED INT HEALTH, V5, P40, DOI 10.1046/j.1365-3156.2000.00513.x; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; Wakefield J, 2002, SPATIAL EPIDEMIOLOGY, P128	33	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69279	10.1371/journal.pone.0069279	http://dx.doi.org/10.1371/journal.pone.0069279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935972	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000097
J	Sung, TC; Chen, ZJ; Thuret, S; Vilar, M; Gage, FH; Riek, R; Lee, KF				Sung, Tsung-Chang; Chen, Zhijiang; Thuret, Sandrine; Vilar, Marcal; Gage, Fred H.; Riek, Roland; Lee, Kuo-Fen			P45 Forms a Complex with FADD and Promotes Neuronal Cell Survival Following Spinal Cord Injury	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; DEATH EFFECTOR DOMAIN; APOPTOSIS; FAS; RECOVERY; BINDING; PROTEIN; SITE; PHOSPHORYLATION; REGENERATION	Fas-associated death domain (DD) adaptor (FADD), a member of the DD superfamily, contains both a DD and a death effector domain (DED) that are important in mediating FAS ligand-induced apoptotic signaling. P45 is a unique member of the DD superfamily in that it has a domain with sequence and structural characteristics of both DD and DED. We show that p45 forms a complex with FADD and diminishes Fas-FADD mediated death signaling. The DED of FADD is required for the complex formation with p45. Following spinal cord injury, transgenic mice over-expressing p45 exhibit increased neuronal survival, decreased retraction of corticospinal tract fibers and improved functional recovery. Understanding p45-mediated cellular and molecular mechanisms may provide insights into facilitating nerve regeneration in humans.	[Sung, Tsung-Chang; Chen, Zhijiang; Thuret, Sandrine; Vilar, Marcal; Gage, Fred H.; Riek, Roland; Lee, Kuo-Fen] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA; [Thuret, Sandrine] Kings Coll London, Inst Psychiat, Ctr Cellular Basis Behav, London WC2R 2LS, England; [Thuret, Sandrine] Kings Coll London, Inst Psychiat, Med Res Council Ctr Neurodegenerat Res, London WC2R 2LS, England; [Vilar, Marcal] Inst Salud Carlos III, Neurodegenerat Unit, Madrid, Spain; [Riek, Roland] ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland	Salk Institute; University of London; King's College London; University of London; King's College London; Instituto de Salud Carlos III; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lee, KF (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA.	klee@salk.edu	Vilar, Marçal/B-4581-2016; Thuret, Sandrine/Y-5784-2019	Vilar, Marçal/0000-0002-9376-6544; Thuret, Sandrine/0000-0003-1260-8083	NIH [HD034534, NS060833, NS072031, AG010435, CA014195, AG042985]; MDA; Clayton foundation; National Institute of Aging [T32 AG00216]; Ministerio de Economia y Competitividad [BFU2010-15276]; ISCIII [MPY1413/09]; Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Christopher & Dana Reeve Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216, RF1AG042985, P01AG010435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); Clayton foundation; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministerio de Economia y Competitividad(Spanish Government); ISCIII(Instituto de Salud Carlos III); Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Christopher & Dana Reeve Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the NIH (K.F.L.: HD034534, NS060833, NS072031, AG010435, CA014195 and AG042985), MDA (K.F.L.) and Clayton foundation (K.F.L.). T.S. was supported by a training grant from the National Institute of Aging (T32 AG00216). M. V. was supported by Ministerio de Economia y Competitividad (BFU2010-15276) and ISCIII (MPY1413/09). S.T. was supported by the Paralyzed Veterans of America Spinal Cord Research Foundation, the Paralysis Project of America and the Christopher & Dana Reeve Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczyk O, 2007, BIOCHEMISTRY-US, V46, P9174, DOI 10.1021/bi7002058; Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Bareyre FM, 2005, NAT MED; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frankowski H, 2002, NEUROMOL MED, V1, P153; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Haase G, 2008, CURR OPIN NEUROBIOL; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Jia L, 2011, NEUROCHEM RES, V36, P419, DOI 10.1007/s11064-010-0357-2; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kaufmann M, 2002, FEBS LETT, V527, P250, DOI 10.1016/S0014-5793(02)03146-0; Kim T, 2009, EMBO J; Kuzhandaivel A, 2011, FRONTIERS CELLULAR N, V5; Lambert C, 2003, APOPTOSIS, V8, P551, DOI 10.1023/A:1026113222478; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Murray SS, 2004, J NEUROSCI, V24, P2742, DOI 10.1523/JNEUROSCI.3960-03.2004; Panahian N, 2001, J NEUROCHEM, V76, P539, DOI 10.1046/j.1471-4159.2001.00023.x; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Wang X, 2003, CELL DEATH DIFFER, V10, P580, DOI 10.1038/sj.cdd.4401208; Wong AW, 2008, J NEUROCHEM, V106, P1964, DOI 10.1111/j.1471-4159.2008.05539.x; Wu B, 2009, J NEUROTRAUM, V26, P1847, DOI 10.1089/neu.2008.0551; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zhang J, 2004, IUBMB LIFE, V56, P395, DOI 10.1080/15216540400008929	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69286	10.1371/journal.pone.0069286	http://dx.doi.org/10.1371/journal.pone.0069286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935974	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000099
J	Liang, TJ; Liu, HJ; Zhao, XQ; Yu, CH; Li, CS				Liang, Tie-Jun; Liu, Hong-Jun; Zhao, Xiao-Qian; Yu, Cui-Hua; Li, Chen-Sheng			Lack of Association of MiR-34b/c Polymorphism (rs4938723) with Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; MICRORNAS; CANCER; SUSCEPTIBILITY; POPULATION	Background: Previous studies have focused on the association of miR-34 family members with carcinogenesis of many cancers, including hepatocellular carcinoma (HCC). It has been suggested that miR-34b/c polymorphism (rs4938723) is associated with susceptibility to HCC. In the present study, we performed a meta-analysis to systematically summarize the possible association between rs4938723 and the risk for HCC. Methodology/Principal Findings: We conducted a search of case-control studies on the associations of rs4938723 with susceptibility to HCC in PubMed, EMBASE, ISI Web of Science, Cochrane Central Register of Controlled Trials, ScienceDirect, Wiley Online Library, Wangfang database in China, and Chinese National Knowledge Infrastructure databases. Data from eligible studies were extracted for meta-analysis. HCC risk associated with rs4938723 was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). 3 studies on rs4938723 were included in our meta-analysis. Our results showed that neither allele frequency nor genotype distribution of the rs4938723 was associated with risk for HCC in all genetic models. Conclusions/Significance: This meta-analysis suggests that rs4938723 is not associated with the risk of HCC. Well-designed studies with larger sample size and more ethnic groups are required to further validate the results.	[Liang, Tie-Jun; Liu, Hong-Jun; Zhao, Xiao-Qian; Yu, Cui-Hua; Li, Chen-Sheng] Shandong Univ, Prov Hosp, Dept Digest Dis, Jinan 250100, Shandong, Peoples R China	Shandong University	Li, CS (corresponding author), Shandong Univ, Prov Hosp, Dept Digest Dis, Jinan 250100, Shandong, Peoples R China.	LiChenSheng@126.com			National Natural Science Foundation of China [ZR2012HM070]; Young and Middle-Aged Scientists Research Award Fund of Shandong Province of China [BS2010YY060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young and Middle-Aged Scientists Research Award Fund of Shandong Province of China	This work was supported by the National Natural Science Foundation of China (No. ZR2012HM070) and the Young and Middle-Aged Scientists Research Award Fund of Shandong Province of China (No. BS2010YY060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Han YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058564; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Son MS, 2013, GENE, V524, P156, DOI 10.1016/j.gene.2013.04.042; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342	13	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68588	10.1371/journal.pone.0068588	http://dx.doi.org/10.1371/journal.pone.0068588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935875	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700010
J	Payne, AC; Andregg, M; Kemmish, K; Hamalainen, M; Bowell, C; Bleloch, A; Klejwa, N; Lehrach, W; Schatz, K; Stark, H; Marblestone, A; Church, G; Own, CS; Andregg, W				Payne, Andrew C.; Andregg, Michael; Kemmish, Kent; Hamalainen, Mark; Bowell, Charlotte; Bleloch, Andrew; Klejwa, Nathan; Lehrach, Wolfgang; Schatz, Ken; Stark, Heather; Marblestone, Adam; Church, George; Own, Christopher S.; Andregg, William			Molecular Threading: Mechanical Extraction, Stretching and Placement of DNA Molecules from a Liquid-Air Interface	PLOS ONE			English	Article							HIGH-RESOLUTION; TEMPLATED FABRICATION; SINGLE; ALIGNMENT; MICROSCOPE; TWEEZERS; BIOLOGY; ARRAYS	We present "molecular threading", a surface independent tip-based method for stretching and depositing single and double-stranded DNA molecules. DNA is stretched into air at a liquid-air interface, and can be subsequently deposited onto a dry substrate isolated from solution. The design of an apparatus used for molecular threading is presented, and fluorescence and electron microscopies are used to characterize the angular distribution, straightness, and reproducibility of stretched DNA deposited in arrays onto elastomeric surfaces and thin membranes. Molecular threading demonstrates high straightness and uniformity over length scales from nanometers to micrometers, and represents an alternative to existing DNA deposition and linearization methods. These results point towards scalable and high-throughput precision manipulation of single-molecule polymers.	[Payne, Andrew C.; Marblestone, Adam; Church, George] Harvard Univ, Wyss Inst, Boston, MA 02115 USA; [Payne, Andrew C.; Andregg, Michael; Kemmish, Kent; Hamalainen, Mark; Bowell, Charlotte; Bleloch, Andrew; Klejwa, Nathan; Lehrach, Wolfgang; Schatz, Ken; Stark, Heather; Own, Christopher S.; Andregg, William] Halcyon Mol Inc, Redwood City, CA USA; [Marblestone, Adam; Church, George] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Church, George] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Church, G (corresponding author), Harvard Univ, Biophys Program, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu; csown@voxa.co		Marblestone, Adam/0000-0001-9833-9931; church, george/0000-0001-6232-9969	U.S. Department of Energy [DE-FG02-02ER63445]; NIH [RC2 HG005592]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005592] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank the U.S. Department of Energy Grant No. DE-FG02-02ER63445 and NIH Grant No. RC2 HG005592 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand JF, 1997, BIOPHYS J, V73, P2064, DOI 10.1016/S0006-3495(97)78236-5; Andregg W, 2010, US Patent App, Patent No. [12/753,722, 12753722]; Bell DC, 2012, MICROSC MICROANAL, V18, P1049, DOI 10.1017/S1431927612012615; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Bleloch A.L., 2011, MICROSCOPY MICRO SS2, V17, P1274; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Cerf A, 2011, NANO LETT; Cerf A, 2009, MICROELECTRON ENG, V86, P1419, DOI 10.1016/j.mee.2009.01.057; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Deng ZX, 2003, NANO LETT, V3, P1545, DOI 10.1021/nl034720q; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Gentile F, 2012, NANO LETT, V12, P6453, DOI 10.1021/nl3039162; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Gu Q, 2006, PHYSICA E, V33, P92, DOI 10.1016/j.physe.2005.11.010; Herrick J, 1999, CHROMOSOME RES, V7, P409, DOI 10.1023/A:1009276210892; Kanavarioti A, 2012, ELEC TROPHORESIS; Kim HJ, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-30; Kim HJ, 2009, DIAM RELAT MATER, V18, P1015, DOI 10.1016/j.diamond.2009.02.027; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; Kudo H, 2008, COLLOID SURFACE A, V313, P651, DOI 10.1016/j.colsurfa.2007.04.126; Kwak KJ, 2003, APPL SURF SCI, V210, P73, DOI 10.1016/S0169-4332(02)01482-4; Lam E, 2012, NATURE BIOTECHNOLOGY; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lund J, 2006, NANOTECHNOLOGY, V17, P2752, DOI 10.1088/0957-4484/17/11/007; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Nakao H, 2003, J AM CHEM SOC, V125, P7162, DOI 10.1021/ja034185w; Nyamjav D, 2003, ADV MATER, V15, P1805, DOI 10.1002/adma.200305342; Oshige M, 2010, ANAL BIOCHEM, V400, P145, DOI 10.1016/j.ab.2010.01.021; Own CS, UNPUB; Own CS, 2013, MICROSCOPY IN PRESS; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; Sagnes M, 2003, MICROELECTRON ENG, V67-8, P683, DOI 10.1016/S0167-9317(03)00130-8; Sasou M, 2003, LANGMUIR, V19, P9845, DOI 10.1021/la035054b; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwob Etienne, 2009, V521, P673, DOI 10.1007/978-1-60327-817-5_36; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3; Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WILKINS MHF, 1951, NATURE, V167, P759, DOI 10.1038/167759a0; Zhang JM, 2005, LANGMUIR, V21, P4180, DOI 10.1021/la050129s; Zlatanova J, 2000, PROG BIOPHYS MOL BIO, V74, P37, DOI 10.1016/S0079-6107(00)00014-6	44	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69058	10.1371/journal.pone.0069058	http://dx.doi.org/10.1371/journal.pone.0069058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935923	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700017
J	Schenten, V; Gueguinou, N; Baatout, S; Frippiat, JP				Schenten, Veronique; Gueguinou, Nathan; Baatout, Sarah; Frippiat, Jean-Pol			Modulation of Pleurodeles waltl DNA Polymerase mu Expression by Extreme Conditions Encountered during Spaceflight	PLOS ONE			English	Article							POL-MU; HEAVY-CHAIN; LIGASE-IV; LAMBDA; TDT; TRANSCRIPTION; DEFICIENT; DEFINES; SYSTEM; REPAIR	DNA polymerase m is involved in DNA repair, V(D)J recombination and likely somatic hypermutation of immunoglobulin genes. Our previous studies demonstrated that spaceflight conditions affect immunoglobulin gene expression and somatic hypermutation frequency. Consequently, we questioned whether Pol mu expression could also be affected. To address this question, we characterized Pol mu of the Iberian ribbed newt Pleurodeles waltl and exposed embryos of that species to spaceflight conditions or to environmental modifications corresponding to those encountered in the International Space Station. We noted a robust expression of Pol mu mRNA during early ontogenesis and in the testis, suggesting that Pol mu is involved in genomic stability. Full-length Pol mu transcripts are 8-9 times more abundant in P. waltl than in humans and mice, thereby providing an explanation for the somatic hypermutation predilection of G and C bases in amphibians. Pol mu transcription decreases after 10 days of development in space and radiation seem primarily involved in this down-regulation. However, space radiation, alone or in combination with a perturbation of the circadian rhythm, did not affect Pol mu protein levels and did not induce protein oxidation, showing the limited impact of radiation encountered during a 10-day stay in the International Space Station.	[Schenten, Veronique; Gueguinou, Nathan; Frippiat, Jean-Pol] Lorraine Univ, Stress Immun Pathogens Lab, EA7300, Vandoeuvre Les Nancy, France; [Baatout, Sarah] SCK CEN, Belgian Nucl Res Ctr, Radiobiol Unit, Mol, Belgium; [Baatout, Sarah] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium	Universite de Lorraine; Belgian Nuclear Research Centre (SCK-CEN); Ghent University	Frippiat, JP (corresponding author), Lorraine Univ, Stress Immun Pathogens Lab, EA7300, Vandoeuvre Les Nancy, France.	jean-pol.frippiat@univ-lorraine.fr		Frippiat, Jean-Pol/0000-0002-4027-6269; Baatout, Sarah/0000-0001-8110-751X	French National Space Agency (CNES); National Research Agency [ANR NT09-632666]; French Ministry of Higher Education and Research; Lorraine University; Lorraine area; BELSPO/PRODEX/ESA [42-000-90-380]; National Research Fund of Luxembourg; CNES	French National Space Agency (CNES)(Centre National D'etudes Spatiales); National Research Agency(French National Research Agency (ANR)); French Ministry of Higher Education and Research; Lorraine University; Lorraine area; BELSPO/PRODEX/ESA(European Space AgencyBelgian Federal Science Policy Office); National Research Fund of Luxembourg(Luxembourg National Research Fund); CNES(Centre National D'etudes Spatiales)	This work was supported by the French National Space Agency (CNES) (www.cnes.fr), the National Research Agency (grant ANR NT09-632666)(www.agence-nationale-recherche.fr), the French Ministry of Higher Education and Research (www.enseignementsup-recherche.gouv.fr), the Lorraine University (www.univ-lorraine.fr/), the Lorraine area (www.lorraine.eu/) and BELSPO/PRODEX/ESA (contract 42-000-90-380) (www.belspo.be). N.G. was supported by a PhD fellowship from the National Research Fund of Luxembourg (www.fnr.lu) and V.S. by a CNES post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Bascove M, 2011, FASEB J, V25, P2947, DOI 10.1096/fj.11-185215; Bascove M, 2010, MOL IMMUNOL, V47, P1640, DOI 10.1016/j.molimm.2010.01.005; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Beetz S, 2007, IMMUNOGENETICS, V59, P735, DOI 10.1007/s00251-007-0241-7; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Boudarra N, 2002, DEV COMP IMMUNOL, V26, P659, DOI 10.1016/S0145-305X(02)00014-9; Boxio R, 2005, J APPL PHYSIOL, V98, P905, DOI 10.1152/japplphysiol.00957.2004; Capp JP, 2007, NUCLEIC ACIDS RES, V35, P3551, DOI 10.1093/nar/gkm243; Chayot R, 2010, DNA REPAIR, V9, P1187, DOI 10.1016/j.dnarep.2010.09.001; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; Frippiat C, 2001, IMMUNOGENETICS, V52, P264; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; GALLIEN L., 1957, BULL BIOL FRANCE ET BELGIQUE, V91, P97; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; Gozalbo-Lopez B, 2009, MOL CELL BIOL, V29, P1266, DOI 10.1128/MCB.01518-08; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Heyer BS, 2000, GENE DEV, V14, P2072; Huin-Schohn C, 2013, FASEB J, V27, P333, DOI 10.1096/fj.12-217547; Kimzey SL, 1977, BIOMEDICAL RESULTS S, P248; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; KONSTANTINOVA IV, 1993, J LEUKOCYTE BIOL, V54, P189, DOI 10.1002/jlb.54.3.189; Leach JK, 2001, CANCER RES, V61, P3894; Lieber MR, 2008, CELL RES, V18, P125, DOI 10.1038/cr.2007.108; Lucas D, 2005, EUR J IMMUNOL, V35, P1601, DOI 10.1002/eji.200526015; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Reynaud CA, 2001, PHILOS T ROY SOC B, V356, P91, DOI 10.1098/rstb.2000.0753; Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929; Ruiz JF, 2001, PHILOS T R SOC B, V356, P99, DOI 10.1098/rstb.2000.0754; Schaerlinger B, 2008, MOL IMMUNOL, V45, P776, DOI 10.1016/j.molimm.2007.06.356; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Smith JT, 2012, BIOL LETTERS, V8, P594, DOI 10.1098/rsbl.2012.0150; Space Radiation Expert Group Report, 2012, HUM EXPL SPAC EUROPE; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69647	10.1371/journal.pone.0069647	http://dx.doi.org/10.1371/journal.pone.0069647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936065	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700035
J	Ziegler, E; Foret, A; Mascetti, L; Muto, V; Le Bourdiec-Shaffii, A; Stender, J; Balteau, E; Dideberg, V; Bours, V; Maquet, P; Phillips, C				Ziegler, Erik; Foret, Ariane; Mascetti, Laura; Muto, Vincenzo; Le Bourdiec-Shaffii, Anahita; Stender, Johan; Balteau, Evelyne; Dideberg, Vinciane; Bours, Vincent; Maquet, Pierre; Phillips, Christophe			Altered White Matter Architecture in BDNF Met Carriers	PLOS ONE			English	Article							VAL66MET POLYMORPHISM; DIFFUSION MRI; MEMORY; INVENTORY	Brain-derived neurotrophic factor (BDNF) modulates the pruning of synaptically silent axonal arbors. The Met allele of the BDNF gene is associated with a reduction in the neurotrophin's activity-dependent release. We used diffusion-weighted imaging to construct structural brain networks for 36 healthy subjects with known BDNF genotypes. Through permutation testing we discovered clear differences in connection strength between subjects carrying the Met allele and those homozygotic for the Val allele. We trained a Gaussian process classifier capable of identifying the subjects' allelic group with 86% accuracy and high predictive value. In Met carriers structural connectivity was greatly increased throughout the forebrain, particularly in connections corresponding to the anterior and superior corona radiata as well as corticothalamic and corticospinal projections from the sensorimotor, premotor, and prefrontal portions of the internal capsule. Interhemispheric connectivity was also increased via the corpus callosum and anterior commissure, and extremely high connectivity values were found between inferior medial frontal polar regions via the anterior forceps. We propose that the decreased availability of BDNF leads to deficits in axonal maintenance in carriers of the Met allele, and that this produces mesoscale changes in white matter architecture.	[Ziegler, Erik; Foret, Ariane; Mascetti, Laura; Muto, Vincenzo; Le Bourdiec-Shaffii, Anahita; Stender, Johan; Balteau, Evelyne; Maquet, Pierre; Phillips, Christophe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Dideberg, Vinciane; Bours, Vincent] CHU Sart Tilman, Dept Human Genet, B-4000 Liege, Belgium; [Maquet, Pierre] CHU Liege, Dept Neurol, Liege, Belgium; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Phillips, C (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	c.phillips@ulg.ac.be	Muto, Vincenzo/AAS-5220-2020; Phillips, Christophe/M-3025-2017	Muto, Vincenzo/0000-0001-5100-9927; , Pierre/0000-0003-3106-3357; Ziegler, Erik/0000-0003-1857-8129; Phillips, Christophe/0000-0002-4990-425X	Belgian National Fund for Scientific Research; University of Liege; Queen Elisabeth Medical Foundation; Leon Fredericq Foundation; Belgian Inter-University Attraction Program; Walloon Excellence in Life Sciences and Biotechnology program; Marie Curie Initial Training Network in Neurophysics [PITN-GA-2009-238593]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); Queen Elisabeth Medical Foundation; Leon Fredericq Foundation; Belgian Inter-University Attraction Program; Walloon Excellence in Life Sciences and Biotechnology program; Marie Curie Initial Training Network in Neurophysics	This research was supported by the Belgian National Fund for Scientific Research, the University of Liege, the Queen Elisabeth Medical Foundation, the Leon Fredericq Foundation, the Belgian Inter-University Attraction Program, the Walloon Excellence in Life Sciences and Biotechnology program, and the Marie Curie Initial Training Network in Neurophysics (PITN-GA-2009-238593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Buysse D J, 1989, Psychiatry Res, V28, P193; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chiang MC, 2011, NEUROIMAGE, V55, P448, DOI 10.1016/j.neuroimage.2010.12.053; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P7, DOI 10.1098/rstb.2000.0546; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Raven J.C., 1998, ADV PROGR MATRICES; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	43	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69290	10.1371/journal.pone.0069290	http://dx.doi.org/10.1371/journal.pone.0069290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935975	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700023
J	Cheng, HH; Mitchell, PS; Kroh, EM; Dowell, AE; Chery, L; Siddiqui, J; Nelson, PS; Vessella, RL; Knudsen, BS; Chinnaiyan, AM; Pienta, KJ; Morrissey, C; Tewari, M				Cheng, Heather H.; Mitchell, Patrick S.; Kroh, Evan M.; Dowell, Alexander E.; Chery, Lisly; Siddiqui, Javed; Nelson, Peter S.; Vessella, Robert L.; Knudsen, Beatrice S.; Chinnaiyan, Arul M.; Pienta, Kenneth J.; Morrissey, Colm; Tewari, Muneesh			Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia	PLOS ONE			English	Article							MIR-210; TUMORIGENESIS; SIGNATURE; CORRELATE; ORIGIN; MIRNAS; TISSUE	MicroRNAs (miRNAs) are small (similar to 22 nucleotide) non-coding RNAs that regulate a myriad of biological processes and are frequently dysregulated in cancer. Cancer-associated microRNAs have been detected in serum and plasma and hold promise as minimally invasive cancer biomarkers, potentially for assessing disease characteristics in patients with metastatic disease that is difficult to biopsy. Here we used miRNA profiling to identify cancer-associated miRNAs that are differentially expressed in sera from patients with metastatic castration resistant prostate cancer (mCRPC) as compared to healthy controls. Of 365 miRNAs profiled, we identified five serum miRNAs (miR-141, miR-200a, miR-200c, miR-210 and miR-375) that were elevated in cases compared to controls across two independent cohorts. One of these, miR-210, is a known transcriptional target of the hypoxia-responsive HIF-1 alpha signaling pathway. Exposure of cultured prostate cancer cells to hypoxia led to induction of miR-210 and its release into the extracellular environment. Moreover, we found that serum miR-210 levels varied widely amongst mCRPC patients undergoing therapy, and correlated with treatment response as assessed by change in PSA. Our results suggest that (i) cancer-associated hypoxia is a frequent, previously under-appreciated characteristic of mCRPC, and (ii) serum miR-210 may be further developed as a predictive biomarker in patients with this distinct disease biology.	[Cheng, Heather H.; Nelson, Peter S.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Cheng, Heather H.; Nelson, Peter S.; Tewari, Muneesh] Univ Washington, Dept Med, Seattle, WA USA; [Mitchell, Patrick S.; Kroh, Evan M.; Nelson, Peter S.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Dowell, Alexander E.; Chery, Lisly; Vessella, Robert L.; Morrissey, Colm] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Siddiqui, Javed; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Siddiqui, Javed] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Vessella, Robert L.] Dept Vet Affairs Med Ctr, Seattle, WA USA; [Knudsen, Beatrice S.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI USA; [Pienta, Kenneth J.] Johns Hopkins Univ Hosp, Dept Urol, Baltimore, MD 21287 USA; [Pienta, Kenneth J.] Johns Hopkins Univ Hosp, Dept Oncol, Baltimore, MD 21287 USA; [Pienta, Kenneth J.] Johns Hopkins Univ Hosp, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tewari, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	mtewari@fhcrc.org		Cheng, Heather/0000-0002-1365-0702; Mitchell, Patrick/0000-0001-8375-9060	Canary Foundation; Damon Runyon-Rachleff Innovation Award; DOD Prostate Cancer New Investigator Award; National Institutes of Health (NIH) [CA093900, CA143055, PO1 CA085859, SPORE P50 CA69568, SPORE P50 CA97186, TR01 5R01DK085714, T32CA009515-28]; Prostate Cancer Foundation Creativity Award; Richard M. Lucas Foundation; NATIONAL CANCER INSTITUTE [P50CA097186, P50CA069568, U01CA143055, P01CA093900, P01CA085859, T32CA009515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	Canary Foundation; Damon Runyon-Rachleff Innovation Award; DOD Prostate Cancer New Investigator Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation Creativity Award; Richard M. Lucas Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Canary Foundation (to M. T.), Damon Runyon-Rachleff Innovation Award (to M. T.), DOD Prostate Cancer New Investigator Award (to M. T.), National Institutes of Health (NIH) CA093900 (to K.J.P.), NIH CA143055 (to K.J.P.), NIH PO1 CA085859 (to R. L. V.), NIH SPORE P50 CA69568 (to K.J.P. and A. M. C), NIH SPORE P50 CA97186 (to P.S.N., M. T., and R. L. V.), NIH TR01 5R01DK085714 (to M. T.), NIH T32CA009515-28 (to H. H. C.), Prostate Cancer Foundation Creativity Award (to M. T.), and Richard M. Lucas Foundation (to R. L. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jones ML, 2013, PROSTATE, V73, P176, DOI 10.1002/pros.22553; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Loberg RD, 2006, UROL ONCOL-SEMIN ORI, V24, P161, DOI 10.1016/j.urolonc.2005.11.005; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mathew LK, 2009, MOL CELL, V35, P737, DOI 10.1016/j.molcel.2009.09.008; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nguyen HC, 2012, PROSTATE; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Varadhachary GR, 2011, CLIN CANCER RES, V17, P4063, DOI 10.1158/1078-0432.CCR-10-2599; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Watahiki A, 2013, INT J MOL SCI, V14, P7757, DOI 10.3390/ijms14047757; Zhang HL, 2013, ASIAN J ANDROL, V15, P231, DOI 10.1038/aja.2012.116; Zhong H, 1999, CANCER RES, V59, P5830	26	126	126	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69239	10.1371/journal.pone.0069239	http://dx.doi.org/10.1371/journal.pone.0069239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935962	Green Published, gold			2022-12-27	WOS:000323114200030
J	Bastola, P; Stratton, Y; Kellner, E; Mikhaylova, O; Yi, Y; Sartor, MA; Medvedovic, M; Biesiada, J; Meller, J; Czyzyk-Krzeska, MF				Bastola, Prabhat; Stratton, Yiwen; Kellner, Emily; Mikhaylova, Olga; Yi, Ying; Sartor, Maureen A.; Medvedovic, Mario; Biesiada, Jacek; Meller, Jarek; Czyzyk-Krzeska, Maria F.			Folliculin Contributes to VHL Tumor Suppressing Activity in Renal Cancer through Regulation of Autophagy	PLOS ONE			English	Article							RNA-POLYMERASE-II; HOGG-DUBE SYNDROME; MTOR ACTIVATION; BINDING-PROTEIN; CELL CARCINOMAS; LARGE SUBUNIT; KIDNEY; HYDROXYLATION	Von Hippel-Lindau tumor suppressor (VHL) is lost in the majority of clear cell renal cell carcinomas (ccRCC). Folliculin (FLCN) is a tumor suppressor whose function is lost in Birt-Hogg-Dube syndrome (BHD), a disorder characterized by renal cancer of multiple histological types including clear cell carcinoma, cutaneous fibrofolliculoma, and pneumothorax. Here we explored whether there is connection between VHL and FLCN in clear cell renal carcinoma cell lines and tumors. We demonstrate that VHL regulates expression of FLCN at the mRNA and protein levels in RCC cell lines, and that FLCN protein expression is decreased in human ccRCC tumors with VHL loss, as compared with matched normal kidney tissue. Knockdown of FLCN results in increased formation of tumors by RCC cells with wild-type VHL in orthotopic xenografts in nude mice, an indication that FLCN plays a role in the tumor-suppressing activity of VHL. Interestingly, FLCN, similarly to VHL, is necessary for the activity of LC3C-mediated autophagic program that we have previously characterized as contributing to the tumor suppressing activity of VHL. The results show the existence of functional crosstalk between two major tumor suppressors in renal cancer, VHL and FLCN, converging on regulation of autophagy.	[Bastola, Prabhat; Stratton, Yiwen; Kellner, Emily; Mikhaylova, Olga; Yi, Ying; Czyzyk-Krzeska, Maria F.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA; [Czyzyk-Krzeska, Maria F.] VA Res Serv, Dept Vet Affairs, Cincinnati, OH USA; [Sartor, Maureen A.; Medvedovic, Mario; Meller, Jarek] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Biesiada, Jacek; Meller, Jarek] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Meller, Jarek] Nicolas Copernicus Univ, Dept Informat, Torun, Poland	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Nicolaus Copernicus University	Czyzyk-Krzeska, MF (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.	Maria.Czyzykkrzeska@uc.edu	Meller, Jaroslaw/A-1971-2011; Sartor, Maureen/L-2902-2019; Biesiada, Jacek/I-2844-2018	Meller, Jaroslaw/0000-0002-1162-8253; Biesiada, Jacek/0000-0003-0435-2225	Myrovlytis Trust; NIH/NCI [CA122346]; BLRD VAmerit Award [B101BX0011100-02]; UC [P30-ES006096CEG]; NATIONAL CANCER INSTITUTE [R01CA122346] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Myrovlytis Trust; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BLRD VAmerit Award; UC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Myrovlytis Trust, Research Grant; NIH/NCI CA122346; BLR&D VAmerit AwardB101BX0011100-02; UC P30-ES006096CEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Elsea SH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001827; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Nookala RK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120071; Pelekanou V, 2011, ANAL CELL PATHOL, V34, P49, DOI [10.3233/ACP-2011-0001, 10.1155/2011/108631]; Preston RS, 2011, ONCOGENE, V30, P1159, DOI 10.1038/onc.2010.497; Schmidt LS, 2005, AM J HUM GENET, V76, P1023, DOI 10.1086/430842; Yi Y, 2010, CLIN CANCER RES, V16, P5142, DOI 10.1158/1078-0432.CCR-09-3416; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283	16	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70030	10.1371/journal.pone.0070030	http://dx.doi.org/10.1371/journal.pone.0070030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922894	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700122
J	Kaczmarek, E; Bakker, JP; Clarke, DN; Csizmadia, E; Kocher, O; Veves, A; Tecilazich, F; O'Donnell, CP; Ferran, C; Malhotra, A				Kaczmarek, Elzbieta; Bakker, Jessie P.; Clarke, Douglas N.; Csizmadia, Eva; Kocher, Olivier; Veves, Aristidis; Tecilazich, Francesco; O'Donnell, Christopher P.; Ferran, Christiane; Malhotra, Atul			Molecular Biomarkers of Vascular Dysfunction in Obstructive Sleep Apnea	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; CELLULAR ADHESION MOLECULES; HYPOXIA-INDUCIBLE FACTOR-1; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; GENE-EXPRESSION; IN-VIVO; DEPENDENT MECHANISM	Untreated and long-lasting obstructive sleep apnea (OSA) may lead to important vascular abnormalities, including endothelial cell (EC) dysfunction, hypertension, and atherosclerosis. We observed a correlation between microcirculatory reactivity and endothelium-dependent release of nitric oxide in OSA patients. Therefore, we hypothesized that OSA affects (micro) vasculature and we aimed to identify vascular gene targets of OSA that could possibly serve as reliable biomarkers of severity of the disease and possibly of vascular risk. Using quantitative RT-PCR, we evaluated gene expression in skin biopsies of OSA patients, mouse aortas from animals exposed to 4-week intermittent hypoxia (IH; rapid oscillations in oxygen desaturation and reoxygenation), and human dermal microvascular (HMVEC) and coronary artery endothelial cells (HCAEC) cultured under IH. We demonstrate a significant upregulation of endothelial nitric oxide synthase (eNOS), tumor necrosis factor-alpha-induced protein 3 (TNFAIP3; A20), hypoxia-inducible factor 1 alpha (HIF-1 alpha?? and vascular endothelial growth factor (VEGF) expression in skin biopsies obtained from OSA patients with severe nocturnal hypoxemia (nadir saturated oxygen levels [SaO(2)]<75%) compared to mildly hypoxemic OSA patients (SaO(2) 75%-90%) and a significant upregulation of vascular cell adhesion molecule 1 (VCAM-1) expression compared to control subjects. Gene expression profile in aortas of mice exposed to IH demonstrated a significant upregulation of eNOS and VEGF. In an in vitro model of OSA, IH increased expression of A20 and decreased eNOS and HIF-1 alpha expression in HMVEC, while increased A20, VCAM-1 and HIF-1 alpha expression in HCAEC, indicating that EC in culture originating from distinct vascular beds respond differently to IH stress. We conclude that gene expression profiles in skin of OSA patients may correlate with disease severity and, if validated by further studies, could possibly predict vascular risk in OSA patients.	[Kaczmarek, Elzbieta; Clarke, Douglas N.; Csizmadia, Eva; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Div Vasc & Endovasc Surg,Dept Surg,Med Sch, Boston, MA 02215 USA; [Bakker, Jessie P.; Malhotra, Atul] Harvard Univ, Brigham & Womens Hosp, Div Sleep Med, Sch Med, Boston, MA 02115 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Dept Pathol,Med Sch, Boston, MA 02215 USA; [Veves, Aristidis; Tecilazich, Francesco] Harvard Univ, Beth Israel Deaconess Med Ctr, Microcirculat Lab, Sch Med, Boston, MA 02215 USA; [Veves, Aristidis; Tecilazich, Francesco] Harvard Univ, Beth Israel Deaconess Med Ctr, Joslin Beth Israel Deaconess Foot Ctr, Dept Surg,Med Sch, Boston, MA 02215 USA; [O'Donnell, Christopher P.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Malhotra, Atul] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Joslin Diabetes Center, Inc.; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Kaczmarek, E (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Div Vasc & Endovasc Surg,Dept Surg,Med Sch, Boston, MA 02215 USA.	ekaczmar@bidmc.harvard.edu		O'Donnell, Christopher/0000-0002-9120-6850	National Institutes of Health (NIH) [HL106227, HL077785, HL080130, HL090897, HL093218, HL095491, HL110350, HL085188]; AHA [0840159N]; Harvard Catalyst [RR025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, R01HL110350, R01HL090897, R01HL080130, R01HL077785, R21HL106227, P01HL095491, K24HL093218] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Harvard Catalyst; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from National Institutes of Health (NIH) (EK - HL106227; CPO - HL077785; CF - HL080130; AM - HL090897, HL093218, HL095491, HL110350, HL085188), AHA (AM - 0840159N), and Harvard Catalyst (AM - RR025758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Atkeson A, 2009, PROG CARDIOVASC DIS, V51, P351, DOI 10.1016/j.pcad.2008.08.002; Belaidi E, 2009, J AM COLL CARDIOL, V53, P1309, DOI 10.1016/j.jacc.2008.12.050; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Bhardwaj S, 2005, EUR J CLIN INVEST, V35, P669, DOI 10.1111/j.1365-2362.2005.01555.x; Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Chu SY, 2004, AM J PHYSIOL-RENAL, V287, pF384, DOI 10.1152/ajprenal.00006.2004; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Bravo MD, 2007, SLEEP BREATH, V11, P177, DOI 10.1007/s11325-007-0100-7; de la Pena M, 2008, RESPIRATION, V76, P28, DOI 10.1159/000109643; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; El-Solh AA, 2002, CHEST, V121, P1541, DOI 10.1378/chest.121.5.1541; Feng J, 2012, SLEEP BREATH, V16, P283, DOI 10.1007/s11325-011-0519-8; Ferran C, 1998, BLOOD, V91, P2249, DOI 10.1182/blood.V91.7.2249.2249_2249_2258; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FRIES JWU, 1993, AM J PATHOL, V143, P725; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Galkin A, 2007, ESSAYS BIOCHEM, V43, P29, DOI 10.1042/bse0430029; Gautier E, 2012, EUROP RESP J OFFICIA; Gozal D, 2002, SLEEP, V25, P59, DOI 10.1093/sleep/25.1.59; Gozal D, 2008, AM J RESP CRIT CARE, V177, P369, DOI 10.1164/rccm.200608-1190PP; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Ho JJD, 2012, J MOL MED, V90, P217, DOI 10.1007/s00109-012-0880-5; Huang PL, 2003, CURR HYPERTENS REP, V5, P473, DOI 10.1007/s11906-003-0055-4; Imagawa S, 2001, BLOOD, V98, P1255, DOI 10.1182/blood.V98.4.1255; Jelic S, 2008, CIRCULATION, V117, P2270, DOI 10.1161/CIRCULATIONAHA.107.741512; Jelkmann W, 2001, CLIN CHEM, V47, P617; Jurado-Gamez B, 2012, INTERNAL MED, V51, P363, DOI 10.2169/internalmedicine.51.6571; Kato M, 2000, CIRCULATION, V102, P2607; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lavie L, 2003, SLEEP MED REV, V7, P35, DOI 10.1053/smrv.2002.0261; Levy P, 2009, PROG CARDIOVASC DIS, V51, P400, DOI 10.1016/j.pcad.2008.03.001; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004; MASINOVSKY B, 1990, J IMMUNOL, V145, P2886; Montesi SB, 2012, CHEST, V142, P239, DOI 10.1378/chest.11-2322; Morsi WG, 2006, CLIN BIOCHEM, V39, P1057, DOI 10.1016/j.clinbiochem.2006.08.003; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Ohga E, 2003, J APPL PHYSIOL, V94, P179, DOI 10.1152/japplphysiol.00177.2002; Peppard PE, 2013, AM J EPIDEMIOL; Polotsky VY, 2010, PHYSIOL GENOMICS, V41, P306, DOI 10.1152/physiolgenomics.00091.2009; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rahangdale S, 2009, FRONT BIOSCI-LANDMRK, V14, P192, DOI 10.2741/3240; Ramar K, 2011, FUTUR CARDIOL, V7, P241, DOI [10.2217/fca.10.123, 10.2217/FCA.10.123]; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Ryan Silke, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P76; Schulz R, 2002, AM J RESP CRIT CARE, V165, P67, DOI 10.1164/ajrccm.165.1.2101062; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Semenza GL, 2007, SCI STKE SIGNAL TRAN; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Testelmans D, 2013, CYTOKINE, V62, P210, DOI 10.1016/j.cyto.2013.02.021; Toffoli S, 2009, ANGIOGENESIS, V12, P47, DOI 10.1007/s10456-009-9131-y; Veves A, 1997, DIABETES, V46, P1846, DOI 10.2337/diabetes.46.11.1846; Wang BS, 2013, SLEEP MED, V14, P165, DOI 10.1016/j.sleep.2012.10.020; Wang Z, 2013, UPSALA J MED SCI, V118, P65, DOI 10.3109/03009734.2013.766914; Xu WQ, 2011, BASIC RES CARDIOL, V106, P329, DOI 10.1007/s00395-011-0159-y; Yim-Yeh S, 2010, SLEEP, V33, P1177, DOI 10.1093/sleep/33.9.1177; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Zhao Hai-yan, 2007, Zhonghua Yi Xue Za Zhi, V87, P2189	68	65	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70559	10.1371/journal.pone.0070559	http://dx.doi.org/10.1371/journal.pone.0070559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923005	Green Published, gold			2022-12-27	WOS:000323369700194
J	Tornack, J; Seiler, K; Grutzkau, A; Grun, JR; Onodera, M; Melchers, F; Tsuneto, M				Tornack, Julia; Seiler, Katharina; Gruetzkau, Andreas; Gruen, Joachim R.; Onodera, Masafumi; Melchers, Fritz; Tsuneto, Motokazu			Ectopic Runx1 Expression Rescues Tal-1-Deficiency in the Generation of Primitive and Definitive Hematopoiesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; FETAL LIVER HEMATOPOIESIS; TRANSCRIPTION FACTOR PU.1; DEVELOPMENT IN-VITRO; YOLK-SAC; PARAAORTIC SPLANCHNOPLEURA; ENDOTHELIAL-CELLS; DEVELOPING MOUSE; SCL/TAL-1 GENE; MICE LACKING	The transcription factors SCL/Tal-1 and AML1/Runx1 control the generation of pluripotent hematopoietic stem cells (pHSC) and, thereby, primitive and definitive hematopoiesis, during embryonic development of the mouse from mesoderm. Thus, Runx1-deficient mice generate primitive, but not definitive hematopoiesis, while Tal-1-deficient mice are completely defective. Primitive as well as definitive hematopoiesis can be developed "in vitro" from embryonic stem cells (ESC). We show that wild type, as well as Tal-1(-/-) and Runx1(-/-) ESCs, induced to differentiation, all expand within 5 days to comparable numbers of Flk1(+) mesodermal cells. While wild type ESCs further differentiate to primitive and definitive erythrocytes, to c-fms(+)Gr1(+)Mac1(+) myeloid cells, and to B220(+)CD19(+) B- and CD4(+)/CD8(+) T-lymphoid cells, Runx1(-/-) ESCs, as expected, only develop primitive erythrocytes, and Tal-1(-/-) ESCs do not generate any hematopoietic cells. Retroviral transduction with Runx1 of Runx1(-/-) ESCs, differentiated for 4 days to mesoderm, rescues definitive erythropoiesis, myelopoiesis and lymphopoiesis, though only with 1-10% of the efficiencies of wild type ESC hematopoiesis. Surprisingly, Tal-1(-/-) ESCs can also be rescued at comparably low efficiencies to primitive and definitive erythropoiesis, and to myelopoiesis and lymphopoiesis by retroviral transduction with Runx1. These results suggest that Tal-1 expression is needed to express Runx1 in mesoderm, and that ectopic expression of Runx1 in mesoderm is sufficient to induce primitive as well as definitive hematopoiesis in the absence of Tal-1. Retroviral transduction of "in vitro" differentiating Tal-1(-/-) and Runx1(-/-) ESCs should be a useful experimental tool to probe selected genes for activities in the generation of hematopoietic progenitors "in vitro", and to assess the potential transforming activities in hematopoiesis of mutant forms of Tal-1 and Runx1 from acute myeloid leukemia and related tumors.	[Tornack, Julia; Melchers, Fritz; Tsuneto, Motokazu] Max Planck Inst Infect Biol, Berlin, Germany; [Seiler, Katharina] Inst Stem Cell Biol & Regenerat Med, Stamford, CT USA; [Gruetzkau, Andreas; Gruen, Joachim R.] Deutsch Rheumaforschungszentrum, Berlin, Germany; [Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan	Max Planck Society; Deutsches Rheuma-Forschungszentrum (DRFZ); National Center for Child Health & Development - Japan	Melchers, F (corresponding author), Max Planck Inst Infect Biol, Berlin, Germany.	melchers@mpiib-berlin.mpg.de; tsuneto@mpiib-berlin.mpg.de		Grun, Joachim R./0000-0002-2875-3691	Deutsche Forschungsgemeinschaft [ME 2764/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported in parts by a Reinhard Koselleck-Grant of the Deutsche Forschungsgemeinschaft ME 2764/1-1 to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Cai XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028430; Califano A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P75; Choi K, 1998, DEVELOPMENT, V125, P725; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; de Pooter R, 2007, CURR OPIN IMMUNOL, V19, P163, DOI 10.1016/j.coi.2007.02.011; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Endoh M, 2002, EMBO J, V21, P6700, DOI 10.1093/emboj/cdf674; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Hayashi SI, 1998, BIOCHEM CELL BIOL, V76, P911; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kuo YH, 2008, BLOOD, V111, P1543, DOI 10.1182/blood-2007-07-104422; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Landry JR, 2008, BLOOD, V15; Liakhovitskaia A, 2009, STEM CELLS, V27, P1616, DOI 10.1002/stem.71; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Menssen A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-98; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; ORKIN SH, 1992, BLOOD, V80, P575; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seiler K, 2011, STEM CELLS DEV, V20, P1131, DOI 10.1089/scd.2010.0391; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Tanaka Y, 2012, DEV BIOL, V366, P404, DOI 10.1016/j.ydbio.2012.03.024; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045; Wong WF, 2011, IMMUNOLOGY, V132, P157, DOI 10.1111/j.1365-2567.2010.03381.x; Yokomizo T, 2008, BLOOD, V111, P4075, DOI 10.1182/blood-2007-05-091637; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	60	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70116	10.1371/journal.pone.0070116	http://dx.doi.org/10.1371/journal.pone.0070116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922928	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700140
J	Bian, GR; Ma, L; Su, Y; Zhu, WY				Bian, Gaorui; Ma, Li; Su, Yong; Zhu, Weiyun			The Microbial Community in the Feces of the White Rhinoceros (Ceratotherium simum) as Determined by Barcoded Pyrosequencing Analysis	PLOS ONE			English	Article							EQUINE LARGE-INTESTINE; AEROCOCCUS-VIRIDANS; FECAL MICROBIOTA; ECOLOGY; POPULATION; DIVERSITY; INFECTION; BACTERIA; DNA	As a non-ruminant herbivore, the white rhinoceros has the ability to utilize fibrous plant matter through microbial fermentation in the hindgut. So far, there has been no report using molecular techniques to study the gut microbiota of the white rhinoceros. We used barcoded pyrosequencing to characterize 105,651 sequences of 16S rRNA genes obtained from fecal samples from five white rhinoceroses. Results showed that Firmicutes and Bacteroidetes were the predominant phyla in the samples, which were comprised largely of unclassified bacteria. The microbiota of one animal treated with drug therapy differed from those in other healthy animals, and was dominated by Aerococcus -related bacteria. The core microbiota in the healthy rhinoceros were dominated by phyla Firmicutes and Bacteroidetes, represented by the Ruminococcaceae, Lachnospiraceae, Rikenellaceae and Prevotellaceae families. The present work provides a phylogenetic framework for understanding the complex microbial community of the rhinoceros; however, further studies are required to link the distinctive microbiota with their digestive role in the hindgut of the white rhinoceros.	[Bian, Gaorui; Ma, Li; Su, Yong; Zhu, Weiyun] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Su, Y (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Jiangsu, Peoples R China.	yong.su@njau.edu.cn			Fundamental Research Funds for the Central Universities [KYZ201153]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by a grant from the Fundamental Research Funds for the Central Universities (KYZ201153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Chen LY, 2012, J MICROBIOL IMMUNOL, V45, P158, DOI 10.1016/j.jmii.2011.09.010; Clauss M, 2006, J NUTR, V136, p2017S, DOI 10.1093/jn/136.7.2017S; CLEMENS ET, 1982, J ZOOL, V198, P141, DOI 10.1111/j.1469-7998.1982.tb02066.x; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Facklam R, 2003, J CLIN MICROBIOL, V41, P2587, DOI 10.1128/JCM.41.6.2587-2592.2003; FACKLAM R, 1995, CLIN MICROBIOL REV, V8, P479, DOI 10.1128/CMR.8.4.479; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett LA, 2002, VET MICROBIOL, V87, P81, DOI 10.1016/S0378-1135(02)00018-4; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gopalachar A, 2004, MED SCI MONITOR, V10, pCS73; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; HENRY JS, 1991, GEN COMP ENDOCR, V84, P440, DOI 10.1016/0016-6480(91)90093-L; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Lynch MDJ, 2012, ISME J, V6, P2067, DOI 10.1038/ismej.2012.50; Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x; Martin V, 2007, J CLIN MICROBIOL, V45, P3053, DOI 10.1128/JCM.00156-07; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; Popescu GA, 2005, J HEART VALVE DIS, V14, P317; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Su Y, 2013, ANAEROBE, V19, P27, DOI 10.1016/j.anaerobe.2012.11.006; Uh Y, 2002, J KOREAN MED SCI, V17, P113, DOI 10.3346/jkms.2002.17.1.113; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Wei GF, 2007, MICROB ECOL, V54, P194, DOI 10.1007/s00248-007-9225-2; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011	40	31	35	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70103	10.1371/journal.pone.0070103	http://dx.doi.org/10.1371/journal.pone.0070103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922920	Green Submitted, gold, Green Published			2022-12-27	WOS:000322838900147
J	Kruijt, AW; Antypa, N; Booij, L; de Jong, PJ; Glashouwer, K; Penninx, BWJH; Van der Does, W				Kruijt, Anne-Wil; Antypa, Niki; Booij, Linda; de Jong, Peter J.; Glashouwer, Klaske; Penninx, Brenda W. J. H.; Van der Does, Willem			Cognitive Reactivity, Implicit Associations, and the Incidence of Depression: A Two-Year Prospective Study	PLOS ONE			English	Article							DYSFUNCTIONAL ATTITUDES; SELF-ASSOCIATIONS; VULNERABILITY; MOOD; PHARMACOTHERAPY; NETHERLANDS; THERAPY; ACTIVATION; WOMEN; ONSET	Background: Cognitive reactivity to sad mood is a vulnerability marker of depression. Implicit self-depressed associations are related to depression status and reduced remission probability. It is unknown whether these cognitive vulnerabilities precede the first onset of depression. Aim: To test the predictive value of cognitive reactivity and implicit self-depressed associations for the incidence of depressive disorders. Methods: Prospective cohort study of 834 never-depressed individuals, followed over a two-year period. The predictive value of cognitive reactivity and implicit self-depressed associations for the onset of depressive disorders was assessed using binomial logistic regression. The multivariate model corrected for baseline levels of subclinical depressive symptoms, neuroticism, for the presence of a history of anxiety disorders, for family history of depressive or anxiety disorders, and for the incidence of negative life events. Results: As single predictors, both cognitive reactivity and implicit self-depressed associations were significantly associated with depression incidence. In the multivariate model, cognitive reactivity was significantly associated with depression incidence, together with baseline depressive symptoms and the number of negative life events, whereas implicit self-depressed associations were not. Conclusion: Cognitive reactivity to sad mood is associated with the incidence of depressive disorders, also when various other depression-related variables are controlled for. Implicit self-depressed associations predicted depression incidence in a bivariate test, but not when controlling for other predictors.	[Kruijt, Anne-Wil; Antypa, Niki; Penninx, Brenda W. J. H.; Van der Does, Willem] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Booij, Linda] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Booij, Linda] Sainte Justine Hosp Res Ctr, Montreal, PQ, Canada; [Booij, Linda] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [de Jong, Peter J.; Glashouwer, Klaske] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Penninx, Brenda W. J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Van der Does, Willem] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Van der Does, Willem] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Universite de Montreal; McGill University; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Kruijt, AW (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	KruijtJ@fsw.leidenuniv.nl	Penninx, Brenda WJH/S-7627-2017; Kruijt, Anne-Wil/B-7927-2017; Van der Does, Willem/B-1465-2008; de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	Penninx, Brenda WJH/0000-0001-7779-9672; Van der Does, Willem/0000-0002-9753-2454; de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Kruijt, Anne-Wil/0000-0003-2318-6576; Antypa, Niki/0000-0001-9343-8842	Netherlands Organisation for Health Research and Development [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); N.W.O. Vici grant [453-06-005]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); N.W.O. Vici grant(Netherlands Organization for Scientific Research (NWO))	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (grant number 10-000-1002; www.zonmw.nl) and is supported by participating universities and mental health care organisations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute)). The preparation of the present paper was made possible by an N.W.O. Vici grant (grant number 453-06-005; www.nwo.nl) to WVDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloy LB, 2006, J ABNORM PSYCHOL, V115, P145, DOI 10.1037/0021-843X.115.1.145; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Antypa N, 2010, GENES BRAIN BEHAV, V9, P615, DOI 10.1111/j.1601-183X.2010.00593.x; Antypa N, 2010, J AFFECT DISORDERS, V122, P46, DOI 10.1016/j.jad.2009.06.013; Beck AT, 1967, DEPRESSION CAUSES TR; Bijl RV, 2002, SOC PSYCH PSYCH EPID, V37, P372, DOI 10.1007/s00127-002-0566-3; Booij L, 2007, J ABNORM PSYCHOL, V116, P86, DOI 10.1037/0021-843X.116.1.86; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Costa PT, 2007, REVISED NEO PERSONAL; Elgersma HJ, HIDDEN SCARS D UNPUB; Evans J, 2005, BRIT J PSYCHIAT, V186, P302, DOI 10.1192/bjp.186.4.302; EVANS MD, 1992, ARCH GEN PSYCHIAT, V49, P802; Fava GA, 1998, AM J PSYCHIAT, V155, P1443, DOI 10.1176/ajp.155.10.1443; Friedman MA, 2004, CLIN PSYCHOL-SCI PR, V11, P47, DOI 10.1093/clipsy/bph052; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Glashouwer KA, 2010, PSYCHOL MED, V40, P1101, DOI 10.1017/S0033291709991371; Glashouwer KA, 2013, J BEHAV THER EXP PSY, V44, P105, DOI 10.1016/j.jbtep.2012.07.015; Glashouwer KA, 2012, BEHAV RES THER, V50, P479, DOI 10.1016/j.brat.2012.05.002; Glashouwer KA, 2010, J PSYCHOPATHOL BEHAV, V32, P428, DOI 10.1007/s10862-009-9156-y; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; HAMILTON EW, 1983, J ABNORM PSYCHOL, V92, P173, DOI 10.1037/0021-843X.92.2.173; Just N, 2001, CLIN PSYCHOL REV, V21, P63, DOI 10.1016/S0272-7358(99)00035-5; Klok MD, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.59; LaGrange B, 2011, J ABNORM PSYCHOL, V120, P511, DOI 10.1037/a0024685; Lamers F, 2012, COMPR PSYCHIAT, V53, P63, DOI 10.1016/j.comppsych.2011.01.011; LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203; Merens Wendelien, 2008, Depress Anxiety, V25, pE27, DOI 10.1002/da.20391; MIRANDA J, 1988, J ABNORM PSYCHOL, V97, P76, DOI 10.1037/0021-843X.97.1.76; Miranda J, 1998, COGNITIVE THER RES, V22, P363; Moulds ML, 2008, BEHAV THER, V39, P65, DOI 10.1016/j.beth.2007.05.001; Paykel ES, 2007, INT J NEUROPSYCHOPH, V10, P131, DOI 10.1017/S1461145706006912; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; PERSONS JB, 1992, COGNITIVE THER RES, V16, P485, DOI 10.1007/BF01183170; Raes F, 2009, BEHAV RES THER, V47, P623, DOI 10.1016/j.brat.2009.03.007; Raymaeker, 2009, NETHERLANDS J PSYCHO, V65, DOI [https://doi.org/10.1007/BF03080128, DOI 10.1007/BF03080128, 10.1007/BF03080128]; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Scher CD, 2005, CLIN PSYCHOL REV, V25, P487, DOI 10.1016/j.cpr.2005.01.005; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Segal ZV, 1999, J ABNORM PSYCHOL, V108, P3, DOI 10.1037/0021-843X.108.1.3; SILVERMAN JS, 1984, ARCH GEN PSYCHIAT, V41, P28; SIMONS AD, 1984, ARCH GEN PSYCHIAT, V41, P45; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927; Van der Does A.J.W., 2003, LEIDEN INDEX DEPRESS; Van der Does W, 2005, BRIT J CLIN PSYCHOL, V44, P1, DOI 10.1348/014466504x19442; Van der Does W, 2002, BEHAV RES THER, V40, P105, DOI 10.1016/S0005-7967(00)00111-X; van Harmelen AL, 2010, BEHAV RES THER, V48, P486, DOI 10.1016/j.brat.2010.02.003; Verhoeven FEA, 2012, BRAIN BEHAV, V2, P806, DOI 10.1002/brb3.96; Williams JMG, 2008, COGNITIVE THER RES, V32, P83, DOI 10.1007/s10608-006-9105-y	51	37	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70245	10.1371/journal.pone.0070245	http://dx.doi.org/10.1371/journal.pone.0070245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922962	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900164
J	Doi, H; Chang, KH; Nishibe, Y; Imai, H; Nakano, S				Doi, Hideyuki; Chang, Kwang-Hyeon; Nishibe, Yuichiro; Imai, Hiroyuki; Nakano, Shin-ichi			Lack of Congruence in Species Diversity Indices and Community Structures of Planktonic Groups Based on Local Environmental Factors	PLOS ONE			English	Article							BIODIVERSITY PATTERNS; BOTTOM-UP; TOP-DOWN; RICHNESS; CONCORDANCE; GRADIENTS; CASCADES; LAKES; FISH	The importance of analyzing the determinants of biodiversity and community composition by using multiple trophic levels is well recognized; however, relevant data are lacking. In the present study, we investigated variations in species diversity indices and community structures of the plankton taxonomic groups-zooplankton, rotifers, ciliates, and phytoplankton-under a range of local environmental factors in pond ecosystems. For each planktonic group, we estimated the species diversity index by using linear models and analyzed the community structure by using canonical correspondence analysis. We showed that the species diversity indices and community structures varied among the planktonic groups and according to local environmental factors. The observed lack of congruence among the planktonic groups may have been caused by niche competition between groups with similar trophic guilds or by weak trophic interactions. Our findings highlight the difficulty of predicting total biodiversity within a system, based upon a single taxonomic group. Thus, to conserve the biodiversity of an ecosystem, it is crucial to consider variations in species diversity indices and community structures of different taxonomic groups, under a range of local conditions.	[Doi, Hideyuki; Imai, Hiroyuki; Nakano, Shin-ichi] Ehime Univ, Fac Agr, LAFWEDY, Matsuyama, Ehime 790, Japan; [Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Chang, Kwang-Hyeon; Nishibe, Yuichiro] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Chang, Kwang-Hyeon] Kyung Hee Univ, Dept Environm Sci & Engn, Seocheon Dong, Yongin Si, South Korea; [Nishibe, Yuichiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Nakano, Shin-ichi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Ehime University; Hiroshima University; Ehime University; Kyung Hee University; University of Tokyo; Kyoto University	Doi, H (corresponding author), Ehime Univ, Fac Agr, LAFWEDY, Matsuyama, Ehime 790, Japan.	doih@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Nakano, Shin-ichi/M-5483-2016	Doi, Hideyuki/0000-0002-2701-3982; Nakano, Shin-ichi/0000-0001-5235-8547; chang, Kwang-Hyeon/0000-0002-7952-4047	JSPS [24770022]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number: 24770022 to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P739, DOI 10.1139/cjfas-56-5-739; Declerck S, 2005, ECOLOGY, V86, P1905, DOI 10.1890/04-0373; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Dyer LA, 2003, ECOL LETT, V6, P60, DOI 10.1046/j.1461-0248.2003.00398.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Heino J, 2005, BIODIVERS CONSERV, V14, P415, DOI 10.1007/s10531-004-5064-z; Heino J, 2003, CAN J FISH AQUAT SCI, V60, P1039, DOI 10.1139/F03-081; Heino J, 2003, J ANIM ECOL, V72, P425, DOI 10.1046/j.1365-2656.2003.00711.x; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; HUNTER MD, 1992, ECOLOGY, V73, P724; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; JACKSON DA, 1993, CAN J FISH AQUAT SCI, V50, P2641, DOI 10.1139/f93-287; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Leibold MA, 1999, EVOL ECOL RES, V1, P73; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Pace ML, 1981, LIMNOL OCEANOGR, V26, P822; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Sommer U, 1989, PLANKTON ECOLOGY SUC; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; [No title captured]	23	7	7	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69594	10.1371/journal.pone.0069594	http://dx.doi.org/10.1371/journal.pone.0069594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936054	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300052
J	Johansen, MB; Izarzugaza, JMG; Brunak, S; Petersen, TN; Gupta, R				Johansen, Morten Bo; Izarzugaza, Jose M. G.; Brunak, Soren; Petersen, Thomas Nordahl; Gupta, Ramneek			Prediction of Disease Causing Non-Synonymous SNPs by the Artificial Neural Network Predictor NetDiseaseSNP	PLOS ONE			English	Article							PROTEIN; MUTATIONS; DATABASE; GENE; SIFT; POLYMORPHISMS; ANNOTATION; CONSENSUS; VARIANTS; SERVER	We have developed a sequence conservation-based artificial neural network predictor called NetDiseaseSNP which classifies nsSNPs as disease-causing or neutral. Our method uses the excellent alignment generation algorithm of SIFT to identify related sequences and a combination of 31 features assessing sequence conservation and the predicted surface accessibility to produce a single score which can be used to rank nsSNPs based on their potential to cause disease. NetDiseaseSNP classifies successfully disease-causing and neutral mutations. In addition, we show that NetDiseaseSNP discriminates cancer driver and passenger mutations satisfactorily. Our method outperforms other state-of-the-art methods on several disease/neutral datasets as well as on cancer driver/passenger mutation datasets and can thus be used to pinpoint and prioritize plausible disease candidates among nsSNPs for further investigation. NetDiseaseSNP is publicly available as an online tool as well as a web service: http://www.cbs.dtu.dk/services/NetDiseaseSNP	[Johansen, Morten Bo; Izarzugaza, Jose M. G.; Brunak, Soren; Gupta, Ramneek] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark; [Johansen, Morten Bo; Petersen, Thomas Nordahl] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Gupta, R (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, Kongens Lyngby, Denmark.	ramneek@cbs.dtu.dk	Gupta, Ramneek/G-7278-2012; Izarzugaza, Jose/N-4503-2014; Brunak, Soren/O-6621-2016	Gupta, Ramneek/0000-0001-6841-6676; Izarzugaza, Jose/0000-0003-1754-5122; Petersen, Thomas Nordahl/0000-0002-2484-5716; Brunak, Soren/0000-0003-0316-5866	Novo Nordisk Foundation; European Union [259348]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was funded by the Novo Nordisk Foundation and the European Union grant #259348 (ASSET; FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baldi P, 2001, BIOINFORMATICS MACHI; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Crockett DK, 2012, GENOME MED, V4, DOI 10.1186/gm347; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Izarzugaza JMG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S3; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008311; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Thorisson GA, 2009, NUCLEIC ACIDS RES, V37, pD797, DOI 10.1093/nar/gkn748; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	32	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68370	10.1371/journal.pone.0068370	http://dx.doi.org/10.1371/journal.pone.0068370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935863	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300007
J	Maione, L; Albarel, F; Bouchard, P; Gallant, M; Flanagan, CA; Bobe, R; Cohen-Tannoudji, J; Pivonello, R; Colao, A; Brue, T; Millar, RP; Lombes, M; Young, J; Guiochon-Mantel, A; Bouligand, J				Maione, Luigi; Albarel, Frederique; Bouchard, Philippe; Gallant, Megan; Flanagan, Colleen A.; Bobe, Regis; Cohen-Tannoudji, Joelle; Pivonello, Rosario; Colao, Annamaria; Brue, Thierry; Millar, Robert P.; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne; Bouligand, Jerome			R31C GNRH1 Mutation and Congenital Hypogonadotropic Hypogonadism	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; DIGENIC MUTATIONS; RECEPTOR; BINDING; GENE; DEFICIENCY; SECRETION; MOUSE; ACIDS; CELL	Normosmic congenital hypogonadotropic hypogonadism (nCHH) is a rare reproductive disease leading to lack of puberty and infertility. Loss-of-function mutations of GNRH1 gene are a very rare cause of autosomal recessive nCHH. R31C GNRH1 is the only missense mutation that affects the conserved GnRH decapeptide sequence. This mutation was identified in a CpG islet in nine nCHH subjects from four unrelated families, giving evidence for a putative "hot spot''. Interestingly, all the nCHH patients carry this mutation in heterozygosis that strikingly contrasts with the recessive inheritance associated with frame shift and non-sense mutations. Therefore, after exclusion of a second genetic event, a comprehensive functional characterization of the mutant R31C GnRH was undertaken. Using different cellular models, we clearly demonstrate a dramatic reduction of the mutant decapeptide capacity to bind GnRH-receptor, to activate MAPK pathway and to trigger inositol phosphate accumulation and intracellular calcium mobilization. In addition it is less able than wild type to induce lh-beta transcription and LH secretion in gonadotrope cells. Finally, the absence of a negative dominance in vitro offers a unique opportunity to discuss the complex in vivo patho-physiology of this form of nCHH.	[Maione, Luigi; Lombes, Marc; Young, Jacques; Guiochon-Mantel, Anne; Bouligand, Jerome] Univ Paris Sud, Fac Med Paris Sud, Unite Mixte Rech Sante 693, F-94275 Le Kremlin Bicetre, France; [Maione, Luigi; Young, Jacques] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Albarel, Frederique; Brue, Thierry] Hop Enfants La Timone, Dept Endocrinol, Marseille, France; [Albarel, Frederique; Brue, Thierry] Hop Enfants La Timone, Ctr Reference Malad Rares Origine Hypophysaire, Marseille, France; [Bouchard, Philippe] Hop St Antoine, AP HP, Serv Endocrinol Diabetol & Endocrinol Reprod, F-75571 Paris, France; [Gallant, Megan; Flanagan, Colleen A.; Millar, Robert P.] Univ Cape Town, Sch Med, Med Res Council, Receptor Biol Res Unit,Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Flanagan, Colleen A.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Johannesburg, South Africa; [Bobe, Regis] Univ Paris Sud, Unite Mixte Rech Sante 770, F-94275 Le Kremlin Bicetre, France; [Cohen-Tannoudji, Joelle] Univ Paris 07, Equipe Physiol Axe Gonadotrope, Unite Biol Fonct & Adaptat, Sorbonne Paris Cite, Paris, France; [Maione, Luigi; Pivonello, Rosario; Colao, Annamaria] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Sez Endocrinol & Metab, Naples, Italy; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, Fac Nat & Agr Sci, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Guiochon-Mantel, Anne; Bouligand, Jerome] Hop Bicetre, AP HP, Lab Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; South African Medical Research Council; University of Cape Town; University of Witwatersrand; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; University of Naples Federico II; University of Pretoria; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Bouligand, J (corresponding author), Univ Paris Sud, Fac Med Paris Sud, Unite Mixte Rech Sante 693, F-94275 Le Kremlin Bicetre, France.	jerome.bouligand@bct.aphp.fr	Brue, Thierry/AAI-2328-2019; BOULIGAND, Jérôme/S-5716-2018; Flanagan, Colleen/ABG-2109-2020; Young, Jacques/T-2976-2018; Young, Jacques/N-5251-2019; Brue, Thierry/P-6571-2019; Maione, Luigi/N-5300-2019; Guiochon-Mantel, Anne S/S-8408-2018; BOBE, Regis/F-4951-2016; Lombes, Marc/L-5933-2018	Brue, Thierry/0000-0001-8482-6691; Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Brue, Thierry/0000-0001-8482-6691; Maione, Luigi/0000-0001-8526-8046; Guiochon-Mantel, Anne S/0000-0003-1737-1409; BOBE, Regis/0000-0002-8225-9117; Lombes, Marc/0000-0003-3189-023X; Flanagan, Colleen A./0000-0003-2803-8986; Millar, Robert P/0000-0003-3606-2708	Paris-Sud 11 University (Bonus Qualite Recherche); Paris-Sud 11 University (Attractivite Univ. Paris Sud); PHRC HYPOPROTEO [P081212]; Fondation pour la Recherche Medicale	Paris-Sud 11 University (Bonus Qualite Recherche); Paris-Sud 11 University (Attractivite Univ. Paris Sud); PHRC HYPOPROTEO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by grants from Paris-Sud 11 University (Bonus Qualite Recherche 2009, Attractivite Univ. Paris Sud 2010), PHRC HYPOPROTEO P081212 and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Bakalkin G, 2010, AM J HUM GENET, V87, P593, DOI 10.1016/j.ajhg.2010.10.001; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; Bouligand J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013563; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Chan YM, 2011, MOL CELL ENDOCRINOL, V346, P51, DOI 10.1016/j.mce.2011.06.013; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Cohen-Tannoudji Joelle, 2012, Front Endocrinol (Lausanne), V3, P107, DOI 10.3389/fendo.2012.00107; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; DONG KW, 1993, MOL ENDOCRINOL, V7, P1654, DOI 10.1210/me.7.12.1654; Eloit Corinne, 1994, Rhinology (Utrecht), V32, P57; Fianagan CA, 1999, J BIOL CHEM, V274, P28880, DOI 10.1074/jbc.274.41.28880; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; FLANAGAN CA, 1994, J BIOL CHEM, V269, P22636; Flanagan CA, 1998, ENDOCRINOLOGY, V139, P4115, DOI 10.1210/en.139.10.4115; Francou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025614; Fromme BJ, 2001, MOL PHARMACOL, V60, P1280, DOI 10.1124/mol.60.6.1280; Fromme BJ, 2004, MOL CELL ENDOCRINOL, V219, P47, DOI 10.1016/j.mce.2004.01.009; Garrel G, 2011, ENDOCRINOLOGY, V152, P3905, DOI 10.1210/en.2011-1167; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Millar R, 1995, METH NEUROSCI, P145; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; MILLAR RP, 1989, J BIOL CHEM, V264, P21007; Nelson SB, 1998, MOL CELL ENDOCRINOL, V140, P151, DOI 10.1016/S0303-7207(98)00043-4; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Quaynor SD, 2011, FERTIL STERIL, V96, P1424, DOI 10.1016/j.fertnstert.2011.09.046; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Tello JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038456; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Trabado S, 2011, FERTIL STERIL, V95, P2324, DOI 10.1016/j.fertnstert.2011.03.091; Vagenakis GA, 2005, FERTIL STERIL, V84, P1762, DOI 10.1016/j.fertnstert.2005.06.031; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69616	10.1371/journal.pone.0069616	http://dx.doi.org/10.1371/journal.pone.0069616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936060	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300055
J	Kumar, S; Sharma, P; Kumar, D; Chakraborty, G; Gorain, M; Kundu, GC				Kumar, Santosh; Sharma, Priyanka; Kumar, Dhiraj; Chakraborty, Goutam; Gorain, Mahadeo; Kundu, Gopal C.			Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis	PLOS ONE			English	Article							PROMOTES TUMOR-GROWTH; STEM-CELL NICHE; HEMATOPOIETIC STEM; IN-VIVO; PROMATRIX METALLOPROTEINASE-2; THERAPEUTIC TARGET; PROGENITOR CELLS; LUNG METASTASIS; CANCER CELLS; ACTIVATION	Background: Recent studies demonstrated that not only tumor derived-but stroma derived factors play crucial role in cancer development. Osteopontin (OPN) is a secreted non-collagenous, sialic acid rich, chemokine-like phosphoglycoprotein that facilitates cell-matrix interactions and promotes tumor progression. Elevated level of OPN has been shown in melanoma patient and predicted as a prognostic marker. Recent reports have indicated that stroma-derived OPN are involved in regulating stem cell microenvironment and pre-neoplastic cell growth. However, the function of stroma derived OPN in regulation of side population (SP) enrichment leading to melanoma growth, angiogenesis and metastasis is not well studied and yet to be the focus of intense investigation. Methodology/Principal Findings: In this study, using melanoma model, in wild type and OPN knockout mice, we have demonstrated that absence of host OPN effectively curbs melanoma growth, angiogenesis and metastasis. Melanoma cells isolated from tumor of OPN wild type (OPN+/+) mice exhibited more tumorigenic feature as compared to the parental cell line or cells isolated from the tumors of OPN KO (OPN-/-) mice. Furthermore, host OPN induces VEGF, ABCG2 and ERK1/2 expression and activation in B16-WT cells. We report for the first time that stroma derived OPN regulates SP phenotype in murine melanoma cells. Moreover, loss in and gain of function studies demonstrated that stroma-derived OPN regulates SP phenotype specifically through ERK2 activation. Conclusions: This study establish at least in part, the molecular mechanism underlying the role of host OPN in melanoma growth and angiogenesis, and better understanding of host OPN-tumor interaction may assist the advancement of novel therapeutic strategy for the management of malignant melanoma.	[Kumar, Santosh; Sharma, Priyanka; Kumar, Dhiraj; Chakraborty, Goutam; Gorain, Mahadeo; Kundu, Gopal C.] NCCS, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Kundu, GC (corresponding author), NCCS, NCCS Complex, Pune, Maharashtra, India.	kundu@nccs.res.in	Kumar, Santosh/I-9171-2019; Chakraborty, Goutam/B-5099-2014; Kumar, Dhiraj/AAJ-6305-2020; Kundu, Gopal C./ABA-9897-2020; Chakraborty, Goutam/U-5559-2019	Kumar, Santosh/0000-0002-4044-7005; Kumar, Dhiraj/0000-0002-6085-5911; 	University Grant Commission, Government of India; Council of Scientific and Industrial Research, Government of India	University Grant Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the University Grant Commission, Government of India (to S.K. and D.K.) and Council of Scientific and Industrial Research, Government of India (to P.S. and G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, EXPERT OPIN THER TAR, V15, P1113, DOI 10.1517/14728222.2011.594438; Anborgh PH, 2010, J CELL MOL MED, V14, P2037, DOI 10.1111/j.1582-4934.2010.01115.x; Behera R, 2010, CARCINOGENESIS, V31, P192, DOI 10.1093/carcin/bgp289; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Chakraborty G, 2008, MOL MED REP, V1, P641, DOI 10.3892/mmr_00000005; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; Chang PL, 2003, CARCINOGENESIS, V24, P1749, DOI 10.1093/carcin/bgg138; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Dou J, 2009, CELL BIOL INT, V33, P807, DOI 10.1016/j.cellbi.2009.05.003; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Geissinger E, 2002, CANCER RES, V62, P4820; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Jain S, 2007, EXPERT OPIN THER TAR, V11, P81, DOI 10.1517/14728222.11.1.81; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Kumar SKS, 2012, J AM DENT ASSOC, V143, P12, DOI 10.14219/jada.archive.2012.0003; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Luo XM, 2011, MOL CANCER RES, V9, P1018, DOI 10.1158/1541-7786.MCR-10-0472; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Ohyama Y, 2004, J BONE MINER RES, V19, P1706, DOI 10.1359/jbmr.2004.19.10.1706; Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Ping YF, 2011, STEM CELLS, V29, P888, DOI 10.1002/stem.650; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Rangaswami H, 2007, ONCOL REP, V18, P909; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Saika S, 2007, LAB INVEST, V87, P130, DOI 10.1038/labinvest.3700508; Sharma P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-178; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Smolle J, 1996, SEMIN CUTAN MED SURG, V15, P326, DOI 10.1016/S1085-5629(96)80046-0; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sumitomo A, 2010, MOL CELL BIOL, V30, P4818, DOI 10.1128/MCB.01348-09; Sun BC, 2004, INT J ONCOL, V25, P1609; van Kempen LCL, 2005, FRONT BIOSCI-LANDMRK, V10, P2922, DOI 10.2741/1748; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x	47	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69116	10.1371/journal.pone.0069116	http://dx.doi.org/10.1371/journal.pone.0069116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935934	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000078
J	Volgyi, B; Pan, F; Paul, DL; Wang, JT; Huberman, AD; Bloomfield, SA				Voelgyi, Bela; Pan, Feng; Paul, David L.; Wang, Jack T.; Huberman, Andrew D.; Bloomfield, Stewart A.			Gap Junctions Are Essential for Generating the Correlated Spike Activity of Neighboring Retinal Ganglion Cells	PLOS ONE			English	Article							SYNCHRONOUS ACTIVITY; ELECTRICAL SYNAPSES; HORIZONTAL CELLS; X-CELL; CONNEXIN36; SYNCHRONIZATION; PARASOL; INPUTS; OSCILLATIONS; INFORMATION	Neurons throughout the brain show spike activity that is temporally correlated to that expressed by their neighbors, yet the generating mechanism(s) remains unclear. In the retina, ganglion cells (GCs) show robust, concerted spiking that shapes the information transmitted to central targets. Here we report the synaptic circuits responsible for generating the different types of concerted spiking of GC neighbors in the mouse retina. The most precise concerted spiking was generated by reciprocal electrical coupling of GC neighbors via gap junctions, whereas indirect electrical coupling to a common cohort of amacrine cells generated the correlated activity with medium precision. In contrast, the correlated spiking with the lowest temporal precision was produced by shared synaptic inputs carrying photoreceptor noise. Overall, our results demonstrate that different synaptic circuits generate the discrete types of GC correlated activity. Moreover, our findings expand our understanding of the roles of gap junctions in the retina, showing that they are essential for generating all forms of concerted GC activity transmitted to central brain targets.	[Voelgyi, Bela; Pan, Feng; Bloomfield, Stewart A.] NYU, Langone Med Ctr, Dept Ophthalmol, New York, NY USA; [Pan, Feng; Bloomfield, Stewart A.] NYU, Langone Med Ctr, Dept Physiol & Neurosci, New York, NY USA; [Voelgyi, Bela] Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary; [Voelgyi, Bela] Janos Szentagothai Res Ctr, Pecs, Hungary; [Paul, David L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wang, Jack T.] Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94304 USA; [Huberman, Andrew D.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Pecs; Harvard University; Harvard Medical School; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Volgyi, B (corresponding author), NYU, Langone Med Ctr, Dept Ophthalmol, New York, NY USA.	volgyi01@gamma.ttk.pte.hu	Volgyi, Bela/A-9079-2013; Volgyi, Bela/B-1016-2011	Volgyi, Bela/0000-0001-7481-390X; PAN, Feng/0000-0002-5256-4380	National Institutes of Health/National Eye Institute (NIH/NEI) [EY017832]; OTKA [K105247]; Hungarian Academy of Sciences; NIH/NEI [EY007360, EY014127]; NATIONAL EYE INSTITUTE [R01EY014127, R01EY007360, R01EY017832] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health/National Eye Institute (NIH/NEI) EY017832, OTKA K105247 and a Bolyai Fellowship of the Hungarian Academy of Sciences to BV; NIH/NEI EY007360 to SAB; and NIH/NEI EY014127 to DLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Ackert JM, 2009, J PHYSIOL-LONDON, V587, P4481, DOI 10.1113/jphysiol.2009.173344; Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Ala-Laurila P, 2011, NAT NEUROSCI, V14, P1309, DOI 10.1038/nn.2927; Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BLOOMFIELD SA, 1982, J COMP NEUROL, V208, P288, DOI 10.1002/cne.902080306; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Ciolofan C, 2007, NEUROSCIENCE, V148, P473, DOI 10.1016/j.neuroscience.2007.06.003; DACEY DM, 1992, VISUAL NEUROSCI, V9, P279, DOI 10.1017/S0952523800010695; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Du YM, 2012, ACTA PHARMACOL SIN, V33, P752, DOI 10.1038/aps.2012.22; Du YM, 2009, J ETHNOPHARMACOL, V125, P318, DOI 10.1016/j.jep.2009.06.016; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Hidaka S, 2004, J NEUROSCI, V24, P10553, DOI 10.1523/JNEUROSCI.3319-04.2004; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Hu EH, 2010, J PHYSIOL-LONDON, V588, P4145, DOI 10.1113/jphysiol.2010.193268; Hu EH, 2000, J NEUROSCI METH, V103, P209, DOI 10.1016/S0165-0270(00)00319-8; Hu EH, 2003, J NEUROSCI, V23, P6768; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; Jacoby R, 1996, J NEUROSCI, V16, P8041; Janssen-Bienhoid U, 2009, J COMP NEUROL, V513, P363, DOI 10.1002/cne.21965; Jeon CJ, 1998, J NEUROSCI, V18, P8936; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; Matchkov VV, 2004, BRIT J PHARMACOL, V142, P961, DOI 10.1038/sj.bjp.0705870; Matsumura M, 1996, NEUROREPORT, V7, P749, DOI 10.1097/00001756-199602290-00017; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Neuenschwander S, 1999, VISION RES, V39, P2485, DOI 10.1016/S0042-6989(99)00042-5; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Pan F, 2010, J COMP NEUROL, V518, P911, DOI 10.1002/cne.22254; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; Schubert T, 2005, J COMP NEUROL, V485, P191, DOI 10.1002/cne.20510; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shelley J, 2006, EUR J NEUROSCI, V23, P3176, DOI 10.1111/j.1460-9568.2006.04848.x; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Vidne M, 2012, J COMPUT NEUROSCI, V33, P97, DOI 10.1007/s10827-011-0376-2; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	69	45	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69426	10.1371/journal.pone.0069426	http://dx.doi.org/10.1371/journal.pone.0069426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936012	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000118
J	Thomassen, HA; Fuller, T; Asefi-Najafabady, S; Shiplacoff, JAG; Mulembakani, PM; Blumberg, S; Johnston, SC; Kisalu, NK; Kinkela, TL; Fair, JN; Wolfe, ND; Shongo, RL; LeBreton, M; Meyer, H; Wright, LL; Muyembe, JJ; Buermann, W; Okitolonda, E; Hensley, LE; Lloyd-Smith, JO; Smith, TB; Rimoin, AW				Thomassen, Henri A.; Fuller, Trevon; Asefi-Najafabady, Salvi; Shiplacoff, Julia A. G.; Mulembakani, Prime M.; Blumberg, Seth; Johnston, Sara C.; Kisalu, Neville K.; Kinkela, Timothee L.; Fair, Joseph N.; Wolfe, Nathan D.; Shongo, Robert L.; LeBreton, Matthew; Meyer, Hermann; Wright, Linda L.; Muyembe, Jean-Jacques; Buermann, Wolfgang; Okitolonda, Emile; Hensley, Lisa E.; Lloyd-Smith, James O.; Smith, Thomas B.; Rimoin, Anne W.			Pathogen-Host Associations and Predicted Range Shifts of Human Monkeypox in Response to Climate Change in Central Africa	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; ECOLOGICAL NICHE; PUBLIC-HEALTH; RISK-FACTORS; SAMPLE-SIZE; VIRUS; PERFORMANCE; OUTBREAK; CONGO; BIODIVERSITY	Climate change is predicted to result in changes in the geographic ranges and local prevalence of infectious diseases, either through direct effects on the pathogen, or indirectly through range shifts in vector and reservoir species. To better understand the occurrence of monkeypox virus (MPXV), an emerging Orthopoxvirus in humans, under contemporary and future climate conditions, we used ecological niche modeling techniques in conjunction with climate and remote-sensing variables. We first created spatially explicit probability distributions of its candidate reservoir species in Africa's Congo Basin. Reservoir species distributions were subsequently used to model current and projected future distributions of human monkeypox (MPX). Results indicate that forest clearing and climate are significant driving factors of the transmission of MPX from wildlife to humans under current climate conditions. Models under contemporary climate conditions performed well, as indicated by high values for the area under the receiver operator curve (AUC), and tests on spatially randomly and non-randomly omitted test data. Future projections were made on IPCC 4th Assessment climate change scenarios for 2050 and 2080, ranging from more conservative to more aggressive, and representing the potential variation within which range shifts can be expected to occur. Future projections showed range shifts into regions where MPX has not been recorded previously. Increased suitability for MPX was predicted in eastern Democratic Republic of Congo. Models developed here are useful for identifying areas where environmental conditions may become more suitable for human MPX; targeting candidate reservoir species for future screening efforts; and prioritizing regions for future MPX surveillance efforts.	[Thomassen, Henri A.; Fuller, Trevon; Shiplacoff, Julia A. G.; Buermann, Wolfgang; Smith, Thomas B.] Univ Calif Los Angeles, Ctr Trop Res, Los Angeles, CA USA; [Thomassen, Henri A.] Univ Tubingen, Dept Comparat Zool, Tubingen, Germany; [Asefi-Najafabady, Salvi] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Asefi-Najafabady, Salvi] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA; [Mulembakani, Prime M.; Kinkela, Timothee L.; Okitolonda, Emile] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Blumberg, Seth; Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Blumberg, Seth; Lloyd-Smith, James O.; Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Johnston, Sara C.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Kisalu, Neville K.; Rimoin, Anne W.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Fair, Joseph N.; Wolfe, Nathan D.; LeBreton, Matthew] Global Viral Forecasting, San Francisco, CA USA; [Wolfe, Nathan D.] Stanford Univ, Program Human Biol, Stanford, CA 94305 USA; [Shongo, Robert L.] Minist Hlth, Kinshasa, DEM REP CONGO; [Meyer, Hermann] Bundeswehr Inst Microbiol, Munich, Germany; [Wright, Linda L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Muyembe, Jean-Jacques] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Buermann, Wolfgang] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA; [Hensley, Lisa E.] Med Countermeasures Initiat, Silver Spring, MD USA; [Rimoin, Anne W.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Eberhard Karls University of Tubingen; Arizona State University; Arizona State University-Tempe; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Los Angeles; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of California System; University of California Los Angeles; Stanford University; Bundeswehr Institute of Microbiology (IMB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institute Nacional de Recherche Biomedical; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rimoin, AW (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	arimoin@ucla.edu	/K-4080-2012; Lloyd-Smith, James/AAG-4463-2021; Fuller, Trevon/B-8087-2014	/0000-0001-7941-502X; Hensley, Lisa/0000-0003-1188-4342; Fuller, Trevon/0000-0001-9954-4267	Faucett Family Foundation; National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States of America; National Science Foundation-National Institutes of Health Ecology of Infectious Diseases Program [EF-0430146]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; National Institute of Allergy and Infectious Diseases [EID-1R01AI074059-01]; NIH [DP1-OD00370]; Google.org; Skoll Foundation; Henry M. Jackson Foundation for the Advancement of Military Medicine; US Armed Forces Health Surveillance Center Division of GEIS Operations; United States Agency for International Development (USAID) Emerging Pandemic Threats Program; PREDICT project [GHN-A-OO-09-00010-00]; Department of Homeland Security/National Biodefense Analysis and Countermeasures Center [HSQDC-05-X-000-35/P400006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074059] Funding Source: NIH RePORTER	Faucett Family Foundation; National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States of America; National Science Foundation-National Institutes of Health Ecology of Infectious Diseases Program(National Science Foundation (NSF)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Google.org(Google Incorporated); Skoll Foundation; Henry M. Jackson Foundation for the Advancement of Military Medicine; US Armed Forces Health Surveillance Center Division of GEIS Operations; United States Agency for International Development (USAID) Emerging Pandemic Threats Program(United States Agency for International Development (USAID)); PREDICT project; Department of Homeland Security/National Biodefense Analysis and Countermeasures Center(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible by the support of the Faucett Family Foundation. The authors thank the DRC Ministry of Health and local health workers who were responsible for specimen collection and case investigation. Additional support for this study was provided by the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, United States of America, by the joint National Science Foundation-National Institutes of Health Ecology of Infectious Diseases Program (grant number EF-0430146), and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, by the Fogarty International Center, National Institutes of Health, and by the National Institute of Allergy and Infectious Diseases (grant number EID-1R01AI074059-01). NDW is supported by the NIH Director's Pioneer Award (DP1-OD00370). Global Viral Forecasting is supported by Google.org, the Skoll Foundation, the Henry M. Jackson Foundation for the Advancement of Military Medicine, the US Armed Forces Health Surveillance Center Division of GEIS Operations, and the United States Agency for International Development (USAID) Emerging Pandemic Threats Program, PREDICT project, under the terms of Cooperative Agreement Number GHN-A-OO-09-00010-00. This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. Further support came from the Department of Homeland Security/National Biodefense Analysis and Countermeasures Center Project #HSQDC-05-X-000-35/P400006 (RSCB-09-00343). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuja S, 2010, INTERNAL DISPLACEMEN; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Asefi-Najafabady S, GEOPHYS RES IN PRESS; Baines PG, 2007, J CLIMATE, V20, P2721, DOI 10.1175/JCLI4177.1; Balk D, 2005, ENV NATURAL RESOURCE, V24; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Breman JG, 2000, EMERGING INFECTIONS 4, P45; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Brugger K, 2009, PREV VET MED, V88, P24, DOI 10.1016/j.prevetmed.2008.06.023; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chylek P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042793; Damon IK, 2006, NEW ENGL J MED, V355, P962, DOI 10.1056/NEJMc060792; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Eisen RJ, 2010, AM J TROP MED HYG, V82, P904, DOI 10.4269/ajtmh.2010.09-0737; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith Jane, 2002, P39; Ellis CK, 2012, J WILDLIFE DIS, V48, P335, DOI 10.7589/0090-3558-48.2.335; FACET - Initiative for remote sensing forest monitoring in Central Africa, 2010, ATL FOR COV CHANG 20; Fair J, 2007, VECTOR-BORNE ZOONOT, V7, P167, DOI 10.1089/vbz.2006.0581; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Formenty P, 2010, EMERG INFECT DIS, V16, P1539, DOI 10.3201/eid1610.100713; Fuller T, 2011, ECOHEALTH, V8, P14, DOI 10.1007/s10393-010-0355-5; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Jezek Z., 1988, MONOGRAPHS VIROLOGY, V17; Jiang ZY, 2006, REMOTE SENS ENVIRON, V101, P366, DOI 10.1016/j.rse.2006.01.003; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; KHODAKEVICH L, 1988, B WORLD HEALTH ORGAN, V66, P747; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; KINGDON J, 1979, E AFRICAN MAMMALS B, V3; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., 2021, SATSCANTM USER GUIDE; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; LONG D. G., 2001, EOS T AM GEOPHYS UN, V82, P503, DOI DOI 10.1029/01EO00303; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Madhi SA, 2000, INT J TUBERC LUNG D, V4, P448; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Melski J, 2003, JAMA-J AM MED ASSOC, V290, P30; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; Nakoune E, 2012, INT J INFECT DIS, V16, pE266, DOI 10.1016/j.ijid.2012.05.916; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Ramirez-Villegas J, 2010, 1 CIAT; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2007, EMERG INFECT DIS, V13, P1332, DOI 10.3201/eid1309.070175; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; Root ED, 2009, SOC SCI MED, V68, P1361, DOI 10.1016/j.socscimed.2009.01.034; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; United Nations Population Division, 2008, WORLD POP PROSP 2008; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wittmann EJ, 2000, VET J, V160, P107, DOI 10.1053/tvjl.2000.0470	89	16	16	9	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e66071	10.1371/journal.pone.0066071	http://dx.doi.org/10.1371/journal.pone.0066071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935820	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700002
J	Marentette, JO; Hauser, PJ; Hurst, RE; Klumpp, DJ; Rickard, A; McHowat, J				Marentette, John O.; Hauser, Paul J.; Hurst, Robert E.; Klumpp, David J.; Rickard, Alice; McHowat, Jane			Tryptase Activation of Immortalized Human Urothelial Cell Mitogen-Activated Protein Kinase	PLOS ONE			English	Article							INTERSTITIAL CYSTITIS; MAST-CELLS; ANTIPROLIFERATIVE FACTOR; PATHOGENESIS; PHOSPHORYLATION; INFLAMMATION; EXPRESSION; RECEPTORS; DIAGNOSIS; PATHWAYS	The pathogenesis of interstitial cystitis/painful bladder syndrome (IC/PBS) is multifactorial, but likely involves urothelial cell dysfunction and mast cell accumulation in the bladder wall. Activated mast cells in the bladder wall release several inflammatory mediators, including histamine and tryptase. We determined whether mitogen-activated protein (MAP) kinases are activated in response to tryptase stimulation of urothelial cells derived from human normal and IC/PBS bladders. Tryptase stimulation of normal urothelial cells resulted in a 2.5-fold increase in extracellular signal regulated kinase 1/2 (ERK 1/2). A 5.5-fold increase in ERK 1/2 activity was observed in urothelial cells isolated from IC/PBS bladders. No significant change in p38 MAP kinase was observed in tryptase-stimulated normal urothelial cells but a 2.5-fold increase was observed in cells isolated from IC/PBS bladders. Inhibition of ERK 1/2 with PD98059 or inhibition of p38 MAP kinase with SB203580 did not block tryptase-stimulated iPLA(2) activation. Incubation with the membrane phospholipid-derived PLA(2) hydrolysis product lysoplasmenylcholine increased ERK 1/2 activity, suggesting the iPLA(2) activation is upstream of ERK 1/2. Real time measurements of impedance to evaluate wound healing of cell cultures indicated increased healing rates in normal and IC/PBS urothelial cells in the presence of tryptase, with inhibition of ERK 1/2 significantly decreasing the wound healing rate of IC/PBS urothelium. We conclude that activation of ERK 1/2 in response to tryptase stimulation may facilitate wound healing or cell motility in areas of inflammation in the bladder associated with IC/PBS.	[Marentette, John O.; Rickard, Alice; McHowat, Jane] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Hauser, Paul J.; Hurst, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Saint Louis University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Northwestern University; Feinberg School of Medicine	McHowat, J (corresponding author), St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.	mchowaj@slu.edu		McHowat, Jane/0000-0003-3133-3388; Hurst, Robert/0000-0003-0370-1817	National Institutes of Health [R01 DK69808, R01 DK66119, 1P20DK097799-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK097799, R01DK066119, R01DK069808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK69808 (to RH), R01 DK66119 (to JM) and 1P20DK097799-01 (to RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1350, DOI 10.1152/ajpcell.00487.2005; Birder LA, 2005, AM J PHYSIOL-RENAL, V289, pF489, DOI 10.1152/ajprenal.00467.2004; Bjorling DE, 1999, J UROLOGY, V162, P231, DOI 10.1097/00005392-199907000-00073; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298; Elbadawi A, 1997, UROLOGY, V49, P14, DOI 10.1016/S0090-4295(99)80329-X; Gonzalez RR, 2005, J UROLOGY, V173, P630, DOI 10.1097/01.ju.0000143192.68223.f7; Goo YA, 2010, INT BRAZ J UROL, V36, P464, DOI 10.1590/S1677-55382010000400010; Keay S, 2008, CELL SIGNAL, V20, P2174, DOI 10.1016/j.cellsig.2008.06.004; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kim JY, 2009, BJU INT, V103, P541, DOI 10.1111/j.1464-410X.2008.08097.x; Klumpp DJ, 2008, NAT CLIN PRACT UROL, V5, P494, DOI 10.1038/ncpuro1203; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Lin CC, 2009, CARDIOVASC RES, V82, P522, DOI 10.1093/cvr/cvp069; Martin R, 2009, J NEUROCHEM, V111, P988, DOI 10.1111/j.1471-4159.2009.06377.x; McHowat J, 1997, AM J PHYSIOL-HEART C, V272, pH1972, DOI 10.1152/ajpheart.1997.272.4.H1972; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; Parsons CL, 1998, J UROLOGY, V159, P1862, DOI 10.1016/S0022-5347(01)63178-1; Peeker R, 2000, J UROLOGY, V163, P1009, DOI 10.1016/S0022-5347(05)67873-1; Qiao LY, 2007, AM J PHYSIOL-REG I, V292, pR1368, DOI 10.1152/ajpregu.00570.2006; Rastogi P, 2008, AM J PHYSIOL-RENAL, V294, pF1129, DOI 10.1152/ajprenal.00572.2007; Richter B, 2010, HISTOPATHOLOGY, V57, P371, DOI 10.1111/j.1365-2559.2010.03640.x; Rickard A, 2002, AM J PHYSIOL-RENAL, V283, pF944, DOI 10.1152/ajprenal.00072.2002; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; Shie JH, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.049; Swiatkowski S, 2003, EXP CELL RES, V282, P48, DOI 10.1006/excr.2002.5647; Theoharides TC, 2001, UROLOGY, V57, P47, DOI 10.1016/S0090-4295(01)01129-3; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Wang ZY, 2009, AM J PHYSIOL-REG I, V297, pR1127, DOI 10.1152/ajpregu.00310.2009; WHEELDON LW, 1965, J LIPID RES, V6, P481; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69948	10.1371/journal.pone.0069948	http://dx.doi.org/10.1371/journal.pone.0069948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922867	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700108
J	Bear, AS; Kennedy, LC; Young, JK; Perna, SK; Almeida, JPM; Lin, AY; Eckels, PC; Drezek, RA; Foster, AE				Bear, Adham S.; Kennedy, Laura C.; Young, Joseph K.; Perna, Serena K.; Almeida, Joao Paulo Mattos; Lin, Adam Y.; Eckels, Phillip C.; Drezek, Rebekah A.; Foster, Aaron E.			Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MYELOID SUPPRESSOR-CELLS; RADIOFREQUENCY ABLATION; DENDRITIC CELLS; TUMOR MICROENVIRONMENT; PHOTODYNAMIC THERAPY; CANCER-IMMUNOTHERAPY; ANTITUMOR IMMUNITY; IN-VIVO; VACCINE	Ablative treatments such as photothermal therapy (PTT) are attractive anticancer strategies because they debulk accessible tumor sites while simultaneously priming antitumor immune responses. However, the immune response following thermal ablation is often insufficient to treat metastatic disease. Here we demonstrate that PTT induces the expression of proinflammatory cytokines and chemokines and promotes the maturation of dendritic cells within tumor-draining lymph nodes, thereby priming antitumor T cell responses. Unexpectedly, however, these immunomodulatory effects were not beneficial to overall antitumor immunity. We found that PTT promoted the infiltration of secondary tumor sites by CD11b(+)Ly-6G/C+ myeloid-derived suppressor cells, consequently failing to slow the growth of poorly immunogenic B16-F10 tumors and enhancing the growth of distant lung metastases. To exploit the beneficial effects of PTT activity against local tumors and on antitumor immunity whilst avoiding the adverse consequences, we adoptively transferred gp100-specific pmel T cells following PTT. The combination of local control by PTT and systemic antitumor immune reactivity provided by adoptively transferred T cells prevented primary tumor recurrence post-ablation, inhibited tumor growth at distant sites, and abrogated the outgrowth of lung metastases. Hence, the combination of PTT and systemic immunotherapy prevented the adverse effects of PTT on metastatic tumor growth and optimized overall tumor control.	[Bear, Adham S.; Perna, Serena K.; Eckels, Phillip C.; Foster, Aaron E.] Baylor Coll Med, Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Bear, Adham S.; Perna, Serena K.; Eckels, Phillip C.; Foster, Aaron E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Bear, Adham S.; Foster, Aaron E.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Kennedy, Laura C.; Almeida, Joao Paulo Mattos; Lin, Adam Y.; Drezek, Rebekah A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Young, Joseph K.; Drezek, Rebekah A.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA; [Foster, Aaron E.] Bellicum Pharmaceut, Houston, TX USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Rice University; Rice University	Drezek, RA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	drezek@rice.edu; afoster@bellicum.com		Kennedy, Laura/0000-0001-8958-7909; Lin, Adam/0000-0001-9359-882X	Cancer Prevention Research Institute of Texas [RP100189]; Norman Hackerman Advanced Research Program; John Dunn Foundation; NATIONAL CANCER INSTITUTE [R01CA172836] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; Norman Hackerman Advanced Research Program; John Dunn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Studies were supported by the Cancer Prevention Research Institute of Texas grant number RP100189 (http://www.cprit.state.tx.us), the Norman Hackerman Advanced Research Program (https://www1.thecb.state.tx.us), and the John Dunn Foundation Collaborative Research Award (http://johnsdunnfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay D, 2008, EUR CYTOKINE NETW, V19, P1, DOI 10.1684/ecn.2008.0113; Albini A, 2005, CANCER RES, V65, P10637, DOI 10.1158/0008-5472.CAN-05-3473; Bronte V, 1999, J IMMUNOL, V162, P5728; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cuenca AG, 2013, MOL MED CAMBRIDGE MA, V17, P281; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Finnerty CC, 2009, CYTOKINE, V45, P20, DOI 10.1016/j.cyto.2008.10.005; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; FU YX, 1990, CANCER RES, V50, P227; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gottschalk S, 2003, BLOOD, V101, P1905, DOI 10.1182/blood-2002-05-1514; Habibi M, 2009, BREAST CANCER RES TR, V114, P423, DOI 10.1007/s10549-008-0024-3; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang XF, 2003, CANCER RES, V63, P7321; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kim YH, 2012, BLOOD, V119, P355, DOI 10.1182/blood-2011-05-355222; Kodumudi KN, 2012, J IMMUNOL, V189, P5147, DOI 10.4049/jimmunol.1200274; Liu Q, 2009, MOL THER, V17, P2049, DOI 10.1038/mt.2009.221; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Prevo BG, 2008, SMALL, V4, P1183, DOI 10.1002/smll.200701290; Rai R, 2005, J SURG RES, V129, P147, DOI 10.1016/j.jss.2005.03.020; Rao P, 2011, CARDIOVASC INTER RAD, V34, P424, DOI 10.1007/s00270-010-9896-9; Redondo P, 2007, J INVEST DERMATOL, V127, P1673, DOI 10.1038/sj.jid.5700777; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; SOANES WA, 1970, J UROLOGY, V104, P154, DOI 10.1016/S0022-5347(17)61690-2; Song XT, 2011, MOL THER, V19, P211, DOI 10.1038/mt.2010.223; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Turnis ME, 2010, J IMMUNOL, V185, P4223, DOI 10.4049/jimmunol.0903507; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Waitz R, 2012, CANCER RES, V72, P430, DOI 10.1158/0008-5472.CAN-11-1782; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang WL, 2004, ANN SURG ONCOL, V11, P399, DOI 10.1245/ASO.2004.08.013	53	118	119	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69073	10.1371/journal.pone.0069073	http://dx.doi.org/10.1371/journal.pone.0069073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935927	Green Published, gold			2022-12-27	WOS:000325211000073
J	Huang, CJ; Wang, ZC; Huang, HY; Huang, HD; Peng, HL				Huang, Ching-Jou; Wang, Zhe-Chong; Huang, Hsi-Yuan; Huang, Hsien-Da; Peng, Hwei-Ling			YjcC, a c-di-GMP Phosphodiesterase Protein, Regulates the Oxidative Stress Response and Virulence of Klebsiella pneumoniae CG43	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; DIGUANYLATE CYCLASE; SIGNAL-TRANSDUCTION; TWITCHING MOTILITY; BIOFILM FORMATION; LIVER-ABSCESS; FUMARASE FUMA; EAL DOMAIN	This study shows that the expression of yjcC, an in vivo expression (IVE) gene, and the stress response regulatory genes soxR, soxS, and rpoS are paraquat inducible in Klebsiella pneumoniae CG43. The deletion of rpoS or soxRS decreased yjcC expression, implying an RpoS- or SoxRS-dependent control. After paraquat or H2O2 treatment, the deletion of yjcC reduced bacterial survival. These effects could be complemented by introducing the DyjcC mutant with the YjcC-expression plasmid pJR1. The recombinant protein containing only the YjcC-EAL domain exhibited phosphodiesterase (PDE) activity; overexpression of yjcC has lower levels of cyclic di-GMP. The yjcC deletion mutant also exhibited increased reactive oxygen species (ROS) formation, oxidation damage, and oxidative stress scavenging activity. In addition, the yjcC deletion reduced capsular polysaccharide production in the bacteria, but increased the LD50 in mice, biofilm formation, and type 3 fimbriae major pilin MrkA production. Finally, a comparative transcriptome analysis showed 34 upregulated and 29 downregulated genes with the increased production of YjcC. The activated gene products include glutaredoxin I, thioredoxin, heat shock proteins, chaperone, and MrkHI, and proteins for energy metabolism (transporters, cell surface structure, and transcriptional regulation). In conclusion, the results of this study suggest that YjcC positively regulates the oxidative stress response and mouse virulence but negatively affects the biofilm formation and type 3 fimbriae expression by altering the c-di-GMP levels after receiving oxidative stress signaling inputs.	[Huang, Ching-Jou; Peng, Hwei-Ling] Natl Chiao Tung Univ, Inst Mol Med & Biol Technol, Hsinchu, Taiwan; [Wang, Zhe-Chong; Huang, Hsien-Da; Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Huang, Hsi-Yuan; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Peng, HL (corresponding author), Natl Chiao Tung Univ, Inst Mol Med & Biol Technol, Hsinchu, Taiwan.	hlpeng@mail.nctu.edu.tw	Huang, Hsien-Da/AAA-7376-2019		National Science Council [NSC 350 99-2320-B-009-003-MY3, NSC 100-2320-B-009-003-MY3]; "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. [100W962]	National Science Council(Ministry of Science and Technology, Taiwan); "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C.	This work was supported by grants from the National Science Council (NSC 350 99-2320-B-009-003-MY3, and NSC 100-2320-B-009-003-MY3) and "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education (100W962), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna LG, 2009, ARCH MICROBIOL, V191, P473, DOI 10.1007/s00203-009-0473-z; Adedapo AA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-53; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caldas T, 2006, BIOCHEM BIOPH RES CO, V343, P780, DOI 10.1016/j.bbrc.2006.03.028; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Chattopadhyay S, 1997, J BACTERIOL, V179, P4868, DOI 10.1128/jb.179.15.4868-4873.1997; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Cruz DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-139; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Jovanovic G, 2010, MICROBIOL-SGM, V156, P2920, DOI 10.1099/mic.0.040055-0; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Keynan Y, 2007, SCAND J INFECT DIS, V39, P828, DOI 10.1080/00365540701266763; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; KOH YS, 1995, J BACTERIOL, V177, P2673, DOI 10.1128/jb.177.10.2673-2678.1995; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Lacey MM, 2010, MICROBIOL-SGM, V156, P2873, DOI 10.1099/mic.0.037887-0; Lai YC, 2001, INFECT IMMUN, V69, P7140, DOI 10.1128/IAI.69.11.7140-7145.2001; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Li TN, 2009, PROTEINS, V75, P282, DOI 10.1002/prot.22330; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Liyana-Pathirana CM, 2005, J AGR FOOD CHEM, V53, P2433, DOI 10.1021/jf049320i; Ljrah Mnench, 1937, AM J HYG, V27, P493; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; MATHER MW, 1995, GENE, V156, P85, DOI 10.1016/0378-1119(95)00074-G; MembrilloHernandez J, 1997, J BACTERIOL, V179, P3164, DOI 10.1128/jb.179.10.3164-3170.1997; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; Reents H, 2006, J BACTERIOL, V188, P1103, DOI 10.1128/JB.188.3.1103-1112.2006; Renzette N, 2007, MOL MICROBIOL, V63, P103, DOI 10.1111/j.1365-2958.2006.05496.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Sahly H, 2000, INFECT IMMUN, V68, P6744, DOI 10.1128/IAI.68.12.6744-6749.2000; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Spurbeck RR, 2012, MBIO, V3, DOI 10.1128/mBio.00307-12; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tanaka K, 1997, BBA-GENE STRUCT EXPR, V1352, P161, DOI 10.1016/S0167-4781(97)00044-4; Thomas JG, 2000, MOL MICROBIOL, V36, P1360, DOI 10.1046/j.1365-2958.2000.01951.x; Tolla DA, 2010, J MOL BIOL, V397, P893, DOI 10.1016/j.jmb.2010.02.015; Tseng CP, 1997, FEMS MICROBIOL LETT, V157, P67, DOI 10.1016/S0378-1097(97)00455-2; Tseng CP, 2001, J BACTERIOL, V183, P461, DOI 10.1128/JB.183.2.461-467.2001; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wu MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023500; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003	71	33	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e66740	10.1371/journal.pone.0066740	http://dx.doi.org/10.1371/journal.pone.0066740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935824	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000006
J	Li, YJ; Raman, I; Du, Y; Yan, M; Min, SY; Yang, JC; Fang, XD; Li, W; Lu, JX; Zhou, XJ; Mohan, C; Li, QZ				Li, Yajuan; Raman, Indu; Du, Yong; Yan, Mei; Min, Soyoun; Yang, Jichen; Fang, Xiangdong; Li, Wei; Lu, Jianxin; Zhou, Xin J.; Mohan, Chandra; Li, Quan-Zhen			Kallikrein Transduced Mesenchymal Stem Cells Protect against Anti-GBM Disease and Lupus Nephritis by Ameliorating Inflammation and Oxidative Stress	PLOS ONE			English	Article							RENAL ISCHEMIA/REPERFUSION INJURY; BONE-MARROW; TISSUE KALLIKREIN; KININ SYSTEM; EXPERIMENTAL GLOMERULONEPHRITIS; INHIBITING APOPTOSIS; ERYTHEMATOSUS MICE; STROMAL CELLS; KIDNEY INJURY; GENE-TRANSFER	Previously we have shown that kallikreins (klks) play a renoprotective role in nephrotoxic serum induced nephritis. In this study, we have used mesenchymal stem cells (MSCs) as vehicles to deliver klks into the injured kidneys and have measured their therapeutic effect on experimental antibody induced nephritis and lupus nephritis. Human KLK-1 (hKLK1) gene was transduced into murine MSCs using a retroviral vector to generate a stable cell line, hKLK1-MSC, expressing high levels of hKLK1. 129/svj mice subjected to anti-GBM induced nephritis were transplanted with 10(6) hKLK1-MSCs and hKLK1 expression was confirmed in the kidneys. Compared with vector-MSCs injected mice, the hKLK1-MSCs treated mice showed significantly reduced proteinuria, blood urea nitrogen (BUN) and ameliorated renal pathology. Using the same strategy, we treated lupus-prone B6.Sle1.Sle3 bicongenic mice with hKLK1-MSCs and demonstrated that hKLK1-MSCs delivery also attenuated lupus nephritis. Mechanistically, hKLK1-MSCs reduced macrophage and T-lymphocyte infiltration into the kidney by suppressing the expression of inflammation cytokines. Moreover, hKLK1 transduced MSCs were more resistant to oxidative stress-induced apoptosis. These findings advance genetically modified MSCs as potential gene delivery tools for targeting therapeutic agents to the kidneys in order to modulate inflammation and oxidative stress in lupus nephritis.	[Li, Yajuan; Raman, Indu; Du, Yong; Yan, Mei; Min, Soyoun; Mohan, Chandra; Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Yang, Jichen] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Li, Yajuan; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Li, Wei; Lu, Jianxin; Li, Quan-Zhen] Wenzhou Med Coll, Key Lab Med Genet, Sch Lab Med & Life Sci, Wenzhou, Peoples R China; [Zhou, Xin J.] Pathologist BioMed Labs, Lewisville, TX USA; [Mohan, Chandra] Univ Houston, BME Dept, Houston, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Wenzhou Medical University; University of Houston System; University of Houston	Mohan, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA.	texascmohan@gmail.com; quan.li@UTSouthwestern.edu	yang, jichen/HDL-9203-2022; yan, mei/AAA-1379-2022; DU, YONG/B-9964-2011; Mohan, Chandra/GPX-8233-2022	DU, YONG/0000-0003-1687-9024	National Institutes of Health [P50 CORT AR055503, R01 AR050812, R03 AR055778]; National Natural Science Foundation of China [81070611, 31100924]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055503, R03AR055778, R01AR050812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants P50 CORT AR055503, R01 AR050812 and R03 AR055778; National Natural Science Foundation of China, No. 81070611 and No. 31100924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aringer M, 2005, LUPUS, V14, P13, DOI 10.1191/0961203305lu2053oa; Balabanian K, 2003, J IMMUNOL, V170, P3392, DOI 10.4049/jimmunol.170.6.3392; Bledsoe G, 2006, NEPHROL DIAL TRANSPL, V21, P624, DOI 10.1093/ndt/gfi225; Bledsoe G, 2008, TOXICOL SCI, V102, P433, DOI 10.1093/toxsci/kfn008; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Bodin S, 2009, KIDNEY INT, V76, P395, DOI 10.1038/ki.2009.208; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Cao CC, 2004, KIDNEY INT, V65, P834, DOI 10.1111/j.1523-1755.2004.00463.x; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Che N, 2012, CELL TRANSPLANT; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; De Miguel MP, 2012, CURR MOL MED, V12, P574; Deng WW, 2003, AM J PHYSIOL-CELL PH, V285, pC1322, DOI 10.1152/ajpcell.00141.2003; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Iwata Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/594809; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Ji SY, 2012, CELL PHYSIOL BIOCHEM, V29, P705, DOI 10.1159/000178590; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Kakoki M, 2009, KIDNEY INT, V75, P1019, DOI 10.1038/ki.2008.647; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kulkarni O, 2008, FRONT BIOSCI-LANDMRK, V13, P3312; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Li QZ, 2009, GENES IMMUN, V10, P503, DOI 10.1038/gene.2009.7; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Liu K, 2009, J CLIN INVEST, V119, P911, DOI 10.1172/JCI36728; Lu H, 2010, AM J PHYSIOL-RENAL, V299, pF445, DOI 10.1152/ajprenal.00583.2009; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Makino H, 2003, VIRCHOWS ARCH, V443, P67, DOI 10.1007/s00428-003-0827-x; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Rookmaaker MB, 2003, AM J PATHOL, V163, P553, DOI 10.1016/S0002-9440(10)63683-8; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Sharma JN, 2006, THESCIENTIFICWORLDJO, V6, P1247, DOI 10.1100/tsw.2006.226; Sun LY, 2010, ARTHRITIS RHEUM-US, V62, P2467, DOI 10.1002/art.27548; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Timoshanko JR, 2004, AM J PATHOL, V164, P1967, DOI 10.1016/S0002-9440(10)63757-1; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Uchimura H, 2005, J AM SOC NEPHROL, V16, P997, DOI 10.1681/ASN.2004050367; Urushihara M, 2002, NEPHROL DIAL TRANSPL, V17, P1189, DOI 10.1093/ndt/17.7.1189; van der Vlag J, 2011, SEMIN NEPHROL, V31, P376, DOI 10.1016/j.semnephrol.2011.06.009; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Xie C, 2011, J CLIN IMMUNOL, V31, P128, DOI 10.1007/s10875-010-9470-x; Yao YY, 2007, REGUL PEPTIDES, V140, P12, DOI 10.1016/j.regpep.2006.11.020; Yokoo T., 2003, Current Gene Therapy, V3, P387, DOI 10.2174/1566523034578221; Zhang JJ, 2004, KIDNEY INT, V66, P722, DOI 10.1111/j.1523-1755.2004.00794.x; Zhou KX, 2008, CELL MOL IMMUNOL, V5, P417, DOI 10.1038/cmi.2008.52; Zykova SN, 2007, ANN NY ACAD SCI, V1108, P1, DOI 10.1196/annals.1422.001	64	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67790	10.1371/journal.pone.0067790	http://dx.doi.org/10.1371/journal.pone.0067790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935844	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000018
J	Tokito, A; Jougasaki, M; Ichiki, T; Hamasaki, S				Tokito, Akinori; Jougasaki, Michihisa; Ichiki, Tomoko; Hamasaki, Shuichi			Cardiotrophin-1 Induces Matrix Metalloproteinase-1 in Human Aortic Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; ONCOSTATIN-M; CARDIAC FIBROBLASTS; INHIBITORY FACTOR; VASCULAR-LESIONS; TISSUE INHIBITOR; MMP-1 EXPRESSION; JAK-STAT; KAPPA-B	Rupture of an atherosclerotic plaque is a key event in the development of cardiovascular disorders, in which matrix metalloproteinase-1 (MMP-1) plays a crucial role by degradation of extracellular matrix resulting in plaque instability. Cardiotrophin-1 (CT-1), a member of interleukin-6-type proinflammatory cytokines, has potent cardiovascular actions and is highly expressed in vascular endothelium, however its role in atherosclerosis has not been fully elucidated to date. The present study was designed to investigate whether CT-1 induces MMP-1 in human aortic endothelial cells (HAECs). Ribonuclease protection assay demonstrated that MMP-1 gene level in HAECs was enhanced by the treatment of CT-1 in a dose-and time-dependent manner. Immunocytochemical staining, Western immunoblot analysis and enzyme-linked immunosorbent assay revealed that CT-1 augmented MMP-1 protein synthesis and secretion. MMP-1 activity assay revealed that MMP-1 present in the supernatant of HAECs was exclusively precursor form. Casein zymography disclosed proteolytic activity in the supernatant of HAECs, which was enhanced by CT-1 treatment. Furthermore, pharmacological inhibitor study indicated the important roles of extracellular signal-regulated kinase (ERK) 1/2, p38 mitogen-activated protein (MAP) kinase, c-Jun N-terminal kinase (JNK) and Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways in mediating CT-1-induced MMP-1 gene and protein expression. These data reveal for the first time that CT-1 induces the proteolytic potential in HAECs by upregulating MMP-1 expression through ERK1/2, p38 MAP kinase, JNK and JAK/STAT pathways, and suggest that CT-1 may play an important role in the pathophysiology of atherosclerosis and plaque instability.	[Tokito, Akinori; Jougasaki, Michihisa; Ichiki, Tomoko] Natl Hosp Org, Kagoshima Med Ctr, Inst Clin Res, Kagoshima, Japan; [Hamasaki, Shuichi] Kagoshima Univ, Grad Sch Med, Dept Cardiovasc Resp & Metab Med, Kagoshima 890, Japan	Kagoshima University	Jougasaki, M (corresponding author), Natl Hosp Org, Kagoshima Med Ctr, Inst Clin Res, Kagoshima, Japan.	jougasaki@kagomc2.hosp.go.jp		Tokito, Akinori/0000-0002-3848-8780	National Hospital Organization Collaborative Clinical Research	National Hospital Organization Collaborative Clinical Research	The present study was supported by a grant from National Hospital Organization Collaborative Clinical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2012, CELL BIOL INT, V36, P367, DOI 10.1042/CBI20110150; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Demyanets S, 2012, VASC PHARMACOL, V56, P34, DOI 10.1016/j.vph.2011.12.004; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Fritzenwanger M, 2006, CYTOKINE, V36, P101, DOI 10.1016/j.cyto.2006.10.015; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Ichiki T, 2008, AM J PHYSIOL-HEART C, V294, pH750, DOI 10.1152/ajpheart.00161.2007; Jougasaki M, 2002, PEPTIDES, V23, P1441, DOI 10.1016/S0196-9781(02)00078-5; Jougasaki M, 1998, HYPERTENSION, V32, P917, DOI 10.1161/01.HYP.32.5.917; Jougasaki M, 2010, ADV CLIN CHEM, V52, P41, DOI 10.1016/S0065-2423(10)52002-X; Kim S, 2008, J LIPID RES, V49, P2571, DOI 10.1194/jlr.M800112-JLR200; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; Laragione T, 2012, MOL MED, V18, P194, DOI 10.2119/molmed.2011.00410; Li WQ, 2001, J IMMUNOL, V166, P3491, DOI 10.4049/jimmunol.166.5.3491; Liao ZH, 2002, CARDIOVASC RES, V53, P902, DOI 10.1016/S0008-6363(01)00531-4; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Montero I, 2006, J AM COLL CARDIOL, V47, P1369, DOI 10.1016/j.jacc.2005.10.070; Nagata T, 2003, ARTERIOSCL THROM VAS, V23, P588, DOI 10.1161/01.ATV.0000060891.31516.24; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Ruixing Yin, 2004, J Med Invest, V51, P29; Sakata K, 2010, CIRC J, V74, P1670, DOI 10.1253/circj.CJ-09-0980; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Talwar S, 2000, HEART, V84, P421, DOI 10.1136/heart.84.4.421; Tsuruda T, 2002, CIRC RES, V90, P128, DOI 10.1161/hh0202.103613; Turner NA, 2010, MATRIX BIOL, V29, P613, DOI 10.1016/j.matbio.2010.06.007; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Weiss TW, 2005, J MOL CELL CARDIOL, V39, P545, DOI 10.1016/j.yjmcc.2005.03.015; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Zhu Y, 2000, J CARDIOVASC PHARM, V36, P152, DOI 10.1097/00005344-200008000-00003	37	10	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68801	10.1371/journal.pone.0068801	http://dx.doi.org/10.1371/journal.pone.0068801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935888	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000036
J	Kanwal, S; Fardini, Y; Pagesy, P; N'Tumba-Byn, T; Pierre-Eugene, C; Masson, E; Hampe, C; Issad, T				Kanwal, Shahzina; Fardini, Yann; Pagesy, Patrick; N'Tumba-Byn, Thierry; Pierre-Eugene, Cecile; Masson, Elodie; Hampe, Cornelia; Issad, Tarik			O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor alpha Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells	PLOS ONE			English	Article							LINKED N-ACETYLGLUCOSAMINE; TYROSINE-PHOSPHATASE 1B; TRANSCRIPTION FACTORS; GLCNAC MODIFICATION; INSULIN-RECEPTOR; GENE-TRANSCRIPTION; FOXO1 INCREASES; CYCLE ARREST; C-MYC; SP1	O-GlcNAcylation (addition of N-acetyl-glucosamine on serine or threonine residues) is a post-translational modification that regulates stability, activity or localization of cytosolic and nuclear proteins. O-linked N-acetylgluocosmaine transferase (OGT) uses UDP-GlcNAc, produced in the hexosamine biosynthetic pathway to O-GlcNacylate proteins. Removal of O-GlcNAc from proteins is catalyzed by the beta-N-Acetylglucosaminidase (OGA). Recent evidences suggest that O-GlcNAcylation may affect the growth of cancer cells. However, the consequences of O-GlcNAcylation on anti-cancer therapy have not been evaluated. In this work, we studied the effects of O-GlcNAcylation on tamoxifen-induced cell death in the breast cancer-derived MCF-7 cells. Treatments that increase O-GlcNAcylation (PUGNAc and/or glucosoamine) protected MCF-7 cells from death induced by tamoxifen. In contrast, inhibition of OGT expression by siRNA potentiated the effect of tamoxifen on cell death. Since the PI-3 kinase/Akt pathway is a major regulator of cell survival, we used BRET to evaluate the effect of PUGNAc+glucosamine on PIP3 production. We observed that these treatments stimulated PIP3 production in MCF-7 cells. This effect was associated with an increase in Akt phosphorylation. However, the PI-3 kinase inhibitor LY294002, which abolished the effect of PUGNAc+glucosamine on Akt phosphorylation, did not impair the protective effects of PUGNAc+glucosamine against tamoxifen-induced cell death. These results suggest that the protective effects of O-GlcNAcylation are independent of the PI-3 kinase/Akt pathway. As tamoxifen sensitivity depends on the estrogen receptor (ER alpha) expression level, we evaluated the effect of PUGNAc+glucosamine on the expression of this receptor. We observed that O-GlcNAcylation-inducing treatment significantly reduced the expression of ER alpha mRNA and protein, suggesting a potential mechanism for the decreased tamoxifen sensitivity induced by these treatments. Therefore, our results suggest that inhibition of O-GlcNAcylation may constitute an interesting approach to improve the sensitivity of breast cancer to anti-estrogen therapy.	[Kanwal, Shahzina; Fardini, Yann; Pagesy, Patrick; N'Tumba-Byn, Thierry; Pierre-Eugene, Cecile; Masson, Elodie; Hampe, Cornelia; Issad, Tarik] Univ Paris 05, Inst Cochin, CNRS UMR8104, Paris, France; [Kanwal, Shahzina; Fardini, Yann; Pagesy, Patrick; N'Tumba-Byn, Thierry; Pierre-Eugene, Cecile; Masson, Elodie; Hampe, Cornelia; Issad, Tarik] INSERM, U1016, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Issad, T (corresponding author), Univ Paris 05, Inst Cochin, CNRS UMR8104, Paris, France.	tarik.issad@inserm.fr	Pagesy, Patrick/GLN-4814-2022; Pagesy, Patrick/M-9345-2017	Pagesy, Patrick/0000-0002-6153-8926; Issad, Tarik/0000-0002-2638-6330; MASSON, Elodie/0000-0001-6312-0913; Hampe, Christiane/0000-0001-9111-6671	Higher Education Commission of Pakistan; French Centre National de la Recherche Scientifique [9ADO1204/1B1BIOCE]; Agence Nationale de la Recherche grant (ANR Genopath Diab-O-Glyc); Association pour la Recherche sur le Cancer [1069]; "Ligue contre le Cancer" (Comite de Paris) [RS10/75-46]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche grant (ANR Genopath Diab-O-Glyc)(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); "Ligue contre le Cancer" (Comite de Paris)(Ligue nationale contre le cancer)	SK was supported by a grant of the Higher Education Commission of Pakistan and by the French Centre National de la Recherche Scientifique, Ressources propres: Grant no 9ADO1204/1B1BIOCE. YF, EM and CPE were supported by an Agence Nationale de la Recherche grant (ANR Genopath Diab-O-Glyc). This work was supported by the "Association pour la Recherche sur le Cancer" (Grant no 1069) and the "Ligue contre le Cancer" (Comite de Paris, Grant no RS10/75-46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Boubekeur S, 2011, J BIOL CHEM, V286, P19373, DOI 10.1074/jbc.M111.222984; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; Clark AS, 2002, MOL CANCER THER, V1, P707; deGraffenried LA, 2004, BREAST CANCER RES TR, V85, P111, DOI 10.1023/B:BREA.0000025398.93829.78; Dogan S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1840; Dossus L, 2008, BEST PRACT RES CL EN, V22, P551, DOI 10.1016/j.beem.2008.08.003; Gillette CA, 1997, CARCINOGENESIS, V18, P1183, DOI 10.1093/carcin/18.6.1183; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HORWITZ KB, 1978, J BIOL CHEM, V253, P8185; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KIANG DT, 1989, CANCER RES, V49, P5312; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Kwei KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046518; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Laios I, 2003, J STEROID BIOCHEM, V87, P207, DOI 10.1016/j.jsbmb.2003.09.011; Lefebvre T, 2004, EUR J BIOCHEM, V271, P3843, DOI 10.1111/j.1432-1033.2004.04316.x; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Lim K, 2010, BIOSCI BIOTECH BIOCH, V74, P1668, DOI 10.1271/bbb.100289; Lim K, 2010, BIOCHEM BIOPH RES CO, V393, P314, DOI 10.1016/j.bbrc.2010.01.128; Lim K, 2009, BIOCHEM BIOPH RES CO, V382, P593, DOI 10.1016/j.bbrc.2009.03.075; Lim K, 2009, BIOCHEM BIOPH RES CO, V380, P569, DOI 10.1016/j.bbrc.2009.01.121; Lim K, 2009, FEBS LETT, V583, P512, DOI 10.1016/j.febslet.2008.12.007; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Mabuchi S, 2004, ENDOCRINOLOGY, V145, P1302, DOI 10.1210/en.2003-0709; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; NARDELLI G B, 1986, European Journal of Gynaecological Oncology, V7, P151; NARDELLI G B, 1988, European Journal of Gynaecological Oncology, V9, P54; Nouaille S, 2006, EMBO REP, V7, P512, DOI 10.1038/sj.embor.7400668; Olivier-Van Stichelen S, 2011, AM J PHYSIOL-ENDOC M, V302, pE417; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Pichard C, 2008, MATURITAS, V60, P19, DOI 10.1016/j.maturitas.2008.03.002; Pierre-Eugene C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041992; Ronski K, 2005, CANCER-AM CANCER SOC, V104, P925, DOI 10.1002/cncr.21262; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Strobel A, 1999, DIABETOLOGIA, V42, P527, DOI 10.1007/s001250051190; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Vendrell JA, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2158; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zhu Q, 2010, MED ONCOL, V29, P985	64	50	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2013	8	7							e69150	10.1371/journal.pone.0069150	http://dx.doi.org/10.1371/journal.pone.0069150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188UA	23935944	Green Published, Green Submitted, gold			2022-12-27	WOS:000322218800067
J	Adisetiyo, H; Liang, MM; Liao, CP; Aycock-Williams, A; Cohen, MB; Xu, SL; Neamati, N; Conway, EM; Cheng, CY; Nikitin, AY; Roy-Burman, P				Adisetiyo, Helty; Liang, Mengmeng; Liao, Chun-Peng; Aycock-Williams, Ari; Cohen, Michael B.; Xu, Shili; Neamati, Nouri; Conway, Edward M.; Cheng, Chieh-Yang; Nikitin, Alexander Yu.; Roy-Burman, Pradip			Loss of Survivin in the Prostate Epithelium Impedes Carcinogenesis in a Mouse Model of Prostate Adenocarcinoma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; ONCOGENE-INDUCED SENESCENCE; RB DEFICIENCY; CANCER CELLS; APOPTOSIS; EXPRESSION; PTEN; PHOSPHORYLATION; TUMORIGENESIS; INHIBITION	The inhibitor of apoptosis protein survivin is expressed in most cancers. Using the conditional PTEN deletion mouse model, we previously reported that survivin levels increase with prostate tumor growth. Here we evaluated the functional role of survivin in prostate tumor growth. First, we demonstrated that mice lacking the survivin gene in prostate epithelium were fertile and had normal prostate growth and development. We then serially, from about 1056 weeks of age, evaluated histopathologic changes in the prostate of mice with PTEN deletion combined with survivin mono- or bi-allelic gene deletion. While within this time period most of the animals with wild-type or monoallelic survivin deletion developed adenocarcinomas, the most severe lesions in the biallelic survivin deleted mice were high-grade prostatic intra-epithelial neoplasia with distinct histopathology. Many atypical cells contained large hypertrophic cytoplasm and desmoplastic reaction in the prostatic intra-epithelial neoplasia lesions of this group was minimal until the late ages. A reduced proliferation index as well as apoptotic and senescent cells were detected in the lesions of mice with compound PTEN/survivin deficiency throughout the time points examined. Survivin deletion was also associated with reduced tumor expression of another inhibitor of apoptosis member, the X-linked inhibitor of apoptosis. Our findings suggest that survivin participates in the progression of prostatic intraepithelial neoplasia to adenocarcinoma, and that survivin interference at the prostatic intraepithelial neoplasia stages may be a potential therapeutic strategy to halt or delay further progression.	[Adisetiyo, Helty; Roy-Burman, Pradip] Univ So Calif, Genet Mol & Cellular Biol Grad Program, Los Angeles, CA 90089 USA; [Liang, Mengmeng; Liao, Chun-Peng; Aycock-Williams, Ari; Roy-Burman, Pradip] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Cohen, Michael B.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Xu, Shili; Neamati, Nouri] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Conway, Edward M.] Univ British Columbia, Ctr Blood Res, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Cheng, Chieh-Yang; Nikitin, Alexander Yu.] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA	University of Southern California; University of Southern California; Utah System of Higher Education; University of Utah; University of Southern California; University of British Columbia; Cornell University	Roy-Burman, P (corresponding author), Univ So Calif, Genet Mol & Cellular Biol Grad Program, Los Angeles, CA 90089 USA.	royburma@usc.edu	Xu, Shili/H-4820-2015	Xu, Shili/0000-0002-4933-8673; Conway, Edward/0000-0003-0081-0305; Liao, Chun-Peng/0000-0001-8920-4322	National Cancer Institute of the National Institutes of Health [R01CA059705, R01CA113392, R01CA096823]; California Institute for Regenerative Medicine training grant [TG2-01161]; Canadian Institutes of Health Research; Canada Foundations for Innovation; NATIONAL CANCER INSTITUTE [R01CA113392, R01CA059705, R01CA096823] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute for Regenerative Medicine training grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundations for Innovation(Canada Foundation for Innovation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA059705 and R01CA113392 (to PRB), and number R01CA096823 (to AYN), and, in part, by California Institute for Regenerative Medicine training grant TG2-01161 (HA). EMC is supported by the Canadian Institutes of Health Research and the Canada Foundations for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1998, J BIOL CHEM, V273, P11177, DOI 10.1074/jbc.273.18.11177; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Bandyopadhyay D, 2005, CURRENT PROTOC CELL, V18, P1; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866; Carrasco RA, 2011, MOL CANCER THER, V10, P221, DOI 10.1158/1535-7163.MCT-10-0756; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheung CHA, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-36; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Couto SS, 2009, DIFFERENTIATION, V77, P103, DOI 10.1016/j.diff.2008.09.010; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Kanwar JR, 2001, J NATL CANCER I, V93, P1541, DOI 10.1093/jnci/93.20.1541; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Liao CP, 2007, CANCER RES, V67, P7525, DOI 10.1158/0008-5472.CAN-07-0668; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xing Z, 2003, T CELL DEV MATURATIO, V99, P69; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yang SX, 2005, CANCER RES, V65, P5769, DOI 10.1158/0008-5472.CAN-05-0289; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	43	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69484	10.1371/journal.pone.0069484	http://dx.doi.org/10.1371/journal.pone.0069484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936028	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700029
J	Denham, J; Nelson, CP; O'Brien, BJ; Nankervis, SA; Denniff, M; Harvey, JT; Marques, FZ; Codd, V; Zukowska-Szczechowska, E; Samani, NJ; Tomaszewski, M; Charchar, FJ				Denham, Joshua; Nelson, Christopher P.; O'Brien, Brendan J.; Nankervis, Scott A.; Denniff, Matthew; Harvey, Jack T.; Marques, Francine Z.; Codd, Veryan; Zukowska-Szczechowska, Ewa; Samani, Nilesh J.; Tomaszewski, Maciej; Charchar, Fadi J.			Longer Leukocyte Telomeres Are Associated with Ultra-Endurance Exercise Independent of Cardiovascular Risk Factors	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; LENGTH; MEN; MORTALITY; CAPACITY; HEALTHY	Telomere length is recognized as a marker of biological age, and shorter mean leukocyte telomere length is associated with increased risk of cardiovascular disease. It is unclear whether repeated exposure to ultra-endurance aerobic exercise is beneficial or detrimental in the long-term and whether it attenuates biological aging. We quantified 67 ultra-marathon runners' and 56 apparently healthy males' leukocyte telomere length (T/S ratio) using real-time quantitative PCR. The ultra-marathon runners had 11% longer telomeres (T/S ratio) than controls (ultra-marathon runners: T/S ratio = 3.5 +/- 0.68, controls: T/S ratio = 3.1 +/- 0.41; beta = 0.40, SE = 0.10, P = 1.4x10(-4)) in age-adjusted analysis. The difference remained statistically significant after adjustment for cardiovascular risk factors (P = 2.2x10(-4)). The magnitude of this association translates into 16.2 +/- 0.26 years difference in biological age and approximately 324-648bp difference in leukocyte telomere length between ultra-marathon runners and healthy controls. Neither traditional cardiovascular risk factors nor markers of inflammation/adhesion molecules explained the difference in leukocyte telomere length between ultra-marathon runners and controls. Taken together these data suggest that regular engagement in ultra-endurance aerobic exercise attenuates cellular aging.	[Denham, Joshua; O'Brien, Brendan J.; Nankervis, Scott A.; Harvey, Jack T.; Marques, Francine Z.; Charchar, Fadi J.] Univ Ballarat, Sch Hlth Sci, Mt Helen, Australia; [Nelson, Christopher P.; Denniff, Matthew; Codd, Veryan; Samani, Nilesh J.; Tomaszewski, Maciej; Charchar, Fadi J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Denniff, Matthew; Codd, Veryan; Samani, Nilesh J.; Tomaszewski, Maciej; Charchar, Fadi J.] Glenfield Hosp, Leicester Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England; [Zukowska-Szczechowska, Ewa] Med Univ Silesia, Dept Internal Med Diabetol & Nephrol, Zabrze, Poland	Federation University Australia; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Medical University Silesia	Charchar, FJ (corresponding author), Univ Ballarat, Sch Hlth Sci, Mt Helen, Australia.	f.charchar@ballarat.edu.au	Charchar, Fadi/I-6656-2017; Marques, Francine/AAH-1562-2021; Marques, Francine/AAA-5767-2020	Charchar, Fadi/0000-0002-6164-9941; Marques, Francine/0000-0003-4920-9991; Codd, Veryan/0000-0002-9430-8254; Harvey, Jack/0000-0001-6927-6580; Denham, Joshua/0000-0001-5804-4960; O'Brien, Brendan/0000-0002-6371-1796; Tomaszewski, Maciej/0000-0001-8215-6567; Nankervis, Scott/0000-0003-3455-7424; Nelson, Christopher/0000-0001-8025-2897	LEW Carty Charitable Fund; National Health and Medical Research Council of Australia; British Heart Foundation [PG/12/9/29376]; NIHR; British Heart Foundation	LEW Carty Charitable Fund; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); NIHR(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was funded by the LEW Carty Charitable Fund, the National Health and Medical Research Council of Australia to FJC. MT is supported by British Heart Foundation (PG/12/9/29376). CPN is funded by the NIHR Leicester Cardiovascular BRU and VC and NJS are funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026983; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009; Laye MJ, 2012, J APPL PHYSIOL, V112, P773, DOI 10.1152/japplphysiol.00997.2011; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa; Marcon F, 2012, MUTAGENESIS, V27, P49, DOI 10.1093/mutage/ger056; Mathur S, 2013, J INVEST MED, V61, P613, DOI [10.231/JIM.0b013e3182814cc2, 10.2310/JIM.0b013e3182814cc2]; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Osthus IBO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052769; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Rae DE, 2010, EUR J APPL PHYSIOL, V109, P323, DOI 10.1007/s00421-010-1353-6; Sanchis-Gomar F, 2011, INT J SPORTS MED, V32, P644, DOI 10.1055/s-0031-1271711; Savela S, 2013, EXP GERONTOL, V48, P81, DOI 10.1016/j.exger.2012.02.003; Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Skenderi KP, 2008, EUR J CLIN INVEST, V38, P159, DOI 10.1111/j.1365-2362.2007.01917.x; Tomaszewski M, 2003, ARTERIOSCL THROM VAS, V23, P1640, DOI 10.1161/01.ATV.0000087036.75849.0B; Tomaszewski M, 2004, AM J CARDIOL, V94, P125, DOI 10.1016/j.amjcard.2004.03.043; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Woo J, 2008, ARCH INTERN MED, V168, P2163, DOI 10.1001/archinte.168.19.2163	36	70	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69377	10.1371/journal.pone.0069377	http://dx.doi.org/10.1371/journal.pone.0069377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936000	Green Published, gold			2022-12-27	WOS:000322633700027
J	Liu, H; Patil, HP; de Vries-Idema, J; Wilschut, J; Huckriede, A				Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke			Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100-Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; PROTECTIVE IMMUNITY; DNA VACCINE; TH2 RESPONSES; VIRUS; INDUCTION; ANTIBODY; MEMORY; CELLS; MICE	Vaccines for protection against respiratory infections should optimally induce a mucosal immune response in the respiratory tract in addition to a systemic immune response. However, current parenteral immunization modalities generally fail to induce mucosal immunity, while mucosal vaccine delivery often results in poor systemic immunity. In order to find an immunization strategy which satisfies the need for induction of both mucosal and systemic immunity, we compared local and systemic immune responses elicited by two mucosal immunizations, given either by the intranasal (IN) or the intrapulmonary (IPL) route, with responses elicited by a mucosal prime followed by a systemic boost immunization. The study was conducted in BALB/c mice and the vaccine formulation was an influenza subunit vaccine supplemented with GPI-0100, a saponin-derived adjuvant. While optimal mucosal antibody titers were obtained after two intrapulmonary vaccinations, optimal systemic antibody responses were achieved by intranasal prime followed by intramuscular boost. The latter strategy also resulted in the best T cell response, yet, it was ineffective in inducing nose or lung IgA. Successful induction of secretory IgA, IgG and T cell responses was only achieved with prime-boost strategies involving intrapulmonary immunization and was optimal when both immunizations were given via the intrapulmonary route. Our results underline that immunization via the lungs is particularly effective for priming as well as boosting of local and systemic immune responses.	[Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands	University of Groningen	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands.	a.l.w.huckriede@umcg.nl	Huckriede, Anke/P-3558-2019	Huckriede, Anke/0000-0002-2646-5143	Netherlands Organization for Health Research and Development (ZonMw)	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Financially supported by the Netherlands Organization for Health Research and Development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bice DE, 1996, IMMUNOLOGY, V88, P191, DOI 10.1111/j.1365-2567.1996.tb00004.x; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Cristillo AD, 2011, J GEN VIROL, V92, P128, DOI 10.1099/vir.0.023242-0; Crouch CF, 2005, VET IMMUNOL IMMUNOP, V108, P345, DOI 10.1016/j.vetimm.2005.06.009; de Haan L, 2001, VACCINE, V19, P2898, DOI 10.1016/S0264-410X(00)00556-9; Defang GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048229; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; Geeraedts F, 2010, AAPS J, V12, P215, DOI 10.1208/s12248-010-9179-z; Huang XG, 2007, VACCINE, V25, P8874, DOI 10.1016/j.vaccine.2007.08.066; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052135; Liu H, 2011, VACCINE, V29, P2037, DOI 10.1016/j.vaccine.2011.01.012; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; MASON M J, 1989, Regional Immunology, V2, P149; MASON MJ, 1985, AM REV RESPIR DIS, V132, P657; McCluskie MJ, 2002, FEMS IMMUNOL MED MIC, V32, P179, DOI 10.1016/S0928-8244(01)00305-4; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Park KS, 2009, VIROLOGY, V395, P182, DOI 10.1016/j.virol.2009.09.018; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Ranasinghe C, 2011, VACCINE, V29, P3008, DOI 10.1016/j.vaccine.2011.01.106; Schulte R, 2009, VIROLOGY, V383, P300, DOI 10.1016/j.virol.2008.10.012; Schulze K, 2008, VACCINE, V26, P6678, DOI 10.1016/j.vaccine.2008.09.006; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Vajdy M, 2003, IMMUNOLOGY, V110, P86, DOI 10.1046/j.1365-2567.2003.01711.x; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Vindurampulle CJ, 2004, VACCINE, V22, P3744, DOI 10.1016/j.vaccine.2004.03.025; Yamamoto M, 1996, ANN NY ACAD SCI, V778, P64, DOI 10.1111/j.1749-6632.1996.tb21115.x	40	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69649	10.1371/journal.pone.0069649	http://dx.doi.org/10.1371/journal.pone.0069649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936066	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700036
J	Knapp, B; Kaderali, L				Knapp, Bettina; Kaderali, Lars			Reconstruction of Cellular Signal Transduction Networks Using Perturbation Assays and Linear Programming	PLOS ONE			English	Article							EFFECTS PROPAGATION NETWORKS; CYCLIN-DEPENDENT KINASES; NESTED EFFECTS MODELS; WIDE RNAI SCREEN; PROTEIN ARRAY; PATHWAYS; IDENTIFICATION; GENES; REGULATORS; INFERENCE	Perturbation experiments for example using RNA interference (RNAi) offer an attractive way to elucidate gene function in a high throughput fashion. The placement of hit genes in their functional context and the inference of underlying networks from such data, however, are challenging tasks. One of the problems in network inference is the exponential number of possible network topologies for a given number of genes. Here, we introduce a novel mathematical approach to address this question. We formulate network inference as a linear optimization problem, which can be solved efficiently even for large-scale systems. We use simulated data to evaluate our approach, and show improved performance in particular on larger networks over state-of-the art methods. We achieve increased sensitivity and specificity, as well as a significant reduction in computing time. Furthermore, we show superior performance on noisy data. We then apply our approach to study the intracellular signaling of human primary nave CD4(+) T-cells, as well as ErbB signaling in trastuzumab resistant breast cancer cells. In both cases, our approach recovers known interactions and points to additional relevant processes. In ErbB signaling, our results predict an important role of negative and positive feedback in controlling the cell cycle progression.	[Knapp, Bettina; Kaderali, Lars] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Knapp, Bettina; Kaderali, Lars] Heidelberg Univ, BioQuant, ViroQuant Res Grp Modeling, Heidelberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg	Kaderali, L (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Med Informat & Biometry, D-01062 Dresden, Germany.	lars.kaderali@tu-dresden.de		Kaderali, Lars/0000-0002-2359-2294	German Ministry of Education and Research (BMBF) via ForSys/ViroQuant [0313923]; German Ministry of Education and Research (BMBF) via GerontoSys/AgeNet [0315898]; European Union seventh framework program via SysPatho [260429]; German Research Foundation; Open Access Publication Funds of the TU Dresden	German Ministry of Education and Research (BMBF) via ForSys/ViroQuant(Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research (BMBF) via GerontoSys/AgeNet(Federal Ministry of Education & Research (BMBF)); European Union seventh framework program via SysPatho; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	We acknowledge funding from the German Ministry of Education and Research (BMBF) via ForSys/ViroQuant (grant 0313923) and GerontoSys/AgeNet (grant 0315898), the European Union seventh framework program via SysPatho (grant number 260429), and the German Research Foundation and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Anchang B, 2009, P NATL ACAD SCI USA, V106, P6447, DOI 10.1073/pnas.0809822106; BATES S, 1994, ONCOGENE, V9, P71; Bender C, 2010, BIOINFORMATICS, V26, pi596, DOI 10.1093/bioinformatics/btq385; Bock M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035077; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Charboneau Lu, 2002, Briefings in Functional Genomics & Proteomics, V1, P305, DOI 10.1093/bfgp/1.3.305; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Frohlich H, 2011, BIOINFORMATICS, V27, P238, DOI 10.1093/bioinformatics/btq631; Frohlich H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-322; Frohlich H, 2009, BIOMETRICAL J, V51, P304, DOI 10.1002/bimj.200800185; Frohlich H, 2008, BIOINFORMATICS, V24, P2650, DOI 10.1093/bioinformatics/btm634; Furlong EE, 2005, DEV CELL, V8, P624, DOI 10.1016/j.devcel.2005.04.006; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hashemikhabir S, 2012, IEEE ACM T COMPUT BI; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Kaderali L, 2009, BIOINFORMATICS, V25, P2229, DOI 10.1093/bioinformatics/btp375; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KHACHIIAN LG, 1979, DOKL AKAD NAUK SSSR+, V244, P1093; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lan A, 2011, NUCLEIC ACIDS RES, V39, pW424, DOI 10.1093/nar/gkr359; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Neise D, 2010, CELL CYCLE, V9, P3575, DOI 10.4161/cc.9.17.12799; Ourfali O, 2007, BIOINFORMATICS, V23, pI359, DOI 10.1093/bioinformatics/btm170; R Core Team, 2012, R LANG ENV STAT COMP; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Sachs K, 2009, J COMPUT BIOL, V16, P201, DOI 10.1089/cmb.2008.07TT; Sachs L., 2006, ANGEW STAT METHODENS, V12th ed., DOI [10.1007/978-3-540-32161-3, DOI 10.1007/978-3-540-32161-3]; Schrijver A., 1999, THEORY LINEAR INTEGE; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sutherland RL, 1998, J MAMMARY GLAND BIOL, V3, P63, DOI 10.1023/A:1018774302092; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Theis M, 2011, METHODS, V53, P424, DOI 10.1016/j.ymeth.2010.12.021; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tresch A, 2008, STAT APPL GENET MOL, V7; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	52	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69220	10.1371/journal.pone.0069220	http://dx.doi.org/10.1371/journal.pone.0069220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935958	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200029
J	Fernandez-Santander, A; Gaibar, M; Novillo, A; Romero-Lorca, A; Rubio, M; Chicharro, LM; Tejerina, A; Bandres, F				Fernandez-Santander, Ana; Gaibar, Maria; Novillo, Apolonia; Romero-Lorca, Alicia; Rubio, Margarita; Chicharro, Luis Miguel; Tejerina, Armando; Bandres, Fernando			Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients	PLOS ONE			English	Article							PATIENTS RECEIVING TAMOXIFEN; GENETIC POLYMORPHISMS; SULFOTRANSFERASE SULT1A1; ALLELE FREQUENCIES; ESTROGEN-RECEPTOR; CYP3A5; RISK; ASSOCIATION; SURVIVAL; ENZYMES	Tamoxifen is a pro-drug widely used in breast cancer patients to prevent tumor recurrence. Prior work has revealed a role of cytochrome and sulfotransferase enzymes in tamoxifen metabolism. In this descriptive study, correlations were examined between concentrations of tamoxifen metabolites and genotypes for CYP2D6, CYP3A4, CYP3A5, SULT1A1, SULT1A2 and SULT1E1 in 135 patients with estrogen receptor-positive breast cancer. Patients were genotyped using the Roche-AmpliChip (R) CYP450 Test, and Real-Time and conventional PCR-RFLP. Plasma tamoxifen, 4-hydroxy-tamoxifen, N-desmethyl-tamoxifen, endoxifen and tamoxifen-N-oxide were isolated and quantified using a high-pressure liquid chromatography-tandem mass spectrometry system. Significantly higher endoxifen levels were detected in patients with the wt/wt CYP2D6 compared to the v/v CYP2D6 genotype (p<0.001). No differences were detected in the remaining tamoxifen metabolites among CYP2D6 genotypes. Patients featuring the SULT1A2*2 and SULT1A2*3 alleles showed significantly higher plasma levels of 4-hydroxy-tamoxifen and endoxifen (p = 0.025 and p = 0.006, respectively), as likely substrates of the SULT1A2 enzyme. Our observations indicate that besides the CYP2D6 genotype leading to tamoxifen conversion to potent hydroxylated metabolites in a manner consistent with a gene-dose effect, SULT1A2 also seems to play a role in maintaining optimal levels of both 4-hydroxy-tamoxifen and endoxifen.	[Fernandez-Santander, Ana; Gaibar, Maria; Novillo, Apolonia; Romero-Lorca, Alicia] Univ Europea Madrid, Catedra Florencio Tejerina Univ Europea Madrid, Fac Biomed Sci, Dept Basic Biomed Sci, Madrid, Spain; [Rubio, Margarita] Univ Europea Madrid, Fac Biomed Sci, Dept Appl Med Special Psychol & Educ, Madrid, Spain; [Chicharro, Luis Miguel] Univ Europea Madrid, Fac Hlth Sci, Dept Morphol Sci, Madrid, Spain; [Tejerina, Armando; Bandres, Fernando] Univ Europea Madrid, Sch Adv Studies Catedra Florencio Tejerina, Madrid, Spain	European University of Madrid; European University of Madrid; European University of Madrid; European University of Madrid	Fernandez-Santander, A (corresponding author), Univ Europea Madrid, Catedra Florencio Tejerina Univ Europea Madrid, Fac Biomed Sci, Dept Basic Biomed Sci, Madrid, Spain.	ana.fernandez@uem.es	Gaibar, Maria/AHA-5931-2022; Lorca, Alicia Romero/O-4074-2016; Rubio, Margarita/K-9593-2014; FERNÁNDEZ SANTANDER, ANA/ABT-4005-2022; Novillo, Apolonia/M-7389-2017; Fernandez-Santander, Ana/L-5707-2014; Rubio, Margarita/Q-8825-2018	Lorca, Alicia Romero/0000-0002-1920-034X; Novillo, Apolonia/0000-0003-0902-0991; Fernandez-Santander, Ana/0000-0001-7545-1170; BANDRES MOYA, FERNANDO/0000-0002-4675-8226; , GAIBAR/0000-0003-3881-8345; Rubio, Margarita/0000-0003-2484-1042	Spanish Health Ministry (FIS) [PI07/0416]; Fundacion de Investigacion Medica Mutua Madrilena [AP27072008]; Catedra Florencio Tejerina-UEM; Universidad Europea de Madrid [2011/07]	Spanish Health Ministry (FIS)(Instituto de Salud Carlos IIISpanish Government); Fundacion de Investigacion Medica Mutua Madrilena; Catedra Florencio Tejerina-UEM; Universidad Europea de Madrid	This work has been supported partially by a grant from Spanish Health Ministry (FIS, ref number PI07/0416), a grant from Fundacion de Investigacion Medica Mutua Madrilena (ref number AP27072008), a grant from Catedra Florencio Tejerina-UEM and by Universidad Europea de Madrid (project number 2011/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2003, BRIT J PHARMACOL, V139, P1373, DOI 10.1038/sj.bjp.0705369; Arslan S, 2010, BIOCHEM GENET, V48, P987, DOI 10.1007/s10528-010-9387-3; Arvanitidis K, 2007, FUND CLIN PHARMACOL, V21, P419, DOI 10.1111/j.1472-8206.2007.00510.x; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; Choi JY, 2005, CANCER EPIDEM BIOMAR, V14, P1090, DOI 10.1158/1055-9965.EPI-04-0688; Chu W, 2007, CARCINOGENESIS, V28, P2139, DOI 10.1093/carcin/bgm087; Coughtrie MWH, 1999, BIOCHEM J, V337, P45, DOI 10.1042/0264-6021:3370045; Damodaran SE, 2012, CANCER CHEMOTH PHARM, V70, P75, DOI 10.1007/s00280-012-1891-1; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dunn BK, 2010, INT J MOL EPIDEMIOL, V1, P332; Falany JL, 1996, CANCER RES, V56, P1551; Falany JL, 2006, DRUG METAB DISPOS, V34, P361, DOI 10.1124/dmd.105.006551; Falany JL, 2002, BREAST CANCER RES TR, V74, P167, DOI 10.1023/A:1016147004188; Fernandez-Santander A, 2012, CLIN TRANSL ONCOL, V14, P157, DOI 10.1007/s12094-012-0776-4; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Fleeman N, 2011, HEALTH TECHNOL ASSES, V15, pXIII, DOI 10.3310/hta15330; Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434; GJERDE J, 2010, BMC CANCER, V21, P10; Gjerde J, 2005, 28 ANN SAN ANT BREAS; Glatt H, 2004, N-S ARCH PHARMACOL, V369, P55, DOI 10.1007/s00210-003-0826-0; Hildebrandt M, 2009, PHARMACOGENET GENOM, V19, P404, DOI 10.1097/FPC.0b013e32832e042e; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Keshava C, 2004, AM J EPIDEMIOL, V160, P825, DOI 10.1093/aje/kwh294; Kim KA, 2005, EUR J CLIN PHARMACOL, V61, P743, DOI 10.1007/s00228-005-0989-3; King BP, 2003, BRIT J CLIN PHARMACO, V55, P625, DOI 10.1046/j.1365-2125.2003.01798.x; Kiyotani K, 2012, DRUG METAB PHARMACOK, V27, P122, DOI 10.2133/dmpk.DMPK-11-RV-084; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lee KH, 2003, J CHROMATOGR B, V791, P245, DOI 10.1016/S1570-0232(03)00218-6; Lee SJ, 2005, PHARMACOGENOMICS, V6, P357, DOI 10.1517/14622416.6.4.357; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; Murdter TE, 2011, CLIN PHARMACOL THER, V89, P708, DOI 10.1038/clpt.2011.27; Mugundu GM, 2012, DRUG METAB DISPOS, V40, P389, DOI 10.1124/dmd.111.039388; Nowell S, 2002, J NATL CANCER I, V94, P1635; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Oliveira E, 2007, PHARMACOGENOMICS, V8, P703, DOI 10.2217/14622416.8.7.703; Salameh G, 2012, ENVIRON TOXICOL PHAR, V34, P23, DOI 10.1016/j.etap.2012.01.006; Scordo MG, 2004, PHARMACOL RES, V50, P195, DOI 10.1016/j.phrs.2004.01.004; Sim Sarah C., 2010, Human Genomics, V4, P278; Sistonen J, 2007, PHARMACOGENET GENOM, V17, P93; Spurdle AB, 2002, PHARMACOGENETICS, V12, P355, DOI 10.1097/00008571-200207000-00003; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Tan SH, 2008, CLIN CANCER RES, V14, P8027, DOI 10.1158/1078-0432.CCR-08-0993; Van Schaik RHN, 2002, CLIN CHEM, V48, P1668; van Schaik RHN, 2001, CLIN CHEM, V47, P1104	49	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70183	10.1371/journal.pone.0070183	http://dx.doi.org/10.1371/journal.pone.0070183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922954	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700154
J	Jiang, SY; Ramachandran, S				Jiang, Shu-Ye; Ramachandran, Srinivasan			Genome-Wide Survey and Comparative Analysis of LTR Retrotransposons and Their Captured Genes in Rice and Sorghum	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; EXPRESSION PROFILES; SEQUENCE; MAIZE; ANNOTATION; EVOLUTION; IDENTIFICATION; ARABIDOPSIS; STRATEGIES; DIVERSITY	Long terminal repeat (LTR) retrotransposons are the major class I mobile elements in plants. They play crucial roles in gene expansion, diversification and evolution. However, their captured genes are yet to be genome-widely identified and characterized in most of plants although many genomes have been completely sequenced. In this study, we have identified 7,043 and 23,915 full-length LTR retrotransposons in the rice and sorghum genomes, respectively. High percentages of rice full-length LTR retrotransposons were distributed near centromeric region in each of the chromosomes. In contrast, sorghum full-length LTR retrotransposons were not enriched in centromere regions. This dissimilarity could be due to the discrepant retrotransposition during and after divergence from their common ancestor thus might be contributing to species divergence. A total of 672 and 1,343 genes have been captured by these elements in rice and sorghum, respectively. Gene Ontology (GO) and gene set enrichment analysis (GSEA) showed that no over-represented GO term was identified in LTR captured rice genes. For LTR captured sorghum genes, GO terms with functions in DNA/RNA metabolism and chromatin organization were over-represented. Only 36% of LTR captured rice genes were expressed and expression divergence was estimated as 11.9%. Higher percentage of LTR captured rice genes have evolved into pseudogenes under neutral selection. On the contrary, higher percentage of LTR captured sorghum genes were under purifying selection and 72.4% of them were expressed. Thus, higher percentage of LTR captured sorghum genes was functional. Small RNA analysis suggested that some of LTR captured genes in rice and sorghum might have been involved in negative regulation. On the other hand, positive selection has been observed in both rice and sorghum LTR captured genes and some of them were still expressed and functional. The data suggest that some of these LTR captured genes might have evolved into new gene functions.	[Jiang, Shu-Ye; Ramachandran, Srinivasan] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Ramachandran, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	sri@tll.org.sg		Jiang, Shu-Ye/0000-0003-4867-2335	Temasek Life Sciences Laboratory (Singapore); Singapore National Research Foundation [NRF-CRP7-2010-02]	Temasek Life Sciences Laboratory (Singapore)(National University of Singapore); Singapore National Research Foundation(National Research Foundation, Singapore)	This research was supported by Temasek Life Sciences Laboratory (Singapore) and by the Singapore National Research Foundation under the Competitive Research Programme Funding Scheme (CRP Award No. NRF-CRP7-2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Baucom RS, 2009, GENOME RES, V19, P243, DOI 10.1101/gr.083360.108; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Birchler JA, 2012, GENE DEV, V26, P638, DOI 10.1101/gad.191049.112; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Elrouby N, 2010, PLANT PHYSIOL, V153, P1413, DOI 10.1104/pp.110.157420; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032010; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hanada K, 2009, PLANT CELL, V21, P25, DOI 10.1105/tpc.108.063206; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jiang SY, 2009, PLANT PHYSIOL, V150, P1997, DOI 10.1104/pp.109.139402; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Nagaki K, 2003, GENETICS, V163, P759; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang YJ, 2005, PLANT PHYSIOL, V138, P935, DOI 10.1104/pp.105.060244	37	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71118	10.1371/journal.pone.0071118	http://dx.doi.org/10.1371/journal.pone.0071118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923055	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700227
J	Markussen, T; Dahle, MK; Tengs, T; Lovoll, M; Finstad, OW; Wiik-Nielsen, CR; Grove, S; Lauksund, S; Robertsen, B; Rimstad, E				Markussen, Turhan; Dahle, Maria K.; Tengs, Torstein; Lovoll, Marie; Finstad, Oystein W.; Wiik-Nielsen, Christer R.; Grove, Soren; Lauksund, Silje; Robertsen, Borre; Rimstad, Espen			Sequence Analysis of the Genome of Piscine Orthoreovirus (PRV) Associated with Heart and Skeletal Muscle Inflammation (HSMI) in Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							CELL-ATTACHMENT PROTEIN; DOUBLE-STRANDED-RNA; GRASS CARP REOVIRUS; FACTORY-LIKE INCLUSIONS; CENTRAL-NERVOUS-SYSTEM; AMINO-TERMINAL REGION; OUTER-CAPSID PROTEINS; LAMBDA 1 PROTEIN; AVIAN REOVIRUS; MU-NS	Piscine orthoreovirus (PRV) is associated with heart-and skeletal muscle inflammation (HSMI) of farmed Atlantic salmon (Salmo salar). We have performed detailed sequence analysis of the PRV genome with focus on putative encoded proteins, compared with prototype strains from mammalian (MRV T3D)- and avian orthoreoviruses (ARV-138), and aquareovirus (GCRV-873). Amino acid identities were low for most gene segments but detailed sequence analysis showed that many protein motifs or key amino acid residues known to be central to protein function are conserved for most PRV proteins. For M-class proteins this included a proline residue in mu 2 which, for MRV, has been shown to play a key role in both the formation and structural organization of virus inclusion bodies, and affect interferon-beta signaling and induction of myocarditis. Predicted structural similarities in the inner core-forming proteins lambda 1 and sigma 2 suggest a conserved core structure. In contrast, low amino acid identities in the predicted PRV surface proteins mu 1, sigma 1 and sigma 3 suggested differences regarding cellular interactions between the reovirus genera. However, for s1, amino acid residues central for MRV binding to sialic acids, and cleavage- and myristoylation sites in m1 required for endosomal membrane penetration during infection are partially or wholly conserved in the homologous PRV proteins. In PRV s3 the only conserved element found was a zinc finger motif. We provide evidence that the S1 segment encoding sigma 3 also encodes a 124 aa (p13) protein, which appears to be localized to intracellular Golgi-like structures. The S2 and L2 gene segments are also potentially polycistronic, predicted to encode a 71 aa-(p8) and a 98 aa (p11) protein, respectively. It is concluded that PRV has more properties in common with orthoreoviruses than with aquareoviruses.	[Markussen, Turhan; Dahle, Maria K.; Tengs, Torstein; Lovoll, Marie; Wiik-Nielsen, Christer R.; Grove, Soren] Natl Vet Inst, Dept Lab Serv, Oslo, Norway; [Lauksund, Silje; Robertsen, Borre] Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway; [Finstad, Oystein W.; Rimstad, Espen] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian Veterinary Institute; UiT The Arctic University of Tromso; Norwegian University of Life Sciences	Rimstad, E (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	espen.rimstad@nvh.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X	Norwegian Research Council of Norway [186907, 183196/S40]; Strategic Internal Research programme at the National Veterinary Institute, Norway [31002]	Norwegian Research Council of Norway(Research Council of Norway); Strategic Internal Research programme at the National Veterinary Institute, Norway	This work was supported by the Norwegian Research Council of Norway grant nos. 186907 and 183196/S40, and the Strategic Internal Research programme no. 31002 at the National Veterinary Institute, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; BARTLETT JA, 1988, VIROLOGY, V167, P31, DOI 10.1016/0042-6822(88)90051-7; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bergan V, 2006, FEBS J, V273, P3893, DOI 10.1111/j.1742-4658.2006.05382.x; Bisaillon M, 1997, J BIOL CHEM, V272, P18298, DOI 10.1074/jbc.272.29.18298; Bisaillon M, 1999, VIRUS GENES, V18, P13, DOI 10.1023/A:1008013117929; Bisaillon M, 1997, J BIOL CHEM, V272, P29954, DOI 10.1074/jbc.272.47.29954; Bisaillon M, 1997, VIRUS RES, V51, P231, DOI 10.1016/S0168-1702(97)00092-0; Bodelon G, 2001, VIROLOGY, V290, P181, DOI 10.1006/viro.2001.1159; Boehme KW, 2011, J VIROL, V85, P11781, DOI 10.1128/JVI.02289-10; Boehme KW, 2009, P NATL ACAD SCI USA, V106, P19986, DOI 10.1073/pnas.0907412106; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Brentano L, 1998, J VIROL, V72, P8354, DOI 10.1128/JVI.72.10.8354-8357.1998; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Broering TJ, 2000, J VIROL, V74, P5516, DOI 10.1128/JVI.74.12.5516-5524.2000; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cai L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-168; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Chappell JD, 2000, J VIROL, V74, P8472, DOI 10.1128/JVI.74.18.8472-8479.2000; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; CHAPPELL JD, 1994, J VIROL, V68, P750, DOI 10.1128/JVI.68.2.750-756.1994; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; Chulu JLC, 2010, J VIROL, V84, P7683, DOI 10.1128/JVI.02604-09; CLEVELAND DR, 1986, J VIROL, V60, P307, DOI 10.1128/JVI.60.1.307-311.1986; Coombs KM, 1998, VIROLOGY, V243, P218, DOI 10.1006/viro.1998.9061; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; DERMODY TS, 1990, J VIROL, V64, P5173, DOI 10.1128/JVI.64.10.5173-5176.1990; DERMODY TS, 1991, J VIROL, V65, P5721, DOI 10.1128/JVI.65.11.5721-5731.1991; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; ERNST H, 1985, P NATL ACAD SCI USA, V82, P48, DOI 10.1073/pnas.82.1.48; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; FAUSNAUGH J, 1990, J BIOL CHEM, V265, P7669; FRASER RDB, 1990, J VIROL, V64, P2990, DOI 10.1128/JVI.64.6.2990-3000.1990; FURUICHI Y, 1976, J BIOL CHEM, V251, P5043; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; Gillian AL, 1998, VIROLOGY, V240, P1, DOI 10.1006/viro.1997.8905; Gonzalez-Lopez C, 2003, J GEN VIROL, V84, P1629, DOI 10.1099/vir.0.19004-0; Grande A, 2002, J GEN VIROL, V83, P131, DOI 10.1099/0022-1317-83-1-131; Guardado-Calvo P, 2008, J VIROL, V82, P11208, DOI 10.1128/JVI.00733-08; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Harrison SJ, 1999, VIROLOGY, V258, P54, DOI 10.1006/viro.1999.9707; Hoyt CC, 2005, J VIROL, V79, P2743, DOI 10.1128/JVI.79.5.2743-2753.2005; Hsiao J, 2002, VIROLOGY, V296, P288, DOI 10.1006/viro.2002.1427; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; Irvin SC, 2012, J VIROL, V86, P2302, DOI 10.1128/JVI.06236-11; Ivanovic T, 2011, TRAFFIC, V12, P1179, DOI 10.1111/j.1600-0854.2011.01233.x; JAYASURIYA AK, 1988, VIROLOGY, V163, P591, DOI 10.1016/0042-6822(88)90300-5; John KR, 2001, DIS AQUAT ORGAN, V46, P83, DOI 10.3354/dao046083; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Ke F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-323; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kim J, 2004, VIRUS RES, V101, P15, DOI 10.1016/j.virusres.2003.12.003; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; LEMAY G, 1994, J GEN VIROL, V75, P3261, DOI 10.1099/0022-1317-75-11-3261; LI JKK, 1980, VIROLOGY, V105, P41, DOI 10.1016/0042-6822(80)90154-3; Lovoll M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-309; LUCIAJANDRIS P, 1993, J VIROL, V67, P5339, DOI 10.1128/JVI.67.9.5339-5345.1993; Luongo CL, 1998, J BIOL CHEM, V273, P23773, DOI 10.1074/jbc.273.37.23773; Luongo CL, 2000, J BIOL CHEM, V275, P2804, DOI 10.1074/jbc.275.4.2804; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MAO ZX, 1991, VIROLOGY, V185, P377, DOI 10.1016/0042-6822(91)90785-A; Martinez-Costas J, 2000, J VIROL, V74, P1124, DOI 10.1128/JVI.74.3.1124-1131.2000; MARTINEZCOSTAS J, 1995, VIROLOGY, V206, P1017, DOI 10.1006/viro.1995.1024; MartinezCostas J, 1997, J VIROL, V71, P59; MCCRAE MA, 1978, VIROLOGY, V89, P578, DOI 10.1016/0042-6822(78)90199-X; McCutcheon AM, 1999, VIROLOGY, V264, P16, DOI 10.1006/viro.1999.9990; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Mohd JF, 2008, VIROLOGY, V373, P310, DOI 10.1016/J.VIROL.2007.12.006; MORA M, 1987, VIROLOGY, V159, P265, DOI 10.1016/0042-6822(87)90464-8; MOROZOV SY, 1989, NUCLEIC ACIDS RES, V17, P5394, DOI 10.1093/nar/17.13.5394; MUSTOE TA, 1978, VIROLOGY, V89, P594, DOI 10.1016/0042-6822(78)90200-3; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1990, J VIROL, V64, P2976, DOI 10.1128/JVI.64.6.2976-2989.1990; Noad L, 2006, VIRUS RES, V116, P45, DOI 10.1016/j.virusres.2005.08.014; Noble S, 1997, J VIROL, V71, P2182, DOI 10.1128/JVI.71.3.2182-2191.1997; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poggioli GJ, 2000, J VIROL, V74, P9562, DOI 10.1128/JVI.74.20.9562-9570.2000; Qiu T, 2003, VIROLOGY, V316, P313, DOI 10.1016/j.virol.2003.08.027; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Reiter DM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002166; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RICHARDSON MA, 1983, NUCLEIC ACIDS RES, V11, P6399, DOI 10.1093/nar/11.18.6399; SCHIFF LA, 1988, MOL CELL BIOL, V8, P273, DOI 10.1128/MCB.8.1.273; SCHIFF LA, 2007, FIELDS VIROLOGY, P1853; SCHNITZER TJ, 1982, J VIROL, V43, P1006, DOI 10.1128/JVI.43.3.1006-1014.1982; SHAPOURI MRS, 1995, J GEN VIROL, V76, P1515, DOI 10.1099/0022-1317-76-6-1515; Shaw AL, 1996, STRUCTURE, V4, P957, DOI 10.1016/S0969-2126(96)00102-5; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; SILVERSTEIN SC, 1972, VIROLOGY, V47, P797, DOI 10.1016/0042-6822(72)90571-5; STRONG JE, 1991, VIROLOGY, V184, P23, DOI 10.1016/0042-6822(91)90818-V; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Su YP, 2007, J GEN VIROL, V88, P1797, DOI 10.1099/vir.0.82592-0; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; Touris-Otero F, 2005, J GEN VIROL, V86, P1159, DOI 10.1099/vir.0.80491-0; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; TYLER KL, 1993, J VIROL, V67, P3446, DOI 10.1128/JVI.67.6.3446-3453.1993; VARELA R, 1994, J VIROL, V68, P6775, DOI 10.1128/JVI.68.10.6775-6777.1994; Varela R, 1996, J VIROL, V70, P2974, DOI 10.1128/JVI.70.5.2974-2981.1996; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; WEINER HL, 1980, J INFECT DIS, V141, P609, DOI 10.1093/infdis/141.5.609; WEINER HL, 1980, J IMMUNOL, V124, P2143; WIENER JR, 1989, VIROLOGY, V169, P293, DOI 10.1016/0042-6822(89)90154-2; WIENER JR, 1988, VIROLOGY, V163, P603, DOI 10.1016/0042-6822(88)90301-7; WIENER JR, 1989, VIROLOGY, V169, P194, DOI 10.1016/0042-6822(89)90055-X; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xu WH, 2009, VIRUS RES, V144, P44, DOI 10.1016/j.virusres.2009.03.020; Xu WH, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-153; Yin HS, 1997, J VIROL METHODS, V67, P93, DOI 10.1016/S0166-0934(97)00080-3; Yin HS, 2000, VIROLOGY, V266, P33, DOI 10.1006/viro.1999.0020; Yin P, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-6; ZOU S, 1992, VIROLOGY, V186, P377, DOI 10.1016/0042-6822(92)90003-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	150	51	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70075	10.1371/journal.pone.0070075	http://dx.doi.org/10.1371/journal.pone.0070075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922911	Green Published, gold			2022-12-27	WOS:000323369700130
J	Mishra, A; Afik, O; Cabrera, ML; Delaplane, KS; Mowrer, JE				Mishra, Archana; Afik, Ohad; Cabrera, Miguel L.; Delaplane, Keith S.; Mowrer, Jason E.			Inorganic Nitrogen Derived from Foraging Honey Bees Could Have Adaptive Benefits for the Plants They Visit	PLOS ONE			English	Article							MINERALIZATION	In most terrestrial ecosystems, nitrogen (N) is the most limiting nutrient for plant growth. Honey bees may help alleviate this limitation because their feces (frass) have high concentration of organic nitrogen that may decompose in soil and provide inorganic N to plants. However, information on soil N processes associated with bee frass is not available. The objectives of this work were to 1) estimate the amount of bee frass produced by a honey bee colony and 2) evaluate nitrogen mineralization and ammonia volatilization from bee frass when surface applied or incorporated into soil. Two cage studies were conducted to estimate the amount of frass produced by a 5000-bee colony, and three laboratory studies were carried out in which bee frass, surface-applied or incorporated into soil, was incubated at 25 degrees C for 15 to 45 days. The average rate of bee frass production by a 5,000-bee colony was estimated at 2.27 to 2.69 g N month(-1). Nitrogen mineralization from bee frass during 30 days released 20% of the organic N when bee frass was surface applied and 34% when frass was incorporated into the soil. Volatilized NH3 corresponded to 1% or less of total N. The potential amount of inorganic N released to the soil by a typical colony of 20,000 bees foraging in an area similar to that of the experimental cages (3.24 m(2)) was estimated at 0.62 to 0.74 g N m(-2) month(-1) which may be significant at a community scale in terms of soil microbial activity and plant growth. Thus, the deposition of available N by foraging bees could have adaptive benefits for the plants they visit, a collateral benefit deriving from the primary activity of pollination.	[Mishra, Archana; Cabrera, Miguel L.; Mowrer, Jason E.] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Afik, Ohad; Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Cabrera, ML (corresponding author), Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA.	mcabrera@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	University of Georgia Agricultural Experiment Station; Vaadia-BARD postdoctoral fellowship from Binational Agricultural Research and Development Fund (BARD) [FI-407-2008]; United States-Israel Binational Agricultural Research and Development Fund	University of Georgia Agricultural Experiment Station; Vaadia-BARD postdoctoral fellowship from Binational Agricultural Research and Development Fund (BARD); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation)	This research was supported by funds from the University of Georgia Agricultural Experiment Station and from the Vaadia-BARD postdoctoral fellowship FI-407-2008 from Binational Agricultural Research and Development Fund (BARD), the United States-Israel Binational Agricultural Research and Development Fund (O.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1965, J EXP BIOL, V43, P535; BURSELL E., 1965, J INSECT PHYSIOL, V11, P993, DOI 10.1016/0022-1910(65)90202-7; Cabrera ML, 2005, J ENVIRON QUAL, V34, P75, DOI 10.2134/jeq2005.0075; CROOKE WM, 1971, J SCI FOOD AGR, V22, P9, DOI 10.1002/jsfa.2740220104; DEMANCHE JM, 1973, LIMNOL OCEANOGR, V18, P686, DOI 10.4319/lo.1973.18.4.0686; Egelkraut TM, 2003, NUTR CYCL AGROECOSYS, V66, P1, DOI 10.1023/A:1023306500473; Frost CJ, 2004, ECOLOGY, V85, P3335, DOI 10.1890/04-0003; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; Gordillo RM, 1997, J ENVIRON QUAL, V26, P1672, DOI 10.2134/jeq1997.00472425002600060030x; Havlin JL., 2005, SOIL FERTILITY FERTI, V7th; Kagata H, 2012, POPUL ECOL, V54, P75, DOI 10.1007/s10144-011-0281-6; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; Kissel DE, 2009, SOIL SCI SOC AM J, V73, P630, DOI 10.2136/sssaj2007.0377; Kissel D.E., 2005, ENCY SOILS ENV, P56, DOI [10.1016/B0-12-348530-4/00177-6, DOI 10.1016/B0-12-348530-4/00177-6]; LOVETT GM, 1995, OECOLOGIA, V104, P133, DOI 10.1007/BF00328577; Lovett GM, 1998, OECOLOGIA, V117, P513, DOI 10.1007/s004420050687; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MCNALLY JB, 1965, J NUTR, V85, P113, DOI 10.1093/jn/85.1.113; MILLER WP, 1987, COMMUN SOIL SCI PLAN, V18, P1, DOI 10.1080/00103628709367799; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Rothrock MJ, 2010, J ENVIRON QUAL, V39, P1848, DOI 10.2134/jeq2010.0024; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Tautz J, 2008, CURR BIOL, V18, pR1125, DOI 10.1016/j.cub.2008.10.038; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WIGGLESWORTH V B, 1972, P827; Wigglesworth VB, 1950, PRINCIPLES INSECT PH, P364; WINSTON ML, 1992, HIVE HONEY BEE; Zaady E, 2003, SOIL BIOL BIOCHEM, V35, P1299, DOI 10.1016/S0038-0717(03)00200-1	32	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70591	10.1371/journal.pone.0070591	http://dx.doi.org/10.1371/journal.pone.0070591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923006	Green Published, gold			2022-12-27	WOS:000323369700195
J	Zheng, Z; Nonomura, T; Appiano, M; Pavan, S; Matsuda, Y; Toyoda, H; Wolters, AMA; Visser, RGF; Bai, YL				Zheng, Zheng; Nonomura, Teruo; Appiano, Michela; Pavan, Stefano; Matsuda, Yoshinori; Toyoda, Hideyoshi; Wolters, Anne-Marie A.; Visser, Richard G. F.; Bai, Yuling			Loss of Function in Mlo Orthologs Reduces Susceptibility of Pepper and Tomato to Powdery Mildew Disease Caused by Leveillula taurica	PLOS ONE			English	Article							CAPSICUM-ANNUUM; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; ORYZA-SATIVA; CELL-DEATH; RESISTANCE; BARLEY; FAMILY; IDENTIFICATION; DISCOVERY	Powdery mildew disease caused by Leveillula taurica is a serious fungal threat to greenhouse tomato and pepper production. In contrast to most powdery mildew species which are epiphytic, L. taurica is an endophytic fungus colonizing the mesophyll tissues of the leaf. In barley, Arabidopsis, tomato and pea, the correct functioning of specific homologues of the plant Mlo gene family has been found to be required for pathogenesis of epiphytic powdery mildew fungi. The aim of this study was to investigate the involvement of the Mlo genes in susceptibility to the endophytic fungus L. taurica. In tomato (Solanum lycopersicum), a loss-of-function mutation in the SlMlo1 gene results in resistance to powdery mildew disease caused by Oidium neolycopersici. When the tomato Slmlo1 mutant was inoculated with L. taurica in this study, it proved to be less susceptible compared to the control, S. lycopersicum cv. Moneymaker. Further, overexpression of SlMlo1 in the tomato Slmlo1 mutant enhanced susceptibility to L. taurica. In pepper, the CaMlo2 gene was isolated by applying a homology-based cloning approach. Compared to the previously identified CaMlo1 gene, the CaMlo2 gene is more similar to SlMlo1 as shown by phylogenetic analysis, and the expression of CaMlo2 is up-regulated at an earlier time point upon L. taurica infection. However, results of virus-induced gene silencing suggest that both CaMlo1 and CaMlo2 may be involved in the susceptibility of pepper to L. taurica. The fact that overexpression of CaMlo2 restored the susceptibility of the tomato Slmlo1 mutant to O. neolycopersici and increased its susceptibility to L. taurica confirmed the role of CaMlo2 acting as a susceptibility factor to different powdery mildews, though the role of CaMlo1 as a co-factor for susceptibility cannot be excluded.	[Zheng, Zheng; Appiano, Michela; Wolters, Anne-Marie A.; Visser, Richard G. F.; Bai, Yuling] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Nonomura, Teruo; Matsuda, Yoshinori; Toyoda, Hideyoshi] Kinki Univ, Lab phytoprotect Sci & Technol, Nara, Japan; [Appiano, Michela; Pavan, Stefano] Univ Bari, Dept Soil Plant & Food Sci, Bari, Italy	Wageningen University & Research; Kindai University (Kinki University); Universita degli Studi di Bari Aldo Moro	Bai, YL (corresponding author), Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands.	bai.yuling@wur.nl	Wolters, Anne-Marie/N-8810-2013; Pavan, Stefano/A-7395-2016; pavan, stefano/AAA-4927-2020; Visser, Richard GF/B-3423-2012	Visser, Richard GF/0000-0002-0213-4016; Wolters, Anne-Marie/0000-0001-8537-5132; Pavan, Stefano/0000-0002-3666-7291	Technological Top Institute Green Genetics, the Netherlands [TTI-GG: 2CFD023RP]; Monsanto Holland B.V., Nunhems Netherlands B.V.; Rijk Zwaan Zaadteelt en Zaadhandel B.V.; Italian Ministery of University and Research through the GenHort PON RC project	Technological Top Institute Green Genetics, the Netherlands(Netherlands Government); Monsanto Holland B.V., Nunhems Netherlands B.V.; Rijk Zwaan Zaadteelt en Zaadhandel B.V.; Italian Ministery of University and Research through the GenHort PON RC project	This work was funded by the Technological Top Institute Green Genetics, the Netherlands (TTI-GG: 2CFD023RP) together with Monsanto Holland B.V., Nunhems Netherlands B.V. and Rijk Zwaan Zaadteelt en Zaadhandel B.V. (http://www.groenegenetica.nl/site/public/go/article.aspx?id=92&title=projects% 2021-30). Financial support to the activities of M. Appiano and S. Pavan was granted by the Italian Ministery of University and Research through the GenHort PON R&C project. The funders had no role in study design, data collection and analysis or preparation of the manuscript. The Funders have agreed to published the data presented in this manuscript.	Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Bai YL, 2003, MOL PLANT MICROBE IN, V16, P169, DOI 10.1094/MPMI.2003.16.2.169; Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; Bent AF, 1996, PLANT CELL, V8, P1757, DOI 10.1105/tpc.8.10.1757; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Blat Sally F., 2005, Hortic. Bras., V23, P72, DOI 10.1590/S0102-05362005000100015; Braun U., 1987, NOVA HEDWIGIA S, V89; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cerkauskas RF, 2003, PLANT DIS, V87, P1151, DOI 10.1094/PDIS.2003.87.9.1151C; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; CHUNWONGSE J, 1994, THEOR APPL GENET, V89, P76, DOI 10.1007/BF00226986; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; DAUBEZE AM, 1995, PLANT BREEDING, V114, P327, DOI 10.1111/j.1439-0523.1995.tb01243.x; de Souza VL, 2003, PLANT PATHOL, V52, P613, DOI 10.1046/j.1365-3059.2003.00920.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Eckardt NA, 2002, PLANT CELL, V14, P1983, DOI 10.1105/tpc.140910; Elad Y, 2007, PHYTOPATHOLOGY, V97, P813, DOI 10.1094/PHYTO-97-7-0813; Feechan A, 2008, FUNCT PLANT BIOL, V35, P1255, DOI 10.1071/FP08173; Fu XL, 2009, J INTEGR PLANT BIOL, V51, P21, DOI 10.1111/j.1744-7909.2008.00728.x; HEWITT HG, 1998, FUNGICIDES CROP PROT, P221; Huckelhoven R, 2001, MOL PLANT PATHOL, V2, P199, DOI 10.1046/j.1464-6722.2001.00067.x; Huckelhoven R, 2000, MOL PLANT PATHOL, V1, P287, DOI 10.1046/j.1364-3703.2000.00032.x; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim DS, 2012, PLANT J, V72, P843, DOI 10.1111/tpj.12003; Konishi S, 2010, GENES GENET SYST, V85, P167, DOI 10.1266/ggs.85.167; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lefebvre V, 2003, THEOR APPL GENET, V107, P661, DOI 10.1007/s00122-003-1307-z; Liu Q, 2008, GENE, V409, P1, DOI 10.1016/j.gene.2007.10.031; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; Nonomura T, 2009, MYCOL RES, V113, P364, DOI 10.1016/j.mycres.2008.11.012; Panstruga R, 2005, PLANT MOL BIOL, V59, P485, DOI 10.1007/s11103-005-0353-0; Pavan S, 2008, EUPHYTICA, V162, P91, DOI 10.1007/s10681-007-9570-8; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Reinstadler A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-31; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; SHIFRISS C, 1992, PHYTOPARASITICA, V20, P279, DOI 10.1007/BF02980848; Silvar C, 2008, J PLANT PHYSIOL, V165, P1120, DOI 10.1016/j.jplph.2007.11.008; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Xiao SY, 2003, MOL PLANT MICROBE IN, V16, P289, DOI 10.1094/MPMI.2003.16.4.289; Zheng Z, 2013, PHYTOPATHOLOGY, V103, P623, DOI 10.1094/PHYTO-08-12-0198-R	52	79	88	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70723	10.1371/journal.pone.0070723	http://dx.doi.org/10.1371/journal.pone.0070723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923019	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700204
J	de Lendonck, LY; Eddahri, F; Delmarcelle, Y; Nguyen, M; Leo, O; Goriely, S; Marchant, A				de Lendonck, Laure Ysebrant; Eddahri, Fouad; Delmarcelle, Yves; Nguyen, Muriel; Leo, Oberdan; Goriely, Stanislas; Marchant, Arnaud			STAT3 Signaling Induces the Differentiation of Human ICOS+ CD4 T Cells Helping B lymphocytes	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; COSTIMULATOR MESSENGER-RNA; CXC CHEMOKINE RECEPTOR-5; HYPER-IGE SYNDROME; ANTIBODY-RESPONSES; HYPERIMMUNOGLOBULIN-E; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; IL-21; EXPRESSION	The generation of high-affinity antibodies and the development of B cell memory are dependent on the help provided by CD4 T cells. Mouse studies indicate that STAT3 signaling in CD4 T cells promotes the acquisition of the B cell help function. However, the role of STAT3 in humans has been controversial. In this study, we show that IL-6 and other STAT3 activating cytokines (IL-21 and IL-27) induce the differentiation of CD4 T cells promoting antibody production by B cells. The acquisition of B cell stimulating properties by naive cord blood CD4 T cells required the STAT3-dependent expression of ICOS and IL-21. Gene reporter and ChIP experiments unambiguously demonstrated that upon IL-6 stimulation, STAT3 induces the transcription of the ICOS gene through direct recruitment to the proximal promoter region indicating that STAT3 acts in part through the direct activation of the ICOS gene.	[de Lendonck, Laure Ysebrant; Nguyen, Muriel; Leo, Oberdan; Goriely, Stanislas; Marchant, Arnaud] Univ Libre Brussels, IMI, Charleroi, Belgium; [Eddahri, Fouad; Delmarcelle, Yves; Marchant, Arnaud] ImmuneHealth, Charleroi, Belgium		Goriely, S (corresponding author), Univ Libre Brussels, IMI, Charleroi, Belgium.	stgoriel@ulb.ac.be; arnaud.marchant@ulb.ac.be		Goriely, Stanislas/0000-0002-7005-6195	Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium), an Interuniversity Attraction Pole grant of the Belgian Federal Science Policy; European Regional Development Fund; Walloon Region; government of the Walloon Region; GlaxoSmithKline Biologicals; Televie, FRS-FNRS	Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium), an Interuniversity Attraction Pole grant of the Belgian Federal Science Policy(Fonds de la Recherche Scientifique - FNRS); European Regional Development Fund(European Commission); Walloon Region; government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline); Televie, FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was supported by the Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium), an Interuniversity Attraction Pole grant of the Belgian Federal Science Policy and by the European Regional Development Fund and the Walloon Region. The Institute for Medical Immunology is co-funded by the government of the Walloon Region and GlaxoSmithKline Biologicals. LY is supported by the Televie, FRS-FNRS. SG is a research associate and AM is a senior research associate of the FRS-FNRS. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Bossaller L, 2006, J IMMUNOL, V177, P4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bryant VL, 2007, J IMMUNOL, V179, P8180; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; DRESKIN SC, 1985, J CLIN INVEST, V75, P26, DOI 10.1172/JCI111683; Ebert LM, 2004, EUR J IMMUNOL, V34, P3562, DOI 10.1002/eji.200425478; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Glimcher LH, 2000, GENE DEV, V14, P1693; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; LEUNG DYM, 1988, J ALLERGY CLIN IMMUN, V81, P1082, DOI 10.1016/0091-6749(88)90873-1; Li L, 2006, J BIOL CHEM, V281, P33172, DOI 10.1074/jbc.M606940200; Lim HW, 2004, J CLIN INVEST, V114, P1640, DOI 10.1172/JCI22325; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; SHEERIN KA, 1991, J ALLERGY CLIN IMMUN, V87, P803, DOI 10.1016/0091-6749(91)90126-9; Speckmann C, 2008, CLIN IMMUNOL, V129, P448, DOI 10.1016/j.clim.2008.08.002; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang Q, 2011, BLOOD, V118, P3062, DOI 10.1182/blood-2011-01-332916; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71029	10.1371/journal.pone.0071029	http://dx.doi.org/10.1371/journal.pone.0071029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923047	Green Submitted, gold, Green Published			2022-12-27	WOS:000322838900187
J	Kobryn, HT; Wouters, K; Beckley, LE; Heege, T				Kobryn, Halina T.; Wouters, Kristin; Beckley, Lynnath E.; Heege, Thomas			Ningaloo Reef: Shallow Marine Habitats Mapped Using a Hyperspectral Sensor	PLOS ONE			English	Article							LANDSAT-THEMATIC-MAPPER; REMOTE-SENSING DATA; CORAL-REEFS; SPECTRAL DISCRIMINATION; BENTHIC COMMUNITIES; SPATIAL-RESOLUTION; SATELLITE; CLASSIFICATION; CONSERVATION; REFLECTANCE	Research, monitoring and management of large marine protected areas require detailed and up-to-date habitat maps. Ningaloo Marine Park (including the Muiron Islands) in north-western Australia (stretching across three degrees of latitude) was mapped to 20 m depth using HyMap airborne hyperspectral imagery (125 bands) at 3.5 m resolution across the 762 km(2) of reef environment between the shoreline and reef slope. The imagery was corrected for atmospheric, air-water interface and water column influences to retrieve bottom reflectance and bathymetry using the physics-based Modular Inversion and Processing System. Using field-validated, image-derived spectra from a representative range of cover types, the classification combined a semi-automated, pixel-based approach with fuzzy logic and derivative techniques. Five thematic classification levels for benthic cover (with probability maps) were generated with varying degrees of detail, ranging from a basic one with three classes (biotic, abiotic and mixed) to the most detailed with 46 classes. The latter consisted of all abiotic and biotic seabed components and hard coral growth forms in dominant or mixed states. The overall accuracy of mapping for the most detailed maps was 70% for the highest classification level. Macro-algal communities formed most of the benthic cover, while hard and soft corals represented only about 7% of the mapped area (58.6 km(2)). Dense tabulate coral was the largest coral mosaic type (37% of all corals) and the rest of the corals were a mix of tabulate, digitate, massive and soft corals. Our results show that for this shallow, fringing reef environment situated in the arid tropics, hyperspectral remote sensing techniques can offer an efficient and cost-effective approach to mapping and monitoring reef habitats over large, remote and inaccessible areas.	[Kobryn, Halina T.; Wouters, Kristin; Beckley, Lynnath E.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Heege, Thomas] EOMAP, Gilching, Germany	Murdoch University	Kobryn, HT (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	H.Kobryn@murdoch.edu.au	Kobryn, Halina/E-5051-2012	Kobryn, Halina/0000-0003-1004-7593	CSIRO Wealth from Oceans Flagship Collaboration Fund; Murdoch University; BHP Billiton Petroleum	CSIRO Wealth from Oceans Flagship Collaboration Fund; Murdoch University; BHP Billiton Petroleum	This project was funded through the CSIRO Wealth from Oceans Flagship Collaboration Fund (http://www.csiro.au/en/Organisation-Structure/Flagships/Wealth-from-Oceans-Flagship.aspx) and Murdoch University (www.murdoch.edu.au). The authors would also like to acknowledge the support of BHP Billiton Petroleum (funding of Hymap survey). The authors would like to declare that the commercial source (BHP Billiton Petroleum) who, through an agreement with the Australian Institute of Marine Science, funded the flights for this project had no involvement in any of the data analysis, nor did this work result or involve any employment, consultancy, patents, products in development or such. The authors can declare that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	AHMAD W, 1994, INT J REMOTE SENS, V15, P2583, DOI 10.1080/01431169408954268; Albert A, 2003, OPT EXPRESS, V11, P2873, DOI 10.1364/OE.11.002873; Andrefouet S, 2005, CORAL REEFS, V24, P31, DOI 10.1007/s00338-004-0444-4; Andrefouet S, 2003, REMOTE SENS ENVIRON, V88, P128, DOI 10.1016/j.rse.2003.04.005; Andrefouet S, 2002, CORAL REEFS, V21, P147, DOI 10.1007/s00338-002-0233-x; Andrefouet S, 2001, CORAL REEFS, V19, P259; Bancroft K. P., 2000, MAJOR MARINE HABITAT; Beckley LE, 2012, MAR FRESHWATER RES, V63, P17, DOI 10.1071/MF11074; Bejarano S, 2010, REMOTE SENS ENVIRON, V114, P2768, DOI 10.1016/j.rse.2010.06.012; Benfield SL, 2007, INT J REMOTE SENS, V28, P5047, DOI 10.1080/01431160701258062; Bertels L, 2008, INT J REMOTE SENS, V29, P2359, DOI 10.1080/01431160701408469; BoM, 2012, WEATH CLIM DAT; Bour W, 1996, GEOCARTO INT, V11, P29; Call KA, 2003, INT J REMOTE SENS, V24, P2627, DOI 10.1080/0143116031000066990; CALM. MPRA, 2005, MAN PLAN NING MAR PA, P111; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cerdeira-Estrada S, 2012, INT GEOSCI REMOTE SE, P4383, DOI 10.1109/IGARSS.2012.6350402; Choudhury I, 2006, INT J REMOTE SENS, V27, P519, DOI 10.1080/01431160500239172; Collins LB, 2003, SEDIMENT GEOL, V159, P81, DOI 10.1016/S0037-0738(03)00096-4; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; CRESSWELL GR, 1980, DEEP-SEA RES, V27, P449, DOI 10.1016/0198-0149(80)90055-2; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; DEHWA, 2010, NING COAST WORLD HER; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Dustan P, 2001, CONSERV BIOL, V15, P892, DOI 10.1046/j.1523-1739.2001.015004892.x; Elvidge CD, 2004, CORAL REEFS, V23, P461, DOI 10.1007/s00338-004-0418-6; Goodman JA, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2815907; Gopal S, 1994, PHOTOGRAMMETRIC ENG, V60, P191; Green EP, 1996, COAST MANAGE, V24, P1, DOI 10.1080/08920759609362279; Green EP, 2000, REMOTE SENSING TROPI; Hamylton S, 2011, INT J REMOTE SENS, V32, P9673, DOI 10.1080/01431161.2011.574162; Hanson CE, 2007, DEEP-SEA RES PT II, V54, P902, DOI 10.1016/j.dsr2.2006.10.002; Harvey MJ, 2009, THESIS MURDOCH U PER, P280; Harvey MJ, 2007, MAPPING SHALLOW MARI, P11; Hedley JD, 2004, CORAL REEFS, V23, P60, DOI 10.1007/s00338-003-0354-x; Hedley JD, 2002, ADV MAR BIOL, V43, P277, DOI 10.1016/S0065-2881(02)43006-4; Hedley JD, 2012, REMOTE SENS-BASEL, V4, P271, DOI 10.3390/rs4010271; Heege T, 2004, CAN J REMOTE SENS, V30, P77, DOI 10.5589/m03-056; Heege T, 2003, MAPPING SUBMERGED AQ, P45; Heege T, 2000, SUN GLITTER CORRECTI; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P174, DOI 10.1016/S0034-4257(02)00202-X; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Holden H, 1998, REMOTE SENS ENVIRON, V65, P217, DOI 10.1016/S0034-4257(98)00029-7; Holthus PF., 1995, MARINE COASTAL BIODI, P239; Joyce KE, 2003, LIMNOL OCEANOGR, V48, P489, DOI 10.4319/lo.2003.48.1_part_2.0489; Karpouzli E, 2004, CORAL REEFS, V23, P141, DOI 10.1007/s00338-003-0363-9; Kuchler D. A., 1986, Geocarto International, P3; Kutser T, 2006, ESTUAR COAST SHELF S, V69, P607, DOI 10.1016/j.ecss.2006.05.026; Kutser T, 2006, ESTUAR COAST SHELF S, V70, P449, DOI 10.1016/j.ecss.2006.06.026; Lidz BH, 2006, J COASTAL RES, V22, P260, DOI 10.2112/05A-0023.1; Long S, 2007, MBI200705 DEP ENV CO, P73; Lubin D, 2001, REMOTE SENS ENVIRON, V75, P127, DOI 10.1016/S0034-4257(00)00161-9; Maeder J, 2002, PHOTOGRAMM ENG REM S, V68, P1297; Mather P., 2004, COMPUTER PROCESSING, V3rd; McCoy R.M., 2005, FIELD METHODS REMOTE; Mishra D, 2006, PHOTOGRAMM ENG REM S, V72, P1037, DOI 10.14358/PERS.72.9.1037; Mishra DR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003892; Mumby PJ, 2004, CORAL REEFS, V23, P171, DOI 10.1007/s00338-004-0382-1; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Mumby PJ, 2002, REMOTE SENS ENVIRON, V82, P248, DOI 10.1016/S0034-4257(02)00041-X; Mumby PJ, 2001, NATURE, V413, P36, DOI 10.1038/35092617; Mumby PJ, 1999, BIOL CONSERV, V88, P155, DOI 10.1016/S0006-3207(98)00108-6; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Ohlendorf S, 2011, P SOC PHOTO-OPT INS, V8175; Phinn SR, 2003, ENVIRON MANAGE, V31, P429, DOI 10.1007/s00267-002-2837-x; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Purkis SJ, 2006, REMOTE SENS ENVIRON, V101, P82, DOI 10.1016/j.rse.2005.11.009; Richards J. A., 2006, REMOTE SENSING DIGIT; Riegl BM, 2005, REMOTE SENS ENVIRON, V95, P96, DOI 10.1016/j.rse.2004.11.016; Roelfsema CM, 2002, CORAL REEFS, V21, P264, DOI 10.1007/s00338-002-0242-9; Schweizer D, 2005, INT J REMOTE SENS, V26, P2657, DOI 10.1080/01431160500104111; SETTLE JJ, 1993, INT J REMOTE SENS, V14, P1159, DOI 10.1080/01431169308904402; Short A. D., 2009, COAST AUSTR; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stephens FC, 2003, LIMNOL OCEANOGR, V48, P535, DOI 10.4319/lo.2003.48.1_part_2.0535; Vanderstraete T, 2006, INT J REMOTE SENS, V27, P3645, DOI 10.1080/01431160500500342; Wabnitz CC, 2008, REMOTE SENS ENVIRON, V112, P3455, DOI 10.1016/j.rse.2008.01.020; Wells S., 1988, CORAL REEFS WORLD IN; ZAINAL AJM, 1993, PHOTOGRAMM ENG REM S, V59, P415; Zharikov Y, 2005, BIOL CONSERV, V125, P87, DOI 10.1016/j.biocon.2005.03.016	81	61	63	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70105	10.1371/journal.pone.0070105	http://dx.doi.org/10.1371/journal.pone.0070105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922921	Green Published, gold			2022-12-27	WOS:000322838900148
J	Nagy, L; Docsa, T; Szanto, M; Brunyanszki, A; Hegedus, C; Marton, J; Konya, B; Virag, L; Somsak, L; Gergely, P; Bai, P				Nagy, Lilla; Docsa, Tibor; Szanto, Magdolna; Brunyanszki, Attila; Hegedues, Csaba; Marton, Judit; Konya, Balint; Virag, Laszlo; Somsak, Laszlo; Gergely, Pal; Bai, Peter			Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N '-(beta-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism	PLOS ONE			English	Article							GLUCOPYRANOSYLIDENE-SPIRO-THIOHYDANTOIN; UNCOUPLING PROTEIN-2; LIVER; MUSCLE; MICE; REVEALS; CANCER; CELLS; MTOR; PROLIFERATION	Glycogen phosphorylase (GP) catalyzes the breakdown of glycogen and largely contributes to hepatic glucose production making GP inhibition an attractive target to modulate glucose levels in diabetes. Hereby we present the metabolic effects of a novel, potent, glucose-based GP inhibitor (KB228) tested in vitro and in vivo under normoglycemic and diabetic conditions. KB228 administration enhanced glucose sensitivity in chow-fed and obese, diabetic mice that was a result of higher hepatic glucose uptake. Besides improved glucose sensitivity, we have observed further unexpected metabolic rearrangements. KB228 administration increased oxygen consumption that was probably due to the overexpression of uncoupling protein-2 (UCP2) that was observed in animal and cellular models. Furthermore, KB228 treatment induced mammalian target of rapamycin complex 2 (mTORC2) in mice. Our data demonstrate that glucose based GP inhibitors are capable of reducing glucose levels in mice under normo and hyperglycemic conditions. Moreover, these GP inhibitors induce accommodation in addition to GP inhibition - such as enhanced mitochondrial oxidation and mTORC2 signaling - to cope with the glucose influx and increased glycogen deposition in the cells, however the molecular mechanism of accommodation is unexplored.	[Nagy, Lilla; Docsa, Tibor; Szanto, Magdolna; Brunyanszki, Attila; Hegedues, Csaba; Marton, Judit; Virag, Laszlo; Gergely, Pal; Bai, Peter] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Debrecen, Hungary; [Szanto, Magdolna; Virag, Laszlo; Gergely, Pal; Bai, Peter] Hungarian Acad Sci, Cell Biol & Signaling Res Grp, Debrecen, Hungary; [Konya, Balint; Somsak, Laszlo] Univ Debrecen, Dept Organ Chem, Debrecen, Hungary	University of Debrecen; Hungarian Academy of Sciences; University of Debrecen	Bai, P (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Debrecen, Hungary.	baip@med.unideb.hu	Gergely, Pál/A-5547-2008	Szanto, Magdolna/0000-0002-7714-7065	National Innovation Office [TeT_09-2010-0023]; OTKA [CNK80709, CK77712, K82009, K75864, PD83473, TAMOP 4.2.2/B-10/1-2010-0024, TAMOP 4.2.1/B-09/1/KONV-2012-0025, TAMOP-4.2.1./B-09/KONV-2010-0007]; Medical and Health Science Center [Mecenatura Mec-8/2011]	National Innovation Office; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Medical and Health Science Center	This work was supported by grants from the National Innovation Office (Baross program Seahorse grant; TeT_09-2010-0023), OTKA CNK80709, CK77712, K82009, K75864, PD83473, TAMOP 4.2.2/B-10/1-2010-0024, TAMOP 4.2.1/B-09/1/KONV-2012-0025, TAMOP-4.2.1./B-09/KONV-2010-0007 and Medical and Health Science Center (Mecenatura Mec-8/2011). PB, TD and MS were recipients of Bolyai fellowships of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Agius L, 2010, MINI-REV MED CHEM, V10, P1175, DOI 10.2174/1389557511009011175; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; Aiston S, 2004, BIOCHEM J, V377, P195, DOI 10.1042/BJ20031191; Aiston S, 2001, J BIOL CHEM, V276, P23858, DOI 10.1074/jbc.M101454200; Aiston S, 2000, DIABETOLOGIA, V43, P589, DOI 10.1007/s001250051348; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Baffy G, 2002, HEPATOLOGY, V35, P753, DOI 10.1053/jhep.2002.32028; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Baker DJ, 2006, DIABETES, V55, P1855, DOI 10.2337/db05-1687; Baker DJ, 2005, DIABETES, V54, P2453, DOI 10.2337/diabetes.54.8.2453; Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019; BRANA MF, 1981, J HETEROCYCLIC CHEM, V18, P869, DOI 10.1002/jhet.5570180503; Brunyanszki A, 2010, J INVEST DERMATOL, V130, P2629, DOI 10.1038/jid.2010.190; Chrysina ED, 2010, MINI-REV MED CHEM, V10, P1093; Chrysina ED, 2005, PROTEIN SCI, V14, P873, DOI 10.1110/ps.041216105; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Docsa T, 2011, MOL MED REP, V4, P477, DOI 10.3892/mmr.2011.464; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Floettmann E, 2010, TOXICOL PATHOL, V38, P393, DOI 10.1177/0192623310362707; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; Furukawa S, 2005, J ANTIBIOT, V58, P497, DOI 10.1038/ja.2005.66; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lerin C, 2004, BIOCHEM J, V378, P1073, DOI 10.1042/BJ20030971; Likhosherstov LM, 2002, DOKL CHEM, V383, P89, DOI 10.1023/A:1015428720733; Martin WH, 1998, P NATL ACAD SCI USA, V95, P1776, DOI 10.1073/pnas.95.4.1776; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oikonomakos NG, 2008, CURR OPIN INVEST DR, V9, P379; Osz E, 1999, BIOORG MED CHEM LETT, V9, P1385, DOI 10.1016/S0960-894X(99)00192-4; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Somsak L, 2008, CURR MED CHEM, V15, P2933, DOI 10.2174/092986708786848659; Somsak L, 2008, CARBOHYD RES, V343, P2083, DOI 10.1016/j.carres.2008.01.045; Somsak L, 2011, CR CHIM, V14, P211, DOI 10.1016/j.crci.2010.09.004; SPEZIALE AJ, 1965, J ORG CHEM, V30, P4306, DOI 10.1021/jo01023a501; STALMANS W, 1987, Diabetes Metabolism Reviews, V3, P127; STALMANS W, 1990, ADV ENZYME REGUL, V30, P305; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Varga G, 2012, BIOORG MED CHEM LETT, DOI [10.1016/j.bmcl.2013.1001.1042, DOI 10.1016/J.BMCL.2013.1001.1042]; Nagy V, 2012, BIOORGAN MED CHEM, V20, P1801, DOI 10.1016/j.bmc.2011.12.059; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	49	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69420	10.1371/journal.pone.0069420	http://dx.doi.org/10.1371/journal.pone.0069420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936011	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000322433300038
J	Ross, AP; Mansilla, MA; Choe, Y; Helminski, S; Sturm, R; Maute, RL; May, SR; Hozyasz, KK; Wojcicki, P; Mostowska, A; Davidson, B; Adamopoulos, IE; Pleasure, SJ; Murray, JC; Zarbalis, KS				Ross, Adam P.; Mansilla, M. Adela; Choe, Youngshik; Helminski, Simon; Sturm, Richard; Maute, Roy L.; May, Scott R.; Hozyasz, Kamil K.; Wojcicki, Piotr; Mostowska, Adrianna; Davidson, Beth; Adamopoulos, Iannis E.; Pleasure, Samuel J.; Murray, Jeffrey C.; Zarbalis, Konstantinos S.			A Mutation in Mouse Pak1ip1 Causes Orofacial Clefting while Human PAK1IP1 Maps to 6p24 Translocation Breaking Points Associated with Orofacial Clefting	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; LIP; PALATE; PROTEIN; IDENTIFICATION; FAMILIES; KINASE; GENE; PAK; EXPRESSION	Orofacial clefts are among the most common birth defects and result in an improper formation of the mouth or the roof of the mouth. Monosomy of the distal aspect of human chromosome 6p has been recognized as causative in congenital malformations affecting the brain and cranial skeleton including orofacial clefts. Among the genes located in this region is PAK1IP1, which encodes a nucleolar factor involved in ribosomal stress response. Here, we report the identification of a novel mouse line that carries a point mutation in the Pak1ip1 gene. Homozygous mutants show severe developmental defects of the brain and craniofacial skeleton, including a median orofacial cleft. We recovered this line of mice in a forward genetic screen and named the allele manta-ray (mray). Our findings prompted us to examine human cases of orofacial clefting for mutations in the PAK1IP1 gene or association with the locus. No deleterious variants in the PAK1IP1 gene coding region were recognized, however, we identified a borderline association effect for SNP rs494723 suggesting a possible role for the PAK1IP1 gene in human orofacial clefting.	[Ross, Adam P.; Helminski, Simon; Zarbalis, Konstantinos S.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Mansilla, M. Adela; Davidson, Beth; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Sturm, Richard] Heidelberg Univ, Interdisciplinary Ctr Neurosci, Heidelberg, Germany; [Maute, Roy L.] Columbia Univ, Inst Canc Genet, New York, NY USA; [May, Scott R.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Hozyasz, Kamil K.] Inst Mother & Child Hlth, Dept Pediat, Warsaw, Poland; [Wojcicki, Piotr] Wroclaw Med Univ, Dept Plast Surg, Polanica Zdroj, Poland; [Wojcicki, Piotr] Med Ctr, Dept Plast Surg, Polanica Zdroj, Poland; [Mostowska, Adrianna] Poznan Univ Med Sci, Dept Biochem & Mol Biol, Poznan, Poland; [Adamopoulos, Iannis E.] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Adamopoulos, Iannis E.; Zarbalis, Konstantinos S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis; University of Iowa; University of California System; University of California San Francisco; Ruprecht Karls University Heidelberg; Columbia University; Salk Institute; Wroclaw Medical University; Poznan University of Medical Sciences; University of California System; University of California Davis	Zarbalis, KS (corresponding author), Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	kzarbalis@ucdavis.edu	Adamopoulos, Iannis/AAE-5624-2022; Adamopoulos, Iannis/L-1944-2019; Hozyasz, Kamil/AAJ-3490-2020; Wojcicki, Piotr/T-1174-2018	Adamopoulos, Iannis/0000-0002-3708-2965; Hozyasz, Kamil/0000-0001-8606-2509; Wojcicki, Piotr/0000-0001-7569-4105; Mostowska, Adrianna/0000-0003-4181-9402	Shriners Hospitals for Children; National Institutes of Health [NIH DE08559]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Shriners Hospitals for Children; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by Shriners Hospitals for Children (KSZ) and National Institutes of Health grant NIH DE08559 (JCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; DAVIES AF, 1995, HUM MOL GENET, V4, P121; Davies SJ, 2004, CYTOGENET GENOME RES, V105, P47, DOI 10.1159/000078008; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griffin JN, 2013, DEV BIOL, V374, P185, DOI 10.1016/j.ydbio.2012.11.014; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jean S, 2012, BIOL OPEN, V1, P731, DOI 10.1242/bio.2012968; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HW, 2001, MOL CELL, V7, P1095, DOI 10.1016/S1097-2765(01)00248-9; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mansilla MA, 2006, CLEFT PALATE-CRAN J, V43, P21, DOI 10.1597/04-169R.1; Marszalek Bozena, 2002, Journal of Applied Genetics, V43, P223; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Murray JC, 1997, CLEFT PALATE-CRAN J, V34, P7, DOI 10.1597/1545-1569(1997)034<0007:CAESOC>2.3.CO;2; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Qu SM, 1999, DEVELOPMENT, V126, P359; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rozen S, 2000, Methods Mol Biol, V132, P365; Saveanu C, 2007, MOL CELL BIOL, V27, P2897, DOI 10.1128/MCB.00064-07; Scapoli L, 1997, GENOMICS, V43, P216, DOI 10.1006/geno.1997.4798; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Soriano P, 1997, DEVELOPMENT, V124, P2691; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zarbalis K, 2000, MECH DEVELOP, V93, P165, DOI 10.1016/S0925-4773(00)00252-5	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69333	10.1371/journal.pone.0069333	http://dx.doi.org/10.1371/journal.pone.0069333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935987	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300033
J	Wang, X; Yang, JG; Chen, L; Wang, JL; Cheng, Q; Dixon, R; Wang, YP				Wang, Xia; Yang, Jian-Guo; Chen, Li; Wang, Ji-Long; Cheng, Qi; Dixon, Ray; Wang, Yi-Ping			Using Synthetic Biology to Distinguish and Overcome Regulatory and Functional Barriers Related to Nitrogen Fixation	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; GENETIC-REGULATION; CLONING VEHICLES; CONSTRUCTION; EXPRESSION; PROTEIN; PROMOTER	Biological nitrogen fixation is a complex process requiring multiple genes working in concert. To date, the Klebsiella pneumoniae nif gene cluster, divided into seven operons, is one of the most studied systems. Its nitrogen fixation capacity is subject to complex cascade regulation and physiological limitations. In this report, the entire K. pneumoniae nif gene cluster was reassembled as operon-based BioBrick parts in Escherichia coli. It provided similar to 100% activity of native K. pneumoniae system. Based on the expression levels of these BioBrick parts, a T7 RNA polymerase-Lacl expression system was used to replace the sigma(54)-dependent promoters located upstream of nif operons. Expression patterns of nif operons were critical for the maximum activity of the recombinant system. By mimicking these expression levels with variable-strength T7-dependent promoters, similar to 42% of the nitrogenase activity of the sigma(54)-dependent nif system was achieved in E. coli. When the newly constructed T7-dependent nif system was challenged with different genetic and physiological conditions, it bypassed the original complex regulatory circuits, with minor physiological limitations. Therefore, we have successfully replaced the nif regulatory elements with a simple expression system that may provide the first step for further research of introducing nif genes into eukaryotic organelles, which has considerable potentials in agro-biotechnology.	[Wang, Xia; Yang, Jian-Guo; Chen, Li; Wang, Ji-Long; Wang, Yi-Ping] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Cheng, Qi] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Dixon, Ray] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	Peking University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dixon, R (corresponding author), John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich, Norfolk, England.	ray.dixon@jic.ac.uk; wangyp@pku.edu.cn	Cheng, Qi/C-9922-2018	Cheng, Qi/0000-0003-1269-6386; /0000-0002-6602-3462; CHEN, LI/0000-0002-1108-7645; Dixon, Ray/0000-0002-6348-639X; Wang, Yiping/0000-0002-1995-8521	973 National Key Basic Research Program in China [2010CB126503]; National Natural Science Foundation of China [30830005]; Program of Introducing Talents of Discipline to Universities [B06001]; State Key Laboratory of Protein and Plant Gene Research [B02]; National Science Fund for Distinguished Young Scholars [NSFC] [39925017]; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000016] Funding Source: researchfish	973 National Key Basic Research Program in China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Key Laboratory of Protein and Plant Gene Research; National Science Fund for Distinguished Young Scholars [NSFC](National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by 973 National Key Basic Research Program in China [No. 2010CB126503 [YPW is the chief scientist of the program]; the National Natural Science Foundation of China [No. 30830005 to YPW]; the Program of Introducing Talents of Discipline to Universities [No. B06001]; the State Key Laboratory of Protein and Plant Gene Research [No. B02]; YPW is recipient of the National Science Fund for Distinguished Young Scholars [NSFC, No. 39925017]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOLIVAR F, 1977, GENE, V2, P75, DOI 10.1016/0378-1119(77)90074-9; BOONSTRA J, 1978, J BACTERIOL, V136, P844, DOI 10.1128/JB.136.3.844-853.1978; BROOKS SJ, 1984, J BACTERIOL, V157, P460, DOI 10.1128/JB.157.2.460-464.1984; BUCK M, 1986, NATURE, V320, P374, DOI 10.1038/320374a0; CANNON FC, 1976, J GEN MICROBIOL, V93, P111, DOI 10.1099/00221287-93-1-111; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; DIXON R, 1976, NATURE, V260, P268, DOI 10.1038/260268a0; DIXON RA, 1971, NATURE, V234, P47, DOI 10.1038/234047a0; Dubeau MP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-7; FU HA, 1989, GENE, V85, P153, DOI 10.1016/0378-1119(89)90475-7; Gamer M, 2009, APPL MICROBIOL BIOT, V82, P1195, DOI 10.1007/s00253-009-1952-5; Gavini N, 2006, J BACTERIOL, V188, P6020, DOI 10.1128/JB.00379-06; HILL S, 1981, NATURE, V290, P424, DOI 10.1038/290424a0; HOWARD KS, 1986, J BIOL CHEM, V261, P772; Huo YX, 2009, NUCLEIC ACIDS RES, V37, P3878, DOI 10.1093/nar/gkp258; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jarboe LR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/761042; Johnson JL, 2000, BBA-PROTEIN STRUCT M, V1543, P24, DOI 10.1016/S0167-4838(00)00195-3; KONG QT, 1986, J BACTERIOL, V166, P353, DOI 10.1128/jb.166.1.353-356.1986; LAANE C, 1980, EUR J BIOCHEM, V103, P39, DOI 10.1111/j.1432-1033.1980.tb04286.x; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Miller JH., 1972, EXPT MOL GENETICS; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; PINKHAM JL, 1994, MOL CELL BIOL, V14, P4643, DOI 10.1128/MCB.14.7.4643; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Sambrook J., 2002, MOL CLONING LAB MANU; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; THORNELEY RNF, 1992, BIOCHEMISTRY-US, V31, P1216, DOI 10.1021/bi00119a035	34	37	41	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68677	10.1371/journal.pone.0068677	http://dx.doi.org/10.1371/journal.pone.0068677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935879	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300010
J	Wu, VC; Wang, CY; Shiao, CC; Chang, CH; Huang, HY; Huang, TM; Lai, CF; Lin, MC; Ko, WJ; Wu, KD; Yu, CJ; Shu, CC; Lee, CH; Wang, JY				Wu, Vin-Cent; Wang, Chen-Yi; Shiao, Chih-Chung; Chang, Chia-Hsui; Huang, Hui-Yu; Huang, Tao-Min; Lai, Chun-Fu; Lin, Meng-Chun; Ko, Wen-Je; Wu, Kwan-Dun; Yu, Chong-Jen; Shu, Chin-Chung; Lee, Chih-Hsin; Wang, Jann-Yuan		Natl Taiwan Univ Study Grp Acute R; Taiwan Anti-Mycobacteria Invest TA	Increased Risk of Active Tuberculosis following Acute Kidney Injury: A Nationwide, Population-Based Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; REPLACEMENT THERAPY; DIALYSIS; ASSOCIATION; OUTCOMES; CARE	Background: Profound alterations in immune responses associated with uremia and exacerbated by dialysis increase the risk of active tuberculosis (TB). Evidence of the long-term risk and outcome of active TB after acute kidney injury (AKI) is limited. Methods: This population-based-cohort study used claim records retrieved from the Taiwan National Health Insurance database. We retrieved records of all hospitalized patients, more than 18 years, who underwent dialysis for acute kidney injury (AKI) during 1999-2008 and validated using the NSARF data. Time-dependent Cox proportional hazards model to adjust for the ongoing effect of end-stage renal disease (ESRD) was conducted to predict long-term de novo active TB after discharge from index hospitalization. Results: Out of 2,909 AKI dialysis patients surviving 90 days after index discharge, 686 did not require dialysis after hospital discharge. The control group included 11,636 hospital patients without AKI, dialysis, or history of TB. The relative risk of active TB in AKI dialysis patients, relative to the general population, after a mean follow-up period of 3.6 years was 7.71. Patients who did (hazard ratio [HR], 3.84; p<0.001) and did not (HR, 6.39; p<0.001) recover from AKI requiring dialysis had significantly higher incidence of TB than patients without AKI. The external validated data also showed nonrecovery subgroup (HR = subgroup (HR = 4.37; p = 0.049) had high risk of developing active TB compared with non-AKI. Additionally, active TB was; p = 0.049) had high risk of developing active TB compared with non-AKI. Additionally, active TB was associated with long-term all-cause mortality after AKI requiring dialysis (HR, 1.34; p = 0.032). Conclusions: AKI requiring dialysis seems to independently increase the long-term risk of active TB, even among those who weaned from dialysis at discharge. These results raise concerns that the increasing global burden of AKI will in turn increase the incidence of active TB.	[Wu, Vin-Cent; Chang, Chia-Hsui; Huang, Hui-Yu; Lai, Chun-Fu; Lin, Meng-Chun; Wu, Kwan-Dun; Yu, Chong-Jen; Shu, Chin-Chung; Wang, Jann-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Chen-Yi] Fu Jen Catholic Univ, Cardinal Tien Hosp, Dept Internal Med, New Taipei City, Taiwan; [Wang, Chen-Yi] Fu Jen Catholic Univ, Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Shiao, Chih-Chung] St Marys Hosp, Dept Internal Med, Div Nephrol, Luodong, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Med Nursing & Management Coll, Luodong, Yilan, Taiwan; [Huang, Tao-Min] Natl Taiwan Univ Hosp, Yun Lin Branch, Taipei, Taiwan; [Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Wu, Vin-Cent; Shiao, Chih-Chung; Huang, Tao-Min; Lai, Chun-Fu; Lin, Meng-Chun; Ko, Wen-Je; Wu, Kwan-Dun] Natl Taiwan Univ, Study Grp Acute Renal Failure, NSARF, Taipei 10764, Taiwan; [Lee, Chih-Hsin; Wang, Jann-Yuan] Taiwan Antimycobacteria Invest Grp, TAMI, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Cardinal Tien Hospital; Fu Jen Catholic University; Cardinal Tien Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wang, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jannyuanwang@gmail.com	Shiao, Chih-Chung/AAM-2716-2020; Lee, Chih-Hsin/D-2697-2014	Shiao, Chih-Chung/0000-0003-2220-7574; LAI, CHUN-FU/0000-0003-2109-1522; WU, KWAN-DUN/0000-0002-3339-1509; WANG, JANN-YUAN/0000-0003-3406-366X; SHU, CHIN-CHUNG/0000-0003-0311-5148; WU, VIN-CENT/0000-0001-7935-0991; Yu, Chong-Jen/0000-0001-5664-9392; Lee, Chih-Hsin/0000-0003-1492-3044	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 101-2314-B-002-132-MY3, NSC 100-2314-B-002-119, NSC 101-2314-B-002-085-MY3, NTUH 098-001177, NTUH 100-001667]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the Ta-Tung Kidney Foundation and Taiwan National Science Council (grants NSC 101-2314-B-002-132-MY3, NSC 100-2314-B-002-119, NSC 101-2314-B-002-085-MY3) and NTUH 098-001177, NTUH 100-001667. Role of the Sponsors: No role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Benfield T, 2008, CHEST, V134, P46, DOI 10.1378/chest.07-2933; Centers for Disease Control: Department of Health EYT, 2009, TAIW TUB INC MORT RA; Chang CH, 2011, GUT, V60, P1372, DOI 10.1136/gut.2010.229906; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YH, 2012, J INFECTION, V65, P150, DOI 10.1016/j.jinf.2012.03.006; Cheng SH, 2009, HEALTH POLICY, V92, P158, DOI 10.1016/j.healthpol.2009.03.008; Chou KJ, 2001, NEPHRON, V88, P138, DOI 10.1159/000045974; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Descamps-Latscha B, 1993, Curr Opin Nephrol Hypertens, V2, P883, DOI 10.1097/00041552-199311000-00005; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; KAY N E, 1986, Blood Purification, V4, P120, DOI 10.1159/000169435; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Kumar VA, 2000, AM J KIDNEY DIS, V36, P294, DOI 10.1053/ajkd.2000.8973; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Levesque LE, 2010, BMJ, V340, pb5087, DOI DOI 10.1136/BMJ.B5087; Li SY, 2011, CLIN MICROBIOL INFEC, V17, P1646, DOI 10.1111/j.1469-0691.2011.03473.x; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Lin YF, 2009, AM J SURG, V198, P325, DOI 10.1016/j.amjsurg.2008.10.021; LUNDIN AP, 1979, AM J MED, V67, P597, DOI 10.1016/0002-9343(79)90240-7; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Milburn H, 2010, THORAX, V65, P559, DOI 10.1136/thx.2009.133173; Motosugi H, 1996, AM J PATHOL, V149, P963; Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Waikar SS, 2009, JAMA-J AM MED ASSOC, V302, P1227, DOI 10.1001/jama.2009.1364; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2007, J AM COLL SURGEONS, V205, P266, DOI 10.1016/j.jamcollsurg.2007.04.006; Wu VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030836; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Wu VC, 2010, AM J SURG, V199, P466, DOI 10.1016/j.amjsurg.2009.01.007; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b	41	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69556	10.1371/journal.pone.0069556	http://dx.doi.org/10.1371/journal.pone.0069556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936044	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300046
J	Czerwinski, M; McNutt, LA; DeHovitz, JA; Zielinski, A; Rosinska, M				Czerwinski, Michal; McNutt, Louise-Anne; DeHovitz, Jack A.; Zielinski, Andrzej; Rosinska, Magdalena			Refining HIV Risk: The Modifying Effects of Youth, Gender and Education among People Who Inject Drugs in Poland	PLOS ONE			English	Article							SAN-FRANCISCO; USERS; BEHAVIORS; ASSOCIATION; COHORT; WOMEN	Objective: The goal of this study was to examine specific factors placing young (aged,30) women who inject drugs at higher risk for HIV, and to establish the need for targeted interventions within this population. Methods: A national cross-sectional sero-survey was conducted in 2004-2005 in six regions in Poland. A snowball sample of ever-injectors was recruited from drug treatment facilities and the surrounding community. Log-binomial regression was used to estimate adjusted prevalence ratios (PRs). Results: A total of 491 injection drug users younger than 30 were recruited, of whom 159 were women and 332 were men. The prevalence of HIV was 16.4% and 9.6% among women and men, respectively. In multivariate analysis, young female injectors whose education terminated at the primary level were more likely to be HIV-positive compared to males with a similar level of education (PR = 3.34, 95% CI = 1.86-6.00) and more highly educated women (PR = 4.16, 95% CI = 2.21-7.82). Conclusions: This study confirms an elevated risk of HIV among under-educated young women. Suggestions for specific interventions to reduce HIV transmission are presented. Additional research is needed to quantify the differential distribution of risk behaviors which amplify their likelihood of transmission.	[Czerwinski, Michal; Zielinski, Andrzej; Rosinska, Magdalena] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, PL-00791 Warsaw, Poland; [McNutt, Louise-Anne] SUNY Albany, Sch Publ Hlth, Dept Epidemiol, Albany, NY 12222 USA; [DeHovitz, Jack A.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA	National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Czerwinski, M (corresponding author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Epidemiol, PL-00791 Warsaw, Poland.	mczerwinski@pzh.gov.pl	Rosińska, Magdalena/Q-2068-2018; Rosińska, Magdalena/K-5857-2019; Zielinski, Andrzej/ABA-2921-2020	Rosińska, Magdalena/0000-0002-6256-7809; Rosińska, Magdalena/0000-0002-6256-7809; DeHovitz, Jack/0000-0001-7307-0614; Czerwinski, Michal/0000-0002-1983-0405	New York State International Training and Research Program (NYS-ITRP); Fogarty International Center; National Institute of Drug Abuse, National Institutes of Health, USA (NIH) [D43 TW000233]; FOGARTY INTERNATIONAL CENTER [D43TW000233] Funding Source: NIH RePORTER	New York State International Training and Research Program (NYS-ITRP); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Drug Abuse, National Institutes of Health, USA (NIH); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by New York State International Training and Research Program (NYS-ITRP) sponsored by the Fogarty International Center and National Institute of Drug Abuse, National Institutes of Health, USA (NIH Grant D43 TW000233). NYS-ITRP contributed to conception and design of the work and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P461; [Anonymous], 1995, Q REPORT, V48, P46; [Anonymous], 2007, 75 HIV AIDS SURV EUR; [Anonymous], 1993, AIDS SURV EUR Q REP, V37, P23; Bennett GA, 2000, AIDS CARE, V12, P77, DOI 10.1080/09540120047495; Buxton MB, 2004, DRUG ALCOHOL DEPEN, V75, P177, DOI 10.1016/j.drugalcdep.2004.01.014; Cleland CM, 2007, BMC PUBLIC HLTH; Davies AG, 1996, AIDS CARE, V8, P517, DOI 10.1080/09540129650125489; Deddens JA, 2003, SUGI P; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Estebanez PE, 2000, INT J EPIDEMIOL, V29, P734, DOI 10.1093/ije/29.4.734; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Frajzyngier V, 2007, DRUG ALCOHOL DEPEN, V89, P145, DOI 10.1016/j.drugalcdep.2006.12.021; Gollub EL, 1998, SEX TRANSM DIS, V25, P483, DOI 10.1097/00007435-199810000-00008; Hahn JA, 2010, ADDICTION, V105, P1254, DOI 10.1111/j.1360-0443.2010.02949.x; Hasnain M, 2007, AIDS CARE, V19, P87, DOI 10.1080/09540120600872075; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lau JTF, 2008, DRUG ALCOHOL DEPEN, V97, P54, DOI 10.1016/j.drugalcdep.2008.03.024; Lum PJ, 2005, SUBST USE MISUSE, V40, P1681, DOI 10.1080/10826080500222834; Malczewski A, 2008, 1 NATL SURVEY LOW TH; Malczewski A., 2010, POLAND NEW DEV TREND; Malczewski A, 2009, ANN REPORT 2009 POLA; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; NELSON KE, 1995, ARCH INTERN MED, V155, P1305, DOI 10.1001/archinte.155.12.1305; Niedzwiedzka-Stadnik Marta, 2012, Przegl Epidemiol, V66, P315; Pinkham S., 2012, ADV PREV MED; Platt L, 2005, SEX TRANSM DIS, V32, P605, DOI 10.1097/01.olq.0000175391.13947.f7; Roberts A., 2010, WOMEN WHO INJECT DRU; Rosinska M, 2006, CURRENT TRENDS HIV A; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; STARK K, 1994, J ACQ IMMUN DEF SYND, V7, P877; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Svensson N. P., 2003, OUTREACH WORK YOUNG; Umesh Sharma H, 2012, OUTREACH INJECTING D; Vidal-Trecan G, 1998, REV EPIDEMIOL SANTE, V46, P193	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68018	10.1371/journal.pone.0068018	http://dx.doi.org/10.1371/journal.pone.0068018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23935852	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000025
J	Ishikado, A; Morino, K; Nishio, Y; Nakagawa, F; Mukose, A; Sono, Y; Yoshioka, N; Kondo, K; Sekine, O; Yoshizaki, T; Ugi, S; Uzu, T; Kawai, H; Makino, T; Okamura, T; Yamamoto, M; Kashiwagi, A; Maegawa, H				Ishikado, Atsushi; Morino, Katsutaro; Nishio, Yoshihiko; Nakagawa, Fumiyuki; Mukose, Atsushi; Sono, Yoko; Yoshioka, Nagisa; Kondo, Keiko; Sekine, Osamu; Yoshizaki, Takeshi; Ugi, Satoshi; Uzu, Takashi; Kawai, Hiromichi; Makino, Taketoshi; Okamura, Tomio; Yamamoto, Masayuki; Kashiwagi, Atsunori; Maegawa, Hiroshi			4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; VASCULAR OXIDATIVE STRESS; EICOSAPENTAENOIC ACID; HEME OXYGENASE-1; ANTIOXIDANT RESPONSE; HYPERCHOLESTEROLEMIC PATIENTS; ADHESION MOLECULES; INDUCED EXPRESSION; GENE-EXPRESSION; FISH-OIL	Recent studies have proposed that n-3 polyunsaturated fatty acids (n-3 PUFAs) have direct antioxidant and anti-inflammatory effects in vascular tissue, explaining their cardioprotective effects. However, the molecular mechanisms are not yet fully understood. We tested whether n-3 PUFAs showed antioxidant activity through the activation of nuclear factor erythroid 2-related factor 2 (Nrf2), a master transcriptional factor for antioxidant genes. C57BL/6 or Nrf2(-/-) mice were fed a fish-oil diet for 3 weeks. Fish-oil diet significantly increased the expression of heme oxygenase-1 (HO-1), and endothelium-dependent vasodilation in the aorta of C57BL/6 mice, but not in the Nrf2(-/-) mice. Furthermore, we observed that 4-hydroxy hexenal (4-HHE), an end-product of n-3 PUFA peroxidation, was significantly increased in the aorta of C57BL/6 mice, accompanied by intra-aortic predominant increase in docosahexaenoic acid (DHA) rather than that in eicosapentaenoic acid (EPA). Human umbilical vein endothelial cells were incubated with DHA or EPA. We found that DHA, but not EPA, markedly increased intracellular 4-HHE, and nuclear expression and DNA binding of Nrf2. Both DHA and 4-HHE also increased the expressions of Nrf2 target genes including HO-1, and the siRNA of Nrf2 abolished these effects. Furthermore, DHA prevented oxidant-induced cellular damage or reactive oxygen species production, and these effects were disappeared by an HO-1 inhibitor or the siRNA of Nrf2. Thus, we found protective effects of DHA through Nrf2 activation in vascular tissue, accompanied by intra-vascular increases in 4-HHE, which may explain the mechanism of the cardioprotective effects of DHA.	[Nishio, Yoshihiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Diabet Metab & Endocrinol, Kagoshima 890, Japan; [Nakagawa, Fumiyuki; Yoshioka, Nagisa] JCL Bioassay Corp, Osaka Lab, Osaka, Japan; [Ishikado, Atsushi; Sono, Yoko; Makino, Taketoshi] Sunstar Inc, Dept Res & Dev, Osaka, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Kagoshima University; Tohoku University	Nishio, Y (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Diabet Metab & Endocrinol, Kagoshima 890, Japan.	ynishio@m3.kufm.kagoshima-u.ac.jp	Koya, Daisuke/J-3257-2014; Yamamoto, Masayuki/A-4873-2010; MORINO, KATSUTARO/I-3207-2019; Kashiwagi, Atsunori/H-8712-2019	Yamamoto, Masayuki/0000-0002-9073-9436; MORINO, KATSUTARO/0000-0003-2420-3817; Kondo, Keiko/0000-0002-9709-4474; Maegawa, Hiroshi/0000-0002-4611-8149	Kimura Memorial Heart Foundation; Diabetes Masters Conference; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [24591350] Funding Source: KAKEN	Kimura Memorial Heart Foundation; Diabetes Masters Conference; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by Kimura Memorial Heart Foundation, Diabetes Masters Conference and Japan Diabetes Foundation (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2012, BIOCHEM J, V441, P359, DOI 10.1042/BJ20110626; Bowen CL, 2010, J CHROMATOGR B, V878, P3125, DOI 10.1016/j.jchromb.2010.09.020; Calzada C, 2010, ATHEROSCLEROSIS, V208, P467, DOI 10.1016/j.atherosclerosis.2009.07.049; Cao JA, 2011, HUM GENE THER, V22, P271, DOI 10.1089/hum.2010.059; Casos K, 2010, FREE RADICAL RES, V44, P821, DOI 10.3109/10715762.2010.485992; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Chung HT, 2008, CURR PHARM DESIGN, V14, P422, DOI 10.2174/138161208783597335; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Freidja ML, 2011, J HYPERTENS, V29, P102, DOI 10.1097/HJH.0b013e32833db36e; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gladine C, 2012, BRIT J NUTR, V107, P1254, DOI 10.1017/S0007114511004259; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 1999, LANCET, V354, P447; Hashimoto M, 1999, LIPIDS, V34, P1297, DOI 10.1007/s11745-999-0481-6; Ishikado A, 2012, FREE RADIC IN PRESS; Ishikado A, 2010, BIOCHEM BIOPH RES CO, V402, P99, DOI 10.1016/j.bbrc.2010.09.124; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Majkova Z, 2011, TOXICOL APPL PHARM, V251, P41, DOI 10.1016/j.taap.2010.11.013; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; O'Brien-Coker IC, 2001, RAPID COMMUN MASS SP, V15, P920, DOI 10.1002/rcm.324; Ober MD, 1998, PROSTAG LEUKOTR ESS, V59, P127, DOI 10.1016/S0952-3278(98)90091-6; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Peake JM, 2011, MOL NUTR FOOD RES, V55, P400, DOI 10.1002/mnfr.201000195; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Saito Y, 2008, ATHEROSCLEROSIS, V200, P135, DOI 10.1016/j.atherosclerosis.2008.06.003; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Sekikawa A, 2011, STROKE, V42, P2538, DOI 10.1161/STROKEAHA.110.613042; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang DH, 2009, J CARDIOL, V54, P368, DOI 10.1016/j.jjcc.2009.06.004; Wang H, 2010, MOL PHARMACEUT, V7, P2185, DOI 10.1021/mp100199m; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; WEBER C, 1995, ARTERIOSCL THROM VAS, V15, P622, DOI 10.1161/01.ATV.15.5.622; Yamada H, 2008, ARTERIOSCL THROM VAS, V28, P2173, DOI 10.1161/ATVBAHA.108.171736; Yang YC, 2013, J NUTR BIOCHEM, V24, P204, DOI 10.1016/j.jnutbio.2012.05.003; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	51	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69415	10.1371/journal.pone.0069415	http://dx.doi.org/10.1371/journal.pone.0069415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936010	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000117
J	Anderson, AS; Storlie, CJ; Shoo, LP; Pearson, RG; Williams, SE				Anderson, Alexander S.; Storlie, Collin J.; Shoo, Luke P.; Pearson, Richard G.; Williams, Stephen E.			Current Analogues of Future Climate Indicate the Likely Response of a Sensitive Montane Tropical Avifauna to a Warming World	PLOS ONE			English	Article							ELEVATIONAL RANGE SHIFTS; AUSTRALIAN WET TROPICS; RAIN-FOREST BIRDS; DISTRIBUTION MODELS; EXTINCTION; IMPACTS; NORTHERN; HABITAT; VULNERABILITY; ABUNDANCE	Among birds, tropical montane species are likely to be among the most vulnerable to climate change, yet little is known about how climate drives their distributions, nor how to predict their likely responses to temperature increases. Correlative models of species' environmental niches have been widely used to predict changes in distribution, but direct tests of the relationship between key variables, such as temperature, and species' actual distributions are few. In the absence of historical data with which to compare observations and detect shifts, space-for-time substitutions, where warmer locations are used as analogues of future conditions, offer an opportunity to test for species' responses to climate. We collected density data for rainforest birds across elevational gradients in northern and southern subregions within the Australian Wet Tropics (AWT). Using environmental optima calculated from elevational density profiles, we detected a significant elevational difference between the two regions in ten of 26 species. More species showed a positive (19 spp.) than negative (7 spp.) displacement, with a median difference of similar to 80.6 m across the species analysed that is concordant with that expected due to latitudinal temperature differences (similar to 75.5 m). Models of temperature gradients derived from broad-scale climate surfaces showed comparable performance to those based on in-situ measurements, suggesting the former is sufficient for modeling impacts. These findings not only confirm temperature as an important factor driving elevational distributions of these species, but also suggest species will shift upslope to track their preferred environmental conditions. Our approach uses optima calculated from elevational density profiles, offering a data-efficient alternative to distribution limits for gauging climate constraints, and is sensitive enough to detect distribution shifts in this avifauna in response to temperature changes of as little as 0.4 degrees. We foresee important applications in the urgent task of detecting and monitoring impacts of climate change on montane tropical biodiversity.	[Anderson, Alexander S.; Storlie, Collin J.; Williams, Stephen E.] James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Shoo, Luke P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Pearson, Richard G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; University of Queensland; James Cook University	Anderson, AS (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.	alexander.anderson@my.jcu.edu.au	Anderson, Alexander/G-6937-2013; Shoo, Luke P/A-2715-2009; Pearson, Richard/GQH-2760-2022; Williams, Stephen E/A-7250-2008	Williams, Stephen E/0000-0002-2510-7408; Pearson, Richard/0000-0001-6047-031X	Australian Government's National Environmental Research Program; Stuart Leslie Bird Research Award from Birds Australia; Earthwatch Institute; Marine and Tropical Sciences Research Facility (MTSRF)	Australian Government's National Environmental Research Program(Australian Government); Stuart Leslie Bird Research Award from Birds Australia; Earthwatch Institute; Marine and Tropical Sciences Research Facility (MTSRF)	This research was funded by the Australian Government's National Environmental Research Program, the Stuart Leslie Bird Research Award from Birds Australia (http://www.birdsaustralia.com.au/), the Earthwatch Institute (http://www.earthwatch.org/australia/), the Marine and Tropical Sciences Research Facility (MTSRF: http://www.rrrc.org.au/mtsrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; AUSTIN MP, 1976, VEGETATIO, V33, P33, DOI 10.1007/BF00055297; Austin MP, 2006, ECOL MODEL, V199, P20, DOI [10.1016/j.ecolmodel.2006.05.023, DOI 10.1016/J.EC0LM0-DEL.2006.05.023]; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Birdlife International, 2008, STAT WORLDS BIRDS, P1; Boyle WA, 2010, P ROY SOC B-BIOL SCI, V277, P2511, DOI 10.1098/rspb.2010.0344; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Dutson G., 2009, AUSTR IMPORTANT BIRD; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hilbert D., 2010, THREATS ECOSYSTEMS W, P24; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; Houlder D, 2000, ANUCLIM 5 0; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; HUISMAN J, 1993, J VEG SCI, V4, P37, DOI 10.2307/3235732; Humphries MM, 2004, INTEGR COMP BIOL, V44, P152, DOI 10.1093/icb/44.2.152; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; JOSEPH L, 1994, AUST J ZOOL, V42, P385, DOI 10.1071/ZO9940385; KEAST A, 1981, ECOLOGICAL BIOGEOGRA; Kindt R, 2011, R PACKAGE BIODIVERSI, P1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J, 2001, ECOLOGY, V82, P1191, DOI 10.2307/2679914; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Payton M, 2003, J INSECT SCI, V34, pE1; Peterson A. Townsend, 2008, Biodiversity (Ottawa), V9, P114; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; *QUEENSL HERB, 2011, REG EC DESCR DAT RED; R Development Core Team, 2011, R LANG ENV STAT COMP; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rastetter EB, 1996, BIOSCIENCE, V46, P190, DOI 10.2307/1312740; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stork NE, 2008, LIVING DYNAMIC TROPI, P663; Storlie CJ, 2013, DIVERS DISTRIB, V19, P1; Suppiah R., 2007, CLIMATE CHANGE UNPUB, P38; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams S. E., 1996, Pacific Conservation Biology, V2, P327; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	72	17	19	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69393	10.1371/journal.pone.0069393	http://dx.doi.org/10.1371/journal.pone.0069393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936005	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000322633700028
J	Pistis, G; Okonkwo, SU; Traglia, M; Sala, C; Shin, SY; Masciullo, C; Buetti, I; Massacane, R; Mangino, M; Thein, SL; Spector, TD; Ganesh, S; Pirastu, N; Gasparini, P; Soranzo, N; Camaschella, C; Hart, D; Green, MR; Toniolo, D				Pistis, Giorgio; Okonkwo, Shawntel U.; Traglia, Michela; Sala, Cinzia; Shin, So-Youn; Masciullo, Corrado; Buetti, Iwan; Massacane, Roberto; Mangino, Massimo; Thein, Swee-Lay; Spector, Timothy D.; Ganesh, Santhi; Pirastu, Nicola; Gasparini, Paolo; Soranzo, Nicole; Camaschella, Clara; Hart, Daniel; Green, Michael R.; Toniolo, Daniela		CHARGE Consortium Hematology	Genome Wide Association Analysis of a Founder Population Identified TAF3 as a Gene for MCHC in Humans	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; HERITABILITY; CONSORTIUM; MEMBRANE; TRAITS; ANEMIA; CELLS; BIRTH	The red blood cell related traits are highly heritable but their genetics are poorly defined. Only 5-10% of the total observed variance is explained by the genetic loci found to date, suggesting that additional loci should be searched using approaches alternative to large meta analysis. GWAS (Genome Wide Association Study) for red blood cell traits in a founder population cohort from Northern Italy identified a new locus for mean corpuscular hemoglobin concentration (MCHC) in the TAF3 gene. The association was replicated in two cohorts (rs1887582, P = 4.25E-09). TAF3 encodes a transcription cofactor that participates in core promoter recognition complex, and is involved in zebrafish and mouse erythropoiesis. We show here that TAF3 is required for transcription of the SPTA1 gene, encoding alpha spectrin, one of the proteins that link the plasma membrane to the actin cytoskeleton. Mutations in SPTA1 are responsible for hereditary spherocytosis, a monogenic disorder of MCHC, as well as for the normal MCHC level. Based on our results, we propose that TAF3 is required for normal erythropoiesis in human and that it might have a role in controlling the ratio between hemoglobin (Hb) and cell volume and in the dynamics of RBC maturation in healthy individuals. Finally, TAF3 represents a potential candidate or a modifier gene for disorders of red cell membrane.	[Pistis, Giorgio; Traglia, Michela; Sala, Cinzia; Masciullo, Corrado; Buetti, Iwan; Camaschella, Clara; Toniolo, Daniela] San Raffaele Res Inst, Div Genet & Cell Biol, Milan, Italy; [Pistis, Giorgio; Traglia, Michela; Sala, Cinzia; Masciullo, Corrado; Buetti, Iwan; Camaschella, Clara; Toniolo, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Okonkwo, Shawntel U.; Hart, Daniel] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Shin, So-Youn; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Massacane, Roberto] Novi Ligure Hosp, Novi Ligure, AL, Italy; [Mangino, Massimo; Spector, Timothy D.; Soranzo, Nicole] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Thein, Swee-Lay] Kings Coll London, Dept Mol Hematol, London, England; [Ganesh, Santhi] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA; [Pirastu, Nicola; Gasparini, Paolo] Univ Trieste, Dept Reprod Sci & Dev, Trieste, Italy; [Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Lab Med, Trieste, Italy; [Hart, Daniel; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express & Mol Med, Worcester, MA 01605 USA; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy	Vita-Salute San Raffaele University; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; University of London; King's College London; University of London; King's College London; University of Michigan System; University of Michigan; University of Trieste; IRCCS Burlo Garofolo; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Toniolo, D (corresponding author), San Raffaele Res Inst, Div Genet & Cell Biol, Milan, Italy.	daniela.toniolo@hsr.it	Toniolo, Daniela/AAE-2969-2019; Camaschella, Clara/A-3289-2015; Cushman, Mary/K-1157-2019; Pirastu, Nicola/AHB-6226-2022; Gudnason, Vilmundur/K-6885-2015; Sala, Cinzia Felicita/AAN-1900-2020; Gasparini, Paolo/B-6173-2014; Mangino, Massimo/F-5134-2011; Aspelund, Thor/C-5983-2008; Traglia, Michela/AAX-5816-2020; Smith, Albert Vernon/K-5150-2015	Toniolo, Daniela/0000-0001-9545-6032; Cushman, Mary/0000-0002-7871-6143; Gudnason, Vilmundur/0000-0001-5696-0084; Mangino, Massimo/0000-0002-2167-7470; Aspelund, Thor/0000-0002-7998-5433; Soranzo, Nicole/0000-0003-1095-3852; Smith, Albert Vernon/0000-0003-1942-5845; Chen, Ming-Huei/0000-0003-3551-8726; Van Duijn, Cornelia/0000-0002-2374-9204; Gasparini, Paolo/0000-0002-0859-0856; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Pirastu, Nicola/0000-0002-5363-3886; s, hema/0000-0002-3440-9475	Compagnia di San Paolo, Torino, Italy; Fondazione Cariplo, Italy; Ministry of Health, Ricerca Finalizzata [RF-2009-1530968]; Ministry of Health; Fondo Trieste; FVG Region; Wellcome Trust; European Community [HEALTH-F2-2008-201865-GEFOS]; ENGAGE project [HEALTH-F4-2007-201413]; FP-5 GenomEUtwin Project [QLG2-CT-2002-01254]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; Biotechnology and Biological Sciences Research Council (BBSRC) [G20234]; National Eye Institute via an NIH/CIDR genotyping project; NEI/NIH; NIH [N01.AG. 12100]; NIA Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute's Framingham Heart Study [N01.HC. 25195]; Affymetrix, Inc. [N02.HL.6. 4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Italian Ministry of Health; U. S. National Institute on Aging [N01.AG. 916413, N01.AG. 821336, 263 MD 9164 13, 263 MD 821336]; Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI)/NWO [050 060 810]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands organization for scientific research (NWO); Netherlands Organization for the Health Research and Development (ZonMw); Netherlands Heart Foundation; Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; US National Institutes of Health [R01GM033977]; Medical Research Council [G0000111] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008574, R01GM033977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, ZIAAG007380, ZIAAG006000] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; MRC [G0000111] Funding Source: UKRI	Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Fondazione Cariplo, Italy(Fondazione Cariplo); Ministry of Health, Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Ministry of Health; Fondo Trieste; FVG Region(Regione Friuli Venezia Giulia); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); ENGAGE project(General Electric); FP-5 GenomEUtwin Project; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London(General Electric); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Eye Institute via an NIH/CIDR genotyping project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc.; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Italian Ministry of Health(Ministry of Health, Italy); U. S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI)/NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by funds from Compagnia di San Paolo, Torino, Italy (www.compagnia.torino.it/); Fondazione Cariplo, Italy (www.fondazionecariplo.it/) and Ministry of Health, Ricerca Finalizzata 2009 (RF-2009-1530968) to DT. The research was supported by funds from Ministry of Health (to PG), Fondo Trieste (to PG) and FVG Region (to PG). The study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also received support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant. (G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). Genotyping was also performed by CIDR as part of an NEI/NIH project grant. The Age, Gene/Environment Susceptibility Reykjavik Study is funded by NIH contract N01.AG. 12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association) and the Althingi (the Icelandic Parliament). The National Heart, Lung, and Blood Institute's Framingham Heart Study is a joint project of the National Institutes of Health and Boston University School of Medicine and was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract No. N01.HC. 25195) and its contract with Affymetrix, Inc. for genotyping services (contract No. N02.HL.6. 4278). A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA.II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The Invecchiare in Chianti (InCHIANTI) The InCHIANTI Study was supported as a "targeted project" (ICS 110.1RS97.71) by the Italian Ministry of Health, by the U. S. National Institute on Aging (Contracts N01.AG. 916413, N01.AG. 821336, 263 MD 9164 13, and 263 MD 821336) and in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health, USA. The GWAS database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011, 911.03.012) and the Research Institute for Diseases in the Elderly (RIDE). This study was supported by the Netherlands Genomics Initiative (NGI)/NWO project number 050 060 810 (Netherlands Consortium for Healthy Ageing). The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands organization for scientific research (NWO), the Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Heart Foundation, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The functional work was supported by US National Institutes of Health grant R01GM033977 to MRG. MRG is an investigator of the Howard Hughes Medical Institute.; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Colonna V, 2013, EUR J HUM GENET, V21, P89, DOI 10.1038/ejhg.2012.113; Eisenstaedt R, 2006, BLOOD REV, V20, P213, DOI 10.1016/j.blre.2005.12.002; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kamatani Y, NAT GENET, V42, P210; LEW VL, 1995, BLOOD, V86, P334, DOI 10.1182/blood.V86.1.334.bloodjournal861334; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; NUDEL U, 1977, P NATL ACAD SCI USA, V74, P1100, DOI 10.1073/pnas.74.3.1100; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sala C, 2008, HAEMATOL-HEMATOL J, V93, P1372, DOI 10.3324/haematol.12915; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; van der Harst P, 2012, NATURE; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016	23	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69206	10.1371/journal.pone.0069206	http://dx.doi.org/10.1371/journal.pone.0069206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935956	gold, Green Submitted, Green Published			2022-12-27	WOS:000322633700021
J	Mousseau, TA; Moller, AP				Mousseau, Timothy Alexander; Moller, Anders Pape			Elevated Frequency of Cataracts in Birds from Chernobyl	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; SAMPLE-SIZE; RADIATION; RISK; TRANSPLANTATION; ABUNDANCE; SURVIVORS; EXPOSURE	Background: Radiation cataracts develop as a consequence of the effects of ionizing radiation on the development of the lens of the eye with an opaque lens reducing or eliminating the ability to see. Therefore, we would expect cataracts to be associated with reduced fitness in free-living animals. Methodology/Principal Findings: We investigated the incidence of lens opacities typical of cataracts in more than 1100 free-living birds in the Chernobyl region in relation to background radiation. The incidence of cataracts increased with level of background radiation both in analyses based on a dichotomous score and in analyses of continuous scores of intensity of cataracts. The odds ratio per unit change in the regressor was 0.722 (95% CI 0.648, 0.804), which was less than odds ratios from investigations of radiation cataracts in humans. The relatively small odds ratio may be due to increased mortality in birds with cataracts. We found a stronger negative relationship between bird abundance and background radiation when the frequency of cataracts was higher, but also a direct effect of radiation on abundance, suggesting that radiation indirectly affects abundance negatively through an increase in the frequency of cataracts in bird populations, but also through direct effects of radiation on other diseases, food abundance and interactions with other species. There was no increase in incidence of cataracts with increasing age, suggesting that yearlings and older individuals were similarly affected as is typical of radiation cataract. Conclusions/Significance: These findings suggest that cataracts are an under-estimated cause of morbidity in free-living birds and, by inference, other vertebrates in areas contaminated with radioactive materials.	[Mousseau, Timothy Alexander] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.	anders.moller@u-psud.fr	Moller, Anders/O-6665-2016; Mousseau, Timothy A/A-1253-2011	Moller, Anders/0000-0003-3739-4675; Mousseau, Timothy/0000-0002-2235-4868	US National Science Foundation; University of South Carolina; North Atlantic Treaty Organization Collaborative Linkage Grant program; Civilian Research and Development Foundation; Fulbright Program; National Geographic Society; Samuel Freeman Charitable Trust	US National Science Foundation(National Science Foundation (NSF)); University of South Carolina; North Atlantic Treaty Organization Collaborative Linkage Grant program; Civilian Research and Development Foundation; Fulbright Program; National Geographic Society(National Geographic Society); Samuel Freeman Charitable Trust	Financial support was received from the US National Science Foundation, the University of South Carolina, the North Atlantic Treaty Organization Collaborative Linkage Grant program, the Civilian Research and Development Foundation, the Fulbright Program, the National Geographic Society, and the Samuel Freeman Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ann ICRP, V21, P1; Arichin AN, 1998, KURRI KR, V21, P168; Asherie N, 2011, P NATL ACAD SCI USA, V108, P437, DOI 10.1073/pnas.1017543108; Baum ED, 2002, NUCL ISOTOPES CHART; Bibby CJ, 2005, BIRD CENSUS TECHNIQU; Chodick G, 2008, AM J EPIDEMIOL, V168, P620, DOI 10.1093/aje/kwn171; Chumak VV, 2007, RADIAT RES, V167, P606, DOI 10.1667/RR0302.1; Ciraj-Bjelac O, 2010, CATHETER CARDIO INTE, V76, P826, DOI 10.1002/ccd.22670; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLMAN GW, 1988, AM J PUBLIC HEALTH, V78, P1459, DOI 10.2105/AJPH.78.11.1459; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Dunn Erica H., 2004, Studies in Avian Biology, P1; Galvan I, 2012, COMP BIOCHEM PHYS A, V162, P259, DOI 10.1016/j.cbpa.2012.03.012; Galvan I, 2011, OECOLOGIA, V165, P827, DOI 10.1007/s00442-010-1860-5; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Gottlober P, 2001, RADIAT RES, V155, P409, DOI 10.1667/0033-7587(2001)155[0409:TOOLRI]2.0.CO;2; Gurney JG, 2006, CANCER-AM CANCER SOC, V106, P1402, DOI 10.1002/cncr.21752; International Commission on Radiological Protection ICRP, 1990, ICRP PUBL, V20; Junk AK, 1998, NATO SCI SERIES, V50, P33; KEYMER IF, 1977, AVIAN PATHOL, V6, P335, DOI 10.1080/03079457708418243; Levy JMM, 2013, PEDIATR BLOOD CANCER, V60, P700, DOI 10.1002/pbc.24252; Li CC, 1975, PATH ANAL PRIMER; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2007, P ROY SOC B-BIOL SCI, V274, P1443, DOI 10.1098/rspb.2007.0005; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Moller AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035223; Moller AP, 2011, ECOL INDIC, V11, P424, DOI 10.1016/j.ecolind.2010.06.013; Moller AP, 2009, J ORNITHOL, V150, P239, DOI 10.1007/s10336-008-0343-5; Moller AP, 1983, METHODS MONITORING B; Neriishi Kazuo, 2007, Radiation Research, V168, P404, DOI 10.1667/RR0928.1; Neter J., 1996, APPL LINEAR STAT MOD; SAS Institute Inc, 2012, JMP VERS 10 0; Serdiuk A., 2011, HLTH EFFECTS CHORNOB; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; Shore RE, 2010, RADIAT RES, V174, P889, DOI 10.1667/RR1884.1; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Svensson L.A., 2006, IDENTIFICATION GUIDE; TAYLOR A, 1995, AM J CLIN NUTR, V62, P1439, DOI 10.1093/ajcn/62.6.1439S; Tetz MR, 1997, J CATARACT REFR SURG, V23, P1515, DOI 10.1016/S0886-3350(97)80022-3; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, EFF, VII; van Kempen-Harteveld ML, 2002, INT J RADIAT ONCOL, V52, P1375, DOI 10.1016/S0360-3016(01)02757-2; Voitsekhoviych OV., 2007, CHERNOBYL WHAT HAVE, P9, DOI [10.1007/1-4020-5349-5_2, DOI 10.1007/1-4020-5349-5_2]; Vorisek P, 2010, BEST PRACTICE GUIDE; Woraul BV, 2007, RADIAT RES, V167, P233, DOI 10.1667/RR0298.1; YABLOKOV A. V., 2009, CHERNOBYL CONSEQUENC; Garamszegi LZ, 2012, BEHAV ECOL SOCIOBIOL, V66, P1363, DOI 10.1007/s00265-012-1370-z	50	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e66939	10.1371/journal.pone.0066939	http://dx.doi.org/10.1371/journal.pone.0066939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935827	gold, Green Published			2022-12-27	WOS:000323114200003
J	Qian, GQ; Cao, J; Chen, C; Wang, LX; Huang, XY; Ding, C; Cai, XD; Yin, FY; Chu, JG; Li, GX; Ye, JY				Qian, Guoqing; Cao, Jin; Chen, Chan; Wang, Liangxing; Huang, Xiaoying; Ding, Cheng; Cai, Xueding; Yin, Fengying; Chu, Jinguo; Li, Guoxiang; Ye, Jinyan			Paeoniflorin Inhibits Pulmonary Artery Smooth Muscle Cells Proliferation via Upregulating A(2B) Adenosine Receptor in Rat	PLOS ONE			English	Article							MASS-SPECTROMETRY METHOD; INCREASE; GROWTH	Paeoniflorin (PF), which is the main active ingredient in the root of Paeonia Radix, has many pharmacological effects. Here, we investigated the effect of PF on rat pulmonary artery smooth muscle cells (PASMCs) under hypoxic conditions and explored the mechanisms of the effects. The anti-proliferative effect of PF increased in a dose dependent manner. At the highest dose (20 mu mol/L), the anti-proliferative effect of PF peaked at 24 h after administration. However, the selective A(2B) adenosine receptor (A(2B)AR) antagonist MRS1754 abolished it. PF increased A(2B)AR mRNA levels from 0.0763 +/- 0.0067 of beta-actin mRNA levels (hypoxia group) to 0.1190 +/- 0.0139 (P < 0.05) measured by Real Time Reverse Transcription-Polymerase Chain Reaction. A(2B)AR protein expression measured by Western Blot was also increased. PF inhibited the proliferation of PASMCs by blocking cell cycle progression in the S phase. These data indicated that activation of A(2B)AR might be involved in the anti-proliferative effect of PF on PASMCs under hypoxic conditions. The results suggested that a new mechanism of PF could be relevant to the management of clinical hypoxic pulmonary hypertension.	[Qian, Guoqing; Wang, Liangxing; Huang, Xiaoying; Ding, Cheng; Cai, Xueding; Ye, Jinyan] Wenzhou Med Coll, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang, Peoples R China; [Qian, Guoqing; Chu, Jinguo; Li, Guoxiang] Ningbo Univ, Sch Med, Affiliated Ningbo Hosp 1, Dept Resp & Infect Dis, Ningbo 315211, Zhejiang, Peoples R China; [Cao, Jin] Ningbo Univ, Affiliated Hosp, Sch Med, Dept Ophthalmol, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Chan] Wenzhou Med Coll, Affiliated Hosp 1, Dept Geriatr Med, Wenzhou, Zhejiang, Peoples R China; [Yin, Fengying] Ningbo Univ, Affiliated Ningbo Hosp 1, Sch Med, Dept Med Ultrasound, Ningbo 315211, Zhejiang, Peoples R China	Wenzhou Medical University; Ningbo University; Ningbo University; Wenzhou Medical University; Ningbo University	Wang, LX (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang, Peoples R China.	wzyxywlx@163.com	Qian, Guoqing/GRX-0691-2022	Qian, Guoqing/0000-0003-2427-8042	National Natural Science Foundation of China [81270110]; Zhejiang Provincial Natural Science Foundation of China [Y2101208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by National Natural Science Foundation of China (No. 81270110), http://www.nsfc.gov.cn/Portal0/default152.htm Zhejiang Provincial Natural Science Foundation of China (No. Y2101208), http://www.zjnsf.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360; Dubey RK, 1996, HYPERTENSION, V27, P786, DOI 10.1161/01.HYP.27.3.786; Dubey RK, 2000, HYPERTENSION, V35, P267, DOI 10.1161/01.HYP.35.1.267; Dubey RK, 1998, HYPERTENSION, V31, P516, DOI 10.1161/01.HYP.31.1.516; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; Fozard JR, 2000, CLIN EXP ALLERGY, V30, P1213; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hilaire CS, 2008, BIOCHEM BIOPH RES CO, V375, P292, DOI 10.1016/j.bbrc.2008.07.059; Kaiqi Z, 2008, CHINESE PHARMACOL B, V24, P1280; KQ Z, 2008, CHINESE PHARMACOL B, V24, P1280; Lai CW, 1998, LIFE SCI, V62, P1591, DOI 10.1016/S0024-3205(98)00112-X; Liu DZ, 2005, BRIT J PHARMACOL, V146, P604, DOI 10.1038/sj.bjp.0706335; Michoud MC, 2002, AM J RESP CELL MOL, V27, P732, DOI 10.1165/rcmb.4768; Nan Jin S, 2012, J ETHNOPHARMACOLOGY; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; SUGISHITA E, 1984, J PHARMACOBIO-DYNAM, V7, P427; Takeda S, 1995, J PHARM PHARMACOL, V47, P1036, DOI 10.1111/j.2042-7158.1995.tb03293.x; Wakeno M, 2006, CIRCULATION, V114, P1923, DOI 10.1161/CIRCULATIONAHA.106.630087; Wang Q, 2006, BIOMED CHROMATOGR, V20, P173, DOI 10.1002/bmc.548; Xia S, 1995, J JIANGHAN U, V12, P4; Xia SM, 2007, J CHROMATOGR B, V857, P32, DOI 10.1016/j.jchromb.2007.06.022; YAMAHARA J, 1982, J PHARMACOBIO-DYNAM, V5, P921; Zeng DW, 2003, DRUG DEVELOP RES, V58, P405, DOI 10.1002/ddr.10212; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC; Zhou AM, 2004, NEUROSCI RES, V48, P397, DOI 10.1016/j.neures.2003.12.010	29	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69141	10.1371/journal.pone.0069141	http://dx.doi.org/10.1371/journal.pone.0069141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935939	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200025
J	Verbyla, KL; Yap, VB; Pahwa, A; Shao, YL; Huttley, GA				Verbyla, Klara L.; Von Bing Yap; Pahwa, Anuj; Shao, Yunli; Huttley, Gavin A.			The Embedding Problem for Markov Models of Nucleotide Substitution	PLOS ONE			English	Article							RATE HETEROGENEITY; MITOCHONDRIAL-DNA; TIME; REPRESENTATION; SEQUENCES; CHAIN	Continuous-time Markov processes are often used to model the complex natural phenomenon of sequence evolution. To make the process of sequence evolution tractable, simplifying assumptions are often made about the sequence properties and the underlying process. The validity of one such assumption, time-homogeneity, has never been explored. Violations of this assumption can be found by identifying non-embeddability. A process is non-embeddable if it can not be embedded in a continuous time-homogeneous Markov process. In this study, non-embeddability was demonstrated to exist when modelling sequence evolution with Markov models. Evidence of non-embeddability was found primarily at the third codon position, possibly resulting from changes in mutation rate over time. Outgroup edges and those with a deeper time depth were found to have an increased probability of the underlying process being non-embeddable. Overall, low levels of non-embeddability were detected when examining individual edges of triads across a diverse set of alignments. Subsequent phylogenetic reconstruction analyses demonstrated that non-embeddability could impact on the correct prediction of phylogenies, but at extremely low levels. Despite the existence of non-embeddability, there is minimal evidence of violations of the local time homogeneity assumption and consequently the impact is likely to be minor.	[Verbyla, Klara L.; Pahwa, Anuj; Shao, Yunli; Huttley, Gavin A.] Australian Natl Univ, John Curtin Sch Med Res, Computat Genom Lab, Canberra, ACT 2601, Australia; [Von Bing Yap] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Verbyla, Klara L.] CSIRO, CSIRO Math Informat & Stat, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; National University of Singapore; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Verbyla, KL (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Computat Genom Lab, Canberra, ACT 2601, Australia.	klara.verbyla@csiro.au; gavin.huttley@anu.edu.au	Huttley, Gavin A/G-5169-2015; Verbyla, Klara/D-9907-2019	Huttley, Gavin A/0000-0001-7224-2074; Verbyla, Klara/0000-0001-8876-4301	ARC grant (Australian Research Council)	ARC grant (Australian Research Council)(Australian Research Council)	Research was funded by an ARC grant (Australian Research Council - http://www.arcw.gov.au/) awarded to GAH and VBY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Bevan RB, 2007, SYST BIOL, V56, P194, DOI 10.1080/10635150701291804; Bofkin L, 2007, MOL BIOL EVOL, V24, P513, DOI 10.1093/molbev/msl178; Carette P, 1999, J APPL PROBAB, V36, P644, DOI 10.1017/S0021900200017460; Carette P, 1998, APPL STOCH MODEL D A, V14, P219, DOI 10.1002/(SICI)1099-0747(199809)14:3<219::AID-ASM349>3.3.CO;2-X; Chang JT, 1996, MATH BIOSCI, V137, P51, DOI 10.1016/S0025-5564(96)00075-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Elfving G., 1937, ACTA SOC SCI FENN, V2, P1; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; FRYDMAN H, 1979, MATH PROC CAMBRIDGE, V86, P339, DOI 10.1017/S0305004100056152; FRYDMAN H, 1980, MATH PROC CAMBRIDGE, V87, P285, DOI 10.1017/S0305004100056735; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Galtier N, 2001, GENETICS, V159, P907; GEWEKE J, 1986, ECONOMETRICA, V54, P1407, DOI 10.2307/1914306; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; GOODMAN GS, 1970, Z WAHRSCHEINLICHKEIT, V16, P165, DOI 10.1007/BF00534594; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Ho SYW, 1999, SYST BIOL, V48, P86; Jayaswal V, 2005, EVOL BIOINFORM, V1, P62; Jayaswal V, 2011, SYST BIOL, V60, P74, DOI 10.1093/sysbio/syq076; Jermiin LS, 2011, SYST BIOL, V53, P638; JOHANSEN S, 1979, Z WAHRSCHEINLICHKEIT, V47, P107, DOI 10.1007/BF00533254; JOHANSEN S, 1974, J LOND MATH SOC, V8, P345, DOI 10.1112/jlms/s2-8.2.345; JOHANSEN S, 1973, Z WAHRSCHEINLICHKEIT, V26, P191, DOI 10.1007/BF00532721; Kallersjo M, 1999, CLADISTICS, V15, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kingman JFC, 1973, Z WAHRSCHEINLICHKEIT, V1, P14; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lindsay H, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-52; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Oscamou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-511; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Runnenberg J., 1962, P KONINKLIJKE NEDE A, V65, P536; Schranz HW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-550; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SINGER B, 1976, AM J SOCIOL, V82, P1, DOI 10.1086/226269; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Sumner JG, 2012, J THEOR BIOL, V298, P16, DOI 10.1016/j.jtbi.2011.12.017; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wolf MJ, 2000, BIOINFORMATICS, V16, P383, DOI 10.1093/bioinformatics/16.4.383; Xia XH, 1998, MOL BIOL EVOL, V15, P336, DOI 10.1093/oxfordjournals.molbev.a025930; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69187	10.1371/journal.pone.0069187	http://dx.doi.org/10.1371/journal.pone.0069187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935949	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200027
J	Liu, YK; Chen, K; Kou, X; Han, Y; Zhou, L; Zeng, CY				Liu, Yukai; Chen, Ken; Kou, Xun; Han, Yu; Zhou, Lin; Zeng, Chunyu			Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							RENIN INHIBITOR ALISKIREN; CALCIUM-ANTAGONIST TREATMENT; ANGIOTENSIN-II; BLOOD-PRESSURE; DOUBLE-BLIND; COMPARATIVE EFFICACY; COMBINATION; SAFETY; ALISKIREN/AMLODIPINE; TOLERABILITY	Background: Aliskiren is a novel renin- angiotensin aldosterone system (RAAS) inhibitor, the combination therapy of aliskiren and amlodipine for blood pressure control have been reported recently. The primary objective of this analysis is to review recently reported randomized controlled trials (RCTs) to compare antihypertensive effects and adverse events between mono (amlodipine or aliskiren alone) and combination therapy of both medicines. Methods: Databases for the search included Pubmed, Embase and the Cochrane Central Register of Controlled Trials. Revman v5.0 statistical program was used to analyze the data. Weighted mean differences (WMD) with a 95% confidence interval (CI) were used for the calculation of continuous data, and relative risk (RR) with a 95% CI was used for dichotomous data. Results: We analyzed the data from 7 RCTs for a total of 6074 participants in this meta- analysis. We found that the aliskiren/amlodipine combination therapy had a stronger effect in lowering blood pressure as compared with the monotherapy using aliskiren (SBP: WMD=-10.42, 95% CI -13.03 similar to-7.82, P<0.00001; DBP: WMD=-6.60, 95% CI -7.22 similar to-5.97, P<0.00001) or amlodipine (SBP: WMD = -4.85, 95% CI -6.88 similar to-2.81, P<0.00001; DBP: WMD = -2.91, 95% CI -3.85 similar to,-1.97, P<0.00001). No differences were found in terms of adverse events between combination therapy and monotherapy, except for the rates of peripheral edema and hypokalaemia which were significantly lower in the combination therapy than in the amlodipine monotherapy (RR = 0.78, 0.66 similar to 0.92, P = 0.004; RR = 0.51, 0.27 similar to 0.97, P = 0.04). Similar antihypertensive effects were found in both obese (body mass index >=30 kg/m(2)) hypertensive and non-obese (body mass index <30 kg/m(2)) hypertensive patients. Moreover, there was no difference with the blood pressure lowering or adverse effects with regards to the combination therapy in both subgroups. Conclusion: We found that aliskiren/ amlodipine combination therapy provided a more effective blood pressure reduction than monotherapy with either drug without increase in the occurrence of adverse events.	[Liu, Yukai; Chen, Ken; Kou, Xun; Han, Yu; Zhou, Lin; Zeng, Chunyu] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China; [Liu, Yukai; Chen, Ken; Kou, Xun; Han, Yu; Zhou, Lin; Zeng, Chunyu] Chongqing Inst Cardiol, Chongqing, Peoples R China	Army Medical University; Chinese Academy of Sciences	Zhou, L (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China.	zhoulin@mail.tmmu.com.cn; cyzeng1@hotmail.com		Chen, Ken/0000-0002-8958-1088	Natural Science Foundation Project of Chongqing Science and Technology Commission (CQ CSTC) CSTC (Chongqing Science and Technology Commission) [2009BA5044]; National Basic Research Program of China (973 Program) [2008CB517308, 012CB517801]; National Natural Science Foundation of China [30925018, 31130029, 81070559, 81270338]	Natural Science Foundation Project of Chongqing Science and Technology Commission (CQ CSTC) CSTC (Chongqing Science and Technology Commission); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation Project of Chongqing Science and Technology Commission (CQ CSTC) CSTC (Chongqing Science and Technology Commission) 2009BA5044 (http://www.ctin.ac.cn/Class.aspx?clsId = 226); the National Basic Research Program of China (973 Program, 2008CB517308, 012CB517801, http://www.973.gov.cn/AreaMana.aspx); and the grants from the National Natural Science Foundation of China (30925018, 31130029, 81070559, 81270338, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 2008, J HYPERTENS, V26, P589, DOI 10.1097/HJH.0b013e3282f3ad9a; Azizi M, 2004, J AM SOC NEPHROL, V15, P3126, DOI 10.1097/01.ASN.0000146686.35541.29; Biao X, 2002, BRIT J PHARMACOL, V136, P375, DOI 10.1038/sj.bjp.0704753; Braun-Dullaeus RC, 2012, INT J CLIN PRACT, V66, P834, DOI 10.1111/j.1742-1241.2012.02967.x; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Drummond Waymon, 2007, J Clin Hypertens (Greenwich), V9, P742, DOI 10.1111/j.1524-6175.2007.06614.x; Glorioso N, 2012, CURR VASC PHARM; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Imanishi T, 2008, HYPERTENSION, V52, P563, DOI 10.1161/HYPERTENSIONAHA.108.111120; Karas M, 2005, J HYPERTENS, V23, P1251, DOI 10.1097/01.hjh.0000170389.69202.53; Kato J, 2012, J AM SOC HYPERTENS, V6, P393, DOI 10.1016/j.jash.2012.09.001; Kato M, 2004, AM J HYPERTENS, V17, P729, DOI 10.1016/j.amjhyper.2004.05.025; KLONER RA, 1995, J CARDIOVASC PHARM, V26, P471, DOI 10.1097/00005344-199509000-00018; Lindqvist M, 2007, J HYPERTENS, V25, P169, DOI 10.1097/HJH.0b013e3280104dba; Littlejohn 3rd TW, 2012, J HUM HYPERTENS; Littlejohn TW, 2009, CURR MED RES OPIN, V25, P951, DOI 10.1185/03007990902785845 ; Moist L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-12-201206190-02009; MOOSER V, 1990, J CARDIOVASC PHARM, V15, P276, DOI 10.1097/00005344-199002000-00015; Musini VM, 2009, J HUM HYPERTENS, V23, P495, DOI 10.1038/jhh.2008.162; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Oparil S, 2007, LANCET, V370, P221, DOI 10.1016/S0140-6736(07)61124-6; Pfeiffer D, 2012, CURR VASC PHARM; Probstfield Jeffrey L, 2010, Am J Cardiol, V105, p10A, DOI 10.1016/j.amjcard.2009.10.006; Struck J, 2002, J HYPERTENS, V20, P1143, DOI 10.1097/00004872-200206000-00026; Taddei S, 2001, HYPERTENSION, V37, P943, DOI 10.1161/01.HYP.37.3.943; Tepel M, 2008, NEPHROL DIAL TRANSPL, V23, P3605, DOI 10.1093/ndt/gfn304; Villamil A, 2007, J HYPERTENS, V25, P217, DOI 10.1097/HJH.0b013e3280103a6b; Wang JG, 2005, HYPERTENSION, V45, P907, DOI 10.1161/01.HYP.0000165020.14745.79; Weinberger MH, 2011, J AM SOC HYPERTENS, V5, P489, DOI 10.1016/j.jash.2011.08.005; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	31	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70111	10.1371/journal.pone.0070111	http://dx.doi.org/10.1371/journal.pone.0070111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922924	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700136
J	Shankar, A; Singh, A; Kanwar, P; Srivastava, AK; Pandey, A; Suprasanna, P; Kapoor, S; Pandey, GK				Shankar, Alka; Singh, Amarjeet; Kanwar, Poonam; Srivastava, Ashish Kumar; Pandey, Amita; Suprasanna, Penna; Kapoor, Sanjay; Pandey, Girdhar K.			Gene Expression Analysis of Rice Seedling under Potassium Deprivation Reveals Major Changes in Metabolism and Signaling Components	PLOS ONE			English	Article							HIGH-AFFINITY POTASSIUM; CA2+-RESPONSIVE CIS-ELEMENTS; ABSCISIC-ACID; K+ CHANNEL; ABIOTIC STRESS; PROTEIN-KINASE; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTOMIC ANALYSIS; TRANSPORTER FAMILIES; UNIVALENT CATIONS	Plant nutrition is one of the important areas for improving the yield and quality in crops as well as non-crop plants. Potassium is an essential plant nutrient and is required in abundance for their proper growth and development. Potassium deficiency directly affects the plant growth and hence crop yield and production. Recently, potassium-dependent transcriptomic analysis has been performed in the model plant Arabidopsis, however in cereals and crop plants; such a transcriptome analysis has not been undertaken till date. In rice, the molecular mechanism for the regulation of potassium starvation responses has not been investigated in detail. Here, we present a combined physiological and whole genome transcriptomic study of rice seedlings exposed to a brief period of potassium deficiency then replenished with potassium. Our results reveal that the expressions of a diverse set of genes annotated with many distinct functions were altered under potassium deprivation. Our findings highlight altered expression patterns of potassium-responsive genes majorly involved in metabolic processes, stress responses, signaling pathways, transcriptional regulation, and transport of multiple molecules including K+. Interestingly, several genes responsive to low-potassium conditions show a reversal in expression upon resupply of potassium. The results of this study indicate that potassium deprivation leads to activation of multiple genes and gene networks, which may be acting in concert to sense the external potassium and mediate uptake, distribution and ultimately adaptation to low potassium conditions. The interplay of both upregulated and downregulated genes globally in response to potassium deprivation determines how plants cope with the stress of nutrient deficiency at different physiological as well as developmental stages of plants.	[Shankar, Alka; Singh, Amarjeet; Kanwar, Poonam; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Srivastava, Ashish Kumar; Suprasanna, Penna] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay 400085, Maharashtra, India	University of Delhi; Bhabha Atomic Research Center (BARC)	Pandey, GK (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	gkpandey@south.du.ac.in	PENNA, Suprasanna/AAE-1208-2022	Pandey, Amita/0000-0001-8717-3227; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Kanwar, Poonam/0000-0002-9328-9274; Srivastava, Ashish Kumar/0000-0001-9863-528X; Kapoor, Sanjay/0000-0002-0283-1137	Department of Biotechnology (DBT), Ministry of Science and Technology, India	Department of Biotechnology (DBT), Ministry of Science and Technology, India(Department of Biotechnology (DBT) India)	The research work in GKP's lab is supported by Department of Biotechnology (DBT), Ministry of Science and Technology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2004, PLANT PHYSIOL, V134, P1135, DOI 10.1104/pp.103.034660; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; Amrutha RN, 2007, PLANT SCI, V172, P708, DOI 10.1016/j.plantsci.2006.11.019; Amtmann A, 2005, PLANT PHYSIOL, V138, P127, DOI 10.1104/pp.105.059972; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Armengaud P, 2010, MOL PLANT, V3, P390, DOI 10.1093/mp/ssq012; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Bajguz A, 2009, J PLANT PHYSIOL, V166, P882, DOI 10.1016/j.jplph.2008.10.004; Banuelos MA, 2002, PLANT PHYSIOL, V130, P784, DOI 10.1104/pp.007781; Basile B, 2003, SCI HORTIC-AMSTERDAM, V98, P185, DOI 10.1016/S0304-4238(02)00214-5; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Benlloch-Gonzalez M, 2010, J EXP BOT, V61, P1139, DOI 10.1093/jxb/erp379; Bhattacharjee S., 2005, CURR SCI, V89, P7; Castillejo M. A., 2008, OPEN PROTEOMICS J, V1, P59, DOI DOI 10.2174/1875039700801010059; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Corratge C, 2007, J BIOL CHEM, V282, P26057, DOI 10.1074/jbc.M611613200; Czempinski K, 1997, EMBO J, V16, P2565, DOI 10.1093/emboj/16.10.2565; Dare AP, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-17; DELAGUARDIA M, 1980, PHYSIOL PLANTARUM, V49, P443, DOI 10.1111/j.1399-3054.1980.tb03332.x; DHINDSA RS, 1975, PLANT PHYSIOL, V55, P778, DOI 10.1104/pp.55.4.778; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Finkler A, 2007, PLANT SIGNAL BEHAV, V2, P17, DOI 10.4161/psb.2.1.3611; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; GILMARTIN PM, 1990, PLANT CELL, V2, P447, DOI 10.1105/tpc.2.5.447; Grabov A, 2007, ANN BOT-LONDON, V99, P1035, DOI 10.1093/aob/mcm066; GRAHAM RD, 1972, PLANT PHYSIOL, V49, P105, DOI 10.1104/pp.49.2.105; Gupta M, 2008, MOL GENET GENOMICS, V280, P437, DOI 10.1007/s00438-008-0377-7; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Huang CH, 2011, KAOHSIUNG J MED SCI, V27, P544, DOI 10.1016/j.kjms.2011.06.019; Jabnoune M, 2009, PLANT PHYSIOL, V150, P1955, DOI 10.1104/pp.109.138008; Wyn Jones R. G., 1983, Inorganic plant nutrition, P528; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Kanai S, 2011, PLANT SCI, V180, P368, DOI 10.1016/j.plantsci.2010.10.011; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Karuppanapandian T, 2011, AUST J CROP SCI, V5, P709; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; KOCHIAN LV, 1989, PLANT PHYSIOL, V91, P1202, DOI 10.1104/pp.91.3.1202; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lan WZ, 2010, P NATL ACAD SCI USA, V107, P7089, DOI 10.1073/pnas.1000698107; Lee SC, 2007, P NATL ACAD SCI USA, V104, P15959, DOI 10.1073/pnas.0707912104; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Liu CH, 2012, BOT STUD, V53, P229; Liu WH, 2000, J BIOL CHEM, V275, P27924; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; Maathuis FJM, 2003, PLANT J, V35, P675, DOI 10.1046/j.1365-313X.2003.01839.x; MAATHUIS FJM, 1994, P NATL ACAD SCI USA, V91, P9272, DOI 10.1073/pnas.91.20.9272; Maathuis FJM, 1996, PHYSIOL PLANTARUM, V96, P158, DOI 10.1111/j.1399-3054.1996.tb00197.x; MARSCHNER JP, 1995, INT J CLIN PHARM TH, V33, P263; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mohanty B, 2005, ANN BOT-LONDON, V96, P669, DOI 10.1093/aob/mci219; Moinuddin, 2007, J PLANT NUTR, V30, P517, DOI 10.1080/01904160701209196; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; NAKAMURA RL, 1995, PLANT PHYSIOL, V109, P371, DOI 10.1104/pp.109.2.371; NITSOS RE, 1966, PLANT PHYSIOL, V41, P1499, DOI 10.1104/pp.41.9.1499; Pandey GK, 2008, MOL PLANT, V1, P238, DOI 10.1093/mp/ssn003; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; PEASLEE DE, 1968, CROP SCI, V8, P427, DOI 10.2135/cropsci1968.0011183X000800040010x; PEOPLES TR, 1979, PLANT PHYSIOL, V63, P878, DOI 10.1104/pp.63.5.878; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Quinet M, 2012, PLANT CELL ENVIRON, V35, P1837, DOI 10.1111/j.1365-3040.2012.02521.x; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Rubio F, 1996, SCIENCE, V273, P978, DOI 10.1126/science.273.5277.978; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; SORGER GJ, 1965, GENETICS, V52, P777; SORGER GJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P1, DOI 10.1016/S0926-6593(66)80139-X; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sutter JU, 2007, CURR BIOL, V17, P1396, DOI 10.1016/j.cub.2007.07.020; TERRY N, 1973, PLANT PHYSIOL, V51, P1099, DOI 10.1104/pp.51.6.1099; Tokas I, 2013, MOL STRESS PHYSL PLA, DOI [10.1007/978-81-322-0807-5_10, DOI 10.1007/978-81-322-0807-5_]; Toyofuku K, 1998, FEBS LETT, V428, P275, DOI 10.1016/S0014-5793(98)00518-3; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Villain P, 1996, J BIOL CHEM, V271, P32593, DOI 10.1074/jbc.271.51.32593; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wang N, 2012, J PHOTOCH PHOTOBIO B, V110, P1, DOI 10.1016/j.jphotobiol.2012.02.002; Wang TB, 1998, PLANT PHYSIOL, V118, P651, DOI 10.1104/pp.118.2.651; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wang Y, 2010, MOL PLANT, V3, P280, DOI 10.1093/mp/ssq006; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang ZB, 2012, MOL BIOL REP, V39, P8465, DOI 10.1007/s11033-012-1700-2; Zhao DL, 2001, PHOTOSYNTHETICA, V39, P103, DOI 10.1023/A:1012404204910; Zimmermann S, 2001, PLANT J, V28, P517, DOI 10.1046/j.1365-313X.2001.01177.x; Zimmermann S, 1999, CURR OPIN PLANT BIOL, V2, P477, DOI 10.1016/S1369-5266(99)00020-5	120	40	42	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70321	10.1371/journal.pone.0070321	http://dx.doi.org/10.1371/journal.pone.0070321			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922980	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700174
J	Zhang, CP; Tong, JL; Huang, G				Zhang, Chenpeng; Tong, Jinlu; Huang, Gang			Nicotinamide Phosphoribosyl Transferase (Nampt) Is a Target of MicroRNA-26b in Colorectal Cancer Cells	PLOS ONE			English	Article							NAD BIOSYNTHESIS INHIBITOR; BREAST-CANCER; HEMATOLOGIC MALIGNANCIES; EXPRESSION; FK866; OVEREXPRESSION; APOPTOSIS; VISFATIN; SURVIVAL; APO866	A number of cancers show increased expression of Nicotinamide phosphoribosyl transferase (Nampt). However, the mechanism through which Nampt is upregulated is unclear. In our study, we found that the Nampt-specific chemical inhibitor FK866 significantly inhibited cell survival and reduced nicotinamide adenine dinucleotide (NAD) levels in LoVo and SW480 cell lines. Bioinformatics analyses suggested that miR-26b targets Nampt mRNA. We identified Nampt as a new target of miR-26b and demonstrated that miR-26b inhibits Nampt expression at the protein and mRNA levels by binding to the Nampt 3'-UTR. Moreover, we found that miR-26b was down regulated in cancer tissues relative to that in adjacent normal tissues in 18 colorectal cancer patients. A statistically significant inverse correlation between miR-26b and Nampt expression was observed in samples from colorectal cancer patients and in 5 colorectal cell lines (HT-29, SW480, SW1116, LoVo, and HCT116). In addition, over expression of miR-26b strongly inhibited LoVo cell survival and invasion, an effect partially abrogated by the addition of NAD. In conclusion, this study demonstrated that the NAD-salvaging biosynthesis pathway involving Nampt might play a role in colorectal cancer cell survival. MiR-26b may serve as a tumor suppressor by targeting Nampt.	[Zhang, Chenpeng; Huang, Gang] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China; [Zhang, Chenpeng; Huang, Gang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Zhang, Chenpeng; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Tong, Jinlu] Shanghai Jiao Tong Univ, Shanghai Inst Gastrointestinal Dis, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Tong, Jinlu] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, G (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai 200030, Peoples R China.	huang28021@126.com			National Natural Science Foundation of China [30830038, 30970842, 81071180, 81000929]; "973" Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Key Project of Science and Technology Commission of Shanghai Municipality [10JC1410000]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Project(National Basic Research Program of China); New Drug Discovery Project; Key Project of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The study was supported by research grants from National Natural Science Foundation of China (numbers 30830038, 30970842, 81071180, 81000929); "973" Project (2012CB932604); New Drug Discovery Project (2012ZX09506-001-005); Key Project of Science and Technology Commission of Shanghai Municipality (number 10JC1410000); and the Shanghai Leading Academic Discipline Project (number S30203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Cea M, 2009, BLOOD, V113, P6035, DOI 10.1182/blood-2009-03-209213; Chen XY, 2012, INT J BIOCH CELL BIO; Chen YQ, 2012, J NEPHROL, V25, P566, DOI 10.5301/jn.5000034; Dalamaga M, 2012, MED HYPOTHESES, V79, P617, DOI 10.1016/j.mehy.2012.07.036; Drevs J, 2003, ANTICANCER RES, V23, P4853; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-66; Folgueira MAAK, 2005, CLIN CANCER RES, V11, P7434; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Hasmann M, 2003, CANCER RES, V63, P7436; He X, 2012, MOL MED; Hufton SE, 1999, FEBS LETT, V463, P77, DOI 10.1016/S0014-5793(99)01578-1; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim JY, 2009, BBA-MOL CELL RES, V1793, P1759, DOI 10.1016/j.bbamcr.2009.09.006; Koh CM, 2011, ONCOTARGET, V2, P669, DOI 10.18632/oncotarget.327; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Ma YL, 2011, J CELL MOL MED, V15, P1941, DOI 10.1111/j.1582-4934.2010.01170.x; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakajima TE, 2010, CANCER SCI, V101, P1286, DOI 10.1111/j.1349-7006.2010.01518.x; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Solomides CC, 2012, ACTA CYTOL, V56, P645, DOI 10.1159/000343473; Srivastava Mousami, 2012, BMC Res Notes, V5, P617, DOI 10.1186/1756-0500-5-617; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P371, DOI 10.1016/j.bbrc.2012.06.075; Thakur BK, 2012, INT J CANC; van Beijnum JR, 2002, INT J CANCER, V101, P118, DOI 10.1002/ijc.10584; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016264; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Zhang LY, 2012, EUR J PHARMACOL, V674, P163, DOI 10.1016/j.ejphar.2011.11.017; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	47	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69963	10.1371/journal.pone.0069963	http://dx.doi.org/10.1371/journal.pone.0069963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922874	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700110
J	Wang, J; Pan, XL; Ding, LJ; Liu, DY; Lei, DP; Jin, T				Wang, Juan; Pan, Xin-Liang; Ding, Li-Jie; Liu, Da-Yu; Lei, Da-Peng; Jin, Tong			Aberrant Expression of Beclin-1 and LC3 Correlates with Poor Prognosis of Human Hypopharyngeal Squamous Cell Carcinoma	PLOS ONE			English	Article							AUTOPHAGY-RELATED PROTEIN; DECREASED EXPRESSION; CANCER; TUMORIGENESIS; INHIBITION; INDUCTION; APOPTOSIS; LYMPHOMA; HOMOLOG; MARKER	Background: Beclin-1, a key regulator of autophagy. Microtubule-associated protein 1 light chain 3 (LC3), is involved in autophagsome formation during autophagy. The autophagic genes beclin-1 and LC3 paly an important role in the development and progression of tumor. This study was designed to investigate the expression of beclin-1 and LC3 and to clarify their clinical significance in hypopharyngeal squamous cell carcinoma (HSCC). Methods: Eighty-two surgical hypopharyngeal squamous cell carcinoma specimens and fifty-four adjacent non-cancerous mucosal epithelial tissues were obtained. Beclin-1 and LC3-II expression was examined by immunohistochemistry, real-time RT-PCR and Western blotting assays. Correlations with patient clinical characteristics and overall survival were evaluated. Results: Beclin-1 was positively expressed in 42.7% (35/82) of HSCC specimens (adjacent non-cancerous tissues, 79.6%, 43/54; P<0.0001). Furthermore, 41.5% (34/82) of HSCC specimens exhibited high LC3 immunoreactivity (adjacent non-cancerous tissues, 74.1%, 40/54; P=0.0002). Beclin-1 and LC3-II mRNA transcript levels were significantly lower in HSCCs than in paired non-cancerous tissues (P<0.0001, P=0.0001, respectively). Similarly, western blotting assays showed that beclin-1 and LC3-II were markedly decreased in HSCCs (P=0.02, P=0.004, respectively). A positive correlation was observed between the mRNA transcript levels of beclin-1 and LC3-II in HSCCs (r=0.51, P<0.0001; 95% CI: 0.273 to 0.689). Beclin-1 and LC3 expression were significantly correlated with T categories, differentiation and lymph node metastasis. Negative beclin-1 immuoreactivity and low LC3 expression were associated with poorer overall survival in HSCC patients (P<0.0001, P=0.0145, respectively). Multivariate analysis revealed that beclin-1 was an independent prognositic factor for overall survival. Conclusion: Beclin-1 and LC3-II are downregulated in HSCCs and their aberrant expression correlates with poor prognosis of HSCCs.	[Wang, Juan; Pan, Xin-Liang; Liu, Da-Yu; Lei, Da-Peng; Jin, Tong] Shandong Univ, Dept Otolaryngol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Ding, Li-Jie] Shandong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Pan, XL (corresponding author), Shandong Univ, Dept Otolaryngol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	panxinl123@gmail.com			Independent Innovation Foundation of Shandong University (IIFSDU) [2012TS156]	Independent Innovation Foundation of Shandong University (IIFSDU)	This work was supported by a grant from Independent Innovation Foundation of Shandong University (IIFSDU, #2012TS156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Coates JM, 2010, J SURG RES, V164, P301, DOI 10.1016/j.jss.2009.07.011; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Djavaheri-Mergny M, 2010, ONCOGENE, V29, P1717, DOI 10.1038/onc.2009.519; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Giatromanolaki A, 2011, GYNECOL ONCOL, V123, P147, DOI 10.1016/j.ygyno.2011.06.023; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Jiang ZF, 2012, MOL BIOL REP, V39, P259, DOI 10.1007/s11033-011-0734-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Liang C, 2013, J BIOMED RES, V27, P51, DOI 10.7555/JBR.27.20120048; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Miracco C, 2007, INT J ONCOL, V30, P429; Miracco C, 2010, HUM PATHOL, V41, P503, DOI 10.1016/j.humpath.2009.09.004; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Shanmugaratnam K, 1993, CANCER, V71, P387; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; Wycliffe Nathaniel D, 2007, Top Magn Reson Imaging, V18, P243, DOI 10.1097/RMR.0b013e3181570c3f; Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	33	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69038	10.1371/journal.pone.0069038	http://dx.doi.org/10.1371/journal.pone.0069038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935917	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300020
J	An, LW; Liu, YJ; Wu, AH; Guan, YF				An, Liwen; Liu, Yongjun; Wu, Anhua; Guan, Yifu			microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME CELLS; PANCREATIC-CANCER CELLS; RHO-KINASE INHIBITOR; RHO/ROCK PATHWAY; GASTRIC-CANCER; EXPRESSION; MIR-124; PROLIFERATION; TUMORS; DIFFERENTIATION	Background: The extraordinary invasive capability is a major cause of treatment failure and tumor recurrence in glioma, however, the molecular and cellular mechanisms governing glioma invasion remain poorly understood. Evidence in other cell systems has implicated the regulatory role of microRNA in cell motility and invasion, which promotes us to investigate the biological functions of miR-124 in glioma in this regard. Results: We have found that miR-124 is dramatically downregulated in clinical specimen of glioma and is negatively correlated with the tumor pathological grading in the current study. The cells transfected by miR-124 expression vector have demonstrated retarded cell mobility. Using a bioinformatics analysis approach, rho-associated coiled-coil containing protein kinase 1 (ROCK1), a well-known cell mobility-related gene, has been identified as the target of miR-124. A dual-luciferase reporter assay was used to confirm that miR-124 targeted directly the 3'UTR of ROCK1 gene and repressed the ROCK1 expression in U87MG human glioma cell line. Furthermore, experiments have shown that the decreased cell mobility was due to the actin cytoskeleton rearrangements and the reduced cell surface ruffle in U87MG glioma cells. These results are similar to the cellular responses of U87MG glioma cells to the treatment of Y-27632, an inhibitor of ROCK protein. Moreover, a constitutively active ROCK1 in miR-124 over-expressed glioma cells reversed the effects of miR-124. Our results revealed a novel mechanism that miR-124 inhibits glioma cells migration and invasion via ROCK1 downregulation. Conclusions: These results suggest that miR-124 may function as anti-migration and anti-invasion influence in glioma and provides a potential approach for developing miR-124-based therapeutic strategies for malignant glioma therapy.	[An, Liwen; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Liu, Yongjun] China Med Univ, Affiliated Hosp 4, Dept Neurosurg, Shenyang, Peoples R China; [Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China.	yfgcmu@yahoo.com			National Natural Science Foundation of China [31070705, 31000390]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (no. 31070705 and 31000390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; American Cancer Society, 2012, CANC FACTS FIG 2012; Barnholtz-Sloan JS, 2008, J NEUROSURG, V108, P642, DOI 10.3171/JNS/2008/108/4/0642; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; CBTRUS, 2012, CBTRUS STAT REP PRIM; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Chun-Hong, 2006, V342, P229, DOI 10.1385/1-59745-123-1:229; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Fu LL, 2012, INT J BIOCHEM CELL B, V44, P733, DOI 10.1016/j.biocel.2012.02.004; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Huang TC, 2011, FEBS LETT, V585, P3582, DOI 10.1016/j.febslet.2011.10.025; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kaneko K, 2002, PANCREAS, V24, P251, DOI 10.1097/00006676-200204000-00007; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Keller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043584; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee S. H., 2010, MOL CELLS, V29, P311, DOI DOI 10.1007/s10059-010-0053-8; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lin CC, 2009, ONCOL REP, V22, P1033, DOI 10.3892/or_00000532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Oellers P, 2009, GLIA, V57, P499, DOI 10.1002/glia.20777; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Rattan R, 2006, J NEUROSCI RES, V83, P243, DOI 10.1002/jnr.20707; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160; Shi XB, 2012, ONCOGENE IN PRESS; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Spencer C, 2011, CANCER GENOM PROTEOM, V8, P77; Tang AT, 2012, CELL SIGNAL, V24, P1375, DOI 10.1016/j.cellsig.2012.03.005; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; The WHO, 2020, CLASSIFICATION TUMOU; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Wong JWJ, 2010, J NEUROSCI, V30, P3868, DOI 10.1523/JNEUROSCI.0442-10.2010; Wurdinger T, 2009, CELL ADHES MIGR, V3, P230, DOI 10.4161/cam.3.2.7910; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	68	85	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69478	10.1371/journal.pone.0069478	http://dx.doi.org/10.1371/journal.pone.0069478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936026	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000126
J	Ji, GH; Lv, K; Chen, HL; Wang, TM; Wang, YL; Zhao, DS; Qu, LN; Li, YH				Ji, Guohua; Lv, Ke; Chen, Hailong; Wang, Tingmei; Wang, Yanli; Zhao, Dingsheng; Qu, Lina; Li, Yinghui			MiR-146a Regulates SOD2 Expression in H2O2 Stimulated PC12 Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; EPITHELIAL-CELLS; MICRORNAS; DISEASES; ACTIVATION; MECHANISM; LUNG	SOD2 (superoxide dismutase 2) is one of the endogenous antioxidant enzymes that protect against reactive oxygen species. While explorations of SOD2 expression regulation are mainly focused on transcriptional and post-translational activation, there are few reports about the post-transcriptional regulation of SOD2. MicroRNAs (miRNAs) are 21nt-25nt (nucleotide) small noncoding RNAs that have emerged as indispensable regulators of gene expression. Here we show that miR-146a, a widely expressed miRNA, is up-regulated by H2O2-induced stress. By sequence analysis we found a binding site for miR-146a in the sod2 mRNA 3'UTR, and a luciferase reporter assay confirmed that miR-146a can interact with this sod2 regulatory region. Our results further show that miR-146a could down-regulate the SOD2 protein expression, and antisense-miR-146a could reverse the decrease of both the SOD2 level and cell viability in H2O2 treated PC12 cells. In conclusion, here we have identified a novel function of miR-146a in the post-transcriptional regulation of SOD2 expression.	[Ji, Guohua; Lv, Ke; Chen, Hailong; Wang, Tingmei; Wang, Yanli; Zhao, Dingsheng; Qu, Lina; Li, Yinghui] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China		Qu, LN (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China.	linaqu@263.net; yinghuidd@vip.sina.com			National Science and Techology Major Project [2012ZX09J12201]; National Key Techology R&D Program of China [2009BAK59B01]; Medicinal Science and Techology Research Project [BWS11J052]; National Natural Science Foundation of China [30973686]; Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center [SMFA10B01, SMFA12B05, SMFA09A06]	National Science and Techology Major Project; National Key Techology R&D Program of China; Medicinal Science and Techology Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center	This work was supported by the National Science and Techology Major Project (2012ZX09J12201), the National Key Techology R&D Program of China (2009BAK59B01), the Medicinal Science and Techology Research Project (BWS11J052), the National Natural Science Foundation of China (30973686), and the Foundation of State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center(SMFA10B01, SMFA12B05, SMFA09A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Chan EK, 2012, ANN REHUM DIS S2, pii90; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Harrison D., 2003, AM J CARDIOL, V91, P7, DOI [DOI 10.1016/S0002-9149(02)03144-2], 10.1016/s0002-9149(02)03144-2, DOI 10.1016/S0002-9149(02)03144-2]; Hsu JL, 1996, J BIOL CHEM, V271, P17687, DOI 10.1074/jbc.271.30.17687; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Xiqiang, 2009, Cancer Genomics & Proteomics, V6, P131; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Plymate SR, 2003, ONCOGENE, V22, P1024, DOI 10.1038/sj.onc.1206210; Pogue AI, 2011, J INORG BIOCHEM, V105, P1434, DOI 10.1016/j.jinorgbio.2011.05.012; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sharma CS, 2007, J NANOSCI NANOTECHNO, V7, P2466, DOI 10.1166/jnn.2007.431; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422; Wei ZL, 2003, J NEUROSCI RES, V73, P364, DOI 10.1002/jnr.10668	31	61	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69351	10.1371/journal.pone.0069351	http://dx.doi.org/10.1371/journal.pone.0069351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935993	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000107
J	Kim, S; Baek, S; Shin, B; Yoon, SY; Park, SY; Lee, T; Lee, YS; Bae, YJ; Kwon, HS; Cho, YS; Moon, HB; Kim, TB				Kim, Sujeong; Baek, Seunghee; Shin, Bomi; Yoon, Sun-young; Park, So Young; Lee, Taehoon; Lee, Yoon Su; Bae, Yun-Jeong; Kwon, Hyouk Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum			Influence of Initial Treatment Modality on Long-Term Control of Chronic Idiopathic Urticaria	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATURAL-HISTORY; DOUBLE-BLIND; ANGIOEDEMA; PLACEBO; SAFETY	Background: Chronic idiopathic urticaria (CIU) is a common cutaneous disorder but the influence of initial treatment modality on long-term control is not known. The aim of this study was to evaluate clinical features, and the influence of initial treatment modality on long-term control. Methods and Results: 641 CIU patients were enrolled from the allergy clinic in a tertiary referral hospital. Disease duration, aggravating factors and treatment modality at each visit were evaluated. Times required to reach a controlled state were analyzed according to initial treatment modality, using Kaplan-Meier survival curves, the Cox proportional-hazards model, and propensity scores. Female to male ratio was 1.7: 1; mean age at onset was 40.5 years. The most common aggravating factors were food (33.5%), stress (31.5%) and fatigue (21.6%). Most patients (82.2%) used H1-antihistamines alone as initial treatment while 17% used a combination treatment with oral corticosteroids. There was no significant difference in the time taken to reach a controlled state between patients treated with single vs multiple H1-antihistamines or between those who received H1-antihistamine monotherapy vs. a combination therapy with oral corticosteroids. Conclusion: The time required to control CIU is not reduced by use of multiple H1-antihistamines or oral corticosteroids in the initial treatment.	[Kim, Sujeong; Shin, Bomi; Yoon, Sun-young; Park, So Young; Lee, Taehoon; Lee, Yoon Su; Kwon, Hyouk Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea; [Baek, Seunghee] Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Bae, Yun-Jeong] Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, TB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea.	allergy@medimail.co.kr	Lee, Taehoon/AHA-1437-2022	Lee, Taehoon/0000-0002-9224-0866; Cho, You Sook/0000-0001-8767-2667	Asan Institute for Life Sciences, Seoul, Korea [2011-420]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2011-420) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2009, MED DECIS MAKING, V29, P661, DOI 10.1177/0272989X09341755; Breneman DL, 1996, ANN PHARMACOTHER, V30, P1075, DOI 10.1177/106002809603001001; Caproni M, 2004, ACTA DERM-VENEREOL, V84, P288, DOI 10.1080/00015550410026939; CHAMPION RH, 1969, BRIT J DERMATOL, V81, P588, DOI 10.1111/j.1365-2133.1969.tb16041.x; Chung MC, 2010, COMPR PSYCHIAT, V51, P55, DOI 10.1016/j.comppsych.2009.02.005; Chung MC, 2010, PSYCHOL HEALTH, V25, P477, DOI 10.1080/08870440802530780; Greaves M, 2000, J ALLERGY CLIN IMMUN, V105, P664, DOI 10.1067/mai.2000.105706; Handa S, 2004, J Dermatolog Treat, V15, P55; Heinze G, 2011, EUR HEART J; Irinyi B, 2007, INT ARCH ALLERGY IMM, V144, P217, DOI 10.1159/000103995; Jee Ho, 1983, KOREAN J DERMATOLOGY, V21, P673; Kaplan AP, 2005, ANN ALLERG ASTHMA IM, V94, P662, DOI 10.1016/S1081-1206(10)61325-7; Khalaf AT, 2008, J EUR ACAD DERMATOL, V22, P487, DOI 10.1111/j.1468-3083.2007.02511.x; Kozel MMA, 2001, J AM ACAD DERMATOL, V45, P387, DOI 10.1067/mjd.2001.116217; Kulthanan K, 2007, J DERMATOL, V34, P294, DOI 10.1111/j.1346-8138.2007.00276.x; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Leynadier F, 2000, EUR J DERMATOL, V10, P205; Maurer M, 2011, ALLERGY, V66, P317, DOI 10.1111/j.1398-9995.2010.02496.x; Mlynek A, 2008, ALLERGY, V63, P777, DOI 10.1111/j.1398-9995.2008.01726.x; Mlynek A, 2009, ALLERGY, V64, P927, DOI 10.1111/j.1398-9995.2008.01920.x; Najib U, 2009, ANN ALLERG ASTHMA IM, V103, P496, DOI 10.1016/S1081-1206(10)60266-9; Nettis E, 2006, BRIT J DERMATOL, V154, P533, DOI 10.1111/j.1365-2133.2005.07049.x; ODonnell BF, 1997, BRIT J DERMATOL, V136, P197; QUARANTA JH, 1989, ANN ALLERGY, V62, P421; SIBBALD RG, 1991, INT J DERMATOL, V30, P381, DOI 10.1111/j.1365-4362.1991.tb03891.x; Toubi E, 2004, ALLERGY, V59, P869, DOI 10.1111/j.1398-9995.2004.00473.x; Van der Valk PGM, 2002, BRIT J DERMATOL, V146, P110, DOI 10.1046/j.1365-2133.2002.04582.x; Young Ji, 2000, KOREAN J DERMATOLOGY, V38, P221; Zuberbier T, 1996, ACTA DERM-VENEREOL, V76, P295; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	31	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69345	10.1371/journal.pone.0069345	http://dx.doi.org/10.1371/journal.pone.0069345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935990	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000105
J	Kohler, D; Streissenberger, A; Konig, K; Granja, T; Roth, JM; Lehmann, R; Franz, CBD; Rosenberger, P				Koehler, David; Streissenberger, Ariane; Koenig, Klemens; Granja, Tiago; Roth, Judith M.; Lehmann, Rainer; Franz, Claudia Bernardo de Oliveira; Rosenberger, Peter			The Uncoordinated-5 Homolog B (UNC5B) Receptor Increases Myocardial Ischemia-Reperfusion Injury	PLOS ONE			English	Article							NETRIN RECEPTORS; INFARCT SIZE; INFLAMMATION; ANGIOGENESIS; PROTECTS; HYPOXIA; KIDNEY	The UNC5 receptor family are chemorepulsive neuronal guidance receptors with additional functions outside the central nervous system. Previous studies have implicated that the UNC5B receptor influences the migration of leukocytes into sites of tissue inflammation. Given that this process is a critical step during the pathophysiology of myocardial ischemia followed by reperfusion (IR) we investigated the role of UNC5B during myocardial IR. In initial in-vitro experiments, the functional inhibition of UNC5B resulted in a significant reduction of chemotactic migration of neutrophils. In-vivo, using a model of acute myocardial ischemia in UNC5B(+/-) and wild type (WT) animals, we found a significant reduction of infarct sizes in UNC5B(+/-) animals. This was associated with significantly reduced levels of troponin-I and IL-6 in UNC5B(+/-) mice. The repression of UNC5B using siRNA and the functional inhibition of UNC5B significantly dampened the extent of myocardial IR injury. Following depletion of neutrophils, we were not able to observe any further reduction in infarct size through functional inhibition of UNC5B in WT and UNC5B(+/-) mice. In summary our studies demonstrate an important role for UNC5B during myocardial IR injury, and that UNC5B might be a potential therapeutic target to control reperfusion injury in the future.	[Koehler, David; Streissenberger, Ariane; Koenig, Klemens; Granja, Tiago; Roth, Judith M.; Franz, Claudia Bernardo de Oliveira; Rosenberger, Peter] Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Lehmann, Rainer] Univ Hosp, Div Clin Chem, Dept Internal Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Rosenberger, P (corresponding author), Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	peter.rosenberger@medizin.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019; Granja, Tiago/O-2597-2019	Lehmann, Rainer/0000-0003-1218-6810; Granja, Tiago/0000-0002-8137-1449	Deutsche Forschungsgemeinschaft (DFG) [DFG-RO 3671/5-1, DFG-MO 2252/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a Grant from the Deutsche Forschungsgemeinschaft (DFG) grant DFG-RO 3671/5-1 to P. R. and DFG-MO 2252/1 to D. K. and J.M-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Aherne CM, 2011, GUT; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; ENTMAN ML, 1991, FASEB J, V5, P2529, DOI 10.1096/fasebj.5.11.1868978; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Han Y, 2012, INVEST OPHTH VIS SCI, V53, P1285, DOI 10.1167/iovs.11-8722; JOLLY SR, 1986, AM HEART J, V112, P682, DOI 10.1016/0002-8703(86)90461-8; Konig K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041085; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Wang H, 1999, J NEUROSCI, V19, P4938; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	24	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69477	10.1371/journal.pone.0069477	http://dx.doi.org/10.1371/journal.pone.0069477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936025	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000125
J	Rietsch, K; Godina, E; Scheffler, C				Rietsch, Katrin; Godina, Elena; Scheffler, Christiane			Decreased External Skeletal Robustness in Schoolchildren - A Global Trend? Ten Year Comparison of Russian and German Data	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BONE MASS; SECULAR TRENDS; CHILDREN; SCHOOL; TRANSPORTATION; ADOLESCENTS; PREVALENCE; FITNESS; TIME	Objectives: Obesity and a reduced physical activity are global developments. Physical activity affects the external skeletal robustness which decreased in German children. It was assumed that the negative trend of decreased external skeletal robustness can be found in other countries. Therefore anthropometric data of Russian and German children from the years 2000 and 2010 were compared. Methods: Russian (2000/2010 n = 1023/268) and German (2000/2010 n = 2103/1750) children aged 6-10 years were investigated. Height, BMI and external skeletal robustness (Frame-Index) were examined and compared for the years and the countries. Statistical analysis was performed by Mann-Whitney-Test. Results: Comparison 2010 and 2000: In Russian children BMI was significantly higher; boys were significantly taller and exhibited a decreased Frame-Index (p = .002) in 2010. German boys showed significantly higher BMI in 2010. In both sexes Frame-Index (p = .001) was reduced in 2010. Comparison Russian and German children in 2000: BMI, height and Frame-Index were different between Russian and German children. German children were significantly taller but exhibited a lower Frame-Index (p<.001). Even German girls showed a significantly higher BMI. Comparison Russian and German children in 2010: BMI and Frame-Index were different. Russian children displayed a higher Frame-Index (p<.001) compared with Germans. Conclusions: In Russian children BMI has increased in recent years. Frame-Index is still higher in Russian children compared with Germans however in Russian boys Frame-Index is reduced. This trend and the physical activity should be observed in the future.	[Rietsch, Katrin; Scheffler, Christiane] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Godina, Elena] Moscow MV Lomonosov State Univ, Inst & Museum Anthropol, Moscow, Russia	University of Potsdam; Lomonosov Moscow State University	Rietsch, K (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	katrin.rietsch@uni-potsdam.de	Godina, Elena/P-1455-2015	Godina, Elena/0000-0002-0692-420X				Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Buliung RN, 2009, PREV MED, V48, P507, DOI 10.1016/j.ypmed.2009.03.001; FORWOOD MR, 1993, BONE MINER, V21, P89, DOI 10.1016/S0169-6009(08)80012-8; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Godina EZ, 2011, ANTHROPOL ANZ, V68, P367, DOI 10.1127/0003-5548/2011/0156; Hastie P, 2010, J PHYS ACT HEALTH, V7, P150, DOI 10.1123/jpah.7.2.150; Jekauc D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-714; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; Kalinin A, 2011, PUBLIC ADM WP BRP; Klimatskaya L., 2011, Progress in Health Sciences, V1, P39; KnuBmann R, 1988, ANTHR HDB VERGLEICHE; Lammle L, 2012, EUR J PUBLIC HEALTH, V22, P880, DOI 10.1093/eurpub/ckr191; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; Pan H, 2011, LMSCHARTMAKER PROGRA; Permyakova E, 2012, ANTROPOLOGIA, V23, P112; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rietsch K, 2013, AM J HUM BI IN PRESS; Rietsch K, 2011, ANTHROPOL ANZ, V68, P516; Sandercock G, 2010, ARCH DIS CHILD, V95, P46, DOI 10.1136/adc.2009.162107; Scheffler C, 2011, ANTHROPOL ANZ, V68, P153, DOI 10.1127/0003-5548/2011/0095; Scheffler C, 2009, ANTHROPOL ANZ, V67, P53, DOI 10.1127/0003-5548/2009/0007; Sigmundova D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-731; SLEMENDA CW, 1991, J BONE MINER RES, V6, P1227; Southward EF, 2012, AM J PREV MED, V43, P201, DOI 10.1016/j.amepre.2012.04.015; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Tudor-Locke C, 2002, CHILD CARE HLTH DEV, V28, P507, DOI 10.1046/j.1365-2214.2002.00295.x; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; WELTEN DC, 1994, J BONE MINER RES, V9, P1089, DOI 10.1002/jbmr.5650090717	30	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68195	10.1371/journal.pone.0068195	http://dx.doi.org/10.1371/journal.pone.0068195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935857	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000027
J	Yao, YH; Zhang, BP				Yao, Yonghui; Zhang, Baiping			A Preliminary Study of the Heating Effect of the Tibetan Plateau	PLOS ONE			English	Article							GENERAL-CIRCULATION; ELEVATION; SENSITIVITY; TIMBERLINE; CLIMATE; FOREST	The immense and towering Tibetan Plateau acts as a heating source and, thus, deeply shapes the climate of the Eurasian continent and even the whole world. However, due to the scarcity of meteorological observation stations and very limited climatic data, little is quantitatively known about the heating effect of the plateau and its implications. This paper firstly collects climate data (2001-2007) from 109 observation stations and MODIS-based estimated monthly mean temperature data in the plateau and the neighboring Sichuan Basin, and conducts correlation and simple linear regression to reveal the altitudinal pattern of temperature. Then, according to the linear relationships of temperature and altitude for each month, it compares air temperature differences on the same elevation between the main plateau and surrounding mountains and the Sichuan Basin so as to quantify the heating effect and discuss its implication on timberline of the plateau. The results show that: 1) the heating effect of the plateau is significant. The temperature of the main plateau area was higher than that of free air on the same elevation above the neighboring areas; on the elevation of 4500 m (the main plateau), temperature is 1-6 degrees C higher in the main Plateau than over the Sichuan Basin for different months and 5.9-10.7 degrees C higher than in the Qilian Mountains in the northeastern corner of the plateau. 2) Even at altitudes of 5000-6000 m in the main Plateau, there are 4 months with a mean temperature above 0 degrees C. The mean temperature of the warmest month (July) can reach 10 degrees C at about 4600-4700 m. This may help explain why the highest timberline in the northern hemisphere is on the southeastern Tibetan Plateau.	[Yao, Yonghui; Zhang, Baiping] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resource & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, BP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resource & Environm Informat Syst, Beijing, Peoples R China.	Zhangbp@lreis.ac.cn			National Natural Science Foundation of China [41001278, 41030528]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 41001278 and No. 41030528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angot A, 1982, CR HEBD ACAD SCI, V115, P1272; Barry R.G., 2008, MOUNTAIN WEATHER CLI, V3rd ed., P506, DOI [10.1017/CBO9780511754753, DOI 10.1017/CBO9780511754753]; Barry RG, 1987, ATMOSPHERE WEATHER C, P448; CARREGA P, 1995, THEOR APPL CLIMATOL, V52, P69, DOI 10.1007/BF00865508; CHEN LX, 1985, MON WEATHER REV, V113, P1771, DOI 10.1175/1520-0493(1985)113<1771:TAHSOT>2.0.CO;2; de Quervain A., 1904, BEITRAGE ZUE GEOPHYS, V6, P481; Dodson R, 1997, CLIMATE RES, V8, P1, DOI 10.3354/cr008001; Douguedroit A, 1984, REV GEOGRAPHIE ALPIN, V72; Flenley J., 2007, TROPICAL RAINFOREST, P219; FLENLEY JR, 1995, TROPICAL MONTANE CLO, P150; Flohn H., 1968, 130 COL STAT U, P120; Flohn H., 1957, J METEOROL SOC JAPAN, V35A, P180, DOI [10.2151/jmsj1923.35A.0_180, DOI 10.2151/JMSJ1923.35A.0_180]; Forster R.M, 1982, MISCELLANEOUS SERIES, P103; FU C, 1985, J CLIM APPL METEOROL, V24, P841, DOI 10.1175/1520-0450(1985)024<0841:TRBTTO>2.0.CO;2; Han F, 2012, J GEOGR SCI, V22, P609, DOI 10.1007/s11442-012-0950-1; Han F, 2011, ARCT ANTARCT ALP RES, V43, P207, DOI 10.1657/1938-4246-43.2.207; HASTENRATH S, 1968, C GEOGR, V9, P122; HERMES K, 1955, KOLNER GEOGRAPHISCHE, V5, P115; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Holtmeier FK, 2003, MOUNTAIN TIMBERLINES; KUTZBACH JE, 1993, J GEOL, V101, P177, DOI 10.1086/648215; Kutzbach JE, 1992, CENTENNIAL S J GEOLO; Leuschner C, 1996, VEGETATIO, V123, P193, DOI 10.1007/BF00118271; LIAO K, 1990, ATLAS TIBETAN PLATEA; Liu Dongshen, 2003, TIBET PLATEAU RES SC; MALYSHEV L, 1993, VEGETATIO, V109, P175, DOI 10.1007/BF00044749; Miehe G, 2007, MT RES DEV, V27, P169, DOI 10.1659/mrd.0792; Qian YF, 2003, INT J CLIMATOL, V23, P593, DOI 10.1002/joc.901; REITER ER, 1982, MON WEATHER REV, V110, P1694, DOI 10.1175/1520-0493(1982)110<1694:HOTTPA>2.0.CO;2; Rolland C, 2003, J CLIMATE, V16, P1032, DOI 10.1175/1520-0442(2003)016<1032:SASVOA>2.0.CO;2; TOLLNER H., 1949, ARCH METEOROL GEOPHYS U BIOKLIMAT SERIE B, V1, P347, DOI 10.1007/BF02242831; Troll C., 1973, Arctic and Alpine Research, V5, P3; [王传辉 Wang Chuanhui], 2011, [地理科学, Scientia Geographica Sinica], V31, P470; Wang YN, 2008, CHINESE SCI BULL, V53, P3387, DOI 10.1007/s11434-008-0327-0; Wu GX, 1997, MOMORIAL VOLUME ZHAO, P116; [姚永慧 Yao Yonghui], 2013, [地理学报, Acta Geographica Sinica], V68, P95; Ye DZ, 1998, METEOROL ATMOS PHYS, V67, P181, DOI 10.1007/BF01277509; Yeh DZ, 1982, ARCH METEOR GEOPHY A, VA31, P205; Yeh T., 1979, METEOROLOGY QINGHAI, P278; YEH TC, 1974, SCI SINICA, V17, P397; Yeh TC., 1957, ACTA METEOROL SIN, V28, P108; Yoshino MM, 1966, JAPANESE PROGR C NOV, P21; Zhang Baiping, 2002, Journal of Geographical Sciences, V12, P135; Zheng D., 1990, GEOGR RES-AUST, V9, P1	44	14	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68750	10.1371/journal.pone.0068750	http://dx.doi.org/10.1371/journal.pone.0068750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935886	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700013
J	Kim, HK; Hwang, HL; Park, SY; Lee, KM; Park, WC; Kim, HS; Um, TH; Hong, YJ; Lee, JK; Joo, SY; Seoh, JY; Song, YW; Kim, SY; Kim, YN; Hong, KM				Kim, Hyun-Kyoung; Hwang, Hai-Li; Park, Seong-Yeol; Lee, Kwang Man; Park, Won Cheol; Kim, Han-Seong; Um, Tae-Hyun; Hong, Young Jun; Lee, Jin Kyung; Joo, Sun-Young; Seoh, Ju-Young; Song, Yeong-Wook; Kim, Soo-Youl; Kim, Yong-Nyun; Hong, Kyeong-Man			Simple and Versatile Molecular Method of Copy-Number Measurement Using Cloned Competitors	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CONTAINING SEGMENTAL DUPLICATIONS; RELATIVE QUANTIFICATION; GENE AMPLIFICATION; POLYMORPHISM; RISK; SUSCEPTIBILITY; PREDISPOSES; INHIBITOR; TUMORS	Variations and alterations of copy numbers (CNVs and CNAs) carry disease susceptibility and drug responsiveness implications. Although there are many molecular methods to measure copy numbers, sensitivity, reproducibility, cost, and time issues remain. In the present study, we were able to solve those problems utilizing our modified real competitive PCR method with cloned competitors (mrcPCR). First, the mrcPCR for ERBB2 copy number was established, and the results were comparable to current standard methods but with a shorter assay time and a lower cost. Second, the mrcPCR assays for 24 drug-target genes were established, and the results in a panel of NCI-60 cells were comparable to those from real-time PCR and microarray. Third, the mrcPCR results for FCGR3A and the FCGR3B CNVs were comparable to those by the paralog ratio test (PRT), but without PRT's limitations. These results suggest that mrcPCR is comparable to the currently available standard or the most sensitive methods. In addition, mrcPCR would be invaluable for measurement of CNVs in genes with variants of similar structures, because combination of the other methods is not necessary, along with its other advantages such as short assay time, small sample amount requirement, and applicability to all sequences and genes.	[Kim, Hyun-Kyoung; Hwang, Hai-Li; Park, Seong-Yeol; Kim, Soo-Youl; Kim, Yong-Nyun; Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang, South Korea; [Lee, Kwang Man; Park, Won Cheol] Wonkwang Univ, Sch Med, Dept Gen Surg, Iksan, South Korea; [Kim, Han-Seong] Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang, South Korea; [Um, Tae-Hyun] Inje Univ, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea; [Hong, Young Jun; Lee, Jin Kyung] Korea Canc Ctr Hosp, Dept Lab Med, Seoul, South Korea; [Kim, Hyun-Kyoung; Joo, Sun-Young; Seoh, Ju-Young] Ewha Womans Univ, Sch Med, Ewha Med Res Ctr, Dept Microbiol, Seoul, South Korea; [Song, Yeong-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea	National Cancer Center - Korea (NCC); Wonkwang University; Inje University; Inje University; National Cancer Center - Korea (NCC); Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital	Kim, YN (corresponding author), Natl Canc Ctr, Res Inst, Goyang, South Korea.	ynk@ncc.re.kr; kmhong@ncc.re.kr		SEOH, JU-YOUNG/0000-0002-1168-5354	National Cancer Center [1110130]	National Cancer Center	This work was supported by a research grant to KMH from the National Cancer Center (1110130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bang YJ, 2010, LANCET, V376, P1302; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; Casilli F, 2002, HUM MUTAT, V20, P218, DOI 10.1002/humu.10108; Charbonnier F, 2000, CANCER RES, V60, P2760; COLIN Y, 1991, BLOOD, V78, P2747; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hemp ST, 2012, MACROMOL BIOSCI, V12, P29, DOI 10.1002/mabi.201100355; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Killian A, 2007, GASTROENTEROLOGY, V132, P645, DOI 10.1053/j.gastro.2006.12.006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Nakamura K, 2006, GASTROENTEROLOGY, V131, P1530, DOI 10.1053/j.gastro.2006.08.030; Okuyama N, 1999, TUMOR BIOL, V20, P153, DOI 10.1159/000030058; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Saugier-Veber P, 2006, EUR J HUM GENET, V14, P1009, DOI 10.1038/sj.ejhg.5201661; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; SESTINI R, 1994, CLIN CHEM, V40, P630; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wu YL, 2007, J IMMUNOL, V179, P3012, DOI 10.4049/jimmunol.179.5.3012; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	37	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69414	10.1371/journal.pone.0069414	http://dx.doi.org/10.1371/journal.pone.0069414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936009	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200035
J	Bremel, RD; Homan, EJ				Bremel, Robert D.; Homan, E. Jane			Recognition of Higher Order Patterns in Proteins: Immunologic Kernels	PLOS ONE			English	Article							B-CELL RESPONSES; CATHEPSIN-S; T-CELLS; CLASS-I; CYSTEINE CATHEPSINS; EPITOPE VACCINE; CYTOTOXIC T; ANTIGEN; PROTEASES; IDENTIFICATION	By applying analysis of the principal components of amino acid physical properties we predicted cathepsin cleavage sites, MHC binding affinity, and probability of B-cell epitope binding of peptides in tetanus toxin and in ten diverse additional proteins. Cross-correlation of these metrics, for peptides of all possible amino acid index positions, each evaluated in the context of a +/- 25 amino acid flanking region, indicated that there is a strongly repetitive pattern of short peptides of approximately thirty amino acids each bounded by cathepsin cleavage sites and each comprising B-cell linear epitopes, MHC-I and MHC-II binding peptides. Such "immunologic kernel" peptides comprise all signals necessary for adaptive immunologic cognition, response and recall. The patterns described indicate a higher order spatial integration that forms a symbolic logic coordinating the adaptive immune system.	[Bremel, Robert D.; Homan, E. Jane] ioGenetics LLC, Madison, WI USA		Bremel, RD (corresponding author), ioGenetics LLC, Madison, WI USA.	robert_bremel@iogenetics.com		Homan, Jane/0000-0002-2685-8852				Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; ANDERSENBECKH B, 1989, INFECT IMMUN, V57, P3498, DOI 10.1128/IAI.57.11.3498-3505.1989; Bania J, 2003, P NATL ACAD SCI USA, V100, P6664, DOI 10.1073/pnas.1131604100; BARNETT BC, 1989, EUR J IMMUNOL, V19, P515, DOI 10.1002/eji.1830190316; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Biro A, 2003, BBA-GEN SUBJECTS, V1624, P60, DOI 10.1016/j.bbagen.2003.09.010; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bremel Robert D, 2010, Immunome Res, V6, P7, DOI 10.1186/1745-7580-6-7; Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8; Bryant PW, 2002, ADV IMMUNOL, V80, P71, DOI 10.1016/S0065-2776(02)80013-X; Catron DM, 2010, J IMMUNOL, V184, P3609, DOI 10.4049/jimmunol.1000077; Chatterjee B., 2012, BLOOD; Costantino CM, 2009, J IMMUNOL, V183, P945, DOI 10.4049/jimmunol.0900921; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Homan EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026711; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Impens F, 2010, MOL CELL PROTEOMICS, V9, P2327, DOI 10.1074/mcp.M110.001271; JOHNSON NL, 1949, BIOMETRIKA, V36, P149, DOI 10.1093/biomet/36.1-2.149; Landry SJ, 1997, IMMUNOL TODAY, V18, P527, DOI 10.1016/S0167-5699(97)01152-3; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Melton Scott J, 2008, Clin Mol Allergy, V6, P9, DOI 10.1186/1476-7961-6-9; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; Nakamura Y, 1997, VACCINE, V15, P489, DOI 10.1016/S0264-410X(96)00224-1; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Paul S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-212; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Slansky JE, 2010, PLOS BIOL, P8; TAKESHITA T, 1995, J IMMUNOL, V154, P1973; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; van's Gravesande KS, 2002, J IMMUNOL, V168, P4488, DOI 10.4049/jimmunol.168.9.4488; Vaughan K, 2009, PARASITE IMMUNOL, V31, P78, DOI 10.1111/j.1365-3024.2008.01077.x; Vijayakrishnan L, 1997, J IMMUNOL, V159, P1809; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watts C, 2012, BBA-PROTEINS PROTEOM, V1824, P14, DOI 10.1016/j.bbapap.2011.07.006	53	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70115	10.1371/journal.pone.0070115	http://dx.doi.org/10.1371/journal.pone.0070115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922927	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700139
J	Dioletis, E; Dingley, AJ; Driscoll, PC				Dioletis, Evangelos; Dingley, Andrew J.; Driscoll, Paul C.			Structural and Functional Characterization of the Recombinant Death Domain from Death-Associated Protein Kinase	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; ERK MAP KINASE; DAP-KINASE; DOCKING INTERACTIONS; SECONDARY STRUCTURE; INDUCED APOPTOSIS; CELL-DEATH; EFFECTOR DOMAIN; BINDING; NMR	Death-associated protein kinase (DAPk) is a calcium/calmodulin-regulated Ser/Thr-protein kinase that functions at an important point of integration for cell death signaling pathways. DAPk has a structurally unique multi-domain architecture, including a C-terminally positioned death domain (DD) that is a positive regulator of DAPk activity. In this study, recombinant DAPk-DD was observed to aggregate readily and could not be prepared in sufficient yield for structural analysis. However, DAPk-DD could be obtained as a soluble protein in the form of a translational fusion protein with the B1 domain of streptococcal protein G. In contrast to other DDs that adopt the canonical six amphipathic alpha-helices arranged in a compact fold, the DAPk-DD was found to possess surprisingly low regular secondary structure content and an absence of a stable globular fold, as determined by circular dichroism (CD), NMR spectroscopy and a temperature-dependent fluorescence assay. Furthermore, we measured the in vitro interaction between extracellular-regulated kinase-2 (ERK2) and various recombinant DAPk-DD constructs. Despite the low level of structural order, the recombinant DAPk-DD retained the ability to interact with ERK2 in a 1: 1 ratio with a K-d in the low micromolar range. Only the full-length DAPk-DD could bind ERK2, indicating that the apparent 'D-motif' located in the putative sixth helix of DAPk-DD is not sufficient for ERK2 recognition. CD analysis revealed that binding of DAPk-DD to ERK2 is not accompanied by a significant change in secondary structure. Taken together our data argue that the DAPk-DD, when expressed in isolation, does not adopt a classical DD fold, yet in this state retains the capacity to interact with at least one of its binding partners. The lack of a stable globular structure for the DAPk-DD may reflect either that its folding would be supported by interactions absent in our experimental set-up, or a limitation in the structural bioinformatics assignment of the three-dimensional structure.	[Dioletis, Evangelos] UCL, Res Dept Struct & Mol Biol, London, England; [Dingley, Andrew J.] Univ Auckland, Sch Chem Sci, Auckland 1, New Zealand; [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Dingley, Andrew J.] Res Ctr Julich, ICS Struct Biochem 6, Julich, Germany; [Driscoll, Paul C.] Natl Inst Med Res, Med Res Council, Div Mol Struct, London NW7 1AA, England	University of London; University College London; University of Auckland; University of Auckland; Helmholtz Association; Research Center Julich; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Driscoll, PC (corresponding author), Natl Inst Med Res, Med Res Council, Div Mol Struct, Mill Hill, London NW7 1AA, England.	pdrisco@nimr.mrc.ac.uk	Dingley, Andrew/G-6427-2013	Dingley, Andrew/0000-0002-6838-5803; Driscoll, Paul/0000-0002-4124-6950	Medical Research Council [U117574559]; UK Medical Research Council; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574559] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in the PCD group is supported by the Medical Research Council (file reference U117574559). ED is grateful to the UK Medical Research Council for PhD studentship support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER P, 1992, BIOCHEMISTRY-US, V31, P3597, DOI 10.1021/bi00129a007; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Berglund H, 2000, J MOL BIOL, V302, P171, DOI 10.1006/jmbi.2000.4011; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Callaway K, 2005, BBA-PROTEINS PROTEOM, V1754, P316, DOI 10.1016/j.bbapap.2005.11.002; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Carlessi R, 2011, EMBO REP, V12, P917, DOI 10.1038/embor.2011.126; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Chen L, 2011, MOL CELL, V44, P734, DOI 10.1016/j.molcel.2011.09.022; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; De Wilde G, 2001, EUR J BIOCHEM, V268, P1382, DOI 10.1046/j.1432-1327.2001.02004.x; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huth JR, 1997, PROTEIN SCI, V6, P2359; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Moncrieffe MC, 2005, FEBS LETT, V579, P3920, DOI 10.1016/j.febslet.2005.06.009; Mor I, 2012, ONCOGENE, V31, P683, DOI 10.1038/onc.2011.264; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pelled D, 2002, J BIOL CHEM, V277, P1957, DOI 10.1074/jbc.M104677200; Piserchio A, 2012, METHODS MOL BIOL, V831, P359, DOI 10.1007/978-1-61779-480-3_19; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Raveh T, 2001, EXP CELL RES, V264, P185, DOI 10.1006/excr.2000.5134; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Twomey EC, 2012, BBA-PROTEINS PROTEOM, V1824, P1382, DOI 10.1016/j.bbapap.2012.07.001; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Wu PR, 2011, CELL DEATH DIFFER, V18, P1507, DOI 10.1038/cdd.2011.2; Yamamoto M, 2002, EUR J BIOCHEM, V269, P139, DOI 10.1046/j.0014-2956.2002.00029.x; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70095	10.1371/journal.pone.0070095	http://dx.doi.org/10.1371/journal.pone.0070095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922916	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700132
J	Sotgia, S; Pisanu, E; Pintus, G; Erre, GL; Pinna, GA; Deiana, L; Carru, C; Zinellu, A				Sotgia, Salvatore; Pisanu, Elisabetta; Pintus, Gianfranco; Erre, Gian Luca; Pinna, Gerard Aime; Deiana, Luca; Carru, Ciriaco; Zinellu, Angelo			Plasma L-Ergothioneine Measurement by High-Performance Liquid Chromatography and Capillary Electrophoresis after a Pre-Column Derivatization with 5-Iodoacetamidofluorescein (5-IAF) and Fluorescence Detection	PLOS ONE			English	Article							CELL-DEATH; CATION TRANSPORTER; ANTIOXIDANT ACTION; IN-VITRO; ACID; QUANTIFICATION; MODULATION; DAMAGE	Two sensitive and reproducible capillary electrophoresis and high-performance liquid chromatography-fluorescence procedures were established for quantitative determination of L-egothioneine in plasma. After derivatization of L-ergothioneine with 5-iodoacetamidofluorescein, the separation was carried out by HPLC on an ODS-2 C-18 sperisorb column by using a linear gradient elution and by HPCE on an uncoated fused silica capillary, 50 mu m id, and 60 cm length. The methods were validated and found to be linear in the range of 0.3 to 10 mu mol/l. The limit of quantification was 0.27 mu mol/l for HPCE and 0.15 mu mol/l for HPLC. The variations for intra-and inter-assay precision were around 6 RSD%, and the mean recovery accuracy close to 100% (96.11%).	[Sotgia, Salvatore; Pisanu, Elisabetta; Pintus, Gianfranco; Deiana, Luca; Carru, Ciriaco; Zinellu, Angelo] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Erre, Gian Luca] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Pinna, Gerard Aime] Univ Sassari, Dept Chem & Med Chem, I-07100 Sassari, Italy	University of Sassari; University of Sassari; University of Sassari	Sotgia, S (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	salvatore.sotgia@gmail.com	Erre, Gian Luca/C-7907-2017; Carru, Ciriaco/AAI-9996-2021; Pintus, Gianfranco/C-2975-2009; Sotgia, Salvatore/T-6598-2019	Erre, Gian Luca/0000-0001-6818-7666; Pintus, Gianfranco/0000-0002-3031-7733; Carru, Ciriaco/0000-0002-6985-4907; Zinellu, Angelo/0000-0002-8396-0968; Sotgia, Salvatore/0000-0002-3717-3437	"Fondazione Banco di Sardegna", Sassari, Italy; "Ministero dell'Universita e della Ricerca", Italy	"Fondazione Banco di Sardegna", Sassari, Italy(Fondazione Banco di Sardegna); "Ministero dell'Universita e della Ricerca", Italy(Ministry of Education, Universities and Research (MIUR))	Funding was provided by the "Fondazione Banco di Sardegna", Sassari, Italy and by the "Ministero dell'Universita e della Ricerca", Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANMU D, 1991, ARCH BIOCHEM BIOPHYS, V288, P10, DOI 10.1016/0003-9861(91)90158-F; ALPERT AJ, 1990, J CHROMATOGR, V499, P177, DOI 10.1016/S0021-9673(00)96972-3; Aruoma OI, 1999, FOOD CHEM TOXICOL, V37, P1043, DOI 10.1016/S0278-6915(99)00098-8; Aruoma OI, 1997, BIOCHEM BIOPH RES CO, V231, P389, DOI 10.1006/bbrc.1997.6109; ASKARI A, 1962, J BIOL CHEM, V237, P1615; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRUMMEL MC, 1985, MED HYPOTHESES, V18, P351, DOI 10.1016/0306-9877(85)90103-3; CARLSSON J, 1974, BIOCHEM J, V139, P237, DOI 10.1042/bj1390237; Carru C, 2004, ELECTROPHORESIS, V25, P882, DOI 10.1002/elps.200305768; Colognato R, 2006, CLIN NUTR, V25, P135, DOI 10.1016/j.clnu.2005.10.005; Dubost N. Joy, 2006, International Journal of Medicinal Mushrooms, V8, P215, DOI 10.1615/IntJMedMushr.v8.i3.30; Erre GL, 2011, CLIN RHEUMATOL, V30, P21, DOI 10.1007/s10067-010-1589-x; Franzoni F, 2006, BIOMED PHARMACOTHER, V60, P453, DOI 10.1016/j.biopha.2006.07.015; HANLON DP, 1971, J MED CHEM, V14, P1084, DOI 10.1021/jm00293a017; HARTMAN PE, 1988, RADIAT RES, V114, P319, DOI 10.2307/3577228; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Laurenza I, 2008, BIOFACTORS, V33, P237, DOI 10.1002/biof.5520330401; LAWSON A, 1951, NATURE, V167, P82, DOI 10.1038/167082a0; LINDEN JC, 1975, J CHROMATOGR, V105, P125, DOI 10.1016/S0021-9673(01)81096-7; MAYUMI T, 1978, CHEM PHARM BULL, V26, P3772; Mitsuyama H, 1999, CLIN SCI, V97, P407, DOI 10.1042/CS19990111; Muda M, 1998, J CHROMATOGR A, V434, P191; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Song TY, 2010, FOOD CHEM TOXICOL, V48, P3492, DOI 10.1016/j.fct.2010.09.030; Sotgia S, 2008, CLIN CHEM LAB MED, V46, P1046, DOI 10.1515/CCLM.2008.194; Sotgia S, 2013, J SEP SCI, V36, P1002, DOI 10.1002/jssc.201201016; Nguyen TH, 2012, FOOD CHEM, V133, P585, DOI 10.1016/j.foodchem.2012.01.061; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Zinellu A, 2003, ELECTROPHORESIS, V24, P2796, DOI 10.1002/elps.200305570	30	23	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70374	10.1371/journal.pone.0070374	http://dx.doi.org/10.1371/journal.pone.0070374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922985	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700179
J	Kawashima, N; Mita, T; Yoshikawa, M				Kawashima, Noritaka; Mita, Tomoki; Yoshikawa, Masahiro			Inter-Individual Difference in the Effect of Mirror Reflection-Induced Visual Feedback on Phantom Limb Awareness in Forearm Amputees	PLOS ONE			English	Article							PAIN; THERAPY; BRAIN	Objective: To test whether the phantom limb awareness could be altered by observing mirror reflection-induced visual feedback (MVF) in unilateral forearm amputees. Methods: Ten unilateral forearm amputees were asked to perform bilateral (intact and phantom) synchronous wrist motions with and without MVF. During wrist motion, electromyographic activities in the extensor digitorum longus (EDL) and flexor carpi radialis muscles (FCR) were recorded with bipolar electrodes. Degree of wrist range of motion (ROM) was also recorded by electrogoniometry attached to the wrist joint of intact side. Subjects were asked to answer the degree of attainment of phantom limb motion using a visual analog scale (VAS: ranging from 0 (hard) to 10 (easy)). Results: VAS and ROM were significantly increased by utilizing MVF, and the extent of an enhancement of the VAS and wrist ROM was positively correlated (r = 0.72, p<0.05). Although FCR EMG activity also showed significant enhancement by MVF, this was not correlated with the changes of VAS and ROM. Interestingly, while we found negative correlation between EDL EMG activity and wrist ROM, MVF generally affected to be increasing both EDL EMG and ROM. Conclusions: Although there was larger extent of variability in the effect of MVF on phantom limb awareness, MVF has a potential to enhance phantom limb awareness, in case those who has a difficulty for the phantom limb motion. The present result suggests that the motor command to the missing limb can be re-activated by an appropriate therapeutic strategy such as mirror therapy.	[Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Mita, Tomoki] Natl Rehabil Ctr Persons Disabil, Dept Prosthet & Orthot, Res Inst, Tokorozawa, Saitama, Japan; [Yoshikawa, Masahiro] Natl Inst Adv Ind Sci & Technol, Intelligent Syst Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kawashima, N (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.	kawashima-noritaka@rehab.go.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Darnall BD, 2009, AM J PHYS MED REHAB, V88, P78, DOI 10.1097/PHM.0b013e318191105b; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Hunter JP, 2003, BRAIN, V126, P579, DOI 10.1093/brain/awg054; Kawashima N, 2009, NEUROCASE, V15, P478, DOI 10.1080/13554790902950442; MacLachlan M, 2004, DISABIL REHABIL, V26, P901, DOI 10.1080/09638280410001708913; MELZACK R, 1992, SCI AM, V266, P120, DOI 10.1038/scientificamerican0492-120; Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180; Moseley GL, 2008, PAIN, V138, P7, DOI 10.1016/j.pain.2008.06.026; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reilly KT, 2006, BRAIN, V129, P2211, DOI 10.1093/brain/awl154; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170	15	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69324	10.1371/journal.pone.0069324	http://dx.doi.org/10.1371/journal.pone.0069324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935984	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300032
J	Singaravelan, N; Raz, S; Tzur, S; Belifante, S; Pavlicek, T; Beiles, A; Ito, S; Wakamatsu, K; Nevo, E				Singaravelan, Natarajan; Raz, Shmuel; Tzur, Shay; Belifante, Shirli; Pavlicek, Tomas; Beiles, Avigdor; Ito, Shosuke; Wakamatsu, Kazumasa; Nevo, Eviatar			Adaptation of Pelage Color and Pigment Variations in Israeli Subterranean Blind Mole Rats, Spalax Ehrenbergi	PLOS ONE			English	Article							CRYPTIC COLORATION; ADAPTIVE RADIATION; CHEMICAL-ANALYSIS; PHEOMELANIN; MICE; EUMELANIN; SELECTION; POPULATIONS; SPECIATION; EVOLUTION	Background: Concealing coloration in rodents is well established. However, only a few studies examined how soil color, pelage color, hair-melanin content, and genetics (i.e., the causal chain) synergize to configure it. This study investigates the causal chain of dorsal coloration in Israeli subterranean blind mole rats, Spalax ehrenbergi. Methods: We examined pelage coloration of 128 adult animals from 11 populations belonging to four species of Spalax ehrenbergi superspecies (Spalax galili, Spalax golani, Spalax carmeli, and Spalax judaei) and the corresponding coloration of soil samples from the collection sites using a digital colorimeter. Additionally, we quantified hair-melanin contents of 67 animals using HPLC and sequenced the MC1R gene in 68 individuals from all four mole rat species. Results: Due to high variability of soil colors, the correlation between soil and pelage color coordinates was weak and significant only between soil hue and pelage lightness. Multiple stepwise forward regression revealed that soil lightness was significantly associated with all pelage color variables. Pelage color lightness among the four species increased with the higher southward aridity in accordance to Gloger's rule (darker in humid habitats and lighter in arid habitats). Darker and lighter pelage colors are associated with darker basalt and terra rossa, and lighter rendzina soils, respectively. Despite soil lightness varying significantly, pelage lightness and eumelanin converged among populations living in similar soil types. Partial sequencing of the MC1R gene identified three allelic variants, two of which were predominant in northern species (S. galili and S. golani), and the third was exclusive to southern species (S. carmeli and S. judaei), which might have caused the differences found in pheomelanin/eumelanin ratio. Conclusion/Significance: Darker dorsal pelage in darker basalt and terra rossa soils in the north and lighter pelage in rendzina and loess soils in the south reflect the combined results of crypsis and thermoregulatory function following Gloger's rule.	[Singaravelan, Natarajan; Raz, Shmuel; Tzur, Shay; Belifante, Shirli; Pavlicek, Tomas; Beiles, Avigdor; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci Toyoake, Dept Chem, Toyoake, Aichi, Japan	University of Haifa; Fujita Health University	Singaravelan, N (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	yoursings@gmail.com	רז, שמואל/ABD-3478-2021; Pavlicek, Tomas/C-4768-2008; Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) KAKENHI [20591357, 21500358]; University of Haifa; Council of Higher Education, Israel	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); University of Haifa; Council of Higher Education, Israel	EN acknowledges the financial support of the Ancell Teicher Research Foundation for Genetics and Molecular Evolution and the Israel Discount Bank Chair of Evolutionary Biology. KW and SI acknowledge the funding support by Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 20591357, 21500358). NS acknowledges postdoctoral fellowship support by University of Haifa and the Council of Higher Education, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EVOLUTION MODERN SYN; Auffray JC, 1999, J EVOLUTION BIOL, V12, P207, DOI 10.1046/j.1420-9101.1999.00054.x; BURTT EH, 1981, BIOSCIENCE, V31, P723, DOI 10.2307/1308778; Caro T, 2005, BIOSCIENCE, V31, P723; CLEFFMANN G, 1963, ANN NY ACAD SCI, V100, P749, DOI 10.1111/j.1749-6632.1963.tb42888.x; Cloudsley-Thompson JL, 1999, NATURWISSENSCHAFTEN, V86, P123, DOI 10.1007/s001140050584; Cott H.B., 1940, ADAPTIVE COLORATION; COWLES RB, 1958, EVOLUTION, V12, P347, DOI 10.2307/2405856; Dice LR, 1937, CARNEGIE I WASH PUBL, V485; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; HAIM A, 1983, J EXP BIOL, V107, P59; HARDY R, 1945, ECOL MONOGR, V15, P71, DOI 10.2307/1943295; HETH G, 1988, OECOLOGIA, V74, P617, DOI 10.1007/BF00380062; Hoekstra HE, 2005, HEREDITY, V94, P217, DOI 10.1038/sj.hdy.6800600; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hunter Richard Sewall, 1948, J OPT SOC AM, V38, P661, DOI DOI 10.1364/JOSA.48.000985; INGLES LG, 1950, EVOLUTION, V4, P353, DOI 10.2307/2405602; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Kennerly T. E. Jr., 1954, Texas Journal of Science, V6, P297; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Krupa JJ, 2000, J MAMMAL, V81, P86, DOI 10.1644/1545-1542(2000)081<0086:MTCOES>2.0.CO;2; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Le Pape E, 2008, PIGM CELL MELANOMA R, V21, P477, DOI 10.1111/j.1755-148X.2008.00479.x; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Majerus M, 1998, MELANISM EVOLUTION A; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; NEVO E, 1985, B ZOOL, V52, P65, DOI 10.1080/11250008509440344; NEVO E, 1994, P NATL ACAD SCI USA, V91, P8160, DOI 10.1073/pnas.91.17.8160; NEVO E, 1979, OECOLOGIA, V43, P125, DOI 10.1007/BF00344766; NEVO E., 2001, ADAPTIVE RAD BLIND S; Ozeki H, 1996, PIGM CELL RES, V9, P265, DOI 10.1111/j.1600-0749.1996.tb00116.x; Rios E, 2012, MAMM BIOL, V77, P160, DOI 10.1016/j.mambio.2011.12.003; Roulin A, 2009, J EVOLUTION BIOL, V22, P345, DOI 10.1111/j.1420-9101.2008.01651.x; Singaravelan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008708; Sumner F. B., 1924, Journal of Mammalogy, V5, P81, DOI 10.2307/1373613; Sumner FB, 1929, P NATL ACAD SCI USA, V15, P110, DOI 10.1073/pnas.15.2.110; WAHRMAN J, 1969, SCIENCE, V164, P82, DOI 10.1126/science.164.3875.82; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Wakamatsu K, 2009, PIGM CELL MELANOMA R, V22, P474, DOI 10.1111/j.1755-148X.2009.00580.x; Walker WP, 2010, PIGM CELL MELANOMA R, V23, P485, DOI 10.1111/j.1755-148X.2010.00721.x; Walker WP, 2010, PIGM CELL MELANOMA R, V23, P4, DOI 10.1111/j.1755-148X.2009.00654.x	43	10	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69346	10.1371/journal.pone.0069346	http://dx.doi.org/10.1371/journal.pone.0069346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935991	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300034
J	Clendenen, T; Zeleniuch-Jacquotte, A; Wirgin, I; Koenig, KL; Afanasyeva, Y; Lundin, E; Arslan, AA; Axelsson, T; Forsti, A; Hallmans, G; Hemminki, K; Lenner, P; Roy, N; Shore, RE; Chen, Y				Clendenen, Tess; Zeleniuch-Jacquotte, Anne; Wirgin, Isaac; Koenig, Karen L.; Afanasyeva, Yelena; Lundin, Eva; Arslan, Alan A.; Axelsson, Tomas; Forsti, Asta; Hallmans, Goran; Hemminki, Kari; Lenner, Per; Roy, Nirmal; Shore, Roy E.; Chen, Yu			Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer	PLOS ONE			English	Article							DIPHOSPHO-GLUCURONOSYLTRANSFERASE 1A1; GENOME-WIDE ASSOCIATION; POSTMENOPAUSAL WOMEN; BINDING GLOBULIN; PROGESTERONE-RECEPTOR; ENDOMETRIAL CANCER; SUSCEPTIBILITY LOCUS; CYP19 AROMATASE; SHBG GENE; POLYMORPHISMS	Sex hormones play a key role in the development of breast cancer. Certain polymorphic variants (SNPs and repeat polymorphisms) in hormone-related genes are associated with sex hormone levels. However, the relationship observed between these genetic variants and breast cancer risk has been inconsistent. We conducted a case-control study nested within two prospective cohorts to assess the relationship between specific genetic variants in hormone-related genes and breast cancer risk. In total, 1164 cases and 2111 individually-matched controls were included in the study. We did not observe an association between potential functional genetic polymorphisms in the estrogen pathway, SHBG rs6259, ESR1 rs2234693, CYP19 rs10046 and rs4775936, and UGT1A1 rs8175347, or the progesterone pathway, PGR rs1042838, with the risk of breast cancer. Our results suggest that these genetic variants do not have a strong effect on breast cancer risk.	[Clendenen, Tess; Zeleniuch-Jacquotte, Anne; Koenig, Karen L.; Afanasyeva, Yelena; Chen, Yu] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Zeleniuch-Jacquotte, Anne; Arslan, Alan A.] NYU, Sch Med, Inst Canc, New York, NY USA; [Wirgin, Isaac; Arslan, Alan A.; Roy, Nirmal; Shore, Roy E.] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Lundin, Eva] Umea Univ, Dept Med Biosci, Umea, Sweden; [Arslan, Alan A.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Axelsson, Tomas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Forsti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Forsti, Asta; Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, Malmo, Sweden; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med Nutr Res, Umea, Sweden; [Lenner, Per] Umea Univ Hosp, Dept Oncol, S-90185 Umea, Sweden; [Shore, Roy E.] Radiat Effects Res Fdn, Hiroshima, Japan	New York University; New York University; New York University; Umea University; New York University; Uppsala University; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Umea University; Umea University; Radiation Effects Research Foundation - Japan	Clendenen, T (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY USA.	tess.clendenen@nyumc.org		Shore, Roy/0000-0002-6842-2248; Arslan, Alan/0000-0002-7775-8085; Zeleniuch-Jacquotte, Anne/0000-0001-9350-1303; Chen, Yu/0000-0002-1519-4894	National Cancer Institute [R01 CA081212, R01 CA098661, P30 CA016087]; National Institute of Environmental Health Sciences [ES000260]; NATIONAL CANCER INSTITUTE [R01CA081212, R01CA098661, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Cancer Institute grants R01 CA081212, R01 CA098661 and P30 CA016087 and Center grant ES000260 from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke OJ, 2004, BREAST CANCER RES TR, V85, P239, DOI 10.1023/B:BREA.0000025419.26423.b8; Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Beckmann L, 2011, J CLIN ENDOCR METAB, V96, pE360, DOI 10.1210/jc.2010-0912; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Cheng TC, 2005, INT J CANCER, V113, P345, DOI 10.1002/ijc.20630; Cui Y, 2005, CANCER EPIDEM BIOMAR, V14, P1096, DOI 10.1158/1055-9965.EPI-04-0721; De Vivo I, 2004, BREAST CANCER RES, V6, pR636, DOI 10.1186/bcr928; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Guillemette C, 2001, CANCER EPIDEM BIOMAR, V10, P711; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Hein R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042380; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Hui Lester, 2008, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0210s56; Hulten K, 2001, CANCER CAUSE CONTROL, V12, P529, DOI 10.1023/A:1011271222153; Huo DZ, 2008, BREAST CANCER RES TR, V110, P367, DOI 10.1007/s10549-007-9720-7; Johnatty SE, 2008, BREAST CANCER RES TR, V109, P91, DOI 10.1007/s10549-007-9627-3; Johnson N, 2012, JNCI-J NATL CANCER I, V104, P657, DOI 10.1093/jnci/djs156; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Key TJ, 2011, STEROIDS, V76, P812, DOI 10.1016/j.steroids.2011.02.029; Kristensen VN, 2000, ONCOGENE, V19, P1329, DOI 10.1038/sj.onc.1203425; Li N, 2010, BREAST CANCER RES TR, V121, P177, DOI 10.1007/s10549-009-0532-9; Lukanova A, 2004, INT J CANCER, V108, P425, DOI 10.1002/ijc.11529; Lundin E, 2012, CANCER EPIDEMIOL, V36, P445, DOI 10.1016/j.canep.2012.04.006; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Napoli N, 2009, BONE, V45, P1169, DOI 10.1016/j.bone.2009.08.001; Olson JE, 2007, BREAST CANCER RES TR, V102, P237, DOI 10.1007/s10549-006-9324-7; Paynter RA, 2005, INT J CANCER, V116, P267, DOI 10.1002/ijc.21041; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pineda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053902; Pooley KA, 2006, CANCER EPIDEM BIOMAR, V15, P675, DOI 10.1158/1055-9965.EPI-05-0679; Riancho JA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-112; Romano A, 2007, J MOL ENDOCRINOL, V38, P331, DOI 10.1677/jme.1.02170; Sakoda LC, 2011, CANCER EPIDEMIOL, V35, P48, DOI 10.1016/j.canep.2010.08.005; Shen Gong-Qing, 2006, V128, P209; Sparks R, 2004, BREAST CANCER RES, V6, pR488, DOI 10.1186/bcr818; Stevens KN, 2011, CANCER RES, V71, P6240, DOI 10.1158/0008-5472.CAN-11-1266; Thompson DJ, 2008, CANCER EPIDEM BIOMAR, V17, P3490, DOI 10.1158/1055-9965.EPI-08-0734; Tsezou A, 2007, GENET TEST, V11, P303, DOI 10.1089/gte.2007.0020; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Yao L, 2010, BREAST CANCER RES TR, V122, P879, DOI 10.1007/s10549-010-0742-1; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhou JY, 2012, MOL BIOL REP, V39, P8307, DOI 10.1007/s11033-012-1680-2	51	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69367	10.1371/journal.pone.0069367	http://dx.doi.org/10.1371/journal.pone.0069367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935996	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000109
J	Deng, YH; Yan, H; Gu, JB; Xu, JB; Wu, K; Tu, ZJ; James, AA; Chen, XG				Deng, Yuhua; Yan, Hui; Gu, Jinbao; Xu, Jiabao; Wu, Kun; Tu, Zhijian; James, Anthony A.; Chen, Xiaoguang			Molecular and Functional Characterization of Odorant-Binding Protein Genes in an Invasive Vector Mosquito, Aedes albopictus	PLOS ONE			English	Article							SOUTHERN HOUSE MOSQUITO; YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; SWISS-MODEL; MALARIA MOSQUITO; SOLUBLE-PROTEINS; IDENTIFICATION; EXPRESSION; DIPTERA; RESPONSES	Aedes albopictus is a major vector of dengue and Chikungunya viruses. Olfaction plays a vital role in guiding mosquito behaviors and contributes to their ability to transmit pathogens. Odorant-binding proteins (OBPs) are abundant in insect olfactory tissues and involved in the first step of odorant reception. While comprehensive descriptions are available of OBPs from Aedes aegypti, Culex quinquefasciatus and Anopheles gambiae, only a few genes from Ae. albopictus have been reported. In this study, twenty-one putative AalbOBP genes were cloned using their homologues in Ae. aegypti to query an Ae. albopictus partial genome sequence. Two antenna-specific OBPs, AalbOBP37 and AalbOBP39, display a remarkable similarity in their overall folding and binding pockets, according to molecular modeling. Binding affinity assays indicated that AalbOBP37 and AalbOBP39 had overlapping ligand affinities and are affected in different pH condition. Electroantennagrams (EAG) and behavioral tests show that these two genes were involved in olfactory reception. An improved understanding of the Ae. albopictus OBPs is expected to contribute to the development of more efficient and environmentally-friendly mosquito control strategies.	[Deng, Yuhua; Yan, Hui; Gu, Jinbao; Xu, Jiabao; Wu, Kun; Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Higher Educ Inst, Key Lab Prevent & Control Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China; [Tu, Zhijian] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	Southern Medical University - China; Virginia Polytechnic Institute & State University; University of California System; University of California Irvine; University of California System; University of California Irvine	Chen, XG (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Higher Educ Inst, Key Lab Prevent & Control Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China.	xgchen2001@hotmail.com	Gu, Jinbao/AAE-6764-2021	James, Anthony/0000-0001-5577-3308	NSFC of China [U0832004]; National Institutes of Health of USA [AI083202]	NSFC of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NSFC of China (U0832004) and National Institutes of Health of USA (AI083202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbruster P, 2009, J MED ENTOMOL, V46, P271, DOI 10.1603/033.046.0211; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Michereff MFF, 2011, J CHEM ECOL, V37, P273, DOI 10.1007/s10886-011-9917-4; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Kim MS, 1998, GENETICS, V150, P711; KUMAR A, 1991, GENOME, V34, P998, DOI 10.1139/g91-154; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Li CX, 2012, J MED ENTOMOL, V49, P573, DOI 10.1603/ME11239; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Pelletier J, 2011, J INSECT PHYSIOL, V57, P915, DOI 10.1016/j.jinsphys.2011.04.003; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Puri SN, 2006, J MED ENTOMOL, V43, P207, DOI 10.1603/0022-2585(2006)043[0207:EABROC]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015403; Xu XZ, 2009, BIOMOL NMR ASSIGN, V3, P195, DOI 10.1007/s12104-009-9173-5; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	46	27	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68836	10.1371/journal.pone.0068836	http://dx.doi.org/10.1371/journal.pone.0068836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935894	Green Published, gold			2022-12-27	WOS:000325211000043
J	Dikmen, S; Cole, JB; Null, DJ; Hansen, PJ				Dikmen, Serdal; Cole, John B.; Null, Daniel J.; Hansen, Peter J.			Genome-Wide Association Mapping for Identification of Quantitative Trait Loci for Rectal Temperature during Heat Stress in Holstein Cattle	PLOS ONE			English	Article							FULL PEDIGREE; GENETIC EVALUATION; DAIRY-COWS; TOLERANCE; REPRODUCTION; PROTEINS; LENGTH	Heat stress compromises production, fertility, and health of dairy cattle. One mitigation strategy is to select individuals that are genetically resistant to heat stress. Most of the negative effects of heat stress on animal performance are a consequence of either physiological adaptations to regulate body temperature or adverse consequences of failure to regulate body temperature. Thus, selection for regulation of body temperature during heat stress could increase thermotolerance. The objective was to perform a genome-wide association study (GWAS) for rectal temperature (RT) during heat stress in lactating Holstein cows and identify SNPs associated with genes that have large effects on RT. Records on afternoon RT where the temperature-humidity index was >= 78.2 were obtained from 4,447 cows sired by 220 bulls, resulting in 1,440 useable genotypes from the Illumina BovineSNP50 BeadChip with 39,759 SNP. For GWAS, 2, 3, 4, 5, and 10 adjacent SNP were averaged to identify consensus genomic regions associated with RT. The largest proportion of SNP variance (0.07 to 0.44%) was explained by markers flanking the region between 28,877,547 and 28,907,154 bp on Bos taurus autosome (BTA) 24. That region is flanked by U1 (28,822,883 to 28,823,043) and NCAD (28,992,666 to 29,241,119). In addition, the SNP at 58,500,249 bp on BTA 16 explained 0.08% and 0.11% of the SNP variance for 2- and 3-SNP analyses, respectively. That contig includes SNORA19, RFWD2 and SCARNA3. Other SNPs associated with RT were located on BTA 16 (close to CEP170 and PLD5), BTA 5 (near SLCO1C1 and PDE3A), BTA 4 (near KBTBD2 and LSM5), and BTA 26 (located in GOT1, a gene implicated in protection from cellular stress). In conclusion, there are QTL for RT in heat-stressed dairy cattle. These SNPs could prove useful in genetic selection and for identification of genes involved in physiological responses to heat stress.	[Dikmen, Serdal] Uludag Univ, Fac Vet Med, Dept Anim Sci, Bursa, Turkey; [Cole, John B.; Null, Daniel J.] ARS, Anim Improvement Programs Lab, USDA, Beltsville, MD USA; [Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL USA	Uludag University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.	pjhansen@animal.ufl.edu	Melnichuk, Igor/W-2809-2017; Dikmen, Serdal/A-5731-2018; Hansen, Peter/AAI-4693-2021; Шмелев, Геннадий/A-2923-2019; Cole, John B./J-8571-2014; Yevheniia, Bohatyrova/A-6066-2015; Irina, Kosareva/O-2936-2016	Melnichuk, Igor/0000-0002-1701-4842; Dikmen, Serdal/0000-0002-5611-4993; Hansen, Peter/0000-0003-3061-9333; Шмелев, Геннадий/0000-0002-2248-7214; Cole, John B./0000-0003-1242-4401; Yevheniia, Bohatyrova/0000-0002-3922-6694; Irina, Kosareva/0000-0003-2522-5575	USDA National Institute of Food and Agriculture [2010-85122-20623, 2013-68004-20365]; Southeast Dairy Inc. Milk Checkoff Program	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Southeast Dairy Inc. Milk Checkoff Program	Research was supported by Agriculture and Food Research Initiative Competitive Grants 2010-85122-20623 and 2013-68004-20365 from the USDA National Institute of Food and Agriculture, and a grant from Southeast Dairy Inc. Milk Checkoff Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Aho AD, 2003, INFECT IMMUN, V71, P6479, DOI 10.1128/IAI.71.11.6479-6486.2003; [Anonymous], 2010, R LANG ENV STAT COMP; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Dikmen S, 2009, J DAIRY SCI, V92, P109, DOI 10.3168/jds.2008-1370; Dikmen S, 2012, J DAIRY SCI, V95, P3401, DOI 10.3168/jds.2011-4306; ELVINGER F, 1992, J DAIRY SCI, V75, P449, DOI 10.3168/jds.S0022-0302(92)77781-9; Hansen PJ, 2007, THERIOGENOLOGY, V68, pS242, DOI 10.1016/j.theriogenology.2007.04.008; Hansen PJ, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P477; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Ioannidis John P. A., 2013, Frontiers in Genetics, V4, P33, DOI 10.3389/fgene.2013.00033; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Liang YF, 2011, LAB INVEST, V91, P12, DOI 10.1038/labinvest.2010.156; Liu YX, 2011, MOL BIOL REP, V38, P83, DOI 10.1007/s11033-010-0080-8; Marshall J, 2011, ADV EXP MED BIOL, V717, P115, DOI 10.1007/978-1-4419-9557-5_10; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Misztal I., 2002, P 7 WORLD C GEN APPL; NRC National Research Council, 1971, GUID ENV RES AN; Olson TA, 2003, J ANIM SCI, V81, P80; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Robinson PA, 2004, J CELL SCI, V117, P5191, DOI 10.1242/jcs.01539; Sakatani M, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-3; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; SCOTT IM, 1983, INT J BIOMETEOROL, V27, P47, DOI 10.1007/BF02186300; SEATH DM, 1947, J DAIRY SCI, V30, P137, DOI 10.3168/jds.S0022-0302(47)92331-X; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Thompson R, 1999, INTERBULL B, V20, P70; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	42	76	76	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69202	10.1371/journal.pone.0069202	http://dx.doi.org/10.1371/journal.pone.0069202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935954	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000089
J	Golden, A; Steel, C; Yokobe, L; Jackson, E; Barney, R; Kubofcik, J; Peck, R; Unnasch, TR; Nutman, TB; de los Santos, T; Domingo, GJ				Golden, Allison; Steel, Cathy; Yokobe, Lindsay; Jackson, Emily; Barney, Rebecca; Kubofcik, Joseph; Peck, Roger; Unnasch, Thomas R.; Nutman, Thomas B.; de los Santos, Tala; Domingo, Gonzalo J.			Extended Result Reading Window in Lateral Flow Tests Detecting Exposure to Onchocerca volvulus: A New Technology to Improve Epidemiological Surveillance Tools	PLOS ONE			English	Article							IVERMECTIN TREATMENT; ENDEMIC FOCI; 1ST EVIDENCE; ELIMINATION; PROGRAM; MALI	Onchocerciasis is a neglected tropical disease caused by infection with the parasite Onchocerca volvulus (Ov). An estimated 180 million people are at risk for Ov infection, and 37 million people are infected, mostly in Africa. A lateral flow-based assay to detect human IgG4 antibodies to the Ov-specific antigen Ov-16 was developed as a rapid tool to detect exposure to Ov. The test, when performed on 449 sera specimens from patients with microfiladermia and Ov-negative patients, has a sensitivity of 89.1% (95% confidence interval: 86.2%-92.0%), and specificity of 97% (95% confidence interval: 95.4%-98.6%). Because the intended use of the test is for surveillance, it is highly desirable to have a stable, long-lasting result. An extended read window is thus desirable for a high-volume, busy workflow and facilitates post-surveillance quality assurance. The main restriction on achieving an extended read window for this assay was the erythrocyte lysis that can alter the signal-to-noise ratio, especially in those with low IgG4 levels (weak positives). We describe a test housing that incorporates a user-independent feature driven by assay fluid and an expanding wick that detaches the blood separation membrane from the nitrocellulose used in the assay, but before hemolysis occurs. We demonstrated material functionality at extreme operational conditions (37 degrees C, 80% relative humidity) and a read window of a minimum of 70 days. The fluid-driven assay device performs equally as well with whole blood as with plasma, as demonstrated with 100 spiked clinical specimens (with a correlation coefficient of 0.96). We show a novel, inexpensive, and simple approach to actuating the detachment of the blood separation membrane from the nitrocellulose test with no impact on the performance characteristics of the test.	[Golden, Allison; Yokobe, Lindsay; Jackson, Emily; Barney, Rebecca; Peck, Roger; de los Santos, Tala; Domingo, Gonzalo J.] PATH, Diagnost Grp, Seattle, WA USA; [Steel, Cathy; Kubofcik, Joseph; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University System of Florida; University of South Florida	Domingo, GJ (corresponding author), PATH, Diagnost Grp, Seattle, WA USA.	gdomingo@path.org		Domingo, Gonzalo/0000-0002-1004-4395	Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000439] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication is based on research funded by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basanez MG, 2006, PLOS MED, V3, P1454, DOI 10.1371/journal.pmed.0030371; Boatin B, 2008, ANN TROP MED PARASIT, V102, P13, DOI 10.1179/136485908X337427; Boatin BA, 2002, PARASITOLOGY, V125, P545, DOI 10.1017/S0031182002002494; Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438; CRUZORTIZ N, 2012, J PARASITOL RES, V2012, DOI DOI 10.1155/2012/638429; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Fink DL, 2001, J CLIN MICROBIOL, V49, P42; Gustavsen K, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-205; Katabarwa Moses N, 2012, J Parasitol Res, V2012, P748540, DOI 10.1155/2012/748540; Lipner EM, 2006, J INFECT DIS, V194, P216, DOI 10.1086/505081; LOBOS E, 1991, SCIENCE, V251, P1603, DOI 10.1126/science.2011741; Nde PN, 2002, AM J TROP MED HYG, V66, P566, DOI 10.4269/ajtmh.2002.66.566; Rodriguez-Perez MA, 2003, T ROY SOC TROP MED H, V97, P539, DOI 10.1016/S0035-9203(03)80018-4; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629	17	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69231	10.1371/journal.pone.0069231	http://dx.doi.org/10.1371/journal.pone.0069231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935960	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000090
J	Holl, EK; Shumansky, KL; Pitoc, G; Ramsburg, E; Sullenger, BA				Holl, Eda K.; Shumansky, Kara L.; Pitoc, George; Ramsburg, Elizabeth; Sullenger, Bruce A.			Nucleic Acid Scavenging Polymers Inhibit Extracellular DNA-Mediated Innate Immune Activation without Inhibiting Anti-Viral Responses	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; PLASMACYTOID DENDRITIC CELLS; DOUBLE-STRANDED-RNA; AUTOANTIBODY PRODUCTION; MURINE MODEL; IFN-ALPHA; B-CELLS; RECOGNITION; TLR7; TOLL-LIKE-RECEPTOR-7	Toll-like receptor (TLR) family members, 3, 7 and 9 are key components in initiation and progression of autoimmune disorders such as systemic lupus erythematosus (SLE). These TLRs are often referred to as nucleic acid-sensing TLRs based on their ability to recognize DNAs or RNAs produced by pathogens or damaged cells. During autoimmune disease progression these receptors recognize self nucleic acids as well as self nucleic acid-containing complexes and contribute to inflammatory cytokine production and subsequent enhancement of serum autoantibody levels. We have recently discovered that nucleic-acid scavenging polymers (NASPs) can neutralize the proinflammatory effects of nucleic acids. Here, we begin to explore what effects such NASPs have on normal immune function. We show that such NASPs can inhibit TLR activation without affecting nucleic acid-independent T cell activation. Moreover, we observe that stimulation of immune cells by encapsulated nucleic acids, such as those found in viral particles, is unaffected by NASPs. Thus NASPs only limit the activation of the immune system by accessible extra-cellular nucleic acid and do not engender non-specific immune suppression. These important findings suggest that NASPs represent a new approach toward anti-inflammatory drug development as these agents can potentially be utilized to block overt autoimmune disorders and inflammation while allowing normal immune responses to occur.	[Holl, Eda K.; Shumansky, Kara L.; Pitoc, George; Sullenger, Bruce A.] Duke Univ, Dept Surg, Durham, NC USA; [Holl, Eda K.; Shumansky, Kara L.; Pitoc, George; Sullenger, Bruce A.] Duke Univ, Duke Translat Res Inst, Durham, NC USA; [Ramsburg, Elizabeth] Duke Univ, Dept Med, Durham, NC USA	Duke University; Duke University; Duke University	Sullenger, BA (corresponding author), Duke Univ, Dept Surg, Durham, NC USA.	bruce.sullenger@duke.edu			National Institutes of Health [1R56-AI093960, F32 DK094543]; Alliance for Lupus Research [ALR-187329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health 1R56-AI093960 (BAS), a grant from the Alliance for Lupus Research ALR-187329 (BAS) and a National Institutes of Health fellowship F32 DK094543 (EKH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Pulliero A, 2011, MUTAT RES-FUND MOL M, V717, P99, DOI 10.1016/j.mrfmmm.2011.03.018; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; van Deventer HW, 2002, J IMMUNOL, V169, P1634, DOI 10.4049/jimmunol.169.3.1634; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	46	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69413	10.1371/journal.pone.0069413	http://dx.doi.org/10.1371/journal.pone.0069413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936008	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000116
J	Huang, YQ; Jiang, Y; Lu, WQ; Zhang, Y				Huang, Yeqing; Jiang, Ying; Lu, Weiqi; Zhang, Yong			Nemo-Like Kinase Associated with Proliferation and Apoptosis by c-Myb Degradation in Breast Cancer	PLOS ONE			English	Article							EXPRESSION; GENES; BCL-2	Nemo-like kinase (NLK), a mediator of the Wnt signaling pathway, binds directly to c-Myb, leading to its phosphorylation, ubiquitination and proteasome-dependent degradation. NLK was significantly downregulated in the breast cancer tissues compared to corresponding normal tissues. NLK expression was negatively correlated with c-Myb expression. NLK suppressed proliferation, induced apoptosis and mediated c-Myb degradation in MCF-7 cells via a mechanism that seems to involve c-myc and Bcl2. These findings might provide a novel target for therapeutic intervention in patients with breast cancer.	[Huang, Yeqing] Nantong Univ, Coll Med, Affiliated Hosp, Dept Tumor Chemotherapy, Nantong, Jiangsu, Peoples R China; [Jiang, Ying; Lu, Weiqi; Zhang, Yong] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai 200433, Peoples R China	Nantong University; Fudan University	Jiang, Y (corresponding author), Nantong Univ, Coll Med, Affiliated Hosp, Dept Tumor Chemotherapy, Nantong, Jiangsu, Peoples R China.	jiangyzs@163.com		Jiang, Ying/0000-0002-2644-3964				Aaron RT, 2010, PLOS ONE, V5; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Annamaria B, 2001, AM J PATHOL, V158, P1289; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Chie KI, 2004, GENE DEV, V18, P816; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Cui G, 2011, J CLIN NEUROSCI, V18, P271, DOI 10.1016/j.jocn.2010.05.037; Daemen A, 2012, TRANSL CANCER RES, V1, P279, DOI 10.3978/j.issn.2218-676X.2012.10.05; Drabsch Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2614; Emami KH, 2009, PROSTATE, V69, P1481, DOI 10.1002/pros.20998; Fang F, 2009, ENDOCRINOLOGY, V150, P1597, DOI 10.1210/en.2008-1079; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; Hodges LC, 2003, MOL CANCER RES, V1, P300; Ishikawa T, 2012, J THORAC DIS, V4, P650, DOI 10.3978/j.issn.2072-1439.2012.10.17; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kauraniemi P, 2000, CANCER RES, V60, P5323; Kim S, 2010, J BIOL CHEM, V285, P8122, DOI 10.1074/jbc.M110.101824; Kumar A, 2003, J BIOL CHEM, V278, P11480, DOI 10.1074/jbc.M300080200; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; MELANI C, 1991, CANCER RES, V51, P2897; Mirkovic I, 2002, MECH DEVELOP, V119, P9, DOI 10.1016/S0925-4773(02)00289-7; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Ohnishi E, 2010, MOL CELL BIOL, V30, P675, DOI 10.1128/MCB.00576-09; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; RAMSAY RG, 1992, CELL GROWTH DIFFER, V3, P723; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Thompson MA, 1997, ONCOGENE, V14, P1715, DOI 10.1038/sj.onc.1201007; Verheyen EM, 2001, MECH DEVELOP, V101, P119, DOI 10.1016/S0925-4773(00)00574-8; VILLA AE, 1995, CIRC RES, V76, P505, DOI 10.1161/01.RES.76.4.505; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yasuda J, 2003, BIOCHEM BIOPH RES CO, V308, P227, DOI 10.1016/S0006-291X(03)01343-3; Zorbas M, 1999, ONCOGENE, V18, P5821, DOI 10.1038/sj.onc.1202971	38	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69148	10.1371/journal.pone.0069148	http://dx.doi.org/10.1371/journal.pone.0069148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935942	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000083
J	Hueston, L; Toi, CS; Jeoffreys, N; Sorrell, T; Gilbert, G				Hueston, Linda; Toi, Cheryl S.; Jeoffreys, Neisha; Sorrell, Tania; Gilbert, Gwendolyn			Diagnosis of Barmah Forest Virus Infection by a Nested Real-Time SYBR Green RT-PCR Assay	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; SEQUENCE	Barmah Forest virus (BFV) is a mosquito borne (+) ssRNA alphavirus found only in Australia. It causes rash, myalgia and arthralgia in humans and is usually diagnosed serologically. We developed a real-time PCR assay to detect BFV in an effort to improve diagnosis early in the course of infection. The limit of detection was 16 genome equivalents with a specificity of 100%. Fifty five serum samples from BFV-infected patients were tested by the PCR. 52 of 53 antibody-positive samples were PCR negative. Two culture-positive (neutralizing antibody negative) samples were positive on first round PCR, while one sample (IgM and neutralizing antibody strongly positive, IgG negative) was positive on second round PCR, suggesting that viral RNA is detectable and transiently present in early infection. PCR can provide results faster than culture, is capable of high throughput and by sequencing the PCR product strain variants can be characterized.	[Hueston, Linda; Toi, Cheryl S.; Jeoffreys, Neisha; Gilbert, Gwendolyn] Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia; [Sorrell, Tania] Sydney Inst Emerging Infect Dis & Biosecur, Westmead, NSW, Australia		Hueston, L (corresponding author), Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW, Australia.	linda.hueston@swahs.health.nsw.gov.au	Gilbert, Gwendolyn/B-7733-2013; Sorrell, Tania/AAZ-5286-2020	Gilbert, Gwendolyn/0000-0001-7490-6727; Sorrell, Tania/0000-0001-9460-0960				Biosystems A., 2013, CREATING STANDARD CU; BOUGHTON CR, 1988, MED J AUSTRALIA, V148, P146, DOI 10.5694/j.1326-5377.1988.tb112780.x; Cashman P, 2008, COMMUN DIS INTELL, V32, P263; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flexman JP, 1998, MED J AUSTRALIA, V169, P159, DOI 10.5694/j.1326-5377.1998.tb116019.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lee E, 1997, VIROLOGY, V227, P509, DOI 10.1006/viro.1996.8343; Lindsay MD, 1995, MED J AUSTRALIA, V162, P159; MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P457, DOI 10.1038/icb.1982.51; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SELLNER LN, 1994, J VIROL METHODS, V49, P47, DOI 10.1016/0166-0934(94)90054-X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e65197	10.1371/journal.pone.0065197	http://dx.doi.org/10.1371/journal.pone.0065197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935816	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000001
J	Sharma, M; Tiwari, A; Sharma, S; Bhoria, P; Gupta, V; Gupta, A; Luthra-Guptasarma, M				Sharma, Maryada; Tiwari, Anil; Sharma, Shweta; Bhoria, Preeti; Gupta, Vishali; Gupta, Amod; Luthra-Guptasarma, Manni			Fibrotic Remodeling of the Extracellular Matrix through a Novel (Engineered, Dual-Function) Antibody Reactive to a Cryptic Epitope on the N-Terminal 30 kDa Fragment of Fibronectin	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; PROLIFERATIVE VITREORETINOPATHY; RETINAL-DETACHMENT; IN-VITRO; GROWTH; POLYMERIZATION; CONTRACTION; EXPRESSION; MEMBRANES; ADHESION	Fibrosis is characterized by excessive accumulation of scar tissue as a result of exaggerated deposition of extracellular matrix (ECM), leading to tissue contraction and impaired function of the organ. Fibronectin (Fn) is an essential component of the ECM, and plays an important role in fibrosis. One such fibrotic pathology is that of proliferative vitreoretinopathy (PVR), a sight-threatening complication which develops as a consequence of failure of surgical repair of retinal detachment. Such patients often require repeated surgeries for retinal re-attachment; therefore, a preventive measure for PVR is of utmost importance. The contractile membranes formed in PVR, are composed of various cell types including the retinal pigment epithelial cells (RPE); fibronectin is an important constituent of the ECM surrounding these cells. Together with the vitreous, fibronectin creates microenvironments in which RPE cells proliferate. We have successfully developed a dual-action, fully human, fibronectin-specific single chain variable fragment antibody (scFv) termed Fn52RGDS, which acts in two ways: i) binds to cryptic sites in fibronectin, and thereby prevents its self polymerization/fibrillogenesis, and ii) interacts with the cell surface receptors, ie., integrins (through an attached "RGD" sequence tag), and thereby blocks the downstream cell signaling events. We demonstrate the ability of this antibody to effectively reduce some of the hallmark features of fibrosis - migration, adhesion, fibronectin polymerization, matrix metalloprotease (MMP) expression, as well as reduction of collagen gel contraction (a model of fibrotic tissue remodeling). The data suggests that the antibody can be used as a rational, novel anti-fibrotic candidate.	[Sharma, Maryada; Tiwari, Anil; Sharma, Shweta; Luthra-Guptasarma, Manni] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India; [Bhoria, Preeti] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India; [Gupta, Vishali; Gupta, Amod] Postgrad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Luthra-Guptasarma, M (corresponding author), Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India.	guptasarma.manni@pgimer.edu.in	Gupta, Amod/V-7633-2017; Bhoria, Preeti/AAF-5908-2021; Gupta, Vishali/AAU-2549-2021	Gupta, Amod/0000-0001-8427-5738; Bhoria, Preeti/0000-0002-2536-4877; Luthra-Guptasarma, Manni/0000-0002-2740-887X	Department of Science and Technology (DST), Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	The study was funded by the Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2006, INVEST OPHTH VIS SCI, V47, P415, DOI 10.1167/iovs.05-0308; ASAGA H, 1991, EXP CELL RES, V193, P167, DOI 10.1016/0014-4827(91)90552-6; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; CAMPOCHIARO P A, 1984, Archives of Ophthalmology, V102, P1830; CAMPOCHIARO PA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1403; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Chifflet S, 2004, J BIOCHEM BIOPH METH, V59, P139, DOI 10.1016/j.jbbm.2003.12.004; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; DARDENNE AJ, 1984, J PATHOL, V142, P235; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; HISCOTT P, 1992, CELL TISSUE RES, V267, P185, DOI 10.1007/BF00318703; HISCOTT P, 1992, BRIT J OPHTHALMOL, V76, P486, DOI 10.1136/bjo.76.8.486; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Ikuno Y, 2002, INVEST OPHTH VIS SCI, V43, P2406; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee JH, 2003, FEMS MICROBIOL LETT, V223, P293, DOI 10.1016/S0378-1097(03)00401-4; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARANO RPC, 1994, INVEST OPHTH VIS SCI, V35, P2791; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; Pickering JG, 2000, AM J PATHOL, V156, P453, DOI 10.1016/S0002-9440(10)64750-5; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sen T, 2010, BIOCHIMIE, V92, P1422, DOI 10.1016/j.biochi.2010.07.005; Sharma M, 2009, BBA-GEN SUBJECTS, V1790, P1282, DOI 10.1016/j.bbagen.2009.06.010; Sharma R, 2007, BBA-MOL BASIS DIS, V1772, P1258, DOI 10.1016/j.bbadis.2007.10.005; Sheridan CM, 2001, AM J PATHOL, V159, P1555, DOI 10.1016/S0002-9440(10)62540-0; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SMIDDY WE, 1989, OPHTHALMOLOGY, V96, P811; Sottile J, 1998, J CELL SCI, V111, P2933; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Troger J, 2003, BRIT J OPHTHALMOL, V87, P1403, DOI 10.1136/bjo.87.11.1403; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Yoon HS, 2000, CURR EYE RES, V20, P215, DOI 10.1076/0271-3683(200003)20:3;1-9;FT215; Zhu J, 2013, INT J OPHTHALMOL-CHI, V6, P8, DOI 10.3980/j.issn.2222-3959.2013.01.02	50	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69343	10.1371/journal.pone.0069343	http://dx.doi.org/10.1371/journal.pone.0069343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935989	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000104
J	Shin, JM; Jeong, YJ; Cho, HJ; Park, KK; Chung, IK; Lee, IK; Kwak, JY; Chang, HW; Kim, CH; Moon, SK; Kim, WJ; Choi, YH; Chang, YC				Shin, Jae-Moon; Jeong, Yun-Jeong; Cho, Hyun-Ji; Park, Kwan-Kyu; Chung, Il-Kyung; Lee, In-Kyu; Kwak, Jong-Young; Chang, Hyeun-Wook; Kim, Cheorl-Ho; Moon, Sung-Kwon; Kim, Wun-Jae; Choi, Yung-Hyun; Chang, Young-Chae			Melittin Suppresses HIF-1 alpha/VEGF Expression through Inhibition of ERK and mTOR/p70S6K Pathway in Human Cervical Carcinoma Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; GROWTH-FACTOR EXPRESSION; FACTOR 1-ALPHA; CANCER CELLS; SIGNALING PATHWAY; BREAST-CANCER; FACTOR-I; TUMOR; ANGIOGENESIS; ACTIVATION	Objective: Melittin (MEL), a major component of bee venom, has been associated with various diseases including arthritis, rheumatism and various cancers. In this study, the anti-angiogenic effects of MEL in CaSki cells that were responsive to the epidermal growth factor (EGF) were examined. Methodology/Principal Findings: MEL decreased the EGF-induced hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein and significantly regulated angiogenesis and tumor progression. We found that inhibition of the HIF-1 alpha protein level is due to the shortened half-life by MEL. Mechanistically, MEL specifically inhibited the EGF-induced HIF-1 alpha expression by suppressing the phosphorylation of ERK, mTOR and p70S6K. It also blocked the EGF-induced DNA binding activity of HIF-1 alpha and the secretion of the vascular endothelial growth factor (VEGF). Furthermore, the chromatin immunoprecipitation (ChIP) assay revealed that MEL reduced the binding of HIF-1 alpha to the VEGF promoter HRE region. The anti-angiogenesis effects of MEL were confirmed through a matrigel plus assay. Conclusions: MEL specifically suppressed EGF-induced VEGF secretion and new blood vessel formation by inhibiting HIF-1 alpha. These results suggest that MEL may inhibit human cervical cancer progression and angiogenesis by inhibiting HIF-1 alpha and VEGF expression.	[Shin, Jae-Moon; Jeong, Yun-Jeong; Cho, Hyun-Ji; Park, Kwan-Kyu; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Taegu, South Korea; [Shin, Jae-Moon; Jeong, Yun-Jeong; Cho, Hyun-Ji; Park, Kwan-Kyu; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Taegu, South Korea; [Chung, Il-Kyung] Catholic Univ Daegu, Dept Biotechnol, Gyongsan, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kwak, Jong-Young] Dong A Univ, Coll Med, Dept Biochem, Pusan, South Korea; [Chang, Hyeun-Wook] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Moon, Sung-Kwon] Chung Ang Univ, Dept Food Sci & Technol, Ansung, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Personalized Tumor Engn Res Ctr, Cheongju, South Korea; [Choi, Yung-Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan, South Korea	Catholic University of Daegu; Catholic University of Daegu; Catholic University of Daegu; Kyungpook National University; Dong A University; Yeungnam University; Sungkyunkwan University (SKKU); Chung Ang University; Chungbuk National University; Dong-Eui University	Chang, YC (corresponding author), Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Taegu, South Korea.	ycchang@cu.ac.kr	Kim, Cheorl-Ho/T-6753-2019; Lee, In-Kyu/AAR-6374-2021	Kim, Cheorl-Ho/0000-0002-6323-0714; 	Biogreen 21 Program, Rural Development Administration, Republic of Korea [PJ009534022013]; National Research Foundation of Korea (NRF, Personalized Tumor Engineering Research Center); Korea government (MEST) [2008-0062611]	Biogreen 21 Program, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea (NRF, Personalized Tumor Engineering Research Center)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant (PJ009534022013) from Biogreen 21 Program, Rural Development Administration, Republic of Korea and also by the National Research Foundation of Korea (NRF, Personalized Tumor Engineering Research Center) grant funded by the Korea government (MEST) (NO. 2008-0062611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Duyndam MCA, 2003, J BIOL CHEM, V278, P6885, DOI 10.1074/jbc.M206320200; Duyndam MCA, 2007, BIOCHEM PHARMACOL, V74, P191, DOI 10.1016/j.bcp.2007.04.003; Fan Bei, 2005, Shengli Xuebao, V57, P13; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Han JY, 2005, JNCI-J NATL CANCER I, V97, P1272, DOI 10.1093/jnci/dji251; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015823; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Ong SG, 2012, PHARMACOL THERAPEUT, V136, P69, DOI 10.1016/j.pharmthera.2012.07.005; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shan Xiao-Lei, 2010, Chin J Cancer, V29, P20; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhang Jun, 2007, Cancer Ther, V5, P273; Zhang YH, 2008, CANCER RES, V68, P6680, DOI 10.1158/0008-5472.CAN-07-6782; Zhong H, 2000, CANCER RES, V60, P1541	29	41	46	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69380	10.1371/journal.pone.0069380	http://dx.doi.org/10.1371/journal.pone.0069380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936001	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000110
J	Wallis, JC; Rolando, E; Borgman, CL				Wallis, Jillian C.; Rolando, Elizabeth; Borgman, Christine L.			If We Share Data, Will Anyone Use Them? Data Sharing and Reuse in the Long Tail of Science and Technology	PLOS ONE			English	Article							BIG-DATA; SCIENTIFIC-DATA; SENSOR	Research on practices to share and reuse data will inform the design of infrastructure to support data collection, management, and discovery in the long tail of science and technology. These are research domains in which data tend to be local in character, minimally structured, and minimally documented. We report on a ten-year study of the Center for Embedded Network Sensing (CENS), a National Science Foundation Science and Technology Center. We found that CENS researchers are willing to share their data, but few are asked to do so, and in only a few domain areas do their funders or journals require them to deposit data. Few repositories exist to accept data in CENS research areas.. Data sharing tends to occur only through interpersonal exchanges. CENS researchers obtain data from repositories, and occasionally from registries and individuals, to provide context, calibration, or other forms of background for their studies. Neither CENS researchers nor those who request access to CENS data appear to use external data for primary research questions or for replication of studies. CENS researchers are willing to share data if they receive credit and retain first rights to publish their results. Practices of releasing, sharing, and reusing of data in CENS reaffirm the gift culture of scholarship, in which goods are bartered between trusted colleagues rather than treated as commodities.	[Wallis, Jillian C.; Rolando, Elizabeth; Borgman, Christine L.] Univ Calif Los Angeles, Dept Informat Studies, Grad Sch Educ & Informat Studies, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wallis, JC (corresponding author), Univ Calif Los Angeles, Dept Informat Studies, Grad Sch Educ & Informat Studies, Los Angeles, CA 90095 USA.	jwallisi@ucla.edu		Borgman, Christine L./0000-0002-9344-1029	National Science Foundation (NSF) [CCR-0120778, OCI-0750529, 0827322, OCI0830976]; Office of Advanced Cyberinfrastructure (OAC) [1216754] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	Research reported here was supported in part by grants from the National Science Foundation (NSF): (1) The Center for Embedded Networked Sensing (CENS) is funded by NSF Cooperative Agreement number CCR-0120778, Deborah L. Estrin, UCLA, Principal Investigator; (2) Towards a Virtual Organization for Data Cyberinfrastructure, number OCI-0750529, C. L. Borgman, UCLA, PI; G. Bowker, Santa Clara University, Co-PI; Thomas Finholt, University of Michigan, Co-PI; (3) Monitoring, Modeling & Memory: Dynamics of Data and Knowledge in Scientific Cyberinfrastructures: number 0827322, P.N. Edwards, UM, PI; Co-PIs C. L. Borgman, UCLA; G. Bowker, SCU and Pittsburgh; T. Finholt, UM; S. Jackson, UM; D. Ribes, Georgetown; S. L. Star, SCU and Pittsburgh; and (4) The Data Conservancy, NSF Cooperative Agreement (DataNet) award OCI0830976, Sayeed Choudhury, PI, Johns Hopkins University. Microsoft Technical Computing and External Research provided gifts in support of this research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATURE, V461, P145, DOI 10.1038/461145a; [Anonymous], WIRED OPINION; [Anonymous], 2011, SCIENCE, V331, P692, DOI DOI 10.1126/SCIENCE.331.6018.692; [Anonymous], 2011, WHAT RES WANT; [Anonymous], 2012, NATURE, V492, P145, DOI [10.1038/nj7427-145a, DOI 10.1038/NJ7427-145A]; Aronova E, 2010, HIST STUD NAT SCI, V40, P183, DOI 10.1525/hsns.2010.40.2.183; Berman F, 2010, SUSTAINABLE EC DIGI; Bertzky M, 2009, J ENVIRON MANAGE, V90, P8, DOI 10.1016/j.jenvman.2007.11.001; Birney E, 2012, NATURE, V489, P49, DOI 10.1038/489049a; Borgman C. L., 2011, WHY ARE ATTRIBUTION; Borgman C.L., 2007, SCHOLARSHIP DIGITAL; Borgman C, 2006, LECT NOTES COMPUT SC, V4172, P170; Borgman CL, 2012, COMPUT SUPP COOP W J, V21, P485, DOI 10.1007/s10606-012-9169-z; Borgman CL, 2012, J AM SOC INF SCI TEC, V63, P1059, DOI 10.1002/asi.22634; Borgman CL, 2007, ACM-IEEE J CONF DIG, P269, DOI 10.1145/1255175.1255228; Borgman CL, 2007, INT J DIGIT LIBRARIE, V7, P17, DOI 10.1007/s00799-007-0022-9; Bowker GC., 2005, MEMORY PRACTICES SCI; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Buckland Michael, 2011, Bulletin of the American Society for Information Science and Technology, V37, P34, DOI 10.1002/bult.2011.1720370611; Butler MH, 1998, CSCW 98, P335; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Committee on Ensuring the Utility and Integrity of Research Data in a Digital Age, 2009, ENS INT ACC STEW RES; Committee on Issues in the Transborder Flow of Scientific Data and National Research Council, 1997, BITS POW ISS GLOB AC; Consultative Committee for Space Data Systems, 2002, REF MOD OP ARCH INF; Cragin MH, 2010, PHILOS T R SOC A, V368, P4023, DOI 10.1098/rsta.2010.0165; Edwards Paul, 2010, VAST MACHINE COMPUTE; Faniel IM, 2010, COMPUT SUPP COOP W J, V19, P355, DOI 10.1007/s10606-010-9117-8; Foster I, 2013, EMPOWERING LONG TRIA; Foster MW, 2007, NAT REV GENET, V8, P633, DOI 10.1038/nrg2124; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Geeknet Inc, 2012, SOURCEFORGE DOWNL DE; Gitelman L, 2013, RAW DAT IS OXYMORON; Hamilton M, 2004, CENS NEW DIRECTIONS; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Hartswood M, 2012, P 2012 ANN C HUM FAC; Heidorn PB, 2008, LIBR TRENDS, V57, P280; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; Hey T., 2009, 4 PARADIGM DATA INTE; HILGARTNER S, 1994, KNOWLEDGE, V15, P355, DOI 10.1177/107554709401500401; ICiS-Institute for Computing in Science, 2012, I COMP SCI BIG DAT L; Jasny BR, 2011, SCIENCE, V334, P1225, DOI 10.1126/science.334.6060.1225; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Kanfer A. G., 2000, Information Systems Frontiers, V2, P317, DOI 10.1023/A:1026520728644; Latour B., 1988, SCI ACTION FOLLOW SC; Lyman P, 1996, DAEDALUS, V125, P1; Lynch C, 2008, NATURE, V455, P28, DOI 10.1038/455028a; Lyon L., 2007, DEALING DATA ROLES R; Mandell RA, 2012, RES ATTITUDES DATA D; Mandell RA, 2012, LIB DIG AG LIDA P ZA, V12; Mauss M., 2006, GIFT FORM REASON EXC; Mayernik M., 2011, METADATA REALITIES C; Mayernik MS, 2013, COMPUT SUPP COOP W J, V22, P65, DOI 10.1007/s10606-012-9178-y; Merton R.K., 1973, SOCIOLOGY SCI THEORE, P460; MERTON RK, 1994, SCIENTIST, V8, P12; Microsoft, 2012, CODEPLEX OP SOURC PR; National Academy of Sciences, 2012, ATTR DEV DAT ATTR CI; National Science Board (U.S.), 2005, LONG LIV DIG DAT COL; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Organisation for Economic Co-operation and Development, 2007, OECD PRINC GUID ACC; Pepe A, 2010, STRUCTURE EVOLUTION; Pepe A, 2011, J AM SOC INF SCI TEC, V62, P2121, DOI 10.1002/asi.21629; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Porter J., 2010, B ECOL SOC AM, V91, P14, DOI [10.1890/0012-9623-91.1.14, DOI 10.1890/0012-9623-91.1.14]; Price DJdS, 1963, LITTLE SCI BIG SCI; Pritchard S. M., 2004, COLLABORATION KNOWLE; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Ribes David, 2008, SCI COLLABORATION IN, P311; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sieber Joan E, 1989, IRB, V11, P4, DOI 10.2307/3564184; STERLING TD, 1990, COMMUN ACM, V33, P112, DOI 10.1145/79173.79182; Stodden V, 2009, COMPUT SCI ENG, V11, P35, DOI 10.1109/MCSE.2009.19; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Wallis J.C., 2008, INT J DIGITAL CURATI, V3, P114, DOI [10.2218/ijdc.v3i1.46, DOI 10.2218/IJDC.V3I1.46]; Wallis J.C., 2010, P 10 ANN JOINT C DIG, P333, DOI [10.1145/1816123.1816173, DOI 10.1145/1816123.1816173]; Wallis JC, 2007, LECT NOTES COMPUT SC, V4675, P380; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wynholds LA, 2012, P 12 ACM IEEE CS JOI, P19, DOI DOI 10.1145/2232817.2232822; Zimmerman AS, 2008, SCI TECHNOL HUM VAL, V33, P631, DOI 10.1177/0162243907306704	78	216	221	2	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67332	10.1371/journal.pone.0067332	http://dx.doi.org/10.1371/journal.pone.0067332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935830	gold, Green Published			2022-12-27	WOS:000325211000010
J	Larson, JH; Richardson, WB; Vallazza, JM; Nelson, JC				Larson, James H.; Richardson, William B.; Vallazza, Jon M.; Nelson, John C.			Rivermouth Alteration of Agricultural Impacts on Consumer Tissue delta N-15	PLOS ONE			English	Article							GREAT-LAKES; FOOD WEBS; COASTAL; HYDROLOGY; INFERENCE; ISOTOPES; REFLECT; WATER	Terrestrial agricultural activities strongly influence riverine nitrogen (N) dynamics, which is reflected in the delta N-15 of riverine consumer tissues. However, processes within aquatic ecosystems also influence consumer tissue delta N-15. As aquatic processes become more important terrestrial inputs may become a weaker predictor of consumer tissue delta N-15. In a previous study, this terrestrial-consumer tissue delta N-15 connection was very strong at river sites, but was disrupted by processes occurring in rivermouths (the 'rivermouth effect'). This suggested that watershed indicators of N loading might be accurate in riverine settings, but could be inaccurate when considering N loading to the nearshore of large lakes and oceans. In this study, the rivermouth effect was examined on twenty-five sites spread across the Laurentian Great Lakes. Relationships between agriculture and consumer tissue delta N-15 occurred in both upstream rivers and at the outlets where rivermouths connect to the nearshore zone, but agriculture explained less variation and had a weaker effect at the outlet. These results suggest that rivermouths may sometimes be significant sources or sinks of N, which would cause N loading estimates to the nearshore zone that are typically made at discharge gages further upstream to be inaccurate. Identifying definitively the controls over the rivermouth effect on N loading (and other nutrients) will require integration of biogeochemical and hydrologic models.	[Larson, James H.; Richardson, William B.; Vallazza, Jon M.; Nelson, John C.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	United States Department of the Interior; United States Geological Survey	Larson, JH (corresponding author), US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA.	jhlarson@usgs.gov			Great Lakes Restoration Initiative [82]	Great Lakes Restoration Initiative	This project was funded by a Great Lakes Restoration Initiative Grant (Project #82). Any use of trade, product or firm names does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2006, SCI TOTAL ENVIRON, V367, P968, DOI 10.1016/j.scitotenv.2006.01.029; [Anonymous], 2010, R LANG ENV STAT COMP; Baker DB, 2011, SOURCES TRANSPORT 2; Bedard-Haughn A, 2003, J HYDROL, V272, P175, DOI 10.1016/S0022-1694(02)00263-9; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Clapcott JE, 2010, FRESHWATER BIOL, V55, P2181, DOI 10.1111/j.1365-2427.2010.02463.x; Diebel MW, 2009, ECOL APPL, V19, P1127, DOI 10.1890/08-0327.1; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Frost PC, 2009, ECOLOGY, V90, P1631, DOI 10.1890/08-1534.1; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Grigorovich IA, 2008, J GREAT LAKES RES, V34, P342, DOI 10.3394/0380-1330(2008)34[342:TQMITL]2.0.CO;2; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5618, DOI 10.1021/es0520619; Kaur J, 2007, J GREAT LAKES RES, V33, P62, DOI 10.3394/0380-1330(2007)33[62:MDOIAD]2.0.CO;2; Krieger KA, 2003, WETLANDS, V23, P778, DOI 10.1672/0277-5212(2003)023[0778:EOACWI]2.0.CO;2; Larson JH, 2007, LIMNOL OCEANOGR, V52, P60, DOI 10.4319/lo.2007.52.1.0060; Larson JH, 2012, J GREAT LAKES RES, V38, P610, DOI 10.1016/j.jglr.2012.09.016; Larson JH, 2013, J GREAT LAK IN PRESS; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McClelland JW, 1997, LIMNOL OCEANOGR, V42, P930, DOI 10.4319/lo.1997.42.5.0930; Mikhailov VN, 2012, WATER RESOUR+, V39, P247, DOI 10.1134/S0097807812030050; Nestler A, 2011, ENVIRON SCI POLLUT R, V18, P519, DOI 10.1007/s11356-010-0422-z; Ntzoufras I, 2009, BAYESIAN MODELING WI; Openbugs T, 2007, BRUGS PACKAGE; Peterson GS, 2007, J GREAT LAKES RES, V33, P27, DOI 10.3394/0380-1330(2007)33[27:SNIOPA]2.0.CO;2; Qiming C., 1996, J ENVIRON QUAL, V6, P364, DOI DOI 10.2134/JEQ2007.0401; Robertson DM, 2011, J AM WATER RESOUR AS, V47, P1011, DOI 10.1111/j.1752-1688.2011.00574.x; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Stephens BM, 2010, AQUAT SCI, V72, P403, DOI 10.1007/s00027-010-0144-9; Trebitz AS, 2006, J GREAT LAKES RES, V32, P102, DOI 10.3394/0380-1330(2006)32[102:CSATDW]2.0.CO;2; Trebitz AS, 2002, J GREAT LAKES RES, V28, P212, DOI 10.1016/S0380-1330(02)70578-9; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x	33	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69313	10.1371/journal.pone.0069313	http://dx.doi.org/10.1371/journal.pone.0069313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935980	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700024
J	Boldt, ABW; Goeldner, I; Stahlke, ERS; Thiel, S; Jensenius, JC; de Messias-Reason, IJT				Boldt, Angelica Beate Winter; Goeldner, Isabela; Stahlke, Ewalda R. S.; Thiel, Steffen; Jensenius, Jens Christian; de Messias-Reason, Iara Jose Taborda			Leprosy Association with Low MASP-2 Levels Generated by MASP2 Haplotypes and Polymorphisms Flanking MAp19 Exon 5	PLOS ONE			English	Article							LECTIN-PATHWAY ACTIVATION; GENE POLYMORPHISM; SERINE PROTEASE-2; BINDING; COMPLEMENT; SERUM; SERINE-PROTEASE-2; MBL; POPULATIONS; DEFICIENCY	Background: The gene MASP2 (mannan-binding lectin (MBL)-associated serine protease 2) encodes two proteins, MASP-2 and MAp19 (MBL-associated protein of 19 kDa), bound in plasma to MBL and ficolins. The binding of MBL/MASP-2 and ficolin/MASP-2 complexes to microorganisms activates the lectin pathway of complement and may increase the ingestion of intracellular pathogens such as Mycobacterium leprae. Methods: We haplotyped 11 MASP2 polymorphisms with multiplex sequence-specific PCR in 219 Brazilian leprosy patients (131 lepromatous, 29 borderline, 21 tuberculoid, 14 undetermined, 24 unspecified), 405 healthy Brazilians and 291 Danish blood donors with previously determined MASP-2 and MAp19 levels. We also evaluated MASP-2 levels in further 46 leprosy patients and 69 Brazilian controls. Results: Two polymorphisms flanking exon 5 of MASP2 were associated with a dominant effect on high MASP-2 levels and an additive effect on low MAp19 levels. Patients presented lower MASP-2 levels (P = 0.0012) than controls. The frequency of the p.126L variant, associated with low MASP-2 levels (below 200 ng/mL), was higher in the patients (P = 0.0002, OR = 4.92), as was the frequency of genotypes with p.126L (P = 0.00006, OR = 5.96). The *1C2-l[AG] haplotype, which harbors p.126L and the deficiency-causing p.439H variant, has a dominant effect on the susceptibility to the disease (P = 0.007, OR = 4.15). Genotypes composed of the *2B1-i and/or *2B2A-i haplotypes, both associated with intermediate MASP-2 levels (200-600 ng/mL), were found to be protective against the disease (P = 0.0014, OR = 0.6). Low MASP-2 levels (P = 0.022), as well as corresponding genotypes with *1C2-l and/or *2A2-l but without *1B1-h or *1B2-h, were more frequent in the lepromatous than in other patients (P = 0.008, OR = 8.8). Conclusions: In contrast with MBL, low MASP-2 levels increase the susceptibility to leprosy in general and to lepromatous leprosy in particular. MASP2 genotypes and MASP-2 levels might thus be of prognostic value for leprosy progression.	[Boldt, Angelica Beate Winter; Goeldner, Isabela; de Messias-Reason, Iara Jose Taborda] Univ Fed Parana, Hosp Clin, Lab Imunopatol Mol, BR-80060000 Curitiba, Parana, Brazil; [Stahlke, Ewalda R. S.] Dept Estadual Saude Parana, Curitiba, Parana, Brazil; [Thiel, Steffen; Jensenius, Jens Christian] Aarhus Univ, Dept Biomed, Aarhus C, Denmark	Universidade Federal do Parana; Aarhus University	Boldt, ABW (corresponding author), Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil.	iarareason@hc.ufpr.br	Boldt, Angelica/G-3630-2012; Eibofner, Isabela/D-1884-2014	Eibofner, Isabela/0000-0002-9850-6231; Boldt, Angelica/0000-0002-0902-9622; Jose de Messias Reason, Iara/0000-0002-5573-260X; Thiel, Steffen/0000-0002-4817-155X	PRODOC grants of CAPES (Coordenacao de Aperfeicoamento de Pessoal Superior) [01/2007, 518/2010]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [034/2008]; Danish Research Council; Novo Nordic Foundation	PRODOC grants of CAPES (Coordenacao de Aperfeicoamento de Pessoal Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordic Foundation(Novo Nordisk Foundation)	This work was supported by the 01/2007 and 518/2010 PRODOC grants of CAPES (Coordenacao de Aperfeicoamento de Pessoal Superior, http://www.capes.gov.br/bolsas/bolsas-no-pais/prodoc) and by the 034/2008 CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br/web/guest/bolsas-e-auxilios) grants for ABW Boldt and IJT Messias-Reason. Dr. Thiel and Dr. Jensenius were funded by the Danish Research Council and the Novo Nordic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1985, CELEBRATION STAT, P1; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Boldt ABW, 2006, HUM IMMUNOL, V67, P722, DOI 10.1016/j.humimm.2006.05.009; Boldt ABW, 2006, GENES IMMUN, V7, P393, DOI 10.1038/sj.gene.6364312; Boldt ABW, 2011, HUM IMMUNOL, V72, P753, DOI 10.1016/j.humimm.2011.05.015; Boldt ABW, 2002, HUM MUTAT, V19, P296, DOI 10.1002/humu.10051; Boldt ABW, 2013, J CLIN IMMUNOL, V33, P210, DOI 10.1007/s10875-012-9770-4; Boldt ABW, 2011, CLIN IMMUNOL, V140, P63, DOI 10.1016/j.clim.2011.03.008; Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38; Boldt ABW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-97; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; de Messias-Reason IJ, 2007, J INFECT DIS, V196, P1379, DOI 10.1086/521627; de Rooij BJF, 2010, HEPATOLOGY, V52, P1100, DOI 10.1002/hep.23782; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2011, J IMMUNOL METHODS, V373, P89, DOI 10.1016/j.jim.2011.08.006; DEMESSIAS IJT, 1993, CLIN EXP IMMUNOL, V92, P284, DOI 10.1111/j.1365-2249.1993.tb03393.x; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duus K, 2010, FEBS J, V277, P4956, DOI 10.1111/j.1742-4658.2010.07901.x; Garcia-Laorden MI, 2006, J ALLERGY CLIN IMMUN, V118, P1383, DOI 10.1016/j.jaci.2006.08.004; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Holmberg V, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-61; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; Miller Christopher, 2010, Clin Mol Allergy, V8, P6, DOI 10.1186/1476-7961-8-6; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Olesen HV, 2006, CLIN IMMUNOL, V121, P324, DOI 10.1016/j.clim.2006.08.014; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Probst CM, 2000, HUM BIOL, V72, P597; Ramasawmy R, 2008, CLIN VACCINE IMMUNOL, V15, P932, DOI 10.1128/CVI.00324-07; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Schafranski MD, 2008, HUM IMMUNOL, V69, P41, DOI 10.1016/j.humimm.2007.11.003; SCHLESINGER LS, 1994, INFECT IMMUN, V62, P280, DOI 10.1128/IAI.62.1.280-289.1994; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Stover CM, 1999, J IMMUNOL, V162, P3481; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Thiel S, 2007, GENES IMMUN, V8, P154, DOI 10.1038/sj.gene.6364373; Thiel S, 2009, J IMMUNOL, V182, P2939, DOI 10.4049/jimmunol.0802053; Tulio S, 2011, HUM IMMUNOL, V72, P912, DOI 10.1016/j.humimm.2011.06.016; Valles X, 2009, TISSUE ANTIGENS, V74, P298, DOI 10.1111/j.1399-0039.2009.01328.x; World Health Organization, 2012, LEPROSY, V101, P1	46	20	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69054	10.1371/journal.pone.0069054	http://dx.doi.org/10.1371/journal.pone.0069054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935922	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200020
J	Kabir, MA; Goh, KL; Kamal, SMM; Khan, MMH				Kabir, Mohammad Alamgir; Goh, Kim-Leng; Kamal, Sunny Mohammad Mostafa; Khan, Md. Mobarak Hossain			Tobacco Smoking and Its Association with Illicit Drug Use among Young Men Aged 15-24 Years Living in Urban Slums of Bangladesh	PLOS ONE			English	Article							CIGARETTE-SMOKING; USE DISORDERS; ALCOHOL; HEALTH; CONSUMPTION; ADOLESCENTS; PATTERNS; DISPARITIES; PREVALENCE; STUDENTS	Background: Tobacco smoking (TS) and illicit drug use (IDU) are of public health concerns especially in developing countries, including Bangladesh. This paper aims to (i) identify the determinants of TS and IDU, and (ii) examine the association of TS with IDU among young slum dwellers in Bangladesh. Methodology/Principal Findings: Data on a total of 1,576 young slum dwellers aged 15-24 years were extracted for analysis from the 2006 Urban Health Survey (UHS), which covered a nationally representative sample of 13,819 adult men aged 15-59 years from slums, non-slums and district municipalities of six administrative regions in Bangladesh. Methods used include frequency run, Chi-square test of association and multivariable logistic regression. The overall prevalence of TS in the target group was 42.3%, of which 41.4% smoked cigarettes and 3.1% smoked bidis. The regression model for TS showed that age, marital status, education, duration of living in slums, and those with sexually transmitted infections were significantly (p < 0.001 to p < 0.05) associated with TS. The overall prevalence of IDU was 9.1%, dominated by those who had drug injections (3.2%), and smoked ganja (2.8%) and tari (1.6%). In the regression model for IDU, the significant (p, 0.01 to p < 0.10) predictors were education, duration of living in slums, and whether infected by sexually transmitted diseases. The multivariable logistic regression (controlling for other variables) revealed significantly (p < 0.001) higher likelihood of IDU (OR = 9.59, 95% CI = 5.81-15.82) among users of any form of TS. The likelihood of IDU increased significantly (p < 0.001) with increased use of cigarettes. Conclusions/Significance: Certain groups of youth are more vulnerable to TS and IDU. Therefore, tobacco and drug control efforts should target these groups to reduce the consequences of risky lifestyles through information, education and communication (IEC) programs.	[Kabir, Mohammad Alamgir; Goh, Kim-Leng] Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia; [Kabir, Mohammad Alamgir] Jahangirnagar Univ, Dept Stat, Dhaka, Bangladesh; [Kamal, Sunny Mohammad Mostafa] Islami Univ, Dept Math, Kustia, Bangladesh; [Khan, Md. Mobarak Hossain] Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, D-33615 Bielefeld, Germany	Universiti Malaya; Jahangirnagar University; University of Bielefeld	Kabir, MA (corresponding author), Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia.	alamgirfa_juniv@yahoo.com	Goh, Kim-Leng/B-3949-2009; Adianto, Joko/K-9546-2014	Goh, Kim-Leng/0000-0002-2367-8303; Adianto, Joko/0000-0002-3048-5462	University of Malaya	University of Malaya(Universiti Malaya)	The authors gratefully acknowledged funding from the University of Malaya for publication of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algotar AM, 2011, AM J MENS HEALTH, V5, P272, DOI 10.1177/1557988310390030; [Anonymous], 2011, WARM DANG TOB; BAILEY SL, 1992, AM J PUBLIC HEALTH, V82, P1220, DOI 10.2105/AJPH.82.9.1220; Banglapedia, 2006, NAT ENC BANGL; Biederman J, 2006, BIOL PSYCHIAT, V59, P258, DOI 10.1016/j.biopsych.2005.07.009; Centre for Urban Studies (CUS) National Institute of Population Research and Training (NIPORT) and Measure Evaluation, 2005, SLUMS URB BANGL MAPP; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Chan Y. H., 2003, SMJ Singapore Medical Journal, V44, P498; Chen KT, 2001, AM J PUBLIC HEALTH, V91, P1130, DOI 10.2105/AJPH.91.7.1130; Chen XG, 2004, PREV MED, V39, P666, DOI 10.1016/j.ypmed.2004.02.033; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; Dell JL, 2005, AM J PUBLIC HEALTH, V95, P1036, DOI 10.2105/AJPH.2004.051169; Dierker LC, 2007, COMPR PSYCHIAT, V48, P237, DOI 10.1016/j.comppsych.2007.01.002; Dragano N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-255; Duncan C, 1999, SOC SCI MED, V48, P497, DOI 10.1016/S0277-9536(98)00360-8; Ensel WM, 1996, J AGING HEALTH, V8, P389, DOI 10.1177/089826439600800305; Feng GZ, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2010.037093; Fisher E, 2005, NICOTINE TOB RES, V7, pS45, DOI 10.1080/14622200500078105; FLEMING R, 1989, ADDICT BEHAV, V14, P261, DOI 10.1016/0306-4603(89)90057-9; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Gau SSF, 2007, BRIT J PSYCHIAT, V190, P42, DOI 10.1192/bjp.bp.106.022871; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Hanna EZ, 1999, ALCOHOL CLIN EXP RES, V23, P513, DOI 10.1097/00000374-199903000-00020; Hossain Khan M., 2012, PUBLIC HLTH FORUM, V20, DOI [DOI 10.1016/J.PHF.2012.03.012, org/10.1016/j.phf.2012.03.012]; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Jahan M., 2012, INT J DEV SUSTAINABI, V1, P186; Kabir MA, 2013, AM J MENS HEALTH, V7, P128, DOI 10.1177/1557988312462737; Kamal S.M.M., 2010, J APPL SCI TECHNOLOG, V7, P107; Kamal SMM, 2011, ASIA-PAC J PUBLIC HE, V23, P555, DOI 10.1177/1010539509350495; KANDEL D, 1993, AM J PUBLIC HEALTH, V83, P851, DOI 10.2105/AJPH.83.6.851; Khan MMH, 2006, ADDICTION, V101, P1178, DOI 10.1111/j.1360-0443.2006.01514.x; Khan MMH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-254; Khan MMH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-149; Kleinschmidt I, 1995, J EPIDEMIOL COMMUN H, V49, pS72, DOI 10.1136/jech.49.Suppl_2.S72; LEWIT EM, 1981, J LAW ECON, V24, P545, DOI 10.1086/466999; Lu Y, 2010, SOC SCI MED, V70, P412, DOI 10.1016/j.socscimed.2009.10.028; MARCUS SE, 1993, PUBLIC HEALTH REP, V108, P20; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ministry of Health and Family Welfare, 2007, NAT STRAT PLAN ACT T; Mohler-Kuo M, 2003, J AM COLL HEALTH, V52, P17, DOI 10.1080/07448480309595719; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR B) and Associates for Community and Population Research (ACPR), 2008, 2006 BANGL URB HLTH; Padrao P, 2011, J EPIDEMIOL COMMUN H, V65, P445, DOI 10.1136/jech.2009.099440; Palipudi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033466; Pearce J, 2009, J EPIDEMIOL COMMUN H, V63, P69, DOI 10.1136/jech.2007.070656; Peterson, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2; Reijneveld SA, 1998, INT J EPIDEMIOL, V27, P33, DOI 10.1093/ije/27.1.33; Shankle M.D, 2006, HDB LESBIAN GAY BISE; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1003, DOI 10.2105/AJPH.2004.045039; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Volzke H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-146; World Bank, 2007, WORLD BANK DEV SER, V17; World Health Organization, 2009, GLOB AD TOB SURV BAN; Yang T, 2009, PUBLIC HEALTH, V123, P743, DOI 10.1016/j.puhe.2009.09.021	56	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68728	10.1371/journal.pone.0068728	http://dx.doi.org/10.1371/journal.pone.0068728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AX	23935885	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200013
J	Carlberg, C; Seuter, S; de Mello, VDF; Schwab, U; Voutilainen, S; Pulkki, K; Nurmi, T; Virtanen, J; Tuomainen, TP; Uusitupa, M				Carlberg, Carsten; Seuter, Sabine; de Mello, Vanessa D. F.; Schwab, Ursula; Voutilainen, Sari; Pulkki, Kari; Nurmi, Tarja; Virtanen, Jyrki; Tuomainen, Tomi-Pekka; Uusitupa, Matti			Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D-3 Supplementation	PLOS ONE			English	Article							D-RECEPTOR BINDING; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; RESPONSE ELEMENT; D DEFICIENCY; 25-HYDROXYVITAMIN-D; TRANSCRIPTION; RISK; INTERLEUKIN-6; DETERMINANTS; ASSOCIATIONS	Vitamin D deficiency has been associated with an increased risk of developing a number of diseases. Here we investigated samples from 71 pre-diabetic individuals of the VitDmet study, a 5-month high dose vitamin D-3 intervention trial during Finnish winter, for their changes in serum 25-hydroxyvitamin D-3 (25(OH)D-3) concentrations and the expression of primary vitamin D target genes in peripheral blood mononuclear cells and adipose tissue. A negative correlation between serum concentrations of parathyroid hormone and 25(OH)D-3 suggested an overall normal physiological vitamin D response among the participants. The genes CD14 and thrombomodulin (THBD) are up-regulated primary vitamin D targets and showed to be suitable gene expression markers for vitamin D signaling in both primary tissues. However, in a ranking of the samples concerning their expected response to vitamin D only the top half showed a positive correlation between the changes of CD14 or THBD mRNA and serum 25(OH)D-3 concentrations. Interestingly, this categorization allows unmasking a negative correlation between changes in serum concentrations of 25(OH)D-3 and the inflammation marker interleukin 6. We propose the genes CD14 and THBD as transcriptomic biomarkers, from which the effects of a vitamin D-3 supplementation can be evaluated. These biomarkers allow the classification of subjects into those, who might benefit from a vitamin D-3 supplementation, and others who do not.	[Carlberg, Carsten; Seuter, Sabine] Univ Eastern Finland, Sch Med, Inst Biomed, Kuopio, Finland; [de Mello, Vanessa D. F.; Schwab, Ursula; Voutilainen, Sari; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Schwab, Ursula] Internal Med Kuopio Univ Hosp, Inst Clin Med, Kuopio, Finland; [Pulkki, Kari] Univ Eastern Finland, Eastern Finland Lab Ctr, Kuopio, Finland; [Pulkki, Kari] Univ Eastern Finland, Dept Clin Chem, Kuopio, Finland; [Nurmi, Tarja; Virtanen, Jyrki; Tuomainen, Tomi-Pekka] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Publ Hlth, Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Res Unit, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Carlberg, C (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed, Kuopio, Finland.	carsten.carlberg@uef.fi	Virtanen, Jyrki/AAC-8945-2020; Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Carlberg, Carsten/C-9075-2011; Virtanen, Jyrki/G-5149-2013	Virtanen, Jyrki/0000-0002-0648-999X; Carlberg, Carsten/0000-0003-2633-0684; Virtanen, Jyrki/0000-0002-0648-999X; de Mello, Vanessa/0000-0003-3414-6983; Pulkki, Kari/0000-0003-0690-9883	Academy of Finland [118590, 137826, 131593]; Nordforsk for the Sysdiet consortium; Juselius Foundation; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Diabetes Research Foundation	Academy of Finland(Academy of Finland); Nordforsk for the Sysdiet consortium; Juselius Foundation; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Diabetes Research Foundation	This work was supported by the Academy of Finland (grants 118590, 137826 and 131593), Nordforsk for the Sysdiet consortium, the Juselius Foundation, the Juho Vainio Foundation, the Finnish Foundation for Cardiovascular Research and the Finnish Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Carlberg C, 2012, CURR TOP MED CHEM, V12, P528, DOI 10.2174/156802612799436623; Carlberg C, 2012, ANTICANCER RES, V32, P271; Dastani Z, 2013, CALCIFIED TISSUE INT, V92, P106, DOI 10.1007/s00223-012-9660-z; de Mello VDF, 2009, EUR J NUTR, V48, P447, DOI 10.1007/s00394-009-0033-y; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; Engelman CD, 2013, J NUTR, V143, P17, DOI 10.3945/jn.112.169482; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; HOLICK MF, 1977, BIOCHEM BIOPH RES CO, V76, P107, DOI 10.1016/0006-291X(77)91674-6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, NAT REV ENDOCRINOL, V7, P73, DOI 10.1038/nrendo.2010.234; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Institute of Medicine, 2011, DIETARY REFERENCE IN; Kolehmainen M, 2008, INT J OBESITY, V32, P292, DOI 10.1038/sj.ijo.0803718; Kovalenko PL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-26; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Liu SM, 1996, MOL ENDOCRINOL, V10, P206, DOI 10.1210/me.10.2.206; Mackey SL, 1996, MOL ENDOCRINOL, V10, P298, DOI 10.1210/me.10.3.298; McGeough MD, 2012, J IMMUNOL, V189, P2707, DOI 10.4049/jimmunol.1101737; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Nurmi T, 2013, ANAL BIOCHEM, V435, P1, DOI 10.1016/j.ab.2012.12.010; Olsen KS, 2013, EUR J CLIN NUTR, V67, P773, DOI 10.1038/ejcn.2013.53; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Outila TA, 2001, AM J CLIN NUTR, V74, P206; Pandita KK, 2012, CLIN CASES MINER BON, V9, P118; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Seuter S, 2013, NUCLEIC ACIDS RES, V41, P110, DOI 10.1093/nar/gks959; Slattery ML, 2007, CANCER CAUSE CONTROL, V18, P1095, DOI 10.1007/s10552-007-9049-x; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Tuomainen TP, 2013, GLUCOSE METABO UNPUB; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	47	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71042	10.1371/journal.pone.0071042	http://dx.doi.org/10.1371/journal.pone.0071042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923049	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700221
J	Perreault, L; McCurdy, C; Kerege, AA; Houck, J; Faerch, K; Bergman, BC				Perreault, Leigh; McCurdy, Carrie; Kerege, Anna A.; Houck, Julie; Faerch, Kristine; Bergman, Bryan C.			Bisphenol A Impairs Hepatic Glucose Sensing in C57BL/6 Male Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GLUCOKINASE ACTIVITY; GENE-EXPRESSION; RETINOIC ACID; IN-VIVO; INSULIN; RATS; HEPATOCYTES; ADAPTATION; EXPOSURE	Aims/Hypothesis: Glucose sensing (eg. glucokinase activity) becomes impaired in the development of type 2 diabetes, the etiology of which is unclear. Estrogen can stimulate glucokinase activity, whereas the pervasive environmental pollutant bisphenol A (BPA) can inhibit estrogen action, hence we aimed to determine the effect of BPA on glucokinase activity directly. Methods: To evaluate a potential acute effect on hepatic glucokinase activity, BPA in water (n = 5) vs. water alone (n = 5) was administered at the EPA's purported "safe dose" (50 mu g/kg) by gavage to lean 6-month old male C57BL/6 mice. Two hours later, animals were euthanized and hepatic glucokinase activity measured over glucose levels from 1-20 mmol/l in liver homogenate. To determine the effect of chronic BPA exposure on hepatic glucokinase activity, lean 6-month old male C57BL/6 mice were provided with water (n = 15) or water with 1.75 mM BPA (similar to 50 mu g/kg/day; n = 14) for 2 weeks. Following the 2-week exposure, animals were euthanized and glucokinase activity measured as above. Results: Hepatic glucokinase activity was signficantly suppressed after 2 hours in animals given an oral BPA bolus compared to those who received only water (p = 0.002-0.029 at glucose 5-20 mmol/l; overall treatment effect p<0.001). Exposure to BPA over 2 weeks also suppressed hepatic glucokinase activity in exposed vs. unexposed mice (overall treatment effect, p = 0.003). In both experiments, the Hill coefficient was higher and Vmax lower in mice treated with BPA. Conclusions/Interpretation: Both acute and chronic exposure to BPA significantly impair hepatic glucokinase activity and function. These findings identify a potential mechanism for how BPA may increase risk for diabetes.	[Perreault, Leigh; McCurdy, Carrie; Kerege, Anna A.; Bergman, Bryan C.] Univ Colorado, Div Endocrinol Metab & Diabet, Aurora, CO USA; [McCurdy, Carrie; Houck, Julie] Univ Colorado, Dept Pediat, Aurora, CO USA; [Faerch, Kristine] Steno Diabet Ctr, DK-2820 Gentofte, Denmark	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Steno Diabetes Center	Perreault, L (corresponding author), Univ Colorado, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO USA.	leigh.perreault@ucdenver.edu		McCurdy, Carrie/0000-0003-1177-9040; Bergman, Bryan/0000-0002-9561-1052; Faerch, Kristine/0000-0002-6127-0448	American Diabetes Association [1-09-CD-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by American Diabetes Association (1-09-CD-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Cabrera-Valladares G, 2001, LIFE SCI, V68, P2813, DOI 10.1016/S0024-3205(01)01065-7; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; Ginsberg G, 2009, ENVIRON HEALTH PERSP, V117, P1639, DOI 10.1289/ehp.0901010; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Magnaterra R, 1997, J ENDOCRINOL, V155, P247, DOI 10.1677/joe.0.1550247; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Mukhtar M, 1999, FEBS LETT, V462, P453, DOI 10.1016/S0014-5793(99)01580-X; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; PAKOSKEY AM, 1965, J GEN MICROBIOL, V38, P73, DOI 10.1099/00221287-38-1-73; Ratnasabapathy R, 1997, BIOCHEM PHARMACOL, V53, P1425, DOI 10.1016/S0006-2952(97)00084-1; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Romero-Navarro G, 1999, ENDOCRINOLOGY, V140, P4595, DOI 10.1210/en.140.10.4595; Schecter A, 2010, ENVIRON SCI TECHNOL, V44, P9425, DOI 10.1021/es102785d; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1051, DOI 10.1289/ehp.0901717; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Yoon K, 2000, MOL CELL ENDOCRINOL, V162, P211, DOI 10.1016/S0303-7207(99)00261-0; Zhang H, 1997, J NUTR SCI VITAMINOL, V43, P271, DOI 10.3177/jnsv.43.271	27	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69991	10.1371/journal.pone.0069991	http://dx.doi.org/10.1371/journal.pone.0069991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922885	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700113
J	Rinaldi, B; Donniacuo, M; Sodano, L; Gritti, G; Signoriello, S; Parretta, E; Berrino, L; Urbanek, K; Capuano, A; Rossi, F				Rinaldi, Barbara; Donniacuo, Maria; Sodano, Loredana; Gritti, Giulia; Signoriello, Simona; Parretta, Elisabetta; Berrino, Liberato; Urbanek, Konrad; Capuano, Annalisa; Rossi, Francesco			Effects of Sildenafil on the Gastrocnemius and Cardiac Muscles of Rats in a Model of Prolonged Moderate Exercise Training	PLOS ONE			English	Article							SKELETAL-MUSCLE; PHOSPHODIESTERASE-5 INHIBITORS; PGC-1 COACTIVATORS; PGC-1-ALPHA; ANGIOGENESIS; EXPRESSION; INACTIVATION; ACTIVATION; ATROPHY; HEALTH	Moderate exercise training improves energetic metabolism, tissue perfusion and induces cardiac and skeletal muscle remodeling. Sildenafil, a potent phosphodiesterase-5 inhibitor used to treat erectile dysfunction, reduces infarct size and increases tissue oxygenation in experimental models of cardiovascular disease. We have evaluated the effects of prolonged moderate exercise training and a repeat administration of sildenafil on the rat gastrocnemius and cardiac muscles. Animals were divided into two groups: sedentary and trained. Each group was subdivided into animals treated with vehicle or with two doses of sildenafil (10 or 15 mg/kg/day) during the last week of training. Physical exercise did not induce cardiac hypertrophy, whereas it increased mRNA levels of the PGC-1 alpha, HIF-1 alpha and VEGF genes, which are involved in mitochondrial biogenesis and angiogenesis, and reduced mRNA levels of FoxO3a, MuRF-1 and Atrogin-1. Sildenafil dose-dependently promoted both angiogenesis, as shown by increased capillary density, and muscle atrophy, as shown by muscle fibre size. These effects were more pronounced in trained animals. Our data confirm the beneficial effects of a moderate and prolonged training on cardiovascular and skeletal systems and document the positive and negative effects of sildenafil on these tissues at doses higher than those used in clinical practice. This report may impact on the use of sildenafil as a substance able to influence sports performance.	[Rinaldi, Barbara; Donniacuo, Maria; Sodano, Loredana; Gritti, Giulia; Berrino, Liberato; Urbanek, Konrad; Rossi, Francesco] Univ Naples 2, Ctr Excellence Cardiovasc Dis, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy; [Rinaldi, Barbara; Parretta, Elisabetta; Capuano, Annalisa; Rossi, Francesco] Univ Naples 2, Reg Ctr Pharmacovigilance & Pharmacoepidemiol, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy; [Signoriello, Simona] Univ Naples 2, Dept Mental & Phys Hlth & Prevent Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Rinaldi, B (corresponding author), Univ Naples 2, Ctr Excellence Cardiovasc Dis, Dept Expt Med, Sect Pharmacol L Donatelli, Naples, Italy.	barbara.rinaldi@unina2.it		Donniacuo, Maria/0000-0001-7485-5755; Capuano, Annalisa/0000-0002-8653-2408	Italian Ministry of Employment, Health and Social Policy	Italian Ministry of Employment, Health and Social Policy	This work was supported by the Italian Ministry of Employment, Health and Social Policy (Research Program 2008 on drugs, substances and medical practices used as doping in sport). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Borniquel S, 2010, MOL CELL BIOL, V30, P4035, DOI 10.1128/MCB.00175-10; Colahan PT, 2010, EQUINE VET J, V42, P606, DOI 10.1111/j.2042-3306.2010.00286.x; Di Luigi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE972, DOI 10.1152/ajpendo.00573.2011; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Harrold LR, 2000, ARCH INTERN MED, V160, P3401, DOI 10.1001/archinte.160.22.3401; Hettmansperger T. P., 2011, ROBUST NONPARAMETRIC; Hsu AR, 2006, J APPL PHYSIOL, V100, P2031, DOI 10.1152/japplphysiol.00806.2005; Kirsch M, 2008, FASEB J, V22, P30, DOI 10.1096/fj.06-7526com; Kloner RA, 2004, CIRCULATION, V110, P3149, DOI 10.1161/01.CIR.0000146906.42375.D3; Koneru S, 2008, J CELL MOL MED, V12, P2651, DOI 10.1111/j.1582-4934.2008.00319.x; Kubota Y, 2006, BIOL PHARM BULL, V29, P1756, DOI 10.1248/bpb.29.1756; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Kukreja RC, 2005, VASC PHARMACOL, V42, P219, DOI 10.1016/j.vph.2005.02.010; Kulkarni SK, 2004, METHOD FIND EXP CLIN, V26, P789, DOI 10.1358/mf.2004.26.10.872561; Lachance D, 2009, CIRC-HEART FAIL, V2, P437, DOI 10.1161/CIRCHEARTFAILURE.108.845487; Laughlin MH, 2012, AM J PHYSIOL-HEART C, V302, pH10, DOI 10.1152/ajpheart.00574.2011; LeBrasseur NK, 2011, AM J PHYSIOL-ENDOC M, V300, pE3, DOI 10.1152/ajpendo.00512.2010; Lightfoot JT, 2001, MED SCI SPORT EXER, V33, P2053, DOI 10.1097/00005768-200112000-00012; Lin CS, 2006, CURR PHARM DESIGN, V12, P3439, DOI 10.2174/138161206778343064; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Linke A, 2008, FRONT BIOSCI-LANDMRK, V13, P424, DOI 10.2741/2689; Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/H11-076, 10.1139/h11-076]; Marini M, 2008, HISTOCHEM CELL BIOL, V129, P479, DOI 10.1007/s00418-007-0373-8; MILANO G, 2012, PLOS ONE, V7, DOI DOI 10.1371/ANNOTATION/F7AEBEE7-7B7E-4A44-AA23-56E9A32F14F6; Milano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027910; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Pyriochou A, 2007, J CELL PHYSIOL, V211, P197, DOI 10.1002/jcp.20929; Rinaldi B, 2006, EXP GERONTOL, V41, P764, DOI 10.1016/j.exger.2006.05.008; Rinaldi B, 2011, BRIT J PHARMACOL, V163, P609, DOI 10.1111/j.1476-5381.2011.01248.x; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Stepto NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053080; Sugawara J, 2012, J APPL PHYSIOL, V112, P1891, DOI 10.1152/japplphysiol.01460.2011; Szostak J, 2011, CLIN SCI, V121, P91, DOI 10.1042/CS20100520; Tang KC, 2010, RESP PHYSIOL NEUROBI, V170, P16, DOI 10.1016/j.resp.2009.10.007; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098	46	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69954	10.1371/journal.pone.0069954	http://dx.doi.org/10.1371/journal.pone.0069954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922868	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700109
J	Toledo-Silva, G; Cardoso-Silva, CB; Jank, L; Souza, AP				Toledo-Silva, Guilherme; Cardoso-Silva, Claudio Benicio; Jank, Liana; Souza, Anete Pereira			De Novo Transcriptome Assembly for the Tropical Grass Panicum maximum Jacq	PLOS ONE			English	Article							RNA-SEQ DATA; MICROSATELLITE MARKERS; DNA-SEQUENCES; SSR-MARKERS; BIOSYNTHESIS; SWITCHGRASS; ANNOTATION; TOOL; EVOLUTION; CELLULOSE	Guinea grass (Panicum maximum Jacq.) is a tropical African grass often used to feed beef cattle, which is an important economic activity in Brazil. Brazil is the leader in global meat exportation because of its exclusively pasture-raised bovine herds. Guinea grass also has potential uses in bioenergy production due to its elevated biomass generation through the C-4 photosynthesis pathway. We generated approximately 13 Gb of data from Illumina sequencing of P. maximum leaves. Four different genotypes were sequenced, and the combined reads were assembled de novo into 38,192 unigenes and annotated; approximately 63% of the unigenes had homology to other proteins in the NCBI non-redundant protein database. Functional classification through COG (Clusters of Orthologous Groups), GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) analyses showed that the unigenes from Guinea grass leaves are involved in a wide range of biological processes and metabolic pathways, including C-4 photosynthesis and lignocellulose generation, which are important for cattle grazing and bioenergy production. The most abundant transcripts were involved in carbon fixation, photosynthesis, RNA translation and heavy metal cellular homeostasis. Finally, we identified a number of potential molecular markers, including 5,035 microsatellites (SSRs) and 346,456 single nucleotide polymorphisms (SNPs). To the best of our knowledge, this is the first study to characterize the complete leaf transcriptome of P. maximum using high-throughput sequencing. The biological information provided here will aid in gene expression studies and marker-assisted selection-based breeding research in tropical grasses.	[Toledo-Silva, Guilherme; Cardoso-Silva, Claudio Benicio; Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Ctr Mol Biol, Campinas, SP, Brazil; [Toledo-Silva, Guilherme; Cardoso-Silva, Claudio Benicio; Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Genet Engn CBMEG, Campinas, SP, Brazil; [Jank, Liana] Embrapa Beef Cattle, Campo Grande, MS, Brazil; [Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual de Campinas	Souza, AP (corresponding author), Univ Estadual Campinas, UNICAMP, Ctr Mol Biol, Campinas, SP, Brazil.	anete@unicamp.br	Jank, Liana/AAC-9128-2022; Cardoso da Silva, Cláudio Benício/J-2326-2015; DE SOUZA, ANETE PEREIRA/B-8663-2012	Cardoso da Silva, Cláudio Benício/0000-0002-4592-0113; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/51010-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Embrapa Beef Cattle; Association for Promotion of Breeding Research in Tropical Forages (Unipasto)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Embrapa Beef Cattle(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Association for Promotion of Breeding Research in Tropical Forages (Unipasto)	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support grant 2005/51010-0) and scholarships to GTS and CBCS, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for research fellowships to APS and LJ, and Embrapa Beef Cattle and Association for Promotion of Breeding Research in Tropical Forages (Unipasto) for financial support for field activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anterola AM, 2002, J BIOL CHEM, V277, P18272, DOI 10.1074/jbc.M112051200; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Batistoti C, 2012, ANIM FEED SCI TECH, V171, P173, DOI 10.1016/j.anifeedsci.2011.11.008; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bogdan A.V., 1977, TROPICAL PASTURE FOD, P181; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chandra A, 2010, PLANT BREEDING, V129, P120, DOI 10.1111/j.1439-0523.2009.01651.x; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Ebina Masumi, 2007, Grassland Science, V53, P155, DOI 10.1111/j.1744-697X.2007.00086.x; Ebina Masumi, 2005, Grassland Science, V51, P71, DOI 10.1111/j.1744-697X.2005.00011.x; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; FAOSTAT, 2011, LIV AN DAT; Garrison E, 2012, ARXIV120739079, P9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; IBGE, 2011, PESQ PEC MUN; Jank L, 2005, GRASSLAND: A GLOBAL RESOURCE, P69; Jank L, 2011, CROP BREED APPL BIOT, V11, P27, DOI 10.1590/S1984-70332011000500005; JUNG HG, 1995, J ANIM SCI, V73, P2774; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kistner C, 2005, LOTUS JAPONICUS HANDBOOK, P123, DOI 10.1007/1-4020-3735-X_9; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; LULIN H, 2012, PLOS ONE, V0007; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; Mir G, 2004, J EXP BOT, V55, P2483, DOI 10.1093/jxb/erh254; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muir J.P., 2004, WARM SEASON C4 GRASS, V45, P589, DOI DOI 10.2134/AGR0NM0N0GR45.C17; Nasu S, 2002, DNA RES, V9, P163, DOI 10.1093/dnares/9.5.163; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Pupko T, 1999, J MOL EVOL, V48, P313, DOI 10.1007/PL00006474; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Savidan Y., 2000, Plant Breeding Reviews, V18, P13; Savidan Y. H., 1983, Proceedings of the XIV International Grassland Congress, Lexington, Kentucky, June 15-24, 1981, P182; Schrick K, 2004, PLANT J, V38, P227, DOI 10.1111/j.1365-313X.2004.02039.x; Sharma MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033892; Sokhansanj S, 2009, BIOFUEL BIOPROD BIOR, V3, P124, DOI 10.1002/bbb.129; Sousa ACB, 2011, PLANT BREEDING, V130, P104, DOI 10.1111/j.1439-0523.2010.01779.x; Sousa A. C. B. de, 2011, Tropical Plant Biology, V4, P185, DOI 10.1007/s12042-011-9081-6; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tiwari KK, 2010, J ENVIRON BIOL, V31, P965; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Yamada-Akiyama H, 2009, J PLANT PHYSIOL, V166, P750, DOI 10.1016/j.jplph.2008.10.001; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	64	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70781	10.1371/journal.pone.0070781	http://dx.doi.org/10.1371/journal.pone.0070781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923022	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700207
J	de Arruda, MM; Figueiredo, FB; Cardoso, FA; Hiamamoto, RM; Brazuna, JCM; de Oliveira, MRF; Noronha, EF; Romero, GAS				de Arruda, Mauro Maciel; Figueiredo, Fabiano Borges; Cardoso, Fernanda Alvarenga; Hiamamoto, Roberto Mitsuyoshi; Macksoud Brazuna, Julia Cristina; Fernandes de Oliveira, Maria Regina; Noronha, Elza Ferreira; Sierra Romero, Gustavo Adolfo			Validity and Reliability of Enzyme Immunoassays Using Leishmania major or L. infantum Antigens for the Diagnosis of Canine Visceral Leishmaniasis in Brazil	PLOS ONE			English	Article							SEROLOGICAL DIAGNOSIS; SERODIAGNOSIS; CHAGASI; VALIDATION; INFECTION; ASSAYS; URBAN; AREA	Background: American visceral leishmaniasis is caused by the protozoan Leishmania infantum. Dogs are the main reservoirs in the domestic transmission cycle. The limited accuracy of diagnostic tests for canine leishmaniasis may contribute to the lack of impact of control measures recommended by the Brazilian Ministry of Health. The objective of this study was to estimate the accuracy of two enzyme-linked immunosorbent assays employing L. major or L. infantum antigens and their reliability between three laboratories of different levels of complexity. Methods: A validation study of ELISA techniques using L. major or L. infantum antigens was conducted. Direct visualization of the parasite in hematoxylin/eosin-stained histopathological sections, immunohistochemistry, and isolation of the parasite in culture. were used as gold standard. An animal that was positive in at least one of the tests was defined as infected with L. infantum. Serum samples collected from 1,425 dogs were analyzed. Samples were separated in three aliquots and tested in three different laboratories. Sensitivity, specificity and the area under de ROC curve were calculated and the reliability was evaluated between the participant laboratories. Results: The sensitivity was 91.8% and 89.8% for the L. major and L. infantum assays, respectively. The specificity was 83.75% and 82.7% for the L. major and L. infantum assays, respectively. The area under de ROC curve was 0.920 and 0.898 for L. major and L. infantum, respectively. The mean intraclass correlation coefficients between laboratories ranged from 0.890 to 0.948 when L. major was used as antigen, and from 0.818 to 0.879 when L. infantum was used. Interpretation: ELISA tests using L. major or L. infantum antigens have similar accuracy and reliability. Our results do not support the substitution of the L. major antigen of the ELISA test currently used for the diagnosis of canine visceral leishmaniasis in Brazil.	[de Arruda, Mauro Maciel; Fernandes de Oliveira, Maria Regina; Noronha, Elza Ferreira; Sierra Romero, Gustavo Adolfo] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil; [Figueiredo, Fabiano Borges] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Lab Pesquisa Clin Dermatozoonoses Anim Domest, Rio De Janeiro, Brazil; [Cardoso, Fernanda Alvarenga] Fundaco Ezequiel Dias FUNED, Belo Horizonte, MG, Brazil; [Hiamamoto, Roberto Mitsuyoshi] Adolfo Lutz Inst, Sao Paulo, Brazil; [Macksoud Brazuna, Julia Cristina] Ctr Controle Zoonoses Municipio Campo Grande, Campo Grande, Mato Grosso Do, Brazil; [Fernandes de Oliveira, Maria Regina; Sierra Romero, Gustavo Adolfo] Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil	Universidade de Brasilia; Fundacao Oswaldo Cruz; Instituto Adolfo Lutz	de Arruda, MM (corresponding author), Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil.	mauroarruda1@hotmail.com	Romero, Gustavo A.S./F-7214-2012	Romero, Gustavo A.S./0000-0003-1425-926X; Medeiros, Fernanda/0000-0003-4315-3114	Brazilian Ministry of Health; IPEC-FIOCRUZ; Fundacao de Apoio a Pesquisa do Rio de Janeiro (FAPERJ)	Brazilian Ministry of Health; IPEC-FIOCRUZ; Fundacao de Apoio a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by the Brazilian Ministry of Health, IPEC-FIOCRUZ, and the state funding agency Fundacao de Apoio a Pesquisa do Rio de Janeiro (FAPERJ), Young Scientist and Study of Neglected and Reemerging Diseases programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SIST INF AGR NOT SIN; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Barbosa-de-Deus R, 2002, CLIN DIAGN LAB IMMUN, V9, P1361, DOI 10.1128/CDLI.9.6.1361-1366.2002; Bernadina WE, 1997, VET PARASITOL, V73, P207, DOI 10.1016/S0304-4017(97)00124-6; Boarino A, 2008, COMP IMMUNOL MICROB, V31, P527, DOI 10.1016/j.cimid.2007.09.002; Carvalho D, 2009, PESQUI VET BRASIL, V29, P120, DOI 10.1590/S0100-736X2009000200006; Coutinho S G, 1985, Mem Inst Oswaldo Cruz, V80, P17, DOI 10.1590/S0074-02761985000100003; Pinheiro PHD, 2009, VET PARASITOL, V162, P32, DOI 10.1016/j.vetpar.2009.02.011; DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Figueiredo FB, 2010, VET J, V186, P123, DOI 10.1016/j.tvjl.2009.06.030; Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001; KAR K, 1995, CRIT REV MICROBIOL, V21, P123, DOI 10.3109/10408419509113537; Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020; Madeira MF, 2009, RES VET SCI, V87, P260, DOI 10.1016/j.rvsc.2009.03.008; Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005; Moura ST, 1999, BRAZ J VET RES ANIM, V36, P101, DOI DOI 10.1590/S1413-95961999000200009; Costa CHN, 2011, REV SOC BRAS MED TRO, V44, P232, DOI 10.1590/S0037-86822011005000014; Neto JC, 2009, CAD SAUDE PUBLICA, V25, P1543, DOI 10.1590/S0102-311X2009000700012; Oliveira LS, 2005, CIENCIA ANIMAL BRASI, V6, P41; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Shaw JJ, 2006, MEM I OSWALDO CRUZ, V101, P577, DOI 10.1590/S0074-02762006000500017; Silva Alba Valéria Machado da, 2005, Cad. Saúde Pública, V21, P324, DOI 10.1590/S0102-311X2005000100036; Souza AI, 2009, PESQUI VET BRASIL, V29, P150, DOI 10.1590/S0100-736X2009000200011; Troncarelli MZ, 2009, VET PARASITOL, V164, P118, DOI 10.1016/j.vetpar.2009.06.027	32	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69988	10.1371/journal.pone.0069988	http://dx.doi.org/10.1371/journal.pone.0069988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922884	Green Submitted, gold, Green Published			2022-12-27	WOS:000322838900132
J	de Oliveira, EHC; Tagliarini, MM; dos Santos, MS; O'Brien, PCM; Ferguson-Smith, MA				de Oliveira, Edivaldo Herculano C.; Tagliarini, Marcella Mergulhao; dos Santos, Michelly S.; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.			Chromosome Painting in Three Species of Buteoninae: A Cytogenetic Signature Reinforces the Monophyly of South American Species	PLOS ONE			English	Article							OLD-WORLD VULTURES; REARRANGEMENTS; CHICKEN; FALCONIFORMES; PHYLOGENY; BIRDS; PREY; AVES	Buteoninae (Falconiformes, Accipitridae) consist of the widely distributed genus Buteo, and several closely related species in a group called "sub-buteonine hawks'', such as Buteogallus, Parabuteo, Asturina, Leucopternis and Busarellus, with unsolved phylogenetic relationships. Diploid number ranges between 2n = 66 and 2n = 68. Only one species, L. albicollis had its karyotype analyzed by molecular cytogenetics. The aim of this study was to present chromosomal analysis of three species of Buteoninae: Rupornis magnirostris, Asturina nitida and Buteogallus meridionallis using fluorescence in situ hybridization (FISH) experiments with telomeric and rDNA probes, as well as whole chromosome probes derived from Gallus gallus and Leucopternis albicollis. The three species analyzed herein showed similar karyotypes, with 2n = 68. Telomeric probes showed some interstitial telomeric sequences, which could be resulted by fusion processes occurred in the chromosomal evolution of the group, including the one found in the tassociation GGA1p/GGA6. In fact, this association was observed in all the three species analyzed in this paper, and also in L. albicollis, suggesting that it represents a cytogenetic signature which reinforces the monophyly of Neotropical buteoninae species.	[de Oliveira, Edivaldo Herculano C.] Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil; [de Oliveira, Edivaldo Herculano C.] Fed Univ Para, ICEN, Fac Ciencias Exatas & Nat, BR-66059 Belem, PA, Brazil; [de Oliveira, Edivaldo Herculano C.; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Tagliarini, Marcella Mergulhao] Fed Univ Para, ICB, Programa Posgrad Neurociencias & Biol Celular, BR-66059 Belem, PA, Brazil; [dos Santos, Michelly S.] Fed Univ Para, PIBIC, BR-66059 Belem, PA, Brazil	Instituto Evandro Chagas; Universidade Federal do Para; University of Cambridge; Universidade Federal do Para; Universidade Federal do Para	de Oliveira, EHC (corresponding author), Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil.	ehco@ufpa.br	de Oliveira, Edivaldo H. C./C-3368-2013	de Oliveira, Edivaldo H. C./0000-0001-6315-3352	CNPq [300818/2009-7]; Cambridge Resource Centre for Comparative Genomics	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Cambridge Resource Centre for Comparative Genomics	This research was supported by CNPq (no. 300818/2009-7, www.cnpq.br, Comite de Etica em pesquisas com animais de experimentacao CEPAE-UFPA) and a grant to MAF from the Wellcome Trust in support of the Cambridge Resource Centre for Comparative Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADON D, 1988, Proceedings of the Western Foundation of Vertebrate Zoology, V3, P295; Amaral KF, 2003, ARARAJUBA, V11, P65; Oliveira EHC, 2010, CHROMOSOME RES, V18, P349, DOI 10.1007/s10577-010-9117-z; Daniels LM, 2003, CHROMOSOME RES, V11, P305, DOI 10.1023/A:1024008522122; de Oliveira EHC, 2005, CHROMOSOMA, V114, P338, DOI 10.1007/s00412-005-0009-5; Del Hoyo J, 1994, HDB BIRDS WORLD, V2; do Amaral FR, 2009, MOL PHYLOGENET EVOL, V53, P703, DOI 10.1016/j.ympev.2009.07.020; do Amaral FSR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-10; Friedman H, 1950, US NATL MUSEUM B, V50; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; GROSSMAN M.L., 1964, BIRDS PREY WORLD; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; Lerner HRL, 2008, AUK, V125, P304, DOI 10.1525/auk.2008.06161; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Nanda I, 2006, CYTOGENET GENOME RES, V112, P286, DOI 10.1159/000089883; Nishida C, 2008, CHROMOSOME RES, V16, P171, DOI 10.1007/s10577-007-1210-6; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Riesing MJ, 2003, MOL PHYLOGENET EVOL, V27, P328, DOI 10.1016/S1055-7903(02)00450-5; SASAKI M, 1968, EXPERIENTIA, V24, P1292, DOI 10.1007/BF02146680; SCHMUTZ SM, 1993, J RAPTOR RES, V27, P196; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Storer R. W., 1971, P1	22	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70071	10.1371/journal.pone.0070071	http://dx.doi.org/10.1371/journal.pone.0070071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922908	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900140
J	Eriksson, UK; van Bodegom, D; May, L; Boef, AGC; Westendorp, RGJ				Eriksson, Ulrika K.; van Bodegom, David; May, Linda; Boef, Anna G. C.; Westendorp, Rudi G. J.			Low C-Reactive Protein Levels in a Traditional West-African Population Living in a Malaria Endemic Area	PLOS ONE			English	Article							RISK; DISEASE; CHILDREN; MARKERS; OBESITY; RACE; TRANSPLANTATION; INFLAMMATION; DETERMINANT; FREQUENCIES	Background: C-reactive protein (CRP) levels are reported to be elevated in populations of African descent living in affluent environments compared to populations of European ancestry. However, the natural history of CRP levels in populations of African descent living under adverse environments remains largely unknown. Methods: CRP levels were measured with a high sensitivity assay in 624 apparently healthy individuals who contributed blood as part of a study on innate immune responsiveness in a traditional Ghanaian population living under adverse environmental conditions in a malaria endemic area. As a comparison, we included CRP measurements from 2931 apparently healthy individuals from the Dutch population that were included in the same batch of CRP analyses. Associations between CRP and body mass index (BMI), immune responsiveness, and P. falciparum parasitaemia were investigated. Results: In an age-and sex-adjusted model, CRP levels were 0.54 mg/L lower in the Ghanaian compared to the Dutch cohort (1.52 vs. 0.98 mg/L, p<0.001). When accounting for the substantially higher average BMI in the Dutch compared to the Ghanaians (25.6 vs. 18.4 kg/m(2)) the difference in CRP levels disappeared. BMI associated positively with CRP in the Dutch but not in the Ghanaians. In individuals with an acute phase response, CRP levels were higher in the Ghanaian compared to the Dutch cohort (24.6 vs. 17.3 mg/L, p = 0.04). Levels of CRP were positively related to immune responsiveness and P. falciparum parasitaemia (all p<0.001) among Ghanaians. Conclusions: Our study demonstrates that West-Africans do not exhibit an inherently high inflammatory state. The role of genes, environment and gene-environment interaction in explaining reports of elevated CRP levels in populations of African ancestry when compared to other ethnicities living in affluent environments thus merits further investigation.	[Eriksson, Ulrika K.; van Bodegom, David; Boef, Anna G. C.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [May, Linda] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Boef, Anna G. C.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Eriksson, UK (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	ulrika.eriksson@zoho.com		van Bodegom, David/0000-0002-5691-8342; Boef, Anna/0000-0001-6869-9119	Netherlands Foundation for the advancements of Tropical Research [WOTRO 93-467]; Netherlands Organisation for Scientific Research [NWO 051-14-050, 050-60810, 912-03-033\ 2003]; EU [EU FP6 036894]; Prof. Dr. P.C. Flu-foundation; Board of the Leiden University Medical Center; Association Dioraphte; Netherlands Heart Foundation [NHS 98.113]; Dutch Cancer Foundation [RUL 99/1992]	Netherlands Foundation for the advancements of Tropical Research; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Prof. Dr. P.C. Flu-foundation; Board of the Leiden University Medical Center; Association Dioraphte; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Cancer Foundation(KWF Kankerbestrijding)	The Ghana study was supported by the Netherlands Foundation for the advancements of Tropical Research [WOTRO 93-467]; the Netherlands Organisation for Scientific Research [NWO 051-14-050 and 050-60810]; the EU funded Network of Excellence LifeSpan [EU FP6 036894]; the Prof. Dr. P.C. Flu-foundation; an unrestricted grant of the Board of the Leiden University Medical Center and the Association Dioraphte. The Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis study was supported by the Netherlands Heart Foundation [NHS 98.113]; the Dutch Cancer Foundation [RUL 99/1992] and the Netherlands Organisation for Scientific Research [912-03-033 vertical bar 2003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Boef AGC, 2012, GENES IMMUN, V13, P103, DOI 10.1038/gene.2011.57; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Deeg M, 2008, ETHNIC DIS, V18, P427; Ding KY, 2009, CIRCULATION, V119, P459, DOI 10.1161/CIRCULATIONAHA.108.809970; Doumatey AP, 2010, OBESITY, V18, P598, DOI 10.1038/oby.2009.322; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; *GHAN STAT SERV, 2003, GHAN DEM HLTH SURV; Ghana Health Service, 2004, UPP E REG HLTH ADM A; Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x; Huddleston DJ, 2001, JALA-J ASSOC LAB AUT, V6, P30; HURT N, 1994, T ROY SOC TROP MED H, V88, P182, DOI 10.1016/0035-9203(94)90287-9; HURT N, 1994, CLIN DIAGN LAB IMMUN, V1, P437, DOI 10.1128/CDLI.1.4.437-444.1994; Imrie H, 2007, AM J TROP MED HYG, V76, P280, DOI 10.4269/ajtmh.2007.76.280; Israelsson E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-136; Jakobsen PH, 1998, INFECT IMMUN, V66, P1654, DOI 10.1128/IAI.66.4.1654-1659.1998; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; NAIK P, 1984, T ROY SOC TROP MED H, V78, P812, DOI 10.1016/0035-9203(84)90027-0; Nair S, 2002, LANCET, V359, P287, DOI 10.1016/S0140-6736(02)07494-9; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; O'Donnell A, 2009, T ROY SOC TROP MED H, V103, P679, DOI 10.1016/j.trstmh.2009.03.023; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Paul Rudrajit, 2012, Adv Biomed Res, V1, P41, DOI 10.4103/2277-9175.100140; Pennington R, 2009, INFECT GENET EVOL, V9, P1371, DOI 10.1016/j.meegid.2009.09.017; Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shah T, 2010, CIRC-CARDIOVASC GENE, V3, P436, DOI 10.1161/CIRCGENETICS.110.957431; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; van Bodegom D, 2009, T ROY SOC TROP MED H, V103, P795, DOI 10.1016/j.trstmh.2008.12.003; Van Dyke AL, 2009, CYTOKINE, V46, P236, DOI 10.1016/j.cyto.2009.02.003; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Verweij JJ, 2003, MOL CELL PROBE, V17, P223, DOI 10.1016/S0890-8508(03)00057-4; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Young CJ, 2000, NEW ENGL J MED, V343, P1545, DOI 10.1056/NEJM200011233432107	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70076	10.1371/journal.pone.0070076	http://dx.doi.org/10.1371/journal.pone.0070076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922912	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900142
J	Lecourt, S; Mouly, E; Freida, D; Cras, A; Ceccaldi, R; Heraoui, D; Chomienne, C; Marolleau, JP; Arnulf, B; Porcher, R; Caillaud, C; Vanneaux, V; Belmatoug, N; Larghero, J				Lecourt, Severine; Mouly, Enguerran; Freida, Delphine; Cras, Audrey; Ceccaldi, Raphael; Heraoui, Djazia; Chomienne, Christine; Marolleau, Jean-Pierre; Arnulf, Bertrand; Porcher, Raphael; Caillaud, Catherine; Vanneaux, Valerie; Belmatoug, Nadia; Larghero, Jerome			A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; MULTIPLE-MYELOMA; GLUCOCEREBROSIDASE ACTIVITY; MODEL; STORAGE; DIFFERENTIATION; MACROPHAGE; CYTOKINES; REGISTRY; ASSAY	Gaucher disease (GD) is an autosomal recessive disorder characterized by lysosomal glucocerebrosidase (GBA) deficiency leading to hematological and skeletal manifestations. Mechanisms underlying these symptoms have not yet been elucidated. In vivo, bone marrow (BM) mesenchymal stem cells (MSCs) have important role in the regulation of bone mass and in the support of hematopoiesis, thus representing potential candidate that could contribute to the disease. GBA deficiency may also directly impair hematopoietic stem/progenitors cells (HSPCs) intrinsic function and induce hematological defect. In order to evaluate the role of BM stem cells in GD pathophysiology, we prospectively analyzed BM-MSCs and HSPCs properties in a series of 10 patients with type 1 GD. GBA activity was decreased in all tested cell subtypes. GD-MSCs had an impaired growth potential, morphological and cell cycle abnormalities, decreased capacities to differentiate into osteoblasts. Moreover, GD-MSCs secreted soluble factors that stimulated osteoclasts resorbing activities. In vitro and in vivo primitive and mature hematopoiesis were similar between patients and controls. However, GD-MSCs had a lower hematopoietic supportive capacity than those from healthy donors. These data suggest that BM microenvironment is altered in GD and that MSCs are key components of the manifestations observed in GD.	[Lecourt, Severine; Freida, Delphine; Cras, Audrey; Vanneaux, Valerie; Larghero, Jerome] Hop St Louis, AP HP, Unite Therapie Cellulaire, Paris, France; [Lecourt, Severine; Freida, Delphine; Cras, Audrey; Vanneaux, Valerie; Larghero, Jerome] Ctr Invest Clin Biotherapies CIC BT501, Paris, France; [Lecourt, Severine; Cras, Audrey; Chomienne, Christine; Larghero, Jerome] Hop St Louis, INSERM UMRS940, Inst Univ Hematol, Paris, France; [Mouly, Enguerran; Arnulf, Bertrand] Univ Paris Diderot, EA3963, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Ceccaldi, Raphael] Hop St Louis, INSERM U944, Inst Univ Hematol, Paris, France; [Heraoui, Djazia; Belmatoug, Nadia] Hop Beaujon, AP HP, Serv Med Interne, Ctr Reference Malad Lysosomales, Clichy, France; [Marolleau, Jean-Pierre] Hop Amiens, Dept Hematol Clin, Amiens, France; [Arnulf, Bertrand] Hop St Louis, AP HP, Dept Immunohematol, Paris, France; [Porcher, Raphael] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France; [Caillaud, Catherine] Hop Cochin, Lab Genet Metab, F-75674 Paris, France; [Lecourt, Severine; Freida, Delphine; Cras, Audrey; Vanneaux, Valerie; Larghero, Jerome] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Larghero, J (corresponding author), Hop St Louis, AP HP, Unite Therapie Cellulaire, Paris, France.	jerome.larghero@sls.aphp.fr	Cras, Audrey/Q-8784-2017; Vanneaux, Valérie/D-7853-2017	Cras, Audrey/0000-0002-6894-9584; Vanneaux, Valérie/0000-0003-0813-2318; CHOMIENNE, Christine/0000-0001-5513-5752; Porcher, Raphael/0000-0002-5277-4679	Genzyme SAS; Genzyme; Shire; Actelion; Pfizer	Genzyme SAS(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); Shire; Actelion; Pfizer(Pfizer)	The authors state that SL was sponsored as a doctoral student and has been reimbursed for congress travel from Genzyme SAS. NB has consulting fees, fees for speaking. NB received grants (Genzyme, Shire, Actelion, Pfizer) donated to APRIMI (Association pour la Promotion de la Recherche en Infectiologie et Medecine Interne) and to the Department of Clinical Research of the Assistance-Publique Hopitaux de Paris. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Arnulf B, 2007, LEUKEMIA, V21, P158, DOI 10.1038/sj.leu.2404466; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; Berger J, 2010, BRIT J HAEMATOL, V150, P93, DOI 10.1111/j.1365-2141.2010.08214.x; Campeau PM, 2009, BLOOD, V114, P3181, DOI 10.1182/blood-2009-02-205708; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Ciana G, 2003, CALCIFIED TISSUE INT, V72, P185, DOI 10.1007/s00223-001-2072-0; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; de Fost M, 2008, ANN HEMATOL, V87, P439, DOI 10.1007/s00277-008-0441-8; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; Enquist IB, 2009, STEM CELLS, V27, P744, DOI 10.1634/stemcells.2008-0844; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hein LK, 2008, J LIPID RES, V49, P1725, DOI 10.1194/jlr.M800092-JLR200; Hollak CEM, 1997, BLOOD CELL MOL DIS, V23, P201, DOI 10.1006/bcmd.1997.0137; Kobayashi Y, 2005, J BIOL CHEM, V280, P24035, DOI 10.1074/jbc.M500926200; Lecourt S, 2011, STEM CELLS DEV; Lecourt S, 2010, STEM CELLS DEV; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; Lorincz M, 1997, BLOOD, V89, P3412, DOI 10.1182/blood.V89.9.3412; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Mucci JM, 2012, GENE, V509, P51, DOI 10.1016/j.gene.2012.07.071; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Rudensky B, 2003, BLOOD CELL MOL DIS, V30, P97, DOI 10.1016/S1079-9796(03)00010-X; Rudzki Z, 2003, EUR J HAEMATOL, V70, P273, DOI 10.1034/j.1600-0609.2003.00047.x; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Take I, 2005, ENDOCRINOLOGY, V146, P5204, DOI 10.1210/en.2005-0451; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; van Breemen MJ, 2007, BBA-MOL BASIS DIS, V1772, P788, DOI 10.1016/j.bbadis.2007.04.002; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6	35	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69293	10.1371/journal.pone.0069293	http://dx.doi.org/10.1371/journal.pone.0069293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935976	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300030
J	Soraas, A; Sundsfjord, A; Sandven, I; Brunborg, C; Jenum, PA				Soraas, Arne; Sundsfjord, Arnfinn; Sandven, Irene; Brunborg, Cathrine; Jenum, Pal A.			Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae -A Case-Control Study in a Low Prevalence Country	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; EPIDEMIOLOGY; ONSET; RESISTANCE; ANTIBIOTICS; COMORBIDITY	Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, but the clinical epidemiology of these infections in low prevalence countries is largely unknown. A population based case-control study was conducted to assess risk factors for CA-UTI caused by ESBL-producing E. coli or K. pneumoniae. The study was carried out in a source population in Eastern Norway, a country with a low prevalence of infections caused by ESBL-producing Enterobacteriaceae. The study population comprised 100 cases and 190 controls with CA-UTI caused by ESBL-producing and non-ESBL-producing E. coli or K. pneumoniae, respectively. The following independent risk factors of ESBL-positive UTIs were identified: Travel to Asia, The Middle East or Africa either during the past six weeks (Odds ratio (OR) = 21; 95% confidence interval (CI): 4.5-97) or during the past 6 weeks to 24 months (OR = 2.3; 95% CI: 1.1-4.4), recent use of fluoroquinolones (OR = 16; 95% CI: 3.2-80) and beta-lactams (except mecillinam) (OR = 5.0; 95% CI: 2.1-12), diabetes mellitus (OR = 3.2; 95% CI: 1.0-11) and recreational freshwater swimming the past year (OR = 2.1; 95% CI: 1.0-4.0). Factors associated with decreased risk were increasing number of fish meals per week (OR = 0.68 per fish meal; 95% CI: 0.51-0.90) and age (OR = 0.89 per 5 year increase; 95% CI: 0.82-0.97). In conclusion, we have identified risk factors that elucidate mechanisms and routes for dissemination of ESBL-producing Enterobacteriaceae in a low prevalence country, which can be used to guide appropriate treatment of CA-UTI and targeted infection control measures.	[Soraas, Arne; Jenum, Pal A.] Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway; [Sundsfjord, Arnfinn] Univ Hosp North Norway, Reference Ctr Detect Antimicrobial Resistance, Dept Microbiol & Infect Control, Tromso, Norway; [Sundsfjord, Arnfinn] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Sandven, Irene; Brunborg, Cathrine] Oslo Univ Hosp, Unit Biostat & Epidemiol, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo	Soraas, A (corresponding author), Vestre Viken Hosp Trust, Dept Med Microbiol, Baerum, Norway.	arne@meg.no	Sundsfjord, Arnfinn/F-9668-2018	Sundsfjord, Arnfinn/0000-0002-3728-2270; Sandven, Irene/0000-0002-4660-3582				Angelakis E, 2012, FUTURE MICROBIOL, V7, P91, DOI [10.2217/FMB.11.142, 10.2217/fmb.11.142]; Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008; Azap OK, 2010, CLIN MICROBIOL INFEC, V16, P147, DOI 10.1111/j.1469-0691.2009.02941.x; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Berg C, 2011, NORWEGIAN PRESCRIPTI; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Briongos-Figuero LS, 2012, INT J CLIN PRACT, V66, P891, DOI 10.1111/j.1742-1241.2012.02991.x; Cassier P, 2011, CLIN MICROBIOL INFEC, V17, P1746, DOI 10.1111/j.1469-0691.2010.03349.x; Chaudhry S, 2005, MED CARE, V43, P607, DOI 10.1097/01.mlr.0000163658.65008.ec; Chen H, 2010, ENVIRON POLLUT, V158, P2459, DOI 10.1016/j.envpol.2010.03.023; Colodner R, 2004, EUR J CLIN MICROBIOL, V23, P163, DOI 10.1007/s10096-003-1084-2; Colomer-Lluch M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017549; Doi Y, 2013, CLIN INFECT DIS, V56, P641, DOI 10.1093/cid/cis942; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control, 2011, ANN REP EUR ANT RES; Freeman JT, 2008, CLIN INFECT DIS, V47, P689, DOI 10.1086/590941; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Johnson SW, 2013, INFECT CONT HOSP EP, V34, P385, DOI 10.1086/669858; Kang CI, 2012, J CLIN MICROBIOL, V50, P312, DOI 10.1128/JCM.06002-11; Kim B, 2013, INFECTION, V41, P603, DOI 10.1007/s15010-013-0441-z; Kim YK, 2002, ANTIMICROB AGENTS CH, V46, P1481, DOI 10.1128/AAC.46.5.1481-1491.2002; Kleinbaum DG, 2010, LOGISTIC REGRESSION, P345, DOI DOI 10.1002/ART.24070; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Moor CT, 2008, J HOSP INFECT, V68, P355, DOI 10.1016/j.jhin.2008.02.003; Moreno E, 2006, EPIDEMIOL INFECT, V134, P1015, DOI 10.1017/S0950268806005917; Muvunyi CM, 2011, AM J TROP MED HYG, V84, P923, DOI 10.4269/ajtmh.2011.11-0057; Nicolas-Chanoine MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030498; NORM/NORM-VET, 2019, US ANT AG OCC ANT RE; NORM/NORM-VET, 2010, US ANT AG OCC ANT RE; Park SH, 2011, MICROB DRUG RESIST, V17, P537, DOI 10.1089/mdr.2011.0072; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Rottier WC, 2012, J ANTIMICROB CHEMOTH, V67, P1311, DOI 10.1093/jac/dks065; Samadpour N, 2002, J ENVIRON HEALTH, V64, P16; Siedelman L, 2012, AM J INFECT CONTROL, V40, P849, DOI 10.1016/j.ajic.2011.10.019; Sullivan A, 2001, J CHEMOTHERAPY, V13, P299, DOI 10.1179/joc.2001.13.3.299; Tacao M, 2012, APPL ENVIRON MICROB, V78, P4134, DOI 10.1128/AEM.00359-12; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Tian SF, 2008, CAN J MICROBIOL, V54, P781, DOI 10.1139/w08-059; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Topaloglu R, 2010, PEDIATR NEPHROL, V25, P919, DOI 10.1007/s00467-009-1431-3; Wootton M, 2010, J ANTIMICROB CHEMOTH, V65, P79, DOI 10.1093/jac/dkp404	46	128	134	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69581	10.1371/journal.pone.0069581	http://dx.doi.org/10.1371/journal.pone.0069581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936052	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000137
J	Zhang, JQ; He, GJ; Yan, YB				Zhang, Jia-Quan; He, Guang-Jun; Yan, Yong-Bin			Biochemical and Biophysical Characterization of the Deadenylase CrCaf1 from Chlamydomonas reinhardtii	PLOS ONE			English	Article							TRYPTOPHAN FLUORESCENCE-SPECTRA; MESSENGER-RNA DEADENYLASE; LOG-NORMAL COMPONENTS; POLY(A)-SPECIFIC RIBONUCLEASE; THERMAL-STABILITY; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN; CAF1; AGGREGATION	The modulation of mRNA turnover has been increasingly recognized as a hotpoint for gene expression regulation at the post-transcriptional level. In eukaryotic cells, most mRNAs are degraded via the deadenylation-dependent pathway, in which the removal of the poly(A) tail is the initial and rate-limiting step. Caf1, a deadenylase specifically degrades poly(A) from the 3'-end, is highly conserved from yeast to mammalians. Caf1s in higher plants have been shown to be involved in plant development and stress response. However, little is known about the biochemical and biophysical properties of Caf1s in plants. In this research, we cloned the crcaf1 gene from Chlamydomonas reinhardtii and studied the properties of the recombinant proteins. The results showed that CrCaf1 was a deadenylase with conserved sequence motifs, structural features, and catalytic properties of the Caf1 family. CrCaf1 degraded poly(A) in a distributive mode with the optimal reacting conditions at pH 7 and 35 degrees C. CrCaf1 had similar activity when coordinated with Mg2+ and Mn2+, while the enzyme bound to Ca2+ or Zn2+ was almost inactivated. Zn2+ could induce CrCaf1 aggregation with the disruption of the native structure, while Mg2+, Mn2+ and Ca2+ could stabilize CrCaf1 against thermal denaturation by reducing protein aggregation. Among the various metal ions, Mn2+ showed the strongest protective effect on CrCaf1 stability, implying that Mn2+ might play a role in regulating CrCaf1 stability in the C. reinhardtii cells under some stressed conditions. These findings provide a starting point for further investigation of the physiological functions of CrCaf1 in C. reinhardtii.	[Zhang, Jia-Quan; He, Guang-Jun; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Yan, YB (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558	National Natural Science Foundation of China [31170757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This investigation was supported by grant 31170757 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KR, 2009, RNA, V15, P850, DOI 10.1261/rna.1489409; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Cheng YA, 2006, PROTEIN PEPTIDE LETT, V13, P125, DOI 10.2174/092986606775101580; Feng LK, 2012, INT J BIOL MACROMOL, V51, P497, DOI 10.1016/j.ijbiomac.2012.05.032; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gera JF, 1998, MOL CELL BIOL, V18, P1498, DOI 10.1128/MCB.18.3.1498; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; He GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033700; He GJ, 2011, INT J MOL SCI, V12, P2901, DOI 10.3390/ijms12052901; He GJ, 2009, FEBS J, V276, P2849, DOI 10.1111/j.1742-4658.2009.07008.x; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Herrin DL, 2004, PHOTOSYNTH RES, V82, P301, DOI 10.1007/s11120-004-2741-8; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jonstrup AT, 2007, NUCLEIC ACIDS RES, V35, P3153, DOI 10.1093/nar/gkm178; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Liu WF, 2008, PROTEIN EXPRES PURIF, V60, P46, DOI 10.1016/j.pep.2008.03.008; Liu WF, 2007, FEBS LETT, V581, P1047, DOI 10.1016/j.febslet.2007.02.008; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Ohn T, 2007, NUCLEIC ACIDS RES, V35, P3002, DOI 10.1093/nar/gkm196; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Ren YG, 2004, J BIOL CHEM, V279, P48702, DOI 10.1074/jbc.M403858200; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; Sarowar S, 2007, PLANT J, V51, P792, DOI 10.1111/j.1365-313X.2007.03174.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suck D, 1992, CURR OPIN STRUC BIOL, V2, P84; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Walley JW, 2010, PLANT SIGNAL BEHAV, V5, P802, DOI 10.4161/psb.5.7.11578; Walley JW, 2010, PLANT PHYSIOL, V152, P866, DOI 10.1104/pp.109.149005; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	39	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69582	10.1371/journal.pone.0069582	http://dx.doi.org/10.1371/journal.pone.0069582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936053	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000138
J	Monteiro, AC; Leal, AC; Goncalves-Silva, T; Mercadante, ACT; Kestelman, F; Chaves, SB; Azevedo, RB; Monteiro, JP; Bonomo, A				Monteiro, Ana Carolina; Leal, Ana Carolina; Goncalves-Silva, Triciana; Mercadante, Ana Carolina T.; Kestelman, Fabiola; Chaves, Sacha Braun; Azevedo, Ricardo Bentes; Monteiro, Joao P.; Bonomo, Adriana			T Cells Induce Pre-Metastatic Osteolytic Disease and Help Bone Metastases Establishment in a Mouse Model of Metastatic Breast Cancer	PLOS ONE			English	Article							OSTEOCLAST FORMATION; MAMMARY-TUMORS; IMMUNE-SYSTEM; FAMILY-MEMBER; IN-VIVO; RANK; THYMECTOMY; ARTHRITIS; TRANCE; ROLES	Bone metastases, present in 70% of patients with metastatic breast cancer, lead to skeletal disease, fractures and intense pain, which are all believed to be mediated by tumor cells. Engraftment of tumor cells is supposed to be preceded by changes in the target tissue to create a permissive microenvironment, the pre-metastatic niche, for the establishment of the metastatic foci. In bone metastatic niche, metastatic cells stimulate bone consumption resulting in the release of growth factors that feed the tumor, establishing a vicious cycle between the bone remodeling system and the tumor itself. Yet, how the pre-metastatic niches arise in the bone tissue remains unclear. Here we show that tumor-specific T cells induce osteolytic bone disease before bone colonization. T cells pro-metastatic activity correlate with a pro-osteoclastogenic cytokine profile, including RANKL, a master regulator of osteoclastogenesis. In vivo inhibition of RANKL from tumor-specific T cells completely blocks bone loss and metastasis. Our results unveil an unexpected role for RANKL-derived from T cells in setting the pre-metastatic niche and promoting tumor spread. We believe this information can bring new possibilities for the development of prognostic and therapeutic tools based on modulation of T cell activity for prevention and treatment of bone metastasis.	[Monteiro, Ana Carolina; Leal, Ana Carolina; Goncalves-Silva, Triciana; Mercadante, Ana Carolina T.; Bonomo, Adriana] Brazilian Natl Canc Inst, Expt Med Program, Rio De Janeiro, Brazil; [Kestelman, Fabiola] Brazilian Natl Canc Inst, HCIII, Rio De Janeiro, Brazil; [Chaves, Sacha Braun; Azevedo, Ricardo Bentes] Univ Brasilia, Inst Biol, Brasilia, DF, Brazil; [Monteiro, Joao P.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Monteiro, Ana Carolina; Goncalves-Silva, Triciana; Mercadante, Ana Carolina T.; Bonomo, Adriana] Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil; [Goncalves-Silva, Triciana; Bonomo, Adriana] Univ Fed Rio de Janeiro, Microbiol Inst Prof Paulo de Goes, Dept Immunol, Rio De Janeiro, Brazil	National Cancer Institute (Inca); National Cancer Institute (Inca); Universidade de Brasilia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Bonomo, A (corresponding author), Brazilian Natl Canc Inst, Expt Med Program, Rio De Janeiro, Brazil.	abonomo@micro.ufrj.br	Monteiro, Ana Carolina Carolina/AAX-6136-2021	Azevedo, Ricardo/0000-0002-2137-9588; Chaves, Sacha/0000-0002-4300-8059; monteiro, ana/0000-0001-7899-6264	CNPq [57.3806/2008- INCT, 306624/2010-9]; FAPERJ [E-26/111.423/2010, E-26/110.949/2008, E-26/110.323/2010]; Swiss Bridge Foundation [2301500]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swiss Bridge Foundation	This work was supported by CNPq grants 57.3806/2008- INCT, 306624/2010-9, FAPERJ grants #E-26/111.423/2010; E-26/110.949/2008; E-26/110.323/2010 and Swiss Bridge Foundation # 2301500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Das Roy L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-365; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Di Rosa F, 2009, IMMUNOL CELL BIOL, V87, P20, DOI 10.1038/icb.2008.84; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; ERNST CW, 2009, CLIN EXP IMMUNOL, V148, P271; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fournier PGJ, 2006, CURR OPIN RHEUMATOL, V18, P396, DOI 10.1097/01.bor.0000231909.35043.da; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HIRSCH HM, 1961, CANCER RES, V21, P752; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; MARTINEZ C, 1964, NATURE, V203, P1188, DOI 10.1038/2031188a0; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Monteiro JP, 2005, BLOOD, V105, P1484, DOI 10.1182/blood-2004-07-2856; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Noonan K, 2010, BLOOD, V116, P3554, DOI 10.1182/blood-2010-05-283895; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pollinger B, 2011, J IMMUNOL, V186, P2602, DOI 10.4049/jimmunol.1003370; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Suzuki C, 2008, RADIOGRAPHICS, V28, P329, DOI 10.1148/rg.282075068; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YUNIS EJ, 1969, CANCER RES, V29, P174; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	47	62	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2013	8	7							e68171	10.1371/journal.pone.0068171	http://dx.doi.org/10.1371/journal.pone.0068171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214PM	23935856	Green Published, gold, Green Submitted			2022-12-27	WOS:000324146200014
J	Socias, ME; Hermida, L; Singman, M; Kulgis, G; Armas, AD; Cando, O; Sued, O; Perez, H; Hermes, R; Presas, JL; Cahn, P				Eugenia Socias, Maria; Hermida, Laura; Singman, Mariana; Kulgis, Gisela; Diaz Armas, Andres; Cando, Osvaldo; Sued, Omar; Perez, Hector; Hermes, Ricardo; Luis Presas, Jose; Cahn, Pedro			Routine HIV Testing among Hospitalized Patients in Argentina. Is It Time for a Policy Change?	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; TRANSMISSION; ACCEPTANCE; INFECTION; PREVENTION; CARE; RECOMMENDATIONS; MORTALITY	Introduction: The Argentinean AIDS Program estimates that 110,000 persons are living with HIV/AIDS in Argentina. Of those, approximately 40% are unaware of their status, and 30% are diagnosed in advanced stages of immunosuppression. Though studies show that universal HIV screening is cost-effective in settings with HIV prevalence greater than 0.1%, in Argentina, with the exception of antenatal care, HIV testing is always client-initiated. Objective: We performed a pilot study to assess the acceptability of a universal HIV screening program among inpatients of an urban public hospital in Buenos Aires. Methods: Over a six-month period, all eligible adult patients admitted to the internal medicine ward were offered HIV testing. Demographics, uptake rates, reasons for refusal and new HIV diagnoses were analyzed. Results: Of the 350 admissions during this period, 249 were eligible and subsequently enrolled. The enrolled population was relatively old compared to the general population, was balanced on gender, and did not report traditional high risk factors for HIV infection. Only 88 (39%) reported prior HIV testing. One hundred and ninety (76%) patients accepted HIV testing. In multivariable analysis only younger age (OR 1.02; 95% CI 1.003-1.05) was independently associated with test uptake. Three new HIV diagnoses were made (undiagnosed HIV prevalence: 1.58%); none belonged to a most-at-risk population. Conclusions: Our findings suggest that universal HIV screening in this setting is acceptable and potentially effective in identifying undiagnosed HIV-infected individuals. If confirmed in a larger study, our findings may inform changes in the Argentinean HIV testing policy.	[Eugenia Socias, Maria; Kulgis, Gisela; Diaz Armas, Andres; Sued, Omar; Perez, Hector; Cahn, Pedro] Hosp JA Fernandez, Div Infect Dis, Buenos Aires, DF, Argentina; [Eugenia Socias, Maria; Sued, Omar; Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Hermida, Laura; Singman, Mariana; Luis Presas, Jose] Hosp JA Fernandez, Div Internal Med, Buenos Aires, DF, Argentina; [Cando, Osvaldo; Hermes, Ricardo] Hosp JA Fernandez, Lab Div, Buenos Aires, DF, Argentina		Socias, ME (corresponding author), Hosp JA Fernandez, Div Infect Dis, Buenos Aires, DF, Argentina.	eugenia.socias@huesped.org.ar	Sued, Omar/H-3325-2019; PEREZ, HECTOR M./S-9366-2019	Sued, Omar/0000-0001-5818-770X; 				Ashby J, 2012, AIDS CARE, V24, P905, DOI 10.1080/09540121.2011.647675; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; British Association for Sexual Health and HIV (BASHH) British Infection Society (BIS), 2008, UK NATIONAL GUIDELIN; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE REP; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Delpierre C, 2007, INT J STD AIDS, V18, P312, DOI 10.1258/095646207780749709; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duran A, 2012, XIX INTERNATIONAL AI; Dyer JR, 1997, AIDS, V11, P543; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Ellis S, 2011, CLIN MED, V11, P541, DOI 10.7861/clinmedicine.11-6-541; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; de Olalla PG, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-22; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haac BE, 2013, WORLD J SURG, P1; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jain CL, 2008, AIDS PATIENT CARE ST, V22, P657, DOI 10.1089/apc.2007.0189; Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Liddicoat RV, 2006, AIDS PATIENT CARE ST, V20, P84, DOI 10.1089/apc.2006.20.84; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNaghten AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051231; Merchant RC, 2008, PUBLIC HEALTH REP, V123, P27, DOI 10.1177/00333549081230S305; Ministerio de Salud de la Nacion Direccion de SIDA y ETS, 2012, BOLETIN SOBRE EL VIH; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; SADI, 2010, RECOMENDACIONES TRAT; Scott Victor F, 2009, Trans Am Clin Climatol Assoc, V120, P429; Siegel M, 2010, JAIDS-J ACQ IMM DEF, V55, P205, DOI 10.1097/QAI.0b013e3181e15bf4; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wheatley MA, 2011, J URBAN HEALTH, V88, P1015, DOI 10.1007/s11524-011-9588-z; World Health O, 2012, ANTIRETROVIRAL TREAT; World Health Organization, 2010, ANTIRETROVIRAL THERA	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69517	10.1371/journal.pone.0069517	http://dx.doi.org/10.1371/journal.pone.0069517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936034	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700030
J	Tenney, ER; Vazire, S; Mehl, MR				Tenney, Elizabeth R.; Vazire, Simine; Mehl, Matthias R.			This Examined Life: The Upside of Self-Knowledge for Interpersonal Relationships	PLOS ONE			English	Article							ENHANCEMENT BIAS; PERSONALITY; PSYCHOLOGY; ADAPTIVENESS; PERCEPTIONS; ADJUSTMENT; ACCURACY; BENEFITS; OPTIMISM	Although self-knowledge is an unquestioned good in many philosophical traditions, testing this assumption scientifically has posed a challenge because of the difficulty of measuring individual differences in self-knowledge. In this study, we used a novel, naturalistic, and objective criterion to determine individuals' degree of self-knowledge. Specifically, self-knowledge was measured as the congruence between people's beliefs about how they typically behave and their actual behavior as measured with unobtrusive audio recordings from daily life. We found that this measure of self-knowledge was positively correlated with informants' perceptions of relationship quality. These results suggest that self-knowledge is interpersonally advantageous. Given the importance of relationships for our social species, self-knowledge could have great social value that has heretofore been overlooked.	[Tenney, Elizabeth R.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Vazire, Simine] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Mehl, Matthias R.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA	University of California System; University of California Berkeley; Washington University (WUSTL); University of Arizona	Tenney, ER (corresponding author), Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA.	eliz.tenney@gmail.com		Vazire, Simine/0000-0002-3933-9752	John Templeton Foundation	John Templeton Foundation	The preparation of this manuscript was supported by a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2008, PERS SOC PSYCHOL B, V34, P90, DOI 10.1177/0146167207307489; Anderson C, 2006, J PERS SOC PSYCHOL, V91, P1094, DOI 10.1037/0022-3514.91.6.1094; Anderson C, 2012, J PERS SOC PSYCHOL, V103, P718, DOI 10.1037/a0029395; Armor DA, 1998, ADV EXP SOC PSYCHOL, V30, P309, DOI 10.1016/S0065-2601(08)60386-X; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; Bollich KL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00312; Bonanno GA, 2002, PERS SOC PSYCHOL B, V28, P184, DOI 10.1177/0146167202282005; Carlson EN, 2011, J PERS SOC PSYCHOL, V101, P185, DOI 10.1037/a0023781; Chambers JR, 2004, PSYCHOL BULL, V130, P813, DOI 10.1037/0033-2909.130.5.813; Church AT, 2006, J RES PERS, V40, P1169, DOI 10.1016/j.jrp.2006.01.004; COLVIN CR, 1995, J PERS SOC PSYCHOL, V68, P1152, DOI 10.1037/0022-3514.68.6.1152; Craik KH, 1993, PSYCHOL INQ, V4, P278, DOI [DOI 10.1207/S15327965PLI0404_4, 10.1207/s15327965pli0404_4]; Critcher C. R., 2011, HDB SELF ENHANCEMENT, P69; Denton K, 1997, EVOLUTIONARY SOCIAL; Funder DC, 2009, PERSPECT PSYCHOL SCI, V4, P340, DOI 10.1111/j.1745-6924.2009.01135.x; Furr RM, 2008, J PERS, V76, P1267, DOI 10.1111/j.1467-6494.2008.00521.x; Hart D., 2012, HDB SELF KNOWLEDGE, P7; Hasler BP, 2008, J RES PERS, V42, P1537, DOI 10.1016/j.jrp.2008.07.012; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Joplin DA, 2000, SELF KNOWLEDGE SELF, P1, DOI [10.1111/1467-9329.t01-1-00186, DOI 10.1111/1467-9329.T01-1-00186]; Kenny DA, 2001, LEA SER PER CLIN PSY, P265; Kim YH, 2011, EMOTION, V11, P1096, DOI 10.1037/a0025478; Krueger JI, 2004, BEHAV BRAIN SCI, V27, P313, DOI 10.1017/S0140525X04000081; KRUGLANSKI AW, 1989, PSYCHOL BULL, V106, P395, DOI 10.1037/0033-2909.106.3.395; Kurt A, 2008, J RES PERS, V42, P839, DOI 10.1016/j.jrp.2007.11.005; Kwan V. S. Y., 2011, PSYCHOL STUD, V56, P151, DOI [10.1007/s12646-011-0072-3, DOI 10.1007/S12646-011-0072-3]; Kwan VSY, 2008, J PERS SOC PSYCHOL, V94, P1062, DOI 10.1037/0022-3514.94.6.1062; Kwan VSY, 2004, PSYCHOL REV, V111, P94, DOI 10.1037/0033-295X.111.1.94; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Mehl MR, 2007, SCIENCE, V317, P82, DOI 10.1126/science.1139940; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Mehl MR, 2010, PSYCHOL SCI, V21, P539, DOI 10.1177/0956797610362675; Mehl MR, 2001, BEHAV RES METH INS C, V33, P517, DOI 10.3758/BF03195410; Moore DA, 2007, J PERS SOC PSYCHOL, V92, P972, DOI 10.1037/0022-3514.92.6.972; NIEDENTHAL PM, 1985, J PERS SOC PSYCHOL, V48, P575, DOI 10.1037/0022-3514.48.3.575; Paulhus DL, 1998, J PERS SOC PSYCHOL, V74, P1197, DOI 10.1037/0022-3514.74.5.1197; Pettersson E, 2012, EUR J PERSONALITY, V26, P292, DOI 10.1002/per.839; Robins RW, 2001, J PERS SOC PSYCHOL, V80, P340, DOI 10.1037//0022-3514.80.2.340; Sheldon KM., 2002, HDB SELF DETERMINATI, P65, DOI DOI 10.1177/0022022103262245; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tenney ER, 2008, J EXP SOC PSYCHOL, V44, P1368, DOI 10.1016/j.jesp.2008.04.006; Tenney ER, 2007, PSYCHOL SCI, V18, P46, DOI 10.1111/j.1467-9280.2007.01847.x; Tenney ER, 2011, SOC PSYCHOL PERS SCI, V2, P343, DOI 10.1177/1948550610390965; Tenney ER, 2009, J RES PERS, V43, P579, DOI 10.1016/j.jrp.2009.03.004; Trivers R. L., 1985, SOCIAL EVOLUTION; Vazire S., 2012, HDB SELF KNOWLEDGE; Vazire S, 2008, J PERS SOC PSYCHOL, V95, P1202, DOI 10.1037/a0013314; Vazire S, 2011, CURR DIR PSYCHOL SCI, V20, P104, DOI 10.1177/0963721411402478; Vazire S, 2010, SOC PERSONAL PSYCHOL, V4, P605, DOI 10.1111/j.1751-9004.2010.00280.x; von Hippel W, 2011, BEHAV BRAIN SCI, V34, DOI 10.1017/S0140525X10001354; Wilson TD, 2009, PERSPECT PSYCHOL SCI, V4, P384, DOI 10.1111/j.1745-6924.2009.01143.x; Zuckerman M, 1996, J PERS SOC PSYCHOL, V70, P1250, DOI 10.1037/0022-3514.70.6.1250	54	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69605	10.1371/journal.pone.0069605	http://dx.doi.org/10.1371/journal.pone.0069605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	194LB	23936057	Green Published, gold			2022-12-27	WOS:000322633700034
J	Auyang, AG; Chang, YH				Auyang, Arick G.; Chang, Young-Hui			Effects of a Foot Placement Constraint on Use of Motor Equivalence during Human Hopping	PLOS ONE			English	Article							LEG STIFFNESS; SPINAL PROPRIOCEPTION; REFERENCE FRAMES; COMPENSATION; STRATEGIES; MECHANICS; MOVEMENTS; STABILIZATION; COORDINATION; VARIABILITY	Humans can robustly locomote over complex terrains even while simultaneously attending to other tasks such as accurate foot placement on the ground. We investigated whether subjects would exploit motor redundancy across the joints of the leg to stabilize overall limb kinematics when presented with a hopping task that constrained foot placement position. Subjects hopped in place on one leg (2.2 Hz) while having to place their foot into one of three target sizes upon landing (0.250, 0.063, 0.010 m(2)). As takeoff and landing angles are critical to this task performance, we hypothesized smaller target sizes would increase the need to stabilize (i.e., make more consistent) the leg orientation through motor equivalent combinations of segment angles. As it was not critical to the targeting task, we hypothesized no changes for leg length stabilization across target size. With smaller target sizes, we saw total segment angle variance increase due to greater signal-dependent noise associated with an increased activation of leg extensor muscles (medial and lateral gastrocnemius, vastus medialis, vastus lateralis and rectus femoris). At smaller target sizes, more segment angle variance was aligned to kinematic deviations with the goal of maintaining leg orientation trajectory. We also observed a decrease in the variance structure for stabilizing leg length at the smallest target conditions. This trade-off effect is explained by the nearly orthogonal relationship between the two goal-equivalent manifolds for leg length vs. leg orientation stabilization. Our results suggest humans increasingly rely on kinematic redundancy in their legs to achieve robust, consistent locomotion when faced with novel conditions that constrain performance requirements. These principles may generalize to other human locomotor gaits and provide important insights into the control of the legs during human walking and running.	[Auyang, Arick G.; Chang, Young-Hui] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Chang, YH (corresponding author), Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA.	YH.CHANG@AP.GATECH.EDU		Chang, Young-Hui/0000-0001-7987-6459	U.S. National Science Foundation CAREER ARRA grant [BCS-0847325]; U.S. National Institutes of Health NINDS grant [5R01-NS069655]; Division Of Behavioral and Cognitive Sci [0847325] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069655] Funding Source: NIH RePORTER	U.S. National Science Foundation CAREER ARRA grant(National Science Foundation (NSF)); U.S. National Institutes of Health NINDS grant; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the U.S. National Science Foundation CAREER ARRA grant BCS-0847325 and the U.S. National Institutes of Health NINDS grant 5R01-NS069655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyang AG, 2009, EXP BRAIN RES, V192, P253, DOI 10.1007/s00221-008-1582-7; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Beloozerova IN, 2010, J NEUROPHYSIOL, V103, P2285, DOI 10.1152/jn.00360.2009; Bernstein N, 1967, COORDINATION REGULAT; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bosco G, 2000, J NEUROPHYSIOL, V83, P2946, DOI 10.1152/jn.2000.83.5.2946; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; Chang YH, 2008, J BIOMECH, V41, P1832, DOI 10.1016/j.jbiomech.2008.04.006; Chang YH, 2009, J EXP BIOL, V212, P3511, DOI 10.1242/jeb.033886; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Darainy M, 2004, J NEUROPHYSIOL, V92, P3344, DOI 10.1152/jn.00596.2004; Darainy M, 2008, EXP BRAIN RES, V190, P153, DOI 10.1007/s00221-008-1457-y; FARLEY CT, 1993, J EXP BIOL, V185, P71; FARLEY CT, 1991, J APPL PHYSIOL, V71, P2127, DOI 10.1152/jappl.1991.71.6.2127; Ferris DP, 2006, J APPL PHYSIOL, V100, P163, DOI 10.1152/japplphysiol.00821.2005; Ferris DP, 1999, J BIOMECH, V32, P787, DOI 10.1016/S0021-9290(99)00078-0; Ferris DP, 1996, PHYSIOLOGIST, V39, pA59; Gorniak SL, 2008, MOTOR CONTROL, V12, P151, DOI 10.1123/mcj.12.2.151; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hobara H, 2007, NEUROSCI LETT, V418, P55, DOI 10.1016/j.neulet.2007.02.064; Hobara H, 2010, J BIOMECH, V43, P506, DOI 10.1016/j.jbiomech.2009.09.040; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068; Khatib O., 2004, INT J HUM ROBOT, V1, P29, DOI [DOI 10.1142/S0219843604000058, 10.1142/S0219843604000058]; LACQUANITI F, 1990, J PHYSIOL-LONDON, V426, P177, DOI 10.1113/jphysiol.1990.sp018132; Latash M, 2000, MOTOR CONTROL, V4, P259, DOI 10.1123/mcj.4.3.259; Latash ML, 2006, PHYS THER, V86, P1151, DOI 10.1093/ptj/86.8.1151; LAWRENCE JH, 1993, J NEUROPHYSIOL, V69, P282, DOI 10.1152/jn.1993.69.1.282; McMahon T.A., 1984, MUSCLES REFLEXES LOC; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; McMahon TA, 1990, MULTIPLE MUSCLE SYST, P578; Moritz CT, 2004, J APPL PHYSIOL, V97, P1313, DOI 10.1152/japplphysiol.00393.2004; Moritz CT, 2003, P ROY SOC B-BIOL SCI, V270, P1741, DOI 10.1098/rspb.2003.2435; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Pandy MG, 2010, J BIOMECH, V43, P2055, DOI 10.1016/j.jbiomech.2010.04.010; RAIBERT MH, 1984, INT J ROBOT RES, V3, P75, DOI 10.1177/027836498400300207; Schmitt LC, 2008, J ORTHOP RES, V26, P1180, DOI 10.1002/jor.20619; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Shelburne KB, 2005, MED SCI SPORT EXER, V37, P642, DOI 10.1249/01.MSS.0000158187.79100.48; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Wheaton LA, 2007, EXP BRAIN RES, V180, P345, DOI 10.1007/s00221-007-0858-7; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WOOLLACOTT M, 1988, ANN NY ACAD SCI, V515, P42, DOI 10.1111/j.1749-6632.1988.tb32964.x; Yen JT, 2010, J R SOC INTERFACE, V7, P801, DOI 10.1098/rsif.2009.0296; Yen JT, 2009, EXP BRAIN RES, V196, P439, DOI 10.1007/s00221-009-1868-4	48	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69429	10.1371/journal.pone.0069429	http://dx.doi.org/10.1371/journal.pone.0069429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936013	gold, Green Submitted, Green Published			2022-12-27	WOS:000323114200036
J	Stringer, S; Derks, EM; Kahn, RS; Hill, WG; Wray, NR				Stringer, Sven; Derks, Eske M.; Kahn, Rene S.; Hill, William G.; Wray, Naomi R.			Assumptions and Properties of Limiting Pathway Models for Analysis of Epistasis in Complex Traits	PLOS ONE			English	Article							MISSING HERITABILITY; GENETIC ARCHITECTURE; TWIN	For most complex traits, results from genome-wide association studies show that the proportion of the phenotypic variance attributable to the additive effects of individual SNPs, that is, the heritability explained by the SNPs, is substantially less than the estimate of heritability obtained by standard methods using correlations between relatives. This difference has been called the "missing heritability''. One explanation is that heritability estimates from family (including twin) studies are biased upwards. Zuk et al. revisited overestimation of narrow sense heritability from twin studies as a result of confounding with non-additive genetic variance. They propose a limiting pathway (LP) model that generates significant epistatic variation and its simple parametrization provides a convenient way to explore implications of epistasis. They conclude that overestimation of narrow sense heritability from family data ('phantom heritability') may explain an important proportion of missing heritability. We show that for highly heritable quantitative traits large phantom heritability estimates from twin studies are possible only if a large contribution of common environment is assumed. The LP model is underpinned by strong assumptions that are unlikely to hold, including that all contributing pathways have the same mean and variance and are uncorrelated. Here, we relax the assumptions that underlie the LP model to be more biologically plausible. Together with theoretical, empirical, and pragmatic arguments we conclude that in outbred populations the contribution of additive genetic variance is likely to be much more important than the contribution of non-additive variance.	[Stringer, Sven; Derks, Eske M.] Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Stringer, Sven; Kahn, Rene S.] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Stringer, Sven; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hill, William G.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Queensland; University of Edinburgh	Stringer, S (corresponding author), Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	s.stringer@umcutrecht.nl	Wray, Naomi/C-8639-2015; Derks, Eske M/A-1652-2017	Wray, Naomi/0000-0001-7421-3357; Derks, Eske M/0000-0002-6292-6883	Australian Research Council [FT0911360]; Australian National Health and Medical Research Council [1011506]; Netherlands Scientific Organization (NWO) [451-080-010]	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by grants to NRW from the Australian Research Council (FT0911360) and the Australian National Health and Medical Research Council (1011506) and a grant to EMD from the Netherlands Scientific Organization (NWO; project number 451-080-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Crow JF, 2008, J GENET, V87, P349, DOI 10.1007/s12041-008-0057-8; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Falconer D. S., 1996, INTRO QUANTITATIVE G; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; HAENSZEL W, 1959, J NATL CANCER I, V23, P487; Haile-Mariam M, 2013, J ANIM BREED GENET, V130, P20, DOI 10.1111/j.1439-0388.2013.01001.x; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hill WG, 2012, GENETICS, V190, P1131, DOI 10.1534/genetics.111.135681; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149; KEIGHTLEY PD, 1989, GENETICS, V121, P869; Kemper KE, 2012, HUM MOL GENET, V21, pR45, DOI 10.1093/hmg/dds332; Kendler KS, 2013, MOL PSYCHIATR, V18, P1058, DOI 10.1038/mp.2013.50; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lynch M., 1998, GENETICS ANAL QUANTI; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Petersen L, 2011, SCAND J PUBLIC HEALT, V39, P83, DOI 10.1177/1403494810394714; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rahman I, 2009, TWIN RES HUM GENET, V12, P286, DOI 10.1375/twin.12.3.286; Sham P., 1998, STAT HUMAN GENETICS; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Stringer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027964; Suarez RK, 2012, J EXP BIOL, V215, P2351, DOI 10.1242/jeb.059725; Teucher B, 2007, TWIN RES HUM GENET, V10, P734, DOI 10.1375/twin.10.5.734; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Visscher PM, 2010, HFSP J, V4, P6, DOI 10.2976/1.3292182; Wray Naomi R., 2012, Frontiers in Genetics, V3, P118, DOI 10.3389/fgene.2012.00118; Wright S, 1935, J GENET, V30, P243, DOI 10.1007/BF02982239; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68913	10.1371/journal.pone.0068913	http://dx.doi.org/10.1371/journal.pone.0068913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935903	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200016
J	Dowell, JA; Johnson, JA				Dowell, James A.; Johnson, Jeffrey A.			Mechanisms of Nrf2 Protection in Astrocytes as Identified by Quantitative Proteomics and siRNA Screening	PLOS ONE			English	Article							EXOGENOUS HYDROGEN-PEROXIDE; OXIDATIVE STRESS; HEME OXYGENASE-1; REACTIVE OXYGEN; GLUTATHIONE BIOSYNTHESIS; CONFERRING PROTECTION; ALZHEIMERS-DISEASE; INDUCED APOPTOSIS; PHASE-2 ENZYMES; PEROXIREDOXIN 6	The Nrf2 (NF-E2 related factor 2)-ARE (antioxidant response element) pathway controls a powerful array of endogenous cellular antioxidant systems and is an important pathway in the detoxification of reactive oxygen species (ROS) in the brain. Using a combination of quantitative proteomics and siRNA screening, we have identified novel protective mechanisms of the Nrf2-ARE pathway against oxidative stress in astrocytes. Studies from our lab and others have shown Nrf2 overexpression protects astrocytes from oxidative stress. However, the exact mechanisms by which Nrf2 elicits these effects are unknown. In this study, we show that induction of Nrf2 reduces levels of reactive oxygen species (ROS) produced by various oxidative stressors and results in robust cytoprotection. To identify the enzymes responsible for these effects, we used stable isotope labeling by amino acids in cell culture (SILAC) and quantitative shotgun proteomics to identify 72 Nrf2-regulated proteins in astrocytes. We hypothesized a subset of these proteins might play a critical role in Nrf2 protection. In order to identify these critical proteins, we used bioinformatics to narrow our target list of proteins and then systematically screened each candidate with siRNA to assess the role of each in Nrf2 protection. We screened each target against H2O2, tert-butyl hydroperoxide, and 4-hydroxynonenal and subsequently identified three enzymes-catalase, prostaglandin reductase-1, and peroxiredoxin-6-that are critical for Nrf2-mediated protection in astrocytes.	[Dowell, James A.; Johnson, Jeffrey A.] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53715 USA; [Johnson, Jeffrey A.] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Johnson, Jeffrey A.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Johnson, Jeffrey A.] Univ Wisconsin, Ctr Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Johnson, JA (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53715 USA.	jajohnson@pharmacy.wisc.edu			National Institute of Environmental Health Sciences [NIEHS ES08089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES008089, R01ES008089] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (NIEHS ES08089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AS, 2006, NEUROSCIENCE, V141, P1703, DOI 10.1016/j.neuroscience.2006.05.035; Bell KFS, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/689524; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; Desagher S, 1996, J NEUROSCI, V16, P2553; Dick RA, 2001, J BIOL CHEM, V276, P40803, DOI 10.1074/jbc.M105487200; Dick RA, 2004, J BIOL CHEM, V279, P17269, DOI 10.1074/jbc.M400427200; Dringen R, 1997, BRAIN RES, V759, P67, DOI 10.1016/S0006-8993(97)00233-3; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; El Jamali A, 2010, FREE RADICAL BIO MED, V48, P798, DOI 10.1016/j.freeradbiomed.2009.12.018; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gallagher EP, 2007, TOXICOL IN VITRO, V21, P1365, DOI 10.1016/j.tiv.2007.04.004; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hirrlinger J, 2002, J NEUROCHEM, V82, P635, DOI 10.1046/j.1471-4159.2002.00999.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lavoie S, 2009, J NEUROCHEM, V108, P1410, DOI 10.1111/j.1471-4159.2009.05908.x; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Li J, 2002, J BIOL CHEM, V277, P388, DOI 10.1074/jbc.M109380200; Liddell JR, 2004, NEUROSCI LETT, V364, P164, DOI 10.1016/j.neulet.2004.04.042; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Okimoto Y, 2003, FREE RADICAL BIO MED, V35, P576, DOI 10.1016/S0891-5849(03)00330-7; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; Panahian N, 1999, J NEUROCHEM, V72, P1187; Park JS, 2011, J NEUROCHEM, V119, P909, DOI 10.1111/j.1471-4159.2011.07395.x; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Primiano T, 1996, CARCINOGENESIS, V17, P2291, DOI 10.1093/carcin/17.11.2291; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shah ZA, 2011, NEUROSCIENCE, V180, P248, DOI 10.1016/j.neuroscience.2011.02.031; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Strey CW, 2004, AM J PATHOL, V165, P1701, DOI 10.1016/S0002-9440(10)63426-8; Sumner JB, 1937, SCIENCE, V85, P366, DOI 10.1126/science.85.2206.366; Talalay P, 2004, METHOD ENZYMOL, V382, P355; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Xiao HB, 2011, TOXICOLOGY, V290, P286, DOI 10.1016/j.tox.2011.10.007; Yang Y, 2002, J BIOL CHEM, V277, P49446, DOI 10.1074/jbc.M209372200; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058	71	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70163	10.1371/journal.pone.0070163	http://dx.doi.org/10.1371/journal.pone.0070163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922950	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700150
J	Matsa, LS; Rangaraju, A; Vengaldas, V; Latifi, M; Jahromi, HM; Ananthapur, V; Nallari, P				Matsa, Lova Satyanarayana; Rangaraju, Advithi; Vengaldas, Viswamitra; Latifi, Mona; Jahromi, Hossein Mehraban; Ananthapur, Venkateshwari; Nallari, Pratibha			Haplotypes of NOS3 Gene Polymorphisms in Dilated Cardiomyopathy	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; 5'-FLANKING REGION; COMMON VARIANT; HEART-FAILURE; RISK-FACTOR; GLU298ASP; MUTATION	Dilated Cardiomyopathy (DCM) is characterized by systolic dysfunction, followed by heart failure necessitating cardiac transplantation. The genetic basis is well established by the identification of mutations in sarcomere and cytoskeleton gene/s. Modifier genes and environmental factors are also considered to play a significant role in the variable expression of the disease, hence various mechanisms are implicated and one such mechanism is oxidative stress. Nitric Oxide (NO), a primary physiological transmitter derived from endothelium seems to play a composite role with diverse anti-atherogenic effects as vasodilator. Three functional polymorphisms of endothelial nitric oxide synthase (NOS3) gene viz., T-786C of the 59 flanking region, 27bp VNTR in intron4 and G894T of exon 7 were genotyped to identify their role in DCM. A total of 115 DCM samples and 454 controls were included. Genotyping was carried out by PCR -RFLP method. Allelic and genotypic frequencies were computed in both control & patient groups and appropriate statistical tests were employed. A significant association of TC genotype (T-786C) with an odds ratio of 1.74, (95% CI 1.14 - 2.67, p = 0.01) was observed in DCM. Likewise the GT genotypic frequency of G894T polymorphism was found to be statistically significant (OR 2.10, 95% CI 1.34-3.27, p = 0.0011), with the recessive allele T being significantly associated with DCM (OR 1.64, 95% CI 1.18 - 2.30, p = 0.003). The haplotype carrying the recessive alleles of G894T and T-786C, C4bT was found to exhibit 7 folds increased risk for DCM compared to the controls. Hence C4bT haplotype could be the risk haplotype for DCM. Our findings suggest the possible implication of NOS3 gene in the disease phenotype, wherein NOS3 may be synergistically functioning in DCM associated heart failure via the excessive production of NO in cardiomyocytes resulting in decreased myocardial contractility and systolic dysfunction, a common feature of DCM phenotype.	[Matsa, Lova Satyanarayana; Rangaraju, Advithi; Vengaldas, Viswamitra; Latifi, Mona; Jahromi, Hossein Mehraban; Nallari, Pratibha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Ananthapur, Venkateshwari] Inst Genet & Hosp Genet Dis, Hyderabad, Andhra Pradesh, India	Osmania University	Nallari, P (corresponding author), Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India.	prathinallari@yahoo.com			Indian Council of Medical Research (ICMR), New Delhi; OU-DST-PURSE Program	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); OU-DST-PURSE Program	This work is financially supported by Indian Council of Medical Research (ICMR), New Delhi and OU-DST-PURSE Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2008, FORENS SCI INT-GEN S, V1, P63, DOI 10.1016/j.fsigss.2007.12.001; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Balligand JL, 1997, ARTERIOSCL THROM VAS, V17, P1846, DOI 10.1161/01.ATV.17.10.1846; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Cakir DU, 2010, BIOTECHNOL BIOTEC EQ, V24, P2117, DOI 10.2478/V10133-010-0083-6; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; Doshi AA, 2010, J CARD FAIL, V16, P314, DOI 10.1016/j.cardfail.2009.12.013; Fairchild TA, 2001, J BIOL CHEM, V276, P26674, DOI 10.1074/jbc.M103647200; HABIB F, 1994, LANCET, V344, P371, DOI 10.1016/S0140-6736(94)91402-8; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Lepic E, 2006, AM J PHYSIOL-CELL PH, V291, pC1240, DOI 10.1152/ajpcell.00092.2006; Mcnamara DM, 2009, J CARD FAIL, V15, P191, DOI 10.1016/j.cardfail.2008.10.028; McNamara DM, 2003, CIRCULATION, V107, P1598, DOI 10.1161/01.CIR.0000060540.93836.AA; Nakayama M, 2000, AM J CARDIOL, V86, P628, DOI 10.1016/S0002-9149(00)01041-9; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Ozhan H, 2004, TURK KARDIYOL DERN A, V32, P295; Sandrim VC, 2006, ATHEROSCLEROSIS, V186, P428, DOI 10.1016/j.atherosclerosis.2005.08.003; Satyanarayana ML, 2009, INT J HUM GENET, V9, P263; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Stein B, 1998, J AM COLL CARDIOL, V32, P1179, DOI 10.1016/S0735-1097(98)00399-4; Tiret L, 2000, J AM COLL CARDIOL, V35, P29, DOI 10.1016/S0735-1097(99)00522-7; WANG J, 2002, ARTERIOSCLER THROMB, V22, P1; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785	26	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70523	10.1371/journal.pone.0070523	http://dx.doi.org/10.1371/journal.pone.0070523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923002	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700191
J	Mayr, LM; Cohen, S; Spurrier, B; Kong, XP; Zolla-Pazner, S				Mayr, Luzia M.; Cohen, Sandra; Spurrier, Brett; Kong, Xiang-Peng; Zolla-Pazner, Susan			Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; V1/V2 DOMAIN; NEUTRALIZATION; GP120; ALPHA-4-BETA-7; IDENTIFICATION; GENERATION; INTEGRINS; INFECTION; REGIONS	In the case-control study of the RV144 vaccine trial, the levels of antibodies to the V1V2 region of the gp120 envelope glycoprotein were found to correlate inversely with risk of HIV infection. This recent demonstration of the potential role of V1V2 as a vaccine target has catapulted this region into the focus of HIV-1 research. We previously described seven human monoclonal antibodies (mAbs) derived from HIV-infected individuals that are directed against conformational epitopes in the V1V2 domain. In this study, using lysates of SF162 pseudoviruses carrying V1V2 mutations, we mapped the epitopes of these seven mAbs. All tested mAbs demonstrated a similar binding pattern in which three mutations (F176A, Y177T, and D180L) abrogated binding of at least six of the seven mAbs to <= 15% of SF162 wildtype binding. Binding of six or all of the mAbs was reduced to <= 50% of wildtype by single substitutions at seven positions (168, 180, 181, 183, 184, 191, and 193), while one change, V181I, increased the binding of all mAbs. When mapped onto a model of V2, our results suggest that the epitope of the conformational V2 mAbs is located mostly in the disordered region of the available crystal structure of V1V2, overlapping and surrounding the a4b7 binding site on V2.	[Mayr, Luzia M.; Cohen, Sandra; Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Spurrier, Brett; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University	Zolla-Pazner, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	susan.zolla-pazner@nyumc.org	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Kong, Xiang-Peng/0000-0001-5773-2681	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; NIH [P01 AI100151, R01 HL59725, GM088118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088118] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and by NIH grants P01 AI100151 and R01 HL59725. B. S. was supported by NIH training grant GM088118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, AIDS, V15, pW1; [Anonymous], PLOS PATHOG, V7; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gorny MK, 2000, VIROLOGY, V267, P220, DOI 10.1006/viro.1999.0095; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Israel ZR, 1997, AIDS, V11, P128; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; Liao HX, 2013, IMMUNITY; McKeating JA, 1996, IMMUNOL LETT, V51, P101, DOI 10.1016/0165-2478(96)02562-X; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; SHOTTON C, 1995, J VIROL, V69, P222, DOI 10.1128/JVI.69.1.222-230.1995; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Zeller Y, 2001, J CELL BIOCHEM, V83, P304, DOI 10.1002/jcb.1197; Zhang JX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0390-x; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	39	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70859	10.1371/journal.pone.0070859	http://dx.doi.org/10.1371/journal.pone.0070859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923028	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700211
J	Stemmer, K; Nehrke, G; Brey, T				Stemmer, Kristina; Nehrke, Gernot; Brey, Thomas			Elevated CO2 Levels do not Affect the Shell Structure of the Bivalve Arctica islandica from the Western Baltic	PLOS ONE			English	Article							CONCHOLEPAS-CONCHOLEPAS GASTROPODA; MYTILUS-EDULIS; OCEAN ACIDIFICATION; GROWTH LINES; RESPONSES; RECORDS; TEMPERATURES; CARBONATE; SALINITY; SEAWATER	Shells of the bivalve Arctica islandica are used to reconstruct paleo-environmental conditions (e. g. temperature) via biogeochemical proxies, i.e. biogenic components that are related closely to environmental parameters at the time of shell formation. Several studies have shown that proxies like element and isotope-ratios can be affected by shell growth and microstructure. Thus it is essential to evaluate the impact of changing environmental parameters such as high pCO(2) and consequent changes in carbonate chemistry on shell properties to validate these biogeochemical proxies for a wider range of environmental conditions. Growth experiments with Arctica islandica from the Western Baltic Sea kept under different pCO(2) levels (from 380 to 1120 mu atm) indicate no affect of elevated pCO(2) on shell growth or crystal microstructure, indicating that A. islandica shows an adaptation to a wider range of pCO(2) levels than reported for other species. Accordingly, proxy information derived from A. islandica shells of this region contains no pCO(2) related bias.	[Stemmer, Kristina; Nehrke, Gernot; Brey, Thomas] Helmholtz Assoc, Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Stemmer, K (corresponding author), Helmholtz Assoc, Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Kristina.Stemmer@awi.de		Brey, Thomas/0000-0002-6345-2851; Nehrke, Gernot/0000-0002-2851-3049	bmbf (Bundesministerium fur Bildung und Forschung/Federal Ministry of Education and Research)	bmbf (Bundesministerium fur Bildung und Forschung/Federal Ministry of Education and Research)	This work was funded by the bmbf (Bundesministerium fur Bildung und Forschung/Federal Ministry of Education and Research) in the framework of the project BIOACID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2009, EXP GERONTOL, V44, P307, DOI 10.1016/j.exger.2009.02.012; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Begum S, 2009, J SHELLFISH RES, V28, P533, DOI 10.2983/035.028.0315; Begum S, 2010, J SHELLFISH RES, V29, P107, DOI 10.2983/035.029.0103; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; BREY T, 1990, J EXP MAR BIOL ECOL, V136, P217, DOI 10.1016/0022-0981(90)90162-6; CALDEIRA K, 1991, GEOPHYS RES LETT, V18, P987, DOI 10.1029/91GL01237; Carre M, 2006, GEOCHIM COSMOCHIM AC, V70, P4906, DOI 10.1016/j.gca.2006.07.019; Crenshaw M.A., 1980, Topics in Geobiology, V1, P115; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Cuif J., 2011, BIOMINERALS FOSSILS; Dahlgren TG, 2000, MAR BIOL, V137, P487, DOI 10.1007/s002270000342; Dauphin Y, 2003, AQUAT LIVING RESOUR, V16, P95, DOI 10.1016/S0990-7440(03)00022-6; Dissard D, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002417; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dunca E, 2009, INT J EARTH SCI, V98, P3, DOI 10.1007/s00531-008-0348-6; Epple VM, 2006, HOLOCENE, V16, P763, DOI 10.1191/0959683606hl970rr; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Freitas PS, 2009, BIOGEOSCIENCES, V6, P1209, DOI 10.5194/bg-6-1209-2009; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; Hahn S, 2012, BIOGEOSCIENCES, V9, P1897, DOI 10.5194/bg-9-1897-2012; Hansen HP, 1999, ICES J MAR SCI, V56, P65, DOI 10.1006/jmsc.1999.0629; Hickson JA, 1999, PALAEOGEOGR PALAEOCL, V154, P325, DOI 10.1016/S0031-0182(99)00120-0; Hiebenthal C, 2012, AQUAT BIOL, V14, P289, DOI 10.3354/ab00405; Hiebenthal C, 2013, MAR BIOL, V160, P2073, DOI 10.1007/s00227-012-2080-9; Krause-Nehring J, 2012, MAR POLLUT BULL, V64, P233, DOI 10.1016/j.marpolbul.2011.11.028; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; LUTZ RA, 1982, J MAR BIOL ASSOC UK, V62, P745, DOI 10.1017/S0025315400070314; MANN R, 1982, FISH B-NOAA, V80, P315; Marchitto TM, 2000, QUATERNARY RES, V53, P236, DOI 10.1006/qres.1999.2107; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meibom A, 2004, GEOPHYS RES LETT, P31; Melzner F, 2012, MAR BIOL, DOI [10.1007/s00227-00012-01954-00221, DOI 10.1007/S00227-00012-01954-00221]; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Moran AL, 2000, MAR BIOL, V137, P893, DOI 10.1007/s002270000390; Morton B, 2011, MAR BIOL RES, V7, P540, DOI 10.1080/17451000.2010.535833; NICOL DAVID, 1951, JOUR WASHINGTON ACAD SCI, V41, P102; Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044621; Riascos J, 2007, J SHELLFISH RES, V26, P43, DOI 10.2983/0730-8000(2007)26[43:SOTSTM]2.0.CO;2; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; RIISGARD HU, 1981, MAR BIOL, V61, P227, DOI 10.1007/BF00386664; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; ROPES JW, 1984, FISH B-NOAA, V82, P1; ROPES JW, 1984, MAR FISH REV, V46, P27; Schoene Bernd R., 2003, Senckenbergiana Maritima, V32, P165; Schone BR, 2013, PALAEOGEOGR PALAEOCL, V373, P50, DOI 10.1016/j.palaeo.2011.05.013; Schone BR, 2005, GEOL S AM S, V395, P21, DOI 10.1130/2005.2395(03); Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Schone BR, 2004, PALAEOGEOGR PALAEOCL, V212, P215, DOI 10.1016/j.palaeo.2004.05.024; Strahl J, 2007, AQUAT BIOL, V1, P77, DOI 10.3354/ab00008; Strahl J, 2011, J EXP BIOL, V214, P4223, DOI 10.1242/jeb.055178; Strasser CA, 2008, J EXP MAR BIOL ECOL, V355, P153, DOI 10.1016/j.jembe.2007.12.022; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Tunnicliffe V, 2009, NAT GEOSCI, V2, P344, DOI 10.1038/NGEO500; Wallace Lewis, 1998, BASIC PROGRAM CO2 SY; Wanamaker AD, 2008, CLIM DYNAM, V31, P183, DOI 10.1007/s00382-007-0344-8; Wanamaker AD, 2009, INT J EARTH SCI, V98, P19, DOI 10.1007/s00531-008-0318-z; Wanamaker AD, 2008, RADIOCARBON, V50, P399, DOI 10.1017/S0033822200053510; WEIDMAN CR, 1994, J GEOPHYS RES-OCEANS, V99, P18305, DOI 10.1029/94JC01882; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Wheeler A.P., 1992, P179; Wilbur K.M., 1983, P253	67	22	22	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70106	10.1371/journal.pone.0070106	http://dx.doi.org/10.1371/journal.pone.0070106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922922	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700134
J	Stricker, J; Beckham, Y; Davidson, MW; Gardel, ML				Stricker, Jonathan; Beckham, Yvonne; Davidson, Michael W.; Gardel, Margaret L.			Myosin II-Mediated Focal Adhesion Maturation Is Tension Insensitive	PLOS ONE			English	Article							STRESS FIBERS; FORCE; DYNAMICS; GROWTH; DRIVES	Myosin II motors drive changes in focal adhesion morphology and composition in a "maturation process" that is crucial for regulating adhesion dynamics and signaling guiding cell adhesion, migration and fate. The underlying mechanisms of maturation, however, have been obscured by the intermingled effects of myosin II on lamellar actin architecture, dynamics and force transmission. Here, we show that focal adhesion growth rate stays constant even when cellular tension is reduced by 75%. Focal adhesion growth halts only when myosin stresses are sufficiently low to impair actin retrograde flow. Focal adhesion lifetime is reduced at low levels of cellular tension, but adhesion stability can be rescued at low levels of force by over-expression of alpha-actinin or constitutively active Dia1. Our work identifies a minimal myosin activity threshold that is necessary to drive lamellar actin retrograde flow is sufficient to permit focal adhesion elongation. Above this nominal threshold, myosin-mediated actin organization and dynamics regulate focal adhesion growth and stability in a force-insensitive fashion.	[Stricker, Jonathan; Beckham, Yvonne; Gardel, Margaret L.] Univ Chicago, James Franck Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Stricker, Jonathan; Gardel, Margaret L.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	University of Chicago; University of Chicago; State University System of Florida; Florida State University	Gardel, ML (corresponding author), Univ Chicago, James Franck Inst, Inst Biophys Dynam, 5640 S Ellis Ave, Chicago, IL 60637 USA.	gardel@uchicago.edu	Gardel, Margaret/D-1703-2012		Burroughs Wellcome Career Award; Packard Fellowship; American Asthma Foundation	Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Packard Fellowship(The David & Lucile Packard Foundation); American Asthma Foundation	M.L.G. is supported by a Burroughs Wellcome Career Award, Packard Fellowship and American Asthma Foundation Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2011, MOL BIOL CELL; Aratyn-Schaus Yvonne, 2010, J Vis Exp, DOI 10.3791/2173; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; CHOI CK, 2008, NAT CELL BIOL; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Colombelli J, 2009, J CELL SCI; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; Wehrle-Haller B, 2012, CURRENT OPINION CELL; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	27	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70652	10.1371/journal.pone.0070652	http://dx.doi.org/10.1371/journal.pone.0070652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923013	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700200
J	Tang, JS; Liao, YH; Song, M; Gao, JH; Zhou, B; Tan, CL; Liu, TQ; Tang, YQ; Chen, JD; Chen, XG				Tang, Jinsong; Liao, Yanhui; Song, Ming; Gao, Jia-Hong; Zhou, Bing; Tan, Changlian; Liu, Tieqiao; Tang, Yanqing; Chen, Jindong; Chen, Xiaogang			Aberrant Default Mode Functional Connectivity in Early Onset Schizophrenia	PLOS ONE			English	Article							RESTING-STATE NETWORKS; BOLD SIGNAL; BRAIN; FMRI; DISORDERS; CHILDREN; FLUCTUATIONS; COMPONENTS; ADULTS	Background: The default mode network (DMN) has been linked to a number of mental disorders including schizophrenia. However, the abnormal connectivity of DMN in early onset schizophrenia (EOS) has been rarely reported. Methods: Independent component analysis (ICA) was used to investigate functional connectivity (FC) of the DMN in 32 first-episode adolescents with EOS and 32 age and gender-matched healthy controls. Results: Compared to healthy controls, patients with EOS showed increased FC between the medial frontal gyrus and other areas of the DMN. Partial correlation analyses showed that the FC of medial frontal gyrus significantly correlated with PANSS-positive symptoms (partial correlation coefficient = 0.538, Bonferoni corrected P = 0.018). Limitations: Although the sample size of participants was comparable with most fMRI studies to date, it was still relatively small. Pediatric brains were registered to the MNI adult brain template. However, possible age-specific differences in spatial normalization that arise from registering pediatric brains to the MNI adult brain template may have little effect on fMRI results. Conclusion: This study provides evidence for functional abnormalities of DMN in first-episode EOS. These abnormalities could be a source of abnormal introspectively-oriented mental actives.	[Tang, Jinsong; Liao, Yanhui; Liu, Tieqiao; Chen, Jindong; Chen, Xiaogang] Cent S Univ, Inst Mental Hlth, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Tang, Jinsong; Liao, Yanhui; Liu, Tieqiao; Chen, Jindong; Chen, Xiaogang] Hunan Prov Technol Inst Psychiat, Changsha, Hunan, Peoples R China; [Song, Ming] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Gao, Jia-Hong] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Zhou, Bing; Tan, Changlian] Cent S Univ, Dept Radiol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Tang, Yanqing] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang, Liaoning, Peoples R China; [Chen, Xiaogang] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University; Chinese Academy of Sciences; Institute of Automation, CAS; University of Chicago; Central South University; China Medical University; Central South University	Chen, XG (corresponding author), Cent S Univ, Inst Mental Hlth, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	chenjd269@163.com; chenxghn@gmail.com	Liao, Yanhui/L-1590-2016; liu, tieqiao/GSE-2327-2022	Liao, Yanhui/0000-0003-4735-3252; 	Natural Science Foundation of China [30900486, 81100996, 81271484, 81071099, 81271499]; National Key Basic Research and Development Program (973) [2012CB517904]; Central Colleges basic scientific research operating expenses [2011QNZT170]; Specialized Research Fund for the Doctoral Program of Higher Education [20110162120013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); Central Colleges basic scientific research operating expenses; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Natural Science Foundation of China (Grant No. 30900486 to J.T, 81100996 to Y.L, 81271484 to X. C? 81071099 and 81271499 to Y.T), the National Key Basic Research and Development Program (973) (Grant No. 2012CB517904 to X. C), Central Colleges basic scientific research operating expenses (2011QNZT170 to Y.L), and Specialized Research Fund for the Doctoral Program of Higher Education (20110162120013 to Y.L). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Asarnow RF, 2001, ARCH GEN PSYCHIAT, V58, P581, DOI 10.1001/archpsyc.58.6.581; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; First MB, 2002, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FRITH C, 1995, LANCET, V346, P615, DOI 10.1016/S0140-6736(95)91441-2; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Liemburg EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042707; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mingoia G, 2012, SCHIZOPHR RES, V138, P143, DOI 10.1016/j.schres.2012.01.036; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Paillere-Martinot ML, 2001, SCHIZOPHR RES, V50, P19, DOI 10.1016/S0920-9964(00)00137-7; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Zhao XH, 2007, EUR J RADIOL, V63, P373, DOI 10.1016/j.ejrad.2007.02.006; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029	38	52	53	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71061	10.1371/journal.pone.0071061	http://dx.doi.org/10.1371/journal.pone.0071061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923052	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700224
J	Vaz, GMF; Paszko, E; Davies, AM; Senge, MO				Vaz, Gisela M. F.; Paszko, Edyta; Davies, Anthony M.; Senge, Mathias O.			High Content Screening as High Quality Assay for Biological Evaluation of Photosensitizers In Vitro	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; COLORIMETRIC ASSAY; BILIARY-TRACT; FOSCAN(R); CANCER; PHARMACOKINETICS; LOCALIZATION; ACTIVATION; EXPRESSION; EFFICIENCY	A novel single step assay approach to screen a library of photdynamic therapy (PDT) compounds was developed. Utilizing high content analysis (HCA) technologies several robust cellular parameters were identified, which can be used to determine the phototoxic effects of porphyrin compounds which have been developed as potential anticancer agents directed against esophageal carcinoma. To demonstrate the proof of principle of this approach a small detailed study on five porphyrin based compounds was performed utilizing two relevant esophageal cancer cell lines (OE21 and SKGT-4). The measurable outputs from these early studies were then evaluated by performing a pilot screen using a set of 22 compounds. These data were evaluated and validated by performing comparative studies using a traditional colorimetric assay (MTT). The studies demonstrated that the HCS assay offers significant advantages over and above the currently used methods (directly related to the intracellular presence of the compounds by analysis of their integrated intensity and area within the cells). A high correlation was found between the high content screening (HCS) and MTT data. However, the HCS approach provides additional information that allows a better understanding of the behavior of these compounds when interacting at the cellular level. This is the first step towards an automated high-throughput screening of photosensitizer drug candidates and the beginnings of an integrated and comprehensive quantitative structure action relationship (QSAR) study for photosensitizer libraries.	[Vaz, Gisela M. F.; Paszko, Edyta; Senge, Mathias O.] St James Hosp, Trinity Coll Dublin, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland; [Davies, Anthony M.] St James Hosp, Trinity Coll Dublin, Trinity Ctr Hlth Sci, Dept Clin Med,Inst Mol Med, Dublin, Ireland; [Senge, Mathias O.] Trinity Coll Dublin, Trinity Biomed Sci Inst, SFI Tetrapyrrole Lab, Sch Chem, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Senge, MO (corresponding author), St James Hosp, Trinity Coll Dublin, Trinity Ctr Hlth Sci, Inst Mol Med, Dublin, Ireland.	sengem@tcd.ie	Senge, Mathias O./F-1504-2011	Senge, Mathias O./0000-0002-7467-1654	Science Foundation Ireland [PI 09/IN.1/B2650]; Fundacao da Ciencia e Tecnologia [SFRH/BD/62364/2009]; Health Research Board (HRB Translational Research Award) [2007 TRA/2007/11]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fundacao da Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Health Research Board (HRB Translational Research Award)	This work was supported by grants from Science Foundation Ireland (PI 09/IN.1/B2650), Fundacao da Ciencia e Tecnologia (Grant SFRH/BD/62364/2009), and the Health Research Board (HRB Translational Research Award 2007 TRA/2007/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2004, ANN SURG, V239, P491, DOI 10.1097/01.sla.0000118751.95179.c6; Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Abraham VC, 2008, J BIOMOL SCREEN, V13, P527, DOI 10.1177/1087057108318428; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; Barbaric I, 2011, J BIOMOL SCREEN, V16, P603, DOI 10.1177/1087057111406547; BERENBAUM MC, 1986, BRIT J CANCER, V54, P717, DOI 10.1038/bjc.1986.232; BONNETT R, 1989, BIOCHEM J, V261, P277, DOI 10.1042/bj2610277; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; CARMICHAEL J, 1987, CANCER RES, V47, P936; DOUGHERTY TJ, 1993, PHOTOCHEM PHOTOBIOL, V58, P895, DOI 10.1111/j.1751-1097.1993.tb04990.x; Dove A, 2003, NAT BIOTECHNOL, V21, P859, DOI 10.1038/nbt0803-859; Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492; Duggan SP, 2006, CARCINOGENESIS, V27, P319, DOI 10.1093/carcin/bgi211; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Fayter D, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14370; Feest C, 2009, THESIS HUMBOLDT U BE; Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522; Freeley M, 2010, J BIOMOL SCREEN, V15, P541, DOI 10.1177/1087057110369703; FRISOLI JK, 1993, CANCER RES, V53, P5954; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Helmy IM, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-15; Henderson BW, 1997, CANCER RES, V57, P4000; Hitt E, 2003, LANCET ONCOL, V4, P136, DOI 10.1016/S1470-2045(03)01012-X; Huang YY, 2010, J MED CHEM, V53, P4018, DOI 10.1021/jm901908s; Kalayda GV, 2005, J BIOL INORG CHEM, V10, P305, DOI 10.1007/s00775-005-0643-7; Kiesslich T, 2007, PHOTOCH PHOTOBIO SCI, V6, P619, DOI 10.1039/b617659c; Lassalle HP, 2008, J PHOTOCH PHOTOBIO B, V92, P47, DOI 10.1016/j.jphotobiol.2008.04.007; Lieggi NT, 2010, TOXICOL IN VITRO, V24, P2063, DOI 10.1016/j.tiv.2010.07.014; Marchal S, 2007, BRIT J CANCER, V96, P944, DOI 10.1038/sj.bjc.6603631; Martin C, 2003, BRIT J CANCER, V89, P1581, DOI 10.1038/sj.bjc.6601300; Morgan DML, 1998, TETR MTT ASS CELL VI; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nyman ES, 2004, J PHOTOCH PHOTOBIO B, V73, P1, DOI 10.1016/j.jphotobiol.2003.10.002; Paszko E, 2013, EUR J PHARM SCI, V48, P202, DOI 10.1016/j.ejps.2012.10.018; Ramirez CN, 2011, ASSAY DRUG DEV TECHN, V9, P247, DOI 10.1089/adt.2010.0342; Rockett JC, 1997, BRIT J CANCER, V75, P258, DOI 10.1038/bjc.1997.42; Senge MO, 2012, PHOTODIAGN PHOTODYN, V9, P170, DOI 10.1016/j.pdpdt.2011.10.001; Senge MO, 2011, PHOTOCHEM PHOTOBIOL, V87, P1240, DOI 10.1111/j.1751-1097.2011.00986.x; Senge MO, 2010, EUR J ORG CHEM, V2010, P237, DOI 10.1002/ejoc.200901113; Shun TY, 2011, J BIOMOL SCREEN, V16, P1, DOI 10.1177/1087057110389039; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Teiten MH, 2003, BRIT J CANCER, V88, P146, DOI 10.1038/sj.bjc.6600664; Thomas S, 2011, TOXICOL LETT, V205, pS177, DOI 10.1016/j.toxlet.2011.05.616; Wiehe A, 2005, TETRAHEDRON, V61, P5535, DOI 10.1016/j.tet.2005.03.086; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011	49	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70653	10.1371/journal.pone.0070653	http://dx.doi.org/10.1371/journal.pone.0070653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923014	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700201
J	Dhami, MK; Weir, BS; Taylor, MW; Beggs, JR				Dhami, Manpreet K.; Weir, Bevan S.; Taylor, Michael W.; Beggs, Jacqueline R.			Diverse Honeydew-Consuming Fungal Communities Associated with Scale Insects	PLOS ONE			English	Article							NEW-ZEALAND FUNGI; SOOTY MOLDS; TREES; IDENTIFICATION; BASIDIOMYCOTA; EVOLUTION; PROFILES; SOIL	Sooty mould fungi are ubiquitous, abundant consumers of insect-honeydew that have been little-studied. They form a complex of unrelated fungi that coexist and compete for honeydew, which is a chemically complex resource. In this study, we used scanning electron microscopy in combination with T-RFLP community profiling and ITS-based tag-pyrosequencing to extensively describe the sooty mould community associated with the honeydews of two ecologically important New Zealand coelostomidiid scale insects, Coelostomidia wairoensis and Ultracoelostoma brittini. We tested the influence of host plant on the community composition of associated sooty moulds, and undertook limited analyses to examine the influence of scale insect species and geographic location. We report here a previously unknown degree of fungal diversity present in this complex, with pyrosequencing detecting on average 243 operational taxonomic units across the different sooty mould samples. In contrast, T-RFLP detected only a total of 24 different "species'' (unique peaks). Nevertheless, both techniques identified similar patterns of diversity suggesting that either method is appropriate for community profiling. The composition of the microbial community associated with individual scale insect species varied although the differences may in part reflect variation in host preference and site. Scanning electron microscopy visualised an intertwined mass of fungal hyphae and fruiting bodies in near-intact physical condition, but was unable to distinguish between the different fungal communities on a morphological level, highlighting the need for molecular research. The substantial diversity revealed for the first time by pyrosequencing and our inability to identify two-thirds of the diversity to further than the fungal division highlights the significant gap in our knowledge of these fungal groups. This study provides a first extensive look at the community diversity of the fungal community closely associated with the keystone insect-honeydew systems of New Zealand's native forests and suggests there is much to learn about sooty mould communities.	[Dhami, Manpreet K.; Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand; [Dhami, Manpreet K.; Taylor, Michael W.; Beggs, Jacqueline R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Weir, Bevan S.] Landcare Res, Auckland, New Zealand	University of Auckland; University of Auckland; Landcare Research - New Zealand	Dhami, MK (corresponding author), Univ Auckland, Sch Biol Sci, Ctr Microbial Innovat, Auckland 1, New Zealand.	manpreet.dhami@mpi.govt.nz	Beggs, Jacqueline R/I-3796-2014; Weir, Bevan/B-5057-2008	Beggs, Jacqueline R/0000-0002-2112-2803; Weir, Bevan/0000-0003-2580-0701; Taylor, Michael/0000-0002-0463-7813; Dhami, Manpreet K./0000-0002-8956-0674	University of Auckland International Doctoral Scholarship; University of Auckland Faculty Development Research Fund [9841 3624443]	University of Auckland International Doctoral Scholarship; University of Auckland Faculty Development Research Fund	Funding was provided to MKD through the University of Auckland International Doctoral Scholarship and to MWT and JRB through the University of Auckland Faculty Development Research Fund (Grant number 9841 3624443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Avis PG, 2006, MOL ECOL, V15, P873, DOI 10.1111/j.1365-294X.2005.02842.x; BARONIURBANI C, 1980, OECOLOGIA, V44, P287, DOI 10.1007/BF00545229; Beggs JR, 2006, ECOL STU AN, V186, P281; Beggs JR, 2005, NEW ZEAL J ECOL, V29, P105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chomnunti P, 2012, MYCOLOGIA, V104, P382, DOI 10.3852/11-066; Chomnunti P, 2011, FUNGAL DIVERS, V51, P103, DOI 10.1007/s13225-011-0145-6; Dhami MK, 2012, FEMS MICROBIOL ECOL, V81, P537, DOI 10.1111/j.1574-6941.2012.01378.x; Dhami MK, 2011, J CHEM ECOL, V37, P1231, DOI 10.1007/s10886-011-0030-5; Dickie IA, 2002, NEW PHYTOL, V156, P527, DOI 10.1046/j.1469-8137.2002.00535.x; Don RR, 1971, TAXON, V20, P759; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fischer MK, 2002, J INSECT PHYSIOL, V48, P319, DOI 10.1016/S0022-1910(01)00179-2; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Fitzjohn RG, 2007, MOL ECOL NOTES, V7, P583, DOI 10.1111/j.1471-8286.2007.01744.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC; Hazen K. C., 2006, Manual of clinical microbiology: Volume 2, P1762; Hughes S, 1981, NZ FUNGI, V28; HUGHES S. J., 1951, TRANS BRIT MYCOL SOC, V34, P551; HUGHES S J, 1972, New Zealand Journal of Botany, V10, P225; HUGHES SJ, 1976, MYCOLOGIA, V68, P693, DOI 10.2307/3758799; Hughes SJ, 2003, NEW ZEAL J BOT, V41, P139, DOI 10.1080/0028825X.2003.9512834; Hughes SJ, 2001, MYCOLOGIA, V93, P603, DOI 10.2307/3761742; HUGHES SJ, 1981, NEW ZEAL J BOT, V19, P193, DOI 10.1080/0028825X.1981.10425120; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koide RT, 2005, NEW PHYTOL, V166, P251, DOI 10.1111/j.1469-8137.2004.01313.x; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lazera MS, 1996, J MED VET MYCOL, V34, P127; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McKenzie EHC, 2000, NEW ZEAL J BOT, V38, P635; Mibey Richard K., 1997, World Crop Pests, V7A, P275; Millanes AM, 2012, LICHENOLOGIST, V44, P321, DOI 10.1017/S0024282911000788; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Morales CF, 1991, FAUNA NZ; Mwenje E, 2001, CAN J BOT, V79, P1492, DOI 10.1139/cjb-79-12-1492; Nieves-Rivera AM, 2002, ARBORICULTURAL J, V26, P141; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2010, R LANG ENV STAT COMP; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Van Sickle John, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P370; WARCUP JH, 1988, NEW PHYTOL, V110, P227, DOI 10.1111/j.1469-8137.1988.tb00256.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	47	22	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70316	10.1371/journal.pone.0070316	http://dx.doi.org/10.1371/journal.pone.0070316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922978	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900166
J	Wang, CH; Wang, SS; Ko, WJ; Chen, YS; Chang, CY; Chang, RW; Chang, KC				Wang, Chih-Hsien; Wang, Shoei-Shen; Ko, Wen-Je; Chen, Yih-Sharng; Chang, Chun-Yi; Chang, Ru-Wen; Chang, Kuo-Chu			Acetyl-L-Carnitine and Oxfenicine on Cardiac Pumping Mechanics in Streptozotocin-Induced Diabetes in Male Wistar Rats	PLOS ONE			English	Article							LIPID-DERIVED MALONDIALDEHYDE; SINGLE-BEAT ESTIMATION; LEFT-VENTRICLE; SUBSTRATE METABOLISM; SYSTOLIC ELASTANCE; HEART; PRESSURE; VOLUME; PERFORMANCE; RESISTANCE	Introduction: In the treatment of patients with diabetes, one objective is an improvement of cardiac metabolism to alleviate the left ventricular (LV) function. For this study, we compared the effects of acetyl-L-carnitine (one of the carnitine derivatives) and of oxfenicine (a carnitine palmitoyltransferase-1 inhibitor) on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats, with a particular focus on the pressure-flow-volume relationship. Methods: Diabetes was induced by a single tail vein injection of 55 mg kg(-1) streptozotocin. The diabetic animals were treated on a daily basis with either acetyl-L-carnitine (1 g L-1 in drinking water) or oxfenicine (150 mg kg(-1) by oral gavage) for 8 wk. They were also compared with untreated age-matched diabetic controls. LV pressure and ascending aortic flow signals were recorded to calculate the maximal systolic elastance (E-max) and the theoretical maximum flow (Q(max)). Physically, E-max reflects the contractility of the myocardium as an intact heart, whereas Q(max) has an inverse relationship with the LV internal resistance. Results: When comparing the diabetic rats with their age-matched controls, the cardiodynamic condition was characterized by a decline in E-max associated with the unaltered Q(max). Acetyl-L-carnitine (but not oxfenicine) had reduced cardiac levels of malondialdehyde in these insulin-deficient animals. However, treating with acetyl-L-carnitine or oxfenicine resulted in an increase in E-max, which suggests that these 2 drugs may protect the contractile status from deteriorating in the diabetic heart. By contrast, Q(max) showed a significant fall after administration of oxfenicine, but not with acetyl-L-carnitine. The decrease in Q(max) corresponded to an increase in total vascular resistance when treated with oxfenicine. Conclusions: Acetyl-L-carnitine, but not oxfencine, optimizes the integrative nature of cardiac pumping mechanics by preventing the diabetes-induced deterioration in myocardial intrinsic contractility associated with unaltered LV internal resistance.	[Wang, Chih-Hsien; Wang, Shoei-Shen; Chen, Yih-Sharng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Ko, Wen-Je; Chang, Ru-Wen] Natl Taiwan Univ Hosp, Dept Surg & Traumatol, Taipei, Taiwan; [Chang, Chun-Yi] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Wang, Chih-Hsien; Chang, Kuo-Chu] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, KC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei, Taiwan.	kcchang1008@ntu.edu.tw		CHANG, KUO-CHU/0000-0002-4421-5711; Chen, Yih-Sharng/0000-0003-3846-8162; Wang, Shoei-Shen/0000-0003-3201-4143; WANG, CHIH-HSIEN/0000-0003-3214-6867	National Science Council of Taiwan [NSC 97-2320-B-002-040-MY3]; National Taiwan University Hospital, Hsin-Chu Branch [HCH-100-02, HCH-101-19]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Hsin-Chu Branch	This study was supported by grants from the National Science Council of Taiwan (NSC 97-2320-B-002-040-MY3) and National Taiwan University Hospital, Hsin-Chu Branch (HCH-100-02 and HCH-101-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN E, 1988, PHARMACOLOGY, V36, P238, DOI 10.1159/000138390; BARNEA O, 1990, IEEE T BIO-MED ENG, V37, P109, DOI 10.1109/10.43623; Bergman G, 1980, Eur Heart J, V1, P247; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; CAMPBELL KB, 1986, AM J PHYSIOL, V251, pH382, DOI 10.1152/ajpheart.1986.251.2.H382; Chang KC, 1997, J THEOR BIOL, V189, P89, DOI 10.1006/jtbi.1997.0498; Chang KC, 1998, J THEOR BIOL, V194, P409, DOI 10.1006/jtbi.1998.0773; Chang KC, 2002, EXP BIOL MED, V227, P251, DOI 10.1177/153537020222700405; Chang KC, 2010, EUR J CLIN INVEST, V40, P1002, DOI 10.1111/j.1365-2362.2010.02358.x; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dennis JE, 1987, MICROCOMPUTERS LARGE, P116; DILLMANN WH, 1980, DIABETES, V29, P579, DOI 10.2337/diab.29.7.579; Fernandez E, 1989, Neurol Res, V11, P57; Folden DV, 2003, BRIT J PHARMACOL, V139, P1310, DOI 10.1038/sj.bjp.0705384; HUNTER WC, 1983, CIRC RES, V52, P319, DOI 10.1161/01.RES.52.3.319; Lee L, 2004, EUR HEART J, V25, P634, DOI 10.1016/j.ehj.2004.02.018; Liu JK, 2004, ANN NY ACAD SCI, V1033, P117, DOI 10.1196/annals.1320.011; Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b; MALHOTRA A, 1981, CIRC RES, V49, P1243, DOI 10.1161/01.RES.49.6.1243; Malone JI, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-2; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mingorance C, 2011, VASC HEALTH RISK MAN, V7, P169, DOI 10.2147/VHRM.S14356; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; PAULSON DJ, 1992, CURRENT CONCEPTS IN CARNITINE RESEARCH, P215; PENPARGKUL S, 1981, J MOL CELL CARDIOL, V13, P303, DOI 10.1016/0022-2828(81)90318-7; Rice JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1734, DOI 10.1152/ajpheart.1999.276.5.H1734; RODRIGUES B, 1995, J MOL CELL CARDIOL, V27, P169, DOI 10.1016/S0022-2828(08)80016-8; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; RODRIGUES B, 1992, CARDIOVASC RES, V26, P913, DOI 10.1093/cvr/26.10.913; RODRIGUES B, 1988, DIABETES, V37, P1358, DOI 10.2337/diabetes.37.10.1358; Rupp H, 2002, HERZ, V27, P621, DOI 10.1007/s00059-002-2428-x; SCHINETTI ML, 1987, DRUG EXP CLIN RES, V13, P509; SHROFF SG, 1983, AM J PHYSIOL, V245, pH110, DOI 10.1152/ajpheart.1983.245.1.H110; Shroff SG, 1992, HEART CARDIOVASCULAR, P129; Slatter DA, 1999, J BIOL CHEM, V274, P19661, DOI 10.1074/jbc.274.28.19661; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Stanley WC, 1997, CARDIOVASC RES, V34, P25, DOI 10.1016/S0008-6363(97)00047-3; Stanley William C., 2004, Journal of Cardiovascular Pharmacology and Therapeutics, V9, pS31, DOI 10.1177/107424840400900104; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; SUNAGAWA K, 1980, IEEE T BIO-MED ENG, V27, P299, DOI 10.1109/TBME.1980.326737; TAKEUCHI M, 1991, CIRCULATION, V83, P202, DOI 10.1161/01.CIR.83.1.202; Turcani M, 1997, CIRCULATION, V96, P3681; Turpeinen AK, 2000, CLIN AUTON RES, V10, P13, DOI 10.1007/BF02291384; Vitale C, 2008, CURR PHARM DESIGN, V14, P2537, DOI 10.2174/138161208786071281; WEISS JL, 1976, J CLIN INVEST, V58, P751, DOI 10.1172/JCI108522; Wu MS, 2008, BRIT J PHARMACOL, V154, P758, DOI 10.1038/bjp.2008.119; Wu MS, 2012, EXP GERONTOL, V47, P680, DOI 10.1016/j.exger.2012.06.006; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zarain-Herzberg A, 2002, EXPERT OPIN INV DRUG, V11, P345	51	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69977	10.1371/journal.pone.0069977	http://dx.doi.org/10.1371/journal.pone.0069977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922880	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900128
J	Kostrzewa, G; Broda, G; Konarzewska, M; Krajewki, P; Ploski, R				Kostrzewa, Grazyna; Broda, Grazyna; Konarzewska, Magdalena; Krajewki, Pawel; Ploski, Rafal			Genetic Polymorphism of Human Y Chromosome and Risk Factors for Cardiovascular Diseases: A Study in WOBASZ Cohort	PLOS ONE			English	Article							BLOOD-PRESSURE; GENERAL-POPULATION; AROMATASE GENE; ASSOCIATION; HYPERTENSION; MEN; VARIANTS; HEIGHT; ORIGIN; RATS	Genetic variants of Y chromosome predispose to hypertension in rodents, whereas in humans the evidence is conflicting. Our purpose was to study the distribution of a panel of Y chromosome markers in a cohort from a cross-sectional population-based study on the prevalence of cardiovascular risk factors in Poland (WOBASZ study). The HindIII, YAP Y chromosome variants, previously shown to influence blood pressure, lipid traits or height, as well as SNPs defining main Y chromosome haplogroups, were typed in 3026, 2783 and 2652 samples, respectively. In addition, 4 subgroups (N similar to 100 each) representing extremes of LDL concentration or blood pressure (BP) were typed for a panel of 17 STRs. The HindIII and YAP polymorphism were not associated with any of the studied traits. Analysis of the haplogroup distribution showed an association between higher HDL level and hg I-M170 (P = 0.02), higher LDL level and hg F*(xl-M170, J2-M172, K-M9) (P = 0.03) and lower BMI and hg N3-Tat (P = 0.04). Analysis of STRs did not show statistically significant differences. Since all these associations lost statistical significance after Bonferroni correction, we conclude that a major role of Y chromosome genetic variation (defined by HindIII, YAP or main Y chromosome haplogroups) in determining cardiovascular risk in Poles is unlikely.	[Kostrzewa, Grazyna; Konarzewska, Magdalena; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Broda, Grazyna] Inst Cardiol, Dept Cardiovasc Epidemiol & Prevent, Warsaw, Poland; [Krajewki, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland	Medical University of Warsaw; Institute of Cardiology - Poland; Medical University of Warsaw	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Konarzewska, Magdalena/X-1648-2018	Konarzewska, Magdalena/0000-0003-0124-0535; krajewski, Pawel/0000-0001-8352-4077; Ploski, Rafal/0000-0001-6286-5526	Ministry of Science and Higher Education [N404 032 31/1892]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by Ministry of Science and Higher Education Grant N404 032 31/1892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broda G, 2005, KARDIOLOGIA POLSK S4, V63, P604; Charchar FJ, 2004, ARTERIOSCL THROM VAS, V24, P308, DOI 10.1161/01.ATV.0000113291.39267.0a; Charchar FJ, 2002, HYPERTENSION, V39, P353, DOI 10.1161/hy0202.103413; Chromosome Consortium Y, 2002, GENOME RES, V12, P339; DAVIDSON AO, 1995, HYPERTENSION, V26, P452, DOI 10.1161/01.HYP.26.3.452; Ellis JA, 2000, HYPERTENSION, V36, P731, DOI 10.1161/01.HYP.36.5.731; Ellis JA, 2001, J CLIN ENDOCR METAB, V86, P4147, DOI 10.1210/jc.86.9.4147; Ely Daniel, 2009, BMC Physiology, V9, P10, DOI 10.1186/1472-6793-9-10; ELY DL, 1990, HYPERTENSION, V16, P277, DOI 10.1161/01.HYP.16.3.277; Garcia EC, 2003, AM J MED GENET A, V122A, P234, DOI 10.1002/ajmg.a.20376; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hiura Y, 2008, HYPERTENS RES, V31, P1687, DOI 10.1291/hypres.31.1687; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kittler R, 2003, EUR J HUM GENET, V11, P304, DOI 10.1038/sj.ejhg.5200960; Kostrzewa G, 2008, MOL GENET METAB, V94, P259, DOI 10.1016/j.ymgme.2008.02.003; Kreutz R, 1996, HYPERTENSION, V28, P895, DOI 10.1161/01.HYP.28.5.895; Ploski R, 2002, HUM GENET, V110, P592, DOI 10.1007/s00439-002-0728-0; Rodriguez S, 2005, HUM GENET, V116, P311, DOI 10.1007/s00439-004-1221-8; Russo P, 2006, AM J HYPERTENS, V19, P331, DOI 10.1016/j.amjhyper.2005.10.003; Russo P, 2008, ARTERIOSCL THROM VAS, V28, P1569, DOI 10.1161/ATVBAHA.108.168641; Rywik S, 2005, POL POPUL REV, V27, P37; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Shankar RR, 2007, AM J HYPERTENS, V20, P27, DOI 10.1016/j.amjhyper.2006.06.013; Shoji M, 2002, HYPERTENS RES, V25, P1, DOI 10.1291/hypres.25.1; Turner ME, 2009, HYPERTENSION, V53, P430, DOI 10.1161/HYPERTENSIONAHA.108.124131; Uehara Y, 1998, J HUM HYPERTENS, V12, P441, DOI 10.1038/sj.jhh.1000646; Weedon MN, 2003, CLIN ENDOCRINOL, V59, P175, DOI 10.1046/j.1365-2265.2003.01797.x	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68155	10.1371/journal.pone.0068155	http://dx.doi.org/10.1371/journal.pone.0068155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935855	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300005
J	Ma, ZH; Moruzzi, N; Catrina, SB; Hals, I; Oberholzer, J; Grill, V; Bjorklund, A				Ma, Zuheng; Moruzzi, Noah; Catrina, Sergiu-Bogdan; Hals, Ingrid; Oberholzer, Jose; Grill, Valdemar; Bjorklund, Anneli			Preconditioning with Associated Blocking of Ca2+ Inflow Alleviates Hypoxia-Induced Damage to Pancreatic beta-Cells	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; ISLET TRANSPLANTATION; INSULIN-SECRETION; GENE-EXPRESSION; IN-VITRO; B-CELLS; RAT; GLUCOSE; ATP; DIAZOXIDE	Objective: Beta cells of pancreatic islets are susceptible to functional deficits and damage by hypoxia. Here we aimed to characterize such effects and to test for and pharmacological means to alleviate a negative impact of hypoxia. Methods and Design: Rat and human pancreatic islets were subjected to 5.5 h of hypoxia after which functional and viability parameters were measured subsequent to the hypoxic period and/or following a 22 h re-oxygenation period. Preconditioning with diazoxide or other agents was usually done during a 22 h period prior to hypoxia. Results: Insulin contents decreased by 23% after 5.5 h of hypoxia and by 61% after a re-oxygenation period. Preconditioning with diazoxide time-dependently alleviated these hypoxia effects in rat and human islets. Hypoxia reduced proinsulin biosynthesis (H-3-leucine incorporation into proinsulin) by 35%. Preconditioning counteracted this decrease by 91%. Preconditioning reduced hypoxia-induced necrosis by 40%, attenuated lowering of proteins of mitochondrial complexes I-IV and enhanced stimulation of HIF-1-alpha and phosphorylated AMPK proteins. Preconditioning by diazoxide was abolished by co-exposure to tolbutamide or elevated potassium (i.e. conditions which increase Ca2+ inflow). Preconditioning with nifedipine, a calcium channel blocker, partly reproduced effects of diazoxide. Both diazoxide and nifedipine moderately reduced basal glucose oxidation whereas glucose-induced oxygen consumption (tested with diazoxide) was unaffected. Preconditioning with diaxoxide enhanced insulin contents in transplants of rat islets to nondiabetic rats and lowered hyperglycemia vs. non-preconditioned islets in streptozotocin-diabetic rats. Preconditioning of human islet transplants lowered hyperglycemia in streptozotocin-diabetic nude mice. Conclusions: 1) Prior blocking of Ca2+ inflow associates with lesser hypoxia-induced damage, 2) preconditioning affects basal mitochondrial metabolism and accelerates activation of hypoxia-reactive and potentially protective factors, 3) results indicate that preconditioning by K+-ATP-channel openers has therapeutic potential for islet transplantations.	[Ma, Zuheng; Moruzzi, Noah; Catrina, Sergiu-Bogdan; Grill, Valdemar; Bjorklund, Anneli] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hals, Ingrid; Grill, Valdemar] Norwegian Univ Sci & Technol, Fac Med, Inst Canc Res & Mol Med, N-7034 Trondheim, Norway; [Oberholzer, Jose] Univ Illinois, Dept Transplant Surg, Chicago, IL USA; [Grill, Valdemar] St Olavs Univ Hosp, Dept Endocrinol, N-7006 Trondheim, Norway	Karolinska Institutet; Norwegian University of Science & Technology (NTNU); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Norwegian University of Science & Technology (NTNU)	Bjorklund, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	anneli.bjorklund@ki.se	Moruzzi, Noah/M-9869-2014; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Moruzzi, Noah/AAC-8875-2019	Catrina, Sergiu/0000-0002-6914-3902; Moruzzi, Noah/0000-0001-6868-1488; Ma, Zuheng/0000-0003-1186-9396	Swedish Research Council; Swedish Society of Medicine; Norwegian Diabetes Association; EFSD/MSD grant; Chicago Diabetes Project; University of Illinois College of Medicine; National Institutes of Health [R01DK091526]; Integrated Islet Distribution Program [HHSN276200900006C]; Funds of Karolinska Institutet; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091526] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Norwegian Diabetes Association; EFSD/MSD grant; Chicago Diabetes Project; University of Illinois College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Islet Distribution Program; Funds of Karolinska Institutet; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Swedish Research Council, the Swedish Society of Medicine, Funds of Karolinska Institutet, the Norwegian Diabetes Association and an EFSD/MSD grant. This work was partially funded by the Chicago Diabetes Project and the University of Illinois College of Medicine. JO is supported by National Institutes of Health R01DK091526 and the Integrated Islet Distribution Program HHSN276200900006C. Guarantor is Anneli Bjorklund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORKLUND A, 1993, ENDOCRINOLOGY, V132, P1319, DOI 10.1210/en.132.3.1319; Bjorklund A, 2004, DIABETOLOGIA, V47, P885, DOI 10.1007/s00125-004-1386-7; Bjorklund A, 2000, DIABETES, V49, P1840, DOI 10.2337/diabetes.49.11.1840; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; DAWSON CM, 1986, HORM METAB RES, V18, P221, DOI 10.1055/s-2007-1012278; DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12; Grimmsmann T, 1998, BRIT J PHARMACOL, V123, P781, DOI 10.1038/sj.bjp.0701663; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hughes SJ, 2003, TRANSPLANTATION, V75, P1954, DOI 10.1097/01.TP.0000066805.39716.23; Juang JH, 2002, CELL TRANSPLANT, V11, P95; KEEN H, 1963, METABOLISM, V12, P143; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo JF, 2012, ANAL CHEM, V84, P1987, DOI 10.1021/ac2030909; Ma ZH, 2007, DIABETES, V56, P1095, DOI 10.2337/db06-0322; Niwa K, 1996, BIOL SIGNAL, V5, P30; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Sakata N, 2010, PEDIATR DIABETES, V11, P471, DOI 10.1111/j.1399-5448.2009.00629.x; Sandberg M, 2007, MOL CELL ENDOCRINOL, V277, P35, DOI 10.1016/j.mce.2007.07.007; Sandler S, 2008, BIOCHEM PHARMACOL, V76, P1748, DOI 10.1016/j.bcp.2008.09.004; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Taylor JT, 2005, AM J PHYSIOL-ENDOC M, V289, pE900, DOI 10.1152/ajpendo.00101.2005; Vaithilingam V, 2010, AM J TRANSPLANT, V10, P1961, DOI 10.1111/j.1600-6143.2010.03209.x; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	34	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e67498	10.1371/journal.pone.0067498	http://dx.doi.org/10.1371/journal.pone.0067498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935835	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300002
J	Mullins, EA; Sullivan, KL; Kappock, TJ				Mullins, Elwood A.; Sullivan, Kelly L.; Kappock, T. Joseph			Function and X-Ray crystal structure of Escherichia coli YfdE	PLOS ONE			English	Article							FORMYL-COA TRANSFERASE; MULTIPLE SEQUENCE ALIGNMENTS; COENZYME-A DECARBOXYLASE; OXALYL-COENZYME; ACID RESISTANCE; OXALOBACTER-FORMIGENES; MYCOBACTERIUM-TUBERCULOSIS; GENOME ANNOTATION; GENE-EXPRESSION; OXALATE CONTENT	Many food plants accumulate oxalate, which humans absorb but do not metabolize, leading to the formation of urinary stones. The commensal bacterium Oxalobacter formigenes consumes oxalate by converting it to oxalyl-CoA, which is decarboxylated by oxalyl-CoA decarboxylase (OXC). OXC and the class III CoA-transferase formyl-CoA: oxalate CoA-transferase (FCOCT) are widespread among bacteria, including many that have no apparent ability to degrade or to resist external oxalate. The EvgA acid response regulator activates transcription of the Escherichia coli yfdXWUVE operon encoding YfdW (FCOCT), YfdU (OXC), and YfdE, a class III CoA-transferase that is similar to 30% identical to YfdW. YfdW and YfdU are necessary and sufficient for oxalate-induced protection against a subsequent acid challenge; neither of the other genes has a known function. We report the purification, in vitro characterization, 2.1-angstrom crystal structure, and functional assignment of YfdE. YfdE and UctC, an orthologue from the obligate aerobe Acetobacter aceti, perform the reversible conversion of acetylCoA and oxalate to oxalyl-CoA and acetate. The annotation of YfdE as acetyl-CoA: oxalate CoA-transferase (ACOCT) expands the scope of metabolic pathways linked to oxalate catabolism and the oxalate-induced acid tolerance response. FCOCT and ACOCT active sites contain distinctive, conserved active site loops (the glycine-rich loop and the GNxH loop, respectively) that appear to encode substrate specificity.	[Mullins, Elwood A.; Sullivan, Kelly L.; Kappock, T. Joseph] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Mullins, Elwood A.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Washington University (WUSTL)	Kappock, TJ (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	kappock@purdue.edu	Kappock, T. Joseph/AAZ-4150-2020	Kappock, T. Joseph/0000-0002-6819-6826; Mullins, Elwood/0000-0003-3834-1065	National Science Foundation [MCB 0936108]; Purdue University Agricultural Research Programs	National Science Foundation(National Science Foundation (NSF)); Purdue University Agricultural Research Programs	This work was supported by National Science Foundation grant MCB 0936108 and Purdue University Agricultural Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Azcarate-Peril MA, 2006, APPL ENVIRON MICROB, V72, P1891, DOI 10.1128/AEM.72.3.1891-1899.2006; BAETZ AL, 1990, J BACTERIOL, V172, P3537, DOI 10.1128/jb.172.7.3537-3540.1990; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berthold CL, 2008, J BIOL CHEM, V283, P6519, DOI 10.1074/jbc.M709353200; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KL, 2005, J BIOL CHEM, V280, P16550, DOI 10.1074/jbc.M411898200; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontenot EM, 2013, J BACTERIOL, V195, P1446, DOI 10.1128/JB.01936-12; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Fried L, 2013, J BACTERIOL, V195, P807, DOI 10.1128/JB.02051-12; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gruez A, 2003, J BIOL CHEM, V278, P34582, DOI 10.1074/jbc.C300282200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Honow R, 2002, FOOD CHEM, V78, P511, DOI 10.1016/S0308-8146(02)00212-1; JAKOBY WB, 1956, J BIOL CHEM, V222, P435; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jonsson S, 2004, J BIOL CHEM, V279, P36003, DOI 10.1074/jbc.M404873200; KASAI T, 1963, J GEN APPL MICROBIOL, V9, P49, DOI 10.2323/jgam.9.49; Lee KS, 2006, PROTEINS, V64, P817, DOI 10.1002/prot.21029; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; LUNG HY, 1994, J BACTERIOL, V176, P2468, DOI 10.1128/JB.176.8.2468-2472.1994; Lykidis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009729; Maeda T, 2007, APPL MICROBIOL BIOT, V76, P1035, DOI 10.1007/s00253-007-1086-6; Massey LK, 2001, J AGR FOOD CHEM, V49, P4262, DOI 10.1021/jf010484y; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mullins E.A., 2013, ACETIC ACID BACTERIA, V2, pe3, DOI [10.4081/aab.2013.s1.e3, DOI 10.4081/AAB.2013.S1.E3]; Mullins EA, 2008, J BACTERIOL, V190, P4933, DOI 10.1128/JB.00405-08; Mullins EA, 2012, PROTEIN SCI, V21, P686, DOI 10.1002/pro.2054; NAGY PL, 1993, J BACTERIOL, V175, P7066, DOI 10.1128/jb.175.21.7066-7073.1993; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; NYGAARD P, 1993, J BACTERIOL, V175, P3591, DOI 10.1128/jb.175.11.3591-3597.1993; Oglesby AG, 2005, MOL MICROBIOL, V58, P1354, DOI 10.1111/j.1365-2958.2005.04920.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; QUAYLE JR, 1963, BIOCHEM J, V89, P492, DOI 10.1042/bj0890492; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; RUAN ZS, 1992, J BIOL CHEM, V267, P10537; Savolainen K, 2005, J BIOL CHEM, V280, P12611, DOI 10.1074/jbc.M409704200; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; Schneider K, 2012, J BACTERIOL, V194, P3144, DOI 10.1128/JB.00288-12; Sidhu H, 1997, J BACTERIOL, V179, P3378, DOI 10.1128/jb.179.10.3378-3381.1997; Sidhu H, 2001, J UROLOGY, V166, P1487, DOI 10.1016/S0022-5347(05)65817-X; Sidhu H, 1999, J AM SOC NEPHROL, V10, pS334; Siener R, 2006, J AGR FOOD CHEM, V54, P3008, DOI 10.1021/jf052776v; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Toyota CG, 2008, J BACTERIOL, V190, P2556, DOI 10.1128/JB.01823-07; Turroni S, 2007, J APPL MICROBIOL, V103, P1600, DOI 10.1111/j.1365-2672.2007.03388.x; Turroni S, 2010, APPL ENVIRON MICROB, V76, P5609, DOI 10.1128/AEM.00844-10; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; WHITEHEAD TR, 1988, J BACTERIOL, V170, P995, DOI 10.1128/jb.170.2.995-997.1988; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	74	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67901	10.1371/journal.pone.0067901	http://dx.doi.org/10.1371/journal.pone.0067901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935849	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000022
J	Rimsa, V; Eadsforth, TC; Hunter, WN				Rimsa, Vadim; Eadsforth, Thomas C.; Hunter, William N.			Structure of the SCAN Domain of Human Paternally Expressed Gene 3 Protein	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-IIIA; ZINC-BINDING DOMAINS; DNA-BINDING; POZ DOMAIN; MOTIF; PEG3; BOX; SUBFAMILY; ALIGNMENT; DEFINES	Human paternally expressed gene 3 protein (PEG3) is a large multi-domain entity with diverse biological functions, including acting as a transcription factor. PEG3 contains twelve Cys(2)-His(2) type zinc finger domains, extended regions of predicted disorder and at the N-terminus a SCAN domain. PEG3 has been identified as partner of the E3 ubiquitin-protein ligase Siah1, an association we sought to investigate. An efficient bacterial recombinant expression system of the human PEG3-SCAN domain was prepared and crystals appeared spontaneously when the protein was being concentrated after purification. The structure was determined at 1.95 angstrom resolution and reveals a polypeptide fold of five helices in an extended configuration. An extensive dimerization interface, using almost a quarter of the solvent accessible surface, and key salt bridge interactions explain the stability of the dimer. Comparison with other SCAN domains reveals a high degree of conservation involving residues that contribute to the dimer interface. The PEG3-SCAN domain appears to constitute an assembly block, enabling PEG3 homo-or heterodimerization to control gene expression in a combinatorial fashion.	[Rimsa, Vadim; Eadsforth, Thomas C.; Hunter, William N.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee	Hunter, WN (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	w.n.hunter@dundee.ac.uk	Hunter, William/AAE-3947-2019		AstraZeneca	AstraZeneca(AstraZeneca)	This study was partly funded by AstraZeneca by way of contributing to a studentship for VR. Dr. Derek Ogg (Astra Zeneca) provided excellent support and Dr. Navratna Vajpai (Astra Zeneca) ran the NMR experiment. There are no patents, products in development or marketed products to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Champagne FA, 2009, BEHAV NEUROSCI, V123, P469, DOI 10.1037/a0015060; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinas ML, 1999, J BIOL CHEM, V274, P16461, DOI 10.1074/jbc.274.23.16461; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Ivanov D, 2005, MOL CELL, V17, P137, DOI 10.1016/j.molcel.2004.12.015; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Liang Y, 2012, NUCLEIC ACIDS RES, V40, P8721, DOI 10.1093/nar/gks611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noll L, 2008, LEUKEMIA RES, V32, P1582, DOI 10.1016/j.leukres.2008.03.024; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Peterson FC, 2006, J MOL BIOL, V363, P137, DOI 10.1016/j.jmb.2006.07.063; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Sander TL, 2003, GENE, V310, P29, DOI 10.1016/S0378-1119(03)00509-2; Sander TL, 2000, J BIOL CHEM, V275, P12857, DOI 10.1074/jbc.275.17.12857; Schrodinger L., PYMOL MOL GRAPHICS S; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Swaney WT, 2007, P NATL ACAD SCI USA, V104, P6084, DOI 10.1073/pnas.0609471104; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P22143, DOI 10.1074/jbc.270.38.22143; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162	48	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69538	10.1371/journal.pone.0069538	http://dx.doi.org/10.1371/journal.pone.0069538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936039	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000132
J	Wang, MH; Marinotti, O; Zhong, DB; James, AA; Walker, E; Guda, T; Kweka, EJ; Githure, J; Yan, GY				Wang, Mei-Hui; Marinotti, Osvaldo; Zhong, Daibin; James, Anthony A.; Walker, Edward; Guda, Tom; Kweka, Eliningaya J.; Githure, John; Yan, Guiyun			Gene Expression-Based Biomarkers for Anopheles gambiae Age Grading	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; MALARIA TRANSMISSION; IMPREGNATED BEDNETS; MOSQUITO AGE; DIPTERA; MICROARRAY; CULICIDAE	Information on population age structure of mosquitoes under natural conditions is fundamental to the understanding of vectorial capacity and crucial for assessing the impact of vector control measures on malaria transmission. Transcriptional profiling has been proposed as a method for predicting mosquito age for Aedes and Anopheles mosquitoes, however, whether this new method is adequate for natural conditions is unknown. This study tests the applicability of transcriptional profiling for age-grading of Anopheles gambiae, the most important malaria vector in Africa. The transcript abundance of two An. gambiae genes, AGAP009551 and AGAP011615, was measured during aging under laboratory and field conditions in three mosquito strains. Age-dependent monotonic changes in transcript levels were observed in all strains evaluated. These genes were validated as age-grading biomarkers using the mark, release and recapture (MRR) method. The MRR method determined a good correspondence between actual and predicted age, and thus demonstrated the value of age classifications derived from the transcriptional profiling of these two genes. The technique was used to establish the age structure of mosquito populations from two malaria-endemic areas in western Kenya. The population age structure determined by the transcriptional profiling method was consistent with that based on mosquito parity. This study demonstrates that the transcription profiling method based on two genes is valuable for age determination of natural mosquitoes, providing a new approach for determining a key life history trait of malaria vectors.	[Wang, Mei-Hui; Zhong, Daibin; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Wang, Mei-Hui] UCI Med Ctr, Chao Family Comprehens Canc Ctr, Orange, CA USA; [Marinotti, Osvaldo; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Walker, Edward] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Guda, Tom; Githure, John] ICIPE, Human Hlth Div, Nairobi, Kenya; [Kweka, Eliningaya J.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Arusha, Tanzania	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Michigan State University; International Centre of Insect Physiology & Ecology (ICIPE); Kenya Medical Research Institute	Yan, GY (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu	Zhong, Daibin/GRF-0564-2022	Marinotti, Osvaldo/0000-0002-7173-7160; Kweka, Eliningaya/0000-0002-8891-758X; James, Anthony/0000-0001-5577-3308	National Institutes of Health [R01 AI050243, R21 AI078463]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078463, R01AI050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by grants from the National Institutes of Health (R01 AI050243 and R21 AI078463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 1993, MOSQUITO ECOLOGY FIE; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; BEIER JC, 2002, VECTOR ANAL, V72, P95; Bradshaw WE, 2010, J BIOL RHYTHM, V25, P155, DOI 10.1177/0748730410365656; Caputo B, 2005, J MASS SPECTROM, V40, P1595, DOI 10.1002/jms.961; Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Damos Petros, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/123405; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; Gillies M.T., 1987, PUBLICATION S AFRICA, V55; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; Louis C., 1997, MOL BIOL INSECT DIS, P2, DOI DOI 10.1126/science.1241800; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Md. Shahin Mia, 2012, Journal of Environmental Science and Technology, V5, P1; Menge DM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-44; MEYERDIRK D E, 1979, Southwestern Entomologist, V4, P325; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Polovodova V., 1949, MED PARASITOL, V28, P352; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Sarkar S, 2004, ENVIRON POLLUT, V127, P183, DOI 10.1016/j.envpol.2003.08.005; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Southwood T.R.E., 1978, ECOLOGICAL METHODS, V2nd ed., DOI 10.1007/978-94-015-7291-0; Sylla M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-365; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; Warrell DA., 2002, ESSENTIAL MALARIOLOG; *WHO, 1992, ENT FIELD TECHN MA 2; World Health Organization (WHO), 1992, ENT FIELD TECHN MA 1; Yang GJ, 2010, GEOSPATIAL HEALTH, V5, P11, DOI 10.4081/gh.2010.183	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69439	10.1371/journal.pone.0069439	http://dx.doi.org/10.1371/journal.pone.0069439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936017	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000121
J	Wu, CC; Chuang, YT; Hsu, YT; Huang, JT; Wu, TC; Hung, CF; Yang, YC; Chang, CL				Wu, Chao-Chih; Chuang, Yin-Ting; Hsu, Yun-Ting; Huang, Jung-Tang; Wu, T. -C; Hung, Chien-Fu; Yang, Yuh-Cheng; Chang, Chih-Long			Intra-Peritoneal Hyperthermia Combining alpha-Galactosylceramide in the Treatment of Ovarian Cancer	PLOS ONE			English	Article							INTRAPERITONEAL CHEMOTHERAPY HIPEC; TUMOR-CELLS; KRN7000; NKT; INDUCTION; PREVENTS; MICE	The purpose of this study was to investigate the anti-tumor effect and potential mechanisms of i.p. hyperthermia in combination with alpha-galactosylceramide (alpha-GalCer) for the treatment of ovarian cancer. In this study, immuno-competent tumor models were established using murine ovarian cancer cell lines and treated with i.p. hyperthermia combining alpha-GalCer. Th1/Th2 cytokine expression profiles in the serum, NK cell cytotoxicity and phagocytic activities of dendritic cells (DCs) were assayed. We also analyzed the number of CD8(+)/IFN-gamma(+) tumor specific cytotoxic T cells, as well as the tumor growth based on depletion of lymphocyte sub-population. Therapeutic effect on those ovarian tumors was monitored by a non-invasive luminescent imaging system. Intra-peritoneal hyperthermia induced significant pro-inflammatory cytokines expression, and sustained the response of NK and DCs induced by alpha-GalCer treatment. The combination treatment enhanced the cytotoxic T lymphocyte (CTL) immune response in two mouse ovarian cancer models. This novel treatment modality by combination of hyperthermia and glycolipid provides a pronounced anti-tumor immune response and better survival. In conclusion, intra-peritoneal hyperthermia enhanced the pro-inflammatory cytokine secretion and phagocytic activity of DCs stimulated by alpha-GalCer. The subsequent CTL immune response induced by alpha-GalCer was further strengthened by combining with i.p. hyperthermia. Both innate and adaptive immunities were involved and resulted in a superior therapeutic effect in treating the ovarian cancer.	[Wu, Chao-Chih; Huang, Jung-Tang] Natl Taipei Univ Technol, Grad Inst Mech & Elect Engn, Taipei 106, Taiwan; [Chang, Chih-Long] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Chang, Chih-Long] Mackay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan; [Chuang, Yin-Ting; Yang, Yuh-Cheng; Chang, Chih-Long] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Wu, Chao-Chih; Hsu, Yun-Ting] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wu, T. -C; Hung, Chien-Fu] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Wu, T. -C; Hung, Chien-Fu] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Wu, T. -C; Hung, Chien-Fu] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA; [Wu, T. -C; Hung, Chien-Fu] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA	National Taipei University of Technology; Mackay Medical College; Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chang, CL (corresponding author), Mackay Med Coll, Dept Med, New Taipei City, Taiwan.	clchang@mmc.edu.tw	Chang, Chih-Long/AAJ-8784-2020	Chang, Chih-Long/0000-0003-3981-9366	Taiwan National Science Council [NSC 98-2314-B-195-008-MY3]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from Taiwan National Science Council (NSC 98-2314-B-195-008-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Di Giorgio A, 2008, CANCER-AM CANCER SOC, V113, P315, DOI 10.1002/cncr.23553; Dickson J A, 1982, Natl Cancer Inst Monogr, V61, P183; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Guerbet M, 2007, EJSO-EUR J SURG ONC, V33, P623, DOI 10.1016/j.ejso.2007.02.027; Hayakawa Y, 2003, P NATL ACAD SCI USA, V100, P9464, DOI 10.1073/pnas.1630663100; Helm CW, 2009, ONCOLOGIST, V14, P683, DOI 10.1634/theoncologist.2008-0275; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Inoue H, 1997, EXP HEMATOL, V25, P935; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Knippertz I, 2011, INT J HYPERTHER, V27, P591, DOI 10.3109/02656736.2011.589234; Kobayashi E, 2012, CANC EPIDEMIOL BIOMA; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Mukhopadhaya A, 2007, CANCER RES, V67, P7798, DOI 10.1158/0008-5472.CAN-07-0203; Nakagawa R, 1998, ONCOL RES, V10, P561; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; RASMUSSEN L, 1982, ENVIRON HEALTH PERSP, V43, P21, DOI 10.2307/3429163; SCHEIN PS, 1975, ANN INTERN MED, V82, P84, DOI 10.7326/0003-4819-82-1-84; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shimizu K, 2007, J IMMUNOL, V178, P2853, DOI 10.4049/jimmunol.178.5.2853; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Srivastava PK, 2006, CURR OPIN IMMUNOL, V18, P201, DOI 10.1016/j.coi.2006.01.009; Van Ruth S, 2003, ANTICANCER RES, V23, P1501; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69336	10.1371/journal.pone.0069336	http://dx.doi.org/10.1371/journal.pone.0069336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935988	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000103
J	Yang, ZM; Huang, DQ; Tang, WQ; Zheng, Y; Liang, KJ; Cutler, AJ; Wu, WR				Yang, Zemao; Huang, Daiqing; Tang, Weiqi; Zheng, Yan; Liang, Kangjing; Cutler, Adrian J.; Wu, Weiren			Mapping of Quantitative Trait Loci Underlying Cold Tolerance in Rice Seedlings via High-Throughput Sequencing of Pooled Extremes	PLOS ONE			English	Article							RECOMBINANT INBRED LINES; MAJOR QTL; SEGREGANT ANALYSIS; BOOTING STAGE; IDENTIFICATION; JAPONICA; GENES	Low temperature is a major limiting factor in rice growth and development. Mapping of quantitative trait loci (QTLs) controlling cold tolerance is important for rice breeding. Recent studies have suggested that bulked segregant analysis (BSA) combined with next-generation sequencing (NGS) can be an efficient and cost-effective way for QTL mapping. In this study, we employed NGS-assisted BSA to map QTLs conferring cold tolerance at the seedling stage in rice. By deep sequencing of a pair of large DNA pools acquired from a very large F3 population (10,800 individuals), we obtained similar to 450,000 single nucleotide polymorphisms (SNPs) after strict screening. We employed two statistical methods for QTL analysis based on these SNPs, which yielded consistent results. Six QTLs were mapped on chromosomes 1, 2, 5, 8 and 10. The three most significant QTLs on chromosomes 1, 2 and 8 were validated by comparison with previous studies. Two QTLs on chromosomes 2 and 5 were also identified previously, but at the booting stage rather than the seedling stage, suggesting that some QTLs may function at different developmental stages, which would be useful for cold tolerance breeding in rice. Compared with previously reported QTL mapping studies for cold tolerance in rice based on the traditional approaches, the results of this study demonstrated the advantages of NGS-assisted BSA in both efficiency and statistical power.	[Yang, Zemao; Wu, Weiren] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Daiqing; Cutler, Adrian J.] Natl Res Council Canada, Saskatoon, SK, Canada; [Tang, Weiqi; Zheng, Yan; Liang, Kangjing; Wu, Weiren] Fujian Agr & Forestry Univ, Key Lab Minist Educ Genet Breeding & Multiple Uti, Fuzhou, Fujian, Peoples R China	Zhejiang University; National Research Council Canada; Fujian Agriculture & Forestry University	Cutler, AJ (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	Cutler@nrc-cnrc.gc.ca; wuwr@zju.edu.cn						Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Andaya VC, 2007, MOL BREEDING, V20, P349, DOI 10.1007/s11032-007-9096-8; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; DILDAY RH, 1990, CROP SCI, V30, P905, DOI 10.2135/cropsci1990.0011183X003000040030x; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Han Longzhi, 2007, Journal of Genetics and Genomics, V34, P239, DOI 10.1016/S1673-8527(07)60025-3; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jiang L, 2008, J CEREAL SCI, V48, P173, DOI 10.1016/j.jcs.2007.08.013; Koseki M, 2010, MOL GENET GENOMICS, V284, P45, DOI 10.1007/s00438-010-0548-1; Kumar A, 2005, ENG LIFE SCI, V5, P215, DOI 10.1002/elsc.200420075; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Suh JP, 2012, EUPHYTICA, V184, P101, DOI 10.1007/s10681-011-0575-y; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Wang ZF, 2011, EUPHYTICA, V181, P405, DOI 10.1007/s10681-011-0469-z; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Yoshida S, 1976, INT RICE RES INS PHI, P61; Zhang ZH, 2005, PLANT SCI, V168, P527, DOI 10.1016/j.plantsci.2004.09.021	37	207	218	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68433	10.1371/journal.pone.0068433	http://dx.doi.org/10.1371/journal.pone.0068433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935868	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200009
J	Alvarez, TM; Goldbeck, R; dos Santos, CR; Paixao, DAA; Goncalves, TA; Cairo, JPLF; Almeida, RF; Pereira, ID; Jackson, G; Cota, J; Buchli, F; Citadini, AP; Ruller, R; Polo, CC; Neto, MD; Murakami, MT; Squina, FM				Alvarez, Thabata M.; Goldbeck, Rosana; dos Santos, Camila Ramos; Paixao, Douglas A. A.; Goncalves, Thiago A.; Franco Cairo, Joao Paulo L.; Almeida, Rodrigo Ferreira; Pereira, Isabela de Oliveira; Jackson, George; Cota, Junio; Buechli, Fernanda; Citadini, Ana Paula; Ruller, Roberto; Polo, Carla Cristina; Neto, Mario de Oliveira; Murakami, Mario T.; Squina, Fabio M.			Development and Biotechnological Application of a Novel Endoxylanase Family GH10 Identified from Sugarcane Soil Metagenome	PLOS ONE			English	Article							XYLANASE GENE; MECHANISMS; EXPRESSION; LIBRARY; CLONING; XYLOOLIGOSACCHARIDES; RESOLUTION; DIVERSITY; PRODUCT; ENZYMES	Metagenomics has been widely employed for discovery of new enzymes and pathways to conversion of lignocellulosic biomass to fuels and chemicals. In this context, the present study reports the isolation, recombinant expression, biochemical and structural characterization of a novel endoxylanase family GH10 (SCXyl) identified from sugarcane soil metagenome. The recombinant SCXyl was highly active against xylan from beechwood and showed optimal enzyme activity at pH 6,0 and 45 degrees C. The crystal structure was solved at 2.75 angstrom resolution, revealing the classical (beta/alpha)(8)-barrel fold with a conserved activesite pocket and an inherent flexibility of the Trp281-Arg291 loop that can adopt distinct conformational states depending on substrate binding. The capillary electrophoresis analysis of degradation products evidenced that the enzyme displays unusual capacity to degrade small xylooligosaccharides, such as xylotriose, which is consistent to the hydrophobic contacts at the +1 subsite and low-binding energies of subsites that are distant from the site of hydrolysis. The main reaction products from xylan polymers and phosphoric acid-pretreated sugarcane bagasse (PASB) were xylooligosaccharides, but, after a longer incubation time, xylobiose and xylose were also formed. Moreover, the use of SCXyl as pre-treatment step of PASB, prior to the addition of commercial cellulolytic cocktail, significantly enhanced the saccharification process. All these characteristics demonstrate the advantageous application of this enzyme in several biotechnological processes in food and feed industry and also in the enzymatic pretreatment of biomass for feedstock and ethanol production.	[Alvarez, Thabata M.; Goldbeck, Rosana; Paixao, Douglas A. A.; Goncalves, Thiago A.; Franco Cairo, Joao Paulo L.; Almeida, Rodrigo Ferreira; Pereira, Isabela de Oliveira; Jackson, George; Cota, Junio; Buechli, Fernanda; Citadini, Ana Paula; Ruller, Roberto; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [Alvarez, Thabata M.; Goncalves, Thiago A.; Franco Cairo, Joao Paulo L.; Buechli, Fernanda] Univ Estadual Campinas UNICAMP, Dept Bioquim, IB, Campinas, SP, Brazil; [dos Santos, Camila Ramos; Polo, Carla Cristina; Murakami, Mario T.] CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Neto, Mario de Oliveira] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual Paulista	Murakami, MT (corresponding author), CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br; fabio.squina@bioetanol.org.br	Squina, Fabio/J-8130-2012; Goldbeck, Rosana/D-7610-2014; Goldbeck, Rosana/AAI-1635-2021; Neto, Mario Oliveira/F-2717-2013; Büchli, Fernanda/M-8633-2018; Murakami, Mario T/F-5640-2016; Cota, Junio/J-7475-2012; Cairo, João Paulo L Franco/A-3423-2013; Murakami, Mario T/C-2087-2012; Alvarez, Thabata/G-4117-2014; Santos, Camila Ramos dos/F-7095-2013; Ruller, ROBERTO/D-1260-2014	Squina, Fabio/0000-0002-8154-7459; Goldbeck, Rosana/0000-0003-2953-8050; Goldbeck, Rosana/0000-0003-2953-8050; Murakami, Mario T/0000-0002-0405-8010; Cota, Junio/0000-0002-1547-4087; Cairo, João Paulo L Franco/0000-0002-4744-3111; de Oliveira Pereira, Isabela/0000-0002-8902-3115; Santos, Camila Ramos dos/0000-0003-0652-4211; Ruller, Roberto/0000-0001-7501-5176; Ruller, ROBERTO/0000-0002-5087-9493; Goncalves, Thiago Augusto/0000-0001-6526-905X; Oliveira Neto, Mario/0000-0002-6226-7419; Polo, Carla Cristina/0000-0003-2245-7258	FAPESP [2008/58037-9, 2010/11469-1, 2012/18559-5, 2011/20977-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was financially supported by FAPESP: 2008/58037-9 (FMS), 2010/11469-1 (TMA), 2012/18559-5 (RG), 2011/20977-3 (JPLFC) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnard D, 2010, ENVIRON TECHNOL, V31, P871, DOI 10.1080/09593331003710236; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng FS, 2012, J AGR FOOD CHEM, V60, P12516, DOI 10.1021/jf302337w; Cota J, 2011, BIOCHEM BIOPH RES CO, V406, P590, DOI 10.1016/j.bbrc.2011.02.098; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Souza AP, 2013, BIOENERG RES, V6, P564, DOI 10.1007/s12155-012-9268-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Franco PF, 2004, BIOTECHNOL APPL BIOC, V40, P255, DOI 10.1042/BA20030161; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Han SO, 2004, J BACTERIOL, V186, P8347, DOI 10.1128/JB.186.24.8347-8355.2004; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hu Y, 2008, APPL MICROBIOL BIOT, V80, P823, DOI 10.1007/s00253-008-1636-6; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jeong YS, 2012, APPL BIOCHEM BIOTECH, V166, P1328, DOI 10.1007/s12010-011-9520-8; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leresche JE, 2006, ORG PROCESS RES DEV, V10, P572, DOI 10.1021/op0600308; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mo XC, 2010, APPL MICROBIOL BIOT, V87, P2137, DOI 10.1007/s00253-010-2712-2; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos CR, 2010, BIOCHEM BIOPH RES CO, V403, P214, DOI 10.1016/j.bbrc.2010.11.010; Sheehan J, 1999, BIOTECHNOL PROGR, V15, P817, DOI 10.1021/bp990110d; Shi H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-26; Squina FM, 2009, PROTEIN EXPRES PURIF, V68, P65, DOI 10.1016/j.pep.2009.06.014; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Vazquez MJ, 2000, TRENDS FOOD SCI TECH, V11, P387, DOI 10.1016/S0924-2244(01)00031-0; Verma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052459; Wang FC, 2009, MICROBIOL RES, V164, P650, DOI 10.1016/j.micres.2008.12.002; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Winkelhausen E, 1998, J FERMENT BIOENG, V86, P1, DOI 10.1016/S0922-338X(98)80026-3; Xing MN, 2012, BIOTECHNOL ADV, V30, P920, DOI 10.1016/j.biotechadv.2012.01.021; Zaldivar J, 2001, APPL MICROBIOL BIOT, V56, P17, DOI 10.1007/s002530100624; Zhang GM, 2007, APPL MICROBIOL BIOT, V74, P339, DOI 10.1007/s00253-006-0648-3	45	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70014	10.1371/journal.pone.0070014	http://dx.doi.org/10.1371/journal.pone.0070014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922891	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700119
J	Cao, JM; Geng, L; Wu, QH; Wang, W; Chen, QJ; Lu, L; Shen, WF; Chen, Y				Cao, Jiumei; Geng, Liang; Wu, Qihong; Wang, Wei; Chen, Qiujing; Lu, Lin; Shen, Weifeng; Chen, Ying			Spatiotemporal Expression of Matrix Metalloproteinases (MMPs) is Regulated by the Ca2+-Signal Transducer S100A4 in the Pathogenesis of Thoracic Aortic Aneurysm	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MARFAN-SYNDROME; METASTASIS; CELLS; MODEL; INFLAMMATION; DISSECTIONS; INVOLVEMENT; DOXYCYCLINE; INHIBITORS	Aims: This study investigated whether S100A4 plays a potential role in the formation of thoracic aortic aneurysm (TAA). Methods and Results: The thoracic aortas of male Sprague-Dawley rats were exposed to 0.5 M CaCl2 or normal saline (NaCl). Animals were euthanized at specified time-points (2, 4, and 10 weeks post-TAA induction). The treated aortic segments were harvested, and mRNA levels, protein expressions and immunohistochemistry of MMP-2, MMP-9 and S100A4 were analyzed. The A7r5 cell lines were used for an in vitro study. Experiments were also performed using human TAA samples for comparison. Localized aneurysmal dilation was observed in the CaCl2-treated segments. The transcription levels of S100A4 and MMPs were elevated in CaCl2-treated segments versus controls, and a significant correlation between S100A4 and expression of MMPs was observed across all time-points. Immunohistochemical studies revealed similar expression pattern of S100A4 and MMP proteins, as well as co-localization of S100A4 with the cell lineage markers (alpha SMA and CD68) and inflammatory markers (MMPs and NF-kappa B P65 subunit). The proliferative ability of A7r5 cells after transfection with S100A4 siRNA was suppressed, and down-regulation of S100A4 inhibited MMP-2 and MMP-9 expression in vitro. Increased expression of S100A4 was observed in all layers of the aorta wall in human TAA specimens. Serum concentrations of S100A4 determined by ELISA were found to be significantly increased in TAA patients. Conclusions: This study established the important roles of S100A4 and MMPs in the development of TAA.	[Cao, Jiumei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Geratol, Shanghai 200030, Peoples R China; [Cao, Jiumei; Geng, Liang; Wu, Qihong; Wang, Wei; Chen, Qiujing; Lu, Lin; Shen, Weifeng; Chen, Ying] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Chen, Ying] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China.	cybest@hotmail.com			National Natural Science Foundation of China [30971211, 81170284]; Shanghai Pujiang Project [12PJ1406200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Project(Shanghai Pujiang Program)	This work was supported by the National Natural Science Foundation of China (30971211, 81170284), Shanghai Pujiang Project (12PJ1406200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bjornland K, 1999, CANCER RES, V59, P4702; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Brisset AC, 2007, CIRC RES, V100, P1055, DOI 10.1161/01.RES.0000262654.84810.6c; Cao JM, 2010, HUM MOL GENET, V19, P1908, DOI 10.1093/hmg/ddq066; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; ENGELKAMP D, 1992, BIOCHEMISTRY-US, V31, P10258, DOI 10.1021/bi00157a012; Geng LA, 2010, EXP MOL PATHOL, V89, P72, DOI 10.1016/j.yexmp.2010.05.006; Greenway S, 2004, AM J PATHOL, V164, P253, DOI 10.1016/S0002-9440(10)63115-X; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Jones JA, 2006, J VASC SURG, V44, P1314, DOI 10.1016/j.jvs.2006.07.042; Klingelhofer J, 2007, ARTHRITIS RHEUM-US, V56, P779, DOI 10.1002/art.22398; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Oslejskova L, 2008, ANN RHEUM DIS, V67, P1499, DOI 10.1136/ard.2007.079905; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Schmidt-Hansen B, 2004, ONCOGENE, V23, P5487, DOI 10.1038/sj.onc.1207720; Segura AM, 1998, CIRCULATION, V98, pII331; Senolt L, 2006, ANN RHEUM DIS, V65, P1645, DOI 10.1136/ard.2005.047704; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Zhang XM, 2009, VASCULAR, V17, P147, DOI 10.2310/6670.2008.00087	26	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70057	10.1371/journal.pone.0070057	http://dx.doi.org/10.1371/journal.pone.0070057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922901	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700125
J	Dai, J; Brooks, Y; Lefort, K; Getsios, S; Dotto, GP				Dai, Jun; Brooks, Yang; Lefort, Karine; Getsios, Spiro; Dotto, G. Paolo			The Retinoid-Related Orphan Receptor ROR alpha Promotes Keratinocyte Differentiation via FOXN1	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; TERMINAL DIFFERENTIATION; NUCLEAR RECEPTOR; CHOLESTEROL SULFATE; HUMAN EPIDERMIS; STEM-CELLS; SKIN; NOTCH; GENE; EXPRESSION	ROR alpha is a retinoid-related orphan nuclear receptor that regulates inflammation, lipid metabolism, and cellular differentiation of several non-epithelial tissues. In spite of its high expression in skin epithelium, its functions in this tissue remain unclear. Using gain- and loss-of-function approaches to alter ROR alpha gene expression in human keratinocytes (HKCs), we have found that this transcription factor functions as a regulator of epidermal differentiation. Among the 4 ROR alpha isoforms, ROR alpha 4 is prominently expressed by keratinocytes in a manner that increases with differentiation. In contrast, ROR alpha levels are significantly lower in skin squamous cell carcinoma tumors (SCCs) and cell lines. Increasing the levels of ROR alpha 4 in HKCs enhanced the expression of structural proteins associated with early and late differentiation, as well as genes involved in lipid barrier formation. Gene silencing of ROR alpha impaired the ability of keratinocytes to differentiate in an in vivo epidermal cyst model. The pro-differentiation function of ROR alpha is mediated at least in part by FOXN1, a well-known pro-differentiation transcription factor that we establish as a novel direct target of ROR alpha in keratinocytes. Our results point to ROR alpha as a novel node in the keratinocyte differentiation network and further suggest that the identification of ROR alpha ligands may prove useful for treating skin disorders that are associated with abnormal keratinocyte differentiation, including cancer.	[Dai, Jun; Brooks, Yang; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Lefort, Karine] Univ Lausanne Hosp, Dept Dermatol, Epalinges, Switzerland; [Getsios, Spiro] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Harvard University; Massachusetts General Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Northwestern University; Feinberg School of Medicine; University of Lausanne	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA.	Paolo.Dotto@unil.ch	Dai, Jun/J-9718-2015		National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [K01 AR062132, R01 AR039190, AR054856]; Swiss National Science Foundation [3100A0-122281/1, CRSI33-130576/1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039190, K01AR062132, R01AR054856, F32AR059471, R01AR062110, P30AR057216] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) (K01 AR062132 to J.D. and R01 AR039190 and AR054856 to G. P. D.) and by the Swiss National Science Foundation (Grant 3100A0-122281/1; CRSI33-130576/1) to G. P. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; Akiyama M, 2006, J DERMATOL SCI, V42, P83, DOI 10.1016/j.jdermsci.2006.01.003; Baxter RM, 2002, J INVEST DERMATOL, V118, P303, DOI 10.1046/j.0022-202x.2001.01662.x; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Corsini E, 2003, J INVEST DERMATOL, V121, P337, DOI 10.1046/j.1523-1747.2003.12371.x; Crumbley C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033804; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fitzsimmons RL, 2012, J STEROID BIOCHEM, V130, P159, DOI 10.1016/j.jsbmb.2011.06.009; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Hanyu O, 2012, BIOCHEM BIOPH RES CO, V428, P99, DOI 10.1016/j.bbrc.2012.10.013; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hu B, 2012, CELL, V149, P1207, DOI 10.1016/j.cell.2012.03.048; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Krieg P, 2012, J INVESTIGATIVE DERM; Kuroki T, 2000, MUTAT RES-REV MUTAT, V462, P189, DOI 10.1016/S1383-5742(00)00036-3; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Mandinova A, 2009, J CLIN INVEST, V119, P3127, DOI 10.1172/JCI38543; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Pace-Asciak CR, 2009, BRIT J PHARMACOL, V158, P972, DOI 10.1111/j.1476-5381.2009.00168.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schmuth M, 2008, J LIPID RES, V49, P499, DOI 10.1194/jlr.R800001-JLR200; Scott CA, 2012, CELL TISSUE RES; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Simpson CL, 2010, METHODS MOL BIOL, V585, P127, DOI 10.1007/978-1-60761-380-0_10; Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137; Solt LA, 2010, CURR OPIN LIPIDOL, V21, P204, DOI 10.1097/MOL.0b013e328338ca18; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034921; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yamanaka Y, 2007, AM J PATHOL, V171, P43, DOI 10.2353/ajpath.2007.061207; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	59	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70392	10.1371/journal.pone.0070392	http://dx.doi.org/10.1371/journal.pone.0070392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922987	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700181
J	Zou, Y; Howell, GM; Humphrey, LE; Wang, J; Brattain, MG				Zou, Yi; Howell, Gillian M.; Humphrey, Lisa E.; Wang, Jing; Brattain, Michael G.			Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; MACROPHAGE-STIMULATING PROTEIN; TRICHOSTATIN-A; CELL-MIGRATION; COLON-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA CELLS; ONCOGENIC PHENOTYPES; SURVIVIN EXPRESSION	Recepteur d'origine nantais (Ron) is overexpressed in a panel of pancreatic cancer cells and tissue samples from pancreatic cancer patients. Ron can be activated by its ligand macrophage stimulating protein (MSP), thereby activating oncogenic signaling pathways. Crosstalk between Ron and EGFR, c-Met, or IGF-1R may provide a mechanism underlying drug resistance. Thus, targeting Ron may represent a novel therapeutic strategy. IMC-RON8 is the first Ron monoclonal antibody (mAb) entering clinical trial for targeting Ron overexpression. Our studies show IMC-RON8 downmodulated Ron expression in pancreatic cancer cells and significantly blocked MSP-stimulated Ron activation, downstream Akt and ERK phosphorylation, and survivin mRNA expression. IMC-RON8 hindered MSP-induced cell migration and reduced cell transformation. Histone deacetylase inhibitors (HDACi) are reported to target expression of various genes through modification of nucleosome histones and non-histone proteins. Our work shows HDACi TSA and Panobinostat (PS) decreased Ron mRNA and protein expression in pancreatic cancer cells. PS also reduced downstream signaling of pAkt, survivin, and XIAP, as well as enhanced cell apoptosis. Interestingly, PS reduced colony formation in Ron knockdown cells to a greater extent than Ron scramble control cells in colony formation and soft agarose assays. IMC-RON8 could also sensitize pancreatic cancer cells to PS, as reflected by reduced colony numbers and size in combination treatment with IMC-RON8 and PS compared to single treatment alone. The co-treatment further reduced Ron expression and pAkt, and increased PARP cleavage compared to either treatment alone. This study suggests the potential for a novel combination approach which may ultimately be of value in treatment of pancreatic cancer.	[Zou, Yi; Howell, Gillian M.; Humphrey, Lisa E.; Wang, Jing; Brattain, Michael G.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Brattain, MG (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	mbrattain@unmc.edu			National Institutes of Health [CA34432, CA38173, CA72001, CA54807]; NATIONAL CANCER INSTITUTE [R37CA038173, R01CA140988, R01CA054807, R01CA038173, R01CA034432, R01CA072001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health for funding: CA34432, CA38173, CA72001 and CA54807, awarded to MG Brattain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Camp ER, 2007, CANCER-AM CANCER SOC, V109, P1030, DOI 10.1002/cncr.22490; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; Chowdhury S, 2011, J BIOL CHEM, V286, P30937, DOI 10.1074/jbc.M110.212035; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; Donadelli M, 2003, MOL CARCINOGEN, V38, P59, DOI 10.1002/mc.10145; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Fornaro M, 2003, J BIOL CHEM, V278, P50402, DOI 10.1074/jbc.M307627200; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Fuino L, 2003, MOL CANCER THER, V2, P971; Haefner M, 2008, WORLD J GASTROENTERO, V14, P3681, DOI 10.3748/wjg.14.3681; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Hsu PY, 2006, J UROLOGY, V176, P2262, DOI 10.1016/j.juro.2006.07.048; Jaquish DV, 2011, CARCINOGENESIS, V32, P1151, DOI 10.1093/carcin/bgr086; Kortenhorst MSQ, 2006, CELL ONCOL, V28, P191; Li ZZ, 2010, INT J ONCOL, V37, P473, DOI 10.3892/ijo_00000696; Lockhart AC, 2005, GASTROENTEROLOGY, V128, P1642, DOI 10.1053/j.gastro.2005.03.039; Logan-Collins J, 2010, CANCER RES, V70, P1130, DOI 10.1158/0008-5472.CAN-09-0761; Loizos N, 2011, MOL CANCER THER, P10; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Moore PS, 2004, BBA-MOL CELL RES, V1693, P167, DOI 10.1016/j.bbamcr.2004.07.001; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Ouaissi M, 2008, CANCER BIOL THER, V7, P523, DOI 10.4161/cbt.7.4.5480; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Piacentini P, 2006, VIRCHOWS ARCH, V448, P797, DOI 10.1007/s00428-006-0173-x; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Schneider G, 2010, J CELL MOL MED, V14, P1255, DOI 10.1111/j.1582-4934.2009.00974.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; Wang MH, 1996, ONCOGENE, V13, P2167; Wang MH, 2006, ACTA PHARMACOL SIN, V27, P641, DOI 10.1111/j.1745-7254.2006.00361.x; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Willett CG, 1998, AM J RESP CELL MOL, V18, P489, DOI 10.1165/ajrcmb.18.4.2978; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu XM, 2004, ONCOGENE, V23, P8464, DOI 10.1038/sj.onc.1207907; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	51	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69992	10.1371/journal.pone.0069992	http://dx.doi.org/10.1371/journal.pone.0069992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922886	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700114
J	Li, CY; Wallace, RA; Black, WP; Li, YZ; Yang, ZM				Li, Chengyun; Wallace, Regina A.; Black, Wesley P.; Li, Yue-Zhong; Yang, Zhaomin			Type IV Pilus Proteins Form an Integrated Structure Extending from the Cytoplasm to the Outer Membrane	PLOS ONE			English	Article							SOCIAL GLIDING MOTILITY; MYXOCOCCUS-XANTHUS; PSEUDOMONAS-AERUGINOSA; THERMUS-THERMOPHILUS; POLYSACCHARIDE PRODUCTION; GENE ENCODES; BIOGENESIS; SECRETIN; LOCALIZATION; COMPLEX	The bacterial type IV pilus (T4P) is the strongest biological motor known to date as its retraction can generate forces well over 100 pN. Myxococcus xanthus, a delta-proteobacterium, provides a good model for T4P investigations because its social (S) gliding motility is powered by T4P. In this study, the interactions among M. xanthus T4P proteins were investigated using genetics and the yeast two-hybrid (Y2H) system. Our genetic analysis suggests that there is an integrated T4P structure that crosses the inner membrane (IM), periplasm and the outer membrane (OM). Moreover, this structure exists in the absence of the pilus filament. A systematic Y2H survey provided evidence for direct interactions among IM and OM proteins exposed to the periplasm. For example, the IM lipoprotein PilP interacted with its cognate OM protein PilQ. In addition, interactions among T4P proteins from the thermophile Thermus thermophilus were investigated by Y2H. The results indicated similar protein-protein interactions in the T4P system of this non-proteobacterium despite significant sequence divergence between T4P proteins in T. thermophilus and M. xanthus. The observations here support the model of an integrated T4P structure in the absence of a pilus in diverse bacterial species.	[Li, Chengyun; Li, Yue-Zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Li, Chengyun; Wallace, Regina A.; Black, Wesley P.; Yang, Zhaomin] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Shandong University; Virginia Polytechnic Institute & State University	Yang, ZM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	zmyang@vt.edu	Yang, Zhaomin/D-4791-2016; Li, Yuezhong/ACN-5179-2022	Yang, Zhaomin/0000-0002-2044-6793; Li, Yuezhong/0000-0001-8336-6638	National Institutes of Health; National Science Foundation; Fralin Life Science Institute; China Scholarship Council; Post Baccalaureate Research and Education Program (PREP); Multicultural Academic Opportunities Program (MAOP) at Virginia Tech; Virginia Tech's Open Access Subvention Fund; Div Of Molecular and Cellular Bioscience [1239889] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Fralin Life Science Institute; China Scholarship Council(China Scholarship Council); Post Baccalaureate Research and Education Program (PREP); Multicultural Academic Opportunities Program (MAOP) at Virginia Tech; Virginia Tech's Open Access Subvention Fund; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partially supported by the National Institutes of Health, the National Science Foundation and Fralin Life Science Institute. CL was partially supported by the China Scholarship Council. RAW was partially supported by the Post Baccalaureate Research and Education Program (PREP) and the Multicultural Academic Opportunities Program (MAOP) at Virginia Tech. The publication of this article is supported by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Berry JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002923; Black W. P., 2009, MICROBIOLOGY; Black WP, 2006, MOL MICROBIOL, V61, P447, DOI 10.1111/j.1365-2958.2006.05230.x; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Black WP, 2013, PILB ATPASE MA UNPUB; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burkhardt J, 2011, J BIOL CHEM; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; de Souza RF, 2008, BIOINFORMATICS, V24, P2423, DOI 10.1093/bioinformatics/btn449; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gietz R D, 2002, Methods Mol Biol, V185, P471; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Golovanov AP, 2006, J MOL BIOL, V364, P186, DOI 10.1016/j.jmb.2006.08.078; Jakovljevic V, 2008, J BACTERIOL, V190, P2411, DOI 10.1128/JB.01793-07; James P, 1996, GENETICS, V144, P1425; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Julien B, 2003, J BACTERIOL, V185, P6325, DOI 10.1128/JB.185.21.6325-6330.2003; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Miller J.H., 1972, EXPT MOL GENETICS; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Shi WY, 2002, INFECT IMMUN, V70, P1, DOI 10.1128/IAI.70.1.1-4.2002; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tarnmam S., 2013, J BACTERIOL; Ueki T, 1996, GENE, V183, P153, DOI 10.1016/S0378-1119(96)00546-X; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Weimer RM, 1998, J BACTERIOL, V180, P5357, DOI 10.1128/JB.180.20.5357-5368.1998; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wu SS, 1996, J BACTERIOL, V178, P5817, DOI 10.1128/jb.178.19.5817-5821.1996; Wu SS, 1998, MOL MICROBIOL, V29, P1249, DOI 10.1046/j.1365-2958.1998.01013.x; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000	60	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70144	10.1371/journal.pone.0070144	http://dx.doi.org/10.1371/journal.pone.0070144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922942	Green Published, gold			2022-12-27	WOS:000322838900156
J	Muller, M; Diensthuber, RP; Chizhov, I; Claus, P; Heissler, SM; Preller, M; Taft, MH; Manstein, DJ				Mueller, Mirco; Diensthuber, Ralph P.; Chizhov, Igor; Claus, Peter; Heissler, Sarah M.; Preller, Matthias; Taft, Manuel H.; Manstein, Dietmar J.			Distinct Functional Interactions between Actin Isoforms and Nonsarcomeric Myosins	PLOS ONE			English	Article							COCHLEAR HAIR-CELLS; GAMMA-ACTIN; BETA-ACTIN; HEARING IMPAIRMENT; SMOOTH-MUSCLE; CYTOPLASMIC ACTIN; MISSENSE MUTATION; ACTG1 MUTATIONS; DFNA20/26; EXPRESSION	Despite their near sequence identity, actin isoforms cannot completely replace each other in vivo and show marked differences in their tissue-specific and subcellular localization. Little is known about isoform-specific differences in their interactions with myosin motors and other actin-binding proteins. Mammalian cytoplasmic beta- and gamma-actin interact with nonsarcomeric conventional myosins such as the members of the nonmuscle myosin-2 family and myosin-7A. These interactions support a wide range of cellular processes including cytokinesis, maintenance of cell polarity, cell adhesion, migration, and mechano-electrical transduction. To elucidate differences in the ability of isoactins to bind and stimulate the enzymatic activity of individual myosin isoforms, we characterized the interactions of human skeletal muscle a-actin, cytoplasmic beta-actin, and cytoplasmic gamma-actin with human myosin-7A and nonmuscle myosins-2A, -2B and -2C1. In the case of nonmuscle myosins-2A and -2B, the interaction with either cytoplasmic actin isoform results in 4-fold greater stimulation of myosin ATPase activity than was observed in the presence of alpha-skeletal muscle actin. Nonmuscle myosin-2C1 is most potently activated by beta-actin and myosin-7A by gamma-actin. Our results indicate that beta- and gamma-actin isoforms contribute to the modulation of nonmuscle myosin-2 and myosin-7A activity and thereby to the spatial and temporal regulation of cytoskeletal dynamics. FRET-based analyses show efficient copolymerization abilities for the actin isoforms in vitro. Experiments with hybrid actin filaments show that the extent of actomyosin coupling efficiency can be regulated by the isoform composition of actin filaments.	[Mueller, Mirco; Diensthuber, Ralph P.; Chizhov, Igor; Heissler, Sarah M.; Preller, Matthias; Taft, Manuel H.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany; [Claus, Peter] Hannover Med Sch, Inst Neuroanat, Hannover, Germany	Hannover Medical School; Hannover Medical School	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Hannover, Germany.	manstein.dietmar@mh-hannover.de	Taft, Manuel H/T-2508-2017; Manstein, Dietmar J. J/M-1034-2013; Preller, Matthias/P-1176-2016; Claus, Peter/A-7978-2008; Manstein, Dietmar J./AAG-2640-2019; Taft, Manuel/O-1396-2019	Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Preller, Matthias/0000-0002-7784-4012; Claus, Peter/0000-0003-3824-9445; Manstein, Dietmar J./0000-0003-0763-0147; Taft, Manuel/0000-0001-5853-8629	'Deutsche Forschungsgemeinschaft' Grant [MA 1081/11-2]	'Deutsche Forschungsgemeinschaft' Grant(German Research Foundation (DFG))	This work was supported by the 'Deutsche Forschungsgemeinschaft' Grant MA 1081/11-2 (to Dietmar J. Manstein); URL: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bergeron SE, 2010, J BIOL CHEM, V285, P16087, DOI 10.1074/jbc.M110.110130; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Choi BO, 2011, HUM MUTAT, V32, P669, DOI 10.1002/humu.21488; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; Derycke L, 2011, INT J DEV BIOL, V55, P835, DOI 10.1387/ijdb.113336ld; Diensthuber RP, 2011, FEBS LETT, V585, P767, DOI 10.1016/j.febslet.2011.01.042; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Fyrberg EA, 1998, BIOCHEM GENET, V36, P271, DOI 10.1023/A:1018785127079; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Heissler S. M., 2012, CELL MOL LIFE SCI; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Hildebrand MS, 2010, CLIN GENET, V77, P563, DOI 10.1111/j.1399-0004.2009.01344.x; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Ivkovic S, 2012, MOL BIOL CELL, V23, P533, DOI 10.1091/mbc.E11-01-0039; Jochim N, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-48; Kaech S, 1997, J NEUROSCI, V17, P9565; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Kruth KA, 2012, J BIOL CHEM, V287, P27217, DOI 10.1074/jbc.M112.377283; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LEAVITT J, 1987, MOL CELL BIOL, V7, P2467, DOI 10.1128/MCB.7.7.2467; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Liu P, 2008, J GENET GENOMICS, V35, P553, DOI 10.1016/S1673-8527(08)60075-2; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Mounier N, 1997, J CELL SCI, V110, P839; Muller M, 2012, CELL MOL LIFE SCI; Nunoi H, 1999, P NATL ACAD SCI USA, V96, P8693, DOI 10.1073/pnas.96.15.8693; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; Pecci A, 2008, HUM MUTAT, V29, P409, DOI 10.1002/humu.20661; Perrin BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001158; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Procaccio V, 2006, AM J HUM GENET, V78, P947, DOI 10.1086/504271; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Self T, 1998, DEVELOPMENT, V125, P557; Soni LE, 2005, CELL MOTIL CYTOSKEL, V62, P13, DOI 10.1002/cm.20080; TANIGUCHI S, 1986, J BIOL CHEM, V261, P6100; Tondeleir D, 2009, CELL MOTIL CYTOSKEL, V66, P798, DOI 10.1002/cm.20350; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; vonArx P, 1995, J CELL BIOL, V131, P1759, DOI 10.1083/jcb.131.6.1759; Wang AB, 2011, BIOCHEM SOC T, V39, P1131, DOI 10.1042/BST0391131; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Weiss S, 2000, J MUSCLE RES CELL M, V21, P423, DOI 10.1023/A:1005690106951; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Xia ZK, 2012, DIS ESOPHAGUS, V25, P427, DOI 10.1111/j.1442-2050.2011.01261.x; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	61	60	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70636	10.1371/journal.pone.0070636	http://dx.doi.org/10.1371/journal.pone.0070636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923011	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900173
J	Ferdinand, PH; Borne, R; Trotter, V; Pages, S; Tardif, C; Fierobe, HP; Perret, S				Ferdinand, Pierre-Henri; Borne, Romain; Trotter, Valentine; Pages, Sandrine; Tardif, Chantal; Fierobe, Henri-Pierre; Perret, Stephanie			Are Cellulosome Scaffolding Protein CipC and CBM3-Containing Protein HycP, Involved in Adherence of Clostridium cellulolyticum to Cellulose?	PLOS ONE			English	Article							BACTERIUM RUMINOCOCCUS-ALBUS; GRAM-POSITIVE BACTERIA; CELL-SURFACE; ACETIVIBRIO-CELLULOLYTICUS; SUBCELLULAR-LOCALIZATION; DESIGNER CELLULOSOMES; CARBOHYDRATE-BINDING; SIGNAL PEPTIDES; SIGMA FACTORS; GENE-CLUSTER	Clostridium cellulolyticum, a mesophilic anaerobic bacterium, produces highly active enzymatic complexes called cellulosomes. This strain was already shown to bind to cellulose, however the molecular mechanism(s) involved is not known. In this context we focused on the gene named hycP, encoding a 250-kDa protein of unknown function, containing a Family-3 Carbohydrate Binding Module (CBM3) along with 23 hyaline repeat modules (HYR modules). In the microbial kingdom the gene hycP is only found in C. cellulolyticum and the very close strain recently sequenced Clostridium sp BNL1100. Its presence in C. cellulolyticum guided us to analyze its function and its putative role in adhesion of the cells to cellulose. The CBM3 of HycP was shown to bind to crystalline cellulose and was assigned to the CBM3b subfamily. No hydrolytic activity on cellulose was found with a mini-protein displaying representative domains of HycP. A C. cellulolyticum inactivated hycP mutant strain was constructed, and we found that HycP is neither involved in binding of the cells to cellulose nor that the protein has an obvious role in cell growth on cellulose. We also characterized the role of the cellulosome scaffolding protein CipC in adhesion of C. cellulolyticum to cellulose, since cellulosome scaffolding protein has been proposed to mediate binding of other cellulolytic bacteria to cellulose. A second mutant was constructed, where cipC was inactivated. We unexpectedly found that CipC is only partly involved in binding of C. cellulolyticum to cellulose. Other mechanisms for cellulose adhesion may therefore exist in C. cellulolyticum. In addition, no cellulosomal protuberances were observed at the cellular surface of C. cellulolyticum, what is in contrast to reports from several other cellulosomes producing strains. These findings may suggest that C. cellulolyticum has no dedicated molecular mechanism to aggregate the cellulosomes at the cellular surface.	[Ferdinand, Pierre-Henri; Borne, Romain; Trotter, Valentine; Pages, Sandrine; Tardif, Chantal; Fierobe, Henri-Pierre; Perret, Stephanie] Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Perret, S (corresponding author), Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France.	perret@imm.cnrs.fr	Borne, Romain/AAC-6453-2019; Trotter, Valentine/A-9374-2018; FIEROBE, Henri-Pierre/P-4372-2019	Trotter, Valentine/0000-0002-1784-9487; 	French Ministere de l'enseignement superieur et de la recherche; Centre National de la Recherche Scientifique; Aix-Marseille Universite	French Ministere de l'enseignement superieur et de la recherche; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite	The research was supported by a fellowship grant to PHF from the French Ministere de l'enseignement superieur et de la recherche, and funding from the Centre National de la Recherche Scientifique and Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Blair BG, 1998, BIOTECH HISTOCHEM, V73, P107, DOI 10.3109/10520299809140514; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Celik H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056063; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; Dror TW, 2003, J BACTERIOL, V185, P5109, DOI 10.1128/JB.185.17.5109-5116.2003; Dumitrache A, 2013, APPL ENVIRON MICROB, V79, P231, DOI 10.1128/AEM.02563-12; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FUJINO T, 1993, J BACTERIOL, V175, P1891, DOI 10.1128/JB.175.7.1891-1899.1993; GELHAYE E, 1993, J BACTERIOL, V175, P3452, DOI 10.1128/jb.175.11.3452-3458.1993; GELHAYE E, 1992, CURR MICROBIOL, V25, P307, DOI 10.1007/BF01577226; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kosugi A, 2004, J BACTERIOL, V186, P6351, DOI 10.1128/JB.186.19.6351-6359.2004; Kosugi A, 2002, J BACTERIOL, V184, P884, DOI 10.1128/jb.184.4.884-888.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAMED R, 1987, J BACTERIOL, V169, P3792, DOI 10.1128/jb.169.8.3792-3800.1987; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leibovitz E, 1997, J BACTERIOL, V179, P2519, DOI 10.1128/jb.179.8.2519-2523.1997; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li LL, 2012, J BACTERIOL, V194, P6982, DOI 10.1128/JB.01908-12; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; Maamar H, 2004, MOL MICROBIOL, V51, P589, DOI 10.1046/j.1365-2958.2003.03859.x; Maamar H, 2006, J BACTERIOL, V188, P2614, DOI 10.1128/JB.188.7.2614-2624.2006; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Menne KML, 2000, BIOINFORMATICS, V16, P741, DOI 10.1093/bioinformatics/16.8.741; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; Pages S, 1997, J BACTERIOL, V179, P2810, DOI 10.1128/jb.179.9.2810-2816.1997; Pages S, 1999, J BACTERIOL, V181, P1801; Pegden RS, 1998, J BACTERIOL, V180, P5921, DOI 10.1128/JB.180.22.5921-5927.1998; Perret S, 2004, J BACTERIOL, V186, P6544, DOI 10.1128/JB.186.19.6544-6552.2004; Perret S, 2004, J BACTERIOL, V186, P253, DOI 10.1128/JB.186.1.253-257.2004; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETITDEMANGE E, 1984, INT J SYST BACTERIOL, V34, P155, DOI 10.1099/00207713-34-2-155; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; TARDIF C, 2006, CELLULOSOME, P221; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; WALSETH CS, 1952, TAPPI, V35, P228; Wang ZW, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-30; Wessel GM, 1998, DEV BIOL, V193, P115, DOI 10.1006/dbio.1997.8793; Yaniv O, 2012, ACTA CRYSTALLOGR F, V68, P8, DOI 10.1107/S174430911104807X; Yaniv O, 2011, ACTA CRYSTALLOGR D, V67, P506, DOI 10.1107/S0907444911011322	62	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69360	10.1371/journal.pone.0069360	http://dx.doi.org/10.1371/journal.pone.0069360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935995	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300035
J	Yang, HN; Yang, H; Xie, ZH; Wei, LF; Bi, JZ				Yang, Hongna; Yang, Hui; Xie, Zhaohong; Wei, Lifei; Bi, Jianzhong			Systemic Transplantation of Human Umbilical Cord Derived Mesenchymal Stem Cells-Educated T Regulatory Cells Improved the Impaired Cognition in A beta PPswe/PS1dE9 Transgenic Mice	PLOS ONE			English	Article							AMYLOID-BETA DEPOSITION; ALZHEIMERS-DISEASE; THERAPEUTIC APPLICATION; MOUSE MODEL; NEUROGENESIS; INFLAMMATION; MODULATION; ACTIVATION; MECHANISMS; MICROGLIA	Alzheimer's disease (AD) is one of most prevalent dementias, which is characterized by the deposition of extracellular amyloid-beta protein (A beta) and the formation of neurofibrillary tangles within neurons. Although stereotaxic transplantation of mesenchymal stem cells (MSCs) into the hippocampus of AD animal model as immunomodulatory cells has been suggested as a potential therapeutic approach to prevent the progress of AD, it is invasive and difficult for clinical perform. Systemic and central nervous system inflammation play an important role in pathogenesis of AD. T regulatory cells (Tregs) play a crucial role in maintaining systemic immune homeostasis, indicating that transplantation of Tregs could prevent the progress of the inflammation. In this study, we aimed to evaluate whether systemic transplantation of purified autologous Tregs from spleens of A beta PPswe/PS1dE9 double-transgenic mice after MSCs from human umbilical cords (UC-MSCs) education in vitro for 3 days could improve the neuropathology and cognition deficits in A beta PPswe/PS1dE9 double-transgenic mice. We observed that systemic transplantation of autologous Tregs significantly ameliorate the impaired cognition and reduced the A beta plaque deposition and the levels of soluble A beta, accompanied with significantly decreased levels of activated microglia and systemic inflammatory factors. In conclusion, systemic transplantation of autologous Tregs may be an effective and safe intervention to prevent the progress of AD.	[Yang, Hongna; Yang, Hui; Xie, Zhaohong; Wei, Lifei; Bi, Jianzhong] Shandong Univ, Dept Neural Med, Hosp 2, Jinan 250100, Shandong, Peoples R China	Shandong University	Bi, JZ (corresponding author), Shandong Univ, Dept Neural Med, Hosp 2, Jinan 250100, Shandong, Peoples R China.	bjz@sdu.edu.cn			Shandong Province Natural Science Foundation [ZR2010HQ058]; Jinan Science and Technology Development Foundation [200906182-2]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Jinan Science and Technology Development Foundation	This research is supported by Shandong Province Natural Science Foundation (ZR2010HQ058) http://www.sdnsf.gov.cn/portal and Jinan Science and Technology Development Foundation (200906182-2) www.jnsti.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Ferretti MT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-62; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; He F, 2012, WILEY INTERDISCIPLIN; Heneka MT, 2011, CURR ALZHEIMER RES, V8, P115; Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x; Jin L-W, 2012, INT J ALZHEIMERS DIS, V2012, P1; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059; Liu L, 2012, EUR J IMMUNOL, V42, P2190, DOI 10.1002/eji.201142356; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Mohajeri M, 2011, IRAN J ALLERGY ASTHM, V10, P155, DOI 010.03/ijaai.155161; Najar M, 2010, CELL IMMUNOL, V264, P171, DOI 10.1016/j.cellimm.2010.06.006; Parekkadan B, 2012, MOL THER, V20, P178, DOI 10.1038/mt.2011.192; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sardi F, 2011, AUTOIMMUN REV, V11, P149, DOI 10.1016/j.autrev.2011.09.005; Saresella M, 2010, J ALZHEIMERS DIS, V21, P927, DOI 10.3233/JAD-2010-091696; Schwarz A, 2004, J IMMUNOL, V172, P1036, DOI 10.4049/jimmunol.172.2.1036; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Srinivasan, 2012, J NEUROLOGY RES; Stern Y, 2012, COLD SPRING HARB PER, V2; Tasso R, 2012, INVEST OPHTH VIS SCI, V53, P786, DOI 10.1167/iovs.11-8211; Tipnis S, 2010, IMMUNOL CELL BIOL, V88, P795, DOI 10.1038/icb.2010.47; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh JT, 2011, TRENDS MOL MED, V17, P541, DOI 10.1016/j.molmed.2011.05.012; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Zhao Y, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-3; Zhao Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004226; Zhou CH, 2011, CELL IMMUNOL, V272, P33, DOI 10.1016/j.cellimm.2011.09.010; Zou JT, 2008, J NEUROL SCI, V272, P87, DOI 10.1016/j.jns.2008.05.003	47	78	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69129	10.1371/journal.pone.0069129	http://dx.doi.org/10.1371/journal.pone.0069129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935936	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300024
J	Chowdhury, S; Pradhan, RN; Sarkar, RR				Chowdhury, Saikat; Pradhan, Rachana N.; Sarkar, Ram Rup			Structural and Logical Analysis of a Comprehensive Hedgehog Signaling Pathway to Identify Alternative Drug Targets for Glioma, Colon and Pancreatic Cancer	PLOS ONE			English	Article							K-RAS MUTATION; SONIC-HEDGEHOG; EXPRESSION; INHIBITION; GROWTH; GENES; CELLS; PROLIFERATION; AMPLIFICATION; GLI1	Hedgehog is an evolutionarily conserved developmental pathway, widely implicated in controlling various cellular responses such as cellular proliferation and stem cell renewal in human and other organisms, through external stimuli. Aberrant activation of this pathway in human adult stem cell line may cause different types of cancers. Hence, targeting this pathway in cancer therapy has become indispensable, but the non availability of detailed molecular interactions, complex regulations by extra- and intra-cellular proteins and cross talks with other pathways pose a serious challenge to get a coherent understanding of this signaling pathway for making therapeutic strategy. This motivated us to perform a computational study of the pathway and to identify probable drug targets. In this work, from available databases and literature, we reconstructed a complete hedgehog pathway which reports the largest number of molecules and interactions to date. Using recently developed computational techniques, we further performed structural and logical analysis of this pathway. In structural analysis, the connectivity and centrality parameters were calculated to identify the important proteins from the network. To capture the regulations of the molecules, we developed a master Boolean model of all the interactions between the proteins and created different cancer scenarios, such as Glioma, Colon and Pancreatic. We performed perturbation analysis on these cancer conditions to identify the important and minimal combinations of proteins that can be used as drug targets. From our study we observed the under expressions of various oncoproteins in Hedgehog pathway while perturbing at a time the combinations of the proteins GLI1, GLI2 and SMO in Glioma; SMO, HFU, ULK3 and RAS in Colon cancer; SMO, HFU, ULK3, RAS and ERK12 in Pancreatic cancer. This reconstructed Hedgehog signaling pathway and the computational analysis for identifying new combinatory drug targets will be useful for future in-vitro and in-vivo analysis to control different cancers.	[Chowdhury, Saikat; Pradhan, Rachana N.; Sarkar, Ram Rup] CSIR Natl Chem Lab, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sarkar, RR (corresponding author), CSIR Natl Chem Lab, Pune, Maharashtra, India.	rr.sarkar@ncl.res.in	Pradhan, Rachana/M-1374-2019; CHOWDHURY, SAIKAT/X-9949-2019	Pradhan, Rachana/0000-0001-7352-8111; CHOWDHURY, SAIKAT/0000-0002-0783-3959; SARKAR, RAM RUP/0000-0001-7115-163X	Department of Biotechnology, Govt. of India [BT/PR13689/BID/07/363/2010]; CSIR-NCL [MLP026226]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); CSIR-NCL	The work is funded by the Department of Biotechnology, Govt. of India, Grant No. BT/PR13689/BID/07/363/2010 and partly by CSIR-NCL, MLP026226. The funding agency has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Batagelj V, 2004, MATH VIS, P77; Beachy PA, 2012, European Patent Application, Patent No. [EP2404602, 2404602]; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; BOS JL, 1989, CANCER RES, V49, P4682; Buschges R, 1999, BRAIN PATHOL, V9, P435; Chakravarti A, 2001, CLIN CANCER RES, V7, P2387; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; Ding H, 2001, CANCER RES, V61, P3826; Dockendorff C, 2012, ACS MED CHEM LETT, V3, P808, DOI 10.1021/ml300172p; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Galimberti F, 2012, INT J ONCOL, V41, P1751, DOI 10.3892/ijo.2012.1599; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Han SP, 2011, CELL MOL NEUROBIOL, V31, P489, DOI 10.1007/s10571-010-9643-4; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Hornik K, 2012, R FAQ; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Jensen JB, 2002, DIGRAPHS THEORY ALGO, P2; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Kaesler S, 2000, BIOL CHEM, V381, P545, DOI 10.1515/BC.2000.070; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Katoh M, 2007, STEM CELL REV, V3, P30, DOI 10.1007/s12015-007-0006-6; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kawahira H, 2003, DEVELOPMENT, V130, P4871, DOI 10.1242/dev.00653; Kayed H, 2004, INT J CANCER, V110, P668, DOI 10.1002/ijc.20194; Kelleher FC, 2012, PHARMACOL THERAPEUT, V136, P153, DOI 10.1016/j.pharmthera.2012.08.004; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klamt S, 2011, BIOSYSTEMS, V105, P162, DOI 10.1016/j.biosystems.2011.02.002; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Li YW, 2012, EXPERT OPIN THER TAR, V16, P49, DOI 10.1517/14728222.2011.617367; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Maloverjan A, 2010, EXP CELL RES, V316, P627, DOI 10.1016/j.yexcr.2009.10.018; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Mazumdar T, 2011, ONCOTARGET, V2, P638; McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Olive KP, 2012, United States Patent Application Publication, Patent No. [US 2012/0020876 A1, 20120020876]; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Reichrath S, 2010, J STEROID BIOCHEM, V121, P420, DOI 10.1016/j.jsbmb.2010.02.028; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; SAITOH Y, 1995, LAB INVEST, V72, P55; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Sheriff M. Rahuman, 2008, Proceedings of the Indian National Science Academy, V74, P187; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Subramanian K, 2009, CHECKLIST ODONATA IN, P1; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tai CJ, 2012, POL J PATHOL, V63, P93; TANAKA M, 1994, J SURG ONCOL, V57, P57, DOI 10.1002/jso.2930570115; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; TRENT J, 1986, P NATL ACAD SCI USA, V83, P470, DOI 10.1073/pnas.83.2.470; Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wuchty Stefan, 2006, P165; Xie JW, 2011, HEDGEHOG SIGNALING ACTIVATION IN HUMAN CANCER AND ITS CLINICAL IMPLICATIONS, P85, DOI 10.1007/978-1-4419-8435-7_7; Xu XL, 2012, ENDOCR-RELAT CANCER, V19, P167, DOI 10.1530/ERC-11-0305; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036	99	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69132	10.1371/journal.pone.0069132	http://dx.doi.org/10.1371/journal.pone.0069132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935937	gold, Green Submitted, Green Published			2022-12-27	WOS:000325211000079
J	Iacono, G; Altafini, C; Torre, V				Iacono, Giovanni; Altafini, Claudio; Torre, Vincent			Early Phase of Plasticity-Related Gene Regulation and SRF Dependent Transcription in the Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; CAMP EARLY REPRESSOR; SERUM RESPONSE FACTOR; NEURONAL CELL-DEATH; DIFFERENTIAL UP-REGULATION; MESSENGER-RNA EXPRESSION; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; C-FOS	Hippocampal organotypic cultures are a highly reliable in vitro model for studying neuroplasticity: in this paper, we analyze the early phase of the transcriptional response induced by a 20 mu M gabazine treatment (GabT), a GABA-Ar antagonist, by using Affymetrix oligonucleotide microarray, RT-PCR based time-course and chromatin-immuno-precipitation. The transcriptome profiling revealed that the pool of genes up-regulated by GabT, besides being strongly related to the regulation of growth and synaptic transmission, is also endowed with neuro-protective and pro-survival properties. By using RT-PCR, we quantified a time-course of the transient expression for 33 of the highest up-regulated genes, with an average sampling rate of 10 minutes and covering the time interval [ 10: 90] minutes. The cluster analysis of the time-course disclosed the existence of three different dynamical patterns, one of which proved, in a statistical analysis based on results from previous works, to be significantly related with SRF-dependent regulation (p-value<0.05). The chromatin immunoprecipitation (chip) assay confirmed the rich presence of working CArG boxes in the genes belonging to the latter dynamical pattern and therefore validated the statistical analysis. Furthermore, an in silico analysis of the promoters revealed the presence of additional conserved CArG boxes upstream of the genes Nr4a1 and Rgs2. The chip assay confirmed a significant SRF signal in the Nr4a1 CArG box but not in the Rgs2 CArG box.	[Iacono, Giovanni; Altafini, Claudio; Torre, Vincent] Scuola Int Super Studi Avanzati, Dept Funct Anal, Trieste, Italy; [Torre, Vincent] IIT Italian Inst Technol, Genoa, Italy	International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Torre, V (corresponding author), Scuola Int Super Studi Avanzati, Dept Funct Anal, Trieste, Italy.	torre@sissa.it	Altafini, Claudio/AAL-4235-2020	Altafini, Claudio/0000-0003-4142-6502	European Commission [FP7-284553]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge the financial support of the SI-CODE project of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: FP7-284553.	ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bramham CR, 1996, J COMP NEUROL, V368, P371; Broccard Frederic D, 2009, BMC Res Notes, V2, P13, DOI 10.1186/1756-0500-2-13; BROOKS PA, 1987, BRAIN RES, V408, P295, DOI 10.1016/0006-8993(87)90391-X; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; Celikel T, 2007, FRONT NEUROSCI-SWITZ, V1, P97, DOI 10.3389/neuro.01.1.1.007.2007; Chang LF, 2011, J SURG ONCOL, V103, P442, DOI 10.1002/jso.21809; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chen GQ, 1999, J NEUROSCI, V19, P7983; Chen MJ, 2005, MOL BRAIN RES, V135, P181, DOI 10.1016/j.molbrainres.2004.12.001; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cheval H, 2011, HIPPOCAMPUS; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung KC, 1998, NEUROSCI LETT, V255, P155, DOI 10.1016/S0304-3940(98)00733-2; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Crispino M, 1998, MOL BRAIN RES, V59, P178, DOI 10.1016/S0169-328X(98)00143-0; Curran BP, 2003, NEUROSCIENCE, V118, P347, DOI 10.1016/S0306-4522(02)00941-7; Daliri MR, 2006, LECT NOTES COMPUT SC, V4291, P712; Danzer SC, 2002, J NEUROSCI, V22, P9754; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; de Ortiz SP, 2000, NEUROBIOL LEARN MEM, V74, P161, DOI 10.1006/nlme.1999.3952; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Decressac M, 2011, HIPPOCAMPUS, V21, P233, DOI 10.1002/hipo.20765; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Do JH, 2008, MOL CELLS, V25, P279; Domercq M, 2011, J BIOL CHEM, V286, P11825, DOI 10.1074/jbc.M110.153049; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Farioli-Vecchioli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008339; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Francis JS, 2004, MOL BRAIN RES, V124, P199, DOI 10.1016/j.molbrainres.2003.10.027; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Gonzalez YR, 2008, J NEUROSCI, V28, P5559, DOI 10.1523/JNEUROSCI.1014-08.2008; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Ha S, 2008, DEV NEUROBIOL, V68, P1565, DOI 10.1002/dneu.20682; Han D, 2008, FEBS LETT, V582, P1298, DOI 10.1016/j.febslet.2008.02.044; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Heidenreich O, 1999, J BIOL CHEM, V274, P14434, DOI 10.1074/jbc.274.20.14434; Hokfelt T, 2008, NUTRITION, V24, P860, DOI 10.1016/j.nut.2008.06.010; Holm NR, 1997, P NATL ACAD SCI USA, V94, P1002, DOI 10.1073/pnas.94.3.1002; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchison RM, 2009, HIPPOCAMPUS, V19, P687, DOI 10.1002/hipo.20582; Inokuchi K, 1996, BIOCHEM BIOPH RES CO, V221, P430, DOI 10.1006/bbrc.1996.0612; Inoue Y, 2007, NEUROSCIENCE, V150, P841, DOI 10.1016/j.neuroscience.2007.09.081; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Johnson AW, 2011, BEHAV BRAIN RES, V220, P312, DOI 10.1016/j.bbr.2011.02.015; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kadar E, 2011, GENES BRAIN BEHAV, V10, P69, DOI 10.1111/j.1601-183X.2010.00609.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Kawaai K, 2010, J NEUROSCI RES, V88, P2911, DOI 10.1002/jnr.22457; Kelly MP, 2003, J NEUROSCI, V23, P6443; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kim JH, 2012, J NEUROCHEM, V120, P210, DOI 10.1111/j.1471-4159.2011.07555.x; Kim KH, 2003, J BIOL CHEM, V278, P13847, DOI 10.1074/jbc.M210128200; Kim Y, 2006, MOL CELLS, V22, P8; Klejman A, 2006, ACTA NEUROBIOL EXP, V66, P267; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Kuipers SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004885; Kumar V, 2011, J BIOL CHEM; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee KJ, 2011, NEURON, V69, P957, DOI 10.1016/j.neuron.2011.02.004; Lemberger T, 2008, FASEB J, V22, P2872, DOI 10.1096/fj.08-107888; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Lindecke A, 2006, EUR J NEUROSCI, V24, P555, DOI 10.1111/j.1460-9568.2006.04909.x; Liu MG, 2011, BRAIN RES, V1382, P57, DOI 10.1016/j.brainres.2011.01.076; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Ludwig A, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/641248; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Ma'ayan A, 2008, IET SYST BIOL, V2, P103, DOI 10.1049/iet-syb:20070036; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacGillavry HD, 2011, MOL CELL NEUROSCI, V46, P460, DOI 10.1016/j.mcn.2010.11.011; MacGillavry HD, 2009, J NEUROSCI, V29, P15542, DOI 10.1523/JNEUROSCI.3938-09.2009; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marie-Claire C, 2008, BRAIN RES, V1239, P42, DOI 10.1016/j.brainres.2008.08.050; Martin ED, 2011, CEREB CORTEX; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mioduszewska B, 2008, J NEUROSCI RES, V86, P61, DOI 10.1002/jnr.21469; Mohajerani MH, 2005, EUR J NEUROSCI, V22, P107, DOI 10.1111/j.1460-9568.2005.04198.x; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Mouravlev A, 2007, BRAIN RES, V1130, P31, DOI 10.1016/j.brainres.2006.10.076; Niu CC, 2011, J NEUROPATH EXP NEUR, V70, P634, DOI 10.1097/NEN.0b013e318222b97b; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Sullivan NC, 2010, CEREB CORTEX, V20, P1915, DOI 10.1093/cercor/bhp262; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Olesen MV, 2011, J NEUROSCI RES; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Otal R, 2005, CELL TISSUE RES, V319, P349, DOI 10.1007/s00441-004-1020-5; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Passeri D, 2006, MOL CELL BIOL, V26, P5023, DOI 10.1128/MCB.01360-05; Pegoraro S, 2010, J CELL PHYSIOL, V222, P713, DOI 10.1002/jcp.21998; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Penke Z, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00048; Pinato G, 2009, J CELL PHYSIOL, V220, P727, DOI 10.1002/jcp.21820; Pinato G, 2009, NEUROREPORT, V20, P869, DOI 10.1097/WNR.0b013e32832c619b; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Poirier R, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/006.2007, 10.3389/neuro.08.006.2007]; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Porter BE, 2008, NEUROSCIENCE, V152, P829, DOI 10.1016/j.neuroscience.2007.10.064; Racaniello M, 2010, NEUROCHEM RES, V35, P239, DOI 10.1007/s11064-009-0047-0; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Ramsden M, 2003, BRAIN RES, V971, P239, DOI 10.1016/S0006-8993(03)02365-5; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Reibel S, 2001, PEPTIDES, V22, P529, DOI 10.1016/S0196-9781(01)00347-3; Reti IM, 2000, NEUROPSYCHOPHARMACOL, V23, P439, DOI 10.1016/S0893-133X(00)00120-2; Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryser S, 2004, BIOCHEM J, V378, P473, DOI 10.1042/BJ20031022; Ryser S, 2001, J BIOL CHEM, V276, P33319, DOI 10.1074/jbc.M102326200; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sin WC, 2008, J CELL BIOCHEM, V103, P1772, DOI 10.1002/jcb.21571; Slanina KA, 2005, NEUROPHARMACOLOGY, V49, P660, DOI 10.1016/j.neuropharm.2005.04.021; Sokolova OO, 2009, B EXP BIOL MED+, V148, P416, DOI 10.1007/s10517-010-0726-5; Stolle K, 2007, BBA-GENE STRUCT EXPR, V1769, P514, DOI 10.1016/j.bbaexp.2007.05.005; Sun W, 2007, J NEUROCHEM, V100, P269, DOI 10.1111/j.1471-4159.2006.04214.x; Tabuchi A, 2008, BIOL PHARM BULL, V31, P327, DOI 10.1248/bpb.31.327; Tarrega C, 2010, METHODS MOL BIOL, V661, P305, DOI 10.1007/978-1-60761-795-2_18; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Turrigiano G., 2012, COLD SPRING HARB PER, V4; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Uchida I, 1996, EUR J PHARMACOL, V307, P89, DOI 10.1016/0014-2999(96)00156-2; Uvarov P, 2006, J NEUROSCI, V26, P13463, DOI 10.1523/JNEUROSCI.4731-06.2006; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Volmat V, 2001, J CELL SCI, V114, P3433; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Watanabe Y, 1996, J NEUROSCI, V16, P3827; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; Xu B, 2002, NEUROSCIENCE, V115, P1295, DOI 10.1016/S0306-4522(02)00384-6; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Yilmaz-Rastoder E, 2011, HIPPOCAMPUS, V21, P1290, DOI 10.1002/hipo.20838; Yoo MJ, 2007, J MICROBIOL BIOTECHN, V17, P2033; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533; Zhao J, 2007, CELL SIGNAL, V19, P831, DOI 10.1016/j.cellsig.2006.10.006; Zheng D, 1998, NEUROSCIENCE, V83, P251, DOI 10.1016/S0306-4522(97)00311-4; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	200	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68078	10.1371/journal.pone.0068078	http://dx.doi.org/10.1371/journal.pone.0068078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935853	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000026
J	Lee, JK; Gopal, R; Park, SC; Ko, HS; Kim, Y; Hahm, KS; Park, Y				Lee, Jong Kook; Gopal, Ramamourthy; Park, Seong-Cheol; Ko, Hyun Sook; Kim, Yangmee; Hahm, Kyung-Soo; Park, Yoonkyung			A Proline-Hinge Alters the Characteristics of the Amphipathic alpha-helical AMPs	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; DISTANCE GEOMETRY; ANALOG PEPTIDES; N-TERMINUS; CECROPIN; CONFORMATIONS; MEMBRANES; MELITTIN; RESIDUES; DESIGN	HP (2-20) is a 19-aa, amphipathic, alpha-helical peptide with antimicrobial properties that was derived from the N-terminus of Helicobacter pylori ribosomal protein L1. We previously showed that increasing the net hydrophobicity of HP (2-20) by substituting Trp for Gln(17) and Asp(19) (Anal 3) increased the peptide's antimicrobial activity. In hydrophobic medium, Anal 3 forms an amphipathic structure consisting of an N-terminal random coil region (residues 2-5) and an extended helical region (residues 6-20). To investigate the structure-activity relationship of Anal 3, we substituted Pro for Glu(9) (Anal 3-Pro) and then examined the new peptide's three-dimensional structure, antimicrobial activity and mechanism of action. Anal 3-Pro had an alpha-helical structure in the presence of trifluoroethanol (TFE) and sodium dodecyl sulfate (SDS). NMR spectroscopic analysis of Anal 3-Pro's tertiary structure in SDS micelles confirmed that the kink potential introduced by Pro 10 was responsible for the helix distortion. We also found that Anal 3-Pro exhibited about 4 times greater antimicrobial activity than Anal 3. Fluorescence activated flow cytometry and confocal fluorescence microscopy showed that incorporating a Pro-hinge into Anal 3 markedly reduced its membrane permeability so that it accumulated in the cytoplasm without remaining in the cell membrane. To investigate the translocation mechanism, we assessed its ability to release of FITC-dextran. The result showed Anal 3-Pro created a pore <1.8 nm in diameter, which is similar to buforin II. Notably, scanning electron microscopic observation of Candida albicans revealed that Anal 3-Pro and buforin II exert similar effects on cell membranes, whereas magainin 2 exerts a different, more damaging, effect. In addition, Anal 3-Pro assumed a helix-hinge-helix structure in the presence of biological membranes and formed micropores in both bacterial and fungal membranes, through which it entered the cytoplasm and tightly bound to DNA. These results indicate that the bending region of Anal 3-Pro peptide is prerequisite for effective antibiotic activity and may facilitate easy penetration of the lipid bilayers of the cell membrane.	[Lee, Jong Kook; Gopal, Ramamourthy; Park, Seong-Cheol; Hahm, Kyung-Soo; Park, Yoonkyung] Chosun Univ, RCPM, Kwangju 501759, South Korea; [Ko, Hyun Sook; Kim, Yangmee] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea; [Park, Yoonkyung] Chosun Univ, Dept Biotechnol, Kwangju 501759, South Korea	Chosun University; Konkuk University; Chosun University	Park, Y (corresponding author), Chosun Univ, RCPM, Kwangju 501759, South Korea.	y_k_park@chosun.ac.kr			National Research Foundation of Korea (NRF); Korea government (Korean Ministry of Education, Science and Technology) [2011-0017532]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (Korean Ministry of Education, Science and Technology)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Korean Ministry of Education, Science and Technology) ( No. 2011-0017532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREU D, 1985, BIOCHEMISTRY-US, V24, P1683, DOI 10.1021/bi00328a017; Belokoneva OS, 2004, BBA-BIOMEMBRANES, V1664, P182, DOI 10.1016/j.bbamem.2004.05.007; BLONDELLE SE, 1993, BIOCHIM BIOPHYS ACTA, V1202, P331, DOI 10.1016/0167-4838(93)90024-L; BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Brunger A. T., 1993, X PLOR MANUAL VERSIO; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; Circo R, 2002, BIOCHEM BIOPH RES CO, V293, P586, DOI 10.1016/S0006-291X(02)00267-X; CLORE GM, 1987, BIOCHEMISTRY-US, V26, P8012, DOI 10.1021/bi00398a069; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; GAZIT E, 1994, BIOCHEMISTRY-US, V33, P10681, DOI 10.1021/bi00201a016; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lee DG, 2002, BBA-PROTEINS PROTEOM, V1598, P185, DOI 10.1016/S0167-4838(02)00373-4; Lee DG, 2002, BIOCHEM BIOPH RES CO, V291, P1006, DOI 10.1006/bbrc.2002.6548; Lee DG, 1997, BIOCHEM MOL BIOL INT, V43, P489; Lee KH, 1998, PEPTIDES, V19, P1653, DOI 10.1016/S0196-9781(98)00119-3; Maeng CY, 2001, BIOCHEM BIOPH RES CO, V282, P787, DOI 10.1006/bbrc.2001.4641; Mangoni ME, 1996, FEBS LETT, V383, P93, DOI 10.1016/0014-5793(96)00236-0; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Merrifield RB, 1976, SCIENCE, V232, P341, DOI DOI 10.1126/SCIENCE.3961484; MORIKAWA N, 1992, BIOCHEM BIOPH RES CO, V189, P184, DOI 10.1016/0006-291X(92)91542-X; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1996, BIOCHEM BIOPH RES CO, V218, P408, DOI 10.1006/bbrc.1996.0071; Park CH, 2008, BIOCHIM BIOPHYS ACTA, V1778, P229; Putsep K, 1999, NATURE, V398, P671, DOI 10.1038/19439; Shin SY, 1998, BIOCHEM MOL BIOL INT, V44, P1119; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Suh JY, 1999, EUR J BIOCHEM, V266, P665, DOI 10.1046/j.1432-1327.1999.00917.x; Thennarasu S, 1996, PROTEIN ENG, V9, P1219, DOI 10.1093/protein/9.12.1219; Tossi A, 2000, BIOPOLYMERS, V55, P4; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	36	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67597	10.1371/journal.pone.0067597	http://dx.doi.org/10.1371/journal.pone.0067597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935838	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000014
J	Vlastos, D; Mademtzoglou, D; Drosopoulou, E; Efthimiou, I; Chartomatsidou, T; Pandelidou, C; Astyrakaki, M; Chalatsi, E; Mavragani-Tsipidou, P				Vlastos, Dimitris; Mademtzoglou, Despoina; Drosopoulou, Elena; Efthimiou, Ioanna; Chartomatsidou, Tatiana; Pandelidou, Christina; Astyrakaki, Melina; Chalatsi, Eleftheria; Mavragani-Tsipidou, Penelope			Evaluation of the Genotoxic and Antigenotoxic Effects of Chios Mastic Water by the In Vitro Micronucleus Test on Human Lymphocytes and the In Vivo Wing Somatic Test on Drosophila	PLOS ONE			English	Article							PISTACIA-LENTISCUS; ESSENTIAL OIL; MITOMYCIN-C; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITIES; ANTIINFLAMMATORY ACTIVITY; CHEMICAL-COMPOSITION; RECOMBINATION TEST; SAMPLE-SIZE; SPOT-TEST	Chios mastic gum, a plant-derived product obtained by the Mediterranean bush Pistacia lentiscus (L.) var. chia (Duham), has generated considerable interest because of its antimicrobial, anticancer, antioxidant and other beneficial properties. Its aqueous extract, called Chios mastic water (CMW), contains the authentic mastic scent and all the water soluble components of mastic. In the present study, the potential genotoxic activity of CMW, as well as its antigenotoxic properties against the mutagenic agent mitomycin-C (MMC), was evaluated by employing the in vitro Cytokinesis Block MicroNucleus (CBMN) assay and the in vivo Somatic Mutation And Recombination Test (SMART). In the former assay, lymphocytes were treated with 1, 2 and 5% (v/v) of CMW with or without MMC at concentrations 0.05 and 0.50 mu g/ml. No significant micronucleus induction was observed by CMW, while co-treatment with MMC led to a decrease of the MMC-induced micronuclei, which ranged between 22.8 and 44.7%. For SMART, larvae were treated with 50 and 100% (v/v) CMW with or without MMC at concentrations 1.00, 2.50 and 5.00 mg/ml. It was shown that CMW alone did not modify the spontaneous frequencies of spots indicating lack of genotoxic activity. The simultaneous administration of MMC with 100% CMW led to considerable alterations of the frequencies of MMC-induced wing spots with the total mutant clones showing reduction between 53.5 and 74.4%. Our data clearly show a protective role of CMW against the MMC-induced genotoxicity and further research on the beneficial properties of this product is suggested.	[Mademtzoglou, Despoina; Drosopoulou, Elena; Chartomatsidou, Tatiana; Pandelidou, Christina; Astyrakaki, Melina; Chalatsi, Eleftheria; Mavragani-Tsipidou, Penelope] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Vlastos, Dimitris; Efthimiou, Ioanna] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece	Aristotle University of Thessaloniki; University of Patras	Mavragani-Tsipidou, P (corresponding author), Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece.	mavragan@bio.auth.gr	DROSOPOULOU, ELENA/N-2176-2015; Drosopoulou, Elena/AAX-6493-2020; Vlastos, Dimitris/GSD-9592-2022	Drosopoulou, Elena/0000-0001-9805-0572; Vlastos, Dimitris/0000-0002-3157-7529; MADEMTZOGLOU, Despoina/0000-0002-4494-7234	Aristotle University of Thessaloniki; University of Western Greece	Aristotle University of Thessaloniki; University of Western Greece	This work was supported by intramural funds of the Aristotle University of Thessaloniki to PM-T and of the University of Western Greece to DV. Chios mastic water used in the present study was supplied by the Chios Mastiha Growers' Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed A, 2009, FOOD SCI TECHNOL INT, V15, P215, DOI 10.1177/1082013208339705; Abdelwahed A, 2007, CHEM-BIOL INTERACT, V165, P1, DOI 10.1016/j.cbi.2006.10.003; ABRAHAM SK, 1994, MUTAGENESIS, V9, P383, DOI 10.1093/mutage/9.4.383; Abraham SK, 1999, FOOD CHEM TOXICOL, V37, P733, DOI 10.1016/S0278-6915(99)00053-8; Al-Zubairi AS, 2010, TOXICOL IN VITRO, V24, P707, DOI 10.1016/j.tiv.2010.01.011; ALHABBAL MJ, 1984, CLIN EXP PHARMACOL P, V11, P541, DOI 10.1111/j.1440-1681.1984.tb00864.x; ALSAID MS, 1986, J ETHNOPHARMACOL, V15, P271, DOI 10.1016/0378-8741(86)90165-0; de Rezende AAA, 2013, FOOD CHEM TOXICOL, V55, P645, DOI 10.1016/j.fct.2013.01.050; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Assimopoulou AN, 2005, FOOD CHEM, V92, P721, DOI 10.1016/j.foodchem.2004.08.033; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Balan KV, 2007, PHYTOMEDICINE, V14, P263, DOI 10.1016/j.phymed.2006.03.009; Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167; BESTMANN HJ, 1988, J APPL ENTOMOL, V106, P144, DOI 10.1111/j.1439-0418.1988.tb00577.x; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Chan NLS, 2006, TOXICOL APPL PHARM, V213, P98, DOI 10.1016/j.taap.2005.10.002; Clare G, 2006, MUTAT RES, V607, P37, DOI DOI 10.1016/J.MRGENTOX.2006.04.001; Dabos KJ, 2010, J ETHNOPHARMACOL, V127, P205, DOI 10.1016/j.jep.2009.11.021; De Flora S, 2007, MUTAT RES-FUND MOL M, V621, P5, DOI 10.1016/j.mrfmmm.2006.12.008; de Rezende AAA, 2011, FOOD CHEM TOXICOL, V49, P1235, DOI 10.1016/j.fct.2011.03.001; Dedoussis GVZ, 2004, ATHEROSCLEROSIS, V174, P293, DOI 10.1016/j.atherosclerosis.2004.02.011; DEFLORA S, 1988, MUTAT RES, V202, P285, DOI 10.1016/0027-5107(88)90193-5; Demsia G, 2007, MUTAT RES-GEN TOX EN, V634, P32, DOI 10.1016/j.mrgentox.2007.05.018; Doi K, 2009, TOXICOL APPL PHARM, V234, P135, DOI 10.1016/j.taap.2008.10.001; DOUKAS C, 2003, CHEM CHRON, V12, P36; Erickson RP, 2010, MUTAT RES-REV MUTAT, V705, P96, DOI 10.1016/j.mrrev.2010.04.002; Fenech M, 1997, MUTAT RES-GEN TOX EN, V392, P11, DOI 10.1016/S0165-1218(97)00041-4; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Franzios G, 1997, J AGR FOOD CHEM, V45, P2690, DOI 10.1021/jf960685f; FREI H, 1995, MUTAT RES-ENVIR MUTA, V334, P247, DOI 10.1016/0165-1161(95)90018-7; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; Garozzo A, 2009, LETT APPL MICROBIOL, V49, P806, DOI 10.1111/j.1472-765X.2009.02740.x; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; He ML, 2007, ACTA PHARMACOL SIN, V28, P446, DOI 10.1111/j.1745-7254.2007.00536.x; He ML, 2006, CANCER-AM CANCER SOC, V106, P2547, DOI 10.1002/cncr.21935; HODNICK WF, 1993, CANCER RES, V53, P4907; Huang XY, 2010, ACTA PHARMACOL SIN, V31, P741, DOI 10.1038/aps.2010.54; Iauk L, 1996, J CHEMOTHERAPY, V8, P207, DOI 10.1179/joc.1996.8.3.207; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaliora AC, 2007, WORLD J GASTROENTERO, V13, P6031, DOI 10.3748/wjg.13.6031; Kang JS, 2007, FOOD CHEM TOXICOL, V45, P494, DOI 10.1016/j.fct.2006.09.013; KASTENBAUM MA, 1970, MUTAT RES, V9, P527, DOI 10.1016/0027-5107(70)90038-2; Kato FH, 2012, MUTAT RES-GEN TOX EN, V749, P87, DOI 10.1016/j.mrgentox.2012.09.001; Kaya B, 2002, MUTAT RES-GEN TOX EN, V520, P93, DOI 10.1016/S1383-5718(02)00173-0; Kim HJ, 2009, ARCH PHARM RES, V32, P997, DOI 10.1007/s12272-009-1704-1; Kim SI, 2011, J ASIA-PAC ENTOMOL, V14, P509, DOI 10.1016/j.aspen.2011.07.001; Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Koutsoudaki C, 2005, J AGR FOOD CHEM, V53, P7681, DOI 10.1021/jf050639s; Lehmann M, 2000, ENVIRON MOL MUTAGEN, V36, P195, DOI 10.1002/1098-2280(2000)36:3<195::AID-EM2>3.0.CO;2-B; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Loizzo MR, 2008, CELL PROLIFERAT, V41, P1002, DOI 10.1111/j.1365-2184.2008.00561.x; Lorge E, 2006, MUTAT RES-GEN TOX EN, V607, P13, DOI 10.1016/j.mrgentox.2006.04.006; Loutrari H, 2006, NUTR CANCER, V55, P86, DOI 10.1207/s15327914nc5501_11; Mademtzoglou D, 2011, FLAVOUR FRAG J, V26, P447, DOI 10.1002/ffj.2081; Magiatis P, 1999, PLANTA MED, V65, P749, DOI 10.1055/s-2006-960856; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Mahmoudi M, 2010, EUR REV MED PHARMACO, V14, P765; MAREC F, 1994, MUTAT RES-FUND MOL M, V311, P305, DOI 10.1016/0027-5107(94)90189-9; Margaris NS, 1981, ECOSYSTEMS WORLD, P309; MARGOLIN BH, 1983, ENVIRON MUTAGEN, V5, P705, DOI 10.1002/em.2860050509; Mazumdar M, 2011, MUTAT RES-GEN TOX EN, V721, P147, DOI 10.1016/j.mrgentox.2011.01.007; Mills J. S., 1977, STUD CONSERV, V22, P12, DOI [10.2307/1505670, DOI 10.2307/1505670]; Mitic-Culafic D, 2009, FOOD CHEM TOXICOL, V47, P260, DOI 10.1016/j.fct.2008.11.015; Nibret E, 2010, PHYTOMEDICINE, V17, P911, DOI 10.1016/j.phymed.2010.02.009; Niikawa M, 2007, BIOMED PHARMACOTHER, V61, P113, DOI 10.1016/j.biopha.2006.07.094; PAPAPAULOU P, 2001, FRESEN ENVIRON BULL, V10, P421; Paraschos S, 2012, CURR MED CHEM, V19, P2292; Paraschos S, 2011, FOOD CHEM, V129, P907, DOI 10.1016/j.foodchem.2011.05.043; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Resende FA, 2011, MUTAT RES, V700, P62; SELBY PB, 1981, MUTAT RES, V83, P403, DOI 10.1016/0027-5107(81)90022-1; SENGSTAG C, 1994, CRIT REV TOXICOL, V24, P323, DOI 10.3109/10408449409017922; Serpico M, 2000, RESINS AMBER BITUMEN; Slamenova D, 2009, MUTAT RES-GEN TOX EN, V677, P46, DOI 10.1016/j.mrgentox.2009.05.016; Speit G, 2012, MUTAGENESIS, V27, P743, DOI 10.1093/mutage/ges041; SURRALLES J, 1992, MUTAGENESIS, V7, P407, DOI 10.1093/mutage/7.6.407; SURRALLES J, 1995, MUTAT RES-GENET TOX, V341, P169, DOI 10.1016/0165-1218(95)90007-1; Takahashi K, 2003, J PERIODONTOL, V74, P501, DOI 10.1902/jop.2003.74.4.501; Tassou CC, 1995, INT BIODETER BIODEGR, V36, P411, DOI 10.1016/0964-8305(95)00103-4; Tomasz M, 1997, PHARMACOL THERAPEUT, V76, P73, DOI 10.1016/S0163-7258(97)00088-0; Triantafyllou A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-64; Triantafyllou A, 2007, J ETHNOPHARMACOL, V111, P43, DOI 10.1016/j.jep.2006.10.031; Turkez H, 2012, CYTOTECHNOLOGY, V64, P679, DOI 10.1007/s10616-012-9447-0; Vallianou I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020516; Vlastos D, 1998, ARCH DERMATOL RES, V290, P312, DOI 10.1007/s004030050310; Zhou L, 2009, IN VIVO, V23, P583	89	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69494	10.1371/journal.pone.0069494	http://dx.doi.org/10.1371/journal.pone.0069494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936030	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000128
J	Zangle, TA; Burnes, D; Mathis, C; Witte, ON; Teitell, MA				Zangle, Thomas A.; Burnes, Daina; Mathis, Colleen; Witte, Owen N.; Teitell, Michael A.			Quantifying Biomass Changes of Single CD8+T Cells during Antigen Specific Cytotoxicity	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; CD8(+) T-CELLS; PERIPHERAL-BLOOD; GENE-TRANSFER; PEPTIDE-MHC; CANCER; INTERFEROMETRY; METABOLISM; ACTIVATION	Existing approaches that quantify cytotoxic T cell responses rely on bulk or surrogate measurements which impede the direct identification of single activated T cells of interest. Single cell microscopy or flow cytometry methodologies typically rely on fluorescent labeling, which limits applicability to primary cells such as human derived T lymphocytes. Here, we introduce a quantitative method to track single T lymphocyte mediated cytotoxic events within a mixed population of cells using live cell interferometry (LCI), a label-free microscopy technique that maintains cell viability. LCI quantifies the mass distribution within individual cells by measuring the phase shift caused by the interaction of light with intracellular biomass. Using LCI, we imaged cytotoxic T cells killing cognate target cells. In addition to a characteristic target cell mass decrease of 20-60% over 1-4 h following attack by a T cell, there was a significant 4-fold increase in T cell mass accumulation rate at the start of the cytotoxic event and a 2-3 fold increase in T cell mass relative to the mass of unresponsive T cells. Direct, label-free measurement of CD8+ T and target cell mass changes provides a kinetic, quantitative assessment of T cell activation and a relatively rapid approach to identify specific, activated patient-derived T cells for applications in cancer immunotherapy.	[Zangle, Thomas A.; Teitell, Michael A.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Burnes, Daina; Witte, Owen N.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Mathis, Colleen; Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Witte, Owen N.; Teitell, Michael A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Bioengn Interdept Program, Los Angeles, CA USA; [Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu; mteitell@ucla.edu		Zangle, Thomas/0000-0001-5899-3517	UC Discovery/Abraxis Bioscience Biotechnology Award [Bio07-10663]; Broad Stem Cell Research Center at UCLA; Translational Acceleration Grant from the Caltech-UCLA Joint Center for Translational Medicine; NIH [T32CA009120, K25CA157940]; Natural Sciences and Engineering Research Council of Canada [PGS-D3 388938-2010]; NATIONAL CANCER INSTITUTE [R01CA156674, K25CA157940, T32CA009120, R01CA090571] Funding Source: NIH RePORTER	UC Discovery/Abraxis Bioscience Biotechnology Award(University of California System); Broad Stem Cell Research Center at UCLA; Translational Acceleration Grant from the Caltech-UCLA Joint Center for Translational Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a UC Discovery/Abraxis Bioscience Biotechnology Award (Bio07-10663, M. A. T., www.ucop.edu/research-grants-program), the Broad Stem Cell Research Center at UCLA (M. A. T., www.stemcell.ucla.edu), a Translational Acceleration Grant from the Caltech-UCLA Joint Center for Translational Medicine (M. A. T., www.jctm.caltech.edu), and training grants from the NIH (T32CA009120 and K25CA157940, T.A.Z.). D. L. B is supported by the Natural Sciences and Engineering Research Council of Canada Post Graduate Scholarship (PGS-D3 388938-2010). O.N.W. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P12; Delon J, 2002, IMMUNOL REV, V189, P51, DOI 10.1034/j.1600-065X.2002.18906.x; Edwards LJ, 2011, IMMUNOL RES, V50, P39, DOI 10.1007/s12026-011-8204-3; Elkord E, 2006, CLIN IMMUNOL, V120, P91, DOI 10.1016/j.clim.2005.12.008; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Hobeika AC, 2005, J IMMUNOTHER, V28, P63, DOI 10.1097/00002371-200501000-00008; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kalinski P, 2006, IMMUNOL RES, V36, P137, DOI 10.1385/IR:36:1:137; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Malyguine A, 2007, ADV EXP MED BIOL, V601, P273; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Reed J, 2008, ACS NANO, V2, P841, DOI 10.1021/nn700303f; Reed J, 2011, BIOPHYS J, V101, P1025, DOI 10.1016/j.bpj.2011.07.022; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ross K. F. A., 1967, PHASE CONTRAST INTER; Sauce D, 2002, J HEMATOTH STEM CELL, V11, P929, DOI 10.1089/152581602321080592; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Tuma RA, 2002, CURR OPIN IMMUNOL, V14, P348, DOI 10.1016/S0952-7915(02)00338-2; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Whiteside T L, 2004, Dev Biol (Basel), V116, P219; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x	32	27	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68916	10.1371/journal.pone.0068916	http://dx.doi.org/10.1371/journal.pone.0068916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935904	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000061
J	Boric, K; Orio, P; Vieville, T; Whitlock, K				Boric, Katica; Orio, Patricio; Vieville, Thierry; Whitlock, Kathleen			Quantitative Analysis of Cell Migration Using Optical Flow	PLOS ONE			English	Article							CRANIAL NEURAL CREST; SEXUAL-DIMORPHISM; ETHANOL EXPOSURE; FACIAL ASYMMETRY; ALCOHOL; ZEBRAFISH; MORPHOGENESIS; TOXICITY; DEATH; MODEL	Neural crest cells exhibit dramatic migration behaviors as they populate their distant targets. Using a line of zebrafish expressing green fluorescent protein (sox10:EGFP) in neural crest cells we developed an assay to analyze and quantify cell migration as a population, and use it here to characterize in detail the subtle defects in cell migration caused by ethanol exposure during early development. The challenge was to quantify changes in the in vivo migration of all Sox10: EGFP expressing cells in the visual field of time-lapse movies. To perform this analysis we used an Optical Flow algorithm for motion detection and combined the analysis with a fit to an affine transformation. Through this analysis we detected and quantified significant differences in the cell migrations of Sox10:EGFP positive cranial neural crest populations in ethanol treated versus untreated embryos. Specifically, treatment affected migration by increasing the left-right asymmetry of the migrating cells and by altering the direction of cell movements. Thus, by applying this novel computational analysis, we were able to quantify the movements of populations of cells, allowing us to detect subtle changes in cell behaviors. Because cranial neural crest cells contribute to the formation of the frontal mass these subtle differences may underlie commonly observed facial asymmetries in normal human populations.	[Boric, Katica; Orio, Patricio; Whitlock, Kathleen] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia, Valparaiso, Chile; [Vieville, Thierry] Inria, Mnemosyne, Sophia Antipolis, France	Universidad de Valparaiso; Inria	Whitlock, K (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia, Valparaiso, Chile.	kathleen.whitlock@uv.cl	Orio, Patricio/F-6207-2010	Orio, Patricio/0000-0003-0332-8098; Boric, Katica/0000-0003-2319-3063; Whitlock, Kathleen/0000-0002-2677-4368	ICM [Proyecto P09-022-F]; FONDECYT [1111046, 1130862]; ANR-47 CONICYT;  [NIHR01HD50820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050820] Funding Source: NIH RePORTER	ICM; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANR-47 CONICYT(French National Research Agency (ANR)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIHR01HD50820 (KEW), ICM Proyecto P09-022-F (PO, KEW, KB), FONDECYT 1111046 (KEW), ANR-47 CONICYT (PO, TV), FONDECYT 1130862 (PO), ACT-1113 (PO), and CONICYT Doctoral Fellowship (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; Bilotta J, 2004, NEUROTOXICOL TERATOL, V26, P737, DOI 10.1016/j.ntt.2004.06.011; BREEN EJ, 1994, MICROBIOL-SGM, V140, P1241, DOI 10.1099/13500872-140-5-1241; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Cartwright MM, 1995, ALCOHOL CLIN EXP RES, V19, P1454, DOI 10.1111/j.1530-0277.1995.tb01007.x; CARTWRIGHT MM, 1995, ALCOHOL CLIN EXP RES, V19, P378, DOI 10.1111/j.1530-0277.1995.tb01519.x; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Chen SY, 1996, ALCOHOL CLIN EXP RES, V20, P1071, DOI 10.1111/j.1530-0277.1996.tb01948.x; Clouthier DE, 2010, AM J MED GENET A, V152A, P2962, DOI 10.1002/ajmg.a.33568; Delpiano J, 2011, MACHINE VISION APPL; Dormann D, 1996, DEVELOPMENT, V122, P761; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ercan I, 2008, J ANAT, V213, P663, DOI 10.1111/j.1469-7580.2008.01002.x; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Klingenberg CP, 2010, ALCOHOL, V44, P649, DOI 10.1016/j.alcohol.2009.10.016; Kulesa PM, 2010, DEV BIOL, V344, P543, DOI 10.1016/j.ydbio.2010.04.010; Lebel C, 2012, J NEUROSCI, V32, P15243, DOI 10.1523/JNEUROSCI.1161-12.2012; Liu C, 2009, THESIS MIT MASSACHUS; Loucks E, 2004, NEUROTOXICOL TERATOL, V26, P745, DOI 10.1016/j.ntt.2004.06.017; Loucks EJ, 2007, BIRTH DEFECTS RES A, V79, P642, DOI 10.1002/bdra.20387; Loucks EJ, 2009, BIRTH DEFECTS RES A, V85, P556, DOI 10.1002/bdra.20564; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Oliverio M, 2010, AM J MED GENET A, V152A, P2419, DOI 10.1002/ajmg.a.33655; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Ronot X, 2000, CYTOMETRY, V41, P19, DOI 10.1002/1097-0320(20000901)41:1<19::AID-CYTO3>3.0.CO;2-X; ROVASIO RA, 1995, INT J DEV BIOL, V39, P421; Rovasio RA, 2002, ALCOHOL CLIN EXP RES, V26, P1286, DOI 10.1097/01.ALC>0000026102.7386.65; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Shaner DJ, 2000, AM J MED GENET, V93, P143, DOI 10.1002/1096-8628(20000717)93:2<143::AID-AJMG12>3.0.CO;2-Q; Sundquist T., 2006, CELL NOTES, V16, P18; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Theveneau E., 2012, DEV BIOL; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whitlock KE, 2004, MICROSC RES TECHNIQ, V65, P2, DOI 10.1002/jemt.20094; Whitlock KE, 2004, BRAIN BEHAV EVOLUT, V64, P126, DOI 10.1159/000079742	43	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69574	10.1371/journal.pone.0069574	http://dx.doi.org/10.1371/journal.pone.0069574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23936049	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700033
J	Braszewska-Zalewska, AJ; Wolny, EA; Smialek, L; Hasterok, R				Braszewska-Zalewska, Agnieszka J.; Wolny, Elzbieta A.; Smialek, Lukasz; Hasterok, Robert			Tissue-Specific Epigenetic Modifications in Root Apical Meristem Cells of Hordeum vulgare	PLOS ONE			English	Article							HISTONE H3; GENE-EXPRESSION; DNA METHYLATION; ARABIDOPSIS; CHROMATIN; HETEROCHROMATIN; ACETYLATION; PROTEINS; PATTERNS; PEA	Epigenetic modifications of chromatin structure are essential for many biological processes, including growth and reproduction. Patterns of DNA and histone modifications have recently been widely studied in many plant species, although there is virtually no data on the spatial and temporal distribution of epigenetic markers during plant development. Accordingly, we have used immunostaining techniques to investigate epigenetic modifications in the root apical meristem of Hordeum vulgare. Histone H4 acetylation (H4K5ac), histone H3 dimethylation (H3K4me2, H3K9me2) and DNA methylation (5mC) patterns were established for various root meristem tissues. Distinct levels of those modifications were visualised in the root cap, epidermis, cortex and vascular tissues. The lateral root cap cells seem to display the highest level of H3K9me2 and 5mC. In the epidermis, the highest level of 5mC and H3K9me2 was detected in the nuclei from the boundary of the proximal meristem and the elongation zone, while the vascular tissues were characterized by the highest level of H4K5ac. Some of the modified histones were also detectable in the cytoplasm in a highly tissue-specific manner. Immunolocalisation of epigenetic modifications of chromatin carried out in this way, on longitudinal or transverse sections, provides a unique topographic context within the organ, and will provide some answers to the significant biological question of tissue differentiation processes during root development in a monocotyledon plant species.	[Braszewska-Zalewska, Agnieszka J.; Wolny, Elzbieta A.; Smialek, Lukasz; Hasterok, Robert] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Hasterok, R (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	robert.hasterok@us.edu.pl	Hasterok, Robert/A-1629-2008	Hasterok, Robert/0000-0001-6667-2721; Braszewska, Agnieszka/0000-0003-0997-8753; Wolny, Elzbieta/0000-0001-7588-4830	National Science Centre [2011/01/B/NZ3/00177]	National Science Centre(National Science Centre, Poland)	The authors acknowledge financial support from the National Science Centre (grant no. 2011/01/B/NZ3/00177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, MOL PLANT, V3, P719, DOI 10.1093/mp/ssq026; Bitonti MB, 2011, PROG BOT, V72, P37, DOI 10.1007/978-3-642-13145-5_2; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Braszewska-Zalewska A, 2012, GENOME, V55, P68, DOI [10.1139/G11-076, 10.1139/g11-076]; Braszewska-Zalewska A, 2010, GENOME, V53, P203, DOI [10.1139/g09-088, 10.1139/G09-088]; BRIGHAM LA, 1995, PLANT PHYSIOL, V109, P457, DOI 10.1104/pp.109.2.457; Bruex A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002446; Caro E, 2007, NATURE, V447, P213, DOI 10.1038/nature05763; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; Chua YL, 2001, PLANT CELL, V13, P599, DOI 10.1105/tpc.13.3.599; Dutnall RN, 2003, MOL CELL, V12, P3, DOI 10.1016/S1097-2765(03)00282-X; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Hassan H, 2010, DEVELOPMENT, V137, P1523, DOI 10.1242/dev.048777; Heimsch C, 2008, AM J BOT, V95, P1, DOI 10.3732/ajb.95.1.1; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Horn R., 2009, ANN PLANT REV, V37, P64; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Hsieh TF, 2005, ANNU REV PLANT BIOL, V56, P327, DOI 10.1146/annurev.arplant.56.032604.144118; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kwasniewski M, 2006, PLANT PHYSIOL, V141, P1149, DOI 10.1104/pp.106.078626; Liljeroth E, 2001, PHYSIOL PLANTARUM, V111, P365, DOI 10.1034/j.1399-3054.2001.1110314.x; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lorvellec M., 2007, THESIS WAGENINGEN U; Marques A, 2011, CYTOGENET GENOME RES, V134, P72, DOI 10.1159/000323971; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Scacchi E, 2010, P NATL ACAD SCI USA, V107, P22734, DOI 10.1073/pnas.1014716108; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Shen WH, 2009, MOL PLANT, V2, P600, DOI 10.1093/mp/ssp022; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; STEEDMAN HF, 1957, NATURE, V179, P1345, DOI 10.1038/1791345a0; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Volkov RA, 2006, PROG BOT, V67, P101, DOI 10.1007/3-540-27998-9_5; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Zhang WJ, 2011, PLANT J, V68, P1, DOI 10.1111/j.1365-313X.2011.04668.x; Zhu T, 1998, PROTOPLASMA, V204, P84, DOI 10.1007/BF01282296	47	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69204	10.1371/journal.pone.0069204	http://dx.doi.org/10.1371/journal.pone.0069204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935955	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700020
J	Bila, DCA; Young, P; Merks, H; Vubil, AS; Mahomed, M; Augusto, A; Abreu, CM; Mabunda, NJ; Brooks, JI; Tanuri, A; Jani, IV				Adolfo Bila, Dulce Celina; Young, Peter; Merks, Harriet; Vubil, Adolfo Salvador; Mahomed, Mussagy; Augusto, Angelo; Abreu, Celina Monteiro; Mabunda, Nedio Jonas; Brooks, James I.; Tanuri, Amilcar; Jani, Ilesh Vinodrai			Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique	PLOS ONE			English	Article							SURVEILLANCE; MUTATIONS; PREVALENCE; PROTEASE; THERAPY	Objective: In Mozambique, highly active antiretroviral treatment (HAART) was introduced in 2004 followed by decentralization and expansion, resulting in a more than 20-fold increase in coverage by 2009. Implementation of HIV drug resistance threshold surveys (HIVDR-TS) is crucial in order to monitor the emergence of transmitted viral resistance, and to produce evidence-based recommendations to support antiretroviral (ARV) policy in Mozambique. Methods: World Health Organization (WHO) methodology was used to evaluate transmitted drug resistance (TDR) in newly diagnosed HIV-1 infected pregnant women attending ante-natal clinics in Maputo and Beira to non-nucleoside reverse transcriptase inhibitors (NNRTI), nucleoside reverse transcriptase inhibitors (NRTI) and protease inhibitors (PI). Subtypes were assigned using REGA HIV-1 subtyping tool and phylogenetic trees constructed using MEGA version 5. Results: Although mutations associated with resistance to all three drug were detected in these surveys, transmitted resistance was analyzed and classified as < 5% in Maputo in both surveys for all three drug classes. Transmitted resistance to NNRTI in Beira in 2009 was classified between 5-15%, an increase from 2007 when no NNRTI mutations were found. All sequences clustered with subtype C. Conclusions: Our results show that the epidemic is dominated by subtype C, where the first-line option based on two NRTI and one NNRTI is still effective for treatment of HIV infection, but intermediate levels of TDR found in Beira reinforce the need for constant evaluation with continuing treatment expansion in Mozambique.	[Adolfo Bila, Dulce Celina; Vubil, Adolfo Salvador; Mahomed, Mussagy; Augusto, Angelo; Mabunda, Nedio Jonas; Jani, Ilesh Vinodrai] Inst Nacl Saude, Maputo, Mozambique; [Adolfo Bila, Dulce Celina; Abreu, Celina Monteiro; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil; [Young, Peter] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Maputo, Mozambique; [Merks, Harriet; Brooks, James I.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Brooks, James I.] Univ Ottawa, Ottawa, ON, Canada	Universidade Federal do Rio de Janeiro; Public Health Agency of Canada; University of Ottawa	Bila, DCA (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	dulcebila@gmail.com	Abreu, Celina Monteiro/AAT-7447-2020; Tanuri, Amilcar/AAM-8601-2021	Jani, Ilesh/0000-0002-6880-6655	President's Emergency Plan for AIDS Relief (PEPFAR) through the Department of Health and Human Services/Centers for Disease Control and Prevention Division of Global HIV/AIDS [1U2GPS001093]; WHO	President's Emergency Plan for AIDS Relief (PEPFAR) through the Department of Health and Human Services/Centers for Disease Control and Prevention Division of Global HIV/AIDS; WHO(World Health Organization)	Development of this publication was supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Department of Health and Human Services/Centers for Disease Control and Prevention Division of Global HIV/AIDS Cooperative Agreement 1U2GPS001093. This work was also supported by WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CM, 2008, ARCH VIROL, V153, P2013, DOI 10.1007/s00705-008-0215-6; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Bartolo I, 2009, J ACQ IMMUN DEF SYND, P323; Bellocchi MC, 2005, J MED VIROL, V76, P452, DOI 10.1002/jmv.20382; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2005, AIDS, V19, P1329, DOI 10.1097/01.aids.0000180107.19006.02; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dumans AT, 2009, INFECT GENET EVOL, V9, P62, DOI 10.1016/j.meegid.2008.10.002; Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003; INS/INE, 2010, INQ NAC PREV RISC CO; Jayaraman GC, 2006, JAIDS-J ACQ IMM DEF, V42, P86, DOI 10.1097/01.qai.0000196666.16616.fe; Kamoto K, 2008, ANTIVIR THER, V13, P83; Maphalala G, 2008, ANTIVIR THER, V13, P95; Mark M, 2012, SEMIQUANTITATIVE EVA; MISAU, 2009, B EP MIN SAUD MOC MI; MISAU, 2010, GUIA TRAT INF HIV AL; MISAU, 2007, B EP MIN SAUD MOC MI; Myatt M, 2008, ANTIVIR THER, V13, P37; Nyombi Balthazar M, 2008, AIDS Res Ther, V5, P13, DOI 10.1186/1742-6405-5-13; Perno CF, 2002, AIDS, V16, P619, DOI 10.1097/00002030-200203080-00014; Pilay C, 2002, RES HUMAN RETROVIRUS, V18, P605; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; UNAIDS, 2012, GLOBAL REPORT UNAIDS; WHO, 2006, GUID TREATM MON HIV	26	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68213	10.1371/journal.pone.0068213	http://dx.doi.org/10.1371/journal.pone.0068213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935858	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200005
J	Mahboob, A; Vassiliev, S; Poddutoori, PK; van der Est, A; Bruce, D				Mahboob, Abdullah; Vassiliev, Serguei; Poddutoori, Prashanth K.; van der Est, Art; Bruce, Doug			Factors Controlling the Redox Potential of ZnCe6 in an Engineered Bacterioferritin Photochemical 'Reaction Centre'	PLOS ONE			English	Article							PHOTOSYSTEM-II; SYNTHETIC ANALOGS; ELECTRON-TRANSFER; ATOMIC CHARGES; FREE-ENERGIES; TYROSINE; CHLOROPHYLLS; OXIDATION; IRON; MODEL	Photosystem II (PSII) of photosynthesis has the unique ability to photochemically oxidize water. Recently an engineered bacterioferritin photochemical 'reaction centre' (BFR-RC) using a zinc chlorin pigment (ZnCe6) in place of its native heme has been shown to photo-oxidize bound manganese ions through a tyrosine residue, thus mimicking two of the key reactions on the electron donor side of PSII. To understand the mechanism of tyrosine oxidation in BFR-RCs, and explore the possibility of water oxidation in such a system we have built an atomic-level model of the BFR-RC using ONIOM methodology. We studied the influence of axial ligands and carboxyl groups on the oxidation potential of ZnCe6 using DFT theory, and finally calculated the shift of the redox potential of ZnCe6 in the BFR-RC protein using the multi-conformational molecular mechanics-Poisson-Boltzmann approach. According to our calculations, the redox potential for the first oxidation of ZnCe6 in the BRF-RC protein is only 0.57 V, too low to oxidize tyrosine. We suggest that the observed tyrosine oxidation in BRF-RC could be driven by the ZnCe6 di-cation. In order to increase the efficiency of tyrosine oxidation, and ultimately oxidize water, the first potential of ZnCe6 would have to attain a value in excess of 0.8 V. We discuss the possibilities for modifying the BFR-RC to achieve this goal.	[Mahboob, Abdullah; Vassiliev, Serguei; Bruce, Doug] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Poddutoori, Prashanth K.; van der Est, Art] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Brock University; Brock University	Mahboob, A (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	am03ph@brocku.ca	Vassiliev, Serguei/D-6418-2015	Vassiliev, Serguei/0000-0001-7351-3251; Mahboob, Abdulla/0000-0002-3521-5664; Poddutoori, Prashanth/0000-0001-6007-8801	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Discovery and Equipment grants from the Natural Science and Engineering Research Council of Canada. It was made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET) and Compute/Calcul Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; [Anonymous], 2008, AMBER 10; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; Barker PD, 1996, BIOCHEMISTRY-US, V35, P13618, DOI 10.1021/bi961127x; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berry BW, 2012, P NATL ACAD SCI USA, V109, P9739, DOI 10.1073/pnas.1112057109; Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Comte P, 2011, BIOSYSTEMS, V105, P263, DOI 10.1016/j.biosystems.2011.05.013; Conlan B, 2007, PHOTOSYNTH RES, V91, P281; Conlan B, 2009, BBA-BIOENERGETICS, V1787, P1112, DOI 10.1016/j.bbabio.2009.04.011; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; FAJER J, 1970, J AM CHEM SOC, V92, P3451, DOI 10.1021/ja00714a038; Frisch M. J., 2009, GAUSSIAN 16 REVISION; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Hasegawa K, 2005, BIOCHEMISTRY-US, V44, P8865, DOI 10.1021/bi050273c; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Heimdal J, 2007, J BIOL INORG CHEM, V12, P49, DOI 10.1007/s00775-006-0164-z; Hingorani K, 2009, AUST J CHEM, V62, P1351, DOI 10.1071/CH09264; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P4118, DOI 10.1021/bi047922p; Ishikita H, 2006, P NATL ACAD SCI USA, V103, P9855, DOI 10.1073/pnas.0601446103; Ishikita H, 2006, BIOPHYS J, V90, P3886, DOI 10.1529/biophysj.105.076984; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Kee HL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1125, DOI 10.1111/j.1751-1097.2007.00151.x; Kee HL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1110, DOI 10.1111/j.1751-1097.2007.00150.x; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lin CL, 2002, J ELECTROANAL CHEM, V531, P155, DOI 10.1016/S0022-0728(02)01056-2; Marenich AV, 2007, J CHEM THEORY COMPUT, V3, P2011, DOI 10.1021/ct7001418; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Moore GF, 2010, J PHYS CHEM B, V114, P14450, DOI 10.1021/jp101592m; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smith K.M., 1975, PORPHYRINS METALLOPO; Song YF, 2006, BIOCHEMISTRY-US, V45, P7959, DOI 10.1021/bi052183d; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Tan CH, 2006, J PHYS CHEM B, V110, P18680, DOI 10.1021/jp063479b; Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; WILLIAMS JC, 1992, BIOCHEMISTRY-US, V31, P11029, DOI 10.1021/bi00160a012; Wydrzynski T., 2005, PHOTOSYSTEM 2 LIGHT, V22; Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282	45	4	4	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68421	10.1371/journal.pone.0068421	http://dx.doi.org/10.1371/journal.pone.0068421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935866	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200007
J	Chen, YL; Wang, TH; Hsu, HC; Yuan, RH; Jeng, YM				Chen, Yu-Ling; Wang, Ting-Huang; Hsu, Hey-Chi; Yuan, Ray-Hwang; Jeng, Yung-Ming			Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis	PLOS ONE			English	Article							PLANAR CELL POLARITY; TRIPLE-HELIX REPEAT; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; EXPRESSION; PROTEIN; ADHESION; MIGRATION; KINASE; EPIDEMIOLOGY	Collagen triple helix repeat containing-1 (CTHRC1) is a secreted glycoprotein that activates the planar cell polarity pathway of Wnt signaling. Using microarray analysis, we found that the CTHRC1 gene is overexpressed in hepatocellular carcinoma (HCC). The level of CTHRC1 mRNA was measured in 201 surgically resected HCCs using real time reverse transcription-polymerase chain reaction. Overexpression of CTHRC1 in HCC was associated with large tumor size and advanced tumor stage. Furthermore, expression of CTHRC1 as was identified as an independent prognostic factors in the multivariate analysis. Suppression of CTHRC1 expression inhibited tumor migration and invasion whereas overexpression of CTHRC1 promoted tumor invasion. Activation of RhoA, but not Rac1 or Cdc42, was found to play a crucial role in CTHRC1-induced cell migration. CTHRC1 promoted adhesion of cancer cells to extracellular matrix through induction of integrin beta 1 expression and activation of focal adhesion kinase. These results suggest CTHRC1 promotes tumor invasion and metastasis by enhancing the adhesion and migratory abilities of tumor cells. It is also a promising biomarker for predicting the prognosis of patients with HCC.	[Chen, Yu-Ling; Wang, Ting-Huang; Hsu, Hey-Chi; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Chen, Yu-Ling; Wang, Ting-Huang; Hsu, Hey-Chi; Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan.	mrna0912@yahoo.com.tw		Yuan, Ray-Hwang/0000-0002-2767-633X; JENG, YUNG-MING/0000-0002-3878-4491	National Science Council, Taiwan, Republic of China [100-2320-B-002-011-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from National Science Council, Taiwan, Republic of China. (100-2320-B-002-011-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chung S, 2007, GENETICS, V176, P891, DOI 10.1534/genetics.106.069021; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; HSU HC, 1994, HEPATOLOGY, V19, P122, DOI 10.1016/0270-9139(94)90062-0; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wong CCL, 2010, LIVER INT, V30, P642, DOI 10.1111/j.1478-3231.2010.02232.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	26	45	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70324	10.1371/journal.pone.0070324	http://dx.doi.org/10.1371/journal.pone.0070324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922981	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700175
J	Sawada, S; Kon, M; Wada, S; Ushida, T; Suzuki, K; Akimoto, T				Sawada, Shuji; Kon, Michihiro; Wada, Shogo; Ushida, Takashi; Suzuki, Katsuhiko; Akimoto, Takayuki			Profiling of Circulating MicroRNAs after a Bout of Acute Resistance Exercise in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; HORMONAL RESPONSES; MESSENGER-RNAS; EXPRESSION; PLASMA; CELLS; SERUM; MIR-221; CANCER; DEHYDRATION	Recent studies have revealed a new aspect of physiological regulation in which microRNAs (miRNAs) play fundamental roles in diverse biological and pathological processes. Furthermore, it was recently discovered that miRNAs are stably secreted into blood and that circulating miRNAs may play important roles in cell-cell communication. Here, we examined whether the circulating miRNA profile is affected by acute resistance exercise. Twelve males performed a resistance exercise session (bench press and leg press), consisting of five sets of 10 repetitions at 70% of maximum strength, with a 1 min rest between sets. Blood samples were taken before exercise, and at 0 and 60 min, 1 day, and 3 days after exercise. The circulating miRNA profile was determined by microarray analysis. Quantitative real-time PCR confirmed that the miR-149* level increased three days after resistance exercise. In contrast, the miR-146a and miR-221 levels decreased three days after resistance exercise. Our findings suggest that circulating miRNA levels change in response to acute resistance exercise, and miRNAs may play important roles in resistance-exercise-induced adaptation.	[Sawada, Shuji; Suzuki, Katsuhiko] Waseda Univ, Tokyo Univ Agr & Technol, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Kon, Michihiro] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan; [Wada, Shogo; Ushida, Takashi; Akimoto, Takayuki] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Regenerat Med Engn, Tokyo, Japan	Waseda University; University of Tokyo	Akimoto, T (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Regenerat Med Engn, Tokyo, Japan.	akimoto@m.u-tokyo.ac.jp	Suzuki, Katsuhiko/AAI-2197-2019; Akimoto, Takayuki/H-6704-2012	Suzuki, Katsuhiko/0000-0002-6572-5809; Akimoto, Takayuki/0000-0002-8874-7779	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23240097]; Japan Institute of Sports Sciences; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Institute of Sports Sciences; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Grant-in Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23240097 to K. S.), and by Grants-in-Aid for Scientific Research from the Japan Institute of Sports Sciences (to M. K.). M. K. was supported by a fellowship from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Consitt LA, 2002, SPORTS MED, V32, P1, DOI 10.2165/00007256-200232010-00001; COSTILL DL, 1974, J APPL PHYSIOL, V37, P521, DOI 10.1152/jappl.1974.37.4.521; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Drummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Hakkinen K, 1998, EUR J APPL PHYSIOL O, V77, P312, DOI 10.1007/s004210050339; HAKKINEN K, 1993, J APPL PHYSIOL, V74, P882, DOI 10.1152/jappl.1993.74.2.882; Jensen SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-435; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MORITANI T, 1979, AM J PHYS MED REHAB, V58, P115; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Oerlemans MI, 2012, EMBO MOL MED; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Recommendations of the German Society for Clinical Chemistry, 1977, J CLIN CHEM CLIN BIO, V15, P255; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; STARON RS, 1994, J APPL PHYSIOL, V76, P1247, DOI 10.1152/jappl.1994.76.3.1247; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Uhlemann M., 2012, EUR J PREV IN PRESS; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang G, 2010, J RHEUMATOL, V37, P2516, DOI 10.3899/jrheum.100308; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	41	80	84	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70823	10.1371/journal.pone.0070823	http://dx.doi.org/10.1371/journal.pone.0070823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923026	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700209
J	Sethman, CR; Hawiger, J				Sethman, Chad R.; Hawiger, Jacek			The Innate Immunity Adaptor SARM Translocates to the Nucleus to Stabilize Lamins and Prevent DNA Fragmentation in Response to Pro-Apoptotic Signaling	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CELL-DEATH; PROTEIN; MITOCHONDRIA; ACTIVATION; CLEAVAGE; TRANSCRIPTION; LOCALIZATION; REQUIREMENT; EXPRESSION	Sterile alpha and armadillo-motif containing protein (SARM), a highly conserved and structurally unique member of the MyD88 family of Toll-like receptor adaptors, plays an important role in innate immunity signaling and apoptosis. Its exact mechanism of intracellular action remains unclear. Apoptosis is an ancient and ubiquitous process of programmed cell death that results in disruption of the nuclear lamina and, ultimately, dismantling of the nucleus. In addition to supporting the nuclear membrane, lamins serve important roles in chromatin organization, epigenetic regulation, transcription, nuclear transport, and mitosis. Mutations and other damage that destabilize nuclear lamins (laminopathies) underlie a number of intractable human diseases. Here, we report that SARM translocates to the nucleus of human embryonic kidney cells by using its amino-terminal Armadillo repeat region. Within the nucleus, SARM forms a previously unreported lattice akin to the nuclear lamina scaffold. Moreover, we show that SARM protects lamins from apoptotic degradation and reduces internucleosomal DNA fragmentation in response to signaling induced by the proinflammatory cytokine Tumor Necrosis Factor alpha. These findings indicate an important link between the innate immunity adaptor SARM and stabilization of nuclear lamins during inflammation-driven apoptosis in human cells.	[Sethman, Chad R.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Hawiger, Jacek] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA; [Hawiger, Jacek] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hawiger, J (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA.	jacek.hawiger@vanderbilt.edu			National Institutes of Health (NIH) [HL085833, R01AA15752, P30DK058404, P30CA068485]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) Cellular and Molecular Microbiology Postgraduate Training Grant [T32 AI049824]; Ruth L. Kirschstein National Research Service Awards Individual Fellowship [F32 HL084214]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085833, F32HL084214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases (NIAID) Cellular and Molecular Microbiology Postgraduate Training Grant; Ruth L. Kirschstein National Research Service Awards Individual Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health (NIH) grants HL085833 and R01AA15752. CRS was supported by NIH/National Institute of Allergy and Infectious Diseases (NIAID) Cellular and Molecular Microbiology Postgraduate Training Grant (T32 AI049824) and a Ruth L. Kirschstein National Research Service Awards Individual Fellowship (F32 HL084214). Core Services performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by NIH grant P30DK058404 Core Scholarship and the Vanderbilt Ingram Cancer Center supported by NIH grant P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; Broers JLV, 1999, J CELL SCI, V112, P3463; Buendia B, 2001, CELL MOL LIFE SCI, V58, P1781, DOI 10.1007/PL00000818; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cavanagh MM, 2012, CURR OPIN IMMUNOL; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Counis MF, 2000, BIOCHEM CELL BIOL, V78, P405, DOI 10.1139/bcb-78-4-405; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Elcock LS, 2008, BIOCHEM SOC T, V36, P1378, DOI 10.1042/BST0361378; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hou YJ, 2013, J IMMUNOLOGY; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kolb T, 2011, NUCLEUS-PHILA, V2, P425, DOI 10.4161/nucl.2.5.17765; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Martelli AM, 2001, J CELL BIOCHEM, V82, P634, DOI 10.1002/jcb.1186; Matsuzaki J, 2012, CARCINOGENESIS, V33, P996, DOI 10.1093/carcin/bgs118; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Montague P, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-63; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okinaga T, 2007, J MED MICROBIOL, V56, P1399, DOI 10.1099/jmm.0.47193-0; Panneerselvam P, 2013, CELL DEATH DIFFER, V20, P478, DOI 10.1038/cdd.2012.144; Panneerselvam P, 2012, BIOCHEM J, V442, P263, DOI 10.1042/BJ20111653; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Raz V, 2006, J CELL SCI, V119, P4247, DOI 10.1242/jcs.03180; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Salaun B, 2007, EUR J IMMUNOL, V37, P3311, DOI 10.1002/eji.200737744; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shevtsova Z, 2006, EUR J NEUROSCI, V23, P1961, DOI 10.1111/j.1460-9568.2006.04725.x; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Styers ML, 2010, METHODS MOL BIOL, V657, P43, DOI 10.1007/978-1-60761-783-9_4; Szretter KJ, 2009, J VIROL; Thomas LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045088; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Vaidya S, 2011, BIOCHEMISTRY-US, V50, P3282, DOI 10.1021/bi2001664; Wang PH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052088, 10.1371/journal.pone.0057020]; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70994	10.1371/journal.pone.0070994	http://dx.doi.org/10.1371/journal.pone.0070994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923041	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700218
J	Tsujino, N; Tsunematsu, T; Uchigashima, M; Konno, K; Yamanaka, A; Kobayashi, K; Watanabe, M; Koyama, Y; Sakurai, T				Tsujino, Natsuko; Tsunematsu, Tomomi; Uchigashima, Motokazu; Konno, Kohtarou; Yamanaka, Akihiro; Kobayashi, Kazuto; Watanabe, Masahiko; Koyama, Yoshimasa; Sakurai, Takeshi			Chronic Alterations in Monoaminergic Cells in the Locus Coeruleus in Orexin Neuron-Ablated Narcoleptic Mice	PLOS ONE			English	Article							SLEEP-WAKING CYCLE; IN-VIVO MICRODIALYSIS; DORSAL RAPHE NUCLEUS; RAT-BRAIN; NORADRENERGIC NEURONS; EXTRACELLULAR LEVELS; SEROTONIN NEURONS; HYPOTHALAMIC AREA; FRONTAL-CORTEX; WAKE CYCLE	Narcolepsy patients often suffer from insomnia in addition to excessive daytime sleepiness. Narcoleptic animals also show behavioral instability characterized by frequent transitions between all vigilance states, exhibiting very short bouts of NREM sleep as well as wakefulness. The instability of wakefulness states in narcolepsy is thought to be due to deficiency of orexins, neuropeptides produced in the lateral hypothalamic neurons, which play a highly important role in maintaining wakefulness. However, the mechanism responsible for sleep instability in this disorder remains to be elucidated. Because firing of orexin neurons ceases during sleep in healthy animals, deficiency of orexins does not explain the abnormality of sleep. We hypothesized that chronic compensatory changes in the neurophysiologica activity of the locus coeruleus (LC) and dorsal raphe (DR) nucleus in response to the progressive loss of endogenous orexin tone underlie the pathological regulation of sleep/wake states. To evaluate this hypothesis, we examined firing patterns of serotonergic (5-HT) neurons and noradrenergic (NA) neurons in the brain stem, two important neuronal populations in the regulation of sleep/wakefulness states. We recorded single-unit activities of 5-HT neurons and NA neurons in the DR nucleus and LC of orexin neuron-ablated narcoleptic mice. We found that while the firing pattern of 5-HT neurons in narcoleptic mice was similar to that in wildtype mice, that of NA neurons was significantly different from that in wildtype mice. In narcoleptic mice, NA neurons showed a higher firing frequency during both wakefulness and NREM sleep as compared with wildtype mice. In vitro patch-clamp study of NA neurons of narcoleptic mice suggested a functional decrease of GABAergic input to these neurons. These alterations might play roles in the sleep abnormality in narcolepsy.	[Tsujino, Natsuko; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan; [Tsujino, Natsuko; Sakurai, Takeshi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Tsunematsu, Tomomi; Yamanaka, Akihiro] Nagoya Univ, Environm Med Res Inst, Nagoya, Aichi 464, Japan; [Uchigashima, Motokazu; Konno, Kohtarou; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat & Embryol, Sapporo, Hokkaido, Japan; [Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Dept Mol Genet, Fukushima, Japan; [Koyama, Yoshimasa] Fukushima Univ, Dept Sci & Technol, Fukushima, Japan	Kanazawa University; University of Tsukuba; Nagoya University; Hokkaido University; Fukushima Medical University; Fukushima University	Koyama, Y (corresponding author), Fukushima Univ, Dept Sci & Technol, Fukushima, Japan.	koyamay@sss.fukushima-u.ac.jp; tsakurai@med.kanazawa-u.ac.jp	Watanabe, Masahiko/S-3614-2019; Yamanaka, Akihiro/AAD-8641-2021	Watanabe, Masahiko/0000-0001-5037-7138; Yamanaka, Akihiro/0000-0001-6099-7306; Tsunematsu, Tomomi/0000-0002-2711-4679	Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research [23300119, 24700322, 25830031] Funding Source: KAKEN	Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research (B) for Young Scientists and the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown RE, 2002, J NEUROSCI, V22, P8850; Chu M, 2004, NEUROSCI RES, V49, P417, DOI 10.1016/j.neures.2004.05.001; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Fukudome Y, 2004, EUR J NEUROSCI, V19, P2682, DOI 10.1111/j.0953-816X.2004.03384.x; Gervasoni D, 1998, EUR J NEUROSCI, V10, P964, DOI 10.1046/j.1460-9568.1998.00106.x; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; KOYAMA Y, 1993, NEUROSCIENCE, V55, P1117, DOI 10.1016/0306-4522(93)90325-A; KOYAMA Y, 1994, NEUROSCI RES, V19, P31, DOI 10.1016/0168-0102(94)90005-1; KOYAMA Y, 1994, NEUROSCIENCE, V63, P1021, DOI 10.1016/0306-4522(94)90569-X; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lena I, 2005, J NEUROSCI RES, V81, P891, DOI 10.1002/jnr.20602; Liu RJ, 2002, J NEUROSCI, V22, P9453; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Park SP, 1999, BRAIN RES, V833, P291, DOI 10.1016/S0006-8993(99)01511-5; Peyron C, 1998, J NEUROSCI, V18, P9996; Portas CM, 1998, NEUROSCIENCE, V83, P807, DOI 10.1016/S0306-4522(97)00438-7; PUIZILLOUT JJ, 1979, J PHYSIOLOGY PARIS, V75, P531; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; Shouse MN, 2000, BRAIN RES, V860, P181, DOI 10.1016/S0006-8993(00)02013-8; Strecker R E, 1999, Sleep Res Online, V2, P21; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; SZYMUSIAK R, 1989, BRAIN RES BULL, V23, P111, DOI 10.1016/0361-9230(89)90169-X; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Takahashi K, 2005, REGUL PEPTIDES, V126, P43, DOI 10.1016/j.regpep.2004.08.009; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; Taneja P, 2009, J NEUROSCI, V29, P12187, DOI 10.1523/JNEUROSCI.3156-09.2009; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; VANNIMERCIER G, 1984, CR ACAD SCI III-VIE, V298, P195; Verret L, 2006, J COMP NEUROL, V495, P573, DOI 10.1002/cne.20891; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134	43	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70012	10.1371/journal.pone.0070012	http://dx.doi.org/10.1371/journal.pone.0070012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922890	Green Published, gold			2022-12-27	WOS:000323369700118
J	Xu, ZL; Feng, ZD; Yang, JJ; Zheng, JH; Zhang, F				Xu, Zhonglin; Feng, Zhaodong; Yang, Jianjun; Zheng, Jianghua; Zhang, Fang			Nowhere to Invade: Rumex crispus and Typha latifolia Projected to Disappear under Future Climate Scenarios	PLOS ONE			English	Article							POTENTIAL DISTRIBUTIONS; SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; PLANT; INVASION; HABITAT; COMMUNITIES; PREDICTIONS; EVOLUTION; NICHES	Future climate change has been predicted to affect the potential distribution of plant species. However, only few studies have addressed how invasive species may respond to future climate change despite the known effects of plant species invasion on nutrient cycles, ecosystem functions, and agricultural yields. In this study, we predicted the potential distributions of two invasive species, Rumex crispus and Typha latifolia, under current and future (2050) climatic conditions. Future climate scenarios considered in our study include A1B, A2, A2A, B1, and B2A. We found that these two species will lose their habitat under the A1B, A2, A2A, and B1 scenarios. Their distributions will be maintained under future climatic conditions related to B2A scenarios, but the total area will be less than 10% of that under the current climatic condition. We also investigated variations of the most influential climatic variables that are likely to cause habitat loss of the two species. Our results demonstrate that rising mean annual temperature, variations of the coldest quarter, and precipitation of the coldest quarter are the main factors contributing to habitat loss of R. crispus. For T. latifolia, the main factors are rising mean annual temperature, variations in temperature of the coldest quarter, mean annual precipitation, and precipitation of the coldest quarter. These results demonstrate that the warmer and wetter climatic conditions of the coldest season (or month) will be mainly responsible for habitat loss of R. crispus and T. latifolia in the future. We also discuss uncertainties related to our study (and similar studies) and suggest that particular attention should be directed toward the manner in which invasive species cope with rapid climate changes because evolutionary change can be rapid for species that invade new areas.	[Xu, Zhonglin; Yang, Jianjun; Zheng, Jianghua; Zhang, Fang] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China; [Xu, Zhonglin; Zheng, Jianghua] Xinjiang Univ, Key Lab City Intellectualizing & Environm Modelli, Urumqi, Peoples R China; [Feng, Zhaodong] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Xinjiang University; Xinjiang University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Xu, ZL (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Peoples R China.	galinwa@gmail.com	Xu, Zhonglin/GQH-1906-2022; yang, jian/HIK-0188-2022		Nation Natural Science Foundation of China [91025015, 41201032, 41271168, 41265002, 51269030, 51104127]; Key research program of University at Xinjiang [XJDX2012I13]; Yangtse Rive Scholar and Initiative Research Group Development Program (Ministry of Education, China) [IRT1180]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key research program of University at Xinjiang; Yangtse Rive Scholar and Initiative Research Group Development Program (Ministry of Education, China)	This project was supported by Nation Natural Science Foundation of China (No. 91025015, No. 41201032, No. 41271168, No. 41265002, No. 51269030, No. 51104127); Key research program of University at Xinjiang (XJDX2012I13); The Yangtse Rive Scholar and Initiative Research Group Development Program (Ministry of Education, China, No. IRT1180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft MB, 2011, ECOL MODEL, V222, P524, DOI 10.1016/j.ecolmodel.2010.10.003; Barrows CW, 2008, BIOL CONSERV, V141, P1885, DOI 10.1016/j.biocon.2008.05.006; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Bradley BA, 2009, GLOBAL CHANGE BIOL, V15, P1511, DOI 10.1111/j.1365-2486.2008.01824.x; BUSBY JR, 1986, AUST J ECOL, V11, P1, DOI 10.1111/j.1442-9993.1986.tb00912.x; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Center for Natural Resources, 2003, MAINT REST LANDSC IN; Chuine I, 2012, DIVERS DISTRIB, V18, P661, DOI 10.1111/j.1472-4642.2011.00880.x; Davies GM, 2012, ECOL APPL, V22, P1562, DOI 10.1890/10-2089.1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Follak S, 2013, WEED RES, V53, P53, DOI 10.1111/j.1365-3180.2012.00952.x; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; International Panel on Climate Change (IPCC), 2007, CLIM CHANG 2007 4 AS; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; MCNAUGHTON SJ, 1966, ECOL MONOGR, V36, P297, DOI 10.2307/1942372; Meineri E, 2012, ECOL MODEL, V231, P1, DOI 10.1016/j.ecolmodel.2012.01.021; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Ministry of Environment & Forests, 2003, ANN REPORT; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Parmesan C, 2006, ANN REV ECOL EVOL S, V37, P215; Peng RH, 2011, OECOLOGIA, V165, P797, DOI 10.1007/s00442-010-1887-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Robert J., 2008, LANDSCAPE ECOL, V23, P727; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Sergio C, 2007, BIOL CONSERV, V135, P341, DOI 10.1016/j.biocon.2006.10.018; Steiner FM, 2008, DIVERS DISTRIB, V14, P538, DOI 10.1111/j.1472-4642.2008.00472.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sugui JA, 2012, J CLIN MICROBIOL, V50, P3309, DOI 10.1128/JCM.01509-12; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Turner MG, 2003, LANDSCAPE ECOL, V18, P449, DOI 10.1023/A:1026033116193; *USDA, 2010, PLANTS DAT; WALKER PA, 1991, GLOBAL ECOL BIOGEOGR, V1, P108, DOI 10.2307/2997706; Watson AJ, 2008, ENVIRON RESOUR ECON, V39, P37, DOI 10.1007/s10640-007-9173-9; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wickham JD, 2013, GLOBAL ECOL BIOGEOGR, V22, P620, DOI 10.1111/geb.12013; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wilson Peter D., 2009, Plant Protection Quarterly, V24, P84; Wise RM, 2012, J ARID ENVIRON, V84, P80, DOI 10.1016/j.jaridenv.2012.03.001; Zhan AB, 2012, ECOL EVOL, V2, P1331, DOI 10.1002/ece3.258; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	55	11	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70728	10.1371/journal.pone.0070728	http://dx.doi.org/10.1371/journal.pone.0070728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923020	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700205
J	Yi, X; Jin, GH; Zhang, XH; Mao, WF; Li, HM; Qin, JB; Shi, JH; Dai, K; Zhang, F				Yi, Xin; Jin, Guohua; Zhang, Xinhua; Mao, Weifeng; Li, Haoming; Qin, Jianbing; Shi, Jinhong; Dai, Kui; Zhang, Fan			Cortical Endogenic Neural Regeneration of Adult Rat after Traumatic Brain Injury	PLOS ONE			English	Article							STEM-CELLS; SUBVENTRICULAR ZONE; COGNITIVE FUNCTION; GENERATED NEURONS; CEREBRAL-CORTEX; RADIAL GLIA; NEUROGENESIS; NEOCORTEX; PROGENITOR; MIGRATION	Focal and diffuse neuronal loss happened after traumatic brain injury (TBI). With little in the way of effective repair, recent interest has focused on endogenic neural progenitor cells (NPCs) as a potential method for regeneration. Whether endogenic neural regeneration happened in the cortex of adult rat after TBI remains to be determined. In this study, rats were divided into a sham group and a TBI group, and the rat model of medium TBI was induced by controlled cortical impact. Rats were injected with BrdU at 1 to 7 days post-injury (dpi) to allow identification of differentiated cells and sacrificed at 1, 3, 7, 14 and 28 dpi for immunofluorescence. Results showed nestin(+)/sox-2(+) NPCs and GFAP(+)/sox-2(+) radial glial (RG)-like cells emerged in peri-injured cortex at 1, 3, 7, 14 dpi and peaked at 3 dpi. The number of GFAP(+)/sox-2(+) cells was less than that of nestin(+)/sox-2(+) cells. Nestin(+)/sox-2(+) cells from posterior periventricle (pPV) immigrated into peri-injured cortex through corpus callosum (CC) were found. DCX+/BrdU(+) newborn immature neurons in peri-injured cortex were found only at 3, 7, 14 dpi. A few MAP-2(+)/BrdU(+) newborn neurons in peri-injured cortex were found only at 7 and 14 dpi. NeuN(+)/BrdU(+) mature neurons were not found in peri-injured cortex at 1, 3, 7, 14 and 28 dpi. While GFAP(+)/BrdU(+) astrocytes emerged in peri-injured cortex at 1, 3, 7, 14, 28 dpi and peaked at 7 dpi then kept in a stable state. In the corresponding time point, the percentage of GFAP(+)/BrdU(+) astrocytes in BrdU(+) cells was more than that of NPCs or newborn neurons. No CNP+/BrdU(+) oligodendrocytes were found in peri-injured cortex. These findings suggest that NPCs from pPV and reactive RG-like cells emerge in peri-injured cortex of adult rats after TBI. It can differentiate into immature neurons and astrocytes, but the former fail to grow up to mature neurons.	[Yi, Xin] Soochow Univ, Coll Med, Dept Anat & Cytoneurobiol, Suzhou, Peoples R China; [Yi, Xin; Jin, Guohua; Zhang, Xinhua; Mao, Weifeng; Li, Haoming; Qin, Jianbing; Shi, Jinhong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, Nantong, Peoples R China; [Dai, Kui; Zhang, Fan] Nantong Univ, Xinglin Coll, Nantong, Peoples R China	Soochow University - China; Nantong University; Nantong University	Jin, GH (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Dept Anat & Neurobiol, Nantong, Peoples R China.	jguohua@ntu.edu.cn	Li, Hao/GPS-9834-2022	Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of China [31271138]; Jiangsu Natural Science Foundation [BK2012659]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31271138), the Jiangsu Natural Science Foundation (Grant No. BK2012659), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li HM, 2011, IN VITRO CELL DEV-AN, V47, P431, DOI 10.1007/s11626-011-9422-7; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Otero L, 2012, HISTOL HISTOPATHOL, V27, P303, DOI 10.14670/HH-27.303; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2006, ACTA NEUROCHIR, V148, P773, DOI 10.1007/s00701-006-0778-5; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x	38	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70306	10.1371/journal.pone.0070306	http://dx.doi.org/10.1371/journal.pone.0070306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922973	gold, Green Published			2022-12-27	WOS:000323369700168
J	Haines, FJ; Hofmann, MA; King, DP; Drew, TW; Crooke, HR				Haines, Felicity J.; Hofmann, Martin A.; King, Donald P.; Drew, Trevor W.; Crooke, Helen R.			Development and Validation of a Multiplex, Real-Time RT PCR Assay for the Simultaneous Detection of Classical and African Swine Fever Viruses	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RESPIRATORY SYNDROME-VIRUS; DIAGNOSTIC EVALUATION; ROUTINE DIAGNOSIS; CLINICAL-SAMPLES; INTERNAL CONTROL; AMPLIFICATION; BLOOD; APRIL; RNA	A single-step, multiplex, real-time polymerase chain reaction (RT-PCR) was developed for the simultaneous and differential laboratory diagnosis of Classical swine fever virus (CSFV) and African swine fever virus (ASFV) alongside an exogenous internal control RNA (IC-RNA). Combining a single extraction methodology and primer and probe sets for detection of the three target nucleic acids CSFV, ASFV and IC-RNA, had no effect on the analytical sensitivity of the assay and the new triplex RT-PCR was comparable to standard PCR techniques for CSFV and ASFV diagnosis. After optimisation the assay had a detection limit of 5 CSFV genome copies and 22 ASFV genome copies. Analytical specificity of the triplex assay was validated using a panel of viruses representing 9 of the 11 CSFV subgenotypes, at least 8 of the 22 ASFV genotypes as well as non-CSFV pestiviruses. Positive and negative clinical samples from animals infected experimentally, due to field exposure or collected from the UK which is free from both swine diseases, were used to evaluate the diagnostic sensitivity and specificity for detection of both viruses. The diagnostic sensitivity was 100% for both viruses whilst diagnostic specificity estimates were 100% for CSFV detection and 97.3% for ASFV detection. The inclusion of a heterologous internal control allowed identification of false negative results, which occurred at a higher level than expected. The triplex assay described here offers a valuable new tool for the differential detection of the causative viruses of two clinically indistinguishable porcine diseases, whose geographical occurrence is increasingly overlapping.	[Haines, Felicity J.; Drew, Trevor W.; Crooke, Helen R.] Anim Hlth & Vet Labs Agcy, Dept Virol, Surrey, England; [Hofmann, Martin A.] Inst Virol & Immunoprophylaxis, Dept Dev, Mittelhausern, Switzerland; [King, Donald P.] Pirbright Inst, Pirbright Lab, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Crooke, HR (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Virol, Surrey, England.	Helen.Crooke@ahvla.gsi.gov.uk	Drew, Trevor W/C-5200-2011; Crooke, Helen/D-6710-2011; Drew, Trevor W/ABB-5205-2020	Crooke, Helen/0000-0003-1237-6542; Drew, Trevor/0000-0002-0448-1062; King, Donald/0000-0002-6959-2708	DEFRA [SV3000, SV3031]	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by DEFRA project SV3000 and SV3031. www.defra.gov.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2004, VET RES, V35, P551, DOI 10.1051/vetres:2004031; Aguero M, 2003, J CLIN MICROBIOL, V41, P4431, DOI 10.1128/JCM.41.9.4431-4434.2003; AKANE A, 1994, J FORENSIC SCI, V39, P362; [Anonymous], 2012, WORLD ANIMAL HLTH IN; [Anonymous], 2012, INTRO QUANTITATIVE P; Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Blome S, 2010, VET MICROBIOL, V146, P276, DOI 10.1016/j.vetmic.2010.05.035; Cheng D, 2008, J VIROL METHODS, V151, P194, DOI 10.1016/j.jviromet.2008.05.011; Das A, 2011, J VET DIAGN INVEST, V23, P727, DOI 10.1177/1040638711407685; Demeke T, 2010, ANAL BIOANAL CHEM, V396, P1977, DOI 10.1007/s00216-009-3150-9; Depner K, 2006, J VET MED B, V53, P317, DOI 10.1111/j.1439-0450.2006.00972.x; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Everett H, 2011, TRANSBOUND EMERG DIS, V58, P128, DOI 10.1111/j.1865-1682.2011.01202.x; Everett H, 2010, VET MICROBIOL, V142, P26, DOI 10.1016/j.vetmic.2009.09.039; Fernandez-Pinero J, 2013, TRANSBOUND EMERG DIS, V60, P48, DOI 10.1111/j.1865-1682.2012.01317.x; Giammarioli M, 2008, VET RES COMMUN, V32, P255, DOI 10.1007/s11259-007-9026-6; Graham SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029310; Graham SP, 2010, VET MICROBIOL, V142, P34, DOI 10.1016/j.vetmic.2009.09.040; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Perez LJ, 2011, J VIROL METHODS, V174, P53, DOI 10.1016/j.jviromet.2011.03.022; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; Le Dimna M, 2008, J VIROL METHODS, V147, P136, DOI 10.1016/j.jviromet.2007.08.013; Le Potier MF, 2006, DEV BIOLOGICALS, V126, P179; Liu SS, 2011, J VIROL METHODS, V172, P88, DOI 10.1016/j.jviromet.2010.12.023; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; McGoldrick A, 1999, J VIROL METHODS, V79, P85, DOI 10.1016/S0166-0934(99)00010-5; McGoldrick A, 1998, J VIROL METHODS, V72, P125, DOI 10.1016/S0166-0934(97)00208-5; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; OIE, 2008, AFR SWIN FEV MAN DIA, P1069; OIE, 2012, MANUAL DIAGNOSTIC TE, V1, P89; OIE, 2008, CLASS SWIN FEV MAN D, P1092; Ophuis RJAO, 2006, J VIROL METHODS, V131, P78, DOI 10.1016/j.jviromet.2005.07.008; Paton D, 2002, TRENDS IN EMERGING VIRAL INFECTIONS OF SWINE, P153; Risatti G, 2005, J CLIN MICROBIOL, V43, P468, DOI 10.1128/JCM.43.1.468-471.2005; Risatti GR, 2003, J CLIN MICROBIOL, V41, P500, DOI 10.1128/JCM.41.1.500-505.2003; Roberts H, 2012, VET REC, V171, P188, DOI 10.1136/vr.e5586; Roberts H, 2012, VET REC, V170, P146, DOI 10.1136/vr.e605; Roberts H, 2011, VET REC, V169, P118, DOI 10.1136/vr.d4518; Roberts H, 2011, VET REC, V168, P476, DOI 10.1136/vr.d2825; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; Sandvik T, 2005, VET REC, V157, P267, DOI 10.1136/vr.157.9.267; Thiel HJ, 2005, VIRUS TAXONOMY; Tignon M, 2011, J VIROL METHODS, V178, P161, DOI 10.1016/j.jviromet.2011.09.007; WANG JT, 1992, J CLIN MICROBIOL, V30, P750, DOI 10.1128/JCM.30.3.750-753.1992; Wernike K, 2013, J CLIN MICROBIOL, V51, P938, DOI 10.1128/JCM.02947-12; Zsak L, 2005, J CLIN MICROBIOL, V43, P112, DOI 10.1128/JCM.43.1.112-119.2005	48	51	64	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71019	10.1371/journal.pone.0071019	http://dx.doi.org/10.1371/journal.pone.0071019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923045	Green Submitted, gold, Green Published			2022-12-27	WOS:000322838900186
J	Suh, JH; Sieglaff, DH; Zhang, AJ; Xia, XF; Cvoro, A; Winnier, GE; Webb, P				Suh, Ji Ho; Sieglaff, Douglas H.; Zhang, Aijun; Xia, Xuefeng; Cvoro, Aleksandra; Winnier, Glenn E.; Webb, Paul			SIRT1 is a Direct Coactivator of Thyroid Hormone Receptor beta 1 with Gene-Specific Actions	PLOS ONE			English	Article							CPT-I-ALPHA; EXPRESSION PATTERNS; METABOLIC DISEASE; RESPONSE ELEMENT; GAMMA; ACETYLATION; PGC-1-ALPHA; MICROARRAY; BINDING; SYSTEM	Sirtuin 1 (SIRT1) NAD(+)-dependent deacetylase regulates energy metabolism by modulating expression of genes involved in gluconeogenesis and other liver fasting responses. While many effects of SIRT1 on gene expression are mediated by deacetylation and activation of peroxisome proliferator activated receptor coactivator a (PGC-1 alpha), SIRT1 also binds directly to DNA bound transcription factors, including nuclear receptors (NRs), to modulate their activity. Since thyroid hormone receptor beta 1 (TR beta 1) regulates several SIRT1 target genes in liver and interacts with PGC-1 alpha, we hypothesized that SIRT1 may influence TR beta 1. Here, we confirm that SIRT1 cooperates with PGC-1 alpha to enhance response to triiodothyronine, T-3. We also find, however, that SIRT1 stimulates TR beta 1 activity in a manner that is independent of PGC-1 alpha but requires SIRT1 deacetylase activity. SIRT1 interacts with TR beta 1 in vitro, promotes TR beta 1 deacetylation in the presence of T-3 and enhances ubiquitin-dependent TR beta 1 turnover; a common response of NRs to activating ligands. More surprisingly, SIRT1 knockdown only strongly inhibits T-3 response of a subset of TR beta 1 target genes, including glucose 6 phosphatase (G-6-Pc), and this is associated with blockade of TR beta 1 binding to the G-6-Pc promoter. Drugs that target the SIRT1 pathway, resveratrol and nicotinamide, modulate T-3 response at dual TR beta 1/SIRT1 target genes. We propose that SIRT1 is a gene-specific TR beta 1 coregulator and TR beta 1/SIRT1 interactions could play important roles in regulation of liver metabolic response. Our results open possibilities for modulation of subsets of TR target genes with drugs that influence the SIRT1 pathway.	[Suh, Ji Ho; Sieglaff, Douglas H.; Zhang, Aijun; Xia, Xuefeng; Cvoro, Aleksandra; Winnier, Glenn E.; Webb, Paul] Methodist Hosp, Res Inst, Genom Med Program, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston	Webb, P (corresponding author), Methodist Hosp, Res Inst, Genom Med Program, 6535 Fannin, Houston, TX 77030 USA.	PWebb@tmhs.org			Methodist Hospital Research Institute; National Institutes of Health [RC4 DK090849]	Methodist Hospital Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by programmatic funding from the Methodist Hospital Research Institute and National Institutes of Health RC4 DK090849 to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baxter JD, NAT REV DRUG DISCOV, V8, P308; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Brunelle M, 2011, THYROID, V21, P311, DOI 10.1089/thy.2009.0363; Cordeiro A, 2013, J ENDOCRINOL, V216, P181, DOI 10.1530/JOE-12-0420; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; GIRALT M, 1991, J BIOL CHEM, V266, P21991; Hipp D. R, SQLITE; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin HY, 2005, STEROIDS, V70, P444, DOI 10.1016/j.steroids.2005.03.001; Lin JZ, PLOS ONE, V8; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Lonard DM, 2009, PROG MOL BIOL TRANSL, V87, P117, DOI 10.1016/S1877-1173(09)87004-X; LUCAS PC, 1991, MOL CELL BIOL, V11, P6343; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Sadana P, 2007, MOL CELL ENDOCRINOL, V267, P6, DOI 10.1016/j.mce.2006.11.012; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez-Pacheco A, 2009, ENDOCRINOLOGY, V150, P5143, DOI 10.1210/en.2009-0117; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Team RDC, 2009, R LANG ENV STAT COMP; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Vujovic M, 2009, ENDOCRINOLOGY, V150, P2940, DOI 10.1210/en.2008-1085; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002; Weiss RE, 2004, VITAM HORM, V68, P185; Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Weth O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010119; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Yuan CS, 2013, J STEROID BIOCHEM, V133, P58, DOI 10.1016/j.jsbmb.2012.09.001; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200	44	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70097	10.1371/journal.pone.0070097	http://dx.doi.org/10.1371/journal.pone.0070097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922917	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900145
J	Tanaka, M; Ishii, A; Watanabe, Y				Tanaka, Masaaki; Ishii, Akira; Watanabe, Yasuyoshi			Neural Correlates of Central Inhibition during Physical Fatigue	PLOS ONE			English	Article							MENTAL FATIGUE; MUSCLE FATIGUE; AFFERENTS; EXCITABILITY; CONTRACTION; OUTPUT; BEAT	Central inhibition plays a pivotal role in determining physical performance during physical fatigue. Classical conditioning of central inhibition is believed to be associated with the pathophysiology of chronic fatigue. We tried to determine whether classical conditioning of central inhibition can really occur and to clarify the neural mechanisms of central inhibition related to classical conditioning during physical fatigue using magnetoencephalography (MEG). Eight right-handed volunteers participated in this study. We used metronome sounds as conditioned stimuli and maximum handgrip trials as unconditioned stimuli to cause central inhibition. Participants underwent MEG recording during imagery of maximum grips of the right hand guided by metronome sounds for 10 min. Thereafter, fatigue-inducing maximum handgrip trials were performed for 10 min; the metronome sounds were started 5 min after the beginning of the handgrip trials. The next day, neural activities during imagery of maximum grips of the right hand guided by metronome sounds were measured for 10 min. Levels of fatigue sensation and sympathetic nerve activity on the second day were significantly higher relative to those of the first day. Equivalent current dipoles (ECDs) in the posterior cingulated cortex (PCC), with latencies of approximately 460 ms, were observed in all the participants on the second day, although ECDs were not identified in any of the participants on the first day. We demonstrated that classical conditioning of central inhibition can occur and that the PCC is involved in the neural substrates of central inhibition related to classical conditioning during physical fatigue.	[Tanaka, Masaaki; Ishii, Akira; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Watanabe, Yasuyoshi] Ctr Life Sci Technol, RIKEN, Kobe, Hyogo, Japan	Osaka Metropolitan University; RIKEN	Tanaka, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan.	masa-t@msic.med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [KAKENHI: 23300241]; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The authors thank Forte Science Communication for editorial assistance with the manuscript. This work was supported in part by the Grant-in-Aid for Scientific Research B (KAKENHI: 23300241) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the grant from Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Allen D, 2004, SCIENCE, V305, P1112, DOI 10.1126/science.1103078; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Bowyer SM, 2003, J CLIN NEUROPHYSIOL, V20, P87, DOI 10.1097/00004691-200304000-00001; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Doronbekov TK, 2005, PSYCHIAT CLIN NEUROS, V59, P155, DOI 10.1111/j.1440-1819.2005.01351.x; Fredrikson M, 1995, NEUROREPORT, V7, P97, DOI 10.1097/00001756-199512000-00023; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Garland SJ, 1995, ADV EXP MED BIOL, V384, P271; GARLAND SJ, 1988, J PHYSIOL-LONDON, V401, P547, DOI 10.1113/jphysiol.1988.sp017178; GARLAND SJ, 1991, J PHYSIOL-LONDON, V435, P547, DOI 10.1113/jphysiol.1991.sp018524; HAYWARD L, 1991, J NEUROPHYSIOL, V65, P360, DOI 10.1152/jn.1991.65.2.360; HAYWARD L, 1988, BRAIN RES, V440, P199, DOI 10.1016/0006-8993(88)91178-X; Ishii A, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-24; Jouanin JC, 2009, HUM BRAIN MAPP, V30, P675, DOI 10.1002/hbm.20534; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Nugent AC, 2011, INT J PSYCHOPHYSIOL, V80, P182, DOI 10.1016/j.ijpsycho.2011.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagani M, 1997, CIRCULATION, V95, P1441; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Peltier SJ, 2005, BRAIN RES, V1057, P10, DOI 10.1016/j.brainres.2005.06.078; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shigihara Y, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-2; Tajima S, 2010, NEUROL RES INT, P2010; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Tanaka M, 2011, BRAIN RES, V1412, P37, DOI 10.1016/j.brainres.2011.07.021; Tanaka M, 2010, MED HYPOTHESES, V75, P244, DOI 10.1016/j.mehy.2010.02.032; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Tsutsumi K, 2011, EUR J SPORT SCI, V11, P171, DOI 10.1080/17461391.2010.499974; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Vrana J, 2005, NEUROSCI LETT, V386, P170, DOI 10.1016/j.neulet.2005.06.005	39	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70949	10.1371/journal.pone.0070949	http://dx.doi.org/10.1371/journal.pone.0070949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923034	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900179
J	Cheng, SH; Lau, KM; Li, CK; Chan, NPH; Ip, RKL; Cheng, CK; Lee, V; Shing, MMK; Leung, AWK; Ha, SY; Cheuk, DKL; Lee, ACW; Li, CH; Luk, CW; Ling, SC; Hrusak, O; Mejstrikova, E; Leung, Y; Ng, MHL				Cheng, Suk Hang; Lau, Kin Mang; Li, Chi Kong; Chan, Natalie P. H.; Ip, Rosalina K. L.; Cheng, Chi Keung; Lee, Vincent; Shing, Matthew M. K.; Leung, Alex W. K.; Ha, Shau Yin; Cheuk, Daniel K. L.; Lee, Anselm C. W.; Li, Chak Ho; Luk, Chung Wing; Ling, Siu Cheung; Hrusak, Ondrej; Mejstrikova, Ester; Leung, Yonna; Ng, Margaret H. L.			Minimal Residual Disease-Based Risk Stratification in Chinese Childhood Acute Lymphoblastic Leukemia by Flow Cytometry and Plasma DNA Quantitative Polymerase Chain Reaction	PLOS ONE			English	Article							CANCER-PATIENTS; CLINICAL-SIGNIFICANCE; GENE REARRANGEMENTS; PROGNOSTIC-FACTORS; CHILDREN; QUANTIFICATION; CLASSIFICATION; MULTICENTER; INTEGRITY; CELLS	Minimal residual disease, or MRD, is an important prognostic indicator in childhood acute lymphoblastic leukemia. In ALL-IC-BFM 2002 study, we employed a standardized method of flow cytometry MRD monitoring for multiple centers internationally using uniformed gating, and determined the relevant MRD-based risk stratification strategies in our local patient cohort. We also evaluated a novel method of PCR MRD quantitation using peripheral blood plasma. For the bone marrow flow MRD study, patients could be stratified into 3 risk groups according to MRD level using a single time-point at day-15 (Model I) (I-A: <0.1%, I-B: 0.1-10%, I-C: >10%), or using two time-points at day-15 and day-33 (Model II) (II-A: day-15<10% and day-33<0.01%, II-B: day-15 >= 10% or day-33 >= 0.01% but not both, II-C: day-15 >= 10% and day-33 >= 0.01%), which showed significantly superior prediction of relapse (p = .00047 and <0.0001 respectively). Importantly, patients with good outcome (frequency: 56.0%, event-free survival: 90.1%) could be more accurately predicted by Model II. In peripheral blood plasma PCR MRD investigation, patients with day-15-MRD >= 10(-4) were at a significantly higher risk of relapse (p = 0.0117). By multivariate analysis, MRD results from both methods could independently predict patients' prognosis, with 20-35-fold increase in risk of relapse for flow MRD I-C and II- C respectively, and 5.8-fold for patients having plasma MRD of >= 10(-4). We confirmed that MRD detection by flow cytometry is useful for prognostic evaluation in our Chinese cohort of childhood ALL after treatment. Moreover, peripheral blood plasma DNA MRD can be an alternative where bone marrow specimen is unavailable and as a less invasive method, which allows close monitoring.	[Cheng, Suk Hang; Lau, Kin Mang; Chan, Natalie P. H.; Ip, Rosalina K. L.; Cheng, Chi Keung; Leung, Yonna; Ng, Margaret H. L.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Li, Chi Kong; Shing, Matthew M. K.; Leung, Alex W. K.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Ha, Shau Yin; Cheuk, Daniel K. L.] Queen Mary Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Lee, Anselm C. W.; Li, Chak Ho] Tuen Mun Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Luk, Chung Wing] Queen Elizabeth Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Ling, Siu Cheung] Princess Margaret Hosp, Dept Pediat, Hong Kong, Hong Kong, Peoples R China; [Hrusak, Ondrej; Mejstrikova, Ester] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Ng, Margaret H. L.] Chinese Univ Hong Kong, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Tuen Mun Hospital; Charles University Prague; Chinese University of Hong Kong; State Key Lab Oncology South China	Ng, MHL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.	margaretng@cuhk.edu.hk	Leung, Kwan Alex/ABD-7456-2020; Lee, Anselm/AAP-6028-2020; Cheng, Suk Hang/A-6177-2009; Li, Chi-kong/J-8456-2013	Lee, Anselm/0000-0002-0148-8875; Cheng, Suk Hang/0000-0002-2880-2289; Li, Chi-kong/0000-0002-2810-5758; HA, Shau Yin/0000-0002-9191-8743; Lau, Kin-Mang/0000-0001-5888-1937; Leung, Wing kwan/0000-0001-9781-5908; Cheuk, Daniel/0000-0001-9553-3528	Research Grant Council Earmarked Grant [4408/06M]; Children's Cancer Foundation of Hong Kong SAR	Research Grant Council Earmarked Grant; Children's Cancer Foundation of Hong Kong SAR	The study was supported by Research Grant Council Earmarked Grant 4408/06M, and Children's Cancer Foundation of Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Coustan-Smith E, 2002, BLOOD, V100, P52, DOI 10.1182/blood-2002-01-0006; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Coustan-Smith E, 2006, BLOOD, V108, P97, DOI 10.1182/blood-2006-01-0066; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Dworzak MN, 2008, CYTOM PART B-CLIN CY, V74B, P331, DOI 10.1002/cyto.b.20430; Esteller M, 1999, CANCER RES, V59, P67; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Fronkova E, 2008, LEUKEMIA, V22, P989, DOI 10.1038/leu.2008.22; Gao YJ, 2010, CLIN CHEM LAB MED, V48, P1651, DOI 10.1515/CCLM.2010.311; Jahr S, 2001, CANCER RES, V61, P1659; Kalina T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-38; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Mejstrikova E, 2010, PEDIATR BLOOD CANCER, V54, P62, DOI 10.1002/pbc.22261; Ng MHL, 2001, HUM PATHOL, V32, P1016, DOI 10.1053/hupa.2001.27122; Patkar N, 2012, CYTOM PART B-CLIN CY, V82B, P252, DOI 10.1002/cyto.b.21017; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schwarz AK, 2009, ANN HEMATOL, V88, P897, DOI 10.1007/s00277-009-0698-6; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Thorn I, 2011, BRIT J HAEMATOL, V152, P743, DOI 10.1111/j.1365-2141.2010.08456.x; van der Velden VHJ, 2007, LEUKEMIA, V21, P604, DOI 10.1038/sj.leu.2404586; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Vrooman LM, 2009, CURR OPIN PEDIATR, V21, P1, DOI 10.1097/MOP.0b013e32831f1f24; Wang BG, 2003, CANCER RES, V63, P3966	29	20	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69467	10.1371/journal.pone.0069467	http://dx.doi.org/10.1371/journal.pone.0069467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936021	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300040
J	Yanagida, A; Ito, K; Chikada, H; Nakauchi, H; Kamiya, A				Yanagida, Ayaka; Ito, Keiichi; Chikada, Hiromi; Nakauchi, Hiromitsu; Kamiya, Akihide			An In Vitro Expansion System for Generation of Human iPS Cell-Derived Hepatic Progenitor-Like Cells Exhibiting a Bipotent Differentiation Potential	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LIVER DEVELOPMENT; EFFICIENT DIFFERENTIATION; HEMATOPOIETIC STEM; RAT HEPATOCYTES; GROWTH-FACTOR; ONCOSTATIN-M; FIBROBLASTS; LINES; ENRICHMENT	Hepatoblasts, hepatic stem/progenitor cells in liver development, have a high proliferative potential and the ability to differentiate into both hepatocytes and cholangiocytes. In regenerative medicine and drug screening for the treatment of severe liver diseases, human induced pluripotent stem (iPS) cell-derived mature functional hepatocytes are considered to be a potentially good cell source. However, induction of proliferation of these cells is difficult ex vivo. To circumvent this problem, we generated hepatic progenitor-like cells from human iPS cells using serial cytokine treatments in vitro. Highly proliferative hepatic progenitor-like cells were purified by fluorescence-activated cell sorting using antibodies against CD13 and CD133 that are known cell surface markers of hepatic stem/progenitor cells in fetal and adult mouse livers. When the purified CD13(high) CD133(+) cells were cultured at a low density with feeder cells in the presence of suitable growth factors and signaling inhibitors (ALK inhibitor A-83-01 and ROCK inhibitor Y-27632), individual cells gave rise to relatively large colonies. These colonies consisted of two types of cells expressing hepatocytic marker genes (hepatocyte nuclear factor 4 alpha and alpha-fetoprotein) and a cholangiocytic marker gene (cytokeratin 7), and continued to proliferate over long periods of time. In a spheroid formation assay, these cells were found to express genes required for mature liver function, such as cytochrome P450 enzymes, and secrete albumin. When these cells were cultured in a suitable extracellular matrix gel, they eventually formed a cholangiocytic cyst-like structure with epithelial polarity, suggesting that human iPS cell-derived hepatic progenitor-like cells have a bipotent differentiation ability. Collectively these data indicate that this novel procedure using an in vitro expansion system is useful for not only liver regeneration but also for the determination of molecular mechanisms that regulate liver development.	[Yanagida, Ayaka; Ito, Keiichi; Nakauchi, Hiromitsu; Kamiya, Akihide] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo, Japan; [Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Chiyoda Ku, Tokyo, Japan; [Chikada, Hiromi; Kamiya, Akihide] Tokai Univ, Inst Innovat Sci & Technol, Isehara, Kanagawa, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokai University	Kamiya, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo, Japan.	kamiyaa@tokai-u.jp			Global COE Program; Ministry of Education, Culture, Sports, Science and Technology in Japan [23689040, 24249056]; Ministry of Heath, Labor and Welfare in Japan; Nakatomi Foundation; Grants-in-Aid for Scientific Research [25670373, 24112505, 23689040] Funding Source: KAKEN	Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Heath, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Global COE Program and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (23689040 and 24249056) and Grants-in-Aid for Scientific Research from the Ministry of Heath, Labor and Welfare in Japan. This work was also supported by a research grant from the Nakatomi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Basma H, 2009, GASTROENTEROLOGY; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Fiegel HC, 2003, HEPATOLOGY, V37, P148, DOI 10.1053/jhep.2003.50007; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Ito H, 2012, LIVER INT, V32, P592, DOI 10.1111/j.1478-3231.2011.02741.x; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kakinuma S, 2009, J HEPATOL, V51, P127, DOI 10.1016/j.jhep.2009.02.033; Kamiya A, 2001, FEBS LETT, V492, P90, DOI 10.1016/S0014-5793(01)02140-8; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; KOIDE N, 1989, BIOCHEM BIOPH RES CO, V161, P385, DOI 10.1016/0006-291X(89)91609-4; Kojima N, 2000, BIOCHEM BIOPH RES CO, V277, P152, DOI 10.1006/bbrc.2000.3635; Lu HF, 2005, ACTA BIOMATER, V1, P399, DOI 10.1016/j.actbio.2005.04.003; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Meindl-Beinker NM, 2012, DIGEST DIS, V30, P514, DOI 10.1159/000341704; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Minguet S, 2003, J CLIN INVEST, V112, P1152, DOI 10.1172/JCI200317409; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Okada K, 2012, STEM CELLS DEV, V21, P1124, DOI 10.1089/scd.2011.0229; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onitsuka I, 2010, GASTROENTEROLOGY, V138, P1525, DOI 10.1053/j.gastro.2009.12.059; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Si-Tayeb K, 2010, HIGHLY EFFICIENT GEN; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; TAKEZAWA T, 1992, J CELL SCI, V101, P495; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	46	53	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e67541	10.1371/journal.pone.0067541	http://dx.doi.org/10.1371/journal.pone.0067541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935837	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300003
J	Celes, MRN; Malvestio, LM; Suadicani, SO; Prado, CM; Figueiredo, MJ; Campos, EC; Freitas, ACS; Spray, DC; Tanowitz, HB; da Silva, JS; Rossi, MA				Celes, Mara R. N.; Malvestio, Lygia M.; Suadicani, Sylvia O.; Prado, Cibele M.; Figueiredo, Maria J.; Campos, Erica C.; Freitas, Ana C. S.; Spray, David C.; Tanowitz, Herbert B.; da Silva, Joao S.; Rossi, Marcos A.			Disruption of Calcium Homeostasis in Cardiomyocytes Underlies Cardiac Structural and Functional Changes in Severe Sepsis	PLOS ONE			English	Article							SKELETAL-MUSCLE; DYSTROPHIN; MECHANISMS; CA2+; PROTEINS; CALPAIN; HEART; EXPRESSION; PATHOPHYSIOLOGY; CARDIOMYOPATHY	Sepsis, a major cause of morbidity/mortality in intensive care units worldwide, is commonly associated with cardiac dysfunction, which worsens the prognosis dramatically for patients. Although in recent years the concept of septic cardiomyopathy has evolved, the importance of myocardial structural alterations in sepsis has not been fully explored. This study offers novel and mechanistic data to clarify subcellular events that occur in the pathogenesis of septic cardiomyopathy and myocardial dysfunction in severe sepsis. Cultured neonatal mice cardiomyocytes subjected to serum obtained from mice with severe sepsis presented striking increment of [Ca2+](i) and calpain-1 levels associated with decreased expression of dystrophin and disruption and derangement of F-actin filaments and cytoplasmic bleb formation. Severe sepsis induced in mice led to an increased expression of calpain-1 in cardiomyocytes. Moreover, decreased myocardial amounts of dystrophin, sarcomeric actin, and myosin heavy chain were observed in septic hearts associated with depressed cardiac contractile dysfunction and a very low survival rate. Actin and myosin from the sarcomere are first disassembled by calpain and then ubiquitinated and degraded by proteasome or sequestered inside specialized vacuoles called autophagosomes, delivered to the lysosome for degradation forming autophagolysosomes. Verapamil and dantrolene prevented the increase of calpain-1 levels and preserved dystrophin, actin, and myosin loss/reduction as well cardiac contractile dysfunction associated with strikingly improved survival rate. These abnormal parameters emerge as therapeutic targets, which modulation may provide beneficial effects on future vascular outcomes and mortality in sepsis. Further studies are needed to shed light on this mechanism, mainly regarding specific calpain inhibitors.	[Celes, Mara R. N.; Malvestio, Lygia M.; Prado, Cibele M.; Figueiredo, Maria J.; Campos, Erica C.; Freitas, Ana C. S.; Rossi, Marcos A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil; [da Silva, Joao S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Immunol, Sao Paulo, Brazil; [da Silva, Joao S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem, Sao Paulo, Brazil; [Celes, Mara R. N.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Suadicani, Sylvia O.] Yeshiva Univ, Albert Einstein Coll Med, Dept Urol, Bronx, NY USA; [Spray, David C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY USA; [Celes, Mara R. N.; Tanowitz, Herbert B.] Yeshiva Univ, Albert Einstein Coll Med, Dept Pathol, Bronx, NY USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Goias; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Celes, MRN (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil.	mrubia.celes@usp.br	Freitas, Ana CS/H-8953-2012; Silva, Joao/A-4484-2008; Celes, Mara Rubia/I-8707-2019; Celes, Mara/K-7274-2013; Prado, Cibele M/P-5773-2016	Silva, Joao/0000-0002-3410-3927; Celes, Mara Rubia/0000-0002-4733-007X; Celes, Mara/0000-0002-4733-007X; Prado, Cibele M/0000-0003-4321-0879; Spray, David/0000-0001-8368-5073	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [07/58843-2, 09/17787-8, 09/54010-1, 09/02942-8, 09/53544-2, 10/19216-5, 10/18629-4, 10/13199-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [302387/2008-0, 470536/2008-0, 472419/2009-9]; Fogarty International Training Grant [D43-TW007129]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fogarty International Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (07/58843-2, 09/17787-8, 09/54010-1, 09/02942-8, 09/53544-2, 10/19216-5, 10/18629-4, 10/13199-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (302387/2008-0, 470536/2008-0, 472419/2009-9) and by a Fogarty International Training Grant (D43-TW007129). MAR is Senior Investigator (1A) of Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Anderson SA, 1999, J NEUROCHEM, V72, P2617, DOI 10.1046/j.1471-4159.1999.0722617.x; Armstrong SC, 2001, J MOL CELL CARDIOL, V33, P149, DOI 10.1006/jmcc.2000.1288; BHATTACHARYYA J, 1991, CIRC SHOCK, V35, P117; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Celes MRN, 2010, SHOCK, V33, P322, DOI 10.1097/SHK.0b013e3181b38ef6; Celes MRN, 2007, CRIT CARE MED, V35, P2176, DOI 10.1097/01.CCM.0000281454.97901.01; Celes MRN, 2010, LAB INVEST, V90, P531, DOI 10.1038/labinvest.2010.3; COTTIN P, 1992, BIOCHIMIE, V74, P565, DOI 10.1016/0300-9084(92)90156-9; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Dibb KM, 2007, CELL CALCIUM, V42, P503, DOI 10.1016/j.ceca.2007.04.002; ELLIGET KA, 1991, CELL BIOL TOXICOL, V7, P263; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Ghadially F.N, 1975, ULTRASTRUCTURAL PATH; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hassoun SM, 2008, CRIT CARE MED, V36, P2590, DOI 10.1097/CCM.0b013e3181844276; HEIN S, 1994, J MOL CELL CARDIOL, V26, P1291, DOI 10.1006/jmcc.1994.1148; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; Hunter JD, 2010, BRIT J ANAESTH, V104, P3, DOI 10.1093/bja/aep339; Kawada T, 2005, BBA-PROTEINS PROTEOM, V1751, P73, DOI 10.1016/j.bbapap.2005.01.001; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; LIU MS, 1987, BIOCHEM MED METAB B, V37, P73, DOI 10.1016/0885-4505(87)90011-9; Muller-Werdan Ursula, 2006, Exp Clin Cardiol, V11, P226; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NICOTERA P, 1986, FEBS LETT, V209, P139, DOI 10.1016/0014-5793(86)81099-7; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Radimerski TM, 2011, INNATE IMMUN-LONDON, V17, P403, DOI 10.1177/1753425910377100; ROSSI MA, 1983, BRIT J EXP PATHOL, V64, P373; Rossi MA, 2007, SHOCK, V27, P10, DOI 10.1097/01.shk.0000235141.05528.47; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sharov VG, 2005, HEART FAIL REV, V10, P297, DOI 10.1007/s10741-005-7544-2; SMITH MW, 1991, P NATL ACAD SCI USA, V88, P4926, DOI 10.1073/pnas.88.11.4926; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; SONG SK, 1993, P NATL ACAD SCI USA, V90, P3933, DOI 10.1073/pnas.90.9.3933; Suadicani SO, 2000, AM J PHYSIOL-HEART C, V279, pH3076, DOI 10.1152/ajpheart.2000.279.6.H3076; Suadicani SO, 2004, GLIA, V48, P217, DOI 10.1002/glia.20071; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Toyo-Oka T, 2004, P NATL ACAD SCI USA, V101, P7381, DOI 10.1073/pnas.0401944101; Vieillard-Baron A, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-6; Vincent JL, 2005, CRIT CARE, V9, pS9, DOI 10.1186/cc3748; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang SQ, 2000, SCI CHINA SER C, V43, P191, DOI 10.1007/BF02879128; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Williams AB, 1999, FASEB J, V13, P1435, DOI 10.1096/fasebj.13.11.1435; Zhu XS, 2005, CRIT CARE MED, V33, P598, DOI 10.1097/01.ccm.0000152223.27176.A6	54	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68809	10.1371/journal.pone.0068809	http://dx.doi.org/10.1371/journal.pone.0068809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935889	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000037
J	Fye, HKS; Wright-Drakesmith, C; Kramer, HB; Camey, S; da Costa, AN; Jeng, A; Bah, A; Kirk, GD; Sharif, MIF; Ladep, NG; Okeke, E; Hainaut, P; Taylor-Robinson, SD; Kessler, BM; Mendy, ME				Fye, Haddy K. S.; Wright-Drakesmith, Cynthia; Kramer, Holger B.; Camey, Suzi; da Costa, Andre Nogueira; Jeng, Adam; Bah, Alasana; Kirk, Gregory D.; Sharif, Mohamed I. F.; Ladep, Nimzing G.; Okeke, Edith; Hainaut, Pierre; Taylor-Robinson, Simon D.; Kessler, Benedikt M.; Mendy, Maimuna E.			Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; GLOBAL CANCER STATISTICS; HUMAN LIVER-CANCER; ALPHA-FETOPROTEIN; VIRUS-DNA; DIETARY AFLATOXINS; SERUM MARKERS; BIOMARKERS; RISK; IDENTIFICATION	Background: Hepatocellular Carcinoma is the third most common cause of cancer related death worldwide, often diagnosed by measuring serum AFP; a poor performance stand-alone biomarker. With the aim of improving on this, our study focuses on plasma proteins identified by Mass Spectrometry in order to investigate and validate differences seen in the respective proteomes of controls and subjects with LC and HCC. Methods: Mass Spectrometry analysis using liquid chromatography electro spray ionization quadrupole time-of-flight was conducted on 339 subjects using a pooled expression profiling approach. ELISA assays were performed on four significantly differentially expressed proteins to validate their expression profiles in subjects from the Gambia and a pilot group from Nigeria. Results from this were collated for statistical multiplexing using logistic regression analysis. Results: Twenty-six proteins were identified as differentially expressed between the three subject groups. Direct measurements of four; hemopexin, alpha-1-antitrypsin, apolipoprotein A1 and complement component 3 confirmed their change in abundance in LC and HCC versus control patients. These trends were independently replicated in the pilot validation subjects from Nigeria. The statistical multiplexing of these proteins demonstrated performance comparable to or greater than ALT in identifying liver cirrhosis or carcinogenesis. This exercise also proposed preliminary cut offs with achievable sensitivity, specificity and AUC statistics greater than reported AFP averages. Conclusions: The validated changes of expression in these proteins have the potential for development into high-performance tests usable in the diagnosis and or monitoring of HCC and LC patients. The identification of sustained expression trends strengthens the suggestion of these four proteins as worthy candidates for further investigation in the context of liver disease. The statistical combinations also provide a novel inroad of analyses able to propose definitive cutoffs and combinations for evaluation of performance.	[Fye, Haddy K. S.; Wright-Drakesmith, Cynthia; Kramer, Holger B.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Oxford, Oxfordshire, England; [Camey, Suzi; da Costa, Andre Nogueira; Hainaut, Pierre; Mendy, Maimuna E.] Int Agcy Res Canc, Lab Serv, F-69372 Lyon, France; [Camey, Suzi; da Costa, Andre Nogueira; Hainaut, Pierre; Mendy, Maimuna E.] Int Agcy Res Canc, Biobank Grp, F-69372 Lyon, France; [Fye, Haddy K. S.; Jeng, Adam; Bah, Alasana; Mendy, Maimuna E.] Gambia Labs, MRC Unit UK, Dept Dis Control & Eliminat, Banjul, Gambia; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Camey, Suzi] Univ Fed Rio Grande do Sul, Dept Estatist, Inst Matemat, BR-90046900 Rio Grande, Brazil; [Sharif, Mohamed I. F.; Ladep, Nimzing G.; Taylor-Robinson, Simon D.] Imperial Coll London, Dept Med, Liver Unit, Div Diabet Endocrinol & Metab, London, England; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France; [Okeke, Edith] Univ Jos, Teaching Hosp, Jos, Plateau State, Nigeria	University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal do Rio Grande do Sul; Imperial College London; University of Jos	Kessler, BM (corresponding author), Univ Oxford, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol, Oxford, Oxfordshire, England.	bmk@ccmp.ox.ac.uk	Kramer, Holger/AAL-4433-2020; Kessler, Benedikt/AAY-8614-2021; Mendy, Maimuna/ABD-5038-2021; Camey, Suzi A/H-2346-2012; Hainaut, Pierre/B-6018-2012; Camey, Suzi Alves/Y-2756-2019	Kramer, Holger/0000-0002-6400-0945; Kessler, Benedikt/0000-0002-8160-2446; Camey, Suzi A/0000-0002-5564-081X; Hainaut, Pierre/0000-0002-1303-1610; Camey, Suzi Alves/0000-0002-5564-081X; WRIGHT, CYNTHIA/0000-0002-7196-1509	Medical Research Council (The Gambia); EU [Health-F2-2011-265994, 265994]; National Cancer Institute, National Institutes of Health, Department of Health and Human Services [N02CP40521]; American Cancer Society [MRSG-07-284-01-CCE]; Biomedical Research Centre (NIHR) Oxford, UK	Medical Research Council (The Gambia)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Biomedical Research Centre (NIHR) Oxford, UK(National Institute for Health Research (NIHR))	HKSF was supported by the Medical Research Council (The Gambia) and the EU Collaborative Project Prolifica 7th Framework Programme FP7-AFRICA-2010, Health-F2-2011-265994 (Grant Nr. 265994). The GLCS study was supported in part by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services (Contract # N02CP40521). GDK was supported in part by the American Cancer Society (MRSG-07-284-01-CCE). BMK was supported by the Biomedical Research Centre (NIHR) Oxford, UK. SDT, MIFS and NGL acknowledge the NIHR Biomedical Facility at Imperial College London for infrastructure support. The authors are grateful to Drs Fumi Lesi and PH for their contribution to testing single Nucleotide Polymorphisms (SNPs) in the p53 gene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; [Anonymous], 2002, IARC Sci Publ, P1; Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008; Behne T, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/859076; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; CHANG WY, 1988, CANCER-AM CANCER SOC, V62, P227, DOI 10.1002/1097-0142(19880715)62:2<227::AID-CNCR2820620202>3.0.CO;2-D; Chen CF, 2011, GASTROENTEROLOGY, V141, P1240, DOI 10.1053/j.gastro.2011.06.036; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Comunale MA, 2009, J PROTEOME RES, V8, P595, DOI 10.1021/pr800752c; Constantin Cristin Vere, 2010, Maedica (Bucur), V5, P265; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Fu Q, 2005, PROTEOMICS, V5, P2656, DOI 10.1002/pmic.200402048; Giannini EG, 2012, HEPATOLOGY; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Goldman R, 2007, CARCINOGENESIS, V28, P2149, DOI 10.1093/carcin/bgm177; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; He QY, 2003, PROTEOMICS, V3, P666, DOI 10.1002/pmic.200300394; HINO O, 1984, HEPATOLOGY, V4, P90, DOI 10.1002/hep.1840040116; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; Hsieh SY, 2011, J PROTEOME RES, V10, P4715, DOI 10.1021/pr200519q; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Kang XN, 2010, J CANCER RES CLIN, V136, P1151, DOI 10.1007/s00432-010-0762-6; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kirk GD, 2000, JNCI-J NATL CANCER I, V92, P148, DOI 10.1093/jnci/92.2.148; Kobayashi S, 2012, HEPATOL RES; Kolarich D, 2006, PROTEOMICS, V6, P3369, DOI 10.1002/pmic.200500751; Lee IN, 2006, PROTEOMICS, V6, P2865, DOI 10.1002/pmic.200500488; Lee YY, 2011, J PROTEOME RES, V10, P5070, DOI 10.1021/pr2005204; Li Chang-yu, 2011, Front Biosci (Elite Ed), V3, P212, DOI 10.2741/e235; LIN DY, 1993, J CLIN ULTRASOUND, V21, P303, DOI 10.1002/jcu.1870210502; Masuzaki R, 2012, SEMIN ONCOL, V39, P434, DOI 10.1053/j.seminoncol.2012.05.009; MATSUBARA K, 1990, MOL BIOL MED, V7, P243; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morota K, 2011, CLIN CHEM LAB MED, V49, P711, DOI 10.1515/CCLM.2011.097; NAMIENO T, 1995, ANN SURG, V221, P308, DOI 10.1097/00000658-199503000-00014; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; OKUDA K, 1982, CANCER, V49, P450, DOI 10.1002/1097-0142(19820201)49:3<450::AID-CNCR2820490310>3.0.CO;2-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; PEERS FG, 1976, INT J CANCER, V17, P167, DOI 10.1002/ijc.2910170204; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; Qiu JG, 2008, J CANCER RES CLIN, V134, P299, DOI 10.1007/s00432-007-0236-7; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Shang S, 2011, HEPATOLOGY; SHANK RC, 1972, FOOD COSMET TOXICOL, V10, P171, DOI 10.1016/S0015-6264(72)80195-0; Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t; Steel LF, 2003, PROTEOMICS, V3, P601, DOI 10.1002/pmic.200300399; Stuver SO, 1998, SEMIN CANCER BIOL, V8, P299, DOI 10.1006/scbi.1998.0079; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wright CA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005686; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416	61	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68381	10.1371/journal.pone.0068381	http://dx.doi.org/10.1371/journal.pone.0068381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935864	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200006
J	Jaafar, L; Podolsky, RH; Dynan, WS				Jaafar, Lahcen; Podolsky, Robert H.; Dynan, William S.			Long-Term Effects of Ionizing Radiation on Gene Expression in a Zebrafish Model	PLOS ONE			English	Article							IN-VIVO; QUALITY ASSESSMENT; VERTEBRATE EMBRYO; IRRADIATION; INDUCTION; DISCOVERY; APOPTOSIS; KIDNEY; LEVEL; CELLS	Understanding how initial radiation injury translates into long-term effects is an important problem in radiation biology. Here, we define a set of changes in the transcription profile that are associated with the long-term response to radiation exposure. The study was performed in vivo using zebrafish, an established radiobiological model organism. To study the long-term response, 24 hour post-fertilization embryos were exposed to 0.1 Gy (low dose) or 1.0 Gy (moderate dose) of whole-body gamma radiation and allowed to develop for 16 weeks. Liver mRNA profiles were then analyzed using the Affymetrix microarray platform, with validation by quantitative PCR. As a basis for comparison, 16-week old adults were exposed at the same doses and analyzed after 4 hours. Statistical analysis was performed in a way to minimize the effects of multiple comparisons. The responses to these two treatment regimes differed greatly: 360 probe sets were associated primarily with the long-term response, whereas a different 2062 probe sets were associated primarily with the response when adults of the same age were irradiated 4 hours before exposure. Surprisingly, a ten-fold difference in radiation dose (0.1 versus 1.0 Gy) had little effect. Analysis at the gene and pathway level indicated that the long-term response includes the induction of cytokine and inflammatory regulators and transcription and growth factors. The acute response includes the induction of p53 target genes and modulation of the hypoxia-induced transcription factor-C/EBP axis. Results help define genes and pathways affected in the long-term, low and moderate dose radiation response and differentiate them from those affected in an acute response in the same tissue.	[Jaafar, Lahcen; Dynan, William S.] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA USA; [Podolsky, Robert H.] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Jaafar, Lahcen; Dynan, William S.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Jaafar, Lahcen; Dynan, William S.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Dynan, William S.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University; Emory University; Emory University	Dynan, WS (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA USA.	wdynan@emory.edu	Podolsky, Robert/GRY-0740-2022	Dynan, William/0000-0002-4045-5662	US Department of Energy [DE-SC0002343]	US Department of Energy(United States Department of Energy (DOE))	This work was supported by an award from the Low Dose Radiation Research Program of the US Department of Energy ("Links between persistent DNA damage, genome instability, and aging," award number DE-SC0002343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Amundson SA, 2008, RADIAT ENVIRON BIOPH, V47, P25, DOI 10.1007/s00411-007-0140-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bladen CL, 2007, NEUROSCI LETT, V422, P97, DOI 10.1016/j.neulet.2007.05.045; Bladen CL, 2007, RADIAT RES, V168, P149, DOI 10.1667/RR0803.1; Bladen CL, 2005, NUCLEIC ACIDS RES, V33, P3002, DOI 10.1093/nar/gki613; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Brettschneider J, 2008, TECHNOMETRICS, V50, P279, DOI 10.1198/004017008000000389; Choi VWY, 2013, J RADIOL PROT, V33, P101, DOI 10.1088/0952-4746/33/1/101; Cook JA, 2006, ANTIOXID REDOX SIGN, V8, P1263, DOI 10.1089/ars.2006.8.1263; Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287; Epperly MW, 2012, IN VIVO, V26, P889; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; Geiger GA, 2006, CANCER RES, V66, P8172, DOI 10.1158/0008-5472.CAN-06-0466; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Hsieh YC, 2003, BIOCHEM BIOPH RES CO, V304, P667, DOI 10.1016/S0006-291X(03)00646-6; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janardhan HP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143jc2; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Kruse JJCM, 2004, RADIAT RES, V161, P28, DOI 10.1667/RR3097; Lu TP, 2010, INT J RADIAT ONCOL, V76, P212, DOI 10.1016/j.ijrobp.2009.08.015; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; McAleer MF, 2005, INT J RADIAT ONCOL, V61, P10, DOI 10.1016/j.ijrobp.2004.09.046; Mello SS, 2011, ENVIRON MOL MUTAGEN, V52, P117, DOI 10.1002/em.20591; Mothersill C, 2007, ENVIRON SCI TECHNOL, V41, P3382, DOI 10.1021/es062978n; Richardson RB, 2009, AGING-US, V1, P887, DOI 10.18632/aging.100081; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418	36	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69445	10.1371/journal.pone.0069445	http://dx.doi.org/10.1371/journal.pone.0069445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936019	Green Published, gold			2022-12-27	WOS:000323114200037
J	Almilaji, A; Munoz, C; Pakladok, T; Alesutan, I; Feger, M; Foller, M; Lang, UE; Shumilina, E; Lang, F				Almilaji, Ahmad; Munoz, Carlos; Pakladok, Tatsiana; Alesutan, Ioana; Feger, Martina; Foeller, Michael; Lang, Undine E.; Shumilina, Ekaterina; Lang, Florian			Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GLUTAMATE TRANSPORTER; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN-KINASE; NEOCORTICAL EPILEPSY; CALCIUM HOMEOSTASIS; ELDERLY-PATIENTS; XENOPUS-OOCYTES; UP-REGULATION	Klotho, a transmembrane protein, which can be cleaved off as beta-glucuronidase and hormone, is released in both, kidney and choroid plexus and encountered in blood and cerebrospinal fluid. Klotho deficiency leads to early appearance of age-related disorders and premature death. Klotho may modify transport by inhibiting 1,25(OH)(2)D-3 formation or by directly affecting channel and carrier proteins. The present study explored whether Klotho influences the activity of the Na+-coupled excitatory amino acid transporters EAAT3 and EAAT4, which are expressed in kidney (EAAT3), intestine (EAAT3) and brain (EAAT3 and EAAT4). To this end, cRNA encoding EAAT3 or EAAT4 was injected into Xenopus oocytes with and without additional injection of cRNA encoding Klotho. EAAT expressing Xenopus oocytes were further treated with recombinant human beta-Klotho protein with or without beta-glucuronidase inhibitor D-saccharic acid 1,4-lactone monohydrate (DSAL). Electrogenic excitatory amino acid transport was determined as L-glutamate-induced current (I-glu) in two electrode voltage clamp experiments. EAAT3 and EAAT4 protein abundance in the Xenopus oocyte cell membrane was visualized by confocal microscopy and quantified utilizing chemiluminescence. As a result, coexpression of Klotho cRNA significantly increased I-glu in both, EAAT3 or EAAT4-expressing Xenopus oocytes. Klotho cRNA coexpression significantly increased the maximal current and cell membrane protein abundance of both EAAT3 and EAAT4. The effect of Klotho coexpression on EAAT3 and EAAT4 activity was mimicked by treating EAAT3 or EAAT4-expressing Xenopus oocytes with recombinant human beta-Klotho protein. The effects of Klotho coexpression and of treatment with recombinant human beta-Klotho protein were both abrogated in the presence of DSAL (10 mu M). In conclusion, Klotho is a novel, powerful regulator of the excitatory amino acid transporters EAAT3 and EAAT4.	[Almilaji, Ahmad; Munoz, Carlos; Pakladok, Tatsiana; Alesutan, Ioana; Feger, Martina; Foeller, Michael; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Lang, Undine E.] Univ Psychiat Clin UPK Basel, Dept Psychiat & Psychotherapy, Basel, Switzerland	Eberhard Karls University of Tubingen	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Lang, Undine Emmi E/K-5553-2015	Lang, Undine Emmi E/0000-0002-3585-6533	Deutsche Forschungsgemeinschaft [GK 1302, FO 695/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (GK 1302, FO 695/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Alesutan I, 2012, CELL PHYSIOL BIOCHEM, V30, P458, DOI 10.1159/000339039; Alesutan IS, 2010, CELL PHYSIOL BIOCHEM, V25, P187, DOI 10.1159/000276569; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Bogatikov E, 2012, CELL PHYSIOL BIOCHEM, V30, P1538, DOI 10.1159/000343341; Bohmer C, 2004, BIOCHEM BIOPH RES CO, V324, P1242, DOI 10.1016/j.bbrc.2004.09.193; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chan H, 2003, NEUROCHEM INT, V43, P137, DOI 10.1016/S0197-0186(02)00215-2; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Deng XD, 2007, AM J MED GENET B, V144B, P271, DOI 10.1002/ajmg.b.30351; Dermaku-Sopjani M, 2011, CELL PHYSIOL BIOCHEM, V28, P251, DOI 10.1159/000331737; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Dowd LA, 1996, MOL PHARMACOL, V49, P465; Furuta A, 1997, J NEUROSCI, V17, P8363; Furuta A, 2005, DEV BRAIN RES, V155, P155, DOI 10.1016/j.devbrainres.2005.01.005; Gourley SL, 2012, P NATL ACAD SCI USA, V109, P20714, DOI 10.1073/pnas.1208342109; Grewer C, 2008, IUBMB LIFE, V60, P609, DOI 10.1002/iub.98; Henrion U, 2012, CELL PHYSIOL BIOCHEM, V29, P809, DOI 10.1159/000178470; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hosseinzadeh Z, 2012, CELL PHYSIOL BIOCHEM, V29, P737, DOI 10.1159/000178560; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Huerta B, 2006, SYNAPSE, V59, P394, DOI 10.1002/syn.20250; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kim JH, 2005, ALCOHOL CLIN EXP RES, V29, P2046, DOI 10.1097/01.alc.0000187594.92476.07; Klaus F, 2009, BIOCHEM BIOPH RES CO, V381, P407, DOI 10.1016/j.bbrc.2009.02.053; Kosakai A, 2011, BRAIN RES, V1382, P109, DOI 10.1016/j.brainres.2011.01.056; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2010, PFLUG ARCH EUR J PHY, V459, P333, DOI 10.1007/s00424-009-0722-7; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; LANG F, 1992, PHYSIOL REV, V72, P1, DOI 10.1152/physrev.1992.72.1.1; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Maddock RJ, 2012, CURRTOPBEHAVNEUROSCI; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; McCullumsmith RE, 2002, NEUROPSYCHOPHARMACOL, V26, P368, DOI 10.1016/S0893-133X(01)00370-0; Mia S, 2012, CELL PHYSIOL BIOCHEM, V30, P1039, DOI 10.1159/000341480; Miralles VJ, 2001, BRAIN RES, V922, P21, DOI 10.1016/S0006-8993(01)03124-9; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Nudrnamud-Thanoi S, 2007, J NEURAL TRANSM-SUPP, P281; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Pathare G, 2012, KIDNEY BLOOD PRESS R, V36, P149, DOI 10.1159/000343405; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Rakhade SN, 2008, EPILEPSIA, V49, P226, DOI 10.1111/j.1528-1167.2007.01310.x; Ramasamy I, 2006, CLIN CHEM LAB MED, V44, P237, DOI 10.1515/CCLM.2006.046; Rao JS, 2012, J AFFECT DISORDERS, V136, P63, DOI 10.1016/j.jad.2011.08.017; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Sanacora G, 2007, BIOL PSYCHIAT, V61, P822, DOI 10.1016/j.biopsych.2006.08.037; Schmitt A, 2003, NEUROSCI LETT, V347, P81, DOI 10.1016/S0304-3940(03)00653-0; Schniepp R, 2004, INVEST OPHTH VIS SCI, V45, P1442, DOI 10.1167/iovs.03-0062; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF769, DOI 10.1152/ajprenal.00248.2006; Shan D, 2013, SCHIZOPHR RES, V144, P1, DOI 10.1016/j.schres.2012.12.019; Shashidharan P, 1997, BRAIN RES, V773, P139, DOI 10.1016/S0006-8993(97)00921-9; Simantov R, 1999, MOL BRAIN RES, V65, P112, DOI 10.1016/S0169-328X(98)00349-0; Smith RE, 2001, AM J PSYCHIAT, V158, P1393, DOI 10.1176/appi.ajp.158.9.1393; Sopjani M, 2011, FEBS LETT, V585, P1759, DOI 10.1016/j.febslet.2011.05.021; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Teocchi MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-53; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; van Landeghem FKH, 2007, REGUL PEPTIDES, V142, P52, DOI 10.1016/j.regpep.2007.01.008; Voelkl J, 2013, J CLIN INVEST; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057391; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	75	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70988	10.1371/journal.pone.0070988	http://dx.doi.org/10.1371/journal.pone.0070988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923038	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700216
J	Bui, BV; Batcha, AH; Fletcher, E; Wong, VHY; Fortune, B				Bui, Bang V.; Batcha, Abrez H.; Fletcher, Erica; Wong, Vickie H. Y.; Fortune, Brad			Relationship between the Magnitude of Intraocular Pressure during an Episode of Acute Elevation and Retinal Damage Four Weeks later in Rats	PLOS ONE			English	Article							OPTIC-NERVE HEAD; EXPERIMENTAL GLAUCOMA; FUNCTIONAL-CHANGES; LAMINA-CRIBROSA; B-WAVE; MODEL; ELECTRORETINOGRAM; TRANSPORT; MICROVASCULATURE; PHOTORECEPTORS	Purpose: To determine relationship between the magnitude of intraocular pressure (IOP) during a fixed-duration episode of acute elevation and the loss of retinal function and structure 4 weeks later in rats. Methods: Unilateral elevation of IOP (105 minutes) was achieved manometrically in adult Brown Norway rats (9 groups; n = 4 to 8 each, 10-100 mm Hg and sham control). Full-field ERGs were recorded simultaneously from treated and control eyes 4 weeks after IOP elevation. Scotopic ERG stimuli were white flashes (-6.04 to 2.72 log cd.s.m(-2)). Photopic ERGs were recorded (1.22 to 2.72 log cd.s.m(-2)) after 15 min of light adaptation (150 cd/m(2)). Relative amplitude (treated/control, %) of ERG components versus IOP was described with a cummulative normal function. Retinal ganglion cell (RGC) layer density was determined post mortem by histology. Results: All ERG components failed to recover completely normal amplitudes by 4 weeks after the insult if IOP was 70 mmHg or greater during the episode. There was no ERG recovery at all if IOP was 100 mmHg. Outer retinal (photoreceptor) function demonstrated the least sensitivity to prior acute IOP elevation. ERG components reflecting inner retinal function were correlated with post mortem RGC layer density. Conclusions: Retinal function recovers after IOP normalization, such that it requires a level of acute IOP elevation approximately 10 mmHg higher to cause a pattern of permanent dysfunction similar to that observed during the acute event. There is a 'threshold' for permanent retinal functional loss in the rat at an IOP between 60 and 70 mmHg if sustained for 105 minutes or more.	[Bui, Bang V.; Wong, Vickie H. Y.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia; [Batcha, Abrez H.] Natl Vis Res Inst, Carlton, Vic, Australia; [Batcha, Abrez H.; Fletcher, Erica] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Fortune, Brad] Legacy Hlth, Discoveries Sight Res Labs, Devers Eye Inst, Portland, OR USA; [Fortune, Brad] Legacy Hlth, Legacy Res Inst, Portland, OR USA	University of Melbourne; University of Melbourne; Devers Eye Institute; Legacy Health; Legacy Health	Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.	bvb@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Wong, Vickie/AAL-5158-2020; Batcha, Abrez Hussain/AAW-2855-2020; Fletcher, Erica/E-6364-2012	Bui, Bang/0000-0001-7298-1352; Wong, Vickie/0000-0001-9356-7556; Fortune, Brad/0000-0003-0284-5173; Fletcher, Erica/0000-0001-9412-9523	NHMRC Australia; NHMRC [566570, 1046203]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by an NH&MRC Australia CJ Martin Fellowship (BVB) and NHMRC project grant 566570 and 1046203 (BVB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoumi Y, 2011, OPHTHALMOLOGY, V118, P52, DOI 10.1016/j.ophtha.2010.05.016; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fortune B, 2004, INVESTIGATI IN PRESS; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; FULTON AB, 1988, DOC OPHTHALMOL, V68, P293, DOI 10.1007/BF00156435; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; He Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031104; Holcombe DJ, 2008, ACTA OPHTHALMOL, V86, P408, DOI 10.1111/j.1600-0420.2007.01052.x; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P3415; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kong YX, 2009, INVEST OPHTH VIS SCI, V50, P5732, DOI 10.1167/iovs.09-3814; Kong YX, 2009, INVEST OPHTHALMOL VI; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Lu DW, 2001, J OCUL PHARMACOL TH, V17, P343, DOI 10.1089/108076801753162753; MORRISON JC, 1995, INVEST OPHTH VIS SCI, V36, P751; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; PARRISH R, 1982, OPHTHALMOLOGY, V89, P1472; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Selbach MJ, 1999, EXP EYE RES, V69, P301, DOI 10.1006/exer.1999.0702; SMITH GG, 1952, AM J OPHTHALMOL, V35, P133, DOI 10.1016/0002-9394(52)90266-3; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Uckermann O, 2005, INVEST OPHTH VIS SCI, V46, P2592, DOI 10.1167/iovs.04-1402; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P7109, DOI 10.1167/iovs.11-7448; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	41	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70513	10.1371/journal.pone.0070513	http://dx.doi.org/10.1371/journal.pone.0070513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922999	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700189
J	Cabrera-Guzman, E; Crossland, MR; Brown, GP; Shine, R				Cabrera-Guzman, Elisa; Crossland, Michael R.; Brown, Gregory P.; Shine, Richard			Larger Body Size at Metamorphosis Enhances Survival, Growth and Performance of Young Cane Toads (Rhinella marina)	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; BUFO-MARINUS; LARVAL DENSITY; NATURAL-SELECTION; INVASION FRONT; COMMON FROG; MATE CHOICE; LIFE; PREDATOR; HISTORY	Body size at metamorphosis is a key trait in species (such as many anurans) with biphasic life-histories. Experimental studies have shown that metamorph size is highly plastic, depending upon larval density and environmental conditions (e.g. temperature, food supply, water quality, chemical cues from conspecifics, predators and competitors). To test the hypothesis that this developmental plasticity is adaptive, or to determine if inducing plasticity can be used to control an invasive species, we need to know whether or not a metamorphosing anuran's body size influences its subsequent viability. For logistical reasons, there are few data on this topic under field conditions. We studied cane toads (Rhinella marina) within their invasive Australian range. Metamorph body size is highly plastic in this species, and our laboratory studies showed that larger metamorphs had better locomotor performance (both on land and in the water), and were more adept at catching and consuming prey. In mark-recapture trials in outdoor enclosures, larger body size enhanced metamorph survival and growth rate under some seasonal conditions. Larger metamorphs maintained their size advantage over smaller siblings for at least a month. Our data support the critical but rarely-tested assumption that all else being equal, larger body size at metamorphosis is likely to enhance an individual's long term viability. Thus, manipulations to reduce body size at metamorphosis in cane toads may help to reduce the ecological impact of this invasive species.	[Cabrera-Guzman, Elisa; Crossland, Michael R.; Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia	University of Sydney	Cabrera-Guzman, E (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	elicabguz@hotmail.com	Crossland, Michael R/G-1091-2012; Brown, Gregory P./F-9897-2011	Crossland, Michael R/0000-0001-9967-7158; Brown, Gregory P./0000-0002-2924-9040	Australian Research Council; Australian Government; National Council on Science and Technology of Mexico (CONACyT); University of Sydney	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); National Council on Science and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Sydney(University of Sydney)	The work was funded by the Australian Research Council, the Australian Government, the National Council on Science and Technology of Mexico (CONACyT), and the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford R., 1995, WETLAND RES WET DRY, P173; Altwegg R, 2003, EVOLUTION, V57, P872; Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Amezquita A, 1999, HERPETOLOGICA, V55, P295; Aubret F, 2012, AM NAT, V179, P756, DOI 10.1086/665653; Bardsley L, 1998, ECOLOGY, V79, P1751, DOI 10.2307/176793; Barnett HK, 2002, OECOLOGIA, V132, P436, DOI 10.1007/s00442-002-0981-x; Beck CW, 1999, CAN J ZOOL, V77, P944, DOI 10.1139/cjz-77-6-944; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; Blanckenhorn WU, 1998, EVOLUTION, V52, P1394, DOI [10.2307/2411309, 10.1111/j.1558-5646.1998.tb02021.x]; Blaustein L, 1999, HYDROBIOLOGIA, V392, P187, DOI 10.1023/A:1003559332439; Boone MD, 2005, J HERPETOL, V39, P416, DOI 10.1670/187-04A.1; Cabrera-Guzman E, 2013, AUSTRAL ECOL, V38, P896, DOI 10.1111/aec.12029; Cabrera-Guzman E, 2011, J APPL ECOL, V48, P462, DOI 10.1111/j.1365-2664.2010.01933.x; Capellan E, 2007, EVOL ECOL, V21, P445, DOI 10.1007/s10682-006-9133-9; Chelgren ND, 2006, ECOL APPL, V16, P250, DOI 10.1890/04-0329; Child T, 2008, AUSTRAL ECOL, V33, P630, DOI 10.1111/j.1442-9993.2007.01829.x; Child T, 2008, J EXP ZOOL PART A, V309A, P215, DOI 10.1002/jez.450; Child T, 2009, J TROP ECOL, V25, P193, DOI 10.1017/S0266467408005695; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; COHEN MP, 1993, WILDLIFE RES, V20, P1; Cooch E., 2010, PROGRAM MARK GENTLE, V9th; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Crossland MR, 2012, BIOL LETTERS, V8, P226, DOI 10.1098/rsbl.2011.0794; Cvetkovic D, 2007, ARCH BIOL SCI, V59, P327, DOI 10.2298/ABS0704327C; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; Denoel M, 2006, BIOL J LINN SOC, V89, P373, DOI 10.1111/j.1095-8312.2006.00681.x; Ficetola GF, 2006, EVOL ECOL, V20, P143, DOI 10.1007/s10682-005-5508-6; FORSMAN A, 1991, J ANIM ECOL, V60, P253, DOI 10.2307/5458; Forsman A, 1996, J HERPETOL, V30, P307, DOI 10.2307/1565167; FREELAND WJ, 1991, WILDLIFE RES, V18, P431, DOI 10.1071/WR9910431; FREELAND WJ, 1986, AUST WILDLIFE RES, V13, P489; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; GOATER CP, 1994, ECOLOGY, V75, P2264, DOI 10.2307/1940882; Goldberg T, 2012, ZOOL STUD, V51, P345; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Gramapurohit NP, 2009, CURR SCI INDIA, V97, P1243; Greenlees MJ, 2010, BIOL J LINN SOC, V100, P329, DOI 10.1111/j.1095-8312.2010.01432.x; Hagman M, 2009, FUNCT ECOL, V23, P126, DOI 10.1111/j.1365-2435.2008.01470.x; Hagman M, 2006, AUSTRAL ECOL, V31, P551, DOI 10.1111/j.1442-9993.2006.01627.x; Hagman M, 2009, CHEMOECOLOGY, V19, P211, DOI 10.1007/s00049-009-0027-5; Hayes RA, 2009, J CHEM ECOL, V35, P391, DOI 10.1007/s10886-009-9608-6; HOGLUND J, 1989, J EVOLUTION BIOL, V2, P367, DOI 10.1046/j.1420-9101.1989.2050367.x; Indermaur L, 2010, OECOLOGIA, V163, P637, DOI 10.1007/s00442-010-1586-4; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Johnson JB, 2001, EVOLUTION, V55, P1486; Kelehear C, 2009, PARASITOLOGY, V136, P919, DOI 10.1017/S0031182009006325; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kishida O, 2009, ECOLOGY, V90, P3150, DOI 10.1890/08-2158.1; Kohler A, 2011, HERPETOL J, V21, P17; Kraus Fred, 2009, Aliens (Auckland), V28, P13; Kunz C, 2000, J EVOLUTION BIOL, V13, P199; LAURIE WA, 1990, J ANIM ECOL, V59, P529, DOI 10.2307/4879; LEVER C., 2001, CANE TOAD HIST ECOLO; Liao WB, 2009, J ETHOL, V27, P413, DOI 10.1007/s10164-008-0135-7; Lind MI, 2008, P ROY SOC B-BIOL SCI, V275, P1073, DOI 10.1098/rspb.2007.1737; Louette G, 2012, WILDLIFE RES, V39, P271, DOI 10.1071/WR11125; MADSEN T, 1992, EVOLUTION, V46, P1220, DOI 10.1111/j.1558-5646.1992.tb00630.x; Marco A, 1998, ANIM BEHAV, V55, P1631, DOI 10.1006/anbe.1997.0711; Marr SR, 2010, BIOL CONTROL, V54, P69, DOI 10.1016/j.biocontrol.2010.04.012; Merila J, 2000, ECOSCIENCE, V7, P18, DOI 10.1080/11956860.2000.11682566; Morey S, 2001, ECOLOGY, V82, P510, DOI 10.2307/2679876; Newman RA, 1999, HERPETOLOGICA, V55, P507; Newman RA, 1998, OECOLOGIA, V115, P9, DOI 10.1007/s004420050485; O'Donnell S, 2010, J APPL ECOL, V47, P558, DOI 10.1111/j.1365-2664.2010.01802.x; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Pizzatto L, 2008, BEHAV ECOL SOCIOBIOL, V63, P123, DOI 10.1007/s00265-008-0642-0; Pizzatto L, 2008, BEHAV ECOL, V19, P990, DOI 10.1093/beheco/arn060; POUGH FH, 1984, OECOLOGIA, V65, P138, DOI 10.1007/BF00384476; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Richter-Boix A, 2006, EVOL ECOL RES, V8, P309; Richter-Boix A, 2011, ECOL EVOL, V1, P15, DOI 10.1002/ece3.2; Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; SADLER LM, 1994, TRENDS ECOL EVOL, V9, P5, DOI 10.1016/0169-5347(94)90222-4; Schwarz CJ, 2010, PROGRAM MARK GENTLE, P131; Scott DE, 2007, OECOLOGIA, V153, P521, DOI 10.1007/s00442-007-0755-6; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SHINE R, 1991, FUNCT ECOL, V5, P493, DOI 10.2307/2389631; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Shine R, 2009, FRONT ECOL ENVIRON, V7, P359, DOI 10.1890/080081; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Snow Nathan P., 2011, Pacific Conservation Biology, V17, P285; Sorci G, 1999, EVOL ECOL RES, V1, P303; Stamper CE, 2008, HERPETOL J, V18, P187; Stepanyan I. E., 2011, Journal of Environmental Science and Technology, V4, P172; TAYLOR JA, 1985, AUST J ECOL, V10, P281, DOI 10.1111/j.1442-9993.1985.tb00890.x; TEJEDO M, 1992, J ZOOL, V228, P545, DOI 10.1111/j.1469-7998.1992.tb04454.x; Tracy Christopher R., 2007, Copeia, V2007, P901, DOI 10.1643/0045-8511(2007)7[901:EOAIAC]2.0.CO;2; Walsh PT, 2008, J THERM BIOL, V33, P244, DOI 10.1016/j.jtherbio.2008.02.002; Ward-Fear G, 2010, BIOL J LINN SOC, V99, P738, DOI 10.1111/j.1095-8312.2010.01395.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wildy EL, 2001, OECOLOGIA, V128, P202, DOI 10.1007/s004420100641; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	96	110	112	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70121	10.1371/journal.pone.0070121	http://dx.doi.org/10.1371/journal.pone.0070121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922930	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700142
J	Hu, BL; Ma, J; Tang, J				Hu, Bolin; Ma, Jun; Tang, Jun			Selection of Multiarmed Spiral Waves in a Regular Network of Neurons	PLOS ONE			English	Article							HODGKIN-HUXLEY NEURONS; EXCITABLE MEDIA; ROTATING SPIRALS; SURFACE-REACTION; SPIKING ACTIVITY; CARDIAC TISSUE; CHANNEL NOISE; EQUATIONS; MEMBRANES; NEOCORTEX	Formation and selection of multiarmed spiral wave due to spontaneous symmetry breaking are investigated in a regular network of Hodgkin-Huxley neuron by changing the excitability and imposing spatial forcing currents on the neurons in the network. The arm number of the multiarmed spiral wave is dependent on the distribution of spatial forcing currents and excitability diversity in the network, and the selection criterion for supporting multiarmed spiral waves is discussed. A broken spiral segment is measured by a short polygonal line connected by three adjacent points (controlled nodes), and a double-spiral wave can be developed from the spiral segment. Multiarmed spiral wave is formed when a group of double-spiral waves rotate in the same direction in the network. In the numerical studies, a group of controlled nodes are selected and spatial forcing currents are imposed on these nodes, and our results show that l-arm stable spiral wave (l = 2, 3, 4,...8) can be induced to occupy the network completely. It is also confirmed that low excitability is critical to induce multiarmed spiral waves while high excitability is important to propagate the multiarmed spiral wave outside so that distinct multiarmed spiral wave can occupy the network completely. Our results confirm that symmetry breaking of target wave in the media accounts for emergence of multiarmed spiral wave, which can be developed from a group of spiral waves with single arm under appropriate condition, thus the potential formation mechanism of multiarmed spiral wave in the media is explained.	[Hu, Bolin; Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China; [Tang, Jun] China Univ Min & Technol, Coll Sci, Xuzhou, Peoples R China	Lanzhou University of Technology; China University of Mining & Technology	Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China.	hyperchaos@163.com	Tang, Jun/H-5964-2011; Ma, Jun/G-2376-2010; Tang, Jun/C-6958-2015	Ma, Jun/0000-0002-6127-000X; Tang, Jun/0000-0001-5942-9248	National Nature Science of Foundation of China [11265008]	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Nature Science of Foundation of China under the Grant No.11265008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BAR M, 1994, J CHEM PHYS, V100, P1202, DOI 10.1063/1.466650; Bruyn JR, 2001, PHYS REV E, V63; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Butson CR, 2008, BRAIN STIMUL, V1, P7, DOI 10.1016/j.brs.2007.08.004; Cai MC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016208; Chen JX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066209; Chik DTW, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021913; Cronin J., 1987, MATH ASPECTS HODGKIN, DOI [10.1017/CBO9780511983955, DOI 10.1017/CBO9780511983955]; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; DEFELICE LJ, 1993, J STAT PHYS, V70, P339, DOI 10.1007/BF01053972; Deng LY, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036107; Dong LF, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046215; FRISCH T, 1994, PHYS REV LETT, V72, P1471, DOI 10.1103/PhysRevLett.72.1471; FROMHERZ P, 1994, P NATL ACAD SCI USA, V91, P4604, DOI 10.1073/pnas.91.10.4604; Ginn BT, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046109; Glatt E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026206; Gosak M, 2009, PHYSICA D, V238, P506, DOI 10.1016/j.physd.2008.11.007; Gosak M, 2009, BIOPHYS CHEM, V139, P53, DOI 10.1016/j.bpc.2008.10.001; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Gu HG, 2013, PHYSICA A, V392, P1361, DOI 10.1016/j.physa.2012.11.049; HAGAN PS, 1982, SIAM J APPL MATH, V42, P762, DOI 10.1137/0142054; Hasegawa H, 2000, PHYS REV E, V61, P718, DOI 10.1103/PhysRevE.61.718; He DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055204; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hou ZH, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.280601; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; JAKUBITH S, 1990, PHYS REV LETT, V65, P3013, DOI 10.1103/PhysRevLett.65.3013; Janks D.L., 2009, CARDIAC BIOELECTRIC, P63; Kiyashko SV, 1996, PHYS REV E, V54, P5037, DOI 10.1103/PhysRevE.54.5037; Lee SG, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041924; Li XJ, 1996, PHYS REV E, V54, pR3105, DOI 10.1103/PhysRevE.54.R3105; Dong LF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/330; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2013, NONLINEAR DYNAM, V73, P73, DOI 10.1007/s11071-013-0767-1; Ma J, 2013, SCI CHINA PHYS MECH, V56, P1126, DOI 10.1007/s11433-013-5096-3; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, J BIOL SYST, V18, P243, DOI 10.1142/S0218339010003275; Palsson E, 1996, P NATL ACAD SCI USA, V93, P1151, DOI 10.1073/pnas.93.3.1151; PANG JZ, 1992, PHYS REV LETT, V69, P2783, DOI 10.1103/PhysRevLett.69.2783; Patel SG, 2000, IEEE T BIO-MED ENG, V47, P1284, DOI 10.1109/10.867964; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; PEREZMUNUZURI V, 1991, NATURE, V353, P740, DOI 10.1038/353740a0; Puwal S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041904; Puwal S, 2009, IEEE T BIO-MED ENG, V56, P532, DOI 10.1109/TBME.2008.2003279; Roth BJ, 2001, PHYSICA D, V150, P127, DOI 10.1016/S0167-2789(01)00145-2; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Sandstede B, 2001, PHYS REV LETT, V86, P171, DOI 10.1103/PhysRevLett.86.171; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Schmid G, 2004, PHYS BIOL, V1, P61, DOI 10.1088/1478-3967/1/2/002; Schmid G, 2004, PHYSICA A, V344, P665, DOI 10.1016/j.physa.2004.06.049; Shanahan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041924; Sinha S, 2008, PHYS REV E, V76; Ten Tusscher KHWJ, 2008, PROG BIOPHYS MOL BIO, V96, P152, DOI 10.1016/j.pbiomolbio.2007.07.026; Thompson KL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046218; Vasiev B, 1997, PHYS REV LETT, V78, P2489, DOI 10.1103/PhysRevLett.78.2489; Wang CN, 2012, NONLINEAR DYNAM, V67, P139, DOI 10.1007/s11071-011-9965-x; Wang YQ, 2000, PHYS REV E, V62, P1063, DOI 10.1103/PhysRevE.62.1063; Winfree A.T., 2000, GEOMETRY BIOL TIME; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Zaritski RM, 2005, INT J BIFURCAT CHAOS, V15, P4087, DOI 10.1142/S0218127405014532; Zaritski RM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066120; Zemlin CW, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016207; Zhou LQ, 2000, PHYS REV LETT, V85, P1650, DOI 10.1103/PhysRevLett.85.1650	67	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69251	10.1371/journal.pone.0069251	http://dx.doi.org/10.1371/journal.pone.0069251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23935966	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700027
J	Kleinebecker, T; Poelen, MDM; Smolders, AJP; Lamers, LPM; Holzel, N				Kleinebecker, Till; Poelen, Moni D. M.; Smolders, Alfons J. P.; Lamers, Leon P. M.; Hoelzel, Norbert			Fast and Inexpensive Detection of Total and Extractable Element Concentrations in Aquatic Sediments Using Near-Infrared Reflectance Spectroscopy (NIRS)	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; SOIL PROPERTIES; ORGANIC-MATTER; HEAVY-METALS; PREDICTION; NETHERLANDS; WATER; TOOL; MOBILIZATION; RESTORATION	Adequate biogeochemical characterization and monitoring of aquatic ecosystems, both for scientific purposes and for water management, pose high demands on spatial and temporal replication of chemical analyses. Near-infrared reflectance spectroscopy (NIRS) may offer a rapid, low-cost and reproducible alternative to standard analytical sample processing (digestion or extraction) and measuring techniques used for the chemical characterization of aquatic sediments. We analyzed a total of 191 sediment samples for total and NaCl-extractable concentrations of Al, Ca, Fe, K, Mg, Mn, N, Na, P, S, Si, and Zn as well as oxalate-extractable concentrations of Al, Fe, Mn and P. Based on the NIR spectral data and the reference values, calibration models for the prediction of element concentrations in unknown samples were developed and tested with an external validation procedure. Except Mn, all prediction models of total element concentrations were found to be acceptable to excellent (ratio of performance deviation: RPD 1.8-3.1). For extractable element fractions, viable model precision could be achieved for NaCl-extractable Ca, K, Mg, NH4+-N, S and Si (RPD 1.7-2.2) and oxalate-extractable Al, Fe and P (RPD 1.9-2.3). For those elements that showed maximum total values below 3 g kg(-1) prediction models were found to become increasingly critical (RPD <2.0). Low concentrations also limited the performance of NIRS calibrations for extracted elements, with critical concentration thresholds <0.1 g kg(-1) and 3.3 g kg(-1) for NaCl and oxalate extractions, respectively. Thus, reliable NIRS measurements of trace metals are restricted to sediments with high metal content. Nevertheless, we demonstrated the suitability of NIRS measurements to determine a large array of chemical properties of aquatic sediments. The results indicate great potential of this fast technique as an analytical tool to better understand the large spatial and temporal variation of sediment characteristics in an economically viable way.	[Kleinebecker, Till; Hoelzel, Norbert] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Poelen, Moni D. M.; Smolders, Alfons J. P.; Lamers, Leon P. M.] B Ware Res Ctr, Nijmegen, Netherlands; [Smolders, Alfons J. P.; Lamers, Leon P. M.] Radboud Univ Nijmegen, Dept Aquat Ecol & Environm Biol, NL-6525 ED Nijmegen, Netherlands	University of Munster; Radboud University Nijmegen	Kleinebecker, T (corresponding author), Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany.	till.kleinebecker@uni-muenster.de	Hölzel, Norbert/H-8753-2013; Smolders, Alfons J.P./H-2583-2012; Lamers, Leon P.M./A-8718-2012	Hölzel, Norbert/0000-0002-6367-3400; Lamers, Leon P.M./0000-0003-3769-2154; Kleinebecker, Till/0000-0003-1121-2861	Ministry of Economic Affairs/Agentschap NL (The Netherlands)	Ministry of Economic Affairs/Agentschap NL (The Netherlands)	Part of this work was carried out within the Water Framework Directive Innovation Project 'Maatregelen Baggeren en Nutrienten (BAGGERNUT)' which was financed by the Ministry of Economic Affairs/Agentschap NL (The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arain MB, 2008, CHEMOSPHERE, V70, P1845, DOI 10.1016/j.chemosphere.2007.08.005; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Chang CW, 2005, APPL GEOCHEM, V20, P1637, DOI 10.1016/j.apgeochem.2005.04.011; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chang CW, 2002, SOIL SCI, V167, P110, DOI 10.1097/00010694-200202000-00003; Chodak M, 2008, POL J ENVIRON STUD, V17, P631; Chodak M, 2004, J NEAR INFRARED SPEC, V12, P315, DOI 10.1255/jnirs.440; CLARK DH, 1987, AGRON J, V79, P485, DOI 10.2134/agronj1987.00021962007900030016x; Cozzolino D, 2003, J AGR SCI-CAMBRIDGE, V140, P65, DOI 10.1017/S0021859602002836; Eggleton J, 2004, ENVIRON INT, V30, P973, DOI 10.1016/j.envint.2004.03.001; Fidencio PH, 2002, COMMUN SOIL SCI PLAN, V33, P1607, DOI 10.1081/CSS-120004302; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Fuentes M, 2012, COMMUN SOIL SCI PLAN, V43, P346, DOI 10.1080/00103624.2012.641471; Geurts JJM, 2008, FRESHWATER BIOL, V53, P2101, DOI 10.1111/j.1365-2427.2008.02038.x; Geurts JJM, 2010, WATER RES, V44, P3487, DOI 10.1016/j.watres.2010.03.030; HOUDIJK ALF, 1993, ENVIRON POLLUT, V80, P73, DOI 10.1016/0269-7491(93)90012-D; Kelderman P, 2000, WATER RES, V34, P936, DOI 10.1016/S0043-1354(99)00218-3; Klaus VH, 2012, ECOL INDIC, V14, P82, DOI 10.1016/j.ecolind.2011.07.016; Kleinebecker T, 2011, J NEAR INFRARED SPEC, V19, P495, DOI 10.1255/jnirs.957; Kleinebecker T, 2009, NEW PHYTOL, V184, P732, DOI 10.1111/j.1469-8137.2009.02995.x; Lamers LPM, 2002, HYDROBIOLOGIA, V478, P107, DOI 10.1023/A:1021022529475; Lucassen ECHET, 2002, ENVIRON POLLUT, V120, P635, DOI 10.1016/S0269-7491(02)00190-2; Malley D. F., 1996, Journal of Aquatic Ecosystem Health, V5, P135, DOI 10.1007/BF00662802; Malley DF, 1996, WATER RES, V30, P1325, DOI 10.1016/0043-1354(95)00296-0; Malley DF, 1997, ENVIRON SCI TECHNOL, V31, P3461, DOI 10.1021/es970214p; Malley DF, 1998, WATER SCI TECHNOL, V37, P181, DOI 10.2166/wst.1998.0751; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Moron A, 2007, COMMUN SOIL SCI PLAN, V38, P1965, DOI 10.1080/00103620701548498; Prego R, 2008, MAR POLLUT BULL, V56, P1031, DOI 10.1016/j.marpolbul.2008.01.036; Reeves JB, 2009, APPL GEOCHEM, V24, P1472, DOI 10.1016/j.apgeochem.2009.04.017; Ritchie GE, 2002, J PHARMACEUT BIOMED, V29, P159, DOI 10.1016/S0731-7085(02)00010-9; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Saeys W, 2005, BIOSYST ENG, V91, P393, DOI 10.1016/j.biosystemseng.2005.05.001; Santos-Echeandia J, 2009, MAR CHEM, V117, P77, DOI 10.1016/j.marchem.2009.05.001; SCHWERTMANN U., 1964, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V105, P194, DOI 10.1002/jpln.3591050303; Shenk Jr JS, 2008, HDB NEAR INFRARED AN, P383; Shomar B. H., 2005, Wetlands Ecology and Management, V13, P419, DOI 10.1007/s11273-004-0412-3; Smolders AJP, 2006, CHEM ECOL, V22, P93, DOI 10.1080/02757540600579730; Sorensen LK, 2005, SOIL SCI SOC AM J, V69, P159, DOI 10.2136/sssaj2005.0159; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Terhoeven-Urselmans T, 2006, J PLANT NUTR SOIL SC, V169, P168, DOI 10.1002/jpln.200521712; Tomassen HBM, 2003, J ECOL, V91, P357, DOI 10.1046/j.1365-2745.2003.00771.x; VANDERMOLEN DT, 1994, HYDROBIOLOGIA, V275, P379, DOI 10.1007/BF00026728; WORKMAN JJ, 2008, HDB NEAR INFRARED AN, P123; Zornoza R, 2008, SOIL BIOL BIOCHEM, V40, P1923, DOI 10.1016/j.soilbio.2008.04.003	46	16	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70517	10.1371/journal.pone.0070517	http://dx.doi.org/10.1371/journal.pone.0070517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923001	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700190
J	Powell, SL; Hansen, AJ; Rodhouse, TJ; Garrett, LK; Betancourt, JL; Dicus, GH; Lonneker, MK				Powell, Scott L.; Hansen, Andrew J.; Rodhouse, Thomas J.; Garrett, Lisa K.; Betancourt, Julio L.; Dicus, Gordon H.; Lonneker, Meghan K.			Woodland Dynamics at the Northern Range Periphery: A Challenge for Protected Area Management in a Changing World	PLOS ONE			English	Article							WESTERN UNITED-STATES; CLIMATE-CHANGE; JUNIPER WOODLAND; GLOBAL-CHANGE; LATE-HOLOCENE; PINYON PINE; FIRE; CONSERVATION; VEGETATION; RESTORATION	Managers of protected natural areas increasingly are confronted with novel ecological conditions and conflicting objectives to preserve the past while fostering resilience for an uncertain future. This dilemma may be pronounced at range peripheries where rates of change are accelerated and ongoing invasions often are perceived as threats to local ecosystems. We provide an example from City of Rocks National Reserve (CIRO) in southern Idaho, positioned at the northern range periphery of pinyon-juniper (P-J) woodland. Reserve managers are concerned about P-J woodland encroachment into adjacent sagebrush steppe, but the rates and biophysical variability of encroachment are not well documented and management options are not well understood. We quantified the rate and extent of woodland change between 1950 and 2009 based on a random sample of aerial photo interpretation plots distributed across biophysical gradients. Our study revealed that woodland cover remained at approximately 20% of the study area over the 59-year period. In the absence of disturbance, P-J woodlands exhibited the highest rate of increase among vegetation types at 0.37% yr(-1). Overall, late-successional P-J stands increased in area by over 100% through the process of densification (infilling). However, wildfires during the period resulted in a net decrease of woody evergreen vegetation, particularly among early and mid-successional P-J stands. Elevated wildfire risk associated with expanding novel annual grasslands and drought is likely to continue to be a fundamental driver of change in CIRO woodlands. Because P-J woodlands contribute to regional biodiversity and may contract at trailing edges with global warming, CIRO may become important to P-J woodland conservation in the future. Our study provides a widely applicable toolset for assessing woodland ecotone dynamics that can help managers reconcile the competing demands to maintain historical fidelity and contribute meaningfully to the U. S. protected area network in a future with novel, no-analog ecosystems.	[Powell, Scott L.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Hansen, Andrew J.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Rodhouse, Thomas J.] Natl Pk Serv, Upper Columbia Basin Network, Bend, OR USA; [Garrett, Lisa K.] Natl Pk Serv, Atlanta, GA USA; [Betancourt, Julio L.] US Geol Survey, Natl Res Program, Reston, VA 22092 USA; [Dicus, Gordon H.; Lonneker, Meghan K.] Natl Pk Serv, Upper Columbia Basin Network, Moscow, ID USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Department of the Interior; United States Department of the Interior; United States Geological Survey; United States Department of the Interior	Powell, SL (corresponding author), Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA.	spowell@montana.edu		Rodhouse, Thomas/0000-0001-5953-9113	National Park Service (NPS) for enhanced monitoring for climate change, Rocky Mountains Cooperative Ecosystem Studies Unit Agreement [H1200090004]; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Park Service (NPS) for enhanced monitoring for climate change, Rocky Mountains Cooperative Ecosystem Studies Unit Agreement; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for this project came from the National Park Service (NPS) for enhanced monitoring for climate change, Rocky Mountains Cooperative Ecosystem Studies Unit Agreement # H1200090004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, N AMERICAL TERRESTRI; Baker WL, 2004, FOREST ECOL MANAG, V189, P1, DOI 10.1016/j.foreco.2003.09.006; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Betancourt J.L., 2012, HIST ENV VARIATION C, P307, DOI 10.1002/9781118329726.ch23; BETANCOURT JL, 1991, ECOLOGY, V72, P1685, DOI 10.2307/1940968; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brooks ML, 2011, RANGELAND ECOL MANAG, V64, P431, DOI 10.2111/REM-D-09-00165.1; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Cole D.N., 2008, G WRIGHT FORUM, V25, P36; Cole D.N., 2010, NATURALNESS RETHINKI; Cottam W. P., 1940, Journal of Forestry, V38, P613; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Erixson J, 2011, NPSUCBNNRR2011450; GEDNEY DR, 1999, PNWGTR464 USDA FOR S; Gray ST, 2006, ECOLOGY, V87, P1124, DOI 10.1890/0012-9658(2006)87[1124:ROMCVI]2.0.CO;2; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hobbs RJ, 2010, FRONT ECOL ENVIRON, V8, P483, DOI 10.1890/090089; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Keane RE, 2009, FOREST ECOL MANAG, V258, P1025, DOI 10.1016/j.foreco.2009.05.035; Klett M., 2004, 3 VIEWS 2 SIGHTS REP; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lindenmayer DB, 2008, CONSERV LETT, V1, P129, DOI 10.1111/j.1755-263X.2008.00021.x; Little Jr E. L., 1971, MISCELLANEOUS PUBLIC, V1146, P1; Mack R.N., 1986, ECOLOGY BIOL INVASIO, P191; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Miller R.F, 2008, RMRSRP69; Minckley TA, 2007, QUATERNARY SCI REV, V26, P2167, DOI 10.1016/j.quascirev.2007.04.009; Morris LA, 2006, FIRE HIST CITY UNPUB; Morris LA, 2006, ECOLOGICAL HIS UNPUB; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Nelson NA, 2010, HOLOCENE, V20, P1179, DOI 10.1177/0959683610371992; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavlacky DC, 2001, CONDOR, V103, P322, DOI 10.1650/0010-5422(2001)103[0322:HPOPJS]2.0.CO;2; Powell SL, 2007, ECOSYSTEMS, V10, P204, DOI 10.1007/s10021-007-9023-1; Rodhouse TJ, 2010, J MAMMAL, V91, P447, DOI 10.1644/09-MAMM-A-060.1; Rodhouse TJ, 2011, NPSUCBNNRTR2011462; Romme WH, 2009, RANGELAND ECOL MANAG, V62, P203, DOI 10.2111/08-188R1.1; Sankey TT, 2008, RANGELAND ECOL MANAG, V61, P412, DOI 10.2111/07-141.1; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sheley RL, 2008, WEED SCI, V56, P469, DOI 10.1614/WS-07-131.1; Shinneman DJ, 2008, J ARID ENVIRON, V72, P207, DOI 10.1016/j.jaridenv.2007.06.002; Smith TB, 2001, TRENDS ECOL EVOL, V16, P431, DOI 10.1016/S0169-5347(01)02201-7; Soule PT, 2004, ECOL APPL, V14, P96, DOI 10.1890/02-5300; Spector S, 2002, CONSERV BIOL, V16, P1480, DOI 10.1046/j.1523-1739.2002.00573.x; Stucki DS, 2012, NATURAL RESOURCE DAT; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; TAUSCH RJ, 1999, P EC MAN PIN JUN COM, P12; Tausch RJ, 2009, PINYON JUNIPER FIELD; Weisberg PJ, 2008, LANDSCAPE ECOL, V23, P931, DOI 10.1007/s10980-008-9249-0; Weppner KN, 2013, QUATERNARY RES, V80, P143, DOI 10.1016/j.yqres.2013.06.004; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WHISENANT SG, 1990, P S CHEATGR INV SHRU; Wiens J, 2012, HIST ENV VARIATION C; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172	60	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70454	10.1371/journal.pone.0070454	http://dx.doi.org/10.1371/journal.pone.0070454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922994	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700185
J	Feng, L; Peng, Y; Wu, P; Hu, K; Jiang, WD; Liu, Y; Jiang, J; Li, SH; Zhou, XQ				Feng, Lin; Peng, Yan; Wu, Pei; Hu, Kai; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu			Threonine Affects Intestinal Function, Protein Synthesis and Gene Expression of TOR in Jian Carp (Cyprinus carpio var. Jian)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; GLUTAMYL-TRANSFERASE TRANSPEPTIDASE; DIGESTIVE ENZYME-ACTIVITIES; BASS DICENTRARCHUS-LABRAX; JUVENILE JIAN; RAINBOW-TROUT; AMINO-ACIDS; EPITHELIAL-CELLS; ATLANTIC SALMON; SEA BASS	This study aimed to investigate the effects of threonine (Thr) on the digestive and absorptive ability, proliferation and differentiation of enterocytes, and gene expression of juvenile Jian carp (Cyprinus carpio var. Jian). First, seven isonitrogenous diets containing graded levels of Thr (7.4-25.2 g/kg diet) were fed to the fishes for 60 days. Second, enterocyte proliferation and differentiation were assayed by culturing enterocytes with graded levels of Thr (0-275 mg/l) in vitro. Finally, enterocytes were cultured with 0 and 205 mg/l Thr to determine protein synthesis. The percent weight gain (PWG), specific growth rate, feed intake, feed efficiency, protein retention value, activities of trypsin, lipase and amylase, weights and protein contents of hepatopancreas and intestine, folds heights, activities of alkaline phosphatase (AKP), gamma-glutamyl transpeptidase and Na+/K+-ATPase in all intestinal segments, glutamate-oxaloacetate transaminase (GOT) and glutamate-pyruvate transaminase (GPT) activities in hepatopancreas, and 4E-BP2 gene expression in muscle, hepatopancreas and intestinal segments were significantly enhanced by Thr (p<0.05). However, the plasma ammonia concentration and TOR gene expression decreased (p<0.05). In vitro, Thr supplement significantly increased cell numbers, protein content, the activities of GOT, GPT, AKP and Na+/K+-ATPase, and protein synthesis rate of enterocytes, and decreased LDH activity and ammonia content in cell medium (p<0.05). In conclusion, Thr improved growth, digestive and absorptive capacity, enterocyte proliferation and differentiation, and protein synthesis and regulated TOR and 4E-BP2 gene expression in juvenile Jian carp. The dietary Thr requirement of juvenile Jian carp was 16.25 g/kg diet (51.3 g/kg protein) based on quadratic regression analysis of PWG.	[Feng, Lin; Peng, Yan; Wu, Pei; Hu, Kai; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Peng, Yan; Wu, Pei; Hu, Kai; Jiang, Wei-Dan; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Zhou, Xiao-Qiu] Sichuan Agr Univ, Key Lab Sichuan Prov, Fish Nutr & Safety Prod Univ, Chengdu, Sichuan, Peoples R China; [Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Zhou, XQ (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	xqzhouqq@tom.com	jiang, jun/GWC-9329-2022; liu, yang/HHY-8583-2022; Jun, Jiang/CAE-8962-2022		National Science Foundation of China [30871926]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-08-0905]; National Department Public Benefit Research Foundation (Agriculture) of China [201003020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); National Department Public Benefit Research Foundation (Agriculture) of China	This research was financially supported by National Science Foundation of China (30871926) (http://www.nsfc.gov.cn/Portal0/default152.htm), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-08-0905) (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A08/index.html) and National Department Public Benefit Research Foundation (Agriculture) of China (201003020) (http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2004, AQUAC RES, V35, P162, DOI 10.1111/j.1365-2109.2004.00997.x; Ahmed I, 2007, AQUACULT INT, V15, P337, DOI 10.1007/s10499-007-9097-y; Alam M.S., 2003, ASIAN FISH SCI, V16, P175, DOI [10.33997/j.afs.2003.16.2.009, DOI 10.33997/J.AFS.2003.16.2.009]; ALSEVER R N, 1970, Endocrinology, V86, P332; AOAC, 2005, AOAC OFFICIAL METHOD, V18th ed.; Bakke AM, 2011, FISH PHYSIOL, V30, P57, DOI 10.1016/S1546-5098(10)03002-5; BAUERMEISTER A, 1983, COMP BIOCHEM PHYS C, V74, P89, DOI 10.1016/0742-8413(83)90155-X; BECCARIA C, 1991, AQUACULTURE, V99, P339, DOI 10.1016/0044-8486(91)90254-5; BELL JG, 1987, J COMP PHYSIOL B, V157, P161, DOI 10.1007/BF00692360; Bergmeyer, 1974, METHOD ENZYMAT AN, V2, P727, DOI 10.1016/B978-0-12-091302-2.50042-6; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P2752; Bergmeyer HU., 1985, METHOD ENZYMAT AN, V8, P454; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bodin N, 2008, AQUACULTURE, V274, P353, DOI 10.1016/j.aquaculture.2007.11.031; BORLONGAN IG, 1993, J NUTR, V123, P125, DOI 10.1093/jn/123.1.125; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Chen J, 2009, AQUACULTURE, V288, P285, DOI 10.1016/j.aquaculture.2008.10.053; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Dahly EM, 2002, J NUTR, V132, P2010, DOI 10.1093/jn/132.7.2010; DALY JG, 1995, FISH SHELLFISH IMMUN, V5, P265, DOI 10.1006/fsim.1995.0026; DEAN JC, 1986, COMP BIOCHEM PHYS B, V83, P355, DOI 10.1016/0305-0491(86)90380-9; Farhangi M, 2001, AQUAC RES, V32, P329, DOI 10.1046/j.1355-557x.2001.00044.x; Faure M, 2005, J NUTR, V135, P486, DOI 10.1093/jn/135.3.486; Figueiredo MSRB, 2001, J CRUSTACEAN BIOL, V21, P334, DOI 10.1651/0278-0372(2001)021[0334:DEAITA]2.0.CO;2; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; FOSSET M, 1974, BIOCHEMISTRY-US, V13, P1783, DOI 10.1021/bi00706a001; FUKAMACHI H, 1992, J CELL SCI, V103, P511; Furne M, 2005, AQUACULTURE, V250, P391, DOI 10.1016/j.aquaculture.2005.05.017; Garcia-Gasca A, 2006, AQUACULTURE, V251, P366, DOI 10.1016/j.aquaculture.2005.05.029; GOLDSPINK DF, 1984, BIOCHEM J, V217, P527, DOI 10.1042/bj2170527; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GUTMAN A, 1991, TRENDS GENET, V7, P49, DOI 10.1016/0168-9525(91)90231-E; Hamard A, 2010, J NUTR BIOCHEM, V21, P914, DOI 10.1016/j.jnutbio.2009.07.004; Hamard A, 2009, COMP BIOCHEM PHYS A, V152, P491, DOI 10.1016/j.cbpa.2008.12.002; He W, 2009, AQUACULT NUTR, V15, P402, DOI 10.1111/j.1365-2095.2008.00604.x; Helland SJ, 2011, AQUACULTURE, V321, P230, DOI 10.1016/j.aquaculture.2011.09.008; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; HOKIN LE, 1951, BIOCHEM J, V50, P216, DOI 10.1042/bj0500216; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157; HUNG SSO, 1987, AQUACULTURE, V65, P307, DOI 10.1016/0044-8486(87)90243-2; INFANTE JLZ, 1994, FISH PHYSIOL BIOCHEM, V12, P399, DOI 10.1007/BF00004304; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Jiang J, 2009, AQUACULT NUTR, V15, P409, DOI 10.1111/j.1365-2095.2008.00605.x; Jiang J, 2009, THESIS SICHUAN AGR U; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Jiang WD, 2009, AQUAC RES, V40, P955, DOI 10.1111/j.1365-2109.2009.02191.x; JOHNSON LR, 1988, PHYSIOL REV, V68, P456, DOI 10.1152/physrev.1988.68.2.456; Keembiyehetty CN, 1997, AQUACULT NUTR, V3, P217, DOI 10.1046/j.1365-2095.1997.00089.x; Kim SG, 2007, TOXICOL SCI, V96, P206, DOI 10.1093/toxsci/kfl175; KONTUREK SJ, 1973, P SOC EXP BIOL MED, V143, P305; Law GK, 2007, AM J PHYSIOL-GASTR L, V292, pG1293, DOI 10.1152/ajpgi.00221.2006; Li W, 2010, AQUACULT NUTR, V16, P137, DOI 10.1111/j.1365-2095.2008.00645.x; Lim CB, 2001, J EXP BIOL, V204, P1605; Lin Y, 2006, AQUACULTURE, V256, P389, DOI 10.1016/j.aquaculture.2006.02.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarthy ID, 2011, J EXP BIOL, V214, P1821, DOI 10.1242/jeb.052753; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; MOYANO FJ, 1991, COMP BIOCHEM PHYS A, V100, P759, DOI 10.1016/0300-9629(91)90404-Z; Nose T., 1979, Finfish nutrition and fishfeed technology. Volume 1, P145; NRC, 1993, NUTR REQ FISH, DOI [10.17226/2115, DOI 10.17226/2115]; Payne EM, 2012, BLOOD, V120, P2214, DOI 10.1182/blood-2011-10-382986; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; PUJARA CP, 1995, INT J PHARM, V114, P197, DOI 10.1016/0378-5173(94)00238-Z; Ribeiro L, 1999, AQUACULTURE, V179, P465, DOI 10.1016/S0044-8486(99)00180-5; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Ronnestad I, 2007, AQUACULTURE, V268, P82, DOI 10.1016/j.aquaculture.2007.04.031; Schaart MW, 2005, J NUTR, V135, P765, DOI 10.1093/jn/135.4.765; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Seiliez I, 2011, AM J PHYSIOL-REG I, V300, pR733, DOI 10.1152/ajpregu.00579.2010; SMITH MH, 1966, J THEOR BIOL, V13, P261, DOI 10.1016/0022-5193(66)90021-X; Stoll B., 2006, Banff Pork Seminar Proceedings 2006. The Pork Wars - Internal & External Threats, 17-20 January, 2006, Banff, Alberta, Canada, P257; STROBAND HWJ, 1978, CELL TISSUE RES, V187, P181; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Sun XY, 1995, AQUACULTURE, V137, P276; Sweeney G, 1998, MOL CELL BIOCHEM, V182, P121, DOI 10.1023/A:1006805510749; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; TESHIMA S, 1986, AQUACULTURE, V51, P225, DOI 10.1016/0044-8486(86)90314-5; Tibaldi E, 1999, AQUACULTURE, V175, P155, DOI 10.1016/S0044-8486(99)00029-0; van der Schoor SRD, 2007, AM J CLIN NUTR, V86, P1132, DOI 10.1093/ajcn/86.4.1132; Wacyk J, 2012, AQUACULTURE, V356, P223, DOI 10.1016/j.aquaculture.2012.05.013; Wang WW, 2010, J NUTR, V140, P981, DOI 10.3945/jn.109.118497; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; Wen ZP, 2009, AQUACULT NUTR, V15, P470, DOI 10.1111/j.1365-2095.2008.00612.x; Williams JA, 1997, NEWS PHYSIOL SCI, V12, P117; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; Wu P, 2011, AQUACULTURE, V317, P107, DOI 10.1016/j.aquaculture.2011.03.042; ZEITOUN IH, 1976, J FISH RES BOARD CAN, V33, P167, DOI 10.1139/f76-019; Zhou XQ, 2008, AQUACULT NUTR, V14, P381, DOI 10.1111/j.1365-2095.2007.00535.x	94	56	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69974	10.1371/journal.pone.0069974	http://dx.doi.org/10.1371/journal.pone.0069974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922879	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900127
J	Singh, J; Khan, M; Pujol, A; Baarine, M; Singh, I				Singh, Jaspreet; Khan, Mushfiquddin; Pujol, Aurora; Baarine, Mauhamad; Singh, Inderjit			Histone Deacetylase Inhibitor Upregulates Peroxisomal Fatty Acid Oxidation and Inhibits Apoptotic Cell Death in Abcd1-Deficient Glial Cells	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; X-LINKED ADRENOLEUKODYSTROPHY; CULTURED SKIN FIBROBLASTS; CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; INFLAMMATORY DISEASE; IMPAIRED OXIDATION; ABCD2 TRANSPORTER; MEMBRANE-PROTEIN; LIGNOCERIC ACID	In X-ALD, mutation/deletion of ALD gene (ABCD1) and the resultant very long chain fatty acid (VLCFA) derangement has dramatically opposing effects in astrocytes and oligodendrocytes. While loss of Abcd1 in astrocytes produces a robust inflammatory response, the oligodendrocytes undergo cell death leading to demyelination in X-linked adrenoleukodystrophy (X-ALD). The mechanisms of these distinct pathways in the two cell types are not well understood. Here, we investigated the effects of Abcd1-knockdown and the subsequent alteration in VLCFA metabolism in human U87 astrocytes and rat B12 oligodendrocytes. Loss of Abcd1 inhibited peroxisomal beta-oxidation activity and increased expression of VLCFA synthesizing enzymes, elongase of very long chain fatty acids (ELOVLs) (1 and 3) in both cell types. However, higher induction of ELOVL's in Abcd1-deficient B12 oligodendrocytes than astrocytes suggests that ELOVL pathway may play a prominent role in oligodendrocytes in X-ALD. While astrocytes are able to maintain the cellular homeostasis of antiapoptotic proteins, Abcd1-deletion in B12 oligodendrocytes downregulated the anti-apototic (Bcl-2 and Bcl-xL) and cell survival (phospho-Erk1/2) proteins, and upregulated the pro-apoptotic proteins (Bad, Bim, Bax and Bid) leading to cell loss. These observations provide insights into different cellular signaling mechanisms in response to Abcd1-deletion in two different cell types of CNS. The apoptotic responses were accompanied by activation of caspase-3 and caspase-9 suggesting the involvement of mitochondrial-caspase-9-dependent mechanism in Abcd1-deficient oligodendrocytes. Treatment with histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) corrected the VLCFA derangement both in vitro and in vivo, and inhibited the oligodendrocytes loss. These observations provide a proof-of principle that HDAC inhibitor SAHA may have a therapeutic potential for X-ALD.	[Singh, Jaspreet; Khan, Mushfiquddin; Baarine, Mauhamad; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Darby Children Res Inst, Charleston, SC 29425 USA; [Pujol, Aurora] Hosp Llobregat, Bellvitge Inst Biomed Res IDIBELL, Inst Neuropathol, Neurometab Dis Lab, Barcelona, Spain; [Pujol, Aurora] Ctr Biomed Res Rare Dis CIBERER, Barcelona, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Medical University of South Carolina; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, Darby Children Res Inst, 171 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu	Pujol, Aurora/N-4990-2014	Pujol, Aurora/0000-0002-9606-0600	National Institutes of Health [NS-22576, NS-37766, C06 RR018823, C06 RR015455]; VA merit award [BX1072-01]; Autonomous Government of Catalonia [2009SGR85]; Spanish Institute for Health Carlos III [FIS PI11/01043]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022576, R01NS037766, R37NS022576] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA merit award(US Department of Veterans Affairs); Autonomous Government of Catalonia(Generalitat de Catalunya); Spanish Institute for Health Carlos III; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ICREA(ICREA)	This work was supported in part by grants from the National Institutes of Health: NS-22576, NS-37766, C06 RR018823, C06 RR015455, and VA merit award BX1072-01 to IS, and also by grants of the Autonomous Government of Catalonia [2009SGR85] and the Spanish Institute for Health Carlos III (FIS PI11/01043) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Albet S, 2001, BBA-GENE STRUCT EXPR, V1517, P257, DOI 10.1016/S0167-4781(00)00291-8; ASANO J, 1994, BRAIN DEV-JPN, V16, P454, DOI 10.1016/0387-7604(94)90007-8; Asheuer M, 2005, HUM MOL GENET, V14, P1293, DOI 10.1093/hmg/ddi140; Aubourg P, 2000, GLIA, V29, P186, DOI 10.1002/(SICI)1098-1136(20000115)29:2<186::AID-GLIA13>3.0.CO;2-5; AUBOURG P, 1993, NEW ENGL J MED, V329, P745, DOI 10.1056/NEJM199309093291101; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bottelbergs A, 2010, GLIA, V58, P1532, DOI 10.1002/glia.21027; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Chen SH, 2012, BRIT J PHARMACOL, V165, P494, DOI 10.1111/j.1476-5381.2011.01575.x; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; Contreras M, 1996, ARCH BIOCHEM BIOPHYS, V334, P369, DOI 10.1006/abbi.1996.0467; Di Benedetto R, 2009, NEUROCHEM INT, V54, P37, DOI 10.1016/j.neuint.2008.10.002; Eyupoglu IY, 2005, J NEUROCHEM, V93, P992, DOI 10.1111/j.1471-4159.2005.03098.x; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; Fourcade S, 2008, HUM MOL GENET, V17, P1762, DOI 10.1093/hmg/ddn085; Fourcade S, 2010, HUM MOL GENET, V19, P2005, DOI 10.1093/hmg/ddq082; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Galea E, 2012, BIOCH BIOPHYSICA ACT; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gilg AG, 2000, J NEUROPATH EXP NEUR, V59, P1063, DOI 10.1093/jnen/59.12.1063; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Hashioka S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-113; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; HOSHI M, 1973, J BIOL CHEM, V248, P4123; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Kemp S, 2005, MOL GENET METAB, V84, P144, DOI 10.1016/j.ymgme.2004.09.015; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Khan M, 1998, J NEUROCHEM, V71, P78; Khan M, 2008, J NEUROCHEM, V106, P1766, DOI 10.1111/j.1471-4159.2008.05513.x; Khan M, 2010, J LIPID RES, V51, P1685, DOI 10.1194/jlr.M002329; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Li YQ, 2009, SHOCK, V32, P517, DOI 10.1097/SHK.0b013e3181a44c79; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; McGuinness MC, 2001, MOL GENET METAB, V74, P256, DOI 10.1006/mgme.2001.3239; MCGUINNESS MC, 1995, J NEUROIMMUNOL, V61, P161, DOI 10.1016/0165-5728(95)00084-F; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSER HW, 1993, ANN NEUROL, V34, P121, DOI 10.1002/ana.410340202; MOSER HW, 1995, BRAIN PATHOL, V5, P259, DOI 10.1111/j.1750-3639.1995.tb00602.x; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Pai GS, 2000, MOL GENET METAB, V69, P312; Paintlia AS, 2003, NEUROBIOL DIS, V14, P425, DOI 10.1016/j.nbd.2003.08.013; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; POWERS JM, 1992, J NEUROPATH EXP NEUR, V51, P630, DOI 10.1097/00005072-199211000-00007; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Schluter A, 2012, HUM MOL GENET, V21, P1062, DOI 10.1093/hmg/ddr536; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; SHARP P, 1991, J NEUROCHEM, V56, P30, DOI 10.1111/j.1471-4159.1991.tb02558.x; Silva-Zolezzi I, 2003, AM J HUM GENET, V73, P199; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; Singh I, 2004, BRAIN RES, V1022, P1, DOI 10.1016/j.brainres.2004.06.059; SINGH I, 1981, BIOCHEM BIOPH RES CO, V102, P1223, DOI 10.1016/S0006-291X(81)80142-8; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; Singh I, 1998, NEW ENGL J MED, V339, P702, DOI 10.1056/NEJM199809033391012; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Singh J, 2011, J LIPID RES, V52, P2056, DOI 10.1194/jlr.M017491; Singh J, 2009, J LIPID RES, V50, P135, DOI 10.1194/jlr.M800321-JLR200; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Uto Takuhiro, 2008, Dev Neurosci, V30, P410, DOI 10.1159/000191212; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; WILSON R, 1993, J NEUROCHEM, V61, P290, DOI 10.1111/j.1471-4159.1993.tb03567.x	89	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70712	10.1371/journal.pone.0070712	http://dx.doi.org/10.1371/journal.pone.0070712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923017	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900175
J	Hung, YP; Lin, HJ; Wu, TC; Liu, HC; Lee, JC; Lee, CI; Wu, YH; Wan, L; Tsai, PJ; Ko, WC				Hung, Yuan-Pin; Lin, Hsiao-Ju; Wu, Tai-Chieh; Liu, Hsiu-Chuan; Lee, Jen-Chieh; Lee, Chih-I; Wu, Yi-Hui; Wan, Lei; Tsai, Pei-Jane; Ko, Wen-Chien			Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure	PLOS ONE			English	Article							DIARRHEA; DISEASE; INFECTION; GENE; PREVENTION; SUSCEPTIBILITY; EPIDEMIC; HAMSTERS; PROMOTER; TRAUMA	Background: This study is to investigate the significance and risk factors of fecal toxigenic (tCdC) or non-toxigenic Clostridium difficile colonization (ntCdC) among hospitalized patients. Methods: Adults admitted to medical wards in a district hospital between January 2011 and June 2012 were enrolled, and those with a history of colectomy, C. difficile fecal colonization or infection or receipt of either metronidazole or oral vancomycin within 3 months, were excluded. Stools collected within 48 hours after admission and every week during hospitalization were cultured for C. difficile. Findings: Among the 441 enrolled patients, 84 (20.0%) had CdC at initial screening, including 58 (13.2%) with tCdC and 26 (6.8%) with ntCdC. Among patients with initial negative fecal screening for CdC, it took an average of 70.6 days or 66.5 days to develop tCdC or ntCdC during the study period. Finally 78 (17.7%) had tCdC and 34 (7.7%) had ntCdC. During the follow-up period, the patients with tCdC had a higher risk of CDAD (11/79, 14.1%) than those without CdC (3/328, 0.9%) and those with ntCdC (0/34, 0%) (P<0.001). In multivariate analysis, the TLR4 rs1927914 polymorphism (GG genotype) (odds ratio [OR] 4.4, 95% confidence interval [CI] 1.6-11.8, P = 0.003) and recent cefepime therapy (OR 5.3, 95% CI 2.1-13.2, P<0.001) were independently associated with tCdC, whereas recent cefuroxime (OR 4.4, 95% confidence interval [CI] 1.6-11.8, P = 0.003) and recent cefepime therapy (OR 5.3, 95% CI 2.1-13.2, P<0.001) were, 95% CI 2.3-60.2, P = 0.003) and glycopeptide therapy (OR 10.9, CI: 2.1-57.2, P = 0.005) associated with ntCdC. Conclusion: The incidence of CDAD is highest in patients with tCdC and lowest in patients with ntCdC, and the TLR4 rs1927914 polymorphism GG genotype and recent cefepime therapy were independently associated with tCdC.	[Hung, Yuan-Pin; Lin, Hsiao-Ju; Lee, Chih-I] Tainan Hosp, Dept Hlth, Dept Internal Med, Tainan, Taiwan; [Liu, Hsiu-Chuan] Tainan Hosp, Dept Hlth, Dept Expt & Diag, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju; Lee, Jen-Chieh; Wu, Yi-Hui; Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju] Natl Hlth Res Inst, Grad Inst Clin Med, Tainan, Taiwan; [Wu, Tai-Chieh; Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Wu, Yi-Hui] PingTung Christian Hosp, Dept Internal Med, Pingtung, Taiwan; [Wan, Lei] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan 70428, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Dept Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Tsai, PJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	peijtsai@mail.ncku.edu.com; winston3415@gmail.com	Wan, Lei/F-4719-2010; Tsai, Pei-Jane/G-3563-2011; Ko, Wen-Chien/ABG-4316-2020; hong, hesse/EUM-0179-2022	Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X	National Science Council [100-2314-B-675-002]; Department of Health, Executive Yuan, Taiwan [DOH100-TD-B-111-002]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan	The study is supported by the grants from the National Science Council (100-2314-B-675-002) and Department of Health, Executive Yuan (DOH100-TD-B-111-002), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann G, 2001, DIAGN MICR INFEC DIS, V40, P103, DOI 10.1016/S0732-8893(01)00259-0; Baxter R, 2008, INFECT CONT HOSP EP, V29, P44, DOI 10.1086/524320; Borysiewicz E, 2009, J NEUROSCI RES, V87, P1565, DOI 10.1002/jnr.21968; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Chung CH, 2010, J MICROBIOL IMMUNOL, V43, P119, DOI 10.1016/S1684-1182(10)60019-9; Gao M, 2012, DNA CELL BIOL, V31, P611, DOI 10.1089/dna.2011.1389; Garey KW, 2010, CLIN INFECT DIS, V51, P1406, DOI 10.1086/657398; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; Hansson GK, 2005, ARTERIOSCL THROM VAS, V25, P1085, DOI 10.1161/01.ATV.0000168894.43759.47; Hsieh YY, 2009, INT J BIOL SCI, V5, P74; Hung YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042415; Hunley TE, 2008, PEDIATR NEPHROL, V23, P1171, DOI 10.1007/s00467-008-0774-5; Hutin Y, 1997, CLIN INFECT DIS, V24, P920, DOI 10.1093/clinids/24.5.920; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Martirosian Gayane, 2004, Polish Journal of Microbiology, V53, P197; Merrigan MM, 2003, J INFECT DIS, V188, P1922, DOI 10.1086/379836; Minmin Shi, 2011, PLoS One, V6, pe19466, DOI 10.1371/journal.pone.0019466; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Satomura Hideyuki, 2009, Kansenshogaku Zasshi, V83, P549; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; SEAL D, 1987, EUR J CLIN MICROBIOL, V6, P51, DOI 10.1007/BF02097191; Shah K, 2012, J TRAUMA ACUTE CARE, V72, P691, DOI 10.1097/TA.0b013e31823c5637; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Songer JG, 2007, VET MICROBIOL, V124, P358, DOI 10.1016/j.vetmic.2007.04.019; Spencer RC, 1998, J ANTIMICROB CHEMOTH, V41, P21, DOI 10.1093/jac/41.suppl_3.21; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Zhang Q, 2011, J INVEST ALLERG CLIN, V21, P370	40	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69577	10.1371/journal.pone.0069577	http://dx.doi.org/10.1371/journal.pone.0069577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936050	gold, Green Submitted, Green Published			2022-12-27	WOS:000322433300050
J	Harrison, C; Britt, H; Miller, G; Henderson, J				Harrison, Christopher; Britt, Helena; Miller, Graeme; Henderson, Joan			Prevalence of Chronic Conditions in Australia	PLOS ONE			English	Article							MEDICAL-RECORDS; STANDARDIZED PATIENTS; CHART ABSTRACTION; VALIDATION; AGREEMENT; ACCURACY; QUALITY; CARE	Objectives: To estimate prevalence of chronic conditions among patients seeing a general practitioner (GP), patients attending general practice at least once in a year, and the Australian population. Design, setting and participants: A sub-study of the BEACH (Bettering the Evaluation and Care of Health) program, a continuous national study of general practice activity conducted between July 2008 and May 2009. Each of 290 GPs provided data for about 30 consecutive patients (total 8,707) indicating diagnosed chronic conditions, using their knowledge of the patient, patient self-report, and patient's health record. Main outcome measures: Estimates of prevalence of chronic conditions among patients surveyed, adjusted prevalence in patients who attended general practice at least once that year, and national population prevalence. Results: Two-thirds (66.3%) of patients surveyed had at least one chronic condition: most prevalent being hypertension (26.6%), hyperlipidaemia (18.5%), osteoarthritis (17.8%), depression (13.7%), gastro-oesophageal reflux disease (11.6%), asthma (9.5%) and Type 2 diabetes (8.3%). For patients who attended general practice at least once, we estimated 58.8% had at least one chronic condition. After further adjustment we estimated 50.8% of the Australian population had at least one chronic condition: hypertension (17.4%), hyperlipidaemia (12.7%), osteoarthritis (11.1%), depression (10.5%) and asthma (8.0%) being most prevalent. Conclusions: This study used GPs to gather information from their knowledge, the patient, and health records, to provide prevalence estimates that overcome weaknesses of studies using patient self-report or health record audit alone. Our results facilitate examination of primary care resource use in management of chronic conditions and measurement of prevalence of multimorbidity in Australia.	[Harrison, Christopher; Britt, Helena; Miller, Graeme; Henderson, Joan] Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Parramatta, NSW, Australia	University of Sydney	Harrison, C (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Family Med Res Ctr, Parramatta, NSW, Australia.	christopher.harrison@sydney.edu.au		Harrison, Christopher/0000-0002-8769-6877	Australian Government Department of Health and Ageing; Australian Institute of Health and Welfare; AstraZeneca Pty Ltd (Australia); Janssen-Cilag Pty Ltd; Merck Sharp and Dohme (Australia) Pty Ltd; Pfizer Australia; Abbott Australiasia Pty Ltd; Sanofi-Aventis Australia Pty Ltd; Wyeth Australia Pty Ltd; Novartis Pharmaceuticals Australia Pty Ltd; GloxoSmithKline Australia Pty Ltd; Australian Government Department of Veterans' Affairs	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Institute of Health and Welfare; AstraZeneca Pty Ltd (Australia)(AstraZeneca); Janssen-Cilag Pty Ltd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Sharp and Dohme (Australia) Pty Ltd(Merck & Company); Pfizer Australia(PfizerPfizer Australia); Abbott Australiasia Pty Ltd; Sanofi-Aventis Australia Pty Ltd(Sanofi-Aventis); Wyeth Australia Pty Ltd; Novartis Pharmaceuticals Australia Pty Ltd; GloxoSmithKline Australia Pty Ltd; Australian Government Department of Veterans' Affairs(US Department of Veterans Affairs)	The BEACH program from which the data for this study is drawn is supported by a consortium of industry and government bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding organisations during the period the data for this study was collected were: The Australian Government Department of Health and Ageing, the Australian Institute of Health and Welfare, AstraZeneca Pty Ltd (Australia), Janssen-Cilag Pty Ltd, Merck Sharp and Dohme (Australia) Pty Ltd, Pfizer Australia, Abbott Australiasia Pty Ltd, Sanofi-Aventis Australia Pty Ltd, Wyeth Australia Pty Ltd, Novartis Pharmaceuticals Australia Pty Ltd, GloxoSmithKline Australia Pty Ltd and the Australian Government Department of Veterans' Affairs.	Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; Australian Bureau of Statistics. Australian demographic statistics, 2011, AUSTR DEM STAT JUN 2; Australian Institute of Health and Welfare, 2013, NAT HLTH PRIOR AR; Baker IDI Heart and Diabetes Institute, 2011, GOV INV 3 ROUND AUSD; BRITT H, 1992, FAM PRACT, V9, P191, DOI 10.1093/fampra/9.2.191; Britt H, 2009, GEN PRACTICE AUSTR H; Britt H, 2011, GEN PRACTICE ACTIVIT; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Cameron AJ, 2007, US ENDOCRINE DIS, P26; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Harrison C, 2011, AUST FAM PHYSICIAN, V40, P12; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; King H, 1999, DIABETES NONCOMMUNIC; Knox SA, 2008, MED J AUSTRALIA, V189, P66, DOI 10.5694/j.1326-5377.2008.tb01918.x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4; Luck J, 2000, AM J MED, V108, P642, DOI 10.1016/S0002-9343(00)00363-6; Magliano DJ, 2006, AUSDIAB 2005 AUSTR D; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Merkin SS, 2007, J CLIN EPIDEMIOL, V60, P634, DOI 10.1016/j.jclinepi.2006.09.003; Mohangoo AD, 2006, EUR J PUBLIC HEALTH, V16, P101, DOI 10.1093/eurpub/cki043; National Center for Health Statistics. National Health Interview Survey, 2013, NAT HLTH INT SURV; National Heart Foundation of Australia, 2010, GUID MAN HYP 2008 AS; NHS Information Centre for Health and Social Care, 2013, HLTH SURV ENGL; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Statistics Canada, 2013, CAN COMM HLTH SURV; United Nations, 2001, WORLD POP AG 1950 20; Valenti L., 2008, THESIS; Wonca International Classification Committee, 1998, ICPC 2 ENGL 2 PAG; Zhu KM, 1999, INT J EPIDEMIOL, V28, P409, DOI 10.1093/ije/28.3.409	32	103	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67494	10.1371/journal.pone.0067494	http://dx.doi.org/10.1371/journal.pone.0067494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935834	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000012
J	Jiang, YH; Zhu, Y; Shi, Y; He, YP; Kuang, ZC; Sun, ZG; Wang, J				Jiang, Yahong; Zhu, Yan; Shi, Yan; He, Yaping; Kuang, Zhichao; Sun, Zhaogui; Wang, Jian			Downregulation of SPARC Expression Inhibits the Invasion of Human Trophoblast Cells In Vitro	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; GROWTH-FACTOR; OSTEONECTIN SPARC; INSULIN; MIGRATION; TUMOR; GENE; METASTASIS; PROTEINS; SURVIVAL	Successful pregnancy depends on the precise regulation of extravilloustrophoblast (EVT) invasion into the uterine decidua. SPARC (secreted protein acidic and rich in cysteine) is a matricellular glycoprotein that plays critical roles in the pathologies associated with obesity and diabetes, as well as tumorigenesis. The objective of this study was to investigate the role of SPARC in the process of trophoblast invasion which shares many similarities with tumor cell invasion. By Western blot, higher expression of SPARC was observed in mouse brain, ovary and uterus compared to other mouse tissues. Immunohistochemistry analysis revealed a spatio-temporal expression of SPARC in mouse uterus in the periimplantation period. At the implantation site of d8 pregnancy, SPARC mainly accumulated in the secondary decidua zone (SDZ), trophoblast cells and blastocyst. The expression of SPARC was also detected in human placental villi and trophoblast cell lines. In a Matrigel invasion assay, we found SPARC-specific RNA interference significantly reduced the invasion of human extravilloustrophoblast HTR8/SVneo cells. Microarray analysis revealed that SPARC depletion upregulated the expression of interleukin 11 (IL11), KISS1, insulin-like growth factor binding protein 4 (IGFBP4), collagen type I alpha 1 (COLIA1), matrix metallopeptidase 9 (MMP9), and downregulated the expression of the alpha polypeptide of chorionic gonadotropin (CGA), MMP1, gap junction protein alpha 1 (GJA1), et al. The gene array result was further validated by qRT-PCR and Western blot. The present data indicate that SPARC may play an important role in the regulation of normal placentation by promoting the invasion of trophoblast cells into the uterine decidua.	[Jiang, Yahong; Zhu, Yan; Shi, Yan; He, Yaping; Kuang, Zhichao; Sun, Zhaogui; Wang, Jian] Shanghai Inst Planned Parenthood Res, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China		Wang, J (corresponding author), Shanghai Inst Planned Parenthood Res, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China.	wangjiansippr@126.com			National Natural Science Foundation [81000270]; Shanghai Science and Technology Committee Rising-Star Program [11QA1405600]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Rising-Star Program	This work was supported by National Natural Science Foundation (81000270) and Shanghai Science and Technology Committee Rising-Star Program (11QA1405600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Atorrasagasti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054962; Bhoopathi P, 2010, BRIT J CANCER, V102, P530, DOI 10.1038/sj.bjc.6605538; Bornstein P, 2002, METHOD CELL BIOL, V69, P7, DOI 10.1016/S0091-679X(02)69003-X; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; CHANDRASEKHAR S, 1994, BBA-MOL CELL RES, V1221, P7, DOI 10.1016/0167-4889(94)90209-7; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fowlkes JL, 1997, TRENDS ENDOCRIN MET, V8, P299, DOI 10.1016/S1043-2760(97)00112-4; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; Harris LK, 2010, PLACENTA, V31, pS93, DOI 10.1016/j.placenta.2009.12.012; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Hwa V, 1999, ACTA PAEDIATR, V88, P37, DOI 10.1111/j.1651-2227.1999.tb14349.x; Jorgensen LH, 2009, J HISTOCHEM CYTOCHEM, V57, P29, DOI 10.1369/jhc.2008.951954; KNISS DA, 1994, J REPROD MED, V39, P249; Knofler M, 2008, PLACENTA, V29, pS26, DOI 10.1016/j.placenta.2007.11.008; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; NESTLER JE, 1987, ENDOCRINOLOGY, V121, P1845, DOI 10.1210/endo-121-5-1845; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Prast J, 2008, ENDOCRINOLOGY, V149, P979, DOI 10.1210/en.2007-1282; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Rempel SA, 1999, CLIN CANCER RES, V5, P237; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Schittenhelm J, 2006, NEUROPATH APPL NEURO, V32, P525, DOI 10.1111/j.1365-2990.2006.00761.x; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Soundararajan Rama, 2004, Reprod Biol Endocrinol, V2, P15, DOI 10.1186/1477-7827-2-15; Staun-Ram E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-56; Strup-Perrot C, 2004, AM J PHYSIOL-GASTR L, V287, pG875, DOI 10.1152/ajpgi.00088.2004; Sturm RA, 2002, CANCER RES, V62, P226; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; Tsukihara S, 2004, AM J REPROD IMMUNOL, V52, P218, DOI 10.1111/j.1600-0897.2004.00209.x; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; WEWER UM, 1988, AM J PATHOL, V132, P345; White Christine A, 2004, Reprod Biol Endocrinol, V2, P76, DOI 10.1186/1477-7827-2-76; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	48	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69079	10.1371/journal.pone.0069079	http://dx.doi.org/10.1371/journal.pone.0069079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935929	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000075
J	Liu, P; Song, JW; Su, H; Li, LL; Lu, N; Yang, RL; Peng, ZH				Liu, Ping; Song, Jianwen; Su, Hui; Li, Linli; Lu, Ning; Yang, Rongli; Peng, Zhenhui			IL-10 Gene Polymorphisms and Susceptibility to Systemic Lupus Erythematosus: A Meta-Analysis	PLOS ONE			English	Article							B-LYMPHOCYTE HYPERACTIVITY; PROMOTER POLYMORPHISMS; RHEUMATOID-ARTHRITIS; INTERLEUKIN-10 GENES; T-CELLS; ASSOCIATION; ONSET; RISK	Background: A number of observational studies have been conducted to investigate the association of the IL-10 gene polymorphisms with systemic lupus erythematosus (SLE) susceptibility. However, their results are conflicting. Method: We searched published case-control studies on the IL-10 polymorphisms and SLE in PubMed, EMBASE and Chinese Biomedical Literature Database. A meta-analysis was conducted using a fixed-effect or random-effect model based on between-study heterogeneity. Results: A total of 42 studies with 7948 cases and 11866 controls were included in this meta-analysis. Among Caucasians, the CA27 allele of the IL10.G microsatellites (OR 2.38, 95% CI 1.01-5.62), the G allele of the IL-10 -1082G/A polymorphism (G vs. A: OR 1.21, 95% CI 1.02-1.44; GG vs. AA: OR 1.45, 95% CI 1.16-1.82; GG+GA vs. AA: OR 1.16, 95% CI 1.03-1.29) and its associated haplotype -1082G/-819C/-592C (OR 1.25, 95% CI 1.10-1.42) were associated with increased SLE susceptibility without or with unimportant between-study heterogeneity. Removing studies deviating from Hardy-Weinberg equilibrium (HWE) hardly changed these results. Among Asians, the CA21 allele of the IL-10. G microsatellites (OR 1.28, 95% CI 1.02-1.60) and the -1082G/-819C/-592C haplotype (OR 1.24, 95% CI 1.00-1.53) were associated with increased SLE susceptibility, but with substantial between-study heterogeneity or sensitive to HWE status. Removing studies deviating from HWE also produced statistically significant associations of the IL-10 -1082G/A (GG vs. AA: OR 3.21, 95% CI 1.24-8.28; GG vs. AA+GA: OR 2.85, 95% CI 1.19-6.79) and -592C/A polymorphisms (CC+CA vs. AA: OR 0.69, 95% CI 0.51-0.94) with SLE among Asians. Conclusion: This meta-analysis showed that the IL10.G microsatellites, the IL-10 -1082G/A and -592C/A polymorphisms and the haplotype -1082G/-819C/-592C are associated with SLE susceptibility. Besides, this is the first time to report an association between the CA27 allele of the IL-10. G microsatellites and SLE among Caucasians. Further studies are needed to confirm these findings.	[Liu, Ping; Su, Hui; Yang, Rongli; Peng, Zhenhui] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Xian 710049, Shaanxi, Peoples R China; [Song, Jianwen] Xian Childrens Hosp, Dept Dermatol, Xian, Shaanxi, Peoples R China; [Li, Linli] Cent Hosp, Dept Dermatol, Shijiazhuang, Hebei, Peoples R China; [Lu, Ning] First Hosp, Dept Dermatol, Baoding, Hebei, Peoples R China	Xi'an Jiaotong University	Liu, P (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Xian 710049, Shaanxi, Peoples R China.	medlp@163.com; freedomsong@163.com						Alarcon-Riquelme ME, 2002, RHEUMATOLOGY, V41, pA364; Chong WP, 2004, GENES IMMUN, V5, P484, DOI 10.1038/sj.gene.6364119; Claudino M, 2008, J LEUKOCYTE BIOL, V84, P1565, DOI 10.1189/jlb.0308184; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Dang SS, 2012, HEPATO-GASTROENTEROL, V59, P461, DOI 10.5754/hge11312; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656; Groux H, 2003, J AUTOIMMUN, V20, P281, DOI 10.1016/S0896-8411(03)00044-1; Guarnizo-Zuccardi P, 2007, TISSUE ANTIGENS, V70, P376, DOI 10.1111/j.1399-0039.2007.00917.x; Hagiwara E, 1996, ARTHRITIS RHEUM, V39, P379, DOI 10.1002/art.1780390305; Hirankarn N, 2006, TISSUE ANTIGENS, V68, P399, DOI 10.1111/j.1399-0039.2006.00681.x; Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Kurreeman FAS, 2004, HUM MOL GENET, V13, P1755, DOI 10.1093/hmg/ddh187; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Lauwerys BR, 2000, ARTHRITIS RHEUM, V43, P1976, DOI 10.1002/1529-0131(200009)43:9<1976::AID-ANR8>3.0.CO;2-V; Lazarus M, 1997, J RHEUMATOL, V24, P2314; Lin YJ, 2010, CLIN EXP RHEUMATOL, V28, P318; LITTLE J, 2006, HUGENET HUGE REV HDB; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; LLORENTE L, 1994, ARTHRITIS RHEUM-US, V37, P1647, DOI 10.1002/art.1780371114; Lu LY, 2005, J FORMOS MED ASSOC, V104, P563; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nath SK, 2005, HUM GENET, V118, P225, DOI 10.1007/s00439-005-0044-6; Ou Tsan-Teng, 1998, Kaohsiung Journal of Medical Sciences, V14, P599; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Rees LEN, 2002, CELL MOL LIFE SCI, V59, P560, DOI 10.1007/s00018-002-8448-0; Rood MJ, 1999, ANN RHEUM DIS, V58, P85, DOI 10.1136/ard.58.2.85; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Schotte H, 2004, RHEUMATOLOGY, V43, P1357, DOI 10.1093/rheumatology/keh353; [沈南 Shen Nan], 2003, [上海医学, Shanghai medical journal], V26, P452; Sobkowiak A, 2009, RHEUMATOL INT, V29, P921, DOI 10.1007/s00296-008-0776-4; Song GG, 2013, HUM IMMUNOL, V74, P364, DOI 10.1016/j.humimm.2012.11.020; Sullivan KE, 2000, RHEUM DIS CLIN N AM, V26, P229, DOI 10.1016/S0889-857X(05)70137-X; TAGA K, 1992, J IMMUNOL, V148, P1143; Torres-Poveda K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-32; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; [王芙艳 WANG Fuyan], 2007, [激光生物学报, Acta Laser Biology Sinica], V16, P344; Yu HH, 2010, LUPUS, V19, P1219, DOI 10.1177/0961203310371152; Yu Y, 2012, MOL BIOL REP, V39, P8457, DOI 10.1007/s11033-012-1699-4; Zhou H, 2007, CHINESE J DERMATOLOG, V21, P517; Zhou M, 2013, LUPUS, V22, P128, DOI 10.1177/0961203312468623	51	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69547	10.1371/journal.pone.0069547	http://dx.doi.org/10.1371/journal.pone.0069547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936042	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000134
J	Prunier, F; Terrien, G; Le Corre, Y; Apana, ALY; Biere, L; Kauffenstein, G; Furber, A; Bergen, AAB; Gorgels, TGMF; Le Saux, O; Leftheriotis, G; Martin, L				Prunier, Fabrice; Terrien, Gwenola; Le Corre, Yannick; Apana, Ailea L. Y.; Biere, Loic; Kauffenstein, Gilles; Furber, Alain; Bergen, Arthur A. B.; Gorgels, Theo G. M. F.; Le Saux, Olivier; Leftheriotis, Georges; Martin, Ludovic			Pseudoxanthoma Elasticum: Cardiac Findings in Patients and Abcc6-Deficient Mouse Model	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ABCC6 GENE; PREVALENCE; CALCIFICATION; MUTATIONS; R1141X; RECOMMENDATIONS; QUANTIFICATION; MANIFESTATIONS; MINERALIZATION	Background: Pseudoxanthoma elasticum (PXE), caused by mutations in the ABCC6 gene, is a rare multiorgan disease characterized by the mineralization and fragmentation of elastic fibers in connective tissue. Cardiac complications reportedly associated with PXE are mainly based on case reports. Methods: A cohort of 67 PXE patients was prospectively assessed. Patients underwent physical examination, electrocardiogram, transthoracic echocardiography, cardiac magnetic resonance imaging (CMR), treadmill testing, and perfusion myocardial scintigraphy (SPECT). Additionally, the hearts of a PXE mouse models (Abcc6(-/-)) and wild-type controls (WT) were analyzed. Results: Three patients had a history of proven coronary artery disease. In total, 40 patients underwent exercise treadmill tests, and 28 SPECT. The treadmill tests were all negative. SPECT showed mild perfusion abnormalities in two patients. Mean left ventricular (LV) dimension and function values were within the normal range. LV hypertrophy was found in 7 (10.4%) patients, though the hypertrophy etiology was unknown for 3 of those patients. Echocardiography revealed frequent but insignificant mitral and tricuspid valvulopathies. Mitral valve prolapse was present in 3 patients (4.5%). Two patients exhibited significant aortic stenosis (3.0%). While none of the functional and histological parameters diverged significantly between the Abcc6(-/-) and WT mice groups at age of 6 and 12 months, the 24-month-old Abcc6(-/-) mice developed cardiac hypertrophy without contractile dysfunction. Conclusions: Despite sporadic cases, PXE does not appear to be associated with frequent cardiac complications. However, the development of cardiac hypertrophy in the 24-month-old Abcc6(-/-) mice suggests that old PXE patients might be prone to developing late cardiopathy.	[Prunier, Fabrice; Terrien, Gwenola; Le Corre, Yannick; Biere, Loic; Kauffenstein, Gilles; Furber, Alain; Leftheriotis, Georges; Martin, Ludovic] LUNAM Univ, Angers, France; [Prunier, Fabrice; Terrien, Gwenola; Biere, Loic; Furber, Alain] Univ Angers, CHU Angers, Serv Cardiol, Lab Protect & Remodelage Myocarde, Angers, France; [Prunier, Fabrice; Terrien, Gwenola; Le Corre, Yannick; Biere, Loic; Furber, Alain; Leftheriotis, Georges; Martin, Ludovic] CHU Angers, Ctr Consultat PXE, Angers, France; [Le Corre, Yannick; Kauffenstein, Gilles; Leftheriotis, Georges; Martin, Ludovic] Univ Angers, UMR INSERM CNRS 6214 1083, Angers, France; [Apana, Ailea L. Y.; Le Saux, Olivier] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Bergen, Arthur A. B.; Gorgels, Theo G. M. F.] NIN, Dept Mol & Clin Ophthalmogenet, Amsterdam, Netherlands	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Hawaii System; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	FaPrunier@chu-angers.fr	Martin, Ludovic/K-2674-2015; Prunier, Fabrice/A-5210-2011; Kauffenstein, Gilles/K-2867-2015; Le Saux, Olivier/P-4668-2017	Kauffenstein, Gilles/0000-0003-4994-8305; Le Saux, Olivier/0000-0002-5605-3617; Bergen, Arthur/0000-0002-6333-9576	Societe Francaise de Dermatologie; PXE France; CHU d'Angers; Hawaii Community Foundation [11ADVC-49234]; American Heart Association [11GRNT5840005]; National Institutes of Health [R21HL087289, RO1HL108249, RR16453, RR003061]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108249, R21HL087289] Funding Source: NIH RePORTER	Societe Francaise de Dermatologie; PXE France; CHU d'Angers; Hawaii Community Foundation; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from Societe Francaise de Dermatologie, PXE France and CHU d'Angers. Financial support for this work was also provided to OLS by the Hawaii Community Foundation (11ADVC-49234), the American Heart Association (11GRNT5840005) and the National Institutes of Health (R21HL087289 and RO1HL108249). The authors would like to also acknowledge additional support from the National Institutes of Health (RR16453 and RR003061) to the Histology and Imaging Core Facility at the John A. Burns School of Medicine, University of Hawaii. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Brampton C, 2011, CELL CYCLE, V10, P1810, DOI 10.4161/cc.10.11.15681; Chassaing N, 2005, J MED GENET, V42, P881, DOI 10.1136/jmg.2004.030171; Enbergs A, 2000, EUR HEART J, V21, P45, DOI 10.1053/euhj.1999.1763; Finger RP, 2009, SURV OPHTHALMOL, V54, P272, DOI 10.1016/j.survophthal.2008.12.006; FUKUDA K, 1992, CHEST, V101, P1706, DOI 10.1378/chest.101.6.1706; GARDIN JM, 1995, CIRC RES, V76, P907, DOI 10.1161/01.RES.76.5.907; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Hornstrup LS, 2011, CIRC-CARDIOVASC GENE, V4, P534, DOI 10.1161/CIRCGENETICS.110.958801; Jiang QJ, 2009, J INVEST DERMATOL, V129, P348, DOI 10.1038/jid.2008.212; Kevorkian JP, 1997, ANGIOLOGY, V48, P735, DOI 10.1177/000331979704800810; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Koblos G, 2010, GENET TEST MOL BIOMA, V14, P75, DOI 10.1089/gtmb.2009.0094; Kocaman SA, 2007, ACTA CARDIOL, V62, P417, DOI 10.2143/AC.62.4.2022288; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Le Corre Y, 2012, AM J PATHOL, V180, P2208, DOI 10.1016/j.ajpath.2012.02.007; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Le Saux Olivier, 2012, Frontiers in Genetics, V3, P289, DOI 10.3389/fgene.2012.00289; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4; LEBWOHL MG, 1982, NEW ENGL J MED, V307, P228, DOI 10.1056/NEJM198207223070406; Leftheriotis G, 2011, J VASC SURG, V54, P1390, DOI 10.1016/j.jvs.2011.04.041; MENDELSOHN G, 1978, ARCH PATHOL LAB MED, V102, P298; Miki K, 2007, MED MOL MORPHOL, V40, P172, DOI 10.1007/s00795-007-0368-5; Miwa K, 2004, HEART, V90, DOI 10.1136/hrt.2004.040592; Mungrue IN, 2011, ARTERIOSCL THROM VAS, V31, P2806, DOI 10.1161/ATVBAHA.111.237420; NAVARROLOPEZ F, 1980, CHEST, V78, P113, DOI 10.1378/chest.78.1.113; NELDNER KH, 1988, CLIN DERMATOL, V6, pR8; Nguyen LD, 2006, AM J CARDIOL, V97, P1535, DOI 10.1016/j.amjcard.2005.11.091; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Nolte KB, 2000, HUM PATHOL, V31, P1002, DOI 10.1053/hupa.2000.0311002; Plomp AS, 2009, GENET MED, V11, P852, DOI 10.1097/GIM.0b013e3181c00a96; Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001; Rossiter-Thornton M, 2011, HEART LUNG CIRC, V20, P726, DOI 10.1016/j.hlc.2011.08.007; Sakata S, 2006, J PAEDIATR CHILD H, V42, P817, DOI 10.1111/j.1440-1754.2006.00984.x; Sasai H, 2012, JACC-CARDIOVASC INTE, V5, P112, DOI 10.1016/j.jcin.2011.08.020; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Trip MD, 2002, CIRCULATION, V106, P773, DOI 10.1161/01.CIR.0000028420.27813.C0; Uitto J, 2011, AM J MED GENET A, V155A, P3176, DOI [10.1002/ajmg.a.34243, 10.1002/ajmg.a.34067]; van den Berg JSP, 2000, CEREBROVASC DIS, V10, P315, DOI 10.1159/000016076; Vanakker Olivier M, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9514; Vasseur M, 2011, EUR J VASC ENDOVASC, V42, P292, DOI 10.1016/j.ejvs.2011.05.007; WILHELM K, 1972, MED J AUSTRALIA, V2, P1363, DOI 10.5694/j.1326-5377.1972.tb92932.x; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	46	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68700	10.1371/journal.pone.0068700	http://dx.doi.org/10.1371/journal.pone.0068700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935882	Green Published, gold			2022-12-27	WOS:000325211000033
J	Beck, IM; Drebert, ZJ; Hoya-Arias, R; Bahar, AA; Devos, M; Clarisse, D; Desmet, S; Bougarne, N; Ruttens, B; Gossye, V; Denecker, G; Lievens, S; Bracke, M; Tavernier, J; Declercq, W; Gevaert, K; Vanden Berghe, W; Haegeman, G; De Bosscher, K				Beck, Ilse M.; Drebert, Zuzanna J.; Hoya-Arias, Ruben; Bahar, Ali A.; Devos, Michael; Clarisse, Dorien; Desmet, Sofie; Bougarne, Nadia; Ruttens, Bart; Gossye, Valerie; Denecker, Geertrui; Lievens, Sam; Bracke, Marc; Tavernier, Jan; Declercq, Wim; Gevaert, Kris; Vanden Berghe, Wim; Haegeman, Guy; De Bosscher, Karolien			Compound A, a Selective Glucocorticoid Receptor Modulator, Enhances Heat Shock Protein Hsp70 Gene Promoter Activation	PLOS ONE			English	Article							PROTEASOME INHIBITION LEADS; BETA-CATENIN; MOLECULAR CHAPERONES; RNA ACTIVATOR; CELL-LINE; KAPPA; TRANSCRIPTION; EXPRESSION; CARCINOMA; SURVIVAL	Compound A possesses glucocorticoid receptor (GR)-dependent anti-inflammatory properties. Just like classical GR ligands, Compound A can repress NF-kappa B-mediated gene expression. However, the monomeric Compound A-activated GR is unable to trigger glucocorticoid response element-regulated gene expression. The heat shock response potently activates heat shock factor 1 (HSF1), upregulates Hsp70, a known GR chaperone, and also modulates various aspects of inflammation. We found that the selective GR modulator Compound A and heat shock trigger similar cellular effects in A549 lung epithelial cells. With regard to their anti-inflammatory mechanism, heat shock and Compound A are both able to reduce TNF-stimulated I kappa B alpha degradation and NF-kappa B p65 nuclear translocation. We established an interaction between Compound A-activated GR and Hsp70, but remarkably, although the presence of the Hsp70 chaperone as such appears pivotal for the Compound A-mediated inflammatory gene repression, subsequent novel Hsp70 protein synthesis is uncoupled from an observed CpdA-induced Hsp70 mRNA upregulation and hence obsolete in mediating CpdA's anti-inflammatory effect. The lack of a Compound A-induced increase in Hsp70 protein levels in A549 cells is not mediated by a rapid proteasomal degradation of Hsp70 or by a Compound A-induced general block on translation. Similar to heat shock, Compound A can upregulate transcription of Hsp70 genes in various cell lines and BALB/c mice. Interestingly, whereas Compound A-dependent Hsp70 promoter activation is GR-dependent but HSF1-independent, heat shock-induced Hsp70 expression alternatively occurs in a GR-independent and HSF1-dependent manner in A549 lung epithelial cells.	[Beck, Ilse M.; Drebert, Zuzanna J.; Clarisse, Dorien; Bracke, Marc] Univ Ghent, Dept Radiat Therapy & Expt Canc Res, Lab Expt Canc Res, B-9000 Ghent, Belgium; [Beck, Ilse M.; Hoya-Arias, Ruben; Bahar, Ali A.; Gossye, Valerie; Vanden Berghe, Wim; Haegeman, Guy; De Bosscher, Karolien] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Clarisse, Dorien; Desmet, Sofie; Bougarne, Nadia; Lievens, Sam; Tavernier, Jan; De Bosscher, Karolien] VIB, Dept Med Prot Res, Cytokine Receptor Lab, Ghent, Belgium; [Clarisse, Dorien; Desmet, Sofie; Bougarne, Nadia; Lievens, Sam; Tavernier, Jan; De Bosscher, Karolien] Univ Ghent, Dept Biochem, Cytokine Receptor Lab, B-9000 Ghent, Belgium; [Devos, Michael; Denecker, Geertrui; Declercq, Wim] Univ Ghent, VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9000 Ghent, Zwijnaarde, Belgium; [Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Ruttens, Bart; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Ruttens, Bart; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Ghent University; Memorial Sloan Kettering Cancer Center; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University	Beck, IM (corresponding author), Univ Ghent, Dept Radiat Therapy & Expt Canc Res, Lab Expt Canc Res, B-9000 Ghent, Belgium.	Ilse.Beck@Ugent.be	Vanden Berghe, Wim/HGE-4696-2022; Clarisse, Dorien/AAS-9957-2021; Berghe, Wim Vanden/S-6425-2018; Tavernier, Jan/AAG-3636-2019; Gevaert, Kris/D-6489-2017; Beck, Ilse/B-2410-2014; Gevaert, Kris/AAE-4212-2019	Berghe, Wim Vanden/0000-0003-0161-7355; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Denecker, Geertrui/0000-0002-2515-2911; Clarisse, Dorien/0000-0002-2580-2291; Beck, Ilse/0000-0002-1927-5480; Devos, Michael/0000-0001-9522-6026; De Bosscher, Karolien/0000-0001-5059-9718	Research Foundation-Flanders (FWO); Flemish League against Cancer 'Vlaamse Liga tegen Kanker' (VLK); Strategic Basic Research (SBO) project of IWT-Vlaanderen; UGent; Interuniversity Attraction Poles (IAP) [6/18]	Research Foundation-Flanders (FWO)(FWO); Flemish League against Cancer 'Vlaamse Liga tegen Kanker' (VLK); Strategic Basic Research (SBO) project of IWT-Vlaanderen; UGent; Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office)	IMB (full) and KDB (in part) are postdoctoral fellows supported by the Research Foundation-Flanders (FWO) (www.fwo.be). SD holds a Ph. D. fellowship of the Research Foundation-Flanders (FWO) (www.fwo.be). DC is supported by the Flemish League against Cancer 'Vlaamse Liga tegen Kanker' (VLK) (www.tegenkanker.be) and thus the research project was realized with the support of the VLK. NB is sponsored by a Strategic Basic Research (SBO) project of IWT-Vlaanderen (www.iwt.be). Financial support was provided by 'Geconcerteerde Onderzoeksactiviteiten' (GOA) from UGent (www.ugent.be) and by Interuniversity Attraction Poles (IAP) [6/18] (http://www.belspo.be/belspo/iap/index_en.stm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachar-Dahan L, 2006, MOL BIOL CELL, V17, P2572, DOI 10.1091/mbc.E06-01-0052; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Colley SM, 2011, BIOCHIMIE, V93, P1966, DOI 10.1016/j.biochi.2011.07.004; Cooper C, 2011, BIOCHIMIE, V93, P1973, DOI 10.1016/j.biochi.2011.07.002; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Dunsmore KE, 2006, INFLAMM RES, V55, P254, DOI 10.1007/s00011-006-0080-2; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; Gossye V, 2009, ARTHRITIS RHEUM-US, V60, P3241, DOI 10.1002/art.24963; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Hunter-Lavin C, 2004, BIOCHEM BIOPH RES CO, V324, P511, DOI 10.1016/j.bbrc.2004.09.075; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Jolly C, 1999, J CELL BIOL, V145, P1133, DOI 10.1083/jcb.145.6.1133; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lievens S, 2012, METHODS MOL BIOL, V812, P283, DOI 10.1007/978-1-61779-455-1_17; Lievens S, 2011, CYTOKINE GROWTH F R, V22, P321, DOI 10.1016/j.cytogfr.2011.11.001; Liu H, 1996, J BIOL CHEM, V271, P4805; Malhotra V, 2002, CRIT CARE MED, V30, pS89, DOI 10.1097/00003246-200201001-00012; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Reuter KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029756; Risseeuw MDP, 2013, CHEMMEDCHEM, V8, P521, DOI 10.1002/cmdc.201200493; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Romero D, 2008, CARCINOGENESIS, V29, P1070, DOI 10.1093/carcin/bgn054; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Song DH, 2005, BRIT J CANCER, V92, P1581, DOI 10.1038/sj.bjc.6602509; Stangl K, 2002, BIOCHEM BIOPH RES CO, V291, P542, DOI 10.1006/bbrc.2002.6476; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 1999, MOL PHARMACOL, V56, P797; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; Wadekar SA, 2001, MOL ENDOCRINOL, V15, P1396, DOI 10.1210/me.15.8.1396; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Wong HR, 1999, CELL STRESS CHAPERON, V4, P1; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104	65	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69115	10.1371/journal.pone.0069115	http://dx.doi.org/10.1371/journal.pone.0069115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935933	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200023
J	Zhao, YL; Zhao, FF; Zong, L; Zhang, P; Guan, LP; Zhang, JG; Wang, DY; Wang, J; Chai, W; Lan, L; Li, Q; Han, B; Yang, L; Jin, X; Yang, WY; Hu, XX; Wang, XN; Li, N; Li, YR; Petit, C; Wang, J; Yang, HM; Wang, J; Wang, QJ				Zhao, Yali; Zhao, Feifan; Zong, Liang; Zhang, Peng; Guan, Liping; Zhang, Jianguo; Wang, Dayong; Wang, Jing; Chai, Wei; Lan, Lan; Li, Qian; Han, Bing; Yang, Ling; Jin, Xin; Yang, Weiyan; Hu, Xiaoxiang; Wang, Xiaoning; Li, Ning; Li, Yingrui; Petit, Christine; Wang, Jun; Yang, Huanming; Wang, Jian; Wang, Qiuju			Exome Sequencing and Linkage Analysis Identified Tenascin-C (TNC) as a Novel Causative Gene in Nonsyndromic Hearing Loss	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; PROTEIN; CELL; EXPRESSION; MUTATIONS; ALIGNMENT; DEAFNESS	In this study, a five-generation Chinese family (family F013) with progressive autosomal dominant hearing loss was mapped to a critical region spanning 28.54 Mb on chromosome 9q31.3-q34.3 by linkage analysis, which was a novel DFNA locus, assigned as DFNA56. In this interval, there were 398 annotated genes. Then, whole exome sequencing was applied in three patients and one normal individual from this family. Six single nucleotide variants and two indels were found co-segregated with the phenotypes. Then using mass spectrum (Sequenom, Inc.) to rank the eight sites, we found only the TNC gene be co-segregated with hearing loss in 53 subjects of F013. And this missense mutation (c.5317G>A, p.V1773M) of TNC located exactly in the critical linked interval. Further screening to the coding region of this gene in 587 subjects with nonsyndromic hearing loss (NSHL) found a second missense mutation, c.5368A>T (p. T1796S), co-segregating with phenotype in the other family. These two mutations located in the conserved region of TNC and were absent in the 387 normal hearing individuals of matched geographical ancestry. Functional effects of the two mutations were predicted using SIFT and both mutations were deleterious. All these results supported that TNC may be the causal gene for the hearing loss inherited in these families. TNC encodes tenascin-C, a member of the extracellular matrix (ECM), is present in the basilar membrane (BM), and the osseous spiral lamina of the cochlea. It plays an important role in cochlear development. The up-regulated expression of TNC gene in tissue repair and neural regeneration was seen in human and zebrafish, and in sensory receptor recovery in the vestibular organ after ototoxic injury in birds. Then the absence of normal tenascin-C was supposed to cause irreversible injuries in cochlea and caused hearing loss.	[Zhao, Yali; Zhao, Feifan; Zong, Liang; Wang, Dayong; Lan, Lan; Li, Qian; Han, Bing; Yang, Weiyan; Wang, Qiuju] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China; [Zhang, Peng; Guan, Liping; Zhang, Jianguo; Jin, Xin; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Jianguo] Fudan Univ, T Life Res Ctr, Shanghai 200433, Peoples R China; [Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Chai, Wei] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed Surg, Beijing, Peoples R China; [Yang, Ling] BGI Tianjin, Tianjin, Peoples R China; [Jin, Xin] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab AgroBiotechnol, Beijing 100094, Peoples R China; [Wang, Xiaoning] Chinese Peoples Liberat Army Gen Hosp, Inst Life Sci, Beijing, Peoples R China; [Petit, Christine] Coll France, F-75231 Paris, France; [Petit, Christine] Inst Pasteur, Paris, France; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI); Fudan University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI); South China University of Technology; China Agricultural University; Chinese People's Liberation Army General Hospital; UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen	Wang, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.	wqcr@263.net	Jin, Xin/ABF-1329-2020; Li, Yingrui/K-1064-2015; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Wang, Jun/0000-0002-8540-8931; Petit, Christine/0000-0002-9069-002X; Wang, Jun/0000-0002-2113-5874	National Natural Science Foundation of China [81120108009]; National Natural Science Foundation of Youth Science Foundation [81100719]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Youth Science Foundation	This work was supported by the grants of the National Natural Science Foundation of China, Major Project, No. 81120108009 and National Natural Science Foundation of Youth Science Foundation No.81100719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; ANNIKO M, 1986, HEARING RES, V22, P279, DOI 10.1016/0378-5955(86)90104-8; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Imanaka-Yoshida K, 2004, HISTOL HISTOPATHOL, V19, P517, DOI 10.14670/HH-19.517; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakoshi Y, 2008, J RHEUMATOL, V35, P147; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Petersen MB, 2002, CLIN GENET, V62, P1, DOI 10.1034/j.1399-0004.2002.620101.x; Pillers DM, 2002, MOL GENET METAB, V76, P217, DOI 10.1016/S1096-7192(02)00039-2; Robertson NG, 2001, HUM MOL GENET, V10, P2493, DOI 10.1093/hmg/10.22.2493; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Warchol ME, 2007, J COMP NEUROL, V500, P646, DOI 10.1002/cne.21153; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043	18	40	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69549	10.1371/journal.pone.0069549	http://dx.doi.org/10.1371/journal.pone.0069549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936043	gold, Green Published, Green Submitted			2022-12-27	WOS:000323114200039
J	Sela, D; Buxdorf, K; Shi, JX; Feldmesser, E; Schreiber, L; Aharoni, A; Levy, M				Sela, Dikla; Buxdorf, Kobi; Shi, Jian Xin; Feldmesser, Ester; Schreiber, Lukas; Aharoni, Asaph; Levy, Maggie			Overexpression of AtSHN1/WIN1 Provokes Unique Defense Responses	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; PLANT DEFENSE; CELL-DEATH; CUTIN MONOMERS; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; BOTRYTIS-CINEREA; GENE-EXPRESSION; ARABIDOPSIS; PROTEIN	The plant cell cuticle serves as the first barrier protecting plants from mechanical injury and invading pathogens. The cuticle can be breached by cutinase-producing pathogens and the degradation products may activate pathogenesis signals in the invading pathogens. Cuticle degradation products may also trigger the plant's defense responses. Botrytis cinerea is an important plant pathogen, capable of attacking and causing disease in a wide range of plant species. Arabidopsis thaliana shn1-1D is a gain-of-function mutant, which has a modified cuticular lipid composition. We used this mutant to examine the effect of altering the whole-cuticle metabolic pathway on plant responses to B. cinerea attack. Following infection with B. cinerea, the shn1-1D mutant discolored more quickly, accumulated more H2O2, and showed accelerated cell death relative to wild-type (WT) plants. Whole transcriptome analysis of B. cinerea-inoculated shn1-1D vs. WT plants revealed marked upregulation of genes associated with senescence, oxidative stress and defense responses on the one hand, and genes involved in the magnitude of defense-response control on the other. We propose that altered cutin monomer content and composition of shn1-1D plants triggers excessive reactive oxygen species accumulation and release which leads to a strong, unique and uncontrollable defense response, resulting in plant sensitivity and death.	[Sela, Dikla; Buxdorf, Kobi; Levy, Maggie] Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Shi, Jian Xin; Feldmesser, Ester; Aharoni, Asaph] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Shi, Jian Xin; Feldmesser, Ester; Aharoni, Asaph] Weizmann Inst Sci, Bioinformat Unit, IL-76100 Rehovot, Israel; [Schreiber, Lukas] Univ Bonn, Inst Cellular & Mol Bot IZMB, Dept Ecophysiol, Bonn, Germany; [Shi, Jian Xin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Natl Ctr Mol Characterizat Genetically Modified O, Shanghai 200030, Peoples R China	Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; University of Bonn; Shanghai Jiao Tong University	Levy, M (corresponding author), Hebrew Univ Jerusalem, Dept Plant Pathol & Microbiol, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	Maggie.Levy@mail.huji.ac.il	aharoni, asaph/W-6670-2019; Shi, Jianxin/AAE-7123-2020; Lukas, Schreiber/AAJ-9201-2020	Lukas, Schreiber/0000-0001-7003-9929	Niedersachsen-Israel Fund; Israel Science Foundation (ISF); European Research Council (ERC) SAMIT project	Niedersachsen-Israel Fund; Israel Science Foundation (ISF)(Israel Science Foundation); European Research Council (ERC) SAMIT project	Work in L.M.'s laboratory was supported by the Niedersachsen-Israel Fund. Work in A.A.'s laboratory was supported by the Israel Science Foundation (ISF) and the European Research Council (ERC) SAMIT project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Anderson JP, 2010, FUNCT PLANT BIOL, V37, P499, DOI 10.1071/FP09304; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAJAR A, 1991, P NATL ACAD SCI USA, V88, P8208, DOI 10.1073/pnas.88.18.8208; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bessire M, 2007, EMBO J, V26, P2158, DOI 10.1038/sj.emboj.7601658; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Chassot C, 2005, PLANT BIOSYST, V139, P28, DOI 10.1080/11263500500056344; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chassot C, 2008, PLANT SIGNAL BEHAV, V3, P142, DOI 10.4161/psb.3.2.5071; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Fauth M, 1996, PLANT PHYSIOL, V110, P347, DOI 10.1104/pp.110.2.347; Fauth M, 1998, PLANT PHYSIOL, V117, P1373, DOI 10.1104/pp.117.4.1373; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Huckelhoven R, 2003, PLANTA, V216, P891, DOI 10.1007/s00425-003-0973-z; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kauss H, 1999, PLANT PHYSIOL, V120, P1175, DOI 10.1104/pp.120.4.1175; Kim MC, 2002, J BIOL CHEM, V277, P19304, DOI 10.1074/jbc.M108478200; Kim TH, 2008, J PLANT PHYSIOL, V165, P345, DOI 10.1016/j.jplph.2007.06.004; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; L'Haridon F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002148; Lazniewska J, 2012, WIRES NANOMED NANOBI, V4, P469, DOI 10.1002/wnan.1181; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; LIN TS, 1978, J BACTERIOL, V133, P942, DOI 10.1128/JB.133.2.942-951.1978; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Mang HG, 2009, PLANT PHYSIOL, V151, P290, DOI 10.1104/pp.109.142158; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; McLusky SR, 1999, PLANT J, V17, P523, DOI 10.1046/j.1365-313X.1999.00403.x; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Park JH, 2008, PLANT PHYSIOL BIOCH, V46, P1015, DOI 10.1016/j.plaphy.2008.06.008; Rolke Y, 2004, MOL PLANT PATHOL, V5, P17, DOI 10.1111/j.1364-3703.2004.00201.x; Schmelzer E, 2002, TRENDS PLANT SCI, V7, P411, DOI 10.1016/S1360-1385(02)02307-5; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schweizer P, 1996, PHYSIOL MOL PLANT P, V49, P103, DOI 10.1006/pmpp.1996.0043; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; vanKan JAL, 1997, MOL PLANT MICROBE IN, V10, P30, DOI 10.1094/MPMI.1997.10.1.30; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Weigel D., 2002, ARABIDOPSIS LAB MANU; WOLOSHUK CP, 1986, P NATL ACAD SCI USA, V83, P1704, DOI 10.1073/pnas.83.6.1704; Xia XJ, 2010, PLANT SIGNAL BEHAV, V5, P532, DOI 10.4161/psb.10989; Xia Y, 2009, CELL HOST MICROBE, V5, P151, DOI 10.1016/j.chom.2009.01.001; YANG J, 1992, PLANT SOIL, V142, P315, DOI 10.1007/BF00010977	67	23	26	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70146	10.1371/journal.pone.0070146	http://dx.doi.org/10.1371/journal.pone.0070146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922943	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700147
J	Semont, A; Demarquay, C; Bessout, R; Durand, C; Benderitter, M; Mathieu, N				Semont, Alexandra; Demarquay, Christelle; Bessout, Raphaelle; Durand, Christelle; Benderitter, Marc; Mathieu, Noelle			Mesenchymal Stem Cell Therapy Stimulates Endogenous Host Progenitor Cells to Improve Colonic Epithelial Regeneration	PLOS ONE			English	Article							RADIATION PROCTITIS; WNT/BETA-CATENIN; PELVIC-RADIATION; R-SPONDINS; IN-VITRO; LGR5; DAMAGE; WNT; BLADDER; MICE	Patients who undergo pelvic radiotherapy may develop severe and chronic complications resulting from gastrointestinal alterations. The lack of curative treatment highlights the importance of novel and effective therapeutic strategies. We thus tested the therapeutic benefit of mesenchymal stem cells (MSC) treatment and proposed molecular mechanisms of action. MSC efficacy was tested in an experimental model of radiation-induced severe colonic ulceration histologically similar to that observed in patients. In this model, MSC from bone marrow were administered intravenously, immediately or three weeks (established lesions) after irradiation. MSC therapy reduces radiation-induced colonic ulceration and increases animal survival. MSC treatment induces therapeutic efficacy whatever the time of cell infusion. Infused-MSC engraft in the colon but also increase endogenous MSC mobilization in blood that have lasting benefits over time. In vitro analysis demonstrates that the MSC effect is mediated by paracrine mechanisms through the non-canonical WNT (Wingless integration site) pathway. In irradiated rat colons, MSC treatment increases the expression of the non-canonical WNT4 ligand by epithelial cells. The epithelial regenerative process is improved after MSC injection by stimulation of colonic epithelial cells positive for SOX9 (SRY-box containing gene 9) progenitor/stem cell markers. This study demonstrates that MSC treatment induces stimulation of endogenous host progenitor cells to improve the regenerative process and constitutes an initial approach to arguing in favor of the use of MSC to limit/reduce colorectal damage induced by radiation.	[Semont, Alexandra; Demarquay, Christelle; Bessout, Raphaelle; Durand, Christelle; Benderitter, Marc; Mathieu, Noelle] Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France		Mathieu, N (corresponding author), Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France.	noelle.mathieu@irsn.fr			Ile de France regional council	Ile de France regional council(Region Ile-de-France)	This work was supported by grants from Ile de France regional council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyev HJN, 2010, LANCET ONCOL, V11, P310, DOI 10.1016/S1470-2045(10)70026-7; Barcellos LM, 2013, MICRON, V47, P18, DOI 10.1016/j.micron.2013.01.001; Basinski C, 2003, NEUROUROL URODYNAM, V22, P683, DOI 10.1002/nau.10101; Berbee M, 2012, CURR OPIN SUPPORT PA, V6, P54, DOI 10.1097/SPC.0b013e32834e3bd7; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Blirando K, 2011, AM J PATHOL, V178, P640, DOI 10.1016/j.ajpath.2010.10.003; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Dincbas FO, 2009, MED ONCOL, V26, P402, DOI 10.1007/s12032-008-9136-1; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gremy O, 2008, WORLD J GASTROENTERO; Guadalajara H, 2012, INT J COLORECTAL DIS, V27, P595, DOI 10.1007/s00384-011-1350-1; Henson Caroline, 2010, Therap Adv Gastroenterol, V3, P359, DOI 10.1177/1756283X10371558; Jaal J, 2006, RADIOTHER ONCOL, V80, P250, DOI 10.1016/j.radonc.2006.07.015; Jullien N, 2009, INT J RADIAT ONCOL, V74, P528, DOI 10.1016/j.ijrobp.2008.12.086; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Liu ZJ, 2009, J CELL BIOCHEM, V106, P984, DOI 10.1002/jcb.22091; Malykhina AP, 2012, NEUROUROL URODYNAM, V31, P352, DOI 10.1002/nau.21228; Mansilla E, 2006, TRANSPL P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	41	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70170	10.1371/journal.pone.0070170	http://dx.doi.org/10.1371/journal.pone.0070170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922953	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700153
J	Veta, M; van Diest, PJ; Kornegoor, R; Huisman, A; Viergever, MA; Pluim, JPW				Veta, Mitko; van Diest, Paul J.; Kornegoor, Robert; Huisman, Andre; Viergever, Max A.; Pluim, Josien P. W.			Automatic Nuclei Segmentation in H&E Stained Breast Cancer Histopathology Images	PLOS ONE			English	Article							PROGNOSTIC VALUE; SECTIONS; REGIONS; MODEL	The introduction of fast digital slide scanners that provide whole slide images has led to a revival of interest in image analysis applications in pathology. Segmentation of cells and nuclei is an important first step towards automatic analysis of digitized microscopy images. We therefore developed an automated nuclei segmentation method that works with hematoxylin and eosin (H&E) stained breast cancer histopathology images, which represent regions of whole digital slides. The procedure can be divided into four main steps: 1) pre-processing with color unmixing and morphological operators, 2) marker-controlled watershed segmentation at multiple scales and with different markers, 3) post-processing for rejection of false regions and 4) merging of the results from multiple scales. The procedure was developed on a set of 21 breast cancer cases (subset A) and tested on a separate validation set of 18 cases (subset B). The evaluation was done in terms of both detection accuracy (sensitivity and positive predictive value) and segmentation accuracy (Dice coefficient). The mean estimated sensitivity for subset A was 0.875 (+/- 0.092) and for subset B 0.853 (+/- 0.077). The mean estimated positive predictive value was 0.904 (+/- 0.075) and 0.886 (+/- 0.069) for subsets A and B, respectively. For both subsets, the distribution of the Dice coefficients had a high peak around 0.9, with the vast majority of segmentations having values larger than 0.8.	[Veta, Mitko; Viergever, Max A.; Pluim, Josien P. W.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [van Diest, Paul J.; Kornegoor, Robert; Huisman, Andre] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Veta, M (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	mitko@isi.uu.nl	Viergever, Max A/J-1215-2014		project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) of the EU research programme ITEA (Information Technologyfor European Advancement)	project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) of the EU research programme ITEA (Information Technologyfor European Advancement)	MV was financially supported by the project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research programme ITEA (Information Technologyfor European Advancement, http://www.itea2.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Bamford P, 1998, SIGNAL PROCESS, V71, P203, DOI 10.1016/S0165-1684(98)00145-5; Belhomme P, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S3; Belien JAM, 1997, CYTOMETRY, V28, P135, DOI 10.1002/(SICI)1097-0320(19970601)28:2<135::AID-CYTO6>3.3.CO;2-R; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Chekkoury A, 2012, P SOC PHOTO-OPT INS, P8315; Cosatto E, 2008, INT C PATT RECOG, P672; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fatakdawala H, 2010, IEEE T BIO-MED ENG, V57, P1676, DOI 10.1109/TBME.2010.2041232; FLEEGE JC, 1993, ANAL QUANT CYTOL, V15, P281; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Gutierrez R, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-26; Huang PW, 2010, PATTERN RECOGN, V43, P1550, DOI 10.1016/j.patcog.2009.10.014; JANNINK I, 1995, BREAST CANCER RES TR, V36, P55, DOI 10.1007/BF00690185; Kachouie NN, 2010, CYTOM PART A, V77A, P1148, DOI 10.1002/cyto.a.20951; KAYSER K, 2008, DIAGN PATHOL, V3, pS1, DOI DOI 10.1186/1746-1596-3-S1-S1.PUBMED:18673497; Kayser K, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-6; Kong H, 2011, IEEE T MED IMAGING, V30, P1661, DOI 10.1109/TMI.2011.2141674; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Meijer GA, 1997, J CLIN PATHOL, V50, P365, DOI 10.1136/jcp.50.5.365; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Romo D, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S22; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schmitt O, 2008, PATTERN RECOGN, V41, P1905, DOI 10.1016/j.patcog.2007.11.006; Sertel O, 2010, IEEE T BIO-MED ENG, V57, P2613, DOI 10.1109/TBME.2010.2055058; Veta M, 2011, I S BIOMED IMAGING, P618, DOI 10.1109/ISBI.2011.5872483; Veta M, 2012, MODERN PATHOL, V25, P1559, DOI 10.1038/modpathol.2012.126; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Yang XD, 2006, IEEE T CIRCUITS-I, V53, P2405, DOI 10.1109/TCSI.2006.884469	33	222	233	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70221	10.1371/journal.pone.0070221	http://dx.doi.org/10.1371/journal.pone.0070221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922958	gold, Green Published			2022-12-27	WOS:000323369700157
J	Wang, YQ; Jin, SX; Wang, MJ; Zhu, LF; Zhang, XL				Wang, Yanqin; Jin, Shuangxia; Wang, Maojun; Zhu, Longfu; Zhang, Xianlong			Isolation and Characterization of a Conserved Domain in the Eremophyte H+-PPase Family	PLOS ONE			English	Article							TRANSLOCATING INORGANIC PYROPHOSPHATASE; SUBSTRATE-BINDING SUBUNIT; PROTON-PYROPHOSPHATASE; MOLECULAR-CLONING; SEQUENCE MOTIFS; K+; EVOLUTION; ACIDOCALCISOMES; IDENTIFICATION; POLYPHOSPHATE	H+-translocating inorganic pyrophosphatases (H+-PPase) were recognized as the original energy donors in the development of plants. A large number of researchers have shown that H+-PPase could be an early-originated protein that participated in many important biochemical and physiological processes. In this study we cloned 14 novel sequences from 7 eremophytes: Sophora alopecuroid (Sa), Glycyrrhiza uralensis (Gu), Glycyrrhiza inflata (Gi), Suaeda salsa (Ss), Suaeda rigida (Sr), Halostachys caspica (Hc), and Karelinia caspia (Kc). These novel sequences included 6 ORFs and 8 fragments, and they were identified as H+-PPases based on the typical conserved domains. Besides the identified domains, sequence alignment showed that there still were two novel conserved motifs. A phylogenetic tree was constructed, including the 14 novel H+-PPase amino acid sequences and the other 34 identified H+-PPase protein sequences representing plants, algae, protozoans and bacteria. It was shown that these 48 H+-PPases were classified into two groups: type I and type II H+-PPase. The novel 14 eremophyte H+-PPases were classified into the type I H+-PPase. The 3D structures of these H+-PPase proteins were predicted, which suggested that all type I H+-PPases from higher plants and algae were homodimers, while other type I H+-PPases from bacteria and protozoans and all type II H+-PPases were monomers. The 3D structures of these novel H+-PPases were homodimers except for SaVP3, which was a monomer. This regular structure could provide important evidence for the evolutionary origin and study of the relationship between the structure and function among members of the H+-PPase family.	[Wang, Yanqin; Jin, Shuangxia; Wang, Maojun; Zhu, Longfu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Wang, Yanqin] Tarim Univ, Coll Life Sci, Alaer, Xinjiang, Peoples R China	Huazhong Agricultural University; Tarim University	Zhu, LF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	lfzhu@mail.hzau.edu.cn	Wang, Maojun/M-2587-2019	Wang, Maojun/0000-0002-4791-3742; Zhu, Longfu/0000-0002-4947-8609; Jin, Shuangxia/0000-0002-1495-9154	Ministry of Agriculature of China [2013ZX08005-004]	Ministry of Agriculature of China	This work was supported financially from the Ministry of Agriculature of China (2013ZX08005-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltscheffsky H, 2004, CELL ORIG LIFE EXTRE, V7, P107; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; BALTSCHEFFSKY M, 1969, ARCH BIOCHEM BIOPHYS, V133, P46, DOI 10.1016/0003-9861(69)90486-X; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baltscheffsky M, 1999, FEBS LETT, V452, P121, DOI 10.1016/S0014-5793(99)00617-1; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; BRITTEN CJ, 1989, FEBS LETT, V256, P200, DOI 10.1016/0014-5793(89)81748-X; CHANSON A, 1989, PLANT PHYSIOL, V90, P934, DOI 10.1104/pp.90.3.934; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Docampo R, 2010, PHILOS T R SOC B, V365, P775, DOI 10.1098/rstb.2009.0179; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Hirono M, 2005, J BIOCHEM, V138, P183, DOI 10.1093/jb/mvi112; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Lipmann F, 1965, ORIGINS PREBIOLOGICA, P361; Lopez-Marques RL, 2004, J BACTERIOL, V186, P5418, DOI 10.1128/JB.186.16.5418-5426.2004; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Meng XZ, 2011, MOL BIOL REP, V38, P3375, DOI 10.1007/s11033-010-0445-z; Mitsuda N, 2001, FEBS LETT, V488, P29, DOI 10.1016/S0014-5793(00)02400-5; Motta LS, 2009, INSECT BIOCHEM MOLEC, V39, P198, DOI 10.1016/j.ibmb.2008.11.003; Perez-Castineira JR, 2002, BIOCHEM BIOPH RES CO, V294, P567, DOI 10.1016/S0006-291X(02)00517-X; Perez-Castineira JR, 2001, FEBS LETT, V496, P6, DOI 10.1016/S0014-5793(01)02390-0; REA PA, 1992, PLANT PHYSIOL, V100, P723, DOI 10.1104/pp.100.2.723; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SATO MH, 1991, FEBS LETT, V290, P177, DOI 10.1016/0014-5793(91)81254-6; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; Seufferheld MJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-50; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340; Zhu LongFu, 2005, Acta Agronomica Sinica, V31, P1657	42	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70099	10.1371/journal.pone.0070099	http://dx.doi.org/10.1371/journal.pone.0070099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922918	gold, Green Published, Green Submitted			2022-12-27	WOS:000323369700133
J	Fukuda, N; Doi, M; Honda, S				Fukuda, Nobuo; Doi, Motomichi; Honda, Shinya			Yeast One-Hybrid G gamma Recruitment System for Identification of Protein Lipidation Motifs	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ALPHA-SUBUNIT; N-MYRISTOYLTRANSFERASE; MYRISTOYL-COA; PALMITOYLATION; RAFTS; MEMBRANE; RESIDUES; DOMAIN	Fatty acids and isoprenoids can be covalently attached to a variety of proteins. These lipid modifications regulate protein structure, localization and function. Here, we describe a yeast one-hybrid approach based on the G gamma recruitment system that is useful for identifying sequence motifs those influence lipid modification to recruit proteins to the plasma membrane. Our approach facilitates the isolation of yeast cells expressing lipid-modified proteins via a simple and easy growth selection assay utilizing G-protein signaling that induces diploid formation. In the current study, we selected the N-terminal sequence of G alpha subunits as a model case to investigate dual lipid modification, i.e., myristoylation and palmitoylation, a modification that is widely conserved from yeast to higher eukaryotes. Our results suggest that both lipid modifications are required for restoration of G-protein signaling. Although we could not differentiate between myristoylation and palmitoylation, N-terminal position 7 and 8 play some critical role. Moreover, we tested the preference for specific amino-acid residues at position 7 and 8 using library-based screening. This new approach will be useful to explore protein-lipid associations and to determine the corresponding sequence motifs.	[Fukuda, Nobuo; Doi, Motomichi; Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Higashi Ku, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Honda, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Higashi Ku, Tsukuba, Ibaraki, Japan.	s.honda@aist.go.jp	Doi, Motomichi/L-7438-2018; Honda, Shinya/K-6894-2016; Fukuda, Nobuo/J-1872-2018	Doi, Motomichi/0000-0002-7837-3056; Honda, Shinya/0000-0002-7878-3944; Fukuda, Nobuo/0000-0001-7053-7194	JSPS [23860074]; Grants-in-Aid for Scientific Research [23510273] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 23860074. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; Brachmann CB, 1998, YEAST, V14, P115; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Fukuda N, 2013, ACS SYNTH BIOL, V2, P697, DOI 10.1021/sb400016j; Fukuda N, 2011, FEBS J, V278, P3086, DOI 10.1111/j.1742-4658.2011.08232.x; Fukuda N, 2010, FEBS J, V277, P1704, DOI 10.1111/j.1742-4658.2010.07592.x; Fukuda N, 2009, FEBS J, V276, P2636, DOI 10.1111/j.1742-4658.2009.06991.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gillen KM, 1998, J CELL SCI, V111, P3235; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Meinnel T, 2008, FRONT BIOSCI, V13, P6326, DOI 10.2741/3157; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Parker MH, 1997, PROTEIN ENG, V10, P487, DOI 10.1093/protein/10.5.487; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Song JP, 1996, BIOCHEMISTRY-US, V35, P14806, DOI 10.1021/bi961846b; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Waheed AA, 2002, J BIOL CHEM, V277, P32409, DOI 10.1074/jbc.C200383200; Yamauchi S, 2010, FEBS J, V277, P3596, DOI 10.1111/j.1742-4658.2010.07768.x	24	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70100	10.1371/journal.pone.0070100	http://dx.doi.org/10.1371/journal.pone.0070100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922919	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900146
J	Irtegun, S; Wood, RJ; Ormsby, AR; Mulhern, TD; Hatters, DM				Irtegun, Sevgi; Wood, Rebecca J.; Ormsby, Angelique R.; Mulhern, Terrence D.; Hatters, Danny M.			Tyrosine 416 Is Phosphorylated in the Closed, Repressed Conformation of c-Src	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; FAMILY KINASE HCK; ATP-BINDING SITE; IN-VIVO; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; PROTEIN; ACTIVATION; PP60C-SRC; AUTOPHOSPHORYLATION	c-Src kinase activity is regulated by phosphorylation of Y527 and Y416. Y527 phosphorylation stabilizes a closed conformation, which suppresses kinase activity towards substrates, whereas phosphorylation at Y416 promotes an elevated kinase activity by stabilizing the activation loop in a manner permissive for substrate binding. Here we investigated the correlation of Y416 phosphorylation with c-Src activity when c-Src was locked into the open and closed conformations (by mutations Y527F and Q528E, P529E, G530I respectively). Consistent with prior findings, we found Y416 to be more greatly phosphorylated when c-Src was in an open, active conformation. However, we also observed an appreciable amount of Y416 was phosphorylated when c-Src was in a closed, repressed conformation under conditions by which c-Src was unable to phosphorylate substrate STAT3. The phosphorylation of Y416 in the closed conformation arose by autophosphorylation, since abolishing kinase activity by mutating the ATP binding site (K295M) prevented phosphorylation. Basal Y416 phosphorylation correlated positively with cellular levels of c-Src suggesting autophosphorylation depended on self-association. Using sedimentation velocity analysis on cell lysate with fluorescence detection optics, we confirmed that c-Src forms monomers and dimers, with the open conformation also forming a minor population of larger mass complexes. Collectively, our studies suggest a model by which dimerization of c-Src primes c-Src via Y416 phosphorylation to enable rapid potentiation of activity when Src adopts an open conformation. Once in the open conformation, c-Src can amplify the response by recruiting and phosphorylating substrates such as STAT3 and increasing the extent of autophosphorylation.	[Mulhern, Terrence D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Mulhern, TD (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.	tmulhern@unimelb.edu.au; dhatters@unimelb.edu.au	Wood, Rebecca/R-8704-2018	Wood, Rebecca/0000-0001-7900-6998; , Angelique/0000-0002-2780-9550; Mulhern, Terrence/0000-0002-1609-7498; Hatters, Danny/0000-0002-9965-2847	NHMRC [566640, APP1049458, APP1049459]; ARC [DP120102763]; Miegunyah Trust; University of Melbourne	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Miegunyah Trust; University of Melbourne(University of Melbourne)	This work was funded by grants to DMH (NHMRC project grants 566640, APP1049458, APP1049459; ARC Discovery grant DP120102763). DMH was a Grimwade Fellow, supported by the Miegunyah Trust and is currently an ARC Future Fellow (FT120100039). The University of Melbourne also provided support for DMH and TDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Gingrich JR, 2004, P NATL ACAD SCI USA, V101, P6237, DOI 10.1073/pnas.0401413101; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HARVEY R, 1989, MOL CELL BIOL, V9, P3647, DOI 10.1128/MCB.9.9.3647; HIRAI H, 1990, GENE DEV, V4, P2342, DOI 10.1101/gad.4.12b.2342; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; Laird AD, 2003, MOL CANCER THER, V2, P461; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Perez Y, 2009, J MOL BIOL, V391, P136, DOI 10.1016/j.jmb.2009.06.018; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; PURCHIO AF, 1982, J VIROL, V41, P1; REUTER C, 1990, EUR J BIOCHEM, V190, P343, DOI 10.1111/j.1432-1033.1990.tb15581.x; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772, DOI 10.1128/MCB.5.7.1772; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	45	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71035	10.1371/journal.pone.0071035	http://dx.doi.org/10.1371/journal.pone.0071035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923048	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900188
J	Li, HL; Gorfe, AA				Li, Hualin; Gorfe, Alemayehu A.			Aggregation of Lipid-Anchored Full-Length H-Ras in Lipid Bilayers: Simulations with the MARTINI Force Field	PLOS ONE			English	Article							SOLID-STATE NMR; COARSE-GRAINED MODEL; MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTORS; N-RAS; PLASMA-MEMBRANE; PHOSPHOINOSITIDE 3-KINASE; EXCHANGE FACTORS; ACTIVATE RAF-1; C-TERMINUS	Lipid-anchored Ras oncoproteins assemble into transient, nano-sized substructures on the plasma membrane. These substructures, called nanoclusters, were proposed to be crucial for high-fidelity signal transmission in cells. However, the molecular basis of Ras nanoclustering is poorly understood. In this work, we used coarse-grained (CG) molecular dynamics simulations to investigate the molecular mechanism by which full-length H-ras proteins form nanoclusters in a model membrane. We chose two different conformations of H-ras that were proposed to represent the active and inactive state of the protein, and a domain-forming model bilayer made up of di16:0-PC (DPPC), di18:2-PC (DLiPC) and cholesterol. We found that, irrespective of the initial conformation, Ras molecules assembled into a single large aggregate. However, the two binding modes, which are characterized by the different orientation of the G-domain with respect to the membrane, differ in dynamics and organization during and after aggregation. Some of these differences involve regions of Ras that are important for effector/modulator binding, which may partly explain observed differences in the ability of active and inactive H-ras nanoclusters to recruit effectors. The simulations also revealed some limitations in the CG force field to study protein assembly in solution, which we discuss in the context of proposed potential avenues of improvement.	[Li, Hualin; Gorfe, Alemayehu A.] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Gorfe, AA (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	alemayehu.g.abebe@uth.tmc.edu			NIH/NIGMS [1RO101GM100078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100078] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from NIH/NIGMS(1RO101GM100078) and the Texas Advanced Computing Center (TACC) for computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2008, CELL CYCLE, V7, P2667, DOI 10.4161/cc.7.17.6596; Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bennett WFD, 2009, J AM CHEM SOC, V131, P12714, DOI 10.1021/ja903529f; Crowet JM, 2012, J PHYS CHEM B, V116, P13713, DOI 10.1021/jp3027385; de Jong DH, 2013, FARADAY DISCUSS, V161, P347, DOI 10.1039/c2fd20086d; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; Fegan SK, 2012, J CHEM THEORY COMPUT, V8, P1304, DOI 10.1021/ct200739s; Fischer T, 2012, PHYS CHEM CHEM PHYS, V14, P14500, DOI 10.1039/c2cp41417a; Gao XL, 2001, J BIOL CHEM, V276, P42219, DOI 10.1074/jbc.M105760200; Gautieri A, 2010, J CHEM THEORY COMPUT, V6, P1210, DOI 10.1021/ct100015v; Gorfe AA, 2004, J AM CHEM SOC, V126, P15277, DOI 10.1021/ja046607n; Gorfe AA, 2007, ANGEW CHEM, V119, P8382; Gorfe AA, 2008, BIOPHYS J, V95, P3269, DOI 10.1529/biophysj.108.136481; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinner MJ, 2009, J PHYS CHEM B, V113, P15807, DOI 10.1021/jp907981y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huster D, 2003, J AM CHEM SOC, V125, P4070, DOI 10.1021/ja0289245; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Jaumot M, 2002, J BIOL CHEM, V277, P272, DOI 10.1074/jbc.M108423200; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Li Zhenlong, 2012, Small GTPases, V3, P244, DOI 10.4161/sgtp.21829; Li ZL, 2012, J AM CHEM SOC, V134, P17278, DOI 10.1021/ja307716z; Lindau M, 2012, BIOPHYS J, V103, P959, DOI 10.1016/j.bpj.2012.08.007; Lopez CA, 2013, J CHEM THEORY COMPUT, V9, P1694, DOI 10.1021/ct3009655; Lumb CN, 2013, BIOPHYS J, V104, P613, DOI 10.1016/j.bpj.2012.12.002; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Meersman F, 2013, REV MINERAL GEOCHEM, V75, P607, DOI 10.2138/rmg.2013.75.19; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nicolini C, 2006, J AM CHEM SOC, V128, P192, DOI 10.1021/ja055779x; Paul W.B., 1993, ADV MATER, V5, P223, DOI [10.1002/adma.19930050319, DOI 10.1002/ADMA.19930050319]; Periole X, 2007, J AM CHEM SOC, V129, P10126, DOI 10.1021/ja0706246; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Reuther G, 2006, J AM CHEM SOC, V128, P13840, DOI 10.1021/ja063635s; Reuther G, 2006, ANGEW CHEM INT EDIT, V45, P5387, DOI 10.1002/anie.200504266; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sengupta D, 2010, PHYS CHEM CHEM PHYS, V12, P12987, DOI 10.1039/c0cp00101e; Singh G, 2011, J CHEM THEORY COMPUT, V7, P2316, DOI 10.1021/ct2002623; Smith MJ, 2013, P NATL ACAD SCI; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogel A, 2005, J AM CHEM SOC, V127, P12263, DOI 10.1021/ja051856c; Vogel A, 2007, BIOPHYS J, V93, P2697, DOI 10.1529/biophysj.107.104562; Vogel A, 2009, ANGEW CHEM INT EDIT, V48, P8784, DOI 10.1002/anie.200903396; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Vuorela T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000964; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	69	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71018	10.1371/journal.pone.0071018	http://dx.doi.org/10.1371/journal.pone.0071018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923044	Green Published, gold			2022-12-27	WOS:000322838900185
J	Mendoza, MR; da Fonseca, GC; Loss-Morais, G; Alves, R; Margis, R; Bazzan, ALC				Mendoza, Mariana R.; da Fonseca, Guilherme C.; Loss-Morais, Guilherme; Alves, Ronnie; Margis, Rogerio; Bazzan, Ana L. C.			RFMirTarget: Predicting Human MicroRNA Target Genes with a Random Forest Classifier	PLOS ONE			English	Article							MESSENGER-RNAS; BINDING-SITES; IDENTIFICATION; MACHINE; BIOGENESIS; DATABASE; MIRNAS; BAYES	MicroRNAs are key regulators of eukaryotic gene expression whose fundamental role has already been identified in many cell pathways. The correct identification of miRNAs targets is still a major challenge in bioinformatics and has motivated the development of several computational methods to overcome inherent limitations of experimental analysis. Indeed, the best results reported so far in terms of specificity and sensitivity are associated to machine learning-based methods for microRNA-target prediction. Following this trend, in the current paper we discuss and explore a microRNA-target prediction method based on a random forest classifier, namely RFMirTarget. Despite its well-known robustness regarding general classifying tasks, to the best of our knowledge, random forest have not been deeply explored for the specific context of predicting microRNAs targets. Our framework first analyzes alignments between candidate microRNA-target pairs and extracts a set of structural, thermodynamics, alignment, seed and position-based features, upon which classification is performed. Experiments have shown that RFMirTarget outperforms several well-known classifiers with statistical significance, and that its performance is not impaired by the class imbalance problem or features correlation. Moreover, comparing it against other algorithms for microRNA target prediction using independent test data sets from TarBase and starBase, we observe a very promising performance, with higher sensitivity in relation to other methods. Finally, tests performed with RFMirTarget show the benefits of feature selection even for a classifier with embedded feature importance analysis, and the consistency between relevant features identified and important biological properties for effective microRNA-target gene alignment.	[Mendoza, Mariana R.; Bazzan, Ana L. C.] Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil; [da Fonseca, Guilherme C.; Loss-Morais, Guilherme; Margis, Rogerio] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Alves, Ronnie] Inst Tecnol Vale Desenvolvimento Sustentavel, Belem, Para, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Instituto Tecnologico Vale Desenvolvimento Sustentavel	Bazzan, ALC (corresponding author), Univ Fed Rio Grande do Sul, Inst Informat, Porto Alegre, RS, Brazil.	bazzan@inf.ufrgs.br	da Fonseca, Guilherme Cordenonsi/E-5500-2015; da Fonseca, Guilherme Cordenonsi/M-3128-2019; Morais, Guilherme/M-9853-2013; Margis, Rogerio/A-7230-2008; Recamonde Mendoza, Mariana/F-6818-2015; Alves, Ronnie/U-9893-2019; Bazzan, Ana L.C./K-8742-2012	da Fonseca, Guilherme Cordenonsi/0000-0002-0007-9834; da Fonseca, Guilherme Cordenonsi/0000-0002-0007-9834; Margis, Rogerio/0000-0002-2871-4473; Recamonde Mendoza, Mariana/0000-0003-2800-1032; Alves, Ronnie/0000-0003-4139-0562; Bazzan, Ana L.C./0000-0002-2803-9607	Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was partially supported by the Brazilian funding agencies Coordination for the Improvement of Higher Education Personnel (CAPES) and National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Betancur JG, 2011, RNA, V18, P1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Dai XB, 2011, BRIEF BIOINFORM, V12, P115, DOI 10.1093/bib/bbq065; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Domingos P, 2012, COMMUN ACM, V55, P78, DOI 10.1145/2347736.2347755; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn M., 2013, CARET CLASSIFICATION; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lhakhang TW, 2011, J APPL GENET, P1; Liaw A., 2002, R NEWS, V2, P118; Liu J, 2011, INT J ORAL SCI, V3, P165, DOI 10.4248/IJOS11063; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mayumi Oshiro Thais, 2012, Machine Learning and Data Mining in Pattern Recognition. Proceedings 8th International Conference, MLDM 2012, P154, DOI 10.1007/978-3-642-31537-4_13; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Mendoza Mariana R., 2012, Advances in Bioinformatics and Computational Biology. Proceedings 7th Brazilian Symposium on Bioinformatics, BSB 2012, P97, DOI 10.1007/978-3-642-31927-3_9; Mitra R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024583; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Touw WG, 2012, BRIEFINGS BIOINFORMA; Witkos TM, 2011, CURR MOL MED, V11, P93; Xiao JM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-427; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yousef M, 2007, BIOINFORMATICS, V23, P2987, DOI 10.1093/bioinformatics/btm484; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	48	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70153	10.1371/journal.pone.0070153	http://dx.doi.org/10.1371/journal.pone.0070153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922946	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900158
J	Then, FS; Luppa, M; Schroeter, ML; Konig, HH; Angermeyer, MC; Riedel-Heller, SG				Then, Francisca S.; Luppa, Melanie; Schroeter, Matthias L.; Koenig, Hans-Helmut; Angermeyer, Matthias C.; Riedel-Heller, Steffi G.			Enriched Environment at Work and the Incidence of Dementia: Results of the Leipzig Longitudinal Study of the Aged (LEILA 75+)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; COGNITIVE DECLINE; RISK; PREVALENCE; COMPLEXITY; MIDLIFE; TWINS	Background: The high incidence of cognitive impairments in the aging population together with the challenges it imposes on health systems raise the question of what effect working life has on cognitive abilities. Animal models have demonstrated that so called enriched environments protect against neurodegenerative diseases, such as dementia. The aim was to investigate the impact of enriched environment at work on the incidence of dementia. Methods: The Leipzig Longitudinal Study of the Aged (LEILA 75+) is an ongoing representative population cohort study that examines cognitive functioning and dementia in individuals aged 75 years and older. The participants' occupational information was matched to O*NET SOC codes and the relevant job descriptors were used to create occupational context indices describing enriched environment at work. Results: Results of logistic regression modeling suggest that a higher level of the index Executive was associated with a lower risk of incident dementia (odds ratio = 0.61, 95% confidence interval = 0.47-0.79, p<0.001). Adjustment for various confounders did not alter the association. The cognitive stimulation indices were only significant in univariate analysis. The Novelty-index remained non-significant. Conclusions: The results suggest that occupational contexts enriched with independent planning/performance of work tasks might decrease the risk of developing dementia. A protective effect of enriched environment at work in general, namely high cognitive stimulation or confrontation with new tasks, could not be confirmed by the results.	[Then, Francisca S.; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Then, Francisca S.; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schroeter, Matthias L.] Consortium Frontotemporal Lobar Degenerat, Leipzig, Germany; [Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol & Hlth Econ, Hamburg, Germany; [Angermeyer, Matthias C.] Ctr Publ Mental Hlth, Gosing Am Wagram, Austria; [Angermeyer, Matthias C.] Univ Cagliari, Dept Publ Hlth, Cagliari, Italy	Leipzig University; Leipzig University; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cagliari	Then, FS (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Franziska.Then@medizin.uni-leipzig.de	Rodriguez, Francisca S./N-4360-2018; Riedel-Heller, Steffi/ABG-1537-2021; Rodriguez, Francisca/AAD-6803-2019; König, Hans-Helmut/P-1211-2018; Luppa, Melanie/AAQ-7338-2021	Rodriguez, Francisca S./0000-0003-2919-5510; Rodriguez, Francisca/0000-0003-2919-5510; König, Hans-Helmut/0000-0001-5711-6862; 	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig [LIFE-102P7]; European Social Fund; Free State of Saxony; Interdisciplinary Centre for Clinical Research, University of Leipzig (JZKF) [C7]; German Consortium for Frontotemporal Lobar Degeneration	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Social Fund(European Social Fund (ESF)); Free State of Saxony; Interdisciplinary Centre for Clinical Research, University of Leipzig (JZKF); German Consortium for Frontotemporal Lobar Degeneration	This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig (LIFE-102P7), which was funded by means of the European Social Fund and the Free State of Saxony. The study was supported by the Interdisciplinary Centre for Clinical Research, University of Leipzig (JZKF, Project C7). MLS has been supported by the German Consortium for Frontotemporal Lobar Degeneration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AEA, 2009, NEUROBIOL LEARN MEM, V92, P381, DOI 10.1016/j.nlm.2009.05.004; Andel R, 2005, J GERONTOL B-PSYCHOL, V60, pP251, DOI 10.1093/geronb/60.5.P251; Andel R, 2011, J GERONTOL B-PSYCHOL, V66, P287, DOI 10.1093/geronb/gbq105; Bano D, 2011, MOL NEUROBIOL, V43, P124, DOI 10.1007/s12035-011-8164-6; Berenson M.L, 2004, BASIC BUSINESS STAT; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; Bharmal MF, 2012, AM J GERIAT PSYCHIAT, V20, P73, DOI 10.1097/JGP.0b013e318209dce4; Bosma H, 2003, EXP AGING RES, V29, P33, DOI 10.1080/03610730303710; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gustavsson A, 2010, J NUTR HEALTH AGING, V14, P648, DOI 10.1007/s12603-010-0311-7; He S, 2010, J NEUROSCI, V30, P7910, DOI 10.1523/JNEUROSCI.6375-09.2010; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Karp A, 2009, AM J GERIAT PSYCHIAT, V17, P227, DOI 10.1097/JGP.0b013e318190b691; Konig W, 1988, 12 CASMIN U MANNH, P96; Kroger E, 2008, AM J EPIDEMIOL, V167, P820, DOI 10.1093/aje/kwm382; Laske C, 2011, INT J NEUROPSYCHOPH, V14, P399, DOI 10.1017/S1461145710001008; Laviola G, 2004, EUR J NEUROSCI, V20, P1655, DOI 10.1111/j.1460-9568.2004.03597.x; Leicht H, 2011, ACTA PSYCHIAT SCAND, V124, P384, DOI 10.1111/j.1600-0447.2011.01741.x; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Penn DC, 2007, ANNU REV PSYCHOL, V58, P97, DOI 10.1146/annurev.psych.58.110405.085555; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Potter GG, 2006, NEUROLOGY, V67, P1377, DOI 10.1212/01.wnl.0000240061.51215.ed; Riedel-Heller SG, 2001, BRIT J PSYCHIAT, V179, P250; Salthouse T. A., 1991, AGING CLIN EXP RES, P297; Seidler A, 2004, OCCUP ENVIRON MED, V61, P962, DOI 10.1136/oem.2003.012153; Smyth KA, 2004, NEUROLOGY, V63, P498, DOI 10.1212/01.WNL.0000133007.87028.09; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tullis JG, 2011, J MEM LANG, V64, P109, DOI 10.1016/j.jml.2010.11.002; Zaudig M, 1995, SIDAM STRUKTURIERTES	29	31	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70906	10.1371/journal.pone.0070906	http://dx.doi.org/10.1371/journal.pone.0070906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23923030	Green Published, gold			2022-12-27	WOS:000322838900178
J	Fapohunda, BM; Orobaton, NG				Fapohunda, Bolaji M.; Orobaton, Nosakhare G.			When Women Deliver with No One Present in Nigeria: Who, What, Where and So What?	PLOS ONE			English	Article							TRADITIONAL BIRTH ATTENDANTS; MATERNAL MORTALITY; HEALTH INTERVENTIONS; INCOME COUNTRIES; STATE; CARE; FACILITIES; COUNTDOWN; SERVICES; NEWBORN	With the current maternal mortality ratio (MMR) of 630/100,000 live births, Nigeria ranks among the nations with the highest mortality rates in the world. The use of skilled assistants during delivery has been identified a key predictor in the reduction of mortality rates in the world over. Not only are Nigerian women predominantly using unskilled attendants, one in five births are delivered with No One Present (NOP). We assessed who, what, where and the so what of this practice using 2008 Nigeria DHS (NDHS) data. The study revealed that the prevalence of NOP is highest in the northern part of Nigeria with 94% of all observed cases. Socio-demographic factors, including, women's age at birth, birth order, being Muslim, and region of residence, were positively associated with NOP deliveries. Mother's education, higher wealth quintiles, urban residence, decision-making autonomy, and a supportive environment for women's social and economic security were inversely associated with NOP deliveries. Women's autonomy and social standing were critical to choosing to deliver with skilled attendance, which were further amplified by economic prosperity. Women's' economic wellbeing is entwined with their feelings of independence and freedom. Programs that seek to improve the autonomy of women and their strategic participation in sound health seeking decisions will, most likely, yield better results with improvements in women's education, income, jobs, and property ownership. As a short term measure, the use of conditional cash transfer, proven to work in several countries, including 18 in sub-Saharan Africa, is recommended. Its use has the potential to reduce household budget constraint by lowering cost-related barriers associated with women's ability to demand and use life-saving services. Given the preponderance of NOP in the Northern region, the study suggests that interventions to eradicate NOP deliveries must initially focus this region as priority.	[Fapohunda, Bolaji M.] John Snow Inc, MEASURE Evaluat, Int Div, Rosslyn, VA USA; [Orobaton, Nosakhare G.] John Snow Inc, Int Div, Rosslyn, VA USA; [Orobaton, Nosakhare G.] TSHIP, Bauchi, Bauchi State, Nigeria		Fapohunda, BM (corresponding author), John Snow Inc, MEASURE Evaluat, Int Div, Rosslyn, VA USA.	bfapohunda@jsi.com			USAID/Nigeria	USAID/Nigeria(United States Agency for International Development (USAID))	Funding was provided by USAID/Nigeria (www.usaid.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimbola S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001211; Abodunrin O L, 2010, Afr J Reprod Health, V14, P77; ADETORO OO, 1987, INT J GYNECOL OBSTET, V25, P93, DOI 10.1016/0020-7292(87)90001-4; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bassey EB, 2007, INT NURS REV, V54, P354, DOI 10.1111/j.1466-7657.2007.00535.x; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Caldwell JC, 1982, THEORY FERTILITY DEC, P1503; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; Doctor Henry V, 2010, Afr J Reprod Health, V14, P37; Doctor HV, 2012, TROP DOCT, V42, P140, DOI 10.1258/td.2012.120062; Ebuehi OM, 2012, INT J WOMENS HEALTH, V4, P25, DOI 10.2147/IJWH.S23173; Ekanem E I, 2008, Niger J Med, V17, P78; Enwereji Ezinne E, 2010, Oman Med J, V25, P91, DOI 10.5001/omj.2010.27; Erim DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039555; Eze JN, 2010, SINGAP MED J, V51, P506; Ezeanochie M C, 2010, Afr J Reprod Health, V14, P9; Ezeonwu MC, 2011, HEALTH CARE WOMEN IN, V32, P492, DOI 10.1080/07399332.2011.555827; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Glassman A, 2013, 019 CDG; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Ijadunola KT, 2010, BMC WOMENS HEALTH, V17, P16; Iyaniwura C A, 2009, Afr J Reprod Health, V13, P111; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lawoyin T O, 2010, West Afr J Med, V29, P19; Limwattananon S, 2011, REPROD HEALTH MATTER, V19, P75, DOI 10.1016/S0968-8080(11)37564-7; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Nyango Dalyop D, 2010, Afr J Reprod Health, V14, P129; Okoli U, 2012, INT J GYNECOL OBSTET, V117, P61, DOI 10.1016/j.ijgo.2011.11.014; Olusanya BO, 2008, BJOG-INT J OBSTET GY, V115, P1419, DOI 10.1111/j.1471-0528.2008.01871.x; Olusanya BO, 2011, HEALTH CARE WOMEN IN, V32, P474, DOI 10.1080/07399332.2011.565531; Onayade A A, 2010, Niger Postgrad Med J, V17, P30; Orimadegun AE, 2008, PEDIATR EMERG CARE, V24, P354, DOI 10.1097/PEC.0b013e318177a73c; Osungbade KO, 2010, NIGER J CLIN PRACT, V13, P210; Ozumba BC, 2008, PUBLIC HEALTH, V122, P354, DOI 10.1016/j.puhe.2007.04.018; Prata N, 2012, SOC SCI MED, V74, P1288, DOI 10.1016/j.socscimed.2011.11.035; Singh Kavita, 2012, Afr J Reprod Health, V16, P123; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Udo JJ, 2008, NIGER J CLIN PRACT, V11, P285; Umeora OUJ, 2010, TROP DOCT, V40, P13, DOI 10.1258/td.2009.080207; United Nations Fund for Population Activities - UNFPA, 2009, UNFPA SUPP TRAD REL; United Nations Statistics Division, 2002, MILL IND; WHO UNICEF and The World Bank, 2012, TRENDS MAT MORT 1990	42	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69569	10.1371/journal.pone.0069569	http://dx.doi.org/10.1371/journal.pone.0069569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936047	Green Published, gold			2022-12-27	WOS:000322433300049
J	Kuhn, T; Kaaks, R; Teucher, B; Hirche, F; Dierkes, J; Weikert, C; Katzke, V; Boeing, H; Stangl, GI; Buijsse, B				Kuehn, Tilman; Kaaks, Rudolf; Teucher, Birgit; Hirche, Frank; Dierkes, Jutta; Weikert, Cornelia; Katzke, Verena; Boeing, Heiner; Stangl, Gabriele I.; Buijsse, Brian			Plasma 25-Hydroxyvitamin D and Its Genetic Determinants in Relation to Incident Myocardial Infarction and Stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study	PLOS ONE			English	Article							D-BINDING PROTEIN; CIRCULATING VITAMIN-D; CARDIOVASCULAR-DISEASE; EPIC-GERMANY; RISK; ASSOCIATION; COHORT; REPRODUCIBILITY; REGRESSION; MORTALITY	Circulating 25-hydroxyvitamin D (25(OH) D) has been associated with cardiovascular disease (CVD) risk in observational studies. Also, SNPs to explain variation in 25(OH) D have been identified by genome-wide association studies. Detection of direct associations between SNPs that significantly affect 25(OH) D and CVD risk would indicate a causal role of vitamin D, as reverse causation could be excluded and confounding could be better controlled. Thus, a combined analysis of candidate SNPs in relation to circulating 25(OH) D and CVD risk was carried out. A case-cohort study within the EPIC-Germany study was conducted comprising a randomly drawn subcohort of 2,132 subjects (57.9% women, mean age: 50.6 years) and incident cases of myocardial infarction (n=559) and stroke (n=471) that occurred during a mean follow-up duration of 7.6 years. 25(OH) D concentrations were measured by LC-MS/MS in baseline plasma samples. Additionally, eight candidate SNPs were assayed. Associations between 25(OH) D, SNPs and the risks of myocardial infarction and stroke were assessed by multivariable regression analyses. Mean 25(OH) D level was 47.2 nmol/L in the subcohort. Four SNPs were associated with 25(OH) D (p<0.05). In subjects with 25(OH) D levels <25 nmol/L, the risks of CVD as composite endpoint (Hazard Ratio: 1.53, 95% confidence interval: 1.12-2.09), myocardial infarction, and stroke were significantly increased compared to subjects with levels >= 50 nmol/L, while no significant linear associations were observed. A SNP score was not related to the risks of total CVD (Hazard Ratio: 1.0, 95% confidence interval: 0.71-1.42), myocardial infarction, or stroke. The same was true concerning single SNPs. Given the lack of association between SNPs and the risks of stroke and myocardial infarction, the present findings do not point to a major causal role of vitamin D in the development of these diseases. However, a detection of modest associations between genetic markers and CVD risk in larger consortia cannot be ruled out.	[Kuehn, Tilman; Kaaks, Rudolf; Teucher, Birgit; Katzke, Verena] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Saale, Germany; [Dierkes, Jutta] Univ Bergen, Dept Clin Med, Bergen, Norway; [Weikert, Cornelia; Boeing, Heiner; Buijsse, Brian] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Martin Luther University Halle Wittenberg; University of Bergen; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Kuhn, T (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	t.kuehn@dkfz.de	Teucher, Birgit/J-6380-2015	Buijsse, Brian/0000-0003-0026-9360	German Federal Ministry of Education and Ressearch (BMBF) [0315668]	German Federal Ministry of Education and Ressearch (BMBF)(Federal Ministry of Education & Research (BMBF))	The present work was part of the joint project "Vitamin D and Cardiovascular Health" funded by the German Federal Ministry of Education and Ressearch (BMBF, http://www.bmbf.de/en/index.php), grant number 0315668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; Bischoff-Ferrari HA, 2010, OSTEOPOROSIS INT, V21, P1121, DOI 10.1007/s00198-009-1119-3; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Borkowf CB, 2003, STAT MED, V22, P1477, DOI 10.1002/sim.1507; Brandenburg VM, 2012, ATHEROSCLEROSIS, V225, P253, DOI 10.1016/j.atherosclerosis.2012.08.005; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hiraki LT, 2013, GENET EPIDEMIOL, V37, P92, DOI 10.1002/gepi.21694; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; *I MED US COMM REV, 2011, DIETARY REFERENCE IN, P63941; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karakas M, 2013, J CLIN ENDOCR METAB, V98, P272, DOI 10.1210/jc.2012-2368; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Kupferschmidt K, 2012, SCIENCE, V337, P1476, DOI 10.1126/science.337.6101.1476; Langenberg C, 2011, DIABETOLOGIA, V54, P2272, DOI 10.1007/s00125-011-2182-9; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; McGreevy C, 2011, ANN INTERN MED, V155, P820, DOI 10.7326/0003-4819-155-12-201112200-00004; Mondul AM, 2012, BRIT J CANCER, V107, P1589, DOI 10.1038/bjc.2012.417; Motiwala SR, 2011, CURR OPIN NEPHROL HY, V20, P345, DOI 10.1097/MNH.0b013e3283474985; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; Pilz S, 2012, SCIENCE, V338, P883, DOI 10.1126/science.338.6109.883-c; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sonderman JS, 2012, AM J EPIDEMIOL, V176, P615, DOI 10.1093/aje/kws141; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Trummer O, 2013, CLIN CHEM, V59, P793, DOI 10.1373/clinchem.2012.193185; Van der Schueren BJ, 2012, CURR OPIN LIPIDOL, V23, P17, DOI 10.1097/MOL.0b013e32834d7357; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Weinstein SJ, 2013, INT J CANCER, V132, P2940, DOI 10.1002/ijc.27969; Weinstein SJ, 2012, CANCER RES, V72, P1190, DOI 10.1158/0008-5472.CAN-11-2950; Welsh P, 2012, J CLIN ENDOCR METAB, V97, P4578, DOI 10.1210/jc.2012-2272; Zittermann A, 2012, NUTR METAB CARDIOVAS, V22, P541, DOI 10.1016/j.numecd.2012.02.004	48	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69080	10.1371/journal.pone.0069080	http://dx.doi.org/10.1371/journal.pone.0069080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935930	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300021
J	Makobongo, MO; Einck, L; Peek, RM; Merrell, DS				Makobongo, Morris O.; Einck, Leo; Peek, Richard M., Jr.; Merrell, D. Scott			In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ANTIBIOTIC-RESISTANCE; RESCUE THERAPY; AMOXICILLIN RESISTANCE; INFECTION; ERADICATION; OXAZOLIDINONES; DRUGS; LEVOFLOXACIN; MANAGEMENT	The most evident challenge to treatment of Helicobacter pylori, a bacterium responsible for gastritis, peptic ulcers and gastric cancer, is the increasing rate of resistance to all currently used therapeutic antibiotics. Thus, the development of novel therapies is urgently required. N-geranyl-N'-(2-adamantyl) ethane-1, 2-diamine (SQ109) is an ethylene diamine-based antitubercular drug that is currently in clinical trials for the treatment of tuberculosis (TB). Previous pharmacokinetic studies of SQ109 revealed that persistently high concentrations of SQ109 remain in the stomach 4 hours post oral administration in rats. This finding, combined with the need for new anti-Helicobacter therapies, prompted us to define the in vitro efficacy of SQ109 against H. pylori. Liquid broth micro-dilution was used for susceptibility studies to determine the antimicrobial activity of SQ109 against a total of 6 laboratory strains and 20 clinical isolates of H. pylori; the clinical isolates included a multi-drug resistant strain. All strains tested were susceptible to SQ109 with MIC and MBC ranges of 6-10 mu M and 50-60 mu M, respectively. SQ109 killing kinetics were concentration- and time-dependent. SQ109 killed H. pylori in 8-10 h at 140 mu M (2MBCs) or 4-6 h at 200 mu M (similar to 3MBCs). Importantly, though the kinetics of killing were altered, SQ109 retained potent bactericidal activity against H. pylori at low pH. Additionally, SQ109 demonstrated robust thermal stability and was effective at killing slow growing or static bacteria. In fact, pretreatment of cultures with a bacteriostatic concentration of chloramphenicol (Cm) synergized the effects of typically bacteriostatic concentrations of SQ109 to the level of five-logs of bacterial killing. A molar-to-molar comparison of the efficacy of SQ109 as compared to metronidazole (MTZ), amoxicillin (AMX), rifampicin (RIF) and clarithromycin (CLR), revealed that SQ109 was superior to MTZ, AMX and RIF but not to CLR. Finally, the frequency of resistance to SQ109 was low and electron microscopy studies revealed that SQ109 interacted with bacterial inner membrane and cytoplasmic content(s). Collectively, our in vitro data demonstrate that SQ109 is an effective monotherapy against susceptible and multi-drug resistant strains of H. pylori and may be useful alone or in combination with other antibiotics for development as a new class of anti-Helicobacter drugs.	[Makobongo, Morris O.; Merrell, D. Scott] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Einck, Leo] Sequella Inc, Rockville, MD USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN USA	Uniformed Services University of the Health Sciences - USA; Vanderbilt University	Merrell, DS (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	douglas.merrell@usuhs.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058587] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ables AZ, 2007, AM FAM PHYSICIAN, V75, P351; Ahmed Niyaz, 2005, Ann Clin Microbiol Antimicrob, V4, P1, DOI 10.1186/1476-0711-4-1; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Baltz RH, 2006, NAT BIOTECHNOL, V24, P1533, DOI 10.1038/nbt1265; Belhoussine-Idrissi L, 2002, CURR OPIN GASTROEN, V18, P26, DOI 10.1097/00001574-200201000-00005; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Calafatti SA, 2001, BRIT J CLIN PHARMACO, V52, P205, DOI 10.1046/j.0306-5251.2001.01435.x; Chen P, 2006, J ANTIMICROB CHEMOTH, V58, P332, DOI 10.1093/jac/dkl227; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Chuah SK, 2011, WORLD J GASTROENTERO, V17, P3971, DOI 10.3748/wjg.v17.i35.3971; Diekema DJ, 2000, DRUGS, V59, P7, DOI 10.2165/00003495-200059010-00002; Dubois A, 2007, GASTROENTEROLOGY, V132, P1177, DOI 10.1053/j.gastro.2007.01.068; Fakheri H, 2012, HELICOBACTER, V17, P43, DOI 10.1111/j.1523-5378.2011.00896.x; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gisbert JP, 2008, WORLD J GASTROENTERO, V14, P5385, DOI 10.3748/wjg.14.5385; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P71, DOI 10.1111/j.1572-0241.2007.01500.x; Gisbert JP, 2011, GASTROENT HEPAT-BARC, V34, P89, DOI 10.1016/j.gastrohep.2010.10.013; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P939, DOI 10.3109/00365529309098288; Guy Elizabeth S, 2008, Ther Adv Respir Dis, V2, P401, DOI 10.1177/1753465808099522; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; Han SR, 1999, J CLIN MICROBIOL, V37, P2740, DOI 10.1128/JCM.37.8.2740-2741.1999; HANCOCK REW, 1984, ANTIMICROB AGENTS CH, V26, P48, DOI 10.1128/AAC.26.1.48; Horwith G., 2007, 45 IDSA ANN M 2007 O; Jia J, 2005, BRIT J PHARMACOL, V144, P80, DOI 10.1038/sj.bjp.0705984; Jia L, 2006, BRIT J PHARMACOL, V147, P476, DOI 10.1038/sj.bjp.0706650; Jia L, 2005, J PHARMACOL EXP THER, V315, P905, DOI 10.1124/jpet.105.087817; Kearney DJ, 2001, AM J GASTROENTEROL, V96, P1335, DOI 10.1111/j.1572-0241.2001.03788.x; Kim J, 2004, NAT HIST, V113, P16; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee RE, 2003, J COMB CHEM, V5, P172, DOI 10.1021/cc020071p; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Makobongo MO, 2012, ANTIMICROB AGENTS CH, V56, P378, DOI 10.1128/AAC.00689-11; Makobongo MO, 2009, ANTIMICROB AGENTS CH, V53, P4231, DOI 10.1128/AAC.00510-09; MALFERTHEINER P, 1993, SCAND J GASTROENTERO, V28, P34, DOI 10.3109/00365529309098341; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Marchese A, 2001, CLIN MICROBIOL INFEC, V7, P66, DOI 10.1046/j.1469-0691.2001.00060.x; MATSUZAKI J, 2011, ANTIMICROB AGENTS CH; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Meurer LN, 2002, AM FAM PHYSICIAN, V65, P1327; MILLAR MR, 1992, ANTIMICROB AGENTS CH, V36, P185, DOI 10.1128/AAC.36.1.185; Mukhtar TA, 2005, CHEM BIOL, V12, P229, DOI 10.1016/j.chembiol.2004.12.009; Mukhtar TA, 2005, CHEM REV, V105, P529, DOI 10.1021/cr030110z; *NAT I ALL, 2010, DOS ESC STUD SQ109 H; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Nikonenko BV, 2007, ANTIMICROB AGENTS CH, V51, P1563, DOI 10.1128/AAC.01326-06; OH HS, 2011, J GASTROENTEROL HEPA; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Okamoto T, 2002, J ANTIMICROB CHEMOTH, V50, P849, DOI 10.1093/jac/dkf140; Ouellette SP, 2012, MOL MICROBIOL, V85, P164, DOI 10.1111/j.1365-2958.2012.08100.x; Park HG, 2012, ALIMENT PHARM THER, V35, P56, DOI 10.1111/j.1365-2036.2011.04902.x; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Piddock LJ, 2011, LANCET INFECT DIS; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Rokkas T, 2006, AM J GASTROENTEROL, V101, P1938; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Sanchez F, 2011, ENFERM INFEC MICR CL, V29, P47, DOI 10.1016/S0213-005X(11)70018-0; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; STRATTON CW, 1995, DIAGN MICR INFEC DIS, V22, P35, DOI 10.1016/0732-8893(95)00094-Q; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takacs CN, 2010, J BACTERIOL, V192, P1671, DOI 10.1128/JB.01311-09; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Torres J, 1998, J INFECT DIS, V178, P1089, DOI 10.1086/515663; Treiber G, 1998, AM J GASTROENTEROL, V93, P1080, DOI 10.1111/j.1572-0241.1998.00333.x; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; Wang YH, 2009, AUTOPHAGY, V5, P540, DOI 10.4161/auto.5.4.8167	74	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68917	10.1371/journal.pone.0068917	http://dx.doi.org/10.1371/journal.pone.0068917			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935905	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300014
J	Gipson, B; Moll, M; Kavraki, LE				Gipson, Bryant; Moll, Mark; Kavraki, Lydia E.			SIMS: A Hybrid Method for Rapid Conformational Analysis	PLOS ONE			English	Article							MALTOSE-BINDING-PROTEIN; STOCHASTIC ROADMAP SIMULATION; NORMAL-MODE ANALYSIS; B-CELL EPITOPE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; FOLDING KINETICS; CYANOVIRIN-N; X-RAY; PRES2 REGION	Proteins are at the root of many biological functions, often performing complex tasks as the result of large changes in their structure. Describing the exact details of these conformational changes, however, remains a central challenge for computational biology due the enormous computational requirements of the problem. This has engendered the development of a rich variety of useful methods designed to answer specific questions at different levels of spatial, temporal, and energetic resolution. These methods fall largely into two classes: physically accurate, but computationally demanding methods and fast, approximate methods. We introduce here a new hybrid modeling tool, the Structured Intuitive Move Selector (SIMS), designed to bridge the divide between these two classes, while allowing the benefits of both to be seamlessly integrated into a single framework. This is achieved by applying a modern motion planning algorithm, borrowed from the field of robotics, in tandem with a well-established protein modeling library. SIMS can combine precise energy calculations with approximate or specialized conformational sampling routines to produce rapid, yet accurate, analysis of the large-scale conformational variability of protein systems. Several key advancements are shown, including the abstract use of generically defined moves (conformational sampling methods) and an expansive probabilistic conformational exploration. We present three example problems that SIMS is applied to and demonstrate a rapid solution for each. These include the automatic determination of "active'' residues for the hinge-based system Cyanovirin-N, exploring conformational changes involving long-range coordinated motion between non-sequential residues in Ribose-Binding Protein, and the rapid discovery of a transient conformational state of Maltose-Binding Protein, previously only determined by Molecular Dynamics. For all cases we provide energetic validations using well-established energy fields, demonstrating this framework as a fast and accurate tool for the analysis of a wide range of protein flexibility problems.	[Gipson, Bryant; Moll, Mark; Kavraki, Lydia E.] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA	Rice University	Kavraki, LE (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	kavraki@rice.edu	Moll, Mark/A-1776-2011; Moll, Mark/M-3574-2019; Kavraki, Lydia E/N-6325-2018	Moll, Mark/0000-0002-0451-2797; Moll, Mark/0000-0002-0451-2797; Kavraki, Lydia E/0000-0003-0699-8038	Texas Higher Education Coordinating Board [NHARP 01907]; John and Ann Doerr Fund for Computational Biomedicine at Rice University; NSF [DUE 0920721, IIS 0713623, ABI-0960612, EIA-0216467, CNS-0821727]; Rice University funds; Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia (NLM) [T15LM007093]; NIH [NCRR S10RR02950]; IBM Shared University Research (SUR) Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002950] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	Texas Higher Education Coordinating Board; John and Ann Doerr Fund for Computational Biomedicine at Rice University; NSF(National Science Foundation (NSF)); Rice University funds; Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia (NLM); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBM Shared University Research (SUR) Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work has been supported in part by The Texas Higher Education Coordinating Board (NHARP 01907), The John and Ann Doerr Fund for Computational Biomedicine at Rice University, NSF DUE 0920721, NSF IIS 0713623, NSF ABI-0960612 and Rice University funds. BG is also supported in part by a training fellowship from the Keck Center NLM Training Program in Biomedical Informatics of the Gulf Coast Consortia (NLM Grant No. T15LM007093). Experiments were run on (i) equipment of the Shared University Grid at Rice funded by NSF under Grant EIA-0216467, and a partnership between Rice University, Sun Microsystems, and Sigma Solutions, Inc., and (ii) equipment funded by NSF CNS-0821727 and by NIH award NCRR S10RR02950 and an IBM Shared University Research (SUR) Award in partnership with CISCO, Qlogic and Adaptive Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Al-Bluwi I, 2012, COMPUT SCI REV, V6, P125, DOI 10.1016/j.cosrev.2012.07.002; Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; Apaydin MS, 2003, J COMPUT BIOL, V10, P257, DOI 10.1089/10665270360688011; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; Chao JA, 2003, J MOL BIOL, V326, P999, DOI 10.1016/S0022-2836(02)01476-6; Chiang TH, 2007, J COMPUT BIOL, V14, P578, DOI 10.1089/cmb.2007.R004; Chiang TH, 2010, BIOINFORMATICS, V26, pi269, DOI 10.1093/bioinformatics/btq177; Choset HM., 2005, PRINCIPLES ROBOT MOT; Cortes J, 2005, BIOINFORMATICS, V21, pI116, DOI 10.1093/bioinformatics/bti1017; Cortes J, 2004, J COMPUT CHEM, V25, P956, DOI 10.1002/jcc.20021; Crawley SW, 2011, J BIOL CHEM, V286, P2607, DOI 10.1074/jbc.M110.177014; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Duan XQ, 2001, J MOL BIOL, V306, P1115, DOI 10.1006/jmbi.2001.4456; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; Finn PW, 1999, ALGORITHMICA, V25, P347, DOI 10.1007/PL00008282; Gilbreth RN, 2008, J MOL BIOL, V381, P407, DOI 10.1016/j.jmb.2008.06.014; Gipson B, 2012, ANNU REV ANAL CHEM, V5, P273, DOI 10.1146/annurev-anchem-062011-143024; Gladue DP, 2012, J VIROL, V86, P6778, DOI 10.1128/JVI.00560-12; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haspel N, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S1; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hsu D, 1999, INT J COMPUT GEOM AP, V9, P495, DOI 10.1142/S0218195999000285; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; Jolliffe I.T., 1986, PRINCIPAL COMPONENT; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kavraki LE, 1996, IEEE T ROBOTIC AUTOM, V12, P566, DOI 10.1109/70.508439; Ke A, 2003, PROTEIN SCI, V12, P306, DOI 10.1110/ps.0219103; Kirillova S, 2008, PROTEINS, V70, P131, DOI 10.1002/prot.21570; Knight C, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4743958; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kruger DM, 2012, NUCLEIC ACIDS RES, V40, pW310, DOI 10.1093/nar/gks478; Latombe JC, 1990, ROBOT MOTION PLANNIN; LaValle SM, 2001, INT J ROBOT RES, V20, P378, DOI 10.1177/02783640122067453; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Martin DR, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/3/036004; Minary P, 2010, J COMPUT BIOL, V17, P993, DOI 10.1089/cmb.2010.0016; Moll Mark, 2008, V413, P219; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piana S, 2012, P NATL ACAD SCI USA, V109, P17845, DOI 10.1073/pnas.1201811109; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Raveh B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000295; Rubin SM, 2002, J MOL BIOL, V322, P425, DOI 10.1016/S0022-2836(02)00739-8; Saul FA, 1997, PROTEINS, V27, P1, DOI 10.1002/(SICI)1097-0134(199701)27:1<1::AID-PROT2>3.0.CO;2-L; Saul FA, 1998, J MOL BIOL, V280, P185, DOI 10.1006/jmbi.1998.1866; Saul FA, 2003, PROTEIN SCI, V12, P577, DOI 10.1110/ps.0235103; Schafer K, 2004, J MOL BIOL, V335, P261, DOI 10.1016/j.jmb.2003.10.042; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHARFF AJ, 1995, J MOL BIOL, V246, P8, DOI 10.1006/jmbi.1994.0059; Shehu A, 2012, ENTROPY-SWITZ, V14, P252, DOI 10.3390/e14020252; Shilton BH, 1996, J MOL BIOL, V264, P364, DOI 10.1006/jmbi.1996.0646; Sim AYL, 2012, P NATL ACAD SCI USA, V109, P2890, DOI 10.1073/pnas.1119918109; Singh A P, 1999, Proc Int Conf Intell Syst Mol Biol, P252; Skjaerven L, 2009, J MOL STRUC-THEOCHEM, V898, P42, DOI 10.1016/j.theochem.2008.09.024; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Srinivasan U, 2002, PROTEIN ENG, V15, P895, DOI 10.1093/protein/15.11.895; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; SUCAN IA, 2009, IEEE RSJ INT C INT R, P2434, DOI DOI 10.1109/IR0S.2009.5354403; Sucan IA, 2012, IEEE ROBOT AUTOM MAG, V19, P72, DOI 10.1109/MRA.2012.2205651; Sucan IA, 2012, IEEE T ROBOT, V28, P116, DOI 10.1109/TRO.2011.2160466; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang XY, 2008, J MOL BIOL, V381, P1055, DOI 10.1016/j.jmb.2008.02.007; Tapia L, 2007, BIOINFORMATICS, V23, pI539, DOI 10.1093/bioinformatics/btm199; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Thomas S, 2005, PHYS BIOL, V2, pS148, DOI 10.1088/1478-3975/2/4/S09; Thomas S, 2007, J COMPUT BIOL, V14, P839, DOI 10.1089/cmb.2007.R019; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; Venkatraman V, 2012, PROTEINS, V80, P2262, DOI 10.1002/prot.24115; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yao P, 2008, IEEE ACM T COMPUT BI, V5, P534, DOI 10.1109/TCBB.2008.96; Zimmermann MT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-264	101	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68826	10.1371/journal.pone.0068826	http://dx.doi.org/10.1371/journal.pone.0068826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935893	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000042
J	Pei, ZT; Fraisl, P; Shi, XH; Gabrielson, E; Forss-Petter, S; Berger, J; Watkins, PA				Pei, Zhengtong; Fraisl, Peter; Shi, Xiaohai; Gabrielson, Edward; Forss-Petter, Sonja; Berger, Johannes; Watkins, Paul A.			Very Long-Chain Acyl-CoA Synthetase 3: Overexpression and Growth Dependence in Lung Cancer	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; BRONCHIAL EPITHELIAL-CELLS; CLONING; EXPRESSION; MOUSE; PROTEIN-1; RELEVANCE; COENZYME; SYNTHASE; LIGASE-4	Lung cancer is the leading cause of cancer deaths worldwide. In the United States, only one in six lung cancer patients survives five years after diagnosis. These statistics may improve if new therapeutic targets are identified. We previously reported that an enzyme of fatty acid metabolism, very long-chain acyl-CoA synthetase 3 (ACSVL3), is overexpressed in malignant glioma, and that depleting glioblastoma cells of ACSVL3 diminishes their malignant properties. To determine whether ACSVL3 expression was also increased in lung cancer, we studied tumor histologic sections and lung cancer cell lines. Immunohistochemical analysis of normal human lung showed moderate ACSVL3 expression only in bronchial epithelial cells. In contrast, all of 69 different lung tumors tested, including adeno-, squamous cell, large cell, and small cell carcinomas, had robustly elevated ACSVL3 levels. Western blot analysis of lung cancer cell lines derived from these tumor types also had significantly increased ACSVL3 protein compared to normal bronchial epithelial cells. Decreasing the growth rate of lung cancer cell lines did not change ACSVL3 expression. However, knocking down ACSVL3 expression by RNA interference reduced cell growth rates in culture by 65-76%, and the ability of tumor cells to form colonies in soft agar suspension by 65-80%. We also conducted studies to gain a better understanding of the biochemical properties of human ACSVL3. ACSVL3 mRNA was detected in many human tissues, but the expression pattern differed somewhat from that of the mouse. The enzyme activated long-and very long-chain saturated fatty acid substrates, as well as long-chain mono-and polyunsaturated fatty acids to their respective coenzyme A derivatives. Endogenous human ACSVL3 protein was found in a punctate subcellular compartment that partially colocalized with mitochondria as determined by immunofluorescence microscopy and subcellular fractionation. From these studies, we conclude that ACSVL3 is a promising new therapeutic target in lung cancer.	[Pei, Zhengtong; Shi, Xiaohai; Watkins, Paul A.] Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD USA; [Pei, Zhengtong; Shi, Xiaohai; Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gabrielson, Edward] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fraisl, Peter; Forss-Petter, Sonja; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Johns Hopkins University; Johns Hopkins University; Medical University of Vienna	Watkins, PA (corresponding author), Kennedy Krieger, Hugo W Moser Res Inst, Baltimore, MD USA.	watkins@kennedykrieger.org	Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Watkins, Paul A./0000-0002-3246-1405	National Institutes of Health [HD024061, NS037355, NS062043]; Austrian Science Fund (FWF) [P14163-MOB]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062043, R01NS037355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants HD024061, NS037355, and NS062043 (PAW) and the Austrian Science Fund (FWF) P14163-MOB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2001, CANCER RES, V61, P8429; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Chong CPK, 2012, J INHERIT METAB DIS, V35, P521, DOI 10.1007/s10545-011-9416-3; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Fraisl P, 2004, BIOCHEM J, V377, P85, DOI 10.1042/BJ20031062; Fraisl P, 2006, ARCH BIOCHEM BIOPHYS, V451, P23, DOI 10.1016/j.abb.2006.04.013; Gaisa NT, 2013, HISTOL HISTOPATHOL, V28, P353, DOI 10.14670/HH-28.353; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; LECHNER JF, 1982, IN VITRO CELL DEV B, V18, P633; Mihalik SJ, 2002, J BIOL CHEM, V277, P24771, DOI 10.1074/jbc.M203295200; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Pei ZT, 2009, CANCER RES, V69, P9175, DOI 10.1158/0008-5472.CAN-08-4689; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Shibata Y, 2001, BIOTECHNIQUES, V30, P1250, DOI 10.2144/01306st01; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steinberg SJ, 2000, J BIOL CHEM, V275, P35162, DOI 10.1074/jbc.M006403200; Steinberg SJ, 1999, MOL GENET METAB, V68, P32, DOI 10.1006/mgme.1999.2883; Steinberg SJ, 2000, J BIOL CHEM, V275, P15605, DOI 10.1074/jbc.C000015200; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Sung YK, 2003, CANCER SCI, V94, P421, DOI 10.1111/j.1349-7006.2003.tb01458.x; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Visca P, 2004, ANTICANCER RES, V24, P4169; WATKINS PA, 1995, AM J HUM GENET, V57, P292; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	41	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69392	10.1371/journal.pone.0069392	http://dx.doi.org/10.1371/journal.pone.0069392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936004	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000113
J	Pereira, MJR; Palmeirim, JM				Ramos Pereira, Maria Joao; Palmeirim, Jorge M.			Latitudinal Diversity Gradients in New World Bats: Are They a Consequence of Niche Conservatism?	PLOS ONE			English	Article							SPECIES RICHNESS; MOLECULAR PHYLOGENY; ECOLOGY; EVOLUTION; NORTH; SPECIATION; CLIMATE; BIRDS; RATES; BIOGEOGRAPHY	The increase in species diversity from the Poles to the Equator is a major biogeographic pattern, but the mechanisms underlying it remain obscure. Our aim is to contribute to their clarification by describing the latitudinal gradients in species richness and in evolutionary age of species of New World bats, and testing if those patterns may be explained by the niche conservatism hypothesis. Maps of species ranges were used to estimate species richness in a 100 x 100 km grid. Root distances in a molecular phylogeny were used as a proxy for the age of species, and the mean root distance of the species in each cell of the grid was estimated. Generalised additive models were used to relate latitude with both species richness and mean root distance. This was done for each of the three most specious bat families and for all Chiroptera combined. Species richness increases towards the Equator in the whole of the Chiroptera and in the Phyllostomidae and Molossidae, families that radiated in the tropics, but the opposite trend is observed in the Vespertilionidae, which has a presumed temperate origin. In the whole of the Chiroptera, and in the three main families, there were more basal species in the higher latitudes, and more derived species in tropical areas. In general, our results were not consistent with the predictions of niche conservatism. Tropical niche conservatism seems to keep bat clades of tropical origin from colonizing temperate zones, as they lack adaptations to survive cold winters, such as the capacity to hibernate. However, the lower diversity of Vespertilionidae in the Neotropics is better explained by competition with a diverse pre-existing community of bats than by niche conservatism.	[Ramos Pereira, Maria Joao] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Ramos Pereira, Maria Joao] Univ Aveiro, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Ramos Pereira, Maria Joao; Palmeirim, Jorge M.] Univ Lisbon, Fac Sci, Dept Anim Biol, Ctr Environm Biol, P-1699 Lisbon, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Lisboa	Pereira, MJR (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	mariajoaopereira@ua.pt	Palmeirim, Jorge M/A-1323-2014; Pereira, Maria João Ramos/AAH-9411-2021; Ramos Pereira, Maria João/P-6221-2014	Palmeirim, Jorge M/0000-0003-4734-8162; Pereira, Maria João Ramos/0000-0002-9365-5166; Ramos Pereira, Maria João/0000-0002-9365-5166	Foundation for Science and Technology, Portugal [SFRH/BD/19620/2004, SFRH/BPD/72845/2010]	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	MJRP was supported by Foundation for Science and Technology, Portugal (www.fct.pt), fellowship SFRH/BD/19620/2004 and SFRH/BPD/72845/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2000, ECOLOGY, V81, P1004, DOI 10.1890/0012-9658(2000)081[1004:PTATDA]2.0.CO;2; Baker RJ, 2003, OCCAS PAP MUS TEXAS, V230, P1; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; FLEMING TH, 1973, ECOLOGY, V54, P555, DOI 10.2307/1935340; Gardner AL, 2007, MAMMALS S AM, P690; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hawkins BA, 2005, J BIOGEOGR, V32, P1035, DOI 10.1111/j.1365-2699.2004.01238.x; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Hawkins BA, 2012, J BIOGEOGR, V39, P825, DOI 10.1111/j.1365-2699.2011.02655.x; Hutchinson G. E., 1957, TREATISE LIMNOLOGY; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P229; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; LaVal R.K., 1973, Science Bull nat Hist Mus Los Ang Cty, V15, P1; Lim BK, 2007, MOL PHYLOGENET EVOL, V45, P777, DOI 10.1016/j.ympev.2007.09.003; Lowenberg-Neto P, 2011, J BIOGEOGR, V38, P1936, DOI 10.1111/j.1365-2699.2011.02540.x; Losos JB, 2010, ADAPTIVE RAD INTERAC, P381; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Patten MA, 2004, J BIOGEOGR, V31, P975, DOI 10.1111/j.1365-2699.2004.01087.x; PATTERSON BD, 2005, DIGITAL DISTRIBUTION; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; PIANKA ER, 1966, ECOLOGY, V47, P1055, DOI 10.2307/1935656; Prinzing A, 2004, EVOLUTION, V58, P2622; RACEY PA, 1981, J REPROD FERTIL, V61, P123; RACEY PA, 1969, J REPROD FERTIL, V19, P465; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; RICKLEFS RE, 1992, AM NAT, V139, P1305, DOI 10.1086/285388; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Sears KE, 2008, CELLS TISSUES ORGANS, V187, P6, DOI 10.1159/000109959; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons NB, 2008, SCI AM, V299, P96, DOI 10.1038/scientificamerican1208-96; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Smith BT, 2010, ECOGRAPHY; Speakman JR, 2003, BAT ECOLOGY, P430; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stevens RD, 2004, J BIOGEOGR, V31, P665, DOI 10.1111/j.1365-2699.2003.01042.x; Stevens RD, 2006, P ROY SOC B-BIOL SCI, V273, P2283, DOI 10.1098/rspb.2006.3596; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Utescher T, 2007, PALAEOGEOGR PALAEOCL, V247, P243, DOI 10.1016/j.palaeo.2006.10.022; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Whittaker RJ, 2007, ECOGRAPHY, V30, P321, DOI 10.1111/j.0906-7590.2007.04761.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; WILLIG MR, 1989, J BIOGEOGR, V16, P189, DOI 10.2307/2845093; WILSON DE, 1970, NATURE, V225, P1155, DOI 10.1038/2251155a0	61	33	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69245	10.1371/journal.pone.0069245	http://dx.doi.org/10.1371/journal.pone.0069245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935963	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000092
J	Suzuki, A; Shin, JW; Wang, YH; Min, SH; Poncz, M; Choi, JK; Discher, DE; Carpenter, CL; Lian, LR; Zhao, L; Wang, YF; Abrams, CS				Suzuki, Aae; Shin, Jae-Won; Wang, Yuhuan; Min, Sang H.; Poncz, Morty; Choi, John K.; Discher, Dennis E.; Carpenter, Chris L.; Lian, Lurong; Zhao, Liang; Wang, Yangfeng; Abrams, Charles S.			RhoA Is Essential for Maintaining Normal Megakaryocyte Ploidy and Platelet Generation	PLOS ONE			English	Article							LIGHT-CHAIN; ENDOMITOTIC MEGAKARYOCYTES; PROPLATELET FORMATION; MYOSIN-II; PHOSPHORYLATION; KINASE; MICE; FORM; POLYPLOIDIZATION; DIFFERENTIATION	RhoA plays a multifaceted role in platelet biology. During platelet development, RhoA has been proposed to regulate endomitosis, proplatelet formation, and platelet release, in addition to having a role in platelet activation. These processes were previously studied using pharmacological inhibitors in vitro, which have potential drawbacks, such as non-specific inhibition or incomplete disruption of the intended target proteins. Therefore, we developed a conditional knockout mouse model utilizing the CRE-LOX strategy to ablate RhoA, specifically in megakaryocytes and in platelets to determine its role in platelet development. We demonstrated that deleting RhoA in megakaryocytes in vivo resulted in significant macrothrombocytopenia. RhoA-null megakaryocytes were larger, had higher mean ploidy, and exhibited stiff membranes with micropipette aspiration. However, in contrast to the results observed in experiments relying upon pharmacologic inhibitors, we did not observe any defects in proplatelet formation in megakaryocytes lacking RhoA. Infused RhoA-null megakaryocytes rapidly released platelets, but platelet levels rapidly plummeted within several hours. Our evidence supports the hypothesis that changes in membrane rheology caused infused RhoA-null megakaryocytes to prematurely release aberrant platelets that were unstable. These platelets were cleared quickly from circulation, which led to the macrothrombocytopenia. These observations demonstrate that RhoA is critical for maintaining normal megakaryocyte development and the production of normal platelets.	[Suzuki, Aae; Min, Sang H.; Lian, Lurong; Zhao, Liang; Wang, Yangfeng; Abrams, Charles S.] Univ Penn, Sch Med, Dept Hematol Oncol, Philadelphia, PA 19104 USA; [Shin, Jae-Won; Discher, Dennis E.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Wang, Yuhuan; Poncz, Morty] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Choi, John K.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Carpenter, Chris L.] GlaxoSmithKline, Clin Oncol, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; St Jude Children's Research Hospital; GlaxoSmithKline	Abrams, CS (corresponding author), Univ Penn, Sch Med, Dept Hematol Oncol, Philadelphia, PA 19104 USA.	abrams@mail.med.upenn.edu	; Choi, John/N-7558-2018	Wang, Yanfeng/0000-0002-3859-0937; discher, dennis/0000-0001-6163-2229; Choi, John/0000-0002-2861-0180	National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110110, P01HL120846] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begonja AJ, 2011, BLOOD, V118, P2285, DOI 10.1182/blood-2011-04-348482; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Gao Y, 2012, DEV CELL, V22, P573, DOI 10.1016/j.devcel.2011.12.019; Geddis AE, 2007, CELL CYCLE, V6, P455, DOI 10.4161/cc.6.4.3836; Geddis AE, 2006, CELL CYCLE, V5, P538, DOI 10.4161/cc.5.5.2537; Geddis AE, 2010, BLOOD, V116, P2202, DOI 10.1182/blood-2010-07-293449; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Leven Robert M, 2004, Methods Mol Biol, V272, P281; Lian LR, 2009, BLOOD, V113, P3577, DOI 10.1182/blood-2008-09-178913; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Lordier L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1704; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nieswandt B, 2000, BLOOD, V96, P2520; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Raslova H, 2007, BLOOD, V109, P3225, DOI 10.1182/blood-2006-07-037838; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shivdasani RA, 2005, CURR PROTOC IMMUNOL; Thon JN, 2012, METHODS MOL BIOL, V788, P109, DOI 10.1007/978-1-61779-307-3_9; Thon JN, 2010, SEMIN HEMATOL, V47, P220, DOI 10.1053/j.seminhematol.2010.03.005; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427	35	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69315	10.1371/journal.pone.0069315	http://dx.doi.org/10.1371/journal.pone.0069315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935982	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000101
J	Tiwari, A; Schneider, M; Fiorino, A; Haider, R; Okoniewski, MJ; Roschitzki, B; Uzozie, A; Menigatti, M; Jiricny, J; Marra, G				Tiwari, Amit; Schneider, Mirjam; Fiorino, Antonio; Haider, Ritva; Okoniewski, Michal J.; Roschitzki, Bernd; Uzozie, Anuli; Menigatti, Mirco; Jiricny, Josef; Marra, Giancarlo			Early Insights into the Function of KIAA1199, a Markedly Overexpressed Protein in Human Colorectal Tumors	PLOS ONE			English	Article							BETA-CATENIN; SPHINGOSINE 1-PHOSPHATE; SIGNALING PATHWAY; STATISTICAL-MODEL; GENE; ACTIVATION; RECEPTOR; KINASE; INHIBITION; DEAFNESS	We previously reported that the expression of KIAA1199 in human colorectal tumors (benign and malignant) is markedly higher than that in the normal colonic mucosa. In this study, we investigated the functions of the protein encoded by this gene, which are thus far unknown. Immunostaining studies were used to reveal its subcellular localization, and proteomic and gene expression experiments were conducted to identify proteins that might interact with KIAA1199 and molecular pathways in which it might play roles. Using colon cancer cell lines, we showed that both endogenous and ectopically expressed KIAA1199 is secreted into the extracellular environment. In the cells, it was found mainly in the perinuclear space (probably the ER) and cell membrane. Both cellular compartments were also over-represented in lists of proteins identified by mass spectrometry as putative KIAA1199 interactors and/or proteins encoded by genes whose transcription was significantly changed by KIAA1199 expression. These proteomic and transcriptomic datasets concordantly link KIAA1199 to several genes/proteins and molecular pathways, including ER processes like protein binding, transport, and folding; and Ca2+, G-protein, ephrin, and Wnt signaling. Immunoprecipitation experiments confirmed KIAA1199's interaction with the cell-membrane receptor ephrin A2 and with the ER receptor ITPR3, a key player in Ca2+ signaling. By modulating Ca2+ signaling, KIAA1199 could affect different branches of the Wnt network. Our findings suggest it may negatively regulate the Wnt/CTNNB1 signaling, and its expression is associated with decreased cell proliferation and invasiveness.	[Tiwari, Amit; Schneider, Mirjam; Haider, Ritva; Uzozie, Anuli; Menigatti, Mirco; Jiricny, Josef; Marra, Giancarlo] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Fiorino, Antonio] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Milan, Italy; [Okoniewski, Michal J.; Roschitzki, Bernd] ETH, Funct Genom Ctr, Zurich, Switzerland; [Okoniewski, Michal J.; Roschitzki, Bernd] Univ Zurich, Zurich, Switzerland	University of Zurich; Fondazione IRCCS Istituto Nazionale Tumori Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Marra, G (corresponding author), Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland.	marra@imcr.uzh.ch	Fiorino, Antonio/D-5828-2017	Fiorino, Antonio/0000-0002-2621-9276; /0000-0003-2000-2532	Zurich Cancer League; University Research Priority Program, University of Zurich	Zurich Cancer League; University Research Priority Program, University of Zurich	This study was supported by grants from the Zurich Cancer League (to Giancarlo Marra and Amit Tiwari) and the University Research Priority Program, University of Zurich (to Amit Tiwari). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Akoumianaki T, 2009, J CELL SCI, V122, P1111, DOI 10.1242/jcs.043034; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Beaulieu Jean-Francois, 2010, World J Gastrointest Pathophysiol, V1, P3, DOI 10.4291/wjgp.v1.i1.3; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Di Pietro M, 2005, GASTROENTEROLOGY, V129, P1047, DOI 10.1053/j.gastro.2005.06.028; di Pietro M, 2003, CANCER RES, V63, P8158; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuscu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044661; LaPointe LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029059; Li G, 2002, P NATL ACAD SCI USA, V99, P13254, DOI 10.1073/pnas.202355799; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MacLennan AJ, 2006, HEARING RES, V220, P38, DOI 10.1016/j.heares.2006.06.016; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Menigatti M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-124; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Taylor Colin W, 2012, Subcell Biochem, V59, P1, DOI 10.1007/978-94-007-3015-1_1; TOMITA N, 1992, CANCER RES, V52, P6840; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615	50	45	47	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69473	10.1371/journal.pone.0069473	http://dx.doi.org/10.1371/journal.pone.0069473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936024	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325211000124
J	Bandyopadhyay, S; Cahill, C; Balleidier, A; Huang, CN; Lahiri, DK; Huang, XD; Rogers, JT				Bandyopadhyay, Sanghamitra; Cahill, Catherine; Balleidier, Amelie; Huang, Conan; Lahiri, Debomoy K.; Huang, Xudong; Rogers, Jack T.			Novel 5 ' Untranslated Region Directed Blockers of Iron-Regulatory Protein-1 Dependent Amyloid Precursor Protein Translation: Implications for Down Syndrome and Alzheimer's Disease	PLOS ONE			English	Article							APP-MESSENGER-RNA; 5'-UNTRANSLATED REGION; RESPONSIVE ELEMENT; EXPRESSION; IDENTIFICATION; DYSFUNCTION; INHIBITORS; DAMAGE; ZINC	We reported that iron influx drives the translational expression of the neuronal amyloid precursor protein (APP), which has a role in iron efflux. This is via a classic release of repressor interaction of APP mRNA with iron-regulatory protein-1 (IRP1) whereas IRP2 controls the mRNAs encoding the L-and H-subunits of the iron storage protein, ferritin. Here, we identified thirteen potent APP translation blockers that acted selectively towards the uniquely configured iron-responsive element (IRE) RNA stem loop in the 5' untranslated region (UTR) of APP mRNA. These agents were 10-fold less inhibitory of 5 ' UTR sequences of the related prion protein (PrP) mRNA. Western blotting confirmed that the 'ninth' small molecule in the series selectively reduced neural APP production in SH-SY5Y cells at picomolar concentrations without affecting viability or the expression of a-synuclein and ferritin. APP blocker-9 (JTR-009), a benzimidazole, reduced the production of toxic Ab in SH-SY5Y neuronal cells to a greater extent than other well tolerated APP 5'UTR-directed translation blockers, including posiphen, that were shown to limit amyloid burden in mouse models of Alzheimer's disease (AD). RNA binding assays demonstrated that JTR-009 operated by preventing IRP1 from binding to the IRE in APP mRNA, while maintaining IRP1 interaction with the H-ferritin IRE RNA stem loop. Thus, JTR-009 constitutively repressed translation driven by APP 5'UTR sequences. Calcein staining showed that JTR-009 did not indirectly change iron uptake in neuronal cells suggesting a direct interaction with the APP 5'UTR. These studies provide key data to develop small molecules that selectively reduce neural APP and Ab production at 10-fold lower concentrations than related previously characterized translation blockers. Our data evidenced a novel therapeutic strategy of potential impact for people with trisomy of the APP gene on chromosome 21, which is a phenotype long associated with Down syndrome (DS) that can also cause familial Alzheimer's disease.	[Bandyopadhyay, Sanghamitra; Cahill, Catherine; Balleidier, Amelie; Huang, Conan; Huang, Xudong; Rogers, Jack T.] Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA; [Bandyopadhyay, Sanghamitra; Cahill, Catherine; Balleidier, Amelie; Huang, Conan; Huang, Xudong; Rogers, Jack T.] Harvard Univ, Sch Med, Charlestown, MA USA; [Cahill, Catherine] Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA USA; [Lahiri, Debomoy K.] Indiana Univ Sch Med, Dept Psychiat, Inst Psychiat Res, Mol Neurogenet Lab, Indianapolis, IN 46202 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington	Rogers, JT (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Neurochem Lab, Charlestown, MA USA.	jrogers@partners.org	Huang, Xudong/D-9711-2018; Lahiri, Debomoy/AAZ-3322-2020	Huang, Xudong/0000-0002-4811-1901; Rogers, Jack/0000-0003-1262-8578; Bandyopadhyay, Sanghamitra/0000-0002-1490-3599	Alzheimer's Association Zenith Award; Michael JFOX NADD grant; NICH;  [R21 NS077079-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077079] Funding Source: NIH RePORTER	Alzheimer's Association Zenith Award(Alzheimer's Association); Michael JFOX NADD grant; NICH; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JR was funded from an R21 NS077079-01A1 (Post Transcriptional Control of hemorrhagic iron damage). JR is a recipient of the Alzheimer's Association Zenith Award, and of a Michael JFOX NADD grant. CC was supported by an R01 Supplement from the NICH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2006, J BIOMOL SCREEN, V11, P469, DOI 10.1177/1087057106287271; Bandyopadhyay S, 2010, EXPERT OPIN THER TAR, V14, P1177, DOI 10.1517/14728222.2010.525352; Butterfield DA, 2011, NEUROMOL MED, V13, P19, DOI 10.1007/s12017-010-8123-9; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Donahue CP, 2007, J BIOMOL SCREEN, V12, P789, DOI 10.1177/1087057107302676; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Friedlich AL, 2007, MOL PSYCHIATR, V12, P222, DOI 10.1038/sj.mp.4001937; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; Granic A, 2010, MOL BIOL CELL, V21, P511, DOI 10.1091/mbc.E09-10-0850; Hamy F, 1997, P NATL ACAD SCI USA, V94, P3548, DOI 10.1073/pnas.94.8.3548; Hooli BV, 2012, NEUROLOGY, V78, P1250, DOI 10.1212/WNL.0b013e3182515972; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Kurogi Y, 2001, J MED CHEM, V44, P2304, DOI 10.1021/jm010060v; Kwon OD, 2010, DEMENT GERIATR COGN, V30, P486, DOI 10.1159/000322368; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maccecchini M, 2009, ALZHEIMERS DEMENT, V5, P47; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; McNaughton D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.010; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Morse LJ, 2004, J MOL NEUROSCI, V24, P129, DOI 10.1385/JMN:24:1:129; Nilsson LNG, 2004, NEUROBIOL AGING, V25, P1153, DOI 10.1016/j.neurobiolaging.2003.12.011; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Rogers JT, 2011, J NEURAL TRANSM, V118, P493, DOI 10.1007/s00702-010-0513-5; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SCHULZ WG, 1995, P NATL ACAD SCI USA, V92, P11854, DOI 10.1073/pnas.92.25.11854; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; SKIBO EB, 1994, J MED CHEM, V37, P78, DOI 10.1021/jm00027a010; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Tibodeau JD, 2006, P NATL ACAD SCI USA, V103, P253, DOI 10.1073/pnas.0509744102; Tucker Stephanie, 2006, Current Alzheimer Research, V3, P221, DOI 10.2174/156720506777632835; Utsuki T, 2006, J PHARMACOL EXP THER, V318, P855, DOI 10.1124/jpet.106.103309; Venti A, 2004, ANN NY ACAD SCI, V1035, P34, DOI 10.1196/annals.1332.003; Werstuck G, 1998, SCIENCE, V282, P296, DOI 10.1126/science.282.5387.296; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; Wolk DA, 2009, CURR NEUROL NEUROSCI, V9, P345, DOI 10.1007/s11910-009-0051-4	49	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e65978	10.1371/journal.pone.0065978	http://dx.doi.org/10.1371/journal.pone.0065978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935819	Green Published, gold, Green Submitted			2022-12-27	WOS:000322633700001
J	Sun, W; Ni, R; Yin, JF; Musa, HH; Ding, TJ; Chen, L				Sun, Wei; Ni, Rong; Yin, Jin Feng; Musa, Hassan H.; Ding, Tong Jia; Chen, Ling			Genome Array of Hair Follicle Genes in Lambskin with Different Patterns	PLOS ONE			English	Article							SKIN; MICROARRAY; CELLS; ONTOLOGY; GROWTH	Hu sheep lambskin comes from a specific breed of sheep of China. Hu sheep are considered a protected breed by the Chinese government. The hair follicles of these sheep have three types of waves, large, medium, and small. There are only few histological reports of Hu sheep lambskin, and there are no modern molecular or biological studies, so the molecular mechanisms underlying the formation of hair follicles with different patterns are not currently known. The aim of this article was to study the molecular mechanism of the formation of these types of hair follicles in Hu sheep. Histological and microscopic analysis indicated that the number of follicles with small waves was not significantly higher than the number of follicles with large waves (P > 0.05). The diameters of primary and secondary small-wave follicles were significantly smaller than those of large-wave follicles (P < 0.05; P < 0.01). The ratio between the number primary follicles and the number of secondary follicles was significantly higher among small-wave follicles than among large-wave follicles (P < 0.05). Differentially expressed genes in the skin tissue were screened using an Agilent gene chip and RT-PCR. Differential expression analysis revealed 3 groups of large waves and small waves; 1067, 2071, and 3879 differentially expressed genes; and 137 genes common to all 3 groups. Differentially expressed genes were classified using gene ontology. They were found to be mainly involved in cell differentiation, proliferation, apoptosis, growth, immune response, and ion transport. RT-PCR results of 4 differentially expressed genes were consistent with gene chip results. Combined with related literature, our results suggest that BMP7, MMP2, SNAI1, SFXN1, CDKNIC, MT3, and POU1F1 may have important effects on the formation of large-wave and small-wave hair follicles. This study may enrich knowledge of hair follicle development, and may identify the genes responsible for the formation of hair follicles with different patterns.	[Sun, Wei; Ni, Rong; Yin, Jin Feng; Ding, Tong Jia] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China; [Musa, Hassan H.] Univ Khartoum, Fac Med Lab Sci, Khartoum, Sudan; [Chen, Ling] Anim Sci & Vet Med Bur Suzhou City, Suzhou, Peoples R China	Yangzhou University; University of Khartoum	Sun, W (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China.	dkxmsunwei@163.com			China Postdoctoral Science Foundation [200902154]; Jiangsu Agricultural Science and Technology support program of China [BE2012331]; graduate education innovation project of Jiangsu province China [CXLX12-0929]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project Jiangsu Province Engineering Research Center of China [BM2012308]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Agricultural Science and Technology support program of China; graduate education innovation project of Jiangsu province China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project Jiangsu Province Engineering Research Center of China	This work was supported by China Postdoctoral Science Foundation special funded project (200902154), Jiangsu Agricultural Science and Technology support program of China (BE2012331, http://www.jskjjh.gov.cn/XMSB/All_JBXX.jsp?XMBH = SBE201230119&DJXH = 201203994), the graduate education innovation project of Jiangsu province China (CXLX12-0929), the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Project Jiangsu Province Engineering Research Center of China (BM2012308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; He XM, 2011, ANIMAL HUSBANDRY XIN, P36; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kim BK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-640; Kronick MN, 2004, EXPERT REV PROTEOMIC, V1, P19, DOI 10.1586/14789450.1.1.19; Luo WX, 2011, GENETICS BREEDING, V47, P5; Lv XF, 2010, CHINA ANIMAL HUSBAND, V37, P25; Miao Y, 2008, SHANDONG MED J, V48, P17; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mobini B., 2012, Sokoto Journal of Veterinary Sciences, V10, P1, DOI 10.4314/sokjvs.v10i1.1; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Smith B, 2005, GEN BIO, P461; Sprecher E, 2005, CLIN DERMATOL, V23, P47, DOI 10.1016/j.clindermatol.2004.09.009; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tobin DJ, 2003, J INVEST DERMATOL, V120, P895, DOI 10.1046/j.1523-1747.2003.12237.x; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005; Xi DM, 2011, MOL BIOL REP, V38, P1883, DOI 10.1007/s11033-010-0306-9; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yang XC, 2002, FOREIGN MED SCI SECT, V25, P245; Yu LN, 2010, EFFECT SHRNA MEDIATE; [曾俊杰 Zeng Junjie], 2011, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V28, P19	29	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68840	10.1371/journal.pone.0068840	http://dx.doi.org/10.1371/journal.pone.0068840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935896	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200015
J	Fodor, E; Zsigmond, A; Horvath, B; Molnar, J; Nagy, I; Toth, G; Wilson, SW; Varga, M				Fodor, Erika; Zsigmond, Aron; Horvath, Balazs; Molnar, Janos; Nagy, Istvan; Toth, Gabor; Wilson, Stephen W.; Varga, Mate			Full Transcriptome Analysis of Early Dorsoventral Patterning in Zebrafish	PLOS ONE			English	Article							SPEMANN ORGANIZER; GENE-EXPRESSION; HOMEOBOX GENE; SIGNALING PATHWAY; NEURAL INDUCTION; SPROUTY PROTEINS; AXIS FORMATION; BETA-CATENINS; MESODERM; ANTAGONIST	Understanding the molecular interactions that lead to the establishment of the major body axes during embryogenesis is one of the main goals of developmental biology. Although the past two decades have revolutionized our knowledge about the genetic basis of these patterning processes, the list of genes involved in axis formation is unlikely to be complete. In order to identify new genes involved in the establishment of the dorsoventral (DV) axis during early stages of zebrafish embryonic development, we employed next generation sequencing for full transcriptome analysis of normal embryos and embryos lacking overt DV pattern. A combination of different statistical approaches yielded 41 differentially expressed candidate genes and we confirmed by in situ hybridization the early dorsal expression of 32 genes that are transcribed shortly after the onset of zygotic transcription. Although promoter analysis of the validated genes suggests no general enrichment for the binding sites of early acting transcription factors, most of these genes carry "bivalent" epigenetic histone modifications at the time when zygotic transcription is initiated, suggesting a "poised" transcriptional status. Our results reveal some new candidates of the dorsal gene regulatory network and suggest that a plurality of the earliest upregulated genes on the dorsal side have a role in the modulation of the canonical Wnt pathway.	[Fodor, Erika; Zsigmond, Aron; Varga, Mate] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Horvath, Balazs; Nagy, Istvan] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Molnar, Janos] Biomi Ltd, Godollo, Hungary; [Toth, Gabor] Agr Biotechnol Ctr, Agr Genom & Bioinformat Grp, Godollo, Hungary; [Wilson, Stephen W.; Varga, Mate] UCL, Dept Cell & Dev Biol, London, England	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of London; University College London	Varga, M (corresponding author), Eotvos Lorand Univ, Dept Genet, Budapest, Hungary.	m.varga@ucl.ac.uk	Zebrafish, UCL/A-3125-2009; Toth, Gabor/A-9224-2010; Wilson, Stephen W/B-9404-2008; Varga, Máté/G-9834-2017	Toth, Gabor/0000-0002-6243-4758; Wilson, Stephen W/0000-0002-8557-5940; Varga, Máté/0000-0003-4289-1705	Zoltan Magyary Postdoctoral Fellowship [T/213/2009]; BBSRC; BBSRC [BB/H008462/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008462/1] Funding Source: researchfish	Zoltan Magyary Postdoctoral Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by a Zoltan Magyary Postdoctoral Fellowship (T/213/2009) to MV and a BBSRC project grant to MV and SWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Barth KA, 1999, DEVELOPMENT, V126, P4977; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Blythe SA, 2010, DEV CELL, V19, P220, DOI 10.1016/j.devcel.2010.07.007; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Chan TM, 2009, BBA-GENE REGUL MECH, V1789, P279, DOI 10.1016/j.bbagrm.2008.09.005; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Flowers GP, 2012, DEVELOPMENT, V139, P2416, DOI 10.1242/dev.063206; Fujimi TJ, 2012, DEV BIOL, V361, P220, DOI 10.1016/j.ydbio.2011.10.026; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Grinblat Y, 2001, DEV DYNAM, V222, P688, DOI 10.1002/dvdy.1221; Harvey SA, 2010, DEVELOPMENT, V137, P1127, DOI 10.1242/dev.046318; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Hong SK, 2011, INT J DEV BIOL, V55, P917, DOI 10.1387/ijdb.113288sh; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Imai Y, 2001, DEVELOPMENT, V128, P2407; KANE DA, 1993, DEVELOPMENT, V119, P447; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Kunwar PS, 2003, DEVELOPMENT, V130, P5589, DOI 10.1242/dev.00803; Labalette C, 2011, DEVELOPMENT, V138, P317, DOI 10.1242/dev.057299; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lee HC, 2009, DEV BIOL, V336, P232, DOI 10.1016/j.ydbio.2009.10.001; Lin W, 2005, GENESIS, V41, P110, DOI 10.1002/gene.20103; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Tran LD, 2012, DEVELOPMENT, V139, P3644, DOI 10.1242/dev.082362; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Maegawa S, 2006, DEVELOPMENT, V133, P3265, DOI 10.1242/dev.02483; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P1095, DOI 10.1046/j.1365-2826.2003.01102.x; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Pezeron G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001434; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Pourebrahim R, 2011, J BIOL CHEM, V286, P37732, DOI 10.1074/jbc.M111.242826; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Ryu SL, 2001, DEV BIOL, V231, P397, DOI 10.1006/dbio.2000.0150; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schug J, 2008, CURR PROTOC BIOINFOR; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Seiliez I, 2006, DEV BIOL, V290, P152, DOI 10.1016/j.ydbio.2005.11.021; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Song JB, 2007, DEV BIOL, V303, P561, DOI 10.1016/j.ydbio.2006.11.040; Spemann H, 2001, INT J DEV BIOL, V45, P13; Swartz ME, 2011, DEV DYNAM, V240, P2204, DOI 10.1002/dvdy.22713; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Thisse C, 1999, DEVELOPMENT, V126, P229; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Toyama R, 2004, GENE EXPR PATTERNS, V4, P345, DOI 10.1016/j.modgep.2003.09.011; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Varga M, 2007, MECH DEVELOP, V124, P775, DOI 10.1016/j.mod.2007.05.005; Varga M, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-26; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Weinstein DC, 1997, CURR OPIN NEUROBIOL, V7, P7, DOI 10.1016/S0959-4388(97)80114-6; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Xiang W, 2011, J CELL MOL MED, V15, P359, DOI 10.1111/j.1582-4934.2009.00961.x; Xie XW, 2012, PLOS ONE, V6; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Yan B, 2009, DEV BIOL, V329, P80, DOI 10.1016/j.ydbio.2009.02.019; Yao J, 2001, DEVELOPMENT, V128, P2975; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	104	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70053	10.1371/journal.pone.0070053	http://dx.doi.org/10.1371/journal.pone.0070053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922899	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700124
J	Trenkel, VM; Daures, F; Rochet, MJ; Lorance, P				Trenkel, Verena M.; Daures, Fabienne; Rochet, Marie-Joelle; Lorance, Pascal			Interannual Variability of Fisheries Economic Returns and Energy Ratios Is Mostly Explained by Gear Type	PLOS ONE			English	Article							PROXIMATE COMPOSITION; FISHING FLEETS; MANAGEMENT; BISCAY; BAY; ECOSYSTEM; DYNAMICS; RISK; FOOD; PORTFOLIO	According to portfolio theory applied to fisheries management, economic returns are stabilised by harvesting in a portfolio stocks of species whose returns are negatively correlated and for which the portfolio economic return variance is smaller than the sum of stock specific return variances. Also, variability is expected to decrease with portfolio width. Using a range of indicators, these predictions were tested for the French fishing fleets in the Bay of Biscay (Northeast Atlantic) during the period 2001-2009. For this, vessels were grouped into eight fishing fleets based on the gears used and exploited species were grouped into five functional groups. The portfolio width of fleets ranged from 1-3 functional groups, or 4-19 species. Economic fleet returns (sale revenues minus fishing costs) varied strongly between years; the interannual variability was independent of portfolio width (species or functional groups). Energy ratio expressed by the ratio between fuel energy used for fishing and energy contained in landings varied from 0.3 for purse seines to 9.7 for trawlers using bottom trawls alone or in combination with pelagic trawls independent of portfolio width. Interannual variability in total sale revenues was larger than the sum of species specific sales revenue variability, except for fleets using hooks and pelagic trawlers; it increased with the number of species exploited. In conclusion, the interannual variability of economic returns or energy ratios of French fisheries in the Bay of Biscay did not decrease with the number of species or functional groups exploited, though it varied between fleets.	[Trenkel, Verena M.; Rochet, Marie-Joelle; Lorance, Pascal] IFREMER, Ctr Nantes, F-44311 Nantes 03, France; [Daures, Fabienne] IFREMER, Ctr Brest, UMR Amenagement Usages Ressources & Espaces Mari, F-29280 Plouzane, France	Ifremer; Nantes Universite; Ifremer	Trenkel, VM (corresponding author), IFREMER, Ctr Nantes, F-44311 Nantes 03, France.	verena.trenkel@ifremer.fr	; Lorance, Pascal/F-4668-2011	Trenkel, Verena/0000-0001-7869-002X; Lorance, Pascal/0000-0002-6453-2925	EU [244966]	EU(European Commission)	Funding was received from EU FP7 FACTS project, grant agreement no. 244966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2012, AQUAT LIVING RESOUR, V25, P205, DOI 10.1051/alr/2012018; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Auster PJ, 2009, MAR ECOL PROG SER, V382, P163, DOI 10.3354/meps07962; Ball JR, 2007, POLAR BIOL, V30, P699, DOI 10.1007/s00300-006-0227-1; Brent T, 2012, MARINE RESOURCE EC, V27, P323; Cheung WWL, 2008, ECOL ECON, V66, P193, DOI 10.1016/j.ecolecon.2007.09.001; Christensen V, 2011, ECOL MODEL, V222, P857, DOI 10.1016/j.ecolmodel.2010.09.030; Costanza R, 2000, BIOSCIENCE, V50, P149, DOI 10.1641/0006-3568(2000)050[0149:MOEP]2.3.CO;2; Daures F, 2013, FISH RES, V146, P74, DOI 10.1016/j.fishres.2013.03.022; Daures F, 2009, AQUAT LIVING RESOUR, V22, P535, DOI 10.1051/alr/2009031; Edwards SF, 2004, ECOL ECON, V49, P317, DOI 10.1016/j.ecolecon.2004.04.002; FAO WFP IFAD., 2012, STAT FOOD INS WORLD; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Lassalle G, 2011, PROG OCEANOGR, V91, P561, DOI 10.1016/j.pocean.2011.09.002; Le Floc'h P, 2011, FISH RES, V109, P257, DOI 10.1016/j.fishres.2011.02.012; Leblond E, 2008, FISHERIES INFORM SYS; Lorance P, 2011, ICES J MAR SCI, V68, P290, DOI 10.1093/icesjms/fsq072; Lorance P, 2009, AQUAT LIVING RESOUR, V22, P409, DOI 10.1051/alr/2009049; Marchal P, 2008, ICES J MAR SCI, V65, P674, DOI 10.1093/icesjms/fsn044; Mesnil B, 2008, OCEAN COAST MANAGE, V51, P689, DOI 10.1016/j.ocecoaman.2008.07.009; Minnegal M, 2008, HUM ORGAN, V67, P97, DOI 10.17730/humo.67.1.x38g60k463p26855; Nielsen M, 2012, MAR RESOUR ECON, V27, P165, DOI 10.5950/0738-1360-27.2.165; Nielsen M, 2009, J AGR ECON, V60, P367, DOI 10.1111/j.1477-9552.2008.00190.x; Pincinato RBM, 2010, PROG OCEANOGR, V87, P320, DOI 10.1016/j.pocean.2010.08.006; Rochet MJ, 2013, B MAR SCI, V89, P285, DOI 10.5343/bms.2011.1138; Rochet MJ, 2012, CAN J FISH AQUAT SCI, V69, P695, DOI [10.1139/F2012-002, 10.1139/f2012-002]; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Sanchirico JN, 2008, ECOL ECON, V64, P586, DOI 10.1016/j.ecolecon.2007.04.006; Schaefer MB., 1954, B IATTC BOL CIAT, V1, P23; Sipponen M, 2006, FISHERIES MANAG ECOL, V13, P299, DOI 10.1111/j.1365-2400.2006.00506.x; Spitz J, 2010, ICES J MAR SCI, V67, P909, DOI 10.1093/icesjms/fsq008; Steinmetz F, 2008, AQUAT LIVING RESOUR, V21, P317, DOI 10.1051/alr:2008048; Suuronen P, 2012, FISH RES, P119; Torry Research Station, 1989, YIELD NUTR VAL COMM; Tveteras S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036731; Tyedmers PH, 2005, AMBIO, V34, P635, DOI 10.1639/0044-7447(2005)034[0635:FGFF]2.0.CO;2; Van Iseghem S, 2011, ICES J MAR SCI, V68, P1792, DOI 10.1093/icesjms/fsr112; WIVIOTT DJ, 1975, MAR FISH REV, V37, P21	40	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70165	10.1371/journal.pone.0070165	http://dx.doi.org/10.1371/journal.pone.0070165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	204MP	23922951	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700151
J	Daien, V; Carriere, I; Kawasaki, R; Cristol, JP; Villain, M; Fesler, P; Ritchie, K; Delcourt, C				Daien, Vincent; Carriere, Isabelle; Kawasaki, Ryo; Cristol, Jean-Paul; Villain, Max; Fesler, Pierre; Ritchie, Karen; Delcourt, Cecile			Retinal Vascular Caliber Is Associated with Cardiovascular Biomarkers of Oxidative Stress and Inflammation: The POLA Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LOW-BIRTH-WEIGHT; RISK-FACTORS; ANTIOXIDANT ENZYMES; VESSEL DIAMETERS; ATHEROSCLEROSIS RISK; MACULAR DEGENERATION; ARTERIOLAR; AGE; PLASMA	Purpose: Retinal vascular caliber has been linked with increased cardiovascular risk and is predictive of cardiovascular pathology, including stroke and coronary heart disease. Oxidative stress, as well as inflammatory mechanisms, plays a major role in the pathogenesis and progression of atherosclerosis, plaque rupture and vascular thrombotic propensity. The purpose of this study is to explore the relationship between retinal vascular calibers and biomarkers of oxidative stress and inflammation, in subjects free of cardiovascular pathology. Patients and Methods: Cross-sectional analysis from a community-dwelling cohort comprising 1224 individuals aged 60 years and over, without a history of coronary or peripheral artery disease or stroke. Retinal vascular caliber was measured from fundus photographs using semi-automated standardized imaging software. Oxidative stress was evaluated using plasma superoxide dismutase 2 and glutathione peroxidase (GPx-3) activities, and inflammatory state was assessed using plasma high sensitivity C-reactive protein (hsCRP) and orosomucoid. Results: In a multivariate model controlling for cardiovascular risk factors, larger retinal arteriolar caliber was independently related to higher level of GPx-3 activity (p = 0.003) whereas larger venular caliber was associated with higher levels of hsCRP (p = 0.0001) and orosomucoid (p = 0.01). Conclusion: In the present study, biomarkers of oxidative stress regulation and inflammation were independently associated with retinal vascular calibers. This suggests that an assessment of retinal vessels may offer early and non-invasive detection of subclinical vascular pathology.	[Daien, Vincent; Carriere, Isabelle; Ritchie, Karen] INSERM, U1061, Montpellier, France; [Daien, Vincent; Carriere, Isabelle; Ritchie, Karen] Univ Montpellier I, U1061, Montpellier, France; [Daien, Vincent; Villain, Max] Gui Chauliac Hosp, Dept Ophthalmol, Montpellier, France; [Kawasaki, Ryo] Yamagata Univ, Fac Med, Dept Publ Hlth, Yamagata 990, Japan; [Cristol, Jean-Paul] Lapeyronie Hosp, Dept Biochem, Montpellier, France; [Fesler, Pierre] Hop Lapeyronie, Dept Internal Med, Montpellier, France; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, London, England; [Delcourt, Cecile] INSERM, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Delcourt, Cecile] Univ Bordeaux, ISPED, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Yamagata University; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Delcourt, C (corresponding author), INSERM, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France.	cecile.delcourt@isped.u-bordeaux2.fr	Kawasaki, Ryo/H-9716-2019; DAIEN, Vincent/Z-5516-2019; Carrière, Isabelle/W-8728-2019; Delcourt, Cecile/I-2627-2013; Ritchie, Karen/G-3571-2013; Fesler, Pierre/O-7620-2018; Kawasaki, Ryo/B-7266-2009	DAIEN, Vincent/0000-0001-5675-0861; Delcourt, Cecile/0000-0002-2099-0481; Ritchie, Karen/0000-0002-0688-8982; Fesler, Pierre/0000-0002-7831-6545; Kawasaki, Ryo/0000-0002-7492-6303; Carriere, Isabelle/0000-0002-3617-0752	Institut National de la Sante et de la Recherche Medicale, Paris, France; Fondation de France, Department of Epidemiology of Ageing, Paris; Fondation pour la Recherche Medicale, Paris; Region Languedoc-Roussillon, Montpellier, France; Association Retina-France, Toulouse; Rhones Poulenc; Essilor; Specia; Horiba ABX Montpellier; Centre de Recherche et d'Information Nutritionnelle, Paris	Institut National de la Sante et de la Recherche Medicale, Paris, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation de France, Department of Epidemiology of Ageing, Paris; Fondation pour la Recherche Medicale, Paris(Fondation pour la Recherche Medicale); Region Languedoc-Roussillon, Montpellier, France(Region Occitanie); Association Retina-France, Toulouse; Rhones Poulenc; Essilor; Specia; Horiba ABX Montpellier; Centre de Recherche et d'Information Nutritionnelle, Paris	This study was supported by the Institut National de la Sante et de la Recherche Medicale, Paris, France; by grants from the Fondation de France, Department of Epidemiology of Ageing, Paris, the Fondation pour la Recherche Medicale, Paris, the Region Languedoc-Roussillon, Montpellier, France, and the Association Retina-France, Toulouse; and by financial support from Rhones Poulenc, Essilor, Specia and Horiba ABX Montpellier, and the Centre de Recherche et d'Information Nutritionnelle, Paris. These sponsors funded the preparation of the POLA study and the data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buijsse B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038901; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Daien V, 2013, ACTA OPHTHALMOL, V91, pE283, DOI 10.1111/aos.12094; de Jong FJ, 2007, ANN NEUROL, V61, P491, DOI 10.1002/ana.21129; Delcourt C, 1999, OPHTHALMOLOGY, V106, P215, DOI 10.1016/S0161-6420(99)90059-3; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Delcourt C, 2003, OPHTHALMOLOGY, V110, P2318, DOI 10.1016/S0161-6420(03)00713-9; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dogru-Abbasoglu S, 1999, CLIN BIOCHEM, V32, P671, DOI 10.1016/S0009-9120(99)00076-4; Dupuy AM, 2003, CLIN CHEM LAB MED, V41, P948, DOI 10.1515/CCLM.2003.144; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Freedman JE, 1996, J CLIN INVEST, V97, P979, DOI 10.1172/JCI118522; Fuiano G, 2001, KIDNEY INT, V59, P1052; Granger DN, 2010, MICROCIRCULATION, V17, P192, DOI 10.1111/j.1549-8719.2009.00015.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Jin RC, 2011, CIRCULATION, V123, P1963, DOI 10.1161/CIRCULATIONAHA.110.000034; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; Kifley A, 2007, AM J EPIDEMIOL, V166, P1288, DOI 10.1093/aje/kwm255; Klein R, 2006, ARCH OPHTHALMOL-CHIC, V124, P87, DOI 10.1001/archopht.124.1.87; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Leung H, 2003, CLIN EXP OPHTHALMOL, V31, P326, DOI 10.1046/j.1442-9071.2003.00661.x; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liew G, 2008, HYPERTENSION, V51, P933, DOI 10.1161/HYPERTENSIONAHA.107.101584; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Mitchell P, 2008, CIRCULATION, V118, P518, DOI 10.1161/CIRCULATIONAHA.107.747329; Muzakova V, 2000, PHYSIOL RES, V49, P315; NEWMAN TB, 1991, EPIDEMIOLOGY, V2, P383, DOI 10.1097/00001648-199109000-00014; PORTER M, 1992, CLIN SCI, V83, P343, DOI 10.1042/cs0830343; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; PRESSAC M, 1986, CLIN CHEM, V32, P1386; Rosenberg ML, 2005, CLIN EXP OPHTHALMOL, V33, P107, DOI 10.1111/j.1442-9071.2004.00968.x; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Sun C, 2009, HYPERTENSION, V54, P788, DOI 10.1161/HYPERTENSIONAHA.109.132902; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Voetsch B, 2007, STROKE, V38, P41, DOI 10.1161/01.STR.0000252027.53766.2b; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Williamson TH, 1997, BRIT J OPHTHALMOL, V81, P698, DOI 10.1136/bjo.81.8.698; Wimpissinger B, 2005, GRAEF ARCH CLIN EXP, V243, P646, DOI 10.1007/s00417-004-1083-8; Wolin MS, 2011, CIRCULATION, V123, P1923, DOI 10.1161/CIRCULATIONAHA.111.028688; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; World Health Organization, 2021, TOP 10 CAUS DEATH; Xing C, 2006, HYPERTENSION, V47, P797, DOI 10.1161/01.HYP.0000208330.68355.72; Zhao RZ, 2005, ATHEROSCLEROSIS, V179, P277, DOI 10.1016/j.atherosclerosis.2004.11.013	56	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e71089	10.1371/journal.pone.0071089	http://dx.doi.org/10.1371/journal.pone.0071089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923054	Green Published, gold			2022-12-27	WOS:000322838900189
J	Wicklein, D; Schmidt, A; Labitzky, V; Ullrich, S; Valent, P; Schumacher, U				Wicklein, Daniel; Schmidt, Anna; Labitzky, Vera; Ullrich, Sebastian; Valent, Peter; Schumacher, Udo			E- and P-Selectins Are Essential for Repopulation of Chronic Myelogenous and Chronic Eosinophilic Leukemias in a Scid Mouse Xenograft Model	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM; CARBOHYDRATE LIGAND; TYROSINE KINASE; IMATINIB; CELLS; ADHESION; ABL; FEATURES; FUSION	In chronic myelogenous (CML) and chronic eosinophilic leukemia (CEL), neoplastic cells spread via the circulation into various extramedullary organs. As E-and P-selectin constitute the starting point for the leucocyte adhesion/invasion cascade, and CEL and CML cells share many properties with normal granulocytes, we investigated the role of these selectins in CEL and CML cell expansion and organ invasion in a xenotransplantation model using scid mice. Using two human leukemic cell lines (EOL-1 and K562), we were able to show that E-and P-selectins mediate leukemia cell tethering and adherence in a laminar flow assay. While E-selectin binding depended on sialylated carbohydrate moieties, P-selectin binding was completely (K562) or partially (EOL-1) independent of these carbohydrates indicating the involvement of non-canonical selectin ligands. In a xenograft model in scid mice, both cell lines invaded the bone marrow and other organs, formed chloromas, and ultimately produced an overt leukemia. In contrast, in E-and P-selectin knockout scid mice, the cells failed to show engraftment in 8 out of 10 animals and even if they did engraft, they produced only little organ invasion and chloroma formation. Together, these data suggest that E- and P-selectins play an important role in leukemic dissemination in CML and CEL.	[Wicklein, Daniel; Schmidt, Anna; Labitzky, Vera; Ullrich, Sebastian; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany; [Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwig Boltzmann Institute; Medical University of Vienna	Wicklein, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany.	d.wicklein@uke.de	Test, PV/U-9451-2019; Test, Test/Y-7921-2019; Valent, Peter/B-8533-2016; Gamperl, Susi/V-2715-2019	Valent, Peter/0000-0003-0456-5095; Gamperl, Susi/0000-0003-0456-5095	Mildred Scheel Stiftung	Mildred Scheel Stiftung(Deutsche Krebshilfe)	The financial help of the Mildred Scheel Stiftung in providing the animal core facility is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Crews LA, 2012, CURR HEMATOL MALIG R, V7, P125, DOI 10.1007/s11899-012-0121-6; Druker BJ, 2002, CANCER CELL, V1, P31, DOI 10.1016/S1535-6108(02)00025-9; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Gebauer F, 2012, GUT; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Gotlib J, 2006, BEST PRACT RES CL HA, V19, P535, DOI 10.1016/j.beha.2005.07.013; Haferlach T, 2008, ANN HEMATOL, V87, P1, DOI 10.1007/s00277-007-0403-6; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Ishihara K, 2008, BIOCHEM BIOPH RES CO, V366, P1007, DOI 10.1016/j.bbrc.2007.12.063; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohler S, 2009, BRIT J CANCER, V102, P602; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Kummitha CM, 2012, J IMMUNOL METHODS, V384, P43, DOI 10.1016/j.jim.2012.07.003; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liesveld J, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00086; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Metzgeroth G, 2008, BRIT J HAEMATOL, V143, P707, DOI 10.1111/j.1365-2141.2008.07294.x; Nehmann N, 2010, ACTA HISTOCHEM, V112, P489, DOI 10.1016/j.acthis.2009.05.004; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Richter U, 2011, HISTOCHEM CELL BIOL, V135, P499, DOI 10.1007/s00418-011-0804-4; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Stubke K, 2012, CANCER LETT, V321, P89, DOI 10.1016/j.canlet.2012.02.019; Thies A, 2007, BRIT J CANCER, V96, P609, DOI 10.1038/sj.bjc.6603594; Valent P, 2011, CURR CANCER DRUG TAR, V11, P56, DOI 10.2174/156800911793743655; Valent P, 2008, BRIT J HAEMATOL, V142, P361, DOI 10.1111/j.1365-2141.2008.07197.x; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Valent P, 2009, BLOOD REV, V23, P157, DOI 10.1016/j.blre.2009.01.001; Vandenberghe P, 2004, LEUKEMIA, V18, P734, DOI 10.1038/sj.leu.2403313; Varki A, 1997, J CLIN INVEST, V99, P158, DOI 10.1172/JCI119142; Wicklein D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030567; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	47	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70139	10.1371/journal.pone.0070139	http://dx.doi.org/10.1371/journal.pone.0070139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922938	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900154
J	Jiang, H; Wang, LY; Beier, KT; Cepko, CL; Fekete, DM; Brigande, JV				Jiang, Han; Wang, Lingyan; Beier, Kevin T.; Cepko, Constance L.; Fekete, Donna M.; Brigande, John V.			Lineage Analysis of the Late Otocyst Stage Mouse Inner Ear by Transuterine Microinjection of A Retroviral Vector Encoding Alkaline Phosphatase and an Oligonucleotide Library	PLOS ONE			English	Article							HAIR-CELLS; GENE-TRANSFER; STEM-CELLS; INTEGRATION; HEARING; NEURONS; MORPHOGENESIS; PROGENITOR; BIOLOGY; CLONING	The mammalian inner ear subserves the special senses of hearing and balance. The auditory and vestibular sensory epithelia consist of mechanically sensitive hair cells and associated supporting cells. Hearing loss and balance dysfunction are most frequently caused by compromise of hair cells and/or their innervating neurons. The development of gene- and cell-based therapeutics will benefit from a thorough understanding of the molecular basis of patterning and cell fate specification in the mammalian inner ear. This includes analyses of cell lineages and cell dispersals across anatomical boundaries (such as sensory versus nonsensory territories). The goal of this study was to conduct retroviral lineage analysis of the embryonic day 11.5(E11.5) mouse otic vesicle. A replication-defective retrovirus encoding human placental alkaline phosphatase (PLAP) and a variable 24-bp oligonucleotide tag was microinjected into the E11.5 mouse otocyst. PLAP-positive cells were microdissected from cryostat sections of the postnatal inner ear and subjected to nested PCR. PLAP-positive cells sharing the same sequence tag were assumed to have arisen from a common progenitor and are clonally related. Thirty five multicellular clones consisting of an average of 3.4 cells per clone were identified in the auditory and vestibular sensory epithelia, ganglia, spiral limbus, and stria vascularis. Vestibular hair cells in the posterior crista were related to one another, their supporting cells, and nonsensory epithelial cells lining the ampulla. In the organ of Corti, outer hair cells were related to a supporting cell type and were tightly clustered. By contrast, spiral ganglion neurons, interdental cells, and Claudius' cells were related to cells of the same type and could be dispersed over hundreds of microns. These data contribute new information about the developmental potential of mammalian otic precursors in vivo.	[Jiang, Han; Wang, Lingyan; Brigande, John V.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Jiang, Han] Jilin Univ, Jilin Prov Key Lab Anim Embryo Engn, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China; [Beier, Kevin T.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Oregon Health & Science University; Jilin University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Brigande, JV (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	brigande@ohsu.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246; Beier, Kevin/0000-0002-4934-1338	National Institutes of Health (NIH) [2R01DC008595, ARRA 03S2]; Oregon Hearing Research Center NIH [DC 005983]; NIH [5R01DC002756, F31NS068012]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH093026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS068012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002756, R21DC007159, P30DC005983, R01DC008595] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Hearing Research Center NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by: National Institutes of Health (NIH) 2R01DC008595 and ARRA 03S2 (JVB); the Oregon Hearing Research Center NIH P30 Core Grant DC 005983; NIH 5R01DC002756 (DMF); the Howard Hughes Medical Institute (CLC); and NIH F31NS068012 (KTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigande John V., 2009, V493, P125, DOI 10.1007/978-1-59745-523-7_8; Brigande JV, 2000, P NATL ACAD SCI USA, V97, P11700, DOI 10.1073/pnas.97.22.11700; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Cepko C, 2001, CURR PROTOC MOL BIOL, V36; Cepko CL, 1998, METHODS, V14, P393, DOI 10.1006/meth.1998.0594; Chen P, 1999, DEVELOPMENT, V126, P1581; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DAVIS HAL LOWELL, 1962, JOUR ACOUSTICAL SOC AMER, V34, P1377, DOI 10.1121/1.1918353; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; GATES WM. H., 1932, SCIENCE, V76, P349, DOI 10.1126/science.76.1972.349; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; GOLDEN JA, 1995, P NATL ACAD SCI USA, V92, P5704, DOI 10.1073/pnas.92.12.5704; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Lang HN, 2001, DEV BIOL, V234, P120, DOI 10.1006/dbio.2001.0248; McCall AA, 2010, EAR HEARING, V31, P156, DOI 10.1097/AUD.0b013e3181c351f2; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; Monzack EL, 2013, HEARING RES, DOI [10.1016/j.heares.2013.1001.1008, DOI 10.1016/J.HEARES.2013.1001.1008]; Morsli H, 1998, J NEUROSCI, V18, P3327; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Okano T, 2012, TRENDS AMPLIF, V16, P4, DOI 10.1177/1084713812440336; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Phoon CKL, 2006, PEDIATR RES, V60, P14, DOI 10.1203/01.pdr.0000219441.28206.79; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Ronaghi M, 2012, STEM CELLS, V30, P69, DOI 10.1002/stem.785; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUBEN RJ, 1969, LARYNGOSCOPE, V79, P1546, DOI 10.1288/00005537-196909000-00002; Sacheli R, 2013, GENE THER, V20, P237, DOI 10.1038/gt.2012.51; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Satoh Takunori, 2009, V493, P47, DOI 10.1007/978-1-59745-523-7_4; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tubbs JT, 2011, J AM ASSOC LAB ANIM, V50, P185; Van De Water TR, 2012, ANAT REC, V295, P1741, DOI 10.1002/ar.22598; Wang L, 2012, J VIS EXP; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69314	10.1371/journal.pone.0069314	http://dx.doi.org/10.1371/journal.pone.0069314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935981	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300031
J	Byrne, AJ; Jones, CP; Gowers, K; Rankin, SM; Lloyd, CM				Byrne, Adam J.; Jones, Carla P.; Gowers, Kate; Rankin, Sara M.; Lloyd, Clare M.			Lung Macrophages Contribute to House Dust Mite Driven Airway Remodeling via HIF-1 alpha	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; PROGENITOR CELLS; ASTHMATIC-PATIENTS; BRONCHIAL-ASTHMA; INDUCED SPUTUM; ANGIOGENESIS; INFLAMMATION; INHIBITION; ACTIVATION	HIF-1 alpha is a transcription factor that is activated during hypoxia and inflammation and is a key regulator of angiogenesis in vivo. During the development of asthma, peribronchial angiogenesis is induced in response to aeroallergens and is thought to be an important feature of sustained chronic allergic inflammation. Recently, elevated HIF-1 alpha levels have been demonstrated in both the lung tissue and bronchoalveolar lavage of allergic patients, respectively. Therefore, we investigated the role of HIF-1 alpha on the development of angiogenesis and inflammation following acute and chronic allergen exposure. Our data shows that intranasal exposure to house dust mite (HDM) increases the expression of HIF-1 alpha in the lung, whilst reducing the expression of the HIF-1 alpha negative regulators, PHD1 and PHD3. Blockade of HIF-1 alpha in vivo, significantly decreased allergic inflammation and eosinophilia induced by allergen, due to a reduction in the levels of IL-5 and Eotaxin-2. Importantly, HIF-1 alpha blockade significantly decreased levels of VEGF-A and CXCL1 in the lungs, which in turn led to a profound decrease in the recruitment of endothelial progenitor cells and a reduction of peribronchial angiogenesis. Furthermore, HDM or IL-4 treatment of primary lung macrophages resulted in significant production of both VEGF-A and CXCL1; inhibition of HIF-1 alpha activity abrogated the production of these factors via an up-regulation of PHD1 and PHD3. These findings suggest that novel strategies to reduce the expression and activation of HIF-1 alpha in lung macrophages may be used to attenuate allergen-induced airway inflammation and angiogenesis through the modulation of VEGF-A and CXCL1 expression. Clinical Relevance: This study provides new insights into the role of HIF-1 alpha in the development of peribronchial angiogenesis and inflammation in a murine model of allergic airway disease. These findings indicate that strategies to reduce activation of macrophage derived HIF-1 alpha may be used as a target to improve asthma pathology.	[Byrne, Adam J.; Jones, Carla P.; Gowers, Kate; Rankin, Sara M.; Lloyd, Clare M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London, England; [Byrne, Adam J.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London, England	Imperial College London; University of Oxford	Byrne, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London, England.	c.lloyd@imperial.ac.uk	Byrne, Adam/J-3955-2015; Byrne, Adam/Q-4835-2019	Byrne, Adam/0000-0003-2736-8174; Byrne, Adam/0000-0003-2736-8174; Byrne, Adam/0000-0001-8352-3007; Lloyd, Clare/0000-0001-8977-6726; Jones, Carla P/0000-0002-4329-3267	Welcome Trust [057704, 085851/Z/08/Z]	Welcome Trust(Wellcome Trust)	This work was supported by the Welcome Trust (grants 057704 and 085851/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hafez A, 2009, FASEB J, V23, P1655, DOI 10.1096/fj.08-114611; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Bae YJ, 2009, ANN ALLERG ASTHMA IM, V103, P51, DOI 10.1016/S1081-1206(10)60143-3; Baraldo S, EUR RESP J, V38, P575; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Detoraki A, 2010, ALLERGY, V65, P946, DOI 10.1111/j.1398-9995.2010.02372.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Gregory LG, 2010, AM J RESP CRIT CARE, V182, P143, DOI 10.1164/rccm.200905-0725OC; Guo J, 2009, INT ARCH ALLERGY IMM, V149, P98, DOI 10.1159/000189191; Hackett TL, 2007, CURR OPIN ALLERGY CL, V7, P63, DOI 10.1097/ACI.0b013e328013d61b; Hoenig MR, 2008, CURR DRUG TARGETS, V9, P422, DOI 10.2174/138945008784221215; Holgate ST, 2011, EUR J CLIN INVEST, V41, P1339, DOI 10.1111/j.1365-2362.2011.02534.x; Hossny E, 2009, PEDIAT ALLERG IMM-UK, V20, P89, DOI 10.1111/j.1399-3038.2008.00730.x; Huerta-Yepez S, 2008, CLIN IMMUNOL, V129, P313, DOI 10.1016/j.clim.2008.07.023; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jiang M, 2008, INT J BIOCHEM CELL B, V40, P2284, DOI 10.1016/j.biocel.2008.03.012; Jiang M, 2008, J CELL BIOCHEM, V103, P321, DOI 10.1002/jcb.21416; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Jones CP, 2011, CHEST, V140, P205, DOI 10.1378/chest.10-2348; Jones CP, 2009, STEM CELLS, V27, P3074, DOI 10.1002/stem.222; Kanazawa H, 2007, RECENT PATENTS INFLA, V1, P1, DOI 10.2174/187221307779815066; Kim SR, 2010, EUR J IMMUNOL, V40, P2858, DOI 10.1002/eji.200939948; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Lee SY, 2006, ANN ALLERG ASTHMA IM, V97, P794, DOI 10.1016/S1081-1206(10)60971-4; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Paredi P, 2009, THORAX, V64, P444, DOI 10.1136/thx.2008.100032; Sharma S, 2009, EUR RESPIR J, V33, P1287, DOI 10.1183/09031936.00113008; Siddiqui S, 2007, J ALLERGY CLIN IMMUN, V120, P813, DOI 10.1016/j.jaci.2007.05.028; Song C, 2012, SCAND J IMMUNOL, V75, P599, DOI 10.1111/j.1365-3083.2012.02693.x; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Walmsley SR, 2011, J CLIN INVEST, V121, P1053, DOI 10.1172/JCI43273	39	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69246	10.1371/journal.pone.0069246	http://dx.doi.org/10.1371/journal.pone.0069246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935964	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000093
J	Moreno-Lopez, Y; Perez-Sanchez, J; Martinez-Lorenzana, G; Condes-Lara, M; Rojas-Piloni, G				Moreno-Lopez, Yunuen; Perez-Sanchez, Jimena; Martinez-Lorenzana, Guadalupe; Condes-Lara, Miguel; Rojas-Piloni, Gerardo			Cortical Presynaptic Control of Dorsal Horn C-Afferents in the Rat	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; SPINAL-CORD; NEUROPATHIC PAIN; POSTTETANIC POTENTIATION; A-FIBER; ELECTRICAL-STIMULATION; SENSORIMOTOR CORTEX; INHIBITORY-ACTION; MUSCLE AFFERENTS; PYRAMIDAL TRACT	Lamina 5 sensorimotor cortex pyramidal neurons project to the spinal cord, participating in the modulation of several modalities of information transmission. A well-studied mechanism by which the corticospinal projection modulates sensory information is primary afferent depolarization, which has been characterized in fast muscular and cutaneous, but not in slow-conducting nociceptive skin afferents. Here we investigated whether the inhibition of nociceptive sensory information, produced by activation of the sensorimotor cortex, involves a direct presynaptic modulation of C primary afferents. In anaesthetized male Wistar rats, we analyzed the effects of sensorimotor cortex activation on post tetanic potentiation (PTP) and the paired pulse ratio (PPR) of dorsal horn field potentials evoked by C-fiber stimulation in the sural (SU) and sciatic (SC) nerves. We also explored the time course of the excitability changes in nociceptive afferents produced by cortical stimulation. We observed that the development of PTP was completely blocked when C-fiber tetanic stimulation was paired with cortex stimulation. In addition, sensorimotor cortex activation by topical administration of bicuculline (BIC) produced a reduction in the amplitude of C-fiber responses, as well as an increase in the PPR. Furthermore, increases in the intraspinal excitability of slow-conducting fiber terminals, produced by sensorimotor cortex stimulation, were indicative of primary afferent depolarization. Topical administration of BIC in the spinal cord blocked the inhibition of C-fiber neuronal responses produced by cortical stimulation. Dorsal horn neurons responding to sensorimotor cortex stimulation also exhibited a peripheral receptive field and responded to stimulation of fast cutaneous myelinated fibers. Our results suggest that corticospinal inhibition of nociceptive responses is due in part to a modulation of the excitability of primary C-fibers by means of GABAergic inhibitory interneurons.	[Moreno-Lopez, Yunuen; Perez-Sanchez, Jimena; Martinez-Lorenzana, Guadalupe; Condes-Lara, Miguel; Rojas-Piloni, Gerardo] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Rojas-Piloni, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus UNAM Juriquilla, Queretaro, Mexico.	piloni@unam.mx	, Miguel/A-4374-2015	Condes-Lara, Miguel/0000-0003-1651-8931; Moreno Lopez, Yunuen Leticia/0000-0002-4023-849X; Perez-Sanchez, Jimena/0000-0002-4967-5418	CONACYT [176782, 164536, 233849, 245641]; PAPIIT [IN202610]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	Work was supported by CONACYT 176782 (GRP) and 164536 (MCL), PAPIIT IN202610 (GRP). YML and JPS received a scholarship from CONACyT (233849 and 245641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMOUMENE M, 1970, BRAIN RES, V20, P327, DOI 10.1016/0006-8993(70)90301-X; Aggelopoulos NC, 2008, EXP BRAIN RES, V187, P61, DOI 10.1007/s00221-008-1279-y; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P63, DOI 10.1152/jn.1964.27.1.63; ANDERSEN P, 1962, NATURE, V194, P740, DOI 10.1038/194740a0; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; Bardoni R, 2013, ANN NY ACAD SCI, V1279, P90, DOI 10.1111/nyas.12056; Brown JA, 2003, PAIN, V104, P431, DOI 10.1016/S0304-3959(03)00209-4; BULLOCK TH, 1988, BRAIN RES REV, V13, P57, DOI 10.1016/0165-0173(88)90005-7; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; CALVILLO O, 1982, NEUROSCIENCE, V7, P1389, DOI 10.1016/0306-4522(82)90252-4; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; COULTER JD, 1974, BRAIN RES, V65, P351, DOI 10.1016/0006-8993(74)90049-3; Daniele CA, 2009, J NEUROSCI, V29, P686, DOI 10.1523/JNEUROSCI.5120-08.2009; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Draganic P, 2001, NEUROSCI LETT, V301, P127, DOI 10.1016/S0304-3940(01)01622-6; ECCLES JC, 1959, J PHYSIOL-LONDON, V149, P274, DOI 10.1113/jphysiol.1959.sp006339; Eguibar JR, 1997, EXP BRAIN RES, V113, P411, DOI 10.1007/PL00005595; EGUIBAR JR, 1994, BRAIN RES, V643, P328, DOI 10.1016/0006-8993(94)90042-6; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; FITZGERALD M, 1981, J PHYSIOL-LONDON, V318, P25; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; HENTALL ID, 1979, J NEUROPHYSIOL, V42, P1527, DOI 10.1152/jn.1979.42.6.1527; Hochman S, 2010, ANN NY ACAD SCI, V1198, P140, DOI 10.1111/j.1749-6632.2010.05436.x; HONGO T, 1967, EXP BRAIN RES, V3, P117; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P729, DOI 10.1113/jphysiol.1987.sp016680; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; JANKOWSKA E, 1976, J PHYSIOL-LONDON, V258, P467, DOI 10.1113/jphysiol.1976.sp011431; Katayama Y, 1998, J NEUROSURG, V89, P585, DOI 10.3171/jns.1998.89.4.0585; Le Pera D, 2007, EUR J NEUROSCI, V25, P1900, DOI 10.1111/j.1460-9568.2007.05389.x; Lefaucheur JP, 2001, NEUROPHYSIOL CLIN, V31, P247, DOI 10.1016/S0987-7053(01)00260-X; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; LI CL, 1976, EXP NEUROL, V50, P67, DOI 10.1016/0014-4886(76)90236-3; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; LUNDBERG A, 1962, ACTA PHYSIOL SCAND, V56, P201, DOI 10.1111/j.1748-1716.1962.tb02497.x; Maier MA, 1998, J PHYSIOL-LONDON, V511, P191, DOI 10.1111/j.1469-7793.1998.191bi.x; Mertens P, 1999, STEREOT FUNCT NEUROS, V73, P122, DOI 10.1159/000029769; MEYERSON BA, 1993, ACTA NEUROCHIR, P150; Nguyen JP, 1997, ADV STER F, V12, P54; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nuti C, 2005, PAIN, V118, P43, DOI 10.1016/j.pain.2005.07.020; Osenbach Richard K, 2006, Neurosurg Focus, V21, pE7; Porter R, 1993, CORTICOSPINAL FUNCTI; Quevedo J, 1997, EXP BRAIN RES, V115, P387, DOI 10.1007/PL00005709; Rojas-Piloni G, 2010, BRAIN RES, V1351, P104, DOI 10.1016/j.brainres.2010.06.010; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUDOMIN P, 1987, J NEUROPHYSIOL, V57, P1288, DOI 10.1152/jn.1987.57.5.1288; RUDOMIN P, 1986, J NEUROPHYSIOL, V56, P987, DOI 10.1152/jn.1986.56.4.987; SCHOUENBORG J, 1984, J PHYSIOL-LONDON, V356, P169, DOI 10.1113/jphysiol.1984.sp015459; Senapati AK, 2005, BRAIN RES, V1057, P134, DOI 10.1016/j.brainres.2005.07.044; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; SOLODKIN M, 1984, SCIENCE, V224, P1453, DOI 10.1126/science.6328657; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; Wall PD, 1997, J NEUROPHYSIOL, V78, P860, DOI 10.1152/jn.1997.78.2.860; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011; YEZIERSKI RP, 1983, J NEUROPHYSIOL, V49, P424, DOI 10.1152/jn.1983.49.2.424; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	61	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69063	10.1371/journal.pone.0069063	http://dx.doi.org/10.1371/journal.pone.0069063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935924	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200021
J	Abbott, JK; Innocenti, P; Chippindale, AK; Morrow, EH				Abbott, Jessica K.; Innocenti, Paolo; Chippindale, Adam K.; Morrow, Edward H.			Epigenetics and Sex-Specific Fitness: An Experimental Test Using Male-Limited Evolution in Drosophila melanogaster	PLOS ONE			English	Article							ANTAGONISTIC GENETIC-VARIATION; POSITION-EFFECT VARIEGATION; PARENT-OFFSPRING CONFLICT; Y-CHROMOSOME; LIFE-HISTORY; RATIO BIAS; EXPRESSION; CONSEQUENCES; SELECTION; POPULATION	When males and females have different fitness optima for the same trait but share loci, intralocus sexual conflict is likely to occur. Epigenetic mechanisms such as genomic imprinting (in which expression is altered according to parent-of-origin) and sex-specific maternal effects have been suggested as ways by which this conflict can be resolved. However these ideas have not yet been empirically tested. We designed an experimental evolution protocol in Drosophila melanogaster that enabled us to look for epigenetic effects on the X-chromosome-a hotspot for sexually antagonistic loci. We used special compound-X females to enforce father-to-son transmission of the X-chromosome for many generations, and compared fitness and gene expression levels between Control males, males with a Control X-chromosome that had undergone one generation of father-son transmission, and males with an X-chromosome that had undergone many generations of father-son transmission. Fitness differences were dramatic, with experimentally-evolved males approximately 20% greater than controls, and with males inheriting a non-evolved X from their father about 20% lower than controls. These data are consistent with both strong intralocus sexual conflict and misimprinting of the X-chromosome under paternal inheritance. However, expression differences suggested that reduced fitness under paternal X inheritance was largely due to deleterious maternal effects. Our data confirm the sexually-antagonistic nature of Drosophila's X-chromosome and suggest that the response to male-limited X-chromosome evolution entails compensatory evolution for maternal effects, and perhaps modification of other epigenetic effects via coevolution of the sex chromosomes.	[Abbott, Jessica K.] Lund Univ, Sect Evolutionary Ecol, Dept Biol, Lund, Sweden; [Innocenti, Paolo] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Chippindale, Adam K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Morrow, Edward H.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Lund University; Uppsala University; Queens University - Canada; University of Sussex	Abbott, JK (corresponding author), Lund Univ, Sect Evolutionary Ecol, Dept Biol, Lund, Sweden.	jessica.abbott@biol.lu.se	Morrow, Edward H/Q-6730-2019; Abbott, Jessica K/F-5848-2010	Morrow, Edward H/0000-0002-1853-7469; Abbott, Jessica K/0000-0002-8743-2089; Innocenti, Paolo/0000-0003-2082-0586	Swedish Research Council; Natural Sciences and Engineering Research Council; Carl Tryggers Foundation; Volkswagen Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Carl Tryggers Foundation; Volkswagen Foundation(Volkswagen)	Financial support was provided by the Swedish Research Council (to JKA and EHM), Natural Sciences and Engineering Research Council (to AKC), the Carl Tryggers Foundation (to JKA), and the Volkswagen Foundation (to JKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2010, J EVOLUTION BIOL, V23, P1989, DOI 10.1111/j.1420-9101.2010.02064.x; Abbott JK, 2011, TRENDS ECOL EVOL, V26, P359, DOI 10.1016/j.tree.2011.03.011; Abbott JK, 2011, P ROY SOC B-BIOL SCI, V278, P161, DOI 10.1098/rspb.2010.1401; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Bachtrog D, 2010, CURR BIOL, V20, P1476, DOI 10.1016/j.cub.2010.06.076; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Connallon T, 2005, TRENDS GENET, V21, P495, DOI 10.1016/j.tig.2005.07.006; Connallon T, 2009, EVOLUTION, V63, P2179, DOI 10.1111/j.1558-5646.2009.00692.x; COWLEY DE, 1992, EVOLUTION, V46, P495, DOI [10.2307/2409867, 10.1111/j.1558-5646.1992.tb02054.x]; Cox RM, 2010, SCIENCE, V328, P92, DOI 10.1126/science.1185550; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Friberg U, 2012, BIOL LETTERS, V8, P71, DOI 10.1098/rsbl.2011.0608; Friberg U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023508; Fuller BA, 2007, J EVOLUTION BIOL, V20, P1700, DOI 10.1111/j.1420-9101.2007.01400.x; Gallach M, 2011, TRENDS ECOL EVOL, V26, P222, DOI 10.1016/j.tree.2011.02.004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Golic KG, 1998, CURR BIOL, V8, P1273, DOI 10.1016/S0960-9822(07)00537-4; Haig D, 2010, P NATL ACAD SCI USA, V107, P1731, DOI 10.1073/pnas.0904111106; HALL JG, 1990, AM J HUM GENET, V46, P857; HEARN MG, 1991, GENETICS, V128, P785; Hore TA, 2007, TRENDS GENET, V23, P440, DOI 10.1016/j.tig.2007.07.003; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Iwasa Y, 2001, GENETICS, V158, P1801; Jiang PP, 2010, GENETICS, V186, P109, DOI 10.1534/genetics.110.118109; Katsuki M, 2012, ECOL LETT, V15, P193, DOI 10.1111/j.1461-0248.2011.01725.x; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lloyd V, 2000, GENETICA, V109, P35, DOI 10.1023/A:1026592318341; Lloyd VK, 1999, GENETICS, V151, P1503; Long TAF, 2007, P ROY SOC B-BIOL SCI, V274, P3105, DOI 10.1098/rspb.2007.1140; Maggert KA, 2002, GENETICS, V162, P1245; Menon DU, 2009, GENETICS, V183, P811, DOI 10.1534/genetics.109.107219; Mills SC, 2012, P ROY SOC B-BIOL SCI, V279, P1889, DOI 10.1098/rspb.2011.2340; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; Rice WR, 2002, GENETICA, V116, P179, DOI 10.1023/A:1021205130926; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Roulin A, 2010, ECOL LETT, V13, P616, DOI 10.1111/j.1461-0248.2010.01459.x; Stewart AD, 2010, J HERED, V101, pS94, DOI 10.1093/jhered/esq011; Svensson EI, 2009, EVOLUTION, V63, P3124, DOI 10.1111/j.1558-5646.2009.00782.x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Van Cleve J, 2007, GENETICS, V176, P1101, DOI 10.1534/genetics.107.071555; van Doorn GS, 2009, ANN NY ACAD SCI, V1168, P52, DOI 10.1111/j.1749-6632.2009.04573.x; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Zhou J, 2012, P NATL ACAD SCI USA, V109, P9941, DOI 10.1073/pnas.1207367109	53	7	7	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70493	10.1371/journal.pone.0070493	http://dx.doi.org/10.1371/journal.pone.0070493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922998	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700188
J	Andria, B; Bracco, A; Attanasio, C; Castaldo, S; Cerrito, MG; Cozzolino, S; Di Napoli, D; Giovannoni, R; Mancini, A; Musumeci, A; Mezza, E; Nasti, M; Scuderi, V; Staibano, S; Lavitrano, M; Otterbein, LE; Calise, F				Andria, Barbara; Bracco, Adele; Attanasio, Chiara; Castaldo, Sigismondo; Cerrito, Maria Grazia; Cozzolino, Santolo; Di Napoli, Daniele; Giovannoni, Roberto; Mancini, Antonio; Musumeci, Antonino; Mezza, Ernesto; Nasti, Mario; Scuderi, Vincenzo; Staibano, Stefania; Lavitrano, Marialuisa; Otterbein, Leo E.; Calise, Fulvio			Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine	PLOS ONE			English	Article							CARBON-MONOXIDE PROTECTS; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION INJURY; NITRIC-OXIDE; CAROTID ATHEROSCLEROSIS; SERUM BILIRUBIN; TRANSPLANTATION; REDUCTASE; KIDNEY; DONOR	Ischemia reperfusion injury (IRI) in organ transplantation remains a serious and unsolved problem. Organs that undergo significant damage during IRI, function less well immediately after reperfusion and tend to have more problems at later times when rejection can occur. Biliverdin has emerged as an agent that potently suppress IRI in rodent models. Since the use of biliverdin is being developed as a potential therapeutic modality for humans, we tested the efficacy for its effects on IRI of the liver in swine, an accepted and relevant pre-clinical animal model. Administration of biliverdin resulted in rapid appearance of bilirubin in the serum and significantly suppressed IRI-induced liver dysfunction as measured by multiple parameters including urea and ammonia clearance, neutrophil infiltration and tissue histopathology including hepatocyte cell death. Taken together, our findings, in a large animal model, provide strong support for the continued evaluation of biliverdin as a potential therapeutic in the clinical setting of transplantation of the liver and perhaps other organs.	[Andria, Barbara; Bracco, Adele; Attanasio, Chiara; Castaldo, Sigismondo; Cozzolino, Santolo; Di Napoli, Daniele; Mancini, Antonio; Scuderi, Vincenzo; Calise, Fulvio] Antonio Cardarelli Hosp, Ctr Biotechnol, Naples, Italy; [Scuderi, Vincenzo; Calise, Fulvio] Antonio Cardarelli Hosp, Liver Transplantat Unit, Naples, Italy; [Mezza, Ernesto; Nasti, Mario; Staibano, Stefania] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Musumeci, Antonino] Univ Naples Federico II, Dept Cardiac Surg, Naples, Italy; [Cerrito, Maria Grazia; Giovannoni, Roberto; Lavitrano, Marialuisa] Univ Milano Bicocca, Dept Surg, Milan, Italy; [Otterbein, Leo E.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Antonio Cardarelli Hospital; Antonio Cardarelli Hospital; University of Naples Federico II; University of Naples Federico II; University of Milano-Bicocca; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Bracco, A (corresponding author), Antonio Cardarelli Hosp, Ctr Biotechnol, Naples, Italy.	adele.bracco@ospedalecardarelli.it; lotterbe@bidmc.harvard.edu	Giovannoni, Roberto/A-1413-2009; Attanasio, Chiara/D-6781-2019; Cerrito, Maria Grazia/AAA-1190-2019; Lavitrano, Marialuisa/H-3417-2012	Giovannoni, Roberto/0000-0002-7706-0672; Attanasio, Chiara/0000-0001-5817-4087; Cerrito, Maria Grazia/0000-0002-3347-5817; Scuderi, Vincenzo/0000-0002-0490-7780; Lavitrano, Marialuisa/0000-0003-4852-1318	Regional Committee for Organ Transplantation; FIRB RBAP06LAHL Fondo per le Agevolazioni alla Ricerca (FAR); FAR; NIH [HL-071797, HL-076167];  [L. 488/92];  [DD 21.09.99, n462 ric]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071797, R01HL076167] Funding Source: NIH RePORTER	Regional Committee for Organ Transplantation; FIRB RBAP06LAHL Fondo per le Agevolazioni alla Ricerca (FAR); FAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Regional Committee for Organ Transplantation, from the Italian Minister of Education, University and Research (L. 488/92 and DD 21.09.99, n462 ric), FIRB RBAP06LAHL Fondo per le Agevolazioni alla Ricerca (FAR) 2010 and FAR 2011 to ML. LEO is supported by NIH grant HL-071797 & HL-076167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Ar'Rajab A, 1996, New Horiz, V4, P224; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Bulmer AC, 2011, BRIT J PHARMACOL, V164, P1857, DOI 10.1111/j.1476-5381.2011.01413.x; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Hanto DW, 2010, AM J TRANSPLANT, V10, P2421, DOI 10.1111/j.1600-6143.2010.03289.x; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Kato Y, 2003, HEPATOLOGY, V38, P364, DOI 10.1053/jhep.2003.50300; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Lavitrano M, 2004, FASEB J, V18, P1093, DOI 10.1096/fj.03-0996fje; Moore BA, 2005, CRIT CARE MED, V33, P1317, DOI 10.1097/01.CCM.0000166349.76514.40; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakai M, 2011, J VET MED SCI, V73, P313, DOI 10.1292/jvms.10-0375; Nakao A, 2006, AM J TRANSPLANT, V6, P2243, DOI 10.1111/j.1600-6143.2006.01465.x; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Raman KG, 2006, J VASC SURG, V44, P151, DOI 10.1016/j.jvs.2006.04.004; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Scuderi V, 2006, TRANSPL P, V38, P1069, DOI 10.1016/j.transproceed.2006.04.003; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Vanden Hoek TL, 2002, CRIT CARE MED S, V30, P172; Vitek L, 2006, CEREBROVASC DIS, V21, P408, DOI 10.1159/000091966; Wang HJ, 2005, DIABETES, V54, P1400, DOI 10.2337/diabetes.54.5.1400; Wegiel B, 2013, TRENDS MOL MED, V19, P3, DOI 10.1016/j.molmed.2012.10.001; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wegiel B, 2011, P NATL ACAD SCI USA, V108, P18849, DOI 10.1073/pnas.1108571108; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	33	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e69972	10.1371/journal.pone.0069972	http://dx.doi.org/10.1371/journal.pone.0069972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922878	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700112
J	Botten, D; Fugallo, G; Fraternali, F; Molteni, C				Botten, Dominic; Fugallo, Giorgia; Fraternali, Franca; Molteni, Carla			A Computational Exploration of the Interactions of the Green Tea Polyphenol (-)-Epigallocatechin 3-Gallate with Cardiac Muscle Troponin C	PLOS ONE			English	Article							FREE-ENERGY; DILATED CARDIOMYOPATHY; MOLECULAR-DYNAMICS; COMPLEX; BINDING; DOMAIN; MUTATIONS; CATECHIN; REGION; ACTIN	Thanks to its polyphenols and phytochemicals, green tea is believed to have a number of health benefits, including protecting from heart disease, but its mechanism of action at the molecular level is still not understood. Here we explore, by means of atomistic simulations, how the most abundant of the green tea polyphenols, (-)-Epigallocatechin 3-Gallate (EGCg), interacts with the structural C terminal domain of cardiac muscle troponin C (cCTnC), a calcium binding protein that plays an important role in heart contractions. We find that EGCg favourably binds to the hydrophobic cleft of cCTnC consistently with solution NMR experiments. It also binds to cCTnC in the presence of the anchoring region of troponin I (cTnI(34-71)) at the interface between the E and H helices. This appears to affect the strength of the interaction between cCTnC and cTnI(34-71) and also counter-acts the effects of the Gly159Asp mutation, related to dilated cardiomyopathy. Our simulations support the picture that EGCg interacting with the C terminal domain of troponin C may help in regulating the calcium signalling either through competitive binding with the anchoring domain of cTnI or by affecting the interaction between cCTnC and cTnI(34-71).	[Botten, Dominic; Fugallo, Giorgia; Molteni, Carla] Kings Coll London, Dept Phys, London, England; [Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London, England	University of London; King's College London; University of London; King's College London	Molteni, C (corresponding author), Kings Coll London, Dept Phys, London, England.	carla.molteni@kcl.ac.uk	Molteni, Carla/Q-7850-2018; Fraternali, Franca/D-4410-2011; Fraternali, Franca/C-8912-2009; Fugallo, Giorgia/L-6900-2017	Fraternali, Franca/0000-0002-3143-6574; Fugallo, Giorgia/0000-0002-1514-5726; Molteni, Carla/0000-0002-0402-2376	Office of Science and Technology through Engineering and Physical Sciences Research Council's High End Computing Programme (EPSRC) [EP/F037457/1, EP/K013831/1]; EPSRC United Kingdom National Service for Computational Chemistry Software at Imperial College London [CHEM310]; Engineering and Physical Sciences Research Council [EP/K013831/1, EP/J003921/1, EP/F037457/1] Funding Source: researchfish; EPSRC [EP/F037457/1, EP/J003921/1, EP/K013831/1] Funding Source: UKRI	Office of Science and Technology through Engineering and Physical Sciences Research Council's High End Computing Programme (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC United Kingdom National Service for Computational Chemistry Software at Imperial College London(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work made use of the facilities of HECToR, the United Kingdom's national high-performance computing service, which is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through Engineering and Physical Sciences Research Council's High End Computing Programme (EPSRC grants EP/F037457/1 and EP/K013831/1). The authors also acknowledge the use of the EPSRC United Kingdom National Service for Computational Chemistry Software at Imperial College London (project CHEM310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babin V., 2008, AMBER; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Brice AR, 2011, J COMPUT CHEM, V32, P1431, DOI 10.1002/jcc.21727; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chong LT, 2009, J MOL GRAPH MODEL, V27, P978, DOI 10.1016/j.jmgm.2008.12.006; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Gomes AV, 2002, IUBMB LIFE, V54, P323, DOI 10.1080/15216540216037; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Hertog M, 1992, LANCET, V339, P1523; Hodgson JM, 2008, ASIA PAC J CLIN NUTR, V17, P288; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kekenes-Huskey PM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002777; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kostin SF, 2012, J SURG RES, V177, P255, DOI 10.1016/j.jss.2012.04.023; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levy RM, 2003, J AM CHEM SOC, V125, P9523, DOI 10.1021/ja029833a; Li MX, 2000, BIOCHEMISTRY-US, V39, P8782, DOI 10.1021/bi000473i; Lindert S, 2012, J PHYS CHEM B, V116, P8449, DOI 10.1021/jp212173f; Lindhout DA, 2005, BIOCHEMISTRY-US, V44, P14750, DOI 10.1021/bi051580l; Liou YM, 2008, PFLUG ARCH EUR J PHY, V456, P787, DOI 10.1007/s00424-008-0456-y; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259; Mercier P, 2000, BIOCHEMISTRY-US, V39, P2902, DOI 10.1021/bi992579n; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moreira IS, 2007, J COMPUT CHEM, V28, P644, DOI 10.1002/jcc.20566; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244; Riemersma RA, 2001, QJM-INT J MED, V94, P277, DOI 10.1093/qjmed/94.5.277; Robertson IM, 2009, J BIOL CHEM, V284, P23012, DOI 10.1074/jbc.M109.021352; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Senzaki H, 2000, CIRCULATION, V101, P1040, DOI 10.1161/01.CIR.101.9.1040; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Tadano N, 2010, BRIT J PHARMACOL, V161, P1034, DOI 10.1111/j.1476-5381.2010.00942.x; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Wong WW, 2002, BIOPHYS J, V83, P2726, DOI 10.1016/S0006-3495(02)75282-X; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	56	8	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70556	10.1371/journal.pone.0070556	http://dx.doi.org/10.1371/journal.pone.0070556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923004	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700193
J	Ho, AW; Garg, AV; Monin, L; Simpson-Abelson, MR; Kinner, L; Gaffen, SL				Ho, Allen W.; Garg, Abhishek V.; Monin, Leticia; Simpson-Abelson, Michelle R.; Kinner, Lauren; Gaffen, Sarah L.			The Anaphase-Promoting Complex Protein 5 (AnapC5) Associates with A20 and Inhibits IL-17-Mediated Signal Transduction	PLOS ONE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; E3 UBIQUITIN LIGASE; IL-17 RECEPTOR; INTERLEUKIN-17 RECEPTOR; AUTOIMMUNE INFLAMMATION; TH17 CELLS; HETERODIMERIC CYTOKINE; ADAPTER PROTEIN; GENE-EXPRESSION; HOST-DEFENSE	IL-17 is the founding member of a family of cytokines and receptors with unique structures and signaling properties. IL-17 is the signature cytokine of Th17 cells, a relatively new T cell population that promotes inflammation in settings of infection and autoimmunity. Despite advances in understanding Th17 cells, mechanisms of IL-17-mediated signal transduction are less well defined. IL-17 signaling requires contributions from two receptor subunits, IL-17RA and IL-17RC. Mutants of IL-17RC lacking the cytoplasmic domain are nonfunctional, indicating that IL-17RC provides essential but poorly understood signaling contributions to IL-17-mediated signaling. To better understand the role of IL-17RC in signaling, we performed a yeast 2-hybrid screen to identify novel proteins associated with the IL-17RC cytoplasmic tail. One of the most frequent candidates was the anaphase promoting complex protein 7 (APC7 or AnapC7), which interacted with both IL-17RC and IL-17RA. Knockdown of AnapC7 by siRNA silencing exerted no detectable impact on IL-17 signaling. However, AnapC5, which associates with AnapC7, was also able to bind IL-17RA and IL-17RC. Moreover, AnapC5 silencing enhanced IL-17-induced gene expression, suggesting an inhibitory activity. Strikingly, AnapC5 also associated with A20 (TNFAIP3), a recently-identified negative feedback regulator of IL-17 signal transduction. IL-17 signaling was not impacted by knockdown of Itch or TAXBP1, scaffolding proteins that mediate A20 inhibition in the TNF alpha and IL-1 signaling pathways. These data suggest a model in which AnapC5, rather than TAX1BP1 and Itch, is a novel adaptor and negative regulator of IL-17 signaling pathways.	[Ho, Allen W.; Garg, Abhishek V.; Monin, Leticia; Simpson-Abelson, Michelle R.; Kinner, Lauren; Gaffen, Sarah L.] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15213 USA; [Ho, Allen W.] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gaffen, SL (corresponding author), Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15213 USA.	sig65@pitt.edu		Ho, Allen/0000-0002-5861-0552; Monin Aldama, Leticia/0000-0002-4951-8105	National Institutes of Health (NIH) [AR054389, DE022550, F32-AI098243, T32-AI089443]; Medical Science Training Program at the University at Buffalo, State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089443, F32AI098243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022550] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Science Training Program at the University at Buffalo, State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants AR054389 and DE022550 (to SLG). AWH was supported by the Medical Science Training Program at the University at Buffalo, State University of New York. MSA was supported by NIH grant F32-AI098243 and T32-AI089443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ding J, 2003, BIOSCI BIOTECH BIOCH, V67, P314, DOI 10.1271/bbb.67.314; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Hamilton T, 2010, CYTOKINE, V52, P116, DOI 10.1016/j.cyto.2010.04.003; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Hue S, 2006, J EXP MED; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Linden A, 2007, SCI STKE RE, Vre4, P1; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Onishi RM, 2010, J BIOL CHEM, V285, P32751, DOI 10.1074/jbc.M110.121418; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2012, ANN RHEUM DIS; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shen F, 2008, CYTOKINE, V41, P92, DOI 10.1016/j.cyto.2007.11.013; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sun D, 2011, NAT IMMUNOL IN PRESS; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Xu CW, 1997, P NATL ACAD SCI USA, V94, P12473, DOI 10.1073/pnas.94.23.12473; Xu YY, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P91; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhang B, 2013, J IMMUNOL, V190, P2320, DOI 10.4049/jimmunol.1202922; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhong B, 2012, NAT IMMUNOL IN PRESS; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	69	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70168	10.1371/journal.pone.0070168	http://dx.doi.org/10.1371/journal.pone.0070168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922952	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700152
J	Sreekar, R; Mohan, A; Das, S; Agarwal, P; Vivek, R				Sreekar, Rachakonda; Mohan, Anand; Das, Sandeep; Agarwal, Prerna; Vivek, Ramachandran			Natural Windbreaks Sustain Bird Diversity in a Tea-Dominated Landscape	PLOS ONE			English	Article							WESTERN-GHATS; BIODIVERSITY CONSERVATION; PRIMARY FORESTS; LAND-USE; PLANTATIONS; DISPERSAL; RESPONSES; SULAWESI; AREA	Windbreaks often form networks of forest habitats that improve connectivity and thus conserve biodiversity, but little is known of such effects in the tropics. We determined bird species richness and community composition in windbreaks composed of remnant native vegetation amongst tea plantations (natural windbreaks), and compared it with the surrounding primary forests. Fifty-one, ten-minute point counts were conducted in each habitat type over three days. Despite the limited sampling period, our bird inventories in both natural windbreaks and primary forests were nearly complete, as indicated by bootstrap true richness estimator. Bird species richness and abundance between primary forests and windbreaks were similar, however a difference in bird community composition was observed. Abundances of important functional groups such as frugivores and insectivores did not vary between habitat types but nectarivores were more abundant in windbreaks, potentially as a result of the use of windbreaks as traveling routes, foraging and nesting sites. This preliminary study suggests that natural windbreaks may be important habitats for the persistence of bird species in a production landscape. However, a better understanding of the required physical and compositional characteristics for windbreaks to sustain bird communities is needed for effective conservation management.	[Sreekar, Rachakonda] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Mohan, Anand] Fergusson Coll, Dept Zool, Pune, Maharashtra, India; [Das, Sandeep] Farook Coll, Dept Zool, Kozhikode, Kerala, India; [Agarwal, Prerna] MES Abasaheb Garware Coll, Dept Biodivers, Pune, Maharashtra, India; [Vivek, Ramachandran] ATREE, Bangalore, Karnataka, India; [Sreekar, Rachakonda] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sreekar, R (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	sreekar1988@gmail.com	Sreekar, Rachakonda/C-4377-2008; Das, Sandeep/GWZ-1926-2022	Sreekar, Rachakonda/0000-0001-5445-6589; Das, Sandeep/0000-0003-1536-5793	Academy of Conservation Sciences and Sustainable Studies, Ashoka Trust for Research in Ecology and the Environment; Department of Science and Technology (GOI); NORAGRIC (UMB)	Academy of Conservation Sciences and Sustainable Studies, Ashoka Trust for Research in Ecology and the Environment; Department of Science and Technology (GOI)(Department of Science & Technology (India)); NORAGRIC (UMB)	This study was undertaken with the support of the Academy of Conservation Sciences and Sustainable Studies, Ashoka Trust for Research in Ecology and the Environment. RV would like to thank the Department of Science and Technology (GOI) and NORAGRIC (UMB) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1983, HDB BIRDS INDIA PAKI; Anand MO, 2010, BIOL CONSERV, V143, P2363, DOI 10.1016/j.biocon.2010.01.013; [Anonymous], 2005, BIRDS S ASIA RIPLEY; Bali A, 2007, BIOL CONSERV, V139, P93, DOI 10.1016/j.biocon.2007.06.017; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Chetana HC, 2012, CURR SCI INDIA, V102, P1089; Chetana HC, 2012, J TROP ECOL, V28, P187, DOI 10.1017/S0266467411000721; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Harvey CA, 2000, ECOL APPL, V10, P155, DOI 10.1890/1051-0761(2000)010[0155:WESDIA]2.0.CO;2; International Union for Conservation of Nature, 2012, RED LIST THREAT SPEC; Johnsingh AJT, 2001, CURR SCI INDIA, V80, P378; Magurran A.E., 2004, MEASURING BIOL DIVER; Menon S, 1997, CURR SCI INDIA, V73, P134; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2003, ENVIRON MONIT ASSESS, V87, P215, DOI 10.1023/A:1024878925038; Nielson KB, 2000, ECOLOGY NATURAL HIST, P448; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramachandran Vivek, 2012, Journal of the Bombay Natural History Society, V109, P87; Raman TRS, 2002, ANIM CONSERV, V5, P201, DOI 10.1017/S1367943002002251; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Rasmussen P.C., 2005, BIRDS S ASIA RIPLEY, V2; Schroth Goetz, 2004, P1; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Seshadri Kadaba Shamanna, 2012, Zootaxa, V3410, P19; Shahabuddin, 2005, BIODIVERS CONSERV, V14, P863, DOI 10.1007/s10531-004-0654-7; Sidhu Swati, 2010, Journal of the Bombay Natural History Society, V107, P91; Sodhi N.S., 2011, CONSERVATION TROPICA; Sodhi NS, 2005, BIOL CONSERV, V122, P547, DOI 10.1016/j.biocon.2004.07.023; Tejeda-Cruz C, 2004, ANIM CONSERV, V7, P169, DOI 10.1017/S1367943004001258; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Vetter D, 2011, ECOGRAPHY, V34, P1, DOI 10.1111/j.1600-0587.2010.06453.x; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wanger TC, 2010, CONSERV BIOL, V24, P795, DOI 10.1111/j.1523-1739.2009.01434.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Warton DI, 2011, BIOMETRICS, V67, P116, DOI 10.1111/j.1541-0420.2010.01438.x	45	21	25	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70379	10.1371/journal.pone.0070379	http://dx.doi.org/10.1371/journal.pone.0070379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922986	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700180
J	Manna, S; Le, P; Barth, C				Manna, Sam; Le, Phuong; Barth, Christian			A Unique Mitochondrial Transcription Factor B Protein in Dictyostelium discoideum	PLOS ONE			English	Article							PREDICTING COILED COILS; DNA COPY NUMBER; RIBOSOMAL-RNA; DIMETHYLADENOSINE METHYLTRANSFERASE; FACTOR-A; GENE; MAINTENANCE; BIOGENESIS; SPECIFICITY; POLYMERASE	Unlike their bacteriophage homologs, mitochondrial RNA polymerases require the assistance of transcription factors in order to transcribe mitochondrial DNA efficiently. The transcription factor A family has been shown to be important for transcription of the human mitochondrial DNA, with some of its regulatory activity located in its extended C-terminal tail. The mitochondrial transcription factor B family often has functions not only in transcription, but also in mitochondrial rRNA modification, a hallmark of its alpha-proteobacterial origin. We have identified and characterised a mitochondrial transcription factor B homolog in the soil dwelling cellular slime mould Dictyostelium discoideum, an organism widely established as a model for studying eukaryotic cell biology. Using in bacterio functional assays, we demonstrate that the mitochondrial transcription factor B homolog not only functions as a mitochondrial transcription factor, but that it also has a role in rRNA methylation. Additionally, we show that the transcriptional activation properties of the D. discoideum protein are located in its extended C-terminal tail, a feature not seen before in the mitochondrial transcription factor B family, but reminiscent of the human mitochondrial transcription factor A. This report contributes to our current understanding of the complexities of mitochondrial transcription, and its evolution in eukaryotes.	[Manna, Sam; Barth, Christian] La Trobe Univ, Dept Microbiol, Melbourne, Vic, Australia; [Le, Phuong] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan	La Trobe University; Tokyo Metropolitan University	Barth, C (corresponding author), La Trobe Univ, Dept Microbiol, Melbourne, Vic, Australia.	c.barth@latrobe.edu.au	Manna, Sam/P-2131-2017	Manna, Sam/0000-0002-7694-9605	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	Sam Manna was the recipient of an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accari Jessica E, 2013, Methods Mol Biol, V983, P325, DOI 10.1007/978-1-62703-302-2_18; Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Ahmed AU, 2006, EUKARYOT CELL, V5, P1314, DOI 10.1128/EC.00386-05; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barth C, 1999, CURR GENET, V36, P55, DOI 10.1007/s002940050472; Barth C, 2001, CURR GENET, V39, P355; Barth C, 2007, INT REV CYTOL, V263, P207, DOI 10.1016/S0074-7696(07)63005-8; Barth C, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P241, DOI 10.1007/978-3-642-22380-8_10; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Cotney J, 2009, HUM MOL GENET, V18, P2670, DOI 10.1093/hmg/ddp208; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DARMON M, 1975, P NATL ACAD SCI USA, V72, P3163, DOI 10.1073/pnas.72.8.3163; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FEY P, 1995, GENE, V165, P127, DOI 10.1016/0378-1119(95)00430-E; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Francione LM, 2011, SEMIN CELL DEV BIOL, V22, P120, DOI 10.1016/j.semcdb.2010.11.004; Gilson PR, 2003, EUKARYOT CELL, V2, P1315, DOI 10.1128/EC.2.6.1315-1326.2003; Goto A, 2001, BIOCHEM J, V354, P243, DOI 10.1042/0264-6021:3540243; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; HELSER TL, 1972, NATURE-NEW BIOL, V235, P6, DOI 10.1038/newbio235006a0; JANG SH, 1991, J BIOL CHEM, V266, P22671; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; KLOOTWIJK J, 1975, J MOL BIOL, V97, P337, DOI 10.1016/S0022-2836(75)80044-1; Le P, 2009, RNA, V15, P2321, DOI 10.1261/rna.1710309; Lezza Angela M S, 2012, [Frontiers in Biology, 生物学前沿], V7, P30; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Manna Sam, 2013, BMC Res Notes, V6, P85, DOI 10.1186/1756-0500-6-85; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; NELLEN W, 1984, MOL CELL BIOL, V4, P2890, DOI 10.1128/MCB.4.12.2890; Park AK, 2009, MOL PHYLOGENET EVOL, V50, P282, DOI 10.1016/j.ympev.2008.10.020; Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8; Richter U, 2010, PLANT J, V61, P558, DOI 10.1111/j.1365-313X.2009.04079.x; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Shutt TE, 2006, MOL BIOL EVOL, V23, P1169, DOI 10.1093/molbev/msk001; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; VANBUUL CPJJ, 1985, GENE, V38, P65, DOI 10.1016/0378-1119(85)90204-5; VANBUUL CPJJ, 1983, MOL GEN GENET, V189, P475, DOI 10.1007/BF00325912; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WILCZYNSKA Z, 1994, PLASMID, V32, P182, DOI 10.1006/plas.1994.1054	57	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70614	10.1371/journal.pone.0070614	http://dx.doi.org/10.1371/journal.pone.0070614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923009	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900172
J	Gerlee, P; Schmidt, L; Monsefi, N; Kling, T; Jornsten, R; Nelander, S				Gerlee, Philip; Schmidt, Linnea; Monsefi, Naser; Kling, Teresia; Jornsten, Rebecka; Nelander, Sven			Searching for Synergies: Matrix Algebraic Approaches for Efficient Pair Screening	PLOS ONE			English	Article							MISSING VALUE ESTIMATION; DRUG-COMBINATIONS; GENETIC INTERACTIONS; SEMANTIC SIMILARITY; NETWORKS; ALGORITHMS; PREDICTION	Functionally interacting perturbations, such as synergistic drugs pairs or synthetic lethal gene pairs, are of key interest in both pharmacology and functional genomics. However, to find such pairs by traditional screening methods is both time consuming and costly. We present a novel computational-experimental framework for efficient identification of synergistic target pairs, applicable for screening of systems with sizes on the order of current drug, small RNA or SGA (Synthetic Genetic Array) libraries (>1000 targets). This framework exploits the fact that the response of a drug pair in a given system, or a pair of genes' propensity to interact functionally, can be partly predicted by computational means from (i) a small set of experimentally determined target pairs, and (ii) pre-existing data (e.g. gene ontology, PPI) on the similarities between targets. Predictions are obtained by a novel matrix algebraic technique, based on cyclical projections onto convex sets. We demonstrate the efficiency of the proposed method using drug-drug interaction data from seven cancer cell lines and gene-gene interaction data from yeast SGA screens. Our protocol increases the rate of synergism discovery significantly over traditional screening, by up to 7-fold. Our method is easy to implement and could be applied to accelerate pair screening for both animal and microbial systems.	[Gerlee, Philip; Schmidt, Linnea; Monsefi, Naser; Kling, Teresia; Nelander, Sven] Univ Gothenburg, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Gerlee, Philip; Jornsten, Rebecka] Univ Gothenburg, Gothenburg, Sweden; [Gerlee, Philip; Jornsten, Rebecka] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Schmidt, Linnea; Kling, Teresia; Nelander, Sven] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Schmidt, Linnea; Kling, Teresia; Nelander, Sven] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Chalmers University of Technology; Uppsala University; Uppsala University	Nelander, S (corresponding author), Univ Gothenburg, Sahlgrenska Canc Ctr, Gothenburg, Sweden.	sven.nelander@igp.uu.se		Nelander, Sven/0000-0003-1758-1262	Swedish Research Council; Swedish Cancer Society; Science for Life Laboratory	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Science for Life Laboratory	The research received support from the Swedish Research Council (vr.se), the Swedish Cancer Society (cancerfonden.se), and Science for Life Laboratory (scilifelab.uu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-342; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Bauschke HH, 1996, SIAM REV, V38, P367, DOI 10.1137/S0036144593251710; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; COMBETTES PL, 1993, P IEEE, V81, P182, DOI 10.1109/5.214546; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Hahn G.J., 1994, STAT MODELS ENG; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Hu ZH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r257; Jansen G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.95; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; King R, 2004, NATURE; Komarova NL, 2009, CANCER RES, V69, P4904, DOI 10.1158/0008-5472.CAN-08-1959; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lappe M, 2004, NAT BIOTECHNOL, V22, P98, DOI 10.1038/nbt921; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Nelander S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.53; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Osborne MR, 2000, J COMPUT GRAPH STAT, V9, P319, DOI 10.2307/1390657; Pan XY, 2011, GENOMICS, V97, P257, DOI 10.1016/j.ygeno.2011.03.001; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Recht B., 2008, EXACT MATRIX COMPLET; Ryan C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-197; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schwartz AS, 2009, NAT METHODS, V6, P55, DOI [10.1038/nmeth.1283, 10.1038/NMETH.1283]; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Serbes A, 2010, COMMUN NONLINEAR SCI, V15, P675, DOI 10.1016/j.cnsns.2009.05.013; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vatcheva I, 2000, SELECTION PERTURBATI; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937; Zupan B, 2003, BIOINFORMATICS, V19, P383, DOI 10.1093/bioinformatics/btf871	44	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68598	10.1371/journal.pone.0068598	http://dx.doi.org/10.1371/journal.pone.0068598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935877	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300009
J	Kaundun, SS; Hutchings, SJ; Dale, RP; McIndoe, E				Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard P.; McIndoe, Eddie			Role of a Novel I1781T Mutation and Other Mechanisms in Conferring Resistance to Acetyl-CoA Carboxylase Inhibiting Herbicides in a Black-Grass Population	PLOS ONE			English	Article							ALOPECURUS-MYOSUROIDES HUDS.; COENZYME-A CARBOXYLASE; CARBOXYLTRANSFERASE DOMAIN; CROSS-RESISTANCE; MOLECULAR-BASIS; ACETOLACTATE-SYNTHASE; PCR ASSAYS; ACCASE; ARYLOXYPHENOXYPROPIONATE; ISOLEUCINE	Background: Knowledge of the mechanisms of herbicide resistance is important for designing long term sustainable weed management strategies. Here, we have used an integrated biology and molecular approach to investigate the mechanisms of resistance to acetyl-CoA carboxylase inhibiting herbicides in a UK black-grass population (BG2). Methodology/Principal Findings: Comparison between BG2 phenotypes using single discriminant rates of herbicides and genotypes based on ACCase gene sequencing showed that the I1781L, a novel I1781T, but not the W2027C mutations, were associated with resistance to cycloxydim. All plants were killed with clethodim and a few individuals containing the I1781L mutation were partially resistant to tepraloxydim. Whole plant dose response assays demonstrated that a single copy of the mutant T1781 allele conferred fourfold resistance levels to cycloxydim and clodinafop-propargyl. In contrast, the impact of the I1781T mutation was low (Rf = 1.6) and non-significant on pinoxaden. BG2 was also characterised by high levels of resistance, very likely non-target site based, to the two cereal selective herbicides clodinafop-propargyl and pinoxaden and not to the poorly metabolisable cyclohexanedione herbicides. Analysis of 480 plants from 40 cycloxydim resistant black grass populations from the UK using two very effective and high throughput dCAPS assays established for detecting any amino acid changes at the 1781 ACCase codon and for positively identifying the threonine residue, showed that the occurrence of the T1781 is extremely rare compared to the L1781 allele. Conclusion/Significance: This study revealed a novel mutation at ACCase codon position 1781 and adequately assessed target site and non-target site mechanisms in conferring resistance to several ACCase herbicides in a black-grass population. It highlights that over time the level of suspected non-target site resistance to some cereal selective ACCase herbicides have in some instances surpassed that of target site resistance, including the one endowed by the most commonly encountered I1781L mutation.	[Kaundun, Shiv Shankhar; Hutchings, Sarah-Jane; Dale, Richard P.; McIndoe, Eddie] Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England	Syngenta	Kaundun, SS (corresponding author), Syngenta, Jealotts Hill Int Res Ctr, Bracknell, Berks, England.	deepak.kaundun@syngenta.com	Kaundun, Shiv/AIB-0473-2022					Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Blair AM, 1999, BIOL FRAMEWORK DEV W; Brown AC, 2002, PESTIC BIOCHEM PHYS, V72, P160, DOI 10.1016/S0048-3575(02)00004-4; Busi R, 2011, AGR ECOSYST ENVIRON, V142, P403, DOI 10.1016/j.agee.2011.06.012; Chauvel B, 2009, CROP PROT, V28, P343, DOI 10.1016/j.cropro.2008.11.013; Christoffers MJ, 2002, GENOME, V45, P1049, DOI 10.1139/G02-080; Colbach N, 2006, EUR J AGRON, V24, P95, DOI 10.1016/j.eja.2005.07.001; Collavo A, 2011, CROP PROT, V30, P293, DOI 10.1016/j.cropro.2010.11.011; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Delye C, 2007, WEED RES, V47, P95, DOI 10.1111/j.1365-3180.2007.00544.x; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, WEED RES, V45, P323, DOI 10.1111/j.1365-3180.2005.00467.x; Delye C, 2005, PLANT PHYSIOL, V137, P794, DOI 10.1104/pp.104.046144; Delye C, 2004, PEST MANAG SCI, V60, P35, DOI 10.1002/ps.778; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2002, THEOR APPL GENET, V104, P1114, DOI 10.1007/s00122-001-0852-6; Delye C, 2008, PEST MANAG SCI, V64, P1179, DOI 10.1002/ps.1614; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; Gherekhloo J, 2012, WEED RES, V52, P367, DOI 10.1111/j.1365-3180.2012.00919.x; Hall LM, 1997, PESTIC BIOCHEM PHYS, V57, P87, DOI 10.1006/pest.1997.2259; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Henriet F, 2009, Commun Agric Appl Biol Sci, V74, P471; Herbert D, 1997, PESTIC SCI, V50, P67, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;67::AID-PS552&gt;3.0.CO;2-#; Hofer U, 2006, J PLANT DIS PROTECT, P989; Huan ZB, 2011, J PESTIC SCI, V36, P461, DOI 10.1584/jpestics.G11-29; Incledon BJ, 1997, PESTIC BIOCHEM PHYS, V57, P255, DOI 10.1006/pest.1997.2279; Kaundun SS, 2006, PEST MANAG SCI, V62, P1082, DOI 10.1002/ps.1283; Kaundun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039759; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; Kaundun SS, 2006, WEED RES, V46, P34, DOI 10.1111/j.1365-3180.2006.00487.x; Kershner KS, 2012, CROP SCI, V52, P64, DOI 10.2135/cropsci2011.02.0082; Konishi T, 1996, PLANT CELL PHYSL, V37, P2, DOI DOI 10.1093/OXFORDJOURNALS.PCP.A028920; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Marechal PY, 2012, BIOTECHNOL AGRON SOC, V16, P103; Marshall R, 2012, PEST MANAG IN PRESS; Menchari Y, 2008, J APPL ECOL, V45, P939, DOI 10.1111/j.1365-2664.2008.01462.x; Milner LJ, 2001, PEST MANAG SCI, V57, P1100, DOI 10.1002/ps.403; Moss SR, 2003, PEST MANAG SCI, V59, P190, DOI 10.1002/ps.623; MOSS SR, 1983, WEED RES, V23, P45, DOI 10.1111/j.1365-3180.1983.tb00519.x; Moss SR, 2012, DEV PROMOTING MORE S; Moss SR, 2010, 466 HGCA; Moss SR, 2011, CURRENT STATUS HERBI; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Petit C, 2010, PLANT SCI, V178, P501, DOI 10.1016/j.plantsci.2010.03.007; Petit C, 2010, PEST MANAG SCI, V66, P168, DOI 10.1002/ps.1851; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Price LJ, 2003, BIOCHEM J, V375, P415, DOI 10.1042/BJ20030665; SHORROSH BS, 1994, P NATL ACAD SCI USA, V91, P4323, DOI 10.1073/pnas.91.10.4323; White GM, 2005, WEED RES, V45, P440, DOI 10.1111/j.1365-3180.2005.00478.x; Xiang S, 2009, P NATL ACAD SCI USA, V106, P20723, DOI 10.1073/pnas.0908431106; Yu LPC, 2010, P NATL ACAD SCI USA, V107, P22072, DOI 10.1073/pnas.1012039107; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262; Zagnitko O, 2001, P NATL ACAD SCI USA, V98, P6617, DOI 10.1073/pnas.121172798; Zhang HL, 2004, P NATL ACAD SCI USA, V101, P5910, DOI 10.1073/pnas.0400891101; ZHANG XQ, 2000, WEED SCI SOC AM, V40, P33	56	32	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69568	10.1371/journal.pone.0069568	http://dx.doi.org/10.1371/journal.pone.0069568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936046	gold, Green Published, Green Submitted			2022-12-27	WOS:000322433300048
J	Stroganova, TA; Kozunov, VV; Posikera, IN; Galuta, IA; Gratchev, VV; Orekhova, EV				Stroganova, Tatiana A.; Kozunov, Vladimir V.; Posikera, Irina N.; Galuta, Ilia A.; Gratchev, Vitaliy V.; Orekhova, Elena V.			Abnormal Pre-Attentive Arousal in Young Children with Autism Spectrum Disorder Contributes to Their Atypical Auditory Behavior: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; EVOKED-POTENTIALS; SYSTEM ACTIVITY; ELECTROPHYSIOLOGICAL EVIDENCE; SENSORY ABNORMALITIES; CHOLINERGIC ACTIVITY; SPATIAL ATTENTION; BRAIN POTENTIALS; SPEECH SOUNDS; N1 WAVE	Auditory sensory modulation difficulties and problems with automatic re-orienting to sound are well documented in autism spectrum disorders (ASD). Abnormal preattentive arousal processes may contribute to these deficits. In this study, we investigated components of the cortical auditory evoked potential (CAEP) reflecting preattentive arousal in children with ASD and typically developing (TD) children aged 3-8 years. Pairs of clicks ('S1' and 'S2') separated by a 1 sec S1-S2 interstimulus interval (ISI) and much longer (8-10 sec) S1-S1 ISIs were presented monaurally to either the left or right ear. In TD children, the P50, P100 and N1c CAEP components were strongly influenced by temporal novelty of clicks and were much greater in response to the S1 than the S2 click. Irrespective of the stimulation side, the 'tangential' P100 component was rightward lateralized in TD children, whereas the 'radial' N1c component had higher amplitude contralaterally to the stimulated ear. Compared to the TD children, children with ASD demonstrated 1) reduced amplitude of the P100 component under the condition of temporal novelty (S1) and 2) an attenuated P100 repetition suppression effect. The abnormalities were lateralized and depended on the presentation side. They were evident in the case of the left but not the right ear stimulation. The P100 abnormalities in ASD correlated with the degree of developmental delay and with the severity of auditory sensory modulation difficulties observed in early life. The results suggest that some rightward-lateralized brain networks that are crucially important for arousal and attention re-orienting are compromised in children with ASD and that this deficit contributes to sensory modulation difficulties and possibly even other behavioral deficits in ASD.	[Stroganova, Tatiana A.; Kozunov, Vladimir V.; Posikera, Irina N.; Galuta, Ilia A.] Moscow State Univ Psychol & Educ, MEG Ctr, Moscow, Russia; [Stroganova, Tatiana A.; Posikera, Irina N.] Russian Acad Educ, Inst Psychol, Lab Dev Psychogenet, Moscow, Russia; [Gratchev, Vitaliy V.] Russian Acad Med Sci, Mental Hlth Res Ctr, Clin Dept Study Adolescent Psychiat, Moscow 109801, Russia; [Orekhova, Elena V.] Sahlgrens Acad, MedTech West, Gothenburg, Sweden	Moscow State University of Psychology & Education; Psychological Institute, Russian Academy of Education; Russian Academy of Medical Sciences; University of Gothenburg	Stroganova, TA (corresponding author), Moscow State Univ Psychol & Educ, MEG Ctr, Moscow, Russia.	stroganova56@mail.ru	Orekhova, Elena V/S-9043-2018; Stroganova, Tatiana T.A./C-5773-2014	Orekhova, Elena V/0000-0003-0950-1613; , Vladimir/0000-0001-5560-9145; Stroganova, Tatiana/0000-0003-3750-9890	Swedish Research Council [2009-3765]; Russian Foundation for Basic Research (RFBR) [09-06-12042-ofi_m]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	This research was supported by Grant #2009-3765 from the Swedish Research Council (www.vr.se) and by Grant #09-06-12042-ofi_m from the Russian Foundation for Basic Research (RFBR) (www.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2000, CLIN NEUROPHYSIOL, V111, P2268, DOI 10.1016/S1388-2457(00)00464-8; Ames C, 2010, DEV REV, V30, P52, DOI 10.1016/j.dr.2009.12.003; Atienza M, 2001, INT J PSYCHOPHYSIOL, V41, P131, DOI 10.1016/S0167-8760(00)00196-3; Ben-Sasson A, 2008, J CHILD PSYCHOL PSYC, V49, P817, DOI 10.1111/j.1469-7610.2008.01899.x; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Boutros NN, 2004, PSYCHIAT RES, V126, P203, DOI 10.1016/j.psychres.2004.01.007; Boutros NN, 1999, BIOL PSYCHIAT, V45, P917, DOI 10.1016/S0006-3223(98)00253-4; Brenner CA, 2009, SCHIZOPHR RES, V113, P332, DOI 10.1016/j.schres.2009.06.012; Brinkman MJR, 2007, CLIN NEUROPHYSIOL, V118, P1517, DOI 10.1016/j.clinph.2007.04.002; Bruneau N, 1997, PSYCHOPHYSIOLOGY, V34, P32, DOI 10.1111/j.1469-8986.1997.tb02413.x; BRYSON SE, 1990, DEV ATTENTION RES TH, P405; BUCHWALD JS, 1991, ELECTROEN CLIN NEURO, V80, P303, DOI 10.1016/0168-5597(91)90114-D; BUCHWALD JS, 1992, ELECTROEN CLIN NEURO, V84, P164, DOI 10.1016/0168-5597(92)90021-3; Campbell T, 2007, NEUROREPORT, V18, P377, DOI 10.1097/WNR.0b013e32801b3ce8; CASEY BJ, 1993, J CLIN EXP NEUROPSYC, V15, P933, DOI 10.1080/01688639308402609; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Ceponiene R, 2002, CLIN NEUROPHYSIOL, V113, P870, DOI 10.1016/S1388-2457(02)00078-0; Chait M, 2004, NEUROREPORT, V15, P2455, DOI 10.1097/00001756-200411150-00004; Clementz BA, 2003, EUR J NEUROSCI, V18, P2853, DOI 10.1111/j.1460-9568.2003.03027.x; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 2004, NEUROIMAGE, V22, P315, DOI 10.1016/j.neuroimage.2003.12.022; COURCHESNE E, 1984, ELECTROEN CLIN NEURO, V59, P238, DOI 10.1016/0168-5597(84)90063-7; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; COURCHESNE E, 1994, BEHAV NEUROSCI, V108, P848, DOI 10.1037/0735-7044.108.5.848; D'Cruz AM, 2009, BIOL PSYCHIAT, V66, P393, DOI 10.1016/j.biopsych.2009.01.008; DAHLGREN SO, 1989, EUR ARCH PSY CLIN N, V238, P169; Deouell LY, 2000, BRAIN, V123, P353, DOI 10.1093/brain/123.2.353; Deutsch SI, 2010, CLIN NEUROPHARMACOL, V33, P114, DOI 10.1097/WNF.0b013e3181d6f7ad; Edgar JC, 2003, BIOL PSYCHOL, V65, P1, DOI 10.1016/S0301-0511(03)00094-2; Elsabbagh M, 2009, J CHILD PSYCHOL PSYC, V50, P637, DOI 10.1111/j.1469-7610.2008.02051.x; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Fimm B, 2001, J NEUROL NEUROSUR PS, V71, P652, DOI 10.1136/jnnp.71.5.652; Fox AM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-49; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; GEULA C, 2011, HUMAN NERVOUS SYSTEM, P456; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Gilmore CS, 2009, INT J PSYCHOPHYSIOL, V73, P326, DOI 10.1016/j.ijpsycho.2009.05.005; Gomot M, 2002, PSYCHOPHYSIOLOGY, V39, P577, DOI 10.1017/S0048577202394058; Gomot M, 2011, J AUTISM DEV DISORD, V41, P705, DOI 10.1007/s10803-010-1091-y; Greenwood PM, 2012, NEUROSCI BIOBEHAV R, V36, P1331, DOI 10.1016/j.neubiorev.2012.02.010; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; Groen MA, 2008, BIOL PSYCHOL, V79, P148, DOI 10.1016/j.biopsycho.2008.04.003; Hadlington L, 2004, BRAIN COGNITION, V55, P545, DOI 10.1016/j.bandc.2004.04.001; Harris NS, 1999, COGNITIVE BRAIN RES, V8, P61, DOI 10.1016/S0926-6410(99)00006-3; Hine J, 2007, CLIN NEUROPHYSIOL, V118, P1274, DOI 10.1016/j.clinph.2007.03.012; Howard MF, 2009, HEARING RES, V257, P41, DOI 10.1016/j.heares.2009.07.010; Huang MX, 2003, CLIN NEUROPHYSIOL, V114, P835, DOI 10.1016/S1388-2457(03)00041-5; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kawakubo Y, 2007, CLIN NEUROPHYSIOL, V118, P1464, DOI 10.1016/j.clinph.2007.04.015; Keehn B, 2013, NEUROSCI BIOBEHAV R, V37, P164, DOI 10.1016/j.neubiorev.2012.11.014; Kemner C, 2002, J CLIN PSYCHIAT, V63, P214; KEMNER C, 1995, BIOL PSYCHIAT, V38, P150, DOI 10.1016/0006-3223(94)00247-Z; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Khalfa S, 2001, EUR J NEUROSCI, V13, P628, DOI 10.1046/j.1460-9568.2001.01423.x; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Korzyukov O, 2007, NEUROIMAGE, V35, P814, DOI 10.1016/j.neuroimage.2006.12.011; Korzyukov O, 2009, BRAIN TOPOGR, V22, P166, DOI 10.1007/s10548-009-0108-3; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Liss M, 2006, AUTISM, V10, P155, DOI 10.1177/1362361306062021; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Marshall PJ, 2004, INT J PSYCHOPHYSIOL, V51, P135, DOI 10.1016/j.ijpsycho.2003.08.004; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Metherate R, 2011, NEUROSCI BIOBEHAV R, V35, P2058, DOI 10.1016/j.neubiorev.2010.11.010; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Natale E, 2007, NEUROPSYCHOLOGIA, V45, P263, DOI 10.1016/j.neuropsychologia.2006.07.008; Nguyen HN, 2004, J NEUROCHEM, V90, P40, DOI 10.1111/j.1471-4159.2004.02482.x; Ofek E, 2004, HEARING RES, V189, P107, DOI 10.1016/S0378-5955(03)00392-7; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Oranje B, 2013, PSYCHIAT RES, V206, P287, DOI 10.1016/j.psychres.2012.10.014; Orekhova EV, 2009, CLIN NEUROPHYSIOL, V120, P520, DOI 10.1016/j.clinph.2008.12.034; Orekhova EV, 2008, NEUROSCI LETT, V434, P218, DOI 10.1016/j.neulet.2008.01.066; Orekhova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039906; OREKHOVA EV, 2012, BRAIN TOPOGR, DOI DOI 10.1007/S10548-012-0262-X.PUBMED:23104186; PANTEV C, 1986, AUDIOLOGY, V25, P54; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Ponton CW, 2000, CLIN NEUROPHYSIOL, V111, P220, DOI 10.1016/S1388-2457(99)00236-9; PRIGGE MD, 2013, AUTISM RES, DOI DOI 10.1002/AUR.1265.PUBMED:23436773; Ray MA, 2005, NEUROBIOL DIS, V19, P366, DOI 10.1016/j.nbd.2005.01.017; Reser DH, 2000, CEREB CORTEX, V10, P574, DOI 10.1093/cercor/10.6.574; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rudnick ND, 2010, NICOTINE TOB RES, V12, P589, DOI 10.1093/ntr/ntq049; Ruhnau P, 2011, NEUROIMAGE, V58, P630, DOI 10.1016/j.neuroimage.2011.06.050; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Schopler, 1990, PSYCHOEDUCATIONAL PR; Schopler E., 1986, CHILDHOOD AUTISM RAT; Sharma A, 2011, INT J AUDIOL, V50, P98, DOI 10.3109/14992027.2010.542492; Shaw ME, 2013, NEUROIMAGE, V74, P22, DOI 10.1016/j.neuroimage.2013.02.002; Skinner RD, 2004, PROG BRAIN RES, V143, P291, DOI 10.1016/S0079-6123(03)43028-8; Stiegler LN, 2010, FOCUS AUTISM DEV DIS, V25, P67, DOI 10.1177/1088357610364530; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P563, DOI 10.1016/j.neuropsychologia.2003.11.004; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sussman E, 2008, HEARING RES, V236, P61, DOI 10.1016/j.heares.2007.12.001; Takeshita K, 2002, CLIN NEUROPHYSIOL, V113, P1470, DOI 10.1016/S1388-2457(02)00202-X; Tarkka IM, 2011, INT J PSYCHOPHYSIOL, V79, P272, DOI 10.1016/j.ijpsycho.2010.11.002; Teshiba TM, 2013, CEREB CORTEX, V23, P560, DOI 10.1093/cercor/bhs039; Thoma RJ, 2003, AM J PSYCHIAT, V160, P1595, DOI 10.1176/appi.ajp.160.9.1595; Tonnquist-Uhlen I, 2003, CLIN NEUROPHYSIOL, V114, P685, DOI 10.1016/S1388-2457(03)00005-1; TONNQUISTUHLEN I, 1995, ELECTROEN CLIN NEURO, V95, P34, DOI 10.1016/0013-4694(95)00044-Y; Townsend J, 1996, J Int Neuropsychol Soc, V2, P541; Townsend J, 1996, DEV PSYCHOPATHOL, V8, P563, DOI 10.1017/S0954579400007276; Tsetlin MM, 2008, INT J PSYCHOPHYSIOL, V69, P267, DOI 10.1016/j.ijpsycho.2008.05.209; Vecera SP, 2005, NEUROPSYCHOLOGIA, V43, P1189, DOI 10.1016/j.neuropsychologia.2004.10.009; Wan L, 2006, INT J PSYCHOPHYSIOL, V60, P1, DOI 10.1016/j.ijpsycho.2005.03.024; Weiland BJ, 2008, NEUROIMAGE, V42, P827, DOI 10.1016/j.neuroimage.2008.05.042; Whitehouse AJO, 2008, DEVELOPMENTAL SCI, V11, P516, DOI 10.1111/j.1467-7687.2008.00697.x; Wiggins LD, 2009, J AUTISM DEV DISORD, V39, P1087, DOI 10.1007/s10803-009-0711-x; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Woods AJ, 2012, NEUROCASE, V18, P115, DOI 10.1080/13554794.2011.568498; Wunderlich JL, 2006, HEARING RES, V212, P185, DOI 10.1016/j.heares.2005.11.010; Yoshimura Y, 2012, EUR J NEUROSCI, V35, P644, DOI 10.1111/j.1460-9568.2012.07998.x; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	135	35	35	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69100	10.1371/journal.pone.0069100	http://dx.doi.org/10.1371/journal.pone.0069100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935931	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300022
J	Wang, HE; Shapiro, NI; Safford, MM; Griffin, R; Judd, S; Rodgers, JB; Warnock, DG; Cushman, M; Howard, G				Wang, Henry E.; Shapiro, Nathan I.; Safford, Monika M.; Griffin, Russell; Judd, Suzanne; Rodgers, Joel B.; Warnock, David G.; Cushman, Mary; Howard, George			High-Sensitivity C-Reactive Protein and Risk of Sepsis	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; PROGNOSTIC VALUE; STATIN THERAPY; UNITED-STATES; MORTALITY; PROCALCITONIN; PREDICTION; INFECTION; INDICATOR; STROKE	Background: Conventional C-reactive protein assays have been used to detect or guide the treatment of acute sepsis. The objective of this study was to determine the association between elevated baseline high-sensitivity C-reactive protein (hsCRP) and the risk of future sepsis events. Methods: We studied data from 30,239 community dwelling, black and white individuals, age >= 45 years old enrolled in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. Baseline hsCRP and participant characteristics were determined at the start of the study. We identified sepsis events through review of hospital records. Elevated hsCRP was defined as values >3.0 mg/L. Using Cox regression, we determined the association between elevated hsCRP and first sepsis event, adjusting for sociodemographic factors (age, sex, race, region, education, income), health behaviors (tobacco and alcohol use), chronic medical conditions (coronary artery disease, diabetes, dyslipidemia, hypertension, chronic kidney disease, chronic lung disease) and statin use. Results: Over the mean observation time of 5.7 years (IQR 4.5-7.1), 974 individuals experienced a sepsis event, and 11,447 (37.9%) had elevated baseline hsCRP (>3.0 mg/L). Elevated baseline hsCRP was independently associated with subsequent sepsis (adjusted HR 1.56; 95% CI 1.36-1.79), adjusted for sociodemographics, health behaviors, chronic medical conditions and statin use. Conclusion: Elevated baseline hsCRP was associated with increased risk of future sepsis events. hsCRP may help to identify individuals at increased risk for sepsis.	[Wang, Henry E.; Rodgers, Joel B.] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL 35294 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Safford, Monika M.] Univ Alabama Birmingham, Sch Med, Dept Med, Div Prevent Med, Birmingham, AL USA; [Griffin, Russell] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Judd, Suzanne; Howard, George] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Warnock, David G.] Univ Alabama Birmingham, Sch Med, Dept Med, Div Nephrol, Birmingham, AL USA; [Cushman, Mary] Univ Vermont, Dept Med, Div Hematol & Oncol, Burlington, VT USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Beth Israel Deaconess Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Vermont	Wang, HE (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL 35294 USA.	hwang@uabmc.edu	Shapiro, Nathan/F-1718-2016; Cushman, Mary/K-1157-2019	Cushman, Mary/0000-0002-7871-6143; Griffin, Russell/0000-0002-5004-7996; Howard, George/0000-0002-3068-5720	National Institute for Nursing Research [R01-NR012726]; National Center for Research Resources [UL1-RR025777]; Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01-NS041588]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012726] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Albert MA, 2006, CIRCULATION, V114, pE67, DOI 10.1161/CIRCULATIONAHA.106.613570; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bjerk SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056249; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Fraunberger P, 2006, SHOCK, V26, P10, DOI 10.1097/01.shk.0000215319.06866.bd; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; Lee CC, 2008, SHOCK, V29, P322, DOI 10.1097/SHK.0b013e31815077ca; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Paffen E, 2006, CARDIOVASC RES, V71, P30, DOI 10.1016/j.cardiores.2006.03.004; Povoa P, 1998, INTENS CARE MED, V24, P1052, DOI 10.1007/s001340050715; Povoa P, 2005, CLIN MICROBIOL INFEC, V11, P101, DOI 10.1111/j.1469-0691.2004.01044.x; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schmit X, 2008, INFECTION, V36, P213, DOI 10.1007/s15010-007-7077-9; Sierra R, 2004, INTENS CARE MED, V30, P2038, DOI 10.1007/s00134-004-2434-y; Wang HE, 2013, J CRIT CARE; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC	30	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69232	10.1371/journal.pone.0069232	http://dx.doi.org/10.1371/journal.pone.0069232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935961	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000091
J	Xie, YL; Wang, MJ; Zhang, YJ; Zhang, SJ; Tan, AH; Gao, Y; Liang, ZJ; Shi, DY; Huang, Z; Zhang, HY; Yang, XB; Lu, Z; Wu, CL; Liao, M; Sun, Y; Qin, X; Hu, YL; Li, L; Peng, T; Li, ZX; Yang, XL; Mo, ZN				Xie, Yuanliang; Wang, Mengjie; Zhang, Youjie; Zhang, Shijun; Tan, Aihua; Gao, Yong; Liang, Zhengjia; Shi, Deyi; Huang, Zhang; Zhang, Haiying; Yang, Xiaobo; Lu, Zheng; Wu, Chunlei; Liao, Ming; Sun, Yu; Qin, Xue; Hu, Yanling; Li, Li; Peng, Tao; Li, Zhixian; Yang, Xiaoli; Mo, Zengnan			Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Non-Diabetic Chinese Men	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; NATIONAL-HEALTH; RISK-FACTORS; ASSOCIATION; PREVALENCE; NUTRITION; GENE; HYPERURICEMIA; POPULATION	Increased serum uric acid (SUA) levels may be involved in the development of non-alcoholic fatty liver disease (NAFLD) in men presenting with metabolic syndrome (MetS) and/or insulin resistance. We aimed to determine the independent relationship between SUA and NAFLD in non-diabetic Chinese male population, and to explore the determinants of SUA levels among indexes of adiposity, lipid, and genotypes pertaining to triglycerides metabolism, inflammation, oxidative stress, and SUA concentrations. A total of 1440 men, classified depending on the presence of ultrasonographically detected NAFLD, underwent a complete healthy checkup program. Genotypes were extracted from our previously established genome-wide association study database. After adjusting for age, smoking, drinking, body mass index, homeostasis model assessment of insulin resistance, C-reactive protein, creatinine, alanine aminotransferase (ALT) and components of metabolic syndrome, the odds ratio for NAFLD, comparing the highest with the lowest SUA quartile, was 2.81 (95% confidence interval 1.66-4.76). A stepwise multivariate linear regression analysis (R-2 = 0.238, P<0.001) retained age, waist circumference, serum creatinine, triglycerides, the Q141K variant in ABCG2 (rs2231142) and NAFLD as significant predictors of SUA levels (all P<0.001). Besides, ALT and Met196Arg variant in TNFRSF1B (rs1061622) additionally associated with SUA among individuls with NAFLD. Our data suggest that in Chinese men, elevated SUA is significantly associated with NAFLD, independent of insulin resistance and other metabolic disorders, such as central obesity or hypertriglyceridemia. Meanwhile, among subjects with NAFLD, index of liver damage, such as elevated ALT combined with genetic susceptibility to inflammation associated with increased SUA levels.	[Xie, Yuanliang; Zhang, Youjie; Lu, Zheng; Wu, Chunlei; Liao, Ming; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi Zhuang, Peoples R China; [Wang, Mengjie; Zhang, Shijun; Tan, Aihua; Gao, Yong; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Liang, Zhengjia; Shi, Deyi; Huang, Zhang] Fangchenggang First Peoples Hosp, Med Examinat Ctr, Fangchenggang, Guangxi Zhuang, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi Zhuang, Peoples R China; [Sun, Yu; Li, Zhixian] Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasound, Nanning, Guangxi Zhuang, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China; [Hu, Yanling; Li, Li; Yang, Xiaoli] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi Zhuang, Peoples R China; [Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Yang, XL (corresponding author), Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi Zhuang, Peoples R China.	cncsyxl@gmail.com	Yang, Xiaobo/G-3854-2016; Zhang, Youjie/F-7346-2016; Wang, xiaoxiao/GQQ-2846-2022	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [81060029, 81060234, 30945204, 81060214]; Key Program and University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Chairman Science and Technology Fund and Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]; Guangxi Natural Science Foundation [2011GXNSFA018175, 2010GXNSFA013133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program and University Talents Highland Innovation Team of Guangxi; Chairman Science and Technology Fund and Tackle Program of Guangxi; Guangxi Provincial Department of Finance and Education; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	The work described in this article was supported by grants from the National Natural Science Foundation of China (81060029, 81060234, 30945204, 81060214), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Provincial Department of Finance and Education (2009GJCJ150), and Guangxi Natural Science Foundation (2011GXNSFA018175, and 2010GXNSFA013133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali A, 2010, HEPATOLOGY, V52, P578, DOI 10.1002/hep.23717; Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Beavers KM, 2009, J NUTR HEALTH AGING, V13, P177, DOI 10.1007/s12603-009-0054-5; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Gaffo AL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2761; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hoque R, 2013, J HEPATOL, V58, P1047, DOI 10.1016/j.jhep.2012.12.017; Hou XH, 2011, J GASTROEN HEPATOL, V26, P722, DOI 10.1111/j.1440-1746.2010.06509.x; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kountouras J, 1996, HEPATOLOGY, V23, P229; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lin YC, 2009, PEDIATRICS, V124, pE1221, DOI 10.1542/peds.2008-3087; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meziri M, 2005, ULTRASONICS, V43, P305, DOI 10.1016/j.ultras.2004.09.002; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Peng XE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050256; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Powell EE, 2010, DIGEST DIS, V28, P186, DOI 10.1159/000282084; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Shi Y, 2010, J CLIN INVEST, V120, P1809, DOI 10.1172/JCI43132; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Tian GX, 2012, OBES REV, V13, P381, DOI 10.1111/j.1467-789X.2011.00978.x; Tokushige K, 2007, J HEPATOL, V46, P1104, DOI 10.1016/j.jhep.2007.01.028; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928	41	33	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67152	10.1371/journal.pone.0067152	http://dx.doi.org/10.1371/journal.pone.0067152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935829	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000009
J	Hwang, S; Thangapandian, S; Lee, KW				Hwang, Swan; Thangapandian, Sundarapandian; Lee, Keun Woo			Molecular Dynamics Simulations of Sonic Hedgehog-Receptor and Inhibitor Complexes and Their Applications for Potential Anticancer Agent Discovery	PLOS ONE			English	Article							PSEUDO-ACTIVE-SITE; MESH EWALD METHOD; SIGNALING PATHWAY; CHOLESTEROL MODIFICATION; PROTEINS; SHH; MEDULLOBLASTOMA; LIGAND; CANCER; CELLS	The sonic hedgehog (Shh) signaling pathway is necessary for a variety of development and differentiation during embryogenesis as well as maintenance and renascence of diverse adult tissues. However, an abnormal activation of the signaling pathway is related to various cancers. In this pathway, the Shh signaling transduction is facilitated by binding of Shh to its receptor protein, Ptch. In this study, we modeled the 3D structure of functionally important key loop peptides of Ptch based on homologous proteins. Using this loop model, the molecular interactions between the structural components present in the pseudo-active site of Shh and key residues of Ptch was investigated in atomic level through molecular dynamics (MD) simulations. For the purpose of developing inhibitor candidates of the Shh signaling pathway, the Shh pseudo-active site of this interface region was selected as a target to block the direct binding between Shh and Ptch. Two different structure-based pharmacophore models were generated considering the key loop of Ptch and known inhibitor-induced conformational changes of the Shh through MD simulations. Finally two hit compounds were retrieved through a series of virtual screening combined with molecular docking simulations and we propose two hit compounds as potential inhibitory lead candidates to block the Shh signaling pathway based on their strong interactions to receptor or inhibitor induced conformations of the Shh.	[Hwang, Swan; Thangapandian, Sundarapandian; Lee, Keun Woo] GNU, RINS, PMBBRC, Div Appl Life Sci,Program BK21,SSAC, Jinju, South Korea		Lee, KW (corresponding author), GNU, RINS, PMBBRC, Div Appl Life Sci,Program BK21,SSAC, Jinju, South Korea.	kwlee@gnu.ac.kr			National Research Foundation of Korea (NRF) [2012R1A1A4A01013657, 2009-0081539, 2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ009486]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2012R1A1A4A01013657), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ009486) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advanced Chemistry Development Inc, ACD CNMR PRED V 3 0, P133; [Anonymous], DISC STUD 2 5 5; Bauer RA, 2010, CURR OPIN CHEM BIOL, V14, P308, DOI 10.1016/j.cbpa.2010.02.001; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Caro I, 2010, CLIN CANCER RES, V16, P3335, DOI 10.1158/1078-0432.CCR-09-2570; deSouza ON, 1997, BIOPHYS J, V72, P2395, DOI 10.1016/S0006-3495(97)78884-2; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Etheridge LA, 2010, DEVELOPMENT, V137, P133, DOI 10.1242/dev.043547; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hwang S, 2011, J BIOINFORM COMPUT B, V9, P15, DOI 10.1142/S0219720011005732; Jeong J, 2002, J CLIN INVEST, V110, P591, DOI 10.1172/JCI200216506; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Shahi MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-614; Simmons KJ, 2010, NAT REV MICROBIOL, V8, P501, DOI 10.1038/nrmicro2349; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tostar Ulrica, 2010, Genes Cancer, V1, P941, DOI 10.1177/1947601910385449; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	33	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68271	10.1371/journal.pone.0068271	http://dx.doi.org/10.1371/journal.pone.0068271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935859	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700007
J	Jones, CHD; Cohn, S; Ogilvie, D				Jones, Caroline H. D.; Cohn, Simon; Ogilvie, David			Making Sense of a New Transport System: An Ethnographic Study of the Cambridgeshire Guided Busway	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PHYSICAL-ACTIVITY; HEALTH-CARE; TRANSIT; DRIVERS; STEPS	An increase in public transport use has the potential to contribute to improving population health, and there is growing interest in innovative public transport systems. Yet how new public transport infrastructure is experienced and integrated (or not) into daily practice is little understood. We investigated how the Cambridgeshire Guided Busway, UK, was used and experienced in the weeks following its opening, using the method of participant observation (travelling on the busway and observing and talking to passengers) and drawing on Normalization Process Theory to interpret our data. Using excerpts of field notes to support our interpretations, we describe how the ease with which the new transport system could be integrated into existing daily routines was important in determining whether individuals would continue to use it. It emerged that there were two groups of passengers with different experiences and attitudes. Passengers who had previously travelled frequently on regular bus services did not perceive the new system to be an improvement; consequently, they were frustrated that it was differentiated from and not coherent with the regular system. In contrast, passengers who had previously travelled almost exclusively by car appraised the busway positively and perceived it to be a novel and superior form of travel. Our rich qualitative account highlights the varied and creative ways in which people learn to use new public transport and integrate it into their everyday lives. This has consequences for the introduction and promotion of future transport innovations. It is important to emphasise the novelty of new public transport, but also the ways in which its use can become ordinary and routine. Addressing these issues could help to promote uptake of other public transport interventions, which may contribute to increasing physical activity and improving population health.	[Jones, Caroline H. D.; Ogilvie, David] Univ Cambridge, MRC, Epidemiol Unit, Cambridge CB2 1TN, England; [Jones, Caroline H. D.; Ogilvie, David] Univ Cambridge, UKCRC Ctr Diet & Act Res, Cambridge CB2 1TN, England; [Cohn, Simon] Univ Cambridge, Inst Publ Hlth, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Jones, CHD (corresponding author), Dept Primary Care Hlth Sci, Oxford, England.	caroline.jones@phc.ox.ac.uk		Ogilvie, David/0000-0002-0270-4672	National Institute for Health Research Public Health Research programme [09/3001/06]; Medical Research Council [MC_UP_1001/1]; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MC_UU_12015/6] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/6] Funding Source: researchfish; National Institute for Health Research [09/3001/06] Funding Source: researchfish	National Institute for Health Research Public Health Research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Commuting and Health in Cambridge study is funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: http://www.phr.nihr.ac.uk/funded_projects). DO is also supported by the Medical Research Council [programme number MC_UP_1001/1] and the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. Stagecoach and Whippet provided free travel tickets for the fieldworker. The funding bodies had no part in the study design, in the collection, analysis or interpretation of data, in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Aldred R, 2010, SOC CULT GEOGR, V11, P35, DOI 10.1080/14649360903414593; Association of Social Anthropologists, 2011, ASS SOC ANTHR UK COM; Atkins, 2012, CAMBR GUID BUSW POST; BBC News Cambridgeshire, 2012, BBC NEWS CAMBRIDGESH; BBC News Cambridgeshire, 2011, BBC NEWS CAMBRIDGESH; Besser LM, 2005, AM J PREV MED, V29, P273, DOI 10.1016/j.amepre.2005.06.010; Bryman A., 2013, SOCIAL RES METHODS; Cambridgeshire County Council, 2004, CAMBR GUID BUSW STAT; Census, 2001, STANDARD AREA STAT E; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Creswell J. W., 2007, QUALITATIVE INQUIRY; Department for Transport, 2011, PERS TRAV FACTSH COM; Fujii S, 2003, TRANSPORTATION, V30, P81, DOI 10.1023/A:1021234607980; Geertz C., 1973, INTERPRETATION CULTU, P30; Greene J. C., 1994, HDB QUALITATIVE RES; Guell C, 2012, SOC SCI MED, V75, P233, DOI 10.1016/j.socscimed.2012.01.038; Guell C, QUAL RES IN PRESS; Hammersley M., 2010, ETHNOGRAPHY PRINCIPL; Havergal C, 2011, GUIDED BUS SUCCESS M; Holstein J. A., 1995, ACTIVE INTERVIEW; Honingman JJ, 1989, FIELD RES SOURCEBOOK; Jain J, 2008, J TRANSP GEOGR, V16, P81, DOI 10.1016/j.jtrangeo.2007.05.001; Jones CHD, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-109; MacFarlane A, 2012, QUAL HEALTH RES, V22, P607, DOI 10.1177/1049732311431898; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; May C., 2015, NORMALIZATION PROCES; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; O'Reilly K., 2005, ETHNOGRAPHIC METHODS; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Stokes RJ, 2008, HEALTH PLACE, V14, P45, DOI 10.1016/j.healthplace.2007.04.002; Thogersen J, 2009, TRANSPORT POLICY, V16, P335, DOI 10.1016/j.tranpol.2009.10.008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Travel for Work, 2011, TRAV WORK SURV REP 2; Villanueva K, 2008, PREV MED, V47, P338, DOI 10.1016/j.ypmed.2008.03.005; Watts L, 2008, SOC CULT GEOGR, V9, P711, DOI 10.1080/14649360802292520; Wener RE, 2007, ENVIRON BEHAV, V39, P62, DOI 10.1177/0013916506295571; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017	38	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69254	10.1371/journal.pone.0069254	http://dx.doi.org/10.1371/journal.pone.0069254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	201AX	23935968	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000323114200031
J	Koeck, B; Alos, J; Caro, A; Neveu, R; Crec'hriou, R; Saragoni, G; Lenfant, P				Koeck, Barbara; Alos, Josep; Caro, Anthony; Neveu, Reda; Crec'hriou, Romain; Saragoni, Gilles; Lenfant, Philippe			Contrasting Fish Behavior in Artificial Seascapes with Implications for Resources Conservation	PLOS ONE			English	Article							WHITE SEA BREAM; MOVEMENT PATTERNS; DIPLODUS-SARGUS; REEF FISH; HOME-RANGE; REPRODUCTIVE-BIOLOGY; HABITAT UTILIZATION; ACOUSTIC TELEMETRY; MARINE RESERVES; DIEL ACTIVITY	Artificial reefs are used by many fisheries managers as a tool to mitigate the impact of fisheries on coastal fish communities by providing new habitat for many exploited fish species. However, the comparison between the behavior of wild fish inhabiting either natural or artificial habitats has received less attention. Thus the spatio-temporal patterns of fish that establish their home range in one habitat or the other and their consequences of intra-population differentiation on life-history remain largely unexplored. We hypothesize that individuals with a preferred habitat (i.e. natural vs. artificial) can behave differently in terms of habitat use, with important consequences on population dynamics (e. g. life-history, mortality, and reproductive success). Therefore, using biotelemetry, 98 white seabream (Diplodus sargus) inhabiting either artificial or natural habitats were tagged and their behavior was monitored for up to eight months. Most white seabreams were highly resident either on natural or artificial reefs, with a preference for the shallow artificial reef subsets. Connectivity between artificial and natural reefs was limited for resident individuals due to great inter-habitat distances. The temporal behavioral patterns of white seabreams differed between artificial and natural reefs. Artificial-reef resident fish had a predominantly nocturnal diel pattern, whereas natural-reef resident fish showed a diurnal diel pattern. Differences in diel behavioral patterns of white seabream inhabiting artificial and natural reefs could be the expression of realized individual specialization resulting from differences in habitat configuration and resource availability between these two habitats. Artificial reefs have the potential to modify not only seascape connectivity but also the individual behavioral patterns of fishes. Future management plans of coastal areas and fisheries resources, including artificial reef implementation, should therefore consider the potential effect of habitat modification on fish behavior, which could have key implications on fish dynamics.	[Koeck, Barbara; Caro, Anthony; Neveu, Reda; Crec'hriou, Romain; Saragoni, Gilles; Lenfant, Philippe] Univ Perpignan, Ctr Format & Rech Environn Mediterraneens, F-66025 Perpignan, France; [Koeck, Barbara; Caro, Anthony; Neveu, Reda; Crec'hriou, Romain; Saragoni, Gilles; Lenfant, Philippe] CNRS, Ctr Format & Rech Environn Mediterraneens, Perpignan, France; [Alos, Josep] Inst Mediterraneo Estudios Avanzados, IMEDEA CSIC UIB, Esporles, Illes Balears, Spain	Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Koeck, B (corresponding author), Univ Perpignan, Ctr Format & Rech Environn Mediterraneens, Via Domitia, F-66025 Perpignan, France.	barbara.koeck@univ-perp.fr	Koeck, Barbara/D-5174-2013	Koeck, Barbara/0000-0001-7142-364X; Alos, Josep/0000-0003-4385-9539	French ministry of higher education and research; regional council of Languedoc-Roussillon (France)	French ministry of higher education and research; regional council of Languedoc-Roussillon (France)(Region Occitanie)	This work was in partial fulfillment of the doctoral thesis of Barbara Koeck at the "Ecole Pratique des Hautes Etudes" (EPHE, Paris), who was supported by a grant from the French ministry of higher education and research. The study has been funded by the regional council of Languedoc-Roussillon (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Ashworth JS, 2005, BIOL CONSERV, V121, P333, DOI 10.1016/j.biocon.2004.05.006; Baine M, 2003, REV FISH BIOL FISHER, V13, P187, DOI 10.1023/B:RFBF.0000019480.95010.67; Bates D., 2013, LME4 LINEAR MIXED EF; Beck MW, 2000, J EXP MAR BIOL ECOL, V249, P29, DOI 10.1016/S0022-0981(00)00171-4; BELL JD, 1983, J APPL ECOL, V20, P357, DOI 10.2307/2403513; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bryars S, 2012, MAR FRESHWATER RES, V63, P552, DOI 10.1071/MF12016; Carr SD, 2004, ESTUAR COAST SHELF S, V60, P567, DOI 10.1016/j.ecss.2004.02.012; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Criquet G., 2010, UMR5244 CNRSEPHEUPVD; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Erzini K, 1996, ICES J MAR SCI, V53, P811, DOI 10.1006/jmsc.1996.0102; Fabrizio MC, 2007, J EXP MAR BIOL ECOL, V351, P243, DOI 10.1016/j.jembe.2007.06.031; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; FAO, 2012, SPEC FACT SHEETS DIP; Finstad B, 2005, J FISH BIOL, V66, P86, DOI 10.1111/j.0022-1112.2005.00581.x; Gaucherel C., 2011, Computational Ecology and Software, V1, P69; Goni N, 2009, REV M T FIS, V9, P51, DOI 10.1007/978-1-4020-9640-2_4; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hammerschlag-Peyer CM, 2010, MAR ECOL PROG SER, V415, P211, DOI 10.3354/meps08714; HARMELIN JG, 1987, MAR ECOL-P S Z N I, V8, P263, DOI 10.1111/j.1439-0485.1987.tb00188.x; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Huss M, 2008, OECOLOGIA, V158, P249, DOI 10.1007/s00442-008-1140-9; Hussein C, 2011, FISH RES, V108, P163, DOI 10.1016/j.fishres.2010.12.017; Jadot C, 2002, AQUAT LIVING RESOUR, V15, P343, DOI 10.1016/S0990-7440(02)01193-2; Klimley AP, 1998, MAR TECHNOL SOC J, V32, P94; Koeck B, 2013, J EXP MAR BIOL ECOL, V440, P1, DOI 10.1016/j.jembe.2012.11.014; Koeck B, 2011, BRAZ J OCEANOGR, V59, P1; Leitao F, 2009, FISHERIES MANAG ECOL, V16, P88, DOI 10.1111/j.1365-2400.2008.00646.x; Lino PG, 2009, REV-METHODS TECHNOL, V9, P23, DOI 10.1007/978-14020-9640-2_2; Lloret J, 2003, MAR ECOL PROG SER, V248, P197, DOI 10.3354/meps248197; Lucas MC, 2000, FISH FISH, V1, P283, DOI 10.1046/j.1467-2979.2000.00028.x; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; March D, 2011, ESTUAR COAST SHELF S, V92, P581, DOI 10.1016/j.ecss.2011.02.015; Marshell A, 2011, CORAL REEFS, V30, P631, DOI 10.1007/s00338-011-0770-2; McCoy ED, 1990, HABITAT STRUCTURE PH, P427; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Morato T, 2001, FISH RES, V50, P297, DOI 10.1016/S0165-7836(00)00215-0; Moschella PS, 2005, COAST ENG, V52, P1053, DOI 10.1016/j.coastaleng.2005.09.014; Mouine N, 2012, J MAR BIOL ASSOC UK, V92, P623, DOI 10.1017/S0025315411000798; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Parsons DM, 2010, BIOL CONSERV, V143, P2039, DOI 10.1016/j.biocon.2010.05.009; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Ramos J, 2006, B MAR SCI, V78, P203; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; Rosecchi E., 1987, Revue des Travaux de l'Institut des Peches Maritimes, V49, P125; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Seaman W, 2002, ICES J MAR SCI, V59, pS14, DOI 10.1006/jmsc.2002.1277; SHULMAN MJ, 1985, ECOLOGY, V66, P1056, DOI 10.2307/1940565; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Singh L, 2009, AFR J MAR SCI, V31, P355, DOI 10.2989/AJMS.2009.31.3.8.996; Smith TM, 2011, J EXP MAR BIOL ECOL, V399, P8, DOI 10.1016/j.jembe.2011.01.010; Srisurichan S, 2005, NEW ZEAL J MAR FRESH, V39, P749, DOI 10.1080/00288330.2005.9517350; STONE L, 1995, P ROY SOC B-BIOL SCI, V261, P381, DOI 10.1098/rspb.1995.0163; SWEATMAN H, 1994, MAR ECOL PROG SER, V111, P1, DOI 10.3354/meps111001; Taylor MD, 2011, MAR BIOL, V158, P835, DOI 10.1007/s00227-010-1610-6; Topping DT, 2011, FISH RES, V112, P77, DOI 10.1016/j.fishres.2011.08.013; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Tsantilas H, 2006, AQUACULTURE, V253, P64, DOI 10.1016/j.aquaculture.2005.07.034; Turgeon K, 2010, ECOLOGY, V91, P3332, DOI 10.1890/09-2015.1; UNDERWOOD AJ, 1989, J EXP MAR BIOL ECOL, V134, P175, DOI 10.1016/0022-0981(89)90068-3; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Veiga P, 2010, J FISH BIOL, V76, P2216, DOI 10.1111/j.1095-8649.2010.02665.x; Veiga P, 2011, FISH RES, V108, P58, DOI 10.1016/j.fishres.2010.11.021; Wiens JA, 2009, LANDSCAPE ECOL, V24, P1053, DOI 10.1007/s10980-008-9284-x	87	36	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69303	10.1371/journal.pone.0069303	http://dx.doi.org/10.1371/journal.pone.0069303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935978	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200033
J	Canessa, S; Parris, KM				Canessa, Stefano; Parris, Kirsten M.			Multi-Scale, Direct and Indirect Effects of the Urban Stream Syndrome on Amphibian Communities in Streams	PLOS ONE			English	Article							CATCHMENT URBANIZATION; MELBOURNE REGION; FROG ASSEMBLAGES; LAND-COVER; HABITATS; RIPARIAN; AUSTRALIA; VICTORIA; TADPOLES; IMPACTS	Urbanization affects streams by modifying hydrology, increasing pollution and disrupting in-stream and riparian conditions, leading to negative responses by biotic communities. Given the global trend of increasing urbanization, improved understanding of its direct and indirect effects at multiple scales is needed to assist management. The theory of stream ecology suggests that the riverscape and the surrounding landscape are inextricably linked, and watershed-scale processes will also affect in-stream conditions and communities. This is particularly true for species with semi-aquatic life cycles, such as amphibians, which transfer energy between streams and surrounding terrestrial areas. We related measures of urbanization at different scales to frog communities in streams along an urbanization gradient in Melbourne, Australia. We used boosted regression trees to determine the importance of predictors and the shape of species responses. We then used structural equation models to investigate possible indirect effects of watershed imperviousness on in-stream parameters. The proportion of riparian vegetation and road density surrounding the site at the reach scale (500-m radius) had positive and negative effects, respectively, on species richness and on the occurrence of the two most common species in the area (Crinia signifera and Limnodynastes dumerilii). Road density and local aquatic vegetation interacted in influencing species richness, suggesting that isolation of a site can prevent colonization, in spite of apparently good local habitat. Attenuated imperviousness at the catchment scale had a negative effect on local aquatic vegetation, indicating possible indirect effects on frog species not revealed by single-level models. Processes at the landscape scale, particularly related to individual ranging distances, can affect frog species directly and indirectly. Catchment imperviousness might not affect adult frogs directly, but by modifying hydrology it can disrupt local vegetation and prove indirectly detrimental. Integrating multiple-scale management actions may help to meet conservation targets for streams in the face of urbanization.	[Canessa, Stefano] Univ Melbourne, Sch Bot, ARC Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia; Univ Melbourne, Sch Bot, NERP Environm Decis Hub, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne	Canessa, S (corresponding author), Univ Melbourne, Sch Bot, ARC Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia.	canessas@unimelb.edu.au	Parris, Kirsten/K-7684-2012; Canessa, Stefano/J-2069-2014	Parris, Kirsten/0000-0003-2550-585X; Canessa, Stefano/0000-0002-0932-826X	University of Melbourne; ARC Centre of Excellence for Environmental Decisions	University of Melbourne(University of Melbourne); ARC Centre of Excellence for Environmental Decisions(Australian Research Council)	Data collection was made possible by support from the University of Melbourne. Manuscript preparation was supported by funding from the University of Melbourne and from the ARC Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; [Anonymous], 2002, CAUSE CORRELATION BI; Anstis M., 2002, TADPOLES S E AUSTR G; BARKER J, 1995, FIELD GUIDE AUSTR FR; Barrett K, 2008, BIOL CONSERV, V141, P2290, DOI 10.1016/j.biocon.2008.06.019; Barrett K, 2010, BIOL CONSERV, V143, P1998, DOI 10.1016/j.biocon.2010.05.001; Booth DB, 2001, WATER SCI APPL, V2, P17; Brabec E, 2002, J PLAN LIT, V16, P499, DOI 10.1177/088541202400903563; Canessa S, 2012, BIODIVERS CONSERV, V21, P729, DOI 10.1007/s10531-011-0211-0; Cooper SD, 1998, AUST J ECOL, V23, P27, DOI 10.1111/j.1442-9993.1998.tb00703.x; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 2009, ECOL SOC, V14; Ficetola GF, 2011, ECOL APPL, V21, P1272, DOI 10.1890/10-0431.1; Groffman PM, 2003, FRONT ECOL ENVIRON, V1, P315, DOI 10.2307/3868092; Hamer AJ, 2002, OECOLOGIA, V132, P445, DOI 10.1007/s00442-002-0968-7; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hamer AJ, 2012, URBAN ECOSYST, V15, P451, DOI 10.1007/s11252-011-0212-5; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Heard GW, 2006, WILDLIFE RES, V33, P557, DOI 10.1071/WR04080; Heard GW, 2010, THESIS LA TROPE U VI; Kennen JG, 2005, AM FISH S S, V47, P39; Lane A, 2008, FRESHWATER BIOL, V53, P2484, DOI 10.1111/j.1365-2427.2008.02068.x; Lauck B., 2005, Pacific Conservation Biology, V11, P50; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; Meyer JL, 2005, J N AM BENTHOL SOC, V24, P602, DOI 10.1899/04-021.1; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Parris KM, 2009, ECOL SOC, V14; Parris KM, 1999, AUST J ECOL, V24, P495, DOI 10.1046/j.1442-9993.1999.00989.x; Paul M.J., 2008, P207, DOI 10.1007/978-0-387-73412-5_12; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; Pillsbury FC, 2008, ECOL APPL, V18, P1107, DOI 10.1890/07-1899.1; Plummer M., 2003, P 3 INT WORKSH DISTR; Price SJ, 2006, BIOL CONSERV, V133, P436, DOI 10.1016/j.biocon.2006.07.005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranvestel AW, 2004, FRESHWATER BIOL, V49, P274, DOI 10.1111/j.1365-2427.2004.01184.x; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Schueler T.R., 1992, WATERSHED RESTORATIO, P21; Smith MA, 2005, ECOGRAPHY, V28, P110; Sonneman JA, 2001, FRESHWATER BIOL, V46, P553, DOI 10.1046/j.1365-2427.2001.00689.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taylor SL, 2004, FRESHWATER BIOL, V49, P835, DOI 10.1111/j.1365-2427.2004.01225.x; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; United Nations, 2007, WORLD POP PROSP 2006; van der Ree R, 2005, ANIM CONSERV, V8, P309, DOI 10.1017/S1367943005002258; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Victorian. Government, 2009, DEL MELB NEW SUST CO; Walsh CJ, 2007, FRESHWATER BIOL, V52, P574, DOI 10.1111/j.1365-2427.2006.01706.x; Walsh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045814; Walsh CJ, 2009, J N AM BENTHOL SOC, V28, P977, DOI 10.1899/08-161.1; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Walsh CJ, 2001, FRESHWATER BIOL, V46, P535, DOI 10.1046/j.1365-2427.2001.00690.x; Wang LZ, 2003, T AM FISH SOC, V132, P825, DOI 10.1577/T02-099; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; WASSERSUG RJ, 1975, AM ZOOL, V15, P405	60	16	17	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70262	10.1371/journal.pone.0070262	http://dx.doi.org/10.1371/journal.pone.0070262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922963	Green Published, gold			2022-12-27	WOS:000323369700159
J	Garcia, C; Avila, V; Quesada, H; Caballero, A				Garcia, Carlos; Avila, Victoria; Quesada, Humberto; Caballero, Armando			Candidate Transcriptomic Sources of Inbreeding Depression in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; AVERAGE COEFFICIENT; DOMINANCE; GENOMICS; EVOLUTION; SOFTWARE	The genomic causes of inbreeding depression are poorly known. Several studies have found widespread transcriptomic alterations in inbred organisms, but it remains unclear which of these alterations are causes of the depression and which are mere responses to the ensuing physiological stress induced by increased homozygosity due to inbreeding. Attempting to differentiate causes from responses, we made a c-DNA microarray analysis of inbreeding depression in Drosophila melanogaster. The rationale of the experiment was that, while depression is a general phenomenon involving reductions in fitness in different inbred lines, its first genetic causes would be different for each inbred line, as they are expected to be caused by the fixation of rare deleterious genes. We took four sets of inbred sublines, each set descending from a different founding pair obtained from a large outbred stock, and compared the expression of the three most depressed sublines and the three least depressed sublines from each set. Many changes in expression were common to all sets, but fourteen genes, grouped in four expression clusters, showed strong set-specific changes, and were therefore possible candidates to be sources of the inbreeding depression observed.	[Garcia, Carlos] Univ Santiago de Compostela, Dept Xenet, Santiago De Compostela, Galicia, Spain; [Avila, Victoria] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Quesada, Humberto; Caballero, Armando] Univ Vigo, Dep Bioquim Genet & Inmunol, Vigo 36310, Galicia, Spain	Universidade de Santiago de Compostela; University of Edinburgh; Universidade de Vigo	Garcia, C (corresponding author), Univ Santiago de Compostela, Dept Xenet, Santiago De Compostela, Galicia, Spain.	carlos.garcia.suarez@usc.es	Caballero, Armando/H-5358-2015; Quesada, Humberto/Y-9619-2019; Caballero, Armando/AAX-4960-2020	Caballero, Armando/0000-0001-7391-6974; Quesada, Humberto/0000-0002-2927-0915	Xunta de Galicia [INCITE08PXIB200119PR]; Xunta de Galicia (Grupos de Referencia Competitiva) [2010/80]; Ministerio de Ciencia y Tecnologia [CGL2009-13278-C02, CGL2012-39861-C02]; Fondos Feder "Unha maneira de facer Europa"	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Xunta de Galicia (Grupos de Referencia Competitiva)(Xunta de Galicia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos Feder "Unha maneira de facer Europa"	This work was funded by Xunta de Galicia (INCITE08PXIB200119PR and Grupos de Referencia Competitiva, 2010/80), Ministerio de Ciencia y Tecnologia (CGL2009-13278-C02, CGL2012-39861-C02) and Fondos Feder: "Unha maneira de facer Europa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Ayroles JF, 2009, CONSERV BIOL, V23, P920, DOI 10.1111/j.1523-1739.2009.01186.x; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carr DE, 2003, PHILOS T R SOC B, V358, P1071, DOI 10.1098/rstb.2003.1295; Casellas J, 2009, J ANIM SCI, V87, P72, DOI 10.2527/jas.2008-0897; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crow J. F., 2000, Plant Breeding Reviews, V17, P225; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dudoit S, 2002, 110 U CAL DIV BIOST; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fernandez B, 2005, GENETICS, V171, P2097, DOI 10.1534/genetics.105.044750; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garcia C, 2013, FLY, V7, DOI 10.4161/fly.22559; Garcia C, 2012, GENETICS, V192, P161, DOI 10.1534/genetics.112.142687; Garcia-Dorado A, 1999, GENET RES, V74, P341, DOI 10.1017/S0016672399004206; Garcia-Dorado A, 2000, GENETICS, V155, P1991; Garcia-Dorado Aurora, 2004, P20; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Hughes KA, 2006, GENETICS, V173, P1347, DOI 10.1534/genetics.105.051474; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Laikre L, 1999, ZOO BIOL, V18, P81, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;81::AID-ZOO1&gt;3.0.CO;2-2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Mukai T., 1988, Proceedings of the Second International Conference on Quantitative Genetics., P21; Mukai T., 1985, POPULATION GENETICS, P125; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Paige KN, 2010, BIOSCIENCE, V60, P267, DOI 10.1525/bio.2010.60.4.5; R Core Team, 2021, R LANGUAGE ENV STAT; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Roff DA, 2002, EVOLUTION, V56, P768, DOI 10.1111/j.0014-3820.2002.tb01387.x; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; Suzuki R, 2011, PVCLUST HIERARCHICAL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Vermeulen CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-297; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843	57	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70067	10.1371/journal.pone.0070067	http://dx.doi.org/10.1371/journal.pone.0070067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922905	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700127
J	Nikitopoulou, I; Kaffe, E; Sevastou, I; Sirioti, I; Samiotaki, M; Madan, D; Prestwich, GD; Aidinis, V				Nikitopoulou, Ioanna; Kaffe, Eleanna; Sevastou, Ioanna; Sirioti, Ivi; Samiotaki, Martina; Madan, Damian; Prestwich, Glenn D.; Aidinis, Vassilis			A Metabolically-Stabilized Phosphonate Analog of Lysophosphatidic Acid Attenuates Collagen-Induced Arthritis	PLOS ONE			English	Article							LYSOPHOSPHOLIPASE-D ACTIVITY; RHEUMATOID-ARTHRITIS; AUTOTAXIN EXPRESSION; SELECTIVE AGONISTS; IN-VITRO; LPA; RECEPTOR; IDENTIFICATION; ANTAGONISTS; PATHOGENESIS	Rheumatoid arthritis (RA) is a destructive arthropathy with systemic manifestations, characterized by chronic synovial inflammation. Under the influence of the pro-inflammatory milieu synovial fibroblasts (SFs), the main effector cells in disease pathogenesis become activated and hyperplastic while releasing a number of signals that include pro-inflammatory factors and tissue remodeling enzymes. Activated RA SFs in mouse or human arthritic joints express significant quantities of autotaxin (ATX), a lysophospholipase D responsible for the majority of lysophosphatidic acid (LPA) production in the serum and inflamed sites. Conditional genetic ablation of ATX from SFs resulted in attenuation of disease symptoms in animal models, an effect attributed to diminished LPA signaling in the synovium, shown to activate SF effector functions. Here we show that administration of 1-bromo-3(S)-hydroxy-4-(palmitoyloxy)butyl-phosphonate (BrP-LPA), a metabolically stabilized analog of LPA and a dual function inhibitor of ATX and pan-antagonist of LPA receptors, attenuates collagen induced arthritis (CIA) development, thus validating the ATX/LPA axis as a novel therapeutic target in RA.	[Nikitopoulou, Ioanna; Kaffe, Eleanna; Sevastou, Ioanna; Sirioti, Ivi; Samiotaki, Martina; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Athens, Greece; [Madan, Damian] Echelon Biosci Inc, Salt Lake City, UT USA; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Alexander Fleming Biomedical Sciences Research Center; Utah System of Higher Education; University of Utah	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Athens, Greece.	V.Aidinis@Fleming.gr	Samiotaki, Martina/B-3851-2018; Aidinis, Vassilis/AAF-5380-2021	Samiotaki, Martina/0000-0001-9952-0636; Aidinis, Vassilis/0000-0001-9531-7729	European Commission [LSHG-CT-2005-005203]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission LSHG-CT-2005-005203 grant to VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidinis V, 2005, PLOS GENET, V1, P455, DOI 10.1371/journal.pgen.0010048; Aidinis V, 2003, ARTHRITIS RES THER, V5, pR140, DOI 10.1186/ar749; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Albers HM, 2012, CHEM REV; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Bai Z, 2013, J IMMUNOL; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Boutin JA, 2009, CELL MOL LIFE SCI, V66, P3009, DOI 10.1007/s00018-009-0056-9; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Clair T, 2003, CANCER RES, V63, P5446; Clair Timothy, 2005, Lipids Health Dis, V4, P5, DOI 10.1186/1476-511X-4-5; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Ferguson CG, 2006, ORG LETT, V8, P2023, DOI 10.1021/ol060414i; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Ferry G, 2008, J PHARMACOL EXP THER; Fischer DJ, 2001, MOL PHARMACOL, V60, P776; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gierse J, J PHARM EXP THER, V334, P310; Gierse JK, 2010, J PHARM EXP THER; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Gududuru V, 2006, BIOORG MED CHEM LETT, V16, P451, DOI 10.1016/j.bmcl.2005.08.096; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Hoeglund AB, 2010, J MED CHEM, V53, P1056, DOI 10.1021/jm9012328; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Im DS, 2010, ACTA PHARMACOL SIN, V31, P1213, DOI 10.1038/aps.2010.135; Ishii S, 2009, PROSTAGLANDINS OTHER; Jiang GW, 2007, CHEMMEDCHEM, V2, P679, DOI 10.1002/cmdc.200600280; Jiang GW, 2011, BIOORG MED CHEM LETT, V21, P5098, DOI 10.1016/j.bmcl.2011.03.068; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu SY, 2009, CELL CYCLE, V8, P3695, DOI 10.4161/cc.8.22.9937; Mazzocca A, 2011, HEPATOLOGY, V54, P920, DOI 10.1002/hep.24485; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Nakamura K, 2007, ANAL BIOCHEM, V367, P20, DOI 10.1016/j.ab.2007.05.004; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Ojala PJ, 2007, J LEUKOCYTE BIOL, V82, P1501, DOI 10.1189/jlb.0507292; Orosa B, 2012, ARTHRITIS RHEUM; Parrill AL, 2008, BIOORGAN MED CHEM, V16, P1784, DOI 10.1016/j.bmc.2007.11.018; Plows D, 1999, J IMMUNOL, V162, P1018; Prestwich GD, 2008, BIOCHIM BIOPHYS ACTA, V8, P8; Saunders LP, 2011, J BIOL CHEM, V286, P30130, DOI 10.1074/jbc.M111.246884; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Stanczyk J, 2006, CURR OPIN RHEUMATOL, V18, P262, DOI 10.1097/01.bor.0000218947.42730.dd; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Taube J, 1999, BLOOD, V93, P3792, DOI 10.1182/blood.V93.11.3792.411k06_3792_3797; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; Tokumura A, 1998, LIPIDS, V33, P1009, DOI 10.1007/s11745-998-0299-2; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2009, INT J MED SCI, V6, P168; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2005, J BIOL CHEM, V280, P21155, DOI 10.1074/jbc.M413183200; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Virag T, 2003, MOL PHARMACOL, V63, P1032, DOI 10.1124/mol.63.5.1032; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; WELTZIEN HU, 1977, BIOCHIM BIOPHYS ACTA, V466, P411, DOI 10.1016/0005-2736(77)90334-0; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Xu XY, 2010, CANCER-AM CANCER SOC, V116, P1739, DOI 10.1002/cncr.24907; Yang G., 2012, J CAN RES UPDATES, V1, P69; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao CQ, 2008, MOL PHARMACOL, V73, P587, DOI 10.1124/mol.107.038216; Zhao CQ, 2011, J LIPID RES, V52, P1307, DOI 10.1194/jlr.M008045	83	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70941	10.1371/journal.pone.0070941	http://dx.doi.org/10.1371/journal.pone.0070941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923032	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700214
J	Singh, A; Falk, MK; Subhi, Y; Sorensen, TL				Singh, Amardeep; Falk, Mads Kruger; Subhi, Yousif; Sorensen, Torben Lykke			The Association between Plasma 25-Hydroxyvitamin D and Subgroups in Age-Related Macular Degeneration: A Cross-Sectional Study	PLOS ONE			English	Article							VITAMIN-D LEVELS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; INFLAMMATION; FIBROSIS; ANGIOGENESIS; INHIBITION; EXPRESSION; DISEASE; CANCER	Objectives: To evaluate potential differences in plasma 25-hydroxyvitamin in subtypes of age-related macular degeneration (AMD), and in patients in Clinical Age-Related Maculopathy Staging (CARMS) group 5 with or without subretinal fibrosis. Methods: This single-center cross-sectional study included 178 participants during a period of 20 months. Ninety-five patients belonged to CARMS 5; twelve belonged to CARMS 4; twenty-two belonged to CARMS 2 or 3; and 49 individuals did not have AMD (CARMS 1). Following a structured interview, a detailed bilateral retinal examination was performed and participants were allocated to their respective subgroups in accordance with the Clinical Age-Related Maculopathy Staging system. Plasma 25-hydroxyvitamin D2 and D3 were analyzed using liquid chromatography-tandem mass spectrometry. Genomic DNA was extracted from leukocytes and genotyped for single nucleotide polymorphisms (SNPs) in the vitamin D metabolism. Differences in plasma 25-hydroxyvitamin D were determined in the subgroups as well as between patients in CARMS 5 with or without subretinal fibrosis. Results: Plasma 25-hydroxyvitamin D was comparable in patients across CARMS groups 1 to 5 (p = 0.83). In CARMS 5, the presence of subretinal fibrosis was associated with significantly lower concentrations of 25-hydroxyvitamin D as compared to the absence of subretinal fibrosis (47.2 versus 75.6 nmol/L, p<0.001). Patients in CARMS 5 with subretinal fibrosis were more likely to have insufficient levels of 25-hydroxyvitamin D compared to patients without subretinal fibrosis (p = 0.006). No association was found between the SNPs rs10877012, rs2228570, rs4588, or rs7041 and AMD subgroups or plasma 25-hydroxyvitamin levels. Conclusions: This study suggests that the presence of subretinal fibrosis in patients belonging to CARMS 5 may be associated with a poor vitamin D status. Our observations warrant further investigation into the role of vitamin D in the development of subretinal fibrosis.	[Singh, Amardeep] Copenhagen Univ Hosp, Clin Eye Res Unit, Dept Ophthalmol, Roskilde, Denmark; Univ Copenhagen, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Singh, A (corresponding author), Copenhagen Univ Hosp, Clin Eye Res Unit, Dept Ophthalmol, Roskilde, Denmark.	asingh@dadlnet.dk	Sørensen, Torben Lykke L/N-1417-2014; Subhi, Yousif/ABG-6330-2020; Singh, Amardeep/ABI-4544-2020	Sørensen, Torben Lykke L/0000-0002-6790-0199; Subhi, Yousif/0000-0001-6620-5365; 	Region Zealand's Research Fund; Velux Foundation; Danish Research Eye Foundation; Danish Eye Health Society (Vaern om Synet); Beckett Foundation; Synoptik Foundation	Region Zealand's Research Fund; Velux Foundation(Velux Fonden); Danish Research Eye Foundation; Danish Eye Health Society (Vaern om Synet); Beckett Foundation; Synoptik Foundation	This study was funded by Region Zealand's Research Fund, the Velux Foundation, the Danish Research Eye Foundation, the Danish Eye Health Society (Vaern om Synet), the Beckett Foundation, and the Synoptik Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Akin F, 2012, J INVEST MED, V60, P869, DOI 10.2310/JIM.0b013e31825457cb; Amtul Z, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.014; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Annweiler C, 2012, COGN BEHAV NEUROL, V25, P121, DOI 10.1097/WNN.0b013e31826df647; Annweiler C, 2012, OPHTHALMOLOGY, V119, P1090, DOI 10.1016/j.ophtha.2012.02.005; Arnson Y, 2011, AUTOIMMUN REV, V10, P490, DOI 10.1016/j.autrev.2011.02.002; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Burgisser P, 2007, CYTOM PART A, V71A, P632, DOI 10.1002/cyto.a.20414; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; Cheung FSG, 2012, EXPERT REV ANTICANC, V12, P811, DOI [10.1586/era.12.53, 10.1586/ERA.12.53]; Francis Peter James, 2011, Trans Am Ophthalmol Soc, V109, P115; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Golan S, 2011, EYE, V25, P1122, DOI 10.1038/eye.2011.174; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Graffe A, 2012, J AM GERIATR SOC, V60, P1367, DOI 10.1111/j.1532-5415.2012.04015.x; Guillot X, 2010, JOINT BONE SPINE, V77, P552, DOI 10.1016/j.jbspin.2010.09.018; Halder SK, 2011, J CLIN ENDOCR METAB, V96, pE754, DOI 10.1210/jc.2010-2131; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Iseki K, 1999, INT J CANCER, V81, P730, DOI 10.1002/(SICI)1097-0215(19990531)81:5&lt;730::AID-IJC11&gt;3.0.CO;2-Q; Isik S, 2012, EUR J INTERN MED, V23, P93, DOI 10.1016/j.ejim.2011.09.017; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein BEK, 2008, OPHTHALMOLOGY, V115, P1203, DOI 10.1016/j.ophtha.2007.09.011; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Koleganova N, 2009, NEPHROL DIAL TRANSPL, V24, P778, DOI 10.1093/ndt/gfn549; Krishnan AV, 2011, ANNU REV PHARMACOL, V51, P311, DOI 10.1146/annurev-pharmtox-010510-100611; Lee V, 2012, NEUROBIOL AGING, V33, P2382, DOI 10.1016/j.neurobiolaging.2011.12.002; Liakopoulos S, 2008, INVEST OPHTH VIS SCI, V49, P5048, DOI 10.1167/iovs.08-1877; Lin AMY, 2005, ANN NY ACAD SCI, V1053, P319, DOI 10.1196/annals.1344.028; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Morrison Margaux A., 2011, Human Genomics, V5, P538; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; Owen CG, 2003, BRIT J OPHTHALMOL, V87, P312, DOI 10.1136/bjo.87.3.312; Parekh N, 2007, ARCH OPHTHALMOL-CHIC, V125, P661, DOI 10.1001/archopht.125.5.661; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; SCHECHTMAN KB, 1991, AM J PUBLIC HEALTH, V81, P771, DOI 10.2105/AJPH.81.6.771; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2011, OPHTHALMOLOGY, V118, P1386, DOI 10.1016/j.ophtha.2010.12.020; Shanker J, 2011, CORONARY ARTERY DIS, V22, P324, DOI 10.1097/MCA.0b013e3283472a57; Shen CL, 2012, J MED FOOD, V15, P269, DOI 10.1089/jmf.2011.0163; SHOKRAVI MT, 1995, INVEST OPHTH VIS SCI, V36, P83; Singh A, 2012, AM J OPHTHALMOL, V154, P193, DOI 10.1016/j.ajo.2012.01.036; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Woo JH, 2009, ACTA OPHTHALMOL, V87, P262, DOI 10.1111/j.1755-3768.2008.01376.x; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	52	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70948	10.1371/journal.pone.0070948	http://dx.doi.org/10.1371/journal.pone.0070948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923033	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700215
J	Tuncay, E; Okatan, EN; Vassort, G; Turan, B				Tuncay, Erkan; Okatan, Esma N.; Vassort, Guy; Turan, Belma			beta-Blocker Timolol Prevents Arrhythmogenic Ca2+ Release and Normalizes Ca2+ and Zn2+ Dyshomeostasis in Hyperglycemic Rat Heart	PLOS ONE			English	Article							PROTEIN-KINASE-II; RYANODINE RECEPTOR; SER(16) PHOSPHORYLATION; NA+-CA2+ EXCHANGER; REACTIVE OXYGEN; CALCIUM; ZINC; PHOSPHOLAMBAN; MEMBRANE; CHANNELS	Defective cardiac mechanical activity in diabetes results from alterations in intracellular Ca2+ handling, in part, due to increased oxidative stress. Beta-blockers demonstrate marked beneficial effects in heart dysfunction with scavenging free radicals and/or acting as an antioxidant. The aim of this study was to address how beta-blocker timolol-treatment of diabetic rats exerts cardioprotection. Timolol-treatment (12-week), one-week following diabetes induction, prevented diabetes-induced depressed left ventricular basal contractile activity, prolonged cellular electrical activity, and attenuated the increase in isolated-cardiomyocyte size without hyperglycemic effect. Both in vivo and in vitro timolol-treatment of diabetic cardiomyocytes prevented the altered kinetic parameters of Ca2+ transients and reduced Ca2+ loading of sarcoplasmic reticulum (SR), basal intracellular free Ca2+ and Zn2+ ([Ca2+](i) and [Zn2+](i)), and spatio-temporal properties of the Ca2+ sparks, significantly. Timolol also antagonized hyperphosphorylation of cardiac ryanodine receptor (RyR2), and significantly restored depleted protein levels of both RyR2 and calstabin2. Western blot analysis demonstrated that timolol-treatment also significantly normalized depressed levels of some [Ca2+](i)-handling regulators, such as Na+/Ca2+ exchanger (NCX) and phospho-phospholamban (pPLN) to PLN ratio. Incubation of diabetic cardiomyocytes with 4-mM glutathione exerted similar beneficial effects on RyR2-macromolecular complex and basal levels of both [Ca2+](i) and [Zn2+](i), increased intracellular Zn2+ hyperphosphorylated RyR2 in a concentration-dependent manner. Timolol also led to a balanced oxidant/antioxidant level in both heart and circulation and prevented altered cellular redox state of the heart. We thus report, for the first time, that the preventing effect of timolol, directly targeting heart, seems to be associated with a normalization of macromolecular complex of RyR2 and some Ca2+ handling regulators, and prevention of Ca2+ leak, and thereby normalization of both [Ca2+](i) and [Zn2+](i) homeostasis in diabetic rat heart, at least in part by controlling the cellular redox status of hyperglycemic cardiomyocytes.	[Tuncay, Erkan; Okatan, Esma N.; Turan, Belma] Ankara Univ, Fac Med, Dept Biophys, TR-06100 Ankara, Turkey; [Vassort, Guy] CHU Arnaud Villeneuve, INSERM, U1046, Montpellier, France	Ankara University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Turan, B (corresponding author), Ankara Univ, Fac Med, Dept Biophys, TR-06100 Ankara, Turkey.	belma.turan@medicine.ankara.edu.tr	okatan, esma nur/AAW-6201-2021; Okatan, Esma Nur/A-7202-2016; TURAN, Belma/AAG-8084-2020; TUNCAY, ERKAN/AAG-8065-2020	okatan, esma nur/0000-0002-0795-6078; Okatan, Esma Nur/0000-0002-0795-6078; TURAN, Belma/0000-0003-2583-9294; TUNCAY, ERKAN/0000-0002-6675-2534	TUBITAK [SBAG-111S042]	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work has been supported partially by grant from TUBITAK SBAG-111S042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADAMS JA, 1993, J BIOL CHEM, V268, P7747; Alvarez-Collazo J, 2012, PFLUG ARCH EUR J PHY, V464, P459, DOI 10.1007/s00424-012-1162-3; Aras MA, 2011, ANTIOXID REDOX SIGN, V15, P2249, DOI 10.1089/ars.2010.3607; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Ayaz M, 2006, AM J PHYSIOL-HEART C, V290, pH1071, DOI 10.1152/ajpheart.00754.2005; Ayaz M, 2005, BIOCHEM BIOPH RES CO, V327, P163, DOI 10.1016/j.bbrc.2004.12.003; Ayaz M, 2004, ARCH BIOCHEM BIOPHYS, V426, P83, DOI 10.1016/j.abb.2004.03.030; Aydemir-Koksoy A, 2010, J NUTR BIOCHEM, V21, P827, DOI 10.1016/j.jnutbio.2009.06.006; Bai SZ, 2012, DIABETES RES CLIN PR, V95, P378, DOI 10.1016/j.diabres.2011.11.007; Bidasee KR, 2003, MOL CELL BIOCHEM, V249, P113, DOI 10.1023/A:1024738706470; Bidasee KR, 2003, J PHARMACOL EXP THER, V305, P989, DOI 10.1124/jpet.102.046201; Bilginoglu A, 2007, MOL CELL BIOCHEM, V305, P63, DOI 10.1007/s11010-007-9528-0; Bilginoglu A, 2013, CARDIOVASC TOXICOL, V13, P138, DOI 10.1007/s12012-012-9192-9; Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181; Choi KM, 2002, AM J PHYSIOL-HEART C, V283, pH1398, DOI 10.1152/ajpheart.00313.2002; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; CRAWFORD AJ, 1987, EXP NEUROL, V95, P265, DOI 10.1016/0014-4886(87)90137-3; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Djanani A, 2003, PHARMACOLOGY, V68, P198, DOI 10.1159/000070459; Doi M, 2002, CIRCULATION, V105, P1374, DOI 10.1161/hc1102.105270; Eager KR, 1997, AM J PHYSIOL-CELL PH, V272, pC1908, DOI 10.1152/ajpcell.1997.272.6.C1908; Toblli JE, 2012, VASC HEALTH RISK MAN, V8, P151, DOI 10.2147/VHRM.S20669; FEIN FS, 1980, CIRC RES, V47, P922, DOI 10.1161/01.RES.47.6.922; FELDMAN MD, 1987, CIRCULATION, V75, P331, DOI 10.1161/01.CIR.75.2.331; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Gomes A, 2006, BIOORGAN MED CHEM, V14, P4568, DOI 10.1016/j.bmc.2006.02.023; Hagemann D, 2000, J BIOL CHEM, V275, P22532, DOI 10.1074/jbc.C000253200; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hattori Y, 2000, J PHYSIOL-LONDON, V527, P85, DOI 10.1111/j.1469-7793.2000.00085.x; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; HJALMARSON A, 1994, DRUGS, V47, P31, DOI 10.2165/00003495-199400474-00006; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kamalov G, 2010, AM J PHYSIOL-HEART C, V298, pH385, DOI 10.1152/ajpheart.00593.2009; Kim HW, 2001, LIFE SCI, V70, P367, DOI 10.1016/S0024-3205(01)01483-7; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Lengyel I, 2000, J NEUROCHEM, V75, P594, DOI 10.1046/j.1471-4159.2000.0750594.x; Luo JZ, 2006, J MOL CELL CARDIOL, V40, P64, DOI 10.1016/j.yjmcc.2005.09.013; Malaiyandi LM, 2004, GLIA, V45, P346, DOI 10.1002/glia.10332; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Matias CM, 2010, J FLUORESC, V20, P377, DOI 10.1007/s10895-009-0539-y; Miyamoto N, 2009, INVEST OPHTH VIS SCI, V50, P2777, DOI 10.1167/iovs.08-3061; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Pierce G N, 1985, Can J Cardiol, V1, P48; PIERCE GN, 1985, AM J PHYSIOL, V248, pE170, DOI 10.1152/ajpendo.1985.248.2.E170; PIERCE GN, 1983, P NATL ACAD SCI-BIOL, V80, P5412, DOI 10.1073/pnas.80.17.5412; Qin Y, 2008, J NEUROCHEM, V107, P1304, DOI 10.1111/j.1471-4159.2008.05700.x; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023; Sozmen NN, 2011, CAN J PHYSIOL PHARM, V89, P277, DOI 10.1139/Y11-018; TSUTSUI H, 1994, J CLIN INVEST, V93, P2639, DOI 10.1172/JCI117277; Tuncay E, 2007, MOL CELL BIOCHEM, V304, P255, DOI 10.1007/s11010-007-9508-4; Tuncay E, 2011, J BIOENERG BIOMEMBR, V43, P747, DOI 10.1007/s10863-011-9400-5; Tuncay E, 2011, CARDIOVASC RES, V89, P634, DOI 10.1093/cvr/cvq352; Tuncay E, 2009, CAN J PHYSIOL PHARM, V87, P310, DOI 10.1139/Y09-015; Turan B, 1997, AM J PHYSIOL-HEART C, V272, pH2095, DOI 10.1152/ajpheart.1997.272.5.H2095; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wai B, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-14; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Xia RH, 2000, BIOCHEM J, V345, P279, DOI 10.1042/0264-6021:3450279; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yaras N, 2005, DIABETES, V54, P3082, DOI 10.2337/diabetes.54.11.3082; Yaras N, 2007, AM J PHYSIOL-HEART C, V292, pH912, DOI 10.1152/ajpheart.00824.2006; Zhao JF, 2008, CELL CALCIUM, V44, P422, DOI 10.1016/j.ceca.2008.01.006; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019	74	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71014	10.1371/journal.pone.0071014	http://dx.doi.org/10.1371/journal.pone.0071014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923043	gold, Green Submitted, Green Published			2022-12-27	WOS:000323369700219
J	Turker, I; Yu, CC; Chang, PC; Chen, ZH; Sohma, Y; Lin, SF; Chen, PS; Ai, T				Turker, Isik; Yu, Chih-Chieh; Chang, Po-Cheng; Chen, Zhenhui; Sohma, Yoshiro; Lin, Shien-Fong; Chen, Peng-Sheng; Ai, Tomohiko			Amiodarone Inhibits Apamin-Sensitive Potassium Currents	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; VENTRICULAR-FIBRILLATION; ATRIAL-FIBRILLATION; ELECTRICAL STORM; CA2+ OVERLOAD; HEART-FAILURE; HEK-293 CELLS; CALCIUM; SK2	Background: Apamin sensitive potassium current (I-KAS), carried by the type 2 small conductance Ca2+-activated potassium (SK2) channels, plays an important role in post-shock action potential duration (APD) shortening and recurrent spontaneous ventricular fibrillation (VF) in failing ventricles. Objective: To test the hypothesis that amiodarone inhibits I-KAS in human embryonic kidney 293 (HEK-293) cells. Methods: We used the patch-clamp technique to study I-KAS in HEK-293 cells transiently expressing human SK2 before and after amiodarone administration. Results: Amiodarone inhibited I-KAS in a dose-dependent manner (IC50, 2.67 +/- 0.25 mu M with 1 mu M intrapipette Ca2+). Maximal inhibition was observed with 50 mu M amiodarone which inhibited 85.6 +/- 3.1% of I-KAS induced with 1 mu M intrapipette Ca2+ (n = 3). I-KAS inhibition by amiodarone was not voltage-dependent, but was Ca2+-dependent: 30 mu M amiodarone inhibited 81.5 +/- 1.9% of I-KAS induced with 1 mu M Ca2+ (n = 4), and 16.4 +/- 4.9% with 250 nM Ca2+ (n = 5). Desethylamiodarone, a major metabolite of amiodarone, also exerts voltage-independent but Ca2+ dependent inhibition of I-KAS. Conclusion: Both amiodarone and desethylamiodarone inhibit I-KAS at therapeutic concentrations. The inhibition is independent of time and voltage, but is dependent on the intracellular Ca2+ concentration. SK2 current inhibition may in part underlie amiodarone's effects in preventing electrical storm in failing ventricles.	[Turker, Isik; Yu, Chih-Chieh; Chang, Po-Cheng; Chen, Zhenhui; Lin, Shien-Fong; Chen, Peng-Sheng; Ai, Tomohiko] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Turker, Isik; Yu, Chih-Chieh; Chang, Po-Cheng; Chen, Zhenhui; Lin, Shien-Fong; Chen, Peng-Sheng; Ai, Tomohiko] Indiana Univ Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Yu, Chih-Chieh] Natl Taiwan Univ, Div Cardiol, Dept Med, Taipei 10764, Taiwan; [Sohma, Yoshiro] Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 160, Japan	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Taiwan University; Keio University	Ai, T (corresponding author), Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	ait@iupui.edu	Chang, Po-Cheng/ABA-4979-2020; Lin, Shien-fong/AAQ-1608-2020	Chang, Po-Cheng/0000-0002-6901-5951; Lin, Shien-fong/0000-0003-1270-3961; Ai, Tomohiko/0000-0003-0376-0227; Yu, Chih-Chieh/0000-0002-2136-2444	NIH [P01HL78931, R01HL78932, R01HL71140]; Medtronic-Zipes Endowment; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071140, R01HL078932, P01HL078931] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic-Zipes Endowment; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NIH Grants P01HL78931, R01HL78932, R01HL71140, a Medtronic-Zipes Endowment (P.-S.C.) and an Indiana University Health-Indiana University School of Medicine Strategic Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JP, 2011, ANN REV PHYSL; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Benton DCH, 2003, J PHYSIOL-LONDON, V553, P13, DOI 10.1113/jphysiol.2003.054551; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Chang PC, 2013, J AM HEART ASS, P2; Chen PS, 2012, CIRC-ARRHYTHMIA ELEC, V5, P618, DOI 10.1161/CIRCEP.112.974956; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Credner SC, 1998, J AM COLL CARDIOL, V32, P1909, DOI 10.1016/S0735-1097(98)00495-1; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Dreixler JC, 2000, ANESTH ANALG, V90, P727, DOI 10.1097/00000539-200003000-00040; Gatzoulis KA, 2005, EUROPACE, V7, P184, DOI 10.1016/j.eupc.2005.01.003; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hsieh YC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P410, DOI 10.1161/CIRCEP.111.000152; IKEDA N, 1984, AM HEART J, V108, P890, DOI 10.1016/0002-8703(84)90451-4; Israel CW, 2007, ANN NONINVAS ELECTRO, V12, P375, DOI 10.1111/j.1542-474X.2007.00187.x; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KOJIMA S, 1994, AM J PHYSIOL, V266, pH1473; KORETSUNE Y, 1989, CIRCULATION, V80, P369, DOI 10.1161/01.CIR.80.2.369; KOWEY PR, 1995, CIRCULATION, V92, P3255, DOI 10.1161/01.CIR.92.11.3255; Le Bouter S, 2004, CIRCULATION, V110, P3028, DOI 10.1161/01.CIR.0000147187.78162.AC; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Ogawa M, 2009, HEART RHYTHM, V6, P784, DOI 10.1016/j.hrthm.2009.02.017; Omichi C, 2002, AM J PHYSIOL-HEART C, V282, pH1063, DOI 10.1152/ajpheart.00633.2001; Patterson E, 2006, J AM COLL CARDIOL, V47, P1196, DOI 10.1016/j.jacc.2005.12.023; SBARBARO JA, 1979, AM J CARDIOL, V44, P513, DOI 10.1016/0002-9149(79)90405-3; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Vassallo P, 2007, JAMA-J AM MED ASSOC, V298, P1312, DOI 10.1001/jama.298.11.1312; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Weatherall KL, 2010, PROG NEUROBIOL, V91, P242, DOI 10.1016/j.pneurobio.2010.03.002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zaugg C, 1998, J MOL CELL CARDIOL, V30, P2183, DOI 10.1006/jmcc.1998.0777; Zaugg CE, 2002, J CARDIOVASC ELECTR, V13, P1017, DOI 10.1046/j.1540-8167.2002.01017.x; Zhang YH, 2010, J ELECTROCARDIOL, V43, P440, DOI 10.1016/j.jelectrocard.2010.04.007; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	40	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70450	10.1371/journal.pone.0070450	http://dx.doi.org/10.1371/journal.pone.0070450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922993	Green Submitted, gold, Green Published			2022-12-27	WOS:000323369700184
J	Wu, HY; Ke, TY; Liao, WY; Chang, NY				Wu, Hung-Yi; Ke, Ting-Yung; Liao, Wei-Yu; Chang, Nai-Yun			Regulation of Coronaviral Poly(A) Tail Length during Infection	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; INTERFERING RNA REPLICATION; POSITIVE-STRAND RNA; MESSENGER-RNA; TRANSLATIONAL CONTROL; UNTRANSLATED REGION; BINDING PROTEIN; VIRION RNA; STEM-LOOP; 3' END	The positive-strand coronavirus genome of similar to 30 kilobase in length and subgenomic (sg) mRNAs of shorter lengths, are 5' and 3'-co-terminal by virtue of a common 5'-capped leader and a common 3'-polyadenylated untranslated region. Here, by ligating head-to-tail viral RNAs from bovine coronavirus-infected cells and sequencing across the ligated junctions, it was learned that at the time of peak viral RNA synthesis [6 hours postinfection (hpi)] the 3' poly(A) tail on genomic and sgmRNAs is similar to 65 nucleotides (nt) in length. Surprisingly, this length was found to vary throughout infection from similar to 45 nt immediately after virus entry (at 0 to 4 hpi) to similar to 65 nt later on (at 6 h to 9 hpi) and from similar to 65 nt (at 6 h to 9 hpi) to similar to 30 nt (at 120-144 hpi). With the same method, poly(U) sequences of the same lengths were simultaneously found on the ligated viral negative-strand RNAs. Functional analyses of poly(A) tail length on specific viral RNA species, furthermore, revealed that translation, in vivo, of RNAs with the longer poly(A) tail was enhanced over those with the shorter poly(A). Although the mechanisms by which the tail lengths vary is unknown, experimental results together suggest that the length of the poly(A) and poly(U) tails is regulated. One potential function of regulated poly(A) tail length might be that for the coronavirus genome a longer poly(A) favors translation. The regulation of coronavirus translation by poly(A) tail length resembles that during embryonal development suggesting there may be mechanistic parallels.	[Wu, Hung-Yi; Ke, Ting-Yung; Liao, Wei-Yu; Chang, Nai-Yun] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Coll Vet Med, Taichung 40227, Taiwan	National Chung Hsing University	Wu, HY (corresponding author), Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Coll Vet Med, Taichung 40227, Taiwan.	hwu2@dragon.nchu.edu.tw		Wu, Hung-Yi/0000-0002-1260-6259	National Science Council (NSC) of Republic of China [NSC 101-2313-B005-010-MY3]	National Science Council (NSC) of Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 101-2313-B005-010-MY3 from the National Science Council (NSC) of Republic of China.(http://web1.nsc.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Brown CG, 2007, J VIROL, V81, P7716, DOI 10.1128/JVI.00549-07; CHANG RY, 1994, J VIROL, V68, P8223, DOI 10.1128/JVI.68.12.8223-8231.1994; Chen IH, 2005, J VIROL, V79, P14555, DOI 10.1128/JVI.79.23.14555-14561.2005; Chen ZW, 2010, VET RES, V41, DOI 10.1051/vetres/2009053; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Fischer F, 1997, J VIROL, V71, P5148, DOI 10.1128/JVI.71.7.5148-5160.1997; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Guan BJ, 2011, J VIROL, V85, P5593, DOI 10.1128/JVI.00263-11; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; HOFMANN MA, 1991, J VIROL, V65, P6331, DOI 10.1128/JVI.65.11.6331-6333.1991; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; KING B, 1982, J VIROL, V42, P700, DOI 10.1128/JVI.42.2.700-707.1982; Komine Y, 2000, RNA, V6, P598, DOI 10.1017/S1355838200992252; LAI MMC, 1981, J VIROL, V39, P823, DOI 10.1128/JVI.39.3.823-834.1981; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Ozdarendeli A, 2001, J VIROL, V75, P7362, DOI 10.1128/JVI.75.16.7362-7374.2001; Piccioni F, 2005, CR BIOL, V328, P863, DOI 10.1016/j.crvi.2005.05.006; Poon LLM, 2000, J VIROL, V74, P418, DOI 10.1128/JVI.74.1.418-427.2000; Poon LLM, 1999, J VIROL, V73, P3473, DOI 10.1128/JVI.73.4.3473-3476.1999; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; SACHS A, 1993, J BIOL CHEM, V268, P22955; Spagnolo JF, 2000, J VIROL, V74, P5053, DOI 10.1128/JVI.74.11.5053-5065.2000; Steil BP, 2010, J VIROL, V84, P2843, DOI 10.1128/JVI.02620-08; Szymkowiak C, 2003, J VIROL METHODS, V107, P15, DOI 10.1016/S0166-0934(02)00184-2; van Ooij MJM, 2006, NUCLEIC ACIDS RES, V34, P2953, DOI 10.1093/nar/gkl349; Williams GD, 1999, J VIROL, V73, P8349, DOI 10.1128/JVI.73.10.8349-8355.1999; Wu HY, 2007, J VIROL, V81, P3206, DOI 10.1128/JVI.01817-06; Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107; Wu HY, 2006, J VIROL, V80, P2183, DOI 10.1128/JVI.80.5.2183-2193.2006; YOGO Y, 1977, J BIOCHEM-TOKYO, V82, P1103, DOI 10.1093/oxfordjournals.jbchem.a131782; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002; Zheng HY, 1999, J VIROL, V73, P5240, DOI 10.1128/JVI.73.6.5240-5243.1999	39	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70548	10.1371/journal.pone.0070548	http://dx.doi.org/10.1371/journal.pone.0070548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923003	Green Published, gold			2022-12-27	WOS:000323369700192
J	Zhou, CL; Liu, ZZ; Liu, Y; Fu, WX; Ding, XD; Liu, JF; Yu, Y; Zhang, Q				Zhou, Chuanli; Liu, Zhengzhu; Liu, Yang; Fu, Weixuan; Ding, Xiangdong; Liu, Jianfeng; Yu, Ying; Zhang, Qin			Gene Silencing of Porcine MUC13 and ITGB5: Candidate Genes towards Escherichia coli F4ac Adhesion	PLOS ONE			English	Article							EPITHELIAL-CELL LINES; EXPRESSION; ACTIVATION; INFECTION; FIMBRIAE; INVASION; ROLES; HOST; LPS	Background: Integrin beta-5 (ITGB5) and mucin 13 (MUC13) genes are highly expressed on the apical surface of intestinal epithelia and are thought to be candidate genes for controlling the expression of the receptor for enterotoxigenic Escherichia coli (ETEC) F4ac. Human MUC13 protein has an expected role in protecting intestinal mucosal surfaces and porcine ITGB5 is a newly identified potential receptor for ETEC F4ac. Methodology/Principal Findings: To test the hypothesis that ITGB5 and MUC13 both play key roles in protection of the intestinal mucosa against pathogenic bacterium, porcine intestinal epithelial cells (IPEC-J2) were transfected with ITGB5-targeting, MUC13-targeting or negative control small interfering RNA (siRNA), respectively. Firstly, we measured mRNA expression levels of mucin genes (MUC4, MUC20), pro-inflammatory genes (IL8, IL1A, IL6, CXCL2), anti-inflammatory mediator SLPI, and PLAU after RNAi treatments with and without ETEC infection. Secondly, we compared the adhesions of ETEC to the pre- and post-knockdown IPEC-J2 cells of ITGB5 and MUC13, respectively. We found that ITGB5 and MUC13 knockdown both had small but significant effects in attenuating the inflammation induced by ETEC infection, and both increased bacterial adhesion in response to F4ac ETEC exposure. Conclusions/Significance: Our current study first reported that ITGB5 and MUC13 are important adhesion molecules of mucosal epithelial signaling in response to Escherichia coli in pigs. These data suggest that both ITGB5 and MUC13 play key roles in defending the attachment and adhesion of ETEC to porcine jejunal cells and in maintaining epithelial barrier and immunity function.	[Zhou, Chuanli; Liu, Zhengzhu; Liu, Yang; Fu, Weixuan; Ding, Xiangdong; Liu, Jianfeng; Yu, Ying; Zhang, Qin] China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing 100094, Peoples R China; [Liu, Zhengzhu] Hebei Normal Univ Sci & Technol, Coll Anim Sci & Technol, Dept Anim Sci, Changli, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Hebei Normal University of Science & Technology	Yu, Y (corresponding author), China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing 100094, Peoples R China.	yuying@cau.edu.cn; qzhang@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864	Program of New Breed Development via Transgenic Technology [2009ZX08009-146B]; Project for Science and Technological Innovation of Yunnan Province [2010AB001]; Beijing Municipal Bureau of Agricultural pilot demonstration projects [20100222]; Earmarked Fund for Modern Agro-Industry Technology System [CARS-37-04B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1191]	Program of New Breed Development via Transgenic Technology; Project for Science and Technological Innovation of Yunnan Province; Beijing Municipal Bureau of Agricultural pilot demonstration projects; Earmarked Fund for Modern Agro-Industry Technology System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Program of New Breed Development via Transgenic Technology (2009ZX08009-146B), the Project for Science and Technological Innovation of Yunnan Province (2010AB001), Beijing Municipal Bureau of Agricultural pilot demonstration projects (20100222), the Earmarked Fund for Modern Agro-Industry Technology System (CARS-37-04B) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Arce C, 2010, COMP IMMUNOL MICROB, V33, P161, DOI 10.1016/j.cimid.2008.08.003; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Caporali A, 2011, VASC PHARMACOL, V55, P79, DOI 10.1016/j.vph.2011.06.006; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Devriendt B, 2010, DEV COMP IMMUNOL, V34, P1175, DOI 10.1016/j.dci.2010.06.009; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Ismail HAHA, 2012, KOREAN J PARASITOL, V50, P7, DOI 10.3347/kjp.2012.50.1.7; Jacobsen Mette, 2011, BMC Res Notes, V4, P225, DOI 10.1186/1756-0500-4-225; Ji HY, 2011, MOL BIOL REP, V38, P1593, DOI 10.1007/s11033-010-0268-y; Johnson AM, 2009, INFECT IMMUN, V77, P341, DOI 10.1128/IAI.01097-08; Jonckheere N, 2010, BIOCHIMIE, V92, P1, DOI 10.1016/j.biochi.2009.09.018; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Koh SY, 2008, VET MICROBIOL, V130, P191, DOI 10.1016/j.vetmic.2007.12.018; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Melkebeek V, 2012, MUCOSAL IMMUNOL, V5, P635, DOI 10.1038/mi.2012.37; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Pavlova B, 2008, VET MICROBIOL, V132, P105, DOI 10.1016/j.vetmic.2008.04.024; Peng QL, 2007, ANIM GENET, V38, P397, DOI 10.1111/j.1365-2052.2007.01608.x; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044573; Sheng YH, 2013, MUCOSAL IMMUNOL, V6, P557, DOI 10.1038/mi.2012.98; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Song KS, 2003, J BIOL CHEM, V278, P34890, DOI 10.1074/jbc.M303911200; Tahira AC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-141; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; Thygesen HH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-10; Van den Broeck A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-68; Van Molle I, 2007, J MOL BIOL, V368, P791, DOI 10.1016/j.jmb.2007.02.051; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x; Zhou CL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-330; Zhou H, 2013, INT J RAD BIOL	43	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70303	10.1371/journal.pone.0070303	http://dx.doi.org/10.1371/journal.pone.0070303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922972	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700167
J	Takahashi, Y; Mayne, AE; Khowawisetsut, L; Pattanapanyasat, K; Little, D; Villinger, F; Ansari, AA				Takahashi, Yoshiaki; Mayne, Ann E.; Khowawisetsut, Ladawan; Pattanapanyasat, Kovit; Little, Dawn; Villinger, Francois; Ansari, Aftab A.			In Vivo Administration of a JAK3 Inhibitor to Chronically SIV Infected Rhesus Macaques Leads to NK Cell Depletion Associated with Transient Modest Increase in Viral Loads	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ACTIVE RHEUMATOID-ARTHRITIS; IMMUNE EFFECTOR MECHANISMS; T-CELLS; INNATE; CP-690,550; RESPONSES; ANTIBODY; MEMORY; DIFFERENTIATION	Innate immune responses are reasoned to play an important role during both acute and chronic SIV infection and play a deterministic role during the acute stages on the rate of infection and disease progression. NK cells are an integral part of the innate immune system but their role in influencing the course of SIV infection has been a subject of debate. As a means to delineate the effect of NK cells on SIV infection, use was made of a Janus kinase 3 (JAK3) inhibitor that has previously been shown to be effective in the depletion of NK cells in vivo in nonhuman primates (NHP). Extensive safety and in vitro/in vivo PK studies were conducted and an optimal dose that depletes NK cells and NK cell function in vivo identified. Six chronically SIV infected rhesus macaques, 3 with undetectable/low plasma viral loads and 3 with high plasma viral loads were administered a daily oral dose of 10 mg/kg for 35 days. Data obtained showed that, at the dose tested, the major cell lineage affected both in the blood and the GI tissues were the NK cells. Such depletion appeared to be associated with a transient increase in plasma and GI tissue viral loads. Whereas the number of NK cells returned to baseline values in the blood, the GI tissues remained depleted of NK cells for a prolonged period of time. Recent findings show that the JAK3 inhibitor utilized in the studies reported herein has a broader activity than previously reported with dose dependent effects on both JAK2 and JAK1 suggests that it is likely that multiple pathways are affected with the administration of this drug that needs to be taken into account. The findings reported herein are the first studies on the use of a JAK3 inhibitor in lentivirus infected NHP.	[Takahashi, Yoshiaki; Mayne, Ann E.; Little, Dawn; Ansari, Aftab A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Khowawisetsut, Ladawan] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok 10700, Thailand; [Pattanapanyasat, Kovit] Mahidol Univ, Fac Med, Siriraj Hosp, Off Res & Dev, Bangkok 10700, Thailand; [Villinger, Francois] Emory Univ, Div Pathol, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University; Mahidol University; Mahidol University; Emory University	Ansari, AA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pathaaa@emory.edu	Khowawisetsut, Ladawan/GLR-7783-2022	Khowawisetsut, Ladawan/0000-0003-1585-495X	NIH-NIAID [RO1 AI078773, OD 51POD1113]; Thailand Research Fund (TRF)- The Royal Golden Jubilee Ph.D. Program [PHD/0198/2550]; TRF, Senior Research Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078773, R01AI098628] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Thailand Research Fund (TRF)- The Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); TRF, Senior Research Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by a grant from the NIH-NIAID RO1 AI078773 and OD 51POD1113 to the Yerkes National Primate Research Center. Khowawisetsut L. was financially supported by a fellowship from the Thailand Research Fund (TRF)- The Royal Golden Jubilee Ph.D. Program (PHD/0198/2550). Pattanapanyasat K. was the recipient of the TRF, Senior Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT C, 2013, PLOS PATHOG UNPUB; ALBRIGHT JW, 1985, MECH AGEING DEV, V31, P295, DOI 10.1016/0047-6374(85)90096-X; Ansari AA, 2011, ADV EXP MED BIOL, V780, P143, DOI 10.1007/978-1-4419-5632-3_12; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Borie DC, 2005, TRANSPLANTATION, V80, P1756, DOI 10.1097/01.tp.0000184634.25042.ea; Borie DC, 2004, TRENDS MOL MED, V10, P532, DOI 10.1016/j.molmed.2004.09.007; Bostik Pavel, 2010, HIV Therapy, V4, P483, DOI [10.2217/hiv.10.28, 10.2217/HIV.10.28]; Breed MW, 2013, J VIROL, V87, P1528, DOI 10.1128/JVI.01928-12; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Choi EI, 2008, IMMUNOLOGY, V124, P215, DOI 10.1111/j.1365-2567.2007.02757.x; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cooper MA, 2010, IMMUNOL REV, V235, P297, DOI 10.1111/j.0105-2896.2010.00891.x; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Dymock BW, 2013, EXPERT OPIN THER PAT, V23, P449, DOI 10.1517/13543776.2013.765862; Ehlers M, 2012, ENDOCRINOLOGY, V153, P4367, DOI 10.1210/en.2012-1247; Eissens DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030930; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; FU B, P NATL ACAD SCI US, V110, pE231; Ge MQ, 2012, J IMMUNOL, V189, P2099, DOI 10.4049/jimmunol.1103474; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hall LJ, 2010, J IMMUNOL, V184, P4327, DOI 10.4049/jimmunol.0903357; Haraguchi K, 2009, J IMMUNOL, V182, P6168, DOI 10.4049/jimmunol.0803036; Harrison D.A., 2012, COLD SPRING HARB PER, V4; Hong HS, 2010, AIDS, V24, P1823, DOI 10.1097/QAD.0b013e32833b556f; Hosoya S, 2013, AM J PHYSIOL-GASTR L, V304, pG293, DOI 10.1152/ajpgi.00083.2012; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Jewett A, 2013, J CANCER, V4, P12, DOI 10.7150/jca.5519; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; JOST S, 2013, ANN REV IMMUNOL; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; KHOWAWISETSUT L, 2013, PLOSONE IN PRESS; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Krueger PD, 2011, CRIT REV IMMUNOL, V31, P43, DOI 10.1615/CritRevImmunol.v31.i1.40; Kumar P, 2013, J CANCER, V4, P57, DOI 10.7150/jca.5048; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Li N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00061; Mace EM, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00421; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Murphy WJ, 2012, BIOL BLOOD MARROW TR, V18, pS2, DOI 10.1016/j.bbmt.2011.10.033; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Paniagua R, 2005, TRANSPLANTATION, V80, P1283, DOI 10.1097/01.tp.0000177643.05739.cd; Paniagua R, 2005, THER DRUG MONIT, V27, P608, DOI 10.1097/01.ftd.0000170030.13702.04; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Pereira LE, 2009, CURR HIV RES, V7, P12, DOI 10.2174/157016209787048465; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Raziuddin A, 2000, BLOOD, V95, P3840; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; Soth M, 2013, J MED CHEM, V56, P345, DOI 10.1021/jm301646k; Staprans SI, 1999, J VIROL, V73, P4829, DOI 10.1128/JVI.73.6.4829-4839.1999; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; SUN JC, 2011, PLOS ONE, V7; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Usharauli D, 2006, NAT PROTOC, V1, P673, DOI 10.1038/nprot.2006.107; van Gurp E, 2008, AM J TRANSPLANT, V8, P1711, DOI 10.1111/j.1600-6143.2008.02307.x; Vargas CL, 2011, BLOOD, V118, P3570, DOI 10.1182/blood-2011-06-359679; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Yamada Y, 2012, J IMMUNOL, V188, P6063, DOI 10.4049/jimmunol.1200656; Yokoyama W.M., 2008, FUNDAMENTAL IMMUNOLO, P483; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034	87	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70992	10.1371/journal.pone.0070992	http://dx.doi.org/10.1371/journal.pone.0070992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23923040	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900183
J	Leung, AWS; He, Y; Grady, CL; Alain, C				Leung, Ada W. S.; He, Yu; Grady, Cheryl L.; Alain, Claude			Age Differences in the Neuroelectric Adaptation to Meaningful Sounds	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; AUDITORY-EVOKED POTENTIALS; SENSORY MEMORY; WORKING-MEMORY; OLDER-ADULTS; SELECTIVE ATTENTION; MISMATCH NEGATIVITY; INHIBITORY CONTROL; NEURAL MECHANISM; TRACE FORMATION	Much of what we know regarding the effect of stimulus repetition on neuroelectric adaptation comes from studies using artificially produced pure tones or harmonic complex sounds. Little is known about the neural processes associated with the representation of everyday sounds and how these may be affected by aging. In this study, we used real life, meaningful sounds presented at various azimuth positions and found that auditory evoked responses peaking at about 100 and 180 ms after sound onset decreased in amplitude with stimulus repetition. This neural adaptation was greater in young than in older adults and was more pronounced when the same sound was repeated at the same location. Moreover, the P2 waves showed differential patterns of domain-specific adaptation when location and identity was repeated among young adults. Background noise decreased ERP amplitudes and modulated the magnitude of repetition effects on both the N1 and P2 amplitude, and the effects were comparable in young and older adults. These findings reveal an age-related difference in the neural processes associated with adaptation to meaningful sounds, which may relate to older adults' difficulty in ignoring task-irrelevant stimuli.	[Leung, Ada W. S.] Univ Alberta, Dept Occupat Therapy, Edmonton, AB, Canada; [Leung, Ada W. S.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Leung, Ada W. S.; He, Yu; Grady, Cheryl L.; Alain, Claude] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Grady, Cheryl L.; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Alain, Claude] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto	Alain, C (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	calain@reseach.baycrest.org			Canadian Institutes of Health Research [MOP67131]; Ben and Hilda Katz Postdoctoral Fellowship; Baycrest Foundation; Jack & Rita Catherall Research Fund Award in Baycrest Hospital	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ben and Hilda Katz Postdoctoral Fellowship; Baycrest Foundation; Jack & Rita Catherall Research Fund Award in Baycrest Hospital	This research was supported by grants from the Canadian Institutes of Health Research awarded to Cheryl Grady and Claude Alain (MOP67131). Ada Leung received support from the Ben and Hilda Katz Postdoctoral Fellowship, Baycrest Foundation, and the Jack & Rita Catherall Research Fund Award in Baycrest Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1997, EVOKED POTENTIAL, V104, P531, DOI 10.1016/S0168-5597(97)00057-9; Alain C, 2004, PSYCHOL AGING, V19, P125, DOI 10.1037/0882-7974.19.1.125; Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Alain C., 2006, HDB MODELS HUMAN AGI, P759, DOI [10.1016/B978-0-12-369391-4.X5000-0, DOI 10.1016/B978-012369391-4/50065-5]; Alain C, 2008, CLIN NEUROPHYSIOL, V119, P356, DOI 10.1016/j.clinph.2007.10.024; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; Alain C, 2010, J COGNITIVE NEUROSCI, V22, P392, DOI 10.1162/jocn.2009.21279; Amenedo E, 1998, BIOL PSYCHOL, V48, P235, DOI 10.1016/S0301-0511(98)00040-4; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Ben-David BM, 2011, PSYCHOPHYSIOLOGY, V48, P797, DOI 10.1111/j.1469-8986.2010.01139.x; BOUTROS N, 1995, PSYCHIAT RES, V57, P57, DOI 10.1016/0165-1781(95)02597-P; Boutros NN, 2011, BIOL PSYCHIAT, V69, P883, DOI 10.1016/j.biopsych.2010.12.011; BUDD TW, 1994, NEUROREPORT, V5, P2513, DOI 10.1097/00001756-199412000-00027; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Costa-Faidella J, 2011, PSYCHOPHYSIOLOGY, V48, P774, DOI 10.1111/j.1469-8986.2010.01144.x; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; CZIGLER I, 1992, BIOL PSYCHOL, V33, P195, DOI 10.1016/0301-0511(92)90031-O; Degerman A, 2008, EUR J NEUROSCI, V27, P3329, DOI 10.1111/j.1460-9568.2008.06286.x; Delgutte B., 1997, HDB PHONETIC SCI, P507; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Diaconescu AO, 2011, J COGNITIVE NEUROSCI, V23, P1609, DOI 10.1162/jocn.2010.21465; Dinh TH, 2011, J INTEGR NEUROSCI, V10, P203, DOI 10.1142/S0219635211002701; Fabiani M, 2006, J COGNITIVE NEUROSCI, V18, P637, DOI 10.1162/jocn.2006.18.4.637; Fitzpatrick DC, 1999, J ACOUST SOC AM, V106, P3460, DOI 10.1121/1.428199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDMAN D, 1994, COGNITIVE BRAIN RES, V2, P49, DOI 10.1016/0926-6410(94)90020-5; Gaeta H, 1998, NEUROBIOL AGING, V19, P447, DOI 10.1016/S0197-4580(98)00087-6; Garagnani M, 2011, NEUROIMAGE, V54, P170, DOI 10.1016/j.neuroimage.2010.08.031; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Getzrnann S, 2011, HEARING RES, V272, P21, DOI 10.1016/j.heares.2010.11.005; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Golob EJ, 2001, NEUROBIOL AGING, V22, P755, DOI 10.1016/S0197-4580(01)00244-5; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grady CL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00024; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Healey MK, 2008, PROG BRAIN RES, V169, P353, DOI 10.1016/S0079-6123(07)00022-2; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Horev N, 2007, EAR HEARING, V28, P111, DOI 10.1097/01.aud.0000250021.69163.96; Horvath J, 2004, NEUROSCI LETT, V368, P157, DOI 10.1016/j.neulet.2004.07.004; Javitt DC, 2000, AUDIOL NEURO-OTOL, V5, P207, DOI 10.1159/000013882; Leung AWS, 2011, NEUROIMAGE, V55, P1260, DOI 10.1016/j.neuroimage.2010.12.055; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; LU ZL, 1992, SCIENCE, V258, P1668, DOI 10.1126/science.1455246; MCDOWD JM, 1992, PSYCHOL AGING, V7, P65, DOI 10.1037/0882-7974.7.1.65; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Naatanen R, 2002, NEUROSCI LETT, V318, P49, DOI 10.1016/S0304-3940(01)02438-7; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Ostroff JM, 2003, HEARING RES, V181, P1, DOI 10.1016/S0378-5955(03)00113-8; Payer D, 2006, NEUROREPORT, V17, P487, DOI 10.1097/01.wnr.0000209005.40481.31; PERRAULT N, 1984, ELECTROEN CLIN NEURO, V59, P177, DOI 10.1016/0168-5597(84)90058-3; Phillips DP, 2008, HEARING RES, V238, P124, DOI 10.1016/j.heares.2007.09.007; Picton TW, 1999, AUDIOL NEURO-OTOL, V4, P64, DOI 10.1159/000013823; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; Richardson C, 2011, INT J PSYCHOPHYSIOL, V79, P97, DOI 10.1016/j.ijpsycho.2010.09.007; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Ross B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010101; Sable JJ, 2004, PSYCHOPHYSIOLOGY, V41, P636, DOI 10.1111/j.1469-8986.2004.00192.x; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schweinberger SR, 2011, BRIT J PSYCHOL, V102, P748, DOI 10.1111/j.2044-8295.2011.02048.x; SHORE SE, 1995, HEARING RES, V82, P31, DOI 10.1016/0378-5955(94)00160-R; SMITH DBD, 1980, BIOL PSYCHOL, V11, P135, DOI 10.1016/0301-0511(80)90048-4; Stevens WD, 2008, J NEUROSCI, V28, P12820, DOI 10.1523/JNEUROSCI.2622-08.2008; Teder-Salejarvi WA, 1999, COGNITIVE BRAIN RES, V8, P213, DOI 10.1016/S0926-6410(99)00023-3; Timm J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-2; Todorovic A, 2011, J NEUROSCI, V31, P9118, DOI 10.1523/JNEUROSCI.1425-11.2011; Wascher E, 2011, NEUROSCI LETT, V487, P66, DOI 10.1016/j.neulet.2010.09.075; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Woods DL, 1995, EEG CL N SU, P102; Zhang FW, 2011, BRAIN RES, V1400, P42, DOI 10.1016/j.brainres.2011.05.036	73	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68892	10.1371/journal.pone.0068892	http://dx.doi.org/10.1371/journal.pone.0068892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	191SQ	23935900	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300013
J	Boerebach, BCM; Lombarts, KMJMH; Scherpbier, AJJ; Arah, OA				Boerebach, Benjamin C. M.; Lombarts, Kiki M. J. M. H.; Scherpbier, Albert J. J.; Arah, Onyebuchi A.			The Teacher, the Physician and the Person: Exploring Causal Connections between Teaching Performance and Role Model Types Using Directed Acyclic Graphs	PLOS ONE			English	Article							CLINICAL TEACHER; ATTRIBUTES; QUALITIES; FACULTY	Background: In fledgling areas of research, evidence supporting causal assumptions is often scarce due to the small number of empirical studies conducted. In many studies it remains unclear what impact explicit and implicit causal assumptions have on the research findings; only the primary assumptions of the researchers are often presented. This is particularly true for research on the effect of faculty's teaching performance on their role modeling. Therefore, there is a need for robust frameworks and methods for transparent formal presentation of the underlying causal assumptions used in assessing the causal effects of teaching performance on role modeling. This study explores the effects of different (plausible) causal assumptions on research outcomes. Methods: This study revisits a previously published study about the influence of faculty's teaching performance on their role modeling (as teacher-supervisor, physician and person). We drew eight directed acyclic graphs (DAGs) to visually represent different plausible causal relationships between the variables under study. These DAGs were subsequently translated into corresponding statistical models, and regression analyses were performed to estimate the associations between teaching performance and role modeling. Results: The different causal models were compatible with major differences in the magnitude of the relationship between faculty's teaching performance and their role modeling. Odds ratios for the associations between teaching performance and the three role model types ranged from 31.1 to 73.6 for the teacher-supervisor role, from 3.7 to 15.5 for the physician role, and from 2.8 to 13.8 for the person role. Conclusions: Different sets of assumptions about causal relationships in role modeling research can be visually depicted using DAGs, which are then used to guide both statistical analysis and interpretation of results. Since study conclusions can be sensitive to different causal assumptions, results should be interpreted in the light of causal assumptions made in each study.	[Boerebach, Benjamin C. M.; Lombarts, Kiki M. J. M. H.; Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, NL-1105 AZ Amsterdam, Netherlands; [Scherpbier, Albert J. J.] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Boerebach, BCM (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.c.boerebach@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Arah, Onyebuchi/0000-0002-9067-1697; Boerebach, Benjamin/0000-0002-5931-9783	Dutch Ministry of Health; Academic Medical Center, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht; Netherlands Organization for Scientific Research (NWO) [916.96.059]	Dutch Ministry of Health; Academic Medical Center, Amsterdam; Faculty of Health and Life Sciences of the University of Maastricht; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study is part of the research project "Quality of clinical teachers and residency training programs," which is co-financed by the Dutch Ministry of Health; the Academic Medical Center, Amsterdam; and the Faculty of Health and Life Sciences of the University of Maastricht. BB and KL are employed by the Academic Medical Centre, Amsterdam. AS is employed by the University of Maastricht. OA is a recipient of a Veni grant (#916.96.059) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection, data analysis, data interpretation, decision to publish, or writing of the report.	Arah OA, 2012, MED EDUC, V46, P381, DOI 10.1111/j.1365-2923.2011.04176.x; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; Arah OA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-5; Boerebach BCM, 2012, J SURG EDUC, V69, P511, DOI 10.1016/j.jsurg.2012.04.003; Boerebach BCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032089; Boor K, 2008, EUR J OBSTET GYN R B, V140, P152, DOI 10.1016/j.ejogrb.2008.03.010; Cruess SR, 2008, BRIT MED J, V336, P718, DOI 10.1136/bmj.39503.757847.BE; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; GREENLAND S, 1986, INT J EPIDEMIOL, V15, P413, DOI 10.1093/ije/15.3.413; Greenland S, 2011, INT ENCY STAT SCI, P208; Groenwold RHH, 2008, ANN EPIDEMIOL, V18, P746, DOI 10.1016/j.annepidem.2008.05.007; Jochemsen-van der Leeuw HGAR, 2013, ACAD MED, V88, P26, DOI 10.1097/ACM.0b013e318276d070; Lombarts KMJMH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015202; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Morgan SL, 2007, ANAL METHOD SOC RES, P1, DOI 10.1017/CBO9780511804564; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Pearl J, 2009, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Spirtes R, 2000, CAUSATION PREDICTION; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; ULLIAN JA, 1994, ACAD MED, V69, P832, DOI 10.1097/00001888-199410000-00013; van der Leeuw R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019142; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; Wright SM, 2002, CAN MED ASSOC J, V167, P638	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69449	10.1371/journal.pone.0069449	http://dx.doi.org/10.1371/journal.pone.0069449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936020	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000123
J	Godsey, B				Godsey, Brian			Improved Inference of Gene Regulatory Networks through Integrated Bayesian Clustering and Dynamic Modeling of Time-Course Expression Data	PLOS ONE			English	Article							PROFILES	Inferring gene regulatory networks from expression data is difficult, but it is common and often useful. Most network problems are under-determined-there are more parameters than data points-and therefore data or parameter set reduction is often necessary. Correlation between variables in the model also contributes to confound network coefficient inference. In this paper, we present an algorithm that uses integrated, probabilistic clustering to ease the problems of under-determination and correlated variables within a fully Bayesian framework. Specifically, ours is a dynamic Bayesian network with integrated Gaussian mixture clustering, which we fit using variational Bayesian methods. We show, using public, simulated time-course data sets from the DREAM4 Challenge, that our algorithm outperforms non-clustering methods in many cases (7 out of 25) with fewer samples, rarely underperforming (1 out of 25), and often selects a non-clustering model if it better describes the data. Source code (GNU Octave) for BAyesian Clustering Over Networks (BACON) and sample data are available at: http://code.google.com/p/bacon-for-genetic-networks.	Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria	Technische Universitat Wien	Godsey, B (corresponding author), Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria.	briangodsey@gmail.com						Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P23, DOI 10.1093/bioinformatics/bth915; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Beal M.J., 2003, VARIATIONAL ALGORITH; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Greenfield A, 2010, PLOS ONE, V5; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Klemm S.L., 2008, THESIS U CAMBRIDGE C; Lebre S, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1294; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; R Core Team, 2020, R LANG ENV STAT COMP; Schliep A, 2003, BIOINFORMATICS, V19, pi255, DOI 10.1093/bioinformatics/btg1036; Shiraishi Y, 2010, BIOINFORMATICS, V26, P1073, DOI 10.1093/bioinformatics/btq094; Sivriver J, 2011, BIOINFORMATICS, V27, pI392, DOI 10.1093/bioinformatics/btr250; Teschendorff AE, 2005, BIOINFORMATICS, V21, P3025, DOI 10.1093/bioinformatics/bti466; Winn JM, 2003, THESIS ST JOHNS COLL	22	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68358	10.1371/journal.pone.0068358	http://dx.doi.org/10.1371/journal.pone.0068358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935862	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000029
J	Gu, YY; Mai, XQ; Luo, YJ				Gu, Yuanyuan; Mai, Xiaoqin; Luo, Yue-jia			Do Bodily Expressions Compete with Facial Expressions? Time Course of Integration of Emotional Signals from the Face and the Body	PLOS ONE			English	Article							AUDIOVISUAL INTEGRATION; SELECTIVE ATTENTION; SPATIAL ATTENTION; BRAIN POTENTIALS; NEGATIVITY BIAS; TEMPORAL COURSE; ERP; PERCEPTION; RESPONSES; LANGUAGE	The decoding of social signals from nonverbal cues plays a vital role in the social interactions of socially gregarious animals such as humans. Because nonverbal emotional signals from the face and body are normally seen together, it is important to investigate the mechanism underlying the integration of emotional signals from these two sources. We conducted a study in which the time course of the integration of facial and bodily expressions was examined via analysis of event-related potentials (ERPs) while the focus of attention was manipulated. Distinctive integrating features were found during multiple stages of processing. In the first stage, threatening information from the body was extracted automatically and rapidly, as evidenced by enhanced P1 amplitudes when the subjects viewed compound face-body images with fearful bodies compared with happy bodies. In the second stage, incongruency between emotional information from the face and the body was detected and captured by N2. Incongruent compound images elicited larger N2s than did congruent compound images. The focus of attention modulated the third stage of integration. When the subjects' attention was focused on the face, images with congruent emotional signals elicited larger P3s than did images with incongruent signals, suggesting more sustained attention and elaboration of congruent emotional information extracted from the face and body. On the other hand, when the subjects' attention was focused on the body, images with fearful bodies elicited larger P3s than did images with happy bodies, indicating more sustained attention and elaboration of threatening information from the body during evaluative processes.	[Gu, Yuanyuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Mai, Xiaoqin] Renmin Univ China, Dept Psychol, Beijing, Peoples R China; [Luo, Yue-jia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China	Beijing Normal University; Renmin University of China; Shenzhen University	Luo, YJ (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	Luoyj@bnu.edu.cn			National Basic Research Program of China (973 Program) [2011CB711000]; NSFC [30930031, 91132704]; Global Research Initiative Program, NIH, USA [1R01TW007897]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Global Research Initiative Program, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Basic Research Program of China (973 Program, 2011CB711000), the NSFC (30930031, 91132704), and Global Research Initiative Program, NIH, USA (1R01TW007897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; de Gelder B, 2006, NEUROREPORT, V17, P583, DOI 10.1097/00001756-200604240-00006; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Hartcher-O'Brien J, 2010, BRAIN RES, V1362, P48, DOI 10.1016/j.brainres.2010.09.036; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Kanske P, 2011, HUM BRAIN MAPP, V32, P198, DOI 10.1002/hbm.21012; Kanske P, 2010, NEUROPSYCHOLOGIA, V48, P3661, DOI 10.1016/j.neuropsychologia.2010.07.021; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luck S.J., 2005, INTRO EVENT RELATED; Lukas S, 2010, PSYCHOL RES-PSYCH FO, V74, P255, DOI 10.1007/s00426-009-0246-y; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sander D, 2005, NEURAL NETWORKS, V18, P317, DOI 10.1016/j.neunet.2005.03.001; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Stienen BMC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025517; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; van de Riet WAC, 2009, SOC NEUROSCI-UK, V4, P101, DOI 10.1080/17470910701865367; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; van Heijnsbergen CCRJ, 2007, BRAIN RES, V1186, P233, DOI 10.1016/j.brainres.2007.09.093; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Vuilleumier P., 2011, OXFORD HDB FACE PERC, P449, DOI DOI 10.1093/0XF0RDHB/9780199559053.013.0023; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wang LL, 2012, NEUROSCI LETT, V506, P317, DOI 10.1016/j.neulet.2011.11.034; Willadsen-Jensen EC, 2006, SOC COGNITION, V24, P580, DOI 10.1521/soco.2006.24.5.580	47	18	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e66762	10.1371/journal.pone.0066762	http://dx.doi.org/10.1371/journal.pone.0066762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228SX	23935825	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000007
J	Schindler, S; Schonknecht, P; Schmidt, L; Anwander, A; Strauss, M; Trampel, R; Bazin, PL; Moller, HE; Hegerl, U; Turner, R; Geyer, S				Schindler, Stephanie; Schoenknecht, Peter; Schmidt, Laura; Anwander, Alfred; Strauss, Maria; Trampel, Robert; Bazin, Pierre-Louis; Moeller, Harald E.; Hegerl, Ulrich; Turner, Robert; Geyer, Stefan			Development and Evaluation of an Algorithm for the Computer-Assisted Segmentation of the Human Hypothalamus on 7-Tesla Magnetic Resonance Images	PLOS ONE			English	Article							SCHIZOPHRENIA; ORGANIZATION; VOLUMES; BRAIN; ABNORMALITIES; DEFICITS; NUCLEI	Post mortem studies have shown volume changes of the hypothalamus in psychiatric patients. With 7T magnetic resonance imaging this effect can now be investigated in vivo in detail. To benefit from the sub-millimeter resolution requires an improved segmentation procedure. The traditional anatomical landmarks of the hypothalamus were refined using 7T T1-weighted magnetic resonance images. A detailed segmentation algorithm (unilateral hypothalamus) was developed for colour-coded, histogram-matched images, and evaluated in a sample of 10 subjects. Test-retest and inter-rater reliabilities were estimated in terms of intraclass-correlation coefficients (ICC) and Dice's coefficient (DC). The computer-assisted segmentation algorithm ensured test-retest reliabilities of ICC >=.97 (DC >= 96.8) and inter-rater reliabilities of ICC >=.94 (DC = 95.2). There were no significant volume differences between the segmentation runs, raters, and hemispheres. The estimated volumes of the hypothalamus lie within the range of previous histological and neuroimaging results. We present a computer-assisted algorithm for the manual segmentation of the human hypothalamus using T1-weighted 7T magnetic resonance imaging. Providing very high test-retest and inter-rater reliabilities, it outperforms former procedures established at 1.5T and 3T magnetic resonance images and thus can serve as a gold standard for future automated procedures.	[Schindler, Stephanie; Schoenknecht, Peter; Schmidt, Laura; Strauss, Maria; Hegerl, Ulrich] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Anwander, Alfred] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Trampel, Robert; Bazin, Pierre-Louis; Turner, Robert; Geyer, Stefan] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Moeller, Harald E.] Max Planck Inst Human Cognit & Brain Sci, Nucl Magnet Resonance Unit, Leipzig, Germany	Leipzig University; Max Planck Society; Max Planck Society; Max Planck Society	Schonknecht, P (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.	Peter.Schoenknecht@medizin.uni-leipzig.de	Möller, Harald/AAB-4679-2019; Anwander, Alfred/B-5874-2011; Moller, Harald E/A-1565-2008; Schoenknecht, Peter/GVU-7600-2022	Möller, Harald/0000-0002-5659-1925; Anwander, Alfred/0000-0002-4861-4808; Moller, Harald E/0000-0002-5659-1925; Turner, Robert/0000-0001-5055-9644; Schindler, Stephanie/0000-0003-1378-0053; Bazin, Pierre-Louis/0000-0002-0141-5510; Hegerl, Ulrich/0000-0002-3039-7470; Strauss, Maria/0000-0002-0072-2199				Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Bielau H, 2005, EUR ARCH PSY CLIN N, V255, P401, DOI 10.1007/s00406-005-0581-y; Blu T, 2004, IEEE T IMAGE PROCESS, V13, P710, DOI 10.1109/TIP.2004.826093; Bogerts B, 2010, J NEUROL NEUROCHIR P, V11, P29; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Draganski B, 2002, NAT MED, V8, P1186, DOI 10.1038/nm1102-1186; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Pol HEH, 2006, EUR J ENDOCRINOL, V155, pS107, DOI 10.1530/eje.1.02248; Kim SJ, 2009, ACTA NEUROL SCAND, V119, P61, DOI 10.1111/j.1600-0404.2008.01063.x; Klomp A, 2012, INT J NEUROPSYCHOPH, V15, P281, DOI 10.1017/S1461145711000794; Koutcherov Y, 2000, J COMP NEUROL, V423, P299; Koutcherov Y, 2002, J COMP NEUROL, V446, P301, DOI 10.1002/cne.10175; Koutcherov Y, 2007, J COMP NEUROL, V503, P392, DOI 10.1002/cne.21355; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Lemaire JJ, 2011, BRAIN RES, V34, P554; LOES DJ, 1991, AM J ROENTGENOL, V156, P579, DOI 10.2214/ajr.156.3.1899763; Koolschijn PCMP, 2008, EUR NEUROPSYCHOPHARM, V18, P312, DOI 10.1016/j.euroneuro.2007.12.004; Mai JK., 2007, ATLAS HUMAN BRAIN; Makris N, 2013, NEUROIMAGE, V69, P1, DOI 10.1016/j.neuroimage.2012.12.008; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McAuliffe MJ, 2001, P 14 IEEE S COMP BAS; MILLER MJ, 1994, AM J NEURORADIOL, V15, P117; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Peper JS, 2010, PSYCHONEUROENDOCRINO, V35, P133, DOI 10.1016/j.psyneuen.2009.05.025; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Riley H. A, 1943, ATLAS BASAL GANGLIA; Schindler S, 2012, PSYCHIAT RES-NEUROIM, V201, P1, DOI 10.1016/j.pscychresns.2011.06.005; Schonknecht P, 2013, EUR ARCH PSY CLIN N, V263, P497, DOI 10.1007/s00406-012-0389-5; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Swaab DF., 2003, HDB CLIN NEUROLOGY, P79; Talairach J, 1988, COPLANAR STEROTAXIC; Terlevic R, 2013, J AFFECT DISORDERS, V146, P390, DOI 10.1016/j.jad.2012.09.024; Tognin S, 2012, PSYCHIAT RES-NEUROIM, V204, P75, DOI 10.1016/j.pscychresns.2012.10.006; Turner DA, 2013, WORLD NEUROSURG, V80, P476, DOI 10.1016/j.wneu.2012.05.014; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	40	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e66394	10.1371/journal.pone.0066394	http://dx.doi.org/10.1371/journal.pone.0066394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935821	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000004
J	Wessels, HJCT; Vogel, RO; Lightowlers, RN; Spelbrink, JN; Rodenburg, RJ; van den Heuvel, LP; van Gool, AJ; Gloerich, J; Smeitink, JAM; Nijtmans, LG				Wessels, Hans J. C. T.; Vogel, Rutger O.; Lightowlers, Robert N.; Spelbrink, Johannes N.; Rodenburg, Richard J.; van den Heuvel, Lambert P.; van Gool, Alain J.; Gloerich, Jolein; Smeitink, Jan A. M.; Nijtmans, Leo G.			Analysis of 953 Human Proteins from a Mitochondrial HEK293 Fraction by Complexome Profiling	PLOS ONE			English	Article							BLUE NATIVE ELECTROPHORESIS; LARGE GENE LISTS; MASS-SPECTROMETRY; RIBOSOMAL-SUBUNIT; PROTEOMICS; DATABASE; MEMBRANE; YEAST; PAGE; POLYADENYLATION	Complexome profiling is a novel technique which uses shotgun proteomics to establish protein migration profiles from fractionated blue native electrophoresis gels. Here we present a dataset of blue native electrophoresis migration profiles for 953 proteins by complexome profiling. By analysis of mitochondrial ribosomal complexes we demonstrate its potential to verify putative protein-protein interactions identified by affinity purification - mass spectrometry studies. Protein complexes were extracted in their native state from a HEK293 mitochondrial fraction and separated by blue native gel electrophoresis. Gel lanes were cut into gel slices of even size and analyzed by shotgun proteomics. Subsequently, the acquired protein migration profiles were analyzed for co-migration via hierarchical cluster analysis. This dataset holds great promise as a comprehensive resource for de novo identification of protein-protein interactions or to underpin and prioritize candidate protein interactions from other studies. To demonstrate the potential use of our dataset we focussed on the mitochondrial translation machinery. Our results show that mitoribosomal complexes can be analyzed by blue native gel electrophoresis, as at least four distinct complexes. Analysis of these complexes confirmed that 24 proteins that had previously been reported to co-purify with mitoribosomes indeed co-migrated with subunits of the mitochondrial ribosome. Co-migration of several proteins involved in biogenesis of inner mitochondrial membrane complexes together with mitoribosomal complexes suggested the possibility of co-translational assembly in human cells. Our data also highlighted a putative ribonucleotide complex that potentially contains MRPL10, MRPL12 and MRPL53 together with LRPPRC and SLIRP.	[Wessels, Hans J. C. T.; van Gool, Alain J.; Gloerich, Jolein] Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Disorders, Radboud Prote Ctr,Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Wessels, Hans J. C. T.; Vogel, Rutger O.; Spelbrink, Johannes N.; Rodenburg, Richard J.; van den Heuvel, Lambert P.; Smeitink, Jan A. M.; Nijtmans, Leo G.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6525 ED Nijmegen, Netherlands; [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Welcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Spelbrink, Johannes N.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Spelbrink, Johannes N.] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland	Radboud University Nijmegen; Radboud University Nijmegen; Newcastle University - UK; Tampere University; Tampere University; Tampere University Hospital	Wessels, HJCT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Genet Endocrine & Metab Disorders, Radboud Prote Ctr,Dept Lab Med, NL-6525 ED Nijmegen, Netherlands.	j.wessels@labgk.umcn.nl	van Gool, Alain J./L-4328-2015; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Spelbrink, Johannes N/L-4661-2015; Smeitink, Jan/C-1351-2013; Wessels, Hans J/P-6248-2015; Nijtmans, L.G.J./L-4549-2015; Gloerich, Jolein/L-4327-2015; Rodenburg, Richard/N-3579-2014	van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Spelbrink, Johannes N/0000-0002-9756-2602; Wessels, Hans J/0000-0001-5957-3127; Gloerich, Jolein/0000-0001-5976-8426; Rodenburg, Richard/0000-0001-5227-3527; van Gool, Alain/0000-0003-0010-5286	Sixth Framework Program Priority 1; Rational treatment strategies combatting mitochondrial oxidative phosphorylation (OXPHOS) disorders (EUMITOCOMBAT) [503116]; Prinses Beatrix Fonds [WAR05-0128]	Sixth Framework Program Priority 1; Rational treatment strategies combatting mitochondrial oxidative phosphorylation (OXPHOS) disorders (EUMITOCOMBAT); Prinses Beatrix Fonds	Part of this work has been supported by the Sixth Framework Program Priority 1, project titled "Rational treatment strategies combatting mitochondrial oxidative phosphorylation (OXPHOS) disorders (EUMITOCOMBAT)'', Contract Number 503116 and by grant WAR05-0128 from the Prinses Beatrix Fonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajan ER, 2012, J CLIN INVEST; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; [Anonymous], 1996, ONL MEND INH MAN OMI; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Christie DA, 2012, J IMMUNOL; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Gregersen N, 2001, PROTEIN INTERACTION; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Helbig AO, 2009, PROTEOMICS, V9, P4787, DOI 10.1002/pmic.200800951; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peterman Scott M, 2005, J Biomol Tech, V16, P112; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Remmerie N, 2011, J PROTEOMICS, V74, P1201, DOI 10.1016/j.jprot.2011.03.023; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Ryan DP, 2005, CURR OPIN STRUC BIOL, V15, P441, DOI 10.1016/j.sbi.2005.06.001; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wessels HJCT, 2011, METHOD ENZYMOL, V486, P465, DOI [10.1016/S0076-6879(11)86021-0, 10.1016/B978-0-12-381294-0.00021-3]; Wessels HJCT, 2009, PROTEOMICS, V9, P4221, DOI 10.1002/pmic.200900157; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151	54	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68340	10.1371/journal.pone.0068340	http://dx.doi.org/10.1371/journal.pone.0068340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935861	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000028
J	Wu, SL; Wang, SC; Tsou, HH; Kuo, HW; Ho, IK; Liu, SW; Hsu, YT; Chang, YS; Liu, YL				Wu, Shiow-Ling; Wang, Sheng-Chang; Tsou, Hsiao-Hui; Kuo, Hsiang-Wei; Ho, Ing-Kang; Liu, Sheng-Wen; Hsu, Ya-Ting; Chang, Yao-Sheng; Liu, Yu-Li			Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration	PLOS ONE			English	Article							ALANINE AMINOTRANSFERASE; GENETIC POLYMORPHISMS; CIRRHOSIS; RATIO; (R)-METHADONE; TRANSAMINASE; FIBROSIS; CYP2B6	Background and Objectives: Heroin-dependent patients typically contract hepatitis C virus (HCV) at a disproportionately high level due to needle exchange. The liver is the primary target organ of HCV infection and also the main organ responsible for drug metabolism. Methadone maintenance treatment (MMT) is a major treatment regimen for opioid dependence. HCV infection may affect methadone metabolism but this has rarely been studied. In our current study, we aimed to test the hypothesis that HCV may influence the methadone dosage and its plasma metabolite concentrations in a MMT cohort from Taiwan. Methods: A total of 366 MMT patients were recruited. The levels of plasma hepatitis B virus (HBV), HCV, human immunodeficiency virus (HIV) antibodies (Ab), liver aspartate aminotransferase (AST) and alanine aminotransferase (ALT), as well as methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) were measured along with the urine morphine concentration and amphetamine screening. Results: Of the 352 subjects in our cohort with HCV test records, 95% were found to be positive for plasma anti-HCV antibody. The liver functional parameters of AST (Wilcoxon Rank-Sum test, P = 0.02) and ALT (Wilcoxon Rank-Sum test, P = 0.04), the plasma methadone concentrations (Wilcoxon Rank-Sum test, P = 0.043) and the R-enantiomer of methadone concentrations (Wilcoxon Rank-Sum test, P = 0.032) were significantly higher in the HCV antibody-positive subjects than in the HCV antibody-negative patients, but not the S-EDDP/methadone dose ratio. The HCV levels correlated with the methadone dose ((beta) over cap = 14.65 and 14.13; P = 0.029 and 0.03) and the S-EDDP/methadone dose ratio ((beta) over cap = 20.41 and 20.40; P = 0.00084 and 0.002) in both univariate and multivariate regression analyses. Conclusions: We conclude that HCV may influence the methadone dose and plasma S-EDDP/methadone dose ratio in MMT patients in this preliminary study.	[Wu, Shiow-Ling; Liu, Yu-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Wu, Shiow-Ling] Ctr Dis Control, Dept Hlth, Ctr Res & Diagnost, Taipei, Taiwan; [Wang, Sheng-Chang; Kuo, Hsiang-Wei; Ho, Ing-Kang; Liu, Sheng-Wen; Chang, Yao-Sheng; Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Miaoli County, Taiwan; [Tsou, Hsiao-Hui; Hsu, Ya-Ting] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan; [Ho, Ing-Kang] China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan; [Ho, Ing-Kang] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Liu, Yu-Li] China Med Univ, Grad Inst Drug Safety, Taichung, Taiwan; [Liu, Yu-Li] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Yu-Li] Taiwan Natl Univ, Coll Med, Taipei, Taiwan	National Defense Medical Center; Centers For Disease Control - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Liu, YL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	ylliou@nhri.org.tw	Tsou, Hsiao-Hui/E-3837-2010; Wang, Sheng-Chang/G-9350-2011; Liu, Yu-Li/E-3829-2010	Tsou, Hsiao-Hui/0000-0001-6773-4111; 	National Research Program for Genomic Medicine [NSC 98-3112-B-400-011, NSC 99-3112-B-400-003, NSC 100-3112-B-400-015]; National Science Council [NSC 97-2314-B-400-001-MY3, NSC 100-2314-B-400-002-MY3]; National Health Research Institutes, Taiwan [PH-098-PP-41, PH-098-PP-46, PH-098-PP-38, PH-098, 99-PP-42, PH-100-PP-37, PH-101-PP-32, PH-98, 99, 100-SP-11, NHRI-101A1-PDCO-1312141]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Research Program for Genomic Medicine (NSC 98-3112-B-400-011, NSC 99-3112-B-400-003 and NSC 100-3112-B-400-015), the National Science Council (NSC 97-2314-B-400-001-MY3 and NSC 100-2314-B-400-002-MY3) and National Health Research Institutes (PH-098-PP-41, PH-098-PP-46, PH-098-PP-38, PH-098, 99-PP-42, PH-100-PP-37, PH-101-PP-32 and PH-98, 99, 100-SP-11, NHRI-101A1-PDCO-1312141), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Alberti A, 2005, ALIMENT PHARM THER, V22, P74, DOI 10.1111/j.1365-2036.2005.02602.x; Ansermot N, 2010, ARCH INTERN MED, V170, P529, DOI 10.1001/archinternmed.2010.26; Aragon G, 2010, CLEV CLIN J MED, V77, P195, DOI 10.3949/ccjm.77a.09064; Batki SL, 2010, J ADDICT DIS, V29, P359, DOI 10.1080/10550887.2010.489449; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Crettol S, 2005, CLIN PHARMACOL THER, V78, P593, DOI 10.1016/j.clpt.2005.08.011; CROFTS N, 1993, MED J AUSTRALIA, V159, P237, DOI 10.5694/j.1326-5377.1993.tb137822.x; de Vos JW, 1998, EUR ADDICT RES, V4, P134, DOI 10.1159/000018936; Deeb TZ, 2009, MOL PHARMACOL, V75, P908, DOI 10.1124/mol.108.053322; Eugenio Kenneth R, 2004, J Pain Palliat Care Pharmacother, V18, P47; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Gerber JG, 2004, CHIRALITY, V16, P36, DOI 10.1002/chir.10303; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Heintges T, 1997, HEPATOLOGY, V26, P521, DOI 10.1002/hep.510260338; Inturrisi C E, 2005, Minerva Anestesiol, V71, P435; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Kristensen K, 1995, LIFE SCI, V56, pPL45; Lang TA, 2006, REPORT STAT MED ANNO; Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307; Lindenburg CEA, 2011, EUR J GASTROEN HEPAT, V23, P23, DOI 10.1097/MEG.0b013e328340c451; Liu Zhihua, 2006, Int J Med Sci, V3, P57; Marsden J, 2008, ADDICTION, V103, P1450, DOI 10.1111/j.1360-0443.2008.02284.x; Maxwell S, 2002, HEROIN ADDICT REL CL, V4, P5; Peles E, 2011, J ADDICT MED, V5, P214, DOI 10.1097/ADM.0b013e31820e13dd; Reedy DW, 1998, DIGEST DIS SCI, V43, P2156, DOI 10.1023/A:1018888021118; SHERMAN KE, 1991, ARCH INTERN MED, V151, P260, DOI 10.1001/archinte.151.2.260; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shiffman ML, 2006, CLIN GASTROENTEROL H, V4, P645, DOI 10.1016/j.cgh.2006.02.002; Tennant F, 2001, J ADDICT DIS, V20, P9, DOI 10.1300/J069v20n01_02; Tian JN, 2012, PHARMACOGENOMICS, V13, P879, DOI [10.2217/PGS.12.69, 10.2217/pgs.12.69]; Verrando R, 2005, ACTA GASTRO-ENT BELG, V68, P81; Wang JS, 2004, PSYCHOPHARMACOLOGY, V173, P132, DOI 10.1007/s00213-003-1718-1; Wang JS, 2003, DRUG METAB DISPOS, V31, P742, DOI 10.1124/dmd.31.6.742; Wang J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/819636; Wang SC, 2012, EUR NEUROPSYCHOPHARM, V22, P695, DOI 10.1016/j.euroneuro.2012.02.002; Wang SC, 2011, J CLIN PSYCHOPHARM, V31, P463, DOI 10.1097/JCP.0b013e318222b5dd; Wang SC, 2010, BIOMED CHROMATOGR, V24, P782, DOI 10.1002/bmc.1363; Wang X, 2011, J NEUROIMMUNE PHARM, V6, P477, DOI 10.1007/s11481-011-9296-1; Wang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045632; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042937	46	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69310	10.1371/journal.pone.0069310	http://dx.doi.org/10.1371/journal.pone.0069310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935979	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000100
J	Serra, J; Ozaslan, TH; Arcos, JL				Serra, Joan; Hakan Oezaslan, Tan; Lluis Arcos, Josep			Note Onset Deviations as Musical Piece Signatures	PLOS ONE			English	Article							PERFORMANCE	A competent interpretation of a musical composition presents several non-explicit departures from the written score. Timing variations are perhaps the most important ones: they are fundamental for expressive performance and a key ingredient for conferring a human-like quality to machine-based music renditions. However, the nature of such variations is still an open research question, with diverse theories that indicate a multi-dimensional phenomenon. In the present study, we consider event-shift timing variations and show that sequences of note onset deviations are robust and reliable predictors of the musical piece being played, irrespective of the performer. In fact, our results suggest that only a few consecutive onset deviations are already enough to identify a musical composition with statistically significant accuracy. We consider a mid-size collection of commercial recordings of classical guitar pieces and follow a quantitative approach based on the combination of standard statistical tools and machine learning techniques with the semi-automatic estimation of onset deviations. Besides the reported results, we believe that the considered materials and the methodology followed widen the testing ground for studying musical timing and could open new perspectives in related research fields.	[Serra, Joan; Hakan Oezaslan, Tan; Lluis Arcos, Josep] Spanish Natl Res Council, Artificial Intelligence Res Inst, IIIA CSIC, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Inteligencia Artificial (IIIA)	Arcos, JL (corresponding author), Spanish Natl Res Council, Artificial Intelligence Res Inst, IIIA CSIC, Barcelona, Spain.	arcos@iiia.csic.es	ARCOS, JOSEP LLUIS/B-1793-2008; Arcos, Josep Lluis/U-6445-2019	Arcos, Josep Lluis/0000-0001-7751-1210	Catalan Government [2009-SGR-1434]; European Commission [ICT-2011-8-318770]; Spanish National Research Council [JAEDOC069/2010, JAEPRE074/2009]	Catalan Government; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish National Research Council	This work has been supported by Catalan Government grant 2009-SGR-1434 (all authors), European Commission grant ICT-2011-8-318770 (JS and JLA), and Spanish National Research Council grants JAEDOC069/2010 (JS) and JAEPRE074/2009 (THO). THO is a PhD student of the doctoral program in Information, Communication, and Audiovisual Technologies of Universitat Pompeu Fabra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho M, 2012, J INTERDISCIPLINARY, V6; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bello JP, 2005, IEEE T SPEECH AUDI P, V13, P1035, DOI 10.1109/TSA.2005.851998; Bilmes J., 1992, P 1992 INT COMP MUS, P207; Brossier P, 2006, THESIS QUEEN MARY U; Clarke, 2001, GENERATIVE PROCESSES, P1; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cook N, 2008, NATURE, V453, P1186, DOI 10.1038/4531186a; Demsar J, 2006, J MACH LEARN RES, V7, P1; Gabrielsson A., 2003, PSYCHOL MUSIC, V31, P221, DOI [10.1177/03057356030313002, DOI 10.1177/03057356030313002]; Gabrielsson A, 2001, GENERATIVE PROCESSES, P27; Gabrielsson A., 1999, PSYCHOL MUSIC, P501, DOI [10.1016/B978-012213564-4/50015-9, DOI 10.1016/B978-012213564-4/50015-9]; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Grachten M, 2009, 10 INT SOC MUS INF R, P51; Hainsworth S., 2003, P INT COMP MUS C, P163; Ozaslan TH, 2011, LECT NOTES COMPUT SC, V6684, P219, DOI 10.1007/978-3-642-23126-1_15; Haro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033993; Hastie T., 2009, UNSUPERVISED LEARNIN; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HOLM S, 1979, SCAND J STAT, V6, P65; Honing H, 2001, COMPUT MUSIC J, V25, P50, DOI 10.1162/014892601753189538; Honing H, 2006, J EXP PSYCHOL HUMAN, V32, P780, DOI 10.1037/0096-1523.32.3.780; Istok E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055150; Juslin P.N., 2003, PSYCHOL MUSIC, V31, P273, DOI [10.1177/03057356030313003, DOI 10.1177/03057356030313003]; Juslin PN, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P583, DOI 10.1016/B978-0-12-381460-9.00015-8; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Levitin DJ, 2012, P NATL ACAD SCI USA, V109, P3716, DOI 10.1073/pnas.1113828109; Liem CCS, 2011, P AUD ENG SOC C AES; de Mantaras RL, 2012, AI MAG, V33, P22; Mitchell T.M, 2003, MACH LEARN; Muller M, 2011, IEEE J-STSP, V5, P1088, DOI 10.1109/JSTSP.2011.2112333; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Palmer C, 1996, MUSIC PERCEPT, V13, P433; Penel A, 1998, PSYCHOL RES-PSYCH FO, V61, P12, DOI 10.1007/PL00008161; Repp BH, 1998, J ACOUST SOC AM, V104, P1085, DOI 10.1121/1.423325; REPP BH, 1992, J ACOUST SOC AM, V92, P2546, DOI 10.1121/1.404425; REPP BH, 1990, J ACOUST SOC AM, V88, P622, DOI 10.1121/1.399766; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Serra J, 2011, THESIS U P FABRA BAR; Serra J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00521; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; SLOBODA JA, 1983, Q J EXP PSYCHOL-A, V35, P377, DOI 10.1080/14640748308402140; Stamatatos E, 2005, ARTIF INTELL, V165, P37, DOI 10.1016/j.artint.2005.01.007; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sundberg J, 2001, GENERATIVE PROCESSES, P52; TODD NPM, 1992, J ACOUST SOC AM, V91, P3540, DOI 10.1121/1.402843; Todd NPM, 1992, MUSIC PERCEPT, V91, P3540; Witten I. H., 2005, DATA MINING PRACTICA	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e69268	10.1371/journal.pone.0069268	http://dx.doi.org/10.1371/journal.pone.0069268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	194LB	23935971	Green Published, Green Submitted, gold			2022-12-27	WOS:000322633700022
J	Sverzellati, N; Colombi, D; Randi, G; Pavarani, A; Silva, M; Walsh, SL; Pistolesi, M; Alfieri, V; Chetta, A; Vaccarezza, M; Vitale, M; Pastorino, U				Sverzellati, Nicola; Colombi, Davide; Randi, Giorgia; Pavarani, Antonio; Silva, Mario; Walsh, Simon L.; Pistolesi, Massimo; Alfieri, Veronica; Chetta, Alfredo; Vaccarezza, Mauro; Vitale, Marco; Pastorino, Ugo			Computed Tomography Measurement of Rib Cage Morphometry in Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHEST-WALL MECHANICS; THORACIC DIMENSIONS; LUNG-INFLATION; HOOVERS SIGN; HYPERINFLATION; DIAPHRAGM; CT; EXERCISE; SURGERY	Background: Factors determining the shape of the human rib cage are not completely understood. We aimed to quantify the contribution of anthropometric and COPD-related changes to rib cage variability in adult cigarette smokers. Methods: Rib cage diameters and areas (calculated from the inner surface of the rib cage) in 816 smokers with or without COPD, were evaluated at three anatomical levels using computed tomography (CT). CTs were analyzed with software, which allows quantification of total emphysema (emphysema%). The relationship between rib cage measurements and anthropometric factors, lung function indices, and % emphysema were tested using linear regression models. Results: A model that included gender, age, BMI, emphysema%, forced expiratory volume in one second (FEV1)%, and forced vital capacity (FVC)% fit best with the rib cage measurements (R-2 = 64% for the rib cage area variation at the lower anatomical level). Gender had the biggest impact on rib cage diameter and area (105.3 cm(2); 95% CI: 111.7 to 98.8 for male lower area). Emphysema% was responsible for an increase in size of upper and middle CT areas (up to 5.4 cm(2); 95% CI: 3.0 to 7.8 for an emphysema increase of 5%). Lower rib cage areas decreased as FVC% decreased (5.1 cm(2); 95% CI: 2.5 to 7.6 for 10 percentage points of FVC variation). Conclusions: This study demonstrates that simple CT measurements can predict rib cage morphometric variability and also highlight relationships between rib cage morphometry and emphysema.	[Sverzellati, Nicola; Colombi, Davide; Pavarani, Antonio; Silva, Mario] Univ Parma, Dept Surg, Sect Diagnost Imaging, I-43100 Parma, Italy; [Randi, Giorgia] Mario Negri Inst Pharmacol Res, Dept Epidemiol, Milan, Italy; [Walsh, Simon L.] Univ London St Georges Hosp, Dept Radiol, London, England; [Pistolesi, Massimo] Univ Florence, Dept Internal Med, Sect Resp Med, Florence, Italy; [Alfieri, Veronica; Chetta, Alfredo] Univ Parma, Resp Dis & Lung Funct Unit, Dept Clin & Expt Med, I-43100 Parma, Italy; [Vaccarezza, Mauro] Univ Cassino, Dept Human Social & Hlth Sci, I-03043 Cassino, Italy; [Vitale, Marco] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Human Anat Sect S Bi Bi T, I-43100 Parma, Italy; [Pastorino, Ugo] Fdn IRCCS Ist Nazl Tumori, Thorac Surg Sect, Dept Surg, Milan, Italy	University of Parma; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; St Georges University London; University of Florence; University of Parma; University Hospital of Parma; University of Cassino; University of Parma; Fondazione IRCCS Istituto Nazionale Tumori Milan	Sverzellati, N (corresponding author), Univ Parma, Dept Surg, Sect Diagnost Imaging, I-43100 Parma, Italy.	nicola.sverzellati@unipr.it	Silva, Mario/B-9509-2016; Colombi, Davide/ABD-3626-2020; Vitale, Marco/O-8751-2015; Pastorino, Ugo/C-2712-2017; Sverzellati, Nicola/AIC-5706-2022; VACCAREZZA, Mauro/S-9637-2019	Silva, Mario/0000-0002-2538-7032; Vitale, Marco/0000-0002-3261-6868; Pastorino, Ugo/0000-0001-9974-7902; VACCAREZZA, Mauro/0000-0003-3060-318X; Colombi, davide/0000-0002-2794-5237; SVERZELLATI, Nicola/0000-0002-4820-3785; Chetta, Alfredo/0000-0002-0416-5334	Italian Association for Research on Cancer (AIRC); Lombardia-Cariplo Foundation; Italian Ministry of Health	Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Lombardia-Cariplo Foundation; Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by grants from the Italian Association for Research on Cancer (AIRC), Lombardia-Cariplo Foundation and Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2004, THORAX, V59, P210, DOI 10.1136/thorax.2003.011494; Aliverti A, 2008, RESP PHYSIOL NEUROBI, V163, P90, DOI 10.1016/j.resp.2008.07.025; Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; Bellemare JF, 2001, CHEST, V119, P376, DOI 10.1378/chest.119.2.376; BENHAIM SA, 1989, J BIOMECH, V22, P559, DOI 10.1016/0021-9290(89)90007-9; Binazzi B, 2008, RESP PHYSIOL NEUROBI, V160, P325, DOI 10.1016/j.resp.2007.10.019; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; Bruyneel M, 2011, EUR J INTERN MED, V22, pE115, DOI 10.1016/j.ejim.2011.08.020; Cassart M, 1996, AM J RESP CRIT CARE, V154, P800, DOI 10.1164/ajrccm.154.3.8810622; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; De Troyer A, 2012, J APPL PHYSIOL, V112, P529, DOI 10.1152/japplphysiol.01067.2011; De Troyer A, 2009, J APPL PHYSIOL, V107, P315, DOI 10.1152/japplphysiol.91472.2008; Decramer M, 1997, EUR RESPIR J, V10, P934; Fauroux B, 2009, EUR RESPIR J, V33, P113, DOI 10.1183/09031936.00050708; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GILMARTIN JJ, 1986, AM REV RESPIR DIS, V134, P683; Girotti P, 2011, ANN THORAC SURG, V92, P1208, DOI 10.1016/j.athoracsur.2011.05.016; HALLER JA, 1987, J PEDIATR SURG, V22, P904, DOI 10.1016/S0022-3468(87)80585-7; Johnston Chambless R 3rd, 2008, Clin Mol Allergy, V6, P8, DOI 10.1186/1476-7961-6-8; JUBRAN A, 1992, AM REV RESPIR DIS, V146, P1378, DOI 10.1164/ajrccm/146.6.1378; KILBURN KH, 1969, ARCH INTERN MED, V123, P379, DOI 10.1001/archinte.123.4.379; Leduc D, 2012, J APPL PHYSIOL, V112, P1311, DOI 10.1152/japplphysiol.01422.2011; LEE M, 1995, J BIOMECH, V28, P1403, DOI 10.1016/0021-9290(95)00001-X; LENNON EA, 1965, BRIT J RADIOL, V38, P937, DOI 10.1259/0007-1285-38-456-937; Leo F, 2010, ANN THORAC SURG, V90, P2065, DOI 10.1016/j.athoracsur.2010.02.043; Ley-Zaporozhan J, 2008, EUR RADIOL, V18, P510, DOI 10.1007/s00330-007-0772-1; Malaguti C, 2009, RESP CARE, V54, P1703; MARAZZINI L, 1970, RESPIRATION, V27, P105, DOI 10.1159/000192676; Mitton D, 2008, J BIOMECH, V41, P706, DOI 10.1016/j.jbiomech.2007.09.034; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; PIERCE JA, 1958, AM J MED, V25, P13, DOI 10.1016/0002-9343(58)90193-1; Priori R, 2013, J APPL PHYSIOL, V114, P1066, DOI 10.1152/japplphysiol.00414.2012; ROTHPEARL A, 1988, CHEST, V94, P907, DOI 10.1378/chest.94.5.907; SHARP JT, 1986, J APPL PHYSIOL, V61, P2050, DOI 10.1152/jappl.1986.61.6.2050; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Standring A., 2008, ANATOMICAL BASIS CLI, V40th, p409?421; TAKAHASHI EIJI, 1955, HUMAN BIOL, V27, P65; Testut L, 1899, TRAITE ANATOMY HUMAI; WALSH JM, 1992, J APPL PHYSIOL, V72, P1270, DOI 10.1152/jappl.1992.72.4.1270	42	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68546	10.1371/journal.pone.0068546	http://dx.doi.org/10.1371/journal.pone.0068546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935872	gold, Green Published			2022-12-27	WOS:000322633700009
J	Nadkarni, NA; Chaumontet, C; Azzout-Marniche, D; Piedcoq, J; Fromentin, G; Tome, D; Even, PC				Nadkarni, Nachiket A.; Chaumontet, Catherine; Azzout-Marniche, Dalila; Piedcoq, Julien; Fromentin, Gilles; Tome, Daniel; Even, Patrick C.			The Carbohydrate Sensitive Rat as a Model of Obesity	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENERGY-EXPENDITURE; INDIRECT CALORIMETRY; SKELETAL-MUSCLE; HIGH-FAT; PRONE; RESISTANT; THERMOGENESIS; WEIGHT; FOOD	Background: Sensitivity to obesity is highly variable in humans, and rats fed a high fat diet (HFD) are used as a model of this inhomogeneity. Energy expenditure components (basal metabolism, thermic effect of feeding, activity) and variations in substrate partitioning are possible factors underlying the variability. Unfortunately, in rats as in humans, results have often been inconclusive and measurements usually made after obesity onset, obscuring if metabolism was a cause or consequence. Additionally, the role of high carbohydrate diet (HCD) has seldom been studied. Methodology/Findings: Rats (n=24) were fed for 3 weeks on HCD and then 3 weeks on HFD. Body composition was tracked by MRI and compared to energy expenditure components measured prior to obesity.Results: 1) under HFD, as expected, by adiposity rats were variable enough to be separable into relatively fat resistant (FR) and sensitive (FS) groups, 2) under HCD, and again by adiposity, rats were also variable enough to be separable into carbohydrate resistant (CR) and sensitive (CS) groups, the normal body weight of CS rats hiding viscerally-biased fat accumulation, 3) HCD adiposity sensitivity was not related to that under HFD, and both HCD and HFD adiposity sensitivities were not related to energy expenditure components (BMR, TEF, activity cost), and 4) only carbohydrate to fat partitioning in response to an HCD test meal was related to HCD-induced adiposity. Conclusions/Significance: The rat model of human obesity is based on substantial variance in adiposity gains under HFD (FR/FS model). Here, since we also found this phenomenon under HCD, where it was also linked to an identifiable metabolic difference, we should consider the existence of another model: the carbohydrate resistant (CR) or sensitive (CS) rat. This new model is potentially complementary to the FR/FS model due to relatively greater visceral fat accumulation on a low fat high carbohydrate diet.	[Nadkarni, Nachiket A.] AgroParisTech, Chaire Aliment Nutr Comportement Alimentaire, Paris, France; [Chaumontet, Catherine; Azzout-Marniche, Dalila; Piedcoq, Julien; Fromentin, Gilles; Tome, Daniel; Even, Patrick C.] AgroParisTech, Inst Natl Rech Agronom, Unite Mixte Rech 914, Paris, France	AgroParisTech; AgroParisTech; INRAE	Even, PC (corresponding author), AgroParisTech, Inst Natl Rech Agronom, Unite Mixte Rech 914, Paris, France.	patrick.even@agroparistech.fr		Azzout-Marniche, Dalila/0000-0001-8397-9143; Even, Patrick/0000-0001-5733-3023	Region Ile-de-France (DIM ASTREA); Chaire ANCA; CNRS; AgroParisTech; INRA; Fondation Benjamin Delessert	Region Ile-de-France (DIM ASTREA)(Region Ile-de-France); Chaire ANCA; CNRS(Centre National de la Recherche Scientifique (CNRS)); AgroParisTech; INRA; Fondation Benjamin Delessert	NN is funded by the Region Ile-de-France (DIM ASTREA) and Chaire ANCA. PCE is funded by CNRS. DT, DA, and JP are funded by AgroParisTech. GF and CC are funded by INRA. The experiment was funded by INRA and the Fondation Benjamin Delessert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; CHANG S, 1990, AM J PHYSIOL, V259, pR1103, DOI 10.1152/ajpregu.1990.259.6.R1103; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Commerford SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE875, DOI 10.1152/ajpendo.2000.279.4.E875; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; DALESSIO DA, 1988, J CLIN INVEST, V81, P1781, DOI 10.1172/JCI113520; de Jonge L, 1997, OBES RES, V5, P622, DOI 10.1002/j.1550-8528.1997.tb00584.x; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2011, J AM COLL CARDIOL, V57, P1887, DOI 10.1016/j.jacc.2010.10.063; Dourmashkin JT, 2006, PHYSIOL BEHAV, V87, P666, DOI 10.1016/j.physbeh.2006.01.008; Dourmashkin JT, 2005, INT J OBESITY, V29, P1368, DOI 10.1038/sj.ijo.0803017; Esparza J, 2000, INT J OBESITY, V24, P55, DOI 10.1038/sj.ijo.0801085; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Even PC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00096; Even PC, 2001, AM J PHYSIOL-REG I, V280, pR1887; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; FELIG P, 1983, AM J PHYSIOL, V244, pE45, DOI 10.1152/ajpendo.1983.244.1.E45; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fink BD, 2007, AM J PHYSIOL-REG I, V293, pR1773, DOI 10.1152/ajpregu.00478.2007; Flatt JP, 2007, OBESITY, V15, P2546, DOI 10.1038/oby.2007.304; FLATT JP, 1987, ANN NY ACAD SCI, V499, P104, DOI 10.1111/j.1749-6632.1987.tb36202.x; Friedman MI, 1998, AM J CLIN NUTR, V67, p513S, DOI 10.1093/ajcn/67.3.513S; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Goran MI, 2000, MED CLIN N AM, V84, P347, DOI 10.1016/S0025-7125(05)70225-X; Granata GP, 2002, NUTR REV, V60, P223, DOI 10.1301/002966402320289359; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Jackman MR, 2010, AM J PHYSIOL-REG I, V299, pR1097, DOI 10.1152/ajpregu.00549.2009; Karatayev O, 2009, BRAIN RES, V1298, P111, DOI 10.1016/j.brainres.2009.08.001; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAVUSSIN E, 1995, INT J OBESITY, V19, pS8; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROBERTS SB, 1995, OBES RES, V3, P3, DOI 10.1002/j.1550-8528.1995.tb00002.x; Sarkar D., 2019, NLME LINEAR NONLINEA; Solinas G, 2004, FEBS LETT, V577, P539, DOI 10.1016/j.febslet.2004.10.066; STOCK MJ, 1989, P NUTR SOC, V48, P189, DOI 10.1079/PNS19890029; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Stubbs RJ, 1997, ANN NY ACAD SCI, V819, P44, DOI 10.1111/j.1749-6632.1997.tb51798.x; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Van Klinken JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036162; VERGA S, 1994, ACTA DIABETOL, V31, P47, DOI 10.1007/BF00580761; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Xie WD, 2010, MOL MED REP, V3, P1047, DOI 10.3892/mmr.2010.354; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	54	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68436	10.1371/journal.pone.0068436	http://dx.doi.org/10.1371/journal.pone.0068436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935869	Green Published, Green Submitted, gold			2022-12-27	WOS:000323114200010
J	Gu, YH; Li, Y; Huang, XF; Zheng, JF; Yang, J; Diao, H; Yuan, Y; Xu, Y; Liu, M; Shi, HJ; Xu, WP				Gu, Yi-hua; Li, Yan; Huang, Xue-feng; Zheng, Ju-fen; Yang, Jun; Diao, Hua; Yuan, Yao; Xu, Yan; Liu, Miao; Shi, Hui-juan; Xu, Wen-ping			Reproductive Effects of Two Neonicotinoid Insecticides on Mouse Sperm Function and Early Embryonic Development In Vitro	PLOS ONE			English	Article							DEVELOPING MALE RATS; ANTIOXIDANT ENZYMES; FEMALE RATS; NICOTINE; MOTILITY; TOXICITY; EXPOSURE; ADULT; APPLICATORS; PESTICIDES	Acetamiprid (ACE) and imidacloprid (IMI) are two major members in the family of neonicotinoid pesticides, which are synthesized with a higher selectivity to insects. The present study determined and compared in vitro effects of ACE, IMI and nicotine on mammalian reproduction by using an integrated testing strategy for reproductive toxicology, which covered sperm quality, sperm penetration into oocytes and preimplantation embryonic development. Direct chemical exposure (500 mu M or 5 mM) on spermatozoa during capacitation was performed, and in vitro fertilization (IVF) process, zygotes and 2-cell embryos were respectively incubated with chemical-supplemented medium until blastocyst formation to evaluate the reproductive toxicity of these chemicals and monitor the stages mainly affected. Generally, treatment of 500 mu M or 5 mM chemicals for 30 min did not change sperm motility and DNA integrity significantly but the fertilization ability in in vitro fertilization (IVF) process, indicating that IVF process could detect and distinguish subtle effect of spermatozoa exposed to different chemicals. Culture experiment in the presence of chemicals in medium showed that fertilization process and zygotes are adversely affected by direct exposure of chemicals (P<0.05), in an order of nicotine>IMI>ACE, whereas developmental progression of 2-cell stage embryos was similar to controls (P>0.05). These findings unveiled the hazardous effects of neonicotinoid pesticides exposure on mammalian sperm fertilization ability as well as embryonic development, raising the concerns that neonicotinoid pesticides may pose reproductive risks on human reproductive health, especially in professional populations.	[Gu, Yi-hua; Huang, Xue-feng; Diao, Hua; Xu, Yan; Liu, Miao; Shi, Hui-juan] Fudan Univ, Obstet & Gynecol Hosp, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Gu, Yi-hua; Zheng, Ju-fen; Yang, Jun; Diao, Hua; Yuan, Yao; Shi, Hui-juan] Fudan Univ, Shanghai Inst Planned Parenthood Res, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Li, Yan; Huang, Xue-feng] Wenzhou Med Univ, Affiliated Hosp 1, Reprod Med Ctr, Wenzhou, Zhejiang, Peoples R China; [Xu, Wen-ping] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Fudan University; Fudan University; Wenzhou Medical University; East China University of Science & Technology	Shi, HJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Inst Reprod & Dev, Shanghai 200433, Peoples R China.	shihuijuan2011@163.com; xuwp@ecust.edu.cn			National Key Technologies RD Program [2011BAE06B04]; National Natural Science Foundation of China [30872765]; Three National Comprehensive Programs of Reproductive Health & Family Planning [C1-93]; Basic Research Key Program of Shanghai [10JC1410800]	National Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Three National Comprehensive Programs of Reproductive Health & Family Planning; Basic Research Key Program of Shanghai	Research support was provided by National Key Technologies R&D Program (2011BAE06B04), The National Natural Science Foundation of China (No. 30872765), Three National Comprehensive Programs of Reproductive Health & Family Planning (C1-93), and the Basic Research Key Program of Shanghai (10JC1410800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi M, 2004, ANDROLOGIA, V36, P305, DOI 10.1111/j.1439-0272.2004.00623.x; Arabi Mehran, 2005, Zhonghua Nan Ke Xue, V11, P323; Arrick DM, 2007, J APPL PHYSIOL, V103, P2062, DOI 10.1152/japplphysiol.00411.2007; Bal R, 2012, CELL BIOCHEM FUNCT, V30, P492, DOI 10.1002/cbf.2826; Bal R, 2012, CELL BIOL TOXICOL, V28, P187, DOI 10.1007/s10565-012-9215-0; Bal R, 2012, J ENVIRON SCI HEAL B, V47, P434, DOI 10.1080/03601234.2012.663311; BALDWIN KV, 1988, REPROD TOXICOL, V1, P173; Claassens OE, 2000, HUM REPROD, V15, P1586, DOI 10.1093/humrep/15.7.1586; Cope GF, 1998, HUM REPROD, V13, P777, DOI 10.1093/humrep/13.3.777; D'Occhio MJ, 2007, ANIM REPROD SCI, V101, P1, DOI 10.1016/j.anireprosci.2007.01.005; Duzgunerb V ES, 2012, PESTIC BIOCHEM PHYS, V104, P7; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Ezzatabadipour M, 2012, ANDROLOGIA, V44, P330, DOI 10.1111/j.1439-0272.2012.01284.x; Gandini L, 1997, HUM REPROD, V12, P727, DOI 10.1093/humrep/12.4.727; Harris SA, 2010, J AGR FOOD CHEM, V58, P10253, DOI 10.1021/jf101209g; Huang XF, PLOS ONE, V7; Jain A, 2012, J ENVIRON BIOL, V33, P233; Jana K, 2010, TOXICOL SCI, V116, P647, DOI 10.1093/toxsci/kfq149; Jelks K, 2001, REPROD TOXICOL, V15, P11; Kapoor U, 2011, FOOD CHEM TOXICOL, V49, P3086, DOI 10.1016/j.fct.2011.09.009; Kapoor U, 2010, J TOXICOL SCI, V35, P577, DOI 10.2131/jts.35.577; Lorenzetti S. A. I., 2011, ANN I SUPER SANITA, V47, P16; Marin A, 2004, J CHROMATOGR B, V804, P269, DOI 10.1016/j.jchromb.2004.01.022; PEKARSKY A, 1995, ARCH ANDROLOGY, V34, P77, DOI 10.3109/01485019508987834; Perreault SD, 2001, REPRODUCTION, V121, P207, DOI 10.1530/rep.0.1210207; Ramazzini C, 2009, AM J IND MED, V52, P176, DOI 10.1002/ajim.20654; REDDY A, 1995, J ASSIST REPROD GEN, V12, P217, DOI 10.1007/BF02211802; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Vine MF, 1996, FERTIL STERIL, V65, P835, DOI 10.1016/S0015-0282(16)58223-5; Wakayama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006753; Wamhoff H, 1999, J AGR FOOD CHEM, V47, P1730, DOI 10.1021/jf980820j; Zenzes Maria Teresa, 2004, Tob Induc Dis, V2, P151, DOI 10.1186/1617-9625-2-3-151	32	60	63	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70112	10.1371/journal.pone.0070112	http://dx.doi.org/10.1371/journal.pone.0070112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922925	Green Published, gold			2022-12-27	WOS:000323369700137
J	Hurh, S; Cho, B; You, DJ; Kim, H; Lee, EM; Lee, SH; Park, SJ; Park, HC; Koo, OJ; Yang, J; Oh, KH; Lee, BC; Hwang, JI; Ahn, C				Hurh, Sunghoon; Cho, Bumrae; You, Dong-Joo; Kim, Hwajung; Lee, Eun Mi; Lee, Sang Hoon; Park, Sol Ji; Park, Hayne Cho; Koo, Ok Jae; Yang, Jaeseok; Oh, Kook-Hwan; Lee, Byeong Chun; Hwang, Jong-Ik; Ahn, Curie			Expression Analysis of Combinatorial Genes Using a BiCistronic T2A Expression System in Porcine Fibroblasts	PLOS ONE			English	Article							RIBOSOME ENTRY SITES; TRANSGENIC PIGS; 2A PEPTIDE; LENTIVIRAL VECTOR; RETROVIRAL VECTOR; SIGNAL SEQUENCES; STEM-CELLS; PROTEINS; XENOTRANSPLANTATION; COAGULOPATHY	In pig-to-primate xenotransplantation, multiple transgenic pigs are required to overcome a series of transplant rejections. The generation of multiple transgenic pigs either by breeding or the introduction of several mono-cistronic vectors has been hampered by the differential expression patterns of the target genes. To achieve simultaneous expression of multiple genes, a poly-cistronic expression system using the 2A peptide derived from the Thosea asigna virus (T2A) can be considered an alternative choice. Before applying T2A expression system to pig generation, the expression patterns of multiple genes in this system should be precisely evaluated. In this study, we constructed several bi-cistronic T2A expression vectors, which combine target genes that are frequently used in the xenotransplantation field, and introduced them into porcine fibroblasts. The proteins targeted to the same or different subcellular regions were efficiently expressed without affecting the localization or expression levels of the other protein. However, when a gene with low expression efficiency was inserted into the upstream region of the T2A sequences, the expression level of the downstream gene was significantly decreased compared with the expression efficiency without the insertion. A small interfering RNA targeting one gene in this system resulted in the significant downregulation of both the target gene and the other gene, indicating that multiple genes combined into a T2A expression vector can be considered as a single gene in terms of transcription and translation. In summary, the efficient expression of a downstream gene can be achieved if the expression of the upstream gene is efficient.	[Hurh, Sunghoon; Cho, Bumrae; Kim, Hwajung; Lee, Eun Mi; Lee, Sang Hoon; Yang, Jaeseok; Ahn, Curie] Seoul Natl Univ, Coll Med, Transplantat Res Inst, Seoul, South Korea; [Hurh, Sunghoon; Lee, Eun Mi] Seoul Natl Univ, Coll Med, Grad Sch Immunol, Seoul, South Korea; [Cho, Bumrae; Park, Sol Ji; Lee, Byeong Chun] Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea; [Cho, Bumrae; Park, Sol Ji; Lee, Byeong Chun] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [You, Dong-Joo; Hwang, Jong-Ik] Korea Univ, Grad Sch Med, Seoul, South Korea; [Park, Hayne Cho; Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Koo, Ok Jae; Lee, Byeong Chun; Ahn, Curie] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea; [Yang, Jaeseok; Ahn, Curie] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, Seoul, South Korea.	hjibio@korea.ac.kr; curie@snu.ac.kr	; Koo, Ok Jae/I-4267-2013	Yang, Jeaseok/0000-0002-5378-7797; Koo, Ok Jae/0000-0001-6399-6472; Hwang, Jong-Ik/0000-0002-0729-1782	Ministry of the Knowledge Economy [2009-67-10033838, 2009-67-10033805]	Ministry of the Knowledge Economy	This study was supported by the Ministry of the Knowledge Economy (grant #2009-67-10033838,#2009-67-10033805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cowan PJ, 2000, TRANSPLANTATION, V69, P2504, DOI 10.1097/00007890-200006270-00008; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; de Felipe P., 2002, Current Gene Therapy, V2, P355, DOI 10.2174/1566523023347742; Deng W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019986; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fisicaro N, 2011, XENOTRANSPLANTATION, V18, P121, DOI 10.1111/j.1399-3089.2011.00631.x; Funston GM, 2008, J GEN VIROL, V89, P389, DOI 10.1099/vir.0.83444-0; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hu T, 2009, BIOTECHNOL LETT, V31, P353, DOI 10.1007/s10529-008-9882-3; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Le Bas-Bernardet S, 2011, TRANSPL P, V43, P3426, DOI 10.1016/j.transproceed.2011.09.024; Lengler J, 2005, ANAL BIOCHEM, V343, P116, DOI 10.1016/j.ab.2005.05.004; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Lin CC, 2010, AM J TRANSPLANT, V10, P1556, DOI 10.1111/j.1600-6143.2010.03147.x; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Webster NL, 2005, MOL REPROD DEV, V72, P68, DOI 10.1002/mrd.20316; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; Yeom HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046646; Zhou CY, 2005, XENOTRANSPLANTATION, V12, P142, DOI 10.1111/j.1399-3089.2005.00209.x; Zhou Y, 1998, HUM GENE THER, V9, P287, DOI 10.1089/hum.1998.9.3-287	43	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70486	10.1371/journal.pone.0070486	http://dx.doi.org/10.1371/journal.pone.0070486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922997	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700187
J	Kelly, LE; Chaudhry, SA; Rieder, MJ; 't Jong, G; Moretti, ME; Lausman, A; Ross, C; Berger, H; Carleton, B; Hayden, MR; Madadi, P; Koren, G				Kelly, Lauren E.; Chaudhry, Shahnaz A.; Rieder, Michael J.; 't Jong, Geert; Moretti, Myla E.; Lausman, Andrea; Ross, Colin; Berger, Howard; Carleton, Bruce; Hayden, Michael R.; Madadi, Parvaz; Koren, Gideon			A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; MORPHINE; PHARMACOGENETICS; POLYMORPHISMS; GUIDELINES; TOXICITY; THERAPY; RISK; GENE; PAIN	Background: Neonates are commonly exposed to maternal codeine through breast milk. Central Nervous System (CNS) depression has been reported in up to 24% of nurslings following codeine exposure. In 2009, we developed guidelines to improve the safety of codeine use during breastfeeding based on previously established pharmacogenetic and clinical risk factors. The primary objective of this study was to prospectively evaluate the effectiveness of these guidelines in ensuring neonatal safety. Methods and Findings: Women taking codeine for pain following caesarean section were given safety guidelines, including advice to use the lowest codeine dose for no longer than four days and to switch to a non-opioid when possible. Mothers provided a saliva sample for analysis of genes involved in opioid disposition, metabolism and response. A total of 238 consenting women participated. Neonatal sedation was reported in 2.1% (5/238) of breastfeeding women taking codeine according to our safety guidelines. This rate was eight fold lower than that reported in previous prospective studies. Women reporting sedated infants were taking codeine for a significantly longer period of time (4.80+/-2.59 days vs. 2.52+/-1.58 days, p = 0.0018). While following the codeine safety guidelines, mothers were less likely to supplement with formula, reported lower rates of sedation in themselves and breastfed more frequently throughout the day when compared to previously reported rates. Genotyping analysis of cytochrome p450 2D6 (CYP2D6), uridine-diphosphate glucuronosyltransferase (UGT) 2B7, p-glycoprotein (ABCB1), the mu-opioid receptor (OPRM1) and catechol-o-demethyltransferase (COMT) did not predict codeine response in breastfeeding mother/infant pairs when following the safety guidelines. Conclusions: The only cases of CNS depression occurred when the length of codeine use exceeded the guideline recommendations. Neonatal safety of codeine can be improved using evidence-based guidelines, even in those deemed by genetics to be at high risk for toxicity.	[Kelly, Lauren E.; Rieder, Michael J.] Univ Western Ontario, Schulich Sch Med, Dept Physiol & Pharmacol, London, ON, Canada; [Kelly, Lauren E.; Rieder, Michael J.] London Hlth Sci Ctr, Dept Clin Pharmacol, London, ON, Canada; [Kelly, Lauren E.; Koren, Gideon] Univ Western Ontario, Ivey Chair Mol Toxicol, London, ON, Canada; [Chaudhry, Shahnaz A.; 't Jong, Geert; Madadi, Parvaz; Koren, Gideon] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Chaudhry, Shahnaz A.; 't Jong, Geert; Moretti, Myla E.; Madadi, Parvaz; Koren, Gideon] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Ross, Colin; Carleton, Bruce; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Carleton, Bruce] Child & Family Res Inst, Vancouver, BC, Canada; [Lausman, Andrea; Berger, Howard] St Michaels Hosp, Dept Obstet & Gynecol, Toronto, ON M5B 1W8, Canada	Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; Child & Family Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Koren, G (corresponding author), Univ Western Ontario, Ivey Chair Mol Toxicol, London, ON, Canada.	gkoren@sickkids.ca	Rieder, Michael J/L-2397-2013; Kelly, Lauren E/I-5543-2019; Berger, Howard/N-6424-2019; Hayden, Michael R/D-8581-2011; Koren, Gideon/AAG-7726-2019	Kelly, Lauren E/0000-0001-7567-0816; Hayden, Michael R/0000-0001-5159-1419; Koren, Gideon/0000-0002-9234-0875; Carleton, Bruce/0000-0002-4485-4054; Ross, Colin/0000-0003-1476-7037; Berger, Howard/0000-0003-3842-213X	Canadian Pharmacogenomic Network for Drug Safety; Canadian Institutes for Health Research (CIHR); Queen Elizabeth II Graduate Studentship in Science and Technology (QEIIGSST); Ivey Chair in Molecular Toxicology, Western University; Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation, Sickkids Hospital; GSK-CIHR Chair in Developmental Pharmacology	Canadian Pharmacogenomic Network for Drug Safety; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Studentship in Science and Technology (QEIIGSST); Ivey Chair in Molecular Toxicology, Western University; Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation, Sickkids Hospital; GSK-CIHR Chair in Developmental Pharmacology	The study, Miss Kelly and Dr. Ross were funded by the Canadian Pharmacogenomic Network for Drug Safety and the Canadian Institutes for Health Research (CIHR). Miss Kelly was also awarded a Queen Elizabeth II Graduate Studentship in Science and Technology (QEIIGSST). Dr. Ross is supported by a CIHR New Investigator award and Dr. Madadi a CIHR Postdoctoral Fellowship. Dr. Koren is supported by the Ivey Chair in Molecular Toxicology, Western University and the Research Leadership for Better Pharmacotherapy During Pregnancy and Lactation, Sickkids Hospital, Dr. Rieder is supported by the GSK-CIHR Chair in Developmental Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics Committee on Drugs, 2001, Pediatrics, V108, P776; Canadian Institute for Health Information -Childbirth indicators by place of residence, 2009, CHILDB IND PLAC RES; Center for Disease Control-Births Methods of Delivery, BIRTHS METH DEL; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Juurlink DN, 2012, CLIN TOXICOL, V50, P390, DOI 10.3109/15563650.2012.681052; Kirchheiner J, 2007, PHARMACOGENOMICS J, V7, P257, DOI 10.1038/sj.tpj.6500406; Koren G, 2006, LANCET, V368, P704, DOI 10.1016/S0140-6736(06)69255-6; Lam J, 2012, J PEDIATR-US, V160, P33, DOI 10.1016/j.jpeds.2011.06.050; Lotsch J, 2005, TRENDS MOL MED, V11, P82, DOI 10.1016/j.molmed.2004.12.006; Madadi P, 2009, CLIN PHARMACOL THER, V85, P31, DOI 10.1038/clpt.2008.157; Madadi P, 2008, PHARMACOGENOMICS, V9, P1267, DOI 10.2217/14622416.9.9.1267; Madadi P, 2009, CAN FAM PHYSICIAN, V55, P1077; Nauta M, 2009, AM J SURG, V198, P256, DOI 10.1016/j.amjsurg.2008.11.044; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Ross JR, 2008, CANCER-AM CANCER SOC, V112, P1390, DOI 10.1002/cncr.23292; Sawyer MB, 2003, CLIN PHARMACOL THER, V73, P566, DOI 10.1016/S0009-9236(03)00053-5; Sistonen J, 2005, CLIN CHEM, V51, P1291, DOI 10.1373/clinchem.2004.046466; Sistonen J, 2012, CLIN PHARMACOL THER, V91, P692, DOI 10.1038/clpt.2011.280; Statistics Canada- Breastfeeding, 2009, STAT CAN BREASTF; U.S. Food and Drug Administration (FDA), 2008, PUBL HLTH ADV US COD; Willmann S, 2009, CLIN PHARMACOL THER, V86, P634, DOI 10.1038/clpt.2009.151	22	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70073	10.1371/journal.pone.0070073	http://dx.doi.org/10.1371/journal.pone.0070073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922910	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700129
J	Luo, ZY; Wang, YY; Zhao, ZS; Li, B; Chen, JF				Luo, Zu-Yan; Wang, Yuan-Yu; Zhao, Zhong-Sheng; Li, Bo; Chen, Jun-Fa			The Expression of TMPRSS4 and Erk1 Correlates with Metastasis and Poor Prognosis in Chinese Patients with Gastric Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSMEMBRANE SERINE PROTEASES; SURFACE PROTEOLYTIC-ENZYMES; CELL-PROLIFERATION; PROTEIN EXPRESSION; UP-REGULATION; CARCINOMA; OVEREXPRESSION; INVASION; DISEASE	Purpose: The present study investigated the clinical significance of transmembrane protease, serine 4(TMPRSS4) and extracellular signal-regulated kinases 1 (Erk1) in the development, progression and metastasis of gastric cancer. Methods: Immunohistochemistry was employed to analyze TMPRSS4 and Erk1 expression in 436 gastric cancer cases and 92 non-cancerous human gastric tissues. Results: Protein levels of TMPRSS4 and Erk1 were up-regulated in gastric cancer lesions compared with adjacent noncancerous tissues. High expression of TMPRSS4 correlated with age, size, Lauren's classification, depth of invasion, lymph node and distant metastases, regional lymph node stage and TNM stage, and also with expression of Erk1. In stages I, II and III, the 5-year survival rate of patients with high TMPRSS4 expression was significantly lower than in patients with low expression. Further multivariate analysis suggests that up-regulation of TMPRSS4 and Erk1 were independent prognostic indicators for the disease, along with depth of invasion, lymph node and distant metastasis and TNM stage. Conclusions: Expression of TMPRSS4 in gastric cancer is significantly associated with lymph node and distant metastasis, high Erk1 expression, and poor prognosis. TMPRSS4 and Erk1 proteins could be useful markers to predict tumor progression and prognosis of gastric cancer.	[Luo, Zu-Yan; Li, Bo; Chen, Jun-Fa] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuan-Yu] Zhejiang Prov Peoples Hosp, Dept Gastrointestinal Surg, Hangzhou, Zhejiang, Peoples R China; [Zhao, Zhong-Sheng] Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Zhao, ZS (corresponding author), Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China.	zhaozhongsheng1950@163.com			Zhejiang Provincial Department of Science and Technology Research Foundation [2008C33040]; National Special Funds for Health Foundation [200802112]	Zhejiang Provincial Department of Science and Technology Research Foundation; National Special Funds for Health Foundation	This study was support by a grant from Zhejiang Provincial Department of Science and Technology Research Foundation (2008C33040) and National Special Funds for Health Foundation (200802112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Guo DL, 2011, TUMOR BIOL, V32, P921, DOI 10.1007/s13277-011-0194-1; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kebebew E, 2005, ANN SURG, V242, P353, DOI 10.1097/sla.0000179623.87329.6b; Kim S, 2010, CARCINOGENESIS, V31, P597, DOI 10.1093/carcin/bgq024; Kolev Y, 2007, ANN SURG ONCOL, V14, P2738, DOI 10.1245/s10434-007-9484-7; Larzabal L, 2011, BRIT J CANCER, V105, P1608, DOI 10.1038/bjc.2011.432; Lee HS, 2003, J PATHOL, V200, P39, DOI 10.1002/path.1288; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Li T, 2011, CANCER GENE THER, V18, P617, DOI 10.1038/cgt.2011.29; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mao JS, 2008, CANCER SCI, V99, P2120, DOI 10.1111/j.1349-7006.2008.00928.x; Mizokami K, 2006, J SURG ONCOL, V94, P149, DOI 10.1002/jso.20568; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Ramachandran S, 2010, FEBS LETT, V584, P4077, DOI 10.1016/j.febslet.2010.08.035; Song LB, 2006, CANCER LETT, V242, P258, DOI 10.1016/j.canlet.2005.11.013; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Wallrapp C, 2000, CANCER RES, V60, P2602; Zhang DH, 2003, MODERN PATHOL, V16, P79, DOI 10.1097/01.MP.0000047307.96344.93	23	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70311	10.1371/journal.pone.0070311	http://dx.doi.org/10.1371/journal.pone.0070311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922976	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700171
J	Muller, P; Langenbach, A; Kaminski, A; Rychly, J				Mueller, Petra; Langenbach, Anne; Kaminski, Alexander; Rychly, Joachim			Modulating the Actin Cytoskeleton Affects Mechanically Induced Signal Transduction and Differentiation in Mesenchymal Stem Cells	PLOS ONE			English	Article							IN-VITRO; RECEPTORS; POLYMERIZATION; ORGANIZATION; BINDING; KINASE; MATRIX; FATE; RHOA	Mechanical interactions of mesenchymal stem cells (MSC) with the environment play a significant role in controlling the diverse biological functions of these cells. Mechanical forces are transduced by integrins to the actin cytoskeleton that functions as a scaffold to switch mechanical signals into biochemical pathways. To explore the significance of cytoskeletal mechanisms in human MSC we modulated the actin cytoskeleton using the depolymerising drugs cytochalasin D (CytD) and latrunculin A (LatA), as well as the stabilizing drug jasplakinolide (Jasp) and examined the activation of the signalling molecules ERK and AKT during mechanical loading. All three drugs provoked significant changes in cell morphology and organisation of the cytoskeleton. Application of mechanical forces to beta 1-integrin receptors using magnetic beads without deformation of the cell shape induced a phosphorylation of ERK and AKT. Of the two drugs that inhibited the cytoskeletal polymerization, LatA completely blocked the activation of ERK and AKT due to mechanical forces, whereas CytD inhibited the activation of AKT but not of ERK. Activation of both signalling molecules by integrin loading was not affected due to cell treatment with the cytoskeleton stabilizing drug Jasp. To correlate the effects of the drugs on mechanically induced activation of AKT and ERK with parameters of MSC differentiation, we studied ALP activity as a marker for osteogenic differentiation and examined the uptake of fat droplets as marker for adipogenic differentiation in the presence of the drugs. All three drugs inhibited ALP activity of MSC in osteogenic differentiation medium. Adipogenic differentiation was enhanced by CytD and Jasp, but not by LatA. The results indicate that modulation of the cytoskeleton using perturbing drugs can differentially modify both mechanically induced signal transduction and MSC differentiation. In addition to activation of the signalling molecules ERK and AKT, other cytoskeletal mechanisms are involved in MSC differentiation.	[Mueller, Petra; Langenbach, Anne; Rychly, Joachim] Univ Rostock, Med Ctr, Cell Biol Lab, D-18055 Rostock, Germany; [Kaminski, Alexander] Univ Rostock, Med Ctr, Dept Heart Surg, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Rychly, J (corresponding author), Univ Rostock, Med Ctr, Cell Biol Lab, D-18055 Rostock, Germany.	joachim.rychly@med.uni-rostock.de			Rostock University Medical Center	Rostock University Medical Center	The work was supported by the Rostock University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engel E, 2009, ANN ANAT, V191, P136, DOI 10.1016/j.aanat.2008.07.013; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; Feng TS, 2010, STEM CELL REV REP, V6, P74, DOI 10.1007/s12015-010-9115-8; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higashida C, 2013, NAT CELL BIOL, V15, P395, DOI 10.1038/ncb2693; Horiuchi R, 2012, EXP CELL RES, V318, P1726, DOI 10.1016/j.yexcr.2012.05.021; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1310, DOI 10.1016/j.bcp.2008.05.028; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nava MM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/797410; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pommerenke H, 1996, EUR J CELL BIOL, V70, P157; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Tseng PC, 2012, BIOMATERIALS, V33, P556, DOI 10.1016/j.biomaterials.2011.09.090; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yarmola EG, 2007, ANN NY ACAD SCI, V1112, P76, DOI 10.1196/annals.1415.008; Zhang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050899	40	76	78	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e71283	10.1371/journal.pone.0071283	http://dx.doi.org/10.1371/journal.pone.0071283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923061	Green Published, Green Submitted, gold			2022-12-27	WOS:000323369700232
J	Shen, DY; Liu, TL; Ye, WW; Liu, L; Liu, PH; Wu, YR; Wang, YC; Dou, DL				Shen, Danyu; Liu, Tingli; Ye, Wenwu; Liu, Li; Liu, Peihan; Wu, Yuren; Wang, Yuanchao; Dou, Daolong			Gene Duplication and Fragment Recombination Drive Functional Diversification of a Superfamily of Cytoplasmic Effectors in Phytophthora sojae	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTION; PROTEINS; PATHOGEN; EXPRESSION; SUPPRESSION; AVIRULENCE; SEQUENCE; PROGRAM; DEATH	Phytophthora and other oomycetes secrete a large number of putative host cytoplasmic effectors with conserved FLAK motifs following signal peptides, termed crinkling and necrosis inducing proteins (CRN), or Crinkler. Here, we first investigated the evolutionary patterns and mechanisms of CRN effectors in Phytophthora sojae and compared them to two other Phytophthora species. The genes encoding CRN effectors could be divided into 45 orthologous gene groups (OGG), and most OGGs unequally distributed in the three species, in which each underwent large number of gene gains or losses, indicating that the CRN genes expanded after species evolution in Phytophthora and evolved through pathoadaptation. The 134 expanded genes in P. sojae encoded family proteins including 82 functional genes and expressed at higher levels while the other 68 genes encoding orphan proteins were less expressed and contained 50 pseudogenes. Furthermore, we demonstrated that most expanded genes underwent gene duplication or/and fragment recombination. Three different mechanisms that drove gene duplication or recombination were identified. Finally, the expanded CRN effectors exhibited varying pathogenic functions, including induction of programmed cell death (PCD) and suppression of PCD through PAMP-triggered immunity or/and effector-triggered immunity. Overall, these results suggest that gene duplication and fragment recombination may be two mechanisms that drive the expansion and neofunctionalization of the CRN family in P. sojae, which aids in understanding the roles of CRN effectors within each oomycete pathogen.	[Shen, Danyu; Liu, Tingli; Ye, Wenwu; Liu, Li; Liu, Peihan; Wu, Yuren; Wang, Yuanchao; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Ye, Wenwu/J-5624-2014; Dou, Daolong/AAW-1678-2021; wang, yuanchao/G-9667-2011; Shen, Danyu/AAF-1644-2019; Ye, Wenwu/AAE-4961-2022	Ye, Wenwu/0000-0001-7347-8935; Dou, Daolong/0000-0001-5226-6642; wang, yuanchao/0000-0001-5803-5343; Ye, Wenwu/0000-0001-7347-8935	National Natural Science Foundation of China [31171831]; National Basic Research Program of China [2009CB119200]; Natural Science Foundation of Jiangsu Province [BK2012027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (number 31171831), National Basic Research Program of China (number 2009CB119200), and Natural Science Foundation of Jiangsu Province (number BK2012027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Ribeiro DC, 1996, PHYTOPHTHORA DIS WOR, Vxii; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Seidl MF, 2012, GENOME BIOL EVOL, V4, P199, DOI 10.1093/gbe/evs003; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Sun GL, 2011, BMC EVOL BIOL, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106	44	29	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70036	10.1371/journal.pone.0070036	http://dx.doi.org/10.1371/journal.pone.0070036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922898	Green Submitted, Green Published, gold			2022-12-27	WOS:000323369700123
J	Kotz, SA; Anwander, A; Axer, H; Knosche, TR				Kotz, Sonja A.; Anwander, Alfred; Axer, Hubertus; Knoesche, Thomas R.			Beyond Cytoarchitectonics: The Internal and External Connectivity Structure of the Caudate Nucleus	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DIFFUSION TENSOR; BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; SUBCORTICAL PROJECTIONS; FIBER ORIENTATION; HUMAN STRIATUM; ORGANIZATION; TRACKING; CORTEX	While there is ample evidence on the functional and connectional differentiation of the caudate nucleus (CN), less is known about its potential microstructural subdivisions. However, this latter aspect is critical to the local information processing capabilities of the tissue. We applied diffusion MRI, a non-invasive in vivo method that has great potential for the exploration of the brain structure-behavior relationship, in order to characterize the local fiber structure in gray matter of the CN. We report novel evidence of a functionally meaningful structural tri-partition along the anterior-posterior axis of this region. The connectivity of the CN subregions is in line with connectivity evidence from earlier invasive studies in animal models. In addition, histological validation using polarized light imaging (PLI) confirms these results, corroborating the notion that cortico-subcortico-cortical loops involve microstructurally differentiated regions in the caudate nucleus. Methodologically speaking, the comparison with advanced analysis of diffusion MRI shows that diffusion tensor imaging (DTI) yields a simplified view of the CN fiber architecture which is refined by advanced high angular resolution imaging methods.	[Kotz, Sonja A.; Anwander, Alfred; Knoesche, Thomas R.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Kotz, Sonja A.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Axer, Hubertus] Univ Jena, Jena Univ Hosp, Hans Berger Clin Neurol, Jena, Germany	Max Planck Society; University of Manchester; Friedrich Schiller University of Jena	Kotz, SA (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	kotz@cbs.mpg.de	Axer, Hubertus/B-4592-2010; Anwander, Alfred/B-5874-2011	Axer, Hubertus/0000-0002-3191-2796; Anwander, Alfred/0000-0002-4861-4808	Max Planck Society, Munich, Germany; German Research Foundation [DFG KO 2268/1]	Max Planck Society, Munich, Germany(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	This research was funded by the Max Planck Society, Munich, Germany and Sonja A. Kotz by the German Research Foundation (DFG KO 2268/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Axer H, 2000, MICROSC RES TECHNIQ, V51, P481, DOI 10.1002/1097-0029(20001201)51:5<481::AID-JEMT11>3.0.CO;2-N; Axer H, 2011, FRONTIERS NEUROINFOR, V5; Markus A, 2011, NEUROIMAGE, V54, P1091, DOI 10.1016/j.neuroimage.2010.08.075; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Borgmann S, 1999, BRAIN RES, V836, P225, DOI 10.1016/S0006-8993(99)01704-7; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; DeLong M. R., 1981, HDB PHYSL NERVOUS SY, P1017; DEVITO JL, 1964, J COMP NEUROL, V123, P413, DOI 10.1002/cne.901230308; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOX CA, 1975, J COMP NEUROL, V159, P177, DOI 10.1002/cne.901590203; GOLDMAN PS, 1977, J COMP NEUROL, V171, P369, DOI 10.1002/cne.901710305; Goldman-Rakic P S, 1982, Neurosci Res Program Bull, V20, P520; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Heidemann R, 2011, P INT SOC MAG RESON, V19, P1957; Heidemann RM, 2010, MAGN RESON MED, V64, P9, DOI 10.1002/mrm.22480; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; JOHNSON TN, 1968, EXP NEUROL, V21, P20, DOI 10.1016/0014-4886(68)90030-7; Karachi C, 2002, J COMP NEUROL, V450, P122, DOI 10.1002/cne.10312; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Larsen L, 2007, MICROSC RES TECHNIQ, V70, P851, DOI 10.1002/jemt.20488; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; MAY JK, 2004, ATLAS HUMAN BRAIN; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Morel A, 2002, J COMP NEUROL, V443, P86, DOI 10.1002/cne.10096; Morel A., 2007, STEREOTACTIC ATLAS H, DOI 10.3109/9781420016796; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Riley H. A, 1943, ATLAS BASAL GANGLIA; SELEMON LD, 1985, J NEUROSCI, V5, P776; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; WHITLOCK DG, 1956, J COMP NEUROL, V106, P183, DOI 10.1002/cne.901060107; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Wilson S, 1914, EXPT RES ANATOMY PHY; Yeterian EH, 1998, J COMP NEUROL, V399, P384; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8	57	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70141	10.1371/journal.pone.0070141	http://dx.doi.org/10.1371/journal.pone.0070141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922939	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900155
J	Leski, TA; Vora, GJ; Barrows, BR; Pimentel, G; House, BL; Nicklasson, M; Wasfy, M; Abdel-Maksoud, M; Taitt, CR				Leski, Tomasz A.; Vora, Gary J.; Barrows, Brian R.; Pimentel, Guillermo; House, Brent L.; Nicklasson, Matilda; Wasfy, Momtaz; Abdel-Maksoud, Mohamed; Taitt, Chris Rowe			Molecular Characterization of Multidrug Resistant Hospital Isolates Using the Antimicrobial Resistance Determinant Microarray	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; GRAM-NEGATIVE BACTERIA; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; STAPHYLOCOCCUS-AUREUS; DNA MICROARRAY; GENETIC-BASIS; EGYPT; ENTEROBACTERIACEAE	Molecular methods that enable the detection of antimicrobial resistance determinants are critical surveillance tools that are necessary to aid in curbing the spread of antibiotic resistance. In this study, we describe the use of the Antimicrobial Resistance Determinant Microarray (ARDM) that targets 239 unique genes that confer resistance to 12 classes of antimicrobial compounds, quaternary amines and streptothricin for the determination of multidrug resistance (MDR) gene profiles. Fourteen reference MDR strains, which either were genome, sequenced or possessed well characterized drug resistance profiles were used to optimize detection algorithms and threshold criteria to ensure the microarray's effectiveness for unbiased characterization of antimicrobial resistance determinants in MDR strains. The subsequent testing of Acinetobacter baumannii, Escherichia coli and Klebsiella pneumoniae hospital isolates revealed the presence of several antibiotic resistance genes [e.g. belonging to TEM, SHV, OXA and CTX-M classes (and OXA and CTX-M subfamilies) of beta-lactamases] and their assemblages which were confirmed by PCR and DNA sequence analysis. When combined with results from the reference strains, similar to 25% of the ARDM content was confirmed as effective for representing allelic content from both Gram-positive and -negative species. Taken together, the ARDM identified MDR assemblages containing six to 18 unique resistance genes in each strain tested, demonstrating its utility as a powerful tool for molecular epidemiological investigations of antimicrobial resistance in clinically relevant bacterial pathogens.	[Leski, Tomasz A.; Vora, Gary J.; Taitt, Chris Rowe] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA; [Barrows, Brian R.] US Naval Res Lab, Natl Res Council, Washington, DC USA; [Pimentel, Guillermo; House, Brent L.; Nicklasson, Matilda; Wasfy, Momtaz; Abdel-Maksoud, Mohamed] US Naval Med Res Unit 3, Cairo, Egypt	United States Department of Defense; United States Navy; Naval Research Laboratory; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Leski, TA (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	tomasz.leski@nrl.navy.mil	Leski, Tomasz A/K-6916-2013; Vora, Gary J./AAT-7842-2021	Leski, Tomasz A/0000-0001-7688-9887; Vora, Gary J./0000-0002-0657-8597; Taitt, Chris/0000-0002-0125-9239	Defense Medical Research and Development Program Intramural Applied Research and Advanced Technology Development Award	Defense Medical Research and Development Program Intramural Applied Research and Advanced Technology Development Award	This work was supported by a Defense Medical Research and Development Program Intramural Applied Research and Advanced Technology Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Ghani S, 2010, J INFECT DEV COUNTR, V4; Ahmed AM, 2012, MICROBIOL IMMUNOL, V56, P254, DOI 10.1111/j.1348-0421.2012.00429.x; Ahmed AM, 2011, MICROBIOL IMMUNOL, V55, P318, DOI 10.1111/j.1348-0421.2011.00323.x; Ahmed AM, 2009, ACTA TROP, V111, P144, DOI 10.1016/j.actatropica.2009.04.004; Ahmed AM, 2009, VET MICROBIOL, V136, P397, DOI 10.1016/j.vetmic.2008.11.021; Ahmed Shaaban H, 2009, BMC Res Notes, V2, P76, DOI 10.1186/1756-0500-2-76; Al Hashem G, 2011, MED PRIN PRACT, V20, P213, DOI 10.1159/000321242; Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; Al-Agamy M.H., 2006, N EGYPT J MICROBIOL, V13, P17; Al-Agamy MH, 2012, AFR J MICROBIOL RES, V6, P20, DOI 10.5897/AJMRX11.022; Al-Agamy MHM, 2006, INT J ANTIMICROB AG, V27, P545, DOI 10.1016/j.ijantimicag.2006.01.007; Anantham S, 2012, MICROB DRUG RESIST, V18, P364, DOI 10.1089/mdr.2012.0008; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Bogaerts P, 2010, J ANTIMICROB CHEMOTH, V65, P361, DOI 10.1093/jac/dkp453; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Cassone M, 2006, ANTIMICROB AGENTS CH, V50, P2038, DOI 10.1128/AAC.01574-05; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; El Kholy A, 2003, J ANTIMICROB CHEMOTH, V51, P625, DOI 10.1093/jac/dkg101; Fam N, 2011, MICROB DRUG RESIST, V17, P67, DOI 10.1089/mdr.2010.0063; Fam NS, 2008, RES J MED SCI, V3, P84; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fouad S, 2011, P ICAAC SEPT 2011; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Frye JG, 2010, MICROB DRUG RESIST, V16, P9, DOI 10.1089/mdr.2009.0082; Garneau P, 2010, ZOONOSES PUBLIC HLTH, V57, P94, DOI 10.1111/j.1863-2378.2010.01358.x; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hammad AM, 2009, J FOOD PROTECT, V72, P624, DOI 10.4315/0362-028X-72.3.624; Hanson ND, 2010, MICROBE, V5, P333, DOI [10.1128/microbe.5.333.1, DOI 10.1128/MICROBE.5.333.1]; Hansson K, 2002, J BACTERIOL, V184, P1712, DOI 10.1128/JB.184.6.1712-1721.2002; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hussein AIA, 2009, MICROBIOL IMMUNOL, V53, P595, DOI 10.1111/j.1348-0421.2009.00168.x; Ishida Y, 2010, J VET MED SCI, V72, P727, DOI 10.1292/jvms.09-0538; Khalaf NG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-84; Kikuvi G, 1983, MICROB DRUG RESIST, V13, P62; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lascols C, 2012, J CLIN MICROBIOL, V50, P1632, DOI 10.1128/JCM.06115-11; Leski T, 2012, INT J ANTIMICROB AG, V40, P282, DOI 10.1016/j.ijantimicag.2012.05.019; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Meyer WG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S8; Naas T, 2011, J CLIN MICROBIOL, V49, P1608, DOI 10.1128/JCM.02607-10; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Ojo KK, 2002, ANTIMICROB AGENTS CH, V46, P2054, DOI 10.1128/AAC.46.6.2054-2055.2002; Pasteran F, 2010, J CLIN MICROBIOL, V48, P1323, DOI 10.1128/JCM.01771-09; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perreten V, 2005, J CLIN MICROBIOL, V43, P2291, DOI 10.1128/JCM.43.5.2291-2302.2005; Poirel L, 2007, INT J ANTIMICROB AG, V29, pS276, DOI 10.1016/S0924-8579(07)70870-1; Poirel L, 2003, J CLIN MICROBIOL, V41, P3542, DOI 10.1128/JCM.41.8.3542-3547.2003; Poirel L, 2013, INT J ANTIMICROB AG, V41, P90, DOI 10.1016/j.ijantimicag.2012.08.015; Poirel Laurent, 2008, P129, DOI 10.1007/978-0-387-77944-7_7; Post V, 2010, J ANTIMICROB CHEMOTH, V65, P1162, DOI 10.1093/jac/dkq095; Rasheed JK, 2000, ANTIMICROB AGENTS CH, V44, P2382, DOI 10.1128/AAC.44.9.2382-2388.2000; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Roth KM, 2006, ELECTROANAL, V18, P1982, DOI 10.1002/elan.200603603; Saied T, 2011, AM J INFECT CONTROL, V39, pE61, DOI 10.1016/j.ajic.2011.04.009; Salem M. M., 2010, Australian Journal of Basic and Applied Sciences, V4, P398; Sallen B, 1995, MICROB DRUG RESIST, V1, P195, DOI 10.1089/mdr.1995.1.195; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Szabo Dora, 2008, Ann Clin Microbiol Antimicrob, V7, P12, DOI 10.1186/1476-0711-7-12; Tham J, 2010, SCAND J INFECT DIS, V42, P275, DOI 10.3109/00365540903493715; Tracz DM, 2005, J ANTIMICROB CHEMOTH, V55, P768, DOI 10.1093/jac/dki074; Veldman K, 2010, J ANTIMICROB CHEMOTH, V65, P872, DOI 10.1093/jac/dkq049; Wojciechowski J, 2010, ANAL CHIM ACTA, V679, P85, DOI 10.1016/j.aca.2010.09.007; Zurawski DV, 2012, J BACTERIOL, V194, P1619, DOI 10.1128/JB.06749-11	68	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69507	10.1371/journal.pone.0069507	http://dx.doi.org/10.1371/journal.pone.0069507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936031	Green Published, Green Submitted, gold			2022-12-27	WOS:000322433300044
J	Bellezza, I; Roberti, R; Gatticchi, L; Del Sordo, R; Rambotti, MG; Marchetti, MC; Sidoni, A; Minelli, A				Bellezza, Ilaria; Roberti, Rita; Gatticchi, Leonardo; Del Sordo, Rachele; Rambotti, Maria Grazia; Marchetti, Maria Cristina; Sidoni, Angelo; Minelli, Alba			A Novel Role for Tm7sf2 Gene in Regulating TNF alpha Expression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; LIVER-X-RECEPTORS; NUCLEAR RECEPTORS; 3-BETA-HYDROXYSTEROL DELTA(14)-REDUCTASE; CHOLESTEROL-BIOSYNTHESIS; TRANSLATION INITIATION; MAMMALIAN-CELLS; INFLAMMATION	We have explored the role of Tm7sf2 gene, which codifies for 3 beta-hydroxysterol Delta 14-reductase, an endoplasmic reticulum resident protein, in the sensitivity to endoplasmic reticulum stress and in the resulting inflammatory response. We used mouse embryonic fibroblasts, derived from Tm7sf2(+/+) and Tm7sf2(-/-) mice, to determine the in vitro effects of thapsigargin on NF-kappa B activation. Our results show that the Tm7sf2 gene controls the launch of the unfolded protein response and presides an anti-inflammatory loop thus its absence correlates with NF-kappa B activation and TNF alpha up-regulation. Our data also show that Tm7sf2 gene regulates liver X receptor activation and its absence inhibits LXR signalling. By expressing the hTm7sf2 gene in KO MEFs and observing a reduced NF-kappa B activation, we have confirmed that Tm7sf2 gene is linked to NF-kappa B activation. Finally we used genetically modified mice in an in vivo model of ER stress and of inflammation. Our results show a significant increase in renal TNF alpha expression after tunicamycin exposure and in the oedematogenic response in Tm7sf2(-/-) mice. In conclusion, we have shown that the Tm7sf2 gene, to date involved only in cholesterol biosynthesis, also controls an anti-inflammatory loop thereby confirming the existence of cross talk between metabolic pathways and inflammatory response.	[Bellezza, Ilaria; Minelli, Alba] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Biochim Cellulare, I-06100 Perugia, Italy; [Roberti, Rita; Gatticchi, Leonardo] Univ Perugia, Dipartimento Med Interna, Sez Biochim, I-06100 Perugia, Italy; [Del Sordo, Rachele; Sidoni, Angelo] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Anat & Istol Patol, I-06100 Perugia, Italy; [Rambotti, Maria Grazia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Anat, I-06100 Perugia, Italy; [Marchetti, Maria Cristina] Univ Perugia, Dipartimento Med Clin & Sperimentale, Sez Farmacol Tossicol & Chemioterapia, I-06100 Perugia, Italy	University of Perugia; University of Perugia; University of Perugia; University of Perugia; University of Perugia	Bellezza, I (corresponding author), Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Biochim Cellulare, I-06100 Perugia, Italy.	ilaria.bellezza@unipg.it	Gatticchi, Leonardo/AAX-2811-2020; BELLEZZA, ILARIA/AAA-8099-2022; SIDONI, Angelo/K-8171-2016	BELLEZZA, ILARIA/0000-0002-8106-1600; SIDONI, Angelo/0000-0002-8458-5901; ROBERTI, Rita/0000-0003-4131-5933; Gatticchi, Leonardo/0000-0002-0098-7840; MINELLI, Alba/0000-0001-9560-9289; DEL SORDO, RACHELE/0000-0003-3930-2957	PRIN (Progetti di Ricerca di Interesse Nazionele) [20092BE97Y_005]; Fondazione Cassa di Risparmio di Perugia [2011.0184.021, 2011.0099.021]	PRIN (Progetti di Ricerca di Interesse Nazionele)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by PRIN (Progetti di Ricerca di Interesse Nazionele) (20092BE97Y_005), and Fondazione Cassa di Risparmio di Perugia (2011.0184.021 and 2011.0099.021) to RR and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellezza Ilaria, 2010, Cancers (Basel), V2, P483, DOI 10.3390/cancers2020483; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; Bennati AM, 2006, BBA-MOL CELL BIOL L, V1761, P677, DOI 10.1016/j.bbalip.2006.05.004; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dumont JE, 2002, AM J PHYSIOL-CELL PH, V283, pC2, DOI 10.1152/ajpcell.00581.2001; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Huang LH, 2011, KIDNEY INT, V79, P613, DOI 10.1038/ki.2010.469; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200; Lin YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036408; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; MACALA LJ, 1983, J LIPID RES, V24, P1243; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Parmar VM, 2012, ADV EXP MED BIOL, V738, P153, DOI 10.1007/978-1-4614-1680-7_10; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Roberti R, 2002, EUR J BIOCHEM, V269, P283, DOI 10.1046/j.0014-2956.2001.02646.x; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Sala SG, 2008, J PHARMACOL EXP THER, V324, P352, DOI 10.1124/jpet.107.128959; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zong ZH, 2012, BBA-MOL CELL RES, V1823, P1395, DOI 10.1016/j.bbamcr.2012.06.001	52	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68017	10.1371/journal.pone.0068017	http://dx.doi.org/10.1371/journal.pone.0068017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935851	Green Submitted, gold, Green Published			2022-12-27	WOS:000325211000024
J	Chen, E; Tang, MK; Yao, Y; Yau, WWY; Lo, LM; Yang, XS; Chui, YL; Chan, J; Lee, KKH				Chen, Elve; Tang, Mei Kuen; Yao, Yao; Yau, Winifred Wing Yiu; Lo, Lok Man; Yang, Xuesong; Chui, Yiu Loon; Chan, John; Lee, Kenneth Ka Ho			Silencing BRE Expression in Human Umbilical Cord Perivascular (HUCPV) Progenitor Cells Accelerates Osteogenic and Chondrogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FIBROBLAST GROWTH FACTOR-2; LARGE GENE LISTS; BONE-MARROW; SELF-RENEWAL; OSTEOBLAST DIFFERENTIATION; ACTIN CYTOSKELETON; DNA-DAMAGE; SIGNALING PATHWAYS; BINDING-PROTEIN	BRE is a multifunctional adapter protein involved in DNA repair, cell survival and stress response. To date, most studies of this protein have been focused in the tumor model. The role of BRE in stem cell biology has never been investigated. Therefore, we have used HUCPV progenitor cells to elucidate the function of BRE. HUCPV cells are multipotent fetal progenitor cells which possess the ability to differentiate into a multitude of mesenchymal cell lineages when chemically induced and can be more easily amplified in culture. In this study, we have established that BRE expression was normally expressed in HUCPV cells but become down-regulated when the cells were induced to differentiate. In addition, silencing BRE expression, using BRE-siRNAs, in HUCPV cells could accelerate induced chondrogenic and osteogenic differentiation. Hence, we postulated that BRE played an important role in maintaining the stemness of HUCPV cells. We used microarray analysis to examine the transcriptome of BRE-silenced cells. BRE-silencing negatively regulated OCT4, FGF5 and FOXO1A. BRE-silencing also altered the expression of epigenetic genes and components of the TGF-beta/BMP and FGF signaling pathways which are crucially involved in maintaining stem cell self-renewal. Comparative proteomic profiling also revealed that BRE-silencing resulted in decreased expressions of actin-binding proteins. In sum, we propose that BRE acts like an adaptor protein that promotes stemness and at the same time inhibits the differentiation of HUCPV cells.	[Chen, Elve; Tang, Mei Kuen; Yao, Yao; Yau, Winifred Wing Yiu; Lo, Lok Man; Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Hong Kong, Hong Kong, Peoples R China; [Yang, Xuesong; Chan, John; Lee, Kenneth Ka Ho] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Chui, Yiu Loon] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Lee, Kenneth Ka Ho] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen AB9 1FR, Scotland	Chinese University of Hong Kong; Jinan University; Chinese University of Hong Kong; Robert Gordon University	Lee, KKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Hong Kong, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk	Lee, Kenneth Ka Ho/H-6698-2013; Tang, Florence/AAW-4103-2021	Lee, Kenneth Ka Ho/0000-0002-6520-304X; Chui, Yiu-Loon/0000-0002-3441-9729	Hong Kong Research Grant Council [CUHK469809]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This research was supported by the Hong Kong Research Grant Council, "General Research Fund: CUHK469809." (http://www.ugc.edu.hk/eng/rgc/index.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bjornsson JM, 2003, MOL CELL BIOL, V23, P3872, DOI 10.1128/MCB.23.11.3872-3883.2003; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Butteroni C, 2000, J MOL BIOL, V304, P529, DOI 10.1006/jmbi.2000.4238; Chan BL, 2008, ONCOGENE, V27, P1208, DOI 10.1038/sj.onc.1210733; Chan BCL, 2005, BIOCHEM BIOPH RES CO, V326, P268, DOI 10.1016/j.bbrc.2004.11.013; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Chen YH, 2011, J BIOL CHEM, V286, P10671, DOI 10.1074/jbc.M110.199612; Ching AKK, 2001, BIOCHEM BIOPH RES CO, V288, P535; Chui YL, 2010, BIOCHEM BIOPH RES CO, V391, P1522, DOI 10.1016/j.bbrc.2009.12.111; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; DANIELS K, 1991, J CELL SCI, V100, P249; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Gu CH, 1998, FASEB J, V12, P1101, DOI 10.1096/fasebj.12.12.1101; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson M, 2012, STEM CELLS, V30, P150, DOI 10.1002/stem.782; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; LI L, 1995, BIOCHEM BIOPH RES CO, V206, P764, DOI 10.1006/bbrc.1995.1108; Li Q, 2004, J BIOL CHEM, V279, P52106, DOI 10.1074/jbc.M408678200; Lim YB, 2000, BIOCHEM BIOPH RES CO, V273, P609, DOI 10.1006/bbrc.2000.2987; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Machesky LM, 1997, BIOCHEM J, V328, P105; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Montemurro T, 2011, J CELL MOL MED, V15, P796, DOI 10.1111/j.1582-4934.2010.01047.x; Morsczeck C, 2009, CLIN ORAL INVEST, V13, P383, DOI 10.1007/s00784-009-0260-x; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Patterson-Fortin J, 2010, J BIOL CHEM; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Shan SW, 2007, PROTEOMICS, V7, P4303, DOI 10.1002/pmic.200700636; Shimaoka H, 2004, J BIOMED MATER RES A, V68A, P168, DOI 10.1002/jbm.a.20059; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; SOLURSH M, 1989, CONNECT TISSUE RES, V20, P81, DOI 10.3109/03008208909023877; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; STARNAUD R, 1995, J CELL BIOL, V131, P1351, DOI 10.1083/jcb.131.5.1351; Szabo E, 2008, J CELL BIOL, V182, P103, DOI 10.1083/jcb.200712078; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang MK, 2009, PROTEOM CLIN APPL, V3, P1362, DOI 10.1002/prca.200900097; Tang MK, 2006, PROTEOMICS, V6, P2376, DOI 10.1002/pmic.200500603; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Trubiani O, 2008, J CELL PHYSIOL, V214, P706, DOI 10.1002/jcp.21266; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Turner NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1147, DOI 10.1016/j.bbrc.2008.10.131; WALSH TP, 1977, BIOCHEM J, V165, P165, DOI 10.1042/bj1650165; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Yang AX, 2005, STEM CELLS DEV, V14, P270, DOI 10.1089/scd.2005.14.270; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yau WWY, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-3; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang ZJ, 2006, BIOCHEM BIOPH RES CO, V348, P421, DOI 10.1016/j.bbrc.2006.07.073	100	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e67896	10.1371/journal.pone.0067896	http://dx.doi.org/10.1371/journal.pone.0067896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935848	Green Submitted, Green Published, gold			2022-12-27	WOS:000325211000021
J	Goebel, S; Li, ZM; Vogelmann, J; Holthoff, HP; Degen, H; Hermann, DM; Gawaz, M; Ungerer, M; Munch, G				Goebel, Silvia; Li, Zhongmin; Vogelmann, Jasmin; Holthoff, Hans-Peter; Degen, Heidrun; Hermann, Dirk M.; Gawaz, Meinrad; Ungerer, Martin; Muench, Goetz			The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; TISSUE-PLASMINOGEN ACTIVATOR; PLATELET GLYCOPROTEIN-VI; ISCHEMIC-STROKE; ANTITHROMBOTIC PROTECTION; SOLUBLE GPVI; IN-VIVO; ADHESION; COLLAGEN; MICE	Objectives: We examined the effect of Revacept, an Fc fusion protein which is specifically linked to the extracellular domain of glycoprotein VI (GPVI), on thrombus formation after vessel wall injury and on experimental stroke in mice. Background: Several antiplatelet drugs for the treatment of myocardial infarction or ischemic stroke with potent anti-ischemic effects have been developed, but all incur a significant risk of bleeding. Methods: Platelet adhesion and thrombus formation after endothelial injury was monitored in the carotid artery by intravital fluorescence microscopy. The morphological and clinical consequences of stroke were investigated in a mouse model with a one hour-occlusion of the middle cerebral artery. Results: Thrombus formation was significantly decreased after endothelial injury by 1 mg/kg Revacept IV, compared to Fc only. 1 mg/kg Revacept IV applied in mice with ischemic stroke immediately before reperfusion significantly improved functional outcome, cerebral infarct size and edema compared to Fc only. Also treatment with 10 mg/kg rtPA was effective, and functional outcome was similar in both treatment groups. The combination of Revacept with rtPA leads to increased reperfusion compared to treatment with either agent alone. In contrast to rtPA, however, there were no signs of increased intracranial bleeding with Revacept. Both rtPA and Revacept improved survival after stroke compared to placebo treatment. Revacept and vWF bind to collagen and Revacept competitively prevented the binding of vWF to collagen. Conclusions: Revacept reduces arterial thrombus formation, reduces cerebral infarct size and edema after ischemic stroke, improves functional and prognostic outcome without intracranial bleeding. Revacept not only prevents GPVI-mediated, but probably also vWF-mediated platelet adhesion and aggregate formation. Therefore Revacept might be a potent and safe tool to treat ischemic complications of stroke.	[Goebel, Silvia; Li, Zhongmin; Vogelmann, Jasmin; Holthoff, Hans-Peter; Degen, Heidrun; Ungerer, Martin; Muench, Goetz] AdvanceCOR GmbH, Martinsried, Germany; [Hermann, Dirk M.] Univ Klinikum Essen, Dept Neurol, Essen, Germany; [Gawaz, Meinrad] Univ Tubingen, Dept Internal Med 3, Tubingen, Germany	University of Duisburg Essen; Eberhard Karls University of Tubingen	Gawaz, M (corresponding author), AdvanceCOR GmbH, Martinsried, Germany.	gawaz@med.uni-tuebingen.de; ungerer@advancecor.com	Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Lilly; Bristol-Myers Squibb; Bayer-Schering	Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer-Schering(Bayer AG)	The authors have read the journal's policy and have the following conflicts: Martin Ungerer and Gotz Munch are employed by Advancecor and own shares of Advancecor of significant value. Meinrad Gawaz is a cofounder of Advancecor, owns shares of Advancecor and received honoraria payments from Lilly, Bristol-Myers Squibb and Bayer-Schering and is also consultant for Bayer-Schering. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Adams HP, 2005, STROKE, V36, P880, DOI 10.1161/01.STR.0000157668.39374.56; Al-Tamimi M, 2011, STROKE, V42, P498, DOI 10.1161/STROKEAHA.110.602532; Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Bigalke B, 2009, BASIC RES CARDIOL, V104, P352, DOI 10.1007/s00395-009-0779-7; Bultmann A, 2010, J MOL CELL CARDIOL, V49, P532, DOI 10.1016/j.yjmcc.2010.04.009; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; Gakuba C, 2011, STROKE, V42, P2947, DOI 10.1161/STROKEAHA.111.620468; Gruner S, 2005, BLOOD, V105, P1492, DOI 10.1182/blood-2004-06-2391; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Kilic E, 2001, STROKE, V32, P2641, DOI 10.1161/hs1101.097381; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Lenting PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012174; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Mackay J, 2004, ATLAS HEART DIS STRO; Marsh JD, 2010, J AM COLL CARDIOL, V56, P683, DOI 10.1016/j.jacc.2009.12.072; Massberg S, 2005, CIRCULATION, V112, P1180, DOI 10.1161/CIRCULATIONAHA.105.539221; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Papanagiotou P, 2011, J AM COLL CARDIOL, V58, P2363, DOI 10.1016/j.jacc.2011.08.044; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schonberger T, 2008, CARDIOVASC RES, V80, P131, DOI 10.1093/cvr/cvn169; Schulte V, 2006, ARTERIOSCL THROM VAS, V26, P1640, DOI 10.1161/01.ATV.0000225697.98093.ed; Stoll G, 2010, HAMOSTASEOLOGIE, V30, P136; Ungerer M, 2011, CIRCULATION, V123, P1891, DOI 10.1161/CIRCULATIONAHA.110.980623; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Zeibig S, 2011, CIRC RES, V108, P695, DOI 10.1161/CIRCRESAHA.111.240515	37	57	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e66960	10.1371/journal.pone.0066960	http://dx.doi.org/10.1371/journal.pone.0066960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935828	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000008
J	Rowland, M; Boko, P; Odjo, A; Asidi, A; Akogbeto, M; N'Guessan, R				Rowland, Mark; Boko, Pelagie; Odjo, Abibatou; Asidi, Alex; Akogbeto, Martin; N'Guessan, Raphael			A New Long-Lasting Indoor Residual Formulation of the Organophosphate Insecticide Pirimiphos Methyl for Prolonged Control of Pyrethroid-Resistant Mosquitoes: An Experimental Hut Trial in Benin	PLOS ONE			English	Article							ANOPHELES-GAMBIAE S.S.; MALARIA CONTROL; VECTOR CONTROL; TREATED NETS; IMPREGNATED BEDNETS; AREA; BENDIOCARB; EFFICACY; SUSCEPTIBILITY; IDENTIFICATION	Background: Indoor residual spraying (IRS) is widely used for malaria transmission control in sub-Saharan Africa. Resistance to pyrethroids in the mosquito Anopheles gambiae is a growing problem. There is an urgent need to develop long-lasting alternative insecticides to reduce selection pressure for pyrethroid resistance and to provide control with a single IRS application in countries with long transmission seasons. Methods: Two capsule suspension formulations (CS) of the organophosphate pirimiphos methyl were evaluated as IRS treatments in experimental huts in an area of Benin where the mosquitoes Anopheles gambiae and Culex quinquefasciatus are resistant to pyrethroids but susceptible to organophosphates. The CS formulations were tested alongside an emulsifiable concentrate (EC) formulation of pirimiphos methyl and a CS formulation of the pyrethroid lambdacyhalothrin. Results: The two CS formulations of pirimiphos methyl gave prolonged control of An. gambiae and Cx. quinquefasciatus. In cement huts application rates of 0.5 g/m(2) induced high mortality of An. gambiae for almost a year: overall mortality rates 87% (95% CI 82-91%) and 92% (95% CI 88-94%). In mud huts application rates of 1 g/m(2) induced high mortality of An. gambiae for 10 months: overall mortality rates 75% (95% CI 69-81%) and 76% (95% CI 68-83%). The EC formulation of pirimiphos methyl failed to control An. gambiae two months after spraying. The pyrethroid lambdacyhalothrin demonstrated prolonged residual activity in bioassay tests but failed to control pyrethroid resistant An. gambiae that entered the huts. Pirimiphos methyl CS was highly active against Culex quinquefasciatus and gave control for 10 months in cement huts and 6 months in mud huts. Conclusion: Pirimiphos methyl CS (Actellic 300 CS) applied at 1 g/m(2) shows great promise for providing prolonged control of pyrethroid-resistant An gambiae and for delaying pyrethroid resistance. An alternative to DDT, giving year-round transmission control in sub-Saharan Africa is now a realistic prospect.	[Rowland, Mark; N'Guessan, Raphael] London Sch Hyg & Trop Med, London WC1, England; [Boko, Pelagie; Odjo, Abibatou; Asidi, Alex; Akogbeto, Martin; N'Guessan, Raphael] Minist Sante, Lab Natl, Ctr Rech Entomol Cotonou, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Rowland, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	mark.rowland@lshtm.ac.uk			Innovative Vector Control Consortium, Liverpool, UK from a programme grant of the Bill & Melinda Gates Foundation	Innovative Vector Control Consortium, Liverpool, UK from a programme grant of the Bill & Melinda Gates Foundation	Project grant from Innovative Vector Control Consortium, Liverpool, UK from a programme grant of the Bill & Melinda Gates Foundation. http://www.ivcc.com/. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However the IVCC did advise on the study design via their Expert Scientific Committee.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; [Anonymous], 2010, COCHRANE DATABASE SY; [Anonymous], 2006, IND RES SPRAYING US; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; DAS M, 1987, MED VET ENTOMOL, V1, P289, DOI 10.1111/j.1365-2915.1987.tb00357.x; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fuseini G, 2011, J MED ENTOMOL, V48, P437, DOI 10.1603/ME09286; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kolaczinski JH, 2000, B ENTOMOL RES, V90, P125; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-44; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Osse R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-163; Padonou GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-72; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Raghavendra K, 2011, J VECTOR DIS, V48, P18; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; Rowland M, 1997, B WORLD HEALTH ORGAN, V75, P23; Rowland M, 2009, ACS SYM SER, V1014, P13, DOI 10.1021/bk-2009-1014.ch002; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; The President's Malaria Initiative, 2012, 6 ANN REP C; Tomlin C., 2000, PESTICIDE MANUAL WOR; United Nations Environment Program, 2013, ALT DDT INT RAD; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; West PA, 2013, PLOS ONE UNPUB; West PA, 2013, LANCET INFECT UNPUB; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2006, GUIDELINES TESTING M; WHO, 2012, GLOB PLAN INS RES MA	42	63	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69516	10.1371/journal.pone.0069516	http://dx.doi.org/10.1371/journal.pone.0069516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23936033	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000325211000130
J	Thamm, DH; Grunerud, KK; Rose, BJ; Vail, DM; Bailey, SM				Thamm, Douglas H.; Grunerud, Kristen K.; Rose, Barbara J.; Vail, David M.; Bailey, Susan M.			DNA Repair Deficiency as a Susceptibility Marker for Spontaneous Lymphoma in Golden Retriever Dogs: A Case-Control Study	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; MUTAGEN SENSITIVITY; CHROMOSOMAL RADIOSENSITIVITY; GENETIC DIVERSITY; DOSE-RESPONSE; CANCER; RISK; POLYMORPHISMS; PREDISPOSITION; LYMPHOCYTES	There is accumulating evidence that an individual's inability to accurately repair DNA damage in a timely fashion may in part dictate a predisposition to cancer. Dogs spontaneously develop lymphoproliferative diseases such as lymphoma, with the golden retriever (GR) breed being at especially high risk. Mechanisms underlying such breed susceptibility are largely unknown; however, studies of heritable cancer predisposition in dogs may be much more straightforward than similar studies in humans, owing to a high degree of inbreeding and more limited genetic heterogeneity. Here, we conducted a pilot study with 21 GR with lymphoma, 20 age-matched healthy GR and 20 age-matched healthy mixed-breed dogs (MBD) to evaluate DNA repair capability following exposure to either ionizing radiation (IR) or the chemical mutagen bleomycin. Inter-individual variation in DNA repair capacity was evaluated in stimulated canine lymphoctyes exposed in vitro utilizing the G2 chromosomal radiosensitivity assay to quantify clastogen-induced chromatid-type aberrations (gaps and breaks). Golden retrievers with lymphoma demonstrated elevated sensitivity to induction of chromosome damage following either challenge compared to either healthy GR or MBD at multiple doses and time points. Using the 75th percentile of chromatid breaks per 1,000 chromosomes in the MBD population at 4 hours post 1.0 Gy IR exposure as a benchmark to compare cases and controls, GR with lymphoma were more likely than healthy GR to be classified as "sensitive" (odds ratio = 21.2, 95% confidence interval 2.3-195.8). Furthermore, our preliminary findings imply individual (rather than breed) susceptibility, and suggest that deficiencies in heritable factors related to DNA repair capabilities may be involved in the development of canine lymphoma. These studies set the stage for larger confirmatory studies, as well as candidate-based approaches to probe specific genetic susceptibility factors.	[Thamm, Douglas H.; Grunerud, Kristen K.; Rose, Barbara J.] Colorado State Univ, Coll Vet Med & Biomed Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Vail, David M.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Vail, David M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Bailey, Susan M.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Thamm, Douglas H.; Bailey, Susan M.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	Colorado State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Thamm, DH (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA.	dthamm@colostate.edu	Thamm, Douglas/AAG-3672-2020; Thamm, Douglas H/I-5976-2013	Thamm, Douglas H/0000-0002-8914-7767	Morris Animal Foundation [D07CA-506]	Morris Animal Foundation	This work was supported by Grant # D07CA-506 from the Morris Animal Foundation: www.morrisanimalfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello A, 1997, DIAGN MOL PATHOL, V6, P154, DOI 10.1097/00019606-199706000-00005; Au WW, 2003, MUTAT RES-REV MUTAT, V544, P273, DOI 10.1016/j.mrrev.2003.10.002; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bondy ML, 1996, CANCER RES, V56, P1484; Boultwood J, 2001, J CLIN PATHOL, V54, P512, DOI 10.1136/jcp.54.7.512; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Buchholz TA, 2001, INT J RADIAT ONCOL, V49, P533, DOI 10.1016/S0360-3016(00)01502-9; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Glickman L, 1998, 1998 GOLDEN RETRIEVE; GUO K, 1995, ANN RHEUM DIS, V54, P229, DOI 10.1136/ard.54.3.229; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Lan Q, 2007, HUM GENET, V121, P161, DOI 10.1007/s00439-006-0288-9; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; LOEB LA, 1991, CANCER RES, V51, P3075; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Paz-y-Mino C, 2002, CANCER GENET CYTOGEN, V133, P29, DOI 10.1016/S0165-4608(01)00547-7; Sanford KK, 1999, CANCER GENET CYTOGEN, V108, P38, DOI 10.1016/S0165-4608(98)00108-3; Scott D, 1996, RADIAT RES, V145, P3, DOI 10.2307/3579189; Scott D, 2004, CYTOGENET GENOME RES, V104, P365, DOI 10.1159/000077517; Shearin AL, 2012, CANCER EPIDEM BIOMAR, V21, P1019, DOI 10.1158/1055-9965.EPI-12-0190-T; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Spry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4191, DOI 10.2741/2380; Terzoudi GI, 1997, MUTAGENESIS, V12, P271, DOI 10.1093/mutage/12.4.271; Thomas R, 2011, LEUKEMIA LYMPHOMA, V52, P1321, DOI 10.3109/10428194.2011.559802; Tsai KL, 2012, MAMM GENOME, V23, P203, DOI 10.1007/s00335-011-9376-9; Vail DM, 2004, CANC DRUG DISC DEV, P259; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Wade CM, 2011, VET J, V189, P183, DOI 10.1016/j.tvjl.2011.06.017; Walczak A, 2012, DNA CELL BIOL, V31, P297, DOI 10.1089/dna.2011.1325; Wang SS, 2006, CARCINOGENESIS, V27, P1828, DOI 10.1093/carcin/bgl013; Williams ES, 2009, COLD SPRING HARB PRO, V2009; Wu XF, 1996, CANCER EPIDEM BIOMAR, V5, P577; Wu XF, 2007, CANCER RES, V67, P3493, DOI 10.1158/0008-5472.CAN-06-4137; Wu XF, 2006, CANCER RES, V66, P5993, DOI 10.1158/0008-5472.CAN-06-1007	38	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69192	10.1371/journal.pone.0069192	http://dx.doi.org/10.1371/journal.pone.0069192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935952	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000087
J	Barchetta, I; De Bernardinis, M; Capoccia, D; Baroni, MG; Fontana, M; Fraioli, A; Morini, S; Leonetti, F; Cavallo, MG				Barchetta, Ilaria; De Bernardinis, Marzia; Capoccia, Danila; Baroni, Marco Giorgio; Fontana, Mario; Fraioli, Antonio; Morini, Sergio; Leonetti, Frida; Cavallo, Maria Gisella			Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATIONS; VITAMIN-D LEVELS; BODY-MASS INDEX; INSULIN-RESISTANCE; PARATHYROID-HORMONE; ADIPOSITY; FAT; SENSITIVITY; HEALTHY; CALCIUM	Background: Metabolic syndrome (MS) and hypovitaminosis D represent two of the most diffuse condition worldwide, reaching pandemic proportions in industrialized countries, and are both strongly associated with obesity. This study set out to evaluate the presence of an independent association between hypovitaminosis D and MS in an adult population of obese subjects with/without MS. Methods: We recruited 107 consecutive obese subjects, 61 with MS (age(mean +/- SD) 45.3 +/- 13.3 years, BMI(mean +/- SD): 43.1 +/- 8.3 kg/m(2)) and 46 without MS (age: 41.8 +/- 11.5, p = n.s., BMI: 41.6 +/- 6.5 kg/m(2), p = n.s.) comparable for sex, BMI, waist circumference and body fat mass, evaluated by bioimpedentiometry. 25(OH) vitamin D-3 levels were measured by colorimetric method. Insulin resistance was estimated by fasting blood insulin, HOMA-IR and ISI. Results: Serum 25(OH) D3 levels were significantly lower in MS obese patients than in obese subjects without MS (median(range) 13.5(3.3-32) vs 17.4(5.1-37.4), p<0.007). Low 25(OH)D-3 levels correlated with glycaemia (p<0.007), phosphate (p<0.03), PTH (p<0.003) and the MS (p<0.001). Multivariate model confirmed that low 25(OH)D-3 levels were associated with the diagnosis of MS in obese patients independently from gender, age, serum PTH and body fat mass. After stratifying the study population according to 25(OH)D-3 concentrations, patients in the lowest quartile showed a markedly increased prevalence of MS compared to those in the highest quartile (OR = 4.1, CI 1.2-13.7, p = 0.02). Conclusions: A powerful association exists between hypovitaminosis D and MS in obese patients independently from body fat mass and its clinical correlates. This indicates that the association between low 25(OH)D-3 levels and MS is not merely induced by vitamin D deposition in fat tissue and reinforces the hypothesis that hypovitaminosis D represent a crucial independent determinant of MS.	[Barchetta, Ilaria; De Bernardinis, Marzia; Fontana, Mario; Fraioli, Antonio; Cavallo, Maria Gisella] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Capoccia, Danila; Leonetti, Frida] Univ Roma La Sapienza, Dept Med Pathophysiol, I-00185 Rome, Italy; [Baroni, Marco Giorgio] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Morini, Sergio] Univ Campus Biomed, CIR, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University of Cagliari; University Campus Bio-Medico - Rome Italy	Cavallo, MG (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	gisella.cavallo@uniroma1.it	Baroni, Marco Giorgio/AAH-3476-2020; Capoccia, Danila/AAT-2026-2020; Leonetti, Frida/AAL-1295-2020; Morini, Sergio/AAB-8540-2022; Barchetta, Ilaria/I-3016-2019; Fontana, Mario/ABD-6225-2020	Baroni, Marco Giorgio/0000-0002-3224-6078; Morini, Sergio/0000-0001-6137-2404; Barchetta, Ilaria/0000-0003-0530-8568; Fontana, Mario/0000-0002-7524-3395; LEONETTI, Frida/0000-0002-5606-8448; cavallo, maria gisella/0000-0001-6630-8049	Italian Ministry of University and Research (PRIN); Sapienza University of Rome	Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Sapienza University of Rome	This study was funded by research grants from the Italian Ministry of University and Research (PRIN grant 2008) and from the Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Beydoun MA, 2010, J CLIN ENDOCR METAB, V95, P3814, DOI 10.1210/jc.2010-0410; Blum M, 2008, ENDOCRINE, V33, P90, DOI 10.1007/s12020-008-9051-4; Bruyere O, 2007, CURR MED RES OPIN, V23, P1939, DOI 10.1185/030079907X219562; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; COMPSTON JE, 1981, AM J CLIN NUTR, V34, P2359, DOI 10.1093/ajcn/34.11.2359; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Deo R, 2011, HYPERTENSION, V58, P1021, DOI 10.1161/HYPERTENSIONAHA.111.179135; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Florez H, 2007, J STEROID BIOCHEM, V103, P679, DOI 10.1016/j.jsbmb.2006.12.032; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Foss YJ, 2009, MED HYPOTHESES, V72, P314, DOI 10.1016/j.mehy.2008.10.005; Freedman BI, 2010, J CLIN ENDOCR METAB, V95, P1076, DOI 10.1210/jc.2009-1797; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2008, DIABETES, V57, P298, DOI 10.2337/db07-1122; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Kull M, 2009, INTERN MED J, V39, P256, DOI 10.1111/j.1445-5994.2009.01900.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Muscogiuri G, 2010, OBESITY, V18, P1906, DOI 10.1038/oby.2010.11; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pinelli NR, 2010, DIABETES CARE, V33, P1373, DOI 10.2337/dc09-2199; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; ROSENSTREICH SJ, 1971, J CLIN INVEST, V50, P679, DOI 10.1172/JCI106538; Schrager S, 2005, J AM BOARD FAM PRACT, V18, P205, DOI 10.3122/jabfm.18.3.205; Valina-Toth ALB, 2010, CLIN ENDOCRINOL, V72, P595, DOI 10.1111/j.1365-2265.2009.03676.x; Vilarrasa N, 2010, ENDOCRINE, V38, P235, DOI 10.1007/s12020-010-9379-4; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yildizhan R, 2009, ARCH GYNECOL OBSTET, V280, P559, DOI 10.1007/s00404-009-0958-7; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079; Zhao G, 2011, J HYPERTENS; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	37	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2013	8	7							e68689	10.1371/journal.pone.0068689	http://dx.doi.org/10.1371/journal.pone.0068689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194LB	23935881	gold, Green Published, Green Submitted			2022-12-27	WOS:000322633700012
J	Darby, CM; Ingolfsson, HI; Jiang, XJ; Shen, C; Sun, MN; Zhao, N; Burns, K; Liu, G; Ehrt, S; Warren, JD; Anderson, OS; Brickner, SJ; Nathan, C				Darby, Crystal M.; Ingolfsson, Helgi I.; Jiang, Xiuju; Shen, Chun; Sun, Mingna; Zhao, Nan; Burns, Kristin; Liu, Gang; Ehrt, Sabine; Warren, J. David; Anderson, Olaf S.; Brickner, Steven J.; Nathan, Carl			Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							IN-VITRO; BIOLOGICAL-ACTIVITY; INTRABACTERIAL PH; OXIDATIVE STRESS; ACID; PYRAZINAMIDE; MACROPHAGES; RESISTANCE; PROTEIN; ACIDIFICATION	Bacterial pathogens like Mycobacterium tuberculosis (Mtb) encounter acidic microenvironments in the host and must maintain their acid-base homeostasis to survive. A genetic screen identified two Mtb strains that cannot control intrabacterial pH (pH(IB)) in an acidic environment; infection with either strain led to severe attenuation in mice. To search for additional proteins that Mtb requires to survive at low pH, we introduced a whole-cell screen for compounds that disrupt pHIB, along with counter-screens that identify ionophores and membrane perturbors. Application of these methods to a natural product library identified four compounds of interest, one of which may inhibit novel pathway(s). This approach yields compounds that may lead to the identification of pathways that allow Mtb to survive in acidic environments, a setting in which Mtb is resistant to most of the drugs currently used to treat tuberculosis.	[Darby, Crystal M.; Jiang, Xiuju; Zhao, Nan; Burns, Kristin; Ehrt, Sabine; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Ingolfsson, Helgi I.; Anderson, Olaf S.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Shen, Chun; Warren, J. David] Weill Cornell Med Coll, Milstein Chem Core Facil, New York, NY USA; [Warren, J. David] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Sun, Mingna; Liu, Gang] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Sun, Mingna; Liu, Gang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Gang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Gang] Tsinghua Univ, Sch Med, Dept Pharmacol & Pharmaceut, Beijing 100084, Peoples R China; [Brickner, Steven J.] SJ Brickner Consulting, LLC, Ledyard, CT USA	Cornell University; Cornell University; Cornell University; Cornell University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Tsinghua University	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA.	cnathan@med.cornell.edu	Ingolfsson, Helgi I./AAQ-5946-2020; Ehrt, Sabine/AAU-6449-2020; Warren, J David/B-5625-2008	Ingolfsson, Helgi I./0000-0002-7613-9143; Warren, J David/0000-0002-2833-2248	National Institutes of Health [AI081725]; Milstein Program in the Chemical Biology of Infectious Diseases; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Program in the Chemical Biology of Infectious Diseases; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant AI081725 to S. Ehrt and by the Milstein Program in the Chemical Biology of Infectious Diseases. The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chang H.M., 1987, PHARM APPL CHINESE M; Darby CM, 2011, TUBERCULOSIS, V91, P343, DOI 10.1016/j.tube.2011.06.007; de Caryalho LPS, 2011, ACS MED CHEM LETT, V2, P849, DOI 10.1021/ml200157f; FRANZBLAU SG, 1990, ANTIMICROB AGENTS CH, V34, P229, DOI 10.1128/AAC.34.2.229; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Ingolfsson H.I., 2010, J VIS EXP; Ingolfsson HI, 2010, ASSAY DRUG DEV TECHN, V8, P427, DOI 10.1089/adt.2009.0250; Kim JY, 1996, J MED CHEM, V39, P2812, DOI 10.1021/jm950881y; KONG XB, 1992, MOL PHARMACOL, V41, P237; Konig GM, 1999, PHYTOCHEM ANALYSIS, V10, P279, DOI 10.1002/(SICI)1099-1565(199909/10)10:5&lt;279::AID-PCA464&gt;3.0.CO;2-3; Liu C.X., 2002, ASIAN J DRUG METAB P, V2, P133; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montali RJ, 2001, REV SCI TECH OIE, V20, P291, DOI 10.20506/rst.20.1.1268; Mrozik A, 2004, POL J ENVIRON STUD, V13, P487; Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x; Schaible UE, 1998, J IMMUNOL, V160, P1290; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Small JL, 2013, J BIOL CHEM, V288, P12489, DOI 10.1074/jbc.M113.456541; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vandal OH, 2006, INFECT IMMUN, V74, P1751, DOI 10.1128/IAI.74.3.1751-1756.2006; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; WHO, 2011, WHO GLOBAL TUBERCULO; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	33	49	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e68942	10.1371/journal.pone.0068942	http://dx.doi.org/10.1371/journal.pone.0068942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23935911	Green Submitted, Green Published, gold			2022-12-27	WOS:000323114200017
J	Howell, GM; Gomez, H; Collage, RD; Loughran, P; Zhang, XH; Escobar, DA; Billiar, TR; Zuckerbraun, BS; Rosengart, MR				Howell, Gina M.; Gomez, Hernando; Collage, Richard D.; Loughran, Patricia; Zhang, Xianghong; Escobar, Daniel A.; Billiar, Timothy R.; Zuckerbraun, Brian S.; Rosengart, Matthew R.			Augmenting Autophagy to Treat Acute Kidney Injury during Endotoxemia in Mice	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PROTECTS; PHOSPHORYLATION; MTOR; AMPK	Objective: To determine that 1) an age-dependent loss of inducible autophagy underlies the failure to recover from AKI in older, adult animals during endotoxemia, and 2) pharmacologic induction of autophagy, even after established endotoxemia, is of therapeutic utility in facilitating renal recovery in aged mice. Design: Murine model of endotoxemia and cecal ligation and puncture (CLP) induced acute kidney injury (AKI). Setting: Academic research laboratory. Subjects: C57Bl/6 mice of 8 (young) and 45 (adult) weeks of age. Intervention: Lipopolysaccharide (1.5 mg/kg), Temsirolimus (5 mg/kg), AICAR (100 mg/kg). Measurements and Main Results: Herein we report that diminished autophagy underlies the failure to recover renal function in older adult mice utilizing a murine model of LPS-induced AKI. The administration of the mTOR inhibitor temsirolimus, even after established endotoxemia, induced autophagy and protected against the development of AKI. Conclusions: These novel results demonstrate a role for autophagy in the context of LPS-induced AKI and support further investigation into like interventions that have potential to alter the natural history of disease.	[Howell, Gina M.; Gomez, Hernando; Collage, Richard D.; Loughran, Patricia; Zhang, Xianghong; Escobar, Daniel A.; Billiar, Timothy R.; Zuckerbraun, Brian S.; Rosengart, Matthew R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosengart, MR (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.	rosengartmr@upmc.edu	Gomez, Hernando/ABB-4589-2020; Loughran, Patricia/AAB-1184-2021		National Institutes of Health [R01 GM082852]; Surgical Infection Society Foundation Resident Fellowship Award;  [2T32-GM008516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008516, R01GM082830, R01GM082852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Surgical Infection Society Foundation Resident Fellowship Award; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM082852 (MRR), Surgical Infection Society Foundation Resident Fellowship Award (MRR), and 2T32-GM008516 (TRB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; [Anonymous], CRIT CARE MED; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cui J, 2012, AGE, V34, P329, DOI 10.1007/s11357-011-9237-1; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047049; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; Swanlund JM, 2010, AUTOPHAGY, V6, P270, DOI 10.4161/auto.6.2.10439; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Willinger T, 2012, P NATL ACAD SCI USA, V109, P8670, DOI 10.1073/pnas.1205305109; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	27	79	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69520	10.1371/journal.pone.0069520	http://dx.doi.org/10.1371/journal.pone.0069520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936035	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200038
J	Hughes, J; Ayoko, G; Collett, S; Golding, G				Hughes, Juanita; Ayoko, Godwin; Collett, Simon; Golding, Gary			Rapid Quantification of Methamphetamine: Using Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR) and Chemometrics	PLOS ONE			English	Article								In Australia and increasingly worldwide, methamphetamine is one of the most commonly seized drugs analysed by forensic chemists. The current well-established GC/MS methods used to identify and quantify methamphetamine are lengthy, expensive processes, but often rapid analysis is requested by undercover police leading to an interest in developing this new analytical technique. Ninety six illicit drug seizures containing methamphetamine (0.1%-78.6%) were analysed using Fourier Transform Infrared Spectroscopy with an Attenuated Total Reflectance attachment and Chemometrics. Two Partial Least Squares models were developed, one using the principal Infrared Spectroscopy peaks of methamphetamine and the other a Hierarchical Partial Least Squares model. Both of these models were refined to choose the variables that were most closely associated with the methamphetamine % vector. Both of the models were excellent, with the principal peaks in the Partial Least Squares model having Root Mean Square Error of Prediction 3.8, R-2 0.9779 and lower limit of quantification 7% methamphetamine. The Hierarchical Partial Least Squares model had lower limit of quantification 0.3% methamphetamine, Root Mean Square Error of Prediction 5.2 and R-2 0.9637. Such models offer rapid and effective methods for screening illicit drug samples to determine the percentage of methamphetamine they contain.	[Hughes, Juanita; Ayoko, Godwin] Queensland Univ Technol, Fac Sci & Technol, Discipline Chem, Brisbane, Qld 4001, Australia; [Collett, Simon; Golding, Gary] Queensland Hlth Forens & Sci Serv, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland Health	Hughes, J (corresponding author), Queensland Univ Technol, Fac Sci & Technol, Discipline Chem, Brisbane, Qld 4001, Australia.	jm.shin@student.qut.edu.au	Hughes, Juanita/K-8091-2013; Hughes, Juanita/P-5415-2019; Ayoko, Godwin/I-9836-2012	Hughes, Juanita/0000-0002-7004-0820; Hughes, Juanita/0000-0002-7004-0820; Ayoko, Godwin/0000-0001-8160-4209				[Anonymous], 2012, WORLD DRUG REP; Baran O, 2005, DETERMINATION NARCOT; Bukowski EJ, 2007, AM LAB, V39, P16; Eriksson L, 2001, J CHEMOMETR, V15, P337, DOI 10.1002/cem.678; Goh CY, 2008, APPL SPECTROSC, V62, P640, DOI 10.1366/000370208784658002; Janne K, 2001, J CHEMOMETR, V15, P203, DOI 10.1002/cem.677; Lopez-Sanchez M, 2008, ANAL CHIM ACTA, V620, P113, DOI 10.1016/j.aca.2008.05.032; Silvaa FEB, 2008, J PHARMACEUT BIOMED, V49, P5647; Sun HM, 2004, J CHEM INF COMP SCI, V44, P748, DOI 10.1021/ci030304f	9	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2013	8	7							e69609	10.1371/journal.pone.0069609	http://dx.doi.org/10.1371/journal.pone.0069609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201AX	23936058	Green Published, gold, Green Submitted			2022-12-27	WOS:000323114200040
J	Cabibbo, G; Maida, M; Genco, C; Alessi, N; Peralta, M; Butera, G; Galia, M; Brancatelli, G; Genova, C; Raineri, M; Orlando, E; Attardo, S; Giarratano, A; Midiri, M; Di Marco, V; Craxi, A; Camma, C				Cabibbo, Giuseppe; Maida, Marcello; Genco, Chiara; Alessi, Nicola; Peralta, Marco; Butera, Giuseppe; Galia, Massimo; Brancatelli, Giuseppe; Genova, Claudio; Raineri, Maurizio; Orlando, Emanuele; Attardo, Simona; Giarratano, Antonino; Midiri, Massimo; Di Marco, Vito; Craxi, Antonio; Camma, Calogero			Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; CLINICAL-TRIALS; MANAGEMENT; CIRRHOSIS; METAANALYSIS; RATES	Background: Radio-frequency ablation (RFA) has been employed in the treatment of Barcelona Clinic Liver Cancer (BCLC) early stage hepatocellular carcinoma (HCC) as curative treatments. Aim: To assess the effectiveness and the safety of RFA in patients with early HCC and compensated cirrhosis. Methods: A cohort of 151 consecutive patients with early stage HCC (122 Child-Pugh class A and 29 class B patients) treated with RFA were enrolled. Clinical, laboratory and radiological follow-up data were collected from the time of first RFA. A single lesion was observed in 113/151 (74.8%), two lesions in 32/151 (21.2%), and three lesions in 6/151 (4%) of patients. Results: The overall survival rates were 94%, 80%, 64%, 49%, and 41% at 12, 24, 36, 48 and 60 months, respectively. Complete response (CR) at 1 month (p<0.0001) and serum albumin levels (p = 0.0004) were the only variables indipendently linked to survival by multivariate Cox model. By multivariate analysis, tumor size (p = 0.01) is the only variable associated with an increased likehood of CR. The proportion of major complications after treatment was 4%. Conclusions: RFA is safe and effective for managing HCC with cirrhosis, especially for patients with HCC <= 3 cm and higher baseline albumin levels. Complete response after RFA significantly increases survival.	[Cabibbo, Giuseppe; Maida, Marcello; Genco, Chiara; Alessi, Nicola; Peralta, Marco; Butera, Giuseppe; Orlando, Emanuele; Attardo, Simona; Di Marco, Vito; Craxi, Antonio; Camma, Calogero] Univ Palermo, Sez Gastroenterol, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy; [Galia, Massimo; Brancatelli, Giuseppe; Genova, Claudio; Midiri, Massimo] Univ Palermo, Sez Radiol, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy; [Raineri, Maurizio; Giarratano, Antonino] Univ Palermo, Ist Anestesia & Rianimazioma, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Cabibbo, G (corresponding author), Univ Palermo, Sez Gastroenterol, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy.	g.cab@libero.it	Cabibbo, Giuseppe/AAY-8284-2020; Di Marco, Vito/AAC-4612-2022; Cortegiani, Andrea/H-4902-2016; Maida, Marcello Fabio/I-4118-2019; Galia, Massimo/K-5458-2016; Cabibbo, Giuseppe/K-2966-2018; Craxi, Antonio/K-9529-2016	Cabibbo, Giuseppe/0000-0002-0946-3859; Cortegiani, Andrea/0000-0003-1416-9993; Maida, Marcello Fabio/0000-0002-4992-9289; Galia, Massimo/0000-0003-3913-6290; GIARRATANO, Antonino/0000-0001-9344-8311; Raineri, Santi Maurizio/0000-0002-0675-2399; CAMMA', CALOGERO/0000-0002-9224-1914; Craxi, Antonio/0000-0002-4480-9544; Cabibbo, Giuseppe/0000-0002-2463-1849; DI MARCO, VITO/0000-0001-6397-4206				Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Cabibbo G, 2011, ALIMENT PHARM THER, V34, P196, DOI 10.1111/j.1365-2036.2011.04694.x; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Cabibbo G, 2009, NAT CLIN PRACT GASTR, V6, P159, DOI 10.1038/ncpgasthep1357; Cabibbo G, 2009, DIGEST DIS, V27, P142, DOI 10.1159/000218346; Camma C, 2009, LIVER INT, V29, P478, DOI 10.1111/j.1478-3231.2009.01994.x; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Genco C, 2013, EXPERT REV ANTICANC, V13, P469, DOI [10.1586/ERA.13.21, 10.1586/era.13.21]; Kunzli BM, 2011, WORLD J HEPATOL, V3, P8, DOI 10.4254/wjh.v3.i1.8; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Licata A, 2009, WORLD J GASTROENTERO, V15, P2132, DOI 10.3748/wjg.15.2132; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Maida M, 2013, FUTURE ONCOL, V9, P845, DOI [10.2217/FON.13.33, 10.2217/fon.13.33]; Mazzaferro V, 2004, ANN SURG, V240, P900, DOI 10.1097/01.sla.0000143301.56154.95; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Orlando A, 2009, AM J GASTROENTEROL, V104, P514, DOI 10.1038/ajg.2008.80; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Piscaglia F, 2010, DIGEST LIVER DIS, V42, P729, DOI 10.1016/j.dld.2010.03.003; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Sala M, 2004, HEPATOLOGY, V40, P1352, DOI 10.1002/hep.20465; Villanueva Augusto, 2012, Hepatology, V56, P2416, DOI 10.1002/hep.26124; Villanueva Augusto, 2011, Gastroenterology, V141, P1943, DOI 10.1053/j.gastro.2011.09.027; Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9	27	26	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70016	10.1371/journal.pone.0070016	http://dx.doi.org/10.1371/journal.pone.0070016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23922893	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700121
J	He, X; Chen, ZG; Jia, MY; Zhao, XY				He, Xin; Chen, Zhigang; Jia, Minyue; Zhao, Xiaoying			Downregulated E-Cadherin Expression Indicates Worse Prognosis in Asian Patients with Colorectal Cancer: Evidence from Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; BETA-CATENIN EXPRESSION; ADHESION MOLECULES; PRIMARY TUMORS; CARCINOMA PATIENTS; TISSUE MICROARRAY; POOR SURVIVAL; STEM-CELLS; METASTASES; ADENOCARCINOMA	Background: Epithelial-mesenchymal transition (EMT) plays a crucial role in the progression and aggressiveness of colorectal carcinoma. E-cadherin is the best-characterized molecular marker of EMT, but its prognostic significance for patients with CRC remains inconclusive. Methodology: Eligible studies were searched from the PubMed, Embase and Web of Science databases. Correlation between E-cadherin expression and clinicopathological features and prognosis was analyzed. Subgroup analysis was also performed according to study location, number of patients, quality score of studies and cut-off value. Principal Findings: A total of 27 studies comprising 4244 cases met the inclusion criteria. Meta-analysis suggested that downregulated E-cadherin expression had an unfavorable impact on overall survival (OS) of CRC (n = 2730 in 14 studies; HR = 2.27, 95%CI: 1.63-3.17; Z = 4.83; P = 0.000). Subgroup analysis indicated that low E-cadherin expression was significantly associated with worse OS in Asian patients (n = 1054 in 9 studies; HR = 2.86, 95%CI: 2.13-3.7, Z = 7.11; P = 0.000) but not in European patients (n = 1552 in 4 studies; HR = 1.14, 95%CI: 0.95-1.35, Z = 1.39; P = 0.165). In addition, reduced E-cadherin expression indicated an unfavorable OS only when the cut off value of low E-cadherin expression was >50% (n = 512 in 4 studies; HR = 2.08, 95%CI 1.45-2.94, Z = 4.05; P = 0.000). Downregulated E-cadherin expression was greatly related with differentiation grade, Dukes' stages, lymphnode status and metastasis. The pooled OR was 0.36(95%CI: 0.19-0.7, Z = 3.03, P = 0.002), 0.34(95%CI: 0.21-0.55, Z = 6.61, P = 0.000), 0.49(95%CI: 0.32-0.74, Z = 3.02, P = 0.002) and 0.45(95%CI: 0.22-0.91, Z = 3.43, P = 0.001), respectively. Conclusions: This study showed that low or absent E-cadherin expression detected by immunohistochemistry served as a valuable prognostic factor of CRC. However, downregulated E-cadherin expression seemed to be associated with worse prognosis in Asian CRC patients but not in European CRC patients. Additionally, this meta-analysis suggested that the negative threshold of E-cadherin should be >50% when we detected its expression in the immunohistochemistry stain.	[He, Xin; Zhao, Xiaoying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhigang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Minyue] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhao, XY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	zrxzzz@126.com			Natural Science Foundation of Zhejiang province, China [2009c03012-4]	Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Natural Science Foundation of Zhejiang province, China (Grant No. 2009c03012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras C, 2012, HEPATO-GASTROENTEROL, V59, P1091, DOI 10.5754/hge12041; Aoki S, 2003, BRIT J CANCER, V88, P726, DOI 10.1038/sj.bjc.6600778; Aresu L, 2010, RES VET SCI, V89, P409, DOI 10.1016/j.rvsc.2010.04.008; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Barker N, 2001, TRENDS MOL MED, V7, P535, DOI 10.1016/S1471-4914(01)02215-8; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bondi J, 2006, INT J COLORECTAL DIS, V21, P231, DOI 10.1007/s00384-005-0762-1; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860; Chen SQ, 2008, SCAND J GASTROENTERO, V43, P456, DOI 10.1080/00365520701785194; Chen XB, 2012, MOL BIOL REP, V39, P6707, DOI 10.1007/s11033-012-1494-2; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Delektorskaya VV, 2005, B EXP BIOL MED+, V139, P706, DOI 10.1007/s10517-005-0385-0; Fang QX, 2010, J SURG ONCOL, V102, P433, DOI 10.1002/jso.21537; Fernebro E, 2004, INT J CANCER, V111, P921, DOI 10.1002/ijc.20229; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Garinis GA, 2003, BRIT J CANCER, V88, P206, DOI 10.1038/sj.bjc.6600706; Geoghegan JG, 1999, BRIT J SURG, V86, P158, DOI 10.1046/j.1365-2168.1999.01013.x; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hur K, 2012, GUT; Ikeguchi M, 2000, SCAND J GASTROENTERO, V35, P839; Ilyas M, 1997, GUT, V40, P654, DOI 10.1136/gut.40.5.654; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kang H, 2011, ANN SURG ONCOL, V18, P711, DOI 10.1245/s10434-010-1338-z; Karamitopoulou E, 2010, CANCER-AM CANCER SOC, V116, P4474, DOI 10.1002/cncr.25304; Kroepil F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046665; Lampropoulos P, 2012, TUMOR BIOL, V33, P1005, DOI 10.1007/s13277-012-0333-3; Lu MH, 2012, CLIN CANCER RES, V18, P6416, DOI 10.1158/1078-0432.CCR-12-0832; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mohri Y, 1997, SURG TODAY, V27, P606, DOI 10.1007/BF02388215; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Nanashima A, 1999, J GASTROEN HEPATOL, V14, P1004, DOI 10.1046/j.1440-1746.1999.01991.x; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; Ozguven BY, 2011, POL J PATHOL, V62, P19; Pap Z, 2009, PATHOL ONCOL RES, V15, P579, DOI 10.1007/s12253-009-9157-x; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Shiono S, 2006, EJSO-EUR J SURG ONC, V32, P308, DOI 10.1016/j.ejso.2005.12.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wu Y, 2012, MOL BIOL REP, V39, P9621, DOI 10.1007/s11033-012-1827-1; Xing X, 2012, INT J CANC; Ye J, 2012, MOL MED REP, V6, P507, DOI 10.3892/mmr.2012.938; Zlobec I, 2007, J PATHOL, V212, P260, DOI 10.1002/path.2164	48	66	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2013	8	7							e70858	10.1371/journal.pone.0070858	http://dx.doi.org/10.1371/journal.pone.0070858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204MP	23923027	Green Published, gold, Green Submitted			2022-12-27	WOS:000323369700210
J	Ben-Zvi, A; Sweetat, S; Behar, O				Ben-Zvi, Ayal; Sweetat, Sahar; Behar, Oded			Elimination of Aberrant DRG Circuitries in Sema3A Mutant Mice Leads to Extensive Neuronal Deficits	PLOS ONE			English	Article							SENSORY NEURONS; CELL-DEATH; NERVOUS-SYSTEM; AXON GUIDANCE; IN-VIVO; APOPTOSIS; ABSENCE; NEUROTROPHINS; PROJECTIONS; NEUROPILIN	Axon guidance molecules determine the pattern of neuronal circuits. Accuracy of the process is ensured by unknown mechanisms that correct early guidance errors. Since the time frame of error correction in Sema3A null mice partly overlaps with the period of naturally occurring cell death in dorsal root ganglia (DRG) development, we tested the hypothesis that apoptosis of misguided neurons enables error correction. We crossed BAX null mice, in which DRG apoptosis is blocked, with Sema3A null mice to induce errors. Analyses of these double-null mouse embryos showed that the elimination of abnormal projections is not blocked in the absence of BAX. Surprisingly however, there are fewer surviving neurons in Sema3A null or Sema3A/BAX double-null newborn mice than in wild-type mice. These results suggest that guidance errors are corrected by a BAX-independent cell death mechanism. Thus, aberrant axonal guidance may lead to reductions in neuronal numbers to suboptimal levels, perhaps increasing the likelihood of neuropathological consequences later in life.	[Ben-Zvi, Ayal; Sweetat, Sahar; Behar, Oded] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Dev Biol & Canc Res, Jerusalem, Israel	Hebrew University of Jerusalem	Behar, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Dev Biol & Canc Res, Jerusalem, Israel.	odedb@ekmd.huji.ac.il	Behar, Oded/AAH-8806-2019	Behar, Oded/0000-0001-6913-2827	Israel Science Foundation [350/07]; Legacy Heritage Biomedical Science Partnership [1306/10]; Ministry of Health [3000006210]	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Biomedical Science Partnership; Ministry of Health	This work was supported by a grant from the Israel Science Foundation (grant number 350/07), Legacy Heritage Biomedical Science Partnership (grant number 1306/10) (http://www.isf.org.il/) and the Ministry of Health (grant number 3000006210) (http://www.health.gov.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Ben-Zvi A, 2006, J NEUROCHEM, V96, P585, DOI 10.1111/j.1471-4159.2005.03580.x; Ben-Zvi A, 2008, J NEUROSCI, V28, P12427, DOI 10.1523/JNEUROSCI.3573-08.2008; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Genc B, 2004, PLOS BIOL, V2, P2112, DOI 10.1371/journal.pbio.0020403; Haupt C, 2010, EUR J NEUROSCI, V31, P1164, DOI 10.1111/j.1460-9568.2010.07154.x; Hellard D, 2004, DEV BIOL, V275, P34, DOI 10.1016/j.ydbio.2004.07.021; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lerman O, 2007, MOL CELL NEUROSCI, V36, P222, DOI 10.1016/j.mcn.2007.07.003; Masuda T, 2008, J NEUROSCI, V28, P10380, DOI 10.1523/JNEUROSCI.1926-08.2008; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; White FA, 1998, J NEUROSCI, V18, P1428; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	28	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70085	10.1371/journal.pone.0070085	http://dx.doi.org/10.1371/journal.pone.0070085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922915	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900144
J	Choudhari, AS; Suryavanshi, SA; Kaul-Ghanekar, R				Choudhari, Amit S.; Suryavanshi, Snehal A.; Kaul-Ghanekar, Ruchika			The Aqueous Extract of Ficus religiosa Induces Cell Cycle Arrest in Human Cervical Cancer Cell Lines SiHa (HPV-16 Positive) and Apoptosis in HeLa (HPV-18 Positive)	PLOS ONE			English	Article							OXIDATIVE STRESS; MEDICINAL-PLANTS; P53; EXPRESSION; CARCINOMA; MITOCHONDRIA; INDUCTION; CALCIUM; GROWTH; AGENTS	Natural products are being extensively explored for their potential to prevent as well as treat cancer due to their ability to target multiple molecular pathways. Ficus religiosa has been shown to exert diverse biological activities including apoptosis in breast cancer cell lines. In the present study, we report the anti-neoplastic potential of aqueous extract of F. religiosa (FRaq) bark in human cervical cancer cell lines, SiHa and HeLa. FRaq altered the growth kinetics of SiHa (HPV-16 positive) and HeLa (HPV-18 positive) cells in a dose-dependent manner. It blocked the cell cycle progression at G(1)/S phase in SiHa that was characterized by an increase in the expression of p53, p21 and pRb proteins with a simultaneous decrease in the expression of phospho Rb (ppRb) protein. On the other hand, in HeLa, FRaq induced apoptosis through an increase in intracellular Ca2+ leading to loss of mitochondrial membrane potential, release of cytochrome-c and increase in the expression of caspase-3. Moreover, FRaq reduced the migration as well as invasion capability of both the cervical cancer cell lines accompanied with downregulation of MMP-2 and Her-2 expression. Interestingly, FRaq reduced the expression of viral oncoproteins E6 and E7 in both the cervical cancer cell lines. All these data suggest that F. religiosa could be explored for its chemopreventive potential in cervical cancer.	[Choudhari, Amit S.; Suryavanshi, Snehal A.; Kaul-Ghanekar, Ruchika] Bharati Vidyapeeth Univ, IRSHA, Cell & Translat Res Lab, Pune, Maharashtra, India	Bharati Vidyapeeth Deemed University	Kaul-Ghanekar, R (corresponding author), Bharati Vidyapeeth Univ, IRSHA, Cell & Translat Res Lab, Med Coll Campus, Pune, Maharashtra, India.	ruchika.kaulghanekar@gmail.com			IRSHA, Bharati Vidyapeeth University; CSIR	IRSHA, Bharati Vidyapeeth University; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank IRSHA, Bharati Vidyapeeth University and CSIR for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim B, 2002, ONCOGENE, V21, P2334, DOI 10.1038/sj.onc.1205006; Aggarwal BB, 2011, CURR DRUG TARGETS, V12, P1595; Aiyegoro OA, 2009, J MED PLANTS RES, V3, P1147; Al Moustafa AE, 2004, ONCOGENE, V23, P350, DOI 10.1038/sj.onc.1207148; API, 2001, AYURVEDIC PHARMACOPO, pI; Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121; Bravo-Cuellar A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-114; Roa JC, 2009, INT J GYNECOL OBSTET, V105, P150, DOI 10.1016/j.ijgo.2008.12.017; Chan A, 2012, ALTERN THER HEALTH M, V18, P12; Chavez-Blanco A, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-59; Choudhari A.S., 2011, BIOTECHNOLOGY BIOINF, V1, P443; Choudhary G.P., 2006, PLANTA INDICA, V2, P17; Cornelio DB, 2009, RECENT PAT ANTI-CANC, V4, P196, DOI 10.2174/157489209789206887; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; D'Archivio M, 2008, INT J MOL SCI, V9, P213, DOI 10.3390/ijms9030213; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Govind Pandey, 2009, Pharmacognosy Reviews, V3, P259; Haneef J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040055; Helyer Lucy K, 2006, BMC Cancer, V6, P39, DOI 10.1186/1471-2407-6-39; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Ignatoski KMW, 2005, NEOPLASIA, V7, P788, DOI 10.1593/neo.05106; Jones DL, 1997, J VIROL, V71, P2905, DOI 10.1128/JVI.71.4.2905-2912.1997; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Khandelwal K R, 2005, PRACTICAL PHARMACOGN, P149; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049186; Kirana H, 2009, INDIAN J EXP BIOL, V47, P822; Kochetkov D V, 2007, Mol Biol (Mosk), V41, P515; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Korbakis D, 2012, TUMOR BIOL, V33, P865, DOI 10.1007/s13277-011-0313-z; Lee D, 2010, CANCER LETT, V292, P125, DOI 10.1016/j.canlet.2009.11.015; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MITRA AB, 1994, CANCER RES, V54, P637; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nair Rathish, 2007, Turkish Journal of Biology, V31, P231; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Pandit R, 2010, J ETHNOPHARMACOL, V128, P462, DOI 10.1016/j.jep.2010.01.025; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Ratnasooriya WD, 1998, MED SCI RES, V26, P817; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Sa G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-14; Sanchez-Alcazar JA, 2000, J BIOL CHEM, V275, P13353, DOI 10.1074/jbc.275.18.13353; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Singh D, 2011, J ETHNOPHARMACOL, V134, P565, DOI 10.1016/j.jep.2011.01.046; Singh D, 2009, J ETHNOPHARMACOL, V123, P330, DOI 10.1016/j.jep.2009.02.042; Sreelekshmi R., 2007, Natural Product Radiance, V6, P377; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; YU DH, 1994, CANCER RES, V54, P3260; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	59	32	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70127	10.1371/journal.pone.0070127	http://dx.doi.org/10.1371/journal.pone.0070127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922932	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900149
J	dos Santos, LF; Loureiro, SR; Crippa, JADS; Osorio, FDL				dos Santos, Larissa Forni; Loureiro, Sonia Regina; de Souza Crippa, Jose Alexandre; Osorio, Flavia de Lima			Psychometric Validation Study of the Liebowitz Social Anxiety Scale - Self-Reported Version for Brazilian Portuguese	PLOS ONE			English	Article							MINI-SPIN; SCREENING TOOL; FIT INDEXES; INVENTORY; VALIDITY; DISORDER	Social Anxiety Disorder (SAD) is prevalent and rarely diagnosed due to the difficulty in recognizing its symptoms as belonging to a disorder. Therefore, the evaluation/screening scales are of great importance for its detection, with the most used being the Liebowitz Social Anxiety Scale (LSAS). Thus, this study proposed to evaluate the psychometric properties of internal consistency and convergent validity, as well as the confirmatory factorial analysis and reliability of the self-reported version of the LSAS (LSAS-SR), translated into Brazilian Portuguese, in a sample of the general population (N = 413) and in a SAD clinical sample (N = 252). The convergent validity with specific scales for the evaluation of SAD and a general anxiety scale presented correlations ranging from 0.21 to 0.84. The confirmatory factorial analysis did not replicate the previously indicated findings of the literature, with the difficulty being in obtaining a consensus factorial structure common to the diverse cultures in which the instrument was studied. The LSAS-SR presented excellent internal consistency (alpha = 0.90-0.96) and test-retest reliability (Intraclass Correlation Coefficient = 0.81; Pearson's = 0.82). The present findings support those of international studies that attest to the excellent psychometric properties of the LSAS-SR, endorsing its status as the gold standard.	[dos Santos, Larissa Forni; Loureiro, Sonia Regina; de Souza Crippa, Jose Alexandre; Osorio, Flavia de Lima] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav, Ribeirao Preto, SP, Brazil; [Loureiro, Sonia Regina; de Souza Crippa, Jose Alexandre; Osorio, Flavia de Lima] Natl Inst Technol & Translat Med, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	dos Santos, LF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav, Ribeirao Preto, SP, Brazil.	flaliosorio@ig.com.br	Santos, Larissa Forni dos/AAW-9418-2020; de Souza Crippa, José Alexandre/A-1215-2008; Loureiro, Sonia R/L-1579-2016; Osório, Flávia L./H-6079-2012	Loureiro, Sonia R/0000-0001-9423-2897; Forni dos Santos, Larissa/0000-0002-2657-4972; L. Osorio, Flavia/0000-0003-1396-555X	Sao Paulo Research Foundation (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Sao Paulo Research Foundation (FAPESP), http://www.fapesp.br/. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 2000, DIAGN STAT MAN MENT; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Beard C, 2011, J ANXIETY DISORD, V25, P722, DOI 10.1016/j.janxdis.2011.03.009; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blanco C, 2010, ARCH GEN PSYCHIAT, V67, P286, DOI 10.1001/archgenpsychiatry.2010.11; Bobes J, 1999, MED CLIN-BARCELONA, V112, P530; Connor KM, 2000, BRIT J PSYCHIAT, V176, P379, DOI 10.1192/bjp.176.4.379; Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Cox BJ, 1998, BEHAV MODIF, V22, P285, DOI 10.1177/01454455980223004; Cunha JA., 2001, MANUAL VERSAO PORTUG; DAVIDSON JRT, 1991, J CLIN PSYCHIAT, V52, P48; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; First M. B., 1997, STRUCTURED CLIN INTE; Forni-Santos L, 2012, INT J PSYCH IN PRESS; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Gorsuch R., 1983, FACTOR ANAL; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Heimberg RG, 2007, DEPRESS ANXIETY, V24, P447, DOI 10.1002/da.20277; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Levin JB, 2002, DEPRESS ANXIETY, V16, P143, DOI 10.1002/da.10064; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Lotufo-Neto F, 2000, ESCALAS AVALIACAO CL, P157; Muthen L., 2016, MPLUS COMPREHENSIVE; Nurosis M.J., 2005, SPSS 130 GUIDE DATA; Oakman J, 2003, J CLIN PSYCHOL, V59, P149, DOI 10.1002/jclp.10124; Osorio FL, 2010, EUR PSYCHIAT, V25, P178, DOI 10.1016/j.eurpsy.2009.08.002; Osorio FL, 2009, REV PSIQUIATR CLIN, V32, P73; Osorio FD, 2007, EUR PSYCHIAT, V22, P239, DOI 10.1016/j.eurpsy.2007.01.003; Osorio FD, 2006, REV BRAS PSIQUIATR, V28, P212, DOI 10.1590/S1516-44462006000300014; Osorio FD, 2010, PERSPECT PSYCHIATR C, V46, P266, DOI 10.1111/j.1744-6163.2010.00261.x; Osorio FD, 2009, REV BRAS PSIQUIATR, V31, P25, DOI 10.1590/S1516-44462008005000018; Osorio FL, 2010, COMPR PSYCHIAT, V51, P630, DOI 10.1016/j.comppsych.2010.03.004; Romm KL, 2011, EUR PSYCHIAT, V26, P115, DOI 10.1016/j.eurpsy.2010.08.014; Safren SA, 1999, J ANXIETY DISORD, V13, P253, DOI 10.1016/S0887-6185(99)00003-1; Santos Larissa Forni dos, 2011, Arch. Clin. Psychiatry (São Paulo), V38, P238; Santos-Filho A, 2009, ACTA PSYCHIAT SCAND, V121, P1; Schutters SIJ, 2010, INT CLIN PSYCHOPHARM, V25, P302, DOI 10.1097/YIC.0b013e32833a4d71; Soykan C, 2003, PSYCHOL REP, V93, P1059, DOI 10.2466/PR0.93.7.1059-1069; SPSS INCORPORATION, 2001, SPSS WIND STAT PACK; Stein MB, 2010, J CLIN PSYCHIAT, V71, P627, DOI 10.4088/JCP.08m04949gre; Streiner D. L., 2003, HLTH MEASUREMENT SCA; STREINER DL, 1993, CAN J PSYCHIAT, V38, P140, DOI 10.1177/070674379303800214; Tauscher J, 2010, EUR NEUROPSYCHOPHARM, V20, P80, DOI 10.1016/j.euroneuro.2009.10.005; Terra MB, 2006, REV BRAS PSIQUIATR, V28, P265, DOI 10.1590/S1516-44462006000700004; Yao SN, 1999, ENCEPHALE, V25, P429	48	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70235	10.1371/journal.pone.0070235	http://dx.doi.org/10.1371/journal.pone.0070235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	197GU	23922961	Green Submitted, Green Published, gold			2022-12-27	WOS:000322838900163
J	Koblin, BA; Mayer, KH; Eshleman, SH; Wang, L; Mannheimer, S; del Rio, C; Shoptaw, S; Magnus, M; Buchbinder, S; Wilton, L; Liu, TY; Cummings, V; Piwowar-Manning, E; Fields, SD; Griffith, S; Elharrar, V; Wheeler, D				Koblin, Beryl A.; Mayer, Kenneth H.; Eshleman, Susan H.; Wang, Lei; Mannheimer, Sharon; del Rio, Carlos; Shoptaw, Steven; Magnus, Manya; Buchbinder, Susan; Wilton, Leo; Liu, Ting-Yuan; Cummings, Vanessa; Piwowar-Manning, Estelle; Fields, Sheldon D.; Griffith, Sam; Elharrar, Vanessa; Wheeler, Darrell		HPTN 061 Protocol Team	Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061	PLOS ONE			English	Article							INFECTION; DISPARITIES; MORTALITY; SYPHILIS; RISK	Background: Black men who have sex with men (MSM) in the United States (US) are affected by HIV at disproportionate rates compared to MSM of other race/ethnicities. Current HIV incidence estimates in this group are needed to appropriately target prevention efforts. Methods: From July 2009 to October 2010, Black MSM reporting unprotected anal intercourse with a man in the past six months were enrolled and followed for one year in six US cities for a feasibility study of a multi-component intervention to reduce HIV infection. HIV incidence based on HIV seroconversion was calculated as number of events/100 person-years. Multivariate proportional hazards modeling with time-dependent covariates was used to identify correlates of HIV acquisition. Results: Of 1,553 Black MSM enrolled, 1,164 were HIV-uninfected at baseline and included in follow-up. Overall annual HIV incidence was 3.0% (95% confidence interval (CI): 2.0, 4.4%) and 5.9% among men <= 30 years old (95% CI: 3.6, 9.1%). Men <= 30 years old reported significantly higher levels of sexual risk and were more likely to have a sexually transmitted infection diagnosed during follow-up. Younger men also were more likely to not have a usual place for health care, not have visited a health care provider recently, and to have unmet health care needs. In multivariate analysis, age <= 30 years (hazard ratio (HR): 3.4; 95% CI: 1.4, 8.3) and unprotected receptive anal intercourse with HIV-positive or unknown status partners (HR: 4.1; 95% CI: 1.9, 9.1) were significantly associated with HIV acquisition. Conclusion: In the largest cohort of prospectively-followed Black MSM in the US, HIV incidence was high, particularly among young men. Targeted, tailored and culturally appropriate HIV prevention strategies incorporating behavioral, social and biomedical based interventions are urgently needed to lower these rates.	[Koblin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Mayer, Kenneth H.] Fenway Hlth, Boston, MA USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Eshleman, Susan H.; Cummings, Vanessa; Piwowar-Manning, Estelle] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wang, Lei; Liu, Ting-Yuan] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Mannheimer, Sharon] Columbia Univ, Dept Med, Harlem Hosp, New York, NY USA; [Mannheimer, Sharon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [del Rio, Carlos] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Shoptaw, Steven] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA; [Magnus, Manya] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol & Biostat, Washington, DC USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Wilton, Leo] Binghamton Univ, Coll Community & Publ Affairs, Dept Human Dev, New York, NY USA; [Fields, Sheldon D.] Florida Int Univ, Coll Nursing & Hlth Sci, Miami, FL 33199 USA; [Griffith, Sam] FHI 360, Res Triangle Pk, NC USA; [Elharrar, Vanessa] NIAID, Clin Prevent Res Branch, PSP, DAIDS,NIH, Bethesda, MD 20892 USA; [Wheeler, Darrell] Loyola Univ, Grad Sch Social Work, Chicago, IL 60611 USA	New York Blood Center; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Fred Hutchinson Cancer Center; Columbia University; Columbia University; Emory University; Rollins School Public Health; Emory University; University of California System; University of California Los Angeles; George Washington University; San Francisco Department of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University System of Florida; Florida International University; FHI 360; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Loyola University Chicago	Koblin, BA (corresponding author), New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA.	bkoblin@nybloodcenter.org	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517; Shoptaw, Steven/0000-0002-3583-0026	National Institute of Allergy and Infectious Disease (NIAID) [HPTN 061]; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1 AI068619, UM1 AI068617, UM1 AI068613]; Fenway Institute Clinical Research Site (CRS): Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, U01AI068613, U01AI069496, U01AI069466, U01AI069424, P30AI050409, UM1AI069424, UM1AI068619, P30AI087714, U01AI069418, UM1AI069480, P30AI060354, UM1AI069412, U01AI069480, U01AI068619, U01AI068617, UM1AI068613, U01AI069412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute Clinical Research Site (CRS): Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA; Hope Clinic of the Emory Vaccine Center CRS; The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HPTN 061 grant support provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding -Fenway Institute Clinical Research Site (CRS): Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The funder had a role in the design of the study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HIV SURV REP 2010; [Anonymous], 17 CDCP; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P234, DOI 10.1097/QAI.0b013e31815e4011; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Harrell SP, 1997, PSYCHOMETRIC PROPERT; HEREK GM, 1995, PSY PERSP LESB GAY, V2, P55; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lieb S, 2010, JAIDS-J ACQ IMM DEF, V54, P398, DOI 10.1097/QAI.0b013e3181d0c165; Mayer KH, 2008, SEXUALLY TRANSMITTED, P203; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Neaigus A, 2012, AIDS BEHAV, V16, P516, DOI 10.1007/s10461-011-0050-8; Ostrow DG, 2009, JAIDS-J ACQ IMM DEF, V51, P349, DOI 10.1097/QAI.0b013e3181a24b20; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ricca A, 2012, 19 INT AIDS C JUL 22; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Sifakis F, 2007, JAIDS-J ACQ IMM DEF, V46, P343, DOI 10.1097/QAI.0b013e31815724cc; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Tieu HV, 2010, J URBAN HEALTH, V87, P113, DOI 10.1007/s11524-009-9416-x; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Wiysonge CS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007496.pub2	24	148	149	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70413	10.1371/journal.pone.0070413	http://dx.doi.org/10.1371/journal.pone.0070413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922989	Green Published, gold			2022-12-27	WOS:000322838900168
J	Li, XL; Li, BY; Cheng, M; Yu, F; Yin, WB; Cai, Q; Zhang, Z; Zhang, JH; Wang, JF; Zhou, RH; Gao, HQ				Li, Xiao-li; Li, Bao-ying; Cheng, Mei; Yu, Fei; Yin, Wen-bin; Cai, Qian; Zhang, Zhen; Zhang, Jian-hua; Wang, Jun-fu; Zhou, Rui-hai; Gao, Hai-qing			PIMT Prevents the Apoptosis of Endothelial Cells in Response to Glycated Low Density Lipoproteins and Protective Effects of Grape Seed Procyanidin B2	PLOS ONE			English	Article							NF-KAPPA-B; PROANTHOCYANIDIN EXTRACTS; ISOASPARTYL METHYLTRANSFERASE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; EXPRESSION; LDL; PROLIFERATION; INVOLVEMENT; ACTIVATION	Background: The development of diabetic angiopathy is associated with profound vascular endothelial cells (VEC) dysfunction and apoptosis. Glycated low density lipoproteins (gly-LDL) continuously produced in the setting of diabetic patients play an important role in causing VEC dysfunction and apoptosis. However, the underlying molecular mechanism remains largely elusive. Protein L-isoaspartyl methyltransferase (PIMT) is a widely expressed protein repair enzyme by multiple cell types of arterial wall including VEC. Our previous proteomic studies showed that the expression of PIMT was significantly decreased in the aorta of diabetic rats as compared with control rats and treatment with grape seed procyanidin extracts significantly increased the PIMT expression in diabetic rats. We hypothesized that PIMT plays a critical role in gly-LDL induced VEC apoptosis; grape seed procyanidin B2 (GSPB2) protect against gly-LDL induced VEC apoptosis through PIMT regulation. Methods and Results: HUVEC transfected negative control and PIMT siRNA were treated with or without GSPB2 (10 mu mol/L) for 48 h. Moreover, HUVEC of PIMT overexpression were stimulated by gly-LDL (50 mu g/ml) in the presence or absence of GSPB2 (10 mu mol/L) for 48 h. Our results showed that gly-LDL downregulated PIMT expression and PIMT overexpression or GSPB2 significantly attenuated gly-LDL induced VEC apoptosis. PIMT siRNA increased VEC apoptosis with up-regulation of p53, cytochrome c release, caspase-9 and caspase-3 activation. Mechanistically, overexpression of PIMT or GSPB2 increased the phosphorylation of ERK1/2 and GSK3 beta in the gly-LDL induced VEC. Conclusion: In summary, our study identified PIMT as a key player responsible for gly-LDL induced VEC apoptosis and GSPB2 protect against gly-LDL induced VEC apoptosis by PIMT up-regulation. Targeting PIMT including use of GSPB2 could be turned into clinical application in the fighting against diabetic vascular complications.	[Li, Xiao-li; Li, Bao-ying; Cheng, Mei; Yu, Fei; Yin, Wen-bin; Cai, Qian; Zhang, Zhen; Gao, Hai-qing] Shandong Univ, Qi Lu Hosp, Dept Geriatr Endocrinol, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China; [Li, Xiao-li] Shandong Univ, Qi Lu Hosp, Dept Drug Purchase & Supply, Jinan 250100, Peoples R China; [Zhang, Jian-hua; Wang, Jun-fu] Med Sci Acad Shandong, Inst Basic Sci, Jinan, Peoples R China; [Zhou, Rui-hai] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill	Gao, HQ (corresponding author), Shandong Univ, Qi Lu Hosp, Dept Geriatr Endocrinol, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China.	gaohaiqing52@hotmail.com			National Natural Science Foundation of China [81000340, 81100595]; China Postdoctoral Science Foundation [2011M500748]; Natural Science Foundation of Shandong Province [ZR2010HQ067]; Traditional Chinese Medicine Science and Technology Development Projects of Shandong Province [2009-154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Traditional Chinese Medicine Science and Technology Development Projects of Shandong Province	This work was supported by National Natural Science Foundation of China (81000340, 81100595), China Postdoctoral Science Foundation (2011M500748), Natural Science Foundation of Shandong Province (ZR2010HQ067) and Traditional Chinese Medicine Science and Technology Development Projects of Shandong Province (2009-154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Artwohl M, 2003, DIABETES, V52, P1240, DOI 10.2337/diabetes.52.5.1240; Cai Q, 2011, BIOSCI BIOTECH BIOCH, V75, P1692, DOI 10.1271/bbb.110194; Cedo L, 2013, FOOD CHEM, V138, P524, DOI 10.1016/j.foodchem.2012.10.088; Chen TS, 2010, J BIOL CHEM, V285, P37281, DOI 10.1074/jbc.M110.157008; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Devi SA, 2011, EXP GERONTOL, V46, P958, DOI 10.1016/j.exger.2011.08.006; Eriksson L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-27; Fanelus I, 2008, BIOCHEM BIOPH RES CO, V371, P203, DOI 10.1016/j.bbrc.2008.04.009; Huebscher KJ, 1999, GENE, V240, P333, DOI 10.1016/S0378-1119(99)00443-6; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Kang R, 2011, AUTOPHAGY, V7, P91, DOI [10.4161/auto.7.1.13852, 10.1038/cdd.2009.149]; Kinaci MK, 2012, EXP THER MED, V3, P249, DOI 10.3892/etm.2011.382; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Lanthier J, 2006, BIOCHEM CELL BIOL, V84, P684, DOI 10.1139/O06-055; Lee HJ, 2004, J NEUROCHEM, V88, P647, DOI 10.1111/j.1471-4159.2004.02191.x; Lee JB, 2012, YONSEI MED J, V53, P53, DOI 10.3349/ymj.2012.53.1.53; Li BY, 2008, J CELL BIOCHEM, V104, P668, DOI 10.1002/jcb.21658; Li BY, 2011, APOPTOSIS, V16, P732, DOI 10.1007/s10495-011-0602-4; Li BY, 2011, CELL BIOL INT, V35, P663, DOI 10.1042/CBI20100656; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li XL, 2010, INT J MOL MED, V25, P237, DOI 10.3892/ijmm_00000336; Li XL, 2009, BIOSCI BIOTECH BIOCH, V73, P1348, DOI 10.1271/bbb.90008; Liu MJ, 2004, TOXICOL APPL PHARM, V194, P141, DOI 10.1016/j.taap.2003.08.017; Mackenzie GG, 2008, BIOCHEM PHARMACOL, V75, P1461, DOI 10.1016/j.bcp.2007.12.013; Quintela AM, 2012, FREE RADICAL BIO MED, V53, P730, DOI 10.1016/j.freeradbiomed.2012.05.045; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Morrison GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043288; Okouchi M, 2009, CURR NEUROVASC RES, V6, P267, DOI 10.2174/156720209789630348; Onat D, 2011, CURR DIABETES REP, V11, P193, DOI 10.1007/s11892-011-0182-2; Petit-Paitel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005491; Piao S, 2011, J CLIN BIOCHEM NUTR, V49, P50, DOI 10.3164/jcbn.10-120; Prasad R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043064; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sangle GV, 2010, ENDOCRINOLOGY, V151, P4455, DOI 10.1210/en.2010-0323; Sangle GV, 2010, FREE RADICAL BIO MED, V48, P781, DOI 10.1016/j.freeradbiomed.2009.12.017; Shamsara J, 2011, GENE, V487, P107, DOI 10.1016/j.gene.2011.07.020; Soulez M, 2010, STEM CELLS, V28, P810, DOI 10.1002/stem.403; Toma L, 2009, BIOCHEM BIOPH RES CO, V390, P877, DOI 10.1016/j.bbrc.2009.10.066; Turk Z, 2011, LIFE SCI, V89, P485, DOI 10.1016/j.lfs.2011.07.021; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Wagner AM, 2007, DIABETOLOGIA, V50, P676, DOI 10.1007/s00125-006-0556-1; Wagner Ana M, 2008, Rev Diabet Stud, V5, P225, DOI 10.1900/RDS.2008.5.225; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yang ZH, 2008, APOPTOSIS, V13, P1331, DOI 10.1007/s10495-008-0257-y; Yu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052541; Zhang JY, 1998, ARTERIOSCL THROM VAS, V18, P1140, DOI 10.1161/01.ATV.18.7.1140; Zhang X, 2011, ACTA BIOCH BIOPH SIN, V43, P787, DOI 10.1093/abbs/gmr072	49	13	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e69979	10.1371/journal.pone.0069979	http://dx.doi.org/10.1371/journal.pone.0069979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922881	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900129
J	Satoh, S; Mimuro, M; Tanaka, A				Satoh, Soichirou; Mimuro, Mamoru; Tanaka, Ayumi			Construction of a Phylogenetic Tree of Photosynthetic Prokaryotes Based on Average Similarities of Whole Genome Sequences	PLOS ONE			English	Article							MATTHEWS-OLSON PROTEIN; 16S RIBOSOMAL-RNA; EARLY EVOLUTION; GENE-SEQUENCES; SPECIES TREE; PROCHLOROCOCCUS; CYANOBACTERIA; ALIGNMENT; TAXONOMY; BACTERIA	Phylogenetic trees have been constructed for a wide range of organisms using gene sequence information, especially through the identification of orthologous genes that have been vertically inherited. The number of available complete genome sequences is rapidly increasing, and many tools for construction of genome trees based on whole genome sequences have been proposed. However, development of a reasonable method of using complete genome sequences for construction of phylogenetic trees has not been established. We have developed a method for construction of phylogenetic trees based on the average sequence similarities of whole genome sequences. We used this method to examine the phylogeny of 115 photosynthetic prokaryotes, i.e., cyanobacteria, Chlorobi, proteobacteria, Chloroflexi, Firmicutes and nonphotosynthetic organisms including Archaea. Although the bootstrap values for the branching order of phyla were low, probably due to lateral gene transfer and saturated mutation, the obtained tree was largely consistent with the previously reported phylogenetic trees, indicating that this method is a robust alternative to traditional phylogenetic methods.	[Satoh, Soichirou] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 606, Japan; [Mimuro, Mamoru] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Satoh, Soichirou; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Tanaka, Ayumi] Japan Sci & Technol Agcy, CREST, Sapporo, Hokkaido, Japan	Kyoto Prefectural University; Kyoto University; Hokkaido University; Japan Science & Technology Agency (JST)	Tanaka, A (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan.	ayumi@pop.lowtem.hokudai.ac.jp	Tanaka, Ayumi/D-9003-2012	Satoh, Soichirou/0000-0002-7622-1868	Japanese Society for the Promotion of Sciences (JSPS) [17GS0314]	Japanese Society for the Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Creative Research from the Japanese Society for the Promotion of Sciences (JSPS) (Grant No. 17GS0314) to MM and AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2002, ARCH MICROBIOL, V178, P131, DOI 10.1007/s00203-002-0432-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Broughton WJ, 2003, J BACTERIOL, V185, P2975, DOI 10.1128/JB.185.10.2975-2979.2003; Clarke GDP, 2002, J BACTERIOL, V184, P2072, DOI 10.1128/JB.184.8.2072-2080.2002; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Gophna U, 2005, J BACTERIOL, V187, P1305, DOI 10.1128/JB.187.4.1305-1316.2005; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Gupta RS, 1999, MOL MICROBIOL, V32, P893, DOI 10.1046/j.1365-2958.1999.01417.x; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henz Stefan R, 2005, Bioinformatics, V21, P2329, DOI 10.1093/bioinformatics/bth324; Hess WR, 2001, PHOTOSYNTH RES, V70, P53, DOI 10.1023/A:1013835924610; Hong SH, 2004, APPL MICROBIOL BIOT, V65, P203, DOI 10.1007/s00253-004-1641-3; Horiike T, 2009, GENE, V429, P59, DOI 10.1016/j.gene.2008.10.006; Huson DH, 2004, BIOINFORMATICS, V20, P2044, DOI 10.1093/bioinformatics/bth198; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; JUKES T H, 1969, P21; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Roeselers G, 2007, ENVIRON MICROBIOL, V9, P26, DOI 10.1111/j.1462-2920.2006.01103.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato Naoki, 2002, Genome Inform, V13, P173; Satoh S, 2006, PLANT CELL PHYSIOL, V47, P1622, DOI 10.1093/pcp/pcl026; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Snel B, 2005, ANNU REV MICROBIOL, V59, P191, DOI 10.1146/annurev.micro.59.030804.121233; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Swofford David L., 1996, P407; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294; Wang Y, 2000, MICROBIOL-UK, V146, P2845, DOI 10.1099/00221287-146-11-2845; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	49	10	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70290	10.1371/journal.pone.0070290	http://dx.doi.org/10.1371/journal.pone.0070290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922968	Green Published, Green Submitted, gold			2022-12-27	WOS:000322838900165
J	Orrskog, S; Medin, E; Tsolova, S; Semenza, JC				Orrskog, Sofia; Medin, Emma; Tsolova, Svetla; Semenza, Jan C.			Causal Inference Regarding Infectious Aetiology of Chronic Conditions: A Systematic Review	PLOS ONE			English	Review							CHLAMYDIA-PNEUMONIAE INFECTION; HELICOBACTER-PYLORI INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; HUMAN-PAPILLOMAVIRUS INFECTION; CHRONIC LIVER-DISEASE; C VIRUS-INFECTION; PERIPHERAL-BLOOD; HEPATITIS-B; CHRONIC PROSTATITIS; CHAGAS-DISEASE	Background: The global burden of disease has shifted from communicable diseases in children to chronic diseases in adults. This epidemiologic shift varies greatly by region, but in Europe, chronic conditions account for 86% of all deaths, 77% of the disease burden, and up to 80% of health care expenditures. A number of risk factors have been implicated in chronic diseases, such as exposure to infectious agents. A number of associations have been well established while others remain uncertain. Methods and Findings: We assessed the body of evidence regarding the infectious aetiology of chronic diseases in the peer-reviewed literature over the last decade. Causality was assessed with three different criteria: First, the total number of associations documented in the literature between each infectious agent and chronic condition; second, the epidemiologic study design (quality of the study); third, evidence for the number of Hill's criteria and Koch's postulates that linked the pathogen with the chronic condition. We identified 3136 publications, of which 148 were included in the analysis. There were a total of 75 different infectious agents and 122 chronic conditions. The evidence was strong for five pathogens, based on study type, strength and number of associations; they accounted for 60% of the associations documented in the literature. They were human immunodeficiency virus, hepatitis C. virus, Helicobacter pylori, hepatitis B virus, and Chlamydia pneumoniae and were collectively implicated in the aetiology of 37 different chronic conditions. Other pathogens examined were only associated with very few chronic conditions (<= 3) and when applying the three different criteria of evidence the strength of the causality was weak. Conclusions: Prevention and treatment of these five pathogens lend themselves as effective public health intervention entry points. By concentrating research efforts on these promising areas, the human, economic, and societal burden arising from chronic conditions can be reduced.	[Orrskog, Sofia; Medin, Emma] Heron Evidence Dev AB, Stockholm, Sweden; [Medin, Emma] Karolinska Inst, Stockholm, Sweden; [Tsolova, Svetla; Semenza, Jan C.] European Ctr Dis Prevent & Control, Stockholm, Sweden	Karolinska Institutet; European Centre for Disease Prevention & Control	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control, Stockholm, Sweden.	Jan.Semenza@ecdc.europa.eu			European Centre for Disease Prevention and Control (ECDC); HERON Evidence Development LTD.; ECDC Specific Contract (Mapping Infectious Aetiology of Non-Communicable Chronic Diseases) [OJ/2010/05/04-PROC/2010/021]	European Centre for Disease Prevention and Control (ECDC); HERON Evidence Development LTD.; ECDC Specific Contract (Mapping Infectious Aetiology of Non-Communicable Chronic Diseases)	Research under this project was funded by the European Centre for Disease Prevention and Control (ECDC) and performed under an ECDC Specific Contract (Mapping Infectious Aetiology of Non-Communicable Chronic Diseases) Number OJ/2010/05/04-PROC/2010/021, with HERON Evidence Development LTD. ECDC staff specified the terms of reference for the project, helped design the search strategies, collected data and were involved in data analysis, interpretation of the findings, and writing of the manuscript.	Abello M, 2007, ARQ BRAS CARDIOL, V88, P213; Adetifa I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006736.pub2; Adinarayanan S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003758.pub2; Agarwal A, 2008, INDIAN J MED MICROBI, V26, P338, DOI 10.4103/0255-0857.43567; Ahmed I, 2003, J PAK ASS DERMATOL, V13, P179; Ake JA, 2005, PEDIATRICS, V115, pE673, DOI 10.1542/peds.2004-2236; Akhund AA, 2009, J LIAQUAT UNIV MED H, V8, P121; Akman C, 2004, CLIN RADIOL, V59, P573, DOI 10.1016/j.crad.2003.12.001; Anand A C, 2004, J Assoc Physicians India, V52, P785; Aygenc E, 2001, OTOLARYNG HEAD NECK, V125, P520, DOI 10.1016/S0194-5998(01)08222-5; Bansal Arun, 2005, Indian Journal of Pediatrics, V72, P467, DOI 10.1007/BF02724422; Bayram A, 2009, J CLIN VIROL, V45, P212, DOI 10.1016/j.jcv.2009.05.009; Berliner AR, 2008, AM J NEPHROL, V28, P478, DOI 10.1159/000112851; Bestard O, 2005, TRANSPL P, V37, P3774, DOI 10.1016/j.transproceed.2005.09.170; Bodaghi B, 2001, MEDICINE, V80, P263, DOI 10.1097/00005792-200107000-00005; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bostrom A, 2008, MINIM INVAS NEUROSUR, V51, P36, DOI 10.1055/s-2007-1004547; Botoni FA, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.12.017; Boulos PB, 2002, QJM-INT J MED, V95, P749, DOI 10.1093/qjmed/95.11.749; Bozbuga N, 2003, TEX HEART I J, V30, P180; Branden E, 2005, RESP MED, V99, P20, DOI 10.1016/j.rmed.2004.04.014; Bruno CM, 2005, WORLD J GASTROENTERO, V11, P4566, DOI 10.3748/wjg.v11.i29.4566; Carratelli CR, 2006, INT IMMUNOPHARMACOL, V6, P848, DOI 10.1016/j.intimp.2005.10.012; Carter JD, 2009, ARTHRITIS RHEUM, V60, P1311, DOI 10.1002/art.24431; Chan Pei-Chun, 2005, Journal of Microbiology Immunology and Infection, V38, P183; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chieux V, 2001, J MED VIROL, V65, P301, DOI 10.1002/jmv.2034; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Colpan ME, 2004, J CLIN NEUROSCI, V11, P389, DOI 10.1016/S0967-5868(03)00153-X; Corradini C, 2003, Acta Otorhinolaryngol Ital, V23, P168; Costa DL, 2007, P NATL ACAD SCI USA, V104, P13219, DOI 10.1073/pnas.0611077104; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Danso-Appiah A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000053.pub2; Dissanayake S, 2001, INT J EPIDEMIOL, V30, P394, DOI 10.1093/ije/30.2.394; Donta ST, 2004, ANN INTERN MED, V141, P85, DOI 10.7326/0003-4819-141-2-200407200-00006; Donta ST, 2002, MED CLIN N AM, V86, P341, DOI 10.1016/S0025-7125(03)00090-7; Dosa Erika, 2002, Acta Microbiologica et Immunologica Hungarica, V49, P337, DOI 10.1556/AMicr.49.2002.2-3.23; ElSaadany Susie, 2006, Chronic Dis Can, V27, P125; Fabrizi F, 2004, ALIMENT PHARM THER, V20, P1271, DOI 10.1111/j.1365-2036.2004.02290.x; Fassio E, 2010, ANN HEPATOL, V9, P63, DOI 10.1016/S1665-2681(19)31681-3; Feng YQ, 2010, J CLIN NEUROSCI, V17, P1372, DOI 10.1016/j.jocn.2010.02.023; Ferguson BJ, 2007, LARYNGOSCOPE, V117, P2036, DOI 10.1097/MLG.0b013e318123f2d7; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Fratamico PM, 2009, SEQUELAE CONSEQUENCE; Gaig P, 2002, Allergol Immunopathol (Madr), V30, P255; Galadari Ibrahim H, 2006, Skinmed, V5, P172, DOI 10.1111/j.1540-9740.2006.04646.x; Geelhaar A, 2010, INFECT IMMUN, V78, P4589, DOI 10.1128/IAI.00705-10; Georgala S, 2001, J EUR ACAD DERMATOL, V15, P441, DOI 10.1046/j.1468-3083.2001.00331.x; George J, 2009, WORLD J GASTROENTERO, V15, P3516, DOI 10.3748/wjg.15.3516; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gross ND, 2002, LARYNGOSCOPE, V112, P1758, DOI 10.1097/00005537-200210000-00009; Handa S, 2003, CLIN EXP DERMATOL, V28, P245, DOI 10.1046/j.1365-2230.2003.01284.x; Haubitz M, 2001, NEPHROL DIAL TRANSPL, V16, P809, DOI 10.1093/ndt/16.4.809; Hazlina NHN, 2005, INT MED J, V12, P205; Hellmig S, 2005, AM J GASTROENTEROL, V100, P2644, DOI 10.1111/j.1572-0241.2005.00338.x; IARC, 2008, SECT CANC INF GLOBOC; Inaba T, 2005, EUR J CLIN INVEST, V35, P214, DOI 10.1111/j.1365-2362.2005.01471.x; Jaing TH, 2003, ACTA PAEDIATR, V92, P1153, DOI 10.1080/08035250310005648; Jeansson S, 2001, SCAND J IMMUNOL, V53, P610, DOI 10.1046/j.1365-3083.2001.00926.x; Jha HC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-48; Jindal N, 2003, Indian J Med Sci, V57, P12; Karande Sunil, 2005, Neurol India, V53, P191; Kiechl S, 2002, STROKE, V33, P2170, DOI 10.1161/01.STR.0000027209.59821.98; Kiire CA, 2006, BRIT J OPHTHALMOL, V90, P109, DOI 10.1136/bjo.2005.077305; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Knobler S. L., 2004, INFECT ETIOLOGY CHRO; Kocabas A, 2008, J ASTHMA, V45, P39, DOI 10.1080/02770900701815735; Koshiol J, 2006, AM J EPIDEMIOL, V164, P176, DOI 10.1093/aje/kwj165; Krieger JN, 2002, UROLOGY, V60, P8, DOI 10.1016/S0090-4295(02)02294-X; Kuk S, 2006, SOUTH MED J, V99, P719, DOI 10.1097/01.smj.0000223949.11527.48; Kulthanan K, 2007, J DERMATOL, V34, P294, DOI 10.1111/j.1346-8138.2007.00276.x; Kurihara C, 2001, HEPATOL RES, V19, P212, DOI 10.1016/S1386-6346(00)00106-6; Ladeira MSP, 2004, ENVIRON MOL MUTAGEN, V44, P91, DOI 10.1002/em.20045; Lazarus A, 2008, POSTGRAD MED, V120, P113, DOI 10.3810/pgm.2008.09.1912; Leconte Sophie, 2008, Prim Care Respir J, V17, P206, DOI 10.3132/pcrj.2008.00028; Lee CC, 2008, DIAGN MICR INFEC DIS, V62, P219, DOI 10.1016/j.diagmicrobio.2008.05.016; Lee MH, 2010, J HEPATOL, V52, pS406, DOI 10.1016/S0168-8278(10)61051-3; Li L, 2010, HEPATOL INT, V4, P207; Li ZW, 2006, SCAND J GASTROENTERO, V41, P1007, DOI 10.1080/00365520600554477; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Littman AJ, 2004, CANCER EPIDEM BIOMAR, V13, P1624; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Lowe AM, 2008, LANCET INFECT DIS, V8, P720, DOI 10.1016/S1473-3099(08)70257-3; Mabanta CG, 2003, COCHRANE DB SYST REV; Madala ND, 2003, CLIN NEPHROL, V60, P69; Mahler E, 2004, CLIN EXP IMMUNOL, V136, P527, DOI 10.1111/j.1365-2249.2004.02480.x; Mahnel R, 2005, AM J GASTROENTEROL, V100, P1167, DOI 10.1111/j.1572-0241.2005.40128.x; Maqsood Saad, 2006, J Ayub Med Coll Abbottabad, V18, P58; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Medeiros LR, 2009, INT J GYNECOL CANCER, V19, P1166, DOI 10.1111/IGC.0b013e3181a3d100; Mehdi Nighat, 2005, Pediatric Asthma Allergy & Immunology, V18, P55, DOI 10.1089/pai.2005.18.55; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Mete N, 2004, J INVEST ALLERG CLIN, V14, P292; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Monteon Francisco J, 2003, Clin Transpl, P165; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Nagao Y, 2004, INT J MOL MED, V13, P257; Nakamura H, 2001, Mod Rheumatol, V11, P23, DOI 10.3109/s101650170039; Nersesov AV, 2010, HEPATOL RES, V40, P724; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Norton EB, 2004, PEDIATR INFECT DIS J, V23, P145, DOI 10.1097/01.inf.0000109258.82988.40; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Ozdemir A, 2001, QUINTESSENCE INT, V32, P131; Pandya S., 2008, IND J RHEUMATOL, V3, P93, DOI DOI 10.1016/S0973-3698(10)60125-2; Papatheodoridis GV, 2008, ANN GASTROENTEROL, V21, P181; Passarino G, 2005, AM J FOREN MED PATH, V26, P106, DOI 10.1097/01.paf.0000159990.54730.4b; Penrose AS, 2007, WORLD J GASTROENTERO, V13, P4574, DOI 10.3748/wjg.v13.i34.4574; Perez-Fuentes R, 2007, ANN TROP MED PARASIT, V101, P123, DOI 10.1179/136485907X154593; Peters B, 2010, J INT AIDS SOC, V13; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; Ramdial PK, 2006, J CUTAN PATHOL, V33, P474, DOI 10.1111/j.1600-0560.2006.00352.x; Ramos-Casals M, 2006, J RHEUMATOL, V33, P1593; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rekand T, 2002, J INFECT DIS, V186, P1840, DOI 10.1086/345769; Reshetnyak VI, 2002, B EXP BIOL MED+, V133, P399, DOI 10.1023/A:1016218609601; Reyes PA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004102.pub2; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Rudnicka W, 2001, FEMS IMMUNOL MED MIC, V30, P121, DOI 10.1111/j.1574-695X.2001.tb01559.x; Rupp J, 2004, GENES IMMUN, V5, P435, DOI 10.1038/sj.gene.6364112; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Sakurane M, 2002, J DERMATOL, V29, P23, DOI 10.1111/j.1346-8138.2002.tb00160.x; Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.0000079174.13444.9C; Salome MA, 2002, AIDS PATIENT CARE ST, V16, P361, DOI 10.1089/10872910260196387; Saltini C, 2008, SARCOIDOSIS VASC DIF, V25, P100; Savas MC, 2002, MICROBIOLOGICA, V25, P399; Schunemann H, 2011, J EPIDEMIOL COMMUN H, V65, P392, DOI 10.1136/jech.2010.119933; Scottish Intercollegiate Guidelines Network (SIGN), CRIT APPR NOT CHECKL; Sechi LA, 2008, CLIN VACCINE IMMUNOL, V15, P320, DOI 10.1128/CVI.00381-07; Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013; Semenza JC, 2012, CLIN MICROBIOL INFEC; Serano RD, 2010, J NEUROL, V257, pS222; Sharifi-Mood B., 2006, International Journal of Virology, V2, P63; Signorelli SS, 2006, J CHEMOTHERAPY, V18, P103, DOI 10.1179/joc.2006.18.1.103; Skerk V, 2002, J CHEMOTHERAPY, V14, P384, DOI 10.1179/joc.2002.14.4.384; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Sorrentino D, 2004, HELICOBACTER, V9, P46, DOI 10.1111/j.1083-4389.2004.00197.x; Suzuki T, 2005, AM J GASTROENTEROL, V100, P1265, DOI 10.1111/j.1572-0241.2005.41641.x; Thakkar K, 2009, ALIMENT PHARM THER, V30, P662, DOI 10.1111/j.1365-2036.2009.04084.x; Theodoropoulos TAD, 2008, INT J CARDIOL, V128, P22, DOI 10.1016/j.ijcard.2007.11.057; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Tong CYW, 2002, TRANSPLANTATION, V74, P576, DOI 10.1097/00007890-200208270-00026; Toscano MP, 2009, LAB INVEST, V89, p335A; Totin D, 2002, J NUTR, V132, P423, DOI 10.1093/jn/132.3.423; Unsworth N, 2008, QJM-INT J MED, V101, P269, DOI 10.1093/qjmed/hcm149; Uscategui T, 2008, COCHRANE DB SYST REV, P3; Van Der Hilst JCH, 2002, NETH J MED, V60, P140; Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049; Wackemann PV, 2008, J NEUROL SCI, V269, P152, DOI 10.1016/j.jns.2008.01.006; Wadowsky RM, 2002, J CLIN MICROBIOL, V40, P637, DOI 10.1128/JCM.40.2.637-640.2002; Wang YF, 2005, WORLD J GASTROENTERO, V11, P5029, DOI 10.3748/wjg.v11.i32.5029; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020; WHO, GAIN HLTH EUR STRAT; World Health Organization, INT CLASS DIS ICD; Yariktas M, 2007, AM J RHINOL, V21, P248, DOI 10.2500/ajr.2007.21.2990; Yilmaz N, 2007, LIVER TRANSPLANT, V13, P975, DOI 10.1002/lt.21117; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x; Zonta Marise Bueno, 2005, Braz J Infect Dis, V9, P479, DOI 10.1590/S1413-86702005000600005; Zullo A, 2003, J CLIN GASTROENTEROL, V37, P164, DOI 10.1097/00004836-200308000-00014	160	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e68861	10.1371/journal.pone.0068861	http://dx.doi.org/10.1371/journal.pone.0068861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23935899	Green Published, gold, Green Submitted			2022-12-27	WOS:000322433300012
J	Trolle, C; Mortensen, KH; Pedersen, LN; Berglund, A; Jensen, HK; Andersen, NH; Gravholt, CH				Trolle, Christian; Mortensen, Kristian H.; Pedersen, Lisbeth N.; Berglund, Agnethe; Jensen, Henrik K.; Andersen, Niels H.; Gravholt, Claus H.			Long QT Interval in Turner Syndrome - A High Prevalence of LQTS Gene Mutations	PLOS ONE			English	Article							TORSADES-DE-POINTES; EUROPEAN-SOCIETY; HEART-RATE; PROLONGATION; KCNH2; RECOMMENDATIONS; POLYMORPHISMS; MORTALITY; CHANNEL; HERG	Objectives: QT-interval prolongation of unknown aetiology is common in Turner syndrome. This study set out to explore the presence of known long QT mutations in Turner syndrome and to examine the corrected QT-interval (QTc) over time and relate the findings to the Turner syndrome phenotype. Methods: Adult women with Turner syndrome (n = 88) were examined thrice and 68 age-matched healthy controls were examined once. QTc was measured by one blinded reader (intra-reader variability: 0.7%), and adjusted for influence of heart rate by Bazett's (bQTc) and Hodges's formula (hQTc). The prevalence of mutations in genes related to Long QT syndrome was determined in women with Turner syndrome and a QTc > 432.0 milliseconds (ms). Echocardiographic assessment of aortic valve morphology, 24-hour blood pressures and blood samples were done. Results: The mean hQTc in women with Turner syndrome (414.0 +/- 25.5 ms) compared to controls (390.4 +/- 17.8 ms) was prolonged (p < 0.001) and did not change over time (416.9 +/- 22.6 vs. 415.6 +/- 25.5 ms; p = 0.4). 45,X karyotype was associated with increased hQTc prolongation compared to other Turner syndrome karyotypes (418.2 +/- 24.8 vs. 407.6 +/- 25.5 ms; p = 0.055). In women with Turner syndrome and a bQTc > 432 ms, 7 had mutations in major Long QT syndrome genes (SCN5A and KCNH2) and one in a minor Long QT syndrome gene (KCNE2). Conclusion: There is a high prevalence of mutations in the major LQTS genes in women with TS and prolonged QTc. It remains to be settled, whether these findings are related to the unexplained excess mortality in Turner women.	[Trolle, Christian; Mortensen, Kristian H.; Berglund, Agnethe; Gravholt, Claus H.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Trolle, Christian; Mortensen, Kristian H.; Berglund, Agnethe; Gravholt, Claus H.] Aarhus Univ Hosp, Med Res Labs, DK-8000 Aarhus, Denmark; [Mortensen, Kristian H.] Cambridge Univ Hosp, Dept Radiol, Cambridge, England; [Pedersen, Lisbeth N.; Gravholt, Claus H.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Jensen, Henrik K.; Andersen, Niels H.] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; University of Cambridge; Aarhus University; Aarhus University	Gravholt, CH (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	ch.gravholt@dadlnet.dk	Jensen, Henrik/A-7980-2018; Berglund, Agnethe/ABB-6991-2020; Gravholt, Claus H./Z-1435-2018	Jensen, Henrik/0000-0003-1802-4302; Gravholt, Claus H./0000-0001-5924-1720; Trolle, Christian/0000-0003-4556-9113; Andersen, Niels Holmark/0000-0002-5394-3016; Mortensen, Kristian/0000-0002-8986-6067	Danish Ministry for Science and Technology and Innovation; Danish Heart Foundation; Novo Nordisk Foundation; Aase og Ejnar Danielsen Foundation; Korning Foundation; Hede Nielsens Foundation; Eva og Henry Fraenkels Minde Foundation; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Foundation; National Institute for Health Research [ACF-2011-14-016] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005513, NNF13OC0003234] Funding Source: researchfish	Danish Ministry for Science and Technology and Innovation; Danish Heart Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase og Ejnar Danielsen Foundation; Korning Foundation(National Research Foundation of Korea); Hede Nielsens Foundation; Eva og Henry Fraenkels Minde Foundation; Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding from the Danish Ministry for Science and Technology and Innovation, The Danish Heart Foundation, Novo Nordisk Foundation, Aase og Ejnar Danielsen Foundation, Korning Foundation, Hede Nielsens Foundation, Eva og Henry Fraenkels Minde Foundation and Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Berthet M, 1999, CIRCULATION, V99, P1464, DOI 10.1161/01.CIR.99.11.1464; Bokil NJ, 2010, MOL GENET METAB, V101, P1, DOI 10.1016/j.ymgme.2010.05.011; Bondy CA, 2006, MEDICINE, V85, P75, DOI 10.1097/01.md.0000205629.16302.bc; Bondy CA, 2006, PEDIATRICS, V118, pE1220, DOI 10.1542/peds.2006-0776; Chevalier P, 2007, HEART RHYTHM, V4, P170, DOI 10.1016/j.hrthm.2006.10.004; Dalla Pozza R, 2006, EUR J PEDIATR, V165, P831, DOI 10.1007/s00431-006-0194-0; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Genovesi S, 2009, CLIN SCI, V116, P851, DOI 10.1042/CS20080325; Giraldi FP, 2011, OBESITY, V19, P2015, DOI 10.1038/oby.2011.33; Golzio PG, 2006, PACE, V29, P1181, DOI 10.1111/j.1540-8159.2006.00513.x; Gravholt CH, 2004, EUR J ENDOCRINOL, V151, P657, DOI 10.1530/eje.0.1510657; Gravholt CH, 1998, J CLIN EPIDEMIOL, V51, P147, DOI 10.1016/S0895-4356(97)00237-0; Gravholt CH, 2006, J HYPERTENS, V24, P353, DOI 10.1097/01.hjh.0000200509.17947.0f; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; HODGES M, 1983, J AM COLL CARDIOL, V1, P694; Kadish AH, 2004, ANN NONINVAS ELECTRO, V9, P366, DOI 10.1111/j.1542-474X.2004.94580.x; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kapa S, 2009, CIRCULATION, V120, P1752, DOI 10.1161/CIRCULATIONAHA.109.863076; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Larsen LA, 2001, CLIN CHEM, V47, P1390; Li W, 2012, HUM MOL GENET, V21, P32, DOI 10.1093/hmg/ddr435; Mank-Seymour AR, 2006, AM HEART J, V152, P1116, DOI 10.1016/j.ahj.2006.08.020; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; Millat G, 2009, CLIN BIOCHEM, V42, P491, DOI 10.1016/j.clinbiochem.2008.10.014; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Pozza RD, 2009, EUR J PEDIATR, V168, P59, DOI 10.1007/s00431-008-0709-y; Rautaharju PM, 2009, CIRCULATION, V119, pE241, DOI 10.1161/CIRCULATIONAHA.108.191096; RAUTAHARJU PM, 1992, CAN J CARDIOL, V8, P690; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Schoemaker MJ, 2008, J CLIN ENDOCR METAB, V93, P4735, DOI 10.1210/jc.2008-1049; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sohaib SMA, 2008, J ELECTROCARDIOL, V41, P704, DOI 10.1016/j.jelectrocard.2008.01.010; Sozen AB, 2008, PACE, V31, P1140, DOI 10.1111/j.1540-8159.2008.01154.x; Stochholm K, 2006, J CLIN ENDOCR METAB, V91, P3897, DOI 10.1210/jc.2006-0558; Sun ZQ, 2004, J MOL CELL CARDIOL, V37, P1031, DOI 10.1016/j.yjmcc.2004.09.001; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Zuckerman-Levin N, 2006, CLIN ENDOCRINOL, V64, P410, DOI 10.1111/j.1365-2265.2006.02483.x	43	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2013	8	7							e69614	10.1371/journal.pone.0069614	http://dx.doi.org/10.1371/journal.pone.0069614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191SQ	23936059	Green Submitted, Green Published, gold			2022-12-27	WOS:000322433300054
J	Cray, JJ; Khaksarfard, K; Weinberg, SM; Elsalanty, M; Yu, JC				Cray, James J., Jr.; Khaksarfard, Kameron; Weinberg, Seth M.; Elsalanty, Mohammed; Yu, Jack C.			Effects of Thyroxine Exposure on Osteogenesis in Mouse Calvarial Pre-Osteoblasts	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; THYROID-HORMONE; PREMATURE CRANIOSYNOSTOSIS; INTRACRANIAL-PRESSURE; GRAVES-DISEASE; SUTURE; FGF; TWIST; BONE; EXPRESSION	The incidence of craniosynostosis is one in every 1,800-2500 births. The gene-environment model proposes that if a genetic predisposition is coupled with environmental exposures, the effects can be multiplicative resulting in severely abnormal phenotypes. At present, very little is known about the role of gene-environment interactions in modulating craniosynostosis phenotypes, but prior evidence suggests a role for endocrine factors. Here we provide a report of the effects of thyroid hormone exposure on murine calvaria cells. Murine derived calvaria cells were exposed to critical doses of pharmaceutical thyroxine and analyzed after 3 and 7 days of treatment. Endpoint assays were designed to determine the effects of the hormone exposure on markers of osteogenesis and included, proliferation assay, quantitative ALP activity assay, targeted qPCR for mRNA expression of Runx2, Alp, Ocn, and Twist1, genechip array for 28,853 targets, and targeted osteogenic microarray with qPCR confirmations. Exposure to thyroxine stimulated the cells to express ALP in a dose dependent manner. There were no patterns of difference observed for proliferation. Targeted RNA expression data confirmed expression increases for Alp and Ocn at 7 days in culture. The genechip array suggests substantive expression differences for 46 gene targets and the targeted osteogenesis microarray indicated 23 targets with substantive differences. 11 gene targets were chosen for qPCR confirmation because of their known association with bone or craniosynostosis (Col2a1, Dmp1, Fgf1, 2, Igf1, Mmp9, Phex, Tnf, Htra1, Por, and Dcn). We confirmed substantive increases in mRNA for Phex, FGF1, 2, Tnf, Dmp1, Htra1, Por, Igf1 and Mmp9, and substantive decreases for Dcn. It appears thyroid hormone may exert its effects through increasing osteogenesis. Targets isolated suggest a possible interaction for those gene products associated with calvarial suture growth and homeostasis as well as craniosynostosis.	[Cray, James J., Jr.; Khaksarfard, Kameron; Elsalanty, Mohammed] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA; [Cray, James J., Jr.] Georgia Regents Univ, Dept Orthopaed Surg, Augusta, GA USA; [Cray, James J., Jr.] Georgia Regents Univ, Dept Orthodont, Augusta, GA USA; [Cray, James J., Jr.; Yu, Jack C.] Georgia Regents Univ, Div Plast Surg, Dept Surg, Augusta, GA USA; [Cray, James J., Jr.; Elsalanty, Mohammed; Yu, Jack C.] Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Orthodont, Pittsburgh, PA USA; [Elsalanty, Mohammed] Georgia Regents Univ, Dept Oral & Maxillofacial Surg, Augusta, GA USA; [Elsalanty, Mohammed] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Cray, JJ (corresponding author), Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA.	JCRAY@gru.edu		Weinberg, Seth/0000-0001-9467-4556	American Cleft Palate-Cleft/Craniofacial Anomalies Grant Award, Cleft Palate Foundation	American Cleft Palate-Cleft/Craniofacial Anomalies Grant Award, Cleft Palate Foundation	This work was supported by the American Cleft Palate-Cleft/Craniofacial Anomalies Grant Award, Cleft Palate Foundation, www.cleftline.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 1996, PLAST RECONSTR SURG, V97, P1, DOI 10.1097/00006534-199601000-00001; Ang BU, 2010, J CRANIOFAC SURG, V21, P462, DOI 10.1097/SCS.0b013e3181cfe9a0; Arlt W, 2007, REV ENDOCR METAB DIS, V8, P301, DOI 10.1007/s11154-007-9056-y; Bassett JHD, 2008, MOL ENDOCRINOL, V22, P501, DOI 10.1210/me.2007-0221; Bodo M, 1999, EUR J CELL BIOL, V78, P323, DOI 10.1016/S0171-9335(99)80066-1; Boyadjiev SA, 2007, ORTHOD CRANIOFAC RES, V10, P129, DOI 10.1111/j.1601-6343.2007.00393.x; Brent G A, 2000, Rev Endocr Metab Disord, V1, P27, DOI 10.1023/A:1010056202122; BRITTO JM, 1994, ENDOCRINOLOGY, V134, P169, DOI 10.1210/en.134.1.169; CHADDUCK WM, 1992, NEUROSURGERY, V30, P867, DOI 10.1227/00006123-199206000-00008; Cohen MM, 2005, AM J MED GENET A, V136A, P313, DOI 10.1002/ajmg.a.30757; Cohen P.R., 2000, CRANIOSYNOSTOSIS DIA, P177; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Coussens AK, 2008, DIFFERENTIATION, V76, P531, DOI 10.1111/j.1432-0436.2007.00244.x; Esparza J, 2008, NEUROCIRUGIA, V19, P509; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; GAULT DT, 1992, PLAST RECONSTR SURG, V90, P377, DOI 10.1097/00006534-199209000-00003; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Greenwald JA, 2001, AM J PATHOL, V158, P441, DOI 10.1016/S0002-9440(10)63987-9; Harvey CB, 2003, MOL CELL ENDOCRINOL, V213, P87, DOI 10.1016/j.mce.2003.10.037; HASHMI SS, 2012, BIRTH DEFECTS RES A; Huang BK, 2000, J BONE MINER RES, V15, P188, DOI 10.1359/jbmr.2000.15.2.188; Jabs E. W., 2002, UNDERSTANDING CRANIO, P125; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; Kapp-Simon KA, 2007, CHILD NERV SYST, V23, P269, DOI 10.1007/s00381-006-0251-z; KASONO K, 1988, BONE MINER, V4, P355; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Kohara H, 2011, IMMUNOL LETT, V137, P53, DOI 10.1016/j.imlet.2011.02.017; Lee KMA, 2010, BBA-MOL BASIS DIS, V1802, P347, DOI 10.1016/j.bbadis.2009.11.006; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie Pierre J., 2008, V12, P144, DOI 10.1159/000115036; MENKING M, 1972, MONATSSCHR KINDERH, V120, P106; MILLER MT, 2000, CRANIOSYNOSTOSIS DIA, V4, P184; Miraoui H, 2010, GENE, V468, P1, DOI 10.1016/j.gene.2010.07.013; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Oh JH, 2012, BIOCHEM BIOPH RES CO, V418, P634, DOI 10.1016/j.bbrc.2012.01.064; Owen C, 2012, J CELL BIOCHEM, V113, P2432, DOI 10.1002/jcb.24115; PENFOLD JL, 1975, J PEDIATR-US, V86, P360, DOI 10.1016/S0022-3476(75)80963-2; PERSING JA, 2000, CRANIOSYNOSTOSIS DIA, P209; Radetti G, 2002, Minerva Pediatr, V54, P383; Ramajayam G, 2012, MOL CELL BIOCHEM, V368, P77, DOI 10.1007/s11010-012-1345-4; Rasmussen SA, 2007, OBSTET GYNECOL, V110, P369, DOI 10.1097/01.AOG.0000270157.88896.76; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Richtsmeier J.T., 2003, UNDERSTANDING CRANIO, P321, DOI 10.1002/0471221953.ch14; RIGGS W, 1972, RADIOLOGY, V105, P621, DOI 10.1148/105.3.621; ROBINSON DC, 1969, ARCH DIS CHILD, V44, P252, DOI 10.1136/adc.44.234.252; Segni M, 1999, THYROID, V9, P871, DOI 10.1089/thy.1999.9.871; Shackleton CHL, 2012, LIPIDS, V47, P1, DOI 10.1007/s11745-011-3605-6; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Stamper BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026557; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V391, P1374, DOI 10.1016/j.bbrc.2009.12.067; Wadhwa S, 2007, BONE, V40, P861, DOI 10.1016/j.bone.2006.11.003; Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013; Williams GR, 2009, ENDOKRYNOL POL, V60, P380; Xiong Y, 2012, NEUROTOXICOLOGY, V33, P753, DOI 10.1016/j.neuro.2012.04.021; Yao CF, 2007, INT IMMUNOPHARMACOL, V7, P1747, DOI 10.1016/j.intimp.2007.09.015; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	59	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69067	10.1371/journal.pone.0069067	http://dx.doi.org/10.1371/journal.pone.0069067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935926	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325211000072
J	Di Giuro, CML; Konstantinovics, C; Rinner, U; Nowikow, C; Leitner, E; Straganz, GD				Di Giuro, Cristiana M. L.; Konstantinovics, Cornelia; Rinner, Uwe; Nowikow, Christina; Leitner, Erich; Straganz, Grit D.			Chiral Hydroxylation at the Mononuclear Nonheme Fe(II) Center of 4-(S) Hydroxymandelate Synthase - A Structure-Activity Relationship Analysis	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; SWISS-MODEL; DIKETONE DIOXYGENASE; ALPHA-KETOGLUTARATE; CLEAVAGE; ENVIRONMENT; BIOSYNTHESIS; INTERMEDIATE; REACTIVITY	(S)-Hydroxymandelate synthase (Hms) is a nonheme Fe(II) dependent dioxygenase that catalyzes the oxidation of 4-hydroxyphenylpyruvate to (S)-4-hydroxymandelate by molecular oxygen. In this work, the substrate promiscuity of Hms is characterized in order to assess its potential for the biosynthesis of chiral a-hydroxy acids. Enzyme kinetic analyses, the characterization of product spectra, quantitative structure activity relationship (QSAR) analyses and in silico docking studies are used to characterize the impact of substrate properties on particular steps of catalysis. Hms is found to accept a range of alpha-oxo acids, whereby the presence of an aromatic substituent is crucial for efficient substrate turnover. A hydrophobic substrate binding pocket is identified as the likely determinant of substrate specificity. Upon introduction of a steric barrier, which is suspected to obstruct the accommodation of the aromatic ring in the hydrophobic pocket during the final hydroxylation step, the racemization of product is obtained. A steady state kinetic analysis reveals that the turnover number of Hms strongly correlates with substrate hydrophobicity. The analysis of product spectra demonstrates high regioselectivity of oxygenation and a strong coupling efficiency of C-C bond cleavage and subsequent hydroxylation for the tested substrates. Based on these findings the structural basis of enantioselectivity and enzymatic activity is discussed.	[Di Giuro, Cristiana M. L.; Konstantinovics, Cornelia; Straganz, Grit D.] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Rinner, Uwe; Nowikow, Christina] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria; [Leitner, Erich] Graz Univ Technol, Inst Analyt Chem & Food Chem, A-8010 Graz, Austria	Graz University of Technology; University of Vienna; Graz University of Technology	Straganz, GD (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria.	grit.straganz@tugraz.at	Leitner, Erich/AAG-8826-2021	Rinner, Uwe/0000-0002-7067-9990; Leitner, Erich/0000-0003-2520-2111	Austrian Science Fund (FWF) [P18828]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been funded by the Austrian Science Fund (FWF) (http://www.fwf.ac.at); Project number: P18828; Project coordinator and principal investigator: Grit Straganz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, YASARA 12 11 20; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bassan A, 2003, CHEM-EUR J, V9, P4055, DOI 10.1002/chem.200304768; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Borowski T, 2004, BIOCHEMISTRY-US, V43, P12331, DOI 10.1021/bi049503y; Brkic H, 2012, J BIOL INORG CHEM, V17, P801, DOI 10.1007/s00775-012-0898-8; Brownlee J, 2008, BIOCHEMISTRY-US, V47, P2002, DOI 10.1021/bi701438r; Brownlee JM, 2010, BIOCHEMISTRY-US, V49, P7218, DOI 10.1021/bi1008112; Choroba OW, 2000, J AM CHEM SOC, V122, P5389, DOI 10.1021/ja000076v; Di Giuro CML, 2011, J INORG BIOCHEM, V105, P1204, DOI 10.1016/j.jinorgbio.2011.05.018; Diebold AR, 2011, J AM CHEM SOC, V133, P15979, DOI 10.1021/ja203005j; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Glueck SM, 2005, J ORG CHEM, V70, P4028, DOI 10.1021/jo050156n; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunsior M, 2004, BIOCHEMISTRY-US, V43, P663, DOI 10.1021/bi035762w; HA EH, 1995, INORG CHEM, V34, P2265, DOI 10.1021/ic00113a002; Hansch CLA, 1995, HYDROPHOBIC ELECT ST; He PQ, 2010, BIOCHEMISTRY-US, V49, P1998, DOI 10.1021/bi901674q; Hegg EL, 1999, BIOCHEMISTRY-US, V38, P16714, DOI 10.1021/bi991796l; Hofer H, 2004, J BIOTECHNOL, V107, P73, DOI 10.1016/j.jbiotec.2003.09.010; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; Hubbard BK, 2000, CHEM BIOL, V7, P931, DOI 10.1016/S1074-5521(00)00043-0; Johnson-Winters K, 2003, BIOCHEMISTRY-US, V42, P2072, DOI 10.1021/bi026499m; Kezic S, 2000, J CHROMATOGR B, V738, P39, DOI 10.1016/S0378-4347(99)00500-9; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Latifi R, 2009, CHEM-EUR J, V15, P6651, DOI 10.1002/chem.200900211; Lichtenecker RJ, 2008, THESIS U VIENNA; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mehn MP, 2003, J AM CHEM SOC, V125, P7828, DOI 10.1021/ja028867f; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; O'Hare HM, 2006, FEBS LETT, V580, P3445, DOI 10.1016/j.febslet.2006.05.018; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paine TK, 2005, INORG CHEM, V44, P474, DOI 10.1021/ic048427k; Raspail C, 2011, J BIOL CHEM, V286, P26061, DOI 10.1074/jbc.M111.227595; Roduner E, 2013, CHEMCATCHEM, V5, P82, DOI 10.1002/cctc.201200266; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Sandell E., 1950, COLORIMETRIC DETERMI; Shah DD, 2011, BIOCHEMISTRY-US, V50, P7694, DOI 10.1021/bi2009344; Straganz GD, 2005, BIOCATAL BIOTRANSFOR, V23, P261, DOI 10.1080/10242420500183543; Straganz GD, 2004, J AM CHEM SOC, V126, P12202, DOI 10.1021/ja0460918; Straganz GD, 2005, J AM CHEM SOC; Straganz GD, 2010, BIOCHEMISTRY-US, V49, P996, DOI 10.1021/bi901339n; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yang C, 2004, BIOCHEMISTRY-US, V43, P10414, DOI 10.1021/bi049323o	50	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e68932	10.1371/journal.pone.0068932	http://dx.doi.org/10.1371/journal.pone.0068932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935907	Green Published, Green Submitted, gold			2022-12-27	WOS:000325211000064
J	Promerova, M; Kralova, T; Bryjova, A; Albrecht, T; Bryja, J				Promerova, Marta; Kralova, Tereza; Bryjova, Anna; Albrecht, Tomas; Bryja, Josef			MHC Class IIB Exon 2 Polymorphism in the Grey Partridge (Perdix perdix) Is Shaped by Selection, Recombination and Gene Conversion	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I GENES; EXPRESSED CLASS-I; MATE CHOICE; RFP-Y; PASSERINE BIRD; B-GENES; CHICKEN; DIVERSITY; EVOLUTION	Among bird species, the most studied major histocompatibility complex (MHC) is the chicken MHC. Although the number of studies on MHC in free-ranging species is increasing, the knowledge on MHC variation in species closely related to chicken is required to understand the peculiarities of bird MHC evolution. Here we describe the variation of MHC class IIB (MHCIIB) exon 2 in a population of the Grey partridge (Perdix perdix), a species of high conservation concern throughout Europe and an emerging galliform model in studies of sexual selection. We found 12 alleles in 108 individuals, but in comparison to other birds surprisingly many sites show signatures of historical positive selection. Individuals displayed between two to four alleles both on genomic and complementary DNA, suggesting the presence of two functional MHCIIB loci. Recombination and gene conversion appear to be involved in generating MHCIIB diversity in the Grey partridge; two recombination breakpoints and several gene conversion events were detected. In phylogenetic analysis of galliform MHCIIB, the Grey partridge alleles do not cluster together, but are scattered through the tree instead. Thus, our results indicate that the Grey partridge MHCIIB is comparable to most other galliforms in terms of copy number and population polymorphism.	[Promerova, Marta; Kralova, Tereza; Bryjova, Anna; Albrecht, Tomas; Bryja, Josef] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Promerova, Marta] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Kralova, Tereza; Bryja, Josef] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic; [Albrecht, Tomas] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Uppsala University; Masaryk University Brno; Charles University Prague	Bryja, J (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic.	bryja@brno.cas.cz	Bryja, Josef/C-3013-2008; Albrecht, Tomas/A-1130-2011	Bryja, Josef/0000-0003-0516-7742; Kauzalova, Tereza/0000-0003-1247-2497; Albrecht, Tomas/0000-0002-9213-0034	Czech Science Foundation [206/08/1281];  [RVO:68081766]	Czech Science Foundation(Grant Agency of the Czech Republic); 	The study was supported by the Czech Science Foundation, project no. 206/08/1281 and with institutional support RVO:68081766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanassieff M, 2001, J IMMUNOL, V166, P3324, DOI 10.4049/jimmunol.166.5.3324; Agbali M, 2010, EVOLUTION, V64, P1683, DOI 10.1111/j.1558-5646.2010.00961.x; Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; Anmarkrud JA, 2010, J EVOLUTION BIOL, V23, P1206, DOI 10.1111/j.1420-9101.2010.01999.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Baratti M, 2010, GENETICA, V138, P657, DOI 10.1007/s10709-010-9440-5; BEANI L, 1995, ANIM BEHAV, V49, P347, DOI 10.1006/anbe.1995.0047; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Borg AA, 2011, ECOL EVOL, V1, P145, DOI 10.1002/ece3.13; Bos DH, 2009, MOL ECOL, V18, P3307, DOI 10.1111/j.1365-294X.2009.04242.x; BRILES WE, 1993, IMMUNOGENETICS, V37, P408, DOI 10.1007/BF00222464; Brouwer L, 2010, MOL ECOL, V19, P3444, DOI 10.1111/j.1365-294X.2010.04750.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bryja J, 2005, MOL ECOL NOTES, V5, P173, DOI 10.1111/j.1471-8286.2004.00855.x; Burri R, 2008, IMMUNOGENETICS, V60, P543, DOI 10.1007/s00251-008-0308-0; Burri R, 2010, MOL BIOL EVOL, V27, P2360, DOI 10.1093/molbev/msq120; Chaves LD, 2010, IMMUNOGENETICS, V62, P465, DOI 10.1007/s00251-010-0451-2; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Cizkova D, 2011, HEREDITY, V106, P727, DOI 10.1038/hdy.2010.112; de Bellocq JG, 2009, IMMUNOGENETICS, V61, P131, DOI 10.1007/s00251-008-0349-4; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; EBCC, 2012, PAN EUROPEAN COMMON; Eimes JA, 2010, GENETICA, V138, P265, DOI 10.1007/s10709-009-9417-4; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Ekblom R, 2003, IMMUNOGENETICS, V54, P734, DOI 10.1007/s00251-002-0503-3; Ekblom R, 2004, MOL ECOL, V13, P3821, DOI 10.1111/j.1365-294X.2004.02361.x; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Griggio M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-44; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hale ML, 2009, J EVOLUTION BIOL, V22, P1284, DOI 10.1111/j.1420-9101.2009.01746.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hess CM, 2000, GENOME RES, V10, P613, DOI 10.1101/gr.10.5.613; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Hunt HD, 2006, IMMUNOGENETICS, V58, P297, DOI 10.1007/s00251-005-0074-1; Hunt HD, 1998, IMMUNOGENETICS, V47, P456, DOI 10.1007/s002510050383; Janeway C., 2004, IMMUNOBIOLOGY; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Klein J, 1986, NATURAL HISTORY OF T; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lambourne MD, 2005, ANIM GENET, V36, P445, DOI 10.1111/j.1365-2052.2005.01332.x; Miller HC, 2011, IMMUNOGENETICS, V63, P223, DOI 10.1007/s00251-010-0503-7; Miller HC, 2009, P ROY SOC B-BIOL SCI, V276, P1695, DOI 10.1098/rspb.2008.1840; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; Miller MM, 1996, P NATL ACAD SCI USA, V93, P3958, DOI 10.1073/pnas.93.9.3958; NEI M, 1986, MOL BIOL EVOL, V3, P418; OHTA T, 1995, J MOL EVOL, V41, P115, DOI 10.1007/BF00170662; OHTA T, 1991, P NATL ACAD SCI USA, V88, P6716, DOI 10.1073/pnas.88.15.6716; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Cutrera AP, 2012, ANIM BEHAV, V83, P847, DOI 10.1016/j.anbehav.2012.01.006; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Promerova M, 2009, IMMUNOGENETICS, V61, P451, DOI 10.1007/s00251-009-0375-x; Promerova M, 2012, MOL ECOL RESOUR, V12, P285, DOI 10.1111/j.1755-0998.2011.03082.x; Promerova M, 2011, J AVIAN BIOL, V42, P5, DOI 10.1111/j.1600-048X.2010.05221.x; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026; Reed KM, 2011, IMMUNOGENETICS, V63, P753, DOI 10.1007/s00251-011-0549-1; Ricanova S, 2011, CONSERV GENET, V12, P1115, DOI 10.1007/s10592-011-0213-1; Richardson DS, 2005, P ROY SOC B-BIOL SCI, V272, P759, DOI 10.1098/rspb.2004.3028; Rogers S, 2003, IMMUNOGENETICS, V55, P100, DOI 10.1007/s00251-003-0553-1; Sawyer S, 1999, GENECONV A COMPUTER; Schwensow N, 2008, EVOL ECOL, V22, P617, DOI 10.1007/s10682-007-9186-4; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Sepil I, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-68; Setchell JM, 2011, P ROY SOC B-BIOL SCI, V278, P274, DOI 10.1098/rspb.2010.0571; Shaw I, 2007, J IMMUNOL, V178, P5744, DOI 10.4049/jimmunol.178.9.5744; Shen YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-132; Shiina T, 2006, ANIM SCI J, V77, P151, DOI 10.1111/j.1740-0929.2006.00333.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Singh SK, 2010, INT J GENET MOL BIOL, V2, P048; Spurgin LG, 2011, MOL ECOL, V20, P5213, DOI 10.1111/j.1365-294X.2011.05367.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Strand T, 2007, IMMUNOGENETICS, V59, P725, DOI 10.1007/s00251-007-0234-6; Strandh M, 2011, IMMUNOGENETICS, V63, P653, DOI 10.1007/s00251-011-0534-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Von Schantz T, 1997, HEREDITAS, V127, P133, DOI 10.1111/j.1601-5223.1997.t01-1-00133.x; vonSchantz T, 1996, P ROY SOC B-BIOL SCI, V263, P265, DOI 10.1098/rspb.1996.0041; Westerdahl H, 1999, IMMUNOGENETICS, V49, P158, DOI 10.1007/s002510050477; Westerdahl H, 2000, IMMUNOGENETICS, V52, P92, DOI 10.1007/s002510000256; Wittzell H, 1999, MOL BIOL EVOL, V16, P479, DOI 10.1093/oxfordjournals.molbev.a026130; WITTZELL H, 1995, IMMUNOGENETICS, V42, P68, DOI 10.1007/BF00164990; Worley K, 2008, IMMUNOGENETICS, V60, P233, DOI 10.1007/s00251-008-0288-0; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; ZOOROB R, 1990, IMMUNOGENETICS, V31, P179, DOI 10.1007/BF00211553; ZOOROB R, 1993, EUR J IMMUNOL, V23, P1139, DOI 10.1002/eji.1830230524	96	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69135	10.1371/journal.pone.0069135	http://dx.doi.org/10.1371/journal.pone.0069135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935938	gold, Green Published, Green Submitted			2022-12-27	WOS:000325211000080
J	Bertram, SM; Harrison, SJ; Thomson, IR; Fitzsimmons, LP				Bertram, Susan M.; Harrison, Sarah J.; Thomson, Ian R.; Fitzsimmons, Lauren P.			Adaptive Plasticity in Wild Field Cricket's Acoustic Signaling	PLOS ONE			English	Article							CALLING-SONG RECOGNITION; PHENOTYPIC PLASTICITY; GRYLLUS-BIMACULATUS; SEXUAL SELECTION; FEMALE CHOICE; SOUND PRODUCTION; BODY-SIZE; SEARCHING BEHAVIOR; SPECIES ORTHOPTERA; AUDITORY-BEHAVIOR	Phenotypic plasticity can be adaptive when phenotypes are closely matched to changes in the environment. In crickets, rhythmic fluctuations in the biotic and abiotic environment regularly result in diel rhythms in density of sexually active individuals. Given that density strongly influences the intensity of sexual selection, we asked whether crickets exhibit plasticity in signaling behavior that aligns with these rhythmic fluctuations in the socio-sexual environment. We quantified the acoustic mate signaling behavior of wild-caught males of two cricket species, Gryllus veletis and G. pennsylvanicus. Crickets exhibited phenotypically plastic mate signaling behavior, with most males signaling more often and more attractively during the times of day when mating activity is highest in the wild. Most male G. pennsylvanicus chirped more often and louder, with shorter interpulse durations, pulse periods, chirp durations, and interchirp durations, and at slightly higher carrier frequencies during the time of the day that mating activity is highest in the wild. Similarly, most male G. veletis chirped more often, with more pulses per chirp, longer interpulse durations, pulse periods, and chirp durations, shorter interchirp durations, and at lower carrier frequencies during the time of peak mating activity in the wild. Among-male variation in signaling plasticity was high, with some males signaling in an apparently maladaptive manner. Body size explained some of the among-male variation in G. pennsylvanicus plasticity but not G. veletis plasticity. Overall, our findings suggest that crickets exhibit phenotypically plastic mate attraction signals that closely match the fluctuating socio-sexual context they experience.	[Bertram, Susan M.; Harrison, Sarah J.; Thomson, Ian R.; Fitzsimmons, Lauren P.] Carleton Univ Ottawa, Dept Biol, Toronto, ON, Canada		Bertram, SM (corresponding author), Carleton Univ Ottawa, Dept Biol, Toronto, ON, Canada.	Sue.Bertram@carleton.ca	Fitzsimmons, Lauren P/H-5530-2012	Munshi-South, Jason/0000-0002-8067-4341	Natural Science and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarship (OGS); NSERC; Philanthropic Education Organization (PEO); Canadian Foundation for Innovation (CFI); Ontario Research Fund (ORF); Carleton University (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Philanthropic Education Organization (PEO); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF); Carleton University (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by a Natural Science and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship to LPF, an Ontario Graduate Scholarship (OGS) to SJF, an NSERC Undergraduate Research Scholarships to IRT and SJH, and a Philanthropic Education Organization (PEO) Scholar Award to LPF. SMB received funding support from an NSERC Discovery Grant, the Canadian Foundation for Innovation (CFI), the Ontario Research Fund (ORF), and Carleton University (NSERC: http://www.nserc-crsng.gc.ca/, OGS: https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/TCONT003465.html, PEO: http://www.peointernational.org/, CFI: http://www.innovation.ca/, ORF: http://www.mri.gov.on.ca/english/programs/ResearchFund.asp, Carleton: http://www.carleton.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; BAILEY WJ, 1993, J EXP BIOL, V178, P21; Benjamini Y, 2001, ANN STAT, V29, P1165; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; Bertram SM, 2004, ETHOLOGY, V110, P963, DOI 10.1111/j.1439-0310.2004.01031.x; Bertram SM, 2013, PEERJ IN PRESS  0529; Bertram SM, 2012, ECOL EVOL, V2, P181, DOI 10.1002/ece3.76; BIGELOW R. S., 1960, CANADIAN JOUR ZOOL, V38, P509, DOI 10.1139/z60-055; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Buzatto BA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-118; CADE WH, 1992, ANIM BEHAV, V43, P49, DOI 10.1016/S0003-3472(05)80070-3; Crnokrak P, 1995, ANIM BEHAV, V50, P1475, DOI 10.1016/0003-3472(95)80004-2; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; del Castillo RC, 2005, GENET MOL BIOL, V28, P843, DOI 10.1590/S1415-47572005000500030; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Doherty J, 1983, VERH DTSCH ZOOL GES, V188, P188; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Fitzsimmons LP, 2011, BEHAVIOUR, V148, P1045, DOI 10.1163/000579511X588812; FRENCH BW, 1987, BEHAV ECOL SOCIOBIOL, V21, P157, DOI 10.1007/BF00303205; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Garland T, 2006, J EXP BIOL, V209, P2344, DOI 10.1242/jeb.02244; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Ghalambor Cameron K., 2010, P90; GOULD SJ, 1975, CONTRIB PRIMATOL, V5, P244; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Gray DA, 2001, ANIM BEHAV, V62, P871, DOI 10.1006/anbe.2001.1825; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; HEDRICK AV, 1986, BEHAV ECOL SOCIOBIOL, V19, P73, DOI 10.1007/BF00303845; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; Helm B, 2006, ANIM BEHAV, V72, P245, DOI 10.1016/j.anbehav.2005.12.007; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hoback WW, 1997, PHYSIOL ENTOMOL, V22, P286, DOI 10.1111/j.1365-3032.1997.tb01170.x; Holzer B, 2003, BEHAV ECOL, V14, P353, DOI 10.1093/beheco/14.3.353; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jacot A, 2008, P ROY SOC B-BIOL SCI, V275, P579, DOI 10.1098/rspb.2007.1500; Jeffery J, 2005, J EXP ZOOL PART A, V303A, P377, DOI 10.1002/jez.a.176; Judge KA, 2008, EVOLUTION, V62, P868, DOI 10.1111/j.1558-5646.2008.00318.x; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Judge KA, 2010, CAN J ZOOL, V88, P219, DOI 10.1139/Z09-139; Kasumovic MM, 2011, Q REV BIOL, V86, P181, DOI 10.1086/661119; KAVANAGH MW, 1987, J EXP BIOL, V130, P107; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Komers PE, 1997, CAN J ZOOL, V75, P161, DOI 10.1139/z97-023; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; LEVINS RICHARD, 1968; Lyons C, 2006, ANIM BEHAV, V72, P673, DOI 10.1016/j.anbehav.2005.12.006; Martin SD, 2000, CAN J ZOOL, V78, P706, DOI 10.1139/cjz-78-5-706; Millar NP, 2006, OIKOS, V113, P1; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; MOUSSEAU TA, 1989, EVOLUTION, V43, P1483, DOI 10.1111/j.1558-5646.1989.tb02598.x; NUR N, 1984, J THEOR BIOL, V110, P275, DOI 10.1016/S0022-5193(84)80059-4; PFAU HK, 1994, J EXP BIOL, V195, P147; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Popov A, 1977, J COMP PHYSIOL A, V126, P111; POPOV A V, 1974, Journal of Evolutionary Biochemistry and Physiology, V10, P61; Prestwich KN, 2007, PHYSIOL BIOCHEM ZOOL, V80, P157, DOI 10.1086/509238; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Prestwich KN, 2005, J EXP BIOL, V208, P1495, DOI 10.1242/jeb.01550; PRESTWICH KN, 1981, J COMP PHYSIOL, V143, P199; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Rebar D, 2011, BEHAV ECOL, V22, P303, DOI 10.1093/beheco/arq195; Roth T, 2009, P ROY SOC B-BIOL SCI, V276, P2045, DOI 10.1098/rspb.2008.1726; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P313, DOI 10.1007/BF00299969; Snell-Rood EC, 2012, INTEGR COMP BIOL, V52, P31, DOI 10.1093/icb/ics067; Stout J, 2010, PHYSIOL ENTOMOL, V35, P99, DOI 10.1111/j.1365-3032.2009.00713.x; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; Wagner WE, 1996, BEHAV ECOL, V7, P279, DOI 10.1093/beheco/7.3.279; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; WALKER THOMAS J., 1962, ANN ENTOMOL SOC AMER, V55, P303; WALKER THOMAS J., 1957, ANN ENT SOC AMER, V50, P626; WALKER TJ, 1975, J COMP PHYSIOL, V101, P57, DOI 10.1007/BF00660119; WALKER TJ, 1962, EVOLUTION, V16, P407, DOI 10.2307/2406176; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whattam EM, 2011, ANIM BEHAV, V81, P135, DOI 10.1016/j.anbehav.2010.09.024; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	97	70	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2013	8	7							e69247	10.1371/journal.pone.0069247	http://dx.doi.org/10.1371/journal.pone.0069247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228SX	23935965	Green Published, gold, Green Submitted			2022-12-27	WOS:000325211000094
J	Chung, Y; Fu, E				Chung, Yi; Fu, Earl			Crosstalk between Shh and TGF-beta Signaling in Cyclosporine-Enhanced Cell Proliferation in Human Gingival Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SONIC HEDGEHOG; TRANSFORMING GROWTH-FACTOR-BETA-1; PROSTATE-CANCER; UP-REGULATION; IN-VITRO; EXPRESSION; ACTIVATION; INDUCTION; PATHWAY	Background: Immunosuppressant cyclosporine-A induces gingival hyperplasia, which is characterized by increased fibroblast proliferation and overproduction of extracellular matrix components and regulated by transforming growth factor-beta (TGF-beta). The TGF-beta and Sonic hedgehog (Shh) pathways both mediate cell proliferation. Crosstalk between these pathways in cancer has recently been proposed, but the hierarchical pattern of this crosstalk remains unclear. In normal fibroblasts, a TGF-beta-stimulating Shh pattern was observed in induced fibrosis. However, Shh pathway involvement in cyclosporine-enhanced gingival proliferation and the existence of crosstalk with the TGF-beta pathway remain unclear. Methodology/Principal Findings: Cyclosporine enhanced mRNA and protein levels of TGF-beta and Shh in human gingival fibroblasts (RT-PCR and western blotting). A TGF-beta pathway inhibitor mitigated cyclosporine-enhanced cell proliferation and an Shh pathway inhibitor attenuated cyclosporine-enhanced proliferation in fibroblasts (MTS assay and/or RT-PCR of PCNA). Exogenous TGF-beta increased Shh expression; however, exogenous Shh did not alter TGF-beta expression. The TGF-beta pathway inhibitor mitigated cyclosporine-upregulated Shh expression, but the Shh pathway inhibitor did not alter cyclosporineupregulated TGF-beta expression. Conclusions/Significance: The TGF-beta and Shh pathways mediate cyclosporine-enhanced gingival fibroblast proliferation. Exogenous TGF-beta increased Shh expression, and inhibition of TGF-beta signaling abrogated the cyclosporine-induced upregulation of Shh expression; however, TGF-beta expression appeared unchanged by enhanced or inhibited Shh signaling. This is the first study demonstrating the role of Shh in cyclosporine-enhanced gingival cell proliferation; moreover, it defines a hierarchical crosstalk pattern in which TGF-beta regulates Shh in gingival fibroblasts. Understanding the regulation of cyclosporine-related Shh and TGF-beta signaling and crosstalk in gingival overgrowth will clarify the mechanism of cyclosporine-induced gingival enlargement and help develop targeted therapeutics for blocking these pathways, which can be applied in pre-clinical and clinical settings.	[Chung, Yi; Fu, Earl] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Natl Def Med Ctr, Dept Periodontol, Sch Dent, Taipei, Taiwan; [Chung, Yi; Fu, Earl] Tri Serv Gen Hosp, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Fu, E (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	dentalab@tpts5.seed.net.tw	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	Tri-Service General Hospital [TSGH-C98-29]; National Science Council [NSC-100-2314-B-016-022-MY3]; C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	Tri-Service General Hospital; National Science Council(Ministry of Science and Technology, Taiwan); C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by research grants from Tri-Service General Hospital (TSGH-C98-29), National Science Council (NSC-100-2314-B-016-022-MY3), and C.Y. Foundation for Advancement of Education, Sciences, and Medicine, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 1998, J CLIN PERIODONTOL, V25, P48, DOI 10.1111/j.1600-051X.1998.tb02363.x; BARTOLD PM, 1989, J PERIODONTAL RES, V24, P314, DOI 10.1111/j.1600-0765.1989.tb00876.x; Buduneli N, 2001, J PERIODONTOL, V72, P526, DOI 10.1902/jop.2001.72.4.526; Chae HJ, 2006, J DENT RES, V85, P515, DOI 10.1177/154405910608500607; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chen YT, 2005, J PERIODONTOL, V76, P2267, DOI 10.1902/jop.2005.76.12.2267; Chiang CY, 2007, J PERIODONTAL RES, V42, P443, DOI 10.1111/j.1600-0765.2006.00967.x; Chiang CY, 2011, J PERIODONTAL RES, V46, P158, DOI 10.1111/j.1600-0765.2010.01312.x; Chiu HC, 2009, J PERIODONTAL RES, V44, P338, DOI 10.1111/j.1600-0765.2008.01126.x; Cotrim P, 2003, J PERIODONTOL, V74, P1625, DOI 10.1902/jop.2003.74.11.1625; Cotrim P, 2002, J PERIODONTOL, V73, P1313, DOI 10.1902/jop.2002.73.11.1313; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KHANNA A, 1994, BIOCHEM BIOPH RES CO, V204, P1061, DOI 10.1006/bbrc.1994.2570; KHANNA A, 1994, TRANSPLANTATION, V57, P577; Kiefer JC, 2010, DEV DYNAM, V239, P1255, DOI 10.1002/dvdy.22278; King PJ, 2008, J ENDOCRINOL, V198, P439, DOI 10.1677/JOE-08-0161; Kuo PJ, 2012, J PERIODONTAL RES, V47, P431, DOI 10.1111/j.1600-0765.2011.01450.x; Lal BK, 2003, J VASC SURG, V37, P1285, DOI 10.1016/S0741-5214(02)75295-6; Lin YT, 2010, J PERIODONTOL, V81, P1250, DOI 10.1902/jop.2010.090743; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; SCHINCAGLIA GP, 1992, J ORAL PATHOL MED, V21, P181, DOI 10.1111/j.1600-0714.1992.tb00098.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TIPTON DA, 1990, J CELL BIOCHEM, V44, P253, DOI 10.1002/jcb.240440407; TIPTON DA, 1991, J CELL BIOCHEM, V46, P152, DOI 10.1002/jcb.240460209; Tu HP, 2006, J PERIODONTOL, V77, P832, DOI 10.1902/jop.2006.050316; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yoshida T, 2005, J PERIODONTAL RES, V40, P11, DOI 10.1111/j.1600-0765.2004.00762.x; ZEBROWSKI EJ, 1994, J PERIODONTOL, V65, P565, DOI 10.1902/jop.1994.65.6.565	45	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70128	10.1371/journal.pone.0070128	http://dx.doi.org/10.1371/journal.pone.0070128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922933	gold, Green Published, Green Submitted			2022-12-27	WOS:000322838900150
J	Chung, YT; Zhang, N; Wooten, RM				Chung, Yutein; Zhang, Nan; Wooten, R. Mark			Borrelia burgdorferi Elicited-IL-10 Suppresses the Production of Inflammatory Mediators, Phagocytosis, and Expression of Co-Stimulatory Receptors by Murine Macrophages and/or Dendritic Cells	PLOS ONE			English	Article							OUTER SURFACE LIPOPROTEINS; HOST-PATHOGEN INTERACTIONS; LYME-DISEASE SPIROCHETE; TOLL-LIKE RECEPTOR-2; FACTOR-KAPPA-B; GENE-EXPRESSION; INTERLEUKIN-10 PRODUCTION; ARTHRITIS DEVELOPMENT; INNATE; MICE	Borrelia burgdorferi (Bb) is a tick-borne spirochete that is the causative agent for Lyme disease. Our previous studies indicate that virulent Bb can potently enhance IL-10 production by macrophages (MOs) and that blocking IL-10 production significantly enhances bacterial clearance. We hypothesize that skin-associated APC types, such as MOs and dendritic cells (DCs) are potent producers of IL-10 in response to Bb, which may act in autocrine fashion to suppress APC responses critical for efficient Bb clearance. Our goal is to delineate which APC immune functions are dysregulated by Bb-elicited IL-10 using a murine model of Lyme disease. Our in vitro studies indicated that both APCs rapidly produce IL-10 upon exposure to Bb, that these levels inversely correlate with the production of many Lyme-relevant proinflammatory cytokines and chemokines, and that APCs derived from IL-10(-/-) mice produced greater amounts of these proinflammatory mediators than wild-type APCs. Phagocytosis assays determined that Bb-elicited IL-10 levels can diminish Bb uptake and trafficking by MOs, suppresses ROS production, but does not affect NO production; Bb-elicited IL-10 had little effect on phagocytosis, ROS, and NO production by DCs. In general, Bb exposure caused little-to-no upregulation of several critical surface co-stimulatory markers by MOs and DCs, however eliminating Bb-elicited IL-10 allowed a significant upregulation in many of these co-stimulatory receptors. These data indicate that IL-10 elicited from Bb-stimulated MOs and DCs results in decreased production of proinflammatory mediators and co-stimulatory molecules, and suppress phagocytosis-associated events that are important for mediating both innate and adaptive immune responses by APCs.	[Chung, Yutein; Zhang, Nan; Wooten, R. Mark] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Wooten, RM (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	r.mark.wooten@utoledo.edu	Wooten, Ronald Mark/AAO-4263-2020	Fu, Earl/0000-0003-0637-0208; Chung, Yi/0000-0001-7733-6459	NIH [R01 AI073452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding for this study was NIH grant R01 AI073452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barthold S. W., 1996, Journal of Spirochetal and Tick-borne Diseases, V3, P22; Barthold SW, 1996, LAB INVEST, V74, P57; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Behera AK, 2006, INFECT IMMUN, V74, P1462, DOI 10.1128/IAI.74.3.1462-1470.2006; BENACH JL, 1984, YALE J BIOL MED, V57, P599; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bouis DA, 2001, INFECT IMMUN, V69, P518, DOI 10.1128/IAI.69.1.518-528.2001; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Boylan Julie A., 2008, V431, P213; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown JP, 1999, INFECT IMMUN, V67, P5142, DOI 10.1128/IAI.67.10.5142-5150.1999; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Cortez-Retamozo V, 2012, J INNATE IMMUN, V4, P411, DOI 10.1159/000335733; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; DING AH, 1988, J IMMUNOL, V141, P2407; Ebnet K, 1997, J IMMUNOL, V158, P3285; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gautam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043860; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giambartolomei GH, 1998, INFECT IMMUN, V66, P2691, DOI 10.1128/IAI.66.6.2691-2697.1998; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; HASTEY CJ, 2012, INFECT J IMMUNOL; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Iliopoulou BP, 2010, CURR OPIN RHEUMATOL, V22, P451, DOI 10.1097/BOR.0b013e328338f73f; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; MA Y, 1993, INFECT IMMUN, V61, P3843, DOI 10.1128/IAI.61.9.3843-3853.1993; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; Marietta EV, 1997, J IMMUNOL, V159, P2840; Matsushima H, 2009, BLOOD, V114, P64, DOI 10.1182/blood-2009-02-204297; Miller JC, 2006, MICROB PATHOGENESIS, V41, P43, DOI 10.1016/j.micpath.2006.04.004; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; MONTGOMERY RR, 1994, J INFECT DIS, V170, P890, DOI 10.1093/infdis/170.4.890; Montgomery RR, 1996, INFECT IMMUN, V64, P2867, DOI 10.1128/IAI.64.7.2867-2872.1996; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; Morrison TB, 1997, J IMMUNOL, V158, P4838; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Schulze RJ, 2006, MOL MICROBIOL, V59, P1473, DOI 10.1111/j.1365-2958.2006.05039.x; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SELLER KP, 1995, INFECT IMMUN, V63, P3886, DOI 10.1128/IAI.63.10.3886-3895.1995; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Shanafelt MC, 1998, INFECT IMMUN, V66, P266, DOI 10.1128/IAI.66.1.266-271.1998; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Singh SK, 2006, CLIN MICROBIOL INFEC, V12, P705, DOI 10.1111/j.1469-0691.2006.01440.x; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Weis J.J., 2010, BORRELIA MOL BIOL HO, P413; Weis JJ, 2002, CURR OPIN RHEUMATOL, V14, P399, DOI 10.1097/00002281-200207000-00011; Wooten RM, 1996, J IMMUNOL, V157, P4584; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wooten RM, 2001, CURR OPIN MICROBIOL, V4, P274, DOI 10.1016/S1369-5274(00)00202-2; Wooten RM, 1998, J IMMUNOL, V160, P5485; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109; Yoder A, 2003, INFECT IMMUN, V71, P3894, DOI 10.1128/IAI.71.7.3894-3900.2003	88	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2013	8	12							e84980	10.1371/journal.pone.0084980	http://dx.doi.org/10.1371/journal.pone.0084980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HY	23922933	Green Published, Green Submitted, gold			2022-12-27	WOS:000328741900074
J	Li, SG; Berliner, JC; Melton, DH; Li, S				Li, Shengai; Berliner, Jeffrey C.; Melton, Danielle H.; Li, Sheng			Modification of Electrical Pain Threshold by Voluntary Breathing-Controlled Electrical Stimulation (BreEStim) in Healthy Subjects	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; NERVE-STIMULATION; BRAIN ACTIVATION; INSULAR CORTEX; REPRESENTATION; VENTILATION; IMMEDIATE; RESPONSES	Background: Pain has a distinct sensory and affective (i.e., unpleasantness) component. BreEStim, during which electrical stimulation is delivered during voluntary breathing, has been shown to selectively reduce the affective component of post-amputation phantom pain. The objective was to examine whether BreEStim increases pain threshold such that subjects could have improved tolerance of sensation of painful stimuli. Methods: Eleven pain-free healthy subjects (7 males, 4 females) participated in the study. All subjects received BreEStim (100 stimuli) and conventional electrical stimulation (EStim, 100 stimuli) to two acupuncture points (Neiguan and Weiguan) of the dominant hand in a random order. The two different treatments were provided at least three days apart. Painful, but tolerable electrical stimuli were delivered randomly during EStim, but were triggered by effortful inhalation during BreEStim. Measurements of tactile sensation threshold, electrical sensation and electrical pain thresholds, thermal (cold sensation, warm sensation, cold pain and heat pain) thresholds were recorded from the thenar eminence of both hands. These measurements were taken pre-intervention and 10-min post-intervention. Results: There was no difference in the pre-intervention baseline measurement of all thresholds between BreEStim and EStim. The electrical pain threshold significantly increased after BreEStim (27.5 +/- 6.7% for the dominant hand and 28.5 +/- 10.8% for the non-dominant hand, respectively). The electrical pain threshold significantly decreased after EStim (9.1 +/- 2.8% for the dominant hand and 10.2 +/- 4.6% for the non-dominant hand, respectively) (F-[1,F-10] = 30.992, p =.00024). There was no statistically significant change in other thresholds after BreEStim and EStim. The intensity of electrical stimuli was progressively increased, but no difference was found between BreEStim and EStim. Conclusion: Voluntary breathing controlled electrical stimulation selectively increases electrical pain threshold, while conventional electrical stimulation selectively decreases electrical pain threshold. This may translate into improved pain control.	[Li, Shengai; Berliner, Jeffrey C.; Melton, Danielle H.; Li, Sheng] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Shengai; Berliner, Jeffrey C.; Melton, Danielle H.; Li, Sheng] Mem Hermann Hosp, Inst Rehabil & Res TIRR, UTHlth Neurorehabil Res Lab TIRR, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021	He, Kai/0000-0002-6234-2589	NIH under Rehabilitation Institute of Chicago [NIH/NINDS R01NS060774, NIH/NICHD/NCMRR R24 HD050821-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060774] Funding Source: NIH RePORTER	NIH under Rehabilitation Institute of Chicago; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by NIH grants (NIH/NINDS R01NS060774; NIH/NICHD/NCMRR R24 HD050821-08 under subcontract with Rehabilitation Institute of Chicago). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN ACN, 1989, PAIN, V37, P143, DOI 10.1016/0304-3959(89)90126-7; COLEBATCH JG, 1991, J PHYSIOL-LONDON, V443, P91, DOI 10.1113/jphysiol.1991.sp018824; Deadman P., 2007, J CHINESE MED PUBLIC; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Evans KC, 1999, J PHYSIOL-LONDON, V520, P383, DOI 10.1111/j.1469-7793.1999.00383.x; Fink GR, 1995, J PHYSIOL-LONDON, V489, P663, DOI 10.1113/jphysiol.1995.sp021081; Gaytan SP, 1998, BRAIN RES BULL, V47, P625, DOI 10.1016/S0361-9230(98)00125-7; Guz A, 1997, RESP PHYSIOL, V109, P197, DOI 10.1016/S0034-5687(97)00050-9; Hanamori T, 1998, BRAIN RES, V785, P97, DOI 10.1016/S0006-8993(97)01392-9; Haouzi P, 2006, RESP PHYSIOL NEUROBI, V152, P169, DOI 10.1016/j.resp.2005.08.004; Hardy Paul A. J., 1993, Pain Clinic, V6, P233; Hay JL, 2009, J PAIN, V10, P316, DOI 10.1016/j.jpain.2008.10.003; Ikeda ER, 2009, J STRENGTH COND RES, V23, P127, DOI 10.1519/JSC.0b013e31818eb256; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; LaBuda CJ, 2005, NEUROSCIENCE, V136, P311, DOI 10.1016/j.neuroscience.2005.07.010; LaGraize SC, 2006, EXP NEUROL, V197, P22, DOI 10.1016/j.expneurol.2005.05.008; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Li S, 2006, MUSCLE NERVE, V34, P651, DOI 10.1002/mus.20592; Li S, 2013, JOVE-J VIS EXP, DOI 10.3791/50077; Li S, 2012, MOTOR CONTROL, V16, P493, DOI 10.1123/mcj.16.4.493; Li Sheng, 2012, J Pain Res, V5, P71, DOI 10.2147/JPR.S31036; Li S, 2011, J NEUROPHYSIOL, V105, P512, DOI 10.1152/jn.00946.2010; Macey KE, 2004, J APPL PHYSIOL, V97, P1897, DOI 10.1152/japplphysiol.00359.2004; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; MASKILL D, 1991, J PHYSIOL-LONDON, V443, P105, DOI 10.1113/jphysiol.1991.sp018825; Mazzone SB, 2007, AM J RESP CRIT CARE, V176, P327, DOI 10.1164/rccm.200612-1856OC; Moharic M, 2010, INT J REHABIL RES, V33, P211, DOI 10.1097/MRR.0b013e3283352151; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; RAMSAY SC, 1993, J PHYSIOL-LONDON, V461, P85, DOI 10.1113/jphysiol.1993.sp019503; Smejkal V, 1999, PHYSIOL RES, V48, P21; Smejkal V, 2000, PHYSIOL RES, V49, P659; Stehberg J, 2009, EUR J NEUROSCI, V29, P964, DOI 10.1111/j.1460-9568.2009.06634.x; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; Walk D, 2009, CLIN J PAIN, V25, P632, DOI 10.1097/AJP.0b013e3181a68c64	36	82	87	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70282	10.1371/journal.pone.0070282	http://dx.doi.org/10.1371/journal.pone.0070282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	23922995	Green Published, gold, Green Submitted			2022-12-27	WOS:000322167900114
J	Huang, ZB; Li, SZ; Song, W; Li, X; Li, QS; Zhang, ZY; Han, YQ; Zhang, XD; Miao, SY; Du, RL; Wang, LF				Huang, Zebin; Li, Shangze; Song, Wei; Li, Xin; Li, Qinshan; Zhang, Zeyan; Han, Yongqing; Zhang, Xiaodong; Miao, Shiying; Du, Runlei; Wang, Linfang			Lysine-Specific Demethylase 1 (LSD1/KDM1A) Contributes to Colorectal Tumorigenesis via Activation of the Wnt/B-Catenin Pathway by Down-Regulating Dickkopf-1 (DKK1)	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; COLON-CANCER CELLS; BREAST-CANCER; CARCINOMA CELLS; SOMATIC-CELLS; LSD1; METHYLATION; GENE; PROLIFERATION; TRANSCRIPTION	We collected paired samples of tumor and adjacent normal colorectal tissues from 22 patients with colorectal carcinoma to compare the differences in the expression of lysine specific demethylase 1 (LSD1) in these two tissues. The results showed that in 19 paired samples (86.4%), LSD1 is more highly expressed in tumor tissue than in normal tissue. To explore the role of LSD1 in colorectal tumorigenesis, we used somatic cell gene targeting to generate an LSD1 knockout (KO) HCT 116 human colorectal cancer cell line as a research model. The analysis of phenotypic changes showed that LSD1 KO colorectal cancer cells are less tumorigenic, both in vivo and in vitro. The differential expression analysis of the cells by mRNA sequencing (RNA-Seq) yielded 2,663 differentially expressed genes, and 28 of these genes had highly significant differences (Q<0.01). We then selected the 4 colorectal cancer-related genes ADM, DKK1, HAS3 and SMURF2 for quantitative real-time PCR verification. The results showed that the differences in the expression of ADM, DKK1 and HAS3 were consistent with those measured using the RNA-Seq data. As DKK1 was the gene with the most significant differential expression, we analyzed the key proteins of the DKK1-related Wnt/beta-catenin signaling pathway and found that, after knocking out LSD1, the amount of free beta-catenin translocated to the nucleus was significantly reduced and that the transcription of the signaling pathway target gene c-Myc was down-regulated. Our studies show that LSD1 activates the Wnt/beta-catenin signaling pathway by down-regulating the pathway antagonist DKK1, which may be one of the mechanisms leading to colorectal tumorigenesis.	[Huang, Zebin; Song, Wei; Li, Qinshan; Han, Yongqing; Miao, Shiying; Wang, Linfang] Chinese Acad Med Sci, Tsinghua Univ, Peking Union Med Coll,Natl Lab Med Mol Biol, Dept Biochem & Mol Biol,Inst Basic Med Sci, Beijing 100084, Peoples R China; [Li, Shangze; Li, Xin; Zhang, Zeyan; Zhang, Xiaodong; Du, Runlei] Wuhan Univ, Coll Life Sci, Dept Cellular & Dev Biol, Wuhan 430072, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Wuhan University	Du, RL (corresponding author), Wuhan Univ, Coll Life Sci, Dept Cellular & Dev Biol, Wuhan 430072, Peoples R China.	runleidu@whu.edu.cn; wang.linfang@imicams.ac.cn	Zhang, Zeyan/GPT-3882-2022; Zhang, Ze-Yan/ABB-4948-2021; Li, Xin/L-2237-2019; li, shangze/AAW-6317-2021	Zhang, Zeyan/0000-0002-7896-3013; Li, Xin/0000-0002-3914-9377; 	National Basic Research Program of China [2011CB944302, 2011CB944404]; State Key Laboratory Special Fund [2060204]; National Natural Science Foundation of China [81270306, 30971499]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory Special Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (2011CB944302, 2011CB944404, http://www.973.gov.cn), the State Key Laboratory Special Fund (2060204, http://www.chinalab.gov.cn), and the National Natural Science Foundation of China (81270306, 30971499, http://www.nsfc.gov.cn). The experimental study was performed in compliance with the laws of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Chosed R, 2007, MOL CELL, V26, P160, DOI 10.1016/j.molcel.2007.04.009; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Dornhoff H, 2012, GASTROENTEROLOGY, V142, P1183, DOI 10.1053/j.gastro.2012.02.005; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Kauffman EC, 2011, MOL CARCINOGEN, V50, P931, DOI 10.1002/mc.20758; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kocemba KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030359; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li Y, 2012, ONCOGENE, V31, P5007, DOI 10.1038/onc.2012.8; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lv SA, 2010, EUR J CELL BIOL, V89, P557, DOI 10.1016/j.ejcb.2010.01.004; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Musri MM, 2010, J BIOL CHEM, V285, P30034, DOI 10.1074/jbc.M110.151209; Qi LS, 2012, CANCER SCI, V103, P828, DOI 10.1111/j.1349-7006.2012.02222.x; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Scoumanne A, 2007, J BIOL CHEM, V282, P15471, DOI 10.1074/jbc.M701023200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu CY, 2012, INT J CANCER, V131, P1423, DOI 10.1002/ijc.27343; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Zhang P, 2011, MOL CANCER RES, V9, P1418, DOI 10.1158/1541-7786.MCR-11-0147; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou HY, 2010, J BIOL CHEM, V285, P29676, DOI 10.1074/jbc.C110.150599; Zhou XL, 2010, ACTA PHARMACOL SIN, V31, P202, DOI 10.1038/aps.2009.200	58	55	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2013	8	7							e70077	10.1371/journal.pone.0070077	http://dx.doi.org/10.1371/journal.pone.0070077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197GU	23922913	Green Published, gold, Green Submitted			2022-12-27	WOS:000322838900143
J	Harris, SE; Munshi-South, J; Obergfell, C; O'Neill, R				Harris, Stephen E.; Munshi-South, Jason; Obergfell, Craig; O'Neill, Rachel			Signatures of Rapid Evolution in Urban and Rural Transcriptomes of White-Footed Mice (Peromyscus leucopus) in the New York Metropolitan Area	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; GENOME-WIDE SCANS; NEXT-GENERATION; POPULATION GENOMICS; POSITIVE SELECTION; AIR-POLLUTION; GENETIC DIFFERENTIATION; PARUS-MAJOR; SEQUENCE; URBANIZATION	Urbanization is a major cause of ecological degradation around the world, and human settlement in large cities is accelerating. New York City (NYC) is one of the oldest and most urbanized cities in North America, but still maintains 20% vegetation cover and substantial populations of some native wildlife. The white-footed mouse, Peromyscus leucopus, is a common resident of NYC's forest fragments and an emerging model system for examining the evolutionary consequences of urbanization. In this study, we developed transcriptomic resources for urban P. leucopus to examine evolutionary changes in protein-coding regions for an exemplar "urban adapter." We used Roche 454 GS FLX+ high throughput sequencing to derive transcriptomes from multiple tissues from individuals across both urban and rural populations. From these data, we identified 31,015 SNPs and several candidate genes potentially experiencing positive selection in urban populations of P. leucopus. These candidate genes are involved in xenobiotic metabolism, innate immune response, demethylation activity, and other important biological phenomena in novel urban environments. This study is one of the first to report candidate genes exhibiting signatures of directional selection in divergent urban ecosystems.	[Harris, Stephen E.] CUNY, Grad Ctr, Program Ecol Evolutionary Biol & Behav, New York, NY USA; [Munshi-South, Jason] Fordham Univ, Louis Calder Ctr, Armonk, NY USA; [Obergfell, Craig; O'Neill, Rachel] Univ Connecticut, Storrs, CT USA	City University of New York (CUNY) System; Fordham University; University of Connecticut	Munshi-South, J (corresponding author), Fordham Univ, Louis Calder Ctr, Armonk, NY USA.	jason@NYCevolution.org	Fitzsimmons, Lauren P/H-5530-2012	Munshi-South, Jason/0000-0002-8067-4341	National Science Foundation [DEB 0817259]; National Institute of General Medical Sciences/National Institutes of Health [1R15GM099055-01A1]; National Science Foundation Graduate Research Fellowship; Center for Applied Genetics and Technology at UCONN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM099055] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Center for Applied Genetics and Technology at UCONN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Science Foundation (DEB 0817259) and National Institute of General Medical Sciences/National Institutes of Health (1R15GM099055-01A1) to JMS, and a National Science Foundation Graduate Research Fellowship to SEH. The Center for Applied Genetics and Technology at UCONN provided funding for RO and CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; Baldo L, 2011, GENOME BIOL EVOL, V3, P443, DOI 10.1093/gbe/evr047; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barko VA, 2003, SOUTHEAST NAT, V2, P369, DOI 10.1656/1528-7092(2003)002[0369:UHADOW]2.0.CO;2; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Bjorklund M, 2010, BIOL J LINN SOC, V99, P9, DOI 10.1111/j.1095-8312.2009.01335.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLANKENBERG D, 2010, CURRENT PROTOC MOL B, V89, P42727; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Bonin A, 2008, MOL ECOL, V17, P3583, DOI 10.1111/j.1365-294X.2008.03854.x; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brady SP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00235; BUNTGE A, 2010, RACING SIGNATURES PO; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CHAPPLE R, 2012, DEV LIVER TRANSCRIPT; Cheptou PO, 2008, P NATL ACAD SCI USA, V105, P3796, DOI 10.1073/pnas.0708446105; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; CHRISTODOULOU DC, 2011, CURR PROTOC MOL BIOL, V4, P1, DOI DOI 10.1002/0471142727.MB0412S94.C0NSTRUCTI0N; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Degner JF, 2007, CONSERV GENET, V8, P1441, DOI 10.1007/s10592-007-9295-1; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ekblom Robert, 2012, Comparative and Functional Genomics, P281693, DOI 10.1155/2012/281693; EKERNAS LS, 2007, T LINNAEAN SOC NEW Y, V10, P239; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Fu CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-208; Glenn JLW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-300; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hoffman JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023283; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; LANKAU R, 2010, ANNU REV ECOL EVOL S, V42, P335, DOI DOI 10.1146/ANNUREV-EC0LSYS-102710-145100; Lankau RA, 2011, EVOL APPL, V4, P338, DOI 10.1111/j.1752-4571.2010.00173.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnen CR, 2009, COLD SH Q B, V74, P155, DOI 10.1101/sqb.2009.74.045; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; MacManes MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045524; Malik A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021227; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGuire KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058020; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; METZGAR LH, 1971, AM MIDL NAT, V86, P434, DOI 10.2307/2423635; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mlynarski EE, 2010, MAMM GENOME, V21, P77, DOI 10.1007/s00335-009-9242-1; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x; Munshi-South J, 2010, MOL ECOL, V19, P4242, DOI 10.1111/j.1365-294X.2010.04816.x; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nupp TE, 1996, CAN J ZOOL, V74, P467, DOI 10.1139/z96-054; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; ONEILL R, 1998, SEQUENCING GENOME PE, P14; Ozer F, 2011, MOL ECOL, V20, P3525, DOI 10.1111/j.1365-294X.2011.05165.x; Peluc SI, 2008, BEHAV ECOL, V19, P830, DOI 10.1093/beheco/arn033; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pontius J., 2003, NCBI HDB, P1; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Puth LM, 2009, DIVERS DISTRIB, V15, P12, DOI 10.1111/j.1472-4642.2008.00499.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Rice AM, 2011, ECOL LETT, V14, P9, DOI 10.1111/j.1461-0248.2010.01546.x; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Santure AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-283; Shaw TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048472; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Somers CM, 2009, HUM GENET, V125, P119, DOI 10.1007/s00439-008-0613-6; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P1, DOI 10.1644/06-MAMM-S-232R1.1; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Turner LM, 2008, GENETICS, V179, P2075, DOI 10.1534/genetics.107.085902; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; Ungvari Z, 2008, AGE, V30, P121, DOI 10.1007/s11357-008-9059-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vessey SH, 2007, INTEGR ZOOL, V2, P123, DOI 10.1111/j.1749-4877.2007.00053.x; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wandeler P, 2003, MOL ECOL, V12, P647, DOI 10.1046/j.1365-294X.2003.01768.x; Wang GM, 2009, POPUL ECOL, V51, P133, DOI 10.1007/s10144-008-0094-4; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Whitehead A, 2010, MOL ECOL, V19, P5186, DOI 10.1111/j.1365-294X.2010.04829.x; Wirgin I, 2011, SCIENCE, V331, P1322, DOI 10.1126/science.1197296; World Bank, 2015, LEVERAGING URBANIZAT; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang DS, 2009, MOL ECOL, V18, P5115, DOI 10.1111/j.1365-294X.2009.04399.x; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Zhai WW, 2012, MOL BIOL EVOL, V29, P2889, DOI 10.1093/molbev/mss104; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	134	70	69	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e74938	10.1371/journal.pone.0074938	http://dx.doi.org/10.1371/journal.pone.0074938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	23935965	Green Published, gold			2022-12-27	WOS:000323733800116
J	Singh, GP; Dash, D				Singh, Gajinder Pal; Dash, Debasis			Electrostatic Mis-Interactions Cause Overexpression Toxicity of Proteins in E-coli	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; SOLUBILITY; GENES; EVOLUTION; CORRELATE; DISORDER; FEATURES	A majority of E. coli proteins when overexpressed inhibit its growth, but the reasons behind overexpression toxicity of proteins remain unknown. Understanding the mechanism of overexpression toxicity is important from evolutionary, biotechnological and possibly clinical perspectives. Here we study sequence and functional features of cytosolic proteins of E. coli associated with overexpression toxicity to understand its mechanism. We find that number of positively charged residues is significantly higher in proteins showing overexpression toxicity. Very long proteins also show high overexpression toxicity. Among the functional classes, transcription factors and regulatory proteins are enriched in toxic proteins, while catalytic proteins are depleted. Overexpression toxicity could be predicted with reasonable accuracy using these few properties. The importance of charged residues in overexpression toxicity indicates that nonspecific electrostatic interactions resulting from protein overexpression cause toxicity of these proteins and suggests ways to improve the expression level of native and foreign proteins in E. coli for basic research and biotechnology. These results might also be applicable to other bacterial species.	[Singh, Gajinder Pal; Dash, Debasis] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Singh, GP (corresponding author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	gajinder.pal.singh@gmail.com	Singh, Gajinder/I-6062-2015; watson, stuart/B-8728-2009; Sundstrom, Johan/A-6286-2009; Gudnason, Vilmundur/K-6885-2015; Palmieri, Luigi/O-1845-2017; Benn, Marianne/O-4164-2019; Marmot, Michael/Y-3920-2019; Brenner, Hermann/B-4627-2017; Peltonen, Markku/F-3037-2015; Ferrieres, Jean/S-7993-2016; Davey Smith, George/A-7407-2013; Aspelund, Thor/C-5983-2008; Dash, Debasis/F-3137-2012; Stefanadis, Christodoulos/ABH-2232-2020; Tosetto, Alberto/AAM-3200-2020; Dankner, Rachel/Q-5245-2019; Schottker, Ben/F-8183-2014; donfrancesco, chiara/K-1460-2016	Singh, Gajinder/0000-0002-3972-3324; Whincup, Peter/0000-0002-5589-4107; De Stavola, Bianca Lucia/0000-0001-7853-0528; Nijpels, Giel/0000-0002-3679-9710; Woodward, Mark/0000-0001-9800-5296; Ikram, Mohammad Arfan/0000-0003-0372-8585; Lamarche, Benoit/0000-0002-4443-5378; watson, stuart/0000-0002-2558-3367; Gomez de la Camara, Agustin/0000-0001-6827-6319; Ali, Mohammed/0000-0001-7266-2503; Yamagishi, Kazumasa/0000-0003-3301-5519; Ramachandran, Vasan/0000-0001-7357-5970; Sundstrom, Johan/0000-0003-2247-8454; Gudnason, Vilmundur/0000-0001-5696-0084; Rothenbacher, Dietrich/0000-0002-3563-2791; Palmieri, Luigi/0000-0002-4298-2642; Brunner, Eric/0000-0002-0595-4474; Ulmer, Hanno/0000-0001-5911-1002; Benn, Marianne/0000-0002-1701-595X; Jespersen, Jorgen/0000-0002-3059-2356; Amouyel, Philippe/0000-0001-9088-234X; Couper, David/0000-0002-4313-9235; Marmot, Michael/0000-0002-2431-6419; Brenner, Hermann/0000-0002-6129-1572; Arnlov, Johan/0000-0002-6933-4637; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Peltonen, Markku/0000-0002-3767-4223; Koenig, Wolfgang/0000-0002-2064-9603; Zimmet, Paul/0000-0003-0627-0776; Ferrieres, Jean/0000-0001-6144-1297; Davey Smith, George/0000-0002-1407-8314; Lewington, Sarah/0000-0002-4496-4771; Aspelund, Thor/0000-0002-7998-5433; Unwin, Nigel/0000-0002-1368-1648; Dash, Debasis/0000-0002-5647-3785; Tverdal, Aage/0000-0002-2909-5678; Stefanadis, Christodoulos/0000-0001-5974-6454; Tosetto, Alberto/0000-0002-0119-5204; Franco, Oscar/0000-0002-4606-4929; Di Angelantonio, Emanuele/0000-0001-8776-6719; Soderberg, Stefan/0000-0001-9225-1306; Kirkland, Susan/0000-0002-8182-2369; Lindstrom, Jaana/0000-0001-9255-020X; Wood, Angela/0000-0002-7937-304X; Dankner, Rachel/0000-0001-6454-6000; Farzadfar, Farshad/0000-0001-8288-4046; Nordestgaard, Borge/0000-0002-1954-7220; Davidson, Karina/0000-0002-9162-477X; Cushman, Mary/0000-0002-7871-6143; Butterworth, Adam/0000-0002-6915-9015; Lochen, Maja-Lisa/0000-0002-8532-6573; Laatikainen, Tiina/0000-0002-6614-4782; Morris, Richard/0000-0001-7240-4563; Nietert, Paul/0000-0002-3933-4986; strandberg, timo/0000-0001-6299-925X; Schottker, Ben/0000-0002-1217-4521; Haines, Andy/0000-0002-8053-4605; Lennon, Lucy/0000-0002-1738-1351; Lawlor, Debbie A/0000-0002-6793-2262; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Jorgensen, Torben/0000-0001-9453-2830; s, hema/0000-0002-3440-9475; Rubio, Miguel A./0000-0002-0495-6240; donfrancesco, chiara/0000-0002-8040-5571; Bladbjerg, Else Marie/0000-0003-0912-2437; Stehouwer, Coen/0000-0001-8752-3223	CSIR (Council for Scientific and Industrial Research) through IGIB (Institute of Genomics and Integrative Biology)	CSIR (Council for Scientific and Industrial Research) through IGIB (Institute of Genomics and Integrative Biology)	CSIR (Council for Scientific and Industrial Research) funding through IGIB (Institute of Genomics and Integrative Biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benita Y, 2006, MOL CELL PROTEOMICS, V5, P1567, DOI 10.1074/mcp.M600140-MCP200; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cornelis P, 2000, CURR OPIN BIOTECH, V11, P450, DOI 10.1016/S0958-1669(00)00131-2; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Friedmann HC, 2004, PERSPECT BIOL MED, V47, P47, DOI 10.1353/pbm.2004.0007; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Goh CS, 2004, J MOL BIOL, V336, P115, DOI 10.1016/j.jmb.2003.11.053; Hirose S, 2011, J BIOCHEM, V150, P73, DOI 10.1093/jb/mvr042; Idicula-Thomas S, 2006, BIOINFORMATICS, V22, P278, DOI 10.1093/bioinformatics/bti810; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koschorreck M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-49; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504; Makanae K, 2013, GENOME RES, V23, P300, DOI 10.1101/gr.146662.112; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Smialowski P, 2007, BIOINFORMATICS, V23, P2536, DOI 10.1093/bioinformatics/btl623; Soo VWC, 2011, P NATL ACAD SCI USA, V108, P1484, DOI 10.1073/pnas.1012108108; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	37	202	208	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2013	8	5							e64893	10.1371/journal.pone.0064893	http://dx.doi.org/10.1371/journal.pone.0064893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155DJ	23734225	Green Published, gold, Green Submitted			2022-12-27	WOS:000319725500041
J	Kim, J; Kim, G; An, S; Kwon, YK; Yoon, S				Kim, Jinkyu; Kim, Gunn; An, Sungbae; Kwon, Young-Kyun; Yoon, Sungroh			Entropy-Based Analysis and Bioinformatics-Inspired Integration of Global Economic Information Transfer	PLOS ONE			English	Article							FALSE DISCOVERY RATE; TIME-SERIES; STOCK-MARKET; NETWORK; MODEL; COINTEGRATION; RETURNS; GENES; FLOW	The assessment of information transfer in the global economic network helps to understand the current environment and the outlook of an economy. Most approaches on global networks extract information transfer based mainly on a single variable. This paper establishes an entirely new bioinformatics-inspired approach to integrating information transfer derived from multiple variables and develops an international economic network accordingly. In the proposed methodology, we first construct the transfer entropies (TEs) between various intra- and inter-country pairs of economic time series variables, test their significances, and then use a weighted sum approach to aggregate information captured in each TE. Through a simulation study, the new method is shown to deliver better information integration compared to existing integration methods in that it can be applied even when intra-country variables are correlated. Empirical investigation with the real world data reveals that Western countries are more influential in the global economic network and that Japan has become less influential following the Asian currency crisis.	[Kim, Jinkyu; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Kim, Gunn] Sejong Univ, Dept Phys, Seoul, South Korea; [An, Sungbae] Singapore Management Univ, Sch Econ, Singapore, Singapore; [Kwon, Young-Kyun] Kyung Hee Univ, Dept Phys, Seoul, South Korea; [Kwon, Young-Kyun] Kyung Hee Univ, Res Inst Basic Sci, Seoul, South Korea	Seoul National University (SNU); Sejong University; Singapore Management University; Kyung Hee University; Kyung Hee University	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@snu.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0009963, 2012R1A2A4A01008475]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (Grant No. 2011-0009963 to SY and Grant No. 2012R1A2A4A01008475 to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MACR DAT EM DEV MARK; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchard O., 1989, LECT MACROECONOMICS; Box G., 1970, TIME SERIES ANAL; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CARLSTEIN E, 1986, ANN STAT, V14, P1171, DOI 10.1214/aos/1176350057; Corsetti G, 1999, JPN WORLD ECON, V11, P305, DOI 10.1016/S0922-1425(99)00019-5; Dees S, 2007, J APPL ECONOMET, V22, P1, DOI 10.1002/jae.932; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freeman C, 1987, TECHNOLOGY POLICY EC; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Granger CWJ, 2004, AM ECON REV, V94, P421, DOI 10.1257/0002828041464669; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Kim K, 2004, PHYSICA A, V344, P272, DOI 10.1016/j.physa.2004.06.131; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kwon O, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/68003; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Matia K, 2003, EUROPHYS LETT, V61, P422, DOI 10.1209/epl/i2003-00194-y; McCauley JL, 2003, PHYSICA A, V329, P178, DOI 10.1016/S0378-4371(03)00589-2; Park JB, 2007, PHYSICA A, V379, P179, DOI 10.1016/j.physa.2006.12.042; Peter FJ, 2011, THESIS EBERHARD KARL; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Silva AC, 2004, PHYSICA A, V344, P227, DOI 10.1016/j.physa.2004.06.122; Stanley HE, 2001, PHYSICA A, V299, P1, DOI 10.1016/S0378-4371(01)00351-X; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Thurow L., 1993, HEAD HEAD COMING EC; Vincente R, 2011, J COMPUT NEUROSCI, V30, P45; Vogel E. F., 1979, JAPAN NUMBER ONE LES; Yang JS, 2006, PHYSICA A, V363, P377, DOI 10.1016/j.physa.2005.12.039; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835	37	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2013	8	1							e51986	10.1371/journal.pone.0051986	http://dx.doi.org/10.1371/journal.pone.0051986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067UP	23922872	Green Published, Green Submitted, gold			2022-12-27	WOS:000313320900015
J	Kim, JE; Ryu, HJ; Kang, TC				Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon			Status Epilepticus Induces Vasogenic Edema via Tumor Necrosis Factor-alpha/Endothelin-1-Mediated Two Different Pathways	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RAT PIRIFORM CORTEX; NADPH-OXIDASE; FACTOR-ALPHA; KAINIC ACID; NITRIC-OXIDE; RECEPTOR; PERMEABILITY; ENDOTHELIN; SEIZURE	Status epilepticus (SE) induces vasogenic edema in the piriform cortex with disruptions of the blood-brain barrier (BBB). However, the mechanisms of vasogenic edema formation following SE are still unknown. Here we investigated the endothelin B (ETB) receptor-mediated pathway of SE-induced vasogenic edema. Following SE, the release of tumor necrosis factor-alpha (TNF-alpha) stimulated endothelin-1 (ET-1) release and expression in neurons and endothelial cells. In addition, TNF-a-induced ET-1 increased BBB permeability via ETB receptor-mediated endothelial nitric oxide synthase (eNOS) activation in endothelial cells. ETB receptor activation also increased intracellular reactive oxygen species by NADPH oxidase production in astrocytes. These findings suggest that SE results in BBB dysfunctions via endothelial-astroglial interactions through the TNF-alpha-ET-1-eNOS/ NADPH oxidase pathway, and that these ETB receptor-mediated interactions may be an effective therapeutic strategy for vasogenic edema in various neurological diseases.	[Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea; [Kim, Ji-Eun; Ryu, Hea Jin; Kang, Tae-Cheon] Hallym Univ, Coll Med, Inst Epilepsy Res, Chunchon, Kangwon Do, South Korea	Hallym University; Hallym University	Kang, TC (corresponding author), Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chunchon, Kangwon Do, South Korea.	tckang@hallym.ac.kr	Kwon, Young-Kyun/G-1833-2011; AN, Sungbae/D-1416-2009	Kwon, Young-Kyun/0000-0001-6027-8408; Kim, Joonyup/0000-0002-9950-6663; Binder, Brad/0000-0002-8172-2034; Dotson, Bradley/0000-0002-1003-3733	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A111313]; National Research Foundation of Korea [2012R1A2A1A01001775]; Korean government	Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by grants from the Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (Grant number A111313) and the National Research Foundation of Korea (MEST No. 2012R1A2A1A01001775), funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BD, 1989, J INVEST DERMATOL, V93, P280, DOI 10.1111/1523-1747.ep12277592; BEDI KS, 1991, J COMP NEUROL, V311, P425, DOI 10.1002/cne.903110311; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Davenport AP, 2004, J CARDIOVASC PHARM, V44, pS276, DOI 10.1097/01.fjc.0000166284.08657.64; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Kang TC, 2006, GLIA, V54, P258, DOI 10.1002/glia.20380; Kim JE, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-6; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kleeberg J, 2004, AM J PHYSIOL-HEART C, V286, pH1339, DOI 10.1152/ajpheart.00227.2003; Lampl Y, 1997, STROKE, V28, P1951, DOI 10.1161/01.STR.28.10.1951; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Lv S, 2010, LIVER INT, V30, P1198, DOI 10.1111/j.1478-3231.2010.02211.x; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; McCann SK, 2008, J NEUROSCI RES, V86, P2524, DOI 10.1002/jnr.21700; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; NITSCH C, 1985, J NEUROL SCI, V67, P67, DOI 10.1016/0022-510X(85)90023-1; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ryu HJ, 2010, NEUROSCIENCE, V170, P711, DOI 10.1016/j.neuroscience.2010.07.048; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Sheen SH, 2011, BRAIN RES, V1369, P173, DOI 10.1016/j.brainres.2010.10.080; Skopal J, 1998, J CARDIOVASC PHARM, V31, pS370, DOI 10.1097/00005344-199800001-00104; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Tack I, 1997, AM J PHYSIOL-RENAL, V272, pF31, DOI 10.1152/ajprenal.1997.272.1.F31; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375	47	191	195	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2013	8	9							e74458	10.1371/journal.pone.0074458	http://dx.doi.org/10.1371/journal.pone.0074458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219CG	23922872	Green Submitted, gold, Green Published			2022-12-27	WOS:000324481600131
